"","AU","TI","SO","JI","AB","DE","ID","LA","DT","DT2","TC","CR","C1","DI","PA","AR","BE","FU","FX","BN","SN","PN","PP","PU","VL","PY","UT","NR","SC","U2","WC","EM","SE","GA","BO","RP","DB","AU_UN","AU1_UN","AU_UN_NR","SR_FULL","SR"
"CAI YC, 2018, ACTA TROP","CAI YC;WU F;HU W;CHEN J;CHEN SH;XU B;LU Y;AI L;YANG CL;ZHAO S","MOLECULAR CHARACTERIZATION OF BABESIA MICROTI SEROREACTIVE ANTIGEN 5-1-1 AND DEVELOPMENT OF RAPID DETECTION METHODS FOR ANTI-B. MICROTI ANTIBODIES IN SERUM","ACTA TROPICA","ACTA TROP.","BABESIOSIS HAS BECOME A NEW GLOBAL THREAT IMPACTING HUMAN HEALTH, AND MOST HUMAN BABESIOSIS CASES ARE CAUSED BY BABESIA MICROTI. UNTIL NOW FEW ANTIGENS OF B. MICROTI HAVE BEEN DESCRIBED WHICH CAN BE USED FOR THE DIAGNOSIS OF HUMAN BABESIOSIS. IN THE PRESENT STUDY, WE REPORT ON THE BIOINFORMATIC ANALYSIS, CLONING AND EXPRESSION OF THE SEQUENCE ENCODING THE B. MICROTI SEROREACTIVE ANTIGEN 5-1-1 TO INVESTIGATE ITS POTENTIAL INCORPORATION IN SEROLOGIC DIAGNOSTIC TOOLS FOR BABESIOSIS. BIOINFORMATIC ANALYSIS AND RECOMBINANT GENE EXPRESSION WERE PERFORMED TO MOLECULARLY CHARACTERIZE SEROREACTIVE ANTIGEN 5-1-1. ENHANCED CHEMILUMINESCENCE (ECL)-WESTERN BLOT METHODS WERE USED TO DETECT SPECIFIC ANTIBODIES IN INFECTED MICE. IMMUNOFLUORESCENCE ANTIBODY ASSAYS (IFA) WERE PERFORMED TO DETECT THE LOCALIZATION OF BMSA5-1-1 IN B. MICROTI PARASITES. ELISA AND IMMUNOCHROMATOGRAPHIC (ICT) TESTS WERE DEVELOPED USING RECOMBINANT BMSA5-1-1 TO EVALUATE ITS POTENTIAL USE IN RAPID DETECTION METHODS FOR B. MICROTI ANTIBODIES AND FOR THE DIAGNOSIS OF BABESIOSIS. A RECOMBINANT EXPRESSION PLASMID WAS CONSTRUCTED BY INSERTING THE TARGET GENE FRAGMENT IN THE PET28A VECTOR AFTER DOUBLE DIGESTION WITH BAMHI AND XHOL RESTRICTION ENZYMES. THE RECOMBINANT BMSA5-1-1 PROTEIN WAS EXPRESSED IN ESCHERICHIA COLI (RBMSA5-1-1) AND PURIFIED BY MEANS OF NI-NITRILOTRIACETIC ACID (NTA) AGAROSE COLUMNS. POLYCLONAL ANTIBODIES WERE GENERATED AGAINST RBMSA5-1-1. BASED ON INDIRECT IMMUNOFLUORESCENCE ASSAY RESULTS, BMSA5-1-1 APPEARED TO LOCALIZE ON THE SURFACE OF B. MICROTI. ELISA TESTS USING THE RBMSA5-1-1 ANTIGEN DETECTED SPECIFIC ANTIBODIES FROM INFECTED MICE AS EARLY AS 4 DAYS POST-INFECTION. OUR RESULTS INDICATE THAT THE TWO METHODS WE DEVELOPED CAN DETECT SPECIFIC ANTIBODIES IN MICE AT DIFFERENT STAGES OF INFECTION WITH SENSITIVITIES OF 100\% (RBMSA5-1-1 ELISA) AND 90\% (ICT). THE SPECIFICITY OF THE TWO METHODS WAS 100\%. SERA OF PATIENTS SUFFERING FROM OTHER CLOSELY RELATED PARASITIC DISEASES, SUCH AS MALARIA AND TOXOPLASMOSIS, PRODUCED NEGATIVE RESULTS. IN CONCLUSION, SEROREACTIVE ANTIGEN 5-1-1, A MEMBER OF THE BMN1 PROTEIN FAMILY, IS EXPRESSED ON THE OUTER SURFACE OF B. MICROTI AND IS A PROMISING CANDIDATE ANTIGEN FOR THE EARLY DIAGNOSIS OF BABESIOSIS. RBMSA5-1-1 ELISA AND ICT METHODS SHOW GOOD POTENTIAL FOR DETECTING SPECIFIC ANTIBODIES IN MICE AT DIFFERENT STAGES OF INFECTION.","HUMAN BABESIOSIS; BABESIA MICROTI; SEROREACTIVE ANTIGEN 5-1-1; LOCALIZATION; DIAGNOSIS","LINKED-IMMUNOSORBENT-ASSAY; VENATORUM INFECTION; LYME BORRELIOSIS; CHINA; DISEASE; EUROPE; ANAPLASMOSIS; EMERGENCE; ORGANISM; PROTEIN","ENGLISH","ARTICLE","ARTICLE",0,"AKOOLO L, 2017, BMC MICROBIOL, V17, DOI 10.1186/S12866-017-0929-2.;BRASSEUR P, 1992, MEM I OSWALDO CRUZ, V87, P131, DOI 10.1590/S0074-02761992000700019.;BUSH JB, 1990, S AFR MED J, V78, P699.;CAMACHO AT, 2002, ENFERM INFEC MICR CL, V20, P417.;CUSHING M, 2012, TRANSFUSION, V52, P1404, DOI 10.1111/J.1537-2995.2012.03746.X.;EL-BAHNASAWY MAMDOUH M., 2011, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V41, P99.;FOPPA IM, 2002, EMERG INFECT DIS, V8, P722, DOI 10.3201/EID0807.010459.;FOX LAM, 2006, PEDIATR INFECT DIS J, V25, P169, DOI 10.1097/01.INF.0000195438.09628.B0.;GORENFLOT A, 1998, ANN TROP MED PARASIT, V92, P489, DOI 10.1080/00034989859465.;GRAY J, 2010, TICKS TICK-BORNE DIS, V1, P3, DOI 10.1016/J.TTBDIS.2009.11.003.;HEFLE SL, 1994, J FOOD PROTECT, V57, P419, DOI 10.4315/0362-028X-57.5.419.;HERWALDT BL, 1996, ANN INTERN MED, V124, P643, DOI 10.7326/0003-4819-124-7-199604010-00004.;HILDEBRANDT A, 2013, INFECTION, V41, P1057, DOI 10.1007/S15010-013-0526-8.;HOEY J. G., 2008, PATENT NO. [US 20130177941, 20130177941].;HOMER MJ, 2000, CLIN MICROBIOL REV, V13, P451, DOI 10.1128/CMR.13.3.451-469.2000.;HUNFELD KP, 2008, INT J PARASITOL, V38, P1219, DOI 10.1016/J.IJPARA.2008.03.001.;HUNFELD KP, 2002, WIEN KLIN WOCHENSCHR, V114, P580.;JAHFARI S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/JOURNAL.PNTD.0005042.;JIANG JF, 2015, LANCET INFECT DIS, V15, P196, DOI 10.1016/S1473-3099(14)71046-1.;KIM JY, 2007, J CLIN MICROBIOL, V45, P2084, DOI 10.1128/JCM.01334-06.;KRAUSE PJ, 2000, NEW ENGL J MED, V343, P1454, DOI 10.1056/NEJM200011163432004.;LEMPEREUR L, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/J.CMI.2014.07.004.;LEVIN AE, 2016, CURR OPIN HEMATOL, V23, P573, DOI 10.1097/MOH.0000000000000287.;LODES MJ, 2000, INFECT IMMUN, V68, P2783, DOI 10.1128/IAI.68.5.2783-2790.2000.;LUO YZ, 2012, EXP PARASITOL, V130, P178, DOI 10.1016/J.EXPPARA.2011.10.012.;LUO YZ, 2011, PARASITOL INT, V60, P119, DOI 10.1016/J.PARINT.2010.11.001.;MAGNARELLI LA, 1998, J INFECT DIS, V178, P1835, DOI 10.1086/314516.;MAN SQ, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/S40249-016-0121-1.;MAYNE PJ, 2015, INT J GEN MED, V8, P15, DOI 10.2147/IJGM.S75825.;OOKA H, 2012, J PARASITOL, V98, P1045, DOI 10.1645/GE-2999.1.;OOKA H, 2011, EXP PARASITOL, V127, P287, DOI 10.1016/J.EXPPARA.2010.06.018.;PERSING DH, 1995, NEW ENGL J MED, V332, P298, DOI 10.1056/NEJM199502023320504.;PRIEST JW, 2012, CLIN VACCINE IMMUNOL, V19, P1539, DOI 10.1128/CVI.00313-12.;QI CH, 2011, PARASITOL RES, V109, P241, DOI 10.1007/S00436-011-2382-8.;QUICK RE, 1993, ANN INTERN MED, V119, P284, DOI 10.7326/0003-4819-119-4-199308150-00006.;SENANAYAKE SN, 2012, MED J AUSTRALIA, V196, P350, DOI 10.5694/MJA11.11378.;SHIH CM, 1997, J CLIN MICROBIOL, V35, P450.;SILVA JC, 2016, SCI REP-UK, V6, DOI 10.1038/SREP35284.;SKRABALO Z., 1957, DOCUMENTA DE MEDICINA GEOGRAPHICA ET TROPICA, V9, P11.;SOCOLOVSCHI C, 2008, MED TROP (MARS), V68, P119.;SUN Y, 2014, EMERG INFECT DIS, V20, P896, DOI [10.3201/EID2005/121034, 10.3201/EID2005.121034].;VANNIER E, 2008, INFECT DIS CLIN N AM, V22, P469, DOI 10.1016/J.IDC.2008.03.010.;VANNIER E, 2012, NEW ENGL J MED, V366, P2397, DOI 10.1056/NEJMRA1202018.;WITTNER M, 1982, ANN INTERN MED, V96, P601, DOI 10.7326/0003-4819-96-5-601.;WORMSER GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667.;WORMSER GP, 2015, AM J CLIN PATHOL, V144, P94, DOI 10.1309/AJCP2PHH4HBVHZFS.;YAO LINONG, 2012, CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, V30, P118.;YOSHINARI NH, 2003, MEM I OSWALDO CRUZ, V98, P311, DOI 10.1590/S0074-02762003000300004.;ZHANG J., 2014, CHIN J ZOONOSES, V472, P478.;ZHOU X, 2015, PARASITE VECTOR, V8, DOI 10.1186/S13071-015-0978-Z.;ZHOU X, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/EMI.2014.55.","ZHAO, SM (REPRINT AUTHOR), FUDAN UNIV, SCH LIFE SCI, SHANGHAI 200433, PEOPLES R CHINA.;CAI, YU CHUN, HU, WEI, ZHAO, SHIMIN, FUDAN UNIV, SCH LIFE SCI, SHANGHAI 200433, PEOPLES R CHINA.;CAI, YU CHUN, WU, FEN, HU, WEI, CHEN, JIAXU, CHEN, SHAO HONG, XU, BIN, LU, YAN, AI, LIN, YANG, CHUN LI, CHINESE CTR DIS CONTROL \& PREVENT, NATL INST PARASIT DIS, BEIJING, PEOPLES R CHINA.;CAI, YU CHUN, WU, FEN, HU, WEI, CHEN, JIAXU, CHEN, SHAO HONG, XU, BIN, LU, YAN, AI, LIN, YANG, CHUN LI, MINIST PUBL HLTH, LAB PARASITE \& VECTOR BIOL, BEIJING, PEOPLES R CHINA.;CAI, YU CHUN, WU, FEN, HU, WEI, CHEN, JIAXU, CHEN, SHAO HONG, XU, BIN, LU, YAN, AI, LIN, YANG, CHUN LI, MINIST SCI \& TECHNOL, NATL CTR INT RES TROP DIS, WHO COLLABORATING CTR TROP DIS, SHANGHAI 200025, PEOPLES R CHINA.","10.1016/J.ACTATROPICA.2018.03.020","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"SHANGHAI MUNICIPAL COMMISSION OF HEALTH AND FAMILY PLANNING [20154Y0155], NATIONAL S \& T MAJOR PROGRAM [2012ZX10004-220], TROPICAL DISEASES RESOURCE CENTER PROJECT OF THE NATIONAL SCIENCE AND TECHNOLOGY BASIC CONDITIONS PLATFORM PROGRAM, SPECIAL FUND FOR HEALTH RESEARCH IN THE PUBLIC INTEREST [201202019], NATIONAL KEY RESEARCH AND DEVELOPMENT PROGRAM OF CHINA [2016YFC1202000, 2016YFC1202005]","THIS WORK WAS SUPPORTED BY THE YOUTH FUND OF THE SHANGHAI MUNICIPAL COMMISSION OF HEALTH AND FAMILY PLANNING (20154Y0155), THE NATIONAL S \& T MAJOR PROGRAM (GRANT NO. 2012ZX10004-220), THE TROPICAL DISEASES RESOURCE CENTER PROJECT OF THE NATIONAL SCIENCE AND TECHNOLOGY BASIC CONDITIONS PLATFORM PROGRAM, THE SPECIAL FUND FOR HEALTH RESEARCH IN THE PUBLIC INTEREST (GRANT NO 201202019), AND THE NATIONAL KEY RESEARCH AND DEVELOPMENT PROGRAM OF CHINA (NO. 2016YFC1202000, 2016YFC1202005).",NA,"0001-706X",NA,"371-379","ELSEVIER SCIENCE BV","185",2018,"ISI000440126000051","51","PARASITOLOGY, TROPICAL MEDICINE","5","PARASITOLOGY, TROPICAL MEDICINE","CYUCHUN126.COM WUFEN0730163.COM HUWFUDAN.EDU.CN CHENJIAXU1962163.COM CHENSH637163.COM XUBIN677HOTMAIL.COM LYYANER163.COM AILEEN-252120016QQ.COM CHUNLIYANG2014163.COM ZHAOSMFUDAN.EDU.CN",NA,"GO6ED",NA,"ZHAO, SM (REPRINT AUTHOR), FUDAN UNIV, SCH LIFE SCI, SHANGHAI 200433, PEOPLES R CHINA","ISI","FUDAN UNIV;NATL INST PARASIT DIS;LAB PARASITE AND VECTOR BIOL;WHO COLLABORATING CTR TROP DIS","FUDAN UNIV",NA,"CAI YC, 2018, ACTA TROP","CAI YC, 2018, ACTA TROP"
"GOODSWEN SJ, 2018, FRONT GENET","GOODSWEN SJ;KENNEDY PJ;ELLIS JT","A GENE-BASED POSITIVE SELECTION DETECTION APPROACH TO IDENTIFY VACCINE CANDIDATES USING TOXOPLASMA GONDII AS A TEST CASE PROTOZOAN PATHOGEN","FRONTIERS IN GENETICS","FRONT. GENET.","OVER THE LAST TWO DECADES, VARIOUS IN SILICO APPROACHES HAVE BEEN DEVELOPED AND REFINED THAT ATTEMPT TO IDENTIFY PROTEIN AND/OR PEPTIDE VACCINES CANDIDATES FROM INFORMATIVE SIGNALS ENCODED IN PROTEIN SEQUENCES OF A TARGET PATHOGEN. AS TO DATE, NO SIGNAL HAS BEEN IDENTIFIED THAT CLEARLY INDICATES A PROTEIN WILL EFFECTIVELY CONTRIBUTE TO A PROTECTIVE IMMUNE RESPONSE IN A HOST. THE PREMISE FOR THIS STUDY IS THAT PROTEINS UNDER POSITIVE SELECTION FROM THE IMMUNE SYSTEM ARE MORE LIKELY SUITABLE VACCINE CANDIDATES THAN PROTEINS EXPOSED TO OTHER SELECTION PRESSURES. FURTHERMORE, OUR EXPECTATION IS THAT PROTEIN SEQUENCE REGIONS ENCODING MAJOR HISTOCOMPATIBILITY COMPLEXES (MHC) BINDING PEPTIDES WILL CONTAIN CONSECUTIVE POSITIVE SELECTION SITES. USING FREELY AVAILABLE DATA AND BIOINFORMATIC TOOLS, WE PRESENT A HIGH-THROUGHPUT APPROACH THROUGH A PIPELINE THAT PREDICTS POSITIVE SELECTION SITES, PROTEIN SUBCELLULAR LOCATIONS, AND SEQUENCE LOCATIONS OF MEDIUM TO HIGH T-CELL MHC CLASS I BINDING PEPTIDES. POSITIVE SELECTION SITES ARE ESTIMATED FROM A SEQUENCE ALIGNMENT BY COMPARING RATES OF SYNONYMOUS (DS) AND NON-SYNONYMOUS (DN) SUBSTITUTIONS AMONG PROTEIN CODING SEQUENCES OF ORTHOLOGOUS GENES IN A PHYLOGENY. THE MAIN PIPELINE OUTPUT IS A LIST OF PROTEIN VACCINE CANDIDATES PREDICTED TO BE NATURALLY EXPOSED TO THE IMMUNE SYSTEM AND CONTAINING SITES UNDER POSITIVE SELECTION. CANDIDATES ARE RANKED WITH RESPECT TO THE NUMBER OF CONSECUTIVE SITES LOCATED ON PROTEIN SEQUENCE REGIONS ENCODING MHCI-BINDING PEPTIDES. RESULTS ARE CONSTRAINED BY THE RELIABILITY OF PREDICTION PROGRAMS AND QUALITY OF INPUT DATA. PROTEIN SEQUENCES FROM TOXOPLASMA GONDII ME49 STRAIN (TGME49) WERE USED AS A CASE STUDY. SURFACE ANTIGEN (SAG), DENSE GRANULES (GRA), MICRONEME (MIC), AND RHOPTRY (ROP) PROTEINS ARE CONSIDERED WORTHY T. GONDII CANDIDATES. GIVEN 8263 TGME49 PROTEIN SEQUENCES PROCESSED ANONYMOUSLY, THE TOP 10 PREDICTED CANDIDATES WERE ALL WORTHY CANDIDATES. IN PARTICULAR, THE TOP TEN INCLUDED ROP5 AND ROP18, WHICH ARE T GONDII VIRULENCE DETERMINANTS. THE CHANCE OF RANDOMLY SELECTING A ROP PROTEIN WAS 0.2\% GIVEN 8263 SEQUENCES. WE CONCLUDE THAT THE APPROACH DESCRIBED IS A VALUABLE ADDITION TO OTHER IN SILICO APPROACHES TO IDENTIFY VACCINES CANDIDATES WORTHY OF LABORATORY VALIDATION AND COULD BE ADAPTED FOR OTHER APICOMPLEXAN PARASITE SPECIES (WITH APPROPRIATE DATA).","TOXOPLASMA GONDII; HAMMONDIA HAMMONDI; NEOSPORA CANINUM; REVERSE VACCINOLOGY; VACCINE DISCOVERY; POSITIVE SELECTION","REVERSE-VACCINOLOGY; NATURAL-SELECTION; PHYLOGENETIC ANALYSIS; PROTECTIVE IMMUNITY; NEOSPORA-CANINUM; MAXIMUM-LIKELIHOOD; HAMMONDIA-HAMMONDI; DNA VACCINATION; GENOMIC DATA; BALB/C MICE","ENGLISH","ARTICLE","ARTICLE",0,"AURRECOECHEA C, 2010, NUCLEIC ACIDS RES, V38, PD415, DOI 10.1093/NAR/GKP941.;BARRATT JLN, 2010, CLIN MICROBIOL REV, V23, P795, DOI 10.1128/CMR.00001-10.;BARRY AE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/FIMMU.2014.00359.;BEHNKE MS, 2015, PLOS GENET, V11, DOI 10.1371/JOURNAL.PGEN.1005434.;BIGHAM AW, 2018, HUM GENET, V137, P151, DOI 10.1007/S00439-018-1866-3.;BJERKAS I, 1991, ACTA VET SCAND, V32, P407.;BONTELL IL, 2009, GENOME BIOL, V10, DOI 10.1186/GB-2009-10-5-R53.;BOWMAN BN, 2011, VACCINE, V29, P8156, DOI 10.1016/J.VACCINE.2011.07.142.;BROWN AHD, 1970, GENETICA, V41, P399, DOI 10.1007/BF00958921.;CAMACHO C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421.;CHE F.-Y., 2010, MOL CELL PROTEOMICS, V10.;CHEN J, 2015, EXPERT REV VACCINES, V14, P617, DOI 10.1586/14760584.2015.1011133.;CHEN ZQ, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0003611.;CONG H, 2011, VACCINE, V29, P754, DOI 10.1016/J.VACCINE.2010.11.015.;CRAVER MPJ, 2007, MOL BIOCHEM PARASIT, V153, P149, DOI 10.1016/J.MOLBIOPARA.2007.02.013.;DAVIES MN, 2007, DRUG DISCOV TODAY, V12, P389, DOI 10.1016/J.DRUDIS.2007.03.010.;DENKERS EY, 1998, CLIN MICROBIOL REV, V11, P569.;DLUGONSKA H, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/632424.;DONATI C, 2013, ANN NY ACAD SCI, V1285, P115, DOI 10.1111/NYAS.12046.;DOOLAN DL, 2011, INT J PARASITOL, V41, P3, DOI 10.1016/J.IJPARA.2010.08.002.;DOYTCHINOVA IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4.;DUBEY JP, 2002, TRENDS PARASITOL, V18, P66, DOI 10.1016/S1471-4922(01)02172-9.;DZIADEK B, 2012, EXP PARASITOL, V131, P133, DOI 10.1016/J.EXPPARA.2012.02.026.;ELSHEIKHA HM, 2004, PARASITOL RES, V94, P452, DOI 10.1007/S00436-004-1237-Y.;EMANUELSSON O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/NPROT.2007.131.;FLOWER DARREN R, 2010, IMMUNOME RES, V6 SUPPL 2, PS1, DOI 10.1186/1745-7580-6-S2-S1.;FUMAGALLI M, 2011, PLOS GENET, V7, DOI 10.1371/JOURNAL.PGEN.1002355.;GARZON-OSPINA D, 2018, FRONT GENET, V9, DOI 10.3389/FGENE.2018.00010.;GOODSWEN SJ, 2014, BIOINFORMATICS, V30, P2381, DOI 10.1093/BIOINFORMATICS/BTU300.;GOODSWEN SJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-315.;GRZYBEK M, 2015, PARASITOL RES, V114, P523, DOI 10.1007/S00436-014-4214-0.;HANADA K, 2004, NATURE, V427, P252, DOI 10.1038/NATURE02240.;HARRIS EE, 2006, YEARB PHYS ANTHROPOL, V49, P89, DOI 10.1002/AJPA.20518.;HEHL AB, 2015, BMC GENOMICS, V16, DOI 10.1186/S12864-015-1225-X.;HORTON P, 2007, NUCLEIC ACIDS RES, V35, PW585, DOI 10.1093/NAR/GKM259.;HUGHES AL, 1991, GENETICS, V127, P345.;INNES EA, 2002, TRENDS PARASITOL, V18, P497, DOI 10.1016/S1471-4922(02)02372-3.;JEFFARES D., 2015, PARASITE GENOMICS PR, V1201.;JENKINS MC, 1999, PARASITOLOGY, V119, P135, DOI 10.1017/S0031182099004618.;JIN WF, 2012, GENOME RES, V22, P519, DOI 10.1101/GR.124784.111.;JONES D, 2012, NAT REV DRUG DISCOV, V11, P175, DOI 10.1038/NRD3679.;KALL L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/J.JMB.2004.03.016.;KAPLAN NL, 1989, GENETICS, V123, P887.;KIM K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/J.IJPARA.2003.12.009.;KIM SK, 2007, INFECT IMMUN, V75, P1626, DOI 10.1128/IAI.01862-06.;KIM Y, 2012, NUCLEIC ACIDS RES, V40, PW525, DOI 10.1093/NAR/GKS438.;KORBER B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/JOURNAL.PCBI.0020071.;KROGH A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/JMBI.2000.4315.;KRYAZHIMSKIY S, 2008, PLOS GENET, V4, DOI 10.1371/JOURNAL.PGEN.1000304.;KUO CH, 2008, MOL BIOL EVOL, V25, P2689, DOI 10.1093/MOLBEV/MSN213.;KUR J, 2009, EXPERT REV VACCINES, V8, P791, DOI 10.1586/ERV.09.27.;LI L, 2003, GENOME RES, V13, P2178, DOI 10.1101/GR.1224503.;MACHUGH ND, 2011, INFECT IMMUN, V79, P2059, DOI 10.1128/IAI.01285-10.;MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652A0.;MENG M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-494.;MONTIGIANI S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002.;MONTOYA JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X.;MORENO-HAGELSIEB G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/BIOINFORMATICS/BTM585.;MORRISON DA, 2009, TRENDS PARASITOL, V25, P375, DOI 10.1016/J.PT.2009.05.010.;NYGAARD S, 2010, PLOS GENET, V6, DOI 10.1371/JOURNAL.PGEN.1001099.;OBARA I, 2016, IMMUNOGENETICS, V68, P339, DOI 10.1007/S00251-016-0902-5.;OLEKSYK TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/RSTB.2009.0219.;OPREA M, 2013, BIOLOGICALS, V41, P148, DOI 10.1016/J.BIOLOGICALS.2013.03.001.;PACHECO MA, 2012, INFECT GENET EVOL, V12, P978, DOI 10.1016/J.MEEGID.2012.02.009.;PARTHASARATHY S, 2013, AM J TROP MED HYG, V88, P883, DOI 10.4269/AJTMH.12-0727.;PETERSEN TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/NMETH.1701.;PIZZA M, 2000, SCIENCE, V287, P1816, DOI 10.1126/SCIENCE.287.5459.1816.;QU DF, 2013, PARASITOL RES, V112, P2593, DOI 10.1007/S00436-013-3425-0.;RAPPUOLI R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3.;RAPPUOLI R, 2016, J EXP MED, V213, P469, DOI 10.1084/JEM.20151960.;ROOS D. S., 1999, NOVART FDN SYMP, V226, P195.;ROOS DAVID S., 1999, NOVARTIS FOUNDATION SYMPOSIUM, V226, P176.;ROSENBERG C, 2009, VACCINE, V27, P2489, DOI 10.1016/J.VACCINE.2009.02.058.;ROSS BC, 2001, VACCINE, V19, P4135, DOI 10.1016/S0264-410X(01)00173-6.;SALICHOS L, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0018755.;SIEVERS F, 2011, MOL SYST BIOL, V7, DOI 10.1038/MSB.2011.75.;SONG PX, 2017, BMC INFECT DIS, V17, DOI 10.1186/S12879-016-2147-1.;STAMATAKIS A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/BIOINFORMATICS/BTU033.;SU CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/PNAS.1203190109.;SUYAMA M, 2006, NUCLEIC ACIDS RES, V34, PW609, DOI 10.1093/NAR/GKL315.;TAJIMA F, 1989, GENETICS, V123, P585.;TAYLOR S, 2006, SCIENCE, V314, P1776, DOI 10.1126/SCIENCE.1133643.;THILTGEN G, 2017, J MOL EVOL, V84, P39, DOI 10.1007/S00239-016-9765-5.;VITTI JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/ANNUREV-GENET-111212-133526.;WALZER KA, 2013, P NATL ACAD SCI USA, V110, P7446, DOI 10.1073/PNAS.1304322110.;WASMUTH JD, 2012, MBIO, V3, DOI 10.1128/MBIO.00321-12.;WILLIAMS DJL, 2006, PARASITE IMMUNOL, V28, P61, DOI 10.1111/J.1365-3024.2005.00809.X.;WIZEMANN TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001.;WOLLSTEIN A, 2015, INVESTIG GENET, V6, DOI 10.1186/S13323-015-0023-1.;YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154.;YANG ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/MOLBEV/MSI097.;YANG ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/MOLBEV/MSM088.;ZHANG NZ, 2016, BMC INFECT DIS, V16, DOI 10.1186/S12879-016-1496-0.;ZHANG NZ, 2015, EXPERT REV VACCINES, V14, P1289, DOI 10.1586/14760584.2015.1061938.","ELLIS, JT (REPRINT AUTHOR), UNIV TECHNOL SYDNEY, SCH LIFE SCI, ULTIMO, NSW, AUSTRALIA.;GOODSWEN, STEPHEN J., ELLIS, JOHN T., UNIV TECHNOL SYDNEY, SCH LIFE SCI, ULTIMO, NSW, AUSTRALIA.;KENNEDY, PAUL J., UNIV TECHNOL SYDNEY, CTR ARTIFICIAL INTELLIGENCE, FAC ENGN \& INFORMAT TECHNOL, SCH SOFTWARE, ULTIMO, NSW, AUSTRALIA.","10.3389/FGENE.2018.00332","AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND","332",NA,"FACULTY OF SCIENCE, UNIVERSITY OF TECHNOLOGY SYDNEY","THIS PROJECT WAS FUNDED BY AN INCENTIVE GRANT FROM THE FACULTY OF SCIENCE, UNIVERSITY OF TECHNOLOGY SYDNEY.",NA,"1664-8021",NA,NA,"FRONTIERS MEDIA SA","9",2018,"ISI000442154500001","94","GENETICS \& HEREDITY","2","GENETICS \& HEREDITY","JOHN.ELLISUTS.EDU.AU",NA,"GQ9XN",NA,"ELLIS, JT (REPRINT AUTHOR), UNIV TECHNOL SYDNEY, SCH LIFE SCI, ULTIMO, NSW, AUSTRALIA","ISI","UNIV TECHNOL SYDNEY;UNIV TECHNOL SYDNEY","UNIV TECHNOL SYDNEY",NA,"GOODSWEN SJ, 2018, FRONT GENET","GOODSWEN SJ, 2018, FRONT GENET"
"DOROSHENKO A, 2018, BMC MED","DOROSHENKO A;PEPPERELL CS;HEFFERNAN C;EGEDAHL ML;MORTIMER TD;SMITH TM;BUSSAN HE;TYRRELL GJ;LONG R","EPIDEMIOLOGICAL AND GENOMIC DETERMINANTS OF TUBERCULOSIS OUTBREAKS IN FIRST NATIONS COMMUNITIES IN CANADA","BMC MEDICINE","BMC MED.","BACKGROUND: IN CANADA, TUBERCULOSIS DISPROPORTIONATELY AFFECTS FOREIGN-BORN AND FIRST NATIONS POPULATIONS. WITHIN FIRST NATIONS' PEOPLES, A HIGH PROPORTION OF CASES OCCUR IN ASSOCIATION WITH OUTBREAKS. TUBERCULOSIS TRANSMISSION IN THE CONTEXT OF OUTBREAKS IS THOUGHT TO RESULT FROM THE CONVERGENCE OF SEVERAL FACTORS INCLUDING CHARACTERISTICS OF THE CASES, CONTACTS, THE ENVIRONMENT, AND THE PATHOGEN. METHODS: WE EXAMINED THE EPIDEMIOLOGICAL AND GENOMIC DETERMINANTS OF TWO WELL-CHARACTERIZED TUBERCULOSIS OUTBREAKS ATTRIBUTED TO TWO SUPER-SPREADERS AMONG FIRST NATIONS IN THE PROVINCE OF ALBERTA. THESE OUTBREAKS WERE ASSOCIATED WITH TWO DISTINCT DNA FINGERPRINTS (RESTRICTION FRAGMENT-LENGTH POLYMORPHISMS OR RFLPS 0.0142 AND 0.0728). WE COMPARED OUTBREAK ISOLATES WITH ENDEMIC ISOLATES NOT SPATIO-TEMPORARILY LINKED TO OUTBREAK CASES. WE EXTRACTED EPIDEMIOLOGICAL VARIABLES PERTAINING TO TUBERCULOSIS CASES AND CONTACTS FROM INDIVIDUAL PUBLIC HEALTH RECORDS AND THE PROVINCIAL TUBERCULOSIS REGISTRY. WE CONDUCTED GROUP ANALYSES USING PARAMETRIC AND NON-PARAMETRIC STATISTICAL TESTS. WE CARRIED OUT WHOLE-GENOME SEQUENCING AND BIOINFORMATIC ANALYSIS USING VALIDATED PROTOCOLS. RESULTS: WE OBSERVED DIFFERENCES BETWEEN OUTBREAK AND ENDEMIC GROUPS IN THE MEAN NUMBER OF TOTAL AND CHILD-AGED CONTACTS AND THE NUMBER OF CONTACTS WITH NEW POSITIVE AND CONVERTED TUBERCULIN SKIN TESTS IN ALL GROUP COMPARISONS (P < 0.05). DIFFERENCES WERE ALSO DETECTED IN THE PROPORTION OF CASES WITH CAVITATION ON A CHEST RADIOGRAPH AND THE MEAN NUMBER OF CLOSE CONTACTS IN RELECTED GROUP COMPARISONS (P < 0.02). A PHYLOGENETIC NETWORK ANALYSIS OF WHOLE-GENOME SEQUENCING DATA INDICATED THAT MOST OUTBREAK AND ENDEMIC STRAINS WERE CLOSELY RELATED TO THE SOURCE CASE FOR THE 0.0142 FINGERPRINT. FOR THE 0.0728 FINGERPRINT, THE SOURCE CASE HAPLOTYPE WAS CIRCULATING AMONG ENDEMIC CASES PRIOR TO THE OUTBREAK GENETIC AND TEMPORAL DISTANCES WERE NOT CORRELATED FOR EITHER RFLP 0.0142 (R(2)=- 0.05) OR RFLP 0.0728 (R(2)=0.09) WHEN ALL ISOLATES WERE ANALYZED. CONCLUSIONS: WE FOUND NO EVIDENCE THAT ENDEMIC STRAINS ACQUIRED MUTATIONS RESULTING IN THEIR EMERGENCE IN OUTBREAK FORM. WE CONCLUDE THAT THE PROPAGATION OF THESE OUTBREAKS WAS LIKELY DRIVEN BY THE COMBINATION OF CHARACTERISTICS OF THE SOURCE CASES, CONTACTS, AND THE ENVIRONMENT THE ROLE OF WHOLE-GENOME SEQUENCING IN UNDERSTANDING MYCOBACTERIAL EVOLUTION AND IN ASSISTING PUBLIC HEALTH AUTHORITIES IN CONDUCTING CONTACT INVESTIGATIONS AND MANAGING OUTBREAKS IS IMPORTANT AND EXPECTED TO GROW IN THE FUTURE.","TUBERCULOSIS; OUTBREAK; FIRST NATIONS; WHOLE-GENOME SEQUENCING","MYCOBACTERIUM-TUBERCULOSIS; SEQUENCING DATA; TRANSMISSION; POPULATION; DISCOVERY; VACCINE","ENGLISH","ARTICLE","ARTICLE",0,"ACUNA-VILLAORDUNA C, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01578-2017.;ALBERTA HEALTH, 1992, TUB SERV ANN REP.;BABRAHAM BIOINFOMATICS, TRIM GAL.;BABRAHAM BIOINFORMATICS, FASTQC.;BAYM M, 2015, PLOS ONE, V10.;BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289.;BRYANT JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110.;DEPRISTO MA, 2011, NAT GENET, V43, P491, DOI 10.1038/NG.806.;ELDHOLM V, 2015, NAT COMMUN, V6, DOI 10.1038/NCOMMS8119.;ENVIRONMENT CANADA, HIST CLIM DAT.;GALLANT V, 2017, CAN COMMUN DIS REP, V43.;GARDY JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMOA1003176.;GRZYBOWSKI S, 1957, AM REV TUBERC PULM, V75, P432.;HEALTH CANADA, 1999, TB 1 NAT COMM.;JONES-LOPEZ EC, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0138358.;JUUL S, 2014, INTRO STATA HLTH RES.;LAU A, 2016, PLOS ONE, V11, DOI 10.1371/JOURNAL.PONE.0154032.;LEE RS, 2015, P NATL ACAD SCI USA, V112, P13609, DOI 10.1073/PNAS.1507071112.;LEE RS, 2015, J INFECT DIS, V211, P1905, DOI 10.1093/INFDIS/JIV011.;LEIGH JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410.;LI H., ALIGNING SEQUENCE RE.;LONG R, 2016, INT J TUBERC LUNG D, V20, P1285, DOI 10.5588/IJTLD.16.0447.;LONG R, 2004, CAN J PUBLIC HEALTH, V95, P249.;LONG R, 2013, CAN RESPIR J, V20, P223, DOI 10.1155/2013/429496.;PEPPERELL C, 2010, MOL BIOL EVOL, V27, P427, DOI 10.1093/MOLBEV/MSP261.;PEPPERELL CS, 2011, P NATL ACAD SCI USA, V108, P6526, DOI 10.1073/PNAS.1016708108.;PROVINCE OF ALBERTA, REV STAT ALB 2000.;PUBLIC HEALTH AGENCY OF CANADA, 2012, GUID TUB PREV CONTR.;PUBLIC HEALTH AGENCY OF CANADA AND CANADIAN LUNG ASSOCIATION/CANADIAN THORACIC SOCIETY, 2014, CANADIAN TUBERCULOSI.;ROETZER A, 2013, PLOS MED, V10, DOI 10.1371/JOURNAL.PMED.1001387.;VALWAY SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001.;WALKER TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3.;WEINERT LA, 2015, MOL BIOL EVOL, V32, P1020, DOI 10.1093/MOLBEV/MSU406.;WORLD HEALTH ORGANIZATION, 2017, GLOB TUB REP 2017.;YE K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/BIOINFORMATICS/BTP394.","DOROSHENKO, A (REPRINT AUTHOR), UNIV ALBERTA, FAC MED \& DENT, DIV PREVENT MED, DEPT MED, EDMONTON, AB, CANADA.;DOROSHENKO, A (REPRINT AUTHOR), UNIV ALBERTA, SCH PUBL HLTH, EDMONTON, AB, CANADA.;DOROSHENKO, ALEXANDER, UNIV ALBERTA, FAC MED \& DENT, DIV PREVENT MED, DEPT MED, EDMONTON, AB, CANADA.;DOROSHENKO, ALEXANDER, UNIV ALBERTA, SCH PUBL HLTH, EDMONTON, AB, CANADA.;PEPPERELL, CAITLIN S., MORTIMER, TATUM D., SMITH, TRACY M., BUSSAN, HAILEY E., UNIV WISCONSIN, DEPT MED INFECT DIS, SCH MED \& PUBL HLTH, MADISON, WI USA.;PEPPERELL, CAITLIN S., MORTIMER, TATUM D., SMITH, TRACY M., BUSSAN, HAILEY E., UNIV WISCONSIN, DEPT MED MICROBIOL \& IMMUNOL, SCH MED \& PUBL HLTH, MADISON, WI 53706 USA.;HEFFERNAN, COURTNEY, EGEDAHL, MARY LOU, LONG, RICHARD, UNIV ALBERTA, FAC MED, DEPT MED, EDMONTON, AB, CANADA.;HEFFERNAN, COURTNEY, EGEDAHL, MARY LOU, LONG, RICHARD, UNIV ALBERTA, DENT \& TB PROGRAM EVALUAT \& RES UNIT, EDMONTON, AB, CANADA.;TYRRELL, GREGORY J., UNIV ALBERTA, DEPT LAB MED \& PATHOL, ALBERTA HLTH SERV, PROV LAB PUBL HLTH, EDMONTON, AB, CANADA.","10.1186/S12916-018-1112-9","CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND","128",NA,"UNIVERSITY OF ALBERTA, NATIONAL SCIENCE FOUNDATION GRADUATE RESEARCH FELLOWSHIP PROGRAM [DGE-1256259], NATIONAL INSTITUTES OF HEALTH NATIONAL RESEARCH SERVICE AWARD [T32 GM07215], NATIONAL INSTITUTES OF HEALTH [R01AI113287]","THIS STUDY WAS FUNDED THROUGH START-UP FUNDS PROVIDED BY THE UNIVERSITY OF ALBERTA TO AD. THIS MATERIAL IS ALSO BASED UPON WORK SUPPORTED BY THE NATIONAL SCIENCE FOUNDATION GRADUATE RESEARCH FELLOWSHIP PROGRAM UNDER GRANT DGE-1256259 TO TDM. ANY OPINIONS, FINDINGS, AND CONCLUSIONS OR RECOMMENDATIONS EXPRESSED IN THIS MATERIAL ARE THOSE OF THE AUTHORS AND DO NOT NECESSARILY REFLECT THE VIEWS OF THE NATIONAL SCIENCE FOUNDATION. TDM IS ALSO SUPPORTED BY A NATIONAL INSTITUTES OF HEALTH NATIONAL RESEARCH SERVICE AWARD (T32 GM07215). CSP IS SUPPORTED BY THE NATIONAL INSTITUTES OF HEALTH (R01AI113287).",NA,"1741-7015",NA,NA,"BMC","16",2018,"ISI000440965500001","35","GENERAL \& INTERNAL MEDICINE","3","MEDICINE, GENERAL \& INTERNAL","ADOROSHEUALBERTA.CA",NA,"GP6CW",NA,"DOROSHENKO, A (REPRINT AUTHOR), UNIV ALBERTA, FAC MED \& DENT, DIV PREVENT MED, DEPT MED, EDMONTON, AB, CANADA","ISI","UNIV ALBERTA;UNIV ALBERTA;UNIV WISCONSIN;UNIV WISCONSIN;UNIV ALBERTA;UNIV ALBERTA;UNIV ALBERTA","UNIV ALBERTA",NA,"DOROSHENKO A, 2018, BMC MED","DOROSHENKO A, 2018, BMC MED"
"GARRETTO A, 2018, J GEN VIROL","GARRETTO A;THOMAS WHITE K;WOLFE AJ;PUTONTI C","DETECTING VIRAL GENOMES IN THE FEMALE URINARY MICROBIOME","JOURNAL OF GENERAL VIROLOGY","J. GEN. VIROL.","VIRUSES ARE THE MOST ABUNDANT COMPONENT OF THE HUMAN MICROBIOTA. RECENT EVIDENCE HAS UNCOVERED A RICH DIVERSITY OF VIRUSES WITHIN THE FEMALE BLADDER, INCLUDING BOTH BACTERIOPHAGES AND EUKARYOTIC VIRUSES. WE CONDUCTED WHOLE-GENOME SEQUENCING OF THE BLADDER MICROBIOME OF 30 WOMEN: 10 ASYMPTOMATIC `HEALTHY' WOMEN AND 20 WOMEN WITH AN OVERACTIVE BLADDER. THESE METAGENOMES INCLUDE SEQUENCES REPRESENTATIVE OF HUMAN, BACTERIAL AND VIRAL DNA. THIS ANALYSIS, HOWEVER, FOCUSED SPECIFICALLY ON VIRAL SEQUENCES. USING THE BIOINFORMATIC TOOL VIRMINE, WE DISCOVERED SEQUENCE FRAGMENTS, AS WELL AS COMPLETE GENOMES, OF BACTERIOPHAGES AND THE EUKARYOTIC VIRUS JC POLYOMAVIRUS. THE METHOD EMPLOYED HERE IS A CRITICAL PROOF OF CONCEPT: THE GENOMES OF VIRAL POPULATIONS WITHIN THE LOW-BIOMASS BLADDER MICROBIOTA CAN BE RECONSTRUCTED THROUGH WHOLE-GENOME SEQUENCING OF THE ENTIRE MICROBIAL COMMUNITY.","URINARY MICROBIOME; URINARY VIROME; BACTERIOPHAGE; JC POLYOMAVIRUS","JC VIRUS; CLINICAL-IMPLICATIONS; POLYOMAVIRUS; BLADDER; INCONTINENCE; INDIVIDUALS; DNA; ASSOCIATION; BACTERIA; HEALTHY","ENGLISH","ARTICLE","ARTICLE",0,"AGOSTINI HT, 1996, J CLIN MICROBIOL, V34, P159.;ASSETTA B, 2017, BIOL CHEM, V398, P839, DOI 10.1515/HSZ-2016-0345.;AZIZ RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75.;BANKEVICH A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/CMB.2012.0021.;BROWN-JAQUE M, 2016, SCI REP-UK, V6, DOI 10.1038/SREP33000.;BRUBAKER L, 2014, INT UROGYNECOL J, V25, P1179, DOI 10.1007/S00192-013-2325-2.;BURIAN Z, 2011, ARCH VIROL, V156, P1537, DOI 10.1007/S00705-011-1021-0.;CHANG H, 2002, J NEUROVIROL, V8, P447, DOI 10.1080/13550280290100824.;DUTILH BE, 2014, NAT COMMUN, V5, DOI 10.1038/NCOMMS5498.;ECHAVARRIA M, 1998, J CLIN MICROBIOL, V36, P3323.;DIETERLE ME, 2016, APPL MICROBIOL BIOT, V100, P9201, DOI 10.1007/S00253-016-7727-X.;FOUTS DE, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-174.;GARRETTO A, 2017, VIRMINE AUTOMATED DE.;HILT EE, 2014, J CLIN MICROBIOL, V52, P871, DOI 10.1128/JCM.02876-13.;HIRSCH HH, 2013, APMIS, V121, P685, DOI 10.1111/APM.12128.;IWASAWA A, 1992, UROL INT, V48, P235, DOI 10.1159/000282342.;JOSHI NA, 2011, SICKLE A SLIDING WIN.;KARIM RZ, 2005, PATHOLOGY, V37, P176, DOI 10.1080/00313020500058615.;KARSTENS L, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/FCIMB.2016.00078.;KASS EH, 1962, ANN INTERN MED, V56, P46, DOI 10.7326/0003-4819-56-1-46.;KHALILI K, 2006, ADV EXP MED BIOL, V577, P274.;KHASRIYA R, 2013, J CLIN MICROBIOL, V51, P2054, DOI 10.1128/JCM.03314-12.;KOONIN EV, 2006, BIOL DIRECT, V1.;KRUPOVIC M, 2015, ANN NY ACAD SCI, V1341, P41, DOI 10.1111/NYAS.12675.;LANGMEAD B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/NMETH.1923].;MALKI KEMA, 2016, GENOME ANNOUNC, V4, DOI 10.1128/GENOMEA.01003-16.;MALKI K, 2016, PLOS ONE, V11, DOI 10.1371/JOURNAL.PONE.0166757.;MANRIQUE P, 2016, P NATL ACAD SCI USA, V113, P10400, DOI 10.1073/PNAS.1601060113.;MILLER-ENSMINGER T, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00738-17.;MINOT S, 2011, GENOME RES, V21, P1616, DOI 10.1101/GR.122705.111.;MOKILI JL, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0058404.;NIENHOUSE V, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0114185.;PEARCE MM, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/J.AJOG.2015.07.009.;PEARCE MM, 2014, MBIO, V5, DOI 10.1128/MBIO.01283-14.;PRICE MN, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0009490.;PRICE TK, 2016, J CLIN MICROBIOL, V54, P1216, DOI 10.1128/JCM.00044-16.;RANI A., 2016, SCI REP UK, V6, P23656.;REID CE, 2011, J INFECT DIS, V204, P237, DOI 10.1093/INFDIS/JIR256.;RINALDO CH, 2013, APMIS, V121, P728, DOI 10.1111/APM.12134.;SANTIAGO-RODRIGUEZ TM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/FMICB.2015.00014.;SARUWATARI L, 2002, ARCH VIROL, V147, P1, DOI 10.1007/S705-002-8299-4.;SENDER R, 2016, PLOS BIOL, V14, DOI 10.1371/JOURNAL.PBIO.1002533.;SHACKELTON LA, 2006, J VIROL, V80, P9928, DOI 10.1128/JVI.00441-06.;TEATERO S, 2015, EMERG INFECT DIS, V21, P585, DOI [10.3201/EID2014.140759, 10.3201/EID2104.140759].;THOMAS-WHITE KJ, 2018, URINARY SYMPTOMS ASS.;THOMAS-WHITE KJ, 2018, URINARY MICROBES POS.;THOMAS-WHITE KJ, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/J.AJOG.2016.07.049.;THOMAS-WHITE KJ, 2016, INT UROGYNECOL J, V27, P723, DOI 10.1007/S00192-015-2847-X.;VAN LOY T, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0070950.;WOLFE AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11.;YILMAZ S, 2010, NAT METHODS, V7, P943, DOI 10.1038/NMETH1210-943.;YUAN SQ, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0033865.;ZHOU Y, 2011, NUCLEIC ACIDS RES, V39, PW347, DOI 10.1093/NAR/GKR485.","PUTONTI, C (REPRINT AUTHOR), LOYOLA UNIV, BIOINFORMAT PROGRAM, CHICAGO, IL 60611 USA.;PUTONTI, C (REPRINT AUTHOR), LOYOLA UNIV CHICAGO, DEPT MICROBIOL \& IMMUNOL, MAYWOOD, IL 60153 USA.;PUTONTI, C (REPRINT AUTHOR), LOYOLA UNIV, DEPT BIOL, CHICAGO, IL 60626 USA.;PUTONTI, C (REPRINT AUTHOR), LOYOLA UNIV, DEPT COMP SCI, CHICAGO, IL 60611 USA.;GARRETTO, ANDREA, PUTONTI, CATHERINE, LOYOLA UNIV, BIOINFORMAT PROGRAM, CHICAGO, IL 60611 USA.;THOMAS-WHITE, KRYSTAL, WOLFE, ALAN J., PUTONTI, CATHERINE, LOYOLA UNIV CHICAGO, DEPT MICROBIOL \& IMMUNOL, MAYWOOD, IL 60153 USA.;PUTONTI, CATHERINE, LOYOLA UNIV, DEPT BIOL, CHICAGO, IL 60626 USA.;PUTONTI, CATHERINE, LOYOLA UNIV, DEPT COMP SCI, CHICAGO, IL 60611 USA.;THOMAS-WHITE, KRYSTAL, 325 SHARON PK DR,SUITE 522, MENLO PK, CA USA.","10.1099/JGV.0.001097","CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND",NA,NA,"NIH [R01 DK104718], NSF [ABI 1149387, 1661357], CARBON RESEARCH FELLOWSHIP AT LOYOLA UNIVERSITY CHICAGO, CREU RESEARCH FELLOWSHIP","THIS WORK WAS SUPPORTED BY THE NIH (R01 DK104718 TO A.J.W) AND NSF (ABI 1149387 AND 1661357 TO C.P.). A.G. IS SUPPORTED BY THE CARBON RESEARCH FELLOWSHIP AT LOYOLA UNIVERSITY CHICAGO AND THE CREU RESEARCH FELLOWSHIP (CRA).",NA,"0022-1317","8","1141-1146","MICROBIOLOGY SOC","99",2018,"ISI000440461400019","53","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, VIROLOGY","0","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, VIROLOGY","CPUTONTILUC.EDU",NA,"GO9XL",NA,"PUTONTI, C (REPRINT AUTHOR), LOYOLA UNIV, BIOINFORMAT PROGRAM, CHICAGO, IL 60611 USA","ISI","LOYOLA UNIV;LOYOLA UNIV CHICAGO;LOYOLA UNIV;LOYOLA UNIV","LOYOLA UNIV",NA,"GARRETTO A, 2018, J GEN VIROL","GARRETTO A, 2018, J GEN VIROL"
"KHAN MA, 2018, MOL BIOL REP","KHAN MA;ULLAH A;NAEEM M","WHOLE EXOME SEQUENCING IDENTIFIED TWO NOVEL HOMOZYGOUS MISSENSE VARIANTS IN THE SAME CODON OF CLCN7 UNDERLYING AUTOSOMAL RECESSIVE INFANTILE MALIGNANT OSTEOPETROSIS IN A PAKISTANI FAMILY","MOLECULAR BIOLOGY REPORTS","MOL. BIOL. REP.","AUTOSOMAL RECESSIVE OSTEOPETROSIS IS A SEVERE FATAL DISORDER WITH AN AVERAGE INCIDENCE OF AROUND 1:250,000. IT IS DIAGNOSED SOON AFTER BIRTH OR WITHIN THE 1ST YEAR OF LIFE WITH SEVERE SYMPTOMS OF ABNORMAL BONE REMODELLING. THIS STUDY WAS AIMED TO IDENTIFY THE UNDERLYING GENETIC CAUSE OF THE DISEASE IN A PAKISTANI FAMILY SEGREGATING INFANTILE MALIGNANT OSTEOPETROSIS IN AUTOSOMAL RECESSIVE PATTERN. WHOLE EXOME SEQUENCING OF THE PROBAND WAS PERFORMED USING THE 51 MB SURESELECT V4 LIBRARY KIT AND SEQUENCED USING THE ILLUMINA HISEQ2500 SEQUENCING SYSTEM. THE READS WERE ANALYSED USING STANDARD BIOINFORMATIC DATA ANALYSIS PIPELINE. THE GENOTYPE OF CANDIDATE VARIANTS WAS CONFIRMED IN THE PROBAND AND HIS NORMAL PARENTS BY SANGER SEQUENCING. TWO NOVEL HOMOZYGOUS MISSENSE VARIANTS WERE FOUND IN THE SAME CODON 204 OF CLCN7 NM\_001287.5:C.[610A > T,612C > G] PREDICTING P.(SER204TRP) VARIANT IN THE PROTEIN. SANGER SEQUENCING AND RFLP ASSAY VERIFIED THAT BOTH THESE VARIANTS WERE HETEROZYGOUS IN THE UNAFFECTED PARENTS. MOREOVER, THESE VARIANTS WERE NOT DETECTED IN THE UNRELATED HEALTHY PAKISTANI SUBJECTS (200 CHROMOSOMES), EXAC, DBSNP, OR THE 1000 GENOMES PROJECT DATA. MULTIPLE BIOINFORMATICS TOOLS UNANIMOUSLY PREDICTED THE P.(SER204TRP) VARIANT AS DELETERIOUS. CLCN7 MUTATION P.(SER204TRP) IS THE LIKELY CAUSE OF THE OSTEOPETROSIS DISEASE IN THE PAKISTANI FAMILY. THIS STUDY EXPANDS THE RESTRICTED SPECTRUM OF CLCN7 MUTATIONS ASSOCIATED WITH INFANTILE MALIGNANT OSTEOPETROSIS AND INDICATES CLINICAL SIGNIFICANCE OF WHOLE EXOME SEQUENCING IN THE DIAGNOSIS OF CLINICALLY AND GENETICALLY HETEROGENOUS OSTEOPETROSIS PHENOTYPE. THESE DATA SHOULD BE HELPFUL IN THE IMPROVED GENETIC COUNSELLING, CARRIER IDENTIFICATION AND PRENATAL DIAGNOSIS OF THE AFFECTED FAMILY.","MOLECULAR DIAGNOSIS; WHOLE EXOME SEQUENCING; DOUBLE HOMOZYGOTE; CHLORIDE VOLTAGE-GATED CHANNEL 7","MUTATIONS","ENGLISH","ARTICLE","ARTICLE",0,"BARVENCIK F, 2014, J BONE MINER RES, V29, P982, DOI 10.1002/JBMR.2100.;CAMPOS-XAVIER AB, 2003, HUM GENET, V112, P186, DOI 10.1007/S00439-002-0861-9.;FRATTINI A, 2003, J BONE MINER RES, V18, P1740, DOI 10.1359/JBMR.2003.18.10.1740.;GAUDET P, 2017, NUCLEIC ACIDS RES, V45, PD177, DOI 10.1093/NAR/GKW1062.;KUMAR KALENAHALLI JAGADISH, 2013, INDIAN J HUM GENET, V19, P90, DOI 10.4103/0971-6866.112911.;OKAMOTO NANA, 2017, HUM GENOME VAR, V4, P17036, DOI 10.1038/HGV.2017.36.;PANGRAZIO A, 2010, HUM MUTAT, V31, PE1071, DOI 10.1002/HUMU.21167.;PHADKE SR, 2010, INDIAN J MED RES, V131, P508.;SOBACCHI C, 2007, GENEREVIEWS, P1993.;STARK Z, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-5.","NAEEM, M (REPRINT AUTHOR), QUAID I AZAM UNIV, DEPT BIOTECHNOL, MED GENET RES LAB, ISLAMABAD 45320, PAKISTAN.;KHAN, MUHAMMAD AMAN, ULLAH, AMAN, NAEEM, MUHAMMAD, QUAID I AZAM UNIV, DEPT BIOTECHNOL, MED GENET RES LAB, ISLAMABAD 45320, PAKISTAN.;KHAN, MUHAMMAD AMAN, LADY READING HOSP, DEPT PATHOL \& LAB MED, PESHAWAR, PAKISTAN.","10.1007/S11033-018-4194-8","VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS",NA,NA,"HIGHER EDUCATION COMMISSION OF PAKISTAN THROUGH INDIGENOUS PH.D. FELLOWSHIP SCHEME","MUHAMMAD AMAN KHAN IS SUPPORTED BY HIGHER EDUCATION COMMISSION OF PAKISTAN THROUGH INDIGENOUS PH.D. FELLOWSHIP SCHEME.",NA,"0301-4851","4","565-570","SPRINGER","45",2018,"ISI000439948500017","10","BIOCHEMISTRY \& MOLECULAR BIOLOGY","0","BIOCHEMISTRY \& MOLECULAR BIOLOGY","MAKHANSTUDENT.QAU.EDU.PK AMANULLAHBS.QAU.EDU.PK MNAEEMQAU.EDU.PK",NA,"GO4CO",NA,"NAEEM, M (REPRINT AUTHOR), QUAID I AZAM UNIV, DEPT BIOTECHNOL, MED GENET RES LAB, ISLAMABAD 45320, PAKISTAN","ISI","QUAID I AZAM UNIV;LADY READING HOSP","QUAID I AZAM UNIV",NA,"KHAN MA, 2018, MOL BIOL REP","KHAN MA, 2018, MOL BIOL REP"
"SWIFT JF, 2018, EVOL APPL","SWIFT JF;LANCE RF;GUAN X;BRITZKE ER;LINDSAY DL;EDWARDS CE","MULTIFACETED DNA METABARCODING: VALIDATION OF A NONINVASIVE, NEXT-GENERATION APPROACH TO STUDYING BAT POPULATIONS","EVOLUTIONARY APPLICATIONS","EVOL. APPL.","AS MULTIPLE SPECIES OF BATS ARE CURRENTLY EXPERIENCING DRAMATIC DECLINES IN POPULATIONS DUE TO WHITE-NOSE SYNDROME (WNS) AND OTHER FACTORS, CONSERVATION MANAGERS HAVE AN URGENT NEED FOR DATA ON THE ECOLOGY AND OVERALL STATUS OF POPULATIONS OF ONCE-COMMON BAT SPECIES. STANDARD APPROACHES TO OBTAIN DATA ON BAT POPULATIONS OFTEN INVOLVE CAPTURE AND HANDLING, REQUIRING EXTENSIVE EXPERTISE AND UNAVOIDABLY RESULTING IN STRESS TO THE BATS. NEW METHODS TO RAPIDLY OBTAIN CRITICAL DATA ARE NEEDED THAT MINIMIZE BOTH THE STRESS ON BATS AND THE SPREAD OF WNS. GUANO PROVIDES A NONINVASIVE SOURCE OF DNA THAT INCLUDES INFORMATION FROM THE BAT, BUT ALSO DIETARY ITEMS, PARASITES, AND PATHOGENS. DNA METABARCODING IS A HIGH-THROUGHPUT, DNA-BASED IDENTIFICATION TECHNIQUE TO ASSESS THE BIODIVERSITY OF ENVIRONMENTAL OR FECAL SAMPLES. WE INVESTIGATED THE USE OF MULTIFACETED DNA METABARCODING (MDM), A TECHNIQUE COMBINING NEXT-GENERATION DNA SEQUENCING (NGS), DNA BARCODES, AND BIOINFORMATIC ANALYSIS, TO SIMULTANEOUSLY COLLECT DATA ON MULTIPLE PARAMETERS OF INTEREST (BAT SPECIES COMPOSITION, INDIVIDUAL GENOTYPE, SEX RATIOS, DIET, PARASITES, AND PRESENCE OF WNS) FROM FECAL SAMPLES USING A SINGLE NGS RUN. WE TESTED THE ACCURACY OF EACH MDM ASSAY USING SAMPLES IN WHICH THESE PARAMETERS WERE PREVIOUSLY DETERMINED USING CONVENTIONAL APPROACHES. WE FOUND THAT ASSAYS FOR BAT SPECIES IDENTIFICATION, INSECT DIET, PARASITE DIVERSITY, AND GENOTYPE WERE BOTH SENSITIVE AND ACCURATE, THE ASSAY TO DETECT WNS WAS HIGHLY SENSITIVE BUT REQUIRES CAREFUL SAMPLE PROCESSING STEPS TO ENSURE THE RELIABILITY OF RESULTS, WHILE ASSAYS FOR NECTIVOROUS DIET AND SEX SHOWED LOWER SENSITIVITY. MDM WAS ABLE TO QUANTIFY MULTIPLE DATA CLASSES FROM FECAL SAMPLES SIMULTANEOUSLY, AND RESULTS WERE CONSISTENT WHETHER WE INCLUDED ASSAYS FOR A SINGLE DATA CLASS OR MULTIPLE DATA CLASSES. OVERALL, MDM IS A USEFUL APPROACH THAT EMPLOYS NONINVASIVE SAMPLING AND A CUSTOMIZABLE SUITE OF ASSAYS TO GAIN IMPORTANT AND LARGELY ACCURATE INFORMATION ON BAT ECOLOGY AND POPULATION DYNAMICS.","BATS; DNA METABARCODING; NEXT-GENERATION DNA SEQUENCING; NONINVASIVE SAMPLING; POPULATION ASSESSMENT","WHITE-NOSE SYNDROME; ELUSIVE ANIMALS; DIET; IDENTIFICATION; PRIMERS; PHYLOGEOGRAPHY; MICROBIOTA; TAXONOMY; ACCURACY; WILDLIFE","ENGLISH","ARTICLE","ARTICLE",1,"ADAMS JR, 2003, MOL ECOL, V12, P2175, DOI 10.1046/J.1365-294X.2003.01895.X.;AIVELO T, 2016, APPL ENVIRON MICROB, V82, P3537, DOI 10.1128/AEM.00559-16.;AIVELO T, 2015, PARASITOLOGY, V142, P1095, DOI 10.1017/S0031182015000438.;ARANDJELOVIC M, 2010, BIOL CONSERV, V143, P1780, DOI 10.1016/J.BIOCON.2010.04.030.;BARNOSKY AD, 2011, NATURE, V471, P51, DOI 10.1038/NATURE09678.;BEEDE R. H., 1997, WALNUT PRODUCTION MA, P8.;BEJA-PEREIRA A, 2009, MOL ECOL RESOUR, V9, P1279, DOI 10.1111/J.1755-0998.2009.02699.X.;BELLEMAIN E, 2005, CONSERV BIOL, V19, P150, DOI 10.1111/J.1523-1739.2005.00549.X.;BERTHEAU C, 2011, MOL ECOL RESOUR, V11, P1056, DOI 10.1111/J.1755-0998.2011.03050.X.;BHADURY P, 2006, MAR ECOL PROG SER, V320, P1, DOI 10.3354/MEPS320001.;BOYER F, 2016, MOL ECOL RESOUR, V16, P176, DOI 10.1111/1755-0998.12428.;BRANDON-MONG GJ, 2015, B ENTOMOL RES, V105, P717, DOI 10.1017/S0007485315000681.;BURGAR JM, 2014, MOL ECOL, V23, P3605, DOI 10.1111/MEC.12531.;CAMACHO C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421.;CEBALLOS G, 2015, SCI ADV, V1, DOI 10.1126/SCIADV.1400253.;CLARE EL, 2011, MOL ECOL, V20, P1772, DOI 10.1111/J.1365-294X.2011.05040.X.;CLARKE LJ, 2014, MOL ECOL RESOUR, V14, P1160, DOI 10.1111/1755-0998.12265.;COURTIN F, 2010, VET PATHOL, V47, P214, DOI 10.1177/0300985809358614.;DE BARBA M, 2017, MOL ECOL RESOUR, V17, P492, DOI 10.1111/1755-0998.12594.;DE BARBA M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188.;DEAGLE BE, 2014, BIOL LETTERS, V10, DOI 10.1098/RSBL.2014.0562.;DERYCKE S, 2008, ZOOL J LINN SOC-LOND, V152, P1, DOI 10.1111/J.1096-3642.2007.00365.X.;DOYLE J. L. ., 1987, PHYTOCHEMISTRY B, V19, P11.;EGGERT LS, 2003, MOL ECOL, V12, P1389, DOI 10.1046/J.1365-294X.2003.01822.X.;ESLING P, 2015, NUCLEIC ACIDS RES, V43, P2513, DOI 10.1093/NAR/GKV107.;FERNANDO P, 2000, HEREDITY, V84, P362, DOI 10.1046/J.1365-2540.2000.00674.X.;FLAGSTAD O, 2004, CONSERV BIOL, V18, P676, DOI 10.1111/J.1523-1739.2004.00328.X-I1.;FOLEY J, 2011, CONSERV BIOL, V25, P223, DOI 10.1111/J.1523-1739.2010.01638.X.;GERMAIN-AUBREY CC, 2016, APPL PLANT SCI, V4, DOI 10.3732/APPS.1500115.;HERRMANN MATTHIAS, 2006, FRONT ZOOL, V3, P14, DOI 10.1186/1742-9994-3-14.;HUSON DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/JOURNAL.PCBI.1004957.;ILLUMINA, 2013, 16S MET SEQ LIB PREP.;IPCC (INTERGOVERNMENTAL PANEL ON CLIMATE CHANGE): CLIMATE CHANGE, 2007, CONTRIBUTION WORKING.;KALINOWSKI ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/J.1365-294X.2007.03089.X.;KASSO M., 2013, ECOLOGICAL EC IMPORT, V2013, P1, DOI [10.1155/2013/187415, DOI 10.1155/2013/985037].;KING RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/J.1365-294X.2007.03613.X.;KORSTIAN JM, 2013, MOL ECOL RESOUR, V13, P776, DOI 10.1111/1755-0998.12118.;KRESS WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/PNAS.0503123102.;KUNZ TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/J.1749-6632.2011.06004.X.;LANCE R. F., NEW COMPLEMENT UNPUB.;LORCH JM, 2011, NATURE, V480, P376, DOI 10.1038/NATURE10590.;LOTZ J. M., 2008, KEYS TREMATODA, P527.;MAINE JJ, 2015, P NATL ACAD SCI USA, V112, P12438, DOI 10.1073/PNAS.1505413112.;MCALLISTER CT, 2011, COMP PARASITOL, V78, P193, DOI 10.1654/4466.1.;MEIRMANS PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/J.1471-8286.2004.00770.X.;MOSZCZYNSKA A, 2009, MOL ECOL RESOUR, V9, P75, DOI 10.1111/J.1755-0998.2009.02634.X.;MULLER LK, 2013, MYCOLOGIA, V105, P253, DOI 10.3852/12-242.;NCBIRESOURCECOORDINATORS, 2017, NUCLEIC ACIDS RES, V45, PD12, DOI 10.1093/NAR/GKW1071.;PIAGGIO AJ, 2009, MOL ECOL RESOUR, V9, P1191, DOI 10.1111/J.1755-0998.2009.02625.X.;POMPANON F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/J.1365-294X.2011.05403.X.;QUEMERE E, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0058971.;RUDNICK JA, 2005, MOL ECOL, V14, P2959, DOI 10.1111/J.1365-294X.2005.02641.X.;SANG T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155.;SANTOS CP, 2015, ZOOTAXA, V3937, P471, DOI 10.11646/ZOOTAXA.3937.3.3.;SHAW CN, 2003, J MAMMAL, V84, P123, DOI 10.1644/1545-1542(2003)084<0123:ARMMOG>2.0.CO,2.;SHEHZAD W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/J.1365-294X.2011.05424.X.;SOININEN EM, 2013, POLAR BIOL, V36, P1069, DOI 10.1007/S00300-013-1328-2.;SONG H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/PNAS.0803076105.;SPRINGER A, 2017, ECOL EVOL, V7, P5732, DOI 10.1002/ECE3.3148.;STEYER K, 2013, EUR J WILDLIFE RES, V59, P39, DOI 10.1007/S10344-012-0644-0.;SUEZ M, 2016, MOL ECOL RESOUR, V16, P524, DOI 10.1111/1755-0998.12467.;TABERLET P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/J.1365-294X.2012.05470.X.;TANG Z, 2015, MOBILE DNA-UK, V6, DOI 10.1186/S13100-014-0033-1.;TANGE O, 2011, THE USENIX MAGAZINE, V36, P42, DOI DOI 10.5281/ZEN0D0.16303.;THOMAS AC, 2014, MOL ECOL, V23, P3706, DOI 10.1111/MEC.12523.;TRIANT DA, 2007, J MAMMAL, V88, P908, DOI 10.1644/06-MAMM-A-204R1.1.;USFWS, 2016, NAT WHIT NOS SYNDR D.;VESTERINEN EJ, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0082168.;WAITS LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO,2.;WEBBER Q. M. R., 2016, SOCIALITY IN BATS, DOI [10. 1007/978-3-319-38953-0, DOI 10.1007/978-3-319-38953-0].;ZEALE MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/J.1755-0998.2010.02920.X.;ZINCK JM, 2004, MOL ECOL NOTES, V4, P239, DOI 10.1111/J.1471-8286.2004.00629.X.","EDWARDS, CE (REPRINT AUTHOR), MISSOURI BOT GARDEN, CTR CONSERVAT \& SUSTAINABLE DEV, POB 299, ST LOUIS, MO 63166 USA.;SWIFT, JOEL F., EDWARDS, CHRISTINE E., MISSOURI BOT GARDEN, CTR CONSERVAT \& SUSTAINABLE DEV, POB 299, ST LOUIS, MO 63166 USA.;LANCE, RICHARD F., BRITZKE, ERIC R., LINDSAY, DENISE L., US ARMY, ENVIRONM LAB, ENGINEER RES \& DEV CTR, VICKSBURG, MS USA.;GUAN, XIN, BENNETT AEROSP, CARY, NC USA.","10.1111/EVA.12644","111 RIVER ST, HOBOKEN 07030-5774, NJ USA",NA,NA,"U.S. DEPARTMENT OF DEFENSE'S ENVIRONMENTAL SECURITY TECHNOLOGY CERTIFICATION PROGRAM (ESTCP) [14 E-RC3-018]","THIS WORK WAS SUPPORTED BY THE U.S. DEPARTMENT OF DEFENSE'S ENVIRONMENTAL SECURITY TECHNOLOGY CERTIFICATION PROGRAM (ESTCP GRANT NUMBER 14 E-RC3-018).",NA,"1752-4571","7","1120-1138","WILEY","11",2018,"ISI000439505200007","72","EVOLUTIONARY BIOLOGY","17","EVOLUTIONARY BIOLOGY","CHRISTINE.EDWARDSMOBOT.ORG",NA,"GN9HT",NA,"EDWARDS, CE (REPRINT AUTHOR), MISSOURI BOT GARDEN, CTR CONSERVAT \& SUSTAINABLE DEV, POB 299, ST LOUIS, MO 63166 USA","ISI","CTR CONSERVAT AND SUSTAINABLE DEV;ENGINEER RES AND DEV CTR","CTR CONSERVAT AND SUSTAINABLE DEV",NA,"SWIFT JF, 2018, EVOL APPL","SWIFT JF, 2018, EVOL APPL"
"KEROACK CD, 2018, INT J PARASITOL -PARASIT WILDL","KEROACK CD;WILLIAMS KM;FESSLER MK;DEANGELIS KE;TSEKITSIDOU E;TOZLOSKI JM;WILLIAMS SA","A NOVEL QUANTITATIVE REAL-TIME PCR DIAGNOSTIC ASSAY FOR SEAL HEARTWORM (ACANTHOCHEILONEMA SPIROCAUDA) PROVIDES EVIDENCE FOR POSSIBLE INFECTION IN THE GREY SEAL (HALICHOERUS GRYPUS)","INTERNATIONAL JOURNAL FOR PARASITOLOGY-PARASITES AND WILDLIFE","INT. J. PARASITOL.-PARASIT. WILDL.","THE DISTINCT EVOLUTIONARY PRESSURES FACED BY PINNIPEDS HAVE LIKELY RESULTED IN STRONG COEVOLUTIONARY TIES TO THEIR PARASITES (LEIDENBERGER ET AL., 2007). THIS STUDY FOCUSES ON THE PHOCID SEAL FILARIAL HEARTWORM SPECIES ACANTHOCHEILONEMA SPIROCAUDA. A. SPIROCAUDA IS KNOWN TO INFECT A VARIETY OF PHOCID SEALS, BUT DOES NOT APPEAR TO BE RESTRICTED TO A SINGLE HOST SPECIES (MEASURES ET AL., 1997, LEIDENBERGER ET AL., 2007, LEHNERT ET AL., 2015). HOWEVER, TO DATE, SEAL HEARTWORM HAS NEVER BEEN REPORTED IN GREY SEALS (HALICHOERUS GRYPUS) (MEASURES ET AL., 1997, LEIDENBERGER ET AL., 2007, LEHNERT ET AL., 2015). THE PROPOSED VECTOR FOR SEAL HEARTWORM IS ECHINOPHTHIRIUS HORRIDUS, THE SEAL LOUSE. SEAL LICE ARE KNOWN TO PARASITIZE A WIDE ARRAY OF PHOCID SEAL SPECIES, INCLUDING THE GREY SEAL. WITH THE ADVENT OF CLIMATE CHANGE, DISEASE BURDEN IS EXPECTED TO INCREASE ACROSS TERRESTRIAL AND MARINE MAMMALS (HARVELL ET AL., 2002). ACCORDINGLY, INCREASED PREVALENCE OF SEAL HEARTWORM HAS RECENTLY BEEN REPORTED IN HARBOR SEALS (PHOCA VITULINA) (LEHNERT ET AL., 2015). THUS, THE NEED FOR IMPROVED, RAPID, AND COST-EFFECTIVE DIAGNOSTICS IS URGENT. HERE WE PRESENT THE FIRST A. SPIROCAUDA-SPECIFIC RAPID DIAGNOSTIC TEST (A QUANTITATIVE REALTIME PCR ASSAY), BASED ON A HIGHLY REPETITIVE GENOMIC DNA REPEAT IDENTIFIED USING WHOLE GENOME SEQUENCING AND SUBSEQUENT BIOINFORMATIC ANALYSIS. THE PRESENCE OF AN INSECT VECTOR PROVIDES THE OPPORTUNITY TO DEVELOP A MULTIFUNCTIONAL DIAGNOSTIC TOOL THAT CAN BE USED NOT ONLY TO DETECT THE PARASITE DIRECTLY FROM BLOOD OR TISSUE SPECIMENS, BUT ALSO AS A MOLECULAR XENOMONITORING (XM) TOOL THAT CAN BE USED TO ASSESS THE EPIDEMIOLOGICAL PROFILE OF THE PARASITE BY SCREENING THE ARTHROPOD VECTOR. USING THIS ASSAY, WE PROVIDE EVIDENCE FOR THE FIRST REPORTED CASE OF SEAL HEARTWORM IN A GREY SEAL.","HARBOR SEAL; PARASITES; SEAL HEARTWORM; ACANTHOCHEILONEMA SPIROCAUDA; REAL-TIME PCR; MOLECULAR DIAGNOSTICS; XENOMONITORING; GENOMIC REPEATS","POLYMERASE-CHAIN-REACTION; INTERNAL TRANSCRIBED SPACER; DIROFILARIA-IMMITIS; HARBOR SEALS; DNA-SEQUENCE; PHYLOGENETIC-RELATIONSHIPS; FILARIAL NEMATODES; PHOCA-VITULINA; WADDEN SEA; RED FOXES","ENGLISH","ARTICLE","ARTICLE",0,"ALHASSAN A, 2015, TRENDS PARASITOL, V31, P391, DOI 10.1016/J.PT.2015.04.006.;ALVAREZ I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2.;BANOO S, 2008, NAT REV MICROBIOL, V6, PS16, DOI 10.1038/NRMICRO1523.;BLANKENBERG D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/BIOINFORMATICS/BTQ281.;BLAXTER ML, 2004, PHILOS T ROY SOC B, V359, P669, DOI 10.1098/RSTB.2003.1447.;BLOUIN MS, 2002, INT J PARASITOL, V32, P527, DOI 10.1016/S0020-7519(01)00357-5.;BORISENKO AV, 2009, MOL ECOL RESOUR, V9, P27, DOI 10.1111/J.1755-0998.2009.02629.X.;C ELEGANS SEQUENCING CONSORTIUM, 1998, SCIENCE, V282, P2012, DOI 10.1126/SCIENCE.282.5396.2012.;CALIENDO AM, 2013, CLIN INFECT DIS, V57, PS139, DOI 10.1093/CID/CIT578.;CASIRAGHI M, 2004, INT J PARASITOL, V34, P191, DOI 10.1016/J.IJPARA.2003.10.004.;CASIRAGHI M, 2001, PARASITOLOGY, V122, P93, DOI 10.1017/S0031182000007149.;CASIRAGHI M, 2010, BRIEF BIOINFORM, V11, P440, DOI 10.1093/BIB/BBQ003.;CLAUSSEN D, 1991, J VET MED B, V38, P649, DOI 10.1111/J.1439-0450.1991.TB00924.X.;COLEMAN AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5.;DAILEY M. D., 2005, PARASITES MARINE MAM.;DANTASTORRES F, 2013, PARASITE VECTOR, V6.;EDVINSSON B, 2006, CLIN MICROBIOL INFEC, V12, P131, DOI 10.1111/J.1469-0691.2005.01332.X.;FELIX J. R., 2013, REPORTED INCIDENCES.;FERRI E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1.;FLOYD R, 2002, MOL ECOL, V11, P839, DOI 10.1046/J.1365-294X.2002.01485.X.;FURTADO AP, 2010, J PARASITOL, V96, P499, DOI 10.1645/GE-2178.1.;GATEHOUSE HS, 1998, J INVERTEBR PATHOL, V71, P97, DOI 10.1006/JIPA.1997.4737.;GERACI JR, 1981, CAN J ZOOL, V59, P1457, DOI 10.1139/Z81-197.;GORTAZAR C, 1994, J WILDLIFE DIS, V30, P545, DOI 10.7589/0090-3558-30.4.545.;HARRIS DJ, 2000, MOL BIOL EVOL, V17, P284, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A026308.;HARVELL CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/SCIENCE.1063699.;HIGAZI TB, 2011, AM J TROP MED HYG, V84, P753, DOI 10.4269/AJTMH.2011.11-0009.;HILL KM, 2014, DIS AQUAT ORGAN, V110, P33, DOI 10.3354/DAO02738.;HOLTERMAN M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/MOLBEV/MLS044.;HUBERT GF, 1980, J WILDLIFE DIS, V16, P229, DOI 10.7589/0090-3558-16.2.229.;KEROACK CD, 2016, J PARASITOL, V102, P312, DOI 10.1645/15-872.;LEHNERT K, 2007, HELGOLAND MAR RES, V61, P239, DOI 10.1007/S10152-007-0072-9.;LEHNERT K, 2010, INT J PARASITOL, V40, P845, DOI 10.1016/J.IJPARA.2009.12.008.;LEHNERT K, 2016, J SEA RES, V113, P65, DOI 10.1016/J.SEARES.2015.06.014.;LEIDENBERGER S, 2007, DIS AQUAT ORGAN, V77, P235, DOI 10.3354/DAO01823.;LIU GH, 2014, PARASITE VECTOR, V7.;LUNNERYD S. G., 1992, DIPETALONEMA SPIROCA, P267.;MAYER C, 2006, PHOBOS 3 3 11.;MAYER C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-277.;MCREYNOLDS LA, 1986, P NATL ACAD SCI USA, V83, P797, DOI 10.1073/PNAS.83.3.797.;MEASURES LN, 1997, CAN J FISH AQUAT SCI, V54, P842, DOI 10.1139/CJFAS-54-4-842.;MEJIA R, 2013, AM J TROP MED HYG, V88, P1041, DOI 10.4269/AJTMH.12-0726.;MORITZ C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/JOURNAL.PBIO.0020354.;NASSONOVA E, 2010, PROTIST, V161, P102, DOI 10.1016/J.PROTIS.2009.07.003.;NOVAK P, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/NAR/GKX257.;NOVAK P, 2013, BIOINFORMATICS, V29, P792, DOI 10.1093/BIOINFORMATICS/BTT054.;NOVAK P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-378.;PACE NR, 2009, MICROBIOL MOL BIOL R, V73, P565, DOI 10.1128/MMBR.00033-09.;PACKER L, 2009, MOL ECOL RESOUR, V9, P42, DOI 10.1111/J.1755-0998.2009.02631.X.;PAPADOPOULOS E, 2010, J WILDLIFE DIS, V46, P570, DOI 10.7589/0090-3558-46.2.570.;PAPAIAKOVOU M., 2014, THESIS.;PILOTTE N, 2017, TRENDS PARASITOL, V33, P788, DOI 10.1016/J.PT.2017.06.008.;PILOTTE N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/JOURNAL.PNTD.0004641.;PILOTTE N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/JOURNAL.PNTD.0004578.;POWERS T, 2004, ANNU REV PHYTOPATHOL, V42, P367, DOI 10.1146/ANNUREV.PHYTO.42.040803.140348.;RAO RU, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/JOURNAL.PNTD.0004722.;RICCIARDI A, 2015, J BIOMOL SCREEN, V20, P6, DOI 10.1177/1087057114548065.;RISHNIW M, 2006, VET PARASITOL, V135, P303, DOI 10.1016/J.VETPAR.2005.10.013.;ROJAS A, 2015, PARASITE VECTOR, V8, DOI 10.1186/S13071-015-0783-8.;ROSET R, 2003, BIOINFORMATICS, V19, P2475, DOI 10.1093/BIOINFORMATICS/BTG326.;SUBIRANA JA, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0062221.;TAYLOR AER, 1961, J PARASITOL, V47, P971, DOI 10.2307/3275035.;THANCHOMNANG T., 2008, AM J TROP MED HYG, V3.;TREANGEN TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/NRG3117.;VAN DEN BROEK E., 1963, LUTRA, V5, P22.;VARGAS N, 2000, EXP PARASITOL, V96, P147, DOI 10.1006/EXPR.2000.4563.;WAUGH J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/BIES.20529.;WILL KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878.;WILL KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/J.1096-0031.2003.00008.X.;YOUNG I, 2004, MOL PHYLOGENET EVOL, V30, P236, DOI 10.1016/S1055-7903(03)00178-7.;ZHONG M, 1996, AM J TROP MED HYG, V54, P357, DOI 10.4269/AJTMH.1996.54.357.","KEROACK, CD (REPRINT AUTHOR), SMITH COLL, DEPT BIOL SCI, NORTHAMPTON, MA 01063 USA.;KEROACK, CD (REPRINT AUTHOR), HARVARD TH CHAN SCH PUBL HLTH, DEPT IMMUNOL \& INFECT DIS, BOSTON, MA 02115 USA.;KEROACK, CAROLINE D., WILLIAMS, KALANI M., FESSLER, M. K., DEANGELIS, KAELA E., TSEKITSIDOU, EIRINI, TOZLOSKI, JILLIAN M., WILLIAMS, STEVEN A., SMITH COLL, DEPT BIOL SCI, NORTHAMPTON, MA 01063 USA.;KEROACK, CAROLINE D., HARVARD TH CHAN SCH PUBL HLTH, DEPT IMMUNOL \& INFECT DIS, BOSTON, MA 02115 USA.","10.1016/J.IJPPAW.2018.04.001","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"SMITH COLLEGE, SIGMA XI GRANTS IN AID OF RESEARCH [G201503151199414]","THANKS TO DR. SEA ROGERS WILLIAMS (NMLC), FREDERICK WENZEL (NEFSC), AND KATIE PUGLIARES (NEAQ) FOR PROVIDING PARASITE SPECIMENS. THANKS TO LOU ANN BIERWERT AND THE SMITH COLLEGE CENTER FOR MOLECULAR BIOLOGY FOR NEXT-GENERATION SEQUENCING SUPPORT AND SANGER SEQUENCING SERVICES. THANKS TO JENNA WURSTER FOR HELPING TO EDIT THE MANUSCRIPT. THANKS TO SMITH COLLEGE FOR PROVIDING PARTIAL FUNDING FOR RESEARCH AS PART OF A TEACHING LABORATORY COURSE AND THROUGH THE BLAKESLEE FUND FOR GENETICS RESEARCH. THIS RESEARCH WAS PRIMARILY SUPPORTED VIA CROWD-FUNDING ON WWW.EXPERIMENT.COM (DOI: 10.18258/2993) AND THE AUTHORS WOULD LIKE TO THANK ALL THE DONORS WHO SUPPORTED THE RESEARCH. ADDITIONAL FUNDING WAS PROVIDED BY THE SIGMA XI GRANTS IN AID OF RESEARCH (\#G201503151199414).",NA,"2213-2244","2","147-154","ELSEVIER SCIENCE BV","7",2018,"ISI000438781400005","71","ENVIRONMENTAL SCIENCES \& ECOLOGY, PARASITOLOGY","4","ECOLOGY, PARASITOLOGY","CAROLINE\_KEROACKG.HARVARD.EDU",NA,"GN1VB",NA,"KEROACK, CD (REPRINT AUTHOR), SMITH COLL, DEPT BIOL SCI, NORTHAMPTON, MA 01063 USA","ISI","SMITH COLL;HARVARD TH CHAN SCH PUBL HLTH","SMITH COLL",NA,"KEROACK CD, 2018, INT J PARASITOL -PARASIT WILDL","KEROACK CD, 2018, INT J PARASITOL -PARASIT WILDL"
"LI S, 2018, J PERIODONT RES","LI S;LIU X;LI H;PAN H;ACHARYA A;DENG Y;YU Y;HAAK R;SCHMIDT J;SCHMALZ G;ZIEBOLZ D","INTEGRATED ANALYSIS OF LONG NONCODING RNA-ASSOCIATED COMPETING ENDOGENOUS RNA NETWORK IN PERIODONTITIS","JOURNAL OF PERIODONTAL RESEARCH","J. PERIODONT. RES.","BACKGROUND AND OBJECTIVESLONG NONCODING RNAS (LNCRNAS) PLAY CRITICAL AND COMPLEX ROLES IN REGULATING VARIOUS BIOLOGICAL PROCESSES OF PERIODONTITIS. THIS BIOINFORMATIC STUDY AIMS TO CONSTRUCT A PUTATIVE COMPETING ENDOGENOUS RNA (CERNA) NETWORK BY INTEGRATING LNCRNA, MIRNA AND MRNA EXPRESSION, BASED ON HIGH-THROUGHPUT RNA SEQUENCING AND MICROARRAY DATA ABOUT PERIODONTITIS. MATERIAL AND METHODSDATA FROM 1 MIRNA AND 3 MRNA EXPRESSION PROFILES WERE OBTAINED TO CONSTRUCT THE LNCRNA-ASSOCIATED CERNA NETWORK. GENE ONTOLOGY ENRICHMENT ANALYSIS AND PATHWAY ANALYSIS WERE PERFORMED USING THE GENE ONTOLOGY WEBSITE AND KYOTO ENCYCLOPEDIA OF GENES AND GENOMES. A PROTEIN-PROTEIN INTERACTION NETWORK WAS CONSTRUCTED BASED ON THE SEARCH TOOL FOR THE RETRIEVAL OF INTERACTING GENES/PROTEINS. TRANSCRIPTION FACTORS (TFS) OF DIFFERENTIALLY EXPRESSED GENES WERE IDENTIFIED BASED ON TRANSFAC DATABASE AND THEN A REGULATORY NETWORK WAS CONSTRUCTED. RESULTSTHROUGH CONSTRUCTING THE DYSREGULATED CERNA NETWORK, 6 GENES (HSPA4L, PANK3, YOD1, CTNNBIP1, EVI2B, ITGAL) AND 3 MIRNAS (MIR-125A-3P, MIR-200A, MIR-142-3P) WERE DETECTED. THREE LNCRNAS (MALAT1, TUG1, FGD5-AS1) WERE FOUND TO TARGET BOTH MIR-125A-3P AND MIR-142-3P IN THIS CERNA NETWORK. PROTEIN-PROTEIN INTERACTION NETWORK ANALYSIS IDENTIFIED SEVERAL HUB GENES, INCLUDING VCAM1, ITGA4, UBC, LYN AND SSX2IP. THREE PATHWAYS (CYTOKINE-CYTOKINE RECEPTOR, CELL ADHESION MOLECULES, CHEMOKINE SIGNALING PATHWAY) WERE IDENTIFIED TO BE OVERLAPPING RESULTS WITH THE PREVIOUS BIOINFORMATICS STUDIES IN PERIODONTITIS. MOREOVER, 2 TFS INCLUDING FOS AND EGR WERE IDENTIFIED TO BE INVOLVED IN THE REGULATORY NETWORK OF THE DIFFERENTIALLY EXPRESSED GENES-TFS IN PERIODONTITIS. CONCLUSIONTHESE FINDINGS SUGGEST THAT 6 MRNAS (HSPA4L, PANK3, YOD1, CTNNBIP1, EVI2B, ITGAL), 3 MIRNAS (HSA-MIR-125A-3P, HSA-MIR-200A, HSA-MIR-142-3P) AND 3 LNCRNAS (MALAT1, TUG1, FGD5-AS1) MIGHT BE INVOLVED IN THE LNCRNA-ASSOCIATED CERNA NETWORK OF PERIODONTITIS. THIS STUDY SOUGHT TO ILLUMINATE FURTHER THE GENETIC AND EPIGENETIC MECHANISMS OF PERIODONTITIS THROUGH CONSTRUCTING AN LNCRNA-ASSOCIATED CERNA NETWORK.","CERNA; GENE EXPRESSION DATA; LNCRNA; MIRNA; MRNA; PERIODONTITIS; REGULATORY NETWORK","ORAL INFLAMMATORY DISEASES; OSTEOBLAST DIFFERENTIATION; MICRORNA EXPRESSION; POTENTIAL ROLE; GROWTH-FACTOR; CELLS; CANCER; CYTOKINES; TISSUES; GENES","ENGLISH","ARTICLE","ARTICLE",0,"ARABACI TANER, 2010, EUR J DENT, V4, P454.;BAKTHAVATCHALU V, 2011, MOL ORAL MICROBIOL, V26, P303, DOI 10.1111/J.2041-1014.2011.00619.X.;CAO FD, 2017, MOL MED REP, V16, P9301, DOI 10.3892/MMR.2017.7821.;COVANI U, 2008, J PERIODONTOL, V79, P1974, DOI [10.1902/JOP.2008.080062, 10.1902/JOP.2008.080062 ].;CRAWFORD JM, 1994, CRIT REV ORAL BIOL M, V5, P91, DOI 10.1177/10454411940050020301.;EGUCHI T, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0058796.;FABIAN TK, 2009, EUR J INFLAMM, V7, P53.;FABIAN TK, 2007, ARCH IMMUNOL THER EX, V55, P91, DOI 10.1007/S00005-007-0012-Z.;FORDHAM JB, 2016, SCI REP-UK, V6, DOI 10.1038/SREP24980.;GARLET GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402.;GRAVES DT, 1999, CLIN INFECT DIS, V28, P482, DOI 10.1086/515178.;GUO LJ, 2014, EXP CELL RES, V321, P142, DOI 10.1016/J.YEXCR.2013.12.001.;GUO XX, 2015, MOL MED REP, V11, P2541, DOI 10.3892/MMR.2014.3031.;HERBERT BA, 2016, INFECT IMMUN, V85.;HU WH, 2013, MOL MED REP, V7, P689, DOI 10.3892/MMR.2012.1207.;JOHNSON RB, 1999, J PERIODONTOL, V70, P848, DOI 10.1902/JOP.1999.70.8.848.;KEBSCHULL M, 2013, J DENT RES, V92, P1081, DOI 10.1177/0022034513506011.;KEBSCHULL M, 2015, PERIODONTOL 2000, V69, P201, DOI 10.1111/PRD.12095.;KIM J, 2006, ODONTOLOGY, V94, P10, DOI 10.1007/S10266-006-0060-6.;KUNG JTY, 2013, GENETICS, V193, P651, DOI 10.1534/GENETICS.112.146704.;KUROGANE Y, 2012, ARTERIOSCL THROM VAS, V32, P988, DOI 10.1161/ATVBAHA.111.244004.;LEE YH, 2011, BIOCELL, V35, PB43.;LI ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/JBC.M809787200.;LIMA PMA, 2011, J PERIODONTOL, V82, P86, DOI 10.1902/JOP.2010.100248.;LIU N, 2011, J BONE MINER RES, V26, P2082, DOI 10.1002/JBMR.440.;MACFARLANE LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895.;MANIKANDAN M, 2016, MOL CANCER, V15, DOI 10.1186/S12943-016-0512-8.;MEYLE J, 2015, PERIODONTOL 2000, V69, P7, DOI 10.1111/PRD.12104.;MUKHERJEE N, 2016, BBA-MOL BASIS DIS, V1862, P1472, DOI 10.1016/J.BBADIS.2016.05.009.;OGATA Y, 2014, J ORAL SCI, V56, P253, DOI 10.2334/JOSNUSD.56.253.;OHSHIMA M, 2010, J DENT RES, V89, P1315, DOI 10.1177/0022034510378423.;PARK NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736.;SALMENA L, 2011, CELL, V146, P353, DOI 10.1016/J.CELL.2011.07.014.;SANGANI R, 2015, MOL CELL ENDOCRINOL, V410, P19, DOI 10.1016/J.MCE.2015.01.007.;SCHMALZ G., 2016, BIOMED RES INT, V2016, DOI DOI 10.1155/2016/102752527429973.;SEO B, 2016, ARCH ORAL BIOL, V69, P1, DOI 10.1016/J.ARCHORALBIO.2016.04.009.;SILVA TA, 2007, J DENT RES, V86, P306, DOI 10.1177/154405910708600403.;SONG L, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/S12903-015-0086-7.;SRINIVASAN PC, 2016, S. AFR. DENT. J., V71, P26.;SUN Y, 2008, FEMS IMMUNOL MED MIC, V52, P362, DOI 10.1111/J.1574-695X.2008.00386.X.;TAMURA I, 2008, J PERIODONTAL RES, V43, P305, DOI 10.1111/J.1600-0765.2007.01030.X.;TANG WX, 2016, INT J CHRONIC OBSTR, V11, P2951, DOI 10.2147/COPD.S109570.;TIWARI A, 2014, J BIOL CHEM, V289, P32276, DOI 10.1074/JBC.M114.584136.;TRABANDT A, 1992, J ORAL PATHOL MED, V21, P232, DOI 10.1111/J.1600-0714.1992.TB00108.X.;WU TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/JBC.M111.292722.;YAO QW, 2014, TUMOR BIOL, V35, P7073, DOI 10.1007/S13277-014-1951-8.;ZHAO G, 2016, FEBS LETT, V590, P2884, DOI 10.1002/1873-3468.12315.;ZOU YG, 2015, J CELL BIOCHEM, V116, P640, DOI 10.1002/JCB.25015.","ZIEBOLZ, D (REPRINT AUTHOR), UNIV LEIPZIG, DEPT CARIOL ENDODONTOL \& PERIODONTOL, LEIPZIG, GERMANY.;LI, S., HAAK, R., SCHMIDT, J., SCHMALZ, G., ZIEBOLZ, D., UNIV LEIPZIG, DEPT CARIOL ENDODONTOL \& PERIODONTOL, LEIPZIG, GERMANY.;LIU, X., DENG, Y., SHANGHAI GENOMAP TECHNOL, SHANGHAI, PEOPLES R CHINA.;LIU, X., HARBIN MED UNIV, COLL BIOINFORMAT SCI \& TECHNOL, HARBIN, HEILONGJIANG, PEOPLES R CHINA.;LI, H., UNIV LEIPZIG, SAXON INCUBATOR CLIN TRANSLAT SIKT, LEIPZIG, GERMANY.;PAN, H., HARVARD UNIV, HARVARD MED SCH, BRIGHAM \& WOMENS HOSP, DEPT ORTHOPED SURG, BOSTON, MA 02115 USA.;ACHARYA, A., UNIV HONG KONG, FAC DENT, HONG KONG, HONG KONG, PEOPLES R CHINA.;ACHARYA, A., DR DY PATIL VIDYAPEETH, DR DY PATIL DENT COLL \& HOSP, PUNE, MAHARASHTRA, INDIA.;YU, Y., HARBIN MED UNIV, STOMATOL AFFILIATED HOSP, DEPT PERIODONTOL, HARBIN, HEILONGJIANG, PEOPLES R CHINA.","10.1111/JRE.12539","111 RIVER ST, HOBOKEN 07030-5774, NJ USA",NA,NA,"CHINA SCHOLARSHIP COUNCIL [201608080010]","CHINA SCHOLARSHIP COUNCIL, GRANT/AWARD NUMBER: 201608080010.",NA,"0022-3484","4","495-505","WILEY","53",2018,"ISI000438208400002","48","DENTISTRY, ORAL SURGERY \& MEDICINE","4","DENTISTRY, ORAL SURGERY \& MEDICINE","DIRK.ZIEBOLZMEDIZIN.UNI-LEIPZIG.DE",NA,"GM5UN",NA,"ZIEBOLZ, D (REPRINT AUTHOR), UNIV LEIPZIG, DEPT CARIOL ENDODONTOL \& PERIODONTOL, LEIPZIG, GERMANY","ISI","UNIV LEIPZIG;SHANGHAI GENOMAP TECHNOL;HARBIN MED UNIV;UNIV LEIPZIG;HARVARD UNIV;UNIV HONG KONG;DR DY PATIL DENT COLL AND HOSP;HARBIN MED UNIV","UNIV LEIPZIG",NA,"LI S, 2018, J PERIODONT RES","LI S, 2018, J PERIODONT RES"
"ANNA A, 2018, J APPL GENETICS","ANNA A;MONIKA G","SPLICING MUTATIONS IN HUMAN GENETIC DISORDERS: EXAMPLES, DETECTION, AND CONFIRMATION","JOURNAL OF APPLIED GENETICS","J. APPL. GENETICS","PRECISE PRE-MRNA SPLICING, ESSENTIAL FOR APPROPRIATE PROTEIN TRANSLATION, DEPENDS ON THE PRESENCE OF CONSENSUS ``CIS'' SEQUENCES","SPLICING MUTATION; SPLICEOSOME; PRE-MRNA SPLICING; SPLICING ENHANCERS AND SILENCERS","PRE-MESSENGER-RNA; SPINAL MUSCULAR-ATROPHY; DEEP INTRONIC MUTATIONS; FAMILIAL DYSAUTONOMIA; HUMAN-DISEASE; POLYPYRIMIDINE TRACT; STRUCTURE PREDICTION; NONSENSE MUTATIONS; BINDING PROTEINS; SEQUENCE MOTIFS","ENGLISH","REVIEW","ARTICLE",2,"AOYAMA Y, 2017, MOL MED REP, V15, P3879, DOI 10.3892/MMR.2017.6434.;AXELROD FB, 2011, PEDIATR RES, V70, P480, DOI 10.1203/PDR.0B013E31822E1825.;BARALLE D, 2005, J MED GENET, V42, P737, DOI 10.1136/JMG.2004.029538.;BERGSMA AJ, 2018, INT REV CEL MOL BIO, V335, P85, DOI 10.1016/BS.IRCMB.2017.07.008.;BRENDEL V, 2004, BIOINFORMATICS, V20, P1157, DOI 10.1093/BIOINFORMATICS/BTH058.;BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O.;BUHLER M, 2005, RNA, V11, P139, DOI 10.1261/RNA.7183805.;BURGE C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/JMBI.1997.0951.;CACERES JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9.;CAMINSKY NATASHA, 2014, F1000RES, V3, P282, DOI 10.12688/F1000RESEARCH.5654.1.;CARMEL I, 2004, RNA, V10, P828, DOI 10.1261/RNA.5196404.;CARTEGNI L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/NRG775.;CARTEGNI L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853.;CARTEGNI L, 2002, NAT GENET, V30, P377, DOI 10.1038/NG854.;CARTEGNI L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/NAR/GKG616.;CHABOT B, 2016, J CELL BIOL, V212, P13, DOI 10.1083/JCB.201510032.;CHEN M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/NRM2777.;CHIRIBOGA CA, 2017, EXPERT REV NEUROTHER, V17, P955, DOI 10.1080/14737175.2017.1364159.;CORVELO A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/JOURNAL.PCBI.1001016.;CUAJUNGCO MP, 2003, AM J HUM GENET, V72, P749, DOI 10.1086/368263.;DESMET FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/NAR/GKP215.;DIVINA P, 2009, EUR J HUM GENET, V17, P759, DOI 10.1038/EJHG.2008.257.;DOGAN RI, 2007, NUCLEIC ACIDS RES, V35, PW285, DOI 10.1093/NAR/GKM407.;ERKELENZ S, 2014, NUCLEIC ACIDS RES, V42, P10681, DOI 10.1093/NAR/GKU736.;FAIRBROTHER WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/SCIENCE.1073774.;FANG LJ, 2001, J MOL BIOL, V307, P1261, DOI 10.1006/JMBI.2001.4561.;FAUSTINO NA, 2003, GENE DEV, V17, P419, DOI 10.1101/GAD.1048803.;FREDERICKS AM, 2015, BIOMOLECULES, V5, P893, DOI 10.3390/BIOM5020893.;GEUENS T, 2016, HUM GENET, V135, P851, DOI 10.1007/S00439-016-1683-5.;GLISOVIC T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/J.FEBSLET.2008.03.004.;GOREN A, 2006, MOL CELL, V22, P769, DOI 10.1016/J.MOLCEL.2006.05.008.;GRODECKA L, 2017, INT J MOL SCI, V18, DOI 10.3390/IJMS18081668.;HABARA Y, 2009, J MED GENET, V46, P542, DOI 10.1136/JMG.2008.061259.;HAN SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396.;HAUSS OLIVER, 2007, V375, P151.;HEBSGAARD SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/NAR/24.17.3439.;HORI T, 2013, HUM MUTAT, V34, P473, DOI 10.1002/HUMU.22258.;IBRAHIM EC, 2007, HUM MUTAT, V28, P41, DOI 10.1002/HUMU.20401.;JEDRZEJOWSKA M, 2010, NEUROEPIDEMIOLOGY, V34, P152, DOI 10.1159/000275492.;JIAN XQ, 2014, NUCLEIC ACIDS RES, V42, P13534, DOI 10.1093/NAR/GKU1206.;KANSAKOSKI J, 2016, SCI REP-UK, V6, DOI 10.1038/SREP32819.;KASHIMA T, 2007, HUM MOL GENET, V16, P3149, DOI 10.1093/HMG/DDM276.;KHAN SG, 2010, HUM MUTAT, V31, P167, DOI 10.1002/HUMU.21166.;KNUDSEN B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/NAR/GKG614.;KOL G, 2005, HUM MOL GENET, V14, P1559, DOI 10.1093/HMG/DDI164.;KOLOVOS P, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-1.;KRAWCZAK M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/HUMU.20400.;LEE Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/ANNUREV-BIOCHEM-060614-034316.;LEWANDOWSKA MA, 2013, INT J CLIN EXP PATHO, V6, P2675.;LIM KH, 2012, BIOINFORMATICS, V28, P1031, DOI 10.1093/BIOINFORMATICS/BTS074.;LIM KH, 2011, P NATL ACAD SCI USA, V108, P11093, DOI 10.1073/PNAS.1101135108.;MCALINDEN A, 2008, HUM MUTAT, V29, P83, DOI 10.1002/HUMU.20603.;MESSIAEN L. M., 2008, V16, P63, DOI 10.1159/000126545.;MORT M, 2014, GENOME BIOL, V15, DOI 10.1186/GB-2014-15-1-R19.;NISSIM-RAFINIA M, 2004, EMBO REP, V5, P1071, DOI 10.1038/SJ.EMBOR.7400273.;NISSIM-RAFINIA M, 2002, TRENDS GENET, V18, P123, DOI 10.1016/S0168-9525(01)02619-1.;OHNO K, 2018, WIRES RNA, V9, DOI 10.1002/WRNA.1451.;PALHAIS B, 2016, MOL GENET METAB, V119, P258, DOI 10.1016/J.YMGME.2016.08.007.;PARADA GE, 2014, NUCLEIC ACIDS RES, V42, P10564, DOI 10.1093/NAR/GKU744.;PERTEA M, 2001, NUCLEIC ACIDS RES, V29, P1185, DOI 10.1093/NAR/29.5.1185.;PIVA F, 2012, HUM MUTAT, V33, P81, DOI 10.1002/HUMU.21609.;PROS EVA, 2008, HUM MUTAT, V29, PE173, DOI 10.1002/HUMU.20826.;PROS E, 2009, HUM MUTAT, V30, P454, DOI 10.1002/HUMU.20933.;RAHMAN MA, 2015, J INVESTIG GENOMICS, V2.;RAMALHO AS, 2003, J MED GENET, V40, DOI 10.1136/JMG.40.7.E88.;RAPONI M, 2011, HUM MUTAT, V32, P436, DOI 10.1002/HUMU.21458.;REESE MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/CMB.1997.4.311.;ROGOZIN IB, 1997, J MOL EVOL, V45, P50, DOI 10.1007/PL00006200.;SANZ DJ, 2017, PLOS ONE, V12, DOI 10.1371/JOURNAL.PONE.0184009.;SCHWARTZ S, 2009, NUCLEIC ACIDS RES, V37, PW189, DOI 10.1093/NAR/GKP320.;SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/NAR/15.17.7155.;SHARMA N, 2014, HUM MUTAT, V35, P1249, DOI 10.1002/HUMU.22624.;SHIBATA A, 2016, J HUM GENET, V61, P633, DOI 10.1038/JHG.2016.23.;SINGH G, 2006, BIOTECHNIQUES, V41, P177, DOI 10.2144/0001112208.;SIVA K, 2014, NUCLEIC ACID THER, V24, P69, DOI 10.1089/NAT.2013.0461.;SLAUGENHAUPT SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810.;SMITH PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/HMG/DDL171.;SOBCZYNSKA-TOMASZEWSKA A, 2013, EUR J HUM GENET, V21, P391, DOI 10.1038/EJHG.2012.180.;STERNE-WEILER T, 2014, GENOME BIOL, V15, DOI 10.1186/GB4150.;SVAASAND EK, 2015, HEREDITARY GENET, V4, P152.;SYMOENS S, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0020121.;TAKAHARA K, 2002, AM J HUM GENET, V71, P451, DOI 10.1086/342099.;TAZI J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/J.BBADIS.2008.09.017.;THERY JC, 2011, EUR J HUM GENET, V19, P1052, DOI 10.1038/EJHG.2011.100.;TURUNEN JJ, 2013, WIRES RNA, V4, P61, DOI 10.1002/WRNA.1141.;VAN DE WATER NS, 2004, J THROMB HAEMOST, V2, P2073, DOI 10.1111/J.1538-7836.2004.00989.X.;VAZ-DRAGO R, 2017, HUM GENET, V136, P1093, DOI 10.1007/S00439-017-1809-4.;VELTROP M, 2014, EXP CELL RES, V325, P50, DOI 10.1016/J.YEXCR.2014.01.026.;WAGNER EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001.;WANG J, 2002, MOL CELL, V10, P951, DOI 10.1016/S1097-2765(02)00635-4.;WANG ZF, 2004, CELL, V119, P831, DOI 10.1016/J.CELL.2004.11.010.;WARD AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/PATH.2649.;WIMMER K, 2007, HUM MUTAT, V28, P599, DOI 10.1002/HUMU.20493.;XIONG F, 2009, EUR J HUM GENET, V17, P510, DOI 10.1038/EJHG.2008.219.;XIONG HY, 2015, SCIENCE, V347, DOI 10.1126/SCIENCE.1254806.;XU WH, 2014, INT J MOL MED, V34, P53, DOI 10.3892/IJMM.2014.1756.;YEO G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418.;ZENG L, 2013, MOL VIS, V19, P2244.;ZHANG CL, 2008, P NATL ACAD SCI USA, V105, P5797, DOI 10.1073/PNAS.0801692105.;ZHANG XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/GAD.1195304.;ZHANG Z, 2008, CELL, V133, P585, DOI 10.1016/J.CELL.2008.03.031.;ZUKER M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/NAR/GKG595.","MONIKA, G (REPRINT AUTHOR), INST MOTHER \& CHILD HLTH, DEPT MED GENET, KASPRZAKA 17A, PL-01211 WARSAW, POLAND.;ANNA, ABRAMOWICZ, MONIKA, GOS, INST MOTHER \& CHILD HLTH, DEPT MED GENET, KASPRZAKA 17A, PL-01211 WARSAW, POLAND.","10.1007/S13353-018-0444-7","TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY",NA,NA,"INSTITUTE OF MOTHER AND CHILD INTRAMURAL GRANTS, POLISH NATIONAL SCIENCE CENTRE [UMO-2013/09/B/NZ2/03164]","THE STUDIES ON NEUROFIBROMATOSIS TYPE I AND OTHER RASOPATHIES ARE POSSIBLE THANKS TO THE INSTITUTE OF MOTHER AND CHILD INTRAMURAL GRANTS AND POLISH NATIONAL SCIENCE CENTRE GRANT UMO-2013/09/B/NZ2/03164.",NA,"1234-1983","3","253-268","SPRINGER HEIDELBERG","59",2018,"ISI000438138600002","102","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","5","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","MONIKA.GOSIMID.MED.PL",NA,"GM5AJ",NA,"MONIKA, G (REPRINT AUTHOR), INST MOTHER \& CHILD HLTH, DEPT MED GENET, KASPRZAKA 17A, PL-01211 WARSAW, POLAND","ISI","INST MOTHER AND CHILD HLTH","INST MOTHER AND CHILD HLTH",NA,"ANNA A, 2018, J APPL GENETICS","ANNA A, 2018, J APPL GENETICS"
"JAFARBEKLOO A, NA, VECTOR-BORNE ZOONOTIC DIS","JAFARBEKLOO A;RAMZGOUYAN MR;SHIRIAN S;TAJEDIN L;BAKHSHI H;FAGHIHI F;SEDAGHAT M;TELMADARRAIY Z","MOLECULAR CHARACTERIZATION AND PHYLOGENETIC ANALYSIS OF THEILERIA SPP. AND BABESIA SPP. ISOLATED FROM VARIOUS TICKS IN SOUTHEASTERN AND NORTHWESTERN REGIONS OF IRAN","VECTOR-BORNE AND ZOONOTIC DISEASES","VECTOR-BORNE ZOONOTIC DIS.","INTRODUCTION: PIROPLASMS ARE HEMOPROTOZOA COMPRISING HETEROGENEOUS TICK-BORNE PARASITES, WHICH ARE DIFFERENTIATED INTO THREE GENERA, NAMELY BABESIA, THEILERIA, AND CYTAUXZOON. THE AIM OF THIS STUDY WAS TO DETERMINE THE PREVALENCE, MOLECULAR IDENTIFICATION, AND PHYLOGENETIC RELATIONSHIP OF BOTH THEILERIA SPP. AND BABESIA SPP. IN TICK SPECIES ISOLATED FROM DIFFERENT DOMESTIC ANIMALS FROM TWO DIFFERENT GEOGRAPHICAL LOCATIONS OF IRAN. MATERIALS AND METHODS: A TOTAL OF 930 TICKS COLLECTED FROM GOATS, SHEEP, AND CATTLE WERE EXAMINED FOR THE PRESENCE OF THEILERIA SPP. AND BABESIA SPP. USING PCR TARGETING 18S RRNA GENE FOLLOWED BY SEQUENCING. SEQUENCE ANALYSIS WAS PERFORMED BASED ON THE DATA PUBLISHED IN THE GENBANK ON THEILERIA SPP. AND BABESIA SPP. ISOLATES USING BIOINFORMATIC TOOLS, SUCH AS THE STANDARD NUCLEOTIDE BLAST. RESULTS: A 390 OR 430 BASE PAIR FRAGMENT OF 18S RRNA GENE OF THEILERIA AND BABESIA SPECIES WAS SUCCESSFULLY AMPLIFIED IN 17.2\% OF THE EXAMINED TICKS (16OF 93). GENOME OF THEILERIA OR BABESIA SPECIES WAS DETECTED IN 4 TICKS COLLECTED IN HERIS, INCLUDING 3 DERMACENTOR MARGINATUS AND 1 RHIPICEPHALUS SANGUINEUS, AND ALSO IN 12 TICKS COLLECTED IN CHABAHAR, INCLUDING 10 R. SANGUINEUS AND 2 D. MARGINATUS. PARTIAL ANALYSIS OF 18S RRNA GENE SEQUENCE OF THE FOUR D. MARGINATUS, COLLECTED FROM GOATS AND SHEEP IN HERIS, SHOWED THAT THEY WERE INFECTED WITH THEILERIA SPP. THAT WERE 95-97\% IDENTICAL TO IRANIAN THEILERIA OVIS PRESENT IN THE GENBANK DATABASE (GENBANK ACC. NO. KP019206.1). WHILE THE FIVE R. SANGUINEUS, COLLECTED FROM SHEEP AND GOATS IN CHABAHAR, WERE INFECTED WITH BABESIA SPP. THAT WERE 91-97\% IDENTICAL TO IRANIAN BABESIA OVIS PRESENT IN THE GENBANK DATABASE (GENBANK ACC. NO. AY362829.1: KT587794.1). CONCLUSION: THE PREVALENCE OF BABESIA AND THEILERIA IS DIFFERENT IN SOUTHEASTERN AND NORTHWESTERN PARTS OF IRAN, WITH HIGHER PREVALENCE OF BABESIOSIS IN THE SOUTHEASTERN REGION AND THAT OF THEILERIOSIS IN THE NORTHWESTERN REGION. SEQUENCE ANALYSIS OF 18S RRNA GENE REVEALED THAT T. OVIS AND B. OVIS ARE GENETICALLY POLYMORPHIC IN THESE REGIONS.","THEILERIA; BABESIA; PHYLOGENY; TICKS; POLYMORPHISM","BLACK-SEA REGION; SHEEP; IDENTIFICATION; INFECTION; DIVERSITY; ALIGNMENT; TURKEY; GOATS","ENGLISH","ARTICLE, EARLY ACCESS","ARTICLE",0,"AHMED JS, 2006, ANN NY ACAD SCI, V1081, P498, DOI 10.1196/ANNALS.1373.074.;ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;AYDIN MF, 2015, PARASITOL RES, V114, P65, DOI 10.1007/S00436-014-4160-X.;AYDIN MF, 2013, PARASITOL RES, V112, P2817, DOI 10.1007/S00436-013-3452-X.;BEKLOO AJ, 2018, VECTOR-BORNE ZOONOT, V18, P252, DOI 10.1089/VBZ.2017.2219.;CACCIO C, 2000, INT J PARASITOL, V30, P1181, DOI 10.1016/S0020-7519(00)00105-3.;EL IMAM AHMED H., 2016, ANNALS OF PARASITIOLOGY, V62, P47, DOI 10.17420/AP6201.31.;JALALI SM, 2014, IRAN J PARASITOL, V9, P99.;KHAZENI A., 2013, JOURNAL OF BIOMEDICAL SCIENCE AND ENGINEERING, V6, P1.;LECLAIRE S, 2015, PARASITOLOGY, V142, P543, DOI 10.1017/S0031182014001504.;LIU JL, 2016, PARASITE VECTOR, V9, DOI 10.1186/S13071-016-1435-3.;MICHEL AO, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-65.;MISAWA K, 2000, MOL BIOL EVOL, V17, P1879, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A026289.;NAGORE D, 2004, INT J PARASITOL, V34, P1059, DOI 10.1016/J.IJPARA.2004.05.008.;NIU QL, 2009, PARASITOL RES, V104, P1417, DOI 10.1007/S00436-009-1344-X.;ONUMA M, 1998, COMP IMMUNOL MICROB, V21, P165, DOI 10.1016/S0147-9571(98)00008-3.;RANJBAR-BAHADORI S, 2012, PARASITOL RES, V110, P1531, DOI 10.1007/S00436-011-2658-Z.;SAGHAFI POUR A, 2014, J ZOONOSES, P54.;SCHNITTGER L, 2003, PARASITOL RES, V91, P398, DOI 10.1007/S00436-003-0979-2.;SPITALSKA E, 2005, SMALL RUMINANT RES, V57, P245, DOI 10.1016/J.SMALLRUMRES.2004.07.005.;VANSTREELS RET, 2015, INT J PARASITOL-PAR, V4, P198, DOI 10.1016/J.IJPPAW.2015.03.002.;THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/NAR/22.22.4673.;ZAEEMI M, 2011, PARASITOL RES, V2011, P4.","SHIRIAN, S (REPRINT AUTHOR), SHAHREKORD UNIV, SCH VET MED, DEPT PATHOL, SHAHREKORD 8818634141, IRAN.;FAGHIHI, F (REPRINT AUTHOR), IRAN UNIV MED SCI, DEPT BIOTECHNOL, CELLULAR \& MOL RES CTR, TEHRAN 14665354, IRAN.;JAFARBEKLOO, AHMAD, SEDAGHAT, MEHDI, TELMADARRAIY, ZAKKYEH, SCH PUBL HLTH, DEPT MED ENTOMOL \& VECTOR CONTROL, TEHRAN, IRAN.;JAFARBEKLOO, AHMAD, SHAHID BEHESHTI UNIV, DEPT HUMAN RIGHTS, TEHRAN, IRAN.;JAFARBEKLOO, AHMAD, RAMZGOUYAN, MARYAM ROYA, CHABAHAR GULF MARINE CO, DEPT RES \& DEV, CHABAHAR, IRAN.;RAMZGOUYAN, MARYAM ROYA, UNIV TEHRAN MED SCI, SCH ADV TECHNOL MED, DEPT TISSUE ENGN \& APPL CELL SCI, TEHRAN, IRAN.;SHIRIAN, SADEGH, SHAHREKORD UNIV, SCH VET MED, DEPT PATHOL, SHAHREKORD 8818634141, IRAN.;SHIRIAN, SADEGH, SHIRAZ MOL PATHOL RES CTR, DR DANESHBOD LAB, SHIRAZ, IRAN.;TAJEDIN, LEILA, UNIV OULU, FAC BIOCHEM \& MOL MED, DEPT BIOTECHNOL, OULU, FINLAND.;BAKHSHI, HASSAN, PII, MVRG, BRC, TEHRAN, IRAN.;FAGHIHI, FAEZEH, IRAN UNIV MED SCI, DEPT BIOTECHNOL, CELLULAR \& MOL RES CTR, TEHRAN 14665354, IRAN.","10.1089/VBZ.2018.2271","140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA",NA,NA,"CHABAHAR GULF MARINE COMPANY","THE AUTHORS THANK THE CHABAHAR GULF MARINE COMPANY FOR ITS SUPPORT.",NA,"1530-3667",NA,NA,"MARY ANN LIEBERT, INC",NA,NA,"ISI000438200200001","23","PUBLIC, ENVIRONMENTAL \& OCCUPATIONAL HEALTH, INFECTIOUS DISEASES","1","PUBLIC, ENVIRONMENTAL \& OCCUPATIONAL HEALTH, INFECTIOUS DISEASES","SHIRIAN85GMAIL.COM FAEZEFAGHIHIYAHOO.COM",NA,"GM5SF",NA,"SHIRIAN, S (REPRINT AUTHOR), SHAHREKORD UNIV, SCH VET MED, DEPT PATHOL, SHAHREKORD 8818634141, IRAN","ISI","SCH PUBL HLTH;SHAHID BEHESHTI UNIV;DEPT RES AND DEV;UNIV TEHRAN MED SCI;SHAHREKORD UNIV;SHIRAZ MOL PATHOL RES CTR;UNIV OULU;IRAN UNIV MED SCI","SHAHREKORD UNIV",NA,"JAFARBEKLOO A, NA, VECTOR-BORNE ZOONOTIC DIS","JAFARBEKLOO A, NA, VECTOR-BORNE ZOONOTIC DIS"
"KIEL M, 2018, FRONT MICROBIOL","KIEL M;SAGORY ZALKIND P;MIGANEH C;STORK C;LEIMBACH A;SEKSE C;MELLMANN A;RECHENMANN F;DOBRINDT U","IDENTIFICATION OF NOVEL BIOMARKERS FOR PRIORITY SEROTYPES OF SHIGA TOXIN-PRODUCING ESCHERICHIA COLI AND THE DEVELOPMENT OF MULTIPLEX PCR FOR THEIR DETECTION","FRONTIERS IN MICROBIOLOGY","FRONT. MICROBIOL.","IT WOULD BE DESIRABLE TO HAVE AN UNAMBIGUOUS SCHEME FOR THE TYPING OF SHIGA TOXIN-PRODUCING ESCHERICHIA COLI (STEC) ISOLATES TO SUBPOPULATIONS. SUCH A SCHEME SHOULD TAKE THE HIGH GENOMIC PLASTICITY OF E. COLI INTO ACCOUNT AND UTILIZE THE STRATIFICATION OF STEC INTO SUBGROUPS, BASED ON SEROTYPE OR PHYLOGENY. THEREFORE, OUR GOAL WAS TO IDENTIFY SPECIFIC MARKER COMBINATIONS FOR IMPROVED CLASSIFICATION OF STEC SUBTYPES. WE DEVELOPED AND EVALUATED TWO BIOINFORMATIC PIPELINES FOR GENOMIC MARKER IDENTIFICATION FROM LARGER SETS OF BACTERIAL GENOME SEQUENCES. PIPELINE A PERFORMED ALL-AGAINST-ALL BLASTP ANALYSES OF GENE PRODUCTS PREDICTED IN STEC GENOME TEST SETS AGAINST A SET OF CONTROL GENOMES. PIPELINE B IDENTIFIED STEC MARKER GENES BY COMPARING THE STEC CORE PROTEOME AND THE ``PAN PROTEOME'' OF A NON-STEC CONTROL GROUP.","STEC; O157; NON-O157; MULTIPLEX PCR; COMPARATIVE GENOMICS","REAL-TIME PCR; HEMOLYTIC-UREMIC SYNDROME; ANTIGEN GENE-CLUSTER; FOOD SAFETY; BOVINE MASTITIS; UNITED-STATES; OUTBREAK; STRAINS; PATHOGENS; NON-O157","ENGLISH","ARTICLE","ARTICLE",0,"AHMED N, 2008, NAT REV MICROBIOL, V6, P387, DOI 10.1038/NRMICRO1889.;ANDREWS S., 2010, FASTQC QUALITY CONTR.;ARANDA KRS, 2007, FEMS MICROBIOL LETT, V267, P145, DOI 10.1111/J.1574-6968.2006.00580.X.;ASHRAF A, 2017, MOL CELL PROBE, V33, P57, DOI 10.1016/J.MCP.2017.03.004.;BAI XN, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/FCIMB.2018.00125.;BANKEVICH A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/CMB.2012.0021.;BEUTIN L, 2012, J FOOD PROTECT, V75, P408, DOI 10.4315/0362-028X.JFP-11-452.;BIELASZEWSKA M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7.;BLANCO A, 2004, J CLIN MICROBIOL, V42, P645, DOI 10.1128/JCM.42.2.645-651.2004.;BRADLEY P, 2017, BIORXIV, DOI [10.1101/234955, DOI 10.1101/234955].;BROOKS JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536.;BUCHHOLZ U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMOA1106482.;BUGAREL M, 2010, INT J FOOD MICROBIOL, V142, P318, DOI 10.1016/J.IJFOODMICRO.2010.07.010.;BUTCHER H, 2016, EPIDEMIOL INFECT, V144, P2812, DOI 10.1017/S0950268816000509.;CHATTAWAY MA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/FMICB.2016.00258.;CLERMONT O, 2015, MICROBIOL-SGM, V161, P980, DOI 10.1099/MIC.0.000063.;CRESSIER B, 2011, J DAIRY SCI, V94, P2171, DOI 10.3168/JDS.2010-3669.;CROXEN MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13.;DE LANNOY CARLOS, 2017, F1000RES, V6, P1083, DOI 10.12688/F1000RESEARCH.12012.2.;DEBROY C, 2016, PLOS ONE, V11, DOI 10.1371/JOURNAL.PONE.0147434.;DEBROY C, 2011, FOODBORNE PATHOG DIS, V8, P651, DOI 10.1089/FPD.2010.0769.;DELANNOY S, 2016, ENVIRON SCI POLLUT R, V23, P8163, DOI 10.1007/S11356-015-5446-Y.;DELANNOY S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/FMICB.2016.00001.;DELANNOY S, 2013, J CLIN MICROBIOL, V51, P3257, DOI 10.1128/JCM.01471-13.;DELANNOY S, 2013, J CLIN MICROBIOL, V51, P1083, DOI 10.1128/JCM.02864-12.;DELANNOY S, 2012, J CLIN MICROBIOL, V50, P4035, DOI 10.1128/JCM.02097-12.;DELANNOY S, 2012, J CLIN MICROBIOL, V50, P3485, DOI 10.1128/JCM.01656-12.;DIDELOT X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-256.;DIDELOT X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/NRG3226.;EFSA, 2016, EFSA J, V14, DOI 10.2903/J.EFSA.2016.4375.;EFSA PANEL ON BIOLOGICAL HAZARDS (BIOHAZ), 2013, EFSA J, V11, P3138, DOI [10.2903/J.EFSA.2013.3138.EFSA,2013, DOI 10.2903/J.EFSA.2013.3138, 10.2903/J.EFSA.2013.3138].;EPPINGER MARK, 2015, GUT MICROBES, V6, P194, DOI 10.4161/19490976.2014.969979.;EUROPEAN COMMITTEE FOR STANDARDIZATION, 2012, 131362012 ISOTS EUR.;FRANZ E, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0120353.;FRANZ E, 2014, INT J FOOD MICROBIOL, V187, P57, DOI 10.1016/J.IJFOODMICRO.2014.07.002.;FRATAMICO PM, 2014, J FOOD PROTECT, V77, P180, DOI 10.4315/0362-028X.JFP-13-248.;FRATAMICO PM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/FCIMB.2012.00152.;FRUTH A, 2015, INT J MED MICROBIOL, V305, P697, DOI 10.1016/J.IJMM.2015.08.020.;GEUE L, 2014, MICROBIOL IMMUNOL, V58, P77, DOI 10.1111/1348-0421.12120.;GILMOUR MW, 2007, J MED MICROBIOL, V56, P620, DOI 10.1099/JMM.0.47053-0.;GUREVICH A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/BIOINFORMATICS/BTT086.;HARRIS LJ, 2003, COMPR REV FOOD SCI F, V2, P78, DOI DOI 10.1111/J.1541-4337.2003.TB00031.X.;HASMAN H, 2014, J CLIN MICROBIOL, V52, P139, DOI 10.1128/JCM.02452-13.;HEIMAN KE, 2015, EMERG INFECT DIS, V21, P1293, DOI 10.3201/EID2108.141364.;JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/PNAS.87.20.7839.;JOENSEN KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15.;JOENSEN KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13.;JOHNSON KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573.;KAAS RS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-577.;KARCH H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/J.IJMM.2005.06.009.;KARCH H, 2012, EMBO MOL MED, V4, P841, DOI 10.1002/EMMM.201201662.;KERANGART S, 2016, FOOD MICROBIOL, V59, P32, DOI 10.1016/J.FM.2016.05.005.;KINTZ E, 2017, INT J HYG ENVIR HEAL, V220, P57, DOI 10.1016/J.IJHEH.2016.10.011.;KRZYWINSKI M, 2009, GENOME RES, V19, P1639, DOI 10.1101/GR.092759.109.;LAING CR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/FMICB.2017.01345.;LAMBERT D, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0122928.;LAVER T., 2015, BIOMOL DETECT QUANTI, V3, P1, DOI DOI 10.1016/J.BDQ.2015.02.001.;LECHNER M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124.;LEE K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/FMICB.2017.00701.;LEFTEROVA MI, 2013, J CLIN MICROBIOL, V51, P3000, DOI 10.1128/JCM.00991-13.;LEIMBACH A, 2017, BMC GENOMICS, V18, DOI 10.1186/S12864-017-3739-X.;LEOPOLD SR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-183.;LI H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/BIOINFORMATICS/BTP324.;LIN A, 2011, J MICROBIOL METH, V87, P105, DOI 10.1016/J.MIMET.2011.07.019.;LIN A, 2011, FOOD MICROBIOL, V28, P478, DOI 10.1016/J.FM.2010.10.007.;LINDSEY RL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/FMICB.2016.00766.;LU HY, 2016, GENOM PROTEOM BIOINF, V14, P265, DOI 10.1016/J.GPB.2016.05.004.;LUEDTKE BE, 2014, J MICROBIOL METH, V105, P72, DOI 10.1016/J.MIMET.2014.07.015.;MARTINEZ-CASTILLO A, 2013, APPL ENVIRON MICROB, V79, P4862, DOI 10.1128/AEM.01158-13.;MELLMANN A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/EID1408.071082.;MELLMANN A, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0022751.;NEWELL DG, 2018, TRANSBOUND EMERG DIS, V65, P49, DOI 10.1111/TBED.12789.;PAGE AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/BIOINFORMATICS/BTV421.;PARSONS BD, 2016, FRONT MICROBIOL, V7, DOI 10.3389/FMICB.2016.00478.;PIELAAT A, 2015, INT J FOOD MICROBIOL, V213, P130, DOI 10.1016/J.IJFOODMICRO.2015.04.009.;RICE P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2.;SANCHEZ S, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0117660.;SCHEUTZ F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12.;SCHMIDT H, 1995, INFECT IMMUN, V63, P1055.;SEEMANN T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/BIOINFORMATICS/BTU153.;SEKSE C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/FMICB.2017.02029.;SHOME BR, 2011, J APPL MICROBIOL, V111, P1349, DOI 10.1111/J.1365-2672.2011.05169.X.;SIEVERS F, 2011, MOL SYST BIOL, V7, DOI 10.1038/MSB.2011.75.;STAMATAKIS A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/BIOINFORMATICS/BTU033.;STEVENS EL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/FMICB.2017.00808.;TABOADA EN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/FMICB.2017.00909.;TERAJIMA J, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/MICROBIOLSPEC.EHEC-0011-2013.;TOUCHON M, 2009, PLOS GENET, V5, DOI 10.1371/JOURNAL.PGEN.1000344.;WANG F, 2013, FOODBORNE PATHOG DIS, V10, P665, DOI 10.1089/FPD.2012.1448.;WANG GQ, 2011, WORLD J GASTROENTERO, V17, P1910, DOI 10.3748/WJG.V17.I14.1910.;WERBER D, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-11.;WHITESIDE MD, 2016, BMC MICROBIOL, V16, DOI 10.1186/S12866-016-0680-0.;WIRTH T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/J.1365-2958.2006.05172.X.;WONG SY, 2014, ENVIRON SCI TECHNOL, V48, P11462, DOI 10.1021/ES502794H.;YENI F, 2016, CRIT REV FOOD SCI, V56, P1532, DOI 10.1080/10408398.2013.777021.;ZERBINO DR, 2008, GENOME RES, V18, P821, DOI 10.1101/GR.074492.107.;ZHOU Y, 2011, NUCLEIC ACIDS RES, V39, PW347, DOI 10.1093/NAR/GKR485.","DOBRINDT, U (REPRINT AUTHOR), UNIV MUNSTER, INST HYG, MUNSTER, GERMANY.;KIEL, MATTHIAS, STORK, CHRISTOPH, LEIMBACH, ANDREAS, MELLMANN, ALEXANDER, DOBRINDT, ULRICH, UNIV MUNSTER, INST HYG, MUNSTER, GERMANY.;SAGORY-ZALKIND, PIERRE, MIGANEH, CELINE, RECHENMANN, FRANCOIS, GENOSTAR BIOINFORMAT, MONTBONNOT ST MARTIN, FRANCE.;SEKSE, CAMILLA, NORWEGIAN VET INST, OSLO, NORWAY.","10.3389/FMICB.2018.01321","AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND","1321",NA,"EUROPEAN COMMISSION IN THE 7TH FRAMEWORK PROGRAMME WITHIN THE DECATHLON PROJECT [FP7-KBBE-2013-7-613908-DECATHLON]","THIS STUDY WAS FUNDED BY THE EUROPEAN COMMISSION IN THE 7TH FRAMEWORK PROGRAMME WITHIN THE DECATHLON PROJECT (FP7-KBBE-2013-7-613908-DECATHLON).",NA,"1664-302X",NA,NA,"FRONTIERS MEDIA SA","9",2018,"ISI000436262500001","97","MICROBIOLOGY","3","MICROBIOLOGY","DOBRINDTUNI-MUENSTER.DE",NA,"GK6AJ",NA,"DOBRINDT, U (REPRINT AUTHOR), UNIV MUNSTER, INST HYG, MUNSTER, GERMANY","ISI","UNIV MUNSTER;NORWEGIAN VET INST","UNIV MUNSTER",NA,"KIEL M, 2018, FRONT MICROBIOL","KIEL M, 2018, FRONT MICROBIOL"
"SIMON LM, 2018, GIGASCIENCE","SIMON LM;KARG S;WESTERMANN AJ;ENGEL M;ELBEHERY AHA;HENSE B;HEINIG M;DENG L;THEIS FJ","METAMAP: AN ATLAS OF METATRANSCRIPTOMIC READS IN HUMAN DISEASE-RELATED RNA-SEQ DATA","GIGASCIENCE","GIGASCIENCE","BACKGROUND: WITH THE ADVENT OF THE AGE OF BIG DATA IN BIOINFORMATICS, LARGE VOLUMES OF DATA AND HIGH-PERFORMANCE COMPUTING POWER ENABLE RESEARCHERS TO PERFORM RE-ANALYSES OF PUBLICLY AVAILABLE DATASETS AT AN UNPRECEDENTED SCALE. EVER MORE STUDIES IMPLY THE MICROBIOME IN BOTH NORMAL HUMAN PHYSIOLOGY AND A WIDE RANGE OF DISEASES. RNA SEQUENCING TECHNOLOGY (RNA-SEQ) IS COMMONLY USED TO INFER GLOBAL EUKARYOTIC GENE EXPRESSION PATTERNS UNDER DEFINED CONDITIONS, INCLUDING HUMAN DISEASE-RELATED CONTEXTS, HOWEVER, ITS GENERIC NATURE ALSO ENABLES THE DETECTION OF MICROBIAL AND VIRAL TRANSCRIPTS. FINDINGS: WE DEVELOPED A BIOINFORMATIC PIPELINE TO SCREEN EXISTING HUMAN RNA-SEQ DATASETS FOR THE PRESENCE OF MICROBIAL AND VIRAL READS BY RE-INSPECTING THE NON-HUMAN-MAPPING READ FRACTION. WE VALIDATED THIS APPROACH BY RECAPITULATING OUTCOMES FROM SIX INDEPENDENT, CONTROLLED INFECTION EXPERIMENTS OF CELL LINE MODELS AND COMPARED THEM WITH AN ALTERNATIVE METATRANSCRIPTOMIC MAPPING STRATEGY. WE THEN APPLIED THE PIPELINE TO CLOSE TO 150 TERABYTES OF PUBLICLY AVAILABLE RAW RNA-SEQ DATA FROM MORE THAN 17,000 SAMPLES FROM MORE THAN 400 STUDIES RELEVANT TO HUMAN DISEASE USING STATE-OF-THE-ART HIGH-PERFORMANCE COMPUTING SYSTEMS. THE RESULTING DATA FROM THIS LARGE-SCALE RE-ANALYSIS ARE MADE AVAILABLE IN THE PRESENTED METAMAP RESOURCE. CONCLUSIONS: OUR RESULTS DEMONSTRATE THAT COMMON HUMAN RNA-SEQ DATA, INCLUDING THOSE ARCHIVED IN PUBLIC REPOSITORIES, MIGHT CONTAIN VALUABLE INFORMATION TO CORRELATE MICROBIAL AND VIRAL DETECTION PATTERNS WITH DIVERSE DISEASES. THE PRESENTED METAMAP DATABASE THUS PROVIDES A RICH RESOURCE FOR HYPOTHESIS GENERATION TOWARD THE ROLE OF THE MICROBIOME IN HUMAN DISEASE. ADDITIONALLY, CODES TO PROCESS NEW DATASETS AND PERFORM STATISTICAL ANALYSES ARE MADE AVAILABLE.","HIGH-PERFORMANCE COMPUTING; BIG DATA; RNA-SEQ; SEQUENCE READ ARCHIVE; METATRANSCRIPTOMICS; MICROBIOME; VIROME; HUMAN DISEASE; INFECTION","MICROBIOME; OBESITY; PATHOGEN; GENOMES; HEALTH; HOST","ENGLISH","ARTICLE, DATA PAPER","ARTICLE",0,"ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;BAI JW, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0118286.;BONFERT T, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0073071.;CANI PD, 2008, DIABETES, V57, P1470, DOI 10.2337/DB07-1403.;CASTELLARIN M, 2012, GENOME RES, V22, P299, DOI 10.1101/GR.126516.111.;CONESA A, 2016, GENOME BIOL, V17, DOI 10.1186/S13059-016-0881-8.;COX MJ, 2013, HUM MOL GENET, V22, PR88, DOI 10.1093/HMG/DDT398.;DOBIN A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/BIOINFORMATICS/BTS635.;ENGEL M, 2017, PLOS ONE, V12, DOI 10.1371/JOURNAL.PONE.0180859.;ENGSTROM PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/NMETH.2722].;GOUIN A, 2015, HEREDITY, V114, P494, DOI 10.1038/HDY.2014.85.;HENAO-MEJIA J, 2012, NATURE, V482, P179, DOI 10.1038/NATURE10809.;IBN-SALEM J, 2014, GENOME BIOL, V15, DOI 10.1186/S13059-014-0423-1.;KODAMA Y, 2012, NUCLEIC ACIDS RES, V40, PD54, DOI 10.1093/NAR/GKR854.;KOSTIC AD, 2012, GENOME RES, V22, P292, DOI 10.1101/GR.126573.111.;LINDGREEN S, 2016, SCI REP-UK, V6, DOI 10.1038/SREP19233.;LISNIC VJ, 2013, PLOS PATHOG, V9, DOI 10.1371/JOURNAL.PPAT.1003611.;MANGUL S, 2016, BIORXIV, DOI [10.1101/057570, DOI 10.1101/057570].;MUKHERJEE S, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/1944-3277-10-18.;OUNIT R, 2016, BIOINFORMATICS, V32, P3823, DOI 10.1093/BIOINFORMATICS/BTW542.;PARK SJ, 2015, SCI REP-UK, V5, DOI 10.1038/SREP16512.;PENG XQ, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S5-S8.;RUTKOWSKI AJ, 2015, NAT COMMUN, V6, DOI 10.1038/NCOMMS8126.;SANTPERE G, 2014, GENOME BIOL EVOL, V6, P846, DOI 10.1093/GBE/EVU054.;SAXENA K, 2017, P NATL ACAD SCI USA, V114, PE570, DOI 10.1073/PNAS.1615422114.;SIMON LM, 2018, GIGASCIENCE DATABASE, DOI [10.5524/100456, DOI 10.5524/100456].;SIMON LM, 2018, METAMAP PIPELINE PRO, DOI [10.17504/PROTOCOLS.IO.MSEC6BE, DOI 10.17504/PROTOCOLS.IO.MSEC6BE].;STRONG MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/JOURNAL.PPAT.1004437.;TANGE O, 2011, THE USENIX MAGAZINE, V36, P42, DOI DOI 10.5281/ZEN0D0.16303.;TURNBAUGH PJ, 2006, NATURE, V444, P1027, DOI 10.1038/NATURE05414.;WANG ZN, 2011, NATURE, V472, P57, DOI 10.1038/NATURE09922.;WESOLOWSKAANDERSEN, 2017, GENOME BIOL, V18, DOI DOI 10.1186/S13059-016-1140-8.;WESTERMANN AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/JOURNAL.PPAT.1006033.;WESTERMANN AJ, 2016, NATURE, V529, P496, DOI 10.1038/NATURE16547.;WESTERMANN AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/NRMICRO2852.;XU GR, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0089445.;YOUNG VB, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/BMJ.J831.;ZHANG YX, 2016, CLIN CANCER RES, V22, P4735, DOI 10.1158/1078-0432.CCR-16-0323.","SIMON, LM, THEIS, FJ (REPRINT AUTHOR), HELMHOLTZ ZENTRUM MUNCHEN, GERMAN RES CTR ENVIRONM HLTH, INST COMPUTAT BIOL, INGOLSTADTER LANDSTR, D-185764 NEUHERBERG, GERMANY.;SIMON, L. M., KARG, S., ENGEL, M., HENSE, B., HEINIG, M., THEIS, F. J., HELMHOLTZ ZENTRUM MUNCHEN, GERMAN RES CTR ENVIRONM HLTH, INST COMPUTAT BIOL, INGOLSTADTER LANDSTR, D-185764 NEUHERBERG, GERMANY.;WESTERMANN, A. J., UNIV WURZBURG, INST MOL INFECT BIOL, WURZBURG, GERMANY.;WESTERMANN, A. J., HELMHOLTZ INST RNA BASED INFECT RES, WURZBURG, GERMANY.;ENGEL, M., HELMHOLTZ ZENTRUM MUNCHEN, GERMAN RES CTR ENVIRONM HLTH, SCI COMP RES UNIT, NEUHERBERG, GERMANY.;ELBEHERY, A. H. A., DENG, L., HELMHOLTZ ZENTRUM MUNCHEN, GERMAN RES CTR ENVIRONM HLTH, INST VIROL, NEUHERBERG, GERMANY.;THEIS, F. J., TECH UNIV MUNICH, MUNICH, GERMANY.","10.1093/GIGASCIENCE/GIY070","GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND",NA,NA,"EUROPEAN UNION'S HORIZON 2020 RESEARCH AND INNOVATION PROGRAMME UNDER THE MARIE SKLODOWSKA-CURIE GRANT AGREEMENT [753039], BAVARIAN STATE MINISTRY OF EDUCATION, SCIENCE, AND THE ARTS","L.S. ACKNOWLEDGES FUNDING FROM THE EUROPEAN UNION'S HORIZON 2020 RESEARCH AND INNOVATION PROGRAMME UNDER THE MARIE SKLODOWSKA-CURIE GRANT AGREEMENT (753039). THE OPERATION OF THE LRZ LINUX CLUSTER IS FUNDED VIA THE BAVARIAN STATE MINISTRY OF EDUCATION, SCIENCE, AND THE ARTS.",NA,"2047-217X","6",NA,"OXFORD UNIV PRESS","7",2018,"ISI000438576100001","38","SCIENCE \& TECHNOLOGY - OTHER TOPICS","0","MULTIDISCIPLINARY SCIENCES","LUKAS.SIMONHELMHOLTZ-MUENCHEN.DE FABIAN.THEISHELMHOLTZ-MUENCHEN.DE",NA,"GM9NM",NA,"SIMON, LM, THEIS, FJ (REPRINT AUTHOR), HELMHOLTZ ZENTRUM MUNCHEN, GERMAN RES CTR ENVIRONM HLTH, INST COMPUTAT BIOL, INGOLSTADTER LANDSTR, D-185764 NEUHERBERG, GERMANY","ISI","INST COMPUTAT BIOL;UNIV WURZBURG;HELMHOLTZ INST RNA BASED INFECT RES;GERMAN RES CTR ENVIRONM HLTH;INST VIROL;TECH UNIV MUNICH","INST COMPUTAT BIOL",NA,"SIMON LM, 2018, GIGASCIENCE","SIMON LM, 2018, GIGASCIENCE"
"ANKARKLEV J, 2018, INFECT GENET EVOL","ANKARKLEV J;LEBBAD M;EINARSSON E;FRANZEN O;AHOLA H;TROELL K;SVARD SG","A NOVEL HIGH-RESOLUTION MULTILOCUS SEQUENCE TYPING OF GIARDIA INTESTINALIS ASSEMBLAGE A ISOLATES REVEALS ZOONOTIC TRANSMISSION, CLONAL OUTBREAKS AND RECOMBINATION","INFECTION GENETICS AND EVOLUTION","INFECT. GENET. EVOL.","MOLECULAR EPIDEMIOLOGY AND GENOTYPING STUDIES OF THE PARASITIC PROTOZOAN GIARDIA INTESTINALIS HAVE PROVEN DIFFICULT DUE TO MULTIPLE FACTORS, SUCH AS LOW DISCRIMINATORY POWER IN THE COMMONLY USED GENOTYPING LOCI, WHICH HAS HAMPERED MOLECULAR ANALYSES OF OUTBREAK SOURCES, ZOONOTIC TRANSMISSION AND VIRULENCE TYPES. HERE WE HAVE FOCUSED ON ASSEMBLAGE A GIARDIA AND DEVELOPED A HIGH-RESOLUTION ASSEMBLAGE-SPECIFIC MULTILOCUS SEQUENCE TYPING (MLST) METHOD. ANALYSES OF SEQUENCED G. INTESTINALIS ASSEMBLAGE A GENOMES FROM DIFFERENT SUB-ASSEMBLAGES IDENTIFIED A SET OF SIX GENETIC LOCI WITH HIGH GENETIC VARIABILITY. DNA SAMPLES FROM BOTH HUMANS (N=44) AND ANIMALS (N=18) THAT HARBORED GIARDIA ASSEMBLAGE A INFECTIONS, WERE PCR AMPLIFIED (557-700 BP PRODUCTS) AND SEQUENCED AT THE SIX NOVEL GENETIC LOCI. BIOINFORMATIC ANALYSES SHOWED FIVE TO TEN-FOLD HIGHER LEVELS OF POLYMORPHIC SITES THAN WHAT WAS PREVIOUSLY FOUND AMONG ASSEMBLAGE A SAMPLES USING THE CLASSIC GENOTYPING LOCI. PHYLOGENETICALLY, A DIVISION OF TWO MAJOR CLUSTERS IN ASSEMBLAGE A BECAME APPARENT, SEPARATING SAMPLES OF HUMAN AND ANIMAL ORIGIN. A SUBSET OF HUMAN SAMPLES (N=9) FROM A DOCUMENTED GIARDIA OUTBREAK IN A SWEDISH DAY-CARE CENTER, SHOWED FULL COMPLEMENTARITY AT NINE GENETIC LOCI (THE SIX NEW AND THE STANDARD BG, TPI AND GDH LOCI), STRONGLY SUGGESTING ONE SOURCE OF INFECTION. FURTHERMORE, THREE SAMPLES OF HUMAN ORIGIN DISPLAYED MLST PROFILES THAT WERE PHYLOGENETICALLY MORE CLOSELY RELATED TO MLST PROFILES FROM ANIMAL DERIVED SAMPLES, SUGGESTING ZOONOTIC TRANSMISSION. THESE NEW GENOTYPING LOCI ENABLED US TO DETECT EVENTS OF RECOMBINATION BETWEEN DIFFERENT ASSEMBLAGE A ISOLATES BUT ALSO BETWEEN ASSEMBLAGE A AND E ISOLATES. IN SUMMARY, WE PRESENT A NOVEL AND EXPANDED MLST STRATEGY WITH SIGNIFICANTLY IMPROVED SENSITIVITY FOR MOLECULAR ANALYSES OF VIRULENCE TYPES, ZOONOTIC POTENTIAL AND SOURCE TRACKING FOR ASSEMBLAGE A GIARDIA.","PARASITE; DIARRHEA; RECOMBINATION; ZOONOSIS; TRANSMISSION","LAMBLIA; DUODENALIS; IDENTIFICATION; INFECTION; LOCUS; LIFE; GENOTYPES; CHILDREN; EXCHANGE; MEIOSIS","ENGLISH","ARTICLE","ARTICLE",0,"ADAM RD, 2013, GENOME BIOL EVOL, V5, P2498, DOI 10.1093/GBE/EVT197.;ANKARKLEV J, 2015, BMC GENOMICS, V16, DOI 10.1186/S12864-015-1893-6.;ANKARKLEV J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-65.;ANKARKLEV J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/JOURNAL.PNTD.0001780.;BARASH NR, 2017, MSPHERE, V2, DOI [10.1128/MSPHERE.00343-16, 10.1128/MSPHERE.00343-16].;BERNANDER R, 2001, CELL MICROBIOL, V3, P55, DOI 10.1046/J.1462-5822.2001.00094.X.;CARPENTER ML, 2012, J CELL SCI, V125, P2523, DOI 10.1242/JCS.103879.;COOPER MA, 2007, CURR BIOL, V17, P1984, DOI 10.1016/J.CUB.2007.10.020.;COOPER MA, 2010, J INFECT DIS, V202, P1713, DOI 10.1086/657142.;DOROGHAZI JR, 2010, ISME J, V4, P1136, DOI 10.1038/ISMEJ.2010.45.;EINARSSON E, 2016, CURR OPIN MICROBIOL, V34, P47, DOI 10.1016/J.MIB.2016.07.019.;FANTINATTI M, 2016, J INFECT DIS, V214, P1256, DOI 10.1093/INFDIS/JIW361.;FRANZEN O, 2009, PLOS PATHOG, V5, DOI 10.1371/JOURNAL.PPAT.1000560.;GEURDEN T, 2008, INT J PARASITOL, V38, P259, DOI 10.1016/J.IJPARA.2007.07.016.;HAQUE R, 2005, J INFECT DIS, V192, P2171, DOI 10.1086/498169.;JERLSTROMHULTQV.J, 2010, BMC GENOMICS, V0011.;KOTLOFF KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2.;LALLE M, 2005, INT J PARASITOL, V35, P207, DOI 10.1016/J.IJPARA.2004.10.022.;LEBBAD M, 2008, ACTA TROP, V106, P44, DOI 10.1016/J.ACTATROPICA.2008.01.004.;LEBBAD M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/JOURNAL.PNTD.0001262.;LEBBAD M, 2010, VET PARASITOL, V168, P231, DOI 10.1016/J.VETPAR.2009.11.003.;LEVECKE B, 2009, INT J PARASITOL, V39, P1595, DOI 10.1016/J.IJPARA.2009.05.013.;MORRISON HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/SCIENCE.1143837.;ORTEGA-PIERRES M. G., 2017, ACTA TROP.;PHAM JK, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/FCIMB.2017.00227.;PIJNACKER R, 2016, EUR J CLIN MICROBIOL, V35, P2005, DOI 10.1007/S10096-016-2753-2.;POXLEITNER MK, 2008, SCIENCE, V319, P1530, DOI 10.1126/SCIENCE.1153752.;RAMESH MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/J.CUB.2005.01.003.;READ CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/J.MEEGID.2004.02.001.;REYNOSO-ROBLES R, 2015, SCI REP-UK, V5, DOI 10.1038/SREP15168.;ROGAWSKI ET, 2017, J PEDIATR INFECT DIS, V6, P153, DOI 10.1093/JPIDS/PIW082.;GARGANTINI PR, 2016, CURR OPIN MICROBIOL, V32, P52, DOI 10.1016/J.MIB.2016.04.017.;RYAN U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/J.IJPARA.2013.06.001.;SOUCY SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/NRG3962.;SPRONG H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/JOURNAL.PNTD.0000558.;SULAIMAN IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/EID0911.030084.;SVENUNGSSON BO, 2007, LAKARTIDNINGEN, V104, P500.;TAKUMI K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-168.;TAMURA K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/MOLBEV/MST197.;TUMOVA P, 2016, MICROBIOLOGYOPEN, V5, P560, DOI 10.1002/MBO3.351.;WIELINGA C, 2015, MOL BIOCHEM PARASIT, V201, P1, DOI 10.1016/J.MOLBIOPARA.2015.05.002.;XU FF, 2012, MOL BIOL EVOL, V29, P2895, DOI 10.1093/MOLBEV/MSS107.;ZAHEDI A, 2017, PARASITOLOGY, V144, P1154, DOI 10.1017/S0031182017000439.","SVARD, SG (REPRINT AUTHOR), UPPSALA UNIV, DEPT CELL \& MOL BIOL, BMC, BOX 596, SE-75124 UPPSALA, SWEDEN.;ANKARKLEV, J (REPRINT AUTHOR), STOCKHOLM UNIV, WENNER GREN INST, DEPT MOL BIOSCI, SVANTE ARRHENIUS VAG 20C, SE-10691 STOCKHOLM, SWEDEN.;ANKARKLEV, JOHAN, STOCKHOLM UNIV, DEPT MOL BIOSCI, SE-10691 STOCKHOLM, SWEDEN.;LEBBAD, MARIANNE, EINARSSON, ELIN, SVARD, STAFFAN G., UPPSALA UNIV, DEPT CELL \& MOL BIOL, BMC, BOX 596, SE-75124 UPPSALA, SWEDEN.;FRANZEN, OSCAR, KAROLINSKA INST, INTEGRATED CARDIO METAB CTR, NOVUM, BOX 285, SE-14157 STOCKHOLM, SWEDEN.;AHOLA, HARRI, TROELL, KARIN, NATL VET INST, DEPT MICROBIOL, SE-75189 UPPSALA, SWEDEN.","10.1016/J.MEEGID.2018.02.012","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"VETENSKAPSRADET, SWEDEN [2012-03364], LENNANDERS STIFTELSE","THIS WORK WAS SUPPORTED BY VETENSKAPSRADET, SWEDEN (GRANT NUMBER 2012-03364) AND LENNANDERS STIFTELSE (JOHAN ANKARKLEV, 2012).",NA,"1567-1348",NA,"7-16","ELSEVIER SCIENCE BV","60",2018,"ISI000428317200002","43","INFECTIOUS DISEASES","10","INFECTIOUS DISEASES","JOHAN.ANKARKLEVSU.SE ELIN.EINARSSONICM.UU.SE OSCAR.FRANZENKI.SE HARRI.AHOLASVA.SE KARIN.TROELLSVA.SE STAFFAN.SVARDICM.UU.SE",NA,"GA4RD",NA,"SVARD, SG (REPRINT AUTHOR), UPPSALA UNIV, DEPT CELL \& MOL BIOL, BMC, BOX 596, SE-75124 UPPSALA, SWEDEN","ISI","STOCKHOLM UNIV;UPPSALA UNIV;KAROLINSKA INST;NATL VET INST","UPPSALA UNIV",NA,"ANKARKLEV J, 2018, INFECT GENET EVOL","ANKARKLEV J, 2018, INFECT GENET EVOL"
"JAOUADI A, 2018, BIOCHEM BIOPHYS RES COMMUN","JAOUADI A;TABEBI M;ABDELHEDI F;ABID D;KAMOUN F;CHABCHOUB I;MAATOUG S;DOUKALI H;BELGHUITH N;KSENTINI MA;KESKES LA;TRIKI C;HACHICHA M;KAMOUN S;KAMOUN H","A NOVEL TBX1 MISSENSE MUTATION IN PATIENTS WITH SYNDROMIC CONGENITAL HEART DEFECTS","BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS","BIOCHEM. BIOPHYS. RES. COMMUN.","CONGENITAL HEART DEFECTS REPRESENT A CHARACTERISTIC PART OF SEVERAL GENETIC SYNDROMES ASSOCIATED WITH CHROMOSOMAL ABNORMALITIES SUCH AS 22Q11.2 DELETION SYNDROME, MANY GENES LOCATED IN THIS LOCUS, MAINLY TBX1, ARE CANDIDATE GENES FOR CONGENITAL HEART DEFECTS. IN OUR COHORT OF 27 SUBJECTS WITH CONGENITAL HEART DEFECT, BOTH KARYOTYPE ANALYSIS AND FLUORESCENCE IN SITU HYBRIDIZATION (FISH) WERE PERFORMED. THE TBX1 GENE WAS SEQUENCED IN PATIENTS LACKING CHROMOSOMAL ABNORMALITIES. FISH ANALYSIS SHOWED A DE NOVO 22Q11.2 DELETION IN TWO PATIENTS. THE SCREENING OF TBX1 CODING SEQUENCE IDENTIFIED A NOVEL MISSENSE MUTATION C.569C > A (P.P190Q) IN SIX UNRELATED PATIENTS AND DETECTED TWO ASSOCIATED KNOWN SINGLE NUCLEOTIDE POLYMORPHISMS, THE C.664C > T (RS2301558) IN THREE PATIENTS AND THE C.420T > C (P.PHE140 PHE) (RS41298814) IN ONE PATIENT. BIOINFORMATIC TOOLS SHOW THAT THE NOVEL MISSENSE MUTATION C.569C > A COULD MODIFY THE FUNCTION AND THE STABILITY OF THE TBX1 PROTEIN. THE C.569C > A MUTATION WAS NOT FOUND IN 50 HEALTHY CONTROLS. OURS RESULTS SUGGEST A DELETERIOUS ROLE OF THE C.569C > A MUTATION AND STRENGTHEN THE HYPOTHESIS THAT THIS MUTATION MIGHT BE RESPONSIBLE FOR THE SAME PHENOTYPE SPECTRUM AS THE 22Q11.2 DELETION SYNDROME. (C) 2018 ELSEVIER INC. ALL RIGHTS RESERVED.","CONGENITAL HEART DEFECT (CHD); 22Q11.2DELETION SYNDROME; FISH; QUANTITATIVE PCR; TBX1 GENE; C.569C>A","CHROMOSOMAL REGION 22Q11; DELETION SYNDROME; GENE; DIGEORGE; DISEASE; MICRODELETIONS; MECHANISMS; ARCH","ENGLISH","ARTICLE","ARTICLE",0,"BALDINI A, 2005, CURR OPIN GENET DEV, V15, P279, DOI 10.1016/J.GDE.2005.03.001.;CHAPMAN DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO,2-F.;CHIEFFO C, 1997, GENOMICS, V43, P267, DOI 10.1006/GENO.1997.4829.;CHINN A, 1989, TERATOLOGY, V40, P475, DOI 10.1002/TERA.1420400510.;CRIFASI PA, 1995, MAYO CLIN PROC, V70, P1148, DOI 10.4065/70.12.1148.;CUNEO BF, 2001, CURR OPIN PEDIATR, V13, P465, DOI 10.1097/00008480-200110000-00014.;DERBENT M, 2003, AM J MED GENET A, V116A, P129, DOI 10.1002/AJMG.A.10832.;FERNANDEZ L, 2001, GENETICS CHROMOSOME.;GAO WENMING, 2015, HUM GENOME VAR, V2, P15004, DOI 10.1038/HGV.2015.4.;GARG V, 2001, DEV BIOL, V235, P62, DOI 10.1006/DBIO.2001.0283.;GOLDMUNTZ E, 1993, J MED GENET, V30, P807, DOI 10.1136/JMG.30.10.807.;GONG W., 2001, J MED GENET, P38.;GREULICH F, 2011, CARDIOVASC RES, V91, P212, DOI 10.1093/CVR/CVR112.;HACIHAMDIOGLU B, 2015, APPL CLIN GENET, V8, P123, DOI 10.2147/TACG.S82105.;LEWIN HA, 1992, BIOTECHNIQUES, V13, P522.;LI B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/BIOINFORMATICS/BTP528.;ROSA RFM, 2011, REV ASSOC MED BRAS, V57, P62, DOI 10.1590/S0104-42302011000100018.;MCDONALD-MCGINN DM, 2013, J MED GENET, V50, P80, DOI 10.1136/JMEDGENET-2012-101320.;MOLCK MC, 2017, J PEDIAT-BRAZIL, V93, P497, DOI 10.1016/J.JPED.2016.11.007.;PACE CN, 2014, PROTEIN SCI, V23, P652, DOI 10.1002/PRO.2449.;PULIGNANI SILVIA, 2018, PEDIAT CARDIOL, DOI [10.1007/500246-018-1806-Y, DOI 10.1007/500246-018-1806-Y].;TIROSH-FINKEL L, 2010, DEVELOPMENT, V137, P2989, DOI 10.1242/DEV.051649.;WEBBER SA, 1996, J PEDIATR-US, V129, P26, DOI 10.1016/S0022-3476(96)70186-5.;WILSON D. I., 1994, AM J HUM GENET, V55, P169.;XU YJ, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-78.;YAGI H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6.;YANG C, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-16.;ZHANG M, 2018, EXP THER MED, V15, P447, DOI 10.3892/ETM.2017.5362.;ZWEIER C, 2007, AM J HUM GENET, V80, P510, DOI 10.1086/511993.","JAOUADI, A, KAMOUN, H (REPRINT AUTHOR), UNIV SFAX, LAB HUMAN MOL GENET, FAC MED, AVE MAGIDABOULILA, TN-3029 SFAX, TUNISIA.;JAOUADI, AMEL, TABEBI, MOUNA, MAATOUG, SIRINE, DOUKALI, HAJER, KESKES, LEILA AMMAR, KAMOUN, HASSEN, FAC MED, LAB HUMAN MOL GENET, SFAX, TUNISIA.;ABDELHEDI, FATMA, BELGHUITH, NEILA, CHU HEDI CHOKER HOSP, DEPT MED GENET, SFAX, TUNISIA.;ABID, DORRA, KAMOUN, SAMIR, CHU HEDI CHAKER HOSP, DEPT CARDIOL, SFAX, TUNISIA.;KAMOUN, FATMA, TRIKI, CHAHNEZ, CHU HEDI CHAKER HOSP, DEPT CHILD NEUROL, SFAX, TUNISIA.;CHABCHOUB, IMEN, HACHICHA, MONGIA, CHU HEDI CHAKER HOSP, DEPT PEDIAT, SFAX, TUNISIA.;KSENTINI, MOHAMED ALI, PRIVATE LAB KSENTINI, SFAX, TUNISIA.","10.1016/J.BBRC.2018.03.190","525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA",NA,NA,"MINISTRY OF HIGHER EDUCATION AND SCIENTIFIC RESEARCH OF TUNISIA","WE THANK THE PATIENTS AND THEIR FAMILIES FOR THEIR COOPERATION IN THE PRESENT STUDY. THIS WORK WAS SUPPORTED BY THE MINISTRY OF HIGHER EDUCATION AND SCIENTIFIC RESEARCH OF TUNISIA.",NA,"0006-291X","3","563-569","ACADEMIC PRESS INC ELSEVIER SCIENCE","499",2018,"ISI000431287700027","29","BIOCHEMISTRY \& MOLECULAR BIOLOGY, BIOPHYSICS","5","BIOCHEMISTRY \& MOLECULAR BIOLOGY, BIOPHYSICS","AMEL.JAOUADILIVE.FR HASSEN.KAMOUNYAHOO.FR",NA,"GE5UN",NA,"JAOUADI, A, KAMOUN, H (REPRINT AUTHOR), UNIV SFAX, LAB HUMAN MOL GENET, FAC MED, AVE MAGIDABOULILA, TN-3029 SFAX, TUNISIA","ISI","LAB HUMAN MOL GENET;CHU HEDI CHOKER HOSP;CHU HEDI CHAKER HOSP;CHU HEDI CHAKER HOSP;CHU HEDI CHAKER HOSP;PRIVATE LAB KSENTINI","UNIV SFAX",NA,"JAOUADI A, 2018, BIOCHEM BIOPHYS RES COMMUN","JAOUADI A, 2018, BIOCHEM BIOPHYS RES COMMUN"
"MINICH JJ, 2018, MSYSTEMS","MINICH JJ;ZHU Q;JANSSEN S;HENDRICKSON R;AMIR A;VETTER R;HYDE J;DOTY MM;STILLWELL K;BENARDINI J;KIM JH;ALLEN EE;VENKATESWARAN K;KNIGHT R","KATHAROSEQ ENABLES HIGH-THROUGHPUT MICROBIOME ANALYSIS FROM LOW-BIOMASS SAMPLES","MSYSTEMS","MSYSTEMS","MICROBIOME ANALYSES OF LOW-BIOMASS SAMPLES ARE CHALLENGING BECAUSE OF CONTAMINATION AND INEFFICIENCIES, LEADING MANY INVESTIGATORS TO EMPLOY LOW-THROUGHPUT METHODS WITH MINIMAL CONTROLS. WE DEVELOPED A NEW AUTOMATED PROTOCOL, KATHAROSEQ (FROM THE GREEK KATHAROS [CLEAN]), THAT OUTPERFORMS SINGLE-TUBE EXTRACTIONS WHILE PROCESSING AT LEAST FIVE TIMES AS FAST. KATHAROSEQ INCORPORATES POSITIVE AND NEGATIVE CONTROLS TO REVEAL THE WHOLE BACTERIAL COMMUNITY FROM INPUTS OF AS FEW AS 50 CELLS AND CORRECTLY IDENTIFIES 90.6\% (STANDARD ERROR, 0.013\%) OF THE READS FROM 500 CELLS. TO DEMONSTRATE THE BROAD UTILITY OF KATHAROSEQ, WE PERFORMED 16S RRNA AMPLICON AND SHOTGUN METAGENOME ANALYSES OF THE JET PROPULSION LABORATORY SPACECRAFT ASSEMBLY FACILITY (SAF, N=192, 96), 52 ROOMS OF A NEONATAL INTENSIVE CARE UNIT (NICU, N=388, 337), AND AN ENDANGERED-ABALONE-REARING FACILITY (N=192, 123), OBTAINING SPATIALLY RESOLVED, UNIQUE MICROBIOMES REPRODUCIBLE ACROSS HUNDREDS OF SAMPLES. THE SAF, OUR PRIMARY FOCUS, CONTAINS 32 SOTUS (SUB-OTUS, DEFINED AS EXACT SEQUENCE MATCHES) AND THEIR INFERRED VARIANTS IDENTIFIED BY THE DEBLUR ALGORITHM, WITH FOUR (ACINETOBACTER LWOFFII, PARACOCCUS MARCUSII, MYCOBACTERIUM SP., AND NOVOSPHINGOBIUM) BEING PRESENT IN >75\% OF THE SAMPLES. ACCORDING TO MICROBIAL SPATIAL TOPOGRAPHY, THE MOST ABUNDANT CLEANROOM CONTAMINANT, A. LWOFFII, IS RELATED TO HUMAN FOOT TRAFFIC EXPOSURE. IN THE NICU, WE HAVE BEEN ABLE TO DISCRIMINATE ENVIRONMENTAL EXPOSURE RELATED TO PATIENT INFECTIOUS DISEASE, AND IN THE ABALONE FACILITY, WE SHOW THAT MICROBIAL COMMUNITIES REFLECT THE MARINE ENVIRONMENT RATHER THAN HUMAN INPUT. CONSEQUENTLY, WE DEMONSTRATE THE FEASIBILITY AND UTILITY OF LARGE-SCALE, LOW-BIOMASS METAGENOMIC ANALYSES USING THE KATHAROSEQ PROTOCOL. IMPORTANCE VARIOUS INDOOR, OUTDOOR, AND HOST-ASSOCIATED ENVIRONMENTS CONTAIN SMALL QUANTITIES OF MICROBIAL BIOMASS AND REPRESENT A NICHE THAT IS OFTEN UNDERSTUDIED BECAUSE OF TECHNICAL CONSTRAINTS. MANY STUDIES THAT ATTEMPT TO EVALUATE THESE LOW-BIOMASS MICROBIOME SAMPLES ARE RIDDLED WITH ERRONEOUS RESULTS THAT ARE TYPICALLY FALSE POSITIVE SIGNALS OBTAINED DURING THE SAMPLING PROCESS. WE HAVE INVESTIGATED VARIOUS LOW-BIOMASS KITS AND METHODS TO DETERMINE THE LIMIT OF DETECTION OF THESE PIPELINES. HERE WE PRESENT KATHAROSEQ, A HIGH-THROUGHPUT PROTOCOL COMBINING LABORATORY AND BIOINFORMATIC METHODS THAT CAN DIFFERENTIATE A TRUE POSITIVE SIGNAL IN SAMPLES WITH AS FEW AS 50 TO 500 CELLS. WE DEMONSTRATE THE APPLICATION OF THIS METHOD IN THREE UNIQUE LOW-BIOMASS ENVIRONMENTS, INCLUDING A SAF, A HOSPITAL NICU, AND AN ABALONE-REARING FACILITY.","16S RRNA AMPLICON; ACINETOBACTER; STAPHYLOCOCCUS; VIBRIO; ABALONE; BUILT","TOOL; CONTAMINATION; COMMUNITIES; ENVIRONMENT; DIVERSITY","ENGLISH","ARTICLE","ARTICLE",2,"ALIKHAN NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402.;AMIR A, 2017, MSYSTEMS, V2, DOI 10.1128/MSYSTEMS.00191-16.;BANKEVICH A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/CMB.2012.0021.;BEALS EW, 1984, ADV ECOL RES, V14, P1, DOI 10.1016/S0065-2504(08)60168-3.;BEAZ-HIDALGO R, 2010, ENV MICROBIOL REP, V2, P34, DOI 10.1111/J.1758-2229.2010.00135.X.;BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289.;BOLGER AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/BIOINFORMATICS/BTU170.;BOUSLIMANI A, 2015, P NATL ACAD SCI USA, V112, PE2120, DOI 10.1073/PNAS.1424409112.;BROOKS B, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-1.;CAPORASO JG, 2012, ISME J, V6, P1621, DOI 10.1038/ISMEJ.2012.8.;CAPORASO JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/NMETH.F.303.;FIERER N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/PNAS.1000162107.;FRIEDMAN CS, 2000, INT J SYST EVOL MICR, V50, P847, DOI 10.1099/00207713-50-2-847.;GEFRIDES LA, 2010, FORENSIC SCI INT-GEN, V4, P89, DOI 10.1016/J.FSIGEN.2009.06.008.;GUREVICH A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/BIOINFORMATICS/BTT086.;HARTZ LE, 2015, ADV NEONAT CARE, V15, P324, DOI 10.1097/ANC.0000000000000220.;HOSPODSKY D, 2015, INDOOR AIR, V25, P641, DOI 10.1111/INA.12172.;KEMBEL SW, 2012, ISME J, V6, P1469, DOI 10.1038/ISMEJ.2011.211.;KOLMOGOROV M, 2014, BIOINFORMATICS, V30, P302, DOI 10.1093/BIOINFORMATICS/BTU280.;LANGDON WB, 2015, BIODATA MIN, V8, DOI 10.1186/S13040-014-0034-0.;LAX S, 2017, SCI TRANSL MED, V9, DOI 10.1126/SCITRANSLMED.AAH6500.;LAX S, 2014, SCIENCE, V345, P1048, DOI 10.1126/SCIENCE.1254529.;LEUNG MHY, 2016, MICROBIOME, V4, DOI 10.1186/S40168-016-0165-2.;LOZUPONE C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005.;MAHNERT A, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0134848.;MOISSL C, 2007, FEMS MICROBIOL ECOL, V61, P509, DOI 10.1111/J.1574-6941.2007.00360.X.;MOTLEY ST, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-443.;MUGOYELA V, 2010, THER CLIN RISK MANAG, V6, P443, DOI 10.2147/TCRM.S12253.;QUINN RA, 2016, MSYSTEMS, V1, DOI 10.1128/MSYSTEMS.00038-16.;RATHINAVELU S, 2003, MICROBES INFECT, V5, P651, DOI 10.1016/S1286-4579(03)00099-6.;ROMALDE JL, 2014, FRONT MICROBIOL, V4, DOI 10.3389/FMICB.2013.00413.;SALTER SJ, 2014, BMC BIOL, V12, DOI 10.1186/S12915-014-0087-Z.;VANOGTROP ML, 1997, J HOSP INFECT, V36, P95, DOI 10.1016/S0195-6701(97)90115-8.;VAZQUEZ-BAEZA Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16.;VENKATESWARAN K, 2014, MICROBES ENVIRON, V29, P243, DOI 10.1264/JSME2.ME14032.;WALTERS W, 2016, MSYSTEMS, V1, DOI 10.1128/MSYSTEMS.00009-15.;WOOD DE, 2014, GENOME BIOL, V15, DOI 10.1186/GB-2014-15-3-R46.","KNIGHT, R (REPRINT AUTHOR), UNIV CALIF SAN DIEGO, DEPT PEDIAT, LA JOLLA, CA 92093 USA.;KNIGHT, R (REPRINT AUTHOR), UNIV CALIF SAN DIEGO, JACOBS SCH ENGN, CTR MICROBIOME INNOVAT, LA JOLLA, CA 92093 USA.;KNIGHT, R (REPRINT AUTHOR), UNIV CALIF SAN DIEGO, DEPT COMP SCI \& ENGN, LA JOLLA, CA 92093 USA.;MINICH, JEREMIAH J., ALLEN, ERIC E., SCRIPPS INST OCEANOG, MARINE BIOL RES DIV, LA JOLLA, CA USA.;ZHU, QIYUN, JANSSEN, STEFAN, AMIR, AMNON, KNIGHT, ROB, UNIV CALIF SAN DIEGO, DEPT PEDIAT, LA JOLLA, CA 92093 USA.;HENDRICKSON, RYAN, BENARDINI, JAMES, VENKATESWARAN, KASTHURI, CALTECH, JET PROP LAB, 4800 OAK GROVE DR, PASADENA, CA USA.;VETTER, RUSS, HYDE, JOHN, NOAA, SOUTHWEST FISHERIES SCI CTR, LA JOLLA, CA USA.;DOTY, MEGAN M., STILLWELL, KRISTINA, KIM, JAE H., UNIV CALIF SAN DIEGO, DIV NEONATOL, LA JOLLA, CA 92093 USA.;KNIGHT, ROB, UNIV CALIF SAN DIEGO, JACOBS SCH ENGN, CTR MICROBIOME INNOVAT, LA JOLLA, CA 92093 USA.;ALLEN, ERIC E., KNIGHT, ROB, UNIV CALIF SAN DIEGO, DEPT COMP SCI \& ENGN, LA JOLLA, CA 92093 USA.","10.1128/MSYSTEMS.00218-17","1752 N ST NW, WASHINGTON, DC 20036-2904 USA","E00218-17",NA,"UCSD CHANCELLOR'S INITIATIVE IN THE MICROBIOME AND MICROBIAL SCIENCES, ALFRED P. SLOAN FOUNDATION","PART OF THE RESEARCH DESCRIBED IN THIS PUBLICATION WAS CARRIED OUT AT JPL, CALIFORNIA INSTITUTE OF TECHNOLOGY, UNDER A CONTRACT WITH NASA. WE THANK THE UCSD CHANCELLOR'S INITIATIVE IN THE MICROBIOME AND MICROBIAL SCIENCES FOR PROVIDING THE SEED GRANT FUNDING. WE ALSO THANK THE ALFRED P. SLOAN FOUNDATION FOR FUNDING AND TRAINING. GOVERNMENT SPONSORSHIP IS ACKNOWLEDGED.",NA,"2379-5077","3",NA,"AMER SOC MICROBIOLOGY","3",2018,"ISI000436778500030","37","MICROBIOLOGY","6","MICROBIOLOGY","ROBKNIGHTUCSD.EDU",NA,"GL0LK",NA,"KNIGHT, R (REPRINT AUTHOR), UNIV CALIF SAN DIEGO, DEPT PEDIAT, LA JOLLA, CA 92093 USA","ISI","SCRIPPS INST OCEANOG;UNIV CALIF SAN DIEGO;JET PROP LAB;SOUTHWEST FISHERIES SCI CTR;UNIV CALIF SAN DIEGO;UNIV CALIF SAN DIEGO;UNIV CALIF SAN DIEGO","UNIV CALIF SAN DIEGO",NA,"MINICH JJ, 2018, MSYSTEMS","MINICH JJ, 2018, MSYSTEMS"
"BO M, 2018, CLIN EXP RHEUMATOL","BO M;ERRE GL;NIEGOWSKA M;PIRAS M;TARAS L;LONGU MG;PASSIU G;SECHI LA","INTERFERON REGULATORY FACTOR 5 IS A POTENTIAL TARGET OF AUTOIMMUNE RESPONSE TRIGGERED BY EPSTEIN-BARR VIRUS AND MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS IN RHEUMATOID ARTHRITIS: INVESTIGATING A MECHANISM OF MOLECULAR MIMICRY","CLINICAL AND EXPERIMENTAL RHEUMATOLOGY","CLIN. EXP. RHEUMATOL.","OBJECTIVE RHEUMATOID ARTHRITIS (RA) IS A CHRONIC DISEASE CHARACTERISED BY A PRO-INFLAMMATORY CYTOKINES LINKED EROSIVE JOINT DAMAGE AND BY HUMORAL AND CELLULAR RESPONSE AGAINST A BROAD RANGE OF SELF-PEPTIDES. MOLECULAR MIMICRY BETWEEN EPSTEIN-BARR VIRUS (EBV), MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS (MAP) AND HOST PEPTIDES HAS LONG BEEN REGARDED AS AN RA PATHOGENETIC MECHANISM. USING BIOINFORMATIC ANALYSIS WE IDENTIFIED HIGH SEQUENCE HOMOLOGY AMONG INTERFERON REGULATORY FACTOR 5 (IRF5), EBV ANTIGEN BOLF1 AND MAP ANTIGEN MAP\_4027. OUR OBJECTIVE WAS TO EVALUATE THE PRESENCE IN SERA OF RA PATIENTS OF ANTIBODIES (ABS) DIRECTED AGAINST HUMAN HOMOLOGOUS IRF5 CROSS-REACTING WITH BOLF1 AND MAP\_4027. METHODS FREQUENCY OF REACTIVITY AGAINST IRF5(424)(-)(434), BOLF1(305)(.320) AND MAP\_4027 , 8.32 WAS TESTED BY INDIRECT ELISA IN SERA FROM 71 RA PATIENTS AND 60 HEALTHY CONTROLS (HCS). RESULTS RA SERA SHOW A REMARKABLE HIGH FREQUENCY OF REACTIVITY AGAINST IRF5(424.434) IN COMPARISON TO HCS (69\% VS. 8\%, P<0.0001). SIMILARLY, SEROREACTIVITY AGAINST BOLF1(305.320) WAS MORE FREQUENTLY DETECTED IN RA SERA THAN IN HCS COUNTERPART (58\% VS. 8\%, P<0.0001). FREQUENCY OF ABS AGAINST MAP\_4027(18.32) WAS 17\% IN RA SERA VS. 5\% IN HCS WITH A P-VALUE AT THE THRESHOLD LEVEL (P<0.051). PREVALENCE OF ABS AGAINST AT LEAST ONE OF THE ASSESSED EPITOPES REACHED 72\% IN RA PATIENTS AND 15\% AMONG HCS. LEVELS OF ABS IN RA PATIENTS WERE SIGNIFICANTLY RELATED TO SYSTEMIC INFLAMMATION. CONCLUSION IRF5 IS A POTENTIAL AUTOIMMUNE TARGET OF RA. OUR RESULTS SUPPORT THE HYPOTHESIS THAT EBV AND MAP INFECTIONS MAY BE INVOLVED IN THE PATHOGENESIS OF RA, IGNITING A SECONDARY IMMUNE RESPONSE THAT CROSS-REACTS AGAINST RA SELF-PEPTIDES.","INTERFERON REGULATORY FACTOR 5 (IRF5); EPSTEIN-BARR VIRUS (EBV); MYCOBACTERIUM AVIUM SUBSP PARATUBERCULOSIS (MAP); CROSS-REACTIVITY; RHEUMATOID ARTHRITIS","ANTICITRULLINATED PROTEIN ANTIBODIES; B-CELLS; MULTIPLE-SCLEROSIS; IMMUNE-RESPONSE; T-CELL; AUTOANTIBODIES; ASSOCIATION; CLASSIFICATION; SUSCEPTIBILITY; PATHOGENESIS","ENGLISH","ARTICLE","ARTICLE",0,"ADTANI POOJA, 2015, J ORAL MAXILLOFAC PATHOL, V19, P282, DOI 10.4103/0973-029X.174643.;ALBANI S, 1992, J CLIN INVEST, V89, P327, DOI 10.1172/JCI115580.;ANGELOTTI F, 2017, CLIN EXP RHEUMATOL, V35, P368.;ARLEEVSKAYA MI, 2016, FRONT MICROBIOL, V7, DOI 10.3389/FMICB.2016.01296.;ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/ART.1780310302.;BALL RJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/S13075-015-0755-6.;COSSU D, 2015, MULT SCLER J, V21, P984, DOI 10.1177/1352458514557304.;DEKKERS J, 2016, CURR OPIN RHEUMATOL, V28, P275, DOI 10.1097/BOR.0000000000000277.;DIEGUEZ-GONZALEZ R, 2008, ARTHRITIS RHEUM, V58, P1264, DOI 10.1002/ART.23426.;DUARTE JOAO H, 2015, NAT REV RHEUMATOL, V11, P562, DOI 10.1038/NRRHEUM.2015.127.;DUFFAU P, 2015, ARTHRITIS RHEUMATOL, V67, P3146, DOI 10.1002/ART.39321.;EAMES HL, 2016, TRANSL RES, V167, P167, DOI 10.1016/J.TRSL.2015.06.018.;ERRE GL, 2015, VIRAL IMMUNOL, V28, P385, DOI 10.1089/VIM.2015.0035.;FILLATREAU S, 2015, EUR J IMMUNOL, V45, P966, DOI 10.1002/EJI.201545544.;GEIS C, 2010, BRAIN, V133, P3166, DOI 10.1093/BRAIN/AWQ253.;KASTURI S, 2014, RHEUMATOL INT, V34, P407, DOI 10.1007/S00296-013-2865-2.;LINO AC, 2016, IMMUNOL REV, V269, P130, DOI 10.1111/IMR.12374.;MAGRYS A, 2007, J CLIN IMMUNOL, V27, P181, DOI 10.1007/S10875-006-9065-8.;MAHABADI MOSTAFA, 2016, ELECTRON PHYSICIAN, V8, P2181, DOI 10.19082/2181.;MAMELI G, 2016, EUR J NEUROL, V23, P140, DOI 10.1111/ENE.12821.;NEGI VS, 2014, TISSUE ANTIGENS, V84, P465, DOI 10.1111/TAN.12441.;OLALEKAN SA, 2015, EUR J IMMUNOL, V45, P988, DOI 10.1002/EJI.201445036.;POPKO K, 2015, CENT EUR J IMMUNOL, V40, P470, DOI 10.5114/CEJI.2015.56971.;RAO DA, 2017, NATURE, V542, P110, DOI 10.1038/NATURE20810.;SONG YW, 2010, QJM-INT J MED, V103, P139, DOI 10.1093/QJMED/HCP165.;STAHL EA, 2010, NAT GENET, V42, P508, DOI 10.1038/NG.582.;TOUSSIROT E, 2000, ANN RHEUM DIS, V59, P533, DOI 10.1136/ARD.59.7.533.;WANG D, 2015, MINERVA MED, V106, P157.;WESTERGAARD MW, 2015, BIOMED RES INT, V2015.","SECHI, LA (REPRINT AUTHOR), UNIV SASSARI, DIPARTIMENTO SCI BIOMED, VIALE SAN PIETRO 43 B, I-07100 SASSARI, ITALY.;BO, M., NIEGOWSKA, M., SECHI, L. A., UNIV SASSARI, SEZ MICROBIOL \& VIROL, DIPARTIMENTO SCI BIOMED, SASSARI, ITALY.;ERRE, G. L., PIRAS, M., TARAS, L., LONGU, M. G., PASSIU, G., AZIENDA OSPED UNIV SASSARI, DIPARTIMENTO MED CLIN \& SPERIMENTALE, SASSARI, ITALY.",NA,"VIA SANTA MARIA 31, 56126 PISA, ITALY",NA,NA,NA,NA,NA,"0392-856X","3","376-381","CLINICAL \& EXPER RHEUMATOLOGY","36",2018,"ISI000435937500004","29","RHEUMATOLOGY","0","RHEUMATOLOGY","SECHILAUNISS.IT",NA,"GK2DW",NA,"SECHI, LA (REPRINT AUTHOR), UNIV SASSARI, DIPARTIMENTO SCI BIOMED, VIALE SAN PIETRO 43 B, I-07100 SASSARI, ITALY","ISI","UNIV SASSARI;AZIENDA OSPED UNIV SASSARI","UNIV SASSARI",NA,"BO M, 2018, CLIN EXP RHEUMATOL","BO M, 2018, CLIN EXP RHEUMATOL"
"BLOMBERY P, 2018, ARCH PATHOL LAB MED","BLOMBERY P;JONES K;DOIG K;RYLAND G;MCBEAN M;THOMPSON E;YANNAKOU CK;WESTERMAN D","SENSITIVE NPM1 MUTATION QUANTITATION IN ACUTE MYELOID LEUKEMIA USING ULTRADEEP NEXT-GENERATION SEQUENCING IN THE DIAGNOSTIC LABORATORY","ARCHIVES OF PATHOLOGY \& LABORATORY MEDICINE","ARCH. PATHOL. LAB. MED.","CONTEXT.-DETECTION OF MEASURABLE RESIDUAL DISEASE AFTER THERAPY IS AN IMPORTANT PREDICTOR OF OUTCOME IN ACUTE MYELOID LEUKEMIA. OBJECTIVE.-TO INVESTIGATE THE FEASIBILITY OF USING NEXT-GENERATION SEQUENCING (NGS) IN THE DIAGNOSTIC LABORATORY TO PERFORM QUANTITATIVE NPM1 MUTATION ASSESSMENT USING ULTRADEEP (APPROXIMATELY 300 000X-500 000X) SEQUENCING (NGS-QNPM1) AS A METHOD OF ASSESSING RESIDUAL DISEASE BURDEN IN PATIENTS WITH ACUTE MYELOID LEUKEMIA. DESIGN.-A FLEXIBLE NGS-BASED ASSAY FOR THE DETECTION AND QUANTITATION OF NPM1 MUTATIONS WAS DEVELOPED BY POLYMERASE CHAIN REACTION AMPLIFICATION OF TARGET DNA SEQUENCES, SEQUENCING ON AN ILLUMINA (SAN DIEGO, CALIFORNIA) MISEQ, AND ANALYZING DATA WITH AN IN-HOUSE-DESIGNED BIOINFORMATIC PIPELINE. NGS-QNPM1 WAS COM-PARED WITH CURRENT NPM1 QUANTITATION METHODS (REAL-TIME QUANTITATIVE-POLYMERASE CHAIN REACTION AND MULTIPARAMETER FLOW CYTOMETRY). RESULTS.-THE NGS-QNPM1 ASSAY HAD A SENSITIVITY OF BETWEEN 10(-4) AND 10(-5) AND SHOWED HIGH CONCORDANCE AND CORRELATION WITH REFERENCE METHODOLOGIES. MOREOVER, THE NGS-QNPM1 ASSAY WAS ABLE TO BE INTEGRATED INTO THE LABORATORY'S EXISTING, TARGETED AMPLICON-BASED SEQUENCING WORKFLOW. CONCLUSIONS.-AN NGS-BASED, QUANTITATIVE NPM1-MUTATION ASSESSMENT CAN BE USED TO MONITOR PATIENTS WITH ACUTE MYELOID LEUKEMIA, AND IT HAS SOME PRACTICAL ADVANTAGES OVER EXISTING MODALITIES.",NA,"MINIMAL RESIDUAL DISEASE; RISK; AML","ENGLISH","ARTICLE","ARTICLE",0,"FREEMAN SD, 2013, J CLIN ONCOL, V31, P4123, DOI 10.1200/JCO.2013.49.1753.;GORELLO P, 2006, LEUKEMIA, V20, P1103, DOI 10.1038/SJ.LEU.2404149.;GRIMWADE D, 2014, HEMATOL-AM SOC HEMAT, P222, DOI 10.1182/ASHEDUCATION-2014.1.222.;IVEY A, 2016, NEW ENGL J MED, V374, P422, DOI [10.1056/NEJMOA1507471, 10.1056/NEJMC1603847].;JOBBAGY Z, 2007, J MOL DIAGN, V9, P220, DOI 10.2353/JMOLDX.2007.060112.;KAYSER S, 2016, BLOOD CANCER J, V6, DOI 10.1038/BCJ.2016.46.;KIRCHER M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/NAR/GKR771.;KIRCHER M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-382.;KRONKE J, 2011, J CLIN ONCOL, V29, P2709, DOI 10.1200/JCO.2011.35.0371.;LOKEN MR, 2012, BLOOD, V120, P1581, DOI 10.1182/BLOOD-2012-02-408336.;SALIPANTE SJ, 2014, MODERN PATHOL, V27, P1438, DOI 10.1038/MODPATHOL.2014.57.;SCHNITTGER S, 2009, BLOOD, V114, P2220, DOI 10.1182/BLOOD-2009-03-213389.;TERWIJN M, 2013, J CLIN ONCOL, V31, P3889, DOI 10.1200/JCO.2012.45.9628.","BLOMBERY, P (REPRINT AUTHOR), PETER MACCALLUM CANC CTR, 305 GRATTAN ST, MELBOURNE, VIC 3000, AUSTRALIA.;BLOMBERY, PIERS, JONES, KATE, RYLAND, GEORGINA, THOMPSON, ELLA, YANNAKOU, COSTAS K., WESTERMAN, DAVID, PETER MACCALLUM CANC CTR, DEPT PATHOL, MELBOURNE, VIC, AUSTRALIA.;BLOMBERY, PIERS, THOMPSON, ELLA, YANNAKOU, COSTAS K., WESTERMAN, DAVID, UNIV MELBOURNE, SIR PETER MACCALLUM DEPT ONCOL, MELBOURNE, VIC, AUSTRALIA.","10.5858/ARPA.2017-0229-OA","C/O KIMBERLY GACKI, 325 WAUKEGAN RD, NORTHFIELD, IL 60093-2750 USA",NA,NA,"SNOWDOME FOUNDATION","WE THANK ADAM IVEY, MSC, FOR PERFORMING THE CORRELATIVE NPM1 RT-QPCR ASSAYS AND THE SNOWDOME FOUNDATION FOR THEIR SUPPORT OF THIS WORK.",NA,"0003-9985","5","606-612","COLL AMER PATHOLOGISTS","142",2018,"ISI000430796500004","13","MEDICAL LABORATORY TECHNOLOGY, RESEARCH \& EXPERIMENTAL MEDICINE, PATHOLOGY","3","MEDICAL LABORATORY TECHNOLOGY, MEDICINE, RESEARCH \& EXPERIMENTAL, PATHOLOGY","PIERS.BLOMBERYPETERMAC.ORG",NA,"GD8XB",NA,"BLOMBERY, P (REPRINT AUTHOR), PETER MACCALLUM CANC CTR, 305 GRATTAN ST, MELBOURNE, VIC 3000, AUSTRALIA","ISI","PETER MACCALLUM CANC CTR;UNIV MELBOURNE","PETER MACCALLUM CANC CTR",NA,"BLOMBERY P, 2018, ARCH PATHOL LAB MED","BLOMBERY P, 2018, ARCH PATHOL LAB MED"
"BEKLOO AJ, 2018, VECTOR-BORNE ZOONOTIC DIS","BEKLOO AJ;RAMZGOUYAN MR;SHIRIAN S;FAGHIHI F;BAKHSHI H;NASERI F;SEDAGHAT M;TELMADARRAIY Z","MOLECULAR CHARACTERIZATION AND PHYLOGENETIC ANALYSIS OF ANAPLASMA SPP. AND EHRLICHIA SPP. ISOLATED FROM VARIOUS TICKS IN SOUTHEASTERN AND NORTHWESTERN REGIONS OF IRAN","VECTOR-BORNE AND ZOONOTIC DISEASES","VECTOR-BORNE ZOONOTIC DIS.","INTRODUCTION:ANAPLASMA/EHRLICHIA SPECIES ARE TICK-TRANSMITTED PATHOGENS THAT CAUSE INFECTIONS IN HUMANS AND NUMEROUS DOMESTIC AND WILD ANIMAL SPECIES. THERE IS NO INFORMATION AVAILABLE ON THE MOLECULAR CHARACTERISTICS AND PHYLOGENETIC POSITION OF ANAPLASMA/EHRLICHIA SPP. ISOLATED FROM TICK SPECIES FROM DIFFERENT GEOGRAPHIC LOCATIONS IN IRAN. THE AIM OF THIS STUDY WAS TO DETERMINE THE PREVALENCE, MOLECULAR CHARACTERISTICS, AND PHYLOGENETIC RELATIONSHIP OF BOTH ANAPLASMA SPP. AND EHRLICHIA SPP. IN TICK SPECIES ISOLATED FROM DIFFERENT DOMESTIC ANIMALS FROM TWO DIFFERENT GEOGRAPHICAL LOCATIONS OF IRAN. METHODS: A TOTAL OF 930 TICKS WERE COLLECTED FROM 93 CATTLE, 250 SHEEP, AND 587 GOATS INHABITING THE STUDY AREAS. THE COLLECTED TICKS WERE THEN INVESTIGATED FOR THE PRESENCE OF ANAPLASMA/EHRLICHIA SPP. USING NESTED PCR BASED ON THE 16S RRNA GENE, FOLLOWED BY SEQUENCING. SEQUENCE ANALYSIS WAS DONE BASED ON THE DATA PUBLISHED IN THE GENBANK ON ANAPLASMA/EHRLICHIA SPP. ISOLATES USING BIOINFORMATIC TOOLS SUCH AS THE STANDARD NUCLEOTIDE BLAST. RESULTS: GENOME OF ANAPLASMA OR EHRLICHIA SPP. WAS DETECTED IN 14 TICKS COLLECTED IN HERIS, INCLUDING 5 DERMACENTOR MARGINATUS, 1 HAEMAPHYSALIS ERINACEI, 3 HYALOMMA ANATOLICUM, AND 4 RHIPICEPHALUS SANGUINEUS, ALSO IN 29 TICKS COLLECTED IN CHABAHAR, INCLUDING 14 R. SANGUINEUS, 8 D. MARGINATUS, 3 HYALOMMA ANATOLICUM, AND 4 HYALOMMA DROMEDARII. PARTIAL ANALYSIS OF THE 16S RRNA GENE SEQUENCE OF POSITIVE SAMPLES COLLECTED FROM GOATS AND SHEEP SHOWED THAT THEY WERE INFECTED WITH ANAPLASMA/EHRLICHIA SPP. THAT WERE 94-98\% IDENTICAL TO OVINE ANAPLASMA AND 91-96\% IDENTICAL TO NEOEHRLICHIA AND EHRLICHIA SPP. CONCLUSION: THE VARIOUS TICKS IDENTIFIED IN THIS STUDY SUGGEST THE POSSIBLE EMERGENCE OF TICK-BORNE DISEASES IN ANIMALS AND HUMANS IN THESE REGIONS. R. SANGUINEUS AND D. MARGINATUS SEEM TO BE PREDOMINANT VECTORS RESPONSIBLE FOR ANAPLASMOSIS IN THESE REGIONS. PARTIAL SEQUENCE ANALYSIS OF THE 16S RRNA GENE SHOWED THAT A. OVIS IS GENETICALLY POLYMORPHIC IN THESE REGIONS. FURTHERMORE, AN ASSOCIATION BETWEEN THE GENETIC HETEROGENEITY OF THIS MICROORGANISM AND THE GEOGRAPHICAL REGIONS OF ANAPLASMA STRAINS WAS FOUND. THIS STUDY ALSO SHOWED THAT THOSE TICKS THAT WERE COLLECTED FROM THE SAME GEOGRAPHICAL ORIGIN WERE INFECTED WITH CLOSELY RELATED STRAINS OF ANAPLASMA.","16S RRNA GENE; ANAPLASMA; EHRLICHIA; NESTED-PCR; HYLOGENY; TICKS","IXODES-RICINUS TICKS; PHAGOCYTOPHILUM; CATTLE; POLAND; CHINA; SHEEP; INFECTION; ALIGNMENT; GENES; GOATS","ENGLISH","ARTICLE","ARTICLE",1,"ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;DUMLER JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145.;HOTOPP JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/JOURNAL.PGEN.0020021.;GALAN M, 2016, MSYSTEMS, V1, DOI 10.1128/MSYSTEMS.00032-16.;HOSSEINI-VASOUKOLAEI N, 2014, J ARTHROPOD-BORNE DI, V8, P204.;KARBOWIAK G, 2015, ACTA PARASITOL, V60, P645, DOI 10.1515/AP-2015-0091.;KHAZENI A., 2013, JOURNAL OF BIOMEDICAL SCIENCE AND ENGINEERING, V6, P1.;LIU ZJ, 2005, VET MICROBIOL, V107, P145, DOI 10.1016/J.VETMIC.2005.01.007.;MISAWA K, 2000, MOL BIOL EVOL, V17, P1879, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A026289.;NOAMAN V, 2009, IRAN J PARASITOL, V4, P26.;RAMOS CAN, 2009, REV BRAS PARASITOL V, V18, P58, DOI 10.4322/RBPV.018E1011.;RAR VA, 2015, TICKS TICK-BORNE DIS, V6, P658, DOI 10.1016/J.TTBDIS.2015.05.012.;RAR V, 2011, INFECT GENET EVOL, V11, P1842, DOI 10.1016/J.MEEGID.2011.09.019.;RAR VA, 2008, INT J MED MICROBIOL, V298, P222, DOI 10.1016/J.IJMM.2008.01.001.;RAZMI GR, 2006, ANN NY ACAD SCI, V1078, P479, DOI 10.1196/ANNALS.1374.089.;SAGHAFI POUR A, 2014, J ZOONOSES, P54.;SANDELIN LL, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0133250.;SRINIVASAN R, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0117617.;SYTYKIEWICZ H, 2015, ACTA PARASITOL, V60, P654, DOI 10.1515/AP-2015-0093.;SYTYKIEWICZ H, 2012, ANN AGR ENV MED, V19, P45.;THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/NAR/22.22.4673.;YABSLEY MJ, 2005, VECTOR-BORNE ZOONOT, V5, P351, DOI 10.1089/VBZ.2005.5.351.;YANG JF, 2016, PARASITE VECTOR, V9, DOI 10.1186/S13071-016-1880-Z.;YANG JF, 2015, PARASITE VECTOR, V8, DOI 10.1186/S13071-015-0727-3.","SHIRIAN, S (REPRINT AUTHOR), SHAHR EKORD UNIV, SCH VET MED, DEPT PATHOL, SHAHR EKORD 887213, IRAN.;SEDAGHAT, M, TELMADARRAIY, Z (REPRINT AUTHOR), UNIV TEHRAN MED SCI, SCH PUBL HLTH, DEPT MED ENTOMOL \& VECTOR CONTROL, GHODS ST,POB 6446, TEHRAN 141, IRAN.;BEKLOO, AHMAD JAFAR, SHAHID BEHESHTI UNIV, DEPT HUMAN RIGHTS, TEHRAN, IRAN.;BEKLOO, AHMAD JAFAR, RAMZGOUYAN, MARYAM ROYA, CHABAHAR GULF MARINE CO, DEPT RES \& DEV, CHABAHAR, IRAN.;RAMZGOUYAN, MARYAM ROYA, UNIV TEHRAN MED SCI, SCH ADV TECHNOL MED, DEPT TISSUE ENGN \& APPL CELL SCI, TEHRAN, IRAN.;SHIRIAN, SADEGH, SHAHR EKORD UNIV, SCH VET MED, DEPT PATHOL, SHAHR EKORD 887213, IRAN.;SHIRIAN, SADEGH, SHIRAZ MOL PATHOL RES CTR, DEPT CYTOPATHOL, DR DANESHBOD PATH LAB, SHIRAZ, IRAN.;FAGHIHI, FAEZEH, IRAN UNIV MED SCI, DEPT BIOTECHNOL, CELLULAR \& MOL RES CTR, TEHRAN, IRAN.;BAKHSHI, HASSAN, PII, MVRG, DEPT PARASITOL, BRC, TEHRAN, IRAN.;NASERI, FATEMEH, VETERENARY OFF CHABAHAR, CHABAHAR, IRAN.;SEDAGHAT, MEHDI, TELMADARRAIY, ZAKKYEH, UNIV TEHRAN MED SCI, SCH PUBL HLTH, DEPT MED ENTOMOL \& VECTOR CONTROL, GHODS ST,POB 6446, TEHRAN 141, IRAN.","10.1089/VBZ.2017.2219","140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA",NA,NA,"CHABAHAR GULF MARINE COMPANY","THE AUTHORS WOULD LIKE TO THANK CHABAHAR GULF MARINE COMPANY FOR ITS SUPPORT.",NA,"1530-3667","5","252-257","MARY ANN LIEBERT, INC","18",2018,"ISI000428582600001","24","PUBLIC, ENVIRONMENTAL \& OCCUPATIONAL HEALTH, INFECTIOUS DISEASES","3","PUBLIC, ENVIRONMENTAL \& OCCUPATIONAL HEALTH, INFECTIOUS DISEASES","SHIRIAN85GMAIL.COM SADEGHMMTUMS.AC.IR ZTELMAYAHOO.CO.IN",NA,"GE3JB",NA,"SHIRIAN, S (REPRINT AUTHOR), SHAHR EKORD UNIV, SCH VET MED, DEPT PATHOL, SHAHR EKORD 887213, IRAN","ISI","SHAHID BEHESHTI UNIV;DEPT RES AND DEV;UNIV TEHRAN MED SCI;SHAHR EKORD UNIV;SHIRAZ MOL PATHOL RES CTR;IRAN UNIV MED SCI;UNIV TEHRAN MED SCI","SHAHR EKORD UNIV",NA,"BEKLOO AJ, 2018, VECTOR-BORNE ZOONOTIC DIS","BEKLOO AJ, 2018, VECTOR-BORNE ZOONOTIC DIS"
"WIRKA RC, 2018, CIRC RES","WIRKA RC;PJANIC M;QUERTERMOUS T","ADVANCES IN TRANSCRIPTOMICS INVESTIGATING CARDIOVASCULAR DISEASE AT UNPRECEDENTED RESOLUTION","CIRCULATION RESEARCH","CIRC.RES.","WHOLE-GENOME TRANSCRIPTIONAL PROFILING HAS BECOME A STANDARD GENOMIC APPROACH TO INVESTIGATE BIOLOGICAL PROCESSES. RNA SEQUENCING (RNASEQ) IN PARTICULAR HAS WITNESSED MYRIAD APPLICATIONS IN GENETICS AND VARIOUS BIOMEDICAL FIELDS. RNASEQ INVOLVES A RELATIVELY SIMPLE EXPERIMENTAL PROTOCOL OF RNA EXTRACTION AND CDNA LIBRARY PREPARATION AND, BECAUSE OF DECREASING NEXT-GENERATION SEQUENCING COST AND LOWER COMPUTATIONAL BURDEN FOR DATA PROCESSING, HAS OBTAINED A CENTRAL ROLE IN THE MODERN BIOLOGY. THE RECENT APPLICATION OF RNASEQ METHODOLOGY TO SINGLE-CELL TRANSCRIPTIONAL PROFILING HAS ENABLED THE MORE PRECISE CHARACTERIZATION OF CELL LINEAGE AND CELL STATE GENETIC PROFILES. THE DEVELOPMENT OF BIOINFORMATIC AND STATISTICAL TOOLS HAS PROVIDED FOR DIFFERENTIAL GENE EXPRESSION ANALYSIS, RNA ISOFORM ANALYSIS, HAPLOTYPE-SPECIFIC ANALYSIS OF GENE EXPRESSION (ALLELE-SPECIFIC EXPRESSION), AND ANALYSIS OF EXPRESSION QUANTITATIVE TRAIT LOCI. WE GIVE AN OVERVIEW OF THESE AND RECENT DEVELOPMENTS IN RNASEQ METHODOLOGY WITH EMPHASIS ON QUALITY CONTROL, READ MAPPING, FEATURE COUNTING, DIFFERENTIAL GENE EXPRESSION, ALLELE-SPECIFIC EXPRESSION AND EXPRESSION QUANTITATIVE TRAIT LOCI ANALYSIS, AND FUSION TRANSCRIPT DETECTION. WE DESCRIBE UTILIZATION OF RNASEQ AS A DIAGNOSTIC TOOL IN MENDELIAN DISEASES, COMPLEX PHENOTYPES, AND CANCER AND GIVE AN OVERVIEW OF LONG READ RNASEQ TECHNOLOGY. FURTHERMORE, WE DISCUSS IN DETAIL THE RECENT REVOLUTION IN SINGLE-CELL TRANSCRIPTOMICS THAT IS RESHAPING MODERN BIOLOGY.","GENE EXPRESSION; GENOMICS; QUANTITATIVE TRAIT LOCI; RNA ISOFORMS; SINGLE CELL","CELL RNA-SEQ; LONG NONCODING RNAS; DIFFERENTIAL EXPRESSION ANALYSIS; SINGLE-CELL; SEQUENCING DATA; GENE-EXPRESSION; COMPUTATIONAL ANALYSIS; REVEALS; QUANTIFICATION; HETEROGENEITY","ENGLISH","ARTICLE","ARTICLE",1,"ADAMSON B, 2016, CELL, V167, P1867, DOI 10.1016/J.CELL.2016.11.048.;ANDERS S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/BIOINFORMATICS/BTU638.;ANDERS S, 2012, GENOME RES, V22, P2008, DOI 10.1101/GR.133744.111.;ANDERS S, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-10-R106.;BACHER R, 2017, NAT METHODS, V14, P584, DOI 10.1038/NMETH.4263.;BACHER R, 2016, GENOME BIOL, V17, DOI 10.1186/S13059-016-0927-Y.;BAKER SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/NMETH1005-731.;BRADY G, 1990, METHODS IN MOLECULAR AND CELLULAR BIOLOGY, V2, P17.;BRAY NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/NBT.3519.;BRENNECKE P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/NMETH.2645, 10.1038/NMETH.2645].;BUETTNER F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/NBT.3102.;BYRNE A, 2017, NAT COMMUN, V8, DOI 10.1038/NCOMMS16027.;CABILI MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/GAD.17446611.;CAO JY, 2017, SCIENCE, V357, P661, DOI 10.1126/SCIENCE.AAM8940.;CASTEL SE, 2015, GENOME BIOL, V16, DOI 10.1186/S13059-015-0762-6.;CHEN JM, 2016, NAT COMMUN, V7, DOI 10.1038/NCOMMS11101.;CONESA A, 2016, GENOME BIOL, V17, DOI 10.1186/S13059-016-0881-8.;CUMMINGS BB, 2017, SCI TRANSL MED, V9, DOI 10.1126/SCITRANSLMED.AA15209.;DEGNER JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/BIOINFORMATICS/BTP579.;DELAUGHTER DM, 2016, DEV CELL, V39, P480, DOI 10.1016/J.DEVCEL.2016.10.001.;DELUCA DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/BIOINFORMATICS/BTS196.;DOBIN A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/BIOINFORMATICS/BTS635.;FAN J, 2016, NAT METHODS, V13, P241, DOI [10.1038/NMETH.3734, 10.1038/NMETH.3734].;FAN XY, 2015, GENOME BIOL, V16, DOI 10.1186/S13059-015-0706-1.;FANG ZD, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-26.;FINAK G, 2015, GENOME BIOL, V16, DOI 10.1186/S13059-015-0844-5.;FRANZEN O, 2016, SCIENCE, V353, P827, DOI 10.1126/SCIENCE.AAD6970.;GAIDATZIS D, 2015, NAT BIOTECHNOL, V33, P722, DOI 10.1038/NBT.3269.;GAWAD C, 2016, NAT REV GENET, V17, P175, DOI 10.1038/NRG.2015.16.;GIERAHN TM, 2017, NAT METHODS, V14, P395, DOI 10.1038/NMETH.4179.;GOLDSTEIN LD, 2016, PLOS ONE, V11, DOI 10.1371/JOURNAL.PONE.0156132.;GOODWIN S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/NRG.2016.49.;GRABHERR MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/NBT.1883.;GRINDBERG RV, 2013, P NATL ACAD SCI USA, V110, P19802, DOI 10.1073/PNAS.1319700110.;GRUN D, 2015, CELL, V163, P799, DOI 10.1016/J.CELL.2015.10.039.;GRUN D, 2015, NATURE, V525, P251, DOI 10.1038/NATURE14966.;GRUN D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/NMETH.2930].;GUDLAUGSDOTTIR S, 2007, GENETICA, V131, P299, DOI 10.1007/S10709-007-9139-4.;HAGHVERDI L, 2016, NAT METHODS, V13, P845, DOI 10.1038/NMETH.3971.;HASHIMSHONY T, 2016, GENOME BIOL, V17, DOI 10.1186/S13059-016-0938-8.;HASHIMSHONY T, 2012, CELL REPORTS, V2, P666, DOI 10.1016/J.CELREP.2012.08.003.;HOCHGERNER H, 2017, SCI REP-UK, V7, DOI 10.1038/S41598-017-16546-4.;ISLAM S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/NMETH.2772].;ISLAM S, 2011, GENOME RES, V21, P1160, DOI 10.1101/GR.110882.110.;JAITIN DA, 2014, SCIENCE, V343, P776, DOI 10.1126/SCIENCE.1247651.;JIANG H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/BIOINFORMATICS/BTP113.;JUNG- H, 2015, NAT GENET, V47, P1242, DOI 10.1038/NG.3414.;KHARCHENKO PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/NMETH.2967].;KIM JB, 2017, PLOS GENET, V13, DOI 10.1371/JOURNAL.PGEN.1006750.;KIMMERLING RJ, 2016, NAT COMMUN, V7, DOI 10.1038/NCOMMS10220.;KISELEV VY, 2017, NAT METHODS, V14, P483, DOI [10.1038/NMETH.4236, 10.1038/NMETH.4236].;KLEIN AM, 2015, CELL, V161, P1187, DOI 10.1016/J.CELL.2015.04.044.;KOLODZIEJCZYK AA, 2015, MOL CELL, V58, P610, DOI 10.1016/J.MOLCEL.2015.04.005.;KUMAR S, 2016, SCI REP-UK, V6, DOI 10.1038/SREP21597.;KURTZ S, 2004, GENOME BIOL, V5, DOI 10.1186/GB-2004-5-2-R12.;LAKE BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/SCIENCE.AAF1204.;LANGFELDER P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559.;LANGMEAD BEN, 2010, CURR PROTOC BIOINFORMATICS, VCHAPTER 11, DOI 10.1002/0471250953.BI1107S32.;LEE C, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-37.;LEE JH, 2015, NAT PROTOC, V10, DOI 10.1038/NPROT.2014.191.;LENG N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/BIOINFORMATICS/BTT087.;LI G, 2016, DEV CELL, V39, P491, DOI 10.1016/J.DEVCEL.2016.10.014.;LI WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/NRG.2016.4.;LI YI, 2018, NAT GENET, V50, P151, DOI 10.1038/S41588-017-0004-9.;LI YI, 2016, SCIENCE, V352, P600, DOI 10.1126/SCIENCE.AAD9417.;LIAO Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/BIOINFORMATICS/BTT656.;LUN ATL, 2016, GENOME BIOL, V17, DOI 10.1186/S13059-016-0947-7.;MACOSKO EZ, 2015, CELL, V161, P1202, DOI 10.1016/J.CELL.2015.05.002.;MARCO E, 2014, P NATL ACAD SCI USA, V111, PE5643, DOI 10.1073/PNAS.1408993111.;MARCO-SOLA S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/NMETH.2221].;MURARO MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/J.CELS.2016.09.002.;NAGALAKSHMI U, 2008, SCIENCE, V320, P1344, DOI 10.1126/SCIENCE.1158441.;OLSSON A, 2016, NATURE, V537, P698, DOI 10.1038/NATURE19348.;PACHTER L, ARXIV11043889.;PANOUSIS NI, 2014, GENOME BIOL, V15, DOI 10.1186/S13059-014-0467-2.;PATRO R, 2017, NAT METHODS, V14, P417, DOI 10.1038/NMETH.4197.;PATRO R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/NBT.2862.;PERTEA M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/NPROT.2016.095.;PICELLI S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/NMETH.2639].;PIMENTEL H, 2017, NAT METHODS, V14, P687, DOI 10.1038/NMETH.4324.;PJANIC M, 2016, CURR CARDIOL REP, V18, DOI 10.1007/S11886-016-0777-Y.;RAMSKOLD D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/NBT.2282.;RAPPOLEE DA, 1989, J CELL BIOCHEM, V39, P1, DOI 10.1002/JCB.240390102.;ROMANEL A, 2015, BMC MED GENOMICS, V8, DOI 10.1186/S12920-015-0084-2.;ROSENBERG AB, 2017, BIORXIV.;SAKHARKAR MEENA KISHORE, 2004, IN SILICO BIOLOGY, V4, P387.;SATIJA R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/NBT.3192.;SCHULZ MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/BIOINFORMATICS/BTS094.;SCHURCH NJ, 2016, RNA, V22, P839, DOI 10.1261/RNA.053959.115.;SEYEDNASROLLAH F, 2015, BRIEF BIOINFORM, V16, P59, DOI 10.1093/BIB/BBT086.;SHARON D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/NBT.2705.;SHENG KW, 2017, NAT METHODS, V14, P267, DOI [10.1038/NMETH.4145, 10.1038/NMETH.4145].;SHIN J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/J.STEM.2015.07.013.;SONESON CHARLOTTE, 2015, F1000RES, V4, P1521, DOI 10.12688/F1000RESEARCH.7563.2.;STEGLE O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/NRG3833.;SULTAN M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-675.;SUN L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-331.;SUTER DM, 2011, SCIENCE, V332, P472, DOI 10.1126/SCIENCE.1198817.;SVENSSON V, 2017, NAT METHODS, V14, P381, DOI 10.1038/NMETH.4220.;TILGNER H, 2015, NAT BIOTECHNOL, V33, P736, DOI 10.1038/NBT.3242.;TILGNER H, 2014, P NATL ACAD SCI USA, V111, P9869, DOI 10.1073/PNAS.1400447111.;TRAPNELL C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/NBT.2859.;TRAPNELL C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/NBT.2450.;TRAPNELL C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/NBT.1621.;TRAPNELL C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/BIOINFORMATICS/BTP120.;TREUTLEIN B, 2014, NATURE, V509, P371, DOI 10.1038/NATURE13173.;ULITSKY I, 2016, NAT REV GENET, V17, P601, DOI 10.1038/NRG.2016.85.;VALLEJOS CA, 2017, NAT METHODS, V14, P565, DOI [10.1038/NMETH.4292, 10.1038/NMETH.4292].;VAN DE GEIJN B, 2015, NAT METHODS, V12, P1061, DOI [10.1038/NMETH.3582, 10.1038/NMETH.3582].;VAN DER MAATEN L, 2008, J MACH LEARN RES, V9, P2579.;WANG K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/NAR/GKQ622.;WANG Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/NRG2484.;WEIRATHER JASON L, 2017, F1000RES, V6, P100, DOI 10.12688/F1000RESEARCH.10571.2.;WILHELM BT, 2008, NATURE, V453, P1239, DOI 10.1038/NATURE07002.;WILLIAMS CR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/S12859-016-1457-Z.;WU AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/NMETH.2694.;XU C, 2015, BIOINFORMATICS, V31, P1974, DOI 10.1093/BIOINFORMATICS/BTV088.;XU GR, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-2.;ZENG C, 2017, CELL METAB, V25, P1160, DOI 10.1016/J.CMET.2017.04.014.;ZENG WH, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/NAR/GKW739.;ZERBINO DR, 2008, GENOME RES, V18, P821, DOI 10.1101/GR.074492.107.","QUERTERMOUS, T (REPRINT AUTHOR), STANFORD UNIV, DIV CARDIOVASC MED, FALK CARDIOVASC RES CTR, 300 PASTEUR DR, STANFORD, CA 94305 USA.;WIRKA, ROBERT C., PJANIC, MILOS, QUERTERMOUS, THOMAS, STANFORD UNIV, DIV CARDIOVASC MED, DEPT MED, STANFORD, CA 94305 USA.","10.1161/CIRCRESAHA.117.310910","TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",NA,NA,"NATIONAL INSTITUTES OF HEALTH (NIH) [F32HL129670], NIH [R01HL109512, R01HL134817, R33HL120757, R01DK107437, R01HL139478]","THIS STUDY WAS SUPPORTED BY THE NATIONAL INSTITUTES OF HEALTH (NIH) GRANT F32HL129670 (TO R.C. WIRKA) AND ALSO BY GRANTS NIH R01HL109512, R01HL134817, R33HL120757, R01DK107437 AND R01HL139478 (TO T. QUERTERMOUS).",NA,"0009-7330","9","1200-1220","LIPPINCOTT WILLIAMS \& WILKINS","122",2018,"ISI000435406500006","121","CARDIOVASCULAR SYSTEM \& CARDIOLOGY, HEMATOLOGY","3","CARDIAC \& CARDIOVASCULAR SYSTEMS, HEMATOLOGY, PERIPHERAL VASCULAR DISEASE","TOMQ1STANFORD.EDU",NA,"GJ5FJ",NA,"QUERTERMOUS, T (REPRINT AUTHOR), STANFORD UNIV, DIV CARDIOVASC MED, FALK CARDIOVASC RES CTR, 300 PASTEUR DR, STANFORD, CA 94305 USA","ISI","STANFORD UNIV","STANFORD UNIV",NA,"WIRKA RC, 2018, CIRC RES","WIRKA RC, 2018, CIRC RES"
"MAHNDIEH N, 2018, CLIN NEUROL NEUROSURG","MAHNDIEH N;MIKAEELI S;TAVASOLI AR;REZAEI Z;MALEKI M;RABBANI B","GENOTYPE, PHENOTYPE AND IN SILICO PATHOGENICITY ANALYSIS OF HEXB MUTATIONS: PANEL BASED SEQUENCING FOR DIFFERENTIAL DIAGNOSIS OF GANGLIOSIDOSIS","CLINICAL NEUROLOGY AND NEUROSURGERY","CLIN. NEUROL. NEUROSURG.","OBJECTIVES: GANGLIOSIDOSIS IS AN INHERITED METABOLIC DISORDER CAUSING NEURODEGENERATION AND MOTOR REGRESSION. PREVENTIVE DIAGNOSIS IS THE FIRST CHOICE FOR THE AFFECTED FAMILIES DUE TO LACK OF STRAIGHTFORWARD THERAPY. GENETIC STUDIES COULD CONFIRM THE DIAGNOSIS AND HELP FAMILIES FOR CARRIER SCREENING AND PRENATAL DIAGNOSIS. AN UPDATE OF HEXB GENE VARIANTS CONCERNING GENOTYPE, PHENOTYPE AND IN SILICO ANALYSIS ARE PRESENTED. PATIENTS AND METHODS: PANEL BASED NEXT GENERATION SEQUENCING AND DIRECT SEQUENCING OF FOUR CASES WERE PERFORMED TO CONFIRM THE CLINICAL DIAGNOSIS AND FOR REPRODUCTIVE PLANNING. BIOINFORMATIC ANALYSES OF THE HEXB MUTATION DATABASE WERE ALSO PERFORMED. RESULTS: DIRECT SEQUENCING OF HEXA AND HEXB GENES SHOWED RECURRENT HOMOZYGOUS VARIANTS AT C.509G > A (P.ARG170GLN) AND C.850C > T (P.ARG284TER), RESPECTIVELY. A NOVEL VARIANT AT C.416T > A (P.LEU139GLN) WAS IDENTIFIED IN THE GLBJ GENE. PANEL BASED NEXT GENERATION SEQUENCING WAS PERFORMED FOR AN UNDIAGNOSED PATIENT WHICH SHOWED A NOVEL MUTATION AT C.1602C > A (P.CYS534TER) OF HEXB GENE. BIOINFORMATIC ANALYSIS OF THE HEXB MUTATION DATABASE SHOWED 97\% CONSISTENCY OF IN SILICO GENOTYPE ANALYSIS WITH THE PHENOTYPE. BIOINFORMATIC ANALYSIS OF THE NOVEL VARIANTS PREDICTED TO BE DISEASE CAUSING. IN SILICO STRUCTURAL AND FUNCTIONAL ANALYSIS OF THE NOVEL VARIANTS SHOWED STRUCTURAL EFFECT OF HEXB AND FUNCTIONAL EFFECT OF GLB1 VARIANTS WHICH WOULD PROVIDE FAST ANALYSIS OF NOVEL VARIANTS. CONCLUSIONS: PANEL BASED STUDIES COULD BE PERFORMED FOR OVERLAPPING SYMPTOMATIC PATIENTS. CONSEQUENTLY, GENETIC TESTING WOULD HELP AFFECTED FAMILIES FOR PATIENTS' MANAGEMENT, CARRIER DETECTION, AND FAMILY PLANNING'S.","HEX B VARIANTS; GANGLIOSIDOSIS; NEXT GENERATION SEQUENCING; IN SILICO ANALYSIS","HUMAN BETA-HEXOSAMINIDASE; INFANTILE SANDHOFF-DISEASE; TAY-SACHS-DISEASE; LYSOSOMAL STORAGE DISEASES; TANDEM MASS-SPECTROMETRY; MOTOR-NEURON DISEASE; SPLICE-SITE MUTATION; MESSENGER-RNA LEVELS; MOLECULAR-BASIS; GM2 GANGLIOSIDOSIS","ENGLISH","ARTICLE","ARTICLE",0,"ALTSHULER DM, 2015, NATURE, V526, P68, DOI 10.1038/NATURE15393.;ANKALA A, 2012, GENOME RES, V22, P25, DOI 10.1101/GR.123463.111.;ARYAN H, 2012, IRAN J PUBLIC HEALTH, V41, P112.;BANERJEE P, 1991, BIOCHEM BIOPH RES CO, V181, P108, DOI 10.1016/S0006-291X(05)81388-9.;BEKER-ACAY M, 2016, POL J RADIOL, V81, P86, DOI 10.12659/PJR.895911.;BELL CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/SCITRANSLMED.3001756.;BIKKER H, 1989, HUM GENET, V81, P287, DOI 10.1007/BF00279006.;BOLHUIS PA, 1993, BIOCHIM BIOPHYS ACTA, V1182, P142, DOI 10.1016/0925-4439(93)90134-M.;BOUSTANY RMN, 2013, NAT REV NEUROL, V9, P583, DOI 10.1038/NRNEUROL.2013.163.;BROWN CA, 1992, BIOCHIM BIOPHYS ACTA, V1180, P91, DOI 10.1016/0925-4439(92)90031-H.;CHACE DH, 2002, ANNU REV GENOM HUM G, V3, P17, DOI 10.1146/ANNUREV.GENOM.3.022502.103213.;CHOI Y, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0046688.;D'AZZO A, 2001, METABOLIC MOL BASES, VIII, P3811.;DLOTT B, 1990, J BIOL CHEM, V265, P17921.;FITTERER B, 2014, MOL GENET METAB, V111, P382, DOI 10.1016/J.YMGME.2014.01.002.;FITTERER BB, 2012, GENET TEST MOL BIOMA, V16, P401, DOI 10.1089/GTMB.2011.0215.;FUJIMARU M, 1998, HUM GENET, V103, P462, DOI 10.1007/S004390050851.;FURIHATA K, 1999, HUM MUTAT, V13, P38, DOI 10.1002/(SICI)1098-1004(1999)13:1<38::AID-HUMU4>3.0.CO,2-S.;GAIGNARD P, 2013, GENE, V512, P521, DOI 10.1016/J.GENE.2012.09.124.;GELB MH, 2015, CLIN CHEM, V61, P335, DOI 10.1373/CLINCHEM.2014.225771.;GOMEZ-LIRA M, 1998, AM J MED GENET, V75, P330, DOI 10.1002/(SICI)1096-8628(19980123)75:3<330::AID-AJMG21>3.0.CO,2-P.;GOMEZ-LIRA M, 2001, MOL CELL PROBE, V15, P75, DOI 10.1006/MCPR.2000.0342.;GOMEZLIRA M, 1995, HUM MUTAT, V6, P260, DOI 10.1002/HUMU.1380060313.;GOMEZLIRA M, 1995, HUM GENET, V96, P417.;GORT L, 2012, GENE, V506, P25, DOI 10.1016/J.GENE.2012.06.080.;GUPTA P., 2015, PG TXB PEDIAT.;HARA Y, 1994, HUM GENET, V94, P136.;HENG HHQ, 1993, GENOMICS, V18, P429, DOI 10.1006/GENO.1993.1491.;HOU YM, 1998, J BIOL CHEM, V273, P21386, DOI 10.1074/JBC.273.33.21386.;HUANG JQ, 1997, HUM MOL GENET, V6, P1879, DOI 10.1093/HMG/6.11.1879.;HUANG YONGLAN, 2014, ZHONGHUA ER KE ZA ZHI, V52, P313.;KARIMZADEH P, 2014, IRAN J CHILD NEUROL, V8, P55.;KAYA N, 2011, AM J MED GENET A, V155A, P1281, DOI 10.1002/AJMG.A.33932.;KELLEY LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/NPROT.2015.053.;KELLEY LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/NPROT.2009.2.;KIRCHER M, 2014, NAT GENET, V46, P310, DOI 10.1038/NG.2892.;KLEIMAN FE, 1994, HUM GENET, V94, P279, DOI 10.1007/BF00208283.;KORNELUK RG, 1986, J BIOL CHEM, V261, P8407.;KUROKI Y, 1995, BIOCHEM BIOPH RES CO, V212, P564, DOI 10.1006/BBRC.1995.2007.;LEE E H, 2000, HUM MUTAT, V16, P180, DOI 10.1002/1098-1004(200008)16:2<180::AID-HUMU21>3.0.CO,2-X.;LEE H. F., 2016, BRAIN DEV.;LI H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/BIOINFORMATICS/BTP352.;LI H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/BIOINFORMATICS/BTP324.;MAEGAWA GHB, 2007, J BIOL CHEM, V282, P9150, DOI 10.1074/JBC.M609304200.;MAHURAN DJ, 1999, BBA-MOL BASIS DIS, V1455, P105, DOI 10.1016/S0925-4439(99)00074-5.;MAIER T, 2003, J MOL BIOL, V328, P669, DOI 10.1016/S0022-2836(03)00311-5.;MARK BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X.;MATERN D, 2013, DEV DISABIL RES REV, V17, P247, DOI 10.1002/DDRR.1117.;MCINNES B, 1992, BIOCHIM BIOPHYS ACTA, V1138, P315, DOI 10.1016/0925-4439(92)90009-C.;NAKANO T, 1989, J BIOL CHEM, V264, P5155.;NARKIS G, 1997, HUM MUTAT, V10, P424, DOI 10.1002/(SICI)1098-1004(1997)10:6<424::AID-HUMU2>3.3.CO,2-Y.;NEOTE K, 1990, J CLIN INVEST, V86, P1524, DOI 10.1172/JCI114871.;PROIA RL, 1988, P NATL ACAD SCI USA, V85, P1883, DOI 10.1073/PNAS.85.6.1883.;PROIA RL, 2004, NAT GENET, V36, P1147, DOI 10.1038/NG1104-1147.;ROY A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/NPROT.2010.5.;SANDHOFF K, 2013, J NEUROSCI, V33, P10195, DOI 10.1523/JNEUROSCI.0822-13.2013.;SANTORO M, 2007, MOL GENET METAB, V91, P111, DOI 10.1016/J.YMGME.2006.12.004.;SCHWARZ JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/NMETH.2890.;SCRIVER CR, 1995, METABOLIC MOL BASES.;SIM NL, 2012, NUCLEIC ACIDS RES, V40, PW452, DOI 10.1093/NAR/GKS539.;SLY W., 2001, METABOLIC MOL BASES.;SOBEK AKU, 2013, MOL CELL PROBE, V27, P32, DOI 10.1016/J.MCP.2012.08.007.;SUZUKI Y., 2001, METABOLIC MOL BASES, P3775.;SZKLARCZYK D, 2015, NUCLEIC ACIDS RES, V43, PD447, DOI 10.1093/NAR/GKU1003.;TAMHANKAR PM, 2016, J HUM GENET, V61, P163, DOI 10.1038/JHG.2015.130.;TURGEON C, 2008, CLIN CHEM, V54, P657, DOI 10.1373/CLINCHEM.2007.101949.;WAKAMATSU N, 1992, J BIOL CHEM, V267, P2406.;WANG SZ, 2008, MOL GENET METAB, V95, P236, DOI 10.1016/J.YMGME.2008.08.007.;WORTMANN SB, 2009, J INHERIT METAB DIS, V32, PS307, DOI 10.1007/S10545-009-1261-2.;WU TONGFEI, 2013, ZHEJIANG DA XUE XUE BAO YI XUE BAN, V42, P403.;YOSHIZAWA T, 2002, J NEUROL SCI, V195, P129, DOI 10.1016/S0022-510X(02)00007-2.;ZAMPIERI S, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0041516.;ZAMPIERI S, 2009, NEUROGENETICS, V10, P49, DOI 10.1007/S10048-008-0145-1.;ZHANG W, 2016, METAB BRAIN DIS, V31, P861, DOI 10.1007/S11011-016-9819-9.;ZHANG ZX, 1995, HUM MOL GENET, V4, P777, DOI 10.1093/HMG/4.4.777.;ZHANG ZX, 1994, HUM MOL GENET, V3, P139, DOI 10.1093/HMG/3.1.139.","RABBANI, B (REPRINT AUTHOR), IRAN UNIV MED SCI, GENET RES CTR, RAJAIE CARDIOVASC MED \& RES CTR, POB 1996911151, TEHRAN, IRAN.;MAHNDIEH, NEJAT, MIKAEELI, SAHAR, MALEKI, MAJID, RABBANI, BAHAREH, IRAN UNIV MED SCI, GENET RES CTR, RAJAIE CARDIOVASC MED \& RES CTR, POB 1996911151, TEHRAN, IRAN.;TAVASOLI, ALI REZA, REZAEI, ZAHRA, UNIV TEHRAN, CHILDRENS HOSP CTR, PEDIAT CTR EXCELLENCE, MED CTR, TEHRAN, IRAN.;TAVASOLI, ALI REZA, RABBANI, BAHAREH, UNIV TEHRAN MED SCI, GROWTH \& DEV RES, TEHRAN, IRAN.","10.1016/J.CLINEURO.2018.02.011","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,NA,NA,NA,"0303-8467",NA,"43-53","ELSEVIER SCIENCE BV","167",2018,"ISI000430773500008","76","NEUROSCIENCES \& NEUROLOGY, SURGERY","5","CLINICAL NEUROLOGY, SURGERY","NMAHNDIEHRHC.AC.IR BAHAREHRABBANIYAHOO.COM",NA,"GD8PB",NA,"RABBANI, B (REPRINT AUTHOR), IRAN UNIV MED SCI, GENET RES CTR, RAJAIE CARDIOVASC MED \& RES CTR, POB 1996911151, TEHRAN, IRAN","ISI","IRAN UNIV MED SCI;UNIV TEHRAN;UNIV TEHRAN MED SCI","IRAN UNIV MED SCI",NA,"MAHNDIEH N, 2018, CLIN NEUROL NEUROSURG","MAHNDIEH N, 2018, CLIN NEUROL NEUROSURG"
"MA Y, 2018, ONCOL LETT","MA Y;CHEN K;YANG Z;GUAN M","TARGETED SEQUENCING REVEALS DISTINCT PATHOGENIC VARIANTS IN CHINESE PATIENTS WITH LUNG ADENOCARCINOMA BRAIN METASTASES","ONCOLOGY LETTERS","ONCOL. LETT.","LUNG CANCER IS THE MOST COMMON TYPE OF MALIGNANCY TO METASTASIZE TO THE BRAIN, WITH THE MEDIAN SURVIVAL TIME OF PATIENTS BEING 6-11 MONTHS. IN THE PRESENT STUDY, THE AIM WAS TO COMPARE THE ACTIONABLE GENE MUTATION PROFILES OF PRIMARY LUNG ADENOCARCINOMA (LC) SAMPLES AND LC BRAIN METASTASIS (LCBM) SAMPLES THROUGH TARGETED SEQUENCING. NEXT GENERATION SEQUENCING (NGS) OF 13 FORMALIN-FIXED, PARAFFIN-EMBEDDED LC SAMPLES AND 15 LCBM SAMPLES WAS PERFORMED USING A CUSTOMIZED ONCOAIM (TM) CANCER PANEL AND ONCOAIM (TM) RNA FUSION PANEL ON THE MISEQ PLATFORM. THE ONCOAIM (TM) CANCER PANEL PIPELINE AND ONCOAIM (TM) RNA FUSION PANEL PIPELINE WERE USED FOR BIOINFORMATIC ANALYSIS. TOGETHER, 43 VARIANTS WERE OBSERVED IN 7 GENES FROM THE 28 CANCER SAMPLES. THE MUTATED GENES OF LCBM WERE TUMOR PROTEIN (TP) 53, EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), CATENIN BETA 1, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT A, MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 4, KIRSTEN RAT SARCOMA VIRAL ONCOGENE HOMOLOG (KRAS) AND PROTO-ONCOGENE B-RAF, WHICH WERE EXHIBITED IN 10/15 (66.7\%), 6/15 (40.0\%), 3/15 (20.0\%), 2/15 (13.3\%), 2/15 (13.3\%), 1/15 (6.7\%) AND 1/15 (6.7\%) OF SAMPLES, RESPECTIVELY. THE MUTATED GENES OF LC WERE TP53, EGFR AND KRAS, WHICH WERE EXHIBITED IN 11/13 (84.6\%), 5/13 (38.5\%) AND 2/13 (18.2\%) OF SAMPLES, RESPECTIVELY. ECHINODERM MICROTUBULE ASSOCIATED PROTEIN LIKE 4-ANAPLASTIC LYMPHOMA KINASE REARRANGEMENTS WERE PRESENT IN 1 LCBM SAMPLE. FOR 2 LC SAMPLES AND 1 LCBM SAMPLE, NO GENETIC ALTERATIONS WERE OBSERVED. THE NGS DATA ALSO REVEALED A NOVEL 4-CODON DELETION OF TP53 (P.V166\_H169DEL) AND A NOVEL TP53 SPLICE SITE MUTATION (7577157-63DEL TACTCAG). FURTHER POTENTIALLY ACTIONABLE MUTATIONS WERE DETECTED IN LCBM, INDICATING A HIGH DEGREE OF GENETIC HETEROGENEITY BETWEEN THE LC AND LCBM SAMPLES THAT WERE ANALYZED. THE PRESENT STUDY DEMONSTRATED THAT NGS PROVIDES AN IMPROVED APPROACH FOR THE DISCOVERY OF POTENTIALLY ACTIONABLE MUTATIONS AND THE UNDERSTANDING OF THE MECHANISMS UNDERLYING TUMOR PROGRESSION AND EVOLUTION.","GENE MUTATIONS; BRAIN METASTASES; LUNG ADENOCARCINOMA; NEXT-GENERATION SEQUENCING; TARGETED THERAPY","TYROSINE KINASE INHIBITORS; MOLECULAR TESTING GUIDELINE; RADIATION-THERAPY; CANCER PATIENTS; KRAS MUTATIONS; EGFR; GENE; CRIZOTINIB; CARCINOMA; ASSOCIATION","ENGLISH","ARTICLE","ARTICLE",0,"ANDREWS DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8.;ARRIETA O, 2015, J THORAC ONCOL, V10, P838, DOI 10.1097/JTO.0000000000000481.;BAILON O, 2011, REV NEUROL-FRANCE, V167, P579, DOI 10.1016/J.NEUROL.2011.01.017.;BOLAND GM, 2015, ONCOTARGET, V6, P20099, DOI 10.18632/ONCOTARGET.4040.;CARDARELLA S, 2013, AM J RESP CRIT CARE, V188, P770, DOI 10.1164/RCCM.201305-0843PP.;COLLISSON EA, 2014, NATURE, V511, P543, DOI 10.1038/NATURE13385.;DETTERBECK FC, 2017, CHEST, V151, P193, DOI 10.1016/J.CHEST.2016.10.010.;DIENSTMANN R, 2013, J CLIN ONCOL, V31, P1874, DOI 10.1200/JCO.2012.45.2268.;ELLIS MJ, 2012, NATURE, V486, P353, DOI 10.1038/NATURE11143.;FRAMPTON GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/NBT.2696.;GADGEEL SM, 2014, LANCET ONCOL, V15, P1119, DOI 10.1016/S1470-2045(14)70362-6.;GALLIONE CJ, 2004, LANCET, V363, P852, DOI 10.1016/S0140-6736(04)15732-2.;HAGEMANN IS, 2015, CANCER-AM CANCER SOC, V121, P631, DOI 10.1002/CNCR.29089.;HAN ES, 1991, GENE CHROMOSOME CANC, V3, P313, DOI 10.1002/GCC.2870030411.;IMIELINSKI M, 2012, CELL, V150, P1107, DOI 10.1016/J.CELL.2012.08.029.;KITAEVA MN, 1997, CANCER RES, V57, P4478.;LAI MY, 1993, CANCER RES, V53, P1653.;LEMJABBAR-ALAOUI H, 2015, BBA-REV CANCER, V1856, P189, DOI 10.1016/J.BBCAN.2015.08.002.;LINDEMAN NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0B013E318290868F.;LINDEMAN NI, 2013, ARCH PATHOL LAB MED, V137, P828, DOI 10.5858/ARPA.2012-0720-OA.;MAKI-NEVALA S, 2016, LUNG CANCER, V99, P102, DOI 10.1016/J.LUNGCAN.2016.06.024.;MAO C, 2010, LUNG CANCER, V69, P272, DOI 10.1016/J.LUNGCAN.2009.11.020.;MOVVA S, 2015, ONCOTARGET, V6, P12234, DOI 10.18632/ONCOTARGET.3498.;MULVENNA PM, 2010, CLIN ONCOL-UK, V22, P365, DOI 10.1016/J.CLON.2010.03.011.;PAIK PK, 2015, CANCER DISCOV, V5, P610, DOI 10.1158/2159-8290.CD-14-1129.;PREUSSER M, 2015, EUR J CANCER, V51, P1803, DOI 10.1016/J.EJCA.2015.06.107.;RIELY GJ, 2008, CLIN CANCER RES, V14, P5731, DOI 10.1158/1078-0432.CCR-08-0646.;ROBINSON SD, 2014, LUNG CANCER, V85, P326, DOI 10.1016/J.LUNGCAN.2014.05.009.;RUSSO A, 2015, ONCOTARGET, V6, P26814, DOI 10.18632/ONCOTARGET.4254.;SHAW AT, 2014, NEW ENGL J MED, V371, P1963, DOI 10.1056/NEJMOA1406766.;SIE D, 2014, CELL ONCOL, V37, P353, DOI 10.1007/S13402-014-0196-2.;TARTARONE A, 2013, LUNG CANCER, V81, P328, DOI 10.1016/J.LUNGCAN.2013.05.020.;TING CY, 2012, BIOMATERIALS, V33, P704, DOI 10.1016/J.BIOMATERIALS.2011.09.096.;TORRE LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/CAAC.21262.;WELSH JW, 2013, J CLIN ONCOL, V31, P895, DOI 10.1200/JCO.2011.40.1174.;YANAGISAWA K, 2000, ONCOGENE, V19, P2305, DOI 10.1038/SJ.ONC.1203591.;YU JR, 2015, GENE DEV, V29, P250, DOI 10.1101/GAD.248963.114.;ZER A, 2014, FRONT ONCOL, V4, DOI 10.3389/FONC.2014.00329.;ZHENG DF, 2016, ONCOTARGETS THER, V9, P833, DOI 10.2147/OTT.S96834.","GUAN, M (REPRINT AUTHOR), FUDAN UNIV, HUASHAN HOSP NORTH, DEPT LAB MED, 108 LUXIANG RD, SHANGHAI 201907, PEOPLES R CHINA.;YANG, ZH (REPRINT AUTHOR), BAOSHAN DIST HOSP INTEGRATED TRADIT CHINESE \& WES, CLIN LAB, 181 YOUYI RD, SHANGHAI 201999, PEOPLES R CHINA.;MA, YANCHUN, CHEN, KUN, GUAN, MING, FUDAN UNIV, HUASHAN HOSP NORTH, DEPT LAB MED, 108 LUXIANG RD, SHANGHAI 201907, PEOPLES R CHINA.;YANG, ZHENHUA, BAOSHAN DIST HOSP INTEGRATED TRADIT CHINESE \& WES, CLIN LAB, 181 YOUYI RD, SHANGHAI 201999, PEOPLES R CHINA.;GUAN, MING, FUDAN UNIV, HUASHAN HOSP, SHANGHAI MED SCH, CENT LAB, SHANGHAI 200000, PEOPLES R CHINA.","10.3892/OL.2018.7859","POB 18179, ATHENS, 116 10, GREECE",NA,NA,"RESEARCH FUND FOR SHANGHAI LEADING TALENTS","THE PRESENT STUDY WAS SUPPORTED BY THE RESEARCH FUND FOR SHANGHAI LEADING TALENTS (2015-2017).",NA,"1792-1074","4","4503-4510","SPANDIDOS PUBL LTD","15",2018,"ISI000430822500062","39","ONCOLOGY","0","ONCOLOGY","SHBSYZH126.COM GUANMING88YAHOO.COM",NA,"GD9HA",NA,"GUAN, M (REPRINT AUTHOR), FUDAN UNIV, HUASHAN HOSP NORTH, DEPT LAB MED, 108 LUXIANG RD, SHANGHAI 201907, PEOPLES R CHINA","ISI","FUDAN UNIV;BAOSHAN DIST HOSP INTEGRATED TRADIT CHINESE AND WES;FUDAN UNIV","FUDAN UNIV",NA,"MA Y, 2018, ONCOL LETT","MA Y, 2018, ONCOL LETT"
"DE SILVA TI, 2018, AIDS","DE SILVA TI;LELIGDOWICZ A;CARLSON J;GARCIA KNIGHT M;ONYANGO C;MILLER N;YINDOM LM;HUE S;JAYE A;DONG T;COTTEN M;ROWLAND JONES SL","HLA-ASSOCIATED POLYMORPHISMS IN THE HIV-2 CAPSID HIGHLIGHT KEY DIFFERENCES BETWEEN HIV-1 AND HIV-2 IMMUNE ADAPTATION","AIDS","AIDS","OBJECTIVE: HIV-1 FREQUENTLY ADAPTS IN RESPONSE TO IMMUNE PRESSURE FROM CYTOTOXIC T-LYMPHOCYTES (CTL). MANY HIV-2 INFECTED INDIVIDUALS HAVE ROBUST CAPSID-SPECIFIC CTL RESPONSES ASSOCIATED WITH VIRAL CONTROL. DESPITE THIS CTL PRESSURE, ADAPTIVE CHANGES IN THIS KEY IMMUNOGENIC HIV-2 PROTEIN HAVE NOT PREVIOUSLY BEEN DESCRIBED. WE SOUGHT TO COMPARE SELECTIVE PRESSURE ON HIV-1 AND HIV-2 CAPSIDS AND IDENTIFY HLA-ASSOCIATED VIRAL POLYMORPHISMS IN HIV-2. DESIGN AND METHODS: BIOINFORMATIC ALGORITHMS TO IDENTIFY SITES UNDER POSITIVE AND NEGATIVE SELECTIVE PRESSURE AND A STATISTICAL MODEL OF EVOLUTION TO IDENTIFY HLA-ASSOCIATED POLYMORPHISMS IN HIV-2 WAS APPLIED TO SEQUENCES FROM A COMMUNITY COHORT IN GUINEA-BISSAU. IFN-GAMMA ELISPOTS WERE USED TO COMPARE T-CELL RESPONSES TO WILD-TYPE AND VARIANT EPITOPES. RESULTS: WE IDENTIFIED GREATER PURIFYING SELECTION AND LESS SITES UNDER POSITIVE SELECTIVE PRESSURE IN HIV-2 COMPARED WITH HIV-1. FIVE HIV-2 CODONS WITH HLA-ASSOCIATED POLYMORPHISMS WERE DETECTED ALL WITHIN OR AROUND KNOWN OR PREDICTED CTL EPITOPES. ONE SITE WAS WITHIN THE HLA-B58 SUPERTYPE (ST)-RESTRICTED EPITOPE (TSTVEEQIQW), THE HIV-2 EQUIVALENT OF THE HIV-1 TW10 EPITOPE. IN CONTRAST TO HIV-1, WHERE A T -> N MUTATION AT POSITION 3 IS ASSOCIATED WITH RESULTING LOSS OF CTL CONTROL, AN E -> D MUTATION AT POSITION 5 WAS OBSERVED IN HIV-2. ROBUST CTL RESPONSES TO THE VARIANT HIV-2 EPITOPE WERE SEEN, SUGGESTING THAT HIV-2 ADAPTATION MAY BE AT THE LEVEL OF T-CELL RECEPTOR RECOGNITION. CONCLUSION: GREATER CONSTRAINTS ON EVOLUTION MAY EXIST IN HIV-2, RESULTING IN MORE PURIFYING SELECTION AND DIFFERENT IMMUNE ADAPTATION PATHWAYS IN HIV-1 AND HIV-2 CAPSIDS. THIS MAY ALLOW CTL RESPONSES TO PERSIST IN HIV-2. COPYRIGHT (C) 2018 THE AUTHOR(S). PUBLISHED BY WOLTERS KLUWER HEALTH, INC.","CYTOTOXIC T-LYMPHOCYTE; HIV-2; HLA","CYTOTOXIC T-LYMPHOCYTES; IMMUNODEFICIENCY-VIRUS TYPE-1; DISEASE PROGRESSION; VIRAL LOAD; INFECTION; EVOLUTION; SELECTION; VIREMIA; CELLS; GAG","ENGLISH","ARTICLE","ARTICLE",0,"BERRY N, 1998, J HUM VIROL, V1, P457.;BORROW P, 1997, NAT MED, V3, P205, DOI 10.1038/NM0297-205.;BORROW P, 1994, J VIROL, V68, P6103.;CARLSON JM, 2008, MICROBES INFECT, V10, P455, DOI 10.1016/J.MICINF.2008.01.013.;CARLSON JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/JOURNAL.PCBI.1000225.;CHARPENTIER C, 2014, AIDS, V28, P1161, DOI 10.1097/QAD.0000000000000244.;DA SILVA ZJ, 2008, AIDS, V22, P1195, DOI 10.1097/QAD.0B013E328300A33D.;DE SILVA TI, 2013, BLOOD, V121, P4330, DOI 10.1182/BLOOD-2012-12-472787.;DE SILVA TI, 2012, J VIROL, V86, P930, DOI 10.1128/JVI.06126-11.;DE SILVA TI, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-82.;DONG T, 2004, J EXP MED, V200, P1547, DOI 10.1084/JEM.20032044.;GOONETILLEKE N, 2009, J EXP MED, V206, P1253, DOI 10.1084/JEM.20090365.;JALLOW S, 2015, EUR J IMMUNOL, V45, P2232, DOI 10.1002/EJI.201545451.;POND SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/JOURNAL.PCBI.0020062.;LELIGDOWICZ A, 2007, J CLIN INVEST, V117, P3067, DOI 10.1172/JCI32380.;LELIGDOWICZ A, 2010, EUR J IMMUNOL, V40, P1963, DOI 10.1002/EJI.200940295.;LESLIE AJ, 2004, NAT MED, V10, P282, DOI 10.1038/NM992.;LI S, 2000, NATURE, V407, P409, DOI 10.1038/35030177.;MARTINEZ-PICADO J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006.;OGG GS, 1999, J VIROL, V73, P9153.;OGG GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/SCIENCE.279.5359.2103.;ONYANGO CO, 2010, VACCINE, V28, PB60, DOI 10.1016/J.VACCINE.2009.08.060.;POND SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/MOLBEV/MSI105.;POND SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/BIOINFORMATICS/BTI320.;POPPER SJ, 2000, J VIROL, V74, P1554, DOI 10.1128/JVI.74.3.1554-1557.2000.;POPPER SJ, 1999, J INFECT DIS, V180, P1116, DOI 10.1086/315010.;SKAR H, 2010, J VIROL, V84, P7412, DOI 10.1128/JVI.02548-09.;VAN DER LOEFF MFS, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-46.;VAN TIENEN C, 2009, J ACQ IMMUN DEF SYND, V53, P640.;YINDOM LM, 2010, J VIROL, V84, P8202, DOI 10.1128/JVI.00116-10.","DE SILVA, TI (REPRINT AUTHOR), MED RES COUNCIL UNIT GAMBIA, ATLANTIC RD,POB 273, BANJUL, GAMBIA.;DE SILVA, THUSHAN I., LELIGDOWICZ, ALEKSANDRA, ONYANGO, CLAYTON, JAYE, ASSAN, COTTEN, MATTHEW, MED RES COUNCIL UNIT GAMBIA, ATLANTIC RD,POB 273, BANJUL, GAMBIA.;DE SILVA, THUSHAN I., IMPERIAL COLL LONDON, WRIGHT FLEMING INST, DEPT MED, ST MARYS CAMPUS,NORFOLK PL, LONDON, ENGLAND.;LELIGDOWICZ, ALEKSANDRA, MILLER, NICHOLAS, DONG, TAO, JOHN RADCLIFFE HOSP, MRC, HUMAN IMMUNOL UNIT, WEATHERALL INST MOL MED, OXFORD, ENGLAND.;CARLSON, JONATHAN, MICROSOFT RES, REDMOND, WA USA.;GARCIA-KNIGHT, MIGUEL, YINDOM, LOUIS-MARIE, ROWLAND-JONES, SARAH L., UNIV OXFORD, NUFFIELD DEPT CLIN MED, NDM RES BLDG, OXFORD, ENGLAND.;HUE, STEPHANE, LONDON SCH HYG \& TROP MED, LONDON, ENGLAND.;LELIGDOWICZ, ALEKSANDRA, ERASMUS MC, DEPT VIROSCI, ROTTERDAM, NETHERLANDS.;GARCIA-KNIGHT, MIGUEL, UNIV TORONTO, INTERDEPT DIV CRIT CARE MED, DEPT MED, TORONTO, ON, CANADA.","10.1097/QAD.0000000000001753","TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",NA,NA,"MEDICAL RESEARCH COUNCIL [MC\_U190085854, G0801751, MC\_UP\_A900\_1121]",NA,NA,"0269-9370","6","709-714","LIPPINCOTT WILLIAMS \& WILKINS","32",2018,"ISI000427976500003","30","IMMUNOLOGY, INFECTIOUS DISEASES, VIROLOGY","2","IMMUNOLOGY, INFECTIOUS DISEASES, VIROLOGY","TDESILVAMRC.GM",NA,"GA0BF",NA,"DE SILVA, TI (REPRINT AUTHOR), MED RES COUNCIL UNIT GAMBIA, ATLANTIC RD,POB 273, BANJUL, GAMBIA","ISI","MED RES COUNCIL UNIT GAMBIA;IMPERIAL COLL LONDON;WEATHERALL INST MOL MED;MICROSOFT RES;UNIV OXFORD;LONDON SCH HYG AND TROP MED;DEPT VIROSCI;UNIV TORONTO","MED RES COUNCIL UNIT GAMBIA",NA,"DE SILVA TI, 2018, AIDS","DE SILVA TI, 2018, AIDS"
"FENG X, 2018, PARASITES VECTORS","FENG X;ZHOU X;ZHOU S;WANG J;HU W","ANALYSIS OF MICRORNA PROFILE OF ANOPHELES SINENSIS BY DEEP SEQUENCING AND BIOINFORMATIC APPROACHES","PARASITES \& VECTORS","PARASITES VECTORS","BACKGROUND: MICRORNAS (MIRNAS) ARE SMALL NON-CODING RNAS WIDELY IDENTIFIED IN MANY MOSQUITOES. THEY ARE REPORTED TO PLAY IMPORTANT ROLES IN DEVELOPMENT, DIFFERENTIATION AND INNATE IMMUNITY. HOWEVER, MIRNAS IN ANOPHELES SINENSIS, ONE OF THE CHINESE MALARIA MOSQUITOES, REMAIN LARGELY UNKNOWN. METHODS: WE INVESTIGATED THE GLOBAL MIRNA EXPRESSION PROFILE OF AN. SINENSIS USING ILLUMINA HISEQ 2000 SEQUENCING. MEANWHILE, WE APPLIED A BIOINFORMATIC APPROACH TO IDENTIFY POTENTIAL MIRNAS IN AN. SINENSIS. THE IDENTIFIED MIRNA PROFILES WERE COMPARED AND ANALYZED BY TWO APPROACHES. THE SELECTED MIRNAS FROM THE SEQUENCING RESULT AND THE BIOINFORMATIC APPROACH WERE CONFIRMED WITH QRT-PCR. MOREOVER, TARGET PREDICTION, GO ANNOTATION AND PATHWAY ANALYSIS WERE CARRIED OUT TO UNDERSTAND THE ROLE OF MIRNAS IN AN. SINENSIS. RESULTS: WE IDENTIFIED 49 CONSERVED MIRNAS AND 12 NOVEL MIRNAS BY NEXT-GENERATION HIGH-THROUGHPUT SEQUENCING TECHNOLOGY. IN CONTRAST, 43 MIRNAS WERE PREDICTED BY THE BIOINFORMATIC APPROACH, OF WHICH TWO WERE ASSIGNED AS NOVEL. COMPARATIVE ANALYSIS OF MIRNA PROFILES BY TWO APPROACHES SHOWED THAT 21 MIRNAS WERE SHARED BETWEEN THEM. TWELVE NOVEL MIRNAS DID NOT MATCH ANY KNOWN MIRNAS OF ANY ORGANISM, INDICATING THAT THEY ARE POSSIBLY SPECIES-SPECIFIC. FORTY MIRNAS WERE FOUND IN MANY MOSQUITO SPECIES, INDICATING THAT THESE MIRNAS ARE EVOLUTIONALLY CONSERVED AND MAY HAVE CRITICAL ROLES IN THE PROCESS OF LIFE. BOTH THE SELECTED KNOWN AND NOVEL MIRNAS (ASI-MIR-281, ASI-MIR-184, ASI-MIR-14, ASI-MIR-NOV5, ASI-MIR-NOV4, ASI-MIR-9383, AND ASI-MIR-2A) COULD BE DETECTED BY QUANTITATIVE REAL-TIME PCR (QRT-PCR) IN THE SEQUENCED SAMPLE, AND THE EXPRESSION PATTERNS OF THESE MIRNAS MEASURED BY QRT-PCR WERE IN CONCORDANCE WITH THE ORIGINAL MIRNA SEQUENCING DATA. THE PREDICTED TARGETS FOR THE KNOWN AND THE NOVEL MIRNAS COVERED MANY IMPORTANT BIOLOGICAL ROLES AND PATHWAYS INDICATING THE DIVERSITY OF MIRNA FUNCTIONS. WE ALSO FOUND 21 CONSERVED MIRNAS AND EIGHT COUNTERPARTS OF TARGET IMMUNE PATHWAY GENES IN AN. SINENSIS BASED ON THE ANALYSIS OF AN. GAMBIAE. CONCLUSIONS: OUR RESULTS PROVIDE THE FIRST LEAD TO THE ELUCIDATION OF THE MIRNA PROFILE IN AN. SINENSIS. UNVEILING THE ROLES OF MOSQUITO MIRNAS WILL UNDOUBTEDLY LEAD TO A BETTER UNDERSTANDING OF MOSQUITO BIOLOGY AND MOSQUITO-PATHOGEN INTERACTIONS. THIS WORK LAYS THE FOUNDATION FOR THE FURTHER FUNCTIONAL STUDY OF AN. SINENSIS MIRNAS AND WILL FACILITATE THEIR APPLICATION IN VECTOR CONTROL.","MICRORNA; NEXT-GENERATION SEQUENCING; BIOINFORMATIC APPROACH; ANOPHELES SINENSIS","MALARIA MOSQUITO; PLASMODIUM-FALCIPARUM; PYRETHROID RESISTANCE; EXPRESSION PROFILE; AEDES-ALBOPICTUS; CULEX-PIPIENS; WEB SERVER; SMALL RNAS; C-ELEGANS; IDENTIFICATION","ENGLISH","ARTICLE","ARTICLE",0,"ALLEN E, 2005, CELL, V121, P207, DOI 10.1016/J.CELL.2005.04.004.;AN J, 2012, NUCLEIC ACIDS RES, V41, P727.;ASGARI S, 2014, VIRUSES-BASEL, V6, P3514, DOI 10.3390/V6093514.;BAI L, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-10.;BEHURA SK, 2007, INSECT BIOCHEM MOLEC, V37, P3, DOI 10.1016/J.IBMB.2006.10.006.;BIRYUKOVA I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-557.;BRYANT B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/PNAS.1016230107.;CHANG XL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/JOURNAL.PNTD.0002889.;CHATTERJEE R, 2006, ACTA BIOCHIM POL, V53, P303.;CIRIMOTICH CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/J.DCI.2009.12.005.;DENNISON NJ, 2015, DEV COMP IMMUNOL, V49, P170, DOI 10.1016/J.DCI.2014.10.016.;DRITSOU V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1038.;FRIEDLANDER MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/NBT1394.;GELFAND Y, 2007, NUCLEIC ACIDS RES, V35, PD80, DOI 10.1093/NAR/GKL1013.;GRIFFITHS-JONES S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/NAR/GKG006.;GRIFFITHS-JONES S, 2006, NUCLEIC ACIDS RES, V34, PD140, DOI 10.1093/NAR/GKJ112.;GRILLO G, 2010, NUCLEIC ACIDS RES, V38, PD75, DOI 10.1093/NAR/GKP902.;GUIL S, 2015, TRENDS BIOCHEM SCI, V40, P248, DOI 10.1016/J.TIBS.2015.03.001.;HOLT RA, 2002, SCIENCE, V298, P129, DOI 10.1126/SCIENCE.1076181.;HONG S, 2014, INSECT BIOCHEM MOLEC, V55, P39, DOI 10.1016/J.IBMB.2014.10.007.;JAIN S, 2015, PARASITE VECTOR, V8, DOI 10.1186/S13071-015-0772-Y.;JAIN S, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0098402.;KOZOMARA A, 2014, NUCLEIC ACIDS RES, V42, PD68, DOI 10.1093/NAR/GKT1181.;KRISHNAN REMYA, 2015, SYST SYNTH BIOL, V9, P11, DOI 10.1007/S11693-014-9159-1.;KRUGER J, 2006, NUCLEIC ACIDS RES, V34, PW451, DOI 10.1093/NAR/GKL243.;LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y.;LEI ZT, 2015, PARASITOL RES, V114, P699, DOI 10.1007/S00436-014-4236-7.;LI L, 2010, MAMM GENOME, V21, P1, DOI 10.1007/S00335-009-9241-2.;LI RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/BIOINFORMATICS/BTN025.;LI S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-581.;LIU SP, 2014, P NATL ACAD SCI USA, V111, P14460, DOI 10.1073/PNAS.1416278111.;LIU WQ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-159.;LIU YX, 2015, CELL BIOSCI, V5, DOI 10.1186/S13578-015-0009-Y.;LUCAS KJ, 2013, TRENDS PARASITOL, V29, P295, DOI 10.1016/J.PT.2013.04.003.;MEAD EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-244.;MENDES AM, 2011, INFECT IMMUN, V79, P4708, DOI 10.1128/IAI.05647-11.;REN Z, 2016, SCI REP, V6.;SHANNON P, 2003, GENOME RES, V13, P2498, DOI 10.1101/GR.1239303.;SHRINET J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/JOURNAL.PNTD.0002616.;SKALSKY RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119.;WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4.;WINTER F, 2007, NUCLEIC ACIDS RES, V35, P6953, DOI 10.1093/NAR/GKM686.;XIE C, 2011, NUCLEIC ACIDS RES, V39, PW316, DOI 10.1093/NAR/GKR483.;XUE CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310.;YOON SUNGROH, 2006, BIRTH DEFECTS RESEARCH, V78, P118, DOI 10.1002/BDRC.20067.;ZHANG LI, 2015, ZHONGGUO JI SHENG CHONG XUE YU JI SHENG CHONG BING ZA ZHI, V33, P319.;ZHOU S, 2016, MALARIA J, V15, DOI 10.1186/S12936-016-1093-0.;ZHOU XN, 2014, ADV PARASIT, V86, P21, DOI 10.1016/B978-0-12-800869-0.00002-0.;ZUKER M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/NAR/GKG595.;2013, WORLD MALARIA REPORT, P1.","ZHOU, SS, HU, W (REPRINT AUTHOR), CHINESE CTR DIS CONTROL \& PREVENT, NATL CTR INT RES TROP DIS, WHO COLLABORATING CTR TROP DIS,KEY LAB PARASITE \&, NATL INST PARASIT DIS,NATL HLTH \& FAMILY PLANNING, SHANGHAI 200025, PEOPLES R CHINA.;WANG, JW, HU, W (REPRINT AUTHOR), FUDAN UNIV, MINIST EDUC, COLLABORAT INNOVAT CTR GENET \& DEV, SCH LIFE SCI,STATE KEY LAB GENET ENGN,KEY LAB CON, SHANGHAI 200438, PEOPLES R CHINA.;FENG, XINYU, ZHOU, SHUISEN, HU, WEI, CHINESE CTR DIS CONTROL \& PREVENT, NATL CTR INT RES TROP DIS, WHO COLLABORATING CTR TROP DIS,KEY LAB PARASITE \&, NATL INST PARASIT DIS,NATL HLTH \& FAMILY PLANNING, SHANGHAI 200025, PEOPLES R CHINA.;FENG, XINYU, FUDAN UNIV, NATL INST PARASIT DIS, JOINT RES LAB GENET \& ECOL PARASITES HOSTS INTERA, SHANGHAI 200025, PEOPLES R CHINA.;ZHOU, XIAOJIAN, ZHEJIANG UNIV, INST SOFTWARE ENGN, HANGZHOU 310011, ZHEJIANG, PEOPLES R CHINA.;WANG, JINGWEN, HU, WEI, FUDAN UNIV, MINIST EDUC, COLLABORAT INNOVAT CTR GENET \& DEV, SCH LIFE SCI,STATE KEY LAB GENET ENGN,KEY LAB CON, SHANGHAI 200438, PEOPLES R CHINA.","10.1186/S13071-018-2734-7","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","172",NA,"NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA [81271867, 91431104], INTERNATIONAL SCIENCE AND TECHNOLOGY COOPERATION PROGRAM OF CHINA [2014DFA31130], NATIONAL SCIENCE \& TECHNOLOGY MAJOR PROGRAM [2009ZX10004-302], SHANGHAI MUNICIPAL COMMISSION OF HEALTH AND FAMILY PLANNING GRANT [20174Y0089]","THIS WORK WAS SUPPORTED BY THE NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA (NOS. 81271867 AND 91431104), INTERNATIONAL SCIENCE AND TECHNOLOGY COOPERATION PROGRAM OF CHINA (NO. 2014DFA31130) AND NATIONAL SCIENCE \& TECHNOLOGY MAJOR PROGRAM (NO. 2009ZX10004-302). THIS WORK WAS ALSO SUPPORTED BY SHANGHAI MUNICIPAL COMMISSION OF HEALTH AND FAMILY PLANNING GRANT (NO. 20174Y0089).",NA,"1756-3305",NA,NA,"BIOMED CENTRAL LTD","11",2018,"ISI000427134000005","50","PARASITOLOGY, TROPICAL MEDICINE","7","PARASITOLOGY, TROPICAL MEDICINE","ZSS163HOTMAIL.COM JINGWENWANGFUDAN.EDU.CN HUWWYZ163.COM",NA,"FY8SB",NA,"ZHOU, SS, HU, W (REPRINT AUTHOR), CHINESE CTR DIS CONTROL \& PREVENT, NATL CTR INT RES TROP DIS, WHO COLLABORATING CTR TROP DIS,KEY LAB PARASITE \&, NATL INST PARASIT DIS,NATL HLTH \& FAMILY PLANNING, SHANGHAI 200025, PEOPLES R CHINA","ISI","WHO COLLABORATING CTR TROP DIS;FUDAN UNIV;ZHEJIANG UNIV;FUDAN UNIV","WHO COLLABORATING CTR TROP DIS",NA,"FENG X, 2018, PARASITES VECTORS","FENG X, 2018, PARASITES VECTORS"
"ELLISON G, 2018, HUM MUTAT","ELLISON G;AHDESMAKI M;LUKE S;WARING PM;WALLACE A;WRIGHT R;ROTHLISBERGER B;LUDIN K;MERKELBACH BRUSE S;HEYDT C;LIGTENBERG MJL;MENSENKAMP AR;DE CASTRO DG;JONES T;VIVANCOS A;KONDRASHOVA O;PAUWELS P;WEYN C;HAHNEN E;HAUKE J;SOONG R;LAI Z;DOUGHERTY B;CARR TH;JOHNSON J;MILLS J;BARRETT JC","AN EVALUATION OF THE CHALLENGES TO DEVELOPING TUMOR BRCA1 AND BRCA2 TESTING METHODOLOGIES FOR CLINICAL PRACTICE","HUMAN MUTATION","HUM. MUTAT.","OVARIAN CANCER PATIENTS WITH GERMLINE OR SOMATIC PATHOGENIC VARIANTS BENEFIT FROM TREATMENT WITH POLY ADP RIBOSE POLYMERASE (PARP) INHIBITORS. TUMOR BRCA1/2 TESTING IS MORE CHALLENGING THAN GERMLINE TESTING AS THE MAJORITY OF SAMPLES ARE FORMALIN-FIXED PARAFFIN EMBEDDED (FFPE), THE TUMOR GENOME IS COMPLEX, AND THE ALLELIC FRACTION OF SOMATIC VARIANTS CAN BE LOW. WE COLLABORATED WITH 10 LABORATORIES TESTING BRCA1/2 IN TUMORS TO COMPARE DIFFERENT APPROACHES TO IDENTIFY CLINICALLY IMPORTANT VARIANTS WITHIN FFPE TUMOR DNA SAMPLES. THIS WAS NOT A PROFICIENCY STUDY BUT AN INTER-LABORATORY COMPARISON TO IDENTIFY COMMON ISSUES. EACH LABORATORY RECEIVED THE SAME TUMOR DNA SAMPLES RANGING IN GENOTYPE, QUANTITY, QUALITY, AND VARIANT ALLELE FREQUENCY (VAF). EACH LABORATORY PERFORMED THEIR PREFERRED NEXT-GENERATION SEQUENCING METHOD TO REPORT ON THE VARIANTS. NO FALSE POSITIVE RESULTS WERE REPORTED IN THIS SMALL STUDY AND THE MAJORITY OF METHODS DETECTED THE LOW VAF VARIANTS. A NUMBER OF VARIANTS WERE NOT DETECTED DUE TO THE BIOINFORMATICS ANALYSIS, VARIANT CLASSIFICATION, OR INSUFFICIENT DNA. THE USE OF HYBRIDIZATION CAPTURE OR SHORT AMPLICON METHODS ARE RECOMMENDED BASED ON A BIOINFORMATIC ASSESSMENT OF THE DATA. THE STUDY HIGHLIGHTS THE IMPORTANCE OF ESTABLISHING STANDARDS AND STANDARDIZATION FOR TBRCA TESTING PARTICULARLY WHEN THE TEST RESULTS DICTATE CLINICAL DECISIONS REGARDING LIFE EXTENDING THERAPIES.","DIAGNOSTIC; FFPE; NGS; PARP; TBRCA","SEROUS OVARIAN-CANCER; SOMATIC MUTATIONS; COPY NUMBER; CHEMOTHERAPY; CARCINOMAS; SURVIVAL; GENOME; TRIAL; GENE","ENGLISH","ARTICLE","ARTICLE",1,"ALSOP K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545.;CHAPMAN B., BCBIO NEXTGEN VERSIO.;CINGOLANI P, 2012, FLY, V6, P80, DOI 10.4161/FLY.19695.;DANN RB, 2012, GYNECOL ONCOL, V125, P677, DOI 10.1016/J.YGYNO.2012.03.006.;DOUGHERTY BA, 2017, ONCOTARGET, V8, P43653, DOI 10.18632/ONCOTARGET.17613.;ELLISON G, 2015, BMC CLIN PATHOL, V15, DOI 10.1186/S12907-015-0004-6.;ELLISON G, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-132.;ENDRIS V, 2016, VIRCHOWS ARCH, V468, P697, DOI 10.1007/S00428-016-1919-8.;EWALD IP, 2009, GENET MOL BIOL, V32, P437, DOI 10.1590/S1415-47572009005000049.;FAUST GG, 2014, BIOINFORMATICS, V30, P2503, DOI 10.1093/BIOINFORMATICS/BTU314.;HENNESSY BTJ, 2010, J CLIN ONCOL, V28, P3570, DOI 10.1200/JCO.2009.27.2997.;JACOBS S, 2007, CANCER RES, V67, P2544, DOI 10.1158/0008-5472.CAN-06-3597.;KONDRASHOVA O, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0143006.;LAI Z., 2016, NUCLEIC ACIDS RES, V44, P1.;LAI Z., SEQ2C.;LANDRUM MJ, 2016, NUCLEIC ACIDS RES, V44, PD862, DOI 10.1093/NAR/GKV1222.;LEDERMANN J, 2014, LANCET ONCOL, V15, P852, DOI 10.1016/S1470-2045(14)70228-1.;LHEUREUX S., 2017, CLIN CANC RES OFFICI.;LI H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/BIOINFORMATICS/BTP698.;MCALPINE JN, 2012, MODERN PATHOL, V25, P740, DOI 10.1038/MODPATHOL.2011.211.;MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/NG0495-439.;MICHELS E, 2007, GENET MED, V9, P574, DOI 10.1097/GIM.0B013E318145B25B.;NEVELING K, 2017, CLIN CHEM, V63, P503, DOI 10.1373/CLINCHEM.2016.263897.;PATTON S., 2016, COMMUNICATION.;PENNINGTON KP, 2014, CLIN CANCER RES, V20, P764, DOI 10.1158/1078-0432.CCR-13-2287.;WEREN RDA, 2017, HUM MUTAT, V38, P226, DOI 10.1002/HUMU.23137.;YANG D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/JAMA.2011.1456.","AHDESMAKI, M (REPRINT AUTHOR), ASTRAZENECA, IMED BIOTECH UNIT, TRANSLAT SCI, ONCOL, CAMBRIDGE, ENGLAND.;ELLISON, GILLIAN, MILLS, JOHN, ASTRAZENECA, IMED BIOTECH UNIT, PRECIS MED \& GENOM, MACCLESFIELD, CHESHIRE, ENGLAND.;AHDESMAKI, MIIKA, CARR, T. HEDLEY, ASTRAZENECA, IMED BIOTECH UNIT, TRANSLAT SCI, ONCOL, CAMBRIDGE, ENGLAND.;LUKE, SALLY, ASTRAZENECA, R\&D INFORMAT, CAMBRIDGE, ENGLAND.;WARING, PAUL M., KONDRASHOVA, OLGA, UNIV MELBOURNE, DEPT PATHOL, MELBOURNE, VIC, AUSTRALIA.;WALLACE, ANDREW, WRIGHT, RONNIE, ST MARYS HOSP, CENT MANCHESTER UNIV HOSP NHS FDN TRUST, MANCHESTER CTR GENOM MED, GENOM DIAGNOST LAB, MANCHESTER, LANCS, ENGLAND.;ROTHLISBERGER, BENNO, LUDIN, KATJA, KANTONSSPITAL AARAU, ABT MED GENET, INST LABORMED, AARAU, SWITZERLAND.;MERKELBACH-BRUSE, SABINE, HEYDT, CARINA, UNIV HOSP COLOGNE, INST PATHOL, COLOGNE, GERMANY.;LIGTENBERG, MARJOLIJN J. L., MENSENKAMP, ARJEN R., RADBOUD UNIV NIJMEGEN, MED CTR, DEPT HUMAN GENET, NIJMEGEN, NETHERLANDS.;LIGTENBERG, MARJOLIJN J. L., RADBOUD UNIV NIJMEGEN, MED CTR, DEPT PATHOL, NIJMEGEN, NETHERLANDS.;DE CASTRO, DAVID GONZALEZ, QUEENS UNIV BELFAST, CTR CANC RES \& CELL BIOL, BELFAST, ANTRIM, NORTH IRELAND.;DE CASTRO, DAVID GONZALEZ, JONES, THOMAS, ROYAL MARSDEN NHS FT, CTR MOL PATHOL, SUTTON, SURREY, ENGLAND.;VIVANCOS, ANA, VHIO, LAB 201, BARCELONA, SPAIN.;PAUWELS, PATRICK, WEYN, CHRISTINE, UNIV HOSP ANTWERP UZA, PATHOL DEPT, CTR ONCOL RES CORE, EDEGEM, BELGIUM.;HAHNEN, ERIC, HAUKE, JAN, UNIV HOSP COLOGNE, MED FAC, CTR HEREDITARY BREAST \& OVARIAN CANC, COLOGNE, GERMANY.;HAHNEN, ERIC, HAUKE, JAN, UNIV HOSP COLOGNE, MED FAC, CIO, COLOGNE, GERMANY.;SOONG, RICHIE, NATL UNIV SINGAPORE, CANC SCI INST SINGAPORE, SINGAPORE, SINGAPORE.;SOONG, RICHIE, NATL UNIV SINGAPORE, DEPT PATHOL, SINGAPORE, SINGAPORE.;LAI, ZHONGWU, ASTRAZENECA, IMED ONCOL, IMED BIOTECH UNIT, BIOSCI,ONCOL, WALTHAM, MA USA.;DOUGHERTY, BRIAN, JOHNSON, JUSTIN, BARRETT, J. CARL, ASTRAZENECA, IMED BIOTECH UNIT, TRANSLAT SCI, ONCOL, WALTHAM, MA USA.","10.1002/HUMU.23375","111 RIVER ST, HOBOKEN 07030-5774, NJ USA",NA,NA,"ASTRAZENECA PLC.","CONTRACT GRANT SPONSOR: ASTRAZENECA PLC.",NA,"1059-7794","3","394-405","WILEY","39",2018,"ISI000424807600009","27","GENETICS \& HEREDITY","5","GENETICS \& HEREDITY","MIIKA.AHDESMAKILIVE.FI",NA,"FV8AQ",NA,"AHDESMAKI, M (REPRINT AUTHOR), ASTRAZENECA, IMED BIOTECH UNIT, TRANSLAT SCI, ONCOL, CAMBRIDGE, ENGLAND","ISI","IMED BIOTECH UNIT;TRANSLAT SCI;UNIV MELBOURNE;CENT MANCHESTER UNIV HOSP NHS FDN TRUST;INST LABORMED;UNIV HOSP COLOGNE;RADBOUD UNIV NIJMEGEN;RADBOUD UNIV NIJMEGEN;QUEENS UNIV BELFAST;CTR MOL PATHOL;UNIV HOSP ANTWERP UZA;UNIV HOSP COLOGNE;UNIV HOSP COLOGNE;NATL UNIV SINGAPORE;NATL UNIV SINGAPORE;BIOSCI;TRANSLAT SCI","TRANSLAT SCI",NA,"ELLISON G, 2018, HUM MUTAT","ELLISON G, 2018, HUM MUTAT"
"SHIL P, 2018, INDIAN J MED RES","SHIL P;YADAV PD;PATIL AA;BALASUBRAMANIAN R;MOURYA DT","BIOINFORMATICS CHARACTERIZATION OF ENVELOPE GLYCOPROTEIN FROM KYASANUR FOREST DISEASE VIRUS","INDIAN JOURNAL OF MEDICAL RESEARCH","INDIAN J. MED. RES.","BACKGROUND \& OBJECTIVES: KYASANUR FOREST DISEASE (KFD) IS A FEBRILE ILLNESS CHARACTERIZED BY HAEMORRHAGES AND CAUSED BY KFD VIRUS (KFDV), WHICH BELONGS TO THE FLAVIVIRIDAE FAMILY. IT IS REPORTED TO BE AN ENDEMIC DISEASE IN SHIMOGA DISTRICT OF KARNATAKA STATE, INDIA, ESPECIALLY IN FORESTED AND ADJOINING AREAS. SEVERAL OUTBREAKS HAVE BEEN REPORTED IN NEWER AREAS, WHICH RAISED QUERIES REGARDING THE CHANGING NATURE OF STRUCTURAL PROTEINS IF ANY. THE OBJECTIVE OF THE STUDY WAS TO INVESTIGATE AMINO ACID COMPOSITION AND ANTIGENIC VARIABILITY IF ANY, AMONG THE ENVELOPE GLYCOPROTEIN (E-PROTEINS) FROM OLD AND NEW STRAINS OF KFDV. METHODS: BIOINFORMATIC TOOLS AND TECHNIQUES WERE USED TO PREDICT B-CELL EPITOPES AND THREE-DIMENSIONAL STRUCTURES AND TO COMPARE ENVELOPE GLYCOPROTEIN (E-PROTEINS) BETWEEN THE OLD STRAINS OF KFDV AND THOSE FROM EMERGING OUTBREAKS TILL 2015. RESULTS: THE STRAIN FROM RECENT OUTBREAK IN THIRTHAHALLI, KARNATAKA STATE (2014), WAS SIMILAR TO THE OLDER STRAIN OF KFDV (99.2\%). ALTHOUGH MUTATIONS EXISTED IN STRAINS FROM 2015 IN KERALA KFD SEQUENCES, THESE DID NOT ALTER THE EPITOPES. INTERPRETATION \& CONCLUSIONS: THE STUDY REVEALED THAT THOUGH MUTATIONS EXISTED, THERE WERE NO DRASTIC CHANGES IN THE STRUCTURE OR ANTIGENICITY OF THE E-PROTEINS FROM RECENT OUTBREAKS. HENCE, NO CORRELATION COULD BE ESTABLISHED BETWEEN THE MUTATIONS AND DETECTION IN NEW GEOGRAPHICAL AREAS. IT SEEMS THAT KFDV MUST BE PRESENT EARLIER ALSO IN MANY STATES AND DUE TO AVAILABILITY OF TESTING SYSTEM AND ALERTNESS COMING INTO NOTICE NOW.","B-CELL EPITOPES; ELISA; ENVELOPE GLYCOPROTEIN; KYASANUR FOREST DISEASE; PHYLOGENETIC ANALYSES; VIRUS","JAPANESE ENCEPHALITIS-VIRUS; INDIA; OUTBREAK","ENGLISH","ARTICLE","ARTICLE",0,"AWATE P, 2016, J INFECTION, V72, P759, DOI 10.1016/J.JINF.2016.03.006.;BANERJEE K, 1990, ARBOVIRUSES EPIDEMIO, P93.;DODD KA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/JOURNAL.PNTD.0001352.;GANGWAR RS, 2011, VIRUS RES, V158, P179, DOI 10.1016/J.VIRUSRES.2011.03.030.;KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q.;LIU HB, 2015, J VIROL, V89, P5668, DOI 10.1128/JVI.00293-15.;MEHLA R, 2009, EMERG INFECT DIS, V15, P1431, DOI 10.3201/EID1509.080759.;MODIS Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/PNAS.0832193100.;MOURYA DT, 2013, EMERG INFECT DIS, V19, P1540, DOI 10.3201/EID1909.121884.;MOURYA DT, 2012, J VIROL METHODS, V186, P49, DOI 10.1016/J.JVIROMET.2012.07.019.;MOURYA DT, 2016, CURR TROP MED REPORT, V3, P7, DOI DOI 10.1007/S40475-016-0067-1.;PATTNAIK P, 2006, REV MED VIROL, V16, P151, DOI 10.1002/RMV.495.;SHIL PRATIP, 2011, BIOINFORMATION, V7, P76.;SHIL PRATIP, 2011, BIOINFORMATION, V6, P266.;SHIL PRATIP, 2006, IN SILICO BIOLOGY, V6, P373.;TAMURA K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/MOLBEV/MSR121.;TANDALE BV, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/S40249-015-0044-2.;WORK T H, 1957, INDIAN J MED SCI, V11, P341.;YADAV PD, 2014, INT J INFECT DIS, V26, P132, DOI 10.1016/J.IJID.2014.05.013.","MOURYA, DT (REPRINT AUTHOR), NATL INST VIROL, ICMR, SUS RD, PUNE 411021, MAHARASHTRA, INDIA.;SHIL, PRATIP, YADAV, PRAGYA DHRUV, PATIL, AVINASH A., BIOINFORMAT GRP, PUNE, MAHARASHTRA, INDIA.;SHIL, PRATIP, YADAV, PRAGYA DHRUV, PATIL, AVINASH A., MOURYA, DEVENDRA T., NATL INST VIROL, ICMR, SUS RD, PUNE 411021, MAHARASHTRA, INDIA.;BALASUBRAMANIAN, R., NATL INST VIROL, ICMR, KERALA UNIT, ALAPPUZHA, INDIA.","10.4103/IJMR.IJMR\_1445\_16","B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA",NA,NA,NA,NA,NA,"0971-5916",NA,"195-201","MEDKNOW PUBLICATIONS \& MEDIA PVT LTD","147",2018,"ISI000433224900012","19","IMMUNOLOGY, GENERAL \& INTERNAL MEDICINE, RESEARCH \& EXPERIMENTAL MEDICINE","1","IMMUNOLOGY, MEDICINE, GENERAL \& INTERNAL, MEDICINE, RESEARCH \& EXPERIMENTAL","DTMOURYAGMAIL.COM",NA,"GH2IF",NA,"MOURYA, DT (REPRINT AUTHOR), NATL INST VIROL, ICMR, SUS RD, PUNE 411021, MAHARASHTRA, INDIA","ISI","NATL INST VIROL;NATL INST VIROL","NATL INST VIROL",NA,"SHIL P, 2018, INDIAN J MED RES","SHIL P, 2018, INDIAN J MED RES"
"FAN S, 2018, INT J INFECT DIS","FAN S;REN H;WEI Y;MAO C;MA Z;ZHANG L;WANG L;GE Y;LI T;CUI L;WU H;GUAN H","NEXT-GENERATION SEQUENCING OF THE CEREBROSPINAL FLUID IN THE DIAGNOSIS OF NEUROBRUCELLOSIS","INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES","INT. J. INFECT. DIS.","BACKGROUND: BRUCELLOSIS IS THE MOST COMMON ZOONOTIC INFECTION IN THE WORLD. BRUCELLOSIS WITH NERVOUS SYSTEM INVOLVEMENT IS KNOWN AS `NEUROBRUCELLOSIS' (NB). THE DIAGNOSIS OF NB IS DIFFICULT BECAUSE ITS CLINICAL MANIFESTATIONS ARE NON-SPECIFIC AND THE SENSITIVITY OF ROUTINE CULTURE TESTS IS LOW. METHODS: NEXT-GENERATION SEQUENCING (NGS) OF CEREBROSPINAL FLUID (CSF) WAS USED TO DETECT PATHOGENS IN PATIENTS WITH CLINICALLY SUSPECTED CENTRAL NERVOUS SYSTEM (CNS) INFECTIONS AT A TERTIARY REFERRAL CENTER IN CHINA BETWEEN JUNE 1, 2016 AND JUNE 1, 2017. THE CLINICAL CHARACTERISTICS AND NGS RESULTS OF PATIENTS WITH THE DIAGNOSIS OF NB WERE REVIEWED IN THIS STUDY. RESULTS: FOUR PATIENTS WERE RAPIDLY DIAGNOSED WITH NB USING NGS OF THE CSF IN PATIENTS WITH CLINICALLY SUSPECTED CNS INFECTIONS, ALTHOUGH THE CLINICAL MANIFESTATIONS VARIED DRAMATICALLY BETWEEN THESE PATIENTS. NGS OF THE CSF REVEALED THAT THE SEQUENCE READS IDENTIFIED THAT CORRESPONDED TO BRUCELLA SPECIES RANGED FROM 11 TO 104, WITH GENOMIC COVERAGE RANGING FROM 0.043\% TO 0.4\%. RAPID DIAGNOSIS LED TO PROMPT TREATMENT WITH THE APPROPRIATE ANTIBIOTICS. CONCLUSIONS: THIS STUDY DEMONSTRATES THE POWER OF NGS OF THE CSF COUPLED WITH A BIOINFORMATIC PIPELINE IN THE DIAGNOSIS OF NB. (C) 2017 THE AUTHORS. PUBLISHED BY ELSEVIER LTD ON BEHALF OF INTERNATIONAL SOCIETY FOR INFECTIOUS DISEASES.","NEUROBRUCELLOSIS; CEREBROSPINAL FLUID; NEXT-GENERATION SEQUENCING; QUICK DIAGNOSIS","ENDEMIC REGION; MENINGOENCEPHALITIS; BRUCELLOSIS; FEATURES; VIRUS; CSF","ENGLISH","ARTICLE","ARTICLE",1,"AL-SOUS MW, 2004, AM J NEURORADIOL, V25, P395.;ALAVI SM, 2013, CASP J INTERN MED, V4, P636.;BEKTAS O, 2013, TURKISH J PEDIATR, V55, P210.;BOSILKOVSKI M, 2009, ACTA CLIN CROAT, V48, P41.;BUKOWSKA-OSKO I, 2017, ADV EXP MED BIOL, V944, P53, DOI 10.1007/5584\_2016\_42.;BUZGAN T, 2010, INT J INFECT DIS, V14, PE469, DOI 10.1016/J.IJID.2009.06.031.;CERAN N, 2011, BRAZ J INFECT DIS, V15, P52, DOI 10.1590/S1413-86702011000100010.;GUAN HZ, 2016, J NEUROVIROL, V22, P240, DOI 10.1007/S13365-015-0390-7.;GUL HC, 2009, INT J INFECT DIS, V13, PE339, DOI 10.1016/J.IJID.2009.02.015.;GUVEN T, 2013, CLIN INFECT DIS, V56, P1407, DOI 10.1093/CID/CIT072.;KIZILKILIC O, 2011, NEUROIMAG CLIN N AM, V21, P927, DOI 10.1016/J.NIC.2011.07.008.;MONGKOLRATTANOTHAI K, 2017, J PEDIATR INFECT DIS, V6, P393, DOI 10.1093/JPIDS/PIW066.;MAI NTH, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/OFID/OFX046.;PAPPAS G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6.;REGGIO E, 2015, NEUROL INDIA, V63, P776, DOI 10.4103/0028-3886.166548.;WILSON MR, 2017, ANN NEUROL, V82, P105, DOI 10.1002/ANA.24982.;WILSON MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMOA1401268.;YAO M, 2016, J CLIN NEUROL, V12, P446, DOI 10.3988/JCN.2016.12.4.446.","GUAN, HZ (REPRINT AUTHOR), CHINESE ACAD MED SCI, PEKING UNION MED COLL HOSP, DEPT NEUROL, BEIJING 100730, PEOPLES R CHINA.;GUAN, HZ (REPRINT AUTHOR), PEKING UNION MED COLL, BEIJING 100730, PEOPLES R CHINA.;WU, HL (REPRINT AUTHOR), BEIJING GENOM INST TIANJIN, TIANJIN 200308, PEOPLES R CHINA.;FAN, SIYUAN, REN, HAITAO, WEI, YANPING, MAO, CHENHUI, CUI, LIYING, GUAN, HONGZHI, CHINESE ACAD MED SCI, PEKING UNION MED COLL HOSP, DEPT NEUROL, BEIJING 100730, PEOPLES R CHINA.;FAN, SIYUAN, REN, HAITAO, WEI, YANPING, MAO, CHENHUI, GE, YING, LI, TAISHENG, CUI, LIYING, GUAN, HONGZHI, PEKING UNION MED COLL, BEIJING 100730, PEOPLES R CHINA.;MA, ZHENZI, ZHANG, LU, WANG, LI, WU, HONGLONG, BEIJING GENOM INST TIANJIN, TIANJIN 200308, PEOPLES R CHINA.;GE, YING, LI, TAISHENG, CHINESE ACAD MED SCI, PEKING UNION MED COLL HOSP, DEPT INFECT DIS, BEIJING 100730, PEOPLES R CHINA.","10.1016/J.IJID.2017.11.028","THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",NA,NA,NA,NA,NA,"1201-9712",NA,"20-24","ELSEVIER SCI LTD","67",2018,"ISI000425849400005","18","INFECTIOUS DISEASES","2","INFECTIOUS DISEASES","WUHONGLONGBGI.COM GUANHZ263.NET",NA,"FX1XQ",NA,"GUAN, HZ (REPRINT AUTHOR), CHINESE ACAD MED SCI, PEKING UNION MED COLL HOSP, DEPT NEUROL, BEIJING 100730, PEOPLES R CHINA","ISI","PEKING UNION MED COLL HOSP;PEKING UNION MED COLL;BEIJING GENOM INST TIANJIN;PEKING UNION MED COLL HOSP","PEKING UNION MED COLL HOSP",NA,"FAN S, 2018, INT J INFECT DIS","FAN S, 2018, INT J INFECT DIS"
"SZABADOSOVA V, 2018, J CLIN LAB ANAL","SZABADOSOVA V;BORONOVA I;FERENC P;TOTHOVA I;BERNASOVSKA J;ZIGOVA M;KMEC J;BERNASOVSKY I","ANALYSIS OF SELECTED GENES ASSOCIATED WITH CARDIOMYOPATHY BY NEXT-GENERATION SEQUENCING","JOURNAL OF CLINICAL LABORATORY ANALYSIS","J. CLIN. LAB. ANAL.","BACKGROUNDAS THE LEADING CAUSE OF CONGESTIVE HEART FAILURE, CARDIOMYOPATHY REPRESENTS AHETEROGENOUS GROUP OF HEART MUSCLE DISORDERS. DESPITE CONSIDERABLE PROGRESS BEING MADE IN THE GENETIC DIAGNOSIS OF CARDIOMYOPATHY BY DETECTION OF THE MUTATIONS IN THE MOST PREVALENT CARDIOMYOPATHY GENES, THE CAUSE REMAINS UNSOLVED IN MANY PATIENTS. HIGH-THROUGHPUT MUTATION SCREENING IN THE DISEASE GENES FOR CARDIOMYOPATHY IS NOW POSSIBLE BECAUSE OF USING TARGET ENRICHMENT FOLLOWED BY NEXT-GENERATION SEQUENCING. THE AIM OF THE STUDY WAS TO ANALYZE A PANEL OF GENES ASSOCIATED WITH DILATED OR HYPERTROPHIC CARDIOMYOPATHY BASED ON PREVIOUSLY PUBLISHED RESULTS IN ORDER TO IDENTIFY THE SUBJECTS AT RISK. METHODSTHE METHOD OF NEXT-GENERATION SEQUENCING BY ILLUMINAHISEQ 2500 PLATFORM WAS USED TO DETECT SEQUENCE VARIANTS IN 16 INDIVIDUALS DIAGNOSED WITH DILATED OR HYPERTROPHIC CARDIOMYOPATHY. DETECTED VARIANTS WERE FILTERED AND THE FUNCTIONAL IMPACT OF AMINO ACID CHANGES WAS PREDICTED BY COMPUTATIONAL PROGRAMS. RESULTSDNA SAMPLES OF THE 16 PATIENTS WERE ANALYZED BY WHOLE EXOME SEQUENCING. WE IDENTIFIED SIX NONSYNONYMOUS VARIANTS THAT WERE SHOWN TO BE PATHOGENIC IN ALL USED PREDICTION SOFTWARES: RS3744998 (EPG5), RS11551768 (MGME1), RS148374985 (MURC), RS78461695 (PLEC), RS17158558 (RET) AND RS2295190 (SYNE1). TWO OF THE ANALYZED SEQUENCE VARIANTS HAD MINOR ALLELE FREQUENCY (MAF)<0.01: RS148374985 (MURC), RS34580776 (MYBPC3). CONCLUSIONOUR DATA SUPPORT THE POTENTIAL ROLE OF THE DETECTED VARIANTS IN PATHOGENESIS OF DILATED OR HYPERTROPHIC CARDIOMYOPATHY, HOWEVER, THE POSSIBILITY THAT THESE VARIANTS MIGHT NOT BE TRUE DISEASE-CAUSING VARIANTS BUT ARE SUSCEPTIBILITY ALLELES THAT REQUIRE ADDITIONAL MUTATIONS OR INJURY TO CAUSE THE CLINICAL PHENOTYPE OF DISEASE MUST BE CONSIDERED.","BIOINFORMATIC ANALYSIS; CARDIOMYOPATHIES; NEXT-GENERATION SEQUENCING; PANEL OF GENES; PATHOGENIC VARIANTS","FAMILIAL DILATED CARDIOMYOPATHY; EPIDERMOLYSIS-BULLOSA SIMPLEX; HYPERTROPHIC CARDIOMYOPATHY; MUSCULAR-DYSTROPHY; HEART-FAILURE; MUTATIONS; PROTEIN; CLASSIFICATION; DYSFUNCTION; CARDIOLOGY","ENGLISH","ARTICLE","ARTICLE",0,"ADZHUBEI IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/NMETH0410-248.;ASHLEY EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7.;BASTIANI M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/JCB.200903053.;BOLLING MC, 2010, J INVEST DERMATOL, V130, P1178, DOI 10.1038/JID.2009.390.;BRAUCH KM, 2009, J AM COLL CARDIOL, V54, P930, DOI 10.1016/J.JACC.2009.05.038.;BURKETT EL, 2005, J AM COLL CARDIOL, V45, P969, DOI 10.1016/J.JACC.2004.11.066.;CELIK CANAN, 2005, J CLIN NEUROMUSCUL DIS, V6, P157, DOI 10.1097/01.CND.0000159779.32828.E7.;D'ANTONIO M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S11.;ELLIOTT P, 2004, LANCET, V363, P1881, DOI 10.1016/S0140-6736(04)16358-7.;ELLIOTT P, 2008, EUR HEART J, V29, P270, DOI 10.1093/EURHEARTJ/EHM342.;HARAKALOVA M, 2015, EUR J HEART FAIL, V17, P484, DOI 10.1002/EJHF.255.;HERSHBERGER RE, 2010, GENET MED, V12, P655, DOI 10.1097/GIM.0B013E3181F2481F.;HERSHBERGER RE, 2009, J CARD FAIL, V15, P83, DOI 10.1016/J.CARDFAIL.2009.01.006.;KUMAR P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/NPROT.2009.86.;KUSTER DWD, 2014, PFLUG ARCH EUR J PHY, V466, P207, DOI 10.1007/S00424-013-1417-7.;KWAN T, 2008, NAT GENET, V40, P225, DOI 10.1038/NG.2007.57.;LI LL, 2017, CIRC RES, V120, P1084, DOI 10.1161/CIRCRESAHA.116.310559.;LOPES LR, 2015, HEART, V101, P294, DOI 10.1136/HEARTJNL-2014-306387.;MARIAN AJ, 2008, CURR OPIN CARDIOL, V23, P199, DOI 10.1097/HCO.0B013E3282FC27D9.;MARON BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287.;MEDER B, 2011, CIRC-CARDIOVASC GENE, V4, P110, DOI 10.1161/CIRCGENETICS.110.958322.;MEYER S, 2014, EUR J HEART FAIL, V16, P238, DOI 10.1002/EJHF.15.;NAITO D, 2015, AM J PHYSIOL-HEART C, V309, PH2127, DOI 10.1152/AJPHEART.00446.2015.;NORTON N, 2012, CIRC-CARDIOVASC GENE, V5, P167, DOI 10.1161/CIRCGENETICS.111.961805.;OGATA T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07.;PINTO YM, 2011, EUR J HUM GENET, V19, DOI 10.1038/EJHG.2010.243.;POSAFALVI A, 2013, EUR J HUM GENET, V21, DOI 10.1038/EJHG.2012.276.;PRANCKEVICIENE ERINIJA, 2015, BMC RES NOTES, V8, P421, DOI 10.1186/S13104-015-1385-4.;REFAAT MM, 2012, HEART RHYTHM, V9, P390, DOI 10.1016/J.HRTHM.2011.10.016.;RODRIGUEZ G, 2011, CIRC-CARDIOVASC GENE, V4, P349, DOI 10.1161/CIRCGENETICS.111.959866.;RONCARATI R, 2011, J CELL PHYSIOL, V226, P2894, DOI 10.1002/JCP.22636.;SCHRODER R, 2002, J NEUROPATH EXP NEUR, V61, P520, DOI 10.1093/JNEN/61.6.520.;SCHWARZ JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/NMETH0810-575.;SIKKEMA-RADDATZ B, 2013, HUM MUTAT, V34, P1035, DOI 10.1002/HUMU.22332.;VAN DRIEST SL, 2005, MAYO CLIN PROC, V80, P739.;VILLA CR, 2015, NEUROMUSCULAR DISORD, V25, P165, DOI 10.1016/J.NMD.2014.09.011.;WALDMULLER S, 2015, MOL CELL PROBE, V29, P308, DOI 10.1016/J.MCP.2015.05.004.;WATKINS H, 1993, AM J HUM GENET, V53, P1180.;WICHE G., 2011, BIOARCHITECTURE, V1, P14, DOI DOI 10.4161/BI0A.1.1.14630.","SZABADOSOVA, V (REPRINT AUTHOR), UNIV PRESOV, FAC HUMANITIES \& NAT SCI, DEPT BIOL, PRESOV, SLOVAKIA.;SZABADOSOVA, VIKTORIA, BORONOVA, IVETA, FERENC, PETER, TOTHOVA, IVETA, BERNASOVSKA, JARMILA, ZIGOVA, MICHAELA, UNIV PRESOV, FAC HUMANITIES \& NAT SCI, DEPT BIOL, PRESOV, SLOVAKIA.;KMEC, JAN, FAC HOSP JA REIMAN, CARDIOCTR, PRESOV, SLOVAKIA.;BERNASOVSKY, IVAN, UNIV PRESOV, CTR LANGUAGES \& CULTURES NATL MINOR, PRESOV, SLOVAKIA.","10.1002/JCLA.22254","111 RIVER ST, HOBOKEN, NJ 07030 USA","E22254",NA,"SLOVAK RESEARCH AND DEVELOPMENT AGENCY [APVV-0644-12], EUROPEAN REGIONAL DEVELOPMENT FUND [ITMS 26220120041]","SLOVAK RESEARCH AND DEVELOPMENT AGENCY, GRANT/AWARD NUMBER: APVV-0644-12, EUROPEAN REGIONAL DEVELOPMENT FUND, GRANT/AWARD NUMBER: ITMS 26220120041",NA,"0887-8013","2",NA,"WILEY","32",2018,"ISI000425109100030","39","MEDICAL LABORATORY TECHNOLOGY","2","MEDICAL LABORATORY TECHNOLOGY","VIKTORIA.SZABADOSGMAIL.COM",NA,"FW2CM",NA,"SZABADOSOVA, V (REPRINT AUTHOR), UNIV PRESOV, FAC HUMANITIES \& NAT SCI, DEPT BIOL, PRESOV, SLOVAKIA","ISI","UNIV PRESOV;CARDIOCTR;UNIV PRESOV","UNIV PRESOV",NA,"SZABADOSOVA V, 2018, J CLIN LAB ANAL","SZABADOSOVA V, 2018, J CLIN LAB ANAL"
"BENDER JM, 2018, CURR OPIN PEDIATR","BENDER JM;BARD JD","METAGENOMICS IN PEDIATRICS: USING A SHOTGUN APPROACH TO DIAGNOSE INFECTIONS","CURRENT OPINION IN PEDIATRICS","CURR. OPIN. PEDIATR.","PURPOSE OF REVIEW WITH THE ADVENT OF NOVEL MASSIVELY PARALLEL SEQUENCING TECHNOLOGIES AND BIOINFORMATIC PROCESSING CAPABILITIES, CLINICAL APPLICATIONS OF METAGENOMIC STUDIES ARE RAPIDLY BEING INTEGRATED INTO MEDICINE. THROUGH THIS PAPER, WE HOPE TO INTRODUCE THIS POWERFUL NEW TOOL TO CLINICIANS CARING FOR CHILDREN. RECENT FINDINGS VERY FEW STUDIES HAVE LOOKED AT METAGENOMIC APPLICATIONS IN CHILDREN. THE ABILITY TO PERFORM THESE TYPES OF MASSIVE SEQUENCING PROJECTS WAS NOT POSSIBLE AS LITTLE AS 7 YEARS AGO. SUMMARY METAGENOMICS IS DEFINED AS THE STUDY OF ALL GENETIC MATERIAL WITHIN A GIVEN SAMPLE. NOVEL SEQUENCING AND ANALYSIS APPROACHES ALLOW FOR UNBIASED ASSAYS TO IDENTIFY PATHOGENS MISSED BY TARGETED SEQUENCING AND CULTURE METHODS. ALTHOUGH NOT WIDELY AVAILABLE YET, METAGENOMIC STUDIES HAVE BEEN USED TO DIAGNOSE PEDIATRIC INFECTIONS, IDENTIFY RESISTANCE GENES IN CLINICAL SAMPLES, AND CHARACTERIZE OUTBREAKS. ALTHOUGH COST AND TURNAROUND TIME HAVE LIMITED ITS APPLICATION IN CLINICAL LABORATORIES TO DATE, NOVEL PLATFORMS AND INCREASING COMFORT WITH THESE TECHNIQUES CONTINUE TO PUSH DIAGNOSTIC METAGENOMICS INTO CLINICAL PEDIATRIC MEDICINE. MUCH WORK IN THIS FIELD IS YET TO BE DONE. THAT BEING SAID, WE FEEL THAT PEDIATRIC CLINICIANS WILL BE USING METAGENOMIC TECHNIQUES IN THE CARE OF CHILDREN WITH INCREASING FREQUENCY IN THE NEAR FUTURE.","INFECTIOUS DISEASE; METAGENOMICS; OUTBREAK; RESISTANCE GENES; SHOTGUN SEQUENCING","PATHOGEN DETECTION; CLINICAL-SAMPLES; IDENTIFICATION; VIRUSES; ENCEPHALITIS; OUTBREAK; DISCOVERY; BACTERIAL; GENOME; DNA","ENGLISH","REVIEW","ARTICLE",1,"ANDERSEN H, 2016, J CLIN MICROBIOL, V54, P1804, DOI 10.1128/JCM.02638-15.;CHIUS CY, 2013, CURR OPIN MICROBIOL, V16, P468, DOI 10.1016/J.MIB.2013.05.001.;DOAN T, 2017, OPHTHALMOLOGY, V124, P1247, DOI 10.1016/J.OPHTHA.2017.03.045.;FINKBEINER SR, 2009, J VIROL, V83, P10836, DOI 10.1128/JVI.00998-09.;GAYNOR AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/JOURNAL.PPAT.0030064.;GLASER CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330.;GRAF EH, 2016, J CLIN MICROBIOL, V54, P1000, DOI 10.1128/JCM.03060-15.;GRENINGER AL, 2009, VIROL J, V6.;GRENINGER AL, 2017, J PEDIATR INFECT DIS, V6, P168, DOI 10.1093/JPIDS/PIX019.;GRENINGER AL, 2017, J CLIN MICROBIOL, V55, P177, DOI 10.1128/JCM.01881-16.;GRENINGER AL, 2015, GENOME MED, V7, DOI 10.1186/S13073-015-0235-2.;GRENINGER AL, 2015, GENOME MED, V7, DOI 10.1186/S13073-015-0220-9.;GRENINGER AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9.;KILIANSKI A, 2015, GIGASCIENCE, V4, DOI 10.1186/S13742-015-0051-Z.;KIM MH, 2017, ALLERGY ASTHMA IMMUN, V9, P453, DOI 10.4168/AAIR.2017.9.5.453.;LANGELIER C, 2017, AM J RESP CRIT CARE.;MONGKOLRATTANOTHAI K, 2017, J PEDIATRIC INFECT D.;MURKEY JA, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/OFID/OFX121.;NACCACHE SAMIA N, 2015, OPEN FORUM INFECT DIS, V2, P103, DOI 10.1093/OFID/OFV131.23.;NACCACHE SN, 2015, CLIN INFECT DIS, V60, P919, DOI 10.1093/CID/CIU912.;NACCACHE SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/GR.171934.113.;PARIZE P, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/J.CMI.2017.02.006.;QUICK J, 2015, GENOME BIOL, V16, DOI 10.1186/S13059-015-0677-2.;SARDI SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16.;SCHLABERG R, 2017, ARCH PATHOL LAB MED, V141, P776, DOI 10.5858/ARPA.2016-0539-RA.;SCHMIDT K, 2017, J ANTIMICROB CHEMOTH, V72, P104, DOI 10.1093/JAC/DKW397.;STREET TL, 2017, J CLIN MICROBIOL, V55, P2334, DOI 10.1128/JCM.00462-17.;TANG P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/FMB.09.120, 10.2217/FMB.09.120].;THOENDEL M, 2017, J CLIN MICROBIOL, V55, P1789, DOI 10.1128/JCM.02402-16.;VON WINTERSDORFF CJH, 2016, J ANTIMICROB CHEMOTH, V71, P3416, DOI 10.1093/JAC/DKW328.;WILSON MR, 2017, AM J TRANSPLANT, V17, DOI 10.1111/AJT.14058.;WILSON MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMOA1401268.;YOZWIAK NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10.;ZHOU YJ, 2016, J CLIN MICROBIOL, V54, P368, DOI 10.1128/JCM.01965-15.","BARD, JD (REPRINT AUTHOR), UNIV SOUTHERN CALIF, KECK SCH MED, 4650 SUNSET BLVD,MS 32, LOS ANGELES, CA 90027 USA.;BENDER, JEFFREY M., CHILDRENS HOSP LOS ANGELES, DEPT PEDIAT, DIV INFECT DIS, LOS ANGELES, CA 90027 USA.;BENDER, JEFFREY M., BARD, JENNIFER DIEN, UNIV SOUTHERN CALIF, KECK SCH MED, 4650 SUNSET BLVD,MS 32, LOS ANGELES, CA 90027 USA.;BARD, JENNIFER DIEN, CHILDRENS HOSP LOS ANGELES, DEPT PATHOL \& LAB MED, LOS ANGELES, CA 90027 USA.","10.1097/MOP.0000000000000577","TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",NA,NA,"NIH [K12 HD 052954-09]","J.M.B. IS SUPPORTED BY NIH GRANT K12 HD 052954-09.",NA,"1040-8703","1","125-130","LIPPINCOTT WILLIAMS \& WILKINS","30",2018,"ISI000424045000018","34","PEDIATRICS","7","PEDIATRICS","JDIENBARDCHLA.USC.EDU",NA,"FU7PP",NA,"BARD, JD (REPRINT AUTHOR), UNIV SOUTHERN CALIF, KECK SCH MED, 4650 SUNSET BLVD,MS 32, LOS ANGELES, CA 90027 USA","ISI","CHILDRENS HOSP LOS ANGELES;UNIV SOUTHERN CALIF;CHILDRENS HOSP LOS ANGELES","UNIV SOUTHERN CALIF",NA,"BENDER JM, 2018, CURR OPIN PEDIATR","BENDER JM, 2018, CURR OPIN PEDIATR"
"GAO X, 2018, CELL PHYSIOL BIOCHEM","GAO X;HUANG Z;FAN Y;SUN Y;LIU H;WANG L;GU X;YU Y","A FUNCTIONAL MUTATION IN HDAC8 GENE AS NOVEL DIAGNOSTIC MARKER FOR CORNELIA DE LANGE SYNDROME","CELLULAR PHYSIOLOGY AND BIOCHEMISTRY","CELL. PHYSIOL. BIOCHEM.","BACKGROUND/AIMS: CORNELIA DE LANGE SYNDROME (CDLS) IS A RARE GENETIC DISORDER CLASSICALLY CHARACTERIZED BY DISTINCTIVE FACIES, GROWTH RETARDATION, INTELLECTUAL DISABILITY, FEEDING DIFFICULTIES, AND MULTIPLE ORGAN SYSTEM ANOMALIES. PREVIOUSLY, THE DIAGNOSIS OF CDLS WAS BASED MAINLY ON IDENTIFYING THE TYPICAL PHENOTYPE IN PATIENTS. HOWEVER, WITH THE ADVANCES IN CLINICAL MOLECULAR GENETIC DIAGNOSTIC TECHNIQUES, MORE PATIENTS, ESPECIALLY PATIENTS WITH MILDER PHENOTYPES, ARE BEING DIAGNOSED FROM DETECTING PATHOGENIC MUTATION. METHODS: PATHOGENIC MUTATION IN A FEMALE PATIENT WITH A MILDER PHENOTYPE WAS DETECTED USING WHOLE-EXOME SEQUENCING (WES), AND WAS FURTHER CHARACTERIZED USING BIOINFORMATIC ANALYSIS AND IN VITRO FUNCTIONAL EXPERIMENTS, INCLUDING X-CHROMOSOME INACTIVATION ANALYSIS, SODIUM DODECYL SULFATE-POLYACRYLAMIDE GEL ELECTROPHORESIS, AND ENZYME ACTIVITY ASSAY. RESULTS: THIS PATIENT WAS FOUND TO HARBOR A NOVEL MISSENSE MUTATION (C.806T>G, P.I269R) IN THE CODING REGION OF THE HDAC8 GENE, WHICH WAS PREDICTED TO BE PATHOGENIC. COMPARED WITH OTHER CDLS PATIENTS WITH HDAC8 MUTATION, THE PATIENT LACKED TYPICAL FACIES, INCLUDING SYNOPHRYS AND ARCHED EYEBROWS. IN VITRO FUNCTIONAL EXPERIMENTS SHOWED THE PRESENCE OF SKEWED X-CHROMOSOME INACTIVATION. FURTHERMORE, THE NOVEL MUTATION DECREASED THE DISSOLUBILITY AND ENZYMATIC ACTIVITY OF HDAC8 PROTEIN. CONCLUSIONS: THE PRESENT STUDY IDENTIFIED A NOVEL MISSENSE MUTATION (C.806T>G, P.I269R) IN THE HDAC8 GENE LEADING TO CDLS, WHICH NOT ONLY PROVIDED STRONG EVIDENCE FOR DIAGNOSIS IN THIS PRESENT PATIENT, BUT ALSO EXPANDED THE SPECTRUM OF PATHOGENIC MUTATIONS FOR CDLS. (C) 2018 THE AUTHOR(S) PUBLISHED BY S. KARGER AG, BASEL","CORNELIA DE LANGE SYNDROME; HDAC8; GENE MUTATION; ENZYMATIC ACTIVITY; X-CHROMOSOME INACTIVATION","INTELLECTUAL DISABILITY; PREDICTION; SPECTRUM; COHESIN","ENGLISH","ARTICLE","ARTICLE",0,"ADZHUBEI IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/NMETH0410-248.;BOYLE MI, 2015, CLIN GENET, V88, P1, DOI 10.1111/CGE.12499.;DEARDORFF MA, 2012, NATURE, V489, P313, DOI 10.1038/NATURE11316.;DORSETT D, 2009, ANN NY ACAD SCI, V1151, P22, DOI 10.1111/J.1749-6632.2008.03450.X.;FENG L, 2014, J HUM GENET, V59, P536, DOI 10.1038/JHG.2014.60.;FIEREMANS N, 2016, HUM MUTAT, V37, P804, DOI 10.1002/HUMU.23012.;GILLIS LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698.;GUEX N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/ELPS.1150181505.;HARAKALOVA M, 2012, J MED GENET, V49, P539, DOI 10.1136/JMEDGENET-2012-100921.;KAISER FJ, 2014, HUM MOL GENET, V23, P2888, DOI 10.1093/HMG/DDU002.;KLINE AD, 2007, AM J MED GENET C, V145C, P248, DOI 10.1002/AJMG.C.30137.;KLINE AD, 2007, AM J MED GENET A, V143A, P1287, DOI 10.1002/AJMG.A.31757.;KUBOTA T, 1999, HUM GENET, V104, P49, DOI 10.1007/S004390050909.;KUMAR P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/NPROT.2009.86.;NASMYTH K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/ANNUREV-GENET-102108-134233.;PARENTI I, 2016, CLIN GENET, V89, P564, DOI 10.1111/CGE.12717.;RAMOS FJ, 2015, EUR J HUM GENET, V23, DOI 10.1038/EJHG.2014.270.;SCHWARZ JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/NMETH.2890.;ZENG QW, 2017, J PEDIATR ENDOCR MET, V30, P463, DOI 10.1515/JPEM-2016-0333.","GU, XF, YU, YG (REPRINT AUTHOR), SHANGHAI JIAO TONG UNIV, SCH MED, DEPT PEDIAT ENDOCRINOL GENET, XINHUA HOSP, 801 SCI \& EDUC BLDG,1665 KONGJIANG RD, SHANGHAI 200092, PEOPLES R CHINA.;GAO, XUEREN, HUANG, ZHUO, FAN, YANJIE, SUN, YU, LIU, HUILI, WANG, LILI, GU, XUEFAN, YU, YONGGUO, SHANGHAI JIAO TONG UNIV, SHANGHAI INST PEDIAT RES, DEPT PEDIAT ENDOCRINOL GENET, XINHUA HOSP,SCH MED, SHANGHAI, PEOPLES R CHINA.","10.1159/000491613","ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",NA,NA,"``NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA'' [81670812],","THIS STUDY WAS FUNDED BY THE ``NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA'' (NO. 81670812, TO YYG), THE ``JIAOTONG UNIVERSITY CROSS",NA,"1015-8987","6","2388-2395","KARGER","47",2018,"ISI000440152000017","19","CELL BIOLOGY, PHYSIOLOGY","1","CELL BIOLOGY, PHYSIOLOGY","GUXUEFANXINHUAMED.COM YUYONGGUOSHSMU.EDU.CN",NA,"GO6KR",NA,"GU, XF, YU, YG (REPRINT AUTHOR), SHANGHAI JIAO TONG UNIV, SCH MED, DEPT PEDIAT ENDOCRINOL GENET, XINHUA HOSP, 801 SCI \& EDUC BLDG,1665 KONGJIANG RD, SHANGHAI 200092, PEOPLES R CHINA","ISI","SHANGHAI JIAO TONG UNIV","SHANGHAI JIAO TONG UNIV",NA,"GAO X, 2018, CELL PHYSIOL BIOCHEM","GAO X, 2018, CELL PHYSIOL BIOCHEM"
"LI J, 2018, CELL PHYSIOL BIOCHEM","LI J;LIN H;SUN Z;KONG G;YAN X;WANG Y;WANG X;WEN Y;LIU X;ZHENG H;JIA M;SHI Z;XU R;YANG S;YUAN F","HIGH-THROUGHPUT DATA OF CIRCULAR RNA PROFILES IN HUMAN TEMPORAL CORTEX TISSUE REVEALS NOVEL INSIGHTS INTO TEMPORAL LOBE EPILEPSY","CELLULAR PHYSIOLOGY AND BIOCHEMISTRY","CELL. PHYSIOL. BIOCHEM.","BACKGROUND/AIMS: CIRCULAR RNAS (CIRCRNAS) ARE A CLASS OF LONG NONCODING RNAS WITH A CLOSED LOOP STRUCTURE THAT REGULATE GENE EXPRESSION AS MICRORNA SPONGES. CIRCRNAS ARE MORE ENRICHED IN BRAIN TISSUE, BUT KNOWLEDGE OF THE ROLE OF CIRCRNAS IN TEMPORAL LOBE EPILEPSY (TLE) HAS REMAINED LIMITED. THIS STUDY IS THE FIRST TO IDENTIFY THE GLOBAL EXPRESSION PROFILES AND CHARACTERISTICS OF CIRCRNAS IN HUMAN TEMPORAL CORTEX TISSUE FROM TLE PATIENTS. METHODS: TEMPORAL CORTICES WERE COLLECTED FROM 17 TLE PATIENTS AND 17 NON-TLE PATIENTS. TOTAL RNA WAS ISOLATED, AND HIGH-THROUGHPUT SEQUENCING WAS USED TO PROFILE THE TRANSCRIPTOME OF DYSREGULATED CIRCRNAS. QUANTITATIVE PCR WAS PERFORMED FOR THE VALIDATION OF CHANGED CIRCRNAS. RESULTS: IN TOTAL, 78983 CIRCRNAS, INCLUDING 15.29\% KNOWN AND 84.71\% NOVEL CIRCRNAS, WERE DETECTED IN THIS STUDY. INTRIGUINGLY, 442 CIRCRNAS WERE DIFFERENTIALLY EXPRESSED BETWEEN THE TLE AND NON-TLE GROUPS (FOLD CHANGE >= 2.0 AND FDR <= 0.05). OF THESE CIRCRNAS, 188 WERE UP-REGULATED, AND 254 WERE DOWN-REGULATED IN THE TLE PATIENT GROUP. EIGHT CIRCRNAS WERE VALIDATED BY REAL-TIME PCR. REMARKABLY, CIRC-EFCAB2 WAS INTENSELY UP-REGULATED, WHILE CIRC-DROSHA EXPRESSION WAS SIGNIFICANTLY LOWER IN THE TLE GROUP THAN IN THE NON-TLE GROUP (P<0.05). BIOINFORMATIC ANALYSIS REVEALED THAT CIRC-EFCAB2 BINDS TO MIR-485-5P TO INCREASE THE EXPRESSION LEVEL OF THE ION CHANNEL CLCN6, WHILE CIRC-DROSHA INTERACTS WITH MIR-1252-5P TO DECREASE THE EXPRESSION LEVEL OF ATP1A2. CONCLUSIONS: THE DYSREGULATIONS OF CIRCRNAS MAY REFLECT THE PATHOGENESIS OF TLE AND CIRC-EFCAB2 AND CIRC-DROSHA MIGHT BE POTENTIAL THERAPEUTIC TARGETS AND BIOMARKERS IN TLE PATIENTS. (C) 2018 THE AUTHOR(S) PUBLISHED BY S. KARGER AG, BASEL","CIRCRNAS; TEMPORAL CORTEX; TEMPORAL LOBE EPILEPSY (TLE); HIGH-THROUGHPUT SEQUENCING; MICRORNA SPONGE","STATUS EPILEPTICUS; BINDING PROTEIN; EXPRESSION; BRAIN; HAPLOINSUFFICIENCY; EPILEPTOGENESIS; IDENTIFICATION; ACCUMULATION; BIOGENESIS; MUTATIONS","ENGLISH","ARTICLE","ARTICLE",0,"BENSAID M, 2009, NUCLEIC ACIDS RES, V37, P1269, DOI 10.1093/NAR/GKN1058.;BERRYER MH, 2013, HUM MUTAT, V34, P385, DOI 10.1002/HUMU.22248.;BILEN J, 2006, MOL CELL, V24, P157, DOI 10.1016/J.MOLCEL.2006.07.030.;BLUMCKE I, 2016, EPILEPSIA, V57, P348, DOI 10.1111/EPI.13319.;BOISON D, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/FNMOL.2016.00026.;CAVAZOS JE, 2006, EPILEPSY BEHAV, V8, P483, DOI 10.1016/J.YEBEH.2006.01.011.;CHEN LL, 2015, RNA BIOL, V12, P381, DOI 10.1080/15476286.2015.1020271.;COHEN JE, 2014, PHILOS T R SOC B, V369, DOI 10.1098/RSTB.2013.0509.;CONN SJ, 2015, CELL, V160, P1125, DOI 10.1016/J.CELL.2015.02.014.;DE FUSCO M, 2003, NAT GENET, V33, P192, DOI 10.1038/NG1081.;DEPREZ L, 2008, EPILEPSIA, V49, P500, DOI 10.1111/J.1528-1167.2007.01415.X.;DJAMSHIDIAN A, 2002, NEUROSCIENCE, V111, P57, DOI 10.1016/S0306-4522(01)00528-0.;EASTMAN SW, 2005, J BIOL CHEM, V280, P628, DOI 10.1074/JBC.M410384200.;FUNCK VR, 2014, EPILEPSY RES, V108, P1705, DOI 10.1016/J.EPLEPSYRES.2014.09.025.;GAO Y, 2015, GENOME BIOL, V16, DOI 10.1186/S13059-014-0571-3.;GHORBANI P, 2007, NEUROSCI LETT, V425, P162, DOI 10.1016/J.NEULET.2007.08.023.;GRUNER H, 2016, SCI REP-UK, V6, DOI 10.1038/SREP38907.;HANSEN KF, 2014, SCI REP-UK, V4, DOI 10.1038/SREP06930.;HANSEN TB, 2013, NATURE, V495, P384, DOI 10.1038/NATURE11993.;HENSHALL DC, 2015, CSH PERSPECT MED, V5, DOI 10.1101/CSHPERSPECT.A022731.;HENSHALL DC, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/FNMOL.2013.00037.;IVANOV A, 2015, CELL REP, V10, P170, DOI 10.1016/J.CELREP.2014.12.019.;JECK WR, 2013, RNA, V19, P141, DOI 10.1261/RNA.035667.112.;JENTSCH TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ].;KAN AA, 2012, CELL MOL LIFE SCI, V69, P3127, DOI 10.1007/S00018-012-0992-7.;LASDA E, 2014, RNA, V20, P1829, DOI 10.1261/RNA.047126.114.;LEE Y, 2003, NATURE, V425, P415, DOI 10.1038/NATURE01957.;LI ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/NSMB.2959.;LIN CY, 2010, INT J BIOCHEM CELL B, V42, P98, DOI 10.1016/J.BIOCEL.2009.09.012.;LIN SP, 2016, BIOCHEM BIOPH RES CO, V471, P52, DOI 10.1016/J.BBRC.2016.01.183.;LONG HY, 2017, SCI REP-UK, V7, DOI 10.1038/SREP43810.;LU A, 2009, J MOL NEUROSCI, V38, P19, DOI 10.1007/S12031-008-9155-6.;LUDDI A, 2009, NEW ENGL J MED, V360, P881, DOI 10.1056/NEJMOA0806218.;LUKIW WALTER J., 2013, FRONTIERS IN GENETICS, V4, P307, DOI [10.3389/FGENE.2013.00077, 10.3389/FGENE.2013.00307].;MCKIERNAN RC, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0035921.;MEMCZAK S, 2013, NATURE, V495, P333, DOI 10.1038/NATURE11928.;PITKANEN A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/J.YEBEH.2008.09.023.;POST PL, 1998, J CELL SCI, V111, P941.;RAKHADE SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/NRNEUROL.2009.80.;ROBINSON MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/BIOINFORMATICS/BTP616.;RYBAK-WOLF A, 2015, MOL CELL, V58, P870, DOI 10.1016/J.MOLCEL.2015.03.027.;SALZMAN J, 2016, TRENDS GENET, V32, P309, DOI 10.1016/J.TIG.2016.03.002.;SALZMAN J, 2013, PLOS GENET, V9, DOI 10.1371/JOURNAL.PGEN.1003777.;SALZMAN J, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0030733.;SANDER JW, 2003, EPILEPSIA S1, V44, P17.;SANJO H, 1998, J BIOL CHEM, V273, P29066, DOI 10.1074/JBC.273.44.29066.;SEO S, P NATL ACAD SCI US.;THOM M, 2009, J NEUROPATH EXP NEUR, V68, P928, DOI 10.1097/NEN.0B013E3181B05D67.;VAN GASSEN KLI, 2008, EPILEPSIA, V49, P1055, DOI 10.1111/J.1528-1167.2007.01470.X.;VAN ROSSUM D, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/FNMOL.2016.00074.;WAGNER FB, 2015, NEUROIMAGE, V122, P114, DOI 10.1016/J.NEUROIMAGE.2015.08.019.;WANG J, 2015, SCI REP-UK, V5, DOI 10.1038/SREP09522.;WESTHOLM JO, 2014, CELL REP, V9, P1966, DOI 10.1016/J.CELREP.2014.10.062.;WOLFART J, 2015, FRONT PHYSIOL, V6, DOI 10.3389/FPHYS.2015.00168.;YAMAMOTO T, 1999, EUR J BIOCHEM, V265, P481, DOI 10.1046/J.1432-1327.1999.00786.X.;YOU XT, 2015, NAT NEUROSCI, V18, P603, DOI 10.1038/NN.3975.;YUS-NAJERA E, 2003, NEUROSCIENCE, V120, P353, DOI 10.1016/S0306-4522(03)00321-X.;ZHANG Y, 2013, MOL CELL, V51, P792, DOI 10.1016/J.MOLCEL.2013.08.017.;ZHOU J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/FNMOL.2017.00091.","YUAN, F (REPRINT AUTHOR), CAPITAL MED UNIV, BEIJING NEUROSURG INST, BEIJING TIANTAN HOSP, DEPT PATHOPHYSIOL, BEIJING, PEOPLES R CHINA.;SUN, ZR (REPRINT AUTHOR), CAPITAL MED UNIV, BEIJING TIANTAN HOSP, DEPT NEUROSURG, BEIJING, PEOPLES R CHINA.;LI, JIAXIN, YAN, XU, WANG, YUJIAO, WANG, XIAOXUAN, JIA, MEI, SHI, ZHONGFANG, YUAN, FANG, CAPITAL MED UNIV, BEIJING NEUROSURG INST, BEIJING TIANTAN HOSP, DEPT PATHOPHYSIOL, BEIJING, PEOPLES R CHINA.;LIN, HAIJUN, WEN, YANHUA, LIU, XIANG, ZHENG, HONGKUN, BIOMARKER TECHNOL CORP, BEIJING, PEOPLES R CHINA.;SUN, ZHENRONG, CAPITAL MED UNIV, BEIJING TIANTAN HOSP, DEPT NEUROSURG, BEIJING, PEOPLES R CHINA.;KONG, GUANYI, ECHO BIOTECH CO LTD, BEIJING, PEOPLES R CHINA.;XU, RONG, LA TROBE UNIV, LA TROBE INST MOL SCI, DEPT BIOCHEM \& GENET, MELBOURNE, VIC, AUSTRALIA.;YANG, SHAOHUA, UNIV NORTH TEXAS, DEPT PHARMACOL \& NEUROSCI, HLTH SCI CTR, FT WORTH, TX USA.","10.1159/000487161","ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",NA,NA,"NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA [81271286], BEIJING NATURAL SCIENCE FOUNDATION [7152027]","THIS PROJECT WAS SUPPORTED BY GRANTS FROM THE NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA (NOS. 81271286) AND BEIJING NATURAL SCIENCE FOUNDATION (NOS. 7152027).",NA,"1015-8987","2","677-691","KARGER","45",2018,"ISI000426033200019","59","CELL BIOLOGY, PHYSIOLOGY","1","CELL BIOLOGY, PHYSIOLOGY","SUNZR1961163.COM FLORAYUANVIP.SINA.COM",NA,"FX4HH",NA,"YUAN, F (REPRINT AUTHOR), CAPITAL MED UNIV, BEIJING NEUROSURG INST, BEIJING TIANTAN HOSP, DEPT PATHOPHYSIOL, BEIJING, PEOPLES R CHINA","ISI","CAPITAL MED UNIV;BIOMARKER TECHNOL CORP;CAPITAL MED UNIV;ECHO BIOTECH CO LTD;LA TROBE UNIV;UNIV NORTH TEXAS","CAPITAL MED UNIV",NA,"LI J, 2018, CELL PHYSIOL BIOCHEM","LI J, 2018, CELL PHYSIOL BIOCHEM"
"KAYA H, 2018, MSPHERE","KAYA H;HASMAN H;LARSEN J;STEGGER M;JOHANNESEN TB;ALLESOE RL;LEMVIGH CK;AARESTRUP FM;LUND O;LARSEN AR","SCC\&ITMEC\&ITFINDER, A WEB-BASED TOOL FOR TYPING OF STAPHYLOCOCCAL CASSETTE CHROMOSOME \&ITMEC \&ITIN \&ITSTAPHYLOCOCCUS AUREUS\&IT USING WHOLE-GENOME SEQUENCE DATA","MSPHERE","MSPHERE","TYPING OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) IS IMPORTANT IN INFECTION CONTROL AND SURVEILLANCE. THE CURRENT NOMENCLATURE OF MRSA INCLUDES THE GENETIC BACKGROUND OF THE S. AUREUS STRAIN DETERMINED BY MULTILOCUS SEQUENCE TYPING (MLST) OR EQUIVALENT METHODS LIKE SPA TYPING AND TYPING OF THE MOBILE GENETIC ELEMENT STAPHYLOCOCCAL CASSETTE CHROMOSOME MEC (SCCMEC), WHICH CARRIES THE MECA OR MECC GENE. WHEREAS MLST AND SPA TYPING ARE RELATIVELY SIMPLE, TYPING OF SCCMEC IS LESS TRIVIAL BECAUSE OF ITS HETEROGENEITY. WHOLE-GENOME SEQUENCING (WGS) PROVIDES THE ESSENTIAL DATA FOR TYPING OF THE GENETIC BACKGROUND AND SCCRNEC, BUT SO FAR, NO BIOINFORMATIC TOOLS FOR SCCMEC TYPING HAVE BEEN AVAILABLE. HERE, WE REPORT THE DEVELOPMENT AND EVALUATION OF SCCMECFINDER FOR CHARACTERIZATION OF THE SCCMEC ELEMENT FROM S. AUREUS WGS DATA. SCCMECFINDER IS ABLE TO IDENTIFY ALL SCCMEC ELEMENT TYPES, DESIGNATED I TO XIII, WITH SUBTYPING OF SCCMEC TYPES IV (2B) AND V (5C2). SCCMEC ELEMENTS ARE CHARACTERIZED BY TWO DIFFERENT GENE PREDICTION APPROACHES TO ACHIEVE CORRECT ANNOTATION, A BASIC LOCAL ALIGNMENT SEARCH TOOL (BLAST)-BASED APPROACH AND A K-MER-BASED APPROACH. EVALUATION OF SCCMECFINDER BY USING A DIVERSE COLLECTION OF CLINICAL ISOLATES (N=93) SHOWED A HIGH TYPEABILITY LEVEL OF 96.7\%, WHICH INCREASED TO 98.9\% UPON MODIFICATION OF THE DEFAULT SETTINGS. IN CONCLUSION, SCCMECFINDER CAN BE AN ALTERNATIVE TO MORE LABORIOUS SCCMEC TYPING METHODS AND IS FREELY AVAILABLE AT HTTPS://CGE.CBS.DTU.DK/SERVICES/SCCMECFINDER. IMPORTANCE SCCMEC IN MRSA IS ACKNOWLEDGED TO BE OF IMPORTANCE NOT ONLY BECAUSE IT CONTAINS THE MECA OR MECC GENE BUT ALSO FOR STAPHYLOCOCCAL ADAPTATION TO DIFFERENT ENVIRONMENTS, E.G., IN HOSPITALS, THE COMMUNITY, AND LIVESTOCK. TYPING OF SCCMEC BY PCR TECHNIQUES HAS, BECAUSE OF ITS HETEROGENEITY, BEEN CHALLENGING, AND WHOLE-GENOME SEQUENCING HAS ONLY PARTIALLY SOLVED THIS SINCE NO GOOD BIOINFORMATIC TOOLS HAVE BEEN AVAILABLE. IN THIS ARTICLE, WE DESCRIBE THE DEVELOPMENT OF A NEW BIOINFORMATIC TOOL, SCCMECFINDER, THAT INCLUDES MOST OF THE NEEDS FOR INFECTION CONTROL PROFESSIONALS AND RESEARCHERS REGARDING THE INTERPRETATION OF SCCMEC ELEMENTS. THE SOFTWARE DETECTS ALL OF THE SCCMEC ELEMENTS ACCEPTED BY THE INTERNATIONAL WORKING GROUP ON THE CLASSIFICATION OF STAPHYLOCOCCAL CASSETTE CHROMOSOME ELEMENTS, AND USERS WILL BE PROMPTED IF DIVERGING AND POTENTIAL NEW ELEMENTS ARE UPLOADED. FURTHERMORE, SCCMECFINDER WILL BE CURATED AND UPDATED AS NEW ELEMENTS ARE FOUND AND IT IS EASY TO USE AND FREELY ACCESSIBLE.","MRSA; SCCMEC; BIOINFORMATICS; MECA; MECC; TYPING","MEC; MULTIPLEX","ENGLISH","ARTICLE","ARTICLE",4,"BOSWIHI SS, 2016, PLOS ONE, V11, DOI 10.1371/JOURNAL.PONE.0162744.;ENRIGHT MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/PNAS.122108599.;HASMAN H, 2014, J CLIN MICROBIOL, V52, P139, DOI 10.1128/JCM.02452-13.;HENDRIKSEN RS, 2011, MBIO, V2, DOI 10.1128/MBIO.00157-11.;HIGUCHI W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/J.BBRC.2008.10.009.;HIRAMATSU K, 2013, INFECT CHEMOTHER, V45, P117, DOI 10.3947/IC.2013.45.2.117.;ITO T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09.;KONDO Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06.;LARSEN MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11.;MCCLURE-WARNIER JA, 2013, JOVE-J VIS EXP, V79, P50779.;MILHEIRICO C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/JAC/DKM112.;MONECKE S, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0017936.;WU ZW, 2015, ANTIMICROB AGENTS CH, V59, P7597, DOI 10.1128/AAC.01692-15.","LARSEN, AR (REPRINT AUTHOR), STATENS SERUM INST, DEPT BACTERIA PARASITES \& FUNGI, COPENHAGEN, DENMARK.;KAYA, HULYA, HASMAN, HENRIK, LARSEN, JESPER, STEGGER, MARC, JOHANNESEN, THOR BECH, LARSEN, ANDERS RHOD, STATENS SERUM INST, DEPT BACTERIA PARASITES \& FUNGI, COPENHAGEN, DENMARK.;KAYA, HULYA, AARESTRUP, FRANK MOLLER, TECH UNIV DENMARK, NATL FOOD INST, RES GRP GENOM EPIDEMIOL, LYNGBY, DENMARK.;ALLESOE, ROSA LUNDBYE, LEMVIGH, CAMILLA KOLDBAEK, LUND, OLE, TECH UNIV DENMARK, CTR BIOL SEQUENCE ANAL, DEPT BIOINFORMAT, LYNGBY, DENMARK.;KAYA, HULYA, STATENS SERUM INST, COPENHAGEN, DENMARK.","10.1128/MSPHERE.00612-17","1752 N ST NW, WASHINGTON, DC 20036-2904 USA","E00612-17",NA,"DANISH MINISTRY OF HEALTH AND PREVENTION AS PART OF THE SURVEILLANCE OF MRSA, DANISH COUNCIL FOR STRATEGIC RESEARCH [09-067103], EUROPEAN UNION HORIZON RESEARCH AND INNOVATION PROGRAM [643476]","THIS WORK WAS SUPPORTED BY THE DANISH MINISTRY OF HEALTH AND PREVENTION AS PART OF THE SURVEILLANCE OF MRSA, THE DANISH COUNCIL FOR STRATEGIC RESEARCH (GRANT 09-067103), AND THE EUROPEAN UNION HORIZON 2020 RESEARCH AND INNOVATION PROGRAM UNDER GRANT AGREEMENT 643476 TO THE COMPARE PROJECT (HTTP://WWW.COMPARE-EUROPE.EU ).",NA,"2379-5042","1",NA,"AMER SOC MICROBIOLOGY","3",2018,"ISI000425277500041","13","MICROBIOLOGY","3","MICROBIOLOGY","LARSEN.ARLSSI.DK",NA,"FW4IX",NA,"LARSEN, AR (REPRINT AUTHOR), STATENS SERUM INST, DEPT BACTERIA PARASITES \& FUNGI, COPENHAGEN, DENMARK","ISI","STATENS SERUM INST;TECH UNIV DENMARK;TECH UNIV DENMARK;STATENS SERUM INST","STATENS SERUM INST",NA,"KAYA H, 2018, MSPHERE","KAYA H, 2018, MSPHERE"
"YU D, 2018, CURR BIOINFORM","YU D;CHEN Q;HUANG W;WAN S;ZHAN J","CLONING, BIOINFORMATIC ANALYSIS AND EXPRESSION PATTERN OF PHOSPHOLIPASE D GENE FAMILY IN VITIS VINIFERA","CURRENT BIOINFORMATICS","CURR. BIOINFORM.","BACKGROUND: THE PHOSPHOLIPASE D GENES HAVE BEEN IDENTIFIED TO PLAY CRITICAL ROLES IN PLANT GROWTH AND STRESS RESPONSES. THERE ARE 12 AND 17 PLD MEMBERS CONFORMED IN ARABIDOPSIS AND ORYZA SATIVA RESPECTIVELY. DIFFERENT PLD ISOFORMS HAVE DISTINCT REGULATORY AND CATALYTIC PROPERTIES. METHOD: IN THIS STUDY, THE VVPLD GENES WERE CLONED USING THE GENOME-WIDE SEARCH AND RT-PCR AMPLIFICATION FROM SUSPENSON-CULTURED GRAPE CELLS (VITIS VINIFERA L. CV. CABERNET SAUVIGNON). A COMPREHENSIVE BIOINFORMATICS ANALYSIS OF THE VVPLD FAMILY WAS THEN PERFORMED. TO FURTHER INVESTIGATE THE FUNCTION OF THE VVPLD GENES DURING PATHOGEN INFECTION PROCESS, BOTRYTIS CINEREA WAS USED TO ATTACK SUSPENSON-CULTURED CABERNET SAUVIGNON CELLS. THE MRNA EXPRESSION PATTERNS OF VVPLDS WERE EXAMINED BY QUANTITATIVE REAL-TIME PCR. RESULTS: TEN PLD CODING SEQUENCES (CDS) AND TWO PLD GENES SEGMENTS WERE ISOLATED FROM GRAPE BERRY SUSPENSION CELLS. THE VVPLDS WERE CHARACTERIZED AND CLASSIFIED INTO 6 TYPES (2 VVPLD ALPHA S, 2 VVPLD BETA S, 3 VVPLD DELTA S, 1 VVPLD EPSILON, 1 VVPLD RHO AND 1 VVPLD ZETA) AND 3 GROUPS (C2-PLD, PXPH-PLD AND SP-PLD). QUANTITATIVE REAL-TIME RT-PCR ANALYSIS SHOWED THAT VVPLD BETA 1, VVPLD BETA 2, VVPLD DELTA 2, VVPLD RHO AND VVPLD ZETA WERE UP-REGULATED, WHEREAS VVPLD ALPHA AND VVPLD DELTA WERE DOWN-REGULATED DURING BOTRYTIS CINEREA INFECTION. IMMUNOBLOTTING WITH ATPLD ALPHA 1 ANTIBODIES DETECTED A HIGHER ABUNDANCE OF VVPLD ALPHA IN INFECTED GRAPE CELLS, WHICH WAS IN ACCORDANCE WITH ITS ENZYME ACTIVITY. CONCLUSION: THE RESULTS OF THIS STUDY WILL BE USEFUL IN SELECTING CANDIDATE GENES RELATED TO DISEASE RESISTANCE IN GRAPEVINE AND PAVE THE WAY FOR FURTHER FUNCTIONAL VERIFICATION OF THE VVPLD GENES.","PHOSPHOLIPASE D; BIOINFORMATICS ANALYSIS; EXPRESSION PATTERN; VITIS VINIFERA; ARABIDOPSIS; ORYZA SATIVA","PHOSPHATIDIC-ACID; DISEASE RESISTANCE; DEFENSE RESPONSES; FUNGAL PATHOGENS; ORYZA-SATIVA; ACTIVE-SITE; GENOME-WIDE; D PLD; ARABIDOPSIS; IDENTIFICATION","ENGLISH","ARTICLE","ARTICLE",0,"BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/ABIO.1976.9999.;COCKCROFT S, 1984, BIOCHIM BIOPHYS ACTA, V795, P37, DOI 10.1016/0005-2760(84)90102-4.;DEN HARTOG M, 2001, PLANT J, V25, P55, DOI 10.1046/J.1365-313X.2001.00931.X.;DIXON RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178.;ELMORE JM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/MCP.M111.014555.;FROHMAN MA, 1999, BBA-MOL CELL BIOL L, V1439, P175, DOI 10.1016/S1388-1981(99)00093-1.;GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5.;GAO HB, 2013, MOL PLANT, V6, P1692, DOI 10.1093/MP/SST076.;GAO M, 2012, PLANT PHYSIOL BIOCH, V58, P253, DOI 10.1016/J.PLAPHY.2012.07.009.;HANAHAN DJ, 1947, J BIOL CHEM, V169, P699.;HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/PNAS.90.19.9031.;HONG YY, 2010, PLANT CELL ENVIRON, V33, P627, DOI 10.1111/J.1365-3040.2009.02087.X.;ISLA MI, 1998, PHYTOCHEMISTRY, V47, P1189, DOI 10.1016/S0031-9422(97)00757-7.;JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384A0.;KATAGIRI T, 2001, PLANT J, V26, P595, DOI 10.1046/J.1365-313X.2001.01060.X.;KOONIN EV, 1996, TRENDS BIOCHEM SCI, V21, P242, DOI 10.1016/S0968-0004(96)30024-8.;KRINKE O, 2009, PLANT PHYSIOL, V150, P424, DOI 10.1104/PP.108.133595.;LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680A0.;LAXALT AM, 2001, PLANT J, V26, P237, DOI 10.1046/J.1365-313X.2001.01023.X.;LEMMON MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001.;LI G, 2007, CELL RES, V17, P881, DOI 10.1038/CR.2007.77.;LIU Q, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-117.;MORIOKA S, 1997, PLANT PHYSIOL, V114, P396.;MUNNIK T, 1995, PLANT CELL, V7, P2197, DOI 10.1105/TPC.7.12.2197.;MUNNIK T, 2001, TRENDS PLANT SCI, V6, P227, DOI 10.1016/S1360-1385(01)01918-5.;OHASHI Y, 2003, SCIENCE, V300, P1427, DOI 10.1126/SCIENCE.1083695.;PAPPAN K, 1997, J BIOL CHEM, V272, P7048, DOI 10.1074/JBC.272.11.7048.;PAPPAN K, 1999, BBA-MOL CELL BIOL L, V1439, P151, DOI 10.1016/S1388-1981(99)00091-8.;PONTING CP, 1996, PROTEIN SCI, V5, P914.;QIN CB, 2002, PLANT PHYSIOL, V128, P1057, DOI 10.1104/PP.010928.;QIN WS, 1997, J BIOL CHEM, V272, P28267, DOI 10.1074/JBC.272.45.28267.;RYALS JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/TPC.8.10.1809.;SUNG TC, 1997, EMBO J, V16, P4519, DOI 10.1093/EMBOJ/16.15.4519.;TAKABATAKE R, 2007, PLANT CELL PHYSIOL, V48, P414, DOI 10.1093/PCP/PCM011.;UEKI J, 1995, PLANT CELL PHYSIOL, V36, P903, DOI 10.1093/OXFORDJOURNALS.PCP.A078837.;ULBRICHHOFMANN R, 2000, ENZYMES LIPID MODIFI, P219.;WAN SB, 2007, J BIOCHEM MOL BIOL, V40, P595.;WANG XM, 1994, J BIOL CHEM, V269, P20312.;WANG XM, 2002, CURR OPIN PLANT BIOL, V5, P408, DOI 10.1016/S1369-5266(02)00283-2.;WANG XM, 1997, TRENDS PLANT SCI, V2, P261, DOI 10.1016/S1360-1385(97)86348-0.;WANG XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/J.PLIPRES.2006.01.005.;YAMAGUCHI T, 2009, PLANT PHYSIOL, V150, P308, DOI 10.1104/PP.108.131979.;YOUNG SA, 1996, PLANT CELL, V8, P1079.;ZHANG HONG-YU, 2012, FOOD SCIENCE AND TECHNOLOGY, V37, P22.;ZHAO J, 2013, NEW PHYTOL, V199, P228, DOI 10.1111/NPH.12256.;ZHENG L, 2000, J BIOL CHEM, V275, P19700, DOI 10.1074/JBC.M001945200.","ZHAN, JC (REPRINT AUTHOR), CHINA AGR UNIV, COLL FOOD SCI \& NUTR ENGN, BEIJING 100083, PEOPLES R CHINA.;YU, DAN, CHEN, QIMIN, HUANG, WEIDONG, ZHAN, JICHENG, CHINA AGR UNIV, COLL FOOD SCI \& NUTR ENGN, BEIJING 100083, PEOPLES R CHINA.;WAN, SIBAO, SHANGHAI UNIV, SCH LIFE SCI, SHANGHAI 200444, PEOPLES R CHINA.","10.2174/1574893611666160608101716","EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES",NA,NA,"NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA [31171942]","THIS WORK IS SUPPORTED BY THE NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA (31171942). WE ALSO THANK DR. XUEMIN WANG (UNIVERSITY OF MISSOURI-ST. LOUIS, USA) FOR KINDLY PROVIDING US WITH ATPLD ALPHA 1 ANTIBODY.",NA,"1574-8936","1","42-49","BENTHAM SCIENCE PUBL LTD","13",2018,"ISI000425531200006","46","BIOCHEMISTRY \& MOLECULAR BIOLOGY, MATHEMATICAL \& COMPUTATIONAL BIOLOGY","16","BIOCHEMICAL RESEARCH METHODS, MATHEMATICAL \& COMPUTATIONAL BIOLOGY","JCZHAN263.NET",NA,"FW7UO",NA,"ZHAN, JC (REPRINT AUTHOR), CHINA AGR UNIV, COLL FOOD SCI \& NUTR ENGN, BEIJING 100083, PEOPLES R CHINA","ISI","CHINA AGR UNIV;SHANGHAI UNIV","CHINA AGR UNIV",NA,"YU D, 2018, CURR BIOINFORM","YU D, 2018, CURR BIOINFORM"
"KOOSHAVAR D, 2018, INT J PEDIATR OTORHINOLARYNGOL","KOOSHAVAR D;RAZIPOUR M;MOVASAT M;KERAMATIPOUR M","TARGETED NEXT GENERATION SEQUENCING IDENTIFIED A NOVEL MUTATION IN MYO7A CAUSING USHER SYNDROME TYPE 1 IN AN IRANIAN CONSANGUINEOUS PEDIGREE","INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY","INT. J. PEDIATR. OTORHINOLARYNGOL.","BACKGROUND: USHER SYNDROME (USH) IS CHARACTERIZED BY CONGENITAL HEARING LOSS AND RETINITIS PIGMENTOSA (RP) WITH A LATER ONSET. IT IS AN AUTOSOMAL RECESSIVE TRAIT WITH CLINICAL AND GENETIC HETEROGENEITY WHICH MAKES THE MOLECULAR DIAGNOSIS MUCH DIFFICULT. IN THIS STUDY, WE INTRODUCE A PEDIGREE WITH TWO AFFECTED MEMBERS WITH USH TYPE 1 AND REPRESENT A COST AND TIME EFFECTIVE APPROACH FOR GENETIC DIAGNOSIS OF USH AS A GENETICALLY HETEROGENEOUS DISORDER. METHODS: TARGET REGION CAPTURE IN THE GENES OF INTEREST, FOLLOWED BY NEXT GENERATION SEQUENCING (NGS) WAS USED TO DETERMINE THE CAUSATIVE MUTATIONS IN ONE OF THE PROBANDS. THEN SEGREGATION ANALYSIS IN THE PEDIGREE WAS CONDUCTED USING PCR-SANGER SEQUENCING. RESULTS: TARGETED NGS DETECTED A NOVEL HOMOZYGOUS NONSENSE VARIANT C.4513G > T (P.GLU1505TER) IN MYO7A. THE VARIANT IS SEGREGATING IN THE PEDIGREE WITH AN AUTOSOMAL RECESSIVE PATTERN. CONCLUSION: IN THIS STUDY, A NOVEL STOP GAINED VARIANT C.4513G > T (P.GLU1505TER) IN MYO7A WAS FOUND IN AN IRANIAN PEDIGREE WITH TWO AFFECTED MEMBERS WITH USH TYPE 1. BIOINFORMATIC AS WELL AS PEDIGREE SEGREGATION ANALYSES WERE IN LINE WITH PATHOGENIC NATURE OF THIS VARIANT. TARGETED NGS PANEL WAS SHOWED TO BE AN EFFICIENT METHOD FOR MUTATION DETECTION IN HEREDITARY DISORDERS WITH LOCUS HETEROGENEITY.","USHER SYNDROME; MYO7A; MUTATION; TARGETED NEXT GENERATION SEQUENCING","MYOSIN-VIIA; GENETICS; PATHOGENESIS; DISEASE; MECHANISMS; 1B","ENGLISH","ARTICLE","ARTICLE",0,"ADATO A, 1997, AM J HUM GENET, V61, P813, DOI 10.1086/514899.;BAUX D., 2008, HUM MUTAT, V29.;BONNET C, 2012, CURR OPIN NEUROL, V25, P42, DOI 10.1097/WCO.0B013E32834EF8B2.;BROGNA S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/NSMB.1550.;CREMERS FPM, 2007, J MED GENET, V44, P153, DOI 10.1136/JMG.2006.044784.;DAD S, 2016, MOL GENET GENOM MED, V4, P527, DOI 10.1002/MGG3.228.;EBERMANN I, 2010, J CLIN INVEST, V120, P1812, DOI 10.1172/JCI39715.;EISENBERGER T, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-59.;GERBER S, 2006, AM J HUM GENET, V78, P357, DOI 10.1086/500275.;HUG N, 2016, NUCLEIC ACIDS RES, V44, P1483, DOI 10.1093/NAR/GKW010.;JACOBSON S. G., 2009, INVESTIG OPHTHALMOL, V50.;JACOBSON SG, 2008, HUM MOL GENET, V17, P2405, DOI 10.1093/HMG/DDN140.;JACOBSON SG, 2011, INVEST OPHTH VIS SCI, V52, P7924, DOI 10.1167/IOVS.11-8313.;JAIJO T, 2006, HUM MUTAT, V27, P290, DOI 10.1002/HUMU.9404.;JANECKE AR, 1999, HUM MUTAT, V13, P133, DOI 10.1002/(SICI)1098-1004(1999)13:2<133::AID-HUMU5>3.0.CO,2-U.;KHATEB S, 2014, J MED GENET, V51, P460, DOI 10.1136/JMEDGENET-2014-102287.;KOFFLER T, 2015, OTOLARYNG CLIN N AM, V48, P1041, DOI 10.1016/J.OTC.2015.07.007.;KREMER H, 2006, HUM MOL GENET, V15, PR262, DOI 10.1093/HMG/DDL205.;MILLAN JM, 2011, J OPHTHALMOL, DOI 10.1155/2011/417217.;PETIT C, 2001, ANNU REV GENOM HUM G, V2, P271, DOI 10.1146/ANNUREV.GENOM.2.1.271.;PUFFENBERGER EG, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0028936.;REINERS J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/J.EXER.2005.11.010.;RICHARDS S, 2015, GENET MED, V17, P405, DOI 10.1038/GIM.2015.30.;ROUX AF, 2011, INVEST OPHTH VIS SCI, V52, P4063, DOI 10.1167/IOVS.10-6869.;VASTINSALO H, 2006, MOL VIS, V12, P1093.;YAN D, 2010, J HUM GENET, V55, P327, DOI 10.1038/JHG.2010.29.","KERAMATIPOUR, M (REPRINT AUTHOR), UNIV TEHRAN MED SCI, SCH MED, DEPT MED GENET, POURSINA AVE,KESHAVARZ BLVD, TEHRAN 1417613151, IRAN.;KOOSHAVAR, DANIZ, RAZIPOUR, MASOUMEH, KERAMATIPOUR, MOHAMMAD, UNIV TEHRAN MED SCI, SCH MED, DEPT MED GENET, POURSINA AVE,KESHAVARZ BLVD, TEHRAN 1417613151, IRAN.;MOVASAT, MORTEZA, UNIV TEHRAN MED SCI, FARABI EYE HOSP, EYE RES CTR, TEHRAN, IRAN.","10.1016/J.IJPORL.2017.10.022","ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND",NA,NA,NA,NA,NA,"0165-5876",NA,"10-13","ELSEVIER IRELAND LTD","104",2018,"ISI000423646800003","26","OTORHINOLARYNGOLOGY, PEDIATRICS","0","OTORHINOLARYNGOLOGY, PEDIATRICS","KERAMATIPOURSINA.TUMS.AC.IR",NA,"FU1ZA",NA,"KERAMATIPOUR, M (REPRINT AUTHOR), UNIV TEHRAN MED SCI, SCH MED, DEPT MED GENET, POURSINA AVE,KESHAVARZ BLVD, TEHRAN 1417613151, IRAN","ISI","UNIV TEHRAN MED SCI;UNIV TEHRAN MED SCI","UNIV TEHRAN MED SCI",NA,"KOOSHAVAR D, 2018, INT J PEDIATR OTORHINOLARYNGOL","KOOSHAVAR D, 2018, INT J PEDIATR OTORHINOLARYNGOL"
"CHAVHAN RL, 2018, J PLANT BIOCHEM BIOTECHNOL","CHAVHAN RL;VERMA MK;HINGE VR;KADAM US;KOKANE SB;CHAKRABARTY PK","SEQUENCE ANALYSIS OF COAT PROTEIN AND MOLECULAR PROFILING OF SUNFLOWER NECROSIS VIRUS (SNV) STRAINS FROM INDIAN SUBCONTINENT","JOURNAL OF PLANT BIOCHEMISTRY AND BIOTECHNOLOGY","J. PLANT BIOCHEM. BIOTECHNOL.","SUNFLOWER IS ONE OF THE LEADING EDIBLE OILSEED CROPS OF THE WORLD AND IS AN IMPORTANT OIL-PRODUCING CROP OF INDIA. THE SUNFLOWER NECROSIS DISEASE CAUSED BY SUNFLOWER NECROSIS VIRUS (SNV) HAS BECOME A MAJOR HURDLE FOR CULTIVATION OF SUNFLOWER IN INDIA. HOWEVER, THERE IS LACK OF GENETIC INFORMATION AND STANDARD METHODS FOR DETECTION AND IDENTIFICATION OF THE SNV. TO ADDRESS THIS ISSUE, WE HAVE DEVELOPED AN APPLICATION USING COAT PROTEIN (CP) TO PERFORM MOLECULAR PROFILING OF SNV STRAINS. THE NUCLEIC ACID AND AMINO ACID SEQUENCE ANALYSIS OF CP OF SNV STRAINS COLLECTED FROM DIFFERENT REGIONS OF MAHARASHTRA AND KARNATAKA SHOWED HIGH PERCENT HOMOLOGY (96.89-98.87\%). HOWEVER, 3D STRUCTURAL ANALYSIS GENERATED ELEVEN DISTINCT GROUPS OF SNV STRAINS. COMPARATIVE BIOINFORMATIC ANALYSES OF NUCLEIC ACID AND AMINO ACID SEQUENCES WITH DIFFERENT GENERA OF POSITIVE STRANDED (+) SSRNA VIRUSES ESTABLISHED THEIR PHYLOGENTIC RELATIONSHIP WITH SIMILAR TO 25 (+) SSRNA VIRUSES VIZ., ILARVIRUS, BROMOVIRUS, CUCUMOVIRUS, ALFAMOVIRUS, COMOVIRUS, NEPOVIRUS, SEQUIVIRUS, POTYVIRUS AND CLOSTEROVIRUS. ADDITIONALLY, THE PHYLOGENETIC ANALYSIS REVEALED THREE DISTINCT CLUSTERS, WHEREIN MAJOR CLUSTER I COMPRISED SNV STRAINS AND TOBACCO STREAK VIRUS TOGETHER SHOWING 99\% SEQUENCE HOMOLOGY AND ESTABLISHED CLOSER PHYLOGENETIC RELATIONSHIP AMONG ALL MEMBER VIRUSES.","SUNFLOWER NECROSIS DISEASE; REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION; COAT PROTEIN; SUNFLOWER NECROSIS VIRUS; TOBACCO STREAK VIRUS; SEQUENCING","DISEASE; MODEL","ENGLISH","ARTICLE","ARTICLE",0,"ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/NAR/25.17.3389.;BHARGAV DK, 2014, POPULAR KHETI, V2, P201.;BHAT A. I., 2002, INDIAN JOURNAL OF BIOTECHNOLOGY, V1, P350.;CHAVHAN RL, 2015, EUR J PLANT PATHOL, V143, P663, DOI 10.1007/S10658-015-0716-6.;DUJOVNY G, 2000, ARCH VIROL, V145, P2249, DOI 10.1007/S007050070018.;FELSENSTEIN J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A025575.;FELSENSTEIN J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X.;IANDOLINO AB, 2004, PLANT MOL BIOL REP, V22, P269, DOI 10.1007/BF02773137.;JAIN RK, 2000, CURR SCI INDIA, V79, P1703.;KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115.;KUMAR A, 2009, INDIAN J BIOTECHNOL, V8, P214.;LAVANYA N, 2005, ACTA PHYTOPATHOL ENT, V40, P1588.;PRASADA RAO R. D. V. J., 2000, J OILSEEDS RES, V17, P400.;RAMIAH M., 2001, INDIAN PHYTOPATHOLOGY, V54, P246.;RAO RDVJP, 2003, ANN APPL BIOL, V142, P365.;RAVI KS, 2001, PLANT PATHOL, V50, P800, DOI 10.1046/J.1365-3059.2001.00623.X.;SCHWEDE T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/NAR/GKG520.;SINGH HP, 2005, CURR SCI INDIA, V88, P594.;SINGH SJ, 1997, NAT S EC IMP DIS CRO.;SUBBAIAH V, 2000, PLANT DIS, V84, P1343, DOI [10.1094/PDIS.2000.84.12.1343B, DOI 10.1094/PDIS.2000.84.12.1343B].;THIEN H. X., 2003, OMONRICE, V11, P110.;THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/NAR/22.22.4673.","CHAKRABARTY, PK (REPRINT AUTHOR), INDIAN COUNCIL AGR RES, CROP SCI DIV, PLANT PROTECT SECT, DR RAJENDRA PRASAD RD, NEW DELHI 110001, INDIA.;CHAVHAN, R. L., VERMA, M. K., HINGE, V. R., KADAM, U. S., KOKANE, S. B., VD COLL AGR BIOTECHNOL, DEPT PLANT BIOTECHNOL, NANDED RD, LATUR 413512, MAHARASHTRA, INDIA.;KADAM, U. S., GOVT INDIA, SCI \& ENGN RES BOARD DST, NEW DELHI 110070, INDIA.;CHAKRABARTY, PRANJIB K., INDIAN COUNCIL AGR RES, CROP SCI DIV, PLANT PROTECT SECT, DR RAJENDRA PRASAD RD, NEW DELHI 110001, INDIA.","10.1007/S13562-017-0412-Z","7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA",NA,NA,"DEPARTMENT OF BIOTECHNOLOGY, GOVT OF INDIA [BT/PR/3900/GBD/27/386/2012], SERB (DST), GOVT OF INDIA [YSS/2015/000616]","AUTHORS GRATEFULLY ACKNOWLEDGE RESEARCH FUNDING FROM DEPARTMENT OF BIOTECHNOLOGY, GOVT OF INDIA (GRANT\# BT/PR/3900/GBD/27/386/2012) TO RLC. PARTIAL FUNDING FROM SERB (DST), GOVT OF INDIA (GRANT\# YSS/2015/000616) TO USK IS ALSO ACKNOWLEDGED GRATEFULLY.",NA,"0971-7811","1","28-35","SPRINGER INDIA","27",2018,"ISI000422696800003","22","BIOCHEMISTRY \& MOLECULAR BIOLOGY, PLANT SCIENCES","1","BIOCHEMISTRY \& MOLECULAR BIOLOGY, PLANT SCIENCES","PRANJIBCHOTMAIL.COM",NA,"FS8XA",NA,"CHAKRABARTY, PK (REPRINT AUTHOR), INDIAN COUNCIL AGR RES, CROP SCI DIV, PLANT PROTECT SECT, DR RAJENDRA PRASAD RD, NEW DELHI 110001, INDIA","ISI","VD COLL AGR BIOTECHNOL;SCI AND ENGN RES BOARD DST;CROP SCI DIV","CROP SCI DIV",NA,"CHAVHAN RL, 2018, J PLANT BIOCHEM BIOTECHNOL","CHAVHAN RL, 2018, J PLANT BIOCHEM BIOTECHNOL"
"LU N, 2018, CANCER BIOMARK","LU N;WANG J;ZHU B;ZHANG M;QI F;WANG X;GU J","WHOLE-EXOME SEQUENCING TO IDENTIFY NOVEL MUTATIONS OF NEVOID BASAL CELL CARCINOMA SYNDROME IN A CHINESE POPULATION","CANCER BIOMARKERS","CANCER BIOMARK.","BACKGROUND: NEVOID BASAL CELL CARCINOMA SYNDROME (NBCCS) IS A RARE AUTOSOMAL DOMINANT DISEASE WITH A COMPLEX GENETIC ETIOLOGY. ALTHOUGH THREE CAUSATIVE GENES (PTCH1, PTCH2, SUFU) HAVE BEEN IDENTIFIED THROUGH LINKAGE ANALYSIS AND SANGER SEQUENCING, THE GENETIC BACKGROUND OF NBCCS HASN'T BEEN FULLY UNDERSTOOD. METHODS: WE PERFORMED A WHOLE-EXOME SEQUENCING (WES) IN A HAN CHINESE NBCCS FAMILY AND TWO UNAFFECTED VOLUNTEERS TO SEARCH FOR ITS CAUSATIVE GENE. BIOINFORMATIC ANALYSIS WAS USED TO SELECT CANDIDATE GENES AND ANALYZE THE FUNCTIONAL NETWORKS OF EACH CANDIDATE GENE. RESULTS: A TOTAL OF 8 SINGLE-NUCLEOTIDE VARIANTS (SNVS) WERE DETECTED IN PTCH1, PTCH2 AND SUFU IN ALL THE 5 SUBJECTS, HOWEVER NONE OF THEM WAS CONSIDERED THE PATHOGENIC GENETIC MUTATION IN THIS NBCCS FAMILY. THE FOLLOWING FILTERING PROCESS IDENTIFIED 17 NOVEL CANDIDATE GENES (GBP3, AMPD1, ASPM, UNC5C, RBM46, HSPA1L, PNPLA1, GPR126, AP5Z1, ZFHX4, KIF24, C10ORF128, COX15, GPRC5A, UGGT2, RHBDF1, RPUSD1). AMONG THEM ZFHX4 HAD BEEN ALREADY IDENTIFIED AS A NEW BASAL CELL CARCINOMA SUSCEPTIBILITY LOCI THROUGH A GENOME-WIDE ASSOCIATION STUDY (GWAS) AND WAS CONSIDERED THE MOST LIKELY PATHOGENIC GENE FOR THIS NBCCS FAMILY. THE FUNCTIONAL NETWORK ANALYSIS REVEALED THAT ZFHX4 MAY BE INVOLVED IN NOTCH SIGNALING PATHWAY. CONCLUSIONS: OUR STUDY REPORTED THE IDENTIFICATION OF 17 NOVEL CANDIDATE GENES IN A HAN CHINESE FAMILY THROUGH WES. ZFHX4 MAY BE A SUSCEPTIBILITY GENE FOR NBCCS IN CHINESE POPULATION.","GORLIN SYNDROME; NEVOID BASAL CELL CARCINOMA SYNDROME; WHOLE EXOME SEQUENCING; SINGLE-NUCLEOTIDE VARIANTS; ZFHX4","GORLIN SYNDROME; CANDIDATE GENE; NEVUS SYNDROME; COPY-NUMBER; MEDULLOBLASTOMA; IDENTIFICATION; DISEASE; GENOME; FAMILY; LOCI","ENGLISH","ARTICLE","ARTICLE",0,"ALKETBI A, 2015, CURR CANCER DRUG TAR, V15, P364, DOI 10.2174/156800961505150710113353.;ALTSHULER D, 2008, SCIENCE, V322, P881, DOI 10.1126/SCIENCE.1156409.;BAEK SH, 2007, CANCER LETT, V255, P117, DOI 10.1016/J.CANLET.2007.04.002.;BARE JW, 1992, CANCER RES, V52, P1494.;BIALER MG, 1994, LANCET, V344, P477, DOI 10.1016/S0140-6736(94)91810-4.;BRESLER SC, 2016, HEAD NECK PATHOL, V10, P119, DOI 10.1007/S12105-016-0706-9.;CHUDNOVSKY Y, 2014, CELL REP, V6, P313, DOI 10.1016/J.CELREP.2013.12.032.;DEVI BASANTI, 2013, INDIAN J DERMATOL, V58, P241, DOI 10.4103/0019-5154.110853.;FUJII K, 2014, PEDIATR INT, V56, P667, DOI 10.1111/PED.12461.;HAPP H, 2016, AM J MED GENET A, V170, P2471, DOI 10.1002/AJMG.A.37840.;JOHNSON RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/SCIENCE.272.5268.1668.;KIMONIS VE, 1997, AM J MED GENET, V69, P299, DOI 10.1002/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.3.CO,2-\#.;LO MUZIO L, 1999, CLIN GENET, V55, P34, DOI 10.1034/J.1399-0004.1999.550106.X.;LO MUZIO L, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-32.;MAJEWSKI J, 2011, J MED GENET, V48, P580, DOI 10.1136/JMEDGENET-2011-100223.;NAKASHIMA M, 2008, J HUM GENET, V53, P34, DOI 10.1007/S10038-007-0214-6.;NG SB, 2009, NATURE, V461, P272, DOI 10.1038/NATURE08250.;OSOEGAWA K, 2014, AM J MED GENET A, V164, P397, DOI 10.1002/AJMG.A.36291.;PASTORINO L, 2009, AM J MED GENET A, V149A, P1539, DOI 10.1002/AJMG.A.32944.;REDON R, 2006, NATURE, V444, P444, DOI 10.1038/NATURE05329.;SMYTH I, 1999, HUM MOL GENET, V8, P291, DOI 10.1093/HMG/8.2.291.;SPINA R, 2013, ONCOTARGET, V4, P1280, DOI 10.18632/ONCOTARGET.1176.;STACEY SN, 2015, NAT COMMUN, V6, DOI 10.1038/NCOMMS7825.;VULTO-VAN SILFHOUT AT, 2013, HUM MUTAT, V34, P1679, DOI 10.1002/HUMU.22442.;YANG J, 2013, MOL NEUROBIOL, V47, P957, DOI 10.1007/S12035-012-8392-4.","GU, JY (REPRINT AUTHOR), FUDAN UNIV, ZHONGSHAN HOSP, DEPT PLAST \& RECONSTRUCT SURG, 180 FENLING RD, SHANGHAI, PEOPLES R CHINA.;LU, NANHANG, WANG, JINZENG, ZHU, BIJUN, ZHANG, MIAOMIAO, QI, FAZHI, WANG, XIANGDONG, GU, JIANYING, FUDAN UNIV, ZHONGSHAN HOPSITAL, SHANGHAI, PEOPLES R CHINA.","10.3233/CBM-170541","NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS",NA,NA,NA,NA,NA,"1574-0153","1","161-168","IOS PRESS","21",2018,"ISI000418595000018","25","ONCOLOGY","0","ONCOLOGY","ZHONGSHANHOSPITAL163.COM",NA,"FQ8EF",NA,"GU, JY (REPRINT AUTHOR), FUDAN UNIV, ZHONGSHAN HOSP, DEPT PLAST \& RECONSTRUCT SURG, 180 FENLING RD, SHANGHAI, PEOPLES R CHINA","ISI","FUDAN UNIV","FUDAN UNIV",NA,"LU N, 2018, CANCER BIOMARK","LU N, 2018, CANCER BIOMARK"
"WANG P, 2017, VACCINE","WANG P;XIONG X;JIAO J;YANG X;JIANG Y;WEN B;GONG W","TH1 EPITOPE PEPTIDES INDUCE PROTECTIVE IMMUNITY AGAINST RICKETTSIA RICKETTSII INFECTION IN C3H/HEN MICE","VACCINE","VACCINE","RICKETTSIA RICKETTSII IS THE CAUSATIVE PATHOGEN OF ROCKY MOUNTAIN SPOTTED FEVER (RMSF). ADR2, YBGF AND OMPB ARE PROTECTIVE ANTIGENS OF R. RICKETTSII. IN THIS STUDY, 90 CANDIDATE PEPTIDES WERE SELECTED FROM THESE ANTIGENS BASED ON THEIR HIGH-AFFINITY BINDING CAPACITY FOR THE MUIC CLASS II MOLECULE H2 I-A OR H2 I-E USING BIOINFORMATIC METHODS. SIX PEPTIDES WERE DETERMINED USING ELISPOT ASSAY TO BE IMMUNODOMINANT BASED ON THE IFN-GAMMA RECALL RESPONSES OF CD4(+) T CELLS FROM MICE IMMUNIZED WITH R. RICKETTSII. SIX NUCLEOTIDE SEQUENCES ENCODING THE IMMUNODOMINANT PEPTIDES WERE LINKED IN SERIES AND INSERTED INTO A PLASMID FOR EXPRESSION IN ESCHERICHIA COLI CELLS, RESULTING IN A NEW, RECOMBINANT POLYPEPTIDE TERMED GWP. AFTER IMMUNIZATION AND CHALLENGE, THE RICKETTSIAL LOAD OR HISTOPATHOLOGICAL LESIONS IN THE ORGANS OF MICE IMMUNIZED WITH GWP OR POOLED PEPTIDES WAS SIGNIFICANTLY LOWER THAN THAT IN ORGANS OF MICE IMMUNIZED WITH PBS OR THE INDIVIDUAL PEPTIDE OMPB(399). AN IN VITRO NEUTRALIZATION TEST REVEALED THAT SERA FROM MICE IMMUNIZED WITH GWP, OMPB(399), OR POOLED PEPTIDES REDUCED R. RICKETTSII ADHERENCE TO, AND INVASION OF, VASCULAR ENDOTHELIAL CELLS. FURTHERMORE, SIGNIFICANTLY HIGHER LEVELS OF IGG, IGG1, OR IGG2A WERE DETECTED IN SERA FROM MICE IMMUNIZED WITH GWP OR POOLED PEPTIDES, AND SIGNIFICANTLY HIGHER LEVELS OF IFN-GAMMA OR TNF-ALPHA SECRETED BY CD4(+) T CELLS FROM R RICKETTSII-INFECTED MICE WERE DETECTED AFTER IMMUNIZATION WITH GWP. ALTOGETHER, OUR RESULTS INDICATED THAT POLYPEPTIDES, ESPECIALLY GWP, COULD INDUCE A TH1-TYPE IMMUNE RESPONSE AGAINST R. RICKETTSII INFECTION, WHICH MIGHT CONTRIBUTE TO THE RATIONAL DESIGN OF PEPTIDE-BASED VACCINES FOR RMSF. (C) 2017 ELSEVIER LTD. ALL RIGHTS RESERVED.","RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; LMMUNODOMINANT PEPTIDES; POLYPEPTIDE; VACCINE; TH1-TYPE IMMUNE RESPONSE","OUTER-MEMBRANE PROTEIN; MOUNTAIN-SPOTTED-FEVER; T-CELL EPITOPES; ANTIGEN; IDENTIFICATION; TSUTSUGAMUSHI; ANTIBODIES; ADHERENCE; ADHESIN; CONORII","ENGLISH","ARTICLE","ARTICLE",0,"AMMERMAN NICOLE C, 2008, CURR PROTOC MICROBIOL, VCHAPTER 3, DOI 10.1002/9780471729259.MC03A05S11.;ANACKER RL, 1987, INFECT IMMUN, V55, P825.;ANDERSON BE, 1990, INFECT IMMUN, V58, P2760.;BONO MR, 1982, NATURE, V299, P836, DOI 10.1038/299836A0.;CZERKINSKY C, 1988, J IMMUNOL METHODS, V110, P29, DOI 10.1016/0022-1759(88)90079-8.;DAHLGREN FS, 2012, AM J TROP MED HYG, V86, P713, DOI 10.4269/AJTMH.2012.11-0453.;DIAZ-MONTERO CM, 2001, AM J TROP MED HYG, V65, P371, DOI 10.4269/AJTMH.2001.65.371.;DUAN CS, 2011, AM J TROP MED HYG, V85, P504, DOI 10.4269/AJTMH.2011.10-0660.;DUPONT HL, 1973, J INFECT DIS, V128, P340, DOI 10.1093/INFDIS/128.3.340.;EREMEEVA ME, 2011, J MED ENTOMOL, V48, P418, DOI 10.1603/ME10181.;FENG HM, 2004, INFECT IMMUN, V72, P2222, DOI 10.1128/IAI.72.4.2222-2228.2004.;GONG WP, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0124664.;GONG WP, 2015, HUM VACC IMMUNOTHER, V11, P642, DOI 10.1080/21645515.2015.1011572.;GONG WP, 2015, VACCINE, V33, P985, DOI 10.1016/J.VACCINE.2015.01.017.;GONG WP, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0100253.;GONG WP, 2014, VACCINE, V32, P2027, DOI 10.1016/J.VACCINE.2014.02.057.;GRAY PW, 1982, NATURE, V298, P859, DOI 10.1038/298859A0.;HACKSTADT T, 1992, INFECT IMMUN, V60, P159.;HANSON BA, 1983, INFECT IMMUN, V42, P341.;HARRELL GT, 1949, ARCH INTERN MED, V83, P331, DOI 10.1001/ARCHINTE.1949.00220320085007.;HICKMAN CJ, 1991, MICROB PATHOGENESIS, V11, P19, DOI 10.1016/0882-4010(91)90090-W.;HOFHERR SE, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0017076.;HORNEY LF, 1988, SOUTHERN MED J, V81, P915, DOI 10.1097/00007611-198807000-00028.;HU XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/J.IMMUNI.2009.09.002.;HURLEY CK, 1982, J IMMUNOL, V129, P2103.;LABRUNA MB, 2012, EPIDEMIOLOGY BRAZILI.;LI Z, 2003, INFECT IMMUN, V71, P3920, DOI 10.1125/IAI.71.7.3920-3926.2003.;MENG Y, 2014, SCI CHIN LIFE SCI.;NIU DONG-SHENG, 2006, ZHONGHUA LIU XING BING XUE ZA ZHI, V27, P526.;OSTER CN, 1977, NEW ENGL J MED, V297, P859, DOI 10.1056/NEJM197710202971604.;PARKER R. R., 1941, AMER JOUR TROP MED, V21, P369.;QI Y, 2013, VACCINE, V31, P5643, DOI 10.1016/J.VACCINE.2013.09.064.;ROTHOEFT T, 2003, IMMUNOLOGY, V110, P430, DOI 10.1046/J.1365-2567.2003.01758.X.;SILVERMAN DJ, 1986, J INFECT DIS, V153, P694, DOI 10.1093/INFDIS/153.4.694.;SINGH R, 2014, IMMUNOLOGY, V141, P514, DOI 10.1111/IMM.12194.;SUMMERS CM, 2014, EUR J PHARMACOL, V732, P60, DOI 10.1016/J.EJPHAR.2014.03.004.;UCHIYAMA T, 2006, MICROBES INFECT, V8, P801, DOI 10.1016/J.MICINF.2005.10.003.;WALKER DH, 1980, HUM PATHOL, V11, P263, DOI 10.1016/S0046-8177(80)80008-6.;WEINBERG EH, 1969, J BACTERIOL, V98, P398.;XIONG XL, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0087206.;YASUKAWA M, 1991, J IMMUNOL, V146, P1341.","GONG, WP (REPRINT AUTHOR), 309TH HOSP CHINESE PLA, ARMY TB PREVENT \& CONTROL KEY LAB, BEIJING KEY LAB NEW TECHN TB DIAG \& TREATMENT, INST TB RES, 17 HEI SHAN HU RD, BEIJING 100091, PEOPLES R CHINA.;WANG, PENGCHENG, XIONG, XIAOLU, JIAO, JUN, YANG, XIAOMEI, JIANG, YONGQIANG, WEN, BOHAI, GONG, WENPING, BEIJING INST MICROBIOL \& EPIDEMIOL, STATE KEY LAB PATHOGEN \& BIOSECUR, 20 DONG DIA JIE ST, BEIJING 100071, PEOPLES R CHINA.;GONG, WENPING, 309TH HOSP CHINESE PLA, ARMY TB PREVENT \& CONTROL KEY LAB, BEIJING KEY LAB NEW TECHN TB DIAG \& TREATMENT, INST TB RES, 17 HEI SHAN HU RD, BEIJING 100091, PEOPLES R CHINA.","10.1016/J.VACCINE.2017.09.068","THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",NA,NA,"NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA [31470894], MEDICAL SCIENCE AND TECHNOLOGY YOUTH CULTIVATION PROGRAM OF PLA [16QNP075], OUTSTANDING TALENT TRAINING PROJECT OF BEIJING [2016000057592G265]","THIS WORK WAS SUPPORTED BY THE NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA (GRANT 31470894), MEDICAL SCIENCE AND TECHNOLOGY YOUTH CULTIVATION PROGRAM OF PLA (GRANT 16QNP075), AND OUTSTANDING TALENT TRAINING PROJECT OF BEIJING (GRANT 2016000057592G265).",NA,"0264-410X","51","7204-7212","ELSEVIER SCI LTD","35",2017,"ISI000418966800027","41","IMMUNOLOGY, RESEARCH \& EXPERIMENTAL MEDICINE","2","IMMUNOLOGY, MEDICINE, RESEARCH \& EXPERIMENTAL","GWP891015WHU.EDU.CN",NA,"FR3KY",NA,"GONG, WP (REPRINT AUTHOR), 309TH HOSP CHINESE PLA, ARMY TB PREVENT \& CONTROL KEY LAB, BEIJING KEY LAB NEW TECHN TB DIAG \& TREATMENT, INST TB RES, 17 HEI SHAN HU RD, BEIJING 100091, PEOPLES R CHINA","ISI","BEIJING INST MICROBIOL AND EPIDEMIOL;PEOPLES R CHINA.","INST TB RES",NA,"WANG P, 2017, VACCINE","WANG P, 2017, VACCINE"
"KRAVATSKY Y, 2017, VIRUSES-BASEL","KRAVATSKY Y;CHECHETKIN V;FEDOSEEVA D;GORBACHEVA M;KRAVATSKAYA G;KRETOVA O;TCHURIKOV N","A BIOINFORMATIC PIPELINE FOR MONITORING OF THE MUTATIONAL STABILITY OF VIRAL DRUG TARGETS WITH DEEP-SEQUENCING TECHNOLOGY","VIRUSES-BASEL","VIRUSES-BASEL","THE EFFICIENT DEVELOPMENT OF ANTIVIRAL DRUGS, INCLUDING EFFICIENT ANTIVIRAL SMALL INTERFERING RNAS (SIRNAS), REQUIRES CONTINUOUS MONITORING OF THE STRICT CORRESPONDENCE BETWEEN A DRUG AND THE RELATED HIGHLY VARIABLE VIRAL DNA/RNA TARGET(S). DEEP SEQUENCING IS ABLE TO PROVIDE AN ASSESSMENT OF BOTH THE GENERAL TARGET CONSERVATION AND THE FREQUENCY OF PARTICULAR MUTATIONS IN THE DIFFERENT TARGET SITES. THE AIM OF THIS STUDY WAS TO DEVELOP A RELIABLE BIOINFORMATIC PIPELINE FOR THE ANALYSIS OF MILLIONS OF SHORT, DEEP SEQUENCING READS CORRESPONDING TO SELECTED HIGHLY VARIABLE VIRAL SEQUENCES THAT ARE DRUG TARGET(S). THE SUGGESTED BIOINFORMATIC PIPELINE COMBINES THE AVAILABLE PROGRAMS AND THE AD HOC SCRIPTS BASED ON AN ORIGINAL ALGORITHM OF THE SEARCH FOR THE CONSERVED TARGETS IN THE DEEP SEQUENCING DATA. WE ALSO PRESENT THE STATISTICAL CRITERIA FOR THE THRESHOLD OF RELIABLE MUTATION DETECTION AND FOR THE ASSESSMENT OF VARIATIONS BETWEEN CORRESPONDING DATA SETS. THESE CRITERIA ARE ROBUST AGAINST THE POSSIBLE SEQUENCING ERRORS IN THE READS. AS AN EXAMPLE, THE BIOINFORMATIC PIPELINE IS APPLIED TO THE STUDY OF THE CONSERVATION OF RNA INTERFERENCE (RNAI) TARGETS IN HUMAN IMMUNODEFICIENCY VIRUS 1 (HIV-1) SUBTYPE A. THE DEVELOPED PIPELINE IS FREELY AVAILABLE TO DOWNLOAD AT THE WEBSITE HTTP://VIRMUT.EIMB.RU/. BRIEF COMMENTS AND COMPARISONS BETWEEN VIRMUT AND OTHER PIPELINES ARE ALSO PRESENTED.","VIRUSES; DRUG TARGETS; MUTATIONS; DEEP-SEQUENCING; DATA PROCESSING; BIOINFORMATIC PIPELINE","HIV-1 SUBTYPE; MANAGEMENT; RESISTANCE; ALIGNMENT; STRAINS; RUSSIA; VIRUS","ENGLISH","ARTICLE","ARTICLE",2,"ANDREWS S., 2010, FASTQC QUALITY CONTR.;ARCHER J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/JOURNAL.PCBI.1001022.;CASADELLA M, 2017, VIRUS RES, V239, P69, DOI 10.1016/J.VIRUSRES.2016.10.019.;CHABRIA SB, 2014, ANNU REV GENOM HUM G, V15, P295, DOI 10.1146/ANNUREV-GENOM-091212-153406.;CHEN X, 2016, PLOS ONE, V11, DOI 10.1371/JOURNAL.PONE.0149215.;CROOKS GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/GR.849004.;DEL FABBRO C, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0085024.;DYE C, 2013, LANCET, V381, P413, DOI 10.1016/S0140-6736(12)61812-1.;HOULDCROFT CJ, 2017, NAT REV MICROBIOL, V15, P183, DOI 10.1038/NRMICRO.2016.182.;HUANG ZH, 2017, SCI REP-UK, V7, DOI 10.1038/S41598-017-06269-X.;JOHNSON N. L., 1977, STAT EXPT DESIGN ENG.;KATOH K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/MOLBEV/MST010.;KRAVATSKY YV, 2016, MOL BIOL+, V50, P417, DOI [10.1134/S0026893316020114, 10.7868/S0026898416020117].;KRETOVA OV, 2017, AIDS RES HUM RETROV, V33, P194, DOI [10.1089/AID.2016.0088, 10.1089/AID.2016.0088].;LANGMEAD B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/NMETH.1923].;LEBBINK RJ, 2017, SCI REP-UK, V7, DOI 10.1038/SREP41968.;LEFTEROVA MI, 2015, J MOL DIAGN, V17, P623, DOI 10.1016/J.JMOLDX.2015.07.004.;LEIPZIG J, 2017, BRIEF BIOINFORM, V18, P530, DOI 10.1093/BIB/BBW020.;LI H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/BIOINFORMATICS/BTP352.;LIAO Y, 2013, NUCLEIC ACIDS RES, V41, DOI DOI 10.1093/NAR/GKT214.;LOU ZY, 2014, TRENDS PHARMACOL SCI, V35, P86, DOI 10.1016/J.TIPS.2013.11.006.;MARTIN M., 2011, EMBNET J, V3.;MULLER B., 2009, HDB EXP PHARM, V1, P24, DOI [10.1007/978-3-540-79086-0\_1, DOI 10.1007/978-3-540-79086-0\_1].;NOGUERA-JULIAN M, 2017, J INFECT DIS, V216, PS829, DOI 10.1093/INFDIS/JIX397.;OKONECHNIKOV K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/BIOINFORMATICS/BTS091.;POSADA-CESPEDES S, 2017, VIRUS RES, V239, P17, DOI 10.1016/J.VIRUSRES.2016.09.016.;QUINONES-MATEU ME, 2014, J CLIN VIROL, V61, P9, DOI 10.1016/J.JCV.2014.06.013.;SHARMA R. K., 2016, INT J BIOMED DATA MI, V5, P122, DOI [10.4172/2090-4924.1000122, DOI 10.4172/2090-4924.1000122].;TCHURIKOV NA, 2016, GENE, V583, P78, DOI 10.1016/J.GENE.2016.03.001.;VAN LAETHEM K, 2015, CURR OPIN VIROL, V14, P16, DOI 10.1016/J.COVIRO.2015.06.001.;WAINBERG MA, 2011, NEW ENGL J MED, V365, P637, DOI 10.1056/NEJMRA1004180.;WEIR B. S., 1996, GENETIC DATA ANAL, P32.;YACOBY IFTACH, 2007, INFECTIOUS DISORDERS - DRUG TARGETS, V7, P221, DOI 10.2174/187152607782109998.;YIN QQ, 2016, BIOMED ENVIRON SCI, V29, P239, DOI 10.3967/BES2016.031.","TCHURIKOV, N (REPRINT AUTHOR), RUSSIAN ACAD SCI, ENGELHARDT INST MOL BIOL, VAVILOV STR 32, MOSCOW 119334, RUSSIA.;KRAVATSKY, YURI, CHECHETKIN, VLADIMIR, FEDOSEEVA, DARIA, GORBACHEVA, MARIA, KRAVATSKAYA, GALINA, KRETOVA, OLGA, TCHURIKOV, NICKOLAI, RUSSIAN ACAD SCI, ENGELHARDT INST MOL BIOL, VAVILOV STR 32, MOSCOW 119334, RUSSIA.","10.3390/V9120357","ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND","357",NA,"RUSSIAN SCIENCE FOUNDATION [15-14-00005]","THIS WORK WAS SUPPORTED BY A GRANT FROM THE RUSSIAN SCIENCE FOUNDATION (PROJECT NO. 15-14-00005).",NA,"1999-4915","12",NA,"MDPI AG","9",2017,"ISI000419170300003","34","VIROLOGY","1","VIROLOGY","JIRIEIMB.RU VLADIMIR\_CHECHETMAIL.RU DFEDOSEEVA86YANDEX.RU MARUSEOKGMAIL.COM GKEIMB.RU OKRETOVAEIMB.RU TCHURIKOVEIMB.RU",NA,"FR6IY",NA,"TCHURIKOV, N (REPRINT AUTHOR), RUSSIAN ACAD SCI, ENGELHARDT INST MOL BIOL, VAVILOV STR 32, MOSCOW 119334, RUSSIA","ISI","ENGELHARDT INST MOL BIOL","ENGELHARDT INST MOL BIOL",NA,"KRAVATSKY Y, 2017, VIRUSES-BASEL","KRAVATSKY Y, 2017, VIRUSES-BASEL"
"SWAMINATHAN SS, 2017, JAMA OPHTHALMOL","SWAMINATHAN SS;FIELD MG;SANT D;WANG G;GALOR A;DUBOVY SR;HARBOUR JW;KARP CL","MOLECULAR CHARACTERISTICS OF CONJUNCTIVAL MELANOMA USING WHOLE-EXOME SEQUENCING","JAMA OPHTHALMOLOGY","JAMA OPHTHALMOL.","IMPORTANCE CONJUNCTIVAL MELANOMA (CM) IS A HIGHLY AGGRESSIVE OCULAR CANCER FOR WHICH TREATMENT OPTIONS ARE LIMITED, THE MOLECULAR PATHOGENESIS IS POORLY UNDERSTOOD. OBJECTIVE TO IDENTIFY THE MOLECULAR CHARACTERISTICS OF CM USING NEXT-GENERATION WHOLE-EXOME SEQUENCING (WES). DESIGN, SETTING, AND PARTICIPANTS WHOLE-EXOME SEQUENCING WAS PERFORMED ON TUMOR DNA EXTRACTED FROM THE ARCHIVED SPECIMENS OF 5 PATIENTS WITH CM WHO HAD BEEN TREATED WITH SURGICAL EXCISION BETWEEN 2006 AND 2011. THESE SAMPLES WERE ANALYZED AT A TERTIARY ACADEMIC OCULAR ONCOLOGY REFERRAL CENTER USING A CUSTOMIZED BIOINFORMATIC PIPELINE. MAIN OUTCOMES AND MEASURES SAMPLE ANALYSES WERE DESIGNED TO DETECT DRIVER MUTATIONS, CHROMOSOME COPY NUMBER ABERRATIONS, AND MUTATION SIGNATURES. RESULTS THE STUDY'S 5 PATIENTS RANGED IN AGE FROM 51 TO 77 YEARS. FOUR OF THE 5 WERE FEMALE, AND ALL WERE WHITE. MUTATIONS WERE DETECTED IN KNOWN ONCOGENES, INCLUDING BRAF, NRAS, NF1, EGFR, ALK, TERT, AND APC. NONE OF THE MUTATIONS ASSOCIATED WITH UVEAL MELANOMA WERE FOUND. ALL SAMPLES DEMONSTRATED A C -> T MUTATION SIGNATURE TYPICAL OF UV-INDUCED DNA DAMAGE. THE MOST COMMON CNA WAS A GAIN IN CHROMOSOME 6P. CONCLUSIONS AND RELEVANCE IN THESE 5 PATIENTS, WES ALLOWED IDENTIFICATION OF MUTATIONS THAT CAN BE TARGETED WITH THERAPY AND SUPPORTED THE ROLE OF UV LIGHT IN CM PATHOGENESIS. THESE FINDINGS INDICATE A NEED FOR LARGER STUDIES TO EVALUATE THE DIAGNOSTIC, PROGNOSTIC, AND THERAPEUTIC VALUE OF WES FOR CM.",NA,"MUCOSAL MELANOMAS; MALIGNANT-MELANOMA; MUTATIONS; UVEAL; BRAF; LESIONS","ENGLISH","ARTICLE","ARTICLE",1,"CIBULSKIS K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/NBT.2514.;DECATUR CL, 2016, JAMA OPHTHALMOL, V134, P728, DOI 10.1001/JAMAOPHTHALMOL.2016.0903.;DRILON A, 2017, CANCER DISCOV, V7, P400, DOI 10.1158/2159-8290.CD-16-1237.;FURNEY SJ, 2013, J PATHOL, V230, P261, DOI 10.1002/PATH.4204.;GRIEWANK KG, 2013, CLIN CANCER RES, V19, P3143, DOI 10.1158/1078-0432.CCR-13-0163.;HARBOUR JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/SCIENCE.1194472.;KAKAVAND H, 2016, HISTOPATHOLOGY, V69, P680, DOI 10.1111/HIS.12992.;KIM HS, 2017, ONCOGENE, V36, P3334, DOI 10.1038/ONC.2016.486.;KOOPMANS AE, 2014, INVEST OPHTH VIS SCI, V55, P6024, DOI 10.1167/IOVS.14-14901.;LARSEN AC, 2016, ACTA OPHTHALMOL, V94, P463, DOI 10.1111/AOS.13007.;MIKKELSEN LH, 2016, APMIS, V124, P475, DOI 10.1111/APM.12529.;RIVOLTA C, 2016, J HUM GENET, V61, P361, DOI 10.1038/JHG.2015.152.;RUBINSTEIN TJ, 2015, SURV OPHTHALMOL, V60, P72, DOI 10.1016/J.SURVOPHTHAL.2014.08.001.;WONG JR, 2014, EXPERT REV OPHTHALMO, V9, P185, DOI 10.1586/17469899.2014.921119.;YU GP, 2006, PHOTOCHEM PHOTOBIOL, V82, P1621, DOI 10.1562/2006-07-17-RA-970.","KARP, CL (REPRINT AUTHOR), UNIV MIAMI, MILLER SCH MED, BASCOM PALMER EYE INST, DEPT OPHTHALMOL, 900 NW 17TH ST, MIAMI, FL 33136 USA.;SWAMINATHAN, SWARUP S., FIELD, MATTHEW G., WANG, GAOFENG, GALOR, ANAT, DUBOVY, SANDER R., HARBOUR, J. WILLIAM, KARP, CAROL L., UNIV MIAMI, MILLER SCH MED, BASCOM PALMER EYE INST, DEPT OPHTHALMOL, 900 NW 17TH ST, MIAMI, FL 33136 USA.;FIELD, MATTHEW G., HARBOUR, J. WILLIAM, UNIV MIAMI, MILLER SCH MED, SYLVESTER COMPREHENS CANC CTR, MIAMI, FL 33136 USA.;SANT, DAVID, WANG, GAOFENG, UNIV MIAMI, MILLER SCH MED, JOHN P HUSSMAN INST HUMAN GENOM, MIAMI, FL 33136 USA.;GALOR, ANAT, MIAMI VET AFFAIRS MED CTR, DEPT OPHTHALMOL, MIAMI, FL USA.;DUBOVY, SANDER R., UNIV MIAMI, MILLER SCH MED, FLORIDA LIONS OCULAR PATHOL LAB, MIAMI, FL 33136 USA.","10.1001/JAMAOPHTHALMOL.2017.4837","330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA",NA,NA,"DEPARTMENT OF VETERANS AFFAIRS, VETERANS HEALTH ADMINISTRATION, OFFICE OF RESEARCH AND DEVELOPMENT [EPID-006-15S, R01 CA125970, F30 CA206430], FLORIDA LIONS EYE BANK, RONALD AND ALICIA LEPKE GRANT, LEE AND CLAIRE HAGER GRANT, JIMMY AND GAYE BRYAN GRANT, RICHARD AZAR FAMILY GRANT, ROBERT BAER FAMILY GRANT, EMILYN PAGE AND MARK FELDBERG GRANT, GORDON CHARITABLE TRUST, NATIONAL INSTITUTES OF HEALTH [R01EY026174], NATIONAL INSTITUTES OF HEALTH CENTER [P30EY014801], DEPARTMENT OF DEFENSE [W81XWH-13-1-0048], RESEARCH TO PREVENT BLINDNESS, RICHARD AND KATHY LESSER GRANT","FINANCIAL SUPPORT FOR THIS STUDY INCLUDES THE FOLLOWING SOURCES: DR GALOR HAS RECEIVED SUPPORT FROM THE DEPARTMENT OF VETERANS AFFAIRS AND VETERANS HEALTH ADMINISTRATION, DR HARBOUR HAS RECEIVED SUPPORT FROM THE OFFICE OF RESEARCH AND DEVELOPMENT VIA CLINICAL SCIENCES RESEARCH GRANTS EPID-006-15S AND R01 CA125970, AS WELL AS A GENEROUS GIFT FROM MARK J. DAILY, MD, DR FIELD HAS RECEIVED SUPPORT FROM THE OFFICE OF RESEARCH AND DEVELOPMENT VIA CLINICAL SCIENCES RESEARCH GRANT F30 CA206430, AND DR DUBOVY HAS RECEIVED SUPPORT FROM THE FLORIDA LIONS EYE BANK. DR KARP HAS RECEIVED SUPPORT FROM THE RONALD AND ALICIA LEPKE GRANT, THE LEE AND CLAIRE HAGER GRANT, THE JIMMY AND GAYE BRYAN GRANT, THE RICHARD AZAR FAMILY GRANT, THE ROBERT BAER FAMILY GRANT, THE EMILYN PAGE AND MARK FELDBERG GRANT, AND THE GORDON CHARITABLE TRUST. FURTHER GRANTS SPECIFIC TO THE PROJECT INCLUDE NATIONAL INSTITUTES OF HEALTH CLINICAL SCIENCES RESEARCH GRANT R01EY026174, NATIONAL INSTITUTES OF HEALTH CENTER CORE GRANT P30EY014801, DEPARTMENT OF DEFENSE GRANT W81XWH-13-1-0048, AN UNRESTRICTED GRANT FROM RESEARCH TO PREVENT BLINDNESS, AND A RICHARD AND KATHY LESSER GRANT.",NA,"2168-6165","12","1434-1437","AMER MEDICAL ASSOC","135",2017,"ISI000418056800031","15","OPHTHALMOLOGY","2","OPHTHALMOLOGY","CKARPMED.MIAMI.EDU",NA,"FQ0OO",NA,"KARP, CL (REPRINT AUTHOR), UNIV MIAMI, MILLER SCH MED, BASCOM PALMER EYE INST, DEPT OPHTHALMOL, 900 NW 17TH ST, MIAMI, FL 33136 USA","ISI","UNIV MIAMI;UNIV MIAMI;UNIV MIAMI;MIAMI VET AFFAIRS MED CTR;UNIV MIAMI","UNIV MIAMI",NA,"SWAMINATHAN SS, 2017, JAMA OPHTHALMOL","SWAMINATHAN SS, 2017, JAMA OPHTHALMOL"
"DROEGE C, 2017, J HEPATOL","DROEGE C;BONUS M;BAUMANN U;KLINDT C;LAINKA E;KATHEMANN S;BRINKERT F;GRABHORN E;PFISTER ED;WENNING D;FICHTNER A;GOTTHARDT DN;WEISS KH;MCKIERNAN P;PURI RD;VERMA IC;KLUGE S;GOHLKE H;SCHMITT L;KUBITZ R;HAEUSSINGER D;KEITEL V","SEQUENCING OF FIC1, BSEP AND MDR3 IN A LARGE COHORT OF PATIENTS WITH CHOLESTASIS REVEALED A HIGH NUMBER OF DIFFERENT GENETIC VARIANTS","JOURNAL OF HEPATOLOGY","J. HEPATOL.","BACKGROUND \& AIMS: THE BILE SALT EXPORT PUMP (BSEP, ABCB11), MULTIDRUG RESISTANCE PROTEIN 3 (MDR3, ABCB4) AND THE ATPASE FAMILIAL INTRAHEPATIC CHOLESTASIS 1 (FIC1, ATP8B1) MEDIATE BILE FORMATION. THIS STUDY AIMED TO DETERMINE THE CONTRIBUTION OF MUTATIONS AND COMMON VARIANTS IN THE FIC1, BSEP AND MDR3 GENES TO CHOLESTATIC DISORDERS OF DIFFERING DISEASE ONSET AND SEVERITY. METHODS: CODING EXONS WITH FLANKING INTRON REGIONS OF ATP8B1, ABCB11, AND ABCB4 WERE SEQUENCED IN CHOLESTATIC PATIENTS WITH ASSUMED GENETIC CAUSE. THE EFFECTS OF NEW VARIANTS WERE EVALUATED BY BIOINFORMATIC TOOLS AND 3D PROTEIN MODELING. RESULTS: IN 427 PATIENTS WITH SUSPECTED INHERITED CHOLESTASIS, 149 PATIENTS CARRIED AT LEAST ONE DISEASE-CAUSING MUTATION IN FIC1, BSEP OR MDR3, RESPECTIVELY. OVERALL, 154 DIFFERENT MUTATIONS WERE IDENTIFIED, OF WHICH 25 WERE NOVEL. ALL 13 NOVEL MISSENSE MUTATIONS WERE DISEASE-CAUSING ACCORDING TO BIOINFORMATICS ANALYSES AND HOMOLOGY MODELING. EIGHTY-TWO PERCENT OF PATIENTS WITH AT LEAST ONE DISEASE-CAUSING MUTATION IN EITHER OF THE THREE GENES WERE CHILDREN. ONE OR MORE COMMON POLYMORPHISM(S) WERE FOUND IN FIC1 IN 35.3\%, BSEP IN 64.3\% AND MDR3 IN 72.6\% OF PATIENTS WITHOUT DISEASE-CAUSING MUTATIONS IN THE RESPECTIVE GENE. MINOR ALLELE FREQUENCIES OF COMMON POLYMORPHISMS IN BSEP AND MDR3 VARIED IN OUR COHORT COMPARED TO THE GENERAL POPULATION, AS DESCRIBED BY GNOMAD. HOWEVER, DIFFERENCES IN ETHNIC BACKGROUND MAY CONTRIBUTE TO THIS EFFECT. CONCLUSIONS: IN A LARGE COHORT OF PATIENTS, 154 DIFFERENT VARIANTS WERE DETECTED IN FIC1, BSEP, AND MDR3, 25 OF WHICH WERE NOVEL. IN OUR COHORT, FREQUENCIES FOR RISK ALLELES OF BSEP (P.V444A) AND MDR3 (P.I237I) POLYMORPHISMS WERE SIGNIFICANTLY OVERREPRESENTED IN PATIENTS WITHOUT DISEASE-CAUSING MUTATION IN THE RESPECTIVE GENE, INDICATING THAT THESE COMMON VARIANTS CAN CONTRIBUTE TO A CHOLESTATIC PHENOTYPE. (C) 2017 PUBLISHED BY ELSEVIER B.V. ON BEHALF OF EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER.","FIC1; BSEP; MDR3; ATP8B1; ABCB11; ABCB4; ICP; LPAC; BRIC; PFIC; SNP","SALT EXPORT PUMP; FAMILIAL INTRAHEPATIC CHOLESTASIS; NEONATAL SCLEROSING CHOLANGITIS; HUMAN P-GLYCOPROTEIN; LIVER-DISEASE; HEREDITARY CHOLESTASIS; MESSENGER-RNA; ABCB4 GENE; CANALICULAR TRANSPORT; 2 FORMS","ENGLISH","ARTICLE","ARTICLE",5,"ADZHUBEI I, 2013, CURR PROTOC HUM GENE, DOI [10. 1002/0471142905. HG0720S76, 10.1002/0471142905.HG0720S76, DOI 10.1002/0471142905.HG0720S76].;ADZHUBEI IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/NMETH0410-248.;ALTSHULER D, 2010, NATURE, V467, P1061, DOI 10.1038/NATURE09534.;BORATYN GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12.;BRONSKY J, 2010, FOLIA BIOL-PRAGUE, V56, P9.;BULL LN, 1997, HEPATOLOGY, V26, P155.;BULL LN, 1998, NAT GENET, V18, P219, DOI 10.1038/NG0398-219.;BYRNE JA, 2009, HEPATOLOGY, V49, P553, DOI 10.1002/HEP.22683.;CEBECAUEROVA D, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0051650.;DAVIT-SPRAUL A, 2010, HEPATOLOGY, V51, P1645, DOI 10.1002/HEP.23539.;DAVIT-SPRAUL A, 2010, SEMIN LIVER DIS, V30, P134, DOI 10.1055/S-0030-1253223.;DAVIT-SPRAUL A, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-1.;DE JESUS AJ, 2013, BBA-BIOMEMBRANES, V1828, P864, DOI 10.1016/J.BBAMEM.2012.09.009.;DE VREE JML, 1998, P NATL ACAD SCI USA, V95, P282, DOI 10.1073/PNAS.95.1.282.;DEN DUNNEN JT, 2000, HUM MUTAT, V15, P7.;DEPAGTER AGF, 1976, GASTROENTEROLOGY, V71, P202.;DIXON PH, 2009, GUT, V58, P537, DOI 10.1136/GUT.2008.159541.;DIXON PH, 2016, CLIN RES HEPATOL GAS, V40, P141, DOI 10.1016/J.CLINRE.2015.12.008.;DIXON PH, 2014, AM J GASTROENTEROL, V109, P76, DOI 10.1038/AJG.2013.406.;DROGE C, 2016, SCI REP-UK, V6, DOI 10.1038/SREP24827.;ELFERINK RPJO, 1995, BBA-REV BIOMEMBRANES, V1241, P215, DOI 10.1016/0304-4157(95)00006-D.;EPPENS EF, 2001, J HEPATOL, V35, P436, DOI 10.1016/S0168-8278(01)00158-1.;GIRARD M, 2016, HUM MUTAT, V37, P1025, DOI 10.1002/HUMU.23031.;GOMEZ-OSPINA N, 2016, NAT COMMUN, V7, DOI 10.1038/NCOMMS10713.;GONZALES E, 2017, HEPATOLOGY, V65, P164, DOI 10.1002/HEP.28779.;GOTTHARDT D, 2008, HEPATOLOGY, V48, P1157, DOI 10.1002/HEP.22485.;GRAMMATIKOPOULOS T, 2016, J HEPATOL, V65, P1179, DOI 10.1016/J.JHEP.2016.07.017.;GUDBJARTSSON DF, 2015, NAT GENET, V47, P435, DOI 10.1038/NG.3247.;HADJ-RABIA S, 2004, GASTROENTEROLOGY, V127, P1386, DOI 10.1053/J.GAST.2004.07.022.;HAUSSINGER D, 2000, SEMIN LIVER DIS, V20, P307, DOI 10.1055/S-2000-9386.;HAUSSINGER DIETER, 2004, MOLECULAR ASPECTS OF MEDICINE, V25, P221, DOI 10.1016/J.MAM.2004.02.001.;HEBSGAARD SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/NAR/24.17.3439.;HENRICHS S, 2012, EMBO J, V31, P2965, DOI 10.1038/EMBOJ.2012.120.;HOERNING A, 2014, FRONT PEDIATR, V2, DOI 10.3389/FPED.2014.00065.;HSU YC, 2009, HEPATOL RES, V39, P625, DOI 10.1111/J.1872-034X.2009.00499.X.;JACQUEMIN E, 2001, GASTROENTEROLOGY, V120, P1448, DOI 10.1053/GAST.2001.23984.;KATOH K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/MOLBEV/MST010.;KEITEL V, 2016, Z GASTROENTEROL, V54, P1327, DOI 10.1055/S-0042-118388.;KEITEL V, 2006, GASTROENTEROLOGY, V131, P624, DOI 10.1053/J.GASTRO.2006.05.003.;KEITEL V, 2009, HEPATOLOGY, V50, P510, DOI 10.1002/HEP.23083.;KLOMP LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/HEP.20285.;KLUTH M, 2015, J BIOL CHEM, V290, P4896, DOI 10.1074/JBC.M114.588566.;KRAWCZAK M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/HUMU.20400.;KRAWCZYK M, 2010, NAT REV GASTRO HEPAT, V7, P669, DOI 10.1038/NRGASTRO.2010.170.;KUBITZ R, 2005, METHOD ENZYMOL, V400, P558, DOI 10.1016/S0076-6879(05)00031-5.;KUBITZ R, 2006, J CLIN GASTROENTEROL, V40, P171, DOI 10.1097/01.MCG.0000196406.15110.60.;KUBITZ R, 2011, Z GASTROENTEROL, V49, P728, DOI 10.1055/S-0031-1273427.;KUBITZ R, 2015, CLIN REV ALLERG IMMU, V48, P273, DOI 10.1007/S12016-014-8457-4.;KUBITZ R, 2012, CLIN RES HEPATOL GAS, V36, P536, DOI 10.1016/J.CLINRE.2012.06.006.;LAMMERT F, 2015, CLIN RES HEPATOL GAS, V39, P655, DOI 10.1016/J.CLINRE.2015.08.004.;LANG C, 2007, PHARMACOGENET GENOM, V17, P47, DOI 10.1097/01.FPC.0000230418.28091.76.;LEK M, 2016, NATURE, V536, P285, DOI 10.1038/NATURE19057.;LI JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/PRO.2387.;LOO TW, 2011, BIOCHEMISTRY-US, V50, P672, DOI 10.1021/BI1016809.;LUNDBY A, 2012, NAT COMMUN, V3, DOI 10.1038/NCOMMS1871.;MEIER Y, 2006, HEPATOLOGY, V44, P62, DOI 10.1002/HEP.21214.;MEIER Y, 2008, WORLD J GASTROENTERO, V14, P38, DOI 10.3748/WJG.14.38.;MULLENBACH R, 2005, GUT, V54, P829, DOI 10.1136/GUT.2004.058115.;MULLENBACH R, 2003, J MED GENET, V40, DOI 10.1136/JMG.40.5.E70.;PAINTER JN, 2005, EUR J HUM GENET, V13, P435, DOI 10.1038/SJ.EJHG.5201355.;PAULI-MAGNUS C, 2004, HEPATOLOGY, V39, P779, DOI 10.1002/HEP.20159.;PAULI-MAGNUS C, 2004, PHARMACOGENETICS, V14, P91, DOI 10.1097/01.FPC.0000054188.92680.24.;PAWLIKOWSKA L, 2010, J HEPATOL, V53, P170, DOI 10.1016/J.JHEP.2010.01.034.;PORAT-SHLIOM N, 2016, HEPATOLOGY, V64, P1317, DOI 10.1002/HEP.28724.;REESE MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/CMB.1997.4.311.;SAMBROTTA M, 2014, NAT GENET, V46, P326, DOI 10.1038/NG.2918.;SATO T, 2009, FEBS J, V276, P3504, DOI 10.1111/J.1742-4658.2009.07072.X.;SIEBOLD L, 2010, LIVER TRANSPLANT, V16, P856, DOI 10.1002/LT.22074.;SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9.;SMITH AJ, 1994, FEBS LETT, V354, P263, DOI 10.1016/0014-5793(94)01135-4.;STINDT J, 2016, HEPATOLOGY, V63, P524, DOI 10.1002/HEP.28311.;STINDT J, 2013, LIVER INT, V33, P1527, DOI 10.1111/LIV.12217.;STRAUTNIEKS SS, 1997, AM J HUM GENET, V61, P630, DOI 10.1086/515501.;STRAUTNIEKS SS, 1998, NAT GENET, V20, P233.;SZEWCZYK P, 2015, ACTA CRYSTALLOGR D, V71, P732, DOI 10.1107/S1399004715000978.;TRAUNER M, 1998, NEW ENGL J MED, V339, P1217, DOI 10.1056/NEJM199810223391707.;ULZURRUN E, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0094675.;VAN DER WOERD WL, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0080553.;VAN MIL SWC, 2007, GASTROENTEROLOGY, V133, P507, DOI 10.1053/J.GASTRO.2007.05.015.;VAN MIL SWC, 2004, GASTROENTEROLOGY, V127, P379, DOI 10.1053/J.GASTRO.2004.04.065.;VANDERBLIEK AM, 1987, EMBO J, V6, P3325, DOI 10.1002/J.1460-2075.1987.TB02653.X.;VANDERBLIEK AM, 1988, GENE, V71, P401, DOI 10.1016/0378-1119(88)90057-1.;VANHELVOORT A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7.;WASMUTH HE, 2007, GUT, V56, P265, DOI 10.1136/GUT.2006.092742.;YANG ZP, 2008, J PHARMACOL EXP THER, V327, P474, DOI 10.1124/JPET.108.138313.;ZHU K, 2014, PROTEINS, V82, P1646, DOI 10.1002/PROT.24551.;ZIMMER V, 2012, CLIN EXP OBSTET GYN, V39, P32.;ZIOL M, 2008, GASTROENTEROLOGY, V135, P131, DOI 10.1053/J.GASTRO.2008.03.044.","HAUSSINGER, D, KEITEL, V (REPRINT AUTHOR), HEINRICH HEINE UNIV, UNIV HOSP DUSSELDORF, CLIN GASTROENTEROL HEPATOL \& INFECT DIS, MOORENSTR 5, D-40225 DUSSELDORF, GERMANY.;DROEGE, CAROLA, KLINDT, CAROLINE, KLUGE, STEFANIE, KUBITZ, RALF, HAEUSSINGER, DIETER, KEITEL, VERENA, HEINRICH HEINE UNIV DUSSELDORF, UNIV HOSP DUSSELDORF, DEPT GASTROENTEROL HEPATOL \& INFECT DIS, DUSSELDORF, GERMANY.;BONUS, MICHELE, GOHLKE, HOLGER, HEINRICH HEINE UNIV DUSSELDORF, INST PHARMACEUT \& MED CHEM, DUSSELDORF, GERMANY.;BAUMANN, ULRICH, PFISTER, EVA-DOREEN, HANNOVER MED SCH, DEPT PEDIAT KIDNEY LIVER \& METAB DIS, PEDIAT GASTROENTEROL \& HEPATOL, HANNOVER, GERMANY.;LAINKA, ELKE, KATHEMANN, SIMONE, UNIV DUISBURG ESSEN, UNIV CHILDRENS HOSP ESSEN, CLIN PEDIAT 2, DEPT PEDIAT NEPHROL GASTROENTEROL ENDOCRINOL \& TRA, DUISBURG, GERMANY.;BRINKERT, FLORIAN, GRABHORN, ENKE, UNIV MED CTR HAMBURG EPPENDORF, UNIV CHILDRENS HOSP, PEDIAT GASTROENTEROL \& HEPATOL, HAMBURG, GERMANY.;WENNING, DANIEL, FICHTNER, ALEXANDER, HEIDELBERG UNIV HOSP, DEPT GEN PEDIAT, HEIDELBERG, GERMANY.;GOTTHARDT, DANIEL N., WEISS, KARL HEINZ, UNIV HOSP HEIDELBERG, DEPT INTERNAL MED 4, HEIDELBERG, GERMANY.;MCKIERNAN, PATRICK, UNIV PITTSBURGH, PITTSBURGH LIVER RES CTR, PITTSBURGH, PA USA.;MCKIERNAN, PATRICK, UPMC, CHILDRENS HOSP PITTSBURGH, PITTSBURGH, PA USA.;PURI, RATNA DUA, VERMA, I. C., SIR GANGA RAM HOSP, INST MED GENET \& GENOM, NEW DELHI, INDIA.;SCHMITT, LUTZ, HEINRICH HEINE UNIV, INST BIOCHEM, DUSSELDORF, GERMANY.","10.1016/J.JHEP.2017.07.004","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"GERMAN RESEARCH FOUNDATION (DFG) THROUGH THE CLINICAL RESEARCH GROUP [KFO217], COLLABORATIVE RESEARCH CENTRE [SFB974]","THIS WORK WAS FUNDED BY THE GERMAN RESEARCH FOUNDATION (DFG) THROUGH THE CLINICAL RESEARCH GROUP KFO217 AND THE COLLABORATIVE RESEARCH CENTRE SFB974.",NA,"0168-8278","6","1253-1264","ELSEVIER SCIENCE BV","67",2017,"ISI000415325900018","88","GASTROENTEROLOGY \& HEPATOLOGY","7","GASTROENTEROLOGY \& HEPATOLOGY","HAEUSSINUNI-DUESSELDORF.DE VERENA.KEITELMED.UNI-DUESSELDORF.DE",NA,"FM8HB",NA,"HAUSSINGER, D, KEITEL, V (REPRINT AUTHOR), HEINRICH HEINE UNIV, UNIV HOSP DUSSELDORF, CLIN GASTROENTEROL HEPATOL \& INFECT DIS, MOORENSTR 5, D-40225 DUSSELDORF, GERMANY","ISI","HEINRICH HEINE UNIV DUSSELDORF;HEINRICH HEINE UNIV DUSSELDORF;HANNOVER MED SCH;UNIV DUISBURG ESSEN;UNIV MED CTR HAMBURG EPPENDORF;HEIDELBERG UNIV HOSP;UNIV HOSP HEIDELBERG;UNIV PITTSBURGH;CHILDRENS HOSP PITTSBURGH;INST MED GENET AND GENOM;HEINRICH HEINE UNIV","HEINRICH HEINE UNIV",NA,"DROEGE C, 2017, J HEPATOL","DROEGE C, 2017, J HEPATOL"
"FELTEN A, 2017, BMC MICROBIOL","FELTEN A;NOVA MV;DURIMEL K;GUILLIER L;MISTOU MY;RADOMSKI N","FIRST GENE-ONTOLOGY ENRICHMENT ANALYSIS BASED ON BACTERIAL COREGENOME VARIANTS: INSIGHTS INTO ADAPTATIONS OF SALMONELLA SEROVARS TO MAMMALIAN- AND AVIAN-HOSTS","BMC MICROBIOLOGY","BMC MICROBIOL.","BACKGROUND: MANY OF THE BACTERIAL GENOMIC STUDIES EXPLORING EVOLUTION PROCESSES OF THE HOST ADAPTATION FOCUS ON THE ACCESSORY GENOME DESCRIBING HOW THE GAINS AND LOSSES OF GENES CAN EXPLAIN THE COLONIZATION OF NEW HABITATS. CONSEQUENTLY, WE DEVELOPED A NEW APPROACH FOCUSING ON THE COREGENOME IN ORDER TO DESCRIBE THE HOST ADAPTATION OF SALMONELLA SEROVARS. METHODS: IN THE PRESENT WORK, WE PROPOSE BIOINFORMATIC TOOLS ALLOWING (I) ROBUST PHYLOGENETIC INFERENCE BASED ON SNPS AND RECOMBINATION EVENTS, (II) IDENTIFICATION OF FIXED SNPS AND INDELS DISTINGUISHING HOMOPLASTIC AND NON-HOMOPLASTIC COREGENOME VARIANTS, AND (III) GENE-ONTOLOGY ENRICHMENT ANALYSES TO DESCRIBE METABOLIC PROCESSES INVOLVED IN ADAPTATION OF SALMONELLA ENTERICA SUBSP. ENTERICA TO MAMMALIAN- (S. DUBLIN), MULTI( S. ENTERITIDIS), AND AVIAN- (S. PULLORUM AND S. GALLINARUM) HOSTS. RESULTS: THE `VARCALL' WORKFLOW PRODUCED A ROBUST PHYLOGENETIC INFERENCE CONFIRMING THAT THE MONOPHYLETIC CLADE S. DUBLIN DIVERGED FROM THE POLYPHYLETIC CLADE S. ENTERITIDIS WHICH INCLUDES THE DIVERGENT CLADES S. PULLORUM AND S. GALLINARUM (I). THE SCRIPTS `PHYLOFIXEDVAR' AND `FIXEDVAR' DETECTED NON-SYNONYMOUS AND NON-HOMOPLASTIC FIXED VARIANTS SUPPORTING THE PHYLOGENETIC RECONSTRUCTION (II). THE SCRIPTS `GETGOXML' AND `EVERYGO' IDENTIFIED REPRESENTATIVE METABOLIC PATHWAYS RELATED TO HOST ADAPTATION USING THE FIRST GENEONTOLOGY ENRICHMENT ANALYSIS BASED ON BACTERIAL COREGENOME VARIANTS (III). CONCLUSIONS: WE PROPOSE IN THE PRESENT MANUSCRIPT A NEW COREGENOME APPROACH COUPLING IDENTIFICATION OF FIXED SNPS AND INDELS WITH REGARDS TO INFERRED PHYLOGENETIC CLADES, AND GENE-ONTOLOGY ENRICHMENT ANALYSIS IN ORDER TO DESCRIBE THE ADAPTATION OF SALMONELLA SEROVARS DUBLIN (I.E. MAMMALIAN-HOSTS), ENTERITIDIS (I.E. MULTI-HOSTS), PULLORUM (I.E. AVIAN-HOSTS) AND GALLINARUM (I.E. AVIAN-HOSTS) AT THE COREGENOME SCALE. ALL THESE POLYVALENT BIOINFORMATIC TOOLS CAN BE APPLIED ON OTHER BACTERIAL GENUS WITHOUT ADDITIONAL DEVELOPMENTS.","BACTERIAL GENOMICS; BACTERIAL FIXED VARIANTS; GENE-ONTOLOGY ENRICHMENT ANALYSIS","ENTERICA SEROTYPE TYPHIMURIUM; DNA-SEQUENCING DATA; GENOME ANALYSIS; EVOLUTION; ENZYME; DUBLIN; TOOL; PATHOGENOMICS; PATHOGENICITY; ACCUMULATION","ENGLISH","ARTICLE","ARTICLE",1,"ABERER AJ, 2010, J COMPUT SCI-NETH, V1, P107, DOI 10.1016/J.JOCS.2010.03.006.;ALBERS CA, 2011, GENOME RES, V21, P961, DOI 10.1101/GR.112326.110.;ALLEN SW, 1993, NUCLEIC ACIDS RES, V21, P1676, DOI 10.1093/NAR/21.7.1676.;AMATO SM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/FMICB.2014.00070.;ANDERSEN JB, 1998, APPL ENVIRON MICROB, V64, P2240.;ARMSTRONG RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/OPO.12131.;ASHBURNER M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556.;BANKEVICH A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/CMB.2012.0021.;BARROW PA, 2011, AVIAN PATHOL, V40, P1, DOI 10.1080/03079457.2010.542575.;BAUMLER AJ, 1998, INFECT IMMUN, V66, P4579.;BERES SB, 2010, P NATL ACAD SCI USA, V107, P4371, DOI 10.1073/PNAS.0911295107.;BLONDEL CJ, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0011724.;BOLGER AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/BIOINFORMATICS/BTU170.;BOTSFORD JL, 1994, APPL ENVIRON MICROB, V60, P2568.;BRENNEMAN KE, 2013, J BACTERIOL, V195, P3062, DOI 10.1128/JB.00104-13.;CHARLIER D, 2004, ECOSAL PLUS, V1, P1.;CHU CS, 2008, GENOMICS, V92, P339, DOI 10.1016/J.YGENO.2008.07.010.;CINGOLANI P, 2012, FLY, V6, P80, DOI 10.4161/FLY.19695.;CINGOLANI PABLO, 2012, FRONTIERS IN GENETICS, V3, P35, DOI 10.3389/FGENE.2012.00035.;CLAUS SP, 2016, NPJ BIOFILMS MICROBI, V2, DOI 10.1038/NPJBIOFILMS.2016.3.;CORANDER J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539.;CRAIG M, 2013, MOL MICROBIOL, V89, P887, DOI 10.1111/MMI.12318.;CRICHTON PB, 1990, J MED MICROBIOL, V32, P145, DOI 10.1099/00222615-32-3-145.;CSONKA LN, 1994, J BACTERIOL, V176, P6324, DOI 10.1128/JB.176.20.6324-6333.1994.;DANECEK P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/BIOINFORMATICS/BTR330.;DENNIS G, 2003, GENOME BIOL, V4, DOI 10.1186/GB-2003-4-9-R60.;DEPRISTO MA, 2011, NAT GENET, V43, P491, DOI 10.1038/NG.806.;DEVELOPMENT CORE TEAM R., 2015, R LANG ENV STAT COMP.;DHANANI AS, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0137697.;DHANANI AS, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0128773.;DIDELOT X, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/JOURNAL.PCBI.1004041.;ESAKI N, 1986, BIOCHEMISTRY-US, V25, P3261, DOI 10.1021/BI00359A027.;FOLEY SL, 2013, MICROBIOL MOL BIOL R, V77, P582, DOI 10.1128/MMBR.00015-13.;FRICKE WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11.;FRIDJONSSON O, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-179.;FRUZANGOHAR M, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0058759.;GILBERT ER, 2007, POULTRY SCI, V86, P1739, DOI 10.1093/PS/86.8.1739.;GROSSMANN S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/BIOINFORMATICS/BTM440.;HAN J, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0051160.;HEDGE J, 2014, MBIO, V5, DOI 10.1128/MBIO.02158-14.;HUANG DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/NAR/GKN923.;JELSBAK L, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0101869.;JOYCE EA, 2002, NAT REV GENET, V3, P462, DOI 10.1038/NRG820.;JUHAS M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/J.1574-6976.2008.00136.X.;KANEHISA M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/NAR/28.1.27.;KARASOV W, 2013, COMPR PHYSL.;KIEBOOM J, 2006, J BACTERIOL, V188, P5650, DOI 10.1128/JB.00323-06.;LANGRIDGE GC, 2015, P NATL ACAD SCI USA, V112, P863, DOI 10.1073/PNAS.1416707112.;LEE EJ, 2014, P NATL ACAD SCI USA, V111, P3140, DOI 10.1073/PNAS.1316209111.;LEE IH, 2014, HUM MUTAT, V35, P537, DOI 10.1002/HUMU.22520.;LEES JA, 2016, NAT REV MICROBIOL, V14, P1, DOI 10.1038/NRMICRO.2016.82.;LESCAI F, 2014, MOL GENET GENOM MED, V2, P58, DOI 10.1002/MGG3.42.;LETUNIC I, 2016, NUCLEIC ACIDS RES, V44, PW242, DOI 10.1093/NAR/GKW290.;LI H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/BIOINFORMATICS/BTP352.;LI H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/BIOINFORMATICS/BTP324.;LIBBY SJ, 2000, CELL MICROBIOL, V2, P49, DOI 10.1046/J.1462-5822.2000.00030.X.;MAJOWICZ SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733.;MAKENDI C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/JOURNAL.PNTD.0004446.;MANSUETO L, 2017, NUCLEIC ACIDS RES, V45, PD1075, DOI 10.1093/NAR/GKW1135.;MCCLELLAND M, 2001, NATURE, V413, P852, DOI 10.1038/35101614.;MCKENNA A, 2010, GENOME RES, V20, P1297, DOI 10.1101/GR.107524.110.;MULLANEY JM, 2010, HUM MOL GENET, V19, PR131, DOI 10.1093/HMG/DDQ400.;NEUMAN JA, 2013, BRIEF BIOINFORM, V14, P46, DOI 10.1093/BIB/BBS013.;NIELSEN LR, 2013, VET MICROBIOL, V162, P1, DOI 10.1016/J.VETMIC.2012.08.003.;ONDOV BD, 2016, GENOME BIOL, V17, DOI 10.1186/S13059-016-0997-X.;PANG S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-718.;PATTENGALE ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/CMB.2009.0179.;PAULANDER W, 2010, GENETICS, V185, P305, DOI 10.1534/GENETICS.109.113514.;PORWOLLIK S, 2005, J BACTERIOL, V187, P6545, DOI 10.1128/JB.18.6545-6555.2005.;RABSCH W, 2002, INFECT IMMUN, V70, P2249, DOI 10.1128/IAI.70.5.2249-2255.2002.;RADOMSKI N, 2010, J CLIN MICROBIOL, V48, P1026, DOI 10.1128/JCM.01869-09.;READ TD, 2014, GENOME MED, V6, DOI 10.1186/S13073-014-0109-Z.;REVELL LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/J.2041-210X.2011.00169.X.;RIMMER A, 2014, NAT GENET, V46, P912, DOI 10.1038/NG.3036.;ROTGER R, 1999, INT MICROBIOL, V2, P177.;SHABALINA SA, 2013, NUCLEIC ACIDS RES, V41, P2073, DOI 10.1093/NAR/GKS1205.;SOUCY SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/NRG3962.;STAMATAKIS A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/BIOINFORMATICS/BTU033.;THOMSON NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/GR.077404.108.;TOCILJ A, 2005, J BIOL CHEM, V280, P15800, DOI 10.1074/JBC.M413833200.;VAN DER AUWERA GA, 2013, CURR PROTOC BIOINFOR, P1.;WEENING EH, 2005, INFECT IMMUN, V73, P3358, DOI 10.1128/IAI.73.6.3358-3366.2005.;WERNEGREEN JJ, 2002, NAT REV GENET, V3, P850, DOI 10.1038/NRG931.;WIEDEMANN A, 2015, FRONT MICROBIOL, V5, DOI 10.3389/FMICB.2014.00791.;YANG ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/NRG3186.;YOON SH, 2007, NUCLEIC ACIDS RES, V35, PD395, DOI 10.1093/NAR/GKL790.;YUAN C, 2015, J APPL POULTRY RES, V24, P463, DOI 10.3382/JAPR/PFV049.;ZHOU ZM, 2013, PLOS GENET, V9, DOI 10.1371/JOURNAL.PGEN.1003471.","RADOMSKI, N (REPRINT AUTHOR), UNIV PARIS EST, ANSES, LAB FOOD SAFETY, MAISONS ALFORT, FRANCE.;FELTEN, ARNAUD, NOVA, MERYL VILA, DURIMEL, KEVIN, GUILLIER, LAURENT, MISTOU, MICHEL-YVES, RADOMSKI, NICOLAS, UNIV PARIS EST, ANSES, LAB FOOD SAFETY, MAISONS ALFORT, FRANCE.","10.1186/S12866-017-1132-1","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","222",NA,"EUROPEAN UNION [643476]","THIS WORK WAS SUPPORTED BY A GRANT FROM THE EUROPEAN UNION'S HORIZON 2020 RESEARCH AND INNOVATION PROGRAM UNDER GRANT AGREEMENT NO. 643476 (COMPARE). THE FUNDING BODY HAD NO ROLE IN THE DESIGN OF THE STUDY, COLLECTION/ANALYSIS/INTERPRETATION OF DATA, AND WRITING THE MANUSCRIPT.",NA,"1471-2180",NA,NA,"BIOMED CENTRAL LTD","17",2017,"ISI000416898300001","88","MICROBIOLOGY","3","MICROBIOLOGY","NICOLAS.RADOMSKIANSES.FR",NA,"FO5LE",NA,"RADOMSKI, N (REPRINT AUTHOR), UNIV PARIS EST, ANSES, LAB FOOD SAFETY, MAISONS ALFORT, FRANCE","ISI","UNIV PARIS EST","UNIV PARIS EST",NA,"FELTEN A, 2017, BMC MICROBIOL","FELTEN A, 2017, BMC MICROBIOL"
"YANG Z, 2017, INT J FOOD MICROBIOL","YANG Z;MAMMEL M;PAPAFRAGKOU E;HIDA K;ELKINS CA;KULKA M","APPLICATION OF NEXT GENERATION SEQUENCING TOWARD SENSITIVE DETECTION OF ENTERIC VIRUSES ISOLATED FROM CELERY SAMPLES AS AN EXAMPLE OF PRODUCE","INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY","INT. J. FOOD MICROBIOL.","NEXT GENERATION SEQUENCING (NGS) HOLDS PROMISE AS A SINGLE APPLICATION FOR BOTH DETECTION AND SEQUENCE IDENTIFICATION OF FOODBOME VIRUSES, HOWEVER, TECHNICAL CHALLENGES REMAIN DUE TO ANTICIPATED LOW QUANTITIES OF VIRUS IN CONTAMINATED FOOD. IN THIS STUDY, WITH A FOCUS ON DATA ANALYSIS USING SEVERAL BIOINFORMATICS TOOLS, WE APPLIED NGS TOWARD AMPLIFICATION-INDEPENDENT DETECTION AND IDENTIFICATION OF NOROVIRUS AT LOW COPY (< 103 COPIES) OR WITHIN MULTIPLE STRAINS FROM PRODUCE. CELERY SAMPLES WERE INOCULATED WITH HUMAN NOROVIRUS (STOOL SUSPENSION) EITHER AS A SINGLE NOROVIRUS STRAIN, A MIXTURE OF STRAINS (GII.4 AND G11.6), OR A MIXTURE OF DIFFERENT SPECIES (HEPATITIS A VIRUS AND NOROVIRUS). VIRAL RNA ISOLATION AND RECOVERY WAS CONFIRMED BY RT-QPCR, AND OPTIMIZED FOR LIBRARY GENERATION AND SEQUENCING WITHOUT AMPLIFICATION USING THE ILLUMINA MISEQ PLATFORM. EXTRACTS CONTAINING EITHER A SINGLE VIRUS OR A TWO-VIRUS MIXTURE WERE ANALYZED USING TWO DIFFERENT ANALYTIC APPROACHES TO ACHIEVE VIRUS DETECTION AND IDENTIFICATION. FIRST AN OVERALL ASSESSMENT OF VIRAL GENOME COVERAGE FOR SAMPLES VARYING IN COPY NUMBERS (1.1 X 103 TO 1.7 X 107) AND GENOMIC CONTENT (SINGLE OR MULTIPLE STRAINS IN VARIOUS RATIOS) WAS COMPLETED BY REFERENCE-GUIDED MAPPING. NOT UNEXPECTEDLY, THIS TARGETED APPROACH TO IDENTIFICATION WAS SUCCESSFUL IN CORRECTLY MAPPING READS, THUS IDENTIFYING EACH VIRUS CONTAINED IN THE INOCULUMS EVEN AT LOW COPY (ESTIMATED AT 12 COPIES). FOR THE SECOND (METAGENOMIC) APPROACH, SAMPLES WERE TREATED AS ``UNKNOWNS'' FOR DATA","FOODBORNE VIRUS DETECTION; RNA ISOLATION; NEXT GENERATION SEQUENCES; METAGENOMICS","HEPATITIS-A VIRUS; GASTROENTERITIS OUTBREAK; GENOMIC SEQUENCE; VIRAL-INFECTIONS; FRESH PRODUCE; UNITED-STATES; RNA VIRUSES; NOROVIRUS; RECOMBINATION; DIVERSITY","ENGLISH","ARTICLE","ARTICLE",1,"ALBERTI A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-912.;AW TG, 2016, INT J FOOD MICROBIOL, V223, P50, DOI 10.1016/J.IJFOODMICRO.2016.02.008.;CAPOBIANCHI MR, 2013, CLIN MICROBIOL INFEC, V19, P15, DOI 10.1111/1469-0691.12056.;CHIAPPONI C, 2014, FOOD ENVIRON VIROL, V6, P202, DOI 10.1007/S12560-014-9149-1.;CHOFFNES E. R., 2012, IMPROVING FOOD SAFET, P227.;COHEN JI, 1987, J VIROL, V61, P3035.;COMBE M, 2014, PLOS PATHOG, V10, DOI 10.1371/JOURNAL.PPAT.1003855.;COUDRAY-MEUNIER C, 2016, PLOS ONE, V11, DOI 10.1371/JOURNAL.PONE.0147832.;CROMEANS T, 1987, J MED VIROL, V22, P45, DOI 10.1002/JMV.1890220107.;EDEN JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12.;EL-SENOUSY WM, 2013, INT J FOOD MICROBIOL, V167, P74, DOI 10.1016/J.IJFOODMICRO.2013.06.023.;FELIX-VALENZUELA L, 2012, J FOOD SAFETY, V32, P467, DOI 10.1111/JFS.12009.;GARDNER SN, 2003, J CLIN MICROBIOL, V41, P2417, DOI 10.1128/JCM.41.6.2417-2427.2003.;IMAMURA S, 2016, FOODBORNE PATHOG DIS, V13, P559, DOI 10.1089/FPD.2016.2150.;IMAMURA S, 2016, JPN J VET RES, V64, P113, DOI 10.14943/JJVR.64.2.113.;ITURRIZA-GOMARA M, 2016, CURR OPIN INFECT DIS, V29, P495, DOI 10.1097/QCO.0000000000000299.;KAGEYAMA T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003.;KARST SM, 2010, VIRUSES-BASEL, V2, P748, DOI 10.3390/V2030748.;KIM KH, 2011, APPL ENVIRON MICROB, V77, P7663, DOI 10.1128/AEM.00289-11.;LE GUYADER FS, 2006, J CLIN MICROBIOL, V44, P3878, DOI 10.1128/JCM.01327-06.;LE GUYADER FS, 2004, INT J FOOD MICROBIOL, V97, P179, DOI 10.1016/J.IJFOODMICRO.2004.04.018.;LEE GC, 2012, VIRUS GENES, V45, P225, DOI 10.1007/S11262-012-0779-9.;LEMON SM, 1991, J VIROL, V65, P2056.;LINDESMITH LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10.;LOPEZ-BUENO A, 2009, SCIENCE, V326, P858, DOI 10.1126/SCIENCE.1179287.;MARTELLA V, 2013, J CLIN MICROBIOL, V51, P3855, DOI 10.1128/JCM.01847-13.;MAUNULA L, 2009, EUROSURVEILLANCE, V14, P16.;MEAD PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/EID0505.990502.;NAKAGAWA-OKAMOTO R, 2009, JPN J INFECT DIS, V62, P63.;NEWELL DG, 2010, INT J FOOD MICROBIOL, V139, PS3, DOI 10.1016/J.IJFOODMICRO.2010.01.021.;PANTALEO V, 2010, VIROLOGY, V408, P49, DOI 10.1016/J.VIROL.2010.09.001.;POLO D, 2015, INT J FOOD MICROBIOL, V193, P43, DOI 10.1016/J.IJFOODMICRO.2014.10.007.;RASANEN S, 2010, EPIDEMIOL INFECT, V138, P1227, DOI 10.1017/S0950268809991671.;READ DA, 2016, J VIROL METHODS, V237, P107, DOI 10.1016/J.JVIROMET.2016.09.004.;RODRIGUEZ-BRITO B, 2010, ISME J, V4, P739, DOI 10.1038/ISMEJ.2010.1.;RUTVISUTTINUNT W, 2013, J VIROL METHODS, V193, P394, DOI 10.1016/J.JVIROMET.2013.07.001.;SCALLAN E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/EID1701.P11101.;WHEELER C, 2005, NEW ENGL J MED, V353, P890, DOI 10.1056/NEJMOA050855.;WONG THN, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-335.;WOOD DE, 2014, GENOME BIOL, V15, DOI 10.1186/GB-2014-15-3-R46.;YANG ZHIHUI, 2016, GENOME ANNOUNC, V4, DOI 10.1128/GENOMEA.01211-16.;YANG ZHIHUI, 2016, GENOME ANNOUNC, V4, DOI 10.1128/GENOMEA.01648-15.;YANG ZH, 2016, J VIROL METHODS, V236, P221, DOI 10.1016/J.JVIROMET.2016.07.013.;YAO E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-88.;YEZLI S, 2011, FOOD ENVIRON VIROL, V3, P1, DOI 10.1007/S12560-011-9056-7.;YU C, 2016, J VIROL METHODS, V234, P54, DOI 10.1016/J.JVIROMET.2016.03.013.","KULKA, M (REPRINT AUTHOR), US FDA, DIV MOL BIOL, OFF APPL RES \& SAFETY ASSESSMENT, CTR FOOD SAFETY \& APPL NUTR, 8301 MUIRKIRK RD, LAUREL, MD 20708 USA.;YANG, ZHIHUI, MAMMEL, MARK, PAPAFRAGKOU, EFSTATHIA, HIDA, KAORU, ELKINS, CHRISTOPHER A., KULKA, MICHAEL, US FDA, DIV MOL BIOL, OFF APPL RES \& SAFETY ASSESSMENT, CTR FOOD SAFETY \& APPL NUTR, 8301 MUIRKIRK RD, LAUREL, MD 20708 USA.","10.1016/J.IJFOODMICRO.2017.07.021","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"OAK RIDGE INSTITUTE FOR SCIENCE AN EDUCATION (ORISE) FELLOWSHIP","WE THANK DR. VINJE (CDC) FOR PROVIDING US WITH GII.4 POSITIVE HUMAN FECAL SAMPLES. THE USE AND APPLICATION OF THE DE-IDENTIFIED CLINICAL SAMPLE IN THIS INVESTIGATION WAS UNDER RIHSC APPROVAL \# 13-030F. Z.Y. AND K.H. WERE FUNDED THROUGH AN OAK RIDGE INSTITUTE FOR SCIENCE AN EDUCATION (ORISE) FELLOWSHIP. THE AUTHORS HAVE NO CONFLICT OF INTEREST.",NA,"0168-1605",NA,"73-81","ELSEVIER SCIENCE BV","261",2017,"ISI000414882100010","46","FOOD SCIENCE \& TECHNOLOGY, MICROBIOLOGY","13","FOOD SCIENCE \& TECHNOLOGY, MICROBIOLOGY","MICHAEL.KULKAFDA.HHS.GOV",NA,"FM3CO",NA,"KULKA, M (REPRINT AUTHOR), US FDA, DIV MOL BIOL, OFF APPL RES \& SAFETY ASSESSMENT, CTR FOOD SAFETY \& APPL NUTR, 8301 MUIRKIRK RD, LAUREL, MD 20708 USA","ISI","CTR FOOD SAFETY AND APPL NUTR","CTR FOOD SAFETY AND APPL NUTR",NA,"YANG Z, 2017, INT J FOOD MICROBIOL","YANG Z, 2017, INT J FOOD MICROBIOL"
"IACOCCA MA, 2017, J LIPID RES","IACOCCA MA;WANG J;DRON JS;ROBINSON JF;MCINTYRE AD;CAO H;HEGELE RA","USE OF NEXT-GENERATION SEQUENCING TO DETECT LDLR GENE COPY NUMBER VARIATION IN FAMILIAL HYPERCHOLESTEROLEMIA","JOURNAL OF LIPID RESEARCH","J. LIPID RES.","FAMILIAL HYPERCHOLESTEROLEMIA (FH) IS A HERITABLE CONDITION OF SEVERELY ELEVATED LDL CHOLESTEROL, CAUSED PREDOMINANTLY BY AUTOSOMAL CODOMINANT MUTATIONS IN THE LDL RECEPTOR GENE (LDLR). IN PROVIDING A MOLECULAR DIAGNOSIS FOR FH, THE CURRENT PROCEDURE OFTEN INCLUDES TARGETED NEXT-GENERATION SEQUENCING (NGS) PANELS FOR THE DETECTION OF SMALL-SCALE DNA VARIANTS, FOLLOWED BY MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION (MLPA) IN LDLR FOR THE DETECTION OF WHOLE-EXON COPY NUMBER VARIANTS (CNVS). THE LATTER IS ESSENTIAL BECAUSE SIMILAR TO 10\% OF FH CASES ARE ATTRIBUTED TO CNVS IN LDLR, ACCOUNTING FOR THEM DECREASES FALSE NEGATIVE FINDINGS. HERE, WE DETERMINED THE POTENTIAL OF REPLACING MLPA WITH BIOINFORMATIC ANALYSIS APPLIED TO NGS DATA, WHICH USES DEPTH-OF-COVERAGE ANALYSIS AS ITS PRINCIPAL METHOD TO IDENTIFY WHOLE-EXON CNV EVENTS. IN ANALYSIS OF 388 FH PATIENT SAMPLES, THERE WAS 100\% CONCORDANCE IN LDLR CNV DETECTION BETWEEN THESE TWO METHODS: 38 REPORTED CNVS IDENTIFIED BY MLPA WERE ALSO SUCCESSFULLY DETECTED BY OUR NGS METHOD, WHILE 350 SAMPLES NEGATIVE FOR CNVS BY MLPA WERE ALSO NEGATIVE BY NGS. THIS RESULT SUGGESTS THAT MLPA CAN BE REMOVED FROM THE ROUTINE DIAGNOSTIC SCREENING FOR FH, SIGNIFICANTLY REDUCING ASSOCIATED COSTS, RESOURCES, AND ANALYSIS TIME, WHILE PROMOTING MORE WIDESPREAD ASSESSMENT OF THIS IMPORTANT CLASS OF MUTATIONS ACROSS DIAGNOSTIC LABORATORIES.",NA,"DENSITY-LIPOPROTEIN RECEPTOR; DEPENDENT PROBE AMPLIFICATION; MONOGENIC DYSLIPIDEMIAS; INDIVIDUALS; POPULATION; PREVALENCE; MUTATIONS; DIAGNOSIS; DISEASE","ENGLISH","ARTICLE","ARTICLE",5,"ABUL-HUSN NS, 2016, SCIENCE, V354, DOI 10.1126/SCIENCE.AAF7000.;AMSELLEM S, 2002, HUM GENET, V111, P501, DOI 10.1007/S00439-002-0813-4.;AUSTIN MA, 2004, AM J EPIDEMIOL, V160, P407, DOI 10.1093/AJE/KWH236.;BENN M, 2016, EUR HEART J, V37, P1384, DOI 10.1093/EURHEARTJ/EHW028.;BOURBON M, 2017, CURR OPIN LIPIDOL, V28, P120, DOI 10.1097/MOL.0000000000000404.;FROMER M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/J.AJHG.2012.08.005.;GOLDMANN R, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-115.;HEGELE RA, 2015, CURR OPIN LIPIDOL, V26, P103, DOI 10.1097/MOL.0000000000000163.;HOBBS HH, 1985, P NATL ACAD SCI USA, V82, P7651, DOI 10.1073/PNAS.82.22.7651.;HOBBS HH, 1987, NEW ENGL J MED, V317, P734, DOI 10.1056/NEJM198709173171204.;IACOCCA MA, 2017, EXPERT REV MOL DIAGN, V17, P641, DOI 10.1080/14737159.2017.1332997.;JOHANSEN CT, 2014, J LIPID RES, V55, P765, DOI 10.1194/JLR.D045963.;KRUMM N, 2012, GENOME RES, V22, P1525, DOI 10.1101/GR.138115.112.;LOVE MI, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1732.;NORDESTGAARD BG, 2017, EUR HEART J, V38, P1580, DOI 10.1093/EURHEARTJ/EHX136.;NORDESTGAARD BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/EURHEARTJ/EHT273.;PAJAK A, 2016, ARCH MED SCI, V12, P687, DOI 10.5114/AOMS.2016.59700.;PLAGNOL V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/BIOINFORMATICS/BTS526.;POLLEX RL, 2007, CIRCULATION, V115, P3130, DOI 10.1161/CIRCULATIONAHA.106.677591.;RAAL FJ, 2015, LANCET, V385, P341, DOI 10.1016/S0140-6736(14)61374-X.;SCHOUTEN JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/NAR/GNF056.;SJOUKE B, 2015, EUR HEART J, V36, P560, DOI 10.1093/EURHEARTJ/EHU058.;TAYLOR A, 2009, CLIN GENET, V76, P69, DOI 10.1111/J.1399-0004.2009.01168.X.;USIFO E, 2012, ANN HUM GENET, V76, P387, DOI 10.1111/J.1469-1809.2012.00724.X.;WALD DS, 2016, NEW ENGL J MED, V375, P1628, DOI 10.1056/NEJMOA1602777.;WANG J, 2005, J LIPID RES, V46, P366, DOI 10.1194/JLR.D400030-JLR200.;WANG J, 2016, ARTERIOSCL THROM VAS, V36, P2439, DOI 10.1161/ATVBAHA.116.308027.;XIE C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80.","HEGELE, RA (REPRINT AUTHOR), WESTERN UNIV, DEPT MED, SCHULICH SCH MED \& DENT, LONDON, ON, CANADA.;HEGELE, RA (REPRINT AUTHOR), WESTERN UNIV, DEPT BIOCHEM, SCHULICH SCH MED \& DENT, LONDON, ON, CANADA.;HEGELE, RA (REPRINT AUTHOR), WESTERN UNIV, ROBARTS RES INST, LONDON, ON, CANADA.;IACOCCA, MICHAEL A., DRON, JACQUELINE S., HEGELE, ROBERT A., WESTERN UNIV, DEPT MED, SCHULICH SCH MED \& DENT, LONDON, ON, CANADA.;IACOCCA, MICHAEL A., DRON, JACQUELINE S., HEGELE, ROBERT A., WESTERN UNIV, DEPT BIOCHEM, SCHULICH SCH MED \& DENT, LONDON, ON, CANADA.;IACOCCA, MICHAEL A., WANG, JIAN, DRON, JACQUELINE S., ROBINSON, JOHN F., MCINTYRE, ADAM D., CAO, HENIAN, HEGELE, ROBERT A., WESTERN UNIV, ROBARTS RES INST, LONDON, ON, CANADA.","10.1194/JLR.D079301","9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA",NA,NA,"CANADIAN INSTITUTES OF HEALTH RESEARCH, HEART AND STROKE FOUNDATION OF CANADA [G-15-0009214], GENOME CANADA THROUGH GENOME QUEBEC AWARD [4530]","R.A.H. WAS SUPPORTED BY A FOUNDATION GRANT FROM THE CANADIAN INSTITUTES OF HEALTH RESEARCH, HEART AND STROKE FOUNDATION OF CANADA GRANT G-15-0009214, AND GENOME CANADA THROUGH GENOME QUEBEC AWARD 4530. R.A.H. HAS RECEIVED HONORARIA FOR MEMBERSHIP ON ADVISORY BOARDS AND SPEAKERS' BUREAUS FOR AEGERION, AMGEN, GEMPHIRE, ELI LILLY AND COMPANY, MERCK, PFIZER, REGENERON PHARMACEUTICALS, SANOFI, AND VALEANT PHARMACEUTICALS INTERNATIONAL. M.A.I. HAS NO DISCLOSURES.",NA,"0022-2275","11","2202-2209","AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC","58",2017,"ISI000414177500012","28","BIOCHEMISTRY \& MOLECULAR BIOLOGY","3","BIOCHEMISTRY \& MOLECULAR BIOLOGY","HEGELEROBARTS.CA",NA,"FL4DN",NA,"HEGELE, RA (REPRINT AUTHOR), WESTERN UNIV, DEPT MED, SCHULICH SCH MED \& DENT, LONDON, ON, CANADA","ISI","WESTERN UNIV;WESTERN UNIV;WESTERN UNIV","WESTERN UNIV",NA,"IACOCCA MA, 2017, J LIPID RES","IACOCCA MA, 2017, J LIPID RES"
"BATOVSKA J, 2017, J VIROL METHODS","BATOVSKA J;LYNCH SE;RODONI BC;SAWBRIDGE TI;COGAN NOI","METAGENOMIC ARBOVIRUS DETECTION USING MINION NANOPORE SEQUENCING","JOURNAL OF VIROLOGICAL METHODS","J. VIROL. METHODS","WITH ITS SMALL SIZE AND LOW COST, THE HAND-HELD MINION SEQUENCER IS A POWERFUL TOOL FOR IN-FIELD SURVEILLANCE. USING A METAGENOMIC APPROACH, IT ALLOWS NON-TARGETED DETECTION OF VIRUSES IN A SAMPLE WITHIN A FEW HOURS. THIS STUDY AIMED TO DETERMINE THE ABILITY OF THE MINION TO METAGENOMICALLY DETECT AND CHARACTERISE A VIRUS FROM AN INFECTED MOSQUITO. RNA WAS EXTRACTED FROM AN AEDES NOTOSCRIPTUS MOSQUITO INFECTED WITH ROSS RIVER VIRUS (RRV), CONVERTED INTO CDNA AND SEQUENCED ON THE MINION. BIOINFORMATIC ANALYSIS OF THE MINION READS LED TO DETECTION OF FULL-LENGTH RRV, WITH READS OF UP TO 2.5 KB CONTRIBUTING TO THE ASSEMBLY. THE CDNA WAS ALSO SEQUENCED ON THE MISEQ SEQUENCER, AND BOTH PLATFORMS RECOVERED THE RRV GENOME WITH > 98\% ACCURACY. THIS PROOF OF CONCEPT STUDY DEMONSTRATES THE METAGENOMIC DETECTION OF AN ARBOVIRUS, USING THE MINION, DIRECTLY FROM A MOSQUITO WITH MINIMAL SAMPLE PURIFICATION.","MOSQUITO; CULICIDAE; ROSS RIVER VIRUS; MINION; MISEQ; SURVEILLANCE","CLINICAL-SAMPLES; REAL-TIME; IDENTIFICATION; SURVEILLANCE; BACTERIAL; VIRUS; ZIKA","ENGLISH","ARTICLE","ARTICLE",4,"BARZON L, 2011, INT J MOL SCI, V12, P7861, DOI 10.3390/IJMS12117861.;BATOVSKA J., 2017, MOL ECOL RESOUR.;BATOVSKA J, 2016, ECOL EVOL, V6, P3001, DOI 10.1002/ECE3.2095.;DAVID M, 2017, BIOINFORMATICS, V33, P49, DOI 10.1093/BIOINFORMATICS/BTW569.;ECKERT S.E., 2016, MICROB GENOM, V2.;GARALDE D. R., 2016, 068809 BIORXIV.;GRENINGER AL, 2015, GENOME MED, V7, DOI 10.1186/S13073-015-0220-9.;HALL R., 2011, MOL DETECTION HUMAN, P349.;HOENEN T, 2016, EMERG INFECT DIS, V22, P331, DOI 10.3201/EID2202.151796.;HOULDCROFT CJ, 2017, NAT REV MICROBIOL, V15, P183, DOI 10.1038/NRMICRO.2016.182.;JANSEN HJ, 2017, SCI REP UK, V7.;JAWORSKI E, 2017, PLOS PATHOG, V13, DOI 10.1371/JOURNAL.PPAT.1006365.;JONES A, 2010, J GEN VIROL, V91, P182, DOI 10.1099/VIR.0.014209-0.;KEARSE M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/BIOINFORMATICS/BTS199.;KILIANSKI A, 2016, EMERG INFECT DIS, V22, P1448, DOI 10.3201/EID2208.160270.;KILIANSKI A, 2015, GIGASCIENCE, V4, DOI 10.1186/S13742-015-0051-Z.;KNOPE KE, 2016, COMMUN DIS INTELL, V40, PE401.;KRUEGER F., 2015, TRIM GALORE WRAPPER.;LI H, 2013, 13033997 ARXIV, V1303, P3997, DOI DOI 10.1093/BI0INF0RMATICS/BTP352.;LI H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/BIOINFORMATICS/BTP352.;LINDSAY MDA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/JOURNAL.PNTD.0004114.;LOMAN NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/NMETH.3444].;LOMAN NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/BIOINFORMATICS/BTU555.;LU HY, 2016, GENOM PROTEOM BIOINF, V14, P265, DOI 10.1016/J.GPB.2016.05.004.;MARTIN M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200.;MEDLOCK JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/VBZ.2011.0814.;MITSUHASHI S, 2017, SCI REP UK, V7.;MONGAN A. E., 2015, AM J MICROBIOL RES, V3, P118, DOI 10.12691/AIMR-3-3-4.;PATTERSON J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/WESTJEM.2016.9.30904.;QUICK J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/NPROT.2017.066.;QUICK J, 2016, NATURE, V530, P228, DOI 10.1038/NATURE16996.;TEMMAM S, 2014, INT J MOL SCI, V15, P10377, DOI 10.3390/IJMS150610377.;TYSON J., 2017, 099143 BIORXIV.;VAUX AGC, 2015, PARASITE VECTOR, V8, DOI 10.1186/S13071-015-0936-9.;WALTER MC, 2017, J BIOTECHNOL, V250, P16, DOI 10.1016/J.JBIOTEC.2016.12.006.;WANG J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/FMICB.2015.00766.;ZHONG DB, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0068586.","BATOVSKA, J (REPRINT AUTHOR), AGR VICTORIA RES, AGRIBIO CTR AGRIBIOSCI, 5 RING RD, BUNDOORA, VIC 3083, AUSTRALIA.;BATOVSKA, JANA, LYNCH, STACEY E., RODONI, BRENDAN C., SAWBRIDGE, TIM I., COGAN, NOEL O. I., AGR VICTORIA RES, AGRIBIO CTR AGRIBIOSCI, 5 RING RD, BUNDOORA, VIC 3083, AUSTRALIA.;BATOVSKA, JANA, RODONI, BRENDAN C., SAWBRIDGE, TIM I., COGAN, NOEL O. I., LA TROBE UNIV, SCH APPL SYST BIOL, BUNDOORA, VIC 3086, AUSTRALIA.","10.1016/J.JVIROMET.2017.08.019","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"BIOSCIENCES RESEARCH INNOVATION FUND PROGRAM BY DEPARTMENT OF ECONOMIC DEVELOPMENT, JOBS, TRANSPORT AND RESOURCES","THE AUTHORS THANK JONATHAN DARBRO AND ELISE KHO FOR PROVIDING THE MOSQUITO SPECIMEN USED IN THIS STUDY, AND SIMONE WARNER FOR CRITICALLY READING AND APPROVING THE MANUSCRIPT. THIS PROJECT WAS FUNDED THROUGH A BIOSCIENCES RESEARCH INNOVATION FUND PROGRAM PROVIDED BY THE DEPARTMENT OF ECONOMIC DEVELOPMENT, JOBS, TRANSPORT AND RESOURCES.",NA,"0166-0934",NA,"79-84","ELSEVIER SCIENCE BV","249",2017,"ISI000413177000012","37","BIOCHEMISTRY \& MOLECULAR BIOLOGY, BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, VIROLOGY","18","BIOCHEMICAL RESEARCH METHODS, BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, VIROLOGY","JANA.BATOVSKAECODEV.VIC.GOV.AU STACEY.LYNCHECODEV.VIC.GOV.AU BRENDAN.RODONIECODEV.VIC.GOV.AU TIM.SAWBRIDGEECODEV.VIC.GOV.AU NOEL.COGANECODEV.VIC.GOV.AU",NA,"FK0NQ",NA,"BATOVSKA, J (REPRINT AUTHOR), AGR VICTORIA RES, AGRIBIO CTR AGRIBIOSCI, 5 RING RD, BUNDOORA, VIC 3083, AUSTRALIA","ISI","AGRIBIO CTR AGRIBIOSCI;LA TROBE UNIV","AGRIBIO CTR AGRIBIOSCI",NA,"BATOVSKA J, 2017, J VIROL METHODS","BATOVSKA J, 2017, J VIROL METHODS"
"AGGARWALA V, 2017, MOB DNA","AGGARWALA V;LIANG G;BUSHMAN FD","VIRAL COMMUNITIES OF THE HUMAN GUT: METAGENOMIC ANALYSIS OF COMPOSITION AND DYNAMICS","MOBILE DNA","MOB. DNA","BACKGROUND: THE NUMERICALLY MOST ABUNDANT BIOLOGICAL ENTITIES ON EARTH ARE VIRUSES. VAST POPULATIONS PREY ON THE CELLULAR MICROBIOTA IN ALL HABITATS, INCLUDING THE HUMAN GUT. MAIN BODY: HERE WE REVIEW APPROACHES FOR STUDYING THE HUMAN VIROME, AND SOME RECENT RESULTS ON MOVEMENT OF VIRAL SEQUENCES BETWEEN BACTERIAL CELLS AND EUKARYOTIC HOSTS. WE FIRST OVERVIEW BIOCHEMICAL AND BIOINFORMATIC METHODS, EMPHASIZING THAT SPECIFIC CHOICES IN THE METHODS USED CAN HAVE STRONG EFFECTS ON THE RESULTS OBTAINED. WE THEN REVIEW STUDIES CHARACTERIZING THE VIROME OF THE HEALTHY HUMAN GUT, WHICH REVEAL THAT MOST OF THE VIRUSES DETECTED ARE TYPICALLY UNCHARACTERIZED PHAGE - THE VIRAL DARK MATTER - AND THAT VIRUSES THAT INFECT HUMAN CELLS ARE ENCOUNTERED ONLY RARELY. WE THEN REVIEW MOVEMENT OF PHAGE BETWEEN BACTERIAL CELLS DURING ANTIBIOTIC TREATMENT. HERE A RADICAL PROPOSAL FOR EXTENSIVE MOVEMENT OF ANTIBIOTIC GENES ON PHAGE HAS BEEN CHALLENGED BY A CAREFUL REANALYSIS OF THE METAGENOMIC ANNOTATION METHODS USED. WE THEN REVIEW TWO RECENT STUDIES OF MOVEMENT OF WHOLE PHAGE COMMUNITIES BETWEEN HUMAN INDIVIDUALS DURING FECAL MICROBIAL TRANSPLANTATION, WHICH EMPHASIZE THE POSSIBLE ROLE OF LYSOGENY IN DISPERSAL. SHORT CONCLUSION: METHODS FOR STUDYING THE HUMAN GUT VIROME ARE IMPROVING, YIELDING INTERESTING DATA ON MOVEMENT OF PHAGE GENES BETWEEN CELLS AND MAMMALIAN HOST ORGANISMS. HOWEVER, VIRAL POPULATIONS ARE VAST, AND STUDIES OF THEIR COMPOSITION AND FUNCTION ARE JUST BEGINNING.","VIRUS; BACTERIOPHAGE; VIROME; MICROBIOME; METAGENOMICS; DNA; TRANSDUCTION","FECAL MICROBIOTA TRANSPLANTATION; CLOSTRIDIUM-DIFFICILE INFECTION; STRANDED-DNA VIRUSES; DE-NOVO ASSEMBLER; LAMBDA-REPRESSOR; POSITIVE CONTROL; PHAGE REPRESSOR; SEQUENCING DATA; MARINE VIRUSES; HUMAN FECES","ENGLISH","REVIEW","ARTICLE",2,"ABBAS AA, 2017, AM J TRANSPLANT, V17, P1313, DOI 10.1111/AJT.14076.;ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;ANDERSON JE, 1985, NATURE, V316, P596, DOI 10.1038/316596A0.;ANGLY F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41.;BOLGER AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/BIOINFORMATICS/BTU170.;BONDY-DENOMY J, 2016, ISME J, V10, P2854, DOI 10.1038/ISMEJ.2016.79.;BRUM JR, 2015, SCIENCE, V348, DOI 10.1126/SCIENCE.1261498.;BUSHMAN F., 2002, LATERAL DNA TRANSFER.;BUSHMAN FD, 1989, CELL, V58, P1163, DOI 10.1016/0092-8674(89)90514-X.;BUSHMAN FD, 1986, P NATL ACAD SCI USA, V83, P9353, DOI 10.1073/PNAS.83.24.9353.;BUSHMAN FD, 1988, CELL, V54, P191, DOI 10.1016/0092-8674(88)90551-X.;BUSHMAN FD, 1985, NATURE, V316, P651, DOI 10.1038/316651A0.;CADWELL K, 2015, IMMUNITY, V42, P805, DOI 10.1016/J.IMMUNI.2015.05.003.;CASAS V, 2011, FUTURE MICROBIOL, V6, P1461, DOI [10.2217/FMB.11.124, 10.2217/FMB.11.124].;CHEHOUD C, 2016, MBIO, V7, DOI 10.1128/MBIO.00322-16.;COUTINHO FH, 2017, NAT COMMUN, V8, DOI 10.1038/NCOMMS15955.;DAVID LA, 2014, NATURE, V505, P559, DOI 10.1038/NATURE12820.;DEDRICK RM, 2017, NAT MICROBIOL, V2, DOI 10.1038/NMICROBIOL.2016.251.;DIARD M, 2017, SCIENCE, V355, P1211, DOI 10.1126/SCIENCE.AAF8451.;DUFFY S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/NRG2323.;ENAULT F, 2017, ISME J, V11, P237, DOI 10.1038/ISMEJ.2016.90.;FINN RD, 2011, NUCLEIC ACIDS RES, V39, PW29, DOI 10.1093/NAR/GKR367.;GUARENTE L, 1982, P NATL ACAD SCI-BIOL, V79, P2236, DOI 10.1073/PNAS.79.7.2236.;HEROLD S, 2004, INT J MED MICROBIOL, V294, P115, DOI 10.1016/J.IJMM.2004.06.023.;HO T, 2014, VIROLOGY, V471, P54, DOI 10.1016/J.VIROL.2014.09.019.;HOCHSCHILD A, 1983, CELL, V32, P319, DOI 10.1016/0092-8674(83)90451-8.;HOFFMANN C, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0066019.;HULO C, 2011, NUCLEIC ACIDS RES, V39, PD576, DOI 10.1093/NAR/GKQ901.;HUTTENHOWER C, 2012, NATURE, V486, P207, DOI 10.1038/NATURE11234.;KELLERMAYER R, 2015, AM J GASTROENTEROL, V110, P604, DOI 10.1038/AJG.2015.19.;KIM D, 2017, MICROBIOME, V5, DOI 10.1186/S40168-017-0267-5.;KIM KH, 2008, APPL ENVIRON MICROB, V74, P5975, DOI 10.1128/AEM.01275-08.;KIM MS, 2011, APPL ENVIRON MICROB, V77, P8062, DOI 10.1128/AEM.06331-11.;KLEINER M, 2015, BMC GENOMICS, V16, DOI 10.1186/S12864-014-1207-4.;KNOWLES B, 2016, NATURE, V531, P466, DOI 10.1038/NATURE17193.;LANGMEAD B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/NMETH.1923].;LAURING AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/NRMICRO3003.;LEWIS JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/J.CHOM.2015.09.008.;LI SS, 2016, SCIENCE, V352, P586, DOI 10.1126/SCIENCE.AAD8852.;LIM ES, 2015, NAT MED, V21, P1228, DOI 10.1038/NM.3950.;LORENZI HA, 2011, STAND GENOMIC SCI, V4, P418, DOI 10.4056/SIGS.1694706.;LUO RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18.;MARTIN M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200.;MCLEOD SM, 2005, MOL MICROBIOL, V57, P347, DOI 10.1111/J.1365-2958.04676.X.;MINOT S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/PNAS.1300833110.;MINOT S, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0042342.;MINOT S, 2012, P NATL ACAD SCI USA, V109, P3962, DOI 10.1073/PNAS.1119061109.;MINOT S, 2011, GENOME RES, V21, P1616, DOI 10.1101/GR.122705.111.;MODI SR, 2013, NATURE, V499, P219, DOI 10.1038/NATURE12212.;NAGARAJAN N, 2013, NAT REV GENET, V14, P157, DOI 10.1038/NRG3367.;NAMIKI T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/NAR/GKS678.;NORMAN JM, 2015, CELL, V160, P447, DOI 10.1016/J.CELL.2015.01.002.;O'LEARY NUALA A, 2016, NUCLEIC ACIDS RES, V44, PD733, DOI 10.1093/NAR/GKV1189.;OHLENDORF DH, 1983, J MOL BIOL, V169, P757, DOI 10.1016/S0022-2836(83)80169-7.;OTT SJ, 2017, GASTROENTEROLOGY, V152, P799, DOI 10.1053/J.GASTRO.2016.11.010.;PAEZ-ESPINO D, 2016, NATURE, V536, P425, DOI 10.1038/NATURE19094.;PEDULLA ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2.;PENG Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/BIOINFORMATICS/BTS174.;PROCTOR LM, 1997, MICROSC RES TECHNIQ, V37, P136, DOI 10.1002/(SICI)1097-0029(19970415)37:2<136::AID-JEMT3>3.0.CO,2-M.;PROCTOR LM, 1993, MICROBIAL ECOL, V25, P161, DOI 10.1007/BF00177193.;PTASHNE M, 1980, CELL, V19, P1, DOI 10.1016/0092-8674(80)90383-9.;PTASHNE M., 2004, GENETIC SWITCH PHAGE.;PUNTA M, 2012, NUCLEIC ACIDS RES, V40, PD290, DOI 10.1093/NAR/GKR1065.;QIN JJ, 2010, NATURE, V464, P59, DOI 10.1038/NATURE08821.;RAMPELLI S, 2016, BMC GENOMICS, V17, DOI 10.1186/S12864-016-2446-3.;REYESA A, 2015, P NATL ACAD SCI USA, V112, P11941, DOI 10.1073/PNAS.1514285112.;REYES A, 2013, P NATL ACAD SCI USA, V110, P20236, DOI 10.1073/PNAS.1319470110.;REYES A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/NRMICRO2853.;REYES A, 2010, NATURE, V466, P334, DOI 10.1038/NATURE09199.;RICE P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2.;RODRIGUEZ-BRITO B, 2010, ISME J, V4, P739, DOI 10.1038/ISMEJ.2010.1.;RODRIGUEZ-VALERA F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/NRMICRO2235.;ROHLKE F, 2012, THER ADV GASTROENTER, V5, P403, DOI 10.1177/1756283X12453637.;ROHWER F, 2015, NATURE, V528, P46, DOI 10.1038/528046A.;ROUX S, 2016, NATURE, V537, P689, DOI 10.1038/NATURE19366.;ROUX S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-76.;SALTER SJ, 2014, BMC BIOL, V12, DOI 10.1186/S12915-014-0087-Z.;SAUER RT, 1982, NATURE, V298, P447, DOI 10.1038/298447A0.;SAUVAGE V, 2016, TRANSFUS CLIN BIOL, V23, P28, DOI 10.1016/J.TRACLI.2015.12.002.;SENDER R, 2016, PLOS BIOL, V14, DOI 10.1371/JOURNAL.PBIO.1002533.;SEVILLASIERRA P, 1994, J MOL BIOL, V235, P1003, DOI 10.1006/JMBI.1994.1053.;SHI M, 2016, NATURE, V540, P539, DOI 10.1038/NATURE20167.;SKEWES-COX P, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0105067.;SMITH MI, 2013, SCIENCE, V339, P548, DOI 10.1126/SCIENCE.1229000.;SVAROVSKAIA ES, 2003, FRONT BIOSCI, V8, PD117, DOI 10.2741/957.;THURBER RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/NPROT.2009.10.;TURNBAUGH PJ, 2007, NATURE, V449, P804, DOI 10.1038/NATURE06244.;TURNBAUGH PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/SCITRANSLMED.3000322.;VIERTEL TM, 2014, J ANTIMICROB CHEMOTH, V69, P2326, DOI 10.1093/JAC/DKU173.;VIRGIN HW, 2009, CELL, V138, P30, DOI 10.1016/J.CELL.2009.06.036.;WANG D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/JOURNAL.PBIO.0000002.;WANG SL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-451.;WOLBERGER C, 1988, NATURE, V335, P789, DOI 10.1038/335789A0.;WOMMACK KE, 2012, STAND GENOMIC SCI, V6, P421, DOI 10.4056/SIGS.2945050.;WOOD DE, 2014, GENOME BIOL, V15, DOI 10.1186/GB-2014-15-3-R46.;WU GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206.;YOUNG JC, 2015, AM J TRANSPLANT, V15, P200, DOI 10.1111/AJT.13031.;ZANEVELD J, 2008, CURR OPIN CHEM BIOL, V12, P109, DOI 10.1016/J.CBPA.2008.01.015.;ZHANG T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/JOURNAL.PBIO.0040003.;ZHAO GY, 2017, VIROLOGY, V503, P21, DOI 10.1016/J.VIROL.2017.01.005.;ZUO T, 2017, GUT, P1.","BUSHMAN, FD (REPRINT AUTHOR), UNIV PENN, SCH MED, DEPT MICROBIOL, 3610 HAMILTON WALK, PHILADELPHIA, PA 19104 USA.;AGGARWALA, VARUN, LIANG, GUANXIANG, BUSHMAN, FREDERIC D., UNIV PENN, SCH MED, DEPT MICROBIOL, 3610 HAMILTON WALK, PHILADELPHIA, PA 19104 USA.;LIANG, GUANXIANG, CHILDRENS HOSP PHILADELPHIA, DIV GASTROENTEROL HEPATOL \& NUTR, PHILADELPHIA, PA 19104 USA.","10.1186/S13100-017-0095-Y","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","12",NA,"PENN CENTER FOR AIDS RESEARCH [P30 AI 045008], PENNSYLVANIA DEPARTMENT OF HEALTH [SAP 4100068710], PENNCHOP MICROBIOME PROGRAM, [AI082020-05A1], [HL117798-05], [HL113252-04]","THIS WORK WAS SUPPORTED BY AI082020-05A1 (FDB), HL117798-05 (FITZGERALD), HL113252-04 (COLLMAN, BUSHMAN, CHRISTIE), THE PENN CENTER FOR AIDS RESEARCH P30 AI 045008, PENNSYLVANIA DEPARTMENT OF HEALTH SAP 4100068710, AND THE PENNCHOP MICROBIOME PROGRAM. THE FUNDING BODIES HAD NO ROLE IN THE DESIGN OF THE STUDY AND COLLECTION, ANALYSIS, AND INTERPRETATION OF DATA, OR IN WRITING THE MANUSCRIPT.",NA,"1759-8753",NA,NA,"BIOMED CENTRAL LTD","8",2017,"ISI000412276400001","101","GENETICS \& HEREDITY","24","GENETICS \& HEREDITY","BUSHMANMAIL.MED.UPENN.EDU",NA,"FI8UA",NA,"BUSHMAN, FD (REPRINT AUTHOR), UNIV PENN, SCH MED, DEPT MICROBIOL, 3610 HAMILTON WALK, PHILADELPHIA, PA 19104 USA","ISI","UNIV PENN;CHILDRENS HOSP PHILADELPHIA","UNIV PENN",NA,"AGGARWALA V, 2017, MOB DNA","AGGARWALA V, 2017, MOB DNA"
"GUAN T, 2017, BMC OPHTHALMOL","GUAN T;WANG X;ZHENG LB;WU HJ;YAO YF","ANALYSIS OF THE VSX1 GENE IN SPORADIC KERATOCONUS PATIENTS FROM CHINA","BMC OPHTHALMOLOGY","BMC OPHTHALMOL.","BACKGROUND: KERATOCONUS NORMALLY PRESENTS AS A SPORADIC DISEASE. ALTHOUGH DIFFERENT STUDIES HAVE FOUND SEQUENCE VARIANTS OF THE VISUAL SYSTEM HOMEOBOX 1 (VSX1) GENE ASSOCIATED WITH KERATOCONUS IN HUMANS, NO RESEARCH HAS DETECTED SUCH VARIANTS IN SPORADIC KERATOCONUS PATIENTS FROM CHINA. TO INVESTIGATE THE POSSIBILITY OF VSX1 BEING A CANDIDATE SUSCEPTIBILITY GENE FOR CHINESE PATIENTS WITH SPORADIC KERATOCONUS, WE PERFORMED SEQUENCE SCREENING OF THIS GENE IN SUCH PATIENTS. METHODS: WHOLE DNA WAS OBTAINED FROM THE LEUKOCYTES IN THE PERIPHERAL VENOUS BLOOD OF 50 PATIENTS WITH SPORADIC KERATOCONUS AND 50 CONTROL SUBJECTS WITHOUT THIS OCULAR DISORDER. POLYMERASE CHAIN REACTION SINGLE- STRAND CONFORMATION POLYMORPHISM ANALYSIS AND DIRECT DNA SEQUENCING TECHNOLOGY WERE USED TO DETECT SEQUENCE VARIATION IN THE FIVE EXONS AND SPLICING REGIONS OF THE INTRONS OF THE VSX1 GENE. THE SEQUENCING RESULTS WERE ANALYZED USING DNASTAR SOFTWARE. RESULTS: ONE NOVEL MISSENSE HETEROZYGOUS SEQUENCE VARIANT (P. ARG131PRO) WAS FOUND IN THE FIRST EXON OF THE VSX1 GENE IN ONE KERATOCONUS PATIENT. ANOTHER HETEROZYGOUS SEQUENCE VARIANT (P. GLY160VAL) IN THE SECOND EXON WAS FOUND IN TWO KERATOCONUS PATIENTS. THESE VARIANTS WERE NOT DETECTED IN THE CONTROL SUBJECTS. IN THE THIRD INTRON OF THE VSX1 GENE, C. 8326G > A NUCLEOTIDE SUBSTITUTION (INCLUDING HETEROZYGOUS AND HOMOZYGOUS CHANGE) WAS ALSO DISCOVERED. THE FREQUENCY OF THIS VARIATION DID NOT DIFFER SIGNIFICANTLY BETWEEN PATIENTS AND CONTROLS, IT SHOULD BELONG TO SINGLE- NUCLEOTIDE POLYMORPHISM OF THE VSX1 GENE. BIOINFORMATIC ANALYSIS ALSO PREDICTED THAT ONE MISSENSE SEQUENCE VARIATION (P. ARG131PRO) MAY NOT CAUSE A PATHOGENIC CHANGE. CONCLUSIONS: IN THIS STUDY, WE ADDED ONE NOVEL MISSENSE SEQUENCE VARIATION (P. ARG131PRO) IN THE CODING REGION OF THE VSX1 GENE TO THE RANGE OF VSX1 CODING REGION VARIATIONS OBSERVED IN PATIENTS WITH SPORADIC KERATOCONUS FROM CHINA. OUR WORK SUGGESTS THAT VSX1 SEQUENCE VARIANTS MIGHT BE INVOLVED IN THE PATHOGENESIS OF SPORADIC KERATOCONUS, BUT THEIR PRECISE ROLE IN DISEASE CAUSATION REQUIRES FURTHER INVESTIGATION.","SPORADIC KERATOCONUS; VSX1 GENE; SEQUENCE VARIANT; SINGLE-NUCLEOTIDE POLYMORPHISM","POSTERIOR POLYMORPHOUS DYSTROPHY; KOREAN PATIENTS; MUTATION; VARIANT; SOD1; IDENTIFICATION; KERATOPLASTY; INDIA; LOCI","ENGLISH","ARTICLE","ARTICLE",0,"ABU-AMERO KK, 2014, MOL VIS, V20, P1203.;ABU-AMERO KK, 2011, MOL VIS, V17, P667.;ABU-AMERO KK, 2014, J OPHTHALMOL, V2014, DOI DOI 10.1155/2014/641708.;BARBARO V, 2006, INVEST OPHTH VIS SCI, V47, P5243, DOI 10.1167/IOVS.06-0185.;BISCEGLIA L, 2005, INVEST OPHTH VIS SCI, V46, P39, DOI 10.1167/IOVS.04-0533.;BISCEGLIA L, 2009, INVEST OPHTH VIS SCI, V50, P1081, DOI 10.1167/IOVS.08-2382.;BURDON KP, 2008, HUM GENET, V124, P379, DOI 10.1007/S00439-008-0555-Z.;DASH DP, 2010, EYE, V24, P1085, DOI 10.1038/EYE.2009.217.;DE BONIS P, 2011, MOL VIS, V17, P2482.;DEHKORDI FA, 2013, ACTA CYTOL, V57, P646, DOI 10.1159/000353297.;DELAVERI A, 2014, META GENE, V2, P619, DOI 10.1016/J.MGENE.2014.07.009.;ERAN P, 2008, OPHTHALMIC GENET, V29, P53, DOI 10.1080/13816810802008242.;FUNG SSM, 2016, EYE, V30, P553, DOI 10.1038/EYE.2015.273.;GAJECKA M, 2009, INVEST OPHTH VIS SCI, V50, P1531, DOI 10.1167/IOVS.08-2173.;GALVIS V, 2016, CORNEA, V35, PE6, DOI 10.1097/ICO.0000000000000748.;HAMASAKI-KATAGIRI N, 2013, J MOL BIOL, V425, P4023, DOI 10.1016/J.JMB.2013.07.037.;HEON E, 2002, HUM MOL GENET, V11, P1029, DOI 10.1093/HMG/11.9.1029.;JEOUNG JW, 2012, CORNEA, V31, P746, DOI 10.1097/ICO.0B013E3181E16DD0.;KAROLAK JA, 2016, OPHTHALMIC GENET, V37, P37, DOI 10.3109/13816810.2014.926375.;MAHARANA PK, 2014, EYE CONTACT LENS, V40, P382, DOI 10.1097/ICL.0000000000000076.;MOCAN MC, 2008, CLIN EXP OPHTHALMOL, V36, P329, DOI 10.1111/J.1442-9071.2008.01737.X.;MOK JW, 2008, J HUM GENET, V53, P842, DOI 10.1007/S10038-008-0319-6.;NOWAK DM, 2011, MIDDLE EAST AFR J OP, V18, P2, DOI 10.4103/0974-9233.75876.;PALIWAL P, 2011, MOL VIS, V17, P481.;PALIWAL P, 2009, MOL VIS, V15, P2475.;PATEL S, 2011, BRIT J OPHTHALMOL, V95, P759, DOI 10.1136/BJO.2010.200618.;PENA-GARCIA P, 2016, J BIOMECH, V49, P353, DOI 10.1016/J.JBIOMECH.2015.12.031.;RABINOWITZ YARON S, 2003, OPHTHALMOL CLIN NORTH AM, V16, P607, DOI 10.1016/S0896-1549(03)00099-3.;RABINOWITZ YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7.;SAEE-RAD S, 2011, MOL VIS, V17, P3128.;SHETTY R, 2015, BMC MED GENET, V16, DOI 10.1186/S12881-015-0178-X.;STABUC-SILIH M, 2010, ACTA DERMATOVEN ALP, V19, P3.;STABUC-SILIH M, 2010, CORNEA, V29, P172, DOI 10.1097/ICO.0B013E3181AEBF7A.;SZCZOTKA-FLYNN L, 2008, BRIT J OPHTHALMOL, V92, P1108, DOI 10.1136/BJO.2007.130294.;TANG YMG, 2008, CORNEA, V27, P189, DOI 10.1097/ICO.0B013E31815A50E7.;TANWAR M, 2010, MOL VIS, V16, P2395.;VERMA ANSHUMAN, 2013, BMC RES NOTES, V6, P103, DOI 10.1186/1756-0500-6-103.;VINCENT AL, 2013, MOL VIS, V19, P852.","YAO, YF (REPRINT AUTHOR), ZHEJIANG UNIV, SIR RUN RUN SHAW HOSP, DEPT OPHTHALMOL, SCH MED, HANGZHOU 310016, ZHEJIANG, PEOPLES R CHINA.;GUAN, TAO, WU, HAI-JIAN, TAIZHOU MUNICIPAL HOSP, DEPT OPHTHALMOL, TAIZHOU 318000, PEOPLES R CHINA.;WANG, XUE, SECOND HOSP NINGBO YINZHOU, LAB KIDNEY CARCINOMA, NINGBO 315000, ZHEJIANG, PEOPLES R CHINA.;ZHENG, LI-BIN, YAO, YU-FENG, ZHEJIANG UNIV, SIR RUN RUN SHAW HOSP, DEPT OPHTHALMOL, SCH MED, HANGZHOU 310016, ZHEJIANG, PEOPLES R CHINA.","10.1186/S12886-017-0567-3","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","173",NA,"MEDICAL SCIENTIFIC RESEARCH FOUNDATION OF ZHEJIANG PROVINCE, CHINA [2013KYA233]","THE STUDY WAS SUPPORTED BY THE MEDICAL SCIENTIFIC RESEARCH FOUNDATION OF ZHEJIANG PROVINCE, CHINA (GRANT NO. 2013KYA233).",NA,"1471-2415",NA,NA,"BIOMED CENTRAL LTD","17",2017,"ISI000411688800001","38","OPHTHALMOLOGY","2","OPHTHALMOLOGY","1054484763QQ.COM",NA,"FI1JJ",NA,"YAO, YF (REPRINT AUTHOR), ZHEJIANG UNIV, SIR RUN RUN SHAW HOSP, DEPT OPHTHALMOL, SCH MED, HANGZHOU 310016, ZHEJIANG, PEOPLES R CHINA","ISI","TAIZHOU MUNICIPAL HOSP;SECOND HOSP NINGBO YINZHOU;ZHEJIANG UNIV","ZHEJIANG UNIV",NA,"GUAN T, 2017, BMC OPHTHALMOL","GUAN T, 2017, BMC OPHTHALMOL"
"OLSON ND, 2017, PEERJ","OLSON ND;ZOOK JM;MORROW JB;LIN NJ","CHALLENGING A BIOINFORMATIC TOOL'S ABILITY TO DETECT MICROBIAL CONTAMINANTS USING IN SILICO WHOLE GENOME SEQUENCING DATA","PEERJ","PEERJ","HIGH SENSITIVITY METHODS SUCH AS NEXT GENERATION SEQUENCING AND POLYMERASE CHAIN REACTION (PCR) ARE ADVERSELY IMPACTED BY ORGANISMAL AND DNA CONTAMINANTS. CURRENT METHODS FOR DETECTING CONTAMINANTS IN MICROBIAL MATERIALS (GENOMIC DNA AND CULTURES) ARE NOT SENSITIVE ENOUGH AND REQUIRE EITHER A KNOWN OR CULTURABLE CONTAMINANT. WHOLE GENOME SEQUENCING (WGS) IS A PROMISING APPROACH FOR DETECTING CONTAMINANTS DUE TO ITS SENSITIVITY AND LACK OF NEED FOR A PRIORI ASSUMPTIONS ABOUT THE CONTAMINANT. PRIOR TO APPLYING WGS, WE MUST FIRST UNDERSTAND ITS LIMITATIONS FOR DETECTING CONTAMINANTS AND POTENTIAL FOR FALSE POSITIVES. HEREIN WE DEMONSTRATE AND CHARACTERIZE A WGS-BASED APPROACH TO DETECT ORGANISMAL CONTAMINANTS USING AN EXISTING METAGENOMIC TAXONOMIC CLASSIFICATION ALGORITHM. SIMULATED WGS DATASETS FROM TEN GENERA AS INDIVIDUALS AND BINARY MIXTURES OF EIGHT ORGANISMS AT VARYING RATIOS WERE ANALYZED TO EVALUATE THE ROLE OF CONTAMINANT CONCENTRATION AND TAXONOMY ON DETECTION. FOR THE INDIVIDUAL GENOMES THE FALSE POSITIVE CONTAMINANTS REPORTED DEPENDED ON THE GENUS, WITH STAPHYLOCOCCUS, ESCHERTCHTA, AND SHTGELLA HAVING THE HIGHEST PROPORTION OF FALSE POSITIVES. FOR NEARLY ALL BINARY MIXTURES THE CONTAMINANT WAS DETECTED IN THE IN-SILICO DATASETS AT THE EQUIVALENT OF 1 IN 1,000 CELLS, THOUGH F. TULARENSIS WAS NOT DETECTED IN ANY OF THE SIMULATED CONTAMINANT MIXTURES AND Y. PESTIS WAS ONLY DETECTED AT THE EQUIVALENT OF ONE IN 10 CELLS. ONCE A WGS METHOD FOR DETECTING CONTAMINANTS IS CHARACTERIZED, IT CAN BE APPLIED TO EVALUATE MICROBIAL MATERIAL PURITY IN EFFORTS TO ENSURE THAT CONTAMINANTS ARE CHARACTERIZED IN MICROBIAL MATERIALS USED TO VALIDATE PATHOGEN DETECTION ASSAYS, GENERATE GENOME ASSEMBLIES FOR DATABASE SUBMISSION, AND BENCHMARK SEQUENCING METHODS.","GENOMIC PURITY; WHOLE GENOME SEQUENCING; BIOINFORMATICS; BIODETECTION; MICROBIAL MATERIALS; REFERENCE MATERIALS","CLASSIFICATION; METAGENOMICS; IDENTIFICATION; EVOLUTION; BACTERIAL; QUALITY; AGENT","ENGLISH","ARTICLE","ARTICLE",2,"BAZINET AL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-92.;BOKULICH NA, 2016, MSYSTEMS, V1, DOI 10.1128/MSYSTEMS.00062-16.;CHAIN PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI [10.1073/PNAS.0404012101, 10.1073/PNAS.0401412101].;CHAMBERLAIN S, 2016, TAXIZE TAXONOMIC INF.;CHAMBERLAIN SCOTT A, 2013, F1000RES, V2, P191, DOI 10.12688/F1000RESEARCH.2-191.V1.;COATES SG, 2011, J AOAC INT, V94, P1328.;DELMONT TO, 2016, PEERJ, V4, DOI 10.7717/PEERJ.1839.;FRANCIS OE, 2013, GENOME RES, V23, P1721, DOI 10.1101/GR.150151.112.;HECK K, 2016, J MICROBIOL METH, V129, P55, DOI 10.1016/J.MIMET.2016.07.023.;HUANG WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/BIOINFORMATICS/BTR708.;IEVEN M, 2013, CLIN MICROBIOL INFEC, V19, P29, DOI 10.1111/1469-0691.12052.;JERVIS-BARDY J, 2015, MICROBIOME, V3, DOI 10.1186/S40168-015-0083-8.;KIM D, 2016, GENOME RES, V26, P1721, DOI 10.1101/GR.210641.116.;KUMAR SUJAI, 2013, FRONTIERS IN GENETICS, V4, P237, DOI 10.3389/FGENE.2013.00237.;KUNIN V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08.;KURTZ S, 2004, GENOME BIOL, V5, DOI 10.1186/GB-2004-5-2-R12.;LAN RT, 2002, MICROBES INFECT, V4, P1125, DOI 10.1016/S1286-4579(02)01637-4.;LANGMEAD B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/NMETH.1923].;LARSSON P, 2005, NAT GENET, V37, P153, DOI 10.1038/NG1499.;LINDNER MS, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0117711.;MARRON AO, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0061732.;MENZEL P, 2016, NAT COMMUN, V7, DOI 10.1038/NCOMMS11257.;MOTLEY ST, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-443.;MUKHERJEE S, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/1944-3277-10-18.;OLSON ND, 2016, ANAL BIOANAL CHEM, V408, P2975, DOI 10.1007/S00216-015-9299-5.;PARKS DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/GR.186072.114.;PIRO VC, 2016, BIOINFORMATICS, V32, P2272, DOI 10.1093/BIOINFORMATICS/BTW150.;POLZ MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/J.TIG.2012.12.006.;R CORE TEAM, 2016, R LANG ENV STAT COMP.;SCHMIEDER R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/BIOINFORMATICS/BTR026.;SCZYRBA A., 2017, BIORXIV, DOI [10.1101/099127, DOI 10.1101/099127].;SHINTANI M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/FMICB.2015.00242.;SHRESTHA PM, 2013, MBIO, V4, DOI 10.1128/MBIO.00591-12.;TENNESSEN K, 2016, ISME J, V10, P269, DOI 10.1038/ISMEJ.2015.100.;THOMAS TORSTEN, 2012, MICROB INFORM EXP, V2, P3, DOI 10.1186/2042-5783-2-3.;TONG SYC, 2015, INT J SYST EVOL MICR, V65, P15, DOI 10.1099/IJS.0.062752-0.;WATANABE S, 2012, J BACTERIOL, V194, P7007, DOI 10.1128/JB.01798-12.;WENG FC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-565.;WHITE J. M, 2014, PROJECTTEMPLATE AUTO.;WOYKE T, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0026161.","OLSON, ND (REPRINT AUTHOR), NIST, MAT MEASUREMENT LAB, GAITHERSBURG, MD 20899 USA.;OLSON, NATHAN D., ZOOK, JUSTIN M., MORROW, JAYNE B., LIN, NANCY J., NIST, MAT MEASUREMENT LAB, GAITHERSBURG, MD 20899 USA.","10.7717/PEERJ.3729","341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND","E3729",NA,"DEPARTMENT OF HOMELAND SECURITY (DHS) SCIENCE AND TECHNOLOGY DIRECTORATE [HSHQPM-15-T-00019], NIST","THE DEPARTMENT OF HOMELAND SECURITY (DHS) SCIENCE AND TECHNOLOGY DIRECTORATE SUPPORTED THIS WORK UNDER THE INTERAGENCY AGREEMENT HSHQPM-15-T-00019 WITH THE NIST. THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT.",NA,"2167-8359",NA,NA,"PEERJ INC","5",2017,"ISI000410724700002","40","SCIENCE \& TECHNOLOGY - OTHER TOPICS","4","MULTIDISCIPLINARY SCIENCES","NOLSONNIST.GOV",NA,"FG8YN",NA,"OLSON, ND (REPRINT AUTHOR), NIST, MAT MEASUREMENT LAB, GAITHERSBURG, MD 20899 USA","ISI","MAT MEASUREMENT LAB","MAT MEASUREMENT LAB",NA,"OLSON ND, 2017, PEERJ","OLSON ND, 2017, PEERJ"
"YAO Y, 2017, PLOS ONE","YAO Y;ZHENG X;GE X;XIU Y;ZHANG L;FANG W;ZHAO J;GU F;ZHU Y","IDENTIFICATION OF A NOVEL GJA3 MUTATION IN A LARGE CHINESE FAMILY WITH CONGENITAL CATARACT USING TARGETED EXOME SEQUENCING","PLOS ONE","PLOS ONE","AUTOSOMAL DOMINANT CONGENITAL CATARACT (ADCC) IS A CLINICALLY AND GENETICALLY HETEROGENEOUS OCULAR DISEASE IN CHILDREN THAT RESULTS IN SERIOUS VISUAL IMPAIRMENTS OR EVEN BLINDNESS. TARGETED EXOME SEQUENCING (TES) IS AN EFFICIENT METHOD USED FOR GENETIC DIAGNOSES OF INHERITED DISEASES. IN THE PRESENT STUDY, WE USED A CUSTOM-MADE TES PANEL TO IDENTIFY THE GENETIC DEFECT OF A FOUR-GENERATION CHINESE FAMILY WITH BILATERAL PULVERULENT NUCLEAR CATARACTS. A NOVEL HETEROZYGOUS MISSENSE MUTATION C. 443C>T (P. T148I) IN GJA3 WAS IDENTIFIED. THE RESULTS OF THE BIOINFORMATIC ANALYSIS SHOWED THAT THE MUTATION WAS DELETERIOUS TO THE STRUCTURE AND HEMICHANNEL FUNCTION OF CX46 ENCODED BY GJA3. PLASMIDS EXPRESSING WILDTYPE AND MUTANT HUMAN CX46 WERE CONSTRUCTED AND ECTOPICALLY EXPRESSED IN HUMAN LENS EPITHELIAL CELLS (HLECS) OR HUMAN EMBRYONIC KIDNEY (HEK-293) CELLS. FLUORESCENT IMAGES INDICATED AGGREGATED SIGNALS OF MUTANT PROTEIN IN THE CYTOPLASM, AND A HIGHER PROTEIN LEVEL WAS ALSO DETECTED IN T148I STABLE CELL LINES. IN SUMMARY, WE IDENTIFIED A NOVEL MUTATION IN GJA3 FOR ADCC, WHICH PROVIDED MOLECULAR INSIGHTS INTO THE PATHOGENIC MECHANISM OF ADCC.",NA,"GAP-JUNCTIONS; CONNEXIN GENES; HEMICHANNELS; MUTANT; GENETICS; CHANNELS; GROWTH; LENS","ENGLISH","ARTICLE","ARTICLE",1,"BANERJEE D, 2011, J BIOL CHEM, V286, P24519, DOI 10.1074/JBC.M110.217208.;BANKS EA, 2009, J CELL SCI, V122, P378, DOI 10.1242/JCS.034124.;BERTHOUD VM, 2017, BMC CELL BIOL, V18, DOI 10.1186/S12860-016-0116-6.;BEYER EC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/FPHYS.2014.00020.;CHEN C, 2015, GRAEF ARCH CLIN EXP, V253, P915, DOI 10.1007/S00417-015-3019-X.;CHURCHILL A, 2011, PHILOS T R SOC B, V366, P1234, DOI 10.1098/RSTB.2010.0227.;DAS SARMA J, 2002, J BIOL CHEM, V277, P20911, DOI 10.1074/JBC.M111498200.;DAS SARMA J, 2001, J CELL SCI, V114, P4013.;DEROSA AM, 2009, EXP CELL RES, V315, P1063, DOI 10.1016/J.YEXCR.2009.01.017.;DUFLOTDANCER A, 1997, ONCOGENE, V15, P2151, DOI 10.1038/SJ.ONC.1201393.;FOSTER A., 1993, SEMIN OPHTHALMOL, V8, P166.;GE XL, 2014, SCI REP-UK, V4, DOI 10.1038/SREP04121.;GILBERT C, 2001, B WORLD HEALTH ORGAN, V79, P227.;GU F, 2008, HUM MUTAT, V29, P769, DOI 10.1002/HUMU.20724.;HAARGAARD B, 2004, OPHTHALMOLOGY, V111, P2292, DOI 10.1016/J.OPHTHA.2004.06.024.;HEJTMANCIK JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/J.SEMCDB.2007.10.003.;HOANG QV, 2010, MOL VIS, V16, P1343.;HU DN, 1987, J MED GENET, V24, P584, DOI 10.1136/JMG.24.10.584.;HUANG BY, 2010, EUR J MED GENET, V53, P347, DOI 10.1016/J.EJMG.2010.07.001.;KUMAR M, 2013, MOL VIS, V19, P2436.;LIU YY, 2015, J GENET, V94, P221.;MATHIAS RT, 2010, PHYSIOL REV, V90, P179, DOI 10.1152/PHYSREV.00034.2009.;MCCARTY CA, 2001, INVEST OPHTH VIS SCI, V42, P1677.;MEI R, 2016, GRAEFES ARCH CLIN EX, V255, P131 .;MESE G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/SJ.JID.5700770.;MESSINA-BAAS O, 2017, MOL SYNDROMOL, V8, P58, DOI 10.1159/000455752.;MORLEY GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8.;PFENNIGER A, 2011, EUR J CLIN INVEST, V41, P103, DOI 10.1111/J.1365-2362.2010.02378.X.;PONSAERTS R, 2010, FASEB J, V24, P4378, DOI 10.1096/FJ.09-153007.;REN Q, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0074732.;RUBINOS C, 2014, AM J PHYSIOL-CELL PH, V306, PC212, DOI 10.1152/AJPCELL.00098.2013.;SCHLINGMANN B, 2012, J BIOENERG BIOMEMBR, V44, P607, DOI 10.1007/S10863-012-9461-0.;SHIELS A, 2010, MOL VIS, V16, P2007.;SUN WM, 2011, MOL VIS, V17, P1508.;THOMAS BC, 2008, IOVS, V49.;TONG JJ, 2015, J MEMBRANE BIOL, V248, P145, DOI 10.1007/S00232-014-9752-Y.;TONG JJ, 2011, AM J PHYSIOL-CELL PH, V300, PC1055, DOI 10.1152/AJPCELL.00384.2010.;YAO K, 2011, HUM MUTAT, V32, P1367, DOI 10.1002/HUMU.21552.;YU YH, 2016, SCI REP-UK, V6, DOI 10.1038/SREP26551.;ZHAO L, 2015, NATURE, V523, P607, DOI 10.1038/NATURE14650.;ZHU Y, 2014, PLOS ONE, V9.","ZHU, YH (REPRINT AUTHOR), FUJIAN MED UNIV, AFFILIATED HOSP 1, FUZHOU, FUJIAN, PEOPLES R CHINA.;GU, F (REPRINT AUTHOR), WENZHOU MED UNIV, SCH OPHTHALMOL \& OPTOMETRY, EYE HOSP, STATE KEY LAB CULTIVAT BASE, WENZHOU, ZHEJIANG, PEOPLES R CHINA.;GU, F (REPRINT AUTHOR), MINIST HLTH, KEY LAB VIS SCI, WENZHOU, ZHEJIANG, PEOPLES R CHINA.;GU, F (REPRINT AUTHOR), ZHEJIANG PROV KEY LAB OPHTHALMOL \& OPTOMETRY, WENZHOU, ZHEJIANG, PEOPLES R CHINA.;YAO, YIHUA, ZHENG, XUEDONG, XIU, YANGHUI, ZHANG, LIU, FANG, WEIFANG, ZHU, YIHUA, FUJIAN MED UNIV, AFFILIATED HOSP 1, FUZHOU, FUJIAN, PEOPLES R CHINA.;GE, XIANGLIAN, GU, FENG, WENZHOU MED UNIV, SCH OPHTHALMOL \& OPTOMETRY, EYE HOSP, STATE KEY LAB CULTIVAT BASE, WENZHOU, ZHEJIANG, PEOPLES R CHINA.;GE, XIANGLIAN, GU, FENG, MINIST HLTH, KEY LAB VIS SCI, WENZHOU, ZHEJIANG, PEOPLES R CHINA.;GE, XIANGLIAN, GU, FENG, ZHEJIANG PROV KEY LAB OPHTHALMOL \& OPTOMETRY, WENZHOU, ZHEJIANG, PEOPLES R CHINA.;ZHAO, JUNZHAO, WENZHOU MED UNIV, AFFILIATED HOSP 2, WENZHOU, ZHEJIANG, PEOPLES R CHINA.;ZHAO, JUNZHAO, WENZHOU MED UNIV, YUYING CHILDRENS HOSP, WENZHOU, ZHEJIANG, PEOPLES R CHINA.","10.1371/JOURNAL.PONE.0184440","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E0184440",NA,"NATURAL SCIENCE FOUNDATION OF CHINA [81270999/H1204, 81201181/H1818], PROFESSOR ACADEMIC DEVELOPMENT FUND OF FUJIAN MEDICAL UNIVERSITY [JS14019], CHINESE NATIONAL PROGRAM ON KEY BASIC RESEARCH PROJECT (973 PROGRAM) [2013CB967502], ZHEJIANG PROVINCIAL \& MINISTRY OF HEALTH RESEARCH FUND FOR MEDICAL SCIENCES [201339279], WENZHOU MEDICAL UNIVERSITY PI START-UP GRANT [QTJ12011]","THIS WORK WAS SUPPORTED BY GRANTS FROM NATURAL SCIENCE FOUNDATION OF CHINA (81270999/H1204, YHZ, HTTP://WWW.NSFC.GOV.CN/), PROFESSOR ACADEMIC DEVELOPMENT FUND OF FUJIAN MEDICAL UNIVERSITY (JS14019, YHZ, HTTP://WWW.NSFC.GOV.CN/), THE CHINESE NATIONAL PROGRAM ON KEY BASIC RESEARCH PROJECT (973 PROGRAM, 2013CB967502, FG, HTTP://PROGRAM.MOST.GOV.CN/), NATURAL SCIENCE FOUNDATION OF CHINA (81201181/H1818, FG, HTTP://WWW.NSFC.GOV.CN/), ZHEJIANG PROVINCIAL \& MINISTRY OF HEALTH RESEARCH FUND FOR MEDICAL SCIENCES (201339279, FG,HTTP://WWW.ZJKJT.GOV.CN/), WENZHOU MEDICAL UNIVERSITY PI START-UP GRANT (QTJ12011, FG, HTTP://WWW.WMU.EDU.CN/).",NA,"1932-6203","9",NA,"PUBLIC LIBRARY SCIENCE","12",2017,"ISI000409391200103","41","SCIENCE \& TECHNOLOGY - OTHER TOPICS","6","MULTIDISCIPLINARY SCIENCES","FGUMAIL.EYE.AC.CN ZHUYIHUA209163.COM",NA,"FG0EG",NA,"ZHU, YH (REPRINT AUTHOR), FUJIAN MED UNIV, AFFILIATED HOSP 1, FUZHOU, FUJIAN, PEOPLES R CHINA","ISI","FUJIAN MED UNIV;WENZHOU MED UNIV;KEY LAB VIS SCI;ZHEJIANG PROV KEY LAB OPHTHALMOL AND OPTOMETRY;WENZHOU MED UNIV;WENZHOU MED UNIV","FUJIAN MED UNIV",NA,"YAO Y, 2017, PLOS ONE","YAO Y, 2017, PLOS ONE"
"KHAN AS, 2017, MSPHERE","KHAN AS;NG SHS;VANDEPUTTE O;ALJANAHI A;DEYATI A;CASSART JP;CHARLEBOIS RL;TALIAFERRO LP","A MULTICENTER STUDY TO EVALUATE THE PERFORMANCE OF HIGH-THROUGHPUT SEQUENCING FOR VIRUS DETECTION","MSPHERE","MSPHERE","THE CAPABILITY OF HIGH-THROUGHPUT SEQUENCING (HTS) FOR DETECTION OF KNOWN AND UNKNOWN VIRUSES MAKES IT A POWERFUL TOOL FOR BROAD MICROBIAL INVESTIGATIONS, SUCH AS EVALUATION OF NOVEL CELL SUBSTRATES THAT MAY BE USED FOR THE DEVELOPMENT OF NEW BIOLOGICAL PRODUCTS. HOWEVER, LIKE ANY NEW ASSAY, REGULATORY APPLICATIONS OF HTS NEED METHOD STANDARDIZATION. THEREFORE, OUR THREE LABORATORIES INITIATED A STUDY TO EVALUATE PERFORMANCE OF HTS FOR POTENTIAL DETECTION OF VIRAL ADVENTITIOUS AGENTS BY SPIKING MODEL VIRUSES IN DIFFERENT CELLULAR MATRICES TO MIMIC PUTATIVE MATERIALS FOR MANUFACTURING OF BIOLOGICS. FOUR MODEL VIRUSES WERE SELECTED BASED UPON DIFFERENT PHYSICAL AND BIOCHEMICAL PROPERTIES AND COMMERCIAL AVAILABILITY: HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV), EPSTEIN-BARR VIRUS (EBV), FELINE LEUKEMIA VIRUS (FELV), AND HUMAN REOVIRUS (REO). ADDITIONALLY, PORCINE CIRCOVIRUS (PCV) WAS TESTED BY ONE LABORATORY. INDEPENDENT SAMPLES WERE PREPARED FOR HTS BY SPIKING INTACT VIRUSES OR EXTRACTED VIRAL NUCLEIC ACIDS, SINGLY OR MIXED, INTO DIFFERENT HELA CELL MATRICES (RESUSPENDED WHOLE CELLS, CELL LYSATE, OR TOTAL CELLULAR RNA). DATA WERE OBTAINED USING DIFFERENT SEQUENCING PLATFORMS (ROCHE 454, ILLUMINA HISEQ1500 OR HISEQ2500). BIOINFORMATIC ANALYSES WERE PERFORMED INDEPENDENTLY BY EACH LABORATORY USING AVAILABLE TOOLS, PIPELINES, AND DATABASES. THE RESULTS SHOWED THAT COMPARABLE VIRUS DETECTION WAS OBTAINED IN THE THREE LABORATORIES REGARDLESS OF SAMPLE PROCESSING, LIBRARY PREPARATION, SEQUENCING PLATFORM, AND BIOINFORMATIC ANALYSIS: BETWEEN 0.1 AND 3 VIRAL GENOME COPIES PER CELL WERE DETECTED FOR ALL OF THE MODEL VIRUSES USED. THIS STUDY HIGHLIGHTS THE POTENTIAL FOR USING HTS FOR SENSITIVE DETECTION OF ADVENTITIOUS VIRUSES IN COMPLEX BIOLOGICAL SAMPLES CONTAINING CELLULAR BACKGROUND. I MPORTANCE RECENT HIGH-THROUGHPUT SEQUENCING (HTS) INVESTIGATIONS HAVE RESULTED IN UNEXPECTED DISCOVERIES OF KNOWN AND NOVEL VIRUSES IN A VARIETY OF SAMPLE TYPES, INCLUDING RESEARCH MATERIALS, CLINICAL MATERIALS, AND BIOLOGICAL PRODUCTS. THEREFORE, HTS CAN BE A POWERFUL TOOL FOR SUPPLEMENTING CURRENT METHODS FOR DEMONSTRATING THE ABSENCE OF ADVENTITIOUS OR UNWANTED VIRUSES IN BIOLOGICAL PRODUCTS, PARTICULARLY WHEN USING A NEW CELL LINE. HOWEVER, HTS IS A COMPLEX TECHNOLOGY WITH DIFFERENT PLATFORMS, WHICH NEEDS STANDARDIZATION FOR EVALUATION OF BIOLOGICS. THIS COLLABORATIVE STUDY WAS UNDERTAKEN TO INVESTIGATE DETECTION OF DIFFERENT VIRUS TYPES USING TWO DIFFERENT HTS PLATFORMS. THE RESULTS OF THE INDEPENDENTLY PERFORMED STUDIES DEMONSTRATED A SIMILAR SENSITIVITY OF VIRUS DETECTION, REGARDLESS OF THE DIFFERENT SAMPLE PREPARATION AND PROCESSING PROCEDURES AND BIOINFORMATIC ANALYSES DONE IN THE THREE LABORATORIES. COMPARABLE HTS DETECTION OF DIFFERENT VIRUS TYPES SUPPORTS FUTURE DEVELOPMENT OF REFERENCE VIRUS MATERIALS FOR STANDARDIZATION AND VALIDATION OF DIFFERENT HTS PLATFORMS.","454 ROCHE; ILLUMINA; ADVENTITIOUS VIRUSES; HIGH-THROUGHPUT SEQUENCING; SPIKING STUDY; VIRUS DETECTION","POLYMERASE-CHAIN-REACTION; BIOLOGICAL PRODUCTS; VIRAL METAGENOMICS; RNA-SEQ; IDENTIFICATION; INTEGRATION; VACCINES; SAMPLES; VIROME; HEALTH","ENGLISH","ARTICLE","ARTICLE",1,"BOLGER AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/BIOINFORMATICS/BTU170.;BUSTIN SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/CLINCHEM.2008.112797.;CARAGUEL CGB, 2011, J VET DIAGN INVEST, V23, P2, DOI 10.1177/104063871102300102.;CHARLEBOIS ROBERT L, 2014, PDA J PHARM SCI TECHNOL, V68, P602, DOI 10.5731/PDAJPST.2014.01023.;CHEVAL J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11.;CONCEICAO-NETO N, 2015, SCI REP-UK, V5, DOI 10.1038/SREP16532.;DELWART E, 2012, CURR OPIN VIROL, V2, P344, DOI 10.1016/J.COVIRO.2012.02.012.;DUBIN G, 2013, HUM VACC IMMUNOTHER, V9, P2398, DOI 10.4161/HV.25973.;FISCHER N, 2015, J CLIN MICROBIOL, V53, P2238, DOI 10.1128/JCM.02495-14.;GOMBOLD J, 2014, VACCINE, V32, P2916, DOI 10.1016/J.VACCINE.2014.02.021.;GRENINGER AL, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0013381.;HANDLEY SA, 2016, GENOME MED, V8, DOI 10.1186/S13073-016-0287-Y.;HEATHER JM, 2016, GENOMICS, V107, P1, DOI 10.1016/J.YGENO.2015.11.003.;HOU YB, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0009545.;JENSEN RH, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0122636.;KHAN A S, 2010, PDA J PHARM SCI TECHNOL, V64, P451.;KHAN A S, 2010, PDA J PHARM SCI TECHNOL, V64, P426.;KHAN ARIFA S, 2016, PDA J PHARM SCI TECHNOL, V70, P591.;KHAN ARIFA S, 2012, PDA J PHARM SCI TECHNOL, V66, P502, DOI 10.5731/PDAJPST.2012.00895.;KHAN ARIFA S, 2011, PDA J PHARM SCI TECHNOL, V65, P627, DOI 10.5731/PDAJPST.2011.00831.;KHAN AS, 2015, 71 PDA.;LI H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/BIOINFORMATICS/BTP698.;LI L, 2015, J VIROL METHODS, V213, P139, DOI 10.1016/J.JVIROMET.2014.12.002.;LIN CH, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0029101.;MA HL, 2014, J VIROL, V88, P6576, DOI 10.1128/JVI.00780-14.;MALLET LAURENT, 2014, PDA J PHARM SCI TECHNOL, V68, P556, DOI 10.5731/PDAJPST.2014.01012.;MARCUS-SEKURA C, 2011, BIOLOGICALS, V39, P359, DOI 10.1016/J.BIOLOGICALS.2011.08.003.;MEE ET, 2015, VACCINE, V33, P3533, DOI 10.1016/J.VACCINE.2015.05.052.;MEHRA S, 2005, BIOTECHNOL BIOENG, V91, P848, DOI 10.1002/BIT.20555.;MOUNT D. W., 2007, CSH PROTOC.;PETRICCIANI J, 2014, BIOLOGICALS, V42, P223, DOI 10.1016/J.BIOLOGICALS.2014.07.003.;PICKEN RN, 1987, NUCLEIC ACIDS RES, V15, P10068, DOI 10.1093/NAR/15.23.10068.;PRACHAYANGPRECHA S, 2014, J CLIN MICROBIOL, V52, P3722, DOI 10.1128/JCM.01641-14.;QIU YC, 2013, BIOTECHNOL BIOENG, V110, P1342, DOI 10.1002/BIT.24791.;RICE P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2.;ROBINSON JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/NBT.1754.;SUN H, 2015, J PROTEOME RES, V14, P1678, DOI 10.1021/PR500944C.;TALIAFERRO LP, 2014, VIRUSES-BASEL, V6, P1876, DOI 10.3390/V6051876.;THE INTERNATIONAL COUNCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE (ICH), 1999, Q5AR1 VIR SAF EV BIO.;TIMM C, 2014, J VIROL, V88, P2623, DOI 10.1128/JVI.02675-13.;US FOOD AND DRUG ADMINISTRATION, 2010, GUID IND CHAR QUAL C.;VAN DIJK EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/J.TIG.2014.07.001.;VICTORIA JG, 2010, J VIROL, V84, P6033, DOI 10.1128/JVI.02690-09.;WYLIE KM, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0027735.;ZHAO W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-419.;ZHULIDOV PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/NAR/GNH031.","KHAN, AS (REPRINT AUTHOR), US FDA, DIV VIRAL PROD, OFF VACCINES RES \& REVIEW, CTR BIOL EVALUAT \& RES, SILVER SPRING, MD 20993 USA.;KHAN, ARIFA S., ALJANAHI, AISHA, TALIAFERRO, LANYN P., US FDA, DIV VIRAL PROD, OFF VACCINES RES \& REVIEW, CTR BIOL EVALUAT \& RES, SILVER SPRING, MD 20993 USA.;NG, SIEMON H. S., CHARLEBOIS, ROBERT L., SANOFI PASTEUR, ANALYT RES \& DEV NORTH AMER, TORONTO, ON, CANADA.;VANDEPUTTE, OLIVIER, GSK VACCINES, ANALYT RES \& DEV, RIXENSART, BELGIUM.;DEYATI, AVISEK, GSK VACCINES, VACCINE DISCOVERY \& DEV, RIXENSART, BELGIUM.;CASSART, JEAN-POL, GSK VACCINES, CENT QUAL CONTROL, WAVRE, BELGIUM.;ALJANAHI, AISHA, GEORGETOWN UNIV, WASHINGTON, DC USA.;ALJANAHI, AISHA, NIH, BLDG 10, BETHESDA, MD 20892 USA.","10.1128/MSPHERE.00307-17","1752 N ST NW, WASHINGTON, DC 20036-2904 USA","E00307-17",NA,NA,NA,NA,"2379-5042","5",NA,"AMER SOC MICROBIOLOGY","2",2017,"ISI000416998800010","46","MICROBIOLOGY","2","MICROBIOLOGY","ARIFA.KHANFDA.HHS.GOV",NA,"FO6TH",NA,"KHAN, AS (REPRINT AUTHOR), US FDA, DIV VIRAL PROD, OFF VACCINES RES \& REVIEW, CTR BIOL EVALUAT \& RES, SILVER SPRING, MD 20993 USA","ISI","CTR BIOL EVALUAT AND RES;ANALYT RES AND DEV NORTH AMER;ANALYT RES AND DEV;GEORGETOWN UNIV","CTR BIOL EVALUAT AND RES",NA,"KHAN AS, 2017, MSPHERE","KHAN AS, 2017, MSPHERE"
"LI Z, 2017, GENES IMMUN","LI Z;HAYNES K;PENNISI DJ;ANDERSON LK;SONG X;THOMAS GP;KENNA T;LEO P;BROWN MA","EPIGENETIC AND GENE EXPRESSION ANALYSIS OF ANKYLOSING SPONDYLITIS-ASSOCIATED LOCI IMPLICATE IMMUNE CELLS AND THE GUT IN THE DISEASE PATHOGENESIS","GENES AND IMMUNITY","GENES IMMUN.","ANKYLOSING SPONDYLITIS (AS) IS A COMMON IMMUNE-MEDIATED ARTHROPATHY PRIMARILY AFFECTING THE SPINE AND PELVIS. MOST AS PATIENTS HAVE SUBCLINICAL INTESTINAL INFLAMMATION, SUGGESTING THE GUT MICROBIOME AND THE IMMUNE RESPONSE PLAY A ROLE IN PATHOGENESIS. SUSCEPTIBILITY TO AS IS PRIMARILY GENETIC, AND AT LEAST 114 SUSCEPTIBILITY VARIANTS HAVE BEEN IDENTIFIED TO DATE. WE APPLIED BIOINFORMATIC METHODS UTILIZING EPIGENETIC AND GENE AND PROTEIN EXPRESSION DATA TO IDENTIFY THE CELL TYPES THROUGH WHICH AS-ASSOCIATED VARIANTS OPERATE. VARIANTS WERE ENRICHED IN TRANSCRIPTIONALLY REGULATED REGIONS IN MONOCYTES, CD4(+) AND CD8(+) T CELLS, NATURAL KILLER CELLS, REGULATORY T CELLS AND B CELLS AND MUCOSA FROM THE SMALL INTESTINE, SIGMOID COLON AND RECTUM. WEAK SIGNALS WERE DETECTED IN BONE CELLS, CONSISTENT WITH BONE DISEASE BEING A SECONDARY MANIFESTATION. RNA SEQUENCING OF BLOOD CELLS FROM AS PATIENTS AND CONTROLS IDENTIFIED DIFFERENTIALLY EXPRESSED GENES. INTERROGATION OF EXPRESSION DATABASES SHOWED THAT THE UPREGULATED GENES WERE ENRICHED IN MONOCYTES AND DOWNREGULATED GENES WERE ENRICHED IN CD8(+) T CELLS AND NATURAL KILLER CELLS. GENE ONTOLOGY TERM ENRICHMENT ANALYSIS IDENTIFIED MICROBES AND THE GUT IN THE AETIOLOGY OF AS. THESE FINDINGS IDENTIFY THE KEY IMMUNE CELL TYPES THAT DRIVE THE DISEASE, AND FURTHER HIGHLIGHT THE INVOLVEMENT OF THE GUT MICROBIOME IN THE PATHOGENESIS OF AS.",NA,"INTESTINAL INFLAMMATION; SUSCEPTIBILITY LOCI; BONE-FORMATION; MAST-CELLS; VARIANTS; HLA-B27; GENOME; SPONDYLOARTHRITIS; SPONDYLARTHRITIS; MICROBIOTA","ENGLISH","ARTICLE","ARTICLE",2,"BERNSTEIN BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/NBT1010-1045.;BOWNESS P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/JIMMUNOL.1002653.;BRAUN J, 1998, ARTHRITIS RHEUM, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO,2-G.;BREWERTON DA, 1973, LANCET, V1, P904.;BROWN MA, 2000, ANN RHEUM DIS, V59, P883, DOI 10.1136/ARD.59.11.883.;BROWN MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/ART.1780401015.;BROWN MA, 2016, NAT REV RHEUMATOL, V12, P81, DOI 10.1038/NRRHEUM.2015.133.;CAFFREY MFP, 1973, NATURE, V242, P121, DOI 10.1038/242121A0.;CHAN AT, 2005, ARTHRITIS RHEUM, V52, P3586, DOI 10.1002/ART.21395.;CICCIA F, 2012, ARTHRITIS RHEUM-US, V64, P1869, DOI 10.1002/ART.34355.;CICCIA F, 2010, RHEUMATOLOGY, V49, P2076, DOI 10.1093/RHEUMATOLOGY/KEQ239.;CICCIA F, 2009, ARTHRITIS RHEUM, V60, P955, DOI 10.1002/ART.24389.;CONRAD K, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/S13075-015-0694-2.;CORTES A, 2015, NAT COMMUN, V6, DOI 10.1038/NCOMMS8146.;CORTES A, 2013, NAT GENET, V45, P730, DOI 10.1038/NG.2667.;COSTELLO ME, 2015, ARTHRITIS RHEUMATOL, V67, P686, DOI 10.1002/ART.38967.;COSTELLO ME, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/AR4228.;CUA DJ, 2011, NAT MED, V17, P1055, DOI 10.1038/NM0911-1055.;DANOY P, 2010, PLOS GENET, V6, DOI 10.1371/JOURNAL.PGEN.1001195.;DIENZ O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/J.CLIM.2008.08.018.;DUNHAM I, 2012, NATURE, V489, P57, DOI 10.1038/NATURE11247.;ELLINGHAUS D, 2016, NAT GENET, V48, P510, DOI 10.1038/NG.3528.;EVANS DM, 2011, NAT GENET, V43, P761, DOI 10.1038/NG.873.;FARH KKH, 2015, NATURE, V518, P337, DOI 10.1038/NATURE13835.;FRANKE A, 2010, NAT GENET, V42, P1118, DOI 10.1038/NG.717.;FRASER HB, 2009, GENOME RES, V19, P567, DOI 10.1101/GR.083477.108.;IBN-SALEM J, 2014, GENOME BIOL, V15, DOI 10.1186/S13059-014-0423-1.;KAMADA N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/NRI3430.;KENNA TJ, 2013, INT J CLIN RHEUMATOL, V8, P265.;KENNA TJ, 2013, NAT REV RHEUMATOL, V9, P375, DOI 10.1038/NRRHEUM.2012.205.;KENNA TJ, 2012, ARTHRITIS RHEUM-US, V64, P1420, DOI 10.1002/ART.33507.;KUMAR V, 2013, PLOS GENET, V9, DOI 10.1371/JOURNAL.PGEN.1003201.;LAU MC, 2017, ANN RHEUM DIS, V76, P261, DOI 10.1136/ANNRHEUMDIS-2015-208677.;LORIES RJU, 2012, RHEUM DIS CLIN N AM, V38, P555, DOI 10.1016/J.RDC.2012.08.003.;MAKSYMOWYCH WP, 2014, ARTHRITIS RHEUMATOL, V66, P2958, DOI 10.1002/ART.38792.;MAURANO MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/SCIENCE.1222794.;MEI Y, 2011, CLIN RHEUMATOL, V30, P269, DOI 10.1007/S10067-010-1647-4.;MIELANTS H, 1985, J RHEUMATOL, V12, P294.;NEWPORT M, 2007, NAT GENET, V39, P1329, DOI 10.1038/NG.2007.17.;NIU XY, 2013, LIFE SCI, V93, P687, DOI 10.1016/J.LFS.2013.09.003.;NOORDENBOS T, 2012, ARTHRITIS RHEUM-US, V64, P99, DOI 10.1002/ART.33396.;ONENGUT-GUMUSCU S, 2015, NAT GENET, V47, P381, DOI 10.1038/NG.3245.;PHIPSON B, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1585.;PINTO SM, 2014, J PROTEOME RES, V13, P2749, DOI 10.1021/PR401169D.;SCHIRMER M, 2002, ARTHRITIS RES, V4, P71, DOI 10.1186/AR386.;SHEN H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/ART.24568.;SHLYUEVA D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/NRG3682.;SLOWIKOWSKI K, 2014, BIOINFORMATICS, V30, P2496, DOI 10.1093/BIOINFORMATICS/BTU326.;SMITH JA, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/S11882-014-0489-6.;SONG IH, 2010, ARTHRITIS RHEUM-US, V62, P1290, DOI 10.1002/ART.27383.;SZALAY B, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/808724.;TRYNKA G, 2013, NAT GENET, V45, P124, DOI 10.1038/NG.2504.;TSENG HW, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/S13075-015-0805-0.;UDDIN M, 2015, SCI REP-UK, V5, DOI 10.1038/SREP10314.;WANG XW, 2009, RHEUMATOL INT, V29, P1343, DOI 10.1007/S00296-009-0883-X.;WRIGHT C, 2009, ANN RHEUM DIS, V68, P1626, DOI 10.1136/ARD.2008.097204.;ZENG QY, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/AR2368.;ZHU JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/ANNUREV-IMMUNOL-030409-101212.","BROWN, MA (REPRINT AUTHOR), QUEENSLAND UNIV TECHNOL, TRANSLAT RES INST, TRANSLAT GENOM GRP, INST HLTH \& BIOMED INNOVAT,SCH BIOMED SCI, BRISBANE, QLD 4102, AUSTRALIA.;LI, Z., PENNISI, D. J., ANDERSON, L. K., SONG, X., KENNA, T., LEO, P., BROWN, M. A., QUEENSLAND UNIV TECHNOL, TRANSLAT RES INST, TRANSLAT GENOM GRP, INST HLTH \& BIOMED INNOVAT,SCH BIOMED SCI, BRISBANE, QLD 4102, AUSTRALIA.;HAYNES, K., UNIV QUEENSLAND, DIAMANTINA INST, BRISBANE, QLD, AUSTRALIA.;THOMAS, G. P., CHARLES STURT UNIV, RES OFF, WAGGA WAGGA, NSW, AUSTRALIA.","10.1038/GENE.2017.11","MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",NA,NA,"NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL SENIOR PRINCIPAL RESEARCH FELLOWSHIP","WE THANK THE PARTICIPATING PATIENTS AND HEALTHY CONTROLS FOR TAKING PART IN THIS STUDY. MAB IS FUNDED BY A NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL SENIOR PRINCIPAL RESEARCH FELLOWSHIP.",NA,"1466-4879","3","135-143","NATURE PUBLISHING GROUP","18",2017,"ISI000412429800004","58","GENETICS \& HEREDITY, IMMUNOLOGY","3","GENETICS \& HEREDITY, IMMUNOLOGY","MATT.BROWNQUT.EDU.AU",NA,"FJ0VV",NA,"BROWN, MA (REPRINT AUTHOR), QUEENSLAND UNIV TECHNOL, TRANSLAT RES INST, TRANSLAT GENOM GRP, INST HLTH \& BIOMED INNOVAT,SCH BIOMED SCI, BRISBANE, QLD 4102, AUSTRALIA","ISI","QUEENSLAND UNIV TECHNOL;UNIV QUEENSLAND;CHARLES STURT UNIV","QUEENSLAND UNIV TECHNOL",NA,"LI Z, 2017, GENES IMMUN","LI Z, 2017, GENES IMMUN"
"KESKIN C, 2017, J ENDOD","KESKIN C;DEMIRYUREK EO;ONUK EE","PYROSEQUENCING ANALYSIS OF CRYOGENICALLY GROUND SAMPLES FROM PRIMARY AND SECONDARY/PERSISTENT ENDODONTIC INFECTIONS","JOURNAL OF ENDODONTICS","J. ENDOD.","INTRODUCTION: THIS STUDY AIMED TO CHARACTERIZE THE MICROBIAL COMMUNITIES OF PRIMARY AND SECONDARY/PERSISTENT ENDODONTIC INFECTIONS USING HIGH-THROUGHPUT PYROSEQUENCING FROM THE PULVERIZED SAMPLES. METHODS: THE ROOTS OF 20 EXTRACTED HUMAN TEETH WITH PRIMARY ENDODONTIC INFECTION AND 20 TEETH WITH SECONDARY/PERSISTENT ENDODONTIC INFECTION WERE COLLECTED. THE OUTER SURFACES OF THE ROOTS WERE DISINFECTED, AND WHOLE ROOTS WERE CRYOPULVERIZED. 16S AMPLICON PYROSEQUENCING DATA FROM THE DNA EXTRACTED FROM THE PULVERIZED ROOT POWDERS WERE OBTAINED, AND MICROORGANISM ABUNDANCE AND DIVERSITY WERE CALCULATED. DATA WERE ANALYZED USING STATISTICAL AND BIOINFORMATIC METHODS. RESULTS: PYROSEQUENCING ANALYSIS RESULTED A TOTAL OF 2,606,128 SEQUENCES FROM 40 SAMPLES. A TOTAL OF 15 PHYLA, 160 GENERA, AND 368 SPECIES WERE DETECTED. NO SIGNIFICANT DIFFERENCE BETWEEN PRIMARY AND SECONDARY/PERSISTENT ENDODONTIC,INFECTIONS WAS FOUND REGARDING THE DIVERSITY AND RICHNESS OF OPERATIONAL TAXONOMIC UNITS AT THE PHYLA, GENERA, AND SPECIES LEVELS (P>.005). CONCLUSIONS: THE PRESENT STUDY REVEALED THAT THE MICROBIAL DIVERSITY OF SECONDARY/PERSISTENT ENDODONTIC INFECTIONS DID NOT DIFFER THAN THOSE OF PRIMARY ENDODONTIC INFECTIONS. A NEW ARCHAEAL SPECIES, CANDIDATUS NITROSOARCHAEUM LIMNIA, WAS DETECTED IN ROOT CANALS OF 1 PATIENT WITH PRIMARY ENDODONTIC INFECTION FOR THE FIRST TIME.","BACTERIAL DIVEFSITY; CANDIDATUS NITROSOARCHAEUM LIMNIA; NEXT-GENERATION SEQUENCING; ORAL MICROBIOTA","APICAL PERIODONTITIS; MICROBIAL ANALYSIS; ROOT CANALS; BACTERIA; ARCHAEA; IDENTIFICATION; DIVERSITY; COMMUNITY; POINTS","ENGLISH","ARTICLE","ARTICLE",1,"ALVES FRF, 2009, J ENDODONT, V35, P486, DOI 10.1016/J.JOEN.2008.12.022.;ANDERSON AC, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0084960.;BANG C, 2015, FEMS MICROBIOL REV, V39, P631, DOI 10.1093/FEMSRE/FUV010.;BELAY N, 1990, J CLIN MICROBIOL, V28, P1666.;CAPORASO JG, 2011, GENOME BIOL, V12, DOI 10.1186/GB-2011-12-5-R50.;HENRIQUES LCF, 2016, J ENDODONT, V42, P1239, DOI 10.1016/J.JOEN.2016.05.014.;GOMES BPFA, 2015, J ENDODONT, V41, P1975, DOI 10.1016/J.JOEN.2015.08.022.;HOMMEZ GMG, 2002, INT ENDOD J, V35, P680, DOI 10.1046/J.1365-2591.2002.00546.X.;HONG BY, 2013, J ENDODONT, V39, P1136, DOI 10.1016/J.JOEN.2013.05.001.;HSIAO WWL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-345.;KAKEHASHI S, 1965, ORAL SURG ORAL MED O, V20, P340, DOI 10.1016/0030-4220(65)90166-0.;KARYGIANNI L, 2015, CLIN ORAL INVEST, V19, P319, DOI 10.1007/S00784-014-1231-4.;KUCZYNSKI J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/NRG3129.;KULIK EM, 2001, FEMS MICROBIOL LETT, V196, P129, DOI 10.1016/S0378-1097(01)00051-9.;MURAD CF, 2014, J ENDODONT, V40, P899, DOI 10.1016/J.JOEN.2014.02.010.;ORSTAVIK D, 1986, ENDODONTICS AND DENTAL TRAUMATOLOGY, V2, P20.;PERSOON IF, 2016, CLIN ORAL INVEST, V1, P11.;PROBST AJ, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0065388.;PROVENZANO JC, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0076108.;SAKAMOTO M, 2006, ORAL MICROBIOL IMMUN, V21, P112, DOI 10.1111/J.1399-302X.2006.00270.X.;SANTOS AL, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0028088.;SATHORN C, 2007, J ENDODONT, V33, P220, DOI 10.1016/J.JOEN.2006.11.006.;SIQUEIRA JF, 2009, J DENT RES, V88, P969, DOI 10.1177/0022034509346549.;SIQUEIRA J.J., 2012, J ORAL MICROBIOL, V4, P1.;SIQUEIRA JF, 2005, J CLIN MICROBIOL, V43, P3314, DOI 10.1128/JCM.43.7.3314-3319.2005.;SIQUEIRA JF, 2009, J ORAL MICROBIOL, V10, P1, DOI DOI 10.3402/J0M.V1I0.2009.;SIQUEIRA JF, 2011, J ENDODONT, V37, P1499, DOI 10.1016/J.JOEN.2011.08.012.;STIEGLMEIER M., 2014, PROKARYOTES, P347, DOI DOI 10.1007/978-3-642-38954-2\_338.;SUN JL, 2009, J CLIN MICROBIOL, V47, P2218, DOI 10.1128/JCM.00388-09.;TAKEMURA N, 2004, EUR J ORAL SCI, V112, P523, DOI 10.1111/J.1600-0722.2004.00165.X.;TRAN KT, 2013, J ENDODONT, V39, P1057, DOI 10.1016/J.JOEN.2013.04.012.;TZANETAKIS GN, 2015, J ENDODONT, V41, P1226, DOI 10.1016/J.JOEN.2015.03.010.;VAN DER HORST J, 2013, J DENT, V41, P1297, DOI 10.1016/J.JDENT.2013.10.008.;VENGERFELDT V, 2014, J ENDODONT, V40, P1778, DOI 10.1016/J.JOEN.2014.06.017.;VIANNA ME, 2006, J CLIN MICROBIOL, V44, P1274, DOI 10.1128/JCM.44.4.1274-1282.2006.;WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063A0.;WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/PNAS.87.12.4576.;YOUSSEF N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09.","KESKIN, C (REPRINT AUTHOR), ONDOKUZ MAYIS UNIV, FAC DENT, DEPT ENDODONT, TR-55139 SAMSUN, TURKEY.;KESKIN, CANGUL, DEMIRYUREK, EBRU OZSEZER, ONDOKUZ MAYIS UNIV, FAC DENT, KURUPELIT, TURKEY.;ONUK, ERTAN EMEK, ONDOKUZ MAYIS UNIV, FAC VET, SAMSUN, TURKEY.","10.1016/J.JOEN.2017.03.019","360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",NA,NA,"SCIENTIFIC AND TECHNOLOGICAL RESEARCH COUNCIL OF TURKEY-TUBITAK [115S127]","SUPPORTED BY THE SCIENTIFIC AND TECHNOLOGICAL RESEARCH COUNCIL OF TURKEY-TUBITAK (GRANT NO. 115S127).",NA,"0099-2399","8","1309-1316","ELSEVIER SCIENCE INC","43",2017,"ISI000407985700015","38","DENTISTRY, ORAL SURGERY \& MEDICINE","5","DENTISTRY, ORAL SURGERY \& MEDICINE","CANGLKARABULUTGMAIL.COM",NA,"FE1NU",NA,"KESKIN, C (REPRINT AUTHOR), ONDOKUZ MAYIS UNIV, FAC DENT, DEPT ENDODONT, TR-55139 SAMSUN, TURKEY","ISI","ONDOKUZ MAYIS UNIV;ONDOKUZ MAYIS UNIV","ONDOKUZ MAYIS UNIV",NA,"KESKIN C, 2017, J ENDOD","KESKIN C, 2017, J ENDOD"
"RUAN L, 2017, MEDICINE (BALTIMORE)","RUAN L;YANG Y;HUANG Y;DING L;ZHANG C;WU X","FUNCTIONAL PREDICTION OF MIR-3144-5P IN HUMAN CARDIAC MYOCYTES BASED ON TRANSCRIPTOME SEQUENCING AND BIOINFORMATICS","MEDICINE","MEDICINE (BALTIMORE)","BACKGROUND: RAN GUANINE NUCLEOTIDE RELEASE FACTOR (RANGRF) ENCODING PROTEIN MOG1 PLAYS AN IMPORTANT ROLE IN CARDIAC ARRHYTHMIA, SO WE INTENDED TO INVESTIGATE THE REGULATORY MIRNA OF RANGRF AND EXPLORE ITS POTENTIAL REGULATORY MECHANISM IN ARRHYTHMOGENESIS. METHODS: BASED ON BIOINFORMATIC ANALYSIS, MIR-3144-5P WAS PREDICTED TO BE A REGULATORY MIRNA OF RANGRF, WHICH WERE THEN VALIDATED THROUGH A DUAL-LUCIFERASE REPORTER PLASMID ASSAY. SUBSEQUENTLY, THE EXPRESSION LEVEL OF MIR-3144-5P IN HUMAN CARDIAC MYOCYTES (HCMS) WAS DETECTED, FOLLOWED BY CELL TRANSFECTION WITH MIR-3144-5P MIMICS. TRANSCRIPTOME SEQUENCING WAS THEN PERFORMED IN HCMS WITH OR WITHOUT TRANSFECTION. THE SEQUENCING RESULTS WERE SUBJECTED TO BIOINFORMATIC ANALYSES, INCLUDING DIFFERENTIALLY EXPRESSED GENE (DEG) ANALYSIS, FUNCTIONAL ENRICHMENT ANALYSIS, PROTEIN-PROTEIN INTERACTION (PPI) NETWORK ANALYSIS, MIRNA-TARGET GENE ANALYSIS, AND MIRNA-TRANSCRIPTION FACTOR (TF)-TARGET GENE COREGULATORY NETWORK ANALYSIS. RESULTS: THERE REALLY EXISTED A REGULATORY RELATION BETWEEN MIR-3144-5P AND RANGRF. THE EXPRESSION LEVEL OF MIR-3144-5P WAS LOW IN HCMS. AFTER CELL TRANSFECTION, MIR-3144-5P EXPRESSION LEVEL SIGNIFICANTLY INCREASED IN HCMS. BIOINFORMATIC ANALYSES OF THE TRANSCRIPTOME SEQUENCING RESULTS IDENTIFIED 300 UPREGULATED AND 271 DOWNREGULATED DEGS BETWEEN MIR-3144-5P MIMIC AND CONTROL GROUP. THE UPREGULATED GENES ISL1 AND NEUREGULIN 1 (NRG1) WERE SIGNIFICANTLY ENRICHED IN CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION (GO: 0060379). CCL21 WAS ONE OF THE HUB GENES IN THE PPI NETWORK AND ALSO A TARGET GENE OF MIR-3144-5P. MOREOVER, THE TF OF V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE NEUROBLASTOMA-DERIVED HOMOLOG (MYCN) WAS INVOLVED IN THE MIR-3144-5P-TF-TARGET GENE COREGULATORY NETWORK AND INTERACTED WITH THE TARGET GENES OF MIR-3144-5P. CONCLUSION: ISL1, NRG1, CCL21, AND MYCN WERE DIFFERENTIALLY EXPRESSED IN THE MIR-3144-5P MIMIC GROUP, SUGGESTING THAT MIR-3144-5P OVEREXPRESSION PLAYS A ROLE IN HCMS BY REGULATING THESE GENES AND TF. THIS STUDY MAY PROVIDE NEW INSIGHT INTO THE MECHANISMS BEHIND THE PROGRESSION OF CARDIAC ARRHYTHMIA.","BIOINFORMATICS; CARDIAC ARRHYTHMIA; HUMAN CARDIAC MYOCYTE; MIR-3144-5P; TRANSCRIPTOME SEQUENCING","PROTEIN-INTERACTION NETWORKS; MICRORNA-TARGET INTERACTIONS; CARDIOVASCULAR-DISEASE; HEART; DIFFERENTIATION; CENTRALITY; CYTOSCAPE; RESOURCE; MODELS; CELLS","ENGLISH","ARTICLE","ARTICLE",0,"AUKRUST P, 1998, CIRCULATION, V97, P1136, DOI 10.1161/01.CIR.97.12.1136.;BRITSCH S, 2007, ADV ANAT EMBRYOL CEL, V190, P1.;BU L, 2009, NATURE, V460, P113, DOI 10.1038/NATURE08191.;CAI CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0.;DWEEP H, 2015, NAT METHODS, V12, P697, DOI 10.1038/NMETH.3485.;ENRIGHT ANTON J, 2003, GENOME BIOL, V5, PR1, DOI 10.1186/GB-2003-5-1-R1.;FULLER SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/J.YJMCC.2008.02.278.;GEMBERLING M, 2015, ELIFE, V4, DOI 10.7554/ELIFE.05871.;GOH KI, 2003, PHYS REV E, V67, DOI [10.1103/PHYSREVE.67.017101, 10.1103/PHYSREV.E.67.017101].;GU ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/BIOINFORMATICS/BTW313.;HAMFJORD J, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0034150.;HARMELINK C, 2013, DEV BIOL, V373, P53, DOI 10.1016/J.YDBIO.2012.10.005.;HUANG DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/NPROT.2008.211.;JANKY R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/JOURNAL.PCBI.1003731.;JHA SK, 2016, OVERVIEW ARRHYTHMIA.;KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879A0.;LAW CW, 2014, GENOME BIOL, V15, DOI 10.1186/GB-2014-15-2-R29.;LIM J, 2006, CELL, V125, P801, DOI 10.1016/J.CELL.2006.03.032.;LU XH, 2003, CANCER LETT, V197, P125, DOI 10.1016/S0304-3835(03)000096-X.;MARCELIS CLM, 2008, HUM MUTAT, V29, P1125, DOI 10.1002/HUMU.20750.;NAIR N, 2013, MOL CELL BIOCHEM, V376, P33, DOI 10.1007/S11010-012-1546-X.;NGUYEN HCN, 2013, PROSTATE, V73, P346, DOI 10.1002/PROS.22572.;NIKOLAYEVA O, 2014, METHODS MOL BIOL, V1150, P45, DOI 10.1007/978-1-4939-0512-6\_3.;NOVAK J, 2015, ADV EXP MED BIOL, V887, P79, DOI 10.1007/978-3-319-22380-3\_5.;OKAMOTO K, 2008, LECT NOTES COMPUT SC, V5059, P186.;OLESEN MS, 2011, CAN J CARDIOL, V27, DOI 10.1016/J.CJCA.2011.01.003.;RITCHIE ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/NAR/GKV007.;RITO T, 2012, J COMPUT BIOL, V19, P785, DOI 10.1089/CMB.2012.0054.;ROBINSON MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/BIOINFORMATICS/BTP616.;SANTULLI G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/FPHYS.2014.00015.;SHAN HL, 2009, BRIT J PHARMACOL, V158, P1227, DOI 10.1111/J.1476-5381.2009.00377.X.;SHANNON P, 2003, GENOME RES, V13, P2498, DOI 10.1101/GR.1239303.;SMYTH GK, 2005, STAT BIOL HEALTH, P397.;STARK MS, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0009685.;STELZL U, 2005, CELL, V122, P957, DOI 10.1016/J.CELL.2005.08.029.;SZKLARCZYK D, 2014, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKU1003.;TALMAGE DAVID A, 2008, NOVARTIS FOUND SYMP, V289, P74.;TANG Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/J.BIOSYSTEMS.2014.11.005.;TENG YS, 2015, BIOCHEM BIOPH RES CO, V457, P58, DOI 10.1016/J.BBRC.2014.12.058.;TERENTYEV D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651.;TFELT-HANSEN J, 2010, J CARDIOVASC ELECTR, V21, P107, DOI 10.1111/J.1540-8167.2009.01633.X.;VICKERS KC, 2014, CLIN SCI, V126, P183, DOI 10.1042/CS20130203.;WANG Z, 2009, MED BIOL ENG COMPUT, V47, P41, DOI 10.1007/S11517-008-0383-2.;WRONSKA A, 2015, ACTA PHYSIOL, V213, P60, DOI 10.1111/APHA.12416.;WU L, 2008, J BIOL CHEM, V283, P6968, DOI 10.1074/JBC.M709721200.;XIAO FF, 2009, NUCLEIC ACIDS RES, V37, PD105, DOI 10.1093/NAR/GKN851.;YNDESTAD A, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0033038.;YOSHIDA R, 1998, J BIOL CHEM, V273, P7118, DOI 10.1074/JBC.273.12.7118.","WU, XF (REPRINT AUTHOR), HUAZHONG UNIV SCI \& TECHNOL, TONGJI HOSP, DEPT GERONTOL, TONGJI MED COLL, JIE FANG DA DAO 1095, WUHAN 430030, HUBEI, PEOPLES R CHINA.;RUAN, LEI, YANG, YI, HUANG, YI, DING, LING, ZHANG, CUNTAI, WU, XIAOFEN, HUAZHONG UNIV SCI \& TECHNOL, TONGJI HOSP, DEPT GERONTOL, TONGJI MED COLL, JIE FANG DA DAO 1095, WUHAN 430030, HUBEI, PEOPLES R CHINA.","10.1097/MD.0000000000007539","TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA","E7539",NA,"THE INDEPENDENT INNOVATION RESEARCH FUND OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY [2017KFYXJJ131], SPECIALIZED RESEARCH FUND FOR THE DOCTORAL PROGRAM OF HIGHER EDUCATION FROM THE MINISTRY OF EDUCATION [20130142120068]","THIS WORK WAS SUPPORTED BY THE INDEPENDENT INNOVATION RESEARCH FUND OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (PROGRAM NO. 2017KFYXJJ131) AND THE SPECIALIZED RESEARCH FUND FOR THE DOCTORAL PROGRAM OF HIGHER EDUCATION FROM THE MINISTRY OF EDUCATION (PROGRAM NO. 20130142120068).",NA,"0025-7974","32",NA,"LIPPINCOTT WILLIAMS \& WILKINS","96",2017,"ISI000407835000010","48","GENERAL \& INTERNAL MEDICINE","1","MEDICINE, GENERAL \& INTERNAL","WUX2018SINA.COM",NA,"FD9IC",NA,"WU, XF (REPRINT AUTHOR), HUAZHONG UNIV SCI \& TECHNOL, TONGJI HOSP, DEPT GERONTOL, TONGJI MED COLL, JIE FANG DA DAO 1095, WUHAN 430030, HUBEI, PEOPLES R CHINA","ISI","HUAZHONG UNIV SCI AND TECHNOL","HUAZHONG UNIV SCI AND TECHNOL",NA,"RUAN L, 2017, MEDICINE (BALTIMORE)","RUAN L, 2017, MEDICINE (BALTIMORE)"
"JOOSTE TL, 2017, PHYTOPATHOLOGY","JOOSTE TL;VISSER M;COOK G;BURGER JT;MAREE HJ","IN SILICO PROBE-BASED DETECTION OF CITRUS VIRUSES IN NGS DATA","PHYTOPATHOLOGY","PHYTOPATHOLOGY","THE CONSERVATION OF PLANT BIOSECURITY RELIES ON THE RAPID IDENTIFICATION OF PATHOGENIC ORGANISMS, INCLUDING VIRUSES. WITH NEXT-GENERATION SEQUENCING (NGS), IT IS POSSIBLE TO IDENTIFY MULTIPLE VIRUSES WITHIN A METAGENOMIC SAMPLE. IN THIS STUDY, WE EXPLORED THE USE OF ELECTRONIC PROBES (E-PROBES) FOR THE SIMULTANEOUS DETECTION OF 11 RECOGNIZED CITRUS VIRUSES. E-PROBES WERE DESIGNED AND SCREENED AGAINST RAW SEQUENCING DATA TO MINIMIZE THE BIOINFORMATIC PROCESSING TIME REQUIRED. THE E-PROBES WERE ABLE TO ACCURATELY DETECT THEIR COGNATE VIRUSES IN SIMULATED DATASETS, WITHOUT ANY FALSE NEGATIVES OR POSITIVES. THE EFFICIENCY OF THE E-PROBE-BASED APPROACH WAS VALIDATED WITH NGS DATASETS GENERATED FROM DIFFERENT RNA PREPARATIONS: DOUBLE-STRANDED RNA (DSRNA) FROM `MEXICAN' LIME INFECTED WITH DIFFERENT CITRUS TRISTEZA VIRUS (CTV) GENOTYPES, DSRNA FROM FIELD SAMPLES, AND SMALL RNA AND TOTAL RNA FROM GRAPEFRUIT INFECTED WITH THE CTV T3 GENOTYPE. A SET OF PROBES WAS MADE AVAILABLE THAT IS ABLE TO ACCURATELY DETECT CTV IN SEQUENCE DATA REGARDLESS OF THE INPUT DATASET OR THE GENOTYPE THAT PLANTS ARE INFECTED WITH.",NA,"GENERATION SEQUENCING DATA; BIOSECURITY; ASSAY; TOOL","ENGLISH","ARTICLE","ARTICLE",2,"ADAMS IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/J.1364-3703.2009.00545.X].;BEXFIELD N, 2011, VET J, V190, P191, DOI 10.1016/J.TVJL.2010.10.014.;BURGER JT, 2015, METHODS MOL BIOL, V1302, P315, DOI 10.1007/978-1-4939-2620-6\_23.;CARRA A, 2007, ANAL BIOCHEM, V360, P318, DOI 10.1016/J.AB.2006.09.022.;COOK G, 2016, J PHYTOPATHOL, V164, P847, DOI 10.1111/JPH.12454.;GAMLIEL A., 2008, CROP BIOSECURITY ASS, P71.;HUANG WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/BIOINFORMATICS/BTR708.;LIU L, 2012, BMC PUBLIC HEALTH, V12, DOI [10.1186/1471-2458-12-219, 10.1155/2012/251364].;MACDIARMID R, 2013, PLOS PATHOG, V9, DOI 10.1371/JOURNAL.PPAT.1003337.;OCHOA-CORONA FM, 2011, AUSTRALAS PLANT PATH, V40, P335, DOI 10.1007/S13313-011-0052-Z.;RODONI B, 2009, VIRUS RES, V141, P150, DOI 10.1016/J.VIRUSRES.2008.11.019.;SANKARAN S, 2010, COMPUT ELECTRON AGR, V72, P1, DOI 10.1016/J.COMPAG.2010.02.007.;STOBBE AH, 2014, PHYTOPATHOLOGY, V104, P1125, DOI 10.1094/PHYTO-11-13-0310-R.;STOBBE AH, 2013, J MICROBIOL METH, V94, P356, DOI 10.1016/J.MIMET.2013.07.002.;VISSER M, 2016, VIROLOGY, V495, P122, DOI 10.1016/J.VIROL.2016.05.008.","MAREE, HJ (REPRINT AUTHOR), INFRUITEC NIETVOORBIJ FRUIT VINE \& WINE INST, AGR RES COUNCIL, STELLENBOSCH, SOUTH AFRICA.;MAREE, HJ (REPRINT AUTHOR), STELLENBOSCH UNIV, DEPT GENET, STELLENBOSCH, SOUTH AFRICA.;JOOSTE, T. L., VISSER, M., MAREE, H. J., INFRUITEC NIETVOORBIJ FRUIT VINE \& WINE INST, AGR RES COUNCIL, STELLENBOSCH, SOUTH AFRICA.;JOOSTE, T. L., VISSER, M., BURGER, J. T., MAREE, H. J., STELLENBOSCH UNIV, DEPT GENET, STELLENBOSCH, SOUTH AFRICA.;COOK, G., CITRUS RES INT, NELSPRUIT, SOUTH AFRICA.","10.1094/PHYTO-10-16-0379-R","3340 PILOT KNOB ROAD, ST PAUL, MN 55121 USA",NA,NA,"CITRUS RESEARCH INTERNATIONAL, TECHNOLOGY AND HUMAN RESOURCES FOR INDUSTRY PROGRAMME (DEPARTMENT OF TRADE AND INDUSTRY, SOUTH AFRICA) [TP13081327563], NATIONAL RESEARCH FOUNDATION (NRF)","THIS STUDY WAS FUNDED BY CITRUS RESEARCH INTERNATIONAL, THE TECHNOLOGY AND HUMAN RESOURCES FOR INDUSTRY PROGRAMME (DEPARTMENT OF TRADE AND INDUSTRY, SOUTH AFRICA, GRANT TP13081327563), AND THE NATIONAL RESEARCH FOUNDATION (NRF). OPINIONS EXPRESSED AND CONCLUSIONS DRAWN ARE THOSE OF THE AUTHORS AND NOT NECESSARILY TO BE ATTRIBUTED TO THE NRF.",NA,"0031-949X","8","988-993","AMER PHYTOPATHOLOGICAL SOC","107",2017,"ISI000405646400008","15","PLANT SCIENCES","4","PLANT SCIENCES","HJMAREESUN.AC.ZA",NA,"FA7SE",NA,"MAREE, HJ (REPRINT AUTHOR), INFRUITEC NIETVOORBIJ FRUIT VINE \& WINE INST, AGR RES COUNCIL, STELLENBOSCH, SOUTH AFRICA","ISI","STELLENBOSCH;STELLENBOSCH UNIV;CITRUS RES INT","STELLENBOSCH",NA,"JOOSTE TL, 2017, PHYTOPATHOLOGY","JOOSTE TL, 2017, PHYTOPATHOLOGY"
"THOMAS M, 2017, ARCH PATHOL LAB MED","THOMAS M;SUKHAI MA;ZHANG T;DOLATSHAHI R;HARBI D;GARG S;MISYURA M;PUGH T;STOCKLEY TL;KAMEL REID S","INTEGRATION OF TECHNICAL, BIOINFORMATIC, AND VARIANT ASSESSMENT APPROACHES IN THE VALIDATION OF A TARGETED NEXT-GENERATION SEQUENCING PANEL FOR MYELOID MALIGNANCIES","ARCHIVES OF PATHOLOGY \& LABORATORY MEDICINE","ARCH. PATHOL. LAB. MED.","CONTEXT.-DETECTION OF VARIANTS IN HEMATOLOGIC MALIGNANCIES IS INCREASINGLY IMPORTANT BECAUSE OF A GROWING NUMBER OF VARIANTS IMPACTING DIAGNOSIS, PROGNOSIS, AND TREATMENT RESPONSE, AND AS POTENTIAL THERAPEUTIC TARGETS. THE USE OF NEXT-GENERATION SEQUENCING TECHNOLOGIES TO DETECT VARIANTS IN HEMATOLOGIC MALIGNANCIES IN A CLINICAL DIAGNOSTIC LABORATORY SETTING ALLOWS FOR EFFICIENT IDENTIFICATION OF ROUTINELY TESTED MARKERS IN MULTIPLE GENES SIMULTANEOUSLY, AS WELL AS THE IDENTIFICATION OF NOVEL AND RARE VARIANTS IN OTHER CLINICALLY RELEVANT GENES. OBJECTIVE.-TO APPLY A SYSTEMATIC APPROACH TO EVALUATE AND VALIDATE A COMMERCIALLY AVAILABLE NEXT-GENERATION SEQUENCING PANEL (TRUSIGHT MYELOID SEQUENCING PANEL, ILLUMINA, SAN DIEGO, CALIFORNIA) TARGETING 54 GENES. IN THIS MANUSCRIPT, WE FOCUSED ON THE PARAMETERS THAT WERE USED TO EVALUATE ASSAY PERFORMANCE CHARACTERISTICS. DATA SOURCES.-ANALYTICAL VALIDATION WAS PERFORMED USING SAMPLES CONTAINING KNOWN VARIANTS THAT HAD BEEN IDENTIFIED PREVIOUSLY. CASES WERE SELECTED FROM DIFFERENT DISEASE TYPES, WITH VARIANTS IN A RANGE OF GENES. PANEL PERFORMANCE CHARACTERISTICS WERE ASSESSED AND GENOMIC REGIONS REQUIRING ADDITIONAL ANALYSIS OR WET-BENCH APPROACHES IDENTIFIED. CONCLUSIONS.-WE VALIDATED THE PERFORMANCE CHARACTERISTICS OF A MYELOID NEXT-GENERATION SEQUENCING PANEL FOR DETECTION OF VARIANTS. THE TRUSIGHT MYELOID SEQUENCING PANEL COVERS MORE THAN 95\% OF TARGET REGIONS WITH DEPTH GREATER THAN 500X. HOWEVER, BECAUSE OF UNIQUE VARIANT TYPES SUCH AS LARGE INSERTIONS OR DELETIONS OR GENOMIC REGIONS OF HIGH GC CONTENT, VARIANTS IN CEBPA, FLT3, AND CALR REQUIRED SUPPLEMENTATION WITH NON-NEXT-GENERATION SEQUENCING ASSAYS OR WITH INFORMATICS APPROACHES TO ADDRESS DEFICIENCIES IN PERFORMANCE. THE USE OF MULTIPLE BIOINFORMATICS APPROACHES (2 VARIANT CALLERS AND INFORMATICS SCRIPTS) ALLOWS FOR MAXIMIZING CALLING OF TRUE POSITIVES, WHILE IDENTIFYING LIMITATIONS IN USING EITHER METHOD ALONE.",NA,"CHRONIC MYELOMONOCYTIC LEUKEMIA; INTERMEDIATE-RISK KARYOTYPE; PRECISION CANCER MEDICINE; CEBPA GENE-MUTATIONS; PROGNOSTIC RELEVANCE; CALRETICULIN MUTATIONS; POOR-PROGNOSIS; CLASSIFICATION; ASXL1; NEOPLASMS","ENGLISH","ARTICLE","ARTICLE",3,"ABDEL-WAHAB O, 2010, LEUKEMIA, V24, P1656, DOI 10.1038/LEU.2010.144.;AHN JY, 2009, J MOL DIAGN, V11, P319, DOI 10.2353/JMOLDX.2009.080121.;ALTSHULER DM, 2015, NATURE, V526, P68, DOI 10.1038/NATURE15393.;ANDRE F, 2014, ANN ONCOL, V25, P2295, DOI 10.1093/ANNONC/MDU478.;ARBER DA, 2016, BLOOD, V127, P2391, DOI 10.1182/BLOOD-2016-03-643544.;BALASUBRAMANI A, 2015, NAT COMMUN, V6, DOI 10.1038/NCOMMS8307.;BARTELS S, 2016, ONCOTARGET, V7, P30084, DOI 10.18632/ONCOTARGET.8310.;BRANDWEIN JM, 2011, LEUKEMIA, V25, P945, DOI 10.1038/LEU.2011.34.;BROSEUS J, 2013, LEUKEMIA, V27, P1826, DOI 10.1038/LEU.2013.120.;CARR TH, 2016, NAT REV CANCER, V16, P319, DOI 10.1038/NRC.2016.35.;CLINICAL AND LABORATORY STANDARDS INSTITUTE, 2014, MM09A2 CLSI.;DING L, 2012, NATURE, V481, P506, DOI 10.1038/NATURE10738.;DUFOUR A, 2010, J CLIN ONCOL, V28, P570, DOI 10.1200/JCO.2008.21.6010.;GARGIS AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/NBT.2403.;GELSI-BOYER V, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-12.;GROSSMANN V, 2011, LEUKEMIA, V25, P877, DOI 10.1038/LEU.2011.10.;HAFERLACH T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/LEU.2013.336.;HOU HA, 2016, ONCOTARGET, V7, P9084, DOI 10.18632/ONCOTARGET.7000.;HOW J, 2012, CANCER-AM CANCER SOC, V118, P6110, DOI 10.1002/CNCR.27683.;KADRI S, 2015, J MOL DIAGN, V17, P635, DOI 10.1016/J.JMOLDX.2015.06.005.;KANAGAL-SHAMANNA R, 2016, EXPERT REV MOL DIAGN, V16, P461, DOI 10.1586/14737159.2016.1142374.;KLCO JM, 2015, JAMA-J AM MED ASSOC, V314, P811, DOI 10.1001/JAMA.2015.9643.;LEK M, 2016, NATURE, V536, P285, DOI 10.1038/NATURE19057.;LEY TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMOA1301689.;LI HY, 2015, EUR J HAEMATOL, V94, P439, DOI 10.1111/EJH.12450.;LI MM, 2017, J MOL DIAGN, V19, P4, DOI 10.1016/J.JMOLDX.2016.10.002.;MAKISHIMA H, 2013, NAT GENET, V45, P942, DOI 10.1038/NG.2696.;MASON CC, 2016, LEUKEMIA, V30, P906, DOI 10.1038/LEU.2015.337.;MCKENNA A, 2010, GENOME RES, V20, P1297, DOI 10.1101/GR.107524.110.;MCKERRELL T, 2016, BLOOD, V128, PE1, DOI 10.1182/BLOOD-2015-11-683334.;MERIC-BERNSTAM F, 2015, J NATL CANC I, V107.;METZELER KH, 2016, BLOOD, V128, P686, DOI 10.1182/BLOOD-2016-01-693879.;MISYURA M, 2016, J MOL DIAGN, V18, P842, DOI 10.1016/J.JMOLDX.2016.06.004.;PAPAEMMANUIL E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMOA1516192.;PASTORE F, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/S13045-014-0055-7.;PATEL JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMOA1112304.;REHM HL, 2013, GENET MED, V15, P733, DOI 10.1038/GIM.2013.92.;RUFFALO M, 2015, J BIOMED INFORM, V58, P104, DOI 10.1016/J.JBI.2015.10.003.;SCHNITTGER S, 2013, LEUKEMIA, V27, P82, DOI 10.1038/LEU.2012.262.;SHEN W, 2016, BRIT J HAEMATOL, V173, P49, DOI 10.1111/BJH.13921.;SHERRY ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/NAR/29.1.308.;SUKHAI MA, 2016, GENET MED, V18, P128, DOI 10.1038/GIM.2015.47.;TEFFERI A, 2014, LEUKEMIA, V28, P2300, DOI 10.1038/LEU.2014.148.;TEFFERI A, 2014, BLOOD, V124, P2465, DOI 10.1182/BLOOD-2014-07-588426.;VAN ALLEN EM, 2014, NAT MED, V20, P682, DOI 10.1038/NM.3559.;WALTER MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMOA1106968.;YAN B, 2016, J CLIN PATHOL, V69, P801, DOI 10.1136/JCLINPATH-2015-203580.","KAMEL-REID, S (REPRINT AUTHOR), UNIV TORONTO, UNIV HLTH NETWORK, DEPT PATHOL, CLIN LAB GENET, ROOM 11-418,200 ELIZABETH ST, TORONTO, ON M5G 2C4, CANADA.;THOMAS, MARIAM, SUKHAI, MAHADEO A., GARG, SWATI, MISYURA, MAKSYM, STOCKLEY, TRACY L., KAMEL-REID, SUZANNE, UNIV HLTH NETWORK, LAB MED PROGRAM, ADV MOL DIAGNOST LAB, DEPT PATHOL, TORONTO, ON, CANADA.;THOMAS, MARIAM, SUKHAI, MAHADEO A., GARG, SWATI, MISYURA, MAKSYM, STOCKLEY, TRACY L., KAMEL-REID, SUZANNE, UNIV HLTH NETWORK, LAB MED PROGRAM, ADV MOL DIAGNOST LAB, DEPT GENET, TORONTO, ON, CANADA.;THOMAS, MARIAM, SUKHAI, MAHADEO A., ZHANG, TONG, GARG, SWATI, MISYURA, MAKSYM, PUGH, TREVOR, STOCKLEY, TRACY L., KAMEL-REID, SUZANNE, UNIV HLTH NETWORK, PRINCESS MARGARET CANC CTR, TORONTO, ON, CANADA.;DOLATSHAHI, ROOZBEH, HARBI, DJAMEL, UNIV HLTH NETWORK, PRINCESS MARGARET GENOM CTR, HIGH PERFORMANCE COMP \& BIOINFORMAT SERV, TORONTO, ON, CANADA.;PUGH, TREVOR, KAMEL-REID, SUZANNE, UNIV TORONTO, DEPT MED BIOPHYS, TORONTO, ON, CANADA.;STOCKLEY, TRACY L., KAMEL-REID, SUZANNE, UNIV TORONTO, DEPT LAB MED \& PATHOBIOL, TORONTO, ON, CANADA.","10.5858/ARPA.2016-0547-RA","C/O KIMBERLY GACKI, 325 WAUKEGAN RD, NORTHFIELD, IL 60093-2750 USA",NA,NA,"PRINCESS MARGARET CANCER FOUNDATION, GENOME CANADA (GENOMIC APPLICATIONS PARTNERSHIP PROGRAM), ONTARIO GENOMICS INSTITUTE","FUNDING FOR THIS WORK WAS PROVIDED BY THE PRINCESS MARGARET CANCER FOUNDATION, GENOME CANADA (GENOMIC APPLICATIONS PARTNERSHIP PROGRAM), AND THE ONTARIO GENOMICS INSTITUTE. WE THANK PATRICIA VASALOS, BS, FOR PROVIDING SUPPORT AND COORDINATION FOR ALL THE NGS VALIDATION MANUSCRIPTS IN THIS SERIES, SHE IS AN EMPLOYEE OF THE COLLEGE OF AMERICAN PATHOLOGISTS (NORTHFIELD, ILLINOIS).",NA,"0003-9985","6","759-775","COLL AMER PATHOLOGISTS","141",2017,"ISI000402475500005","47","MEDICAL LABORATORY TECHNOLOGY, RESEARCH \& EXPERIMENTAL MEDICINE, PATHOLOGY","3","MEDICAL LABORATORY TECHNOLOGY, MEDICINE, RESEARCH \& EXPERIMENTAL, PATHOLOGY","SUZANNE.KAMEL-REIDUHN.CA",NA,"EW4ML",NA,"KAMEL-REID, S (REPRINT AUTHOR), UNIV TORONTO, UNIV HLTH NETWORK, DEPT PATHOL, CLIN LAB GENET, ROOM 11-418,200 ELIZABETH ST, TORONTO, ON M5G 2C4, CANADA","ISI","UNIV HLTH NETWORK;UNIV HLTH NETWORK;UNIV HLTH NETWORK;UNIV HLTH NETWORK;UNIV TORONTO;UNIV TORONTO","UNIV TORONTO",NA,"THOMAS M, 2017, ARCH PATHOL LAB MED","THOMAS M, 2017, ARCH PATHOL LAB MED"
"LEWANDOWSKA DW, 2017, PLOS ONE","LEWANDOWSKA DW;SCHREIBER PW;SCHUURMANS MM;RUEHE B;ZAGORDI O;BAYARD C;GREINER M;GEISSBERGER FD;CAPAUL R;ZBINDEN A;BONI J;BENDEN C;MUELLER NJ;TRKOLA A;HUBER M","METAGENOMIC SEQUENCING COMPLEMENTS ROUTINE DIAGNOSTICS IN IDENTIFYING VIRAL PATHOGENS IN LUNG TRANSPLANT RECIPIENTS WITH UNKNOWN ETIOLOGY OF RESPIRATORY INFECTION","PLOS ONE","PLOS ONE","BACKGROUND LUNG TRANSPLANT PATIENTS ARE A VULNERABLE GROUP OF IMMUNOSUPPRESSED PATIENTS THAT ARE PRONE TO FREQUENT RESPIRATORY INFECTIONS. WE STUDIED 60 EPISODES OF RESPIRATORY SYMPTOMS IN 71 LUNG TRANSPLANT PATIENTS. ALMOST HALF OF THESE EPISODES WERE OF UNKNOWN INFECTIOUS ETIOLOGY DESPITE EXTENSIVE ROUTINE DIAGNOSTIC TESTING. METHODS WE RE-ANALYZED RESPIRATORY SAMPLES OF ALL EPISODES WITH UNDETERMINED ETIOLOGY IN ORDER TO DETECT POTENTIAL VIRAL PATHOGENS MISSED/NOT ACCOUNTED FOR IN ROUTINE DIAGNOSTICS. RESPIRATORY SAMPLES WERE ENRICHED FOR VIRUSES BY FILTRATION AND NUCLEASE DIGESTION, WHOLE NUCLEIC ACIDS EXTRACTED AND RANDOMLY AMPLIFIED BEFORE HIGH THROUGHPUT METAGENOMIC VIRUS SEQUENCING. VIRUSES WERE IDENTIFIED BY A BIOINFORMATIC PIPELINE AND CONFIRMED AND QUANTIFIED USING SPECIFIC REAL-TIME PCR. RESULTS IN COMPLETION OF ROUTINE DIAGNOSTICS, WE IDENTIFIED AND CONFIRMED A VIRAL ETIOLOGY OF INFECTION BY OUR METAGENOMIC APPROACH IN FOUR PATIENTS (THREE RHINOVIRUS A, ONE RHINOVIRUS B INFECTION) DESPITE INITIAL NEGATIVE RESULTS IN SPECIFIC MULTIPLEX PCR. NOTABLY, THE MAJORITY OF SAMPLES WERE ALSO POSITIVE FOR TORQUE TENO VIRUS (TTV) AND HUMAN HERPESVIRUS 7 (HHV-7). WHILE TTV VIRAL LOADS INCREASED WITH IMMUNOSUPPRESSION IN BOTH THROAT SWABS AND BLOOD SAMPLES, HHV-7 REMAINED AT LOW LEVELS THROUGHOUT THE OBSERVATION PERIOD AND WAS RESTRICTED TO THE RESPIRATORY TRACT. CONCLUSION THIS STUDY HIGHLIGHTS THE POTENTIAL OF METAGENOMIC SEQUENCING FOR VIRUS DIAGNOSTICS IN CASES WITH PREVIOUSLY UNKNOWN ETIOLOGY OF INFECTION AND IN COMPLEX DIAGNOSTIC SITUATIONS SUCH AS IN IMMUNOCOMPROMISED HOSTS.",NA,"BRONCHIOLITIS OBLITERANS SYNDROME; ALLOGRAFT DYSFUNCTION; VIRUS DISCOVERY; DNA LEVELS; TT VIRUS; HERPESVIRUSES; DISEASE; IMPACT; CHILDREN; LIBRARY","ENGLISH","ARTICLE","ARTICLE",4,"BASSIS CM, 2015, MBIO, V6, DOI 10.1128/MBIO.00037-15.;BERGER C, 2001, J MED VIROL, V64, P505, DOI 10.1002/JMV.1078.ABS.;BERGER C, 2007, J MED VIROL, V79, P1147, DOI 10.1002/JMV.20899.;CAMACHO C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421.;DE CLERCQ E, 2001, REV MED VIROL, V11, P381, DOI 10.1002/RMV.336.;DELWART EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/RMV.532.;DOBIN A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/BIOINFORMATICS/BTS635.;EMERY VC, 2001, CLIN INFECT DIS, V32, P1357, DOI 10.1086/320000.;FISHER CE, 2016, CLIN INFECT DIS, V62, P313, DOI 10.1093/CID/CIV871.;FISHMAN JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMRA064928.;FROUSSARD P, 1992, NUCLEIC ACIDS RES, V20, P2900, DOI 10.1093/NAR/20.11.2900.;GARBINO J, 2004, AM J RESP CRIT CARE, V170, P1197, DOI 10.1164/RCCM.200406-781OC.;GORZER I, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0122975.;GORZER I, 2014, J HEART LUNG TRANSPL, V33, P320, DOI 10.1016/J.HEALUN.2013.12.007.;GREGSON AL, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/S11908-016-0529-6.;HALL RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/J.JVIROMET.2013.08.035.;JONES MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005.;KHALIFAH AP, 2004, AM J RESP CRIT CARE, V170, P181, DOI 10.1164/RCCM.200310-1359OC.;KIDD IM, 2000, TRANSPLANTATION, V69, P2400, DOI 10.1097/00007890-200006150-00032.;KRONEMAN A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/J.JCV.2011.03.006.;KUMAR D, 2010, CURR OPIN INFECT DIS, V23, P374, DOI 10.1097/QCO.0B013E32833BC19D.;LEWANDOWSKA DW, 2015, DIAGN MICR INFEC DIS, V83, P133, DOI 10.1016/J.DIAGMICROBIO.2015.06.017.;LI L, 2015, J VIROL METHODS, V213, P139, DOI 10.1016/J.JVIROMET.2014.12.002.;LU XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07.;MAGGI F, 2003, J VIROL, V77, P2418, DOI 10.1128/JVI.77.4.2418-2425.2003.;MAGGI F, 2001, J MED VIROL, V65, P418, DOI 10.1002/JMV.2051.;MAGNUSSON J, 2013, TRANSPLANTATION, V95, P383, DOI 10.1097/TP.0B013E318271D7F0.;MANUEL O, 2009, TRANSPLANTATION, V87, P719, DOI 10.1097/TP.0B013E3181963262.;MENDEZ JC, 2001, J INFECT DIS, V183, P179, DOI 10.1086/317929.;MOKILI JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/J.COVIRO.2011.12.004.;MONTEJO M, 2012, ENFERM INFECC MIC S2, V30, P63.;PALACIOS G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMOA073785.;PETTY TJ, 2014, J CLIN MICROBIOL, V52, P3351, DOI 10.1128/JCM.01389-14.;QUAN PL, 2010, EMERG INFECT DIS, V16, P918, DOI 10.3201/EID1606.091536.;RAZONABLE RR, 2013, AM J TRANSPLANT, V13, P67, DOI 10.1111/AJT.12008.;SAYAH DM, 2013, CLIN TRANSPLANT, V27, PE64, DOI 10.1111/CTR.12054.;SCHUURMANS MM, 2013, SWISS MED WKLY, V143, DOI 10.4414/SMW.2013.13773.;SCHUURMANS MM, 2012, RESPIRATION, V84, P163, DOI 10.1159/000339345.;SCHUURMANS MM, 2015, EURASIAN J PULMONOL, V16, P144.;SCHWARTZ KL, 2014, PEDIATRICS, V133, PE1541, DOI 10.1542/PEDS.2013-3344.;SOLONENKO SA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-320.;VICTORIA JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08.;VICTORIA JG, 2008, PLOS PATHOG, V4, DOI 10.1371/JOURNAL.PPAT.1000163.;WUNDERLI W, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0027483.;YOUNG JC, 2015, AM J TRANSPLANT, V15, P200, DOI 10.1111/AJT.13031.;YUN ZB, 2000, TRANSPLANTATION, V69, P1733.;ZERBINO DR, 2008, GENOME RES, V18, P821, DOI 10.1101/GR.074492.107.","HUBER, M (REPRINT AUTHOR), UNIV ZURICH, INST MED VIROL, ZURICH, SWITZERLAND.;LEWANDOWSKA, DAGMARA W., RUEHE, BETTINA, ZAGORDI, OSVALDO, GEISSBERGER, FABIENNE D., CAPAUL, RICCARDA, ZBINDEN, ANDREA, BONI, JURG, TRKOLA, ALEXANDRA, HUBER, MICHAEL, UNIV ZURICH, INST MED VIROL, ZURICH, SWITZERLAND.;SCHREIBER, PETER W., BAYARD, CORNELIA, GREINER, MICHAEL, MUELLER, NICOLAS J., UNIV HOSP ZURICH, DIV INFECT DIS \& HOSP EPIDEMIOL, ZURICH, SWITZERLAND.;SCHUURMANS, MACE M., BENDEN, CHRISTIAN, UNIV HOSP ZURICH, DIV PULM MED, ZURICH, SWITZERLAND.;RUEHE, BETTINA, LONDON SCH HYG \& TROP MED, LONDON, ENGLAND.","10.1371/JOURNAL.PONE.0177340","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E0177340",NA,"CLINICAL RESEARCH PRIORITY PROGRAM `VIRAL INFECTIOUS DISEASES' OF THE UNIVERSITY OF ZURICH","FUNDING WAS PROVIDED BY THE CLINICAL RESEARCH PRIORITY PROGRAM `VIRAL INFECTIOUS DISEASES' OF THE UNIVERSITY OF ZURICH. THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT.",NA,"1932-6203","5",NA,"PUBLIC LIBRARY SCIENCE","12",2017,"ISI000402058800016","47","SCIENCE \& TECHNOLOGY - OTHER TOPICS","4","MULTIDISCIPLINARY SCIENCES","HUBER.MICHAELVIROLOGY.UZH.CH",NA,"EV8UE",NA,"HUBER, M (REPRINT AUTHOR), UNIV ZURICH, INST MED VIROL, ZURICH, SWITZERLAND","ISI","UNIV ZURICH;UNIV HOSP ZURICH;UNIV HOSP ZURICH;LONDON SCH HYG AND TROP MED","UNIV ZURICH",NA,"LEWANDOWSKA DW, 2017, PLOS ONE","LEWANDOWSKA DW, 2017, PLOS ONE"
"MERINO GA, 2017, HUM MUTAT","MERINO GA;MURUA YA;FRESNO C;SENDOYA JM;GOLUBICKI M;ISEAS S;CORAGLIO M;PODHAJCER OL;LLERA AS;FERNANDEZ EA","TARSEQQC: QUALITY CONTROL ON TARGETED SEQUENCING EXPERIMENTS IN R","HUMAN MUTATION","HUM. MUTAT.","TARGETED SEQUENCING (TS) IS GROWING AS A SCREENING METHODOLOGY USED IN RESEARCH AND MEDICAL GENETICS TO IDENTIFY GENOMIC ALTERATIONS CAUSING HUMAN DISEASES. IN GENERAL, A LIST OF POSSIBLE GENOMIC VARIANTS IS DERIVED FROM MAPPED READS THROUGH A VARIANT CALLING STEP. THIS PROCESSING STEP IS USUALLY BASED ON VARIANT COVERAGE, ALTHOUGH IT MAY BE AFFECTED BY SEVERAL FACTORS. THEREFORE, UNDERCOVERED RELEVANT CLINICAL VARIANTS MAY NOT BE REPORTED, AFFECTING PATHOLOGY DIAGNOSIS OR TREATMENT. THUS, A PRIOR QUALITY CONTROL OF THE EXPERIMENT IS CRITICAL TO DETERMINE VARIANT DETECTION ACCURACY AND TO AVOID ERRONEOUS MEDICAL CONCLUSIONS. THERE ARE SEVERAL QUALITY CONTROL TOOLS, BUT THEY ARE FOCUSED ON ISSUES RELATED TO WHOLE-GENOME SEQUENCING. HOWEVER, IN TS, QUALITY CONTROL SHOULD ASSESS EXPERIMENT, GENE, AND GENOMIC REGION PERFORMANCES BASED ON ACHIEVED COVERAGES. HERE, WE PROPOSE TARSEQQC R PACKAGE FOR QUALITY CONTROL IN TS EXPERIMENTS. THE TOOL IS FREELY AVAILABLE AT BIOCONDUCTOR REPOSITORY. TARSEQQC WAS USED TO ANALYZE TWO DATASETS, LOW-PERFORMANCE PRIMER POOLS AND FEATURES WERE DETECTED, ENHANCING THE QUALITY OF EXPERIMENT RESULTS. READ COUNT PROFILES WERE ALSO EXPLORED, SHOWING TARSEQQC'S EFFECTIVENESS AS AN EXPLORATION TOOL. OUR PROPOSALMAY BE A VALUABLE BIOINFORMATIC TOOL FOR ROUTINELY TS EXPERIMENTS IN BOTH RESEARCH ANDMEDICAL GENETICS.","CANCER PANEL; EXPERIMENT PERFORMANCE; MEDICAL GENETICS; QUALITY CONTROL; R PACKAGE; TARGETED SEQUENCING","COLORECTAL-CANCER; MUTATIONS; PACKAGE","ENGLISH","ARTICLE","ARTICLE",0,"BECKER K, 2013, J CLIN PATHOL, V66, P803, DOI 10.1136/JCLINPATH-2013-201549.;CHANG FQ, 2013, CANCER GENET-NY, V206, P413, DOI 10.1016/J.CANCERGEN.2013.10.003.;HADD AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/J.JMOLDX.2012.11.006.;HARISMENDY O, 2013, BREAST CANCER RES, V15, DOI 10.1186/BCR3584.;HUMMEL M, 2011, BIOINFORMATICS, V27, P1316, DOI 10.1093/BIOINFORMATICS/BTR122.;LI H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/BIOINFORMATICS/BTP352.;LI H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/BIOINFORMATICS/BTP324.;MARTINEZ-ALCANTARA A, 2009, BIOINFORMATICS, V25, P2438, DOI 10.1093/BIOINFORMATICS/BTP429.;MELDRUM CLIFF, 2011, CLIN BIOCHEM REV, V32, P177.;MERINO G. A., 2015, IFMBE P, V49, P659.;METZKER ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/NRG2626.;MORGAN M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/BIOINFORMATICS/BTP450.;MOURADOV D, 2014, CANCER RES, V74, P3238, DOI 10.1158/0008-5472.CAN-14-0013.;MUZNY DM, 2012, NATURE, V487, P330, DOI 10.1038/NATURE11252.;NIELSEN R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/NRG2986.;NIEUWENHUIS MH, 2007, CRIT REV ONCOL HEMAT, V61, P153, DOI 10.1016/J.CRITREVONC.2006.07.004.;NIKIFOROVA MN, 2013, J CLIN ENDOCR METAB, V98, PE1852, DOI 10.1210/JC.2013-2292.;RIZZO JM, 2012, CANCER PREV RES, V5, P887, DOI 10.1158/1940-6207.CAPR-11-0432.;SATYA RV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1073.;SCHWEIGER MR, 2011, CANCER METAST REV, V30, P199, DOI 10.1007/S10555-011-9278-Z.;SEGDITSAS S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/SJ.ONC.1210059.;YOST SE, 2013, BIOINFORMATICS, V29, P1908, DOI 10.1093/BIOINFORMATICS/BTT305.","MERINO, GA, FERNANDEZ, EA (REPRINT AUTHOR), UA AREA CS AGR ING BIO \& S, AVE ARMADA ARGENTINA 3555,X5016DHK, CORDOBA, ARGENTINA.;MERINO, GABRIELA A., FRESNO, CRISTOBAL, FERNANDEZ, ELMER A., UNIV CATOLICA CORDOBA, CONICET, UA AREA CS AGR ING BIO YS, CORDOBA, ARGENTINA.;MERINO, GABRIELA A., FERNANDEZ, ELMER A., UNIV NACL CORDOBA, FAC CIENCIAS EXACTAS FIS \& NAT, CORDOBA, ARGENTINA.;MURUA, YANINA A., SENDOYA, JUAN M., PODHAJCER, OSVALDO L., LLERA, ANDREA S., FDN INST LELOIR, BUENOS AIRES, DF, ARGENTINA.;MURUA, YANINA A., SENDOYA, JUAN M., PODHAJCER, OSVALDO L., LLERA, ANDREA S., CONSEJO NACL INVEST CIENT \& TECN, INST INVEST BIOQUIM BUENOS AIRES, BUENOS AIRES, DF, ARGENTINA.;GOLUBICKI, MARIANO, INTERGRP ARGENTINO TRATAMIENTO TUMORES GASTROINTE, BUENOS AIRES, DF, ARGENTINA.;ISEAS, SOLEDAD, CORAGLIO, MARIANA, HOSP GASTROENTEROL DR CARLOS BONORINO UDAONDO, BUENOS AIRES, DF, ARGENTINA.","10.1002/HUMU.23204","111 RIVER ST, HOBOKEN 07030-5774, NJ USA",NA,NA,"UNIVERSIDAD CATOLICA DE CORDOBA (BOD), MINISTERIO DE CIENCIA, TECNOLOGIA E INNOVACION PRODUCTIVA (FONCYT) [PPL06/2011, PPL04/2011], MINISTERIO DE CIENCIA, TECNOLOGIA E INNOVACION PRODUCTIVA (FONARSEC PBIT) [015/13], SECRETARIA DE CIENCIA Y TECNOLOGIA-UNIVERSIDAD NACIONAL DE CORDOBA [30720150101719CB], CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS (CONICET)","CONTRACT GRANT SPONSORS: UNIVERSIDAD CATOLICA DE CORDOBA (BOD/2016), MINISTERIO DE CIENCIA, TECNOLOGIA E INNOVACION PRODUCTIVA (FONCYT PPL06/2011, FONCYT PPL04/2011, FONARSEC PBIT 015/13), SECRETARIA DE CIENCIA Y TECNOLOGIA-UNIVERSIDAD NACIONAL DE CORDOBA (30720150101719CB), CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS (CONICET).",NA,"1059-7794","5","494-502","WILEY","38",2017,"ISI000400596800003","22","GENETICS \& HEREDITY","3","GENETICS \& HEREDITY","GMERINOBDMG.COM.AR EFERNANDEZBDMG.COM.AR",NA,"ET9AK",NA,"MERINO, GA, FERNANDEZ, EA (REPRINT AUTHOR), UA AREA CS AGR ING BIO \& S, AVE ARMADA ARGENTINA 3555,X5016DHK, CORDOBA, ARGENTINA","ISI","UNIV CATOLICA CORDOBA;UNIV NACL CORDOBA;FDN INST LELOIR;INST INVEST BIOQUIM BUENOS AIRES;INTERGRP ARGENTINO TRATAMIENTO TUMORES GASTROINTE;HOSP GASTROENTEROL DR CARLOS BONORINO UDAONDO","NOTREPORTED",NA,"MERINO GA, 2017, HUM MUTAT","MERINO GA, 2017, HUM MUTAT"
"MA J, 2017, J CANCER RES CLIN ONCOL","MA J;YANG J;JIAN W;WANG X;XIAO D;XIA W;XIONG L;MA D","A NOVEL LOSS-OF-FUNCTION HETEROZYGOUS BRCA2 C.8946\_8947DELAG MUTATION FOUND IN A CHINESE WOMAN WITH FAMILY HISTORY OF BREAST CANCER","JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY","J. CANCER RES. CLIN. ONCOL.","INTRODUCTION BREAST CANCER IS THE MOST FREQUENT FEMALE MALIGNANCY WORLDWIDE. AMONG THEM, SOME CASES HAVE HEREDITARY SUSCEPTIBILITY IN TWO LEADING GENES, BRCA1 AND BRCA2. HETEROZYGOUS GERM LINE MUTATIONS IN THEM ARE RELATED WITH INCREASED RISK OF BREAST, OVARIAN AND OTHER CANCER, FOLLOWING AUTOSOMAL DOMINANT INHERITANCE MODE. METHODS AND RESULTS FOR PURPOSE OF EARLY FINDING, EARLY DIAGNOSIS AND EARLY TREATMENT, MUTATION DETECTING OF BRCA1/2 GENES WAS PERFORMED IN UNSELECTED 300 BREAST OR OVARIAN PATIENTS AND UNAFFECTED WOMEN USING NEXT-GENERATION SEQUENCING AND THEN CONFIRMED BY SANGER SEQUENCING. A NON-PREVIOUSLY REPORTED HETEROZYGOUS MUTATION C.8946\_8947DELAG (P.D2983FFSX34) OF BRCA2 GENE WAS IDENTIFIED IN AN UNAFFECTED CHINESE WOMAN WITH FAMILY HISTORY OF BREAST CANCER (HER BREAST CANCER MOTHER, ALSO CARRYING THIS MUTATION). THE BRCA2-TRUNCATED PROTEIN RESULTED FROM THE FRAME SHIFT MUTATION WAS FOUND TO LOSE TWO PUTATIVE NUCLEAR LOCALIZATION SIGNALS AND A RAD51-BINDING MOTIF IN THE EXTREME C-TERMINAL REGION BY BIOINFORMATIC PREDICTION. AND THEN IN VITRO EXPERIMENTS SHOWED THAT NEARLY ALL THE MUTANT PROTEIN WAS UNABLE TO TRANSLOCATE TO THE NUCLEUS TO PERFORM DNA REPAIR ACTIVITY. THIS NOVEL MUTANT BRCA2 PROTEIN IS DYSFUNCTION. WE CLASSIFY THE MUTATION INTO DISEASE CAUSING AND CONCLUDE THAT IT IS THE RISK FACTOR FOR BREAST CANCER IN THIS FAMILY. SO, CONDUCTING THE SAME MUTATION TEST AND PROVIDING GENETIC COUNSELING FOR THIS FAMILY IS PRACTICALLY MEANINGFUL AND SIGNIFICANT. MEANWHILE, THE IDENTIFICATION OF THIS NEW MUTATION ENRICHES THE BREAST CANCER INFORMATION CORE DATABASE, ESPECIALLY IN CHINA.","BREAST CANCER; BRCA2; MUTATION; FRAME SHIFT; NLS; RAD51","SUSCEPTIBILITY GENE; LOCALIZATION; PROTEIN; REPAIR; RECOMBINATION; EXPRESSION; FILAMENTS; SEQUENCE; RAD51","ENGLISH","ARTICLE","ARTICLE",1,"COLLABORATIVE GROUP ON HORMONAL FACTORS IN BREAST CANCER, 2001, LANCET, V358, P1389, DOI [10.1016/S0140-6736(01)06524-2, DOI 10.1016/S0140-6736(01)06524-2].;D'ARGENIO V, 2015, CLIN CHIM ACTA, V446, P221, DOI 10.1016/J.CCA.2015.03.045.;DAVIES OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/NSMB1251.;ERTURK E, 2015, GENE, V556, P163, DOI 10.1016/J.GENE.2014.11.047.;ESASHI F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/NSMB1245.;FAN L, 2014, LANCET ONCOL, V15, PE279, DOI 10.1016/S1470-2045(13)70567-9.;GERHARDUS A, 2007, EUR J HUM GENET, V15, P619, DOI 10.1038/SJ.EJHG.5201806.;HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/SCIENCE.2270482.;HALLAM S, 2015, CLIN ONCOL-UK, V27, P527, DOI 10.1016/J.CLON.2015.06.001.;HARMSEN MG, 2015, CRIT REV ONCOL HEMAT, V96, P555, DOI 10.1016/J.CRITREVONC.2015.07.010.;LARAQUI A., 2015, DIS MARKERS, V2015.;LARSEN MJ, 2014, BREAST CANCER-BASIC, V8, P145, DOI 10.4137/BCBCR.S18715.;LICHTENSTEIN P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201.;LIM MJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/BCR2722.;MEHRGOU AMIR, 2016, MED J ISLAM REPUB IRAN, V30, P369.;MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/SCIENCE.7545954.;MOYNAHAN ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5.;NG PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/NAR/GKG509.;PATEL KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0.;PISANO M, 2011, FAM CANCER, V10, P65, DOI 10.1007/S10689-010-9389-7.;PRADJATMO HERU, 2015, ASIAN PAC J CANCER PREV, V16, P8599.;PRENSNER JR, 2014, CANCER RES, V74, P1651, DOI 10.1158/0008-5472.CAN-13-3159.;ROY R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/NRC3181.;SCALIA-WILBUR J, 2016, SEMIN RADIAT ONCOL, V26, P3, DOI 10.1016/J.SEMRADONC.2015.09.004.;SCHLACHER K, 2011, CELL, V145, P529, DOI 10.1016/J.CELL.2011.03.041.;SCHWARZ JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/NMETH0810-575.;SHARAN SK, 1997, GENOMICS, V40, P234, DOI 10.1006/GENO.1996.4573.;SHARAN SK, 1997, NATURE, V386, P804, DOI 10.1038/386804A0.;SHEIKH ASFANDYAR, 2015, ASIAN PAC J CANCER PREV, V16, P2177.;SPAIN BH, 1999, P NATL ACAD SCI USA, V96, P13920, DOI 10.1073/PNAS.96.24.13920.;TAVTIGIAN SV, 1996, NAT GENET, V12, P333, DOI 10.1038/NG0396-333.;WEST SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/NRM1127.;WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/SCIENCE.8091231.;YANO K, 2000, BIOCHEM BIOPH RES CO, V270, P171, DOI 10.1006/BBRC.2000.2392.;YIANNAKOPOULOU E, 2014, CELL ONCOL, V37, P1, DOI 10.1007/S13402-013-0158-0.;YOSHIKAWA Y, 2005, BIOMED RES-TOKYO, V26, P109, DOI 10.2220/BIOMEDRES.26.109.","MA, D (REPRINT AUTHOR), FUDAN UNIV, COLLABORAT INNOVAT CTR GENET \& DEV, KEY LAB METAB \& MOL MED,INST BIOMED SCI, MINIST EDUC,DEPT BIOCHEM \& MOL BIOL,SCH BASIC MED, SHANGHAI, PEOPLES R CHINA.;XIONG, LK (REPRINT AUTHOR), BAOAN MATERNAL \& CHILDREN HEALTHCARE HOSP, CTR LAB, KEY LAB BIRTH DEFECTS RES, SHENZHEN, PEOPLES R CHINA.;XIONG, LK (REPRINT AUTHOR), BIRTH DEFECTS PREVENT RES \& TRANSFORMAT TEAM, SHENZHEN, PEOPLES R CHINA.;MA, JING, YANG, JICHUN, XIAO, DEYONG, XIA, WENJUN, MA, DUAN, FUDAN UNIV, COLLABORAT INNOVAT CTR GENET \& DEV, KEY LAB METAB \& MOL MED,INST BIOMED SCI, MINIST EDUC,DEPT BIOCHEM \& MOL BIOL,SCH BASIC MED, SHANGHAI, PEOPLES R CHINA.;MA, JING, XIONG, LIKUAN, BAOAN MATERNAL \& CHILDREN HEALTHCARE HOSP, CTR LAB, KEY LAB BIRTH DEFECTS RES, SHENZHEN, PEOPLES R CHINA.;MA, JING, XIONG, LIKUAN, BIRTH DEFECTS PREVENT RES \& TRANSFORMAT TEAM, SHENZHEN, PEOPLES R CHINA.;JIAN, WENJING, WANG, XIANMING, SHENZHEN UNIV, PEOPLES HOSP 2, DEPT BREAST SURG, AFFILIATED HOSP 1, SHENZHEN, PEOPLES R CHINA.;JIAN, WENJING, SUN YAT SEN UNIV, AFFILIATED HOSP 3, BREAST CANC CTR, GUANGZHOU, GUANGDONG, PEOPLES R CHINA.","10.1007/S00432-016-2327-9","233 SPRING ST, NEW YORK, NY 10013 USA",NA,NA,"NATIONAL KEY RESEARCH AND DEVELOPMENT PROGRAM [2016YFC1000500], SHANGHAI MUNICIPAL COMMISSION OF HEALTH AND FAMILY PLANNING [2013ZYJB0015], SHANGHAI MUNICIPAL COMMISSION OF SCIENCE AND TECHNOLOGY [14DJ1400103]","WE THANK ALL OF THE DONORS WHO PARTICIPATED IN THIS PROGRAM AND ALL OF OUR COLLEAGUES AT BAO'AN MATERNAL AND CHILDREN HEALTHCARE HOSPITAL. THIS WORK WAS SUPPORTED BY GRANTS FROM THE NATIONAL KEY RESEARCH AND DEVELOPMENT PROGRAM (2016YFC1000500), SHANGHAI MUNICIPAL COMMISSION OF HEALTH AND FAMILY PLANNING (2013ZYJB0015) AND SHANGHAI MUNICIPAL COMMISSION OF SCIENCE AND TECHNOLOGY (14DJ1400103).",NA,"0171-5216","4","631-637","SPRINGER","143",2017,"ISI000398718100007","36","ONCOLOGY","4","ONCOLOGY","XIONGLKSINA.CN DUANMAFUDAN.EDU.CN",NA,"ER3SJ",NA,"MA, D (REPRINT AUTHOR), FUDAN UNIV, COLLABORAT INNOVAT CTR GENET \& DEV, KEY LAB METAB \& MOL MED,INST BIOMED SCI, MINIST EDUC,DEPT BIOCHEM \& MOL BIOL,SCH BASIC MED, SHANGHAI, PEOPLES R CHINA","ISI","FUDAN UNIV;CTR LAB;BIRTH DEFECTS PREVENT RES AND TRANSFORMAT TEAM;SHENZHEN UNIV;SUN YAT SEN UNIV","FUDAN UNIV",NA,"MA J, 2017, J CANCER RES CLIN ONCOL","MA J, 2017, J CANCER RES CLIN ONCOL"
"CHEN J, 2017, INT J LAB HEMATOL","CHEN J;WANG J;LIN XY;XU YW;HE ZH;LI HY;CHEN SQ;JIANG WY","GENETIC DIAGNOSIS IN HEMOPHILIA A FROM SOUTHERN CHINA: FIVE NOVEL MUTATIONS AND ONE PREIMPLANTATION GENETIC ANALYSIS","INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY","INT. J. LAB. HEMATOL.","INTRODUCTIONAS THERE IS CURRENTLY NO COMPLETE CURE FOR HEMOPHILIA A (HA), THE IDENTIFICATION OF PATHOGENIC MUTATIONS IN FACTOR VIII (FVIII) GENE FROM HA PATIENTS AND CARRIERS, WHICH CAN CONTRIBUTE TO GENETIC COUNSELING PRENATAL DIAGNOSIS, AND PREIMPLANTATION GENETIC DIAGNOSIS (PGD), IS AN IMPORTANT STEP TO PREVENT HA. METHODSA TOTAL OF 14 UNRELATED CHINESE HA SUBJECTS (FVIII ACTIVITY <40\%), 20 CARRIER SUBJECTS, THREE FETUSES, AND ONE PGD WERE INCLUDED IN THIS STUDY. WE FIRST SCREENED FOR THE PRESENCE OF FVIII INTRON 22 AND INTRON 1 INVERSIONS. SECOND, THE CODING REGION OF THE FVIII GENE WAS SEQUENCED. FOR THE NOVEL MUTATIONS, FVIII MRNA EXPRESSION WAS DETECTED BY REAL-TIME PCR AND THE PROTEIN STRUCTURES WERE ANALYZED BY BIOINFORMATIC TOOLS. RESULTSFIVE NOVEL MUTATIONS (C.1A>C, C.304\_305INSA, C.1594T>A, C.6045G>A, AND C.2645\_2646INSG) WERE FOUND. THE REAL-TIME PCR SHOWED THAT THE EXPRESSION OF FVIII MRNAS WAS LOWER IN HA PATIENTS THAN IN NORMAL SUBJECTS. PRENATAL DIAGNOSIS AND PGD WERE SUCCESSFULLY PERFORMED: TWO OF THREE FETUSES AND FOUR OF EIGHT BLASTOMERES WERE CONFIRMED TO BE NORMAL. CONCLUSIONIN CONCLUSION, GENETIC DIAGNOSIS OF 14 UNRELATED HA SUBJECTS, 20 CARRIER SUBJECTS, THREE FETUSES, AND ONE PGD WAS SUCCESSFULLY PERFORMED IN OUR STUDY.","HEMOPHILIA A; FVIII; GENE DIAGNOSIS; PRENATAL DIAGNOSIS; NOVEL MUTATION; PREIMPLANTATION GENETIC DIAGNOSIS","HUMAN-FACTOR-VIII; BINDING-SITE; PRENATAL-DIAGNOSIS; LIGHT-CHAIN; C2 DOMAIN; AMPLIFICATION; COMPRISES; INVERSION; SUBUNIT","ENGLISH","ARTICLE","ARTICLE",1,"CAI XH, 2006, J THROMB HAEMOST, V4, P1969, DOI 10.1111/J.1538-7836.2006.02105.X.;DAVIS LB, 2010, FERTIL STERIL, V93, P1793, DOI 10.1016/J.FERTNSTERT.2008.12.053.;DERRICK TS, 2004, J PHARM SCI-US, V93, P2549, DOI 10.1002/JPS.20167.;FAY PJ, 1999, J BIOL CHEM, V274, P29826, DOI 10.1074/JBC.274.42.29826.;FAY PJ, 1992, J BIOL CHEM, V267, P13246.;FAY PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0.;FREIJE D, 1992, AM J HUM GENET, V51, P66.;GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326A0.;HARTON GL, 2011, HUM REPROD, V26, P33, DOI 10.1093/HUMREP/DEQ231.;HE ZH, 2012, HAEMOPHILIA, V18, P452, DOI 10.1111/J.1365-2516.2011.02670.X.;HE ZH, 2013, CELL BIOCHEM BIOPHYS, V65, P463, DOI 10.1007/S12013-012-9450-2.;HIGUCHI M, 1991, P NATL ACAD SCI USA, V88, P8307, DOI 10.1073/PNAS.88.19.8307.;KAUFMAN RJ, 1988, J BIOL CHEM, V263, P6352.;LAPAN KA, 1998, THROMB HAEMOSTASIS, V80, P418.;LENTING PJ, 1996, J BIOL CHEM, V271, P1935, DOI 10.1074/JBC.271.4.1935.;LENTING PJ, 1999, J BIOL CHEM, V274, P23734, DOI 10.1074/JBC.274.34.23734.;LIANG Y, 2008, PRENATAL DIAG, V28, P160, DOI 10.1002/PD.1926.;LIU Q, 1998, BLOOD, V92, P1458.;PANIGRAHI I, 2005, INDIAN PEDIATR, V42, P577.;RENWICK PJ, 2007, PRENATAL DIAG, V27, P206, DOI 10.1002/PD.1638.;SAENKO EL, 1997, J BIOL CHEM, V272, P18007, DOI 10.1074/JBC.272.29.18007.;SHEN XT, 2011, J ASSIST REPROD GEN, V28, P957, DOI 10.1007/S10815-011-9598-5.;TAKESHIMA K, 2003, THROMB HAEMOSTASIS, V89, P788.","JIANG, WY (REPRINT AUTHOR), SUN YAT SEN UNIV, ZHONGSHAN SCH MED, DEPT MED GENET, 74,ZHONGSHAN RD 2, GUANGZHOU 510080, GUANGDONG, PEOPLES R CHINA.;CHEN, J., LIN, X. Y., HE, Z. H., LI, H. Y., CHEN, S. Q., JIANG, W. Y., SUN YAT SEN UNIV, ZHONGSHAN SCH MED, DEPT MED GENET, 74,ZHONGSHAN RD 2, GUANGZHOU 510080, GUANGDONG, PEOPLES R CHINA.;WANG, J., XU, Y. W., SUN YAT SEN UNIV, AFFILIATED HOSP 1, GUANGZHOU, GUANGDONG, PEOPLES R CHINA.","10.1111/IJLH.12602","111 RIVER ST, HOBOKEN 07030-5774, NJ USA",NA,NA,"CHINESE NATIONAL NATURAL SCIENTIFIC GRANT [U1132606, 31171214]","ALL AUTHORS' SPECIFIC CONTRIBUTIONS TO THE WORK: JUAN CHEN PERFORMED THE RESEARCH, ANALYZED THE DATA, DRAFTED AND REVISED THE ARTICLE, JING WANG, XIAOYING LIN, AND ZHIHUI HE PERFORMED THE RESEARCH, YANWEN XU, HONGYI LI, AND SUQIN CHEN COLLECTED SPECIMENS, WEIYING JIANG DESIGNED THE RESEARCH STUDY, ANALYZED THE DATA, CONTRIBUTED ESSENTIAL REAGENTS OR TOOLS, REVISED THE PAPER AND APPROVED THE SUBMITTED AND FINAL VERSIONS. W. JIANG IS SUPPORTED BY CHINESE NATIONAL NATURAL SCIENTIFIC GRANT (NO. U1132606 AND NO. 31171214). WE THANK QUN FANG OF THE FETAL CENTER OF THE FIRST AFFILIATED HOSPITAL OF SUN YET-SAN UNIVERSITY FOR HELPING US TO ACQUIRE THE UMBILICAL CORD BLOOD AND AMNIOTIC FLUID.",NA,"1751-5521","2","191-201","WILEY","39",2017,"ISI000397505000014","23","HEMATOLOGY","2","HEMATOLOGY","JIANGWYMAIL.SYSU.EDU.CN",NA,"EP6QW",NA,"JIANG, WY (REPRINT AUTHOR), SUN YAT SEN UNIV, ZHONGSHAN SCH MED, DEPT MED GENET, 74,ZHONGSHAN RD 2, GUANGZHOU 510080, GUANGDONG, PEOPLES R CHINA","ISI","SUN YAT SEN UNIV;SUN YAT SEN UNIV","SUN YAT SEN UNIV",NA,"CHEN J, 2017, INT J LAB HEMATOL","CHEN J, 2017, INT J LAB HEMATOL"
"CHOI JW, 2017, J DENT RES","CHOI JW;KIM SC;HONG SH;LEE HJ","SECRETABLE SMALL RNAS VIA OUTER MEMBRANE VESICLES IN PERIODONTAL PATHOGENS","JOURNAL OF DENTAL RESEARCH","J. DENT. RES.","MICRORNAS (MIRNAS) HAVE BEEN SHOWN TO BE MAJOR REGULATORS OF EUKARYOTIC GENE EXPRESSION. HOWEVER, BACTERIAL RNAS COMPARABLE IN SIZE TO EUKARYOTIC MIRNAS (18-22 NUCLEOTIDES) HAVE RECEIVED LITTLE ATTENTION. RECENTLY, A NOVEL CLASS OF SMALL RNAS SIMILAR IN SIZE TO MIRNAS (MIRNA-SIZE, SMALL RNAS OR MSRNAS) HAVE ALSO BEEN FOUND IN SEVERAL BACTERIA. LIKE MIRNAS, MSRNAS ARE APPROXIMATELY 15 TO 25 NUCLEOTIDES IN LENGTH, AND THEIR PRECURSORS ARE PREDICTED TO FORM A HAIRPIN LOOP SECONDARY STRUCTURE. HERE, WE IDENTIFIED MSRNAS IN THE PERIODONTAL PATHOGENS AGGREGATIBACTER ACTINOMYCETEMCOMITANS, PORPHYROMONAS GINGIVALIS, AND TREPONEMA DENTICOLA. WE EXAMINED THESE MSRNAS USING A DEEP SEQUENCING METHOD AND CHARACTERIZED DOZENS OF MSRNAS THROUGH BIOINFORMATIC ANALYSIS. HIGHLY EXPRESSED MSRNAS WERE SELECTED FOR FURTHER VALIDATION. THE FINDINGS SUGGEST THAT THIS CLASS OF SMALL RNAS IS WELL CONSERVED ACROSS THE DOMAINS OF LIFE. INDEED, MSRNAS SECRETED VIA BACTERIAL OUTER MEMBRANE VESICLES (OMVS) WERE DETECTED. THE ABILITY OF BACTERIAL OMVS TO DELIVER RNAS INTO EUKARYOTIC CELLS WAS ALSO OBSERVED. THESE MSRNAS IN OMVS ALLOWED US TO IDENTIFY THEIR POTENTIAL HUMAN IMMUNE-RELATED TARGET GENES. FURTHERMORE, WE FOUND THAT EXOGENOUS MSRNAS COULD SUPPRESS EXPRESSION OF CERTAIN CYTOKINES IN JURKAT T CELLS. WE PROPOSE MSRNAS MAY FUNCTION AS NOVEL BACTERIAL SIGNALING MOLECULES THAT MEDIATE BACTERIA-TO-HUMAN INTERACTIONS. FURTHERMORE, THIS STUDY MAY PROVIDE FRESH INSIGHT INTO BACTERIAL PATHOGENIC MECHANISMS OF PERIODONTAL DISEASES.","MICRORNA; PERIODONTITIS; DEEP SEQUENCING; EXTRACELLULAR VESICLES; EXOSOMES; RNAI","ESCHERICHIA-COLI; MICRORNA-SIZE; TREPONEMA-DENTICOLA; CELLS; MECHANISMS; EXPRESSION; CYTOKINES; BACTERIA; STORIES; DISEASE","ENGLISH","ARTICLE","ARTICLE",10,"AMANO A, 2010, PERIODONTOL 2000, V54, P9, DOI 10.1111/J.1600-0757.2010.00376.X.;BILLER SJ, 2014, SCIENCE, V343, P183, DOI 10.1126/SCIENCE.1243457.;BUSHATI N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/ANNUREV.CELLBIO.23.090506.123406.;DEATHERAGE BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11.;FENNO JC, 1996, J BACTERIOL, V178, P2489, DOI 10.1128/JB.178.9.2489-2497.1996.;FURUSE Y, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0106434.;GHOSAL A, 2015, MICROBIOLOGYOPEN, V4, P252, DOI 10.1002/MBO3.235.;GOTTESMAN S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/J.TIG.2005.05.008.;GRIFFITHS-JONES S, 2005, NUCLEIC ACIDS RES, V33, PD121, DOI 10.1093/NAR/GRI081.;HORSTMAN AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/JBC.275.17.12489.;HU GUOKU, 2012, FRONTIERS IN GENETICS, V3, P56, DOI 10.3389/FGENE.2012.00056.;IGUCHI HARUHISA, 2010, COMMUN INTEGR BIOL, V3, P478, DOI 10.4161/CIB.3.5.12693.;KANG SM, 2013, CURR MICROBIOL, V67, P609, DOI 10.1007/S00284-013-0411-9.;KHALAF H, 2014, CYTOKINE, V67, P29, DOI 10.1016/J.CYTO.2014.02.007.;KINANE DF, 2007, PERIODONTOL 2000, V45, P14, DOI 10.1111/J.1600-0757.2007.00220.X.;KONONEN E, 2014, PERIODONTOL 2000, V65, P46, DOI 10.1111/PRD.12016.;KOSAKA N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/JBC.M110.107821.;LEE HJ, 2014, EXP BIOL MED, V239, P1275, DOI 10.1177/1535370214544269.;LEE HJ, 2013, EXP BIOL MED, V238, P339, DOI 10.1258/EBM.2012.012251.;LEE HJ, 2012, FEMS MICROBIOL LETT, V326, P131, DOI 10.1111/J.1574-6968.2011.02441.X.;MASSE E, 2003, GENE DEV, V17, P2374, DOI 10.1101/GAD.1127103.;MONTECALVO A, 2012, BLOOD, V119, P756, DOI 10.1182/BLOOD-2011-02-338004.;NAKAO R, 2016, VACCINE, V34, P4626, DOI 10.1016/J.VACCINE.2016.06.016.;NAKAO R, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0026163.;NEJMAN-FALENCZYK B, 2015, SCI REP-UK, V5, DOI 10.1038/SREP10080.;NICOLA AM, 2009, EUKARYOT CELL, V8, P1373, DOI 10.1128/EC.00044-09.;OLOVNIKOV I, 2013, MOL CELL, V51, P594, DOI 10.1016/J.MOLCEL.2013.08.014.;OPAL SM, 2000, CHEST, V117, P1162, DOI 10.1378/CHEST.117.4.1162.;PAGE RC, 1976, LAB INVEST, V34, P235.;PANYUKOV VV, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0062601.;PASTER BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001.;RAJEWSKY N, 2006, NAT GENET, V38, PS8, DOI 10.1038/NG1798.;SCHNEIDER A, 2013, CELL TISSUE RES, V352, P33, DOI 10.1007/S00441-012-1428-2.;SOARES GMS, 2012, J APPL ORAL SCI, V20, P295, DOI 10.1590/S1678-77572012000300002.;THAY B, 2014, INFECT IMMUN, V82, P4034, DOI 10.1128/IAI.01980-14.;THERY CLOTILDE, 2011, F1000 BIOL REP, V3, P15, DOI 10.3410/B3-15.;VERMEULEN A, 2005, RNA, V11, P674, DOI 10.1261/RNA.7272305.;VESEY PM, 2004, MICROBIOL-SGM, V150, P2401, DOI 10.1099/MIC.0.26816-0.;WAI SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2.;YANG JS, 2011, MOL CELL, V43, P892, DOI 10.1016/J.MOLCEL.2011.07.024.","LEE, HJ (REPRINT AUTHOR), KYUNGPOOK NATL UNIV, SCH DENT, DEPT MICROBIOL \& IMMUNOL, 2177 DALGUBEOL DAERO, DAEGU 41940, SOUTH KOREA.;CHOI, J. -W., KIM, S. -C., HONG, S. -H., LEE, H. -J., KYUNGPOOK NATL UNIV, SCH DENT, DEPT MICROBIOL \& IMMUNOL, 2177 DALGUBEOL DAERO, DAEGU 41940, SOUTH KOREA.;LEE, H. -J., KYUNGPOOK NATL UNIV, BRAIN SCI \& ENGN INST, DAEGU, SOUTH KOREA.","10.1177/0022034516685071","2455 TELLER RD, THOUSAND OAKS, CA 91320 USA",NA,NA,"BASIC SCIENCE RESEARCH PROGRAM THROUGH THE NATIONAL RESEARCH FOUNDATION OF KOREA (NRF) - KOREAN GOVERNMENT (MSIP) [2008-0062282, 2015R1D1A3A01019684]","THIS RESEARCH WAS SUPPORTED BY THE BASIC SCIENCE RESEARCH PROGRAM THROUGH THE NATIONAL RESEARCH FOUNDATION OF KOREA (NRF), FUNDED BY THE KOREAN GOVERNMENT (MSIP, 2008-0062282 AND 2015R1D1A3A01019684). THE AUTHORS DECLARE NO POTENTIAL CONFLICTS OF INTEREST WITH RESPECT TO THE AUTHORSHIP AND/OR PUBLICATION OF THIS ARTICLE.",NA,"0022-0345","4","458-466","SAGE PUBLICATIONS INC","96",2017,"ISI000398161900014","40","DENTISTRY, ORAL SURGERY \& MEDICINE","10","DENTISTRY, ORAL SURGERY \& MEDICINE","HEONLEEKNU.AC.KR",NA,"EQ5ZP",NA,"LEE, HJ (REPRINT AUTHOR), KYUNGPOOK NATL UNIV, SCH DENT, DEPT MICROBIOL \& IMMUNOL, 2177 DALGUBEOL DAERO, DAEGU 41940, SOUTH KOREA","ISI","KYUNGPOOK NATL UNIV;KYUNGPOOK NATL UNIV","KYUNGPOOK NATL UNIV",NA,"CHOI JW, 2017, J DENT RES","CHOI JW, 2017, J DENT RES"
"SILLANPAA S, 2017, MSPHERE","SILLANPAA S;KRAMNA L;OIKARINEN S;SIPILA M;RAUTIAINEN M;AITTONIEMI J;LARANNE J;HYOTY H;CINEK O","NEXT-GENERATION SEQUENCING COMBINED WITH SPECIFIC PCR ASSAYS TO DETERMINE THE BACTERIAL 16S RRNA GENE PROFILES OF MIDDLE EAR FLUID COLLECTED FROM CHILDREN WITH ACUTE OTITIS MEDIA","MSPHERE","MSPHERE","THE AIM OF THE STUDY WAS TO ANALYZE THE BACTERIOME OF ACUTE OTITIS MEDIA WITH A NOVEL MODIFICATION OF NEXT-GENERATION SEQUENCING TECHNIQUES. OUTPATIENT CHILDREN WITH ACUTE OTITIS MEDIA WERE ENROLLED IN THE STUDY, AND MIDDLE EAR FLUIDS WERE COLLECTED DURING 90 EPISODES FROM 79 SUBJECTS AGED 5 TO 42 MONTHS (MEDIAN AGE, 19 MONTHS). THE BACTERIOME PROFILES OF MIDDLE EAR FLUID SAMPLES WERE DETERMINED BY A NESTED-PCR AMPLIFICATION OF THE 16S RRNA GENE (V4 REGION), FOLLOWED BY MASS SEQUENCING. THE PROFILING RESULTS WERE COMPARED TO THE RESULTS OF SPECIFIC PCR ASSAYS TARGETING SELECTED PREVALENT PATHOGENS. BACTERIOME PROFILING USING NESTED AMPLIFICATION OF LOW-VOLUME SAMPLES WAS AIDED BY A BIOINFORMATIC SUBTRACTION OF SIGNAL CONTAMINANTS FROM THE RECOMBINANT POLYMERASE, ACHIEVING A SENSITIVITY SLIGHTLY LOWER THAN THAT OF SPECIFIC PCR DETECTION. STREPTOCOCCUS PNEUMONIAE WAS DETECTED IN 28 (31\%) SAMPLES, HAEMOPHILUS INFLUENZAE IN 24 (27\%), MORAXELLA CATARRHALIS IN 18 (20\%), STAPHYLOCOCCUS SPP. IN 21 (23\%), TURICELLA OTITIDIS IN 5 (5.6\%), ALLOIOCOCCUS OTITIDIS IN 3 (3.3\%), AND OTHER BACTERIA IN 14 (16\%) USING BACTERIOME PROFILING. S. PNEUMONIAE WAS THE DOMINANT PATHOGEN IN 14 (16\%) SAMPLES, H. INFLUENZAE IN 15 (17\%), M. CATARRHALIS IN 5 (5.6\%), T. OTITIDIS IN 2, AND STAPHYLOCOCCUS AURICULARIS IN 2. WEAKER SIGNALS OF PREVOTELLA MELANINOGENICA, VEILLONELLA DISPAR, AND VEILLONELLA MONTPELLIERENSIS WERE NOTED IN SEVERAL SAMPLES. FOURTEEN SAMPLES (16\%) WERE NOT EXPLAINABLE BY BACTERIAL PATHOGENS, NOVEL CAUSATIVE AGENTS WERE NOT DETECTED. IN CONCLUSION, UNBIASED BACTERIOME PROFILING HELPED IN DEPICTING THE TRUE MUTUAL QUANTITATIVE RATIOS OF EAR BACTERIA, BUT AT PRESENT, ITS COMPLICATED PROTOCOL IMPEDES ITS ROUTINE CLINICAL USE. IMPORTANCE ALTHOUGH S. PNEUMONIAE, H. INFLUENZAE, AND M. CATARRHALIS HAVE BEEN LONG ESTABLISHED AS THE MOST IMPORTANT PATHOGENS IN ACUTE OTITIS MEDIA USING CULTURE AND SPECIFIC PCR ASSAYS, THE KNOWLEDGE OF THEIR MUTUAL QUANTITATIVE RELATIONS AND POSSIBLE ROLES OF OTHER BACTERIA IS INCOMPLETE. THE ADVENT OF UNBIASED BACTERIOME 16S RRNA GENE PROFILING HAS ALLOWED THE DETECTION OF NEARLY ALL BACTERIA PRESENT IN THE SAMPLE, AND IT HELPS IN DEPICTING THEIR MUTUAL QUANTITATIVE RATIOS. DUE TO THE DIFFICULTIES IN PERFORMING MASS SEQUENCING IN LOW-VOLUME SAMPLES, ONLY A FEW BACTERIOME-PROFILING STUDIES OF OTITIS MEDIA HAVE BEEN PUBLISHED, ALL LIMITED TO CASES OF CHRONIC OTITIS MEDIA. HERE, WE PRESENT A STUDY ON SAMPLES OBTAINED FROM YOUNG CHILDREN WITH ACUTE OTITIS MEDIA, SUCCESSFULLY USING A STRATEGY OF NESTED PCR COUPLED WITH MASS SEQUENCING, AND DEMONSTRATE THAT THE METHOD CAN CONFER QUANTITATIVE INFORMATION HARDLY OBTAINABLE BY OTHER METHODS.","16S PROFILING; ACUTE OTITIS MEDIA; BACTERIOME PROFILING; MASS SEQUENCING; NEXT-GENERATION SEQUENCING","INCLUDING ALLOIOCOCCUS-OTITIDIS; MULTIPLEX-PCR; STAPHYLOCOCCUS-AURICULARIS; NASOPHARYNX; POLYMERASE; EFFUSION; DNA; MICROBIOLOGY; PATHOGENS; PRIMERS","ENGLISH","ARTICLE","ARTICLE",3,"AYDIN E, 2012, CLIN EXP OTORHINOLAR, V5, P81, DOI 10.3342/CEO.2012.5.2.81.;CAPORASO JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/NMETH.F.303.;CARVALHO MDA G, 2007, J CLIN MICROBIOL, V45, P2460.;CASSELBRANT ML, 1995, INT J PEDIATR OTORHI, V33, P1, DOI 10.1016/0165-5876(95)01184-D.;DEVOS D, 1997, J CLIN MICROBIOL, V35, P1295.;EDGAR RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/BIOINFORMATICS/BTQ461.;FADEN H, 1989, J CLIN MICROBIOL, V27, P2488.;HARIMAYA A, 2006, J CLIN MICROBIOL, V44, P946, DOI 10.1128/JCM.44.3.946-949.2006.;HARIMAYA A, 2006, INT J PEDIATR OTORHI, V70, P1009, DOI 10.1016/J.IJPORL.2005.10.012.;HENDOLIN PH, 1997, J CLIN MICROBIOL, V35, P2854.;HENDOLIN PH, 2000, J CLIN MICROBIOL, V38, P125.;HOFFMAN D, 2007, J PERINATOL, V27, P519, DOI 10.1038/SJ.JP.7211773.;HOLDER RC, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0128606.;HOLDER RC, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-87.;JARIC MELITA, 2013, BMC PROC, V7, PS4, DOI 10.1186/1753-6561-7-S7-S4.;JERVIS-BARDY J, 2015, INT J PEDIATR OTORHI, V79, P1548, DOI 10.1016/J.IJPORL.2015.07.013.;KAUR R, 2010, PEDIATR INFECT DIS J, V29, P741, DOI 10.1097/INF.0B013E3181D9E639.;KLINDWORTH A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/NAR/GKS808.;KLOOS WE, 1983, INT J SYST BACTERIOL, V33, P9, DOI 10.1099/00207713-33-1-9.;KOZICH JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13.;LEW SQ, 2004, PERITON DIALYSIS INT, V24, P195.;LIU CM, 2011, ARCH OTOLARYNGOL, V137, P664, DOI 10.1001/ARCHOTO.2011.116.;LUPAN I, 2013, ROM BIOTECH LETT, V18, P8007.;MARSH RL, 2012, BMC EAR NOSE THROAT, V12, DOI 10.1186/1472-6815-12-11.;MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695.;NADKARNI MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257.;NEEFF M, 2016, J CLIN MICROBIOL, V54, P2538, DOI 10.1128/JCM.01068-16.;NIIMI H, 2011, J CLIN MICROBIOL, V49, P3316, DOI 10.1128/JCM.00584-11.;PALMU AAI, 2004, J INFECT DIS, V189, P775, DOI 10.1086/381765.;PICHON B, 2012, J ANTIMICROB CHEMOTH, V67, P2338, DOI 10.1093/JAC/DKS221.;POST JC, 1996, AM J OTOLARYNG, V17, P106, DOI 10.1016/S0196-0709(96)90005-8.;QUAST C, 2013, NUCLEIC ACIDS RES, V41, PD590, DOI 10.1093/NAR/GKS1219.;ROLAND PS, 2002, LARYNGOSCOPE, V112, P1166, DOI 10.1097/00005537-200207000-00005.;RUOHOLA A, 2006, CLIN INFECT DIS, V43, P1417, DOI 10.1086/509332.;SCHLOSS PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09.;SILLANPAA S, 2016, J CLIN MICROBIOL, V54, P2373, DOI 10.1128/JCM.01146-16.;SMITH-VAUGHAN HC, 2013, BMC EAR NOSE THROAT, V13, DOI 10.1186/1472-6815-13-12.;SPANGLER R, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0007010.;STOL K, 2013, INT J PEDIATR OTORHI, V77, P488, DOI 10.1016/J.IJPORL.2012.12.016.;VIROLAINEN A, 1994, J CLIN MICROBIOL, V32, P2667.;VON GRAEVENITZ A, 2014, INFECTION, V42, P1, DOI 10.1007/S15010-013-0488-X.;WESTERBERG BD, 2009, OTOL NEUROTOL, V30, P174, DOI 10.1097/MAO.0B013E31819225A0.;XU QF, 2011, INT J PEDIATR OTORHI, V75, P239, DOI 10.1016/J.IJPORL.2010.11.008.;YATSYSHINA S, 2016, DIAGN MICR INFEC DIS, V85, P125, DOI 10.1016/J.DIAGMICROBIO.2016.02.010.","SILLANPAA, S (REPRINT AUTHOR), UNIV TAMPERE, DEPT OTORHINOLARYNGOL \& HEAD \& NECK SURG, TAMPERE UNIV HOSP, TAMPERE, FINLAND.;SILLANPAA, S (REPRINT AUTHOR), UNIV TAMPERE, SCH MED, TAMPERE, FINLAND.;SILLANPAA, SAARA, SIPILA, MARKKU, RAUTIAINEN, MARKUS, LARANNE, JUSSI, UNIV TAMPERE, DEPT OTORHINOLARYNGOL \& HEAD \& NECK SURG, TAMPERE UNIV HOSP, TAMPERE, FINLAND.;SILLANPAA, SAARA, SIPILA, MARKKU, RAUTIAINEN, MARKUS, LARANNE, JUSSI, UNIV TAMPERE, SCH MED, TAMPERE, FINLAND.;KRAMNA, LENKA, CINEK, ONDREJ, CHARLES UNIV PRAGUE, DEPT PEDIAT, FAC MED 2, PRAGUE, CZECH REPUBLIC.;KRAMNA, LENKA, CINEK, ONDREJ, UNIV HOSP MOTOL, PRAGUE, CZECH REPUBLIC.;OIKARINEN, SAMI, HYOTY, HEIKKI, UNIV TAMPERE, DEPT VIROL, SCH MED, TAMPERE, FINLAND.;AITTONIEMI, JANNE, HYOTY, HEIKKI, FIMLAB LABS, TAMPERE, FINLAND.","10.1128/MSPHERE.00006-17","1752 N ST NW, WASHINGTON, DC 20036-2904 USA","E00006-17",NA,"MINISTRY OF HEALTH OF THE CZECH REPUBLIC [00064203], ACADEMY OF FINLAND","MOLECULAR TESTING IN THIS STUDY WAS SUPPORTED BY THE PROJECT FOR CONCEPTUAL DEVELOPMENT NO. 00064203, MINISTRY OF HEALTH OF THE CZECH REPUBLIC. COLLECTION AND PROCESSING OF THE SAMPLES WAS FUNDED BY THE ACADEMY OF FINLAND.",NA,"2379-5042","2",NA,"AMER SOC MICROBIOLOGY","2",2017,"ISI000399174700002","44","MICROBIOLOGY","5","MICROBIOLOGY","SAARA.SILLANPAAUTA.FI",NA,"ER9VH",NA,"SILLANPAA, S (REPRINT AUTHOR), UNIV TAMPERE, DEPT OTORHINOLARYNGOL \& HEAD \& NECK SURG, TAMPERE UNIV HOSP, TAMPERE, FINLAND","ISI","UNIV TAMPERE;UNIV TAMPERE;CHARLES UNIV PRAGUE;UNIV HOSP MOTOL;UNIV TAMPERE;FIMLAB LABS","UNIV TAMPERE",NA,"SILLANPAA S, 2017, MSPHERE","SILLANPAA S, 2017, MSPHERE"
"MOHEBI M, 2017, IRAN J BASIC MED SCI","MOHEBI M;CHENARI S;AKBARI A;GHASSEMI F;ZAREI GHANAVATI M;FAKHRAIE G;BABAIE N;HEIDARI M","MUTATION ANALYSIS OF CONNEXIN 50 GENE AMONG IRANIAN FAMILIES WITH AUTOSOMAL DOMINANT CATARACTS","IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES","IRAN. J. BASIC MED. SCI.","OBJECTIVE(S): CHILDHOOD CATARACT IS A GENETICALLY HETEROGENEOUS EYE DISORDER THAT RESULTS IN VISUAL IMPAIRMENT. THE AIM OF THIS STUDY WAS TO IDENTIFY THE GENETIC MUTATIONS OF CONNEXIN 50 GENE AMONG IRANIAN FAMILIES SUFFERED FROM AUTOSOMAL DOMINANT CONGENITAL CATARACTS (ADCC). MATERIALS AND METHODS: FAMILIES, HAVING AT LEAST TWO MEMBERS WITH BILATERAL FAMILIAL CONGENITAL CATARACT, WERE SELECTED FOR THE STUDY. PROBANDS WERE EVALUATED BY DETAILED OPHTHALMOLOGIST'S EXAMINATION, AND THE PEDIGREE ANALYSIS WAS PERFORMED. PCR AMPLIFICATIONS WERE PERFORMED CORRESPONDING TO CODING REGION AND INTRON-EXON BOUNDARIES OF GJA8, A CANDIDATE GENE RESPONSIBLE FOR ADCC. PCR PRODUCTS WERE SUBJECTED TO BIDIRECTIONAL SEQUENCING, AND THE CO-SEGREGATION OF IDENTIFIED MUTATIONS WAS EXAMINED AND FINALLY, THE IMPACT OF IDENTIFIED MUTATIONS ON BIOLOGICAL FUNCTIONS OF GJA8 WAS PREDICTED BY IN SILICO EXAMINATION. RESULTS: THREE DIFFERENT GENETIC ALTERATIONS, INCLUDING C. 130G> A (P. V44M), C. 301G> T (P. R101L) AND C. 134G> T (P. W45L) IN GJA8 GENE WERE DETECTED AMONG THREE PROBANDS. TWO IDENTIFIED MUTATIONS, W45L AND V44M HAVE BEEN ALREADY REPORTED, WHILE THE R101L IS A NOVEL MUTATION AND ITS COSEGREGATION WAS EXAMINED. THIS MUTATION WAS EXCLUSIVELY DETECTED IN THE ADCC AND COULD NOT BE FOUND AMONG THE HEALTHY CONTROL GROUP. THE RESULT OF BIOINFORMATIC STUDIES OF R101L MUTATION PREDICTED THAT THIS AMINO ACID SUBSTITUTION WITHIN GJA8 COULD BE A DISEASE-AFFLICTING MUTATION DUE TO ITS POTENTIAL EFFECT ON THE PROTEIN STRUCTURE AND BIOLOGICAL FUNCTION. CONCLUSION: OUR RESULTS SUGGEST THAT MUTATIONS OF LENS CONNEXIN GENES SUCH AS GJA8 GENE COULD BE ONE OF THE MAJOR MECHANISMS OF CATARACT DEVELOPMENT, AT LEAST IN A SIGNIFICANT PROPORTION OF IRANIAN PATIENTS WITH ADCC.","CATARACT; CONGENITAL; CONNEXINE 50 GENE; GJA8; MUTATION","CONGENITAL CATARACTS; COLON ADENOCARCINOMA; MOLECULAR-GENETICS; INHERITED CATARACT; INHIBITOR SD-208; GJA8; LENS; NUCLEAR","ENGLISH","ARTICLE","ARTICLE",1,"AKBARI A, 2016, JUNDISHAPUR J MICROB, V9, DOI 10.5812/JJM.27297.;AKBARI A, 2016, MOL MED REP, V13, P909, DOI 10.3892/MMR.2015.4596.;AKBARI A, 2015, IRAN J BASIC MED SCI, V18, P856.;AKBARI A, 2014, DARU, V22, DOI 10.1186/2008-2231-22-47.;BEYER EC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/FPHYS.2014.00020.;CHEN C, 2015, GRAEF ARCH CLIN EXP, V253, P915, DOI 10.1007/S00417-015-3019-X.;DENG H, 2014, EUR J MED GENET, V57, P113, DOI 10.1016/J.EJMG.2013.12.006.;GARNAI SJ, 2014, MOL VIS, V20, P1579.;HE WG, 2000, HUM GENET, V106, P1, DOI 10.1007/S004390051002.;HEJTMANCIK JF, 2003, DEV OPHTHALMOL, V37, P67.;HUANG BY, 2010, EUR J MED GENET, V53, P347, DOI 10.1016/J.EJMG.2010.07.001.;JIANG JX, 2010, CURR MOL MED, V10, P851.;LI JY, 2013, MOL VIS, V19, P767.;MACKAY DS, 2014, HUM GENOMICS, V8, DOI 10.1186/S40246-014-0019-6.;MINOGUE PJ, 2009, INVEST OPHTH VIS SCI, V50, P5837, DOI 10.1167/IOVS.09-3759.;MOBINI GHOLAM REZA, 2016, ACTA MED IRAN, V54, P302.;MOHEBI MASOUMEH, 2016, ACTA MED IRAN, V54, P778.;PFENNIGER A, 2011, EUR J CLIN INVEST, V41, P103, DOI 10.1111/J.1365-2362.2010.02378.X.;REDDY MA, 2004, SURV OPHTHALMOL, V49, P300, DOI 10.1016/J.SURVOPHTHAL.2004.02.013.;REN Q, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0074732.;RONG XF, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0134864.;RUBINOS C, 2014, AM J PHYSIOL-CELL PH, V306, PC212, DOI 10.1152/AJPCELL.00098.2013.;SARKAR D, 2014, BIOMED RES INT, V2014.;SUKHIJA J, 2015, J PEDIAT OPHTH STRAB, V52, P372, DOI 10.3928/01913913-20150929-15.;UMAR MURTALA M, 2015, MIDDLE EAST AFR J OPHTHALMOL, V22, P92, DOI 10.4103/0974-9233.148356.;WANG L, 2011, MOL VIS, V17, P2380.;WANG MINGYUE, 2015, EYE SCI, V30, P38.;YAZDI MKS, 2011, AFR J BIOTECHNOL, V10, P1522.;YI J, 2011, INT J OPHTHALMOL-CHI, V4, P422, DOI 10.3980/J.ISSN.2222-3959.2011.04.20.;ZHU YP, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0121608.;ZHU YN, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0115406.","HEIDARI, M (REPRINT AUTHOR), ISLAMIC AZAD UNIV, DEPT MOL BIOL \& GENET, BUSHEHR BRANCH, BUSHEHR, IRAN.;MOHEBI, MASOUMEH, CHENARI, SAEED, GHASSEMI, FARIBA, ZAREI-GHANAVATI, MEHRAN, FAKHRAIE, GHASEM, UNIV TEHRAN MED SCI, FARABI EYE HOSP, FARABI EYE RES CTR, TEHRAN, IRAN.;GHASSEMI, FARIBA, IRAN UNIV MED SCI, COLORECTAL RES CTR, TEHRAN, IRAN.;BABAIE, NAHID, HEIDARI, MANSOUR, ISLAMIC AZAD UNIV, DEPT MOL BIOL \& GENET, BUSHEHR BRANCH, BUSHEHR, IRAN.;HEIDARI, MANSOUR, UNIV TEHRAN MED SCI, SCH MED, DEPT MED GENET, TEHRAN, IRAN.;HEIDARI, MANSOUR, UNIV TEHRAN MED SCI, EXPT MED RES CTR, TEHRAN, IRAN.","10.22038/IJBMS.2017.8358","VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN",NA,NA,"TEHRAN UNIVERSITY OF MEDICAL SCIENCES (TUMS)","THIS WORK WAS SUPPORTED BY TEHRAN UNIVERSITY OF MEDICAL SCIENCES (TUMS). WE ALSO THANK STAFF OF THE GENETIC DEPARTMENT FROM FARABI HOSPITAL FOR KEY CONTRIBUTIONS.",NA,"2008-3866","3","288-293","MASHHAD UNIV MED SCIENCES","20",2017,"ISI000398054400009","31","RESEARCH \& EXPERIMENTAL MEDICINE, PHARMACOLOGY \& PHARMACY","2","MEDICINE, RESEARCH \& EXPERIMENTAL, PHARMACOLOGY \& PHARMACY","MHEIDARISINA.TUMS.AC.IR",NA,"EQ4NK",NA,"HEIDARI, M (REPRINT AUTHOR), ISLAMIC AZAD UNIV, DEPT MOL BIOL \& GENET, BUSHEHR BRANCH, BUSHEHR, IRAN","ISI","UNIV TEHRAN MED SCI;IRAN UNIV MED SCI;ISLAMIC AZAD UNIV;UNIV TEHRAN MED SCI;UNIV TEHRAN MED SCI","ISLAMIC AZAD UNIV",NA,"MOHEBI M, 2017, IRAN J BASIC MED SCI","MOHEBI M, 2017, IRAN J BASIC MED SCI"
"MA G, 2017, MOL CANCER","MA G;LIU H;HUA Q;WANG M;DU M;LIN Y;GE Y;GONG W;ZHAO Q;QIANG F;TAO G;ZHANG Z;CHU H","KCNMA1 COOPERATING WITH PTK2 IS A NOVEL TUMOR SUPPRESSOR IN GASTRIC CANCER AND IS ASSOCIATED WITH DISEASE OUTCOME","MOLECULAR CANCER","MOL. CANCER","BACKGROUND: INACTIVATION OF TUMOR SUPPRESSOR GENES BY PROMOTER HYPERMETHYLATION PLAYS A KEY ROLE IN THE TUMORGENESIS. IT IS NECESSARY TO UNCOVER THE DETAILED PATTERN OF WHOLE GENOME-WIDE ABNORMAL DNA METHYLATION DURING THE DEVELOPMENT OF GASTRIC CANCER (GC). METHOD: WE PERFORMED A GENOME-WIDE METHYLATION DETECTION USING 12 PAIRED OF GC TISSUES AND THEIR CORRESPONDING NORMAL TISSUES. METHYLATION-SPECIFIC PCR (MSP) AND BISULPHITE SEQUENCING (BSP) WERE USED TO MEASURE METHYLATION STATUS OF SPECIFIC CPG SITE. BASED ON THE BIOINFORMATIC ANALYSIS, THE CELL PHENOTYPES AND MOUSE MODEL EXPERIMENTS WERE CONSTRUCTED TO DETECT EFFECT OF THE TARGET GENE. USING THE KAPLAN-MEIER SURVIVAL CURVE, THE CLINICAL VALUE OF KCNMA1 WAS ASSESSED IN GC PATIENTS. RESULTS: THE CPG SITE CG24113782 LOCATED AT THE PROMOTER OF KCNMA1 SHOWED THE MOST SIGNIFICANT DIFFERENCE, CONTRIBUTING TO THE COMMONLY SILENCED KCNMA1IN GASTRIC CANCER CELLS AND PRIMARY GC TISSUES. THE PROMOTER METHYLATION OF KCNMA1 WAS DETECTED IN 68.7\% (77/112) OF TUMOR TISSUES, COMPARED WITH 16.2\% (18/112) OF NORMAL TISSUES (P < 0.001). THE SURVIVAL CURVE INDICATED THAT KCNMA1 HYPERMETHYLATION WAS SIGNIFICANTLY ASSOCIATED WITH THE SHORTENED SURVIVAL IN GC PATIENTS (P = 0.036). KCNMA1 SIGNIFICANTLY INHIBITED BIOLOGICAL MALIGNANT BEHAVIOR OF GASTRIC CANCER CELL BY INDUCING CELL APOPTOSIS IN VITRO, AND SUPPRESSED XENOGRAFT TUMOR GROWTH IN SUBCUTANEOUS MOUSE MODELS (BOTH P < 0.001). FURTHERMORE, THE ANTI-TUMOR EFFECT OF KCNMA1 WAS MEDIATED THROUGH SUPPRESSING THE EXPRESSION OF PTK2. CONCLUSION: KCNMA1 IS A CRITICAL TUMOR SUPPRESSOR IN GASTRIC CARCINOGENESIS AND ITS HYPERMETHYLATION IS AN INDEPENDENT PROGNOSTIC FACTOR IN PATIENTS WITH GASTRIC CANCER.","GASTRIC CANCER; KCNMA1 METHYLATION; PROGNOSIS","FOCAL ADHESION KINASE; CELL-PROLIFERATION; CHANNEL EXPRESSION; POTASSIUM CHANNELS; SIGNALING PATHWAY; ENDOTHELIAL FAK; DEATH; BK; CARCINOGENESIS; METHYLATION","ENGLISH","ARTICLE","ARTICLE",2,"ABDULLAEV IF, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0012304.;BASRAI D, 2002, NEUROREPORT, V13, P403, DOI 10.1097/00001756-200203250-00008.;BENJAMINI Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2.;BLOCH M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/SJ.ONC.1210036.;BURY M, 2013, CELL DEATH DIS, V4, DOI 10.1038/CDDIS.2013.85.;CABRITA MA, 2011, MOL ONCOL, V5, P517, DOI 10.1016/J.MOLONC.2011.10.004.;CAMARGO MC, 2014, GUT, V63, P236, DOI 10.1136/GUTJNL-2013-304531.;CAMBIEN B, 2008, INT J CANCER, V123, P365, DOI 10.1002/IJC.23511.;CHEN JS, 2013, CARCINOGENESIS, V34, P10, DOI 10.1093/CARCIN/BGS274.;CHOI IS, 2005, CELL RES, V15, P247, DOI 10.1038/SJ.CR.7290293.;JEAN C, 2014, J CELL BIOL, V204, P247, DOI 10.1083/JCB.201307067.;JEMAL A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/CAAC.20107.;KHAITAN D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258.;KONSTANTINIDOU G, 2013, CANCER DISCOV, V3, P444, DOI 10.1158/2159-8290.CD-12-0388.;LANG F, 2005, J MEMBRANE BIOL, V205, P147, DOI 10.1007/S00232-005-0780-5.;LI W, 2014, CELL DEATH DIS, V5, DOI 10.1038/CDDIS.2014.538.;MACFARLANE SN, 2000, GLIA, V30, P39, DOI 10.1002/(SICI)1098-1136(200003)30:1<39::AID-GLIA5>3.0.CO,2-S.;MARABITA F, 2013, EPIGENETICS-US, V8, P333, DOI 10.4161/EPI.24008.;MARRION NV, 1998, NATURE, V395, P900, DOI 10.1038/27674.;MCLEAN GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/GAD.316304.;MITRA SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/J.CEB.2006.08.011.;MIZUNO N, 1998, ENDOCRINOLOGY, V139, P1429, DOI 10.1210/EN.139.3.1429.;OUADID-AHIDOUCH H, 2008, J MEMBRANE BIOL, V221, P1, DOI 10.1007/S00232-007-9080-6.;PANCRAZIO JJ, 1993, ANTICANCER RES, V13, P1231.;PYLAYEVA Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160.;SAH P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7.;SHIBUE T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/PNAS.0904227106.;SULZMAIER FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/NRC3792.;TAVORA B, 2010, EMBO MOL MED, V2, P516, DOI 10.1002/EMMM.201000106.;TOMITA H, 2011, GASTROENTEROLOGY, V140, P879, DOI 10.1053/J.GASTRO.2010.11.037.;VAITHIANATHAN T, 2008, J GEN PHYSIOL, V132, P13, DOI 10.1085/JGP.200709913.;WANG KN, 2016, GUT, V65, P1619, DOI 10.1136/GUTJNL-2015-309276.;WANG SY, 2013, GUT, V62, P833, DOI 10.1136/GUTJNL-2011-301776.;WEAVER AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/JNR.20240.;XU LX, 2012, GUT, V61, P977, DOI 10.1136/GUTJNL-2011-300411.;YU J, 2009, GASTROENTEROLOGY, V136, P640, DOI 10.1053/J.GASTRO.2008.10.050.;ZHAO J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/S10555-008-9165-4.","ZHANG, ZD, CHU, HY (REPRINT AUTHOR), NANJING MED UNIV, DEPT ENVIRONM GENOM, JIANGSU KEY LAB CANC BIOMARKERS PREVENT \& TREATME, CTR CANC, NANJING, JIANGSU, PEOPLES R CHINA.;MA, GAOXIANG, LIU, HANTING, HUA, QIUHAN, WANG, MEILIN, DU, MULONG, LIN, YADI, GE, YUQIU, ZHANG, ZHENGDONG, CHU, HAIYAN, NANJING MED UNIV, DEPT ENVIRONM GENOM, JIANGSU KEY LAB CANC BIOMARKERS PREVENT \& TREATME, CTR CANC, NANJING, JIANGSU, PEOPLES R CHINA.;MA, GAOXIANG, LIU, HANTING, HUA, QIUHAN, WANG, MEILIN, DU, MULONG, LIN, YADI, GE, YUQIU, ZHANG, ZHENGDONG, CHU, HAIYAN, NANJING MED UNIV, SCH PUBL HLTH, DEPT GENET TOXICOL, KEY LAB MODERN TOXICOL,MINIST EDUC, NANJING, JIANGSU, PEOPLES R CHINA.;GONG, WEIDA, YIXING TUMOR HOSP, DEPT GEN SURG, YIXING, PEOPLES R CHINA.;ZHAO, QINGHONG, NANJING MED UNIV, DEPT GEN SURG, AFFILIATED HOSP 2, NANJING, JIANGSU, PEOPLES R CHINA.;QIANG, FULIN, NANTONG TUMOR HOSP, CORE LAB, NANTONG, PEOPLES R CHINA.;TAO, GUOQUAN, NANJING MED UNIV, DEPT GEN SURG, HUAI AN PEOPLES HOSP 1, HUAIAN, PEOPLES R CHINA.;ZHANG, ZHENGDONG, CHU, HAIYAN, NANJING MED UNIV, DEPT ENVIRONM GENOM, SCH PUBL HLTH, 101 LONGMIAN AVENUEJIANGNING DIST, NANJING 211166, JIANGSU, PEOPLES R CHINA.","10.1186/S12943-017-0613-Z","CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND","46",NA,"NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA [81473049, 81230068, 81302490], JIANGSU PROVINCIAL SCIENCE AND TECHNOLOGY INNOVATION TEAM, JIANGSU PROVINCIAL POSTDOCTORAL SCIENCE FOUNDATION [1501081C], CHINA POSTDOCTORAL SCIENCE FOUNDATION [2015 M580449], COLLABORATIVE INNOVATION CENTER FOR CANCER PERSONALIZED MEDICINE, PRIORITY ACADEMIC PROGRAM DEVELOPMENT OF JIANGSU HIGHER EDUCATION INSTITUTIONS (PUBLIC HEALTH AND PREVENTIVE MEDICINE)","THIS STUDY WAS PARTLY SUPPORTED BY NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA (81473049, 81230068, AND 81302490), JIANGSU PROVINCIAL SCIENCE AND TECHNOLOGY INNOVATION TEAM, JIANGSU PROVINCIAL POSTDOCTORAL SCIENCE FOUNDATION FUNDED PROJECT (1501081C), CHINA POSTDOCTORAL SCIENCE FOUNDATION FUNDED PROJECT (2015 M580449), COLLABORATIVE INNOVATION CENTER FOR CANCER PERSONALIZED MEDICINE, AND THE PRIORITY ACADEMIC PROGRAM DEVELOPMENT OF JIANGSU HIGHER EDUCATION INSTITUTIONS (PUBLIC HEALTH AND PREVENTIVE MEDICINE).",NA,"1476-4598",NA,NA,"BMC","16",2017,"ISI000397799800004","37","BIOCHEMISTRY \& MOLECULAR BIOLOGY, ONCOLOGY","6","BIOCHEMISTRY \& MOLECULAR BIOLOGY, ONCOLOGY","DRZDZHANGGMAIL.COM CHY\_GRAPE126.COM",NA,"EQ0ZT",NA,"ZHANG, ZD, CHU, HY (REPRINT AUTHOR), NANJING MED UNIV, DEPT ENVIRONM GENOM, JIANGSU KEY LAB CANC BIOMARKERS PREVENT \& TREATME, CTR CANC, NANJING, JIANGSU, PEOPLES R CHINA","ISI","NANJING MED UNIV;NANJING MED UNIV;YIXING TUMOR HOSP;NANJING MED UNIV;NANTONG TUMOR HOSP;NANJING MED UNIV;NANJING MED UNIV","NANJING MED UNIV",NA,"MA G, 2017, MOL CANCER","MA G, 2017, MOL CANCER"
"MUNOZ S, 2017, PLOS ONE","MUNOZ S;GUERRERO FD;KELLOGG A;HEEKIN AM;LEUNG MY","BIOINFORMATIC PREDICTION OF G PROTEIN-COUPLED RECEPTOR ENCODING SEQUENCES FROM THE TRANSCRIPTOME OF THE FORELEG, INCLUDING THE HALLER'S ORGAN, OF THE CATTLE TICK, RHIPICEPHALUS AUSTRALIS","PLOS ONE","PLOS ONE","THE CATTLE TICK OF AUSTRALIA, RHIPICEPHALUS AUSTRALIS, IS A VECTOR FOR MICROBIAL PARASITES THAT CAUSE SERIOUS BOVINE DISEASES. THE HALLER'S ORGAN, LOCATED IN THE TICK'S FORELEGS, IS CRUCIAL FOR HOST DETECTION AND MATING. TO FACILITATE THE DEVELOPMENT OF NEW TECHNOLOGIES FOR BETTER CONTROL OF THIS AGRICULTURAL PEST, WE AIMED TO SEQUENCE AND ANNOTATE THE TRANSCRIPTOME OF THE R. AUSTRALIS FORELEGS AND ASSOCIATED TISSUES, INCLUDING THE HALLER'S ORGAN. AS G PROTEIN-COUPLED RECEPTORS (GPCRS) ARE AN IMPORTANT FAMILY OF EUKARYOTIC PROTEINS STUDIED AS PHARMACEUTICAL TARGETS IN HUMANS, WE PRIORITIZED THE IDENTIFICATION AND CLASSIFICATION OF THE GPCRS EXPRESSED IN THE FORELEG TISSUES. THE TWO FORELEGS FROM ADULT R. AUSTRALIS WERE EXCISED, RNA EXTRACTED, AND PYROSEQUENCED WITH 454 TECHNOLOGY. READS WERE ASSEMBLED INTO UNIGENES AND ANNOTATED BY SEQUENCE SIMILARITY. PYTHON SCRIPTS WERE WRITTEN TO FIND OPEN READING FRAMES (ORFS) FROM EACH UNIGENE. THESE ORFS WERE ANALYZED BY DIFFERENT GPCR PREDICTION APPROACHES BASED ON SEQUENCE ALIGNMENTS, SUPPORT VECTOR MACHINES, HIDDEN MARKOV MODELS, AND PRINCIPAL COMPONENT ANALYSIS. GPCRS CONSISTENTLY PREDICTED BY MULTIPLE METHODS WERE FURTHER STUDIED BY PHYLOGENETIC ANALYSIS AND 3D HOMOLOGY MODELING. FROM 4,782 ASSEMBLED UNIGENES, 40,907 POSSIBLE ORFS WERE PREDICTED. USING BLASTP, PFAM, GPCRPRED, TMHMM, AND PCA-GPCR, A BASIC SET OF 46 GPCR CANDIDATES WERE COMPILED AND A PHYLOGENETIC TREE WAS CONSTRUCTED. WITH FURTHER SCREENING OF TERTIARY STRUCTURES PREDICTED BY RAPTORX, 6 LIKELY GPCRS EMERGED AND THE STRONGEST CANDIDATE WAS CLASSIFIED BY PCA-GPCR TO BE A GABA(B) RECEPTOR.",NA,"BOOPHILUS-MICROPLUS ACARI; SYNGANGLION TRANSCRIPTOME; AMBLYOMMA-AMERICANUM; COMPARATIVE GENOMICS; FAMILIES; IXODIDAE; EXPRESSION; CLONING; SYSTEM; GENES","ENGLISH","ARTICLE","ARTICLE",1,"ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;BAIROCH A, 2005, NUCLEIC ACIDS RES, V33, PD154, DOI 10.1093/NAR/GKI070.;BATEMAN A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/NAR/28.1.263.;BHASIN M, 2004, NUCLEIC ACIDS RES, V32, PW383, DOI 10.1093/NAR/GKH416.;BISSINGER BW, 2011, INSECT MOL BIOL, V20, P465, DOI 10.1111/J.1365-2583.2011.01086.X.;BOCK R, 2004, PARASITOLOGY, V129, PS247, DOI 10.1017/S0031182004005190.;CAMPOS TDL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-242.;CHEN A, 2004, INSECT MOL BIOL, V13, P45, DOI 10.1111/J.1365-2583.2004.00457.X.;CHEVREUX B, 2004, GENOME RES, V14, P1147, DOI 10.1101/GR.1917404.;CHRISTIE AE, 2011, GEN COMP ENDOCR, V170, P144, DOI 10.1016/J.YGCEN.2010.09.018.;DEBRUYNE M, 1994, J INSECT PHYSIOL, V40, P143, DOI 10.1016/0022-1910(94)90086-8.;FOELIX RF, 1972, Z ZELLFORSCH MIK ANA, V124, P275, DOI 10.1007/BF00355031.;GEORGE JE, 2004, PARASITOLOGY, V129, PS353, DOI 10.1017/S0031182003004682.;GIBSON AK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-135.;GOOKIN TE, 2013, METHODS MOL BIOL, V1043, P1, DOI 10.1007/978-1-62703-532-3\_1.;GROSS AD, 2015, INSECT BIOCHEM MOLEC, V63, P47, DOI 10.1016/J.IBMB.2015.04.008.;GUERRERO FD, 2016, TICKS TICK-BORNE DIS, V7, P670, DOI 10.1016/J.TTBDIS.2016.02.014.;GULIA-NUSS M, 2016, NAT COMMUN, V7, DOI 10.1038/NCOMMS10507.;HILL CA, 2002, SCIENCE, V298, P176, DOI 10.1126/SCIENCE.1076196.;HOLMES SP, 2000, INSECT MOL BIOL, V9, P457, DOI 10.1046/J.1365-2583.2000.00208.X.;ISBERG V, 2016, NUCLEIC ACIDS RES, V44, PD356, DOI 10.1093/NAR/GKV1178.;KALLBERG M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/NPROT.2012.085.;KING N, 2003, SCIENCE, V301, P361, DOI 10.1126/SCIENCE.1083853.;KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1.;KROGH A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/JMBI.2000.4315.;LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/BIOINFORMATICS/BTM404.;LEONOVICH SA, 2004, EXP APPL ACAROL, V32, P89, DOI 10.1023/B:APPA.0000018200.24760.78.;LIEBMANN C, 2004, CURR PHARM DESIGN, V10, P1937, DOI 10.2174/1381612043384367.;MARGULIES M, 2005, NATURE.;MERUELO AD, 2012, PROTEIN SCI, V21, P1746, DOI 10.1002/PRO.2157.;MIRZADEGAN T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/BI027224+.;MULLER CE, 2012, PHARMACOL THERAPEUT, V135, P292, DOI 10.1016/J.PHARMTHERA.2012.06.002.;NORDSTROM KJV, 2011, MOL BIOL EVOL, V28, P2471, DOI 10.1093/MOLBEV/MSR061.;NOTREDAME C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/JMBI.2000.4042.;PENG ZL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-420.;SCHIOTH HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/J.YGCEN.2004.12.018.;SLIMO L, 2014, BIOL TICKS, V1, P309.;SOARES SF, 2012, ACTA TROP, V124, P192, DOI 10.1016/J.ACTATROPICA.2012.08.007.;STEWART NP, 1982, J PARASITOL, V68, P691, DOI 10.2307/3280930.;SUZEK BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/BIOINFORMATICS/BTM098.;VAIDEHI N, 2002, P NATL ACAD SCI USA, V99, P12622, DOI 10.1073/PNAS.122357199.;VEENSTRA JA, 2016, GEN COMP ENDOCR, V229, P41, DOI [10.1016/J.YGCEN.2015.07.014, 10.1016/J.YGCEN.2015.11.019].;VEENSTRA JA, 2012, INSECT BIOCHEM MOLEC, V42, P277, DOI 10.1016/J.IBMB.2011.12.009.;VIEIRA FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/GBE/EVR033.;WISTRAND M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/PS.051745906.;ZAMANIAN M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-596.","LEUNG, MY (REPRINT AUTHOR), UNIV TEXAS EL PASO, BIOINFORMAT PROGRAM, EL PASO, TX 79968 USA.;MUNOZ, SERGIO, KELLOGG, ANASTASIA, LEUNG, MING-YING, UNIV TEXAS EL PASO, BIOINFORMAT PROGRAM, EL PASO, TX 79968 USA.;GUERRERO, FELIX D., HEEKIN, ANDREW M., USDA ARS, KNIPLING BUSHLAND US LIVESTOCK INSECTS RES LAB, KERRVILLE, TX USA.","10.1371/JOURNAL.PONE.0172326","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E0172326",NA,"USDA-ARS KNIPLING BUSHLAND US LIVESTOCK INSECTS RESEARCH LABORATORY CRIS PROJECT [6205-32000-031-00], USDA-NIFA-HSI [2012-38422-19910], NIH [2G12MD007592], OECD CO-OPERATIVE RESEARCH PROGRAMME: BIOLOGICAL RESOURCE MANAGEMENT FOR SUSTAINABLE AGRICULTURAL SYSTEMS, NATIONAL INSTITUTE OF MINORITY HEALTH AND HEALTH DISPARITIES [2G12MD007592], OECD CO-OPERATIVE RESEARCH PROGRAMME","SM, AK, AND MYL ACKNOWLEDGE FUNDING SUPPORT FROM USDA-NIFA-HSI GRANT 2012-38422-19910 (HTTPS://NIFA.USDA.GOV/) AND NATIONAL INSTITUTE OF MINORITY HEALTH AND HEALTH DISPARITIES (WWW.NIMHD.NIH.GOV) GRANT 2G12MD007592. FDG AND AMH ACKNOWLEDGE FUNDING SUPPORT FROM USDA-ARS KNIPLING BUSHLAND US LIVESTOCK INSECTS RESEARCH LABORATORY (HTTPS://WWW.ARS.USDA.GOV/PLAINS-AREA/KERRVILLE-TX/KNIPLING-BUSHLAND-US- LIVESTOCK-INSECTS-RESEARCH-LABORATORY/) CRIS PROJECT 6205-32000-031-00. FDG ACKNOWLEDGES THE RECEIPT OF A FELLOWSHIP FROM THE OECD CO-OPERATIVE RESEARCH PROGRAMME (HTTP://WWW.OECD.ORG/TAD/CRP/ABOUT-THE-CO-OPERATIVE-RESEARCH-PROGRAMME-C RP.HTM): BIOLOGICAL RESOURCE MANAGEMENT FOR SUSTAINABLE AGRICULTURAL SYSTEMS IN 2009. THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT., THIS ARTICLE REPORTS THE RESULTS OF RESEARCH ONLY. MENTION OF TRADE NAMES OR COMMERCIAL PRODUCTS IN THIS PUBLICATION IS SOLELY FOR THE PURPOSE OF PROVIDING SPECIFIC INFORMATION AND DOES NOT IMPLY RECOMMENDATION OF ENDORSEMENT BY THE U.S. DEPARTMENT OF AGRICULTURE. THE AUTHORS WISH TO THANK DR. LOUISE JACKSON (BIOSECURITY QUEENSLAND, QDAFF) AND MR. JASON TIDWELL (USDA-ARS CFTRL, EDINBURG, TX) FOR HELP WITH OBTAINING TICK MATERIALS, AS WELL AS MR. JON MOHL FOR TECHNICAL SUPPORT FOR THE COMPUTATIONAL ANALYSIS. FDG AND AMH ACKNOWLEDGE FUNDING SUPPORT FROM USDA-ARS KNIPLING BUSHLAND US LIVESTOCK INSECTS RESEARCH LABORATORY CRIS PROJECT 6205-32000-031-00. SM, AK, AND MYL ACKNOWLEDGE FUNDING SUPPORT FROM USDA-NIFA-HSI GRANT 2012-38422-19910 AND NIH GRANT 2G12MD007592. FDG ACKNOWLEDGES THE RECEIPT OF A FELLOWSHIP FROM THE OECD CO-OPERATIVE RESEARCH PROGRAMME: BIOLOGICAL RESOURCE MANAGEMENT FOR SUSTAINABLE AGRICULTURAL SYSTEMS IN 2009. USDA IS AN EQUAL OPPORTUNITY PROVIDER AND EMPLOYER.",NA,"1932-6203","2",NA,"PUBLIC LIBRARY SCIENCE","12",2017,"ISI000394682400036","46","SCIENCE \& TECHNOLOGY - OTHER TOPICS","13","MULTIDISCIPLINARY SCIENCES","MLEUNGUTEP.EDU",NA,"EL5SX",NA,"LEUNG, MY (REPRINT AUTHOR), UNIV TEXAS EL PASO, BIOINFORMAT PROGRAM, EL PASO, TX 79968 USA","ISI","UNIV TEXAS EL PASO;KNIPLING BUSHLAND US LIVESTOCK INSECTS RES LAB","UNIV TEXAS EL PASO",NA,"MUNOZ S, 2017, PLOS ONE","MUNOZ S, 2017, PLOS ONE"
"NIEUWENHUIJSE DF, 2017, FRONT MICROBIOL","NIEUWENHUIJSE DF;KOOPMANS MPG","METAGENOMIC SEQUENCING FOR SURVEILLANCE OF FOOD- AND WATERBORNE VIRAL DISEASES","FRONTIERS IN MICROBIOLOGY","FRONT. MICROBIOL.","A PLETHORA OF VIRUSES CAN BE TRANSMITTED BY THE FOOD- AND WATERBORNE ROUTE. HOWEVER, THEIR RECOGNITION IS CHALLENGING BECAUSE OF THE VARIETY OF VIRUSES, HETEROGENEITY OF SYMPTOMS, THE LACK OF AWARENESS OF CLINICIANS, AND LIMITED SURVEILLANCE EFFORTS. CLASSICAL FOOD-AND WATERBORNE VIRAL DISEASE OUTBREAKS ARE MAINLY CAUSED BY CALICIVIRUSES, BUT THE SOURCE OF THE VIRUS IS OFTEN NOT KNOWN AND THE FOODBORNE MODE OF TRANSMISSION IS DIFFICULT TO DISCRIMINATE FROM HUMAN-TO-HUMAN TRANSMISSION. ATYPICAL FOOD-AND WATERBORNE VIRAL DISEASE CAN BE CAUSED BY VIRUSES SUCH AS HEPATITIS A AND HEPATITIS E. IN ADDITION, A SOURCE OF NOVEL EMERGING VIRUSES WITH A POTENTIAL TO SPREAD VIA THE FOOD-AND WATERBORNE ROUTE IS THE REPEATED INTERACTION OF HUMANS WITH WILDLIFE. WILDLIFE-TO-HUMAN ADAPTATION MAY GIVE RISE TO SELF-LIMITING OUTBREAKS IN SOME CASES, BUT WHEN FULLY ADJUSTED TO THE HUMAN HOST CAN BE DEVASTATING. METAGENOMIC SEQUENCING HAS BEEN INVESTIGATED AS A PROMISING SOLUTION FOR SURVEILLANCE PURPOSES AS IT DETECTS ALL VIRUSES IN A SINGLE PROTOCOL, DELIVERS ADDITIONAL GENOMIC INFORMATION FOR OUTBREAK TRACING, AND DETECTS NOVEL UNKNOWN VIRUSES. NEVERTHELESS, SEVERAL ISSUES MUST BE ADDRESSED TO APPLY METAGENOMIC SEQUENCING IN SURVEILLANCE. FIRST, SAMPLE PREPARATION IS DIFFICULT SINCE THE GENOMIC MATERIAL OF VIRUSES IS GENERALLY OVERSHADOWED BY HOST-AND BACTERIAL GENOMES. SECOND, SEVERAL DATA ANALYSIS ISSUES HAMPER THE EFFICIENT, ROBUST, AND AUTOMATED PROCESSING OF METAGENOMIC DATA. THIRD, INTERPRETATION OF METAGENOMIC DATA IS HARD, BECAUSE OF THE LACK OF GENERAL KNOWLEDGE OF THE VIROME IN THE FOOD CHAIN AND THE ENVIRONMENT. FURTHER DEVELOPMENTS IN VIRUS-SPECIFIC NUCLEIC ACID EXTRACTION METHODS, BIOINFORMATIC DATA PROCESSING APPLICATIONS, AND UNIFYING DATA VISUALIZATION TOOLS ARE NEEDED TO GAIN INSIGHTFUL SURVEILLANCE KNOWLEDGE FROM SUSPECT FOOD SAMPLES.","VIRAL PATHOGENS; METAGENOMICS; HIGH-THROUGHPUT SEQUENCING; SURVEILLANCE; FOODBORNE","HEPATITIS-E VIRUS; HUMAN ENTERIC VIRUSES; INFECTIOUS INTESTINAL DISEASE; DATE PALM SAP; GENERAL-PRACTICE; REAL-TIME; A VIRUS; ENVIRONMENTAL SURVEILLANCE; WASTE-WATER; HUMAN GUT","ENGLISH","ARTICLE","ARTICLE",6,"AARESTRUP FRANK M, 2012, EMERG INFECT DIS, V18, PE1, DOI 10.3201/EID/1811.120453.;AFIAHAYATI, 2015, DNA RES, V22, P69, DOI 10.1093/DNARES/DSU041.;AFSHINNEKOO E, 2015, CELL SYST, V1, P97, DOI 10.1016/J.CELS.2015.07.006.;AHMED SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4.;ALAVANDI SV, 2012, INDIAN J VIROL, V23, P88, DOI 10.1007/S13337-012-0075-2.;AMAR CFL, 2007, EUR J CLIN MICROBIOL, V26, P311, DOI 10.1007/S10096-007-0290-8.;ARIAS A, 2016, VIRUS EVOL, V2, DOI 10.1093/VE/VEW016.;AW TG, 2014, J VIROL METHODS, V210, P15, DOI 10.1016/J.JVIROMET.2014.09.017.;BEERSMA MFC, 2012, J CLIN MICROBIOL, V50, P3040, DOI 10.1128/JCM.00908-12.;BELLOU M, 2013, FOOD ENVIRON VIROL, V5, P13, DOI 10.1007/S12560-012-9097-6.;BENABBES L, 2013, FOOD ENVIRON VIROL, V5, P35, DOI 10.1007/S12560-012-9095-8.;BINNICKER MJ, 2015, J CLIN MICROBIOL, V53, P3723, DOI 10.1128/JCM.02103-15.;BOISVERT S, 2012, GENOME BIOL, V13, DOI 10.1186/GB-2012-13-12-R122.;BRIESE T, 2015, MBIO, V6, DOI 10.1128/MBIO.01491-15.;BRUNI R, 2016, PLOS ONE, V11, DOI 10.1371/JOURNAL.PONE.0149642.;BUCHFINK B, 2015, NAT METHODS, V12, P59, DOI 10.1038/NMETH.3176.;CADWELL K, 2015, IMMUNITY, V42, P805, DOI 10.1016/J.IMMUNI.2015.05.003.;CANTALUPO PG, 2011, MBIO, V2, DOI 10.1128/MBIO.00180-11.;COLSON P, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0010041.;CONCEICAO-NETO N, 2015, SCI REP-UK, V5, DOI 10.1038/SREP16532.;COTTEN M, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0093269.;D'AGOSTINO M, 2011, FOOD ENVIRON VIROL, V3, P55, DOI 10.1007/S12560-011-9063-8.;DE GRAAF M, 2016, NAT REV MICROBIOL, V14, P421, DOI 10.1038/NRMICRO.2016.48.;DE WIT MAS, 2001, EPIDEMIOL INFECT, V127, P389.;DENG XY, 2016, ANNU REV FOOD SCI T, V7, P353, DOI 10.1146/ANNUREV-FOOD-041715-033259.;DI BARTOLO I, 2015, INT J FOOD MICROBIOL, V193, P29, DOI 10.1016/J.IJFOODMICRO.2014.10.005.;EDGAR RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/BIOINFORMATICS/BTQ461.;ESFA, 2016, EFSA SUPPORT PUBL, V13, P989E, DOI [10.2903/SP.EFSA.2016.EN-989, DOI 10.2903/SP.EFSA.2016.EN-989].;EUROPEAN FOOD SAFETY AUTHORITY, 2014, EFSA J, V12, P3884, DOI [10.2903/J.EFSA.2014.3884, DOI 10.2903/J.EFSA.2014.3884].;EUROSURVEILLANCE EDITORIAL TEAM, 2015, EUROSURVEILLANCE, V18, P20449, DOI [10.2903/J.EFSA.2015.3991, DOI 10.2903/J.EFSA.2015.3991].;FLYGARE S, 2016, GENOME BIOL, V17, DOI 10.1186/S13059-016-0969-1.;FREY KG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-96.;FUNK ANNA L, 2016, FRONT VET SCI, V3, P88.;FURTAK V, 2016, EUROSURVEILLANCE, V21, P40, DOI 10.2807/1560-7917.ES.2016.21.15.30193.;GIRE SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/SCIENCE.1259657.;GOSSNER CM, 2014, EUROSURVEILLANCE, V19, P29, DOI 10.2807/1560-7917.ES2014.19.43.20941.;GRENINGER AL, 2017, J CLIN MICROBIOL, V55, P177, DOI 10.1128/JCM.01881-16.;GRENINGER AL, 2015, GENOME MED, V7, DOI 10.1186/S13073-015-0220-9.;GRUBER K, 2015, EMBO REP, V16, P898, DOI 10.15252/EMBR.201540822.;GUILLOIS Y, 2016, CLIN INFECT DIS, V62, P351, DOI 10.1093/CID/CIV862.;HALD T, 2007, FOODBORNE PATHOG DIS, V4, P313, DOI 10.1089/FPD.2007.0002.;HAMZA IA, 2011, INT J HYG ENVIR HEAL, V214, P424, DOI 10.1016/J.IJHEH.2011.07.014.;HANDELSMAN J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004.;HAVELAAR AH, 2015, PLOS MED, V12, DOI 10.1371/JOURNAL.PMED.1001923.;HAY SI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/RSTB.2012.0250.;HELLMER M, 2014, APPL ENVIRON MICROB, V80, P6771, DOI 10.1128/AEM.01981-14.;HINGAMP P, 2013, ISME J, V7, P1678, DOI 10.1038/ISMEJ.2013.59.;HOENEN T, 2016, EMERG INFECT DIS, V22, P331, DOI 10.3201/EID2202.151796.;HONDA K, 2016, NATURE, V535, P75, DOI 10.1038/NATURE18848.;IRITANI N, 2014, J MED VIROL, V86, P2019, DOI 10.1002/JMV.23883.;ISLAM MS, 2016, EMERG INFECT DIS, V22, P664, DOI 10.3201/EID2204.151747.;IZOPET J, 2012, EMERG INFECT DIS, V18, P1274, DOI 10.3201/EID1808.120057.;KARESH WB, 2009, MT SINAI J MED, V76, P429, DOI 10.1002/MSJ.20139.;KAZAMA S, 2016, WATER RES, V92, P244, DOI 10.1016/J.WATRES.2015.10.024.;LA ROSA G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-419.;LEWIS HC, 2010, EPIDEMIOL INFECT, V138, P145, DOI 10.1017/S0950268809990847.;LUSK RW, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0110808.;MANN E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/JOURNAL.PNTD.0004160.;MCCLOSKEY B, 2014, LANCET INFECT DIS, V14, P1001, DOI 10.1016/S1473-3099(14)70846-1.;MENZEL P, 2016, NAT COMMUN, V7, DOI 10.1038/NCOMMS11257.;MOON SHINJE, 2014, OSONG PUBLIC HEALTH RES PERSPECT, V5, P34, DOI 10.1016/J.PHRP.2013.12.004.;MUNNINK BBO, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0078454.;NEWELL DG, 2010, INT J FOOD MICROBIOL, V139, PS3, DOI 10.1016/J.IJFOODMICRO.2010.01.021.;NURK S, 2016, ARXIV160403071.;ONDOV BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385.;OTT JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/J.VACCINE.2011.12.116.;PAYNE DC, 2015, JAMA PEDIATR, V169, P1040, DOI 10.1001/JAMAPEDIATRICS.2015.2002.;PENG Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/BIOINFORMATICS/BTS174.;PETRIGNANI M, 2014, EMERG INFECT DIS, V20, P596, DOI 10.3201/EID2004.130753.;PIRES SM, 2009, FOODBORNE PATHOG DIS, V6, P417, DOI 10.1089/FPD.2008.0208.;QUAIL MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341.;QUICK J, 2016, NATURE, V530, P228, DOI 10.1038/NATURE16996.;QUICK J, 2015, GENOME BIOL, V16, DOI 10.1186/S13059-015-0677-2.;RAHMAN MA, 2012, VECTOR-BORNE ZOONOT, V12, P65, DOI 10.1089/VBZ.2011.0656.;REYES A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/NRMICRO2853.;RODRIGUEZ-MANZANO J, 2014, FOOD ENVIRON VIROL, V6, P31, DOI 10.1007/S12560-013-9133-1.;RZEZUTKA A, 2004, FEMS MICROBIOL REV, V28, P441, DOI 10.1016/J.FEMSRE.2004.02.001.;SARDI SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16.;SCHMIEDER R, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0017288.;SETHI D, 1999, INT J EPIDEMIOL, V28, P106, DOI 10.1093/IJE/28.1.106.;SEVERI E, 2015, EUROSURVEILLANCE, V20, P11, DOI 10.2807/1560-7917.ES2015.20.29.21192.;SMITS SL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/FMICB.2015.01069.;SPJUTH O, 2016, GIGASCIENCE, V5, DOI 10.1186/S13742-016-0132-7.;TAM CC, 2012, GUT, V61, P69, DOI 10.1136/GUT.2011.238386.;TAO ZX, 2015, SCI REP-UK, V5, DOI 10.1038/SREP17444.;TAVOSCHI L, 2015, EUROSURVEILLANCE, V20, P20, DOI 10.2807/1560-7917.ES2015.20.29.21193.;TEI S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1.;TEIXEIRA J, 2017, MED MICROBIOL IMMUN, V206, P77, DOI 10.1007/S00430-016-0484-8.;TEMMAM S, 2017, TRANSBOUND EMERG DIS, V64, P1159, DOI 10.1111/TBED.12481.;TERRY FFN, 2012, J VIROL, V86, P12161, DOI 10.1128/JVI.00869-12.;TREANGEN TJ, 2013, GENOME BIOL, V14, DOI 10.1186/GB-2013-14-1-R2.;VAZQUEZ-CASTELLANOS JF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-37.;VERHOEF L, 2015, EMERG INFECT DIS, V21, P592, DOI 10.3201/EID2104.141073.;VERHOEF L, 2011, EMERG INFECT DIS, V17, P412, DOI 10.3201/EID1703.100979.;WANG Y, 2015, J CLIN VIROL, V73, P55, DOI 10.1016/J.JCV.2015.10.004.;WOLFE ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/EID1112.040789.;WOOD DE, 2014, GENOME BIOL, V15, DOI 10.1186/GB-2014-15-3-R46.;YATSUNENKO T, 2012, NATURE, V486, P222, DOI 10.1038/NATURE11053.;ZHANG T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/JOURNAL.PBIO.0040003.","KOOPMANS, MPG (REPRINT AUTHOR), ERASMUS MC, DEPT VIROSCI, ROTTERDAM, NETHERLANDS.;NIEUWENHUIJSE, DAVID F., KOOPMANS, MARION P. G., ERASMUS MC, DEPT VIROSCI, ROTTERDAM, NETHERLANDS.","10.3389/FMICB.2017.00230","AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND","230",NA,"EUROPEAN UNION'S HORIZON 2020 RESEARCH AND INNOVATION PROGRAM [643476], ZONMW TOP PROJECT [91213058]","EUROPEAN UNION'S HORIZON 2020 RESEARCH AND INNOVATION PROGRAM UNDER GRANT AGREEMENT NO. 643476 (COMPARE). ZONMW TOP PROJECT 91213058.",NA,"1664-302X",NA,NA,"FRONTIERS MEDIA SA","8",2017,"ISI000394039700001","99","MICROBIOLOGY","28","MICROBIOLOGY","M.KOOPMANSERASMUSMC.NL",NA,"EK6MW",NA,"KOOPMANS, MPG (REPRINT AUTHOR), ERASMUS MC, DEPT VIROSCI, ROTTERDAM, NETHERLANDS","ISI","DEPT VIROSCI","DEPT VIROSCI",NA,"NIEUWENHUIJSE DF, 2017, FRONT MICROBIOL","NIEUWENHUIJSE DF, 2017, FRONT MICROBIOL"
"GRANDE G, 2017, CLIN PROTEOM","GRANDE G;VINCENZONI F;MILARDI D;POMPA G;RICCIARDI D;FRUSCELLA E;MANCINI F;PONTECORVI A;CASTAGNOLA M;MARANA R","CERVICAL MUCUS PROTEOME IN ENDOMETRIOSIS","CLINICAL PROTEOMICS","CLIN. PROTEOM.","BACKGROUND: ENDOMETRIOSIS IS A CHRONIC GYNECOLOGICAL INFLAMMATORY DISEASE CHARACTERIZED BY THE PRESENCE OF FUNCTIONAL ENDOMETRIAL GLANDS AND STROMA OUTSIDE OF THE UTERINE CAVITY. IT AFFECTS 7-10\% OF WOMEN OF REPRODUCTIVE AGE AND UP TO 50\% OF WOMEN WITH INFERTILITY. THE CURRENT GOLD STANDARD FOR THE DIAGNOSIS COMBINES LAPAROSCOPIC EVALUATION AND BIOPSY OF THE VISUALIZED LESIONS. HOWEVER, LAPAROSCOPY REQUIRES GENERAL ANESTHESIA AND DEVELOPED SURGICAL SKILLS AND IT HAS A HIGH PROCEDURAL COST. IN ADDITION, IT IS ASSOCIATED WITH THE RISK, ALTHOUGH RARE, OF POTENTIAL INTRAOPERATIVE OR POSTOPERATIVE COMPLICATIONS. TO DATE, SEVERAL NONINVASIVE BIOMARKERS HAVE BEEN PROPOSED, HOWEVER, NO DEFINITE DIAGNOSTIC BIOMARKER IS YET AVAILABLE. THE AIM OF THIS STUDY WAS TO CHARACTERIZE THE CM PROTEOME IN PATIENTS WITH ENDOMETRIOSIS USING HIGH RESOLUTION MASS SPECTROMETRY-BASED PROTEOMICS, IMPLEMENTED BY BIOINFORMATIC TOOLS FOR QUANTITATIVE ANALYSIS, IN ORDER TO INVESTIGATE THE PATHOPHYSIOLOGICAL MECHANISMS OF ENDOMETRIOSIS. METHODS: CERVICAL MUCUS SAMPLES WERE COLLECTED FROM PATIENTS AFFECTED BY ENDOMETRIOSIS AND FERTILE CONTROLS. AN ALIQUOT OF THE SOLUBLE ACIDIC FRACTION OF EACH CERVICAL MUCUS SAMPLE, CORRESPONDING TO 0.5 MG OF TOTAL PROTEIN, WAS LEFT TO DIGEST WITH SEQUENCING GRADE MODIFIED PORCINE TRYPSIN. THE PEPTIDES WERE ANALYZED BY LC-MS/ MS ON A HIGH RESOLUTION ORBITRAP ELITE MASS SPECTROMETER AND DATA WERE EVALUATED USING BIOINFORMATIC TOOLS. RESULTS: WE AIMED AT THE FIRST TOTAL PROFILING OF THE CERVICAL MUCUS PROTEOME IN ENDOMETRIOSIS. FROM THE LIST OF IDENTIFIED PROTEINS, WE DETECTED A NUMBER OF DIFFERENTIALLY EXPRESSED PROTEINS, INCLUDING SOME FUNCTIONALLY SIGNIFICANT PROTEINS. SIX PROTEINS WERE QUANTITATIVELY INCREASED IN ENDOMETRIOSIS, ALMOST ALL BEING INVOLVED IN THE INFLAMMATORY PATTERN. NINE PROTEINS WERE QUANTITATIVELY REDUCED IN ENDOMETRIOSIS, INCLUDING SOME PROTEINS RELATED WITH LOCAL INNATE IMMUNITY (CRISP-3 AND PGLYRP1) AND PROTECTION AGAINST OXIDATIVE STRESS (HSPB1). FIFTEEN PROTEINS WERE NOT DETECTED IN ENDOMETRIOSIS SAMPLES INCLUDING CERTAIN PROTEINS INVOLVED IN ANTIMICROBIAL ACTIVITY (SLURP1 AND KLK13) AND RELATED TO SEMINAL PLASMA LIQUEFACTION AND MALE FERTILITY (KLK13). CONCLUSIONS: THIS IS THE FIRST APPLICATION OF HIGH RESOLUTION MASS SPECTROMETRY-BASED PROTEOMICS AIMED IN DETECTING AN ARRAY OF PROTEINS IN CM TO BE PROPOSED FOR THE NONINVASIVE DIAGNOSIS OF ENDOMETRIOSIS. THIS CHRONIC DISEASE PRESENTS IN CM AN INFLAMMATORY PROTEIN PATTERN.","CERVICAL MUCUS; ENDOMETRIOSIS; NON-INVASIVE; MARKERS; PROTEOMIC","EUTOPIC ENDOMETRIUM; PERITONEAL-FLUID; OXIDATIVE STRESS; MATRIX METALLOPROTEINASES; OOCYTE QUALITY; NITRIC-OXIDE; EXPRESSION; WOMEN; INFERTILITY; SLURP-1","ENGLISH","ARTICLE","ARTICLE",5,"ADERMANN K, 1999, PROTEIN SCI, V8, P810, DOI 10.1110/PS.8.4.810.;ALLAN G, 2003, ENDOCR RES, V29, P53, DOI 10.1081/ERC-120018676.;AMETZAZURRA A, 2009, HUM REPROD, V24, P954, DOI 10.1093/HUMREP/DEN450.;ARREDONDO J, 2007, LIFE SCI, V80, P2243, DOI 10.1016/J.LFS.2007.01.003.;AUTILIO C, 2015, ANDROLOGY-US, V3, P1054, DOI 10.1111/ANDR.12084.;BADAWY SZA, 1989, FERTIL STERIL, V51, P770.;BECHER N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-113.;BECKER CM, 2010, FERTIL STERIL, V94, P2343, DOI 10.1016/J.FERTNSTERT.2010.02.040.;BORRELLI GM, 2013, J REPROD IMMUNOL, V98, P1, DOI 10.1016/J.JRI.2013.03.003.;BOUTTEN A, 1992, CLIN CHIM ACTA, V210, P187, DOI 10.1016/0009-8981(92)90204-4.;BRAUN DP, 1998, CURR OPIN OBSTET GYN, V10, P365, DOI 10.1097/00001703-199810000-00003.;BRIZEK CL, 1995, J ASSIST REPROD GEN, V12, P106, DOI 10.1007/BF02211378.;BROSENS JJ, 2010, MOL HUM REPROD, V16, P273, DOI 10.1093/MOLEHR/GAP108.;BRUNELLI R, 2007, FASEB J, V21, P3872, DOI 10.1096/FJ.07-8189COM.;BURNETT LA, 2008, INT J DEV BIOL, V52, P489, DOI 10.1387/IJDB.072545LB.;CARLI C, 2007, FERTIL STERIL, V88, P1240, DOI 10.1016/J.FERTNSTERT.2007.04.002.;CHO S, 2008, FERTIL STERIL, V90, P2073, DOI 10.1016/J.FERTNSTERT.2008.03.061.;DA BROI MG, 2016, CELL TISSUE RES, V364, P1, DOI 10.1007/S00441-015-2339-9.;DOODY MC, 1988, FERTIL STERIL, V49, P47.;DZIARSKI R, 2010, INNATE IMMUN-LONDON, V16, P168, DOI 10.1177/1753425910366059.;FAHRBACH KM, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0076176.;GERHARD I, 1990, ARCH ANDROLOGY, V24, P129, DOI 10.3109/01485019008986873.;GHAFOURIAN S, 2013, CLIN LAB, V59, P465, DOI 10.7754/CLIN.LAB.2013.130124.;GILABERT-ESTELLES J, 2007, HUM REPROD, V22, P2120, DOI 10.1093/HUMREP/DEM149.;GIUDICE LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5.;GOUD PT, 2014, FERTIL STERIL, V102, P151, DOI 10.1016/J.FERTNSTERT.2014.03.053.;GRANDE G, 2015, MOL BIOSYST, V11, P1717, DOI 10.1039/C5MB00071H.;GREENE E H, 1950, J MED ASSOC GA, V39, P283.;HORIGUCHI K, 2009, J NEUROSCI RES, V87, P2740, DOI 10.1002/JNR.22102.;HOUSHDARAN S, 2016, BIOL REPROD, V95, DOI 10.1095/BIOLREPROD.116.140434.;IWABUCHI T, 2015, OXID MED CELL LONGEV, DOI 10.1155/2015/848595.;JIANG LL, 2016, FRONT BIOSCI-LANDMRK, V21, P941.;JOHANSEN FE, 2011, MUCOSAL IMMUNOL, V4, P598, DOI 10.1038/MI.2011.37.;KARAMAN Y, 2015, WOMENS HEALTH, V11, P685, DOI 10.2217/WHE.15.55.;KENNEDY S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/HUMREP/DEI135.;LIU E., 2015, COCHRANE DB SYST REV, V12.;LUISI S, 2009, GYNECOL ENDOCRINOL, V25, P734, DOI 10.3109/09513590903159664.;LUO ZM, 2015, J PHYSIOL BIOCHEM, V71, P329, DOI 10.1007/S13105-015-0389-9.;MAIRESSE N, 1998, J CELL PHYSIOL, V177, P606, DOI 10.1002/(SICI)1097-4652(199812)177:4<606::AID-JCP11>3.0.CO,2-Z.;MARANA RICCARDO, 2012, UROLOGIA, V79, P160, DOI 10.5301/RU.2012.9391.;MASTRANGELI R, 2003, EUR J DERMATOL, V13, P560.;MATORRAS R, 1996, ACTA OBSTET GYN SCAN, V75, P826, DOI 10.3109/00016349609054711.;MILARDI D, 2013, MOL REPROD DEV, V80, P350, DOI 10.1002/MRD.22178.;MINICI F, 2008, HUM REPROD, V23, P530, DOI 10.1093/HUMREP/DEM399.;MORIWAKI Y, 2007, LIFE SCI, V80, P2365, DOI 10.1016/J.LFS.2006.12.028.;MORIWAKI Y, 2009, NEUROSCI RES, V64, P403, DOI 10.1016/J.NEURES.2009.04.014.;NISENBLAT V, 2016, COCHRANE DB SYST REV, V2.;NISENBLAT V., 2016, COCHRANE DB SYST REV, V5.;NNOAHAM KE, 2012, FERTIL STERIL, V98, P670.;NOTHNICK WB, 2017, REPROD SCI, V24, P1195, DOI 10.1177/1933719116681519.;PETRAKI CD, 2003, J HISTOCHEM CYTOCHEM, V51, P493, DOI 10.1177/002215540305100411.;PRIETO L, 2012, FERTIL STERIL, V98, DOI 10.1016/J.FERTNSTERT.2012.03.052.;RAGGAM RB, 2014, J INTERN MED, V276, P651, DOI 10.1111/JOIM.12238.;RAKHILA H, 2016, J REPROD IMMUNOL, V116, P1, DOI 10.1016/J.JRI.2016.01.005.;RIZNER TL, 2015, EXPERT REV MOL DIAGN, V15, P557, DOI 10.1586/14737159.2015.1015994.;SCHULKE L, 2009, HUM REPROD, V24, P1695, DOI 10.1093/HUMREP/DEP071.;SHARPE KL, 1993, FERTIL STERIL, V60, P839.;SHARPETIMMS KL, 1995, J CLIN ENDOCR METAB, V80, P3784, DOI 10.1210/JC.80.12.3784.;SIGNORILE PIETRO G, 2015, DATA BRIEF, V5, P971, DOI 10.1016/J.DIB.2015.10.047.;STILLEY JAW, 2010, BIOL REPROD, V83, P185, DOI 10.1095/BIOLREPROD.109.083287.;SWAMYNATHAN S, 2014, INVEST OPHTH VIS SCI, V55, P6251, DOI 10.1167/IOVS.14-15107.;SWAMYNATHAN S, 2012, INVEST OPHTH VIS SCI, V53, P8433, DOI 10.1167/IOVS.12-10759.;SZYMANOWSKI K, 2016, ANN AGR ENV MED, V23, P649, DOI 10.5604/12321966.1226861.;TAKEBAYASHI A, 2015, AM J REPROD IMMUNOL, V73, P221, DOI 10.1111/AJI.12331.;TAKEBAYASHI A, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0088354.;TANG LJ, 2007, J PROTEOME RES, V6, P2874, DOI 10.1021/PR0700899.;THIRUCHELVAM U, 2015, AM J REPROD IMMUNOL, V74, P291, DOI 10.1111/AJI.12408.;TIBERI F, 2010, FERTIL STERIL, V94, P2558, DOI 10.1016/J.FERTNSTERT.2010.03.006.;TIBERI F, 2010, FERTIL STERIL, V93, P2145, DOI 10.1016/J.FERTNSTERT.2009.01.105.;UDBY L, 2004, BIOCHEMISTRY-US, V43, P12877, DOI 10.1021/BI048823E.;WATOREK W, 2003, ACTA BIOCHIM POL, V50, P743.;YEO SG, 2013, INT J MED SCI, V10, P1199, DOI 10.7150/IJMS.5169.;YOUSEF GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/ER.22.2.184.","MILARDI, D (REPRINT AUTHOR), INT SCI INST PAUL VI, LGO F VITO 1, I-00168 ROME, ITALY.;GRANDE, GIUSEPPE, MILARDI, DOMENICO, POMPA, GIUSEPPINA, FRUSCELLA, ERIKA, MANCINI, FRANCESCA, MARANA, RICCARDO, INT SCI INST PAUL VI, LGO F VITO 1, I-00168 ROME, ITALY.;VINCENZONI, FEDERICA, CASTAGNOLA, MASSIMO, CATHOLIC UNIV, INST BIOCHEM \& CLIN BIOCHEM, LGO F VITO 1, I-00168 ROME, ITALY.;RICCIARDI, DOMENICO, MARANA, RICCARDO, FDN POLICLIN UNIV A GEMELLI, DEPT OBSTET \& GYNECOL, LGO F VITO 1, I-00168 ROME, ITALY.;PONTECORVI, ALFREDO, CATHOLIC UNIV, DIV ENDOCRINOL, LGO F VITO 1, I-00168 ROME, ITALY.","10.1186/S12014-017-9142-4","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","7",NA,NA,NA,NA,"1542-6416",NA,NA,"BIOMED CENTRAL LTD","14",2017,"ISI000394803700001","73","BIOCHEMISTRY \& MOLECULAR BIOLOGY","7","BIOCHEMICAL RESEARCH METHODS","MILARDIDYAHOO.IT",NA,"EL7LZ",NA,"MILARDI, D (REPRINT AUTHOR), INT SCI INST PAUL VI, LGO F VITO 1, I-00168 ROME, ITALY","ISI","INT SCI INST PAUL VI;CATHOLIC UNIV;FDN POLICLIN UNIV A GEMELLI;CATHOLIC UNIV","INT SCI INST PAUL VI",NA,"GRANDE G, 2017, CLIN PROTEOM","GRANDE G, 2017, CLIN PROTEOM"
"SATTA G, 2017, CLIN MICROBIOL INFECT","SATTA G;ATZENI A;MCHUGH TD","MYCOBACTERIUM TUBERCULOSIS AND WHOLE GENOME SEQUENCING: A PRACTICAL GUIDE AND ONLINE TOOLS AVAILABLE FOR THE CLINICAL MICROBIOLOGIST","CLINICAL MICROBIOLOGY AND INFECTION","CLIN. MICROBIOL. INFECT.","WHOLE GENOME SEQUENCING (WGS) HAS THE POTENTIAL TO REVOLUTIONIZE THE DIAGNOSIS OF MYCOBACTERIUM TUBERCULOSIS INFECTION BUT THE LACK OF BIOINFORMATIC EXPERTISE AMONG CLINICAL MICROBIOLOGISTS IS A BARRIER FOR ADOPTION. SOFTWARE PRODUCTS FOR ANALYSIS SHOULD BE SIMPLE, FREE OF CHARGE, ABLE TO ACCEPT DATA DIRECTLY FROM THE SEQUENCER (FASTQ FILES) AND TO PROVIDE THE BASIC FUNCTIONALITIES ALL-IN-ONE. THE MAIN AIM OF THIS NARRATIVE REVIEW IS TO PROVIDE A PRACTICAL GUIDE FOR THE CLINICAL MICROBIOLOGIST, WITH LITTLE OR NO PRACTICAL EXPERIENCE OF WGS ANALYSIS, WITH A SPECIFIC FOCUS ON SOFTWARE PRODUCTS TAILOR-MADE FOR M. TUBERCULOSIS ANALYSIS. WITH SEQUENCING PERFORMED BY AN EXTERNAL PROVIDER, IT IS NOW FEASIBLE TO IMPLEMENT WGS ANALYSIS IN THE ROUTINE CLINICAL PRACTICE OF ANY MICROBIOLOGY LABORATORY, WITH THE POTENTIAL TO DETECT RESISTANCE WEEKS BEFORE TRADITIONAL PHENOTYPIC CULTURE METHODS, BUT THE CLINICAL MICROBIOLOGIST SHOULD BE AWARE OF THE LIMITATIONS OF THIS APPROACH. (C) 2016 EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. PUBLISHED BY ELSEVIER LTD. ALL RIGHTS RESERVED.","MYCOBACTERIUM TUBERCULOSIS; PHYLOGENETIC ANALYSIS; ONLINE TOOLS; RAPID SUSCEPTIBILITY TESTING; WHOLE GENOME SEQUENCING","ANTIBIOTIC-RESISTANCE; OUTBREAK; DIAGNOSIS; CULTURES","ENGLISH","REVIEW","ARTICLE",4,"BELISLE JOHN T., 2008, V465, P1, DOI 10.1007/978-1-59745-207-6\_1.;BOEHME CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMOA0907847.;BRADLEY P, 2015, NAT COMMUN, V6, DOI 10.1038/NCOMMS10063.;BROWN AC, 2015, J CLIN MICROBIOL, V53, P2230, DOI 10.1128/JCM.00486-15.;BRYANT JM, 2013, LANCET RESP MED, V1, P786, DOI 10.1016/S2213-2600(13)70231-5.;COLL F, 2015, GENOME MED, V7, DOI 10.1186/S13073-015-0164-0.;EILERTSON B, 2014, ANTIMICROB AGENTS CH, V58, P3270, DOI 10.1128/AAC.02066-13.;FEUERRIEGEL S, 2015, J CLIN MICROBIOL, V53, P1908, DOI 10.1128/JCM.00025-15.;GARDY JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMOA1003176.;JAVID B, 2016, LANCET INFECT DIS, V16, P17, DOI 10.1016/S1473-3099(15)00474-0.;KASER MICHAEL, 2010, COLD SPRING HARB PROTOC, V2010, DOI 10.1101/PDB.PROT5408.;KENT L, 1995, J CLIN MICROBIOL, V33, P2290.;KOSER CU, 2012, PLOS PATHOG, V8, DOI 10.1371/JOURNAL.PPAT.1002824.;MALIK SZ, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0036016.;PANKHURST LJ, 2016, LANCET RESP MED, V4, P49, DOI 10.1016/S2213-2600(15)00466-X.;PFYFFER GE, 2012, J CLIN MICROBIOL, V50, P4188, DOI 10.1128/JCM.02283-12.;ROBIN JD, 2016, SCI REP-UK, V6, DOI 10.1038/SREP24067.;ROBINSON E, 2016, B R COLL PATHOLOG, V175, P163.;ROBINSON ER, 2013, GENOME MED, V5, DOI 10.1186/GM440.;SATTA G, 2016, BMC MED, V14, DOI 10.1186/S12916-016-0659-6.;SEKIZUKA T, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0142951.;TOROK ME, 2013, J CLIN MICROBIOL, V51, P611, DOI 10.1128/JCM.02279-12.;VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578.;VOTINTSEVA AA, 2015, J CLIN MICROBIOL, V53, P1137, DOI 10.1128/JCM.03073-14.;WALKER TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3.;WITNEY AA, 2016, BMC MED, V14, DOI 10.1186/S12916-016-0598-2.","SATTA, G (REPRINT AUTHOR), CTR CLIN MICROBIOL, ROYAL FREE CAMPUS,ROWLAND HILL ST, LONDON NW3 2PF, ENGLAND.;SATTA, G., ATZENI, A., MCHUGH, T. D., UCL, CTR CLIN MICROBIOL, DEPT INFECT, LONDON, ENGLAND.;SATTA, G., IMPERIAL COLL HEALTHCARE NHS TRUST, LONDON, ENGLAND.","10.1016/J.CMI.2016.09.005","THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",NA,NA,NA,NA,NA,"1198-743X","2","69-72","ELSEVIER SCI LTD","23",2017,"ISI000397070500003","26","INFECTIOUS DISEASES, MICROBIOLOGY","5","INFECTIOUS DISEASES, MICROBIOLOGY","GIOVANNI.SATTANHS.NET",NA,"EP0IL",NA,"SATTA, G (REPRINT AUTHOR), CTR CLIN MICROBIOL, ROYAL FREE CAMPUS,ROWLAND HILL ST, LONDON NW3 2PF, ENGLAND","ISI","CTR CLIN MICROBIOL;IMPERIAL COLL HEALTHCARE NHS TRUST","CTR CLIN MICROBIOL",NA,"SATTA G, 2017, CLIN MICROBIOL INFECT","SATTA G, 2017, CLIN MICROBIOL INFECT"
"LI R, 2017, J ANTIMICROB CHEMOTHER","LI R;XIE M;ZHANG J;YANG Z;LIU L;LIU X;ZHENG Z;CHAN EWC;CHEN S","GENETIC CHARACTERIZATION OF MCR-1-BEARING PLASMIDS TO DEPICT MOLECULAR MECHANISMS UNDERLYING DISSEMINATION OF THE COLISTIN RESISTANCE DETERMINANT","JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY","J. ANTIMICROB. CHEMOTHER.","OBJECTIVES: TO ANALYSE AND COMPARE MCR-1-BEARING PLASMIDS FROM ANIMAL ESCHERICHIA COLI ISOLATES, AND TO INVESTIGATE POTENTIAL MECHANISMS UNDERLYING DISSEMINATION OF MCR-1. METHODS: NINETY-SEVEN ESBL-PRODUCING E. COLI STRAINS ISOLATED FROM PIG FARMS IN CHINA WERE SCREENED FOR THE MCR-1 GENE. FIFTEEN MCR-1-POSITIVE STRAINS WERE SUBJECTED TO MOLECULAR CHARACTERIZATION AND BIOINFORMATIC ANALYSIS OF THE MCR-1-BEARING PLASMIDS THAT THEY HARBOURED. RESULTS: THREE MAJOR TYPES OF MCR-1-BEARING PLASMIDS WERE RECOVERED: INCX4 (SIMILAR TO 33 KB), INCI2 (SIMILAR TO 60 KB) AND INCHI2 (SIMILAR TO 216-280 KB), AMONG WHICH THE INCX4 AND INCI2 PLASMIDS WERE FOUND TO HARBOUR THE MCR-1 GENE ONLY, WHEREAS MULTIPLE RESISTANCE ELEMENTS INCLUDING BLA(CTX-M), BLA(CMY), BLA(TEM), FOSA, QNRS, FLOR AND OQXAB WERE DETECTED, IN VARIOUS COMBINATIONS, ALONGSIDE MCR-1 IN THE INCHI2 PLASMIDS. THE PROFILES OF MCR-1-BEARING PLASMIDS IN THE TEST STRAINS WERE HIGHLY VARIABLE, WITH COEXISTENCE OF TWO MCR-1-BEARING PLASMIDS BEING COMMON. HOWEVER, THE MIC OF COLISTIN WAS NOT AFFECTED BY THE NUMBER OF MCR-1-CARRYING PLASMIDS HARBOURED. COMPARATIVE ANALYSIS OF THE PLASMIDS SHOWED THAT THEY CONTAINED AN MCR-1 GENE CASSETTE WITH VARIED STRUCTURES (MCR-1-ORF, ISAPL1-MCR1- ORF AND TN6330), WITH THE INCHI2 TYPE BEING THE MOST ACTIVE IN ACQUIRING FOREIGN RESISTANCE GENES. A NOVEL TRANSPOSON, TN6330, WITH THE STRUCTURE ISAPL1-MCR-1-ORF-ISAPL1WAS FOUND TO BE THE KEY ELEMENT MEDIATING TRANSLOCATION OF MCR-1 INTO VARIOUS PLASMID BACKBONES THROUGH FORMATION OF A CIRCULAR INTERMEDIATE. CONCLUSIONS: THE MCR-1 GENE CAN BE DISSEMINATED VIA MULTIPLE MOBILE ELEMENTS INCLUDING TN6330, ITS CIRCULAR INTERMEDIATE AND PLASMIDS HARBOURING SUCH ELEMENTS. IT IS OFTEN CO-TRANSMITTED WITH OTHER RESISTANCE DETERMINANTS THROUGH INCHI2 PLASMIDS. THE FUNCTIONAL MECHANISM OF TN6330, A TYPICAL COMPOSITE TRANSPOSON HARBOURING MCR-1, SHOULD BE FURTHER INVESTIGATED.",NA,"ESCHERICHIA-COLI; MCR-1; SEQUENCE; TRANSPOSITION; POLYMYXINS; INFECTIONS; EMERGENCE","ENGLISH","ARTICLE","ARTICLE",40,"ALIKHAN NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402.;BLAIR JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/NRMICRO3380.;CARATTOLI A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14.;DOUMITH M, 2016, J ANTIMICROB CHEMOTH, V71, P2300, DOI 10.1093/JAC/DKW093.;ELNAHRIRY SS, 2016, ANTIMICROB AGENTS CH, V60, P3249, DOI 10.1128/AAC.00269-16.;FALAGAS ME, 2006, CRIT CARE, V10, DOI 10.1186/CC3995.;FALAGAS ME, 2010, DRUG RESIST UPDATE, V13, P132, DOI 10.1016/J.DRUP.2010.05.002.;FALAGAS ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323.;HE SS, 2015, MBIO, V6, DOI 10.1128/MBIO.00762-15.;KISS J, 1999, MOL MICROBIOL, V34, P37, DOI 10.1046/J.1365-2958.1999.01567.X.;KOSTYANEV T, 2016, J ANTIMICROB CHEMOTH, V71, P1428, DOI 10.1093/JAC/DKV471.;LI AQ, 2016, ANTIMICROB AGENTS CH, V60, P4351, DOI 10.1128/AAC.00550-16.;LI RC, 2015, ANTIMICROB AGENTS CH, V59, P3582, DOI 10.1128/AAC.00518-15.;LIU YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7.;LUO RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18.;MALHOTRA-KUMAR S, 2016, LANCET INFECT DIS, V16, P283, DOI 10.1016/S1473-3099(16)00012-8.;NORRBY SR, 2005, LANCET INFECT DIS, V5, P115.;OLAITAN AO, 2014, FRONT MICROBIOL, V5, DOI 10.3389/FMICB.2014.00643.;OLASZ F, 1997, J BACTERIOL, V179, P7551, DOI 10.1128/JB.179.23.7551-7558.1997.;OVERBEEK R, 2014, NUCLEIC ACIDS RES, V42, PD206, DOI 10.1093/NAR/GKT1226.;PETRILLO M, 2016, LANCET INFECT DIS, V16, P280, DOI [10.1016/S1473-3099(16)00005-0, 10.1016/S1473-3999(16)00005-0].;RAPOPORT M, 2016, ANTIMICROB AGENTS CH, V60, P4412, DOI 10.1128/AAC.00573-16.;SHEN ZQ, 2016, LANCET INFECT DIS, V16, P293, DOI 10.1016/S1473-3099(16)00061-X.;SIGUIER P, 2014, FEMS MICROBIOL REV, V38, P865, DOI 10.1111/1574-6976.12067.;SULLIVAN MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/BIOINFORMATICS/BTR039.;TEGETMEYER HE, 2008, VET MICROBIOL, V128, P342, DOI 10.1016/J.VETMIC.2007.10.025.;VELKOV T, 2010, J MED CHEM, V53, P1898, DOI 10.1021/JM900999H.;YE HY, 2016, MBIO, V7, DOI 10.1128/MBIO.00177-16.;ZHI CP, 2016, LANCET INFECT DIS, V16, P292, DOI 10.1016/S1473-3099(16)00063-3.","CHEN, S (REPRINT AUTHOR), HONG KONG POLYU SHEN ZHEN RES INST, FOOD SAFETY \& TECHNOL RES CTR, SHENZHEN KEY LAB FOOD BIOL SAFETY CONTROL, SHENZHEN, PEOPLES R CHINA.;CHEN, S (REPRINT AUTHOR), HONG KONG POLYTECH UNIV, STATE KEY LAB CHIROSCI, DEPT APPL BIOL \& CHEM TECHNOL, KOWLOON, HONG KONG, PEOPLES R CHINA.;LI, RUICHAO, XIE, MIAOMIAO, ZHANG, JINFEI, YANG, ZHIQIANG, LIU, LIZHANG, LIU, XIAOBO, ZHENG, ZHIWEI, CHEN, SHENG, HONG KONG POLYU SHEN ZHEN RES INST, FOOD SAFETY \& TECHNOL RES CTR, SHENZHEN KEY LAB FOOD BIOL SAFETY CONTROL, SHENZHEN, PEOPLES R CHINA.;LI, RUICHAO, CHAN, EDWARD WAI-CHI, CHEN, SHENG, HONG KONG POLYTECH UNIV, STATE KEY LAB CHIROSCI, DEPT APPL BIOL \& CHEM TECHNOL, KOWLOON, HONG KONG, PEOPLES R CHINA.","10.1093/JAC/DKW411","GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND",NA,NA,"CHINESE NATIONAL KEY BASIC RESEARCH AND DEVELOPMENT PROGRAM [2013CB127200]","THIS WORK WAS SUPPORTED BY THE CHINESE NATIONAL KEY BASIC RESEARCH AND DEVELOPMENT PROGRAM (2013CB127200).",NA,"0305-7453","2","393-401","OXFORD UNIV PRESS","72",2017,"ISI000394045800009","29","INFECTIOUS DISEASES, MICROBIOLOGY, PHARMACOLOGY \& PHARMACY","33","INFECTIOUS DISEASES, MICROBIOLOGY, PHARMACOLOGY \& PHARMACY","SHENG.CHENPOLYU.EDU.HK",NA,"EK6PF",NA,"CHEN, S (REPRINT AUTHOR), HONG KONG POLYU SHEN ZHEN RES INST, FOOD SAFETY \& TECHNOL RES CTR, SHENZHEN KEY LAB FOOD BIOL SAFETY CONTROL, SHENZHEN, PEOPLES R CHINA","ISI","HONG KONG POLYU SHEN ZHEN RES INST;HONG KONG POLYTECH UNIV","HONG KONG POLYU SHEN ZHEN RES INST",NA,"LI R, 2017, J ANTIMICROB CHEMOTHER","LI R, 2017, J ANTIMICROB CHEMOTHER"
"SIRIPHAP A, 2017, PLOS ONE","SIRIPHAP A;LEEKITCHAROENPHON P;KAAS RS;THEETHAKAEW C;AARESTRUP FM;SUTHEINKUL O;HENDRIKSEN RS","CHARACTERIZATION AND GENETIC VARIATION OF VIBRIO CHOLERAE ISOLATED FROM CLINICAL AND ENVIRONMENTAL SOURCES IN THAILAND","PLOS ONE","PLOS ONE","CHOLERA IS STILL AN IMPORTANT PUBLIC HEALTH PROBLEM IN SEVERAL COUNTRIES, INCLUDING THAILAND. IN THIS STUDY, A COLLECTION OF CLINICAL AND ENVIRONMENTAL V. CHOLERAE SEROGROUP 01,0139, AND NON-01/NON-0139 STRAINS ORIGINATING FROM THAILAND (1983 TO 2013) WAS CHARACTERIZED TO DETERMINE PHENOTYPIC AND GENOTYPIC TRAITS AND TO INVESTIGATE THE GENETIC RELATEDNESS. USING A COMBINATION OF CONVENTIONAL METHODS AND WHOLE GENOME SEQUENCING (WGS), 78 V. CHOLERAE STRAINS WERE IDENTIFIED. WGS WAS USED TO DETERMINE THE SEROGROUP, BIOTYPE, VIRULENCE, MOBILE GENETIC ELEMENTS, AND ANTIMICROBIAL RESISTANCE GENES USING ONLINE BIOINFORMATICS TOOLS. IN ADDITION, PHENOTYPIC ANTIMICROBIAL RESISTANCE WAS DETERMINED BY THE MINIMAL INHIBITORY CONCENTRATION (MIC) TEST. THE 78 V. CHOLERAE STRAINS BELONGED TO THE FOLLOWING SEROGROUPS 01: (N=44), 0139 (N=16) AND NON-01/NON-0139 (N=18). INTERESTINGLY, WE FOUND THAT THE TYPICAL EL TOR 01 STRAINS WERE THE MAJOR CAUSE OF CLINICAL CHOLERA DURING 1983-2000 WITH TWO CLASSICAL 01 STRAINS DETECTED IN 2000. IN 2004-2010, THE EL TOR VARIANT STRAINS REVEALED GENOTYPES OF THE CLASSICAL BIOTYPE POSSESSING EITHER ONLY CTXB OR BOTH CTXB AND RSTR WHILE THEY HARBORED TCPA OF THE EL TOR BIOTYPE. THIRTY 01 AND ELEVEN 0139 CLINICAL STRAINS CARRIED CTX4) (CHOLERA TOXIN) AND TCPA AS WELL FOUR DIFFERENT PATHOGENIC ISLANDS (PALS). BESIDE NON-01/NON-0139, THE 01 ENVIRONMENTAL STRAINS ALSO PRESENTED CHXA AND TYPE THREE SECRETION SYSTEM (TTSS). THE IN SILICO MULTILOCUS SEQUENCE TYPING (MLST) DISCRIMINATED THE 01 AND 0139 CLINICAL STRAINS FROM OTHER SEROGROUPS AND ENVIRONMENTAL STRAINS. ST69 WAS DOMINANT IN THE CLINICAL STRAINS BELONGING TO THE 7TH PANDEMIC CLONE. NON01/NON-0139 AND ENVIRONMENTAL STRAINS SHOWED VARIOUS NOVEL STS INDICATING GENETIC VARIATION. MULTIDRUG-RESISTANT (MDR) STRAINS WERE OBSERVED AND CONFERRED RESISTANCE TO AMPICILLIN, AZITHROMYCIN, NALIDIXIC ACID, SULFAMETHOXAZOLE, TETRACYCLINE, AND TRIMETHOPRIM AND HARBOURED VARIANTS OF THE SXT ELEMENTS. FOR THE FIRST TIME SINCE 1986, THE PRESENCE OF V. CHOLERAE 01 CLASSICAL WAS REPORTED CAUSING CHOLERA OUTBREAKS IN THAILAND. IN ADDITION, WE FOUND THAT V. CHOLERAE 01 EL TOR VARIANT AND 0139 WERE PRE-DOMINATING THE PATHOGENIC STRAINS IN THAILAND. USING WGS AND BIOINFORMATIC TOOLS TO ANALYZE BOTH HISTORICAL AND CONTEMPORARY V. CHOLERAE CIRCULATING IN THAILAND PROVIDED A MORE DETAILED UNDERSTANDING OF THE V. CHOLERAE EPIDEMIOLOGY, WHICH ULTIMATELY COULD BE APPLIED FOR CONTROL MEASURES AND MANAGEMENT OF CHOLERA IN THAILAND.",NA,"EL-TOR BIOTYPE; HOSPITALIZED-PATIENTS; MOLECULAR ANALYSIS; ACUTE DIARRHEA; O1; STRAINS; RESISTANT; OUTBREAK; TOXIN; PATHOGENICITY","ENGLISH","ARTICLE","ARTICLE",5,"ABD EL GHANY M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/JOURNAL.PNTD.0002981.;ALAM M, 2007, P NATL ACAD SCI USA, V104, P17801, DOI 10.1073/PNAS.0705599104.;ALBERT MJ, 1993, LANCET, V341, P704.;[ANONYMOUS], 2014, ORGANIZATION.;AWASTHI SP, 2013, INFECT IMMUN, V81, P531, DOI 10.1128/IAI.00982-12.;BHATTACHARYA D, 2016, MED MICROBIOL IMMUN, V205, P195, DOI 10.1007/S00430-015-0433-Y.;BHATTACHARYA SK, 1993, J INFECTION, V27, P11, DOI 10.1016/0163-4453(93)93488-P.;BHUMIRATANA A, 2014, BIOCHEM RES INT, DOI 10.1155/2014/295421.;CHATTERJEE S, 2009, J CLIN MICROBIOL, V47, P1087, DOI 10.1128/JCM.02026-08.;CHIN CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMOA1012928.;CHO YJ, 2010, CURR OPIN MICROBIOL, V13, P646, DOI 10.1016/J.MIB.2010.08.007.;CHOMVARIN C, 2013, J MED MICROBIOL, V62, P599, DOI 10.1099/JMM.0.053801-0.;CHUN J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/PNAS.0907787106.;CLSI, 2015, M100S25 CLSI S.;DALSGAARD A, 1999, EPIDEMIOL INFECT, V122, P217, DOI 10.1017/S0950268899002137.;DEVAULT AM, 2014, NEW ENGL J MED, V370, P334, DOI 10.1056/NEJMOA1308663.;DIXIT SM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-392.;EDGAR RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/NAR/GKH340.;[EPIDEMIOLOGY BO DEPARTMENT OF DISEASE CONTROL MOPH], 2014, ANN EP SURV REP.;FARUQUE SM, 2004, P NATL ACAD SCI USA, V101, P2123, DOI 10.1073/PNAS.0308485100.;FARUQUE SM, 2003, TRENDS MICROBIOL, V11, P505, DOI 10.1016/J.TIM.2003.09.003.;GHOSH-BANERJEE J, 2010, J CLIN MICROBIOL, V48, P4283, DOI 10.1128/JCM.00799-10.;HALLIN PF, 2008, MOL BIOSYST, V4, P363, DOI 10.1039/B717118H.;HARRIS JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X.;HENDRIKSEN RS, 2011, MBIO, V2, DOI 10.1128/MBIO.00157-11.;HOCHHUT B, 1999, MOL MICROBIOL, V32, P99, DOI 10.1046/J.1365-2958.1999.01330.X.;HOGE CW, 1996, AM J EPIDEMIOL, V143, P263.;KAAS RS, 2016, PLOS ONE, V11, DOI 10.1371/JOURNAL.PONE.0155691.;KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48.;KARAOLIS DKR, 1999, NATURE, V399, P375, DOI 10.1038/20715.;KIM EJ, 2014, PLOS PATHOG, V10, DOI 10.1371/JOURNAL.PPAT.1004384.;KIRN TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/J.1365-2958.2000.01764.X.;KITAOKA M, 2011, J MED MICROBIOL, V60, P397, DOI 10.1099/JMM.0.023051-0.;KUMAR P, 2009, J MED MICROBIOL, V58, P234, DOI 10.1099/JMM.0.002089-0.;KUMAR P, 2014, CLIN MICROBIOL INFEC, V20, PO292, DOI 10.1111/1469-0691.12393.;LARSEN MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11.;LI XJ, 2016, CAN J MICROBIOL, V62, P139, DOI 10.1139/CJM-2015-0443.;LUO Y, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-52.;MARIN MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/JOURNAL.PNTD.0002049.;MOORE S, 2014, CLIN MICROBIOL INFEC, V20, P373, DOI 10.1111/1469-0691.12610.;MUTREJA A, 2011, NATURE, V477, P462, DOI 10.1038/NATURE10392.;NA-UBOL M, 2011, INDIAN J MED RES, V133, P387.;NAIR GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002.;OCTAVIA S, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0065342.;OKADA K, 2013, EMERG INFECT DIS, V19, P1015, DOI 10.3201/EID1906.120345.;ONIFADE TJM, 2011, EUROSURVEILLANCE, V16, P10.;PANG B, 2016, PLOS ONE, V11, DOI 10.1371/JOURNAL.PONE.0149742.;PREEPREM S, 2014, FOODBORNE PATHOG DIS, V11, P881, DOI 10.1089/FPD.2014.1772.;RIVERA ING, 2001, APPL ENVIRON MICROB, V67, P2421, DOI 10.1128/AEM.67.6.2421-2429.2001.;SAFA A, 2009, J MED MICROBIOL, V58, P105, DOI 10.1099/JMM.0.004333-0.;SAFA A, 2008, EMERG INFECT DIS, V14, P987, DOI 10.3201/EID1406.080129.;SAFA A, 2006, J MED MICROBIOL, V55, P1563, DOI 10.1099/JMM.0.46689-0.;SINGH DV, 2001, APPL ENVIRON MICROB, V67, P910, DOI 10.1128/AEM.67.2.910-921.2001.;SJOLUND-KARLSSON M, 2011, EMERG INFECT DIS, V17, P2151, DOI 10.3201/EID1711.110720.;SUPAWAT KRONGKAEW, 2009, J MED ASSOC THAI, V92 SUPPL 4, PS82.;TABTIENG R, 1989, AM J TROP MED HYG, V41, P680, DOI 10.4269/AJTMH.1989.41.680.;TAMURA K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/MOLBEV/MSR121.;TAPCHAISRI P, 2008, J HEALTH POPUL NUTR, V26, P79.;WALDOR MK, 1996, J BACTERIOL, V178, P4157, DOI 10.1128/JB.178.14.4157-4165.1996.;WALDOR MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/SCIENCE.272.5270.1910.;*WHO, 1987, MAN LAB INV AC ENT I.","HENDRIKSEN, RS (REPRINT AUTHOR), TECH UNIV DENMARK, NATL FOOD INST, RES GRP GENOM EPIDEMIOL, WHO COLLABORATING CTR ANTIMICROBIAL RESISTANCE FO, LYNGBY, DENMARK.;HENDRIKSEN, RS (REPRINT AUTHOR), EUROPEAN UNION REFERENCE LAB ANTIMICROBIAL RESIST, LYNGBY, DENMARK.;SUTHEINKUL, O (REPRINT AUTHOR), THAMMASAT UNIV, RANGSIT CTR, FAC PUBL HLTH, PATHUM THANI, THAILAND.;SIRIPHAP, ACHIRAYA, THEETHAKAEW, CHONCHANOK, MAHIDOL UNIV, FAC PUBL HLTH, DEPT MICROBIOL, BANGKOK, THAILAND.;LEEKITCHAROENPHON, PIMLAPAS, KAAS, ROLF S., AARESTRUP, FRANK M., HENDRIKSEN, RENE S., TECH UNIV DENMARK, NATL FOOD INST, RES GRP GENOM EPIDEMIOL, WHO COLLABORATING CTR ANTIMICROBIAL RESISTANCE FO, LYNGBY, DENMARK.;LEEKITCHAROENPHON, PIMLAPAS, KAAS, ROLF S., AARESTRUP, FRANK M., HENDRIKSEN, RENE S., EUROPEAN UNION REFERENCE LAB ANTIMICROBIAL RESIST, LYNGBY, DENMARK.;SUTHEINKUL, ORASA, THAMMASAT UNIV, RANGSIT CTR, FAC PUBL HLTH, PATHUM THANI, THAILAND.","10.1371/JOURNAL.PONE.0169324","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E0169324",NA,"DEPARTMENT OF MICROBIOLOGY GRANT, THE CHINA MEDICAL BOARD, THE FACULTY OF PUBLIC HEALTH OF MAHIDOL UNIVERSITY, DANISH COUNCIL FOR STRATEGIC RESEARCH [09067103], WORLD HEALTH ORGANIZATION GLOBAL FOOD-BORNE INFECTIONS NETWORK, WORLD HEALTH ORGANIZATION, FOOD SAFETY OFFICE [WP-12-FOS-003342]","THIS WORK WAS SUPPORTED IN PART BY DEPARTMENT OF MICROBIOLOGY GRANT, THE CHINA MEDICAL BOARD, THE FACULTY OF PUBLIC HEALTH OF MAHIDOL UNIVERSITY TO ORASA SUTHEINKUL, THE DANISH COUNCIL FOR STRATEGIC RESEARCH (GRANT NUMBER 09067103) TO FRANK M. AARESTRUP, AND IN PART BY THE WORLD HEALTH ORGANIZATION GLOBAL FOOD-BORNE INFECTIONS NETWORK AND WORLD HEALTH ORGANIZATION, FOOD SAFETY OFFICE (WP-12-FOS-003342) TO RENE S. HENDRIKSEN. THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT.",NA,"1932-6203","1",NA,"PUBLIC LIBRARY SCIENCE","12",2017,"ISI000392381100012","64","SCIENCE \& TECHNOLOGY - OTHER TOPICS","7","MULTIDISCIPLINARY SCIENCES","ORASA.SFPH.TU.AC.TH RSHEFOOD.DTU.DK",NA,"EI3HP",NA,"HENDRIKSEN, RS (REPRINT AUTHOR), TECH UNIV DENMARK, NATL FOOD INST, RES GRP GENOM EPIDEMIOL, WHO COLLABORATING CTR ANTIMICROBIAL RESISTANCE FO, LYNGBY, DENMARK","ISI","MAHIDOL UNIV;TECH UNIV DENMARK;EUROPEAN UNION REFERENCE LAB ANTIMICROBIAL RESIST;THAMMASAT UNIV","TECH UNIV DENMARK",NA,"SIRIPHAP A, 2017, PLOS ONE","SIRIPHAP A, 2017, PLOS ONE"
"CARISSIMO G, 2017, PLOS ONE","CARISSIMO G;VAN DEN BEEK M;VERNICK KD;ANTONIEWSKI C","METAVISITOR, A SUITE OF GALAXY TOOLS FOR SIMPLE AND RAPID DETECTION AND DISCOVERY OF VIRUSES IN DEEP SEQUENCE DATA","PLOS ONE","PLOS ONE","METAVISITOR IS A SOFTWARE PACKAGE THAT ALLOWS BIOLOGISTS AND CLINICIANS WITHOUT SPECIALIZED BIOINFORMATICS EXPERTISE TO DETECT AND ASSEMBLE VIRAL GENOMES FROM DEEP SEQUENCE DATASETS. THE PACKAGE IS COMPOSED OF A SET OF MODULAR BIOINFORMATIC TOOLS AND WORKFLOWS THAT ARE IMPLEMENTED IN THE GALAXY FRAMEWORK. USING THE GRAPHICAL GALAXY WORKFLOW EDITOR, USERS WITH MINIMAL COMPUTATIONAL SKILLS CAN USE EXISTING METAVISITOR WORKFLOWS OR ADAPT THEM TO SUIT SPECIFIC NEEDS BY ADDING OR MODIFYING ANALYSIS MODULES. METAVISITOR WORKS WITH DNA, RNA OR SMALL RNA SEQUENCING DATA OVER A RANGE OF READ LENGTHS AND CAN USE A COMBINATION OF DE NOVO AND GUIDED APPROACHES TO ASSEMBLE GENOMES FROM SEQUENCING READS. WE SHOW THAT THE SOFTWARE HAS THE POTENTIAL FOR QUICK DIAGNOSIS AS WELL AS DISCOVERY OF VIRUSES FROM A VAST ARRAY OF ORGANISMS. IMPORTANTLY, WE PROVIDE HERE EXECUTABLE METAVISITOR USE CASES, WHICH INCREASE THE ACCESSIBILITY AND TRANSPARENCY OF THE SOFTWARE, ULTIMATELY ENABLING BIOLOGISTS OR CLINICIANS TO FOCUS ON BIOLOGICAL OR MEDICAL QUESTIONS.",NA,"SHORT DNA-SEQUENCES; SMALL RNAS; VIRAL GENOMES; ALIGNMENT","ENGLISH","ARTICLE","ARTICLE",4,"AGUIAR ERGR, 2015, NUCL ACIDS RES.;BANKEVICH A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/CMB.2012.0021.;BENSON DA, 2013, NUCLEIC ACIDS RES, V41, PD36, DOI 10.1093/NAR/GKS1195.;BLANKENBERG DANIEL, 2010, CURR PROTOC MOL BIOL, VCHAPTER 19, DOI 10.1002/0471142727.MB1910S89.;BROWN C. T., 2012, REFERENCE FREE ALGOR.;CAMACHO C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421.;CAPORASO JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/NMETH.F.303.;CARISSIMO G, 2016, PLOS ONE, V11, DOI 10.1371/JOURNAL.PONE.0153881.;COCK PJA, 2015, GIGASCIENCE, V4, DOI 10.1186/S13742-015-0080-7.;DE ANDRADE RRS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-45.;DING SW, 2007, CELL, V130, P413, DOI 10.1016/J.CELL.2007.07.039.;GOECKS J, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-8-R86.;GRABHERR MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/NBT.1883.;HO T, 2014, VIROLOGY, V471, P54, DOI 10.1016/J.VIROL.2014.09.019.;HUANG XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/GR.9.9.868.;KATZOURAKIS A, 2010, PLOS GENET, V6, DOI 10.1371/JOURNAL.PGEN.1001191.;KIM MINCHEOL, 2013, GENOMICS \& INFORMATICS, V11, P102, DOI 10.5808/GI.2013.11.3.102.;KINGSOLVER MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/J.JMB.2013.10.006.;KLOVERPRIS HN, 2016, IMMUNITY, V44, P391, DOI 10.1016/J.IMMUNI.2016.01.006.;KREUZE JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/J.VIROL.2009.03.024.;LANGMEAD B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/NMETH.1923].;LANGMEAD B, 2009, GENOME BIOL, V10, DOI 10.1186/GB-2009-10-3-R25.;MATRANGA CB, 2014, GENOME BIOL, V15, DOI 10.1186/S13059-014-0519-7.;QUAST C, 2013, NUCLEIC ACIDS RES, V41, PD590, DOI 10.1093/NAR/GKS1219.;SARDI SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16.;SCHULZ MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/BIOINFORMATICS/BTS094.;SEGUIN J, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0088513.;SURGET-GROBA Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/GR.103846.109.;VAN MIERLO JT, 2012, PLOS PATHOG, V8, DOI 10.1371/JOURNAL.PPAT.1002872.;VODOVAR N, 2011, J VIROL, V85, P11016, DOI 10.1128/JVI.05647-11.;WANG ZICHEN, 2016, F1000RES, V5, P1574, DOI 10.12688/F1000RESEARCH.9110.1.;WARREN RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/BIOINFORMATICS/BTL629.;WEBSTER CL, 2015, PLOS BIOL, V13, DOI 10.1371/JOURNAL.PBIO.1002210.;WU QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/PNAS.0911353107.;YOZWIAK NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/JOURNAL.PNTD.0001485.;ZERBINO DR, 2008, GENOME RES, V18, P821, DOI 10.1101/GR.074492.107.","ANTONIEWSKI, C (REPRINT AUTHOR), UNIV PARIS 06, SORBONNE UNIV, CNRS, IBPS,DEV BIOL DEPT, PARIS, FRANCE.;ANTONIEWSKI, C (REPRINT AUTHOR), UNIV PARIS 06, SORBONNE UNIV, CNRS, IBPS,ARTBIO BIOINFORMAT ANAL FACIL, PARIS, FRANCE.;CARISSIMO, GUILLAUME, VERNICK, KENNETH D., INST PASTEUR, DEPT PARASITES \& INSECT VECTORS, UNIT INSECT VECTOR GENET \& GENOM, PARIS, FRANCE.;CARISSIMO, GUILLAUME, VERNICK, KENNETH D., CNRS, UNIT HOSTS VECTORS \& PATHOGENS URA3012, PARIS, FRANCE.;CARISSIMO, GUILLAUME, ASTAR, LAB MICROBIAL IMMUN, SINGAPORE IMMUNOL NETWORK, BIOPOLIS, 8A BIOMED GROVE, SINGAPORE, SINGAPORE.;VAN DEN BEEK, MARIUS, ANTONIEWSKI, CHRISTOPHE, UNIV PARIS 06, SORBONNE UNIV, CNRS, IBPS,DEV BIOL DEPT, PARIS, FRANCE.;VAN DEN BEEK, MARIUS, ANTONIEWSKI, CHRISTOPHE, UNIV PARIS 06, SORBONNE UNIV, CNRS, IBPS,ARTBIO BIOINFORMAT ANAL FACIL, PARIS, FRANCE.;VERNICK, KENNETH D., UNIV MINNESOTA, DEPT MICROBIOL, MINNEAPOLIS, MN 55455 USA.","10.1371/JOURNAL.PONE.0168397","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E0168397",NA,"AGENCE NATIONALE DE LA RECHERCHE [ANR-13-BSV2-0007], UNIVERSITAIRE D'INGENIERIE EN SANTE IUIS GRANT ``ARTIMED'' EUROPEAN RESEARCH","THIS WORK RECEIVED FINANCIAL SUPPORT TO CA FROM THE AGENCE NATIONALE DE LA RECHERCHE GRANT ANR-13-BSV2-0007 ``PLASTISIPI'' AND FROM THE",NA,"1932-6203","1",NA,"PUBLIC LIBRARY SCIENCE","12",2017,"ISI000391612300023","36","SCIENCE \& TECHNOLOGY - OTHER TOPICS","2","MULTIDISCIPLINARY SCIENCES","CHRISTOPHE.ANTONIEWSKIUPMC.FR",NA,"EH2QJ",NA,"ANTONIEWSKI, C (REPRINT AUTHOR), UNIV PARIS 06, SORBONNE UNIV, CNRS, IBPS,DEV BIOL DEPT, PARIS, FRANCE","ISI","INST PASTEUR;CNRS;LAB MICROBIAL IMMUN;CNRS;CNRS;UNIV MINNESOTA","NOTDECLARED",NA,"CARISSIMO G, 2017, PLOS ONE","CARISSIMO G, 2017, PLOS ONE"
"ZHAO J, 2017, CELL PHYSIOL BIOCHEM","ZHAO J;LI L;WANG Q;HAN H;ZHAN Q;XU M","CIRCRNA EXPRESSION PROFILE IN EARLY-STAGE LUNG ADENOCARCINOMA PATIENTS","CELLULAR PHYSIOLOGY AND BIOCHEMISTRY","CELL. PHYSIOL. BIOCHEM.","BACKGROUND/AIMS: LUNG ADENOCARCINOMA, A FORM OF NON-SMALL CELL LUNG CANCER WITH HIGH LETHALITY AT AN ADVANCED STAGE, IS BECOMING MORE COMMON IN WOMEN, NON- OR NEVER-SMOKERS, AND EVEN YOUNG ADULTS. AT PRESENT, THERE ARE STILL NO EFFECTIVE EARLY DIAGNOSIS METHODS FOR PATIENTS TO BE CURED IN A TIMELY MANNER. CIRCULAR RNAS (CIRCRNAS), WHICH ARE STABLE AND CONSERVED NON-CODING RNA IN MAMMALIAN CELLS, HAVE BEEN REPORTED TO BE WIDELY INVOLVED IN THE PROCESSES OF CANCER DISEASE. HOWEVER, IT IS STILL A PUZZLE AS TO WHICH SPECIFIC CIRCRNAS ARE INVOLVED IN THE DEVELOPMENT OF EARLY-STAGE LUNG ADENOCARCINOMA. METHODS: TUMOR SAMPLES AND PAIRED ADJACENT NORMAL TISSUES FROM 4 PATIENTS WITH EARLY-STAGE LUNG ADENOCARCINOMA WERE SELECTED TO INVESTIGATE THE EXPRESSION PROFILE OF CIRCRNAS BY USING A HIGH-THROUGHPUT CIRCRNA MICROARRAY. BIOINFORMATIC ANALYSES WERE CONDUCTED TO SCREEN THOSE DIFFERENTIALLY EXPRESSED CIRCRNAS. QRT-PCR AND SEQUENCING WERE PERFORMED TO ASSURE THE MICROARRAY DATA. RESULTS: A TOTAL OF 357 CIRCRNAS WERE DYSREGULATED IN THE TUMOR SAMPLES, WHICH SUGGESTS POTENTIAL ROLES IN LUNG CANCER. QRT-PCR DETECTION SHOWED THAT FIVE SELECTED CIRCRNAS WERE IDENTICAL TO THE MICROARRAY DATA, AND THE POTENTIAL CIRCRNA-MIRNA INTERACTIONS WERE PREDICTED. CONCLUSION: THIS WORK ILLUSTRATES THAT CLUSTERS OF CIRCRNAS ARE ABERRANTLY EXPRESSED IN EARLY-STAGE LUNG ADENOCARCINOMA, WHICH MIGHT OFFER POTENTIAL TARGETS FOR THE EARLY DIAGNOSIS OF THIS DISEASE AND NEW GENETIC INSIGHTS INTO LUNG CANCER. (C) 2017 THE AUTHOR(S) PUBLISHED BY S. KARGER AG, BASEL","LUNG CANCER; LUNG ADENOCARCINOMA; CIRCRNA; MICROARRAY","CLOSED CIRCULAR RNA; CANCER; TRANSLATION; MICROARRAY; BIOMARKER; VIROIDS","ENGLISH","ARTICLE","ARTICLE",9,"ABOUHAIDAR MG, 2014, P NATL ACAD SCI USA, V111, P14542, DOI 10.1073/PNAS.1402814111.;BONIZZATO A, 2016, BLOOD CANCER J, V6, DOI 10.1038/BCJ.2016.81.;CHEN L, 2017, ONCOGENE, V36, P4551, DOI 10.1038/ONC.2017.89.;CHEN LL, 2015, RNA BIOL, V12, P381, DOI 10.1080/15476286.2015.1020271.;COURAUD S, 2012, EUR J CANCER, V48, P1299, DOI 10.1016/J.EJCA.2012.03.007.;DANAN M, 2012, NUCLEIC ACIDS RES, V40, P3131, DOI 10.1093/NAR/GKR1009.;DONG R, 2016, CELL RES, V26, P747, DOI 10.1038/CR.2016.42.;EBBESEN KK, 2017, RNA BIOL, V14, P1035, DOI 10.1080/15476286.2016.1271524.;FLORES R, 2011, RNA BIOL, V8, P200, DOI 10.4161/RNA.8.2.14238.;GRANADOS-RIVERON JT, 2016, BBA-GENE REGUL MECH, V1859, P1245, DOI 10.1016/J.BBAGRM.2016.07.009.;HANSEN TB, 2013, CANCER RES, V73, P5609, DOI 10.1158/0008-5472.CAN-13-1568.;HSIAO KY, 2017, CANCER RES, V77, P2339, DOI 10.1158/0008-5472.CAN-16-1883.;HSU CL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-241.;HU Y., 2017, TUMOR BIOL, V39, DOI DOI 10.1177/1010428317691659.;KULCHESKI FR, 2016, J BIOTECHNOL, V238, P42, DOI 10.1016/J.JBIOTEC.2016.09.011.;LEGNINI I, 2017, MOL CELL, V66, P22, DOI 10.1016/J.MOLCEL.2017.02.017.;LI F, 2015, ONCOTARGET, V6, P6001, DOI 10.18632/ONCOTARGET.3469.;LI HM, 2016, CELL PHYSIOL BIOCHEM, V40, P1334, DOI 10.1159/000453186.;LI PF, 2015, CLIN CHIM ACTA, V444, P132, DOI 10.1016/J.CCA.2015.02.018.;LI ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/NSMB.2959.;MA PATRICK C, 2012, CLEVE CLIN J MED, V79 ELECTRONIC SUPPL 1, PES56, DOI 10.3949/CCJM.79.S2.12.;MEMCZAK S, 2013, NATURE, V495, P333, DOI 10.1038/NATURE11928.;MENG SJ, 2017, MOL CANCER, V16, DOI 10.1186/S12943-017-0663-2.;PAMUDURTI NR, 2017, MOL CELL, V66, P9, DOI 10.1016/J.MOLCEL.2017.02.021.;PENG L, 2015, ONCOL REP, V33, P2669, DOI 10.3892/OR.2015.3904.;SALZMAN J, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0030733.;SANGER HL, 1976, P NATL ACAD SCI USA, V73, P3852, DOI 10.1073/PNAS.73.11.3852.;TIAN MQ, 2018, J CLIN LAB ANAL, V32, DOI 10.1002/JCLA.22281.;TORRE LINDSEY A, 2016, ADV EXP MED BIOL, V893, P1, DOI 10.1007/978-3-319-24223-1\_1.;TORRES-DURAN M, 2014, CANCER LETT, V345, P21, DOI 10.1016/J.CANLET.2013.12.010.;WAN L, 2016, BIOMED RES INT, DOI 10.1155/2016/1579490.;WANG PL, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0090859.;WANG XN, 2015, INT J CLIN EXP PATHO, V8, P16020.;WANG YM, 2017, MOL CANCER, V16, DOI 10.1186/S12943-017-0598-7.;WU KH, 2012, INT J MOL SCI, V13, P11471, DOI 10.3390/IJMS130911471.;XU LL, 2017, J CANCER RES CLIN, V143, P17, DOI 10.1007/S00432-016-2256-7.;YE CY, 2015, NEW PHYTOL, V208, P88, DOI 10.1111/NPH.13585.;ZHANG XO, 2014, CELL, V159, P134, DOI 10.1016/J.CELL.2014.09.001.;ZHANG Y, 2013, MOL CELL, V51, P792, DOI 10.1016/J.MOLCEL.2013.08.017.","ZHAN, Q, XU, M (REPRINT AUTHOR), SHANGHAI JIAO TONG UNIV, SCH MED, SHANGHAI PEOPLES HOSP 9, DEPT ONCOL, 280 MOHE RD, SHANGHAI 201999, PEOPLES R CHINA.;ZHAO, JIANGMIN, WANG, QIAN, XU, MING, SHANGHAI JIAO TONG UNIV, SCH MED, SHANGHAI PEOPLES HOSP 9, DEPT ONCOL, 280 MOHE RD, SHANGHAI 201999, PEOPLES R CHINA.;ZHAO, JIANGMIN, LI, LE, SHANGHAI JIAO TONG UNIV, SCH MED, SHANGHAI PEOPLES HOSP 9, DEPT RADIOL, SHANGHAI, PEOPLES R CHINA.;HAN, HONGXIU, SHANGHAI JIAO TONG UNIV, SCH MED, SHANGHAI PEOPLES HOSP 9, DEPT PATHOL, SHANGHAI, PEOPLES R CHINA.;ZHAN, QING, SHANGHAI UNIV TRADIT CHINESE MED, PEOPLES HOSP 7, DEPT NEUROL \& NEUROREHABIL, SHANGHAI, PEOPLES R CHINA.","10.1159/000485953","ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",NA,NA,"NATIONAL NATURE SCIENCE FOUNDATION OF CHINA [81672708], SCIENCE FOUNDATION OF SHANGHAI 9TH PEOPLE'S HOSPITAL [SYZRC2014-002, SYZ2015-005]","THIS WORK WAS SUPPORTED BY GRANTS FROM THE NATIONAL NATURE SCIENCE FOUNDATION OF CHINA (GRANT NUMBER 81672708) TO M.X., AND FROM THE SCIENCE FOUNDATION OF SHANGHAI 9TH PEOPLE'S HOSPITAL (GRANT NUMBER SYZRC2014-002 AND SYZ2015-005) TO M.X.",NA,"1015-8987","6","2138-2146","KARGER","44",2017,"ISI000424913800005","39","CELL BIOLOGY, PHYSIOLOGY","3","CELL BIOLOGY, PHYSIOLOGY","ZHANQINGTONGJI.EDU.CN MINGXUSHSMU.EDU.CN",NA,"FV9MZ",NA,"ZHAN, Q, XU, M (REPRINT AUTHOR), SHANGHAI JIAO TONG UNIV, SCH MED, SHANGHAI PEOPLES HOSP 9, DEPT ONCOL, 280 MOHE RD, SHANGHAI 201999, PEOPLES R CHINA","ISI","SHANGHAI JIAO TONG UNIV;SHANGHAI JIAO TONG UNIV;SHANGHAI JIAO TONG UNIV;SHANGHAI UNIV TRADIT CHINESE MED","SHANGHAI JIAO TONG UNIV",NA,"ZHAO J, 2017, CELL PHYSIOL BIOCHEM","ZHAO J, 2017, CELL PHYSIOL BIOCHEM"
"HOELZER M, 2017, ADV VIRUS RES","HOELZER M;MARZ M","SOFTWARE DEDICATED TO VIRUS SEQUENCE ANALYSIS ``BIOINFORMATICS GOES VIRAL''","IN LOEFFLER'S FOOTSTEPS - VIRAL GENOMICS IN THE ERA OF HIGH-THROUGHPUT SEQUENCING","ADV.VIRUS RES.","COMPUTER-ASSISTED TECHNOLOGIES OF THE GENOMIC STRUCTURE, BIOLOGICAL FUNCTION, AND EVOLUTION OF VIRUSES REMAIN A LARGELY NEGLECTED AREA OF RESEARCH. THE ATTENTION OF BIOINFORMATICIANS TO THIS CHALLENGING FIELD IS CURRENTLY UNSATISFYING IN RESPECT TO ITS MEDICAL AND BIOLOGICAL IMPORTANCE. THE POWER OF NEW GENOME SEQUENCING TECHNOLOGIES, ASSOCIATED WITH NEW TOOLS TO HANDLE ``BIG DATA'' PROVIDES UNPRECEDENTED",NA,"RNA VIRUSES; MOLECULAR EVOLUTION; QUALITY ASSESSMENT; SINGLE-CELL; REAL-TIME; GENOME; TECHNOLOGIES; PREDICTION; ASSEMBLER; RESOURCE","ENGLISH","REVIEW, BOOK CHAPTER","INCOLLECTION",1,"ANDERS S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/BIOINFORMATICS/BTU638.;ANDREWS S., 2010, FASTQC QUALITY CONTR.;BANKEVICH A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/CMB.2012.0021.;BARZON L, 2011, INT J MOL SCI, V12, P7861, DOI 10.3390/IJMS12117861.;BECKSTEIN C., 2014, DATA 2014 3RD INTERNATIONAL CONFERENCE ON DATA MANAGEMENT TECHNOLOGIES AND APPLICATIONS, P251.;BEERENWINKEL N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/FMICB.2012.00329.;BIELEJEC F, 2014, SYST BIOL, V63, P493, DOI 10.1093/SYSBIO/SYU015.;BIROL I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/BIOINFORMATICS/BTP367.;BLOOMQUIST EW, 2010, TRENDS ECOL EVOL, V25, P626, DOI 10.1016/J.TREE.2010.08.010.;CHARLEBOIS P., VFAT POST ASSEMBLY P.;CHEVREUX B, 2004, GENOME RES, V14, P1147, DOI 10.1101/GR.1917404.;CORNEY D.C., 2013, MAT METHODS, V3, P203, DOI DOI 10.13070/MM.EN.3.203.;CUTHILL JH, 2013, EVOLUTION, V67, P980, DOI 10.1111/EVO.12064.;DE VIENNE DM, 2013, NEW PHYTOL, V198, P347, DOI 10.1111/NPH.12150.;DOMINGO E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/ANNUREV.MICRO.51.1.151.;DRESZER TR, 2012, NUCLEIC ACIDS RES, V40, PD918, DOI 10.1093/NAR/GKR1055.;DRUCE M, 2016, DATABASE-OXFORD, DOI 10.1093/DATABASE/BAW045.;DRUMMOND AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/MOLBEV/MSS075.;FRICKE M., 2017, VRAP FULL LENG UNPUB.;FRICKE M, 2016, BIOINFORMATICS, V32, P2928, DOI 10.1093/BIOINFORMATICS/BTW323.;FRICKE M, 2015, RNA, V21, P1219, DOI 10.1261/RNA.049338.114.;GARDY J, 2015, GENOME BIOL, V16, DOI 10.1186/S13059-015-0726-X.;GOODWIN S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/NRG.2016.49.;GRABHERR MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/NBT.1883.;GRAHAM E. A., 2011, EOS, V92, P313, DOI DOI 10.1029/2011E0380002.;GREGOR I, 2016, BIOINFORMATICS, V32, P649, DOI 10.1093/BIOINFORMATICS/BTW426.;GRUBER AR, 2008, NUCLEIC ACIDS RES, V36, PW70, DOI 10.1093/NAR/GKN188.;GUREVICH A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/BIOINFORMATICS/BTT086.;HATCHER EL, 2017, NUCLEIC ACIDS RES, V45, PD482, DOI 10.1093/NAR/GKW1065.;HENN MR, 2012, PLOS PATHOG, V8, DOI 10.1371/JOURNAL.PPAT.1002529.;HOLZER M, 2016, SCI REP-UK, V6, DOI 10.1038/SREP34589.;HOFACKER IVO L., 2007, V395, P527.;HOFFMANN S, 2014, GENOME BIOL, V15, DOI 10.1186/GB-2014-15-2-R34.;HOLMES EC, 2009, EVOLUTION EMERGENCE.;HOLMES EC, 2011, J VIROL, V85, P5247, DOI 10.1128/JVI.02203-10.;HORIE M, 2011, VIRUSES-BASEL, V3, P1836, DOI 10.3390/V3101836.;HULO C, 2011, NUCLEIC ACIDS RES, V39, PD576, DOI 10.1093/NAR/GKQ901.;HUSON D.H., 2011, PHYLOGENETIC NETWORK.;IBN-SALEM J, 2014, GENOME BIOL, V15, DOI 10.1186/S13059-014-0423-1.;JAIN M, 2016, GENOME BIOL, V17.;JENKINS GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/S00239-001-0064-3.;KEARSE M., 2012, BIOINFORMATICS ENGLA, V28, P1647.;KIM D, 2013, GENOME BIOL, V14, DOI 10.1186/GB-2013-14-4-R36.;KITCHEN A, 2011, P NATL ACAD SCI USA, V108, P238, DOI 10.1073/PNAS.1011090108.;KUIKEN C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/BIOINFORMATICS/BTH485.;LANDER ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062.;LARTILLOT N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/BIOINFORMATICS/BTP368.;LERAT E, 2010, HEREDITY, V104, P520, DOI 10.1038/HDY.2009.165.;LING P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-145.;LIU Y.F., 2009, ELECT J DIFFERENTIAL, V2009, P9, DOI DOI 10.1371/J0URNAL.P0NE.0106787.;LOHMANN V, 2013, CURR TOP MICROBIOL, V369, P167, DOI 10.1007/978-3-642-27340-7\_7.;LUCIANI F, 2012, TRENDS BIOTECHNOL, V30, P443, DOI 10.1016/J.TIBTECH.2012.05.005.;LUO RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18.;MADHUGIRI R, 2014, VIRUS RES, V194, P76, DOI 10.1016/J.VIRUSRES.2014.10.001.;MARDIS ER, 2017, NAT PROTOC, V12, P213, DOI 10.1038/NPROT.2016.182.;MARSCHALL T., 2016, BIORXIV.;MARZ M, 2014, BIOINFORMATICS, V30, P1793, DOI 10.1093/BIOINFORMATICS/BTU105.;MCCARTHY EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/BIOINFORMATICS/BTF878.;MORTAZAVI A, 2008, NAT METHODS, V5, P621, DOI 10.1038/NMETH.1226.;PENG Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/BIOINFORMATICS/BTS174.;PICKETT BE, 2012, NUCLEIC ACIDS RES, V40, PD593, DOI 10.1093/NAR/GKR859.;PULIDO-TAMAYO S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/NAR/GKV478.;QIN JJ, 2012, NATURE, V490, P55, DOI 10.1038/NATURE11450.;QUICK J, 2016, NATURE, V530, P228, DOI 10.1038/NATURE16996.;RAMBAUT A, 2000, BIOINFORMATICS, V16, P395, DOI 10.1093/BIOINFORMATICS/16.4.395.;RHOADS A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/J.GPB.2015.08.002.;RONQUIST F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/BIOINFORMATICS/BTG180.;SANJUAN R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10.;SCHEUCH M, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/S12859-015-0503-6.;SCHMIEDER R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/BIOINFORMATICS/BTR026.;SCHMUTZ J, 2004, NATURE, V429, P365, DOI 10.1038/NATURE02390.;SCHULZ MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/BIOINFORMATICS/BTS094.;SHARP PM, 2011, CURR OPIN VIROL, V1, P436, DOI 10.1016/J.COVIRO.2011.10.018.;SHU YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494.;SIMPSON JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/GR.089532.108.;SMIT A.F.A., REPEAT MASKER OPEN 3.;SPERBER G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S4.;STAMATAKIS A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642.;THORVALDSDOTTIR H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/BIB/BBS017.;TOPFER A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/JOURNAL.PCBI.1003515.;TOPFER A, 2013, VIROLOGY, V438, P14, DOI 10.1016/J.VIROL.2012.11.020.;WEISS RA, 2003, CURR TOP MICROBIOL, V278, P47.;WILL S, 2007, PLOS COMPUT BIOL, V3, P680, DOI 10.1371/JOURNAL.PCBI.0030065.;YANG X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-475.;ZAGORDI O, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0047046.;ZERBINO DR, 2008, GENOME RES, V18, P821, DOI 10.1101/GR.074492.107.;ZUKER M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/NAR/GKG595.","MARZ, M (REPRINT AUTHOR), FRIEDRICH SCHILLER UNIV JENA, FAC MATH \& COMP SCI, RNA BIOINFORMAT \& HIGH THROUGHPUT ANAL, JENA, GERMANY.;MARZ, M (REPRINT AUTHOR), EUROPEAN VIRUS BIOINFORMAT CTR EVBC, JENA, GERMANY.;MARZ, M (REPRINT AUTHOR), FLI LEIBNIZ INST AGE RES, JENA, GERMANY.;HOELZER, MARTIN, MARZ, MANJA, FRIEDRICH SCHILLER UNIV JENA, FAC MATH \& COMP SCI, RNA BIOINFORMAT \& HIGH THROUGHPUT ANAL, JENA, GERMANY.;HOELZER, MARTIN, MARZ, MANJA, EUROPEAN VIRUS BIOINFORMAT CTR EVBC, JENA, GERMANY.;MARZ, MANJA, FLI LEIBNIZ INST AGE RES, JENA, GERMANY.","10.1016/BS.AIVIR.2017.08.004","525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA",NA,"BEER, M AND HOPER, D",NA,NA,"978-0-12-812599-1, 978-0-12-812598-4","0065-3527",NA,"233-257","ELSEVIER ACADEMIC PRESS INC","99",2017,"ISI000414551700009","87","VIROLOGY","5","VIROLOGY","MANJAUNI-JENA.DE","ADVANCES IN VIRUS RESEARCH","BI7OR","IN LOEFFLER'S FOOTSTEPS - VIRAL GENOMICS IN THE ERA OF HIGH-THROUGHPUT SEQUENCING","MARZ, M (REPRINT AUTHOR), FRIEDRICH SCHILLER UNIV JENA, FAC MATH \& COMP SCI, RNA BIOINFORMAT \& HIGH THROUGHPUT ANAL, JENA, GERMANY","ISI","FRIEDRICH SCHILLER UNIV JENA;EUROPEAN VIRUS BIOINFORMAT CTR EVBC;FLI LEIBNIZ INST AGE RES","FRIEDRICH SCHILLER UNIV JENA",NA,"HOELZER M, 2017, ADV VIRUS RES","HOELZER M, 2017, ADV VIRUS RES"
"JAKUBCZAK A, 2017, ANN AGR ENV MED","JAKUBCZAK A;KOWALCZYK M;KOSTRO K;JEZEWSKA WITKOWSKA G","COMPARATIVE MOLECULAR ANALYSIS OF STRAINS OF THE ALEUTIAN DISEASE VIRUS ISOLATED FROM FARMED AND WILD MINK","ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE","ANN. AGR. ENV. MED.","INTRODUCTION AND OBJECTIVE. ALEUTIAN DISEASE IS A SIGNIFICANT BIOLOGICAL FACTOR CAUSING SUBSTANTIAL LOSSES IN MINK FARMING. THE VIRUS INDUCING THE DISEASE ALSO INFECTS WILD POPULATIONS WHICH MAY CONSTITUTE AN ASYMPTOMATIC RESERVOIR. TO COMPARE GENETIC VARIANTS OF THE AMD VIRUS OCCURRING IN WILD AND FARMED MINK POPULATIONS, AN ANALYSIS WAS PERFORMED ON A FRAGMENT OF THE VP2 PROTEIN SEQUENCE OF THE VIRUS INFECTING BOTH POPULATIONS, TAKEN FROM DIFFERENT LIVING ENVIRONMENTS. MATERIAL AND METHOD. GENETIC MATERIAL WAS ISOLATED FROM 11 FARMED ANIMALS IN WHICH ANTI-AMDV ANTIBODIES HAD BEEN DETECTED AND FROM 20 WILD ANIMALS. THE DNA OBTAINED WAS AMPLIFIED USING PRIMERS SPECIFIC FOR THE FRAGMENT ENCODING THE VP2 PROTEIN. THE PRODUCT OBTAINED WAS SEQUENCED AND BIOINFORMATIC ANALYSIS WAS PERFORMED. RESULTS. VIRAL MATERIAL WAS DETECTED IN 11 FARMED AND 7 FREE-LIVING ANIMALS. SIMILARITY OF SEQUENCES AVERAGED 99\% WITHIN GROUPS AND 94\% BETWEEN GROUPS. THE SEQUENCING RESULTS MADE IT POSSIBLE TO IDENTIFY CHARACTERISTIC CHANGES FOR EACH GROUP. IN THE ISOLATES FROM THE WILD ANIMALS, THE FOLLOWING CHANGES WERE OBSERVED IN THE EPITOPE REGION WITH RESPECT TO THE REFERENCE SEQUENCE: C3704T, G3710A, T3722C, T3746C AND A3749G. IN THE ISOLATES FROM THE FARMED ANIMALS A G3779A TRANSITION WAS NOTED. PHYLOGENETIC ANALYSIS SHOWED THAT THE VARIANTS INFECTING THE TWO GROUPS OCCUPY SEPARATE BRANCHES OF THE PHYLOGENETIC TREE. CONCLUSION. THE VARIANTS OF THE VIRUS INFECTING THE TWO GROUPS MAY HAVE A COMMON ORIGIN, BUT AT PRESENT THEY CONSTITUTE TWO SEPARATE GROUPS, WITH CHARACTERISTIC DIFFERENCES MAKING IT POSSIBLE TO RECOGNIZE THEIR GENOTYPE.","AMDV; VP2 PROTEIN; MOLECULAR PHYLOGENETICS; MINK","CANINE PARVOVIRUS; NUCLEOTIDE-SEQUENCE; PATHOGENICITY; EPIDEMIOLOGY; TRANSMISSION; VARIANTS; CPV-2; ADV","ENGLISH","ARTICLE","ARTICLE",0,"ALEXANDERSEN S, 1994, VET PATHOL, V31, P216, DOI 10.1177/030098589403100209.;ALLISON AB, 2012, J VIROL, V86, P865, DOI 10.1128/JVI.06187-11.;BATTILANI M, 2007, VET RES COMMUN, V31, P209, DOI 10.1007/S11259-007-0007-6.;BATTILANI M, 2006, VIROLOGY, V352, P22, DOI 10.1016/J.VIROL.2006.06.002.;BLOOM ME, 1988, J VIROL, V62, P2903.;CLEGG SR, 2012, VET MICROBIOL, V157, P78, DOI 10.1016/J.VETMIC.2011.12.024.;COSTELLO F, 1999, SCAND J IMMUNOL, V49, P347.;FARID AH, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-10.;FOURNIER-CHAMBRILLON C, 2004, J WILDLIFE DIS, V40, P394, DOI 10.7589/0090-3558-40.3.394.;GOTTSCHALCK E, 1991, J VIROL, V65, P4378.;HADLOW WJ, 1983, INFECT IMMUN, V41, P1016.;JAHNS H, 2010, J VET DIAGN INVEST, V22, P101, DOI 10.1177/104063871002200120.;JEPSEN JR, 2009, EMERG INFECT DIS, V15, P2040, DOI 10.3201/EID1512.090514.;KNUUTTILA A, 2009, VET MICROBIOL, V133, P229, DOI 10.1016/J.VETMIC.2008.07.003.;LEIMANN A, 2015, VIRUS RES, V199, P56, DOI 10.1016/J.VIRUSRES.2015.01.011.;MAJER-DZIEDZIC B, 2011, POL J VET SCI, V14, P379, DOI 10.2478/V10181-011-0057-0.;MANAS S, 2001, J WILDLIFE DIS, V37, P138, DOI 10.7589/0090-3558-37.1.138.;MCKENNA R, 1999, J VIROL, V73, P6882.;NITUCH LA, 2015, J WILDLIFE DIS, V51, P389, DOI 10.7589/2014-05-141.;OIE KL, 1996, J VIROL, V70, P852.;REICHERT M, 2014, B VET I PULAWY, V58, P369, DOI 10.2478/BVIP-2014-0057.;REICHERT M, 2014, B VET I PULAWY, V58, P187, DOI 10.2478/BVIP-2014-0028.;SPIBEY N, 2008, VET MICROBIOL, V128, P48, DOI 10.1016/J.VETMIC.2007.09.015.;YAMAGUCHI N, 2001, VET REC, V149, P485, DOI 10.1136/VR.149.16.485.","JAKUBCZAK, A (REPRINT AUTHOR), UNIV LIFE SCI, FAC BIOL \& ANIM BREEDING, DEPT BIOL BASIS ANIM PROD, AKAD 13, PL-20950 LUBLIN, POLAND.;JAKUBCZAK, ANDRZEJ, KOWALCZYK, MAREK, JEZEWSKA-WITKOWSKA, GRAZYNA, UNIV LIFE SCI, FAC BIOL \& ANIM BREEDING, DEPT BIOL BASIS ANIM PROD, AKAD 13, PL-20950 LUBLIN, POLAND.;KOSTRO, KRZYSZTOF, UNIV LIFE SCI, DEPT EPIZOOTIOL \& CLIN INFECT DIS, FAC VET MED, LUBLIN, POLAND.","10.26444/AAEM/75688","JACZEWSKIEGO 2, PO BOX 185, 20-950 LUBLIN, POLAND",NA,NA,"POLISH NATIONAL SCIENCE CENTRE [N N308 599939]","THIS STUDY WAS BEEN FUNDED BY THE POLISH NATIONAL SCIENCE CENTRE (PROJECT N N308 599939).",NA,"1232-1966","3","366-371","INST AGRICULTURAL MEDICINE","24",2017,"ISI000413333700003","24","ENVIRONMENTAL SCIENCES \& ECOLOGY, PUBLIC, ENVIRONMENTAL \& OCCUPATIONAL HEALTH","0","ENVIRONMENTAL SCIENCES, PUBLIC, ENVIRONMENTAL \& OCCUPATIONAL HEALTH","ANDRZEJ.JAKUBCZAKUP.LUBLIN.PL",NA,"FK2SW",NA,"JAKUBCZAK, A (REPRINT AUTHOR), UNIV LIFE SCI, FAC BIOL \& ANIM BREEDING, DEPT BIOL BASIS ANIM PROD, AKAD 13, PL-20950 LUBLIN, POLAND","ISI","UNIV LIFE SCI;UNIV LIFE SCI","UNIV LIFE SCI",NA,"JAKUBCZAK A, 2017, ANN AGR ENV MED","JAKUBCZAK A, 2017, ANN AGR ENV MED"
"KLENNER J, 2017, CURR ISSUES MOL BIOL","KLENNER J;KOHL C;DABROWSKI PW;NITSCHE A","COMPARING VIRAL METAGENOMIC EXTRACTION METHODS","CURRENT ISSUES IN MOLECULAR BIOLOGY","CURR. ISSUES MOL. BIOL.","A CRUCIAL STEP IN THE MOLECULAR DETECTION OF VIRUSES IN CLINICAL SPECIMENS IS THE EFFICIENT EXTRACTION OF VIRAL NUCLEIC ACIDS. THE TOTAL YIELD OF VIRAL NUCLEIC ACID FROM A CLINICAL SPECIMEN IS DEPENDENT ON THE SPECIMEN'S VOLUME, THE INITIAL VIRUS CONCENTRATION AND THE EFFECTIVENESS PROVIDED BY THE EXTRACTION METHOD. RECENT NEXT GENERATION SEQUENCING (NGS)-BASED DIAGNOSTIC APPROACHES (I.E. METAGENOMICS) PROVIDE A MOLECULAR `OPEN VIEW' INTO THE SAMPLE, AS THEY THEORETICALLY GENERATE SEQUENCE READS OF ANY NUCLEIC ACID PRESENT IN A SPECIMEN IN A STATISTICALLY REPRESENTATIVE MANNER. HOWEVER, SINCE A HIGHER VIRUS RELATED READ OUTPUT PROMISES BETTER SENSITIVITY IN THE SUBSEQUENT BIOINFORMATIC ANALYSIS, THE EXTRACTION METHOD SELECTED DETERMINES THE RELIABILITY OF DIAGNOSTIC NGS. IN THIS STUDY NINE COMMERCIALLY AVAILABLE KITS FOR NUCLEIC ACID EXTRACTION WERE COMPARED REGARDING THE SIMULTANEOUS ISOLATION OF DNA AND RNA BY REAL-TIME PCR, FOUR OF WHICH WERE SELECTED FOR SUBSEQUENT COMPARISON BY NGS (QIAAMP VIRAL RNA MINI KIT, QIAAMP DNA BLOOD MINI KIT, QIAAMP CADOR PATHOGEN MINI KIT AND QIAAMP MINELUTE VIRUS SPIN KIT). THE NUCLEIC ACID YIELDS AND THE SEQUENCE READ OUTPUT WERE COMPARED FOR FOUR DIFFERENT MODEL VIRUSES REOVIRUS, ORTHOMYXOVIRUS, ORTHOPOXVIRUS AND PARAMYXOVIRUS - EACH AT DEFINED BUT VARYING CONCENTRATIONS IN THE SAME SAMPLE. THE TOTAL AMOUNT OF NUCLEIC ACID WAS PROCESSED TO SEQUENCE THE RNA (AS CDNA) AND THE DNA WITH QUANTIFICATION BY QUBIT AND VIRUS-SPECIFIC QUANTITATIVE REAL-TIME PCRS. NGS LIBRARIES WERE PREPARED FOR SEQUENCING ON THE ILLUMINA HISEQ 1500 SYSTEM. FINALLY, THE PERCENTAGE OF READS ASSIGNABLE TO EACH VIRUS WAS DETERMINED VIA MAPPING. EVALUATION OF DIFFERENT COMMERCIAL NUCLEIC ACID EXTRACTION KITS WITH FOUR DIFFERENT VIRUSES INDICATES LITTLE VARIATION IN THE READ NUMBERS OBTAINED FOR TRANSCRIBED RNA OR DNA BY NGS. SINCE NGS IS INCREASINGLY BEING USED AS A TOOL IN DIAGNOSTICS OF INFECTIOUS DISEASES, THE INDIVIDUAL STEPS OF THE COMPLETE PROCESS HAVE TO BE VALIDATED CAREFULLY. HERE WE COULD SHOW THAT FOR VIRUS IDENTIFICATION IN LIQUID CLINICAL SPECIMENS, ANY NUCLEIC ACID EXTRACTION KIT THAT IS PERFORMING WELL FOR PCR DIAGNOSTICS CAN BE USED FOR NGS DIAGNOSTICS AS WELL AND THAT THE SELECTION OF THE KIT HAS ONLY A MINOR IMPACT ON THE YIELD OF VIRAL READS.",NA,"REAL-TIME PCR; DIAGNOSIS; VIRUS; KITS; DNA; QUANTIFICATION; TECHNOLOGY; INFECTIONS; SPECIMENS; RECOVERY","ENGLISH","REVIEW","ARTICLE",0,"AHMADIAN A, 2011, LAB CHIP, V11, P2653, DOI [10.1039/C1C90035H, 10.1039/C1LC90035H].;BATTY EM, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0066129.;BLOW JA, 2004, J VIROL METHODS, V119, P195, DOI 10.1016/J.JVIROMET.2004.03.015.;BOOM R, 1990, J CLIN MICROBIOL, V28, P495.;BUSTIN SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/CLINCHEM.2008.112797.;CHEVAL J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11.;DAUPHIN LA, 2010, J APPL MICROBIOL, V108, P163, DOI 10.1111/J.1365-2672.2009.04404.X.;DESAI AN, 2012, CLIN GENET, V81, P503, DOI 10.1111/J.1399-0004.2012.01865.X.;DIDELOT X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/NRG3226.;FAHLE GA, 2000, J CLIN MICROBIOL, V38, P3860.;FINSTERBUSCH T, 2009, VIRUS RES, V143, P177, DOI 10.1016/J.VIRUSRES.2009.02.009.;HAYDEN EC, 2014, NATURE, V507, P294, DOI 10.1038/507294A.;HAZELTON PR, 2003, EMERG INFECT DIS, V9, P294, DOI 10.3201/EID0903.020327.;HULO C, 2011, NUCLEIC ACIDS RES, V39, PD576, DOI 10.1093/NAR/GKQ901.;KLEIN D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9.;KOHL C, 2015, EMERG INFECT DIS, V21, P48, DOI 10.3201/EID2101.140766.;KOHL C, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0043106.;KRAUSE CH, 2006, J CLIN VIROL, V37, P184, DOI 10.1016/J.JCV.2006.07.009.;LANGMEAD B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/NMETH.1923].;LAW J, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0060595.;LECUIT M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/FCIMB.2014.00025.;LIU L, 2012, J BIOMED BIOTECHNOL, V2012, DOI DOI 10.1155/2012/25136422829749.;MARDIS ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/J.TIG.2007.12.007.;METZKER ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/NRG2626.;NAGELE P, 2011, BEST PRACT RES-CLIN, V25, P549, DOI 10.1016/J.BPA.2011.09.001.;NAKAMURA S, 2008, EMERG INFECT DIS, V14, P1784, DOI 10.3201/EID1411.080589.;NASSIRPOUR R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-485.;PABINGER STEPHAN, 2014, BIOMOL DETECT QUANTIF, V1, P23.;PENG X, 2013, J MICROBIOL METH, V95, P455, DOI 10.1016/J.MIMET.2013.07.015.;PERANDIN F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004.;QUAIL MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341.;RENKEMA KY, 2014, NAT REV NEPHROL, V10, P433, DOI 10.1038/NRNEPH.2014.95.;RIBAO C, 2004, J VIROL METHODS, V115, P177, DOI 10.1016/J.JVIROMET.2003.09.026.;SCHMITTGEN TD, 2008, METHODS, V44, P31, DOI 10.1016/J.YMETH.2007.09.006.;SCHROEDER K, 2010, MOL CELL PROBE, V24, P110, DOI 10.1016/J.MCP.2009.10.008.;SCHULZE M, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0009966.;TEMPLETON KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004.;VOELKERDING KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/CLINCHEM.2008.112789.;YAMAMOTO Y, 2002, CLIN DIAGN LAB IMMUN, V9, P508, DOI 10.1128/CDLI.9.3.508-514.2002.","NITSCHEL, A (REPRINT AUTHOR), ROBERT KOCH INST, CTR BIOL THREATS \& SPECIAL PATHOGENS 1, BERLIN, GERMANY.;KLENNER, JEANETTE, KOHL, CLAUDIA, DABROWSKI, PIOTR W., NITSCHE, ANDREAS, ROBERT KOCH INST, CTR BIOL THREATS \& SPECIAL PATHOGENS 1, BERLIN, GERMANY.;KLENNER, JEANETTE, BUNDESWEHR RES INST PROTECT TECHNOL \& NBC PROTECT, MUNSTER, GERMANY.;DABROWSKI, PIOTR W., ROBERT KOCH INST, RES GRP BIOINFORMAT NG4, BERLIN, GERMANY.","10.21775/CIMB.024.059","UNIT 7570, PO BOX 7169, WAREHAM RD, POOLE BH15 9EL, ENGLAND",NA,NA,NA,NA,NA,"1467-3037",NA,"59-70","HORIZON SCIENTIFIC PRESS","24",2017,"ISI000407308200004","39","BIOCHEMISTRY \& MOLECULAR BIOLOGY","9","BIOCHEMISTRY \& MOLECULAR BIOLOGY","NITSCHEARKI.DE",NA,"FD1PC",NA,"NITSCHEL, A (REPRINT AUTHOR), ROBERT KOCH INST, CTR BIOL THREATS \& SPECIAL PATHOGENS 1, BERLIN, GERMANY","ISI","NITSCHE;BUNDESWEHR RES INST PROTECT TECHNOL AND NBC PROTECT;ROBERT KOCH INST","NITSCHEL",NA,"KLENNER J, 2017, CURR ISSUES MOL BIOL","KLENNER J, 2017, CURR ISSUES MOL BIOL"
"DIAZ PI, 2017, VIRULENCE","DIAZ PI;HONG BY;DUPUY AK;STRAUSBAUGH LD","MINING THE ORAL MYCOBIOME: METHODS, COMPONENTS, AND MEANING","VIRULENCE","VIRULENCE","RESEARCH ON ORAL FUNGI HAS CENTERED ON CANDIDA. HOWEVER, RECENT INTERNAL TRANSCRIBED SPACER (ITS)-BASED STUDIES REVEALED A VAST NUMBER OF FUNGAL TAXA AS POTENTIAL ORAL RESIDENTS. WE REVIEW DNA-BASED STUDIES OF THE ORAL MYCOBIOME AND CONTRAST THEM WITH CULTIVATION-BASED SURVEYS, SHOWING THAT MOST GENERA ENCOUNTERED BY CULTIVATION HAVE ALSO BEEN DETECTED MOLECULARLY. SOME TAXA SUCH AS MALASSEZIA, HOWEVER, APPEAR IN HIGH PREVALENCE AND ABUNDANCE IN MOLECULAR STUDIES BUT HAVE NOT BEEN CULTIVATED. IMPORTANT TECHNICAL AND BIOINFORMATIC CHALLENGES TO ITS-BASED ORAL MYCOBIOME STUDIES ARE DISCUSSED. THESE INCLUDE OPTIMIZATION OF SAMPLE LYSIS, VARIABILITY IN LENGTH OF ITS AMPLICONS, HIGH INTRA-SPECIES ITS SEQUENCE VARIABILITY, HIGH INTER-SPECIES VARIABILITY IN ITS COPY NUMBER AND CHALLENGES IN NOMENCLATURE AND MAINTENANCE OF CURATED REFERENCE DATABASES. MOLECULAR SURVEYS ARE POWERFUL FIRST STEPS TO CHARACTERIZE THE ORAL MYCOBIOME BUT FURTHER RESEARCH IS NEEDED TO UNRAVEL WHICH FUNGI DETECTED BY DNA ARE TRUE ORAL RESIDENTS AND WHAT ROLE THEY PLAY IN ORAL HOMEOSTASIS.","INTERNAL TRANSCRIBED SPACER; ITS1; MICROBIOME; MYCOBIOME; ORAL FUNGI; SALIVA","OPPORTUNISTIC FUNGAL PATHOGEN; HIV-POSITIVE PATIENTS; CANDIDA-ALBICANS; RIBOSOMAL DNA; PHYLOGENETIC CIRCUMSCRIPTION; OROPHARYNGEAL CANDIDIASIS; MOLECULAR EPIDEMIOLOGY; TOPOGRAPHIC DIVERSITY; APICAL PERIODONTITIS; DENTURE STOMATITIS","ENGLISH","REVIEW","ARTICLE",4,"AAS JA, 2007, J CLIN PERIODONTOL, V34, P189, DOI 10.1111/J.1600-051X.2006.01034.X.;ABARENKOV K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/J.1469-8137.2009.03160.X.;ALCURE MONICA LEAL, 2006, ORAL SURG ORAL MED ORAL PATHOL ORAL RADIOL ENDOD, V101, PE33, DOI 10.1016/J.TRIPLEO.2005.06.028.;ARENDORF TM, 1980, ARCH ORAL BIOL, V25, P1, DOI 10.1016/0003-9969(80)90147-8.;BARTELS HA, 1964, J DENT RES, V43, P136, DOI 10.1177/00220345640430010701.;BORROMEO GL, 1992, J MED VET MYCOL, V30, P477.;CANNON RD, 1995, J DENT RES, V74, P1152, DOI 10.1177/00220345950740050301.;CARLSON A, 2014, MYCOLOGIA, V106, P735, DOI 10.3852/13-275.;CHEN Q, 2015, STUD MYCOL, P137, DOI 10.1016/J.SIMYCO.2015.10.003.;CONTI HR, 2015, J IMMUNOL, V195, P780, DOI 10.4049/JIMMUNOL.1500909.;CUI LJ, 2015, AM J RESP CRIT CARE, V191, P932, DOI 10.1164/RCCM.201409-1583OC.;CUMMING CG, 1990, ORAL MICROBIOL IMMUN, V5, P82, DOI 10.1111/J.1399-302X.1990.TB00232.X.;DANIEL HM, 2014, ANTON LEEUW INT J G, V106, P67, DOI 10.1007/S10482-014-0170-Z.;DELHAES L, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0036313.;DONGARI-BAGTZOGLOU A, 2009, ORAL MICROBIOL IMMUN, V24, P249, DOI 10.1111/J.1399-302X.2009.00505.X.;DUPUY AK, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0090899.;EGAN MW, 2002, INT ENDOD J, V35, P321, DOI 10.1046/J.1365-2591.2002.00478.X.;FALSETTA ML, 2014, INFECT IMMUN, V82, P1968, DOI 10.1128/IAI.00087-14.;NAVAS EAFD, 2009, J ORAL PATHOL MED, V38, P764, DOI 10.1111/J.1600-0714.2009.00786.X.;FIDEL PL, 1999, CLIN MICROBIOL REV, V12, P80.;FINDLEY K, 2013, NATURE, V498, P367, DOI 10.1038/NATURE12171.;FOX EC, 1958, BRIT MED J, V2, P826, DOI 10.1136/BMJ.2.5100.826.;FREEMAN AF, 2009, ORAL DIS, V15, P2, DOI 10.1111/J.1601-0825.2008.01463.X.;GHANNOUM MA, 2010, PLOS PATHOG, V6, DOI 10.1371/JOURNAL.PPAT.1000713.;GOMES C, 2010, J ENDODONT, V36, P626, DOI 10.1016/J.JOEN.2010.01.016.;HANNULA J, 1999, ORAL MICROBIOL IMMUN, V14, P176, DOI 10.1034/J.1399-302X.1999.140306.X.;GONCALVES RHP, 2006, MYCOPATHOLOGIA, V162, P83, DOI 10.1007/S11046-006-0038-5.;HERRERA ML, 2009, J CLIN MICROBIOL, V47, P1325, DOI 10.1128/JCM.02073-08.;HERSHKOVITZ MA, 1996, MOL BIOL EVOL, V13, P1276, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A025693.;HIBBETT DS, 2013, NAT REV MICROBIOL, V11, P129, DOI 10.1038/NRMICRO2963.;HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338.;HOFFMANN K, 2013, PERSOONIA, V30, P57, DOI 10.3767/003158513X666259.;IATTA R, 2009, ORAL SURG ORAL MED O, V108, P647, DOI 10.1016/J.TRIPLEO.2009.07.010.;IMABAYASHI Y, 2016, SCI REP-UK, V6, DOI 10.1038/SREP28110.;IRINYI L, 2015, MED MYCOL, V53, P313, DOI 10.1093/MMY/MYV008.;JACOBSEN MD, 2008, FEMS YEAST RES, V8, P1334, DOI 10.1111/J.1567-1364.2008.00438.X.;JOHNSON CC, 2012, INFECT IMMUN, V80, P1736, DOI 10.1128/IAI.00019-12.;KAMMA JJ, 1999, J PERIODONTAL RES, V34, P25, DOI 10.1111/J.1600-0765.1999.TB02218.X.;KNIGHTON H. T., 1939, JOUR DENTAL RES, V18, P103, DOI 10.1177/00220345390180020101.;KURTZMAN CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2.;LACKNER M, 2011, IMA FUNGUS, V2, P39, DOI 10.5598/IMAFUNGUS.2011.02.01.07.;LALLA RV, 2010, SUPPORT CARE CANCER, V18, P985, DOI 10.1007/S00520-010-0892-Z.;LASKER BA, 2001, MED MYCOL, V39, P341.;LIU CM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-255.;LIU XZ, 2015, STUD MYCOL, P85, DOI 10.1016/J.SIMYCO.2015.12.001.;MAKIMURA K, 1994, J MED MICROBIOL, V40, P358, DOI 10.1099/00222615-40-5-358.;MARTIN MV, 1981, J MED MICROBIOL, V14, P457, DOI 10.1099/00222615-14-4-457.;MASON KL, 2012, INFECT IMMUN, V80, P3371, DOI 10.1128/IAI.00449-12.;MCGOVERN JJ, 1953, NEW ENGL J MED, V248, P397, DOI 10.1056/NEJM195303052481001.;MCMANUS BA, 2014, INFECT GENET EVOL, V21, P166, DOI 10.1016/J.MEEGID.2013.11.008.;MIRANDA TT, 2009, INT ENDOD J, V42, P839, DOI 10.1111/J.1365-2591.2009.01601.X.;MONTEIRO-DA-SILVA F, 2014, MED MYCOL, V52, P496, DOI 10.1093/MMY/MYU027.;MUKHERJEE PK, 2014, PLOS PATHOG, V10, DOI 10.1371/JOURNAL.PPAT.1003996.;NILSSON RH, 2006, PLOS ONE, V1, DOI 10.1371/JOURNAL.PONE.0000059.;NILSSON RH, 2008, EVOL BIOINFORM, V4, P193.;ODDS F.C., 1988, CANDIDA CANDIDOSIS.;OLIVER DE, 1984, J ORAL PATHOL MED, V13, P265, DOI 10.1111/J.1600-0714.1984.TB01424.X.;PATEL PK, 2012, AIDS RES TREAT, V2012, DOI DOI 10.1155/2012/262471.;PFALLER MA, 2008, J CLIN MICROBIOL, V46, P515, DOI 10.1128/JCM.01915-07.;PITT JI, 2014, MYCOLOGIA, V106, P1051, DOI 10.3852/14-060.;QUAEDVLIEG W, 2014, PERSOONIA, V33, P1, DOI 10.3767/003158514X681981.;RADFAR L, 2003, ORAL SURG ORAL MED O, V96, P283, DOI 10.1016/S1079-2104(03)00224-5.;REDDING SW, 2004, ORAL SURG ORAL MED O, V97, P47, DOI 10.1016/J.TRIPLEO.2003.09.008.;REDDING SW, 2001, ORAL SURG ORAL MED O, V91, P659, DOI 10.1067/MOE.2001.112946.;REDHEAD SA, 2014, IMA FUNGUS, V5, P449, DOI 10.5598/IMAFUNGUS.2014.05.02.09.;ROSSMAN AY, 2015, IMA FUNGUS, V6, P507, DOI 10.5598/IMAFUNGUS.2015.06.02.14.;ROSSMAN AY, 2015, IMA FUNGUS, V6, P145, DOI 10.5598/IMAFUNGUS.2015.06.01.09.;ROSSMAN AY, 2013, IMA FUNGUS, V4, P41, DOI 10.5598/IMAFUNGUS.2013.04.01.05.;RUSTCHENKO EP, 1993, J BACTERIOL, V175, P7189.;SALVATORI O, 2016, J DENT RES, V95, P365, DOI 10.1177/0022034515625222.;SAMSON RA, 2014, STUD MYCOL, P141, DOI 10.1016/J.SIMYCO.2014.07.004.;SCHELENZ S, 2011, J ORAL PATHOL MED, V40, P83, DOI 10.1111/J.1600-0714.2010.00937.X.;SCHWARTZ S, 1997, NEW ENGL J MED, V337, P241, DOI 10.1056/NEJM199707243370405.;SHELBURNE SA, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0139851.;SHIMIZU C, 2008, ORAL SURG ORAL MED O, V105, P445, DOI 10.1016/J.TRIPLEO.2007.11.030.;TANG J, 2015, J IMMUNOL METHODS, V421, P112, DOI 10.1016/J.JIM.2015.04.004.;TAPPERJONES L, 1980, J CLIN PATHOL, V33, P282, DOI 10.1136/JCP.33.3.282.;TAYLOR JW, 2011, IMA FUNGUS, V2, P113, DOI 10.5598/IMAFUNGUS.2011.02.02.01.;WANG QM, 2015, STUD MYCOL, P149, DOI 10.1016/J.SIMYCO.2015.12.002.;WATKINS RR, 2016, J INTENSIVE CARE MED.;WHEELER ML, 2016, CELL HOST MICROBE, V19, P865, DOI 10.1016/J.CHOM.2016.05.003.;WILKIESON C, 1991, J ORAL PATHOL MED, V20, P13, DOI 10.1111/J.1600-0714.1991.TB00880.X.;WILLIAMS DAVID, 2011, J ORAL MICROBIOL, V3, DOI 10.3402/JOM.V3I0.5771.;WU GX, 2015, PLOS GENET, V11, DOI 10.1371/JOURNAL.PGEN.1005614.;XU J, 2007, P NATL ACAD SCI USA, V104, P18730, DOI 10.1073/PNAS.0706756104.;YILMAZ N, 2014, STUD MYCOL, P175, DOI 10.1016/J.SIMYCO.2014.08.001.;YOUNG G, 1951, J DENT RES, V30, P426, DOI 10.1177/00220345510300031901.;ZHANG N, 2013, APSNET FEATURE.","DIAZ, PI (REPRINT AUTHOR), UCONN HLTH, DIV PERIODONTOL, SCH DENT MED, 263 FARMINGTON AVE, FARMINGTON, CT 06030 USA.;DIAZ, PATRICIA I., HONG, BO-YOUNG, UCONN HLTH, DEPT ORAL HLTH \& DIAGNOST SCI, SCH DENT MED, DIV PERIODONTOL, FARMINGTON, CT 06030 USA.;DUPUY, AMANDA K., STRAUSBAUGH, LINDA D., UNIV CONNECTICUT, INST SYST GENOM, STORRS, CT USA.","10.1080/21505594.2016.1252015","530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",NA,NA,"NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH (NIDCR), NATIONAL INSTITUTES OF HEALTH (NIH) [R01 DE021578]","THIS WORK WAS SUPPORTED BY GRANT R01 DE021578 FROM THE NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH (NIDCR), NATIONAL INSTITUTES OF HEALTH (NIH).",NA,"2150-5594","3","313-323","TAYLOR \& FRANCIS INC","8",2017,"ISI000400164600010","88","IMMUNOLOGY, INFECTIOUS DISEASES, MICROBIOLOGY","9","IMMUNOLOGY, INFECTIOUS DISEASES, MICROBIOLOGY","PDIAZUCHC.EDU",NA,"ET3GB",NA,"DIAZ, PI (REPRINT AUTHOR), UCONN HLTH, DIV PERIODONTOL, SCH DENT MED, 263 FARMINGTON AVE, FARMINGTON, CT 06030 USA","ISI","SCH DENT MED;UNIV CONNECTICUT","SCH DENT MED",NA,"DIAZ PI, 2017, VIRULENCE","DIAZ PI, 2017, VIRULENCE"
"SCHMIDT K, 2017, J ANTIMICROB CHEMOTHER","SCHMIDT K;MWAIGWISYA S;CROSSMAN LC;DOUMITH M;MUNROE D;PIRES C;KHAN AM;WOODFORD N;SAUNDERS NJ;WAIN J;O GRADY J;LIVERMORE DM","IDENTIFICATION OF BACTERIAL PATHOGENS AND ANTIMICROBIAL RESISTANCE DIRECTLY FROM CLINICAL URINES BY NANOPORE-BASED METAGENOMIC SEQUENCING","JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY","J. ANTIMICROB. CHEMOTHER.","OBJECTIVES: THE INTRODUCTION OF METAGENOMIC SEQUENCING TO DIAGNOSTIC MICROBIOLOGY HAS BEEN HAMPERED BY SLOWNESS, COST AND COMPLEXITY. WE EXPLORED WHETHER MINION NANOPORE SEQUENCING COULD ACCELERATE DIAGNOSIS AND RESISTANCE PROFILING, USING COMPLICATED URINARY TRACT INFECTIONS AS AN EXEMPLAR. METHODS: BACTERIAL DNA WAS ENRICHED FROM CLINICAL URINES (N=10) AND FROM HEALTHY URINES `SPIKED' WITH MULTIRESISTANT ESCHERICHIA COLI (N=5), THEN SEQUENCED BY MINION. SEQUENCES WERE ANALYSED USING EXTERNAL DATABASES AND BIOINFORMATIC PIPELINES OR, ULTIMATELY, USING INTEGRATED REAL-TIME ANALYSIS APPLICATIONS. RESULTS WERE COMPARED WITH ILLUMINA DATA AND RESISTANCE PHENOTYPES. RESULTS: MINION CORRECTLY IDENTIFIED PATHOGENS WITHOUT CULTURE AND, AMONG 55 ACQUIRED RESISTANCE GENES DETECTED IN THE CULTIVATED BACTERIA BY ILLUMINA SEQUENCING, 51 WERE FOUND BY MINION SEQUENCING DIRECTLY FROM THE URINES, WITH THREE OF THE FOUR FAILURES IN AN EARLY RUN WITH LOW GENOME COVERAGE. RESISTANCE-CONFERRING MUTATIONS AND ALLELIC VARIANTS WERE NOT RELIABLY IDENTIFIED. CONCLUSIONS: MINION SEQUENCING COMPREHENSIVELY IDENTIFIED PATHOGENS AND ACQUIRED RESISTANCE GENES FROM URINE IN A TIMEFRAME SIMILAR TO PCR (4 H FROM SAMPLE TO RESULT). BIOINFORMATIC PIPELINE OPTIMIZATION IS NEEDED TO BETTER DETECT RESISTANCES CONFERRED BY POINT MUTATIONS. METAGENOMIC-SEQUENCING-BASED DIAGNOSIS WILL ENABLE CLINICIANS TO ADJUST ANTIMICROBIAL THERAPY BEFORE THE SECOND DOSE OF A TYPICAL (I. E. EVERY 8 H) ANTIBIOTIC.",NA,"STAPHYLOCOCCUS-AUREUS; REAL-TIME; GENOME; ALIGNMENT; ARTEMIS; SAMPLES","ENGLISH","ARTICLE","ARTICLE",43,"ASHTON PM, 2015, NAT BIOTECHNOL, V33, P296, DOI 10.1038/NBT.3103.;BRADLEY P, 2015, NAT COMMUN, V6, DOI 10.1038/NCOMMS10063.;BROWN C, NO THANKS IVE ALREAD.;CARE QUALITY COMMISSION, 2011, STAT HLTH CAR AD SOC.;CARVER TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/BIOINFORMATICS/BTI553.;CROSSMAN L, GITHUB REPOSITORY.;DIDELOT X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/NRG3226.;EUCAST, 2016, BREAKP TABL INT MICS.;FRITH MC, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/NAR/GKQ010.;FRITH MC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-80.;GORDON NC, 2014, J CLIN MICROBIOL, V52, P1182, DOI 10.1128/JCM.03117-13.;GRENINGER AL, 2015, GENOME MED, V7, DOI 10.1186/S13073-015-0220-9.;GRUMAZ S, 2016, GENOME MED, V8, DOI 10.1186/S13073-016-0326-8.;HASMAN H, 2014, J CLIN MICROBIOL, V52, P139, DOI 10.1128/JCM.02452-13.;IP CAMILLA L C, 2015, F1000RES, V4, P1075, DOI 10.12688/F1000RESEARCH.7201.1.;JOHN M., 2015, SEQUENCING ULTRALONG.;JUUL S, 2015, WHATS MY POT REAL TI.;KIELBASA SM, 2011, GENOME RES, V21, P487, DOI 10.1101/GR.113985.110.;KILIANSKI A, 2015, GIGASCIENCE, V4, DOI 10.1186/S13742-015-0051-Z.;KUMAR SUJAI, 2013, FRONTIERS IN GENETICS, V4, P237, DOI 10.3389/FGENE.2013.00237.;LANDER E S, 1988, GENOMICS, V2, P231, DOI 10.1016/0888-7543(88)90007-9.;LANGMEAD B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/NMETH.1923].;LI H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/BIOINFORMATICS/BTR509.;LI H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/BIOINFORMATICS/BTP352.;LIVERMORE DM, 2013, INFECT CHEMOTHER, V45, P1, DOI 10.3947/IC.2013.45.1.1.;LOMAN NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/BIOINFORMATICS/BTU555.;MCARTHUR AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13.;OXFORD NANOPORE TECHNOLOGIES, 2015, REAL TIM DET ANT RES.;OXFORD NANOPORE TECHNOLOGIES, NAN SEQ LIB PREP LOW.;PHE, 2015, VOL SURV ESCH COL BA, V9.;PHE, UK STAND MICR INV.;QUICK J, 2016, NATURE, V530, P228, DOI 10.1038/NATURE16996.;QUICK J, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-22.;RUTHERFORD K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/BIOINFORMATICS/16.10.944.;SCHAPPERT SM, 2008, NATL HLTH STAT REPOR.;SIMPSON JT, 2016, DETECTING DNA METHYL, DOI [10.1101/047142, DOI 10.1101/047142].;TURTON JF, 2015, J CLIN MICROBIOL, V53, P2622, DOI 10.1128/JCM.00505-15.;TYSON GH, 2015, J ANTIMICROB CHEMOTH, V70, P2763, DOI 10.1093/JAC/DKV186.;WANG Y, 2015, FRONT GENET, V5, DOI 10.3389/FGENE.2014.00449.;WILSON MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMOA1401268.","O'GRADY, J (REPRINT AUTHOR), UNIV EAST ANGLIA, NORWICH MED SCH, NORWICH, NORFOLK, ENGLAND.;SCHMIDT, K., MWAIGWISYA, S., WAIN, J., O'GRADY, J., LIVERMORE, D. M., UNIV EAST ANGLIA, NORWICH MED SCH, NORWICH, NORFOLK, ENGLAND.;CROSSMAN, L. C., NORWICH RES PK, SEQUENCEANAL CO UK, NORWICH, NORFOLK, ENGLAND.;DOUMITH, M., WOODFORD, N., LIVERMORE, D. M., PUBL HLTH ENGLAND, AMRHAI REFERENCE UNIT, NATL INFECT SERV, LONDON, ENGLAND.;MUNROE, D., NORFOLK \& NORWICH UNIV HOSP, DEPT MICROBIOL, NORWICH, NORFOLK, ENGLAND.;PIRES, C., KHAN, A. M., SAUNDERS, N. J., BRUNEL UNIV LONDON, UXBRIDGE, MIDDX, ENGLAND.","10.1093/JAC/DKW397","GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND",NA,NA,"UNIVERSITY OF EAST ANGLIA, ROSETREES TRUST [A749], NORWICH RESEARCH PARK TRANSLATIONAL FUND, MEDICAL RESEARCH COUNCIL [MR/N013956/1], ROSETREES TRUST [M468]","THIS WORK WAS SUPPORTED BY THE UNIVERSITY OF EAST ANGLIA (K. S., D. M. L.), THE ROSETREES TRUST (A749, J. O., S. M.) AND THE NORWICH RESEARCH PARK TRANSLATIONAL FUND (REF1.5, J. O., S. M.).",NA,"0305-7453","1","104-114","OXFORD UNIV PRESS","72",2017,"ISI000394038700015","40","INFECTIOUS DISEASES, MICROBIOLOGY, PHARMACOLOGY \& PHARMACY","58","INFECTIOUS DISEASES, MICROBIOLOGY, PHARMACOLOGY \& PHARMACY","JUSTIN.OGRADYUEA.AC.UK",NA,"EK6MM",NA,"O'GRADY, J (REPRINT AUTHOR), UNIV EAST ANGLIA, NORWICH MED SCH, NORWICH, NORFOLK, ENGLAND","ISI","UNIV EAST ANGLIA;NORWICH RES PK;NATL INFECT SERV;NORFOLK AND NORWICH UNIV HOSP;BRUNEL UNIV LONDON","UNIV EAST ANGLIA",NA,"SCHMIDT K, 2017, J ANTIMICROB CHEMOTHER","SCHMIDT K, 2017, J ANTIMICROB CHEMOTHER"
"EDLIND T, 2017, J FOOD PROT","EDLIND T;BREWSTER JD;PAOLI GC","ENRICHMENT, AMPLIFICATION, AND SEQUENCE-BASED TYPING OF SALMONELLA ENTERICA AND OTHER FOODBORNE PATHOGENS","JOURNAL OF FOOD PROTECTION","J. FOOD PROT.","DETECTION OF SALMONELLA ENTERICA IN FOODS TYPICALLY INVOLVES MICROBIOLOGICAL ENRICHMENT, MOLECULAR-BASED ASSAY, AND SUBSEQUENT ISOLATION AND IDENTIFICATION OF A PURE CULTURE. THIS IS IDEALLY FOLLOWED BY STRAIN TYPING, WHICH PROVIDES INFORMATION CRITICAL TO THE INVESTIGATION OF OUTBREAKS AND THE ATTRIBUTION OF THEIR SOURCES. PULSED-FIELD GEL ELECTROPHORESIS IS THE ``GOLD STANDARD'' FOR S. ENTERICA STRAIN TYPING, BUT ITS LIMITATIONS HAVE ENCOURAGED THE SEARCH FOR ALTERNATIVE METHODS, INCLUDING WHOLE GENOME SEQUENCING. BOTH METHODS TYPICALLY REQUIRE A PURE CULTURE, WHICH ADDS TO THE COST AND TURNAROUND TIME. A MORE RAPID AND COST-EFFECTIVE METHOD WITH SUFFICIENT DISCRIMINATORY POWER WOULD BENEFIT FOOD INDUSTRIES, REGULATORY AGENCIES, AND PUBLIC HEALTH LABORATORIES. TO ADDRESS THIS NEED, A NOVEL ENRICHMENT, AMPLIFICATION, AND SEQUENCE-BASED TYPING (EAST) APPROACH WAS DEVELOPED INVOLVING (I) OVERNIGHT ENRICHMENT AND TOTAL DNA PREPARATION, (II) AMPLIFICATION OF POLYMORPHIC TANDEM REPEATCONTAINING LOCI WITH ELECTROPHORETIC DETECTION, AND (III) DNA SEQUENCING AND BIOINFORMATIC ANALYSIS TO IDENTIFY RELATED STRAINS. EAST REQUIRES 3 DAYS OR LESS AND PROVIDES A STRAIN RESOLUTION THAT EXCEEDS SEROTYPING AND IS COMPARABLE TO PULSED-FIELD GEL ELECTROPHORESIS. EVALUATION WITH SPIKED GROUND TURKEY DEMONSTRATED ITS SENSITIVITY (WITH A STARTING INOCULUM OF <= 1 CFU/G) AND SPECIFICITY (WITH UNIQUE OR NEARLY UNIQUE ALLELES RELATIVE TO DATABASES OF.1,000 STRAINS). IN TESTS WITH UNSPIKED RETAIL CHICKEN PARTS, 3 OF 11 SAMPLES YIELDED S. ENTERICA-SPECIFIC PCR PRODUCTS. SEQUENCE ANALYSIS OF THREE DISTINCT TYPING TARGETS (SEMT1, SECRISPR1, AND SECRISPR2) REVEALED CONSISTENT SIMILARITIES TO SPECIFIC SEROTYPE SCHWARZENGRUND, MONTEVIDEO, AND TYPHIMURIUM STRAINS. EAST PROVIDES A TIME-SAVING AND COST-EFFECTIVE APPROACH FOR DETECTING AND TYPING FOODBORNE S. ENTERICA, AND POSTENRICHMENT STEPS CAN BE COMMERCIALLY OUTSOURCED TO FACILITATE ITS IMPLEMENTATION. INITIAL STUDIES WITH LISTERIA MONOCYTOGENES AND SHIGA TOXIGENIC ESCHERICHIA COLI SUGGEST THAT EAST CAN BE EXTENDED TO THESE FOODBORNE PATHOGENS.","ENRICHMENT; FOODBORNE OUTBREAK; FOODBORNE PATHOGEN; GENOTYPE; LISTERIA; SALMONELLA","ESCHERICHIA-COLI O157/H7; LISTERIA-MONOCYTOGENES; SEROTYPE ENTERITIDIS; TYPHIMURIUM DT104; STRAINS; ASSOCIATION; DIVERSITY","ENGLISH","ARTICLE","ARTICLE",0,"BOXRUD D, 2007, J CLIN MICROBIOL, V45, P536, DOI 10.1128/JCM.01595-06.;BYRNE L, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.31.20866.;DE CESARE A, 2015, J CLIN MICROBIOL, V53, P3021, DOI 10.1128/JCM.01122-15.;DELANNOY S, 2015, J CLIN MICROBIOL, V53, P486, DOI 10.1128/JCM.02290-14.;DENG XY, 2015, J CLIN MICROBIOL, V53, P212, DOI 10.1128/JCM.02332-14.;DONNELLY CW, 1986, APPL ENVIRON MICROB, V52, P689.;DOYLE MP, 1987, APPL ENVIRON MICROB, V53, P2394.;EDEL W, 1973, B WORLD HEALTH ORGAN, V48, P167.;EDLIND T., 2015, JOURNAL OF MICROBIAL AND BIOCHEMICAL TECHNOLOGY, V7, P351.;FABRE L, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0036995.;GEHRING AG, 2012, FOOD CONTROL, V26, P269, DOI 10.1016/J.FOODCONT.2012.01.047.;ISON SA, 2015, APPL ENVIRON MICROB, V81, P3671, DOI 10.1128/AEM.00397-15.;KIM HC, 2008, APPL ENVIRON MICROB, V74, P4853, DOI 10.1128/AEM.02756-07.;KOSER CU, 2012, PLOS PATHOG, V8, DOI 10.1371/JOURNAL.PPAT.1002824.;KRUY SL, 2011, EUR J CLIN MICROBIOL, V30, P465, DOI 10.1007/S10096-010-1110-0.;LI WJ, 2009, FEMS MICROBIOL REV, V33, P892, DOI 10.1111/J.1574-6976.2009.00182.X.;MACCANNELL D, 2013, CLIN LAB MED, V33, P629, DOI 10.1016/J.CLL.2013.03.005.;MARZEL A, 2014, J CLIN MICROBIOL, V52, P2078, DOI 10.1128/JCM.00399-14.;MATHER AE, 2013, SCIENCE, V341, P1514, DOI 10.1126/SCIENCE.1240578.;PAOLI G., UNPUB.;PAOLI GC, 2015, J FOOD PROTECT, V78, P888, DOI 10.4315/0362-028X.JFP-14-472.;SABAT AJ, 2013, EUROSURVEILLANCE, V18, P17.;SCHMID D, 2014, CLIN MICROBIOL INFEC, V20, P431, DOI 10.1111/1469-0691.12638.;SHARIAT N, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-254.;TIMME RE, 2013, GENOME BIOL EVOL, V5, P2109, DOI 10.1093/GBE/EVT159.;TORO M, 2014, APPL ENVIRON MICROB, V80, P1411, DOI 10.1128/AEM.03018-13.;U. S. DEPARTMENT OF AGRICULTURE FOOD SAFETY AND INSPECTION SERVICE., 2012, NAT MICR BAS DAT COL.;U. S. DEPARTMENT OF AGRICULTURE FOOD SAFETY AND INSPECTION SERVICE, 2015, MICR LAB GUID.;WATTIAU P, 2011, APPL ENVIRON MICROB, V77, P7877, DOI 10.1128/AEM.05527-11.;WHITE P., 2014, WHITE PAPER CURRENT.;WUYTS V, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0084055.;ZHOU K, 2014, FEMS MICROBIOL REV, V38, P119, DOI 10.1111/1574-6976.12036.;ZHOU ZM, 2013, PLOS GENET, V9, DOI 10.1371/JOURNAL.PGEN.1003471.;ZIMBRO MJ, 2009, DIFCO BBL MANUAL MAN.","PAOLI, GC (REPRINT AUTHOR), ARS, USDA, MOL CHARACTERIZAT FOODBORNE PATHOGENS RES UNIT, EASTERN REG RES CTR, 600 EAST MERMAID LANE, WYNDMOOR, PA 19038 USA.;EDLIND, TOM, MICROBITYPE LLC, 5110 CAMPUS DR, PLYMOUTH MEETING, PA 19462 USA.;BREWSTER, JEFFREY D., PAOLI, GEORGE C., ARS, USDA, MOL CHARACTERIZAT FOODBORNE PATHOGENS RES UNIT, EASTERN REG RES CTR, 600 EAST MERMAID LANE, WYNDMOOR, PA 19038 USA.","10.4315/0362-028X.JFP-16-014","6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA",NA,NA,NA,NA,NA,"0362-028X","1","15-24","INT ASSOC FOOD PROTECTION","80",2017,"ISI000392483900003","34","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, FOOD SCIENCE \& TECHNOLOGY","9","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, FOOD SCIENCE \& TECHNOLOGY","GEORGE.PAOLIARS.USDA.GOV",NA,"EI4SP",NA,"PAOLI, GC (REPRINT AUTHOR), ARS, USDA, MOL CHARACTERIZAT FOODBORNE PATHOGENS RES UNIT, EASTERN REG RES CTR, 600 EAST MERMAID LANE, WYNDMOOR, PA 19038 USA","ISI","EASTERN REG RES CTR","EASTERN REG RES CTR",NA,"EDLIND T, 2017, J FOOD PROT","EDLIND T, 2017, J FOOD PROT"
"ANTONELLI M, 2017, AM J SURG PATHOL","ANTONELLI M;RASO A;MASCELLI S;GESSI M;NOZZA P;COLI A;GARDIMAN MP;ARCELLA A;MASSIMINO M;BUTTARELLI FR;GIANGASPERO F","SMARCB1/INI1 INVOLVEMENT IN PEDIATRIC CHORDOMA A MUTATIONAL AND IMMUNOHISTOCHEMICAL ANALYSIS","AMERICAN JOURNAL OF SURGICAL PATHOLOGY","AM. J. SURG. PATHOL.","CHORDOMAS ARISE IN THE SKULL BASE AND SPINE AND USUALLY OCCUR IN ADULTS AND ARE RARE IN THE PEDIATRIC POPULATION. CASES OF CHORDOMA IN PEDIATRIC AGE ARE OFTEN POORLY DIFFERENTIATED, SHOWING CYTOLOGIC ATYPIA, INCREASED CELLULARITY, AND MITOSIS, AND THEIR AGGRESSIVE BEHAVIOR IS ASSOCIATED WITH A HIGH INCIDENCE OF METASTATIC SPREAD AND A SHORT PATIENT SURVIVAL. RECENT STUDIES HAVE DESCRIBED LOSS OF SMARCB1/INI1 PROTEIN IN POORLY DIFFERENTIATED CHORDOMAS ASSOCIATED NOT WITH POINT MUTATIONS BUT WITH SMARCB1/INI1 GENE DELETIONS INSTEAD. IN THIS STUDY, WE CONSIDERED IMMUNOHISTOCHEMISTRY AND SMARCB1/INI1 MUTATIONAL STATUS TO EXAMINE SMARCB1 STATUS IN A SERIES OF PEDIATRIC CHORDOMAS (7 CLASSIC AND 1 POORLY DIFFERENTIATED). WE PERFORMED IMMUNOHISTOCHEMICAL TESTS FOR INI1, BRACHYURY, S100, AND CYTOKERATINS AND CONDUCTED A GENETIC ANALYSIS ON THE SMARCB1 CODING SEQUENCE (NM\_003073) USING THE SANGER METHOD AND MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION TO DETECT ABNORMAL COPY NUMBERS OF THE GENE LOCUS. ALL 8 CASES WERE POSITIVE FOR BRACHYURY, WHEREAS THERE WAS NO NUCLEAR SMARCB1/INI1 EXPRESSION IN 4 OF THE 8 CASES, INCLUDING THE POORLY DIFFERENTIATED CHORDOMA. GENETIC ANALYSIS IDENTIFIED A MISSENSE MUTATION IN 2 CASES AND A NONSENSE MUTATION ASSOCIATED WITH LOSS OF SMARCB1/INI1 PROTEIN AND FEATURES OF POORLY DIFFERENTIATED TUMOR IN 1. THESE MUTATIONS WERE NOVEL VARIANTS OCCURRING IN HETEROZYGOSITY, AND THEY WERE JUDGED TO BE PATHOGENIC BY 3 DIFFERENT BIOINFORMATIC TOOLS. IN 7 OF 8 CASES WE PERFORMED MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION, AND 3 CASES SHOWED DELETIONS AT THE SMARCB1 LOCUS. OUR RESULTS CONFIRM THE PATHOGENIC INVOLVEMENT OF SMARCB1/INI1 IN CHILDHOOD CHORDOMA. WE ALSO DESCRIBE 3 NOVEL PATHOGENIC MUTATIONS.","CHORDOMA; ATYPICAL TERATOID/RHABDOID TUMOR; MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION (MLPA); INI1/SMARCB1 PROTEIN; BRACHYURY","ATYPICAL TERATOID/RHABDOID TUMORS; EPITHELIOID SARCOMA; INI1 EXPRESSION; RHABDOID TUMORS; GERM-LINE; SCHWANNOMATOSIS; PROGNOSIS; PROTEIN","ENGLISH","ARTICLE","ARTICLE",10,"ADZHUBEI IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/NMETH0410-248.;BIEGEL JA, 2002, CLIN CANCER RES, V8, P3461.;BIEGEL JA, 1999, CANCER RES, V59, P74.;CARTER JM, 2012, AM J SURG PATHOL, V36, P154, DOI 10.1097/PAS.0B013E3182380802.;CHAVEZ JA, 2014, CLIN NEUROPATHOL, V33, P418, DOI 10.5414/NP300724.;CHENG JX, 2008, MODERN PATHOL, V21, P647, DOI 10.1038/MODPATHOL.2008.44.;COFFA J, 2011, MODERN APPROACHES QU, DOI [10.5772/21898, DOI 10.5772/21898.].;FLANAGAN AM, 2013, WHO CLASSIFICATION T.;GUIDI CJ, 2004, J BIOL CHEM, V279, P4180, DOI 10.1074/JBC.M312043200.;HABERLER C, 2006, AM J SURG PATHOL, V30, P1462, DOI 10.1097/01.PAS.0000213329.71745.EF.;HASSELBLATT M, 2016, ACTA NEUROPATHOL, V132, P149, DOI 10.1007/S00401-016-1574-9.;HASSELBLATT M, 2009, J NEUROPATH EXP NEUR, V68, P1249, DOI 10.1097/NEN.0B013E3181C06A51.;HORNICK JL, 2009, AM J SURG PATHOL, V33, P542, DOI 10.1097/PAS.0B013E3181882C54.;HUANG SC, 2016, GENE CHROMOSOME CANC, V55, P767, DOI 10.1002/GCC.22376.;JUDKINS AR, 2004, AM J SURG PATHOL, V28, P644, DOI 10.1097/00000478-200405000-00013.;KUMAR P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/NPROT.2009.86.;LE LOARER F, 2014, GENE CHROMOSOME CANC, V53, P475, DOI 10.1002/GCC.22159.;LE LP, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0018846.;MOBLEY BC, 2010, ACTA NEUROPATHOL, V120, P745, DOI 10.1007/S00401-010-0767-X.;RENARD C, 2014, CANC GENET, V9, P384.;RIDENOUR RV, 2010, PEDIATR DEVEL PATHOL, V13, P9, DOI 10.2350/09-01-0584.1.;SCHEIL-BERTRAM S, 2014, INT J ONCOL, V44, P1041, DOI 10.3892/IJO.2014.2268.;SCHWARZ JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/NMETH0810-575.;SMITH MJ, 2012, HUM MOL GENET, V21, P5239, DOI 10.1093/HMG/DDS370.;YADAV R, 2014, NEURO-ONCOLOGY, V16, P372, DOI 10.1093/NEUONC/NOT228.","ANTONELLI, M (REPRINT AUTHOR), UNIV ROMA LA SAPIENZA, DEPT RADIOL ONCOL \& ANATOMOPATHOL SCI, VIALE REGINA ELENA 324, I-00161 ROME, ITALY.;ANTONELLI, MANILA, GIANGASPERO, FELICE, UNIV ROMA LA SAPIENZA, DEPT RADIOL ONCOL \& ANATOMOPATHOL SCI, VIALE REGINA ELENA 324, I-00161 ROME, ITALY.;BUTTARELLI, FRANCESCA R., UNIV ROMA LA SAPIENZA, DEPT NEUROL SCI, ROME, ITALY.;COLI, ANTONELLA, CATHOLIC UNIV, INST PATHOL, ROME, ITALY.;RASO, ALESSANDRO, MASCELLI, SAMANTHA, NOZZA, PAOLO, IST GIANNINA GASLINI, DIPARTIMENTO TESTA COLLO \& NEUROSCI, GENOA, ITALY.;GARDIMAN, MARINA P., UROL UNIV PADOVA, DEPT SURG ONCOL \& GASTROENTEROL SCI, PADUA, ITALY.;ARCELLA, ANTONIETTA, GIANGASPERO, FELICE, IRCCS NEUROMED, POZZILLI, IS, ITALY.;MASSIMINO, MAURA, FDN IRCCS IST NAZL TUMORI, PEDIAT UNIT, MILAN, ITALY.;GESSI, MARCO, UNIV BONN, MED CTR, INST NEUROPATHOL, BONN, GERMANY.","10.1097/PAS.0000000000000741","TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",NA,NA,"ASSOCIAZIONE ITALIANA PER LA LOTTA AL NEUROBLASTOMA","M.A. IS SUPPORTED BY A GRANT FROM THE ASSOCIAZIONE ITALIANA PER LA LOTTA AL NEUROBLASTOMA. A.R. AND S.M. ARE FELLOWS OF ASSOCIAZIONE ITALIANA PER LA RICERCA SUI TUMORI CEREBRALI DEL BAMBINO. FOR THE REMAINING AUTHORS NONE WERE DECLARED.",NA,"0147-5185","1","56-61","LIPPINCOTT WILLIAMS \& WILKINS","41",2017,"ISI000391427300006","25","PATHOLOGY, SURGERY","13","PATHOLOGY, SURGERY","MANILA.ANTONELLIUNIROMA1.IT",NA,"EH0BL",NA,"ANTONELLI, M (REPRINT AUTHOR), UNIV ROMA LA SAPIENZA, DEPT RADIOL ONCOL \& ANATOMOPATHOL SCI, VIALE REGINA ELENA 324, I-00161 ROME, ITALY","ISI","UNIV ROMA LA SAPIENZA;UNIV ROMA LA SAPIENZA;CATHOLIC UNIV;DIPARTIMENTO TESTA COLLO AND NEUROSCI;UROL UNIV PADOVA;FDN IRCCS IST NAZL TUMORI;UNIV BONN","UNIV ROMA LA SAPIENZA",NA,"ANTONELLI M, 2017, AM J SURG PATHOL","ANTONELLI M, 2017, AM J SURG PATHOL"
"MA K, 2017, COMP BIOCHEM PHYSIOL B-BIOCHEM MOL BIOL","MA K;LI X;HU H;ZHOU D;SUN Y;MA L;ZHU C;SHEN B","PYRETHROID-RESISTANCE IS MODULATED BY MIR-92A BY TARGETING CPCPR4 IN CULEX PIPIENS PALLENS","COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY \& MOLECULAR BIOLOGY","COMP. BIOCHEM. PHYSIOL. B-BIOCHEM. MOL. BIOL.","THE WIDE USE OF PYRETHROIDS HAS RESULTED IN THE EMERGENCE AND SPREAD OF RESISTANCE IN MOSQUITO POPULATIONS, WHICH REPRESENT A MAJOR OBSTACLE IN THE STRUGGLE AGAINST VECTOR-BORNE DISEASES. RESISTANCE TO PYRETHROIDS IS A COMPLEX GENETIC PHENOMENON ATTRIBUTED BY POLYGENETIC INHERITANCE. WE PREVIOUSLY HAVE SEQUENCED AND ANALYZED THE MIRNA PROFILES OF CULEX PIPIENS POLLENS. MIR-92A WAS FOUND TO BE OVEREXPRESSED IN A DELTAMETHRIN-RESISTANT (DR) STRAIN. THE ASSOCIATION OF MIR-92A WITH PYRETHROID-RESISTANCE WAS INVESTIGATED BY QUANTITATIVE REVERSE TRANSCRIPTION PCR (QRT-PCR). EXPRESSION LEVELS OF MIR-92A WERE 2.72-FOLD HIGHER IN THE DR STRAIN THAN IN THE DELTAMETHRIN-SUSCEPTIBLE (DS) STRAIN. BIOINFORMATIC ANALYSIS SUGGESTED THAT CPCPR4, A MOSQUITO CUTICLE GENE, IS THE TARGET OF MIR-92A. DUAL LUCIFERASE REPORTER ASSAYS FURTHER CONFIRMED THAT CPCPR4 IS MODULATED BY MIR-92A THROUGH BINDING TO A SPECIFIC TARGET SITE IN THE 3' UNTRANSLATED REGION (3' UTR). MICROINJECTION OF THE MIR-92A INHIBITOR UPREGULATED CPCPR4 EXPRESSION LEVELS, LEADING TO AN INCREASE IN THE SUSCEPTIBILITY OF THE DR STRAIN IN THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) BOTTLE BIOASSAY (A SURVEILLANCE TOOL FOR DETECTING RESISTANCE TO INSECTICIDES IN VECTOR POPULATIONS). TAKEN TOGETHER, OUR FINDINGS INDICATE THAT MIR-92A REGULATES PYRETHROID-RESISTANCE THROUGH ITS INTERACTION WITH CPCPR4. (C) 2016 ELSEVIER INC. ALL RIGHTS RESERVED.","CPCPR4; CULEX PIPIENS PALLENS; MIR-92A; PYRETHROID-RESISTANCE","INSECTICIDE RESISTANCE; MICRORNAS; BIOGENESIS; MALARIA; CUTICLE; IDENTIFICATION; DELTAMETHRIN; TRANSMISSION; MOSQUITOS; DISEASE","ENGLISH","ARTICLE","ARTICLE",2,"AHMAD M, 2006, PEST MANAG SCI, V62, P805, DOI 10.1002/PS.1225.;ALIZOUN N., 2013, PARASITE VECTOR, V6, P147.;ALLEN E, 2005, CELL, V121, P207, DOI 10.1016/J.CELL.2005.04.004.;ASGARI S, 2014, VIRUSES-BASEL, V6, P3514, DOI 10.3390/V6093514.;AWOLOLA TS, 2009, T ROY SOC TROP MED H, V103, P1139, DOI 10.1016/J.TRSTMH.2008.08.021.;BARTEL DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5.;BENELLI G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/S00436-015-4586-9.;DITTMER NT, 2012, J PROTEOME RES, V11, P269, DOI 10.1021/PR2009803.;DJURANOVIC S, 2012, SCIENCE, V336, P237, DOI 10.1126/SCIENCE.1215691.;DRAYTON RM, 2012, BIOCHEM SOC T, V40, P821, DOI 10.1042/BST20120055.;FANG FJ, 2015, PARASITOL RES, V114, P4421, DOI 10.1007/S00436-015-4683-9.;FUTAHASHI R, 2008, INSECT BIOCHEM MOLEC, V38, P1138, DOI 10.1016/J.IBMB.2008.05.007.;GENDRIN M, 2015, NAT COMMUN, V6, DOI 10.1038/NCOMMS6921.;HEGDE S, 2015, CURR OPIN VIROL, V15, P97, DOI 10.1016/J.COVIRO.2015.08.011.;HONG S, 2014, INSECT BIOCHEM MOLEC, V55, P39, DOI 10.1016/J.IBMB.2014.10.007.;LADEAU SL, 2015, FUNCT ECOL, V29, P889, DOI 10.1111/1365-2435.12487.;LEI ZT, 2015, PARASITOL RES, V114, P699, DOI 10.1007/S00436-014-4236-7.;LIU NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/ANNUREV-ENTO-010814-020828.;LIVAK KJ, 2001, METHODS, V25, P402, DOI 10.1006/METH.2001.1262.;LUCAS K, 2013, INSECT BIOCHEM MOLEC, V43, P24, DOI 10.1016/J.IBMB.2012.10.009.;MARIMUTHU G, 2012, PARASITOL RES, V111, P65, DOI 10.1007/S00436-011-2802-9.;MOTTAHEDIN A, 2013, ARCH VIROL, V158, P701, DOI 10.1007/S00705-012-1515-4.;NAUEN R, 2007, PEST MANAG SCI, V63, P628, DOI 10.1002/PS.1406.;NKYA TE, 2014, PARASITE VECTOR, V7, DOI 10.1186/S13071-014-0480-Z.;PAPANDREOU NC, 2010, J INSECT PHYSIOL, V56, P1420, DOI 10.1016/J.JINSPHYS.2010.04.002.;REID WR, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0047163.;SIEGWART M., 2015, FRONT PLANT SCI, V19, P381.;SILVA AX, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0036366.;VANNINI L., 2014, PARASITE VECTOR, V15, P24.;VINCENT JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/J.ASD.2004.05.006.;WHITE MT, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0095640.;WILLIAM G., 2015, GUIDELINE EVALUATING.;WOOD OR, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-67.;ZOU FF, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0140923.","SHEN, B (REPRINT AUTHOR), NANJING MED UNIV, DEPT PATHOGEN BIOL, NANJING 210029, JIANGSU, PEOPLES R CHINA.;MA, KAI, LI, XIXI, HU, HONGXIA, ZHOU, DAN, SUN, YAN, MA, LEI, ZHU, CHANGLIANG, SHEN, BO, NANJING MED UNIV, DEPT PATHOGEN BIOL, NANJING 210029, JIANGSU, PEOPLES R CHINA.","10.1016/J.CBPB.2016.09.002","360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",NA,NA,"NATIONAL INSTITUTES OF HEALTH OF US (NIH) [2R01AI075746], NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA [81171610, 81101279, 81301458], NATIONAL S \& T MAJOR PROGRAM [2012ZX10004-219, 2012ZX10004-220], NATURAL SCIENCE FOUNDATION OF JIANGSU PROVINCE, CHINA [81101279]","THIS WORK WAS SUPPORTED BY THE NATIONAL INSTITUTES OF HEALTH OF US (NIH) [GRANT NO. 2R01AI075746], THE NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA [GRANT NOS. 81171610, 81101279 AND 81301458], THE NATIONAL S \& T MAJOR PROGRAM [GRANT NOS. 2012ZX10004-219 AND 2012ZX10004-220], AND THE NATURAL SCIENCE FOUNDATION OF JIANGSU PROVINCE, CHINA [GRANT NO. 81101279].",NA,"1096-4959",NA,"20-24","ELSEVIER SCIENCE INC","203",2017,"ISI000390626800003","34","BIOCHEMISTRY \& MOLECULAR BIOLOGY, ZOOLOGY","15","BIOCHEMISTRY \& MOLECULAR BIOLOGY, ZOOLOGY","SHENBONJMU.EDU.CN",NA,"EF9BX",NA,"SHEN, B (REPRINT AUTHOR), NANJING MED UNIV, DEPT PATHOGEN BIOL, NANJING 210029, JIANGSU, PEOPLES R CHINA","ISI","NANJING MED UNIV","NANJING MED UNIV",NA,"MA K, 2017, COMP BIOCHEM PHYSIOL B-BIOCHEM MOL BIOL","MA K, 2017, COMP BIOCHEM PHYSIOL B-BIOCHEM MOL BIOL"
"BRAHM AJ, 2016, CAN J DIABETES","BRAHM AJ;WANG G;WANG J;MCINTYRE AD;CAO H;BAN MR;HEGELE RA","GENETIC CONFIRMATION RATE IN CLINICALLY SUSPECTED MATURITY-ONSET DIABETES OF THE YOUNG","CANADIAN JOURNAL OF DIABETES","CAN. J. DIABETES","OBJECTIVES: MATURITY-ONSET DIABETES OF THE YOUNG (MODY) IS THE MOST COMMON FORM OF MONOGENIC DIABETES, REPORTEDLY ACCOUNTING FOR 2\% TO 5\% OF ALL CASES OF DIABETES. IN SAMPLES FROM CANADIAN PATIENTS REFERRED FOR MOLECULAR GENETIC CONFIRMATION OF A CLINICALLY SUSPECTED MODY, WE DETERMINED THE PREVALENCE OF LIKELY DISEASE-CAUSING DNA VARIANTS IN KNOWN MODY GENES. METHODS: BETWEEN 1999 AND 2015, OUR CENTRE RECEIVED REQUESTS FROM COLLEAGUES FOR DNA SEQUENCING OF 96 SAMPLES FROM UNRELATED CANADIAN PATIENTS WITH CLINICALLY SUSPECTED MODY. PRIOR TO 2012, WE USED SANGER SEQUENCING, AND SINCE 2012 WE HAVE USED TARGETED NEXT-GENERATION SEQUENCING. RESULTS: OF 96 SAMPLES RECEIVED, 39 (40.6\%) HAD A LIKELY RARE CAUSAL VARIANT IN 1 OF 8 KNOWN MODY GENES. OF THESE, 20 (51.3\%) AND 19 (48.7\%) WERE DIAGNOSED BY SANGER AND TARGETED NEXT-GENERATION SEQUENCING, RESPECTIVELY. THE 39 MUTATION-POSITIVE SAMPLES HAD 1 OF 39 RARE VARIANTS, OF WHICH THE MAJORITY WERE IN GENES ENCODING EITHER GLUCOKINASE (GCK, OR MODY2) OR HEPATOCYTE NUCLEAR FACTOR 1-ALPHA (HNF1A, OR MODY3). FURTHERMORE, 12 (30.8\%) OF THE DETECTED RARE VARIANTS HAD BEEN UNREPORTED PREVIOUSLY BUT WERE LIKELY TO HAVE BEEN CLINICALLY SIGNIFICANT ACCORDING TO STANDARD BIOINFORMATIC METHODS. AN ADDITIONAL 6 SAMPLES HAD RARE VARIANTS IN MODY GENES THAT WERE OF UNCERTAIN CLINICAL SIGNIFICANCE. CONCLUSIONS: THE FINDINGS SUGGEST THAT CLINICAL SUSPICION FOR MODY HAS A DIAGNOSTIC YIELD OF SIMILAR TO 40\% AT THE MOLECULAR LEVEL. CONFIRMATORY GENETIC TESTING IN PATIENTS SUSPECTED TO HAVE MODY ALLOWS FOR DEFINITIVE DIAGNOSES WHICH, IN TURN, MAY GUIDE MANAGEMENT AND PROVIDE RATIONALES FOR SCREENING OTHER FAMILY MEMBERS PRESYMPTOMATICALLY. (C) 2016 CANADIAN DIABETES ASSOCIATION.","GENETICS; GENOTYPE-PHENOTYPE CORRELATION; MONOGENIC DIABETES; MUTATIONS; NEXT-GENERATION DNA SEQUENCING","MUTATIONS; DIAGNOSIS; YOUTH","ENGLISH","ARTICLE","ARTICLE",3,"ADZHUBEI IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/NMETH0410-248.;AMERICAN, 2012, DIABETES CARE S1, V35, PS64, DOI DOI 10.2337/DC12-S064.;GIUFFRIDA FMA, 2005, DIABETES OBES METAB, V7, P318, DOI 10.1111/J.1463-1326.2004.00399.X.;HATTERSLEY AT, 1998, DIABETIC MED, V15, P15, DOI 10.1002/(SICI)1096-9136(199801)15:1<15::AID-DIA562>3.0.CO,2-M.;JOHANSEN CT, 2014, J LIPID RES, V55, P765, DOI 10.1194/JLR.D045963.;MCDONALD TJ, 2013, ANN CLIN BIOCHEM, V50, P403, DOI 10.1177/0004563213483458.;NAYLOR R, 2011, CLIN ENDOCRINOL, V75, P422, DOI 10.1111/J.1365-2265.2011.04049.X.;NAYLOR RN, 2014, DIABETES CARE, V37, P202, DOI 10.2337/DC13-0410.;OWEN K, 2001, BEST PRACT RES CL EN, V15, P309, DOI 10.1053/BEEM.2001.0148.;PIHOKER C, 2013, J CLIN ENDOCR METAB, V98, P4055, DOI 10.1210/JC.2013-1279.;SHIELDS BM, 2012, DIABETOLOGIA, V55, P1265, DOI 10.1007/S00125-011-2418-8.;STRIDE A, 2002, ANN MED, V34, P207, DOI 10.1080/713782136.;VAXILLAIRE M, 2008, ENDOCR REV, V29, P254, DOI 10.1210/ER.2007-0024.;WINTER WE, 2000, CURR OPIN PEDIATR, V12, P388, DOI 10.1097/00008480-200008000-00019.","HEGELE, RA (REPRINT AUTHOR), ROBARTS RES INST, 4288A 1151 RICHMOND ST NORTH, LONDON, ON N6A 5B7, CANADA.;UNIV WESTERN ONTARIO, SCHULICH SCH MED \& DENT, DEPT MED, LONDON, ON, CANADA.;UNIV WESTERN ONTARIO, SCHULICH SCH MED \& DENT, ROBARTS RES INST, LONDON, ON, CANADA.","10.1016/J.JCJD.2016.05.010","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"JACOB J. WOLFE DISTINGUISHED MEDICAL RESEARCH CHAIR, EDITH SCHULICH VINET RESEARCH CHAIR IN HUMAN GENETICS, MARTHA G. BLACKBURN CHAIR IN CARDIOVASCULAR RESEARCH AND OPERATING GRANTS FROM THE CANADIAN INSTITUTES OF HEALTH RESEARCH (FOUNDATION GRANT), HEART AND STROKE FOUNDATION OF ONTARIO [T-000353], GENOME CANADA THROUGH GENOME QUEBEC [4530]","RAH IS SUPPORTED BY THE JACOB J. WOLFE DISTINGUISHED MEDICAL RESEARCH CHAIR, THE EDITH SCHULICH VINET RESEARCH CHAIR IN HUMAN GENETICS, THE MARTHA G. BLACKBURN CHAIR IN CARDIOVASCULAR RESEARCH AND OPERATING GRANTS FROM THE CANADIAN INSTITUTES OF HEALTH RESEARCH (FOUNDATION GRANT), THE HEART AND STROKE FOUNDATION OF ONTARIO (T-000353) AND GENOME CANADA THROUGH GENOME QUEBEC (AWARD 4530).",NA,"1499-2671","6","555-560","ELSEVIER SCIENCE BV","40",2016,"ISI000388744900016","14","ENDOCRINOLOGY \& METABOLISM","9","ENDOCRINOLOGY \& METABOLISM","HEGELEROBARTS.CA",NA,"ED3JH",NA,"HEGELE, RA (REPRINT AUTHOR), ROBARTS RES INST, 4288A 1151 RICHMOND ST NORTH, LONDON, ON N6A 5B7, CANADA","ISI","UNIV WESTERN ONTARIO;UNIV WESTERN ONTARIO","ROBARTS RES INST",NA,"BRAHM AJ, 2016, CAN J DIABETES","BRAHM AJ, 2016, CAN J DIABETES"
"IRUM B, 2016, PLOS ONE","IRUM B;KHAN SY;ALI M;KAUL H;KABIR F;RAUF B;FATIMA F;NADEEM R;KHAN AO;AL OBAISI S;NAEEM MA;NASIR IA;KHAN SN;HUSNAIN T;RIAZUDDIN S;AKRAM J;EGHRARI AO;RIAZUDDIN SA","MUTATION IN LIM2 IS RESPONSIBLE FOR AUTOSOMAL RECESSIVE CONGENITAL CATARACTS","PLOS ONE","PLOS ONE","PURPOSE TO IDENTIFY THE MOLECULAR BASIS OF NON-SYNDROMIC AUTOSOMAL RECESSIVE CONGENITAL CATARACTS (ARCC) IN A CONSANGUINEOUS FAMILY. METHODS ALL FAMILY MEMBERS PARTICIPATING IN THE STUDY RECEIVED A COMPREHENSIVE OPHTHALMIC EXAMINATION TO DETERMINE THEIR OCULAR PHENOTYPE AND CONTRIBUTED A BLOOD SAMPLE, FROM WHICH GENOMIC DNA WAS EXTRACTED. AVAILABLE MEDICAL RECORDS AND INTERVIEWS WITH THE FAMILY WERE USED TO COMPILE THE MEDICAL HISTORY OF THE FAMILY. THE SYMPTOMATIC HISTORY OF THE INDIVIDUALS EXHIBITING CATARACTS WAS CONFIRMED BY SLIT-LAMP BIOMICROSCOPY. A GENOME-WIDE LINKAGE ANALYSIS WAS PERFORMED TO LOCALIZE THE DISEASE INTERVAL. THE CANDIDATE GENE, LIM2 (LENS INTRINSIC MEMBRANE PROTEIN 2), WAS SEQUENCED BI-DIRECTIONALLY TO IDENTIFY THE DISEASE-CAUSING MUTATION. THE PHYSICAL CHANGES CAUSED BY THE MUTATION WERE ANALYZED IN SILICO THROUGH HOMOLOGY MODELING, MUTATION AND BIOINFORMATIC ALGORITHMS, AND EVOLUTIONARY CONSERVATION DATABASES. THE PHYSIOLOGICAL IMPORTANCE OF LIM2 TO OCULAR DEVELOPMENT WAS ASSESSED IN VIVO BY REAL-TIME EXPRESSION ANALYSIS OF LIM2 IN A MOUSE MODEL. RESULTS OPHTHALMIC EXAMINATION CONFIRMED THE DIAGNOSIS OF NUCLEAR CATARACTS IN THE AFFECTED MEMBERS OF THE FAMILY, THE INHERITANCE PATTERN AND CATARACT DEVELOPMENT IN EARLY INFANCY INDICATED ARCC. GENOME-WIDE LINKAGE ANALYSIS LOCALIZED THE CRITICAL INTERVAL TO CHROMOSOME 19Q WITH A TWO-POINT LOGARITHM OF ODDS (LOD) SCORE OF 3.25. BIDIRECTIONAL SEQUENCING IDENTIFIED A NOVEL MISSENSE MUTATION, C.233G> A (P.G78D) IN LIM2. THIS MUTATION SEGREGATED WITH THE DISEASE PHENOTYPE AND WAS ABSENT IN 192 ETHNICALLY MATCHED CONTROL CHROMOSOMES. IN SILICO ANALYSIS PREDICTED LOWER HYDROPATHICITY AND HYDROPHOBICITY BUT HIGHER POLARITY OF THE MUTANT LIM2-ENCODED PROTEIN (MP19) COMPARED TO THE WILD-TYPE. MOREOVER, THESE ANALYSES PREDICTED THAT THE MUTATION WOULD DISRUPT THE SECONDARY STRUCTURE OF A TRANSMEMBRANE DOMAIN OF MP19. THE EXPRESSION OF LIM2, WHICH WAS DETECTED IN THE MOUSE LENS AS EARLY AS EMBRYONIC DAY 15 (E15) INCREASED AFTER BIRTH TO A LEVEL THAT WAS SUSTAINED THROUGH THE POSTNATAL TIME POINTS. CONCLUSION A NOVEL MISSENSE MUTATION IN LIM2 IS RESPONSIBLE FOR AUTOSOMAL RECESSIVE CONGENITAL CATARACTS.",NA,"INTRINSIC MEMBRANE-PROTEIN; CONSANGUINEOUS PAKISTANI FAMILIES; NONSENSE MUTATION; MISSENSE MUTATION; BOVINE LENS; LOCUS; GENE; MP19; IDENTIFICATION; LOCALIZATION","ENGLISH","ARTICLE","ARTICLE",7,"ABU SAFIEH L, 2009, MOL VIS, V15, P980.;ALDAHMESH MA, 2012, HUM MUTAT, V33, P960, DOI 10.1002/HUMU.22071.;ARNESON ML, 1998, EXP EYE RES, V66, P495, DOI 10.1006/EXER.1998.0477.;BUTT T, 2007, MOL VIS, V13, P1635.;CHEN JJ, 2011, AM J HUM GENET, V88, P827, DOI 10.1016/J.AJHG.2011.05.008.;CHEN T, 2002, MOL VIS, V8, P372.;COHEN D, 2007, INVEST OPHTH VIS SCI, V48, P2208, DOI 10.1167/IOVS.06-1019.;GUTEKUNST KA, 1990, CURR EYE RES, V9, P955, DOI 10.3109/02713689009069931.;HEON E, 2001, AM J HUM GENET, V68, P772, DOI 10.1086/318798.;JIAO XD, 2016, PLOS ONE, V11, DOI 10.1371/JOURNAL.PONE.0157005.;JIAOX X, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0137973.;KAUL H, 2010, MOL VIS, V16, P511.;KAUL H, 2010, MOL VIS, V16, P240.;KHAN SY, 2015, INVEST OPHTH VIS SCI, V56, P4919, DOI 10.1167/IOVS.14-16253.;LACHKE SA, 2011, SCIENCE, V331, P1571, DOI 10.1126/SCIENCE.1195970.;LATHROP GM, 1984, AM J HUM GENET, V36, P460.;LOUIS CF, 1989, J BIOL CHEM, V264, P19967.;MAHER GJ, 2012, EXP EYE RES, V103, P115, DOI 10.1016/J.EXER.2011.08.006.;MERIN S, 1971, CAN J OPHTHALMOLOGY, V6, P178.;MULDERS JWM, 1988, CURR EYE RES, V7, P207, DOI 10.3109/02713688808995750.;PONNAM SPG, 2008, MOL VIS, V14, P1204.;PONNAM SPG, 2007, J MED GENET, V44, DOI 10.1136/JMG.2007.050138.;PRAS E, 2000, INVEST OPHTH VIS SCI, V41, P3511.;PRAS E, 2004, INVEST OPHTH VIS SCI, V45, P1940, DOI 10.1167/IOVS.03-1117.;PRAS E, 2002, AM J HUM GENET, V70, P1363, DOI 10.1086/340318.;PRAS E, 2001, ISR MED ASSOC J, V3, P559.;RAMACHANDRAN RD, 2007, HUM GENET, V121, P475, DOI 10.1007/S00439-006-0319-6.;RIAZUDDIN SA, 2005, INVEST OPHTH VIS SCI, V46, P2100, DOI 10.1167/IOVS.04-1481.;RIAZUDDIN SA, 2005, INVEST OPHTH VIS SCI, V46, P623, DOI 10.1167/IOVS.04-0955.;ROBINSON GC, 1987, AM J DIS CHILD, V141, P1321, DOI 10.1001/ARCHPEDI.1987.04460120087041.;SABIR N, 2010, MOL VIS, V16, P2911.;SABIR N, 2010, MOL VIS, V16, P2634.;SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222.;SHI YR, 2011, INVEST OPHTH VIS SCI, V52, P7332, DOI 10.1167/IOVS.11-7724.;SHIELS A, 2007, ARCH OPHTHALMOL-CHIC, V125, P165, DOI 10.1001/ARCHOPHT.125.2.165.;SMAOUI N, 2004, INVEST OPHTH VIS SCI, V45, P2716, DOI 10.1167/IOVS.031370.;STEELE E C JR, 1997, MOL VIS, V3, P5.;TENBROEK E, 1992, J CELL SCI, V103, P245.;YASMEEN A, 2010, MOL VIS, V16, P682.;ZHAO L, 2015, NATURE, V523, P607, DOI 10.1038/NATURE14650.;ZHOU L, 2001, MOL VIS, V7, P79.","RIAZUDDIN, SA (REPRINT AUTHOR), JOHNS HOPKINS UNIV, SCH MED, WILMER EYE INST, BALTIMORE, MD 21287 USA.;RIAZUDDIN, SA (REPRINT AUTHOR), JOHNS HOPKINS UNIV, SCH MED, MCKUSICK NATHANS INST GENET MED, BALTIMORE, MD 21205 USA.;IRUM, BUSHRA, KHAN, SHAHID Y., ALI, MUHAMMAD, KAUL, HAIBA, KABIR, FIROZ, RAUF, BUSHRA, EGHRARI, ALLEN O., RIAZUDDIN, S. AMER, JOHNS HOPKINS UNIV, SCH MED, WILMER EYE INST, BALTIMORE, MD 21287 USA.;IRUM, BUSHRA, RAUF, BUSHRA, FATIMA, FAREEHA, NADEEM, RAHEELA, NAEEM, MUHAMMAD ASIF, NASIR, IDREES A., KHAN, SHAHEEN N., HUSNAIN, TAYYAB, RIAZUDDIN, SHEIKH, UNIV PUNJAB, NATL CTR EXCELLENCE MOL BIOL, LAHORE 53700, PAKISTAN.;KHAN, ARIF O., AL OBAISI, SAIF, KING KHALID EYE SPECIALIST HOSP, RIYADH 12329, SAUDI ARABIA.;RIAZUDDIN, SHEIKH, AKRAM, JAVED, UNIV HLTH SCI, ALLAMA IQBAL MED COLL, LAHORE 54550, PAKISTAN.;RIAZUDDIN, SHEIKH, AKRAM, JAVED, SHAHEED ZULFIQAR ALI BHUTTO MED UNIV, NATL CTR GENET DIS, ISLAMABAD 44000, PAKISTAN.;RIAZUDDIN, S. AMER, JOHNS HOPKINS UNIV, SCH MED, MCKUSICK NATHANS INST GENET MED, BALTIMORE, MD 21205 USA.","10.1371/JOURNAL.PONE.0162620","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E0162620",NA,"NATIONAL EYE INSTITUTE [R01EY022714], KNIGHTS TEMPLAR EYE FOUNDATION GRANT, KING KHALED EYE SPECIALIST HOSPITAL-JOHNS HOPKINS UNIVERSITY COLLABORATION GRANT, NATIONAL ACADEMY OF SCIENCES, WASHINGTON DC USA, HIGHER EDUCATION COMMISSION, ISLAMABAD PAKISTAN","THIS STUDY WAS SUPPORTED IN PART BY THE NATIONAL EYE INSTITUTE, GRANT R01EY022714 (SAR), THE KNIGHTS TEMPLAR EYE FOUNDATION GRANT (SAR), KING KHALED EYE SPECIALIST HOSPITAL-JOHNS HOPKINS UNIVERSITY COLLABORATION GRANT (SAR), THE NATIONAL ACADEMY OF SCIENCES, WASHINGTON DC USA, AND THE HIGHER EDUCATION COMMISSION, ISLAMABAD PAKISTAN.",NA,"1932-6203","11",NA,"PUBLIC LIBRARY SCIENCE","11",2016,"ISI000386911100002","41","SCIENCE \& TECHNOLOGY - OTHER TOPICS","2","MULTIDISCIPLINARY SCIENCES","RIAZUDDINJHMI.EDU",NA,"EA8TH",NA,"RIAZUDDIN, SA (REPRINT AUTHOR), JOHNS HOPKINS UNIV, SCH MED, WILMER EYE INST, BALTIMORE, MD 21287 USA","ISI","JOHNS HOPKINS UNIV;UNIV PUNJAB;KING KHALID EYE SPECIALIST HOSP;UNIV HLTH SCI;SHAHEED ZULFIQAR ALI BHUTTO MED UNIV;JOHNS HOPKINS UNIV","JOHNS HOPKINS UNIV",NA,"IRUM B, 2016, PLOS ONE","IRUM B, 2016, PLOS ONE"
"IWANIAK A, 2016, FOOD RES INT","IWANIAK A;MINKIEWICZ P;DAREWICZ M;HRYNKIEWICZ M","FOOD PROTEIN-ORIGINATING PEPTIDES AS TASTANTS - PHYSIOLOGICAL, TECHNOLOGICAL, SENSORY, AND BIOINFORMATIC APPROACHES","FOOD RESEARCH INTERNATIONAL","FOOD RES. INT.","TASTE IS ONE OF THE FACTORS BASED ON WHICH THE ORGANISM MAKES THE SELECTION OF WHAT TO INGEST. IT ALSO PROTECTS HUMANS FROM INGESTING TOXIC COMPOUNDS AND IS ONE OF THE MAIN ATTRIBUTES WHEN THINKING ABOUT FOOD QUALITY. FIVE BASIC TASTE SENSATIONS ARE RECOGNIZED BY HUMANS: BITTER, SALTY, SOUR, SWEET, AND UMAMI. THE TASTE OF FOODS IS AFFECTED BY SOME MOLECULES OF SOME SPECIFIC CHEMICAL NATURE. ONE OF THEM ARE PEPTIDES DERIVED FROM FOOD PROTEINS. ALTHOUGH THEY ARE NOT THE MAJOR NATURAL COMPOUNDS ORIGINATING FROM FOOD SOURCES THAT ARE RESPONSIBLE FOR THE TASTE, THEY ARE IN THE AREA OF SCIENTIFIC RESEARCH DUE TO THE SPECIFIC COMPOSITION OF AMINO ACIDS WHICH ARE WELL-KNOWN FOR THEIR SENSORY PROPERTIES. LITERATURE DATA IMPLICATE THAT SWEET, BITTER, AND UMAMI ARE THE TASTES ATTRIBUTABLE TO PEPTIDES. MOREOVER, THE BITTER PEPTIDE TASTANTS ARE THE DOMINANT AMONG THE OTHER TASTES. ADDITIONALLY, OTHER BIOLOGICAL ACTIVITIES LIKE, E.G., INHIBITING ENZYMES THAT REGULATE THE BODY FUNCTIONS AND ACTING AS PREVENTIVE FOOD AGENTS OF CIVILIZATION DISEASES, ARE ALSO ASSOCIATED WITH THE TASTE OF PEPTIDES. THE ADVANCE IN INFORMATION TECHNOLOGIES HAS CONTRIBUTED TO THE ELABORATION OF INTERNET ARCHIVES (DATABASES) AS WELL AS IN SILICO TOOLS FOR THE ANALYSIS OF BIOLOGICAL COMPOUNDS. IT ALSO CONCERNS PEPTIDES - NAMELY TASTE CARRIERS ORIGINATING FROM FOODS. THUS, OUR PAPER PROVIDES A SUMMARY OF KNOWLEDGE ABOUT PEPTIDES AS TASTANTS WITH SPECIAL ATTENTION PAID TO THE FOLLOWING ASPECTS: A) BASIS OF TASTE PERCEPTION, B) TASTE PEPTIDES DETECTED IN FOOD PROTEIN SEQUENCES WITH SPECIAL EMPHASIS PUT ON THE ROLE OF BITTER PEPTIDES, C) PEPTIDES THAT MAY ENHANCE/SUPPRESS THE TASTE OF FOODS, D) DATABASES AS WELL AS BIOINFORMATIC APPROACHES SUITABLE TO STUDY THE TASTE OF PEPTIDES, E) TASTE-TASTE INTERACTIONS, F) BASIS OF SENSORY ANALYSIS IN THE EVALUATION OF THE TASTE OF MOLECULES, INCLUDING PEPTIDES, AND G) THE METHODOLOGY APPLIED TO REDUCE/ELIMINATE THE UNDESIRED TASTE OF PEPTIDES. THE LIST OF TASTE PEPTIDES SERVING SOME BIOLOGICAL FUNCTIONS IS PRESENTED IN THE SUPPLEMENT FILE. THE INFORMATION PROVIDED INCLUDES DATABASE RESOURCES, WHEREAS PEPTIDE SEQUENCES ARE GIVEN WITH INCHIKEYS, WHICH IS AIMED AT FACILITATING THE GOOGLE (R) SEARCH. OUR COLLECTION OF DATA REGARDING TASTE PEPTIDES MAY BE SUPPORTIVE FOR THE SCIENTISTS WORKING WITH THE SET OF PEPTIDE DATA IN THE CONTEXT OF STRUCTURE-FUNCTION ACTIVITY OF PEPTIDES. (C) 2016 ELSEVIER LTD. ALL RIGHTS RESERVED.","TASTE; SENSORY PEPTIDES; FOOD PROTEINS; BIOINFORMATICS; DATABASES","BITTER TASTE RECEPTOR; BIOLOGICALLY-ACTIVE PEPTIDES; ENZYME-INHIBITORY-ACTIVITY; LOW-CALORIE SWEETENERS; AMINO-ACIDS; BIOACTIVE PEPTIDES; BIOPEP DATABASE; ANTIHYPERTENSIVE PEPTIDES; TRYPTIC HYDROLYSATE; BETA-LACTOGLOBULIN","ENGLISH","REVIEW","ARTICLE",11,"AHMED J, 2011, NUCLEIC ACIDS RES, V39, PD377, DOI 10.1093/NAR/GKQ917.;ALUKO R.E., 2012, J FOOD SCI, V77, PR11.;ARAI S, 1972, AGR BIOL CHEM TOKYO, V36, P1253, DOI 10.1080/00021369.1972.10860400.;AUBESDUFAU I, 1995, FEBS LETT, V364, P115, DOI 10.1016/0014-5793(95)00361-C.;BARTOSHUK LM, 2013, CURR BIOL, V23, PR374, DOI 10.1016/J.CUB.2013.03.038.;BEAUCHAMP H. K., 2009, J PEDIAT GASTROENTER, V48, PD25.;BENTO AP, 2014, NUCLEIC ACIDS RES, V42, PD1083, DOI 10.1093/NAR/GKT1031.;BORN S, 2013, J NEUROSCI, V33, P201, DOI 10.1523/JNEUROSCI.3248-12.2013.;BRESLIN PAS, 2013, CURR BIOL, V23, PR409, DOI 10.1016/J.CUB.2013.04.010.;BUMBERGER E, 1993, Z LEBENSM UNTERS FOR, V197, P14, DOI 10.1007/BF01202693.;CHANDRASHEKAR J, 2006, NATURE, V444, P288, DOI 10.1038/NATURE05401.;CHANG A, 2015, NUCLEIC ACIDS RES, V43, PD439, DOI 10.1093/NAR/GKU1068.;CHATTOPADHYAY S, 2014, J FOOD SCI TECH MYS, V51, P611, DOI 10.1007/S13197-011-0571-1.;CHEUNG IWY, 2010, FOOD CHEM, V122, P1003, DOI 10.1016/J.FOODCHEM.2010.03.057.;CHEUNG LKY, 2015, J FUNCT FOODS, V13, P262, DOI 10.1016/J.JFF.2014.12.036.;CIOSEK P, 2011, SENSORS-BASEL, V11, P4688, DOI 10.3390/S110504688.;CYGANKIEWICZ AI, 2014, CRIT REV FOOD SCI, V54, P771, DOI 10.1080/10408398.2011.606929.;DANG YL, 2015, LWT-FOOD SCI TECHNOL, V60, P1179, DOI 10.1016/J.LWT.2014.09.014.;DANG YL, 2014, CELL BIOCHEM BIOPHYS, V70, P1841, DOI 10.1007/S12013-014-0141-Z.;DOTY R. L., 1992, DIS NERV SYST, P390.;DUCHROW T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-317.;FISHER C., 1997, FOOD FLAVOURS BIOL C, P56.;FUJIMAKI M, 1970, AGR BIOL CHEM TOKYO, V34, P483, DOI 10.1080/00021369.1970.10859638.;GUPTA S, 2015, METHODS MOL BIOL, V1268, P143, DOI 10.1007/978-1-4939-2285-7\_7.;HERNANDEZ-LEDESMA B, 2007, J DAIRY RES, V74, P336, DOI 10.1017/S0022029907002609.;IWANIAK A, 2016, FOOD RES INT, V85, P155, DOI 10.1016/J.FOODRES.2016.04.031.;IWANIAK A, 2015, J FUNCT FOODS, V16, P334, DOI 10.1016/J.JFF.2015.04.038.;IWANIAK A, 2014, COMPR REV FOOD SCI F, V13, P114, DOI 10.1111/1541-4337.12051.;JACKSON J. F., 2002, VVOLUME 21, P1.;KANAUJIA S., 2004, SRELS J INFORM MANAG, V41.;KANT R, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-5.;KANU P. J., 2009, ASIAN J BIOTECHNOL, V1, P79.;KAWAI M, 2002, CHEM SENSES, V27, P739, DOI 10.1093/CHEMSE/27.8.739.;KEAST R. S. J., 2002, FOOD QUAL PREFER, V14, P111, DOI DOI 10.1016/S0950-3293(02)00110-6.;KESKA P, 2016, FOOD FUNCT, V7, P2878, DOI [10.1039/C5FO01631B, 10.1039/C5FO01631B].;KILARA A, 2003, CRIT REV FOOD SCI, V43, P607, DOI 10.1080/10408690390251138.;KIM HO, 2006, APPL SPECTROSC, V60, P1297, DOI 10.1366/000370206778998978.;KIM MJ, 2015, BIOCHEM BIOPH RES CO, V456, P586, DOI 10.1016/J.BBRC.2014.11.114.;KIM MR, 2003, J FOOD SCI, V68, P2416, DOI 10.1111/J.1365-2621.2003.TB07039.X.;KIM S, 2016, NUCLEIC ACIDS RES, V44, PD1202, DOI 10.1093/NAR/GKV951.;KROGER M, 2006, COMPR REV FOOD SCI F, V5, P35, DOI 10.1111/J.1541-4337.2006.TB00081.X.;KUMAR R, 2015, NUCLEIC ACIDS RES, V43, PD956, DOI 10.1093/NAR/GKU1141.;LAFARGA T., 2016, FOOD REV INT.;LEMIEUX L, 1992, LAIT, V72, P335.;LI I., 2002, PNAS, V99, P4693.;LI-CHAN ECY, 2015, CURR OPIN FOOD SCI, V1, P28, DOI 10.1016/J.COFS.2014.09.005.;LIM JY, 2011, FOOD QUAL PREFER, V22, P733, DOI 10.1016/J.FOODQUAL.2011.05.008.;LIU TQ, 2007, NUCLEIC ACIDS RES, V35, PD198, DOI 10.1093/NAR/GKL999.;LIU XW, 2014, J AGR FOOD CHEM, V62, P5719, DOI 10.1021/JF4019728.;LOW YQ, 2014, NUTRIENTS, V6, P3431, DOI 10.3390/NU6093431.;LU Y, 2016, J DAIRY SCI, V99, P41, DOI 10.3168/JDS.2015-9569.;LYNDQVIST M., 2010, SWEDISH U AGR SCI PU.;MACDONALD SA, 1980, J MED CHEM, V23, P413, DOI 10.1021/JM00178A012.;MAEHASHI K, 2009, CELL MOL LIFE SCI, V66, P1661, DOI 10.1007/S00018-009-8755-9.;MAEHASHI K., 2002, VVOLUME 21, P47.;MATOBA T, 1972, AGR BIOL CHEM TOKYO, V36, P1423, DOI 10.1080/00021369.1972.10860410.;MATOBA T, 1970, AGR BIOL CHEM TOKYO, V34, P1235, DOI 10.1080/00021369.1970.10859753.;MATSUO R, 2000, CRIT REV ORAL BIOL M, V11, P216, DOI 10.1177/10454411000110020501.;MINKIEWICZ P, 2011, FOOD SCI TECHNOL INT, V17, P39, DOI 10.1177/1082013210368461.;MINKIEWICZ P, 2008, J AOAC INT, V91, P965.;MINKIEWICZ P, 2015, J CHEM EDUC, V92, P874, DOI 10.1021/ED5006739.;MIYAKI T., 2015, FLAVOUR, V4, P99.;MIYAMURA N., 2015, FLAVOUR, V4, P95.;MOHAN A, 2015, RSC ADV, V5, P79270, DOI 10.1039/C5RA13419F.;MORTENSEN A., 2006, SCANDINAVIAN JOURNAL OF FOOD \& NUTRITION, V50, P104, DOI 10.1080/17482970600982719.;NELSON GM, 1998, ANAT REC, V253, P70, DOI 10.1002/(SICI)1097-0185(199806)253:3<70::AID-AR3>3.0.CO,2-I.;NONGONIERMA AB, 2016, TRENDS FOOD SCI TECH, V50, P26, DOI 10.1016/J.TIFS.2016.01.022.;OJEDA M. J., 2014, FOODINFORMATICS APPL, P177.;OKUMURA T, 2004, BIOSCI BIOTECH BIOCH, V68, P1657, DOI 10.1271/BBB.68.1657.;ONG L, 2007, LAIT, V87, P149, DOI 10.1051/LAIT:2007004.;OTAGIRI K, 1983, B CHEM SOC JPN, V56, P1116, DOI 10.1246/BCSJ.56.1116.;PEUHKURI K, 2011, FOOD NUTR RES, V55, DOI 10.3402/FNR.V55I0.5955.;PIHLANTO-LEPPALA A, 2000, TRENDS FOOD SCI TECH, V11, P347, DOI 10.1016/S0924-2244(01)00003-6.;PRIPP AH, 2007, FOOD CHEM, V102, P880, DOI 10.1016/J.FOODCHEM.2006.06.026.;RAWLINGS ND, 2014, NUCLEIC ACIDS RES, V42, PD503, DOI 10.1093/NAR/GKT953.;REGA MF, 2015, FOOD CHEM, V173, P1179, DOI 10.1016/J.FOODCHEM.2014.10.151.;SAHA BC, 2001, BIOTECHNOL ADV, V19, P355, DOI 10.1016/S0734-9750(01)00070-2.;SAKURAI T, 2009, J AGR FOOD CHEM, V57, P2508, DOI 10.1021/JF8040148.;SAMARAWEERA H, 2011, J FOOD SCI, V76, PR143, DOI 10.1111/J.1750-3841.2011.02291.X.;SCALBERT A, 2011, J AGR FOOD CHEM, V59, P4331, DOI 10.1021/JF200591D.;SCHINDLER A, 2011, J AGR FOOD CHEM, V59, P12578, DOI 10.1021/JF2041593.;SEO WH, 2008, J FOOD SCI, V73, PS41, DOI 10.1111/J.1750-3841.2007.00610.X.;SHIM J, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0124030.;SILVEIRA ST, 2013, FOOD CHEM, V141, P1072, DOI 10.1016/J.FOODCHEM.2013.03.056.;SOLMS J, 1969, J AGR FOOD CHEM, V17, P686, DOI 10.1021/JF60164A016.;SOLTANI S, 2013, BIOMED RES INT, DOI 10.1155/2013/501310.;SU GW, 2012, FOOD CHEM, V135, P479, DOI 10.1016/J.FOODCHEM.2012.04.130.;SUH JY, 2014, B KOREAN CHEM SOC, V35, P3353, DOI 10.5012/BKCS.2014.35.11.3353.;TAHARA Y, 2013, IEEE SENS J, V13, P3001, DOI 10.1109/JSEN.2013.2263125.;TAMURA M, 1990, AGR BIOL CHEM TOKYO, V54, P41, DOI 10.1080/00021369.1990.10869906.;TEMUSSI PA, 2012, J PEPT SCI, V18, P73, DOI 10.1002/PSC.1428.;TEMUSSI PA, 2009, TRENDS BIOCHEM SCI, V34, P296, DOI 10.1016/J.TIBS.2009.02.005.;THEERASILP S, 1989, J BIOL CHEM, V264, P6655.;VANDENOORD AHA, 1997, Z LEBENSM UNTERS F A, V205, P125, DOI 10.1007/S002170050138.;VAUCHER RD, 2011, INT J PHARMACEUT, V421, P94, DOI 10.1016/J.IJPHARM.2011.09.020.;WANG L, 2015, SENSORS-BASEL, V15, P11169, DOI 10.3390/S150511169.;WANG WY, 2005, COMPR REV FOOD SCI F, V4, P63, DOI 10.1111/J.1541-4337.2005.TB00075.X.;WELCOME MO, 2015, NEUROL RES INT, DOI 10.1155/2015/606479.;WIENER A, 2012, NUCLEIC ACIDS RES, V40, PD413, DOI 10.1093/NAR/GKR755.;WU SF, 2014, EUR J MED CHEM, V84, P100, DOI 10.1016/J.EJMECH.2014.07.015.;YANG S, 2012, EUR FOOD RES TECHNOL, V235, P91, DOI 10.1007/S00217-012-1735-6.;ZAMYATNIN AA, 2006, NUCLEIC ACIDS RES, V34, PD261, DOI 10.1093/NAR/GKJ008.;ZHANG MX, 2012, FOOD CHEM, V135, P1463, DOI 10.1016/J.FOODCHEM.2012.06.026.;ZHANG YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0.;ZHANG Y, 2015, LWT-FOOD SCI TECHNOL, V62, P1154, DOI 10.1016/J.LWT.2015.02.003.;ZHUANG MZ, 2016, FOOD CHEM, V206, P174, DOI 10.1016/J.FOODCHEM.2016.03.058.","IWANIAK, A (REPRINT AUTHOR), UNIV WARMIA \& MAZURY, CHAIR FOOD BIOCHEM, PL CIESZYNSKI 1, PL-10726 OLSZTYN, POLAND.;IWANIAK, ANNA, MINKIEWICZ, PIOTR, DAREWICZ, MALGORZATA, HRYNKIEWICZ, MONIKA, UNIV WARMIA \& MAZURY, CHAIR FOOD BIOCHEM, PL CIESZYNSKI 1, PL-10726 OLSZTYN, POLAND.","10.1016/J.FOODRES.2016.08.010","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN [17.610.014-300]","THIS WORK WAS FINANCED BY THE UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN (PROJECT NUMBER: 17.610.014-300).",NA,"0963-9969","1","27-38","ELSEVIER SCIENCE BV","89",2016,"ISI000388775500003","106","FOOD SCIENCE \& TECHNOLOGY","44","FOOD SCIENCE \& TECHNOLOGY","AMIUWM.EDU.PL",NA,"ED3VB",NA,"IWANIAK, A (REPRINT AUTHOR), UNIV WARMIA \& MAZURY, CHAIR FOOD BIOCHEM, PL CIESZYNSKI 1, PL-10726 OLSZTYN, POLAND","ISI","UNIV WARMIA AND MAZURY","UNIV WARMIA AND MAZURY",NA,"IWANIAK A, 2016, FOOD RES INT","IWANIAK A, 2016, FOOD RES INT"
"LOWE CW, 2016, PLOS ONE","LOWE CW;SATTERFIELD BA;NELSON DB;THIRIOT JD;HEDER MJ;MARCH JK;DRAKE DS;LEW CS;BUNNELL AJ;MOORE ES;O NEILL KL;ROBISON RA","A QUADRUPLEX REAL-TIME PCR ASSAY FOR THE RAPID DETECTION AND DIFFERENTIATION OF THE MOST RELEVANT MEMBERS OF THE B. PSEUDOMALLEI COMPLEX: B. MALLEI, B. PSEUDOMALLEI, AND B-THAILANDENSIS","PLOS ONE","PLOS ONE","THE BURKHOLDERIA PSEUDOMALLEI COMPLEX CLASSICALLY CONSISTED OF B. MALLEI, B. PSEUDOMALLEI, AND B. THAILANDENSIS, BUT HAS NOW EXPANDED TO INCLUDE B. OKLAHOMENSIS, B. HUMPTYDOOENSIS, AND THREE UNASSIGNED BURKHOLDERIA CLADES. METHODS FOR DETECTING AND DIFFERENTIATING THE B. PSEUDOMALLEI COMPLEX HAS BEEN THE TOPIC OF RECENT RESEARCH DUE TO PHENOTYPIC AND GENOTYPIC SIMILARITIES OF THESE SPECIES. B. MALLEI AND B. PSEUDOMALLEI ARE RECOGNIZED AS CDC TIER 1 SELECT AGENTS, AND ARE THE CAUSATIVE AGENTS OF GLANDERS AND MELIOIDOSIS, RESPECTIVELY. ALTHOUGH B. THAILANDENSIS AND B. OKLAHOMENSIS ARE GENERALLY AVIRULENT, BOTH DISPLAY SIMILAR PHENOTYPIC CHARACTERISTICS TO THAT OF B. PSEUDOMALLEI. B. HUMPTYDOOENSIS AND THE BURKHOLDERIA CLADES ARE GENETICALLY SIMILAR TO THE B. PSEUDOMALLEI COMPLEX, AND ARE NOT ASSOCIATED WITH DISEASE. OPTIMAL IDENTIFICATION OF THESE SPECIES REMAINS PROBLEMATIC, AND PCR-BASED METHODS CAN RESOLVE ISSUES WITH B. PSEUDOMALLEI COMPLEX DETECTION AND DIFFERENTIATION. CURRENTLY, NO PCR ASSAY IS AVAILABLE THAT DETECTS THE MAJOR SPECIES OF THE B. PSEUDOMALLEI COMPLEX. A REAL-TIME PCR ASSAY IN A MULTIPLEX SINGLE-TUBE FORMAT WAS DEVELOPED TO SIMULTANEOUSLY DETECT AND DIFFERENTIATE B. MALLEI, B. PSEUDOMALLEI, AND B. THAILANDENSIS, AND A COMMON SEQUENCE FOUND IN B. PSEUDOMALLEI, B. MALLEI, B. THAILANDENSIS, AND B. OKLAHOMENSIS. A TOTAL OF 309 BURKHOLDERIA ISOLATES AND 5 OTHER BACTERIAL SPECIES WERE EVALUATED. THE ASSAY WAS 100\% SENSITIVE AND SPECIFIC, DEMONSTRATED SENSITIVITY BEYOND CULTURE AND GC METHODS FOR THE ISOLATES TESTED, AND IS COMPLETED IN ABOUT AN HOUR WITH A DETECTION LIMIT BETWEEN 2.6PG AND 48.9PG OF GDNA. BIOINFORMATIC ANALYSES ALSO SHOWED THE ASSAY IS LIKELY 100\% SPECIFIC AND SENSITIVE FOR ALL 84 FULLY SEQUENCED B. PSEUDOMALLEI, B. MALLEI, B. THAILANDENSIS, AND B. OKLAHOMENSIS STRAINS CURRENTLY AVAILABLE IN GENBANK. FOR THESE REASONS, THIS ASSAY COULD BE A RAPID AND SENSITIVE TOOL IN THE DETECTION AND DIFFERENTIATION FOR THOSE SPECIES OF THE B. PSEUDOMALLEI COMPLEX WITH RECOGNIZED CLINICAL AND PRACTICAL SIGNIFICANCE.",NA,"POLYMERASE-CHAIN-REACTION; COMMUNITY-ACQUIRED SEPTICEMIA; TROPICAL NORTHERN AUSTRALIA; LATEX AGGLUTINATION-TEST; III SECRETION SYSTEM; BURKHOLDERIA-PSEUDOMALLEI; PSEUDOMONAS-PSEUDOMALLEI; MONOCLONAL-ANTIBODY; MULTIPLEX PCR; API 20NE","ENGLISH","ARTICLE","ARTICLE",6,"ALIBEK K., 1999, BIOHAZARD CHILLING T.;AMORNCHAI P, 2007, J CLIN MICROBIOL, V45, P3774, DOI 10.1128/JCM.00935-07.;ANUNTAGOOL N, 2000, J MED MICROBIOL, V49, P1075, DOI 10.1099/0022-1317-49-12-1075.;BOWERS JR, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0015413.;BRETT PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317.;BRILHANTE RSN, 2012, J CLIN MICROBIOL, V50, P3349, DOI 10.1128/JCM.01577-12.;CHANTRATITA N, 2008, J CLIN MICROBIOL, V46, P568, DOI 10.1128/JCM.01817-07.;CHANTRATITA N, 2007, AM J TROP MED HYG, V77, P814, DOI 10.4269/AJTMH.2007.77.814.;CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/INFDIS/159.5.890.;CHEN YS, 2010, J CLIN MICROBIOL, V48, P1432, DOI 10.1128/JCM.01720-09.;CHENG AC, 2006, AM J TROP MED HYG, V74, P330, DOI 10.4269/AJTMH.2006.74.330.;CHENG AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005.;CHENG AC, 2010, CURR OPIN INFECT DIS, V23, P554, DOI 10.1097/QCO.0B013E32833FB88C.;CHENTHAMARAKSHAN V, 2001, DIAGN MICR INFEC DIS, V39, P1, DOI 10.1016/S0732-8893(00)00212-1.;CHRISTOPHER GW, 1997, JAMA-J AM MED ASSOC, V278, P412, DOI 10.1001/JAMA.278.5.412.;CURRIE BART J, 2008, TRANS R SOC TROP MED HYG, V102 SUPPL 1, PS1, DOI 10.1016/S0035-9203(08)70002-6.;CURRIE BJ, 2000, CLIN INFECT DIS, V31, P981, DOI 10.1086/318116.;CURRIE BJ, 2010, PINCIPLES PRACTICE I, P2869.;DANCE DA, 1996, WELLCOME TRUST ILLUS, P72.;DEPOORTER E, 2016, APPL MICROBIOL BIOT, V100, P5215, DOI 10.1007/S00253-016-7520-X.;DESHAZER D, 2007, FEMS MICROBIOL LETT, V277, P64, DOI 10.1111/J.1574-6968.2007.00946.X.;DHARAKUL T, 1999, J CLIN MICROBIOL, V37, P1906.;FREDRICKS DN, 1999, CLIN INFECT DIS, V29, P475.;FRICKMANN H, 2012, EUR J MICROBIOL IMMU, V2, P148, DOI 10.1556/EUJMI.2.2012.2.8.;GALYOV EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/ANNUREV.MICRO.112408.134030.;GEE JE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-54.;GEE JE, 2003, J CLIN MICROBIOL, V41, P4647, DOI 10.1128/JCM.41.10.4647-4654.2003.;GILAD JACOB, 2007, RECENT PAT ANTIINFECT DRUG DISCOV, V2, P233, DOI 10.2174/157489107782497335.;GINTHER JL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/JOURNAL.PNTD.0003892.;GLASS MB, 2005, J CLIN MICROBIOL, V43, P479, DOI 10.1128/JCM.43.1.479-483.2005.;GLASS MB, 2006, INT J SYST EVOL MICR, V56, P2171, DOI 10.1099/IJS.0.63991-0.;GLASS MB, 2006, J CLIN MICROBIOL, V44, P4601, DOI 10.1128/JCM.01585-06.;GODOY D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003.;GREGORY BC, 2007, MED ASPECTS BIOL WAR, P121.;HAGEN RM, 2011, INT J MED MICROBIOL, V301, P585, DOI 10.1016/J.IJMM.2011.04.017.;HAGEN RM, 2002, J CLIN PATHOL-MOL PA, V55, P398.;HO CC, 2011, J CLIN MICROBIOL, V49, P814, DOI 10.1128/JCM.01702-10.;INGLIS TJJ, 2012, AM J TROP MED HYG, V86, P1039, DOI 10.4269/AJTMH.2012.11-0454.;INGLIS TJJ, 2005, J CLIN MICROBIOL, V43, P2201, DOI 10.1128/JCM.43.5.2201-2206.2005.;INGLIS TJJ, 2003, J CLIN MICROBIOL, V41, P4812, DOI 10.1128/JCM.41.10.4812-4814.2003.;INGLIS TJJ, 1998, PATHOLOGY, V30, P62, DOI 10.1080/00313029800169685.;INNIS MA, 1990, 1 OPTIMIZATION PCRS, P3.;JOHN TJ, 1996, INDIAN J MED RES, V103, P62.;KAESTLI M, 2007, APPL ENVIRON MICROB, V73, P6891, DOI 10.1128/AEM.01038-07.;KAESTLI M, 2012, J CLIN MICROBIOL, V50, P2059, DOI 10.1128/JCM.06737-11.;KE XY, 2001, BIOINFORMATICS, V17, P838, DOI 10.1093/BIOINFORMATICS/17.9.838.;KLEIN D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9.;KOH SF, 2012, J MICROBIOL METH, V90, P305, DOI 10.1016/J.MIMET.2012.06.002.;KUTYAVIN IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/NAR/28.2.655.;KWOK S, 1994, PCR METH APPL, V3, PS39.;LEE MA, 2005, FEMS IMMUNOL MED MIC, V43, P413, DOI 10.1016/J.FEMSIM.2004.10.008.;LEHAVI OFER, 2002, HAREFUAH, V141 SPEC NO, P88.;LERTPATANASUWAN N, 1999, CLIN INFECT DIS, V28, P927, DOI 10.1086/517253.;LIMMATHUROTSAKUL D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/AJTMH.2010.10-0038.;LOWE P, 2002, J CLIN MICROBIOL, V40, P4625, DOI 10.1128/JCM.40.12.4625-4627.2002.;LOWE W, 2014, CURR ISSUES MOL BIOL, V16, P23.;MCCORMICK JB, 1977, J INFECT DIS, V135, P103, DOI 10.1093/INFDIS/135.1.103.;MEUMANN EM, 2012, CLIN INFECT DIS, V54, P362, DOI 10.1093/CID/CIR808.;NEUBAUER H, 2007, ZOONOSES PUBLIC HLTH, V54, P44, DOI 10.1111/J.1863-2378.2007.01008.X.;NIERMAN WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/PNAS.0403306101.;NOVAK RT, 2006, J CLIN MICROBIOL, V44, P85, DOI 10.1128/JCM.44.1.85-90.2006.;NUSSBAUM JJ, 1980, ARCH OPHTHALMOL-CHIC, V98, P1224.;PAL V, 2012, CLIN VACCINE IMMUNOL, V19, P1193, DOI 10.1128/CVI.00137-12.;PRICE EP, 2016, J MED MICROBIOL, V65, P992, DOI 10.1099/JMM.0.000312.;PRICE EP, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0037723.;PURCELL MK, 2011, J AQUAT ANIM HEALTH, V23, P148, DOI 10.1080/08997659.2011.620217.;PUTHUCHEARY SD, 2012, J MOL MICROB BIOTECH, V22, P198, DOI 10.1159/000338985.;RAINBOW L, 2002, J MED MICROBIOL, V51, P374, DOI 10.1099/0022-1317-51-5-374.;RUBIN HL, 1963, MIL MED, V128, P538.;SAMOSORNSUK N, 1999, AM J TROP MED HYG, V61, P735, DOI 10.4269/AJTMH.1999.61.735.;SATTERFIELD BA, 2010, J MED MICROBIOL, V59, P55, DOI 10.1099/JMM.0.012567-0.;SCHOLZ HC, 2006, DIAGN MICR INFEC DIS, V54, P241, DOI 10.1016/J.DIAGMICROBIO.2005.09.018.;SPICKLER A. R., 2008, HDB ZOONOTIC DIS COM, P133.;SPRAGUE LD, 2002, FEMS IMMUNOL MED MIC, V34, P231, DOI 10.1016/S0928-8244(02)00393-0.;STEINMETZ I, 1999, J CLIN MICROBIOL, V37, P225.;SUPAPROM C, 2007, J CLIN MICROBIOL, V45, P2894, DOI 10.1128/JCM.00291-07.;SUPUTTAMONGKOL Y, 1999, CLIN INFECT DIS, V29, P408, DOI 10.1086/520223.;TAMURA K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/MOLBEV/MST197.;TANPIBOONSAK S, 2004, MOL CELL PROBE, V18, P97, DOI 10.1016/J.MCP.2003.09.010.;THIBAULT FM, 2004, J CLIN MICROBIOL, V42, P5871, DOI 10.1128/JCM.42.12.5871-5874.2004.;TOMASO H, 2006, CLIN CHEM, V52, P307, DOI 10.1373/CLINCHEM.2005.059196.;TRUNG TT, 2011, APPL ENVIRON MICROB, V77, P6486, DOI 10.1128/AEM.00735-11.;U'REN JM, 2005, J CLIN MICROBIOL, V43, P5771, DOI 10.1128/JCM.43.11.5771-5774.2005.;ULRICH RL, 2006, DIAGN MICR INFEC DIS, V55, P37, DOI 10.1016/J.DIAGMICROBIO.2005.11.007.;WALSH AL, 1995, CLIN INFECT DIS, V21, P1498, DOI 10.1093/CLINIDS/21.6.1498.;WALSH AL, 1994, J CLIN PATHOL, V47, P377, DOI 10.1136/JCP.47.4.377.;WHITE NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0.;WHITLOCK GC, 2007, FEMS MICROBIOL LETT, V277, P115, DOI 10.1111/J.1574-6968.2007.00949.X.;WINSTANLEY C, 2000, J CLIN MICROBIOL, V38, P883.;WOO PCY, 2002, DIAGN MICR INFEC DIS, V44, P143, DOI 10.1016/S0732-8893(02)00439-X.;WUTHIEKANUN V, 2005, CLIN DIAGN LAB IMMUN, V12, P555, DOI 10.1128/CDLI.12.4.555-556.2005.;WUTHIEKANUN V, 2004, J CLIN MICROBIOL, V42, P3435, DOI 10.1128/JCM.42.8.3435-3437.2004.;YANG S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8.","ROBISON, RA (REPRINT AUTHOR), BRIGHAM YOUNG UNIV, DEPT MICROBIOL \& MOL BIOL, PROVO, UT 84602 USA.;LOWE, CHINN-WOAN, SATTERFIELD, BENJAMIN A., NELSON, DANIEL B., THIRIOT, JOSEPH D., HEDER, MICHAEL J., MARCH, JORDON K., DRAKE, DAVID S., LEW, CYNTHIA S., BUNNELL, ANNETTE J., MOORE, EMILY S., O'NEILL, KIM L., ROBISON, RICHARD A., BRIGHAM YOUNG UNIV, DEPT MICROBIOL \& MOL BIOL, PROVO, UT 84602 USA.","10.1371/JOURNAL.PONE.0164006","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E0164006",NA,"OFFICE OF RESEARCH \& CREATIVE ACTIVITIES - MENTORING ENVIRONMENT GRANTS [547]","THIS STUDY WAS SUPPORTED BY THE OFFICE OF RESEARCH \& CREATIVE ACTIVITIES - MENTORING ENVIRONMENT GRANTS 547, HTTPS://ORCA.BYU.EDU/MEG/.",NA,"1932-6203","10",NA,"PUBLIC LIBRARY SCIENCE","11",2016,"ISI000385505800034","93","SCIENCE \& TECHNOLOGY - OTHER TOPICS","6","MULTIDISCIPLINARY SCIENCES","RICHARD\_ROBISONBYU.EDU",NA,"DZ0CV",NA,"ROBISON, RA (REPRINT AUTHOR), BRIGHAM YOUNG UNIV, DEPT MICROBIOL \& MOL BIOL, PROVO, UT 84602 USA","ISI","BRIGHAM YOUNG UNIV","BRIGHAM YOUNG UNIV",NA,"LOWE CW, 2016, PLOS ONE","LOWE CW, 2016, PLOS ONE"
"GUSTAFSON D, 2016, BEST PRACT RES CLIN ENDOC METAB","GUSTAFSON D;TYRYSHKIN K;RENWICK N","MICRORNA-GUIDED DIAGNOSTICS IN CLINICAL SAMPLES","BEST PRACTICE \& RESEARCH CLINICAL ENDOCRINOLOGY \& METABOLISM","BEST PRACT. RES. CLIN. ENDOC. METAB.","MIRNA-GUIDED DIAGNOSTICS IS A POWERFUL MOLECULAR APPROACH FOR EVALUATING CLINICAL SAMPLES THROUGH MIRNA DETECTION AND/OR VISUALIZATION. TO DATE, THIS APPROACH HAS BEEN SUCCESSFULLY USED TO DIAGNOSE, MANAGE, AND/OR MONITOR A WIDE RANGE OF NEOPLASTIC AND NON-NEOPLASTIC DISEASES. DESPITE THE PROMISE OF MIRNA-GUIDED DIAGNOSTICS, PARTICULARLY IN THE FIELD OF MINIMALLY INVASIVE BIOMARKERS, SEVERAL KNOWLEDGE AND PRACTICAL ISSUES CONFOUND OR HINDER TRANSLATION INTO ROUTINE CLINICAL PRACTICE INCLUDING: MIRNA SEQUENCE DATABASE ERRORS, SUBOPTIMAL RNA EXTRACTION METHODS, DETECTION ASSAY VARIABILITY, A VAST ARRAY OF ONLINE RESOURCES FOR BIOINFORMATIC ANALYSES, AND NON-STANDARDIZED STATISTICAL ANALYSES FOR MIRNA CLINICAL TESTING. IN THIS REVIEW, WE RAISE AWARENESS OF THESE ISSUES AND RECOMMEND RESEARCH DIRECTIONS TO HELP SPECIALISTS IN ENDOCRINOLOGY AND METABOLISM INTEGRATE MIRNA TESTING INTO CLINICAL DECISION-MAKING. (C) 2016 THE AUTHORS. PUBLISHED BY ELSEVIER LTD. THIS IS AN OPEN ACCESS ARTICLE UNDER THE CC BY-NC-ND LICENSE.","MIRNA-GUIDED DIAGNOSTICS; MIRNA; MICRORNA; BIOMARKERS; DETECTION METHODS; CLINICAL DECISION-MAKING","PARAFFIN-EMBEDDED TISSUES; IN-SITU HYBRIDIZATION; CIRCULATING MICRORNA; CDNA LIBRARIES; EXPRESSION ANALYSIS; GENE-EXPRESSION; MIRNA ANALYSIS; SEQ DATA; CANCER; NORMALIZATION","ENGLISH","ARTICLE","ARTICLE",7,"AHMED FARID E., 2009, CANCER GENOMICS \& PROTEOMICS, V6, P281.;[ANONYMOUS], 2016, BASICS RNA ISOLATION.;ARROYO JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/PNAS.1019055108.;BARTEL DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5.;BECKER N, 2013, CLIN BIOCHEM, V46, P861, DOI 10.1016/J.CLINBIOCHEM.2013.02.015.;BENES V, 2010, METHODS, V50, P244, DOI 10.1016/J.YMETH.2010.01.026.;BEREZIKOV E, 2010, NAT GENET, V42, P6, DOI 10.1038/NG0110-6.;BROWN MIGUEL, 2013, FRONTIERS IN GENETICS, V4, P145, DOI 10.3389/FGENE.2013.00145.;BRUNET-VEGA A, 2015, ANAL BIOCHEM, V488, P28, DOI 10.1016/J.AB.2015.07.018.;CALIN GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMOA050995.;CASTOLDI M, 2007, METHODS, V43, P146, DOI 10.1016/J.YMETH.2007.04.009.;CHATTERJEE A, 2015, SCI REP-UK, V5, DOI 10.1038/SREP10438.;CHEN CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/NAR/GNI178.;CHEN X, 2008, CELL RES, V18, P997, DOI 10.1038/CR.2008.282.;CHIANG HR, 2010, GENE DEV, V24, P992, DOI 10.1101/GAD.1884710.;COASSIN SR, 2014, METHODS MOL BIOL, V1211, P189, DOI 10.1007/978-1-4939-1459-3\_15.;DE PLANELL-SAGUER M, 2011, ANAL CHIM ACTA, V699, P134, DOI 10.1016/J.ACA.2011.05.025.;DOLESHAL M, 2008, J MOL DIAGN, V10, P203, DOI 10.2353/JMOLDX.2008.070153.;DUDA R. O., 2001, PATTERN CLASSIFICATI.;DUY J, 2015, BMC GENOMICS, V16, DOI 10.1186/S12864-015-1299-5.;EGATZ-GOMEZ A, 2016, BIOMICROFLUIDICS, V10, DOI 10.1063/1.4948525.;EITAN R, 2009, GYNECOL ONCOL, V114, P253, DOI 10.1016/J.YGYNO.2009.04.024.;EL-KHOURY V, 2016, SCI REP-UK, V6, DOI 10.1038/SREP19529.;FARAZI TA, 2012, METHODS, V58, P171, DOI 10.1016/J.YMETH.2012.07.020.;GARCIA DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/NSMB.2115.;GARMIRE LX, 2012, RNA, V18, P1279, DOI 10.1261/RNA.030916.111.;GEISS GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/NBT1385.;GIT A, 2010, RNA, V16, P991, DOI 10.1261/RNA.1947110.;GU LQ, 2012, EXPERT REV MOL DIAGN, V12, P573, DOI [10.1586/ERM.12.58, 10.1586/ERM.12.58].;HAFNER M, 2012, METHODS, V58, P164, DOI 10.1016/J.YMETH.2012.07.030.;HAFNER M, 2011, RNA, V17, P1697, DOI 10.1261/RNA.2799511.;HAMMOND SM, 2015, ADV DRUG DELIVER REV, V87, P3, DOI 10.1016/J.ADDR.2015.05.001.;HANNA JA, 2012, BIOTECHNIQUES, V52, P235, DOI 10.2144/000113837.;HANSEN TB, 2011, RNA BIOL, V8, P378, DOI 10.4161/RNA.8.3.14333.;HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.2307/2289392.;JI JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMOA0901282.;JIANG QH, 2009, NUCLEIC ACIDS RES, V37, PD98, DOI 10.1093/NAR/GKN714.;JUNG M, 2010, CLIN CHEM, V56, P998, DOI 10.1373/CLINCHEM.2009.141580.;KAPRANOV PHILIPP, 2012, METHODS MOL BIOL, V822, P219, DOI 10.1007/978-1-61779-427-8\_15.;KIM YK, 2012, MOL CELL, V46, P893, DOI 10.1016/J.MOLCEL.2012.05.036.;KOZOMARA A, 2014, NUCLEIC ACIDS RES, V42, PD68, DOI 10.1093/NAR/GKT1181.;KROL J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/NRG2843.;LANDGRAF P, 2007, CELL, V129, P1401, DOI 10.1016/J.CELL.2007.04.040.;LANGMEAD B, 2009, GENOME BIOL, V10, DOI 10.1186/GB-2009-10-3-R25.;LEICHTER AL, 2015, GIGASCIENCE, V4, DOI 10.1186/S13742-015-0099-9.;LI W, 2009, ANAL BIOANAL CHEM, V394, P1117, DOI 10.1007/S00216-008-2570-2.;LI YU, 2012, GENOMICS PROTEOMICS \& BIOINFORMATICS, V10, P246, DOI 10.1016/J.GPB.2012.07.005.;LIU CG, 2008, NAT PROTOC, V3, P563, DOI 10.1038/NPROT.2008.14.;LU J, 2005, NATURE, V435, P834, DOI 10.1038/NATURE03702.;LUDWIG N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/NAR/GKW116.;MENG YJ, 2012, RNA BIOL, V9, P249, DOI 10.4161/RNA.19230.;MEYER SU, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0038946.;MEYER SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/S10529-010-0380-Z.;MITCHELL PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/PNAS.0804549105.;MORIN RD, 2008, GENOME RES, V18, P610, DOI 10.1101/GR.7179508.;NELSON PT, 2006, RNA, V12, P187, DOI 10.1261/RNA.2258506.;NELSON PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717.;NIELSEN BS, 2014, METHODS MOL BIOL, V1211, P77, DOI 10.1007/978-1-4939-1459-3\_7.;NUOVO GJ, 2010, METHODS, V52, P307, DOI 10.1016/J.YMETH.2010.08.009.;ONO S, 2015, J CLIN MED, V4, P1890, DOI 10.3390/JCM4101890.;QIN LX, 2016, SCI REP-UK, V6, DOI 10.1038/SREP24061.;RAWLINGS-GOSS RA, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-53.;RENWICK N, 2014, METHODS MOL BIOL, V1211, P171, DOI 10.1007/978-1-4939-1459-3\_14.;RENWICK N, 2013, J CLIN INVEST, V123, P2694, DOI 10.1172/JCI68760.;ROBINSON MD, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-3-R25.;ROSENFELD N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/NBT1392.;SATO F, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0005540.;SEMPERE LF, 2014, METHODS MOL BIOL, V1211, P151, DOI 10.1007/978-1-4939-1459-3\_13.;SHI WY, 2009, NAT STRUCT MOL BIOL, V16, P183, DOI 10.1038/NSMB.1536.;SZAFRANSKA AE, 2008, J MOL DIAGN, V10, P415, DOI 10.2353/JMOLDX.2008.080018.;TAM S, 2015, BRIEF BIOINFORM, V16, P950, DOI 10.1093/BIB/BBV019.;TURCHINOVICH A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/NAR/GKR254.;TURKEY J. W., 1977, EXPLORATORY DATA ANA.;VERGOULIS T, 2012, NUCLEIC ACIDS RES, V40, PD222, DOI 10.1093/NAR/GKR1161.;VIGNEAULT F, 2012, CURRENT PROTOCOLS HU, V2, P1.;VLACHOS IS, 2013, CLIN BIOCHEM, V46, P879, DOI 10.1016/J.CLINBIOCHEM.2013.03.006.;VLACHOS IS, 2012, NUCLEIC ACIDS RES, V40, PW498, DOI 10.1093/NAR/GKS494.;WANG HW, 2014, METHODS MOL BIOL, V1211, P201, DOI 10.1007/978-1-4939-1459-3\_16.;WANG X, 2015, MOL BIOSYST, V11, P1235, DOI 10.1039/C4MB00711E.;WEBER JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/CLINCHEM.2010.147405.;WILLIAMS Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/PNAS.1214046110.;XI YG, 2007, RNA, V13, P1668, DOI 10.1261/RNA.642907.;ZHOU XB, 2013, RNA, V19, P733, DOI 10.1261/RNA.037895.112.","RENWICK, N (REPRINT AUTHOR), QUEENS UNIV, DEPT PATHOL \& MOL MED, LAB TRANSLAT RNA BIOL, KINGSTON, ON K7L 3N6, CANADA.;GUSTAFSON, DAKOTA, RENWICK, NEIL, QUEENS UNIV, DEPT PATHOL \& MOL MED, LAB TRANSLAT RNA BIOL, KINGSTON, ON K7L 3N6, CANADA.;TYRYSHKIN, KATHRIN, QUEENS UNIV, DEPT PATHOL \& MOL MED, KINGSTON, ON K7L 3N6, CANADA.","10.1016/J.BEEM.2016.07.002","THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",NA,NA,"SOUTHEASTERN ONTARIO ACADEMIC MEDICAL ASSOCIATION, DEPARTMENT OF PATHOLOGY AND MOLECULAR MEDICINE AT QUEEN'S UNIVERSITY, CANADA FOUNDATION FOR INNOVATION JOHN R. EVANS LEADERS FUND","WE WISH TO THANK TO THE SOUTHEASTERN ONTARIO ACADEMIC MEDICAL ASSOCIATION, THE DEPARTMENT OF PATHOLOGY AND MOLECULAR MEDICINE AT QUEEN'S UNIVERSITY, AND THE CANADA FOUNDATION FOR INNOVATION JOHN R. EVANS LEADERS FUND FOR FUNDING OUR PROGRAM ON MIRNA-GUIDED DIAGNOSTICS.",NA,"1521-690X","5","563-575","ELSEVIER SCI LTD","30",2016,"ISI000391906600003","83","ENDOCRINOLOGY \& METABOLISM","2","ENDOCRINOLOGY \& METABOLISM","D.GUSTAFSONQUEENSU.CA KT40QUEENSU.CA NEIL.RENWICKQUEENSU.CA",NA,"EH6TK",NA,"RENWICK, N (REPRINT AUTHOR), QUEENS UNIV, DEPT PATHOL \& MOL MED, LAB TRANSLAT RNA BIOL, KINGSTON, ON K7L 3N6, CANADA","ISI","QUEENS UNIV;QUEENS UNIV","QUEENS UNIV",NA,"GUSTAFSON D, 2016, BEST PRACT RES CLIN ENDOC METAB","GUSTAFSON D, 2016, BEST PRACT RES CLIN ENDOC METAB"
"MORTAZAVI M, 2016, HEPAT MON","MORTAZAVI M;ZARENEZHAD M;GHOLAMZADEH S;ALAVIAN SM;GHORBANI M;DEHGHANI R;MALEKPOUR A;MESHKIBAF M;FAKHRZAD A","BIOINFORMATIC IDENTIFICATION OF RARE CODON CLUSTERS (RCCS) IN HBV GENOME AND EVALUATION OF RCCS IN PROTEINS STRUCTURE OF HEPATITIS B VIRUS","HEPATITIS MONTHLY","HEPAT. MON.","BACKGROUND: HEPATITIS B VIRUS (HBV) AS AN INFECTIOUS DISEASE THAT HAS NINE GENOTYPES (A-I) AND A `PUTATIVE' GENOTYPE J. OBJECTIVES: THE AIM OF THIS STUDY WAS TO IDENTIFY THE RARE CODON CLUSTERS (RCC) IN THE HBV GENOME AND TO EVALUATE THESE RCCS IN THE HBV PROTEINS STRUCTURE. METHODS: FOR DETECTION OF PROTEIN FAMILY ACCESSION NUMBERS (PFAM) IN HBV PROTEINS, THE UNIPROT DATABASE AND PFAM SEARCH TOOL WERE USED. PROTEIN FAMILY ACCESSION NUMBERS IS A COMPREHENSIVE AND ACCURATE COLLECTION OF PROTEIN DOMAINS AND FAMILIES. IT CONTAINS ANNOTATION OF EACH FAMILY IN THE FORM OF TEXTUAL DESCRIPTIONS, LINKS TO OTHER RESOURCES AND LITERATURE REFERENCES. GENOME PROJECTS HAVE USED P FAMEX TENSIVELY FOR LARGE-SCALE FUNCTIONAL ANNOTATION OF GENOMIC DATA, PFAM DATABASE IS A LARGE COLLECTION OF PROTEIN FAMILIES, EACH REPRESENTED BY MULTIPLE SEQUENCE ALIGNMENTS AND HIDDEN MARKOV MODELS (HMMS). THE PFAM SEARCH TOOLS ARE DATABASES THAT IDENTIFY PFAM OF PROTEINS. THESE PFAM IDS WERE ANALYZED IN SHERLOCC PROGRAM AND THE LOCATION OF RCCS IN HBV GENOME AND PROTEINS WERE DETECTED AND REPORTED AS TRANSLATED EMBL NUCLEOTIDE SEQUENCE DATA LIBRARY (TREMBL) ENTRIES. THE TREMBL IS A COMPUTER-ANNOTATED SUPPLEMENT OF SWISS-PROT THAT CONTAINS ALL THE TRANSLATIONS OF EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) NUCLEOTIDE SEQUENCE ENTRIES NOT YET INTEGRATED IN SWISS-PROT. FURTHERMORE, THE STRUCTURES OF TREMBL ENTRIES PROTEINS WERE STUDIED IN THE PDB DATABASE AND 3D STRUCTURES OF THE HBV PROTEINS AND LOCATIONS OF RCCS WERE VISUALIZED AND STUDIED USING SWISS PDB VIEWER SOFTWARE (R). RESULTS: THE PFAM SEARCH TOOL FOUND NINE PROTEIN FAMILIES IN THREE FRAMES. RESULTS OF PFAMS STUDIES IN THE SHERLOCC PROGRAM SHOWED THAT THIS PROGRAM HAS NOT IDENTIFIED RCCS IN THE EXTERNAL CORE ANTIGEN (PF08290) AND TRUNCATED HBEAG GENE (PF08290) OF HBV. BY CONTRAST, THE RCCS WERE IDENTIFIED IN GENE OF HEPATITIS CORE ANTIGEN (PF00906 AND THE RESIDUES 224-234 AND 251-255), LARGE ENVELOPE PROTEIN S (PF00695 AND THE RESIDUES 53-56 AND 70-84), X PROTEIN (PF00739 AND THE RESIDUES 10-24, 29-83, 95-99. 122-129, 139-143), DNA POLYMERASE (VIRAL) N-TERMINAL DOMAIN (PF00242 AND THE RESIDUES 59-62, 214-217, 407-413) AND PROTEIN P (PF00336 AND THE RESIDUES 225-228). IN HBV GENOME, SEVEN RCCS WERE IDENTIFIED IN THE GENE AREA OF HEPATITIS CORE ANTIGEN, LARGE ENVELOPE PROTEIN S ANDDNAPOLYMERASE, WHILE PROTEIN STRUCTURES OF TREMBL ENTRIES SEQUENCES FOUND IN SHERLOCC PROGRAM OUTPUTS WERE NOT COMPLETE. CONCLUSIONS: BASED ON THE LOCATION OF DETECTED RCCS IN THE STRUCTURE OF HBV PROTEINS, IT WAS FOUND THAT THESE RCCS MAY HAVE A CRITICAL ROLE IN CORRECT FOLDING OF HBV PROTEINS AND CAN BE CONSIDERED AS DRUG TARGETS. THE RESULTS OF THIS STUDY PROVIDE NEW AND DEEP PERSPECTIVES ABOUT STRUCTURE OF HBV PROTEINS FOR FURTHER RESEARCHES AND DESIGNING NEW DRUGS FOR TREATMENT OF HBV.","RARE CODON CLUSTER; HEPATITIS B VIRUS; COMPUTATIONAL ANALYSIS; HOMOLOGY MODELING","HIV-1 REVERSE-TRANSCRIPTASE; E-ANTIGEN PRECURSOR; FAMILIES DATABASE; GENETIC DIVERSITY; ESCHERICHIA-COLI; DATA-BANK; X-GENE; POLYMERASE; RNA; TRANSLATION","ENGLISH","ARTICLE","ARTICLE",0,"ABOU JAOUDE G, 2005, J VIROL, V79, P10460, DOI 10.1128/JVI.79.16.10460-10644.2005.;ALEXOPOULOU A, 2009, ANN GASTROENTEROL, V22, P13.;BAIROCH A, 1996, NUCLEIC ACIDS RES, V24, P21, DOI 10.1093/NAR/24.1.21.;BARTHOLOMEUSZ A, 2006, J MED VIROL, V78, PS52, DOI 10.1002/JMV.20608.;BATEMAN A, 2004, NUCLEIC ACIDS RES, V32, PD138, DOI 10.1093/NAR/GKH121.;BERMAN HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/NAR/28.1.235.;BINA SAMANEH, 2015, ASIAN PAC J CANCER PREV, V16, P6073.;CAO F, 2014, J VIRAL HEPATITIS, V21, P882, DOI 10.1111/JVH.12225.;CHARTIER M, 2012, BIOINFORMATICS, V28, P1438, DOI 10.1093/BIOINFORMATICS/BTS149.;CHEN P, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0060098.;CHURIN Y, 2015, HEPATOL SURG NUTR, V4, P1, DOI 10.3978/J.ISSN.2304-3881.2014.12.08.;CLARKE TF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-118.;CLARKE TF, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0003412.;DA SILVEIRA NJF, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-1.;DAGA PR, 2010, PROTEIN SCI, V19, P796, DOI 10.1002/PRO.359.;DELANO WL, PYMOL MOL GRAPHICS S.;DELIUS H, 1983, J VIROL, V47, P337.;ECHEVARRIA JM, 2006, J MED VIROL, V78, PS36, DOI 10.1002/JMV.20605.;EDDY S, HMMER USER GUIDE 200.;FATTAHI MOHAMMADREZA, 2014, MIDDLE EAST J DIG DIS, V6, P214.;FINN RD, 2016, NUCLEIC ACIDS RES, V44, PD279, DOI 10.1093/NAR/GKV1344.;FINN RD, 2010, NUCLEIC ACIDS RES, V38, PD211, DOI 10.1093/NAR/GKP985.;FUNK A, 2007, WORLD J GASTROENTERO, V13, P91, DOI 10.3748/WJG.V13.I1.91.;GANEM D, 2001, FIELDS VIROLOGY, V2, P2923.;GARCIA PD, 1988, J CELL BIOL, V106, P1093, DOI 10.1083/JCB.106.4.1093.;GLEBE D, 2005, GASTROENTEROLOGY, V129, P234, DOI 10.1053/J.GASTRO.2005.03.090.;GLEBE D, 2007, WORLD J GASTROENTERO, V13, P65.;JUNKER M, 1987, NUCLEIC ACIDS RES, V15, P10117, DOI 10.1093/NAR/15.24.10117.;KAMER G, 1984, NUCLEIC ACIDS RES, V12, P7269, DOI 10.1093/NAR/12.18.7269.;KAY A, 2007, VIRUS RES, V127, P164, DOI 10.1016/J.VIRUSRES.2007.02.021.;KIDDLJUNGGREN K, 1995, J GEN VIROL, V76, P2119, DOI 10.1099/0022-1317-76-9-2119.;KOMAR AA, 1995, FEBS LETT, V376, P195, DOI 10.1016/0014-5793(95)01275-0.;KRAMVIS A, 2014, INTERVIROLOGY, V57, P141, DOI 10.1159/000360947.;KYPR J, 1986, BIOCHEM BIOPH RES CO, V139, P1094, DOI 10.1016/S0006-291X(86)80289-3.;LAINE S, 2002, J VIROL METHODS, V103, P67, DOI 10.1016/S0166-0934(02)00019-8.;LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944.;LINGNER J, 1997, SCIENCE, V276, P561, DOI 10.1126/SCIENCE.276.5312.561.;LOCARNINI S, 2004, SEMIN LIVER DIS, V24, P3, DOI 10.1055/S-2004-828672.;LOVELL SC, 2003, PROTEINS, V50, P437, DOI 10.1002/PROT.10286.;MAGNIUS LO, 1995, INTERVIROLOGY, V38, P24, DOI 10.1159/000150411.;MAURO VP, 2014, TRENDS MOL MED, V20, P604, DOI 10.1016/J.MOLMED.2014.09.003.;MEIER A, 2013, HEPATOLOGY, V58, P31, DOI 10.1002/HEP.26181.;MIZOKAMI M, 1997, J MOL EVOL, V44, PS83, DOI 10.1007/PL00000061.;MORTAZAVI M, 2016, TRENDS PHARM SCI, V2.;MORTAZAVI M, 2011, PROTEIN ENG DES SEL, V24, P893, DOI 10.1093/PROTEIN/GZR051.;NAKAMURA Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/NAR/28.1.292.;NORDER H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872.;NORDER H, 1992, J GEN VIROL, V73, P1201, DOI 10.1099/0022-1317-73-5-1201.;OCAMA PONSIANO, 2005, AM J MED, V118, P1413.;ONO-NITA SK, 1999, HEPATOLOGY, V29, P939, DOI 10.1002/HEP.510290340.;PASEK M, 1979, NATURE, V282, P575, DOI 10.1038/282575A0.;POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/J.1460-2075.1989.TB08565.X.;RAHMAN MA, 2016, SPRINGERPLUS, V5, DOI 10.1186/S40064-016-1840-2.;RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6.;RENNER M, 1995, J HEPATOL, V23, P53, DOI 10.1016/0168-8278(95)80311-4.;ROBERTS LISA, 2009, EMBO REP, V10, P449, DOI 10.1038/EMBOR.2009.56.;ROBERTSON BH, 2002, REV MED VIROL, V12, P133, DOI 10.1002/RMV.348.;ROSANO GMC, 2009, CLIMACTERIC, V12, P41, DOI 10.1080/13697130903012306.;SCHWEDE T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/NAR/GKG520.;SONNHAMMER ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO,2-L.;SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X.;SPENCER PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/J.JMB.2012.06.010.;SUMMERS J, 1975, P NATL ACAD SCI USA, V72, P4597, DOI 10.1073/PNAS.72.11.4597.;TANTILLO C, 1994, J MOL BIOL, V243, P369, DOI 10.1006/JMBI.1994.1665.;THANARAJ TA, 1996, PROTEIN SCI, V5, P1973, DOI 10.1002/PRO.5560051003.;TONG SP, 2013, EMERG MICROBES INFEC, V2, DOI [10.1038/EMI2013.10, 10.1038/EMI.2013.10].;TU XY, 2010, NAT STRUCT MOL BIOL, V17, P1202, DOI 10.1038/NSMB.1908.;VAN HEMERT FJ, 2008, VIROLOGY, V370, P362, DOI 10.1016/J.VIROL.2007.08.036.;VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5.;WAINBERG MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/SCIENCE.271.5253.1282.;WANG J, 1991, J VIROL, V65, P5080.;WIDMANN M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-207.;ZHANG DK, 2010, INFECT GENET EVOL, V10, P84, DOI 10.1016/J.MEEGID.2009.10.006.;ZHANG Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40.","MALEKPOUR, A (REPRINT AUTHOR), LEGAL MED ORG IRAN, LEGAL MED RES CTR, TEHRAN, IRAN.;MORTAZAVI, MOJTABA, GRAD UNIV ADV TECHNOL, INST SCI \& HIGH TECHNOL \& ENVIRONM SCI, DEPT BIOTECHNOL, KERMAN, IRAN.;ZARENEZHAD, MOHAMMAD, FAKHRZAD, ALI, SHIRAZ UNIV MED SCI, GASTROENTEROHEPATOL RES CTR, SHIRAZ, IRAN.;ZARENEZHAD, MOHAMMAD, GHOLAMZADEH, SAEID, MALEKPOUR, ABDORRASOUL, LEGAL MED ORG IRAN, LEGAL MED RES CTR, TEHRAN, IRAN.;ALAVIAN, SEYED MOAYED, BAQIYATALLAH UNIV MED SCI, MIDDLE EAST LIVER DIS CTR, BAQIYATALLAH RES CTR GASTROENTEROL \& LIVER DIS, TEHRAN, IRAN.;GHORBANI, MOHAMMAD, FASA UNIV MED SCI, SCH MED, DEPT PATHOL, FASA, IRAN.;DEHGHANI, REZA, SHIRAZ UNIV MED SCI, SCH MED, PHARMACOL DEPT, SHIRAZ, IRAN.;MESHKIBAF, MOHAMMADHASAN, FASA UNIV MED SCI, SCH MED, DEPT BIOCHEM, FASA, IRAN.","10.5812/HEPATMON.39909","PATERSWEG 22,, HOENSBROEK, LIMBURG 6431 GC, NETHERLANDS","E39909",NA,NA,NA,NA,"1735-143X","10",NA,"KOWSAR PUBL","16",2016,"ISI000388297600008","74","GASTROENTEROLOGY \& HEPATOLOGY","7","GASTROENTEROLOGY \& HEPATOLOGY","IMMURASOULYAHOO.COM",NA,"EC7EA",NA,"MALEKPOUR, A (REPRINT AUTHOR), LEGAL MED ORG IRAN, LEGAL MED RES CTR, TEHRAN, IRAN","ISI","GRAD UNIV ADV TECHNOL;SHIRAZ UNIV MED SCI;LEGAL MED RES CTR;BAQIYATALLAH UNIV MED SCI;FASA UNIV MED SCI;SHIRAZ UNIV MED SCI;FASA UNIV MED SCI","LEGAL MED RES CTR",NA,"MORTAZAVI M, 2016, HEPAT MON","MORTAZAVI M, 2016, HEPAT MON"
"BOJAHR J, 2016, THEOR APPL GENET","BOJAHR J;NHENGIWA O;KREZDORN N;ROTTER B;SAAL B;RUGE WEHLING B;STRUCK C;WINTER P","MASSIVE ANALYSIS OF CDNA ENDS (MACE) REVEALS A CO-SEGREGATING CANDIDATE GENE FOR LPPG1 STEM RUST RESISTANCE IN PERENNIAL RYEGRASS (LOLIUM PERENNE)","THEORETICAL AND APPLIED GENETICS","THEOR. APPL. GENET.","MOLECULAR MARKERS INCLUDING A POTENTIAL RESISTANCE GENE CO-SEGREGATING WITH THE LPPG1 STEM RUST RESISTANCE LOCUS IN PERENNIAL RYEGRASS WERE IDENTIFIED BY MASSIVE ANALYSIS OF CDNA ENDS (MACE) TRANSCRIPTOME PROFILING. STEM RUST CAUSED BY PUCCINIA GRAMINIS SUBSP. GRAMINICOLA IS A SEVERE FUNGAL DISEASE IN THE FORAGE CROP PERENNIAL RYEGRASS AND OTHER GRASSES. THE PREVIOUSLY IDENTIFIED LPPG1 LOCUS CONFERS EFFICIENT RESISTANCE AGAINST THE PATHOGEN. THE AIM OF THIS STUDY WAS TO IDENTIFY CANDIDATE GENES INVOLVED IN RUST RESISTANCE AND TO USE THEM AS A RESOURCE FOR THE DEVELOPMENT OF MOLECULAR MARKERS FOR LPPG1. TO IDENTIFY SUCH CANDIDATES, BULKED SEGREGANT ANALYSIS WAS COMBINED WITH NGS-BASED MASSIVE ANALYSIS OF CDNA ENDS (MACE) TRANSCRIPTOME PROFILING. TOTAL RNA WAS ISOLATED FROM BULKS OF INFECTED AND NON-INFECTED LEAF SEGMENTS FROM SUSCEPTIBLE AND RESISTANT GENOTYPES OF A FULL-SIBLING MAPPING POPULATION AND THEIR RESPECTIVE PARENTAL LINES AND MACE WAS PERFORMED. BIOINFORMATIC ANALYSIS DETECTED 330 RESISTANCE-SPECIFIC SNPS IN 178 TRANSCRIPTS AND 341 TRANSCRIPTS THAT WERE EXCLUSIVELY EXPRESSED IN THE RESISTANT BULK. THE SEQUENCES OF MANY OF THESE TRANSCRIPTS WERE HOMOLOGOUS TO GENES IN DISTINCT REGIONS OF CHROMOSOMES ONE AND FOUR OF THE MODEL GRASS BRACHYPODIUM DISTACHYON. OF THESE, 30 WERE GENETICALLY MAPPED TO A 50.8 CM SPANNING REGION SURROUNDING THE LPPG1 LOCUS. ONE CANDIDATE NBS-LRR GENE CO-SEGREGATED WITH THE RESISTANCE LOCUS. QUANTITATIVE ANALYSIS OF GENE EXPRESSION SUGGESTS THAT LPPG1 MEDIATES AN EFFICIENT RESISTANCE MECHANISM CHARACTERIZED BY EARLY RECOGNITION OF THE PATHOGEN, FAST DEFENSE SIGNALING AND RAPID INDUCTION OF ANTIFUNGAL PROTEINS. WE DEMONSTRATE HERE THAT MACE IS A COST-EFFICIENT, FAST AND RELIABLE TOOL THAT DETECTS POLYMORPHISMS FOR GENETIC MAPPING OF CANDIDATE RESISTANCE GENES AND SIMULTANEOUSLY REVEALS DEEP INSIGHT INTO THE MOLECULAR AND GENETIC BASE OF RESISTANCE.",NA,"ARABIDOPSIS TRANSCRIPTION FACTOR; BROAD-SPECTRUM RESISTANCE; GLUTATHIONE-S-TRANSFERASE; NEAR-ISOGENIC LINES; F-SP TRITICI; DISEASE-RESISTANCE; PLANT DEFENSE; PUCCINIA-STRIIFORMIS; EXPRESSION PATTERNS; PLASMA-MEMBRANE","ENGLISH","ARTICLE","ARTICLE",2,"ABBERTON MT, 2008, ADV AGRON, V98, P311, DOI 10.1016/S0065-2113(08)06206-X.;BECKMANN K., 2010, 60. JAHRESTAGUNG DER VEREINIGUNG DER PFLANZENZUCHTER UND SAATGUTKAUFLEUTE OSTERREICHS, 24-26 NOVEMBER 2009, RAUMBERG-GUMPENSTEIN., P101.;BECKMANN K, 2010, ENTWICKLUNG IN VITRO.;BOLTON MD, 2008, MOL PLANT MICROBE IN, V21, P1515, DOI 10.1094/MPMI-21-12-1515.;BOYES DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/PNAS.95.26.15849.;BOZKURT TO, 2010, MOL PLANT PATHOL, V11, P625, DOI [10.1111/J.1364-3703.2010.00633.X, 10.1111/J.1364-3703.2010.00633.X].;BYRNE SL, 2015, PLANT J, V84, P816, DOI 10.1111/TPJ.13037.;CARUSO C, 1996, J PROTEIN CHEM, V15, P35, DOI 10.1007/BF01886809.;CHEN CH, 2002, PLANT PHYSIOL, V129, P706, DOI 10.1104/PP001057.;CHIBUCOS MC, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S5.;CHOI JJ, 2008, FUNCT INTEGR GENOMIC, V8, P341, DOI 10.1007/S10142-008-0080-0.;CORAM TE, 2008, MOL PLANT PATHOL, V9, P157, DOI 10.1111/J.1364-3703.2007.00453.X.;DEAN JD, 2005, J EXP BOT, V56, P1525, DOI 10.1093/JXB/ERI145.;DESCHAMPS S, 2010, MOL BREEDING, V25, P553, DOI 10.1007/S11032-009-9357-9.;DRACATOS PM, 2008, THEOR APPL GENET, V117, P203, DOI 10.1007/S00122-008-0766-7.;FENG J, 2013, J GENET, V92, P267, DOI 10.1007/S12041-013-0260-0.;FEUILLET C, 2003, P NATL ACAD SCI USA, V100, P15253, DOI 10.1073/PNAS.2435133100.;FONDEVILLA S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/FMICB.2015.01329.;FU DL, 2005, PLANT SCI, V168, P671, DOI 10.1016/J.PLANTSCI.2004.09.032.;GAO QM, 2011, PLANT PHYSIOL, V155, P464, DOI 10.1104/PP.110.166876.;GAO ZY, 2011, P NATL ACAD SCI USA, V108, P7619, DOI 10.1073/PNAS.1104410108.;GOMEZ-GOMEZ L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8.;GUO BZ, 2011, TOXINS, V3, P737, DOI 10.3390/TOXINS3070737.;GUTTERSON N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/J.PBI.2004.04.007.;HAHN K, 1994, EUR J BIOCHEM, V226, P619, DOI 10.1111/J.1432-1033.1994.TB20088.X.;HIRATA M, 2006, THEOR APPL GENET, V113, P270, DOI 10.1007/S00122-006-0292-4.;HULBERT SH, 2007, PHYTOPATHOLOGY, V97, P1083, DOI 10.1094/PHYTO-97-9-1083.;JO YK, 2008, THEOR APPL GENET, V117, P531, DOI 10.1007/S00122-008-0797-0.;KAHL G, 2012, J PLANT BIOCHEM BIOT, V21, PS119, DOI 10.1007/S13562-012-0129-Y.;KESARWANI M, 2007, PLANT PHYSIOL, V144, P336, DOI 10.1104/PP.106.095299.;KIM HS, 2009, BIOCHEM BIOPH RES CO, V381, P424, DOI 10.1016/J.BBRC.2009.02.050.;LELLBACH H, 1994, 36 FACHT DLG AUSSCH, P89.;LIN KC, 1998, PHYSIOL MOL PLANT P, V52, P95, DOI 10.1006/PMPP.1997.0139.;LIU JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/S00299-010-0826-8.;LORENZO O, 2003, PLANT CELL, V15, P165, DOI 10.1105/TPC.007468.;MACKINTOSH CA, 2007, PLANT CELL REP, V26, P479, DOI 10.1007/S00299-006-0265-8.;MAMO BE, 2015, PHYTOPATHOLOGY, V105, P99, DOI 10.1094/PHYTO-12-13-0340-R.;MANICKAVELU A, 2010, DNA RES, V17, P211, DOI 10.1093/DNARES/DSQ009.;MARRS KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/ANNUREV.ARPLANT.47.1.127.;MCDOWELL JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/TPC.10.11.1861.;MCGRATH KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/PP.105.068544.;MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/PNAS.88.21.9828.;MOFFAT CS, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0035995.;MUYLLE H, 2005, HEREDITY, V95, P348, DOI 10.1038/SJ.HDY.6800729.;NOLD-PETRY CA, 2015, NAT IMMUNOL, V16, P354, DOI 10.1038/NI.3103.;PANTHEE DR, 2007, FUNCT INTEGR GENOMIC, V7, P291, DOI 10.1007/S10142-007-0045-8.;PFAFFL MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/NAR/30.9.E36.;PFEIFER M, 2013, PLANT PHYSIOL, V161, P571, DOI 10.1104/PP.112.207282.;PFENDER W, 2009, PHYTOPATHOLOGY, V99, P498, DOI 10.1094/PHYTO-99-5-0498.;PFENDER WF, 2013, THEOR APPL GENET, V126, P1213, DOI 10.1007/S00122-013-2048-2.;PFENDER WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/S00122-011-1546-3.;PRE M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/PP.108.117523.;R DEVELOPMENT CORE TEAM, 2008, R LANG ENV STAT COMP.;RANDHAWA M, 2014, THEOR APPL GENET, V127, P317, DOI 10.1007/S00122-013-2220-8.;RINALDI C, 2007, PLANT PHYSIOL, V144, P347, DOI 10.1104/PP.106.094987.;SCHUBIGER FX, 2010, EUPHYTICA, V176, P167, DOI 10.1007/S10681-010-0200-5.;SONG JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/PNAS.1533501100.;SORIA-GUERRA RE, 2010, THEOR APPL GENET, V120, P1315, DOI 10.1007/S00122-009-1258-0.;STEIN N, 2001, PLANT BREEDING, V120, P354, DOI 10.1046/J.1439-0523.2001.00615.X.;STUDER B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-140.;SVENSSON B, 1992, BIOCHEMISTRY-US, V31, P8767, DOI 10.1021/BI00152A012.;TAKAHASHI S, 2007, J BIOL CHEM, V282, P31744, DOI 10.1074/JBC.M703378200.;THEIS T, 2004, CELL MOL LIFE SCI, V61, P437, DOI 10.1007/S00018-003-3231-4.;TORTO-ALALIBO T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S1.;VAN DER VOSSEN E, 2003, PLANT J, V36, P867, DOI 10.1046/J.1365-313X.2003.01934.X.;VAN OOIJEN JW, 2006, JOINMAP 4 SOFTWARE C.;VARGAS WA, 2012, PLANT PHYSIOL, V158, P1342, DOI 10.1104/PP.111.190397.;VOORRIPS RE, 2002, J HERED, V93, P77, DOI 10.1093/JHERED/93.1.77.;WANG L. Z., 2011, THESIS.;WANG LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/BIOINFORMATICS/BTP612.;WANG XM, 2014, CAN J PLANT PATHOL, V36, P202, DOI 10.1080/07060661.2014.920919.;WANG YM, 2014, PLANT PATHOLOGY J, V30, P343, DOI 10.5423/PPJ.OA.06.2014.0055.;WISSER RJ, 2011, P NATL ACAD SCI USA, V108, P7339, DOI 10.1073/PNAS.1011739108.;YE J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134.;ZAWADA AM, 2014, EPIGENETICS-US, V9, P161, DOI 10.4161/EPI.26931.;ZHANG H, 2011, PLANT MOL BIOL REP, V29, P458, DOI 10.1007/S11105-010-0245-6.","BOJAHR, J (REPRINT AUTHOR), UNIV ROSTOCK, FAC AGR \& ENVIRONM SCI, GRP CROP HLTH, SATOWER STR 48, D-18059 ROSTOCK, GERMANY.;BOJAHR, JENS, STRUCK, CHRISTINE, UNIV ROSTOCK, FAC AGR \& ENVIRONM SCI, GRP CROP HLTH, SATOWER STR 48, D-18059 ROSTOCK, GERMANY.;KREZDORN, NICOLAS, ROTTER, BJOERN, WINTER, PETER, GENXPRO GMBH, ALTENHOFERALLEE 3, D-60438 FRANKFURT, GERMANY.;NHENGIWA, OTTILIA, SAAL, BERNHARD, SAATZUCHT STEINACH GMBH \& CO KG, WITTELSBACHERSTR 15, D-94377 STEINACH, GERMANY.;RUGE-WEHLING, BRIGITTE, INST BREEDING RES AGR CROPS, FED RES CTR CULTIVATED PLANTS, RUDOLF SCHICK PL 3A, D-18190 OT GROSS LUSEWITZ, SANITZ, GERMANY.","10.1007/S00122-016-2749-4","233 SPRING ST, NEW YORK, NY 10013 USA",NA,NA,"FEDERAL MINISTRY OF FOOD AND AGRICULTURE (BMEL) BASED ON A DECISION OF THE PARLIAMENT OF THE FEDERAL REPUBLIC OF GERMANY VIA THE FEDERAL OFFICE FOR AGRICULTURE AND FOOD (BLE) UNDER THE INNOVATION SUPPORT PROGRAM [FKZ 511-06.01-28-1-45.010-10]","THE PROJECT WAS SUPPORTED BY FUNDS OF THE FEDERAL MINISTRY OF FOOD AND AGRICULTURE (BMEL) BASED ON A DECISION OF THE PARLIAMENT OF THE FEDERAL REPUBLIC OF GERMANY VIA THE FEDERAL OFFICE FOR AGRICULTURE AND FOOD (BLE) UNDER THE INNOVATION SUPPORT PROGRAM (FKZ 511-06.01-28-1-45.010-10).",NA,"0040-5752","10","1915-1932","SPRINGER","129",2016,"ISI000383711900008","76","AGRICULTURE, PLANT SCIENCES, GENETICS \& HEREDITY","12","AGRONOMY, PLANT SCIENCES, GENETICS \& HEREDITY, HORTICULTURE","JENS.BOJAHRUNI-ROSTOCK.DE",NA,"DW5UG",NA,"BOJAHR, J (REPRINT AUTHOR), UNIV ROSTOCK, FAC AGR \& ENVIRONM SCI, GRP CROP HLTH, SATOWER STR 48, D-18059 ROSTOCK, GERMANY","ISI","UNIV ROSTOCK;INST BREEDING RES AGR CROPS","UNIV ROSTOCK",NA,"BOJAHR J, 2016, THEOR APPL GENET","BOJAHR J, 2016, THEOR APPL GENET"
"MHORA TT, 2016, PHYTOPATHOLOGY","MHORA TT;ERNEST EG;WISSER RJ;EVANS TA;PATZOLDT ME;GREGORY NF;WESTHAFER SE;POISON SW;DONOFRIO NM","GENOTYPING-BY-SEQUENCING TO PREDICT RESISTANCE TO LIMA BEAN DOWNY MILDEW IN A DIVERSITY PANEL","PHYTOPATHOLOGY","PHYTOPATHOLOGY","LIMA BEAN IS AFFECTED BY SEVERE DOWNY MILDEW EPIDEMICS CAUSED BY THE OOMYCETE PHYTOPHTHORA PHASEOLI. THERE ARE SIX DOCUMENTED RACES OF P. PHASEOLI (A TO F). RACE F IS CURRENTLY PREDOMINANT IN THE MID-ATLANTIC REGION, CREATING THE NEED FOR RESISTANT LIMA BEAN CULTIVARS WITH DESIRABLE AGRONOMIC CHARACTERISTICS. IN ORDER TO DEVELOP MARKERS FOR DETECTING RACE F RESISTANCE, BULKED SEGREGANT ANALYSIS (BSA) USING GENOTYPING-BY-SEQUENCING (GBS) WAS USED ON A BIPARENTAL F-2 POPULATION COMPRISED OF 216 LIMA BEAN PROGENY SEGREGATING FOR A DOMINANT RACE F RESISTANCE PHENOTYPE. DATA WERE ANALYZED USING A CUSTOM BIOINFORMATIC ANALYSIS PIPELINE (REDREP). KOMPETITIVE ALLELE-SPECIFIC POLYMERASE CHAIN REACTION ASSAYS WERE DEVELOPED USING 12 GBS MARKERS ASSOCIATED WITH THE RACE F RESISTANCE PHENOTYPE. USING THESE ASSAYS, THE F-2 POPULATION WAS USED TO MAP THE RACE F RESISTANCE LOCUS. SEVEN MARKERS WERE IN LINKAGE AND SIGNIFICANTLY ASSOCIATED WITH RACE F RESISTANCE THAT MAPPED BETWEEN TWO MARKERS LOCATED APPROXIMATELY 4.88 CENTIMORGAN (CM) APART. THESE ASSAYS WERE SUCCESSFULLY USED TO GENOTYPE A NEWLY ACQUIRED LIMA BEAN DIVERSITY PANEL CONSISTING OF 256 LANDRACES, CULTIVARS, AND WILD GERMPLASM, AND A HAPLOTYPE CONSISTING OF TWO OF THE SEVEN LINKED MARKERS WAS DEMONSTRATED TO ACCURATELY PREDICT RACE F RESISTANCE. THIS CONFIRMED THE ABILITY OF OUR CUSTOMIZED METHODS TO ACCURATELY PREDICT PHENOTYPES IN DIVERSE LINES OF LIMA BEAN.",NA,"MARKER-ASSISTED SELECTION; PHASEOLUS-LUNATUS L.; DISEASE-RESISTANCE; CHLOROPLAST DNA; GENOMICS; GENES; RICE; FRAMEWORK; LEGUMES; BLAST","ENGLISH","ARTICLE","ARTICLE",1,"ANDREWS S., 2010, FASTQC QUALITY CONTR.;BONIFACIO EM, 2012, THEOR APPL GENET, V124, P1513, DOI 10.1007/S00122-012-1806-X.;BROMAN KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9\_1.;CATCHEN J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/MEC.12354.;DAVIDSON CR, 2008, PLANT DIS, V92, P670, DOI 10.1094/PDIS-92-5-0670.;DAVIDSON CR, 2002, PLANT DIS, V86, P1049, DOI 10.1094/PDIS.2002.86.9.1049A.;DEBOUCK DG, 1989, ANN REPT BEAN IMPROV, V32, P58.;DEPRISTO MA, 2011, NAT GENET, V43, P491, DOI 10.1038/NG.806.;EDGAR RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/BIOINFORMATICS/BTQ461.;ELSHIRE RJ, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0019379.;ERNEST E. G., 2011, ANN REP BEAN IMPROV, V54, P98.;EVANS TA, 2007, PLANT DIS, V91, P128, DOI 10.1094/PDIS-91-2-0128.;FOFANA B, 2001, GENET RESOUR CROP EV, V48, P437, DOI 10.1023/A:1012016030318.;FOFANA B, 1999, THEOR APPL GENET, V98, P202, DOI 10.1007/S001220051059.;FUKUOKA S, 2015, SCI REP-UK, V5, DOI 10.1038/SREP07773.;GOODSTEIN DM, 2012, NUCLEIC ACIDS RES, V40, PD1178, DOI 10.1093/NAR/GKR944.;HIREMATH PJ, 2012, PLANT BIOTECHNOL J, V10, P716, DOI 10.1111/J.1467-7652.2012.00710.X.;HUANG N, 1997, THEOR APPL GENET, V95, P313, DOI 10.1007/S001220050565.;KEE E., 1997, HORTTECHNOLOGY, V7, P119.;KORESSAAR T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/BIOINFORMATICS/BTM091.;KUMAR J, 2011, PLANT BREEDING, V130, P297, DOI 10.1111/J.1439-0523.2011.01851.X.;LI H, 2013, ARXIV13033997QBIOGN.;LI J, 2012, NUCLEIC ACIDS RES, V40, PD1221, DOI 10.1093/NAR/GKR939.;LI ZK, 1999, MOL GEN GENET, V261, P58, DOI 10.1007/S004380050941.;MACKIE W. W., 1943, HILGARDIA, V15, P1.;MARGARIDO G. R. A., 2013, ONEMAP TUTORIAL SOFT.;MCKENNA A, 2010, GENOME RES, V20, P1297, DOI 10.1101/GR.107524.110.;MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/PNAS.88.21.9828.;NIELSEN R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/NRG2986.;NIENHUIS J, 1995, J AM SOC HORTIC SCI, V120, P300.;NIU ZX, 2011, GENETICS, V187, P1011, DOI 10.1534/GENETICS.110.123588.;PEDERSEN WL, 1988, ANNU REV PHYTOPATHOL, V26, P369, DOI 10.1146/ANNUREV.PY.26.090188.002101.;POLAND JA, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0032253.;SALGADO AG, 1995, GENET RESOUR CROP EV, V42, P15.;SCHMUTZ J, 2014, NAT GENET, V46, P707, DOI 10.1038/NG.3008.;SCHNEIDER KA, 1997, CROP SCI, V37, P51, DOI 10.2135/CROPSCI1997.0011183X003700010008X.;SEMAGN K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/S11032-013-9917-X.;SERRANO-SERRANO ML, 2012, CROP SCI, V52, P1698, DOI 10.2135/CROPSCI2011.12.0642.;SERRANO-SERRANO ML, 2010, MOL PHYLOGENET EVOL, V54, P76, DOI 10.1016/J.YMPEV.2009.08.028.;SHANER G, 1973, PHYTOPATHOLOGY, V63, P867, DOI 10.1094/PHYTO-63-867.;STAVELY J. R, 1991, ANN REP BEAN IMPROV, V34, P155.;THAXTER R, 1889, ANN REP CONN AGR EXP, V1890, P167.;THOMAS CA, 1980, CROP SCI, V20, P553, DOI 10.2135/CROPSCI1980.0011183X002000040044X.;TOLOMEO V., 2013, CALIFORNIA VEGETABLE, P34.;TORRES AM, 2010, FIELD CROP RES, V115, P243, DOI 10.1016/J.FCR.2008.12.002.;UNTERGASSER A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/NAR/GKS596.;WESTER R. E., 1959, ANN REP BEAN IMPR CO, P18.;WESTER R. E, 1961, ANN REP BEAN IMPR CO, P16.;ZAUMEYER W. J., 1968, ANN REP BEAN IMPR CO, P51.","DONOFRIO, NM (REPRINT AUTHOR), UNIV DELAWARE, DEPT PLANT \& SOIL SCI, NEWARK, DE 19716 USA.;MHORA, T. T., WISSER, R. J., EVANS, T. A., PATZOLDT, M. E., GREGORY, N. F., WESTHAFER, S. E., DONOFRIO, N. M., UNIV DELAWARE, DEPT PLANT \& SOIL SCI, NEWARK, DE 19716 USA.;ERNEST, E. G., UNIV DELAWARE, RES \& EDUC CTR, GEORGETOWN, DE USA.;POISON, S. W., UNIV DELAWARE, CTR BIOINFORMAT \& COMPUTAT BIOL, NEWARK, DE 19716 USA.","10.1094/PHYTO-02-16-0087-FI","3340 PILOT KNOB ROAD, ST PAUL, MN 55121 USA",NA,NA,"NATIONAL INSTITUTE OF FOOD AND AGRICULTURE, U.S. DEPARTMENT OF AGRICULTURE [2012-51181-19776], DELAWARE DEPARTMENT OF AGRICULTURE, DELAWARE IDEA NETWORK OF BIOMEDICAL RESEARCH [NIGMS P20 GM103446], STATE OF DELAWARE, DELAWARE BIOTECHNOLOGY INSTITUTE","THIS MATERIAL IS BASED UPON WORK THAT IS SUPPORTED BY THE NATIONAL INSTITUTE OF FOOD AND AGRICULTURE, U.S. DEPARTMENT OF AGRICULTURE UNDER AWARD NUMBER 2012-51181-19776 AND THE DELAWARE DEPARTMENT OF AGRICULTURE. EXPERTISE AND COMPUTATIONAL INFRASTRUCTURE PROVIDED BY THE UNIVERSITY OF DELAWARE BIOINFORMATICS CORE FACILITY WAS MADE POSSIBLE THROUGH SUPPORT FROM DELAWARE IDEA NETWORK OF BIOMEDICAL RESEARCH (NIGMS P20 GM103446), THE STATE OF DELAWARE, AND THE DELAWARE BIOTECHNOLOGY INSTITUTE. WE ALSO ACKNOWLEDGE S. KUNJETI FOR CARRYING OUT CULTURE MAINTENANCE AND INOCULUM PREPARATIONS AMONG OTHER DUTIES THAT ALLOWED THIS PROJECT TO BE SUCCESSFUL.",NA,"0031-949X","10","1152-1158","AMER PHYTOPATHOLOGICAL SOC","106",2016,"ISI000383820100009","49","PLANT SCIENCES","22","PLANT SCIENCES","NDONOFUDEL.EDU",NA,"DW7GV",NA,"DONOFRIO, NM (REPRINT AUTHOR), UNIV DELAWARE, DEPT PLANT \& SOIL SCI, NEWARK, DE 19716 USA","ISI","UNIV DELAWARE;UNIV DELAWARE;UNIV DELAWARE","UNIV DELAWARE",NA,"MHORA TT, 2016, PHYTOPATHOLOGY","MHORA TT, 2016, PHYTOPATHOLOGY"
"ZHONG J, 2016, BRAIN RES","ZHONG J;JIANG L;CHENG C;HUANG Z;ZHANG H;LIU H;HE J;CAO F;PENG J;JIANG Y;SUN X","ALTERED EXPRESSION OF LONG NON-CODING RNA AND MRNA IN MOUSE CORTEX AFTER TRAUMATIC BRAIN INJURY","BRAIN RESEARCH","BRAIN RES.","BACKGROUND AND OBJECTIVE: THE PRESENT STUDY AIMS TO DETECT THE ALTERED LNCRNA EXPRESSION IN THE MOUSE CORTEX AFTER TRAUMATIC BRAIN INJURY (TBI). WE ALSO SIMULTANEOUSLY DETECTED THE ALTERED MRNA PROFILE TO FURTHER ANALYZE THE POSSIBLE FUNCTION OF LNCRNA. METHOD: C57BL/6 MICE (N=18) WERE USED TO CONSTRUCT A CONTROLLED CORTICAL IMPACT MODEL. AT 24 H POST-TBI, THE CORTEX AROUND INJURY SITE WAS COLLECTED AND THE TOTAL RNA WAS EXTRACTED TO CONSTRUCT THE CDNA LIBRARY. RNA SEQUENCING (RNA-SEQ) WAS CARRIED OUT FOLLOWED BY RT-PCR FOR CONFIRMATION. BIOINFORMATIC ANALYSIS (INCLUDING GO ANALYSIS, KEGG PATHWAY AND CO-EXPRESSION ANALYSIS) ALSO WERE PERFORMED. RESULTS: A TOTAL OF 64,530 TRANSCRIPTS WERE DETECTED IN THE CURRENT SEQUENCING STUDY, IN WHICH 27,457 TRANSCRIPTS WERE IDENTIFIED AS MRNA AND 37,073 TRANSCRIPTS AS LNCRNA. A TOTAL OF 1580 MRNAS (1430 UP REGULATED AND 150 DOWN-REGULATED) AND 823 LNCRNAS (667 UP-REGULATED AND 156 DOWN-REGULATED) WERE SIGNIFICANTLY CHANGED ACCORDING TO THE CRITERIA ((L)LOG(2)((FOLD CHANGE))VERTICAL BAR > 1 AND P < 0.05). THESE ALTERED MRNAS WERE MAINLY RELATED TO INFLAMMATORY AND IMMUNOLOGICAL ACTIVITY, METABOLISM, NEURONAL AND VASCULAR NETWORK. THE EXPRESSION OF SINGLE LNCRNA MAY BE RELATED WITH SEVERAL MRNAS, AND SO WAS THE MRNA. ALSO, A TOTAL OF 360 NEW MRNAS AND 8041 NEW LNCRNAS WERE IDENTIFIED. THE GOOD REPRODUCIBILITY AND RELIABILITY OF RNA-SEQ WERE CONFIRMED BY RT-PCR. CONCLUSION: NUMEROUS LNCRNAS AND MRNAS WERE SIGNIFICANTLY ALTERED IN MOUSE CORTEX AROUND THE INJURY SITE 24 H AFTER TBI. OUR PRESENT DATA MAY PROVIDE A PROMISING APPROACH FOR FURTHER STUDY ABOUT TBI. (C) 2016 ELSEVIER B.V. ALL RIGHTS RESERVED.","TRAUMATIC BRAIN INJURY; LONG NONCODING RNA","PROMOTES CELL-PROLIFERATION; RAT CEREBRAL-CORTEX; GENE-EXPRESSION; POOR-PROGNOSIS; GASTRIC-CANCER; DISEASE; PROFILE; IDENTIFICATION; ACTIVATION; MALAT1","ENGLISH","ARTICLE","ARTICLE",10,"BALI KK, 2014, TRENDS MOL MED, V20, P437, DOI 10.1016/J.MOLMED.2014.05.006.;BATISTA PJ, 2013, CELL, V152, P1298, DOI 10.1016/J.CELL.2013.02.012.;BERNARD D, 2010, EMBO J, V29, P3082, DOI 10.1038/EMBOJ.2010.199.;BHAN A, 2013, J MOL BIOL, V425, P3707, DOI 10.1016/J.JMB.2013.01.022.;BIRNEY E, 2007, NATURE, V447, P799, DOI 10.1038/NATURE05874.;CARPENTER S, 2013, SCIENCE, V341, P789, DOI 10.1126/SCIENCE.1240925.;DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/SCIENCE.6171034.;FAGHIHI MA, 2008, NAT MED, V14, P723, DOI 10.1038/NM1784.;FRANCELLE L, 2015, NEUROBIOL AGING, V36, DOI 10.1016/J.NEUROBIOLAGING.2014.11.014.;GOH CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/JMBI.2000.3732.;GOMEZ JA, 2013, CELL, V152, P743, DOI 10.1016/J.CELL.2013.01.015.;HANNON MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/JC.2013-1555.;HUANG XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/NEU.2013.2996.;IMAMURA K, 2014, MOL CELL, V53, P393, DOI 10.1016/J.MOLCEL.2014.01.009.;JIANG BC, 2015, MOL PAIN, V11, DOI 10.1186/S12990-015-0047-9.;JIANG Y, 2012, J NEUROTRAUM, V29, P2332, DOI 10.1089/NEU.2012.2362.;JOHNSON R, 2012, NEUROBIOL DIS, V46, P245, DOI 10.1016/J.NBD.2011.12.006.;KOBORI N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5.;LEI P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/J.BRAINRES.2009.05.074.;LI ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/NEU.2011.1807.;LI ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/PNAS.1313768111.;LIU JY, 2014, CELL DEATH DIS, V5, DOI 10.1038/CDDIS.2014.466.;LIU L, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0103948.;LOANE DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/J.TIPS.2010.09.005.;LONG Y, 2003, J NEUROSCI RES, V71, P710, DOI 10.1002/JNR.10524.;LUCAFO M, 2015, CURR MOL MED, V15, P94, DOI 10.2174/1566524015666150114122354.;MATZILEVICH DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/JNR.10157.;MERCER TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/PNAS.0706729105.;MERCER TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/NRG2521.;MICHALIK KM, 2014, CIRC RES, V114, P1389, DOI 10.1161/CIRCRESAHA.114.303265.;NAGANO T, 2011, CELL, V145, P178, DOI 10.1016/J.CELL.2011.03.014.;NATALE JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777.;NG SY, 2013, MOL CELL, V51, P349, DOI 10.1016/J.MOLCEL.2013.07.017.;NG SY, 2012, EMBO J, V31, P522, DOI 10.1038/EMBOJ.2011.459.;PUTHANVEETIL P, 2015, J CELL MOL MED, V19, P1418, DOI 10.1111/JCMM.12576.;QURESHI IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/NRN3234.;RAMOS AD, 2013, CELL STEM CELL, V12, P616, DOI 10.1016/J.STEM.2013.03.003.;RAO VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/JNR.10486.;RUAN YL, 1997, J NEUROSCI RES, V50, P383, DOI 10.1002/(SICI)1097-4547(19971101)50:3<383::AID-JNR4>3.0.CO,2-E.;SHARMA A, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0112019.;SHI ZH, 2015, CELL PHYSIOL BIOCHEM, V36, P542, DOI 10.1159/000430119.;SUN M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-319.;SUN M, 2014, TUMOR BIOL, V35, P1065, DOI 10.1007/S13277-013-1142-Z.;THUM T, 2014, CIRC RES, V114, P1366, DOI 10.1161/CIRCRESAHA.114.303896.;TRAPNELL C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/NBT.1621.;WANG GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/S13311-012-0157-2.;WERNER C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/BJA/AEM131.;WILHELM BT, 2008, NATURE, V453, P1239, DOI 10.1038/NATURE07002.;YAN K, 2016, INT J MOL SCI, V17, DOI 10.3390/IJMS17010132.;YOSHIOKA N, 2010, J COMP NEUROL, V518, P3867, DOI 10.1002/CNE.22431.;YU B, 2013, NEUROSCI LETT, V534, P117, DOI 10.1016/J.NEULET.2012.12.014.;ZANGRANDO J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-460.;ZHONG J., 2016, NEUROSCIENCE.;ZHU JJ, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0101707.;ZHU L, 2015, BMC NEUROSCI, V16, DOI 10.1186/S12868-015-0157-3.","SUN, XC (REPRINT AUTHOR), CHONGQING MED UNIV, AFFILIATED HOSP 1, DEPT NEUROSURG, CHONGQING 400016, PEOPLES R CHINA.;ZHONG, JIANJUN, JIANG, LI, CHENG, CHONGJIE, HUANG, ZHIJIAN, ZHANG, HONGRONG, LIU, HAN, HE, JUNCHI, SUN, XIAOCHUAN, CHONGQING MED UNIV, AFFILIATED HOSP 1, DEPT NEUROSURG, CHONGQING 400016, PEOPLES R CHINA.;CAO, FANG, ZUNYI MED COLL, AFFILIATED HOSP 1, DEPT CEREBROVASC, ZUNYI 653000, GUIZHOU, PEOPLES R CHINA.;PENG, JIANHUA, JIANG, YONG, SOUTHWEST MED UNIV, AFFILIATED HOSP, DEPT NEUROSURG, LUZHOU 646000, SICHAUN, PEOPLES R CHINA.","10.1016/J.BRAINRES.2016.07.002","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA [81571159, 81371319], CHONGQING GRADUATE INNOVATION PROJECT [40010200100417]","THIS WORK WAS SUPPORTED BY GRANTS FROM THE NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA (GRANT NO.: 81571159, 81371319) AND THE CHONGQING GRADUATE INNOVATION PROJECT (GRANT NO.: 40010200100417). WE EXPRESS SPECIAL ACKNOWLEDGEMENT TO ``CHONGQING KEY LABROTORY OF BIOCHEMISTRY AND MOLECULAR PHARMACOLOGY'' FOR PROVIDING EXPERIMENTAL PLATFORM.",NA,"0006-8993",NA,"589-600","ELSEVIER SCIENCE BV","1646",2016,"ISI000381844700066","55","NEUROSCIENCES \& NEUROLOGY","15","NEUROSCIENCES",NA,NA,"DT9TH",NA,"SUN, XC (REPRINT AUTHOR), CHONGQING MED UNIV, AFFILIATED HOSP 1, DEPT NEUROSURG, CHONGQING 400016, PEOPLES R CHINA","ISI","CHONGQING MED UNIV;ZUNYI MED COLL;SOUTHWEST MED UNIV","CHONGQING MED UNIV",NA,"ZHONG J, 2016, BRAIN RES","ZHONG J, 2016, BRAIN RES"
"VIEGAS M, 2016, INFECT GENET EVOL","VIEGAS M;GOYA S;MISTCHENKO AS","SIXTEEN YEARS OF EVOLUTION OF HUMAN RESPIRATORY SYNCYTIAL VIRUS SUBGROUP A IN BUENOS AIRES, ARGENTINA: GA2 THE PREVALENT GENOTYPE THROUGH THE YEARS","INFECTION GENETICS AND EVOLUTION","INFECT. GENET. EVOL.","HUMAN RESPIRATORY SYNCYTIAL VIRUS (HRSV) IS THEMAIN VIRAL CAUSE OF ACUTE LOWER RESPIRATORY TRACT INFECTIONS (LRTI) IN CHILDREN WORLDWIDE. IN RECENT YEARS, SEVERAL PRECLINICAL TRIALS WITH VACCINE CANDIDATES HAVE BEEN REPORTED. IT IS IN THIS SENSE THAT MOLECULAR EPIDEMIOLOGICAL STUDIES BECOME IMPORTANT. UNDERSTANDING VIRAL DISPERSION PATTERNS BEFORE AND AFTER THE IMPLEMENTATION OF A VACCINE CAN PROVIDE INSIGHT INTO THE EFFECTIVENESS OF THE CONTROL STRATEGIES. IN THIS WORK WE ANALYZED THE MOLECULAR EPIDEMIOLOGY OF HRSV-A OVER A PERIOD OF SIXTEEN YEARS (1999-2014) IN BUENOS AIRES. BY BIOINFORMATIC TOOLS WE ANALYZED 169 SEQUENCES OF THE G GLYCOPROTEIN GENE FROM HOSPITALIZED PEDIATRIC PATIENTS WITH LRTI. WE FOUND THAT GA2 WAS THE MOST PREVALENT GENOTYPE (73.35\%). GA5 GENOTYPE CO-CIRCULATED IN OUR REGION UNTIL 2009 WHEN IT WAS NO LONGER DETECTED, EXCEPT IN 2011. THE RECENTLY GLOBALLY EMERGING ON1 LINEAGE WITH A 72-NT DUPLICATION INCREASED ITS FREQUENCY TO BECOME THE ONLY LINEAGE DETECTED IN BUENOS AIRES IN 2014. BY DISCRETE PHYLOGEOGRAPHIC ANALYSIS OF GLOBAL ON1 STRAINS WE COULD DETERMINE THAT PANAMA COULD BE THE LOCATION OF THE MRCA DATED JUNE 20, 2010, AND THIS LINEAGE COULD BE INTRODUCED IN ARGENTINA FROM SPAIN IN APRIL 2011. THIS ANALYSIS ALSO SHOWED TEMPORARY AND GEOGRAPHICAL CLUSTERING OF ON1 STRAINS OBSERVED AS PHYLOGENETIC CLADES WITH STRAINS EXCLUSIVELY ASSOCIATED FROM A SINGLE COUNTRY, NEVERTHELESS AMONG OUR 44 ON1 STRAINS FROM THREE OUTBREAKS (2012-2014) WE COULD ALSO DETECT POSTERIOR REINTRODUCTIONS AND CIRCULATION FROM UNITED STATES, CUBA, SOUTH KOREA, AND SPAIN. THE CONTINUOUS PHYLOGEOGRAPHIC ANALYSIS OF ONE SUBLINEAGE OF ARGENTINE ON1 STRAINS ALLOWED US TO ESTABLISH THAT THERE COULD BE A LOCAL CLUSTERING OF SOME STRAINS EVEN IN NEIGHBORHOODS. THIS WORK SHOWS THE POTENTIAL OF THIS TYPE OF BIOINFORMATIC TOOLS IN THE CONTEXT OF A FUTURE VACCINE SURVEILLANCE NETWORK TO TRACE THE SPREAD OF NEW GENETIC LINEAGES IN HUMAN POPULATIONS. (C) 2016 ELSEVIER B.V. ALL RIGHTS RESERVED.","HRSV; GENOTYPES; ON1 GENETIC LINEAGE; PHYLOGEOGRAPHY; CIRCULATION PATTERNS","G-PROTEIN; 60-NUCLEOTIDE DUPLICATION; GROUP-A; MOLECULAR EPIDEMIOLOGY; HOSPITALIZED CHILDREN; CIRCULATION PATTERNS; GENETIC DIVERSITY; SOUTH-AFRICA; ON1; REPLACEMENT","ENGLISH","ARTICLE","ARTICLE",5,"AGOTI CN, 2015, J VIROL, V89, P3444, DOI 10.1128/JVI.03391-14.;AGOTI CN, 2014, EMERG INFECT DIS, V20, P950, DOI 10.3201/EID2006.131438.;AVADHANULA V, 2015, J INFECT DIS, V211, P582, DOI 10.1093/INFDIS/JIU473.;BIELEJEC F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/BIOINFORMATICS/BTR481.;BLANC A, 2005, ARCH VIROL, V150, P603, DOI 10.1007/S00705-004-0412-X.;CARBALLAL G, 2001, J MED VIROL, V64, P167, DOI 10.1002/JMV.1032.;COATES HV, 1966, AM J EPIDEMIOL, V83, P299, DOI 10.1093/OXFORDJOURNALS.AJE.A120586.;COLLINS P.L., 2013, FIELDS VIROLOGY, P1086.;CUI GL, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0075020.;DAPAT IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10.;DARRIBA D, 2012, NAT METHODS, V9, P772, DOI 10.1038/NMETH.2109.;DRUMMOND AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/MOLBEV/MSS075.;DUVVURI V.R., 2015, SCI REP, V5.;ESHAGHI A, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0032807.;GARDNER PS, 1968, LANCET, V1, P597.;GUINDON S, 2010, SYST BIOL, V59, P307, DOI 10.1093/SYSBIO/SYQ010.;HOLMES EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/ANNUREV.MICRO.62.081307.162912.;HOTARD AL, 2015, J VIROL, V89, P8258, DOI 10.1128/JVI.01045-15.;KARRON RA, 2015, SCI TRANSL MED, V7, DOI 10.1126/SCITRANSLMED.AAC8463.;KARRON RA, 2013, CURR TOP MICROBIOL, V372, P259, DOI 10.1007/978-3-642-38919-1\_13.;KATZOV-ECKERT H, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0041953.;KIM YJ, 2014, INFECT GENET EVOL, V26, P103, DOI 10.1016/J.MEEGID.2014.05.007.;MAFFEY AF, 2010, PEDIATR PULM, V45, P619, DOI 10.1002/PPUL.21236.;PERET TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221.;PERET TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508.;PRETORIUS MA, 2013, J INFECT DIS, V208, PS227, DOI 10.1093/INFDIS/JIT477.;RONQUIST F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/BIOINFORMATICS/BTG180.;SHOBUGAWA Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09.;STOCKTON J, 1998, J CLIN MICROBIOL, V36, P2990.;TAMURA K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/MOLBEV/MST197.;THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/NAR/22.22.4673.;TRENTO A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006.;TRENTO A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/VIR.0.19357-0.;TRENTO A, 2015, J VIROL, V89, P7776, DOI 10.1128/JVI.00467-15.;TRENTO A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10.;VENTER M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117.;VIDELA C, 1998, CLIN DIAGN VIROL, V10, P17, DOI 10.1016/S0928-0197(98)00017-8.;VIEGAS M, 2005, J MED VIROL, V77, P302, DOI 10.1002/JMV.20457.;VIEGAS M, 2004, J INFECTION, V49, P222, DOI 10.1016/J.JINF.2003.10.006.;VOLZ EM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/JOURNAL.PCBI.1002947.","VIEGAS, M (REPRINT AUTHOR), GALLO 1330 2, RA-1425 BUENOS AIRES, DF, ARGENTINA.;VIEGAS, M., GOYA, S., MISTCHENKO, A. S., RICARDO GUTIERREZ CHILDRENS HOSP, VIROL LAB, GALLO 1330 2, RA-1425 BUENOS AIRES, DF, ARGENTINA.;VIEGAS, M., GOYA, S., CONSEJO NACL INVEST CIENT \& TECN, RA-1033 BUENOS AIRES, DF, ARGENTINA.;MISTCHENKO, A. S., COMIS INVEST CIENT PROV BUENOS AIRS CIC, MAR DEL PLATA, BUENOS AIRES, ARGENTINA.","10.1016/J.MEEGID.2016.04.034","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNOLOGICAS, ARGENTINA [PIP112-201101-00562]","THIS WORK WAS SUPPORTED BY CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNOLOGICAS, ARGENTINA (GRANT PIP112-201101-00562 TO MV). THIS RESEARCH RECEIVED NO SPECIFIC GRANT FROM ANY FUNDING AGENCY IN THE PUBLIC, COMMERCIAL, OR NOT-FOR-PROFIT SECTORS.",NA,"1567-1348",NA,"213-221","ELSEVIER SCIENCE BV","43",2016,"ISI000379701100028","40","INFECTIOUS DISEASES","4","INFECTIOUS DISEASES","VIEGASMARIANACONICET.GOV.AR GOYASTEPHANIECONICET.GOV.AR ASMISTCHENKOHOTMAIL.COM",NA,"DR1YP",NA,"VIEGAS, M (REPRINT AUTHOR), GALLO 1330 2, RA-1425 BUENOS AIRES, DF, ARGENTINA","ISI","RICARDO GUTIERREZ CHILDRENS HOSP;BUENOS AIRES","NOTDECLARED",NA,"VIEGAS M, 2016, INFECT GENET EVOL","VIEGAS M, 2016, INFECT GENET EVOL"
"ASAHCHOP EL, 2016, AIDS","ASAHCHOP EL;AKINWUMI SM;BRANTON WG;FUJIWARA E;GILL MJ;POWER C","PLASMA MICRORNA PROFILING PREDICTS HIV-ASSOCIATED NEUROCOGNITIVE DISORDER","AIDS","AIDS","OBJECTIVE: HIV-ASSOCIATED NEUROCOGNITIVE DISORDER (HAND) IS A COMMON NEUROLOGICAL DISORDER AMONG HIV-INFECTED PATIENTS DESPITE THE AVAILABILITY OF COMBINATION ANTIRETROVIRAL THERAPY. HOST-ENCODED MICRORNAS (MIRNA) REGULATE BOTH HOST AND VIRAL GENE EXPRESSION CONTRIBUTING TO HAND PATHOGENESIS AND CAN ALSO SERVE AS DISEASE BIOMARKERS. HEREIN, PLASMA MIRNA PROFILES WERE INVESTIGATED IN HIV/AIDS PATIENTS WITH HAND. METHODS: DISCOVERY AND VALIDATION COHORTS COMPRISING HIV/AIDS PATIENTS WERE STUDIED THAT INCLUDED PATIENTS WITH AND WITHOUT HAND (NON-HAND). PLASMA MIRNA LEVELS WERE MEASURED BY ARRAY HYBRIDIZATION AND VERIFIED BY QUANTITATIVE REAL-TIME REVERSE TRANSCRIPTASE PCR (QRT-PCR). MULTIPLE BIOINFORMATIC AND BIOSTATISTICAL ANALYSES WERE APPLIED TO THE DATA FROM EACH COHORT. RESULTS: EXPRESSION ANALYSES IDENTIFIED NINE MIRNAS IN THE DISCOVERY COHORT (HAND, N=22, NON-HAND, N=25) WITH INCREASED LEVELS (>= TWO-FOLD) IN THE HAND GROUP COMPARED WITH THE NON-HAND GROUP (P < 0.05). IN THE VALIDATION COHORT (HAND, N=12, NON-HAND, N=12) UPREGULATION (>= TWO-FOLD) OF THREE MIRNAS (MIR-3665, MIR-4516 AND MIR-4707-5P) WAS OBSERVED IN THE HAND GROUP THAT WERE ALSO INCREASED IN THE DISCOVERY COHORT'S HAND PATIENTS, WHICH WERE VERIFIED SUBSEQUENTLY BY QRT-PCR. RECEIVER-OPERATING CHARACTERISTIC CURVE ANALYSES FOR THE THREE MIRNAS ALSO POINTED TO THE DIAGNOSIS OF HAND (AREA UNDER CURVE, 0.87, P < 0.005). BIOINFORMATICS TOOLS PREDICTED THAT ALL THREE MIRNAS TARGETED SEQUENCES OF GENES IMPLICATED IN NEURAL DEVELOPMENT, CELL DEATH, INFLAMMATION, CELL SIGNALLING AND CYTOKINE FUNCTIONS. CONCLUSION: DIFFERENTIALLY EXPRESSED PLASMA-DERIVED MIRNAS WERE DETECTED IN HIV/AIDS PATIENTS WITH HAND THAT WERE CONSERVED ACROSS DIFFERENT PATIENT COHORTS AND LABORATORY METHODS. PLASMA-DERIVED MIRNAS MIGHT REPRESENT BIOMARKERS FOR HAND AND ALSO PROVIDE INSIGHTS INTO DISEASE MECHANISMS. COPYRIGHT (C) 2016 WOLTERS KLUWER HEALTH, INC. ALL RIGHTS RESERVED.","BIOMARKER; HIV; HIV-ASSOCIATED NEUROCOGNITIVE DISORDER; MICRORNA; NERVOUS SYSTEM","CENTRAL-NERVOUS-SYSTEM; ANTIRETROVIRAL THERAPY; MESSENGER-RNA; INFECTION; DISEASE; EXPRESSION; BRAIN; NEURODEGENERATION; FLUID; ACTIVATION","ENGLISH","ARTICLE","ARTICLE",8,"ANTINORI A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8B.;BERNARD MA, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0106006.;BORJABAD A, 2011, PLOS PATHOG, V7, DOI 10.1371/JOURNAL.PPAT.1002213.;CUI LX, 1997, J PHARMACOL EXP THER, V280, P1228.;DESPLATS P, 2013, NEUROLOGY, V80, P1415, DOI 10.1212/WNL.0B013E31828C2E9E.;DUBIN PH, 2014, J MED VIROL, V86, P1507, DOI 10.1002/JMV.23987.;FAN HM, 2015, J MOL NEUROSCI, V56, P562, DOI 10.1007/S12031-015-0503-Z.;FETTERMAN JL, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/S12933-016-0372-Y.;FIELDS J, 2015, J NEUROSCI, V35, P1921, DOI 10.1523/JNEUROSCI.3207-14.2015.;FIELDS JA, 2016, NEUROBIOL DIS, V86, P154, DOI 10.1016/J.NBD.2015.11.015.;GATES TM, 2016, AIDS, V30, P591, DOI 10.1097/QAD.0000000000000951.;GILL AJ, 2014, J CLIN INVEST, V124, P4459, DOI 10.1172/JCI72279.;GISSLEN M, 2016, EBIOMEDICINE, V3, P135, DOI 10.1016/J.EBIOM.2015.11.036.;GUO HL, 2010, NATURE, V466, P835, DOI 10.1038/NATURE09267.;HAQQANI AS, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-4.;HEATON RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0B013E318200D727.;HEATON RK, 2015, CLIN INFECT DIS, V60, P473, DOI 10.1093/CID/CIU862.;JONES GJ, 2007, J NEUROSCI, V27, P3703, DOI 10.1523/JNEUROSCI.5522-06.2007.;KACPERSKA MJ, 2015, J MOL NEUROSCI, V56, P154, DOI 10.1007/S12031-014-0476-3.;KADRI F, 2016, J CELL PHYSIOL, V231, P829, DOI 10.1002/JCP.25131.;KOSAKA N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/J.1349-7006.2010.01650.X.;KUSAO I, 2012, J NEUROPSYCH CLIN N, V24, P71, DOI 10.1176/APPI.NEUROPSYCH.11050109.;LAURITZEN KH, 2015, AM J PHYSIOL-HEART C, V309, PH434, DOI 10.1152/AJPHEART.00253.2014.;LEKOUBOU A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-653.;LIU J, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-40.;MAINGAT F, 2011, FASEB J, V25, P2211, DOI 10.1096/FJ.10-175992.;MCCOMBE JA, 2013, HIV MED, V14, P99, DOI 10.1111/J.1468-1293.2012.01043.X.;MILANINI B, 2014, JAIDS-J ACQ IMM DEF, V67, P67, DOI 10.1097/QAI.0000000000000220.;MITCHELL PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/PNAS.0804549105.;NA H, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-44.;NG EKO, 2009, GUT, V58, P1375, DOI 10.1136/GUT.2008.167817.;NIGHTINGALE S, 2014, LANCET NEUROL, V13, P1139, DOI 10.1016/S1474-4422(14)70137-1.;NOORBAKHSH F, 2011, BRAIN, V134, P2703, DOI 10.1093/BRAIN/AWR200.;NOORBAKHSH F, 2010, FASEB J, V24, P1799, DOI 10.1096/FJ.09-147819.;PACIFICI M, 2013, J CELL PHYSIOL, V228, P1070, DOI 10.1002/JCP.24254.;PEGTEL DM, 2014, PHILOS T R SOC LON B, V369.;PORICHIS F, 2014, NAT COMMUN, V5, DOI 10.1038/NCOMMS6641.;REYNOSO R, 2014, SCI REP-UK, V4, DOI 10.1038/SREP05915.;ROZZI SJ, 2014, J MOL NEUROSCI, V54, P485, DOI 10.1007/S12031-014-0273-Z.;SI QS, 2002, VIROLOGY, V301, P342, DOI 10.1006/VIRO.2002.1613.;SPUDICH S, 2011, J INFECT DIS, V204, P753, DOI 10.1093/INFDIS/JIR387.;STURDEVANT CB, 2015, PLOS PATHOG, V11, DOI 10.1371/JOURNAL.PPAT.1004720.;VAN MARLE G, 2002, AIDS, V16, P1905, DOI 10.1097/00002030-200209270-00007.;VARTAK-SHARMA N, 2014, J BIOL CHEM, V289, P19599, DOI 10.1074/JBC.M114.567644.;VIVITHANAPORN P, 2010, NEUROLOGY, V75, P1150, DOI 10.1212/WNL.0B013E3181F4D5BB.;WALSH JG, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-35.;WEBER JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/CLINCHEM.2010.147405.;WEILNER S, 2013, EXP GERONTOL, V48, P626, DOI 10.1016/J.EXGER.2012.11.017.;WITWER KW, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-5.;WITWER KW, 2011, AIDS, V25, P2057, DOI 10.1097/QAD.0B013E32834B95BF.;WRIGHT PW, 2015, AIDS, V29, P433, DOI 10.1097/QAD.0000000000000560.;XIAO B, 2013, BLOOD, V122, P3365, DOI 10.1182/BLOOD-2013-06-510586.;YELAMANCHILI SV, 2010, CELL DEATH DIS, V1, DOI 10.1038/CDDIS.2010.56.;YUSUF A. J., 2014, J INT ASS PROVIDERS.;ZAMPETAKI A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357.;ZHOU L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-677.","POWER, C (REPRINT AUTHOR), 6 11 HERITAGE MED RES CTR, DEPT MED, DIV NEUROL, EDMONTON, AB T6G 2S2, CANADA.;ASAHCHOP, EUGENE L., BRANTON, WILLIAM G., POWER, CHRISTOPHER, UNIV ALBERTA, DEPT MED NEUROL, EDMONTON, AB, CANADA.;AKINWUMI, SEGUN M., UNIV ALBERTA, DEPT MATH \& STAT SCI, EDMONTON, AB, CANADA.;FUJIWARA, ESTHER, POWER, CHRISTOPHER, UNIV ALBERTA, DEPT PSYCHIAT, EDMONTON, AB, CANADA.;GILL, M. JOHN, POWER, CHRISTOPHER, UNIV CALGARY, SOUTHERN ALBERTA CLIN, CALGARY, AB, CANADA.;GILL, M. JOHN, UNIV CALGARY, DEPT MED, CALGARY, AB, CANADA.;POWER, CHRISTOPHER, UNIV ALBERTA, DEPT MED MICROBIOL \& IMMUNOL, EDMONTON, AB, CANADA.","10.1097/QAD.0000000000001160","TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",NA,NA,"CANADIAN INSTITUTES OF HEALTH RESEARCH (CIHR), CIHR, ALBERTA INNOVATES-HEALTH SOLUTIONS","THESE STUDIES WERE SUPPORTED BY A CANADIAN INSTITUTES OF HEALTH RESEARCH (CIHR) EMERGING TEAM GRANT (C.P., E.F. AND J.M.G.). E.L.A. IS SUPPORTED BY FELLOWSHIPS FROM CIHR AND ALBERTA INNOVATES-HEALTH SOLUTIONS. C.P. HOLDS A CANADA RESEARCH CHAIR IN NEUROLOGICAL INFECTION AND IMMUNITY (TIER 1).",NA,"0269-9370","13","2021-2031","LIPPINCOTT WILLIAMS \& WILKINS","30",2016,"ISI000380812400003","56","IMMUNOLOGY, INFECTIOUS DISEASES, VIROLOGY","6","IMMUNOLOGY, INFECTIOUS DISEASES, VIROLOGY","CHRIS.POWERUALBERTA.CA",NA,"DS5HN",NA,"POWER, C (REPRINT AUTHOR), 6 11 HERITAGE MED RES CTR, DEPT MED, DIV NEUROL, EDMONTON, AB T6G 2S2, CANADA","ISI","UNIV ALBERTA;UNIV ALBERTA;UNIV ALBERTA;UNIV CALGARY;UNIV CALGARY;UNIV ALBERTA","NOTDECLARED",NA,"ASAHCHOP EL, 2016, AIDS","ASAHCHOP EL, 2016, AIDS"
"NORLING M, 2016, PLOS ONE","NORLING M;KARLSSON LINDSJO OE;GOURLE H;BONGCAM RUDLOFF E;HAYER J","METLAB: AN IN SILICO EXPERIMENTAL DESIGN, SIMULATION AND ANALYSIS TOOL FOR VIRAL METAGENOMICS STUDIES","PLOS ONE","PLOS ONE","METAGENOMICS, THE SEQUENCE CHARACTERIZATION OF ALL GENOMES WITHIN A SAMPLE, IS WIDELY USED AS A VIRUS DISCOVERY TOOL AS WELL AS A TOOL TO STUDY VIRAL DIVERSITY OF ANIMALS. METAGENOMICS CAN BE CONSIDERED TO HAVE THREE MAIN STEPS, SAMPLE COLLECTION AND PREPARATION, SEQUENCING AND FINALLY BIOINFORMATICS. BIOINFORMATIC ANALYSIS OF METAGENOMIC DATASETS IS IN ITSELF A COMPLEX PROCESS, INVOLVING FEW STANDARDIZED METHODOLOGIES, THEREBY HAMPERING COMPARISON OF METAGENOMICS STUDIES BETWEEN RESEARCH GROUPS. IN THIS PUBLICATION THE NEW BIOINFORMATICS FRAMEWORK METLAB IS PRESENTED, AIMED AT PROVIDING SCIENTISTS WITH AN INTEGRATED TOOL FOR EXPERIMENTAL DESIGN AND ANALYSIS OF VIRAL METAGENOMES. METLAB PROVIDES SUPPORT IN DESIGNING THE METAGENOMICS EXPERIMENT BY ESTIMATING THE SEQUENCING DEPTH NEEDED FOR THE COMPLETE COVERAGE OF A SPECIES. THIS IS ACHIEVED BY APPLYING A METHODOLOGY TO CALCULATE THE PROBABILITY OF COVERAGE USING AN ADAPTATION OF STEVENS' THEOREM. IT ALSO PROVIDES SCIENTISTS WITH SEVERAL PIPELINES AIMED AT SIMPLIFYING THE ANALYSIS OF VIRAL METAGENOMES, INCLUDING, QUALITY CONTROL, ASSEMBLY AND TAXONOMIC BINNING. WE ALSO IMPLEMENT A TOOL FOR SIMULATING METAGENOMICS DATASETS FROM SEVERAL SEQUENCING PLATFORMS. THE OVERALL AIM IS TO PROVIDE VIROLOGISTS WITH AN EASY TO USE TOOL FOR DESIGNING, SIMULATING AND ANALYZING VIRAL METAGENOMES. THE RESULTS PRESENTED HERE INCLUDE A BENCHMARK TOWARDS OTHER EXISTING SOFTWARE, WITH EMPHASIS ON DETECTION OF VIRUSES AS WELL AS SPEED OF APPLICATIONS. THIS IS PACKAGED, AS COMPREHENSIVE SOFTWARE, READILY AVAILABLE FOR LINUX AND OSX USERS AT HTTPS://GITHUB.COM/NORLING/METLAB.",NA,"PHYLOGENETIC CLASSIFICATION; ALIGNMENT; COVERAGE; COMMUNITIES; CHALLENGES; DATASETS; READS; BLAST","ENGLISH","ARTICLE","ARTICLE",2,"ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/NAR/25.17.3389.;ANDREWS S., 2010, BABRAHAM BIOINFORMAT, P1.;BANKEVICH A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/CMB.2012.0021.;BAZINET AL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-92.;BELAK S, 2013, VET MICROBIOL, V165, P95, DOI 10.1016/J.VETMIC.2013.01.022.;BOISVERT S, 2012, GENOME BIOL, V13, DOI 10.1186/GB-2012-13-12-R122.;BOKULICH NA, 2013, APPL ENVIRON MICROB, V79, P2519, DOI 10.1128/AEM.03870-12.;BRADY A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/NMETH.1358].;BUCHFINK B, 2015, NAT METHODS, V12, P59, DOI 10.1038/NMETH.3176.;BYRD AL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-262.;CHARUVAKA A, 2010, IEEE INT C BIOINFORM, P171, DOI 10.1109/BIBM.2010.5706558.;CHEN K, 2005, PLOS COMPUT BIOL, V1, P106, DOI 10.1371/JOURNAL.PCBI.0010024.;DELWART EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/RMV.532.;EDDY SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/JOURNAL.PCBI.1002195.;EDWARDS RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/NRMICROL163.;FOUSSE L, 2007, ACM T MATH SOFTWARE, V33, DOI 10.1145/1236463.1236468.;GHOSH TARINI SHANKAR, 2011, BIOINFORMATION, V6, P91.;GOMEZ-ALVAREZ V, 2009, ISME J, V3, P1314, DOI 10.1038/ISMEJ.2009.72.;GRANBERG F, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0057459.;HOFF KJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-520.;HUGENHOLTZ P, 2008, NATURE, V455, P481, DOI 10.1038/455481A.;HUSON DH, 2007, GENOME RES, V17, P377, DOI 10.1101/GR.5969107.;KARLSSON OE, 2016, PLOS ONE, V11, DOI 10.1371/JOURNAL.PONE.0151481.;KARLSSON OE, 2013, BIOSECUR BIOTERROR, V11, PS146, DOI 10.1089/BSP.2012.0077.;KOSTIC AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/NBT.1868.;KUNIN V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08.;LANGMEAD B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/NMETH.1923].;LI H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/BIOINFORMATICS/BTP352.;LI ZY, 2012, BRIEF FUNCT GENOMICS, V11, P25, DOI 10.1093/BFGP/ELR035.;MANDE SS, 2012, BRIEF BIOINFORM, V13, P669, DOI 10.1093/BIB/BBS054.;MEACHAM F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451.;MENDE DR, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0031386.;MILLER JR, 2010, GENOMICS, V95, P315, DOI 10.1016/J.YGENO.2010.03.001.;MOKILI JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/J.COVIRO.2011.12.004.;MRAZEK J, 2009, MOL BIOL EVOL, V26, P1163, DOI [10.1093/MOLBEV/MSP032, DOI 10.1093/MOLBEV/MSP032].;NAKAMURA K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/NAR/GKR344.;NALBANTOGLU OU, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-41.;NAMIKI T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/NAR/GKS678.;ONDOV BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385.;PARKS DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-328.;PATEL RK, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0030619.;PENG Y, 2011, BIOINFORMATICS, V27, PI94, DOI 10.1093/BIOINFORMATICS/BTR216.;PIGNATELLI M, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0019984.;POP M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/BIB/BBP026.;RHO M, 2010, NUCLEIC ACIDS RES, V38, P1, DOI DOI 10.1093/NAR/GKQ747.;RODRIGUEZ-R LM, 2014, ISME J, V8, P2349, DOI 10.1038/ISMEJ.2014.76.;RODRIGUEZ-R LM, 2014, BIOINFORMATICS, V30, P629, DOI 10.1093/BIOINFORMATICS/BTT584.;ROSEN GL, 2011, BIOINFORMATICS, V27, P127, DOI 10.1093/BIOINFORMATICS/BTQ619.;ROSSEEL T, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0076144.;SCHMIEDER R, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0017288.;SCHMIEDER R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/BIOINFORMATICS/BTR026.;SKEWES-COX P, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0105067.;STANHOPE SA, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0011652.;SUZUKI S, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0036060.;TEMMAM S, 2014, INT J MOL SCI, V15, P10377, DOI 10.3390/IJMS150610377.;TSAI IJ, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-4-R41.;VOUZIS PD, 2011, BIOINFORMATICS, V27, P182, DOI 10.1093/BIOINFORMATICS/BTQ644.;WENDL MC, 2013, J MATH BIOL, V67, P1141, DOI 10.1007/S00285-012-0586-X.;WOOD DE, 2014, GENOME BIOL, V15, DOI 10.1186/GB-2014-15-3-R46.;WOOLEY JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/JOURNAL.PCBI.1000667.;ZHANHONG WANG, 2011, PROCEEDINGS 2011 19TH INTERNATIONAL CONFERENCE ON GEOINFORMATICS, DOI 10.1109/GEOINFORMATICS.2011.5981000.","HAYER, J (REPRINT AUTHOR), SWEDISH UNIV AGR SCI SLU, DEPT ANIM BREEDING \& GENET HGEN, SLU GLOBAL BIOINFORMAT CTR, UPPSALA, SWEDEN.;NORLING, MARTIN, UPPSALA UNIV, NBIS, UPPSALA, SWEDEN.;KARLSSON-LINDSJO, OSKAR E., GOURLE, HADRIEN, BONGCAM-RUDLOFF, ERIK, HAYER, JULIETTE, SWEDISH UNIV AGR SCI SLU, DEPT ANIM BREEDING \& GENET HGEN, SLU GLOBAL BIOINFORMAT CTR, UPPSALA, SWEDEN.;KARLSSON-LINDSJO, OSKAR E., SWEDISH UNIV AGR SCI SLU, DEPT BIOMED SCI \& VET PUBL HLTH BVF, UPPSALA, SWEDEN.;KARLSSON-LINDSJO, OSKAR E., OIE COLLABORATING CTR BIOTECHNOL BASED DIAG INFEC, UPPSALA, SWEDEN.","10.1371/JOURNAL.PONE.0160334","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E0160334",NA,"SWEDISH RESEARCH COUNCIL FOR ENVIRONMENT, AGRICULTURAL SCIENCES AND SPATIAL PLANNING, FORMAS [221-2012-586], EU PROJECT ANIBIOTHREAT [HOME/2009/ISEC/AG/191], PREVENTION OF AND FIGHT AGAINST CRIME PROGRAMME OF THE EUROPEAN UNION, EUROPEAN COMMISSION-DIRECTORATE GENERAL HOME AFFAIRS, EU FP7 [612583]","FINANCIAL SUPPORT WAS OBTAINED FROM THE SWEDISH RESEARCH COUNCIL FOR ENVIRONMENT, AGRICULTURAL SCIENCES AND SPATIAL PLANNING, FORMAS (221-2012-586), HTTP://WWW.FORMAS.SE/. THIS WORK HAS BEEN SUPPORTED BY GRANTS FROM THE FRAMEWORK OF THE EU PROJECT ANIBIOTHREAT (GRANT AGREEMENT: HOME/2009/ISEC/AG/191) WITH FINANCIAL SUPPORT FROM THE PREVENTION OF AND FIGHT AGAINST CRIME PROGRAMME OF THE EUROPEAN UNION, EUROPEAN COMMISSION-DIRECTORATE GENERAL HOME AFFAIRS. THIS PUBLICATION REFLECTS VIEWS ONLY OF THE AUTHORS, AND THE EUROPEAN COMMISSION CANNOT BE HELD RESPONSIBLE FOR ANY USE THAT MAY BE MADE OF THE INFORMATION CONTAINED THEREIN HTTP://EC.EUROPA.EU/DGS/HOME-AFFAIRS/INDEX\_EN.HTM). THE AUTHORS WOULD LIKE TO EXPRESS SPECIAL THANKS TO THE EU FP7 PROJECT REFERENCE: 612583: ``DEVELOPING AN EUROPEAN AMERICAN NGS NETWORK''",NA,"1932-6203","8",NA,"PUBLIC LIBRARY SCIENCE","11",2016,"ISI000381110300041","61","SCIENCE \& TECHNOLOGY - OTHER TOPICS","9","MULTIDISCIPLINARY SCIENCES","JULIETTE.HAYERSLU.SE",NA,"DS9NO",NA,"HAYER, J (REPRINT AUTHOR), SWEDISH UNIV AGR SCI SLU, DEPT ANIM BREEDING \& GENET HGEN, SLU GLOBAL BIOINFORMAT CTR, UPPSALA, SWEDEN","ISI","UPPSALA UNIV;SWEDISH UNIV AGR SCI SLU;SWEDISH UNIV AGR SCI SLU;OIE COLLABORATING CTR BIOTECHNOL BASED DIAG INFEC","SWEDISH UNIV AGR SCI SLU",NA,"NORLING M, 2016, PLOS ONE","NORLING M, 2016, PLOS ONE"
"RUSMINI M, 2016, ANN RHEUM DIS","RUSMINI M;FEDERICI S;CAROLI F;GROSSI A;BALDI M;OBICI L;INSALACO A;TOMMASINI A;CAORSI R;GALLO E;OLIVIERI AN;MARZANO AV;COVIELLO D;RAVAZZOLO R;MARTINI A;GATTORNO M;CECCHERINI I","NEXT-GENERATION SEQUENCING AND ITS INITIAL APPLICATIONS FOR MOLECULAR DIAGNOSIS OF SYSTEMIC AUTO-INFLAMMATORY DISEASES","ANNALS OF THE RHEUMATIC DISEASES","ANN. RHEUM. DIS.","OBJECTIVES SYSTEMIC AUTO-INFLAMMATORY DISORDERS (SAIDS) ARE A HETEROGENEOUS GROUP OF MONOGENIC DISEASES SHARING A PRIMARY DYSFUNCTION OF THE INNATE IMMUNE SYSTEM. MORE THAN 50\% OF PATIENTS WITH SAID DOES NOT SHOW ANY MUTATION AT GENE(S) TESTED BECAUSE OF LACK OF PRECISE CLINICAL CLASSIFICATION CRITERIA AND/OR INCOMPLETE GENE SCREENING. TO IMPROVE THE MOLECULAR DIAGNOSIS AND GENOTYPE INTERPRETATION OF SAIDS, WE UNDERTOOK THE DEVELOPMENT OF A NEXT-GENERATION SEQUENCING (NGS)-BASED PROTOCOL DESIGNED TO SIMULTANEOUS SCREENING OF 10 GENES. METHODS FIFTY PATIENTS WITH SAID, ALREADY GENOTYPED FOR THE RESPECTIVE CAUSATIVE GENE(S), WERE MASSIVELY SEQUENCED FOR THE CODING PORTIONS OF MEFV, MVK, TNFRSF1A, NLRP3, NLRP12, NOD2, PSTPIP1, IL1RN, LPIN2 AND PSMB8. THREE DIFFERENT BIOINFORMATIC PIPELINES (ION REPORTER, CLC BIO GENOMICS WORKBENCH, GATK-BASED IN-HOUSE WORKFLOW) WERE COMPARED. RESULTS ONCE RESULTING VARIANTS WERE COMPARED WITH THE EXPECTED MUTATION LIST, NO WORKFLOW TURNED OUT TO BE ABLE TO DETECT ALL THE 79 VARIANTS KNOWN IN THE 50 DNAS. ADDITIONAL VARIANTS WERE ALSO DETECTED, VALIDATED BY SANGER SEQUENCING AND COMPARED TO ASSESS TRUE AND FALSE POSITIVE DETECTION RATES OF THE THREE WORKFLOWS. FINALLY, THE OVERALL CLINICAL PICTURE OF 34 PATIENTS WAS RE-EVALUATED IN THE LIGHT OF THE NEW MUTATIONS FOUND. CONCLUSIONS THE PRESENT GENE PANEL HAS RESULTED SUITABLE FOR MOLECULAR DIAGNOSIS OF SAIDS. MOREOVER, GENOTYPE-PHENOTYPE CORRELATION HAS CONFIRMED THAT THE INTERPRETATION OF NGS DATA IN PATIENTS WITH AN UNDEFINED INFLAMMATORY PHENOTYPE IS REMARKABLY DIFFICULT, THUS SUPPORTING THE NEED OF EVIDENCE-BASED AND VALIDATED CLINICAL CRITERIA TO BE USED CONCURRENTLY WITH THE GENETIC ANALYSIS FOR THE FINAL DIAGNOSIS AND CLASSIFICATION OF PATIENTS WITH SAIDS.",NA,"FAMILIAL MEDITERRANEAN FEVER; AUTOINFLAMMATORY DISEASES; PERIODIC FEVERS; CROHNS-DISEASE; BOWEL-DISEASE; GENE; MUTATIONS; CRITERIA; SUSCEPTIBILITY; POLYMORPHISMS","ENGLISH","ARTICLE","ARTICLE",12,"CANTARINI L, 2010, INT J IMMUNOPATH PH, V23, P1133, DOI 10.1177/039463201002300417.;CANTARINI L, 2012, CLIN RES CARDIOL, V101, P525, DOI 10.1007/S00392-012-0422-8.;DE INOCENCIO J, 2015, J ALLERGY CLIN IMMUN, V136.;DORIA A, 2012, AUTOIMMUN REV, V12, P1, DOI 10.1016/J.AUTREV.2012.07.013.;FEDERICI L, 2006, ANN RHEUM DIS, V65, P1427, DOI 10.1136/ARD.2006.054304.;FEDERICI S, 2015, ANN RHEUM DIS, V74, P799, DOI 10.1136/ANNRHEUMDIS-2014-206580.;*FRENCH FMF CONS, 1997, NAT GENET, V17, P25.","CECCHERINI, I (REPRINT AUTHOR), IST GIANNINA GASLINI, UOC GENET MED, I-16148 GENOA, ITALY.;RUSMINI, MARTA, CAROLI, FRANCESCO, GROSSI, ALICE, RAVAZZOLO, ROBERTO, CECCHERINI, ISABELLA, IRCCS IST GIANNINA GASLINI, UOC MED GENET, GENOA, ITALY.;FEDERICI, SILVIA, CAORSI, ROBERTA, MARTINI, ALBERTO, GATTORNO, MARCO, IRCCS IST GIANNINA GASLINI, UOC PEDIAT RHEUMATOL, LAB IMMUNOL RHEUMAT DIS, GENOA, ITALY.;BALDI, MAURIZIA, COVIELLO, DOMENICO, OSPED GALLIERA, LAB HUMAN GENET, GENOA, ITALY.;OBICI, LAURA, FDN IRCCS POLICLIN SAN MATTEO, BIOTECHNOL RES LABS, AMYLOIDOSIS RES \& TREATMENT CTR, PAVIA, ITALY.;INSALACO, ANTONELLA, IRCCS, DEPT PEDIAT MED, DIV RHEUMATOL, BAMBINO GESU CHILDRENS HOSP, ROME, ITALY.;TOMMASINI, ALBERTO, IRCCS BURLO GAROFOLO, INST MATERNAL \& CHILD HLTH, DEPT PEDIAT, TRIESTE, ITALY.;GALLO, ELEONORA, UNIV TURIN, DIPARTIMENTO SALUTE PUBBL \& PEDIA, TURIN, ITALY.;OLIVIERI, ALMA NUNZIA, SECONDA UNIV NAPOLI, DIPARTIMENTO DONNA BAMBINO \& CHIRURG GEN \& SPECIA, NAPLES, ITALY.;MARZANO, ANGELOVALERIO, UNIV MILAN, FDN IRCCS CA GRANDA OSPED MAGGIORE POLICLIN, UO DERMATOL, DIPARTIMENTO FISIOPATOL MED CHIRURG \& TRAPIANTI, MILAN, ITALY.;RAVAZZOLO, ROBERTO, MARTINI, ALBERTO, UNIV GENOA, DIPARTIMENTO NEUROSCI RIABILITAZ OFTALMOL GENET \&, GENOA, ITALY.","10.1136/ANNRHEUMDIS-2015-207701","BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND",NA,NA,"ITALIAN MINISTRY OF HEALTH (''CINQUE PER MILLE''), ITALIAN MINISTRY","THIS WORK HAS BEEN PERFORMED WITH THE CONTRIBUTION OF THE ITALIAN MINISTRY OF HEALTH (''CINQUE PER MILLE'' AND RICERCA CORRENTE TO THE",NA,"0003-4967","8","1550-1557","BMJ PUBLISHING GROUP","75",2016,"ISI000379741100030","33","RHEUMATOLOGY","5","RHEUMATOLOGY","ISA.CUNIGE.IT",NA,"DR2NL",NA,"CECCHERINI, I (REPRINT AUTHOR), IST GIANNINA GASLINI, UOC GENET MED, I-16148 GENOA, ITALY","ISI","LAB IMMUNOL RHEUMAT DIS;LAB HUMAN GENET;AMYLOIDOSIS RES AND TREATMENT CTR;BAMBINO GESU CHILDRENS HOSP;INST MATERNAL AND CHILD HLTH;UNIV TURIN;SECONDA UNIV NAPOLI;UNIV MILAN;UNIV GENOA","NOTREPORTED",NA,"RUSMINI M, 2016, ANN RHEUM DIS","RUSMINI M, 2016, ANN RHEUM DIS"
"VISSER M, 2016, VIROLOGY","VISSER M;BURGER JT;MAREE HJ","TARGETED VIRUS DETECTION IN NEXT-GENERATION SEQUENCING DATA USING AN AUTOMATED E-PROBE BASED APPROACH","VIROLOGY","VIROLOGY","THE USE OF NEXT-GENERATION SEQUENCING FOR PLANT VIRUS DETECTION IS RAPIDLY EXPANDING, NECESSITATING THE DEVELOPMENT OF BIOINFORMATIC PIPELINES TO SUPPORT ANALYSIS OF THESE LARGE DATASETS. PIPELINES NEED TO BE EASY IMPLEMENTABLE TO MITIGATE POTENTIAL INSUFFICIENT COMPUTATIONAL INFRASTRUCTURE AND/OR SKILLS. IN THIS STUDY USER-FRIENDLY SOFTWARE WAS DEVELOPED FOR THE TARGETED DETECTION OF PLANT VIRUSES BASED ON E-PROBES. IT CAN BE USED FOR BOTH CUSTOM E-PROBE DESIGN, AS WELL AS SCREENING PRELOADED PROBES AGAINST RAW NGS DATA FOR VIRUS DETECTION. THE PIPELINE WAS COMPARED TO DE NOVO ASSEMBLY-BASED VIRUS DETECTION IN GRAPEVINE AND PRODUCED COMPARABLE RESULTS, REQUIRING LESS TIME AND COMPUTATIONAL RESOURCES. THE SOFTWARE, NAMED TRUFFLE, IS AVAILABLE FOR THE DESIGN AND SCREENING OF E-PROBES TAILORED FOR USER-SPECIFIC VIRUS SPECIES AND DATA, ALONG WITH PRELOADED PROBE-SETS FOR GRAPEVINE VIRUS DETECTION. (C) 2016 ELSEVIER INC. ALL RIGHTS RESERVED.","BIOINFORMATICS; GRAPEVINE; GRAPEVINE LEAFROLL DISEASE; HIGH-THROUGHPUT SEQUENCING; VIRUS DIAGNOSTICS","INFECTING GRAPEVINES; ALIGNMENT; PIPELINE; GENOMES; VIROME","ENGLISH","ARTICLE","ARTICLE",7,"BI YQ, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0042758.;BOLGER AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/BIOINFORMATICS/BTU170.;BURGER JT, 2015, METHODS MOL BIOL, V1302, P315, DOI 10.1007/978-1-4939-2620-6\_23.;CAMACHO C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421.;COETZEE B, 2010, VIROLOGY, V400, P157, DOI 10.1016/J.VIROL.2010.01.023.;DELCHER AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/NAR/27.11.2369.;DELCHER AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/NAR/30.11.2478.;GU YH, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0098884.;HO T, 2014, VIROLOGY, V471, P54, DOI 10.1016/J.VIROL.2014.09.019.;KURTZ S, 2004, GENOME BIOL, V5, DOI 10.1186/GB-2004-5-2-R12.;MARTELLI G. P., 2014, J PLANT PATHOL S, V96, PS1.;MELCHER U, 2014, FRONT PLANT SCI, V5, DOI 10.3389/FPLS.2014.00268.;ROUX S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-76.;SATYA RV, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-185.;STOBBE AH, 2014, PHYTOPATHOLOGY, V104, P1125, DOI 10.1094/PHYTO-11-13-0310-R.;STOBBE AH, 2013, J MICROBIOL METH, V94, P356, DOI 10.1016/J.MIMET.2013.07.002.;WANG QG, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0064465.;WYLIE SJ, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0105044.;ZHAO GY, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0078470.","MAREE, HJ (REPRINT AUTHOR), AGR RES COUNCIL, INFRUITEC NIETVOORBIJ INST DECIDUOUS FRUIT VINES, STELLENBOSCH, SOUTH AFRICA.;VISSER, MARIKE, MAREE, HANS J., AGR RES COUNCIL, INFRUITEC NIETVOORBIJ INST DECIDUOUS FRUIT VINES, STELLENBOSCH, SOUTH AFRICA.;VISSER, MARIKE, BURGER, JOHAN T., MAREE, HANS J., UNIV STELLENBOSCH, DEPT GENET, ZA-7600 STELLENBOSCH, SOUTH AFRICA.","10.1016/J.VIROL.2016.05.008","525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA",NA,NA,"WINE INDUSTRY NETWORK FOR EXPERTISE AND TECHNOLOGY (WINETECH) [GENUS11/3], CITRUS RESEARCH INTERNATIONAL (CRI) [1100], NATIONAL RESEARCH FOUNDATION (NRF)","THE AUTHORS WOULD LIKE TO ACKNOWLEDGE BERNARD VISSER FOR BIOINFORMATICS SUPPORT, AS WELL AS THE WINE INDUSTRY NETWORK FOR EXPERTISE AND TECHNOLOGY (WINETECH, GRANT GENUS11/3), CITRUS RESEARCH INTERNATIONAL (CRI, GRANT 1100) AND THE NATIONAL RESEARCH FOUNDATION (NRF) FOR THEIR FINANCIAL ASSISTANCE TOWARDS THIS RESEARCH. OPINIONS EXPRESSED AND CONCLUSIONS ARRIVED AT, ARE THOSE OF THE AUTHORS AND ARE NOT NECESSARILY TO BE ATTRIBUTED TO THE NRF.",NA,"0042-6822",NA,"122-128","ACADEMIC PRESS INC ELSEVIER SCIENCE","495",2016,"ISI000378659900013","19","VIROLOGY","15","VIROLOGY","VISSERMARC.AGRIC.ZA JTBSUN.AC.ZA HJMAREESUN.AC.ZA",NA,"DP7DR",NA,"MAREE, HJ (REPRINT AUTHOR), AGR RES COUNCIL, INFRUITEC NIETVOORBIJ INST DECIDUOUS FRUIT VINES, STELLENBOSCH, SOUTH AFRICA","ISI","STELLENBOSCH;UNIV STELLENBOSCH","STELLENBOSCH",NA,"VISSER M, 2016, VIROLOGY","VISSER M, 2016, VIROLOGY"
"YANG J, 2016, ONCOL LETT","YANG J;LIU WQ;LI WL;CHEN C;ZHU Z;HONG M;WANG ZQ;DONG J","INVESTIGATING POLYMORPHISMS BY BIOINFORMATICS IS A POTENTIAL COST-EFFECTIVE METHOD TO SCREEN FOR GERMLINE MUTATIONS IN CHINESE FAMILIAL ADENOMATOUS POLYPOSIS PATIENTS","ONCOLOGY LETTERS","ONCOL. LETT.","THE AIM OF THIS STUDY WAS TO INVESTIGATE GERMLINE MUTATIONS OF THE APC, MUTYH AND AXIN2 GENES IN CHINESE PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP), AND FURTHER ASSESS THE VALUE OF BIOINFORMATICS IN SCREENING THE PATHOGENIC CHANGES PREDISPOSING TO FAP. APC GENES FROM 11 UNRELATED FAP PATIENTS IN YUNNAN PROVINCE IN CHINA WERE FIRSTLY EXAMINED BY EXON-SPECIFIC DNA SEQUENCING. FOR SAMPLES WITHOUT ALREADY KNOWN PATHOGENIC CHANGES PREDISPOSING TO FAP IN THE APC GENE, WHOLE-GENE SEQUENCING OF MUTYH AND AXIN2 WAS PERFORMED. MUTATIONAL ANALYSIS OF EACH GENE WAS PERFORMED BY BIOINFORMATICS. ELEVEN DIFFERENT TYPES OF APC POLYMORPHISMS WERE OBSERVED IN THE COHORT OF FAMILIES ANALYZED. OF THESE POLYMORPHISMS, FOUR WERE MISSENSE SUBSTITUTIONS (V1822D, V1173G, P1760H AND K2057), ONE WAS A NONSENSE SUBSTITUTION (S1196X), AND SIX WERE SILENT SUBSTITUTIONS (Y486Y, T449T, T1493T, G1678G, S1756S AND P1960P). ONE MISSENSE MUTATION (Q335H) AND TWO INTRONIC SUBSTITUTIONS (C. 264+ 11G>A AND C. 420+ 35A>G) WERE DETECTED IN THE MUTYH GENE, AND FOUR SYNONYMOUS MUTATIONS (I144I, P455P, P462P AND L688L) AND THREE INTONIC MUTATIONS (C. 1060-77G>T, C. 1060-287A>G AND C. 1060-282 A>G) OF THE AXIN2 GENE WERE OBSERVED. IN ADDITION TO THE ALREADY REPORTED PATHOGENIC MUTATIONS, BY USING FUNCTION ASSESSMENT TOOLS AND DATABASES, THE SYNONYMOUS SUBSTITUTIONS OBSERVED IN THE APC GENE OF OUR SAMPLES WERE PREDICTED TO AFFECT SPLICING REGULATION IN THE TRANSLATION OF MRNA, WHILE THE MISSENSE MUTATIONS OBSERVED IN THE APC GENE AND MUTYH GENE WERE PREDICTED TO BE DISEASE-RELATED POLYMORPHISMS, HOWEVER, NO FUNCTIONAL EFFECT OF THE MUTATIONS WAS OBSERVED IN THE AXIN2 GENE. COMPREHENSIVE SCREENING FOR GERMLINE MUTATIONS IN APC, MUTYH AND AXIN2 GENES FOLLOWED BY PREDICTION OF PATHOGENICITY USING BIOINFORMATIC TOOLS CONTRIBUTES TO A COST-EFFECTIVE WAY OF SCREENING GERMLINE MUTATIONS IN CHINESE FAMILIAL ADENOMATOUS POLYPOSIS PATIENTS.","FAMILIAL ADENOMATOUS POLYPOSIS; PATHOGENIC CHANGES; MUTATION ANALYSIS; FUNCTIONAL PREDICTION; BIOINFORMATIC TOOLS","EXONIC SPLICING ENHANCERS; GENOTYPE-PHENOTYPE CORRELATIONS; COLORECTAL-CANCER; MISSENSE MUTATIONS; MOLECULAR ANALYSIS; MUTYH GENES; APC GENE; SPECTRUM; IDENTIFICATION; VARIANTS","ENGLISH","ARTICLE","ARTICLE",0,"ADZHUBEI IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/NMETH0410-248.;AL-TASSAN N, 2002, NAT GENET, V30, P227, DOI 10.1038/NG828.;BECHTEL JASON M, 2008, BMC RES NOTES, V1, P3, DOI 10.1186/1756-0500-1-3.;BIANCHI LK, 2008, CLIN GASTROENTEROL H, V6, P180, DOI 10.1016/J.CGH.2007.11.018.;CALABRESE R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/HUMU.21047.;CAPRIOTTI E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S6.;CAPRIOTTI E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S4-S3.;CARTEGNI L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/NRG775.;CARTEGNI L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/NAR/GKG616.;CHEN S, 2011, ISRN GASTROENTEROL, V2011, P909121, DOI 10.5402/2011/909121.;COVACIU C, 2011, BRIT J DERMATOL, V165, P678, DOI 10.1111/J.1365-2133.2011.10414.X.;FAIRBROTHER WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/SCIENCE.1073774.;FOSTIRA F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-389.;FRIEDL W, 2005, HERED CANCER CLIN PR, V3, P95, DOI 10.1186/1897-4287-3-3-95.;GAN Y B, 1994, ZHONGHUA YI XUE ZA ZHI, V74, P352.;GARDNER EJ, 1980, WESTERN J MED, V132, P488.;GOMEZ-FERNANDEZ N, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-57.;GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0.;GROSSO AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/EMBOR.2008.189.;GUERREIRO CS, 2007, AM J CLIN NUTR, V85, P1592.;HERRMANN SM, 2003, BRIT J DERMATOL, V149, P877, DOI 10.1046/J.1365-2133.2003.05640.X.;HUBBARD TJP, 2007, NUCLEIC ACIDS RES, V35, PD610, DOI 10.1093/NAR/GKL996.;KANTER-SMOLER G, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-10.;KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/SCIENCE.1848370.;KRAWCZAK M, 1992, HUM GENET, V90, P41.;LAMMI L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293.;LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/BIOINFORMATICS/BTM404.;LIANG J, 2013, AM J EPIDEMIOL, V177, P1169, DOI 10.1093/AJE/KWS382.;LIU XIAO-RONG, 2005, ACTA GENETICA SINICA, V32, P903.;MENEDEZ M, 2004, INT J CANCER, V112, P161, DOI 10.1002/IJC.20361.;NAKAGAWA H, 1998, CANCER RES, V58, P5176.;NG PC, 2001, GENOME RES, V11, P863, DOI 10.1101/GR.176601.;NOURI N, 2014, GENE, V535, P250, DOI 10.1016/J.GENE.2013.11.022.;NUGENT KP, 1992, BRIT J SURG, V79, P1204, DOI 10.1002/BJS.1800791136.;PAGANI F, 2005, P NATL ACAD SCI USA, V102, P6368, DOI 10.1073/PNAS.0502288102.;PAGANI F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/NRG1327.;PAN M, 2011, HUM MUTAT, V32, P1335, DOI 10.1002/HUMU.21588.;PRIOR TE, 2010, CURRENT PROTOCOLS HU, V64, DOI [10.1002/0471142905., DOI 10.1002/0471142905].;PUNTA M, 2012, NUCLEIC ACIDS RES, V40, PD290, DOI 10.1093/NAR/GKR1065.;RENKONEN ET, 2005, J CLIN ONCOL, V23, P5651, DOI 10.1200/JCO.2005.14.712.;RIVERA B, 2011, ANN ONCOL, V22, P903, DOI 10.1093/ANNONC/MDQ465.;SHENG JQ, 2010, WORLD J GASTROENTERO, V16, P1522, DOI 10.3748/WJG.V16.I12.1522.;SHERRY ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/NAR/29.1.308.;SIEBER OM, 2003, NEW ENGL J MED, V348, P791, DOI 10.1056/NEJMOA025283.;TORREZAN GT, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-54.;TOURNIER I, 2008, HUM MUTAT, V29, P1412, DOI 10.1002/HUMU.20796.;VANDROVCOVA J, 2004, HUM MUTAT, V23, P397, DOI 10.1002/HUMU.9224.;WACHSMANNOVA-MATELOVA L, 2009, NEUROENDOCRINOL L S1, V30, PS25.;WATERHOUSE AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/BIOINFORMATICS/BTP033.;WEI SC, 2004, J BIOMED SCI, V11, P260, DOI 10.1159/000076038.;YEO G, 2004, P NATL ACAD SCI USA, V101, P15700, DOI 10.1073/PNAS.0404901101.;ZHANG T, 2010, HUM MUTAT, V31, PE1801, DOI 10.1002/HUMU.21341.;ZHANG XHF, 2005, MOL CELL BIOL, V25, P7323, DOI 10.1128/MCB.25.16.7323-7332.2005.;ZHENG S, 2005, HERED CANCER CLIN PR, V3, P155, DOI 10.1186/1897-4287-3-4-155.","DONG, J (REPRINT AUTHOR), KUNMING MED UNIV, AFFILIATED HOSP 3, DEPT INTERNAL MED ONCOL, 519 KUNZHOU RD, KUNMING 650106, YUNNAN, PEOPLES R CHINA.;YANG, JUN, LI, WEN LIANG, CHEN, CHENG, ZHU, ZHU, WANG, ZHI QIANG, KUNMING MED UNIV, AFFILIATED HOSP 1, DEPT ONCOL, KUNMING 650032, YUNNAN, PEOPLES R CHINA.;LIU, WEI QING, HONG, MIN, DONG, JIAN, KUNMING MED UNIV, AFFILIATED HOSP 1, DEPT INTERNAL MED ONCOL, KUNMING 650032, YUNNAN, PEOPLES R CHINA.;DONG, JIAN, KUNMING MED UNIV, AFFILIATED HOSP 3, DEPT INTERNAL MED ONCOL, 519 KUNZHOU RD, KUNMING 650106, YUNNAN, PEOPLES R CHINA.","10.3892/OL.2016.4646","POB 18179, ATHENS, 116 10, GREECE",NA,NA,"NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA [81160245], SCIENCE AND TECHNOLOGY PLANNING PROJECT OF YUNNAN PROVINCE, CHINA [2011FB160]","THIS STUDY WAS SUPPORTED BY THE NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA (NO. 81160245) AND THE SCIENCE AND TECHNOLOGY PLANNING PROJECT OF YUNNAN PROVINCE, CHINA (NO. 2011FB160).",NA,"1792-1074","1","421-428","SPANDIDOS PUBL LTD","12",2016,"ISI000379960200071","54","ONCOLOGY","7","ONCOLOGY","YOUNGJEAN1982ALIYUN.COM",NA,"DR5RN",NA,"DONG, J (REPRINT AUTHOR), KUNMING MED UNIV, AFFILIATED HOSP 3, DEPT INTERNAL MED ONCOL, 519 KUNZHOU RD, KUNMING 650106, YUNNAN, PEOPLES R CHINA","ISI","KUNMING MED UNIV;KUNMING MED UNIV;KUNMING MED UNIV","KUNMING MED UNIV",NA,"YANG J, 2016, ONCOL LETT","YANG J, 2016, ONCOL LETT"
"FRATAMICO PM, 2016, FRONT MICROBIOL","FRATAMICO PM;DEBROY C;LIU Y;NEEDLEMAN DS;BARANZONI GM;FENG P","ADVANCES IN MOLECULAR SEROTYPING AND SUBTYPING OF ESCHERICHIA COLI","FRONTIERS IN MICROBIOLOGY","FRONT. MICROBIOL.","ESCHERICHIA COLI PLAYS AN IMPORTANT ROLE AS A MEMBER OF THE GUT MICROBIOTA, HOWEVER, PATHOGENIC STRAINS ALSO EXIST, INCLUDING VARIOUS DIARRHEAGENIC E. COLI PATHOTYPES AND EXTRAINTESTINAL PATHOGENIC E. COLI THAT CAUSE ILLNESS OUTSIDE OF THE GI-TRACT. E. COLS HAVE TRADITIONALLY BEEN SEROTYPED USING ANTISERA AGAINST THE CA. 186 O-ANTIGENS AND 53 H-FLAGELLAR ANTIGENS. PHENOTYPIC METHODS, INCLUDING BACTERIOPHAGE TYPING AND O- AND H- SEROTYPING FOR DIFFERENTIATING AND CHARACTERIZING E. COLI HAVE BEEN USED FOR MANY YEARS, HOWEVER, THESE METHODS ARE GENERALLY TIME CONSUMING AND NOT ALWAYS ACCURATE. ADVANCES IN NEXT GENERATION SEQUENCING TECHNOLOGIES HAVE MADE IT POSSIBLE TO DEVELOP GENETIC-BASED SUBTYPING AND MOLECULAR SEROTYPING METHODS FOR E. COLI, WHICH ARE MORE DISCRIMINATORY COMPARED TO PHENOTYPIC TYPING METHODS. FURTHERMORE, WHOLE GENOME SEQUENCING (WGS) OF E. COLI IS REPLACING ESTABLISHED SUBTYPING METHODS SUCH AS PULSED FIELD GEL ELECTROPHORESIS, PROVIDING A MAJOR ADVANCEMENT IN THE ABILITY TO INVESTIGATE FOOD-BORNE DISEASE OUTBREAKS AND FOR TRACE-BACK TO SOURCES. A VARIETY OF SEQUENCE ANALYSIS TOOLS AND BIOINFORMATIC PIPELINES ARE BEING DEVELOPED TO ANALYZE THE VAST AMOUNT OF DATA GENERATED BY WGS AND TO OBTAIN SPECIFIC INFORMATION SUCH AS O- AND H-GROUP DETERMINATION AND THE PRESENCE OF VIRULENCE GENES AND OTHER GENETIC MARKERS.","ESCHERICHIA COLI; MOLECULAR SEROTYPING; SUBTYPING; DETECTION; IDENTIFICATION; WHOLE GENOME SEQUENCING; O-GROUP; H-TYPE","ANTIGEN GENE-CLUSTER; O SEROGROUP IDENTIFICATION; FIELD GEL-ELECTROPHORESIS; REAL-TIME PCR; MULTIPLEX-PCR; H-ANTIGEN; EXTRAINTESTINAL INFECTIONS; NUCLEOTIDE POLYMORPHISMS; SEQUENCING DATA; STRAINS","ENGLISH","REVIEW","ARTICLE",13,"ABBADI S. H., 2007, EGYPT J MED MICROBIO, V16, P225.;AHMED R, 1987, J INFECT DIS, V155, P806, DOI 10.1093/INFDIS/155.4.806.;BALLMER K, 2007, J CLIN MICROBIOL, V45, P370, DOI 10.1128/JCM.01361-06.;BEUTIN L, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-4.;BEUTIN L, 2016, FRONT MICROBIOL, V7, DOI 10.3389/FMICB.2016.00135.;BEUTIN L, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0126749.;BOTKIN DJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/FCIMB.2012.00008.;BUGAREL M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-142.;BUGAREL M, 2011, APPL ENVIRON MICROB, V77, P2275, DOI 10.1128/AEM.02832-10.;BUGAREL M, 2010, INT J FOOD MICROBIOL, V142, P318, DOI 10.1016/J.IJFOODMICRO.2010.07.010.;BUGAREL M, 2010, APPL ENVIRON MICROB, V76, P203, DOI 10.1128/AEM.01921-09.;BYRNE L, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0085901.;CAMPOS LC, 1994, INFECT IMMUN, V62, P3282.;CARSON CA, 2001, APPL ENVIRON MICROB, V67, P1503, DOI 10.1128/AEM.67.4.1503-1507.2001.;CENTERS FOR DISEASE CONTROL AND PREVENTION, 1999, LAB METH DIAGN EP DY.;CHENG KEDING, 2014, BMC RES NOTES, V7, P444, DOI 10.1186/1756-0500-7-444.;CHUI HX, 2015, J CLIN MICROBIOL, V53, P2480, DOI 10.1128/JCM.00593-15.;CLERMONT O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000.;CLOTILDE LM, 2015, FOODBORNE PATHOG DIS, V12, P118, DOI 10.1089/FPD.2014.1827.;COIMBRA RS, 2000, RES MICROBIOL, V151, P639, DOI 10.1016/S0923-2508(00)00134-0.;DEBROY C, 2016, PLOS ONE, V11, DOI 10.1371/JOURNAL.PONE.0147434.;DEBROY CHITRITA, 2011, ANIMAL HEALTH RESEARCH REVIEWS, V12, P169, DOI 10.1017/S1466252311000193.;DELANNOY S, 2016, ENVIRON SCI POLLUT R, V23, P8163, DOI 10.1007/S11356-015-5446-Y.;DELANNOY S, 2013, J CLIN MICROBIOL, V51, P3257, DOI 10.1128/JCM.01471-13.;DELANNOY S, 2012, J CLIN MICROBIOL, V50, P4035, DOI 10.1128/JCM.02097-12.;DOUMITH M, 2012, J CLIN MICROBIOL, V50, P3108, DOI 10.1128/JCM.01468-12.;EICHHORN I, 2015, APPL ENVIRON MICROB, V81, P7041, DOI 10.1128/AEM.01921-15.;EPPINGER M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/PNAS.1107176108.;EWING W.H., 1986, INT J SYST EVOL MICR, V36, P581.;FRANK C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMOA1106483.;FRANZ E, 2014, INT J FOOD MICROBIOL, V187, P57, DOI 10.1016/J.IJFOODMICRO.2014.07.002.;FRATAMICO PM, 2014, J FOOD PROTECT, V77, P180, DOI 10.4315/0362-028X.JFP-13-248.;FRATAMICO PM, 2010, FOOD ANAL METHOD, V3, P330, DOI 10.1007/S12161-010-9140-X.;GEHRING A, 2013, SENSORS-BASEL, V13, P5737, DOI 10.3390/S130505737.;GEUE L, 2014, MICROBIOL IMMUNOL, V58, P77, DOI 10.1111/1348-0421.12120.;GREENFIELD LK, 2012, CARBOHYD RES, V356, P12, DOI 10.1016/J.CARRES.2012.02.027.;GRIFFING SM, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0131967.;HAHM BK, 2003, J MICROBIOL METH, V53, P387, DOI 10.1016/S0167-7012(02)00259-2.;HEGDE NV, 2013, J MICROBIOL METH, V93, P273, DOI 10.1016/J.MIMET.2013.03.024.;HOBBS M, 1994, MOL MICROBIOL, V12, P855, DOI 10.1111/J.1365-2958.1994.TB01071.X.;HYYTIA-TREES E, 2006, FOODBORNE PATHOG DIS, V3, P118, DOI 10.1089/FPD.2006.3.118.;IGUCHI A, 2015, J CLIN MICROBIOL, V53, P2427, DOI 10.1128/JCM.00321-15.;IGUCHI A, 2015, DNA RES, V22, P101, DOI 10.1093/DNARES/DSU043.;ISON SA, 2016, APPL ENVIRON MICROB, V82, P640, DOI 10.1128/AEM.03182-15.;JOENSEN KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15.;JOENSEN KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13.;KAPER JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/NRMICRO818.;KAUFFMANN F., 1943, ACTA PATH ET MICROBIOL SCAND, V20, P21.;KAUFFMANN F., 1944, ADA PATH ET MICROBIOL SCAND, V21, P20.;KAUFFMANN F, 1947, J IMMUNOL, V57, P71.;KOTEWICZ ML, 2007, MICROBIOL-SGM, V153, P1720, DOI 10.1099/MIC.0.2006/004507-0.;KOTEWICZ ML, 2008, MICROBIOL-SGM, V154, P3518, DOI 10.1099/MIC.0.2008/019026-0.;KRAUSE U, 1996, J CLIN MICROBIOL, V34, P959.;LACHER DW, 2014, APPL ENVIRON MICROB, V80, P4677, DOI 10.1128/AEM.01049-14.;LARSEN MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11.;LEUNG KT, 2004, FEMS MICROBIOL ECOL, V47, P111, DOI [10.1016/S0168-6496(03)00254-X, 10.1016/S0168-9496(03)00254-X].;LIN A, 2011, J MICROBIOL METH, V87, P105, DOI 10.1016/J.MIMET.2011.07.019.;LIU B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/J.1574-6976.2008.00114.X.;LIU B, 2014, FEMS MICROBIOL REV, V38, P56, DOI 10.1111/1574-6976.12034.;LIU YH, 2008, FOODBORNE PATHOG DIS, V5, P449, DOI 10.1089/FPD.2008.0096.;LIU YH, 2006, MOL CELL PROBE, V20, P239, DOI 10.1016/J.MCP.2006.01.001.;LIU YANHONG, 2015, BIOSENSORS (BASEL), V5, P51, DOI 10.3390/BIOS5010051.;MACHADO J, 2000, RES MICROBIOL, V151, P535, DOI 10.1016/S0923-2508(00)00223-0.;MANGES AR, 2015, FOODBORNE PATHOG DIS, V12, P302, DOI 10.1089/FPD.2014.1860.;MANGES AR, 2012, CLIN INFECT DIS, V55, P712, DOI 10.1093/CID/CIS502.;MARTIN IE, 1996, J CLIN MICROBIOL, V34, P720.;MILLER JM, 2013, J CLIN MICROBIOL, V51, P1066, DOI 10.1128/JCM.00093-13.;MITCHELL NM, 2015, APPL ENVIRON MICROB, V81, P1177, DOI 10.1128/AEM.03524-14.;MORENO ACR, 2006, J CLIN MICROBIOL, V44, P1453, DOI 10.1128/JCM.44.4.1453-1458.2006.;NAMBA K, 1989, NATURE, V342, P648, DOI 10.1038/342648A0.;NANDANWAR N, 2014, INT J MED MICROBIOL, V304, P835, DOI 10.1016/J.IJMM.2014.06.009.;NORDSTROM L, 2013, FRONT MICROBIOL, V4, DOI 10.3389/FMICB.2013.00029.;NORMAN KN, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/FCIMB.2015.00021.;NORMAN KN, 2012, APPL ENVIRON MICROB, V78, P6689, DOI 10.1128/AEM.01259-12.;OCHMAN H, 1984, J BACTERIOL, V157, P690.;ORSKOV F, 1984, METHOD MICROBIOL, V14, P43, DOI 10.1016/S0580-9517(08)70447-1.;ORSKOV I, 1977, BACTERIOL REV, V41, P667.;ORSKOV I, 1975, ACTA PATH MICRO IM B, V83, P121.;OULAS A, 2015, BIOINFORM BIOL INSIG, V9, P75, DOI 10.4137/BBI.S12462.;RIBOT EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/FPD.2006.3.59.;RUSSO TA, 2003, MICROBES INFECT, V5, P449, DOI 10.1016/S1286-4579(03)00049-2.;SAMUEL G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/J.CARRES.2003.07.009.;SARKAR S, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0094786.;SCHEUTZ F, 2004, APMIS, V112, P569, DOI 10.1111/J.1600-0463.2004.APM1120903.X.;SELANDER RK, 1986, APPL ENVIRON MICROB, V51, P873.;SHARIAT N, 2014, APPL ENVIRON MICROB, V80, P430, DOI 10.1128/AEM.02790-13.;SINGER RS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/FMICB.2015.00028.;SMITH JL, 2007, FOODBORNE PATHOG DIS, V4, P134, DOI 10.1089/FPD.2007.0087.;STROMBERG ZR, 2015, FOODBORNE PATHOG DIS, V12, P631, DOI 10.1089/FPD.2015.1945.;TSENG M, 2014, APPL ENVIRON MICROB, V80, P6395, DOI 10.1128/AEM.01761-14.;VINCENT C, 2010, EMERG INFECT DIS, V16, P88, DOI 10.3201/EID1601.091118.;WANG L, 2003, J BACTERIOL, V185, P2936, DOI 10.1128/JB.185.9.2936-2943.2003.;WANG W, 2007, MICROBIOL-SGM, V153, P2159, DOI 10.1099/MIC.0.2007/004192-0.;ZHANG W, 2006, GENOME RES, V16, P757, DOI 10.1101/GR.4759706.","FRATAMICO, PM (REPRINT AUTHOR), USDA ARS, EASTERN REG RES CTR, WYNDMOOR, PA USA.;FRATAMICO, PINA M., NEEDLEMAN, DAVID S., BARANZONI, GIAN MARCO, USDA ARS, EASTERN REG RES CTR, WYNDMOOR, PA USA.;DEBROY, CHITRITA, PENN STATE UNIV, DEPT VET \& BIOMED SCI, UNIVERSITY PK, PA 16802 USA.;FENG, PETER, US FDA, DIV MICROBIOL, COLLEGE PK, MD USA.","10.3389/FMICB.2016.00644","PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND","644",NA,"AGRICULTURAL RESEARCH SERVICES (ARS) RESEARCH PARTICIPATION PROGRAM, DOE [DE-AC05-060R23100]","THIS WORK WAS SUPPORTED IN PART BY AN APPOINTMENT TO THE AGRICULTURAL RESEARCH SERVICES (ARS) RESEARCH PARTICIPATION PROGRAM WHICH IS ADMINISTERED BY THE OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION (ORISE) THROUGH AN INTERAGENCY AGREEMENT BETWEEN THE U.S. DEPARTMENT OF ENERGY (DOE) AND THE USDA. ORISE IS MANAGED BY ORAU UNDER DOE CONTRACT NUMBER DE-AC05-060R23100. ALL OPINIONS EXPRESSED IN THIS MANUSCRIPT ARE THE AUTHOR'S AND DO NOT NECESSARILY REFLECT THE POLICIES AND VIEWS OF USDA, ARS, DOE, OR ORAU/ORISE.",NA,"1664-302X",NA,NA,"FRONTIERS MEDIA SA","7",2016,"ISI000375397400001","94","MICROBIOLOGY","26","MICROBIOLOGY","PINA.FRATAMICOARS.USDA.GOV",NA,"DL1MX",NA,"FRATAMICO, PM (REPRINT AUTHOR), USDA ARS, EASTERN REG RES CTR, WYNDMOOR, PA USA","ISI","EASTERN REG RES CTR;PENN STATE UNIV;COLLEGE PK","EASTERN REG RES CTR",NA,"FRATAMICO PM, 2016, FRONT MICROBIOL","FRATAMICO PM, 2016, FRONT MICROBIOL"
"AANENSEN DM, 2016, MBIO","AANENSEN DM;FEIL EJ;HOLDEN MTG;DORDEL J;YEATS CA;FEDOSEJEV A;GOATER R;CASTILLO RAMIREZ S;CORANDER J;COLIJN C;CHLEBOWICZ MA;SCHOULS L;HECK M;PLUISTER G;RUIMY R;KAHLMETER G;AHMAN J;MATUSCHEK E;FRIEDRICH AW;PARKHILL J;BENTLEY SD;SPRATT BG;GRUNDMANN H;ESCMID STUDY GRP MOL EPIDEMIOLOGIC ESCMIDSGME;EUROPEAN STAPHYLOCOCCAL REF LAB WO ESRLW","WHOLE-GENOME SEQUENCING FOR ROUTINE PATHOGEN SURVEILLANCE IN PUBLIC HEALTH: A POPULATION SNAPSHOT OF INVASIVE STAPHYLOCOCCUS AUREUS IN EUROPE","MBIO","MBIO","THE IMPLEMENTATION OF ROUTINE WHOLE-GENOME SEQUENCING (WGS) PROMISES TO TRANSFORM OUR ABILITY TO MONITOR THE EMERGENCE AND SPREAD OF BACTERIAL PATHOGENS. HERE WE COMBINED WGS DATA FROM 308 INVASIVE STAPHYLOCOCCUS AUREUS ISOLATES CORRESPONDING TO A PAN-EUROPEAN POPULATION SNAPSHOT, WITH EPIDEMIOLOGICAL AND RESISTANCE DATA. GEOSPATIAL VISUALIZATION OF THE DATA IS MADE POSSIBLE BY A GENERIC SOFTWARE TOOL DESIGNED FOR PUBLIC HEALTH PURPOSES THAT IS AVAILABLE AT THE PROJECT URL (HTTP://WWW.MICROREACT.ORG/PROJECT/EKUVG9UY?TT=RC). OUR ANALYSIS DEMONSTRATES THAT HIGH-RISK CLONES CAN BE IDENTIFIED ON THE BASIS OF POPULATION LEVEL PROPERTIES SUCH AS CLONAL RELATEDNESS, ABUNDANCE, AND SPATIAL STRUCTURING AND BY INFERRING VIRULENCE AND RESISTANCE PROPERTIES ON THE BASIS OF GENE CONTENT. WE ALSO SHOW THAT IN SILICO PREDICTIONS OF ANTIBIOTIC RESISTANCE PROFILES ARE AT LEAST AS RELIABLE AS PHENOTYPIC TESTING. WE ARGUE THAT THIS WORK PROVIDES A COMPREHENSIVE ROAD MAP ILLUSTRATING THE THREE VITAL COMPONENTS FOR FUTURE MOLECULAR EPIDEMIOLOGICAL SURVEILLANCE: (I) LARGE-SCALE STRUCTURED SURVEYS, (II) WGS, AND (III) COMMUNITY-ORIENTED DATABASE INFRASTRUCTURE AND ANALYSIS TOOLS. IMPORTANCE THE SPREAD OF ANTIBIOTIC-RESISTANT BACTERIA IS A PUBLIC HEALTH EMERGENCY OF GLOBAL CONCERN, THREATENING MEDICAL INTERVENTION AT EVERY LEVEL OF HEALTH CARE DELIVERY. SEVERAL RECENT STUDIES HAVE DEMONSTRATED THE PROMISE OF ROUTINE WHOLE-GENOME SEQUENCING (WGS) OF BACTERIAL PATHOGENS FOR EPIDEMIOLOGICAL SURVEILLANCE, OUTBREAK DETECTION, AND INFECTION CONTROL. HOWEVER, AS THIS TECHNOLOGY BECOMES MORE WIDELY ADOPTED, THE KEY CHALLENGES OF GENERATING REPRESENTATIVE NATIONAL AND INTERNATIONAL DATA SETS AND THE DEVELOPMENT OF BIOINFORMATIC TOOLS TO MANAGE AND INTERPRET THE DATA BECOME INCREASINGLY PERTINENT. THIS STUDY PROVIDES A ROAD MAP FOR THE INTEGRATION OF WGS DATA INTO ROUTINE PATHOGEN SURVEILLANCE. WE EMPHASIZE THE IMPORTANCE OF LARGE-SCALE ROUTINE SURVEYS TO PROVIDE THE POPULATION CONTEXT FOR MORE TARGETED OR LOCALIZED INVESTIGATION AND THE DEVELOPMENT OF OPEN-ACCESS BIOINFORMATIC TOOLS TO PROVIDE THE MEANS TO COMBINE AND COMPARE INDEPENDENTLY GENERATED DATA WITH PUBLICLY AVAILABLE DATA SETS.",NA,"TOXIC-SHOCK-SYNDROME; SINGLE-NUCLEOTIDE POLYMORPHISMS; METHICILLIN-RESISTANT; EVOLUTION; VIRULENCE; STRAIN; MRSA; COMMUNITY; GENES; CLONE","ENGLISH","ARTICLE","ARTICLE",48,"ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;BABA T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5.;BABA T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07.;CANTON R, 2011, CURR OPIN PHARMACOL, V11, P477, DOI 10.1016/J.COPH.2011.07.007.;CHUA K, 2010, J BACTERIOL, V192, P5556, DOI 10.1128/JB.00878-10.;COLLIGNON P, 1998, LANCET, V352, P145, DOI 10.1016/S0140-6736(98)85051-4.;COURVALIN P, 1977, ANTIMICROB AGENTS CH, V11, P619, DOI 10.1128/AAC.11.4.619.;CROUCHER NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/SCIENCE.1198545.;DAVIES J, 1977, AM J MED, V62, P868, DOI 10.1016/0002-9343(77)90654-4.;DELEO FR, 2011, P NATL ACAD SCI USA, V108, P18091, DOI 10.1073/PNAS.1111084108.;DIEP BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7.;DIEP BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907.;ENRIGHT AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/NAR/30.7.1575.;ENRIGHT MC, 2000, J CLIN MICROBIOL, V38, P1008.;ENRIGHT MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/PNAS.122108599.;EVERITT RG, 2014, NAT COMMUN, V5, DOI 10.1038/NCOMMS4956.;FEIL EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004.;GARCIA-ALVAREZ L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8.;GILL SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005.;GILLASPY A, 2006, GRAM POSITIVE PATHOG, V2, P381.;GOERKE C, 2009, J BACTERIOL, V191, P3462, DOI 10.1128/JB.01804-08.;GORDON NC, 2014, J CLIN MICROBIOL, V52, P1182, DOI 10.1128/JCM.03117-13.;GRUNDMANN H., 2014, EUROSURVEILLANCE, V19, P20987, DOI 10.2807/1560-7917.ES2014.19.49.20987.;GRUNDMANN H, 2010, PLOS MED, V7, DOI 10.1371/JOURNAL.PMED.1000215.;GUINANE CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/GBE/EVQ031.;HARRIS SR, 2010, SCIENCE, V327, P469, DOI 10.1126/SCIENCE.1182395.;HERRON-OLSON L, 2007, PLOS ONE, V2, DOI 10.1371/JOURNAL.PONE.0001120.;HIGHLANDER SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99.;HOLDEN MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/GR.147710.112.;HOLDEN MTG, 2010, J BACTERIOL, V192, P888, DOI 10.1128/JB.01255-09.;HOLDEN MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/PNAS.0402521101.;HOWDEN BP, 2010, J BACTERIOL, V192, P5848, DOI 10.1128/JB.00951-10.;HYATT D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119.;JARRAUD S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002.;JARRAUD S, 1999, J CLIN MICROBIOL, V37, P2446.;JOHNSON WM, 1991, J CLIN MICROBIOL, V29, P426.;KELLEY DR, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-11-R116.;KOSER CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMOA1109910.;KURODA M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2.;LI M, 2012, NAT MED, V18, P816, DOI 10.1038/NM.2692.;LINDQVIST M, 2012, EUR J CLIN MICROBIOL, V31, P141, DOI 10.1007/S10096-011-1286-Y.;LINDSAY JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006.;LINDSAY JA, 2004, TRENDS MICROBIOL, V12, P378, DOI 10.1016/J.TIM.2004.06.004.;LOWDER BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/PNAS.0909285106.;LUO RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18.;MCADAM PR, 2012, P NATL ACAD SCI USA, V109, P9107, DOI 10.1073/PNAS.1202869109.;MCCLURE JA, 2006, J CLIN MICROBIOL, V44, P1141, DOI 10.1128/JCM.44.3.1141-1144.2006.;MCKENNA A, 2010, GENOME RES, V20, P1297, DOI 10.1101/GR.107524.110.;MWANGI MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/PNAS.0609839104.;NEOH HM, 2008, ANTIMICROB AGENTS CH, V52, P45, DOI 10.1128/AAC.00534-07.;NUBEL U, 2010, PLOS PATHOG, V6, DOI 10.1371/JOURNAL.PPAT.1000855.;PEARSON T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/PNAS.0403844101.;PRICE MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/MOLBEV/MSP077.;REUTER S, 2013, JAMA INTERN MED, V173, P1397, DOI 10.1001/JAMAINTERNMED.2013.7734.;ROBINSON DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004.;RUIMY R, 2008, J BACTERIOL, V190, P3962, DOI 10.1128/JB.01947-07.;SANGAL V, 2013, J CLIN MICROBIOL, V51, P303, DOI 10.1128/JCM.02238-12.;SCHIJFFELEN MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376.;SCHLIEVERT PM, 1981, J INFECT DIS, V143, P509, DOI 10.1093/INFDIS/143.4.509.;SMITH JM, 2000, BIOESSAYS, V22, P1115, DOI 10.1002/1521-1878(200012)22:12<1115::AID-BIES9>3.3.CO,2-I.;STACH CS, 2014, IMMUNOL RES, V59, P177, DOI 10.1007/S12026-014-8539-7.;STAMATAKIS A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/BIOINFORMATICS/BTU033.;SUNG JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/MIC.0.2007/015289-0.;UHLEMANN AC, 2014, P NATL ACAD SCI USA, V111, P6738, DOI 10.1073/PNAS.1401006111.;WITTE W, 2001, INT J MED MICROBIOL, V290, P677.;WORLD HEALTH ORGANIZATION, 2014, ANT RES DRAFT GLOB A.","GRUNDMANN, H (REPRINT AUTHOR), UNIV GRONINGEN, UNIV MED CTR GRONINGEN, DEPT MED MICROBIOL, GRONINGEN, NETHERLANDS.;GRUNDMANN, H (REPRINT AUTHOR), UNIV FREIBURG, DEPT INFECT PREVENT \& HOSP HYG, FAC MED, FREIBURG, GERMANY.;AANENSEN, DAVID M., YEATS, CORIN A., FEDOSEJEV, ARTEMIJ, SPRATT, BRIAN G., IMPERIAL COLL LONDON, SCH PUBL HLTH, DEPT INFECT DIS EPIDEMIOL, LONDON, ENGLAND.;AANENSEN, DAVID M., YEATS, CORIN A., FEDOSEJEV, ARTEMIJ, GOATER, RICHARD, CTR GENOM PATHOGEN SURVEILLANCE, WELLCOME GENOME CAMPUS, CAMBRIDGE, ENGLAND.;FEIL, EDWARD J., UNIV BATH, DEPT BIOL \& BIOCHEM, MILNER CTR EVOLUT, BATH, AVON, ENGLAND.;HOLDEN, MATTHEW T. G., UNIV ST ANDREWS, SCH MED, ST ANDREWS, FIFE, SCOTLAND.;HOLDEN, MATTHEW T. G., DORDEL, JANINA, PARKHILL, JULIAN, BENTLEY, STEPHEN D., WELLCOME TRUST SANGER INST, PATHOGEN GENOM, WELLCOME TRUST GENOME CAMPUS, CAMBRIDGE, ENGLAND.;DORDEL, JANINA, DREXEL UNIV, DEPT BIOL, PHILADELPHIA, PA 19104 USA.;CASTILLO-RAMIREZ, SANTIAGO, UNIV NACL AUTONOMA MEXICO, CTR CIENCIAS GENOM, PROGRAMA GENOM EVOLUTIVA, CUERNAVACA, MORELOS, MEXICO.;CORANDER, JUKKA, AALTO UNIV, AALTO, FINLAND.;COLIJN, CAROLINE, IMPERIAL COLL LONDON, DEPT MATH, LONDON, ENGLAND.;CHLEBOWICZ, MONIKA A., FRIEDRICH, ALEXANDER W., GRUNDMANN, HAJO, UNIV GRONINGEN, UNIV MED CTR GRONINGEN, DEPT MED MICROBIOL, GRONINGEN, NETHERLANDS.;SCHOULS, LEO, HECK, MAX, PLUISTER, GERLINDE, NATL INST PUBL HLTH \& ENVIRONM RIVM, BILTHOVEN, NETHERLANDS.;RUIMY, RAYMOND, CTR HOSP UNIV NICE, NICE, FRANCE.;KAHLMETER, GUNNAR, AHMAN, JENNY, MATUSCHEK, ERIKA, EUCAST DEV LAB, VAXJO, SWEDEN.;GRUNDMANN, HAJO, UNIV FREIBURG, DEPT INFECT PREVENT \& HOSP HYG, FAC MED, FREIBURG, GERMANY.","10.1128/MBIO.00444-16","1752 N ST NW, WASHINGTON, DC 20036-2904 USA","E00444-16",NA,"WELLCOME TRUST [098051, 099202, 089472], MEDICAL RESEARCH COUNCIL (MRC) [G1000803]","THIS WORK, INCLUDING THE EFFORTS OF MATTHEW HOLDEN, JANINA DORDEL, JULIAN PARKHILL, AND STEPHEN BENTLEY, WAS FUNDED BY WELLCOME TRUST (098051). THIS WORK, INCLUDING THE EFFORTS OF DAVID M. AANENSEN, CORIN YEATS, AND ARTEMIJ FEDOSEJEV, WAS FUNDED BY WELLCOME TRUST (099202). THIS WORK, INCLUDING THE EFFORTS OF BRIAN SPRATT, WAS FUNDED BY WELLCOME TRUST (089472). THIS WORK, INCLUDING THE EFFORTS OF SANTIAGO CASTILLO-RAMIREZ, WAS FUNDED BY MEDICAL RESEARCH COUNCIL (MRC) (G1000803).",NA,"2150-7511","3",NA,"AMER SOC MICROBIOLOGY","7",2016,"ISI000383440300020","66","MICROBIOLOGY","20","MICROBIOLOGY","HAJO.GRUNDMANNUNIKLINIK-FREIBURG.DE",NA,"DW1YP",NA,"GRUNDMANN, H (REPRINT AUTHOR), UNIV GRONINGEN, UNIV MED CTR GRONINGEN, DEPT MED MICROBIOL, GRONINGEN, NETHERLANDS","ISI","IMPERIAL COLL LONDON;CTR GENOM PATHOGEN SURVEILLANCE;UNIV BATH;UNIV ST ANDREWS;WELLCOME TRUST SANGER INST;DREXEL UNIV;UNIV NACL AUTONOMA MEXICO;AALTO UNIV;IMPERIAL COLL LONDON;UNIV GRONINGEN;SCHOULS;CTR HOSP UNIV NICE;MATUSCHEK;UNIV FREIBURG","UNIV GRONINGEN",NA,"AANENSEN DM, 2016, MBIO","AANENSEN DM, 2016, MBIO"
"OGNENOVSKI M, 2016, ARTHRITIS RHEUMATOL","OGNENOVSKI M;RENAUER P;GENSTERBLUM E;KOTTER I;XENITIDIS T;HENES JC;CASALI B;SALVARANI C;DIRESKENELI H;KAUFMAN KM;SAWALHA AH","WHOLE EXOME SEQUENCING IDENTIFIES RARE PROTEIN-CODING VARIANTS IN BEHCET'S DISEASE","ARTHRITIS \& RHEUMATOLOGY","ARTHRITIS RHEUMATOL.","OBJECTIVE. BEHCET'S DISEASE (BD) IS A SYSTEMIC INFLAMMATORY DISEASE WITH AN INCOMPLETELY UNDERSTOOD ETIOLOGY. DESPITE THE IDENTIFICATION OF MULTIPLE COMMON GENETIC VARIANTS ASSOCIATED WITH BD, RARE GENETIC VARIANTS HAVE BEEN LESS EXPLORED. WE UNDERTOOK THIS STUDY TO INVESTIGATE THE ROLE OF RARE VARIANTS IN BD BY PERFORMING WHOLE EXOME SEQUENCING IN BD PATIENTS OF EUROPEAN DESCENT. METHODS. WHOLE EXOME SEQUENCING WAS PERFORMED IN A DISCOVERY SET COMPRISING 14 GERMAN BD PATIENTS OF EUROPEAN DESCENT. FOR REPLICATION AND VALIDATION, SANGER SEQUENCING AND SEQUENOM GENOTYPING WERE PERFORMED IN THE DISCOVERY SET AND IN 2 ADDITIONAL INDEPENDENT SETS OF 49 GERMAN BD PATIENTS AND 129 ITALIAN BD PATIENTS OF EUROPEAN DESCENT. GENETIC ASSOCIATION ANALYSIS WAS THEN PERFORMED IN BD PATIENTS AND 503 CONTROLS OF EUROPEAN DESCENT. FUNCTIONAL EFFECTS OF ASSOCIATED GENETIC VARIANTS WERE ASSESSED USING BIOINFORMATIC APPROACHES. RESULTS. USING WHOLE EXOME SEQUENCING, WE IDENTIFIED 77 RARE VARIANTS (IN 74 GENES) WITH PREDICTED PROTEIN-DAMAGING EFFECTS IN BD. THESE VARIANTS WERE GENOTYPED IN 2 ADDITIONAL PATIENT SETS AND THEN ANALYZED TO REVEAL SIGNIFICANT ASSOCIATIONS WITH BD AT 2 GENETIC VARIANTS DETECTED IN ALL 3 PATIENT SETS THAT REMAINED SIGNIFICANT AFTER BONFERRONI CORRECTION. WE DETECTED GENETIC ASSOCIATION BETWEEN BD AND LIMK2 (RS149034313), INVOLVED IN REGULATING CYTOSKELETAL REORGANIZATION, AND BETWEEN BD AND NEIL1 (RS5745908), INVOLVED IN BASE EXCISION DNA REPAIR (P=3.22 X 10(-4) AND P=5.16 X 10(-4), RESPECTIVELY). THE LIMK2 ASSOCIATION IS A MISSENSE VARIANT WITH PREDICTED PROTEIN DAMAGE THAT MAY INFLUENCE FUNCTIONAL INTERACTIONS WITH PROTEINS INVOLVED IN CYTOSKELETAL REGULATION BY RHO GTPASE, INFLAMMATION MEDIATED BY CHEMOKINE AND CYTOKINE SIGNALING PATHWAYS, T CELL ACTIVATION, AND ANGIOGENESIS (BONFERRONI-CORRECTED P=5.63 X 10(-14), P=7.29 X 10(-6), P=1.15 X 10(-5), AND P=6.40 X 10(-3), RESPECTIVELY). THE GENETIC ASSOCIATION IN NEIL1 IS A PREDICTED SPLICE DONOR VARIANT THAT MAY INTRODUCE A DELETERIOUS INTRON RETENTION AND RESULT IN A NONCODING TRANSCRIPT VARIANT. CONCLUSION. WE USED WHOLE EXOME SEQUENCING IN BD FOR THE FIRST TIME AND IDENTIFIED 2 RARE PUTATIVE PROTEIN-DAMAGING GENETIC VARIANTS ASSOCIATED WITH THIS DISEASE. THESE GENETIC VARIANTS MIGHT INFLUENCE CYTOSKELETAL REGULATION AND DNA REPAIR MECHANISMS IN BD AND MIGHT PROVIDE FURTHER INSIGHT INTO INCREASED LEUKOCYTE TISSUE INFILTRATION AND THE ROLE OF OXIDATIVE STRESS IN BD.",NA,"ENDOTHELIAL GROWTH-FACTOR; LARGE GENE LISTS; LIM-KINASE 2; INTERACTION NETWORKS; ASSOCIATION; GLYCOSYLASE; ACTIVATION; POPULATION; PREDICTION; VASCULITIS","ENGLISH","ARTICLE","ARTICLE",1,"ACIKGOZ N, 2011, ANGIOLOGY, V62, P296, DOI 10.1177/0003319710382417.;ADZHUBEI IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/NMETH0410-248.;ALTSHULER DM, 2012, NATURE, V491, P56, DOI 10.1038/NATURE11632.;BASSYOUNI IH, 2015, HEART VESSELS.;BERMAN HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/NAR/28.1.235.;BOZOGLU E, 2005, CLIN EXP RHEUMATOL, V23, PS42.;BUCHAN DWA, 2013, NUCLEIC ACIDS RES, V41, PW349, DOI 10.1093/NAR/GKT381.;CARAPITO R, 2015, IMMUNOGENETICS, V67, P289, DOI 10.1007/S00251-015-0841-6.;CEKMEN M, 2003, INT J DERMATOL, V42, P870, DOI 10.1046/J.1365-4362.2003.01688.X.;CELIK S, 2015, CLIN EXP RHEUMATOL, V33, PS54.;CHOE JY, 2010, JOINT BONE SPINE, V77, P340, DOI 10.1016/J.JBSPIN.2010.01.014.;CROFT DR, 2011, CELL RES, V21, P666, DOI 10.1038/CR.2010.154.;DAI YP, 2006, VASC PHARMACOL, V44, P275, DOI 10.1016/J.VPH.2005.11.008.;DOUBLIE S, 2004, P NATL ACAD SCI USA, V101, P10284, DOI 10.1073/PNAS.0402051101.;EICHLER EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/NRG2809.;GOODWIN NC, 2015, ACS MED CHEM LETT, V6, P53, DOI 10.1021/ML500242Y.;GUL A, 2000, ANN RHEUM DIS, V59, P622, DOI 10.1136/ARD.59.8.622.;GUL A, 2014, CURR OPIN RHEUMATOL, V26, P56, DOI 10.1097/BOR.0000000000000003.;HABIBAGAHI Z, 2010, MOD RHEUMATOL, V20, P154, DOI 10.1007/S10165-009-0246-1.;HATEMI G, 2014, CLIN EXP RHEUMATOL, V32, PS112.;HAZRA TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/PNAS.062053799.;HIROHATA S, 2008, J NEUROL SCI, V267, P41, DOI 10.1016/J.JNS.2007.09.041.;HONMA M, 2006, MOL BIOL CELL, V17, P1888, DOI 10.1091/MBC.E05-12-1173.;HUANG DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/NPROT.2008.211.;HUANG DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/NAR/GKN923.;HUGHES T, 2014, ARTHRITIS RHEUMATOL, V66, P1648, DOI 10.1002/ART.38409.;HUGHES T, 2013, NAT GENET, V45, P319, DOI 10.1038/NG.2551.;HUMPHREY W., 1996, J MOL GRAPHICS, V14, P[27, 33], DOI DOI 10.1016/0263-7855(96)00018-5.;JOHAR AS, 2015, AUTOIMMUN REV, V14, P204, DOI 10.1016/J.AUTREV.2014.10.021.;JONES DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/JMBI.1999.3091.;KAUFMAN KM, 2014, ARTHRITIS RHEUMATOL, V66, P3486, DOI 10.1002/ART.38793.;KIRAZ S, 2001, CLIN EXP RHEUMATOL, V19, PS25.;KUMAR P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/NPROT.2009.86.;MANETTI F, 2012, MED RES REV, V32, P968, DOI 10.1002/MED.20230.;MCCLELLAN J, 2010, CELL, V141, P210, DOI 10.1016/J.CELL.2010.03.032.;MELIKOGLU M, 2008, CLIN REV ALLERG IMMU, V35, P40, DOI 10.1007/S12016-007-8064-8.;MENDES D, 2009, J AUTOIMMUN, V32, P178, DOI 10.1016/J.JAUT.2009.02.011.;OKANO I, 1995, J BIOL CHEM, V270, P31321, DOI 10.1074/JBC.270.52.31321.;PATEL ZH, 2014, FRONT GENET, V5, DOI 10.3389/FGENE.2014.00016.;POLLARD KS, 2010, GENOME RES, V20, P110, DOI 10.1101/GR.097857.109.;PURCELL S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795.;RENAUER P., 2015, CLIN REV ALLERGY IMM.;REVA B, 2011, NUCLEIC ACIDS RES, V39, PE118, DOI 10.1093/NAR/GKR407.;ROST B, 2004, NUCLEIC ACIDS RES, V32, PW321, DOI 10.1093/NAR/GKH377.;ROZEN S, 2000, METHODS MOL BIOL, V132, P365.;SAWALHA AH, 2016, J AUTOIMMUN, V67, P76, DOI 10.1016/J.JAUT.2015.10.002.;SCHWARZ JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/NMETH.2890.;SHEN MY, 2013, MOL BIOSYST, V9, P2435, DOI 10.1039/C3MB70168A.;SHIHAB HA, 2015, BIOINFORMATICS, V31, P1536, DOI 10.1093/BIOINFORMATICS/BTV009.;SHIHAB HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/HUMU.22225.;SIEPEL A, 2005, GENOME RES, V15, P1034, DOI 10.1101/GR.3715005.;SILMAN AJ, 1990, LANCET, V335, P1078.;SUMI T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/JCB.147.7.1519.;SZKLARCZYK D, 2015, NUCLEIC ACIDS RES, V43, PD447, DOI 10.1093/NAR/GKU1003.;SZKLARCZYK D, 2011, NUCLEIC ACIDS RES, V39, PD561, DOI 10.1093/NAR/GKQ973.;TULUNAY A, 2015, GENES IMMUN, V16, P170, DOI 10.1038/GENE.2014.64.;VERITY DH, 1999, TISSUE ANTIGENS, V54, P213, DOI 10.1034/J.1399-0039.1999.540301.X.;XAVIER JM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/S13075-015-0585-6.","SAWALHA, AH (REPRINT AUTHOR), UNIV MICHIGAN, DEPT INTERNAL MED, DIV RHEUMATOL, ROOM 5520 MSRB-1,SPC 5680,1150 WEST MED CTR DR, ANN ARBOR, MI 48109 USA.;OGNENOVSKI, MIKHAIL, RENAUER, PAUL, GENSTERBLUM, ELIZABETH, SAWALHA, AMR H., UNIV MICHIGAN, ANN ARBOR, MI 48109 USA.;KOTTER, INA, ASKLEPIOS CLIN ALTONA, HAMBURG, GERMANY.;XENITIDIS, THEODOROS, HENES, JORG C., UNIV TUBINGEN, TUBINGEN, GERMANY.;XENITIDIS, THEODOROS, HENES, JORG C., UNIV TUBINGEN HOSP, TUBINGEN, GERMANY.;CASALI, BRUNO, SALVARANI, CARLO, AZIENDA OSPED ARCISPEDALE SANTA MARIA NUOVA IRCCS, REGGIO EMILIA, ITALY.;DIRESKENELI, HANER, MARMARA UNIV, ISTANBUL, TURKEY.;KAUFMAN, KENNETH M., CINCINNATI CHILDRENS HOSP MED CTR, CINCINNATI, OH 45229 USA.;KAUFMAN, KENNETH M., CINCINNATI VA MED CTR, CINCINNATI, OH USA.","10.1002/ART.39545","111 RIVER ST, HOBOKEN 07030-5774, NJ USA",NA,NA,"NIH [HL-102923], WOMEN'S HEALTH INITIATIVE SEQUENCING PROJECT [HL-102924], BROAD GO SEQUENCING PROJECT [HL-102925], SEATTLE GO SEQUENCING PROJECT [HL-102926], HEART GO SEQUENCING PROJECT [HL-103010]","EXOME VARIANT CALLS USED IN THE CURRENT STUDY WERE PROVIDED THROUGH THE NATIONAL HEART, LUNG, AND BLOOD INSTITUTE GRAND OPPORTUNITY (GO) EXOME SEQUENCING PROJECT AND ITS ONGOING NIH-FUNDED STUDIES: THE LUNG GO SEQUENCING PROJECT (HL-102923), THE WOMEN'S HEALTH INITIATIVE SEQUENCING PROJECT (HL-102924), THE BROAD GO SEQUENCING PROJECT (HL-102925), THE SEATTLE GO SEQUENCING PROJECT (HL-102926), AND THE HEART GO SEQUENCING PROJECT (HL-103010).",NA,"2326-5191","5","1272-1280","WILEY","68",2016,"ISI000375551600028","58","RHEUMATOLOGY","6","RHEUMATOLOGY","ASAWALHAUMICH.EDU",NA,"DL3RT",NA,"SAWALHA, AH (REPRINT AUTHOR), UNIV MICHIGAN, DEPT INTERNAL MED, DIV RHEUMATOL, ROOM 5520 MSRB-1,SPC 5680,1150 WEST MED CTR DR, ANN ARBOR, MI 48109 USA","ISI","UNIV MICHIGAN;ASKLEPIOS CLIN ALTONA;UNIV TUBINGEN;UNIV TUBINGEN HOSP;MARMARA UNIV;CINCINNATI CHILDRENS HOSP MED CTR;CINCINNATI VA MED CTR","UNIV MICHIGAN",NA,"OGNENOVSKI M, 2016, ARTHRITIS RHEUMATOL","OGNENOVSKI M, 2016, ARTHRITIS RHEUMATOL"
"MA G, 2016, PARASITES VECTORS","MA G;LUO Y;ZHU H;LUO Y;KORHONEN PK;YOUNG ND;GASSER RB;ZHOU R","MICRORNAS OF TOXOCARA CANIS AND THEIR PREDICTED FUNCTIONAL ROLES","PARASITES \& VECTORS","PARASITES VECTORS","BACKGROUND: TOXOCARA CANIS IS THE CAUSATIVE AGENT OF TOXOCARIASIS OF HUMANS AND OTHER ANIMALS. THIS PARASITIC NEMATODE (ROUNDWORM) HAS A COMPLEX LIFE CYCLE, IN WHICH SUBSTANTIAL DEVELOPMENTAL CHANGES AND SWITCHES OCCUR. AS SMALL NON-CODING RNAS (SRNAS) ARE KEY REGULATORS OF GENE EXPRESSION IN A WIDE RANGE OF ORGANISMS, WE EXPLORED THESE RNAS IN T. CANIS TO PROVIDE A BASIS FOR FUTURE STUDIES OF ITS DEVELOPMENTAL BIOLOGY AS WELL AS HOST INTERACTIONS AND DISEASE AT THE MOLECULAR LEVEL. METHODS: WE CONDUCTED HIGH-THROUGHPUT RNA SEQUENCING AND BIOINFORMATIC ANALYSES TO DEFINE SRNAS IN INDIVIDUAL MALE AND FEMALE ADULTS OF T. CANIS. RESULTS: APART FROM SNRNA AND SNORNA, 560 AND 619 MICRORNAS (MIRNAS), INCLUDING 5 AND 2 NOVEL MIRNAS, WERE IDENTIFIED IN MALE AND FEMALE WORMS, RESPECTIVELY, WITHOUT PIRNAS BEING DETECTED IN EITHER SEX. AN ANALYSIS OF TRANSCRIPTIONAL PROFILES SHOWED THAT, OF 564 MIRNAS PREDICTED AS BEING DIFFERENTIALLY TRANSCRIBED BETWEEN MALE AND FEMALE INDIVIDUALS OF T. CANIS, 218 MIRNAS WERE TRANSCRIBED EXCLUSIVELY IN MALE AND 277 IN FEMALE WORMS. FUNCTIONAL ENRICHMENT ANALYSIS PREDICTED THAT BOTH MALE AND FEMALE MIRNAS WERE MAINLY INVOLVED IN REGULATING EMBRYONIC MORPHOGENESIS, HEMIDESMOSOME ASSEMBLY AND GENETIC INFORMATION PROCESSING. THE MIRNAS DIFFERENTIALLY TRANSCRIBED BETWEEN THE SEXES WERE PREDICTED TO BE ASSOCIATED WITH SEX DETERMINATION, EMBRYONIC MORPHOGENESIS AND NEMATODE LARVAL DEVELOPMENT. THE ROLES OF MIRNAS WERE PREDICTED BASED ON GENE ONTOLOGY (GO) AND KEGG PATHWAY ANNOTATIONS. THE MIRNAS TC-MIR-2305 AND TC-MIR-6090 ARE PROPOSED TO HAVE ROLES IN REPRODUCTION, EMBRYO DEVELOPMENT AND LARVAL DEVELOPMENT, AND TC-LET-7-5P, TC-MIR-34 AND TC-MIR-100 APPEAR TO BE INVOLVED IN HOST-PARASITE INTERACTIONS. TOGETHER WITH PUBLISHED INFORMATION FROM PREVIOUS STUDIES, SOME MIRNAS (SUCH AS TC-MIR-2861, TC-MIR-2881 AND TC-MIR-5126) ARE PREDICTED TO REPRESENT DRUG TARGETS AND/OR ASSOCIATED WITH DRUG RESISTANCE. CONCLUSIONS: THIS IS THE FIRST EXPLORATION OF MIRNAS IN T. CANIS, WHICH COULD PROVIDE A BASIS FOR FUNDAMENTAL INVESTIGATIONS OF THE DEVELOPMENTAL BIOLOGY OF THE PARASITE, PARASITE-HOST INTERACTIONS AND TOXOCARIASIS AS WELL AS APPLIED AREAS, SUCH AS THE DIAGNOSIS OF INFECTION/DISEASE, DRUG TARGET DISCOVERY AND DRUG RESISTANCE DETECTION.","TOXOCARA CANIS; MICRORNAS (MIRNAS); REPRODUCTION AND DEVELOPMENT; HOST-PARASITE INTERACTIONS; DRUG RESISTANCE","PARASITE-DERIVED MICRORNAS; TIME QUANTITATIVE PCR; SMALL RNAS; IMMUNE-SYSTEM; SCHISTOSOMA-JAPONICUM; MOLECULAR-BIOLOGY; EXPANDING WORLD; GENE-EXPRESSION; RISK-FACTORS; PROFILES","ENGLISH","ARTICLE","ARTICLE",7,"AHMED R, 2013, GENOME BIOL EVOL, V5, P1246, DOI 10.1093/GBE/EVT086.;AMERES SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/NRM3611.;BARTEL DP, 2009, CELL, V136, P215, DOI 10.1016/J.CELL.2009.01.002.;BARTEL DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5.;BENES V, 2010, METHODS, V50, P244, DOI 10.1016/J.YMETH.2010.01.026.;BENFEY PN, 2003, NATURE, V425, P244, DOI 10.1038/425244A.;BIDARIMATH M, 2014, CELL MOL IMMUNOL, V11, P538, DOI 10.1038/CMI.2014.45.;BRITTON C, 2014, INT J PARASITOL-DRUG, V4, P85, DOI 10.1016/J.IJPDDR.2014.03.001.;BUCK AH, 2014, NAT COMMUN, V5, DOI 10.1038/NCOMMS6488.;CAI PF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/JOURNAL.PNTD.0001256.;CALDERA F, 2013, INFECTION, V41, P691, DOI 10.1007/S15010-012-0342-6.;CASSENOTE AJ, 2014, PLOS NEGLECT TROP D, V8, PE2830.;CHEN J, 2012, INFECT GENET EVOL, V12, P1344, DOI 10.1016/J.MEEGID.2012.04.019.;CONG W, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/JOURNAL.PNTD.0003082.;DESPOMMIER D, 2003, CLIN MICROBIOL REV, V16, P265, DOI 10.1128/CMR.16.2.265-272.2003.;DEVANEY E, 2010, TRENDS PARASITOL, V26, P428, DOI 10.1016/J.PT.2010.05.003.;DIETERICH C, 2009, TRENDS GENET, V25, P203, DOI 10.1016/J.TIG.2009.03.006.;EL-TRAS WF, 2011, VET PARASITOL, V178, P319, DOI 10.1016/J.VETPAR.2010.12.051.;GASSER RB, 2013, VET PARASITOL, V193, P353, DOI 10.1016/J.VETPAR.2012.12.031.;GROSSHANS H, 2008, NATURE, V451, P414, DOI 10.1038/451414A.;HARRIS JF, 2013, VIRULENCE, V4, P785, DOI 10.4161/VIRU.26119.;HEWITSON JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/J.MOLBIOPARA.2009.04.008.;HOLLAND CV, 2006, TOXOCARA: THE ENIGMATIC PARASITE, P1.;HOOGSTRATE SUZANNE W, 2014, WORM, V3, PE28234, DOI 10.4161/WORM.28234.;HOY AM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/JOURNAL.PNTD.0002701.;IORIO MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936.;JACOBS DE, 1997, ACTA TROP, V68, P191, DOI 10.1016/S0001-706X(97)00093-4.;KAMUYU G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/JOURNAL.PNTD.0002908.;LALAOUNA D, 2014, PLOS PATHOG, V10, DOI 10.1371/JOURNAL.PPAT.1004299.;LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y.;LEE RM, 2014, PLOS NEGLECT TROP D, V8, PE3116.;LEUNG AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/J.MOLCEL.2010.09.027.;LI L, 2014, ANN ALLERG ASTHMA IM, V113, P187, DOI 10.1016/J.ANAI.2014.05.016.;LIVAK KJ, 2001, METHODS, V25, P402, DOI 10.1006/METH.2001.1262.;MACPHERSON CNL, 2013, INT J PARASITOL, V43, P999, DOI 10.1016/J.IJPARA.2013.07.004.;MAIZELS RM, 2013, VET PARASITOL, V193, P365, DOI 10.1016/J.VETPAR.2012.12.032.;MANZANO-ROMAN R, 2012, MOL BIOCHEM PARASIT, V186, P81, DOI 10.1016/J.MOLBIOPARA.2012.10.001.;MARCILLA A, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0045974.;MENDONCA LR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/JOURNAL.PNTD.0001886.;NEEB ZT, 2014, DEV CELL, V28, P111, DOI 10.1016/J.DEVCEL.2014.01.009.;NIJSSE R, 2015, PARASITOL RES, V114, P561, DOI 10.1007/S00436-014-4218-9.;O'CONNELL RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/NRI2708.;OVERGAAUW PAM, 2009, VET PARASITOL, V163, P115, DOI 10.1016/J.VETPAR.2009.03.044.;PINELES BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/J.AJOG.2007.01.008.;PRICHARD RK, 2007, PARASITOLOGY, V134, P1123, DOI 10.1017/S0031182007000091.;RAO VTS, 2009, MOL BIOCHEM PARASIT, V166, P54, DOI 10.1016/J.MOLBIOPARA.2009.02.011.;REHMSMEIER M, 2004, RNA, V10, P1507, DOI 10.1021/RNA.5248604.;REINHART BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607.;SARKIES P, 2015, PLOS BIOL, V13, DOI 10.1371/JOURNAL.PBIO.1002061.;SCHICKEL R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/ONC.2008.274.;MOREIRAL GMSG, 2014, TRENDS PARASITOL, V30, P456, DOI 10.1016/J.PT.2014.07.003.;SCHMIDT MF, 2014, TRENDS BIOTECHNOL, V32, P578, DOI 10.1016/J.TIBTECH.2014.09.002.;SCHOENARDIE ER, 2013, J PARASITOL, V99, P537, DOI 10.1645/GE-3182.;SHAO CC, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-99.;SHELL S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/PNAS.0704372104.;SMITH H, 2009, TRENDS PARASITOL, V25, P182, DOI 10.1016/J.PT.2009.01.006.;SUN J, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-177.;TAIRA K, 2004, VET PARASITOL, V121, P115, DOI 10.1016/J.VETPAR.2004.01.018.;THEODOROPOULOS G, 2001, TRENDS PARASITOL, V17, P130, DOI 10.1016/S1471-4922(00)01775-X.;TRITTEN L, 2014, MOL BIOCHEM PARASIT, V198, P14, DOI 10.1016/J.MOLBIOPARA.2014.11.001.;TRITTEN L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/JOURNAL.PNTD.0002971.;TURNER M, 2014, NAT IMMUNOL, V15, P484, DOI 10.1038/NI.2887.;TWU O, 2014, PLOS PATHOG, V10, DOI 10.1371/JOURNAL.PPAT.1004289.;URQUHART GM, 2003, VET PARASITOLOGY.;WANG JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/GR.121426.111.;WILLIAMSON SM, 2009, PLOS PATHOG, V5, DOI 10.1371/JOURNAL.PPAT.1000517.;WINTER AD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-4.;YATES LA, 2013, CELL, V153, P516, DOI 10.1016/J.CELL.2013.04.003.;ZAMANIAN M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/JOURNAL.PNTD.0004069.;ZHANG L, 2009, DEVELOPMENT, V136, P3043, DOI 10.1242/DEV.039008.;ZHENG YD, 2013, RNA BIOL, V10, P377, DOI 10.4161/RNA.23716.;ZHU XQ, 2015, NAT COMMUN, V6, DOI 10.1038/NCOMMS7145.","GASSER, RB (REPRINT AUTHOR), UNIV MELBOURNE, FAC VET \& AGR SCI, PARKVILLE, VIC 3010, AUSTRALIA.;ZHOU, RQ (REPRINT AUTHOR), RONGCHANG CAMPUS SOUTHWEST UNIV, DEPT VET MED, CHONGQING 402460, PEOPLES R CHINA.;MA, GUANGXU, KORHONEN, PASI K., YOUNG, NEIL D., GASSER, ROBIN B., UNIV MELBOURNE, FAC VET \& AGR SCI, PARKVILLE, VIC 3010, AUSTRALIA.;MA, GUANGXU, LUO, YONGFANG, ZHU, HONGHONG, LUO, YONGLI, ZHOU, RONGQIONG, RONGCHANG CAMPUS SOUTHWEST UNIV, DEPT VET MED, CHONGQING 402460, PEOPLES R CHINA.","10.1186/S13071-016-1508-3","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","229",NA,"NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA [31172313], YOUTH FUND PROJECT OF SOUTHWEST UNIVERSITY RONGCHANG CAMPUS, INTERNATIONAL SCIENCE \& TECHNOLOGY COOPERATION PROGRAM OF CHINA [2013DFA31840], NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL (NHMRC), AUSTRALIAN RESEARCH COUNCIL (ARC), WELLCOME TRUST, MELBOURNE WATER CORPORATION AND YOURGENE BIOSCIENCES","THIS WORK WAS SUPPORTED BY THE NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA (NO. 31172313), THE YOUTH FUND PROJECT (2015) OF SOUTHWEST UNIVERSITY RONGCHANG CAMPUS AND THE INTERNATIONAL SCIENCE \& TECHNOLOGY COOPERATION PROGRAM OF CHINA (GRANT NO. 2013DFA31840). RBG'S RESEARCH IS SUPPORTED PRINCIPALLY BY GRANTS FROM THE NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL (NHMRC), AUSTRALIAN RESEARCH COUNCIL (ARC), WELLCOME TRUST, MELBOURNE WATER CORPORATION AND YOURGENE BIOSCIENCES (DR BILL CHANG). BGI-SHENZHEN (CHINA) PROVIDED SEQUENCING SERVICE.",NA,"1756-3305",NA,NA,"BIOMED CENTRAL LTD","9",2016,"ISI000375038100001","72","PARASITOLOGY, TROPICAL MEDICINE","10","PARASITOLOGY, TROPICAL MEDICINE","ROBINBGUNIMELB.EDU.AU RONGQIONGZHOU163.COM",NA,"DK6ML",NA,"GASSER, RB (REPRINT AUTHOR), UNIV MELBOURNE, FAC VET \& AGR SCI, PARKVILLE, VIC 3010, AUSTRALIA","ISI","UNIV MELBOURNE;RONGCHANG CAMPUS SOUTHWEST UNIV","UNIV MELBOURNE",NA,"MA G, 2016, PARASITES VECTORS","MA G, 2016, PARASITES VECTORS"
"PERROT A, 2016, ARCH MED SCI","PERROT A;TOMASOV P;VILLARD E;FALUDI R;MELACINI P;LOSSIE J;LOHMANN N;RICHARD P;DE BORTOLI M;ANGELINI A;VARGA SZEMES A;SPERLING SR;SIMOR T;VESELKA J;OZCELIK C;CHARRON P","MUTATIONS IN NEBL ENCODING THE CARDIAC Z-DISK PROTEIN NEBULETTE ARE ASSOCIATED WITH VARIOUS CARDIOMYOPATHIES","ARCHIVES OF MEDICAL SCIENCE","ARCH. MED. SCI.","INTRODUCTION: TRANSGENIC MICE OVEREXPRESSING MUTATED NEBL, ENCODING THE CARDIAC-SPECIFIC Z-DISK PROTEIN NEBULETTE, DEVELOP SEVERE CARDIAC PHENOTYPES. SINCE CARDIOMYOPATHIES ARE COMMONLY FAMILIAL AND BECAUSE MUTATIONS IN A SINGLE GENE MAY RESULT IN VARIABLE PHENOTYPES, WE TESTED THE HYPOTHESIS THAT NEBL MUTATIONS ARE ASSOCIATED WITH CARDIOMYOPATHY. MATERIAL AND METHODS: WE ANALYZED 389 PATIENTS, INCLUDING COHORTS OF PATIENTS WITH DILATED CARDIOMYOPATHY (DCM), HYPERTROPHIC CARDIOMYOPATHY (HCM), AND LEFT VENTRICULAR NON-COMPACTION CARDIOMYOPATHY (LVNC). THE 28 CODING EXONS OF THE NEBL GENE WERE SEQUENCED. FURTHER BIOINFORMATIC ANALYSIS WAS USED TO DISTINGUISH VARIANTS. RESULTS: IN TOTAL, WE IDENTIFIED SIX VERY RARE HETEROZYGOUS MISSENSE MUTATIONS IN NEBL IN 7 DIFFERENT PATIENTS (FREQUENCY 1.8\%) IN HIGHLY CONSERVED CODONS. THE MUTATIONS WERE NOT DETECTABLE IN 320 CAUCASIAN SEX-MATCHED UNRELATED INDIVIDUALS WITHOUT CARDIOMYOPATHY AND 192 CAUCASIAN SEX-MATCHED BLOOD DONORS WITHOUT HEART DISEASE. KNOWN CARDIOMYOPATHY GENES WERE EXCLUDED IN THESE PATIENTS. THE MUTATIONS P.H171R AND P.1652L WERE FOUND IN 2 HCM PATIENTS. FURTHER, P.Q581R AND P.S747L WERE DETECTED IN 2 DCM PATIENTS, WHILE THE MUTATION P.A175T WAS IDENTIFIED INDEPENDENTLY IN TWO UNRELATED PATIENTS WITH DCM. ONE LVNC PATIENT CARRIED THE MUTATION P.P916L. ALL HCM AND DCM RELATED MUTATIONS WERE LOCATED IN THE NEBULIN-LIKE REPEATS, DOMAINS RESPONSIBLE FOR ACTIN BINDING. INTERESTINGLY, THE MUTATION ASSOCIATED WITH LVNC WAS LOCATED IN THE C-TERMINAL SERINE-RICH LINKER REGION. CONCLUSIONS: OUR DATA SUGGEST THAT NEBL MUTATIONS MAY CAUSE VARIOUS CARDIOMYOPATHIES. WE HEREIN DESCRIBE THE FIRST NEBL MUTATIONS IN HCM AND LVNC. OUR FINDINGS UNDERLINE THE NOTION THAT THE CARDIOMYOPATHIES ARE TRUE ALLELIC DISEASES.","CARDIOMYOPATHY; HYPERTROPHIC; DILATED; NON-COMPACTION; GENETICS","IDIOPATHIC DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; ACTIN-BINDING; NEBULIN; DISEASE; GENE; MYOPALLADIN; EXPRESSION; ROLES","ENGLISH","ARTICLE","ARTICLE",3,"ADZHUBEI IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/NMETH0410-248.;ARIMURA T, 2000, HUM GENET, V107, P440, DOI 10.1007/S004390000389.;BANG ML, 2001, J CELL BIOL, V153, P413, DOI 10.1083/JCB.153.2.413.;BONZO JR, 2008, EXP CELL RES, V314, P3519, DOI 10.1016/J.YEXCR.2008.09.001.;BOS JM, 2010, J AM COLL CARDIOL, V55, P1136, DOI 10.1016/J.JACC.2009.12.016.;DUBOSCQ-BIDOT L, 2008, CARDIOVASC RES, V77, P118, DOI 10.1093/CVR/CVM015.;ESHAM M, 2007, CELL MOTIL CYTOSKEL, V64, P258, DOI 10.1002/CM.20180.;FOKSTUEN S, 2008, HUM MUTAT, V29, P879, DOI 10.1002/HUMU.20749.;HERSHBERGER RE, 2009, CIRC-HEART FAIL, V2, P253, DOI 10.1161/CIRCHEARTFAILURE.108.817346.;HOLMES WB, 2008, CELL MOTIL CYTOSKEL, V65, P130, DOI 10.1002/CM.20249.;HOUSHMAND M, 2011, ARCH MED SCI, V7, P242, DOI 10.5114/AOMS.2011.22074.;MARON BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287.;MESTRONI L, 1999, EUR HEART J, V20, P93, DOI 10.1053/EUHJ.1998.1145.;MILLEVOI S, 1998, J MOL BIOL, V282, P111, DOI 10.1006/JMBI.1998.1999.;MONCMAN CL, 2000, J MUSCLE RES CELL M, V21, P153, DOI 10.1023/A:1005697226465.;MONCMAN CL, 2002, EXP CELL RES, V273, P204, DOI 10.1006/EXCR.2001.5423.;MONCMAN CL, 1999, CELL MOTIL CYTOSKEL, V44, P1, DOI 10.1002/(SICI)1097-0169(199909)44:1<1::AID-CM1>3.0.CO,2-8.;MONCMAN CL, 1995, CELL MOTIL CYTOSKEL, V32, P205, DOI 10.1002/CM.970320305.;NORTON N, 2012, CIRC-CARDIOVASC GENE, V5, P167, DOI 10.1161/CIRCGENETICS.111.961805.;OGUT O, 2003, J BIOL CHEM, V278, P3089, DOI 10.1074/JBC.M205853200.;PANAVIENE Z, 2007, CELL TISSUE RES, V327, P355.;PERROT A, 2005, J MOL MED-JMM, V83, P468, DOI 10.1007/S00109-005-0635-7.;PERROT A, 2007, EUR J HEART FAIL, V9, P4, DOI 10.1016/J.EJHEART.2006.04.010.;PERROT A, 2006, EUR J HEART FAIL, V8, P484, DOI 10.1016/J.EJHEART.2005.11.004.;PETERSEN SE, 2005, J AM COLL CARDIOL, V46, P101, DOI 10.1016/J.JACC.2005.03.045.;POSCH MG, 2008, MOL GENET METAB, V95, P74, DOI 10.1016/J.YMGME.2008.06.005.;PUREVJAV E, 2010, J AM COLL CARDIOL, V56, P1493, DOI 10.1016/J.JACC.2010.05.045.;RAM R, 2010, J AM COLL CARDIOL, V56, P1503, DOI 10.1016/J.JACC.2010.06.031.;RICHARD P, 2006, J AM COLL CARDIOL, V48, PA79, DOI 10.1016/J.JACC.2006.09.014.;RICHARD R, 2003, CIRCULATION, V107, P2227.;SARACYN M, 2013, ARCH MED SCI, V9, P594, DOI 10.5114/AOMS.2013.34988.;SCHWARZ JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/NMETH0810-575.;TENNESSEN JA, 2012, SCIENCE, V337, P64, DOI 10.1126/SCIENCE.1219240.;VITKUP D, 2003, GENOME BIOL, V4, DOI 10.1186/GB-2003-4-11-R72.;WATKINS H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMRA0902923.","PERROT, A (REPRINT AUTHOR), CHARITE, ECRC, CARDIOVASC GENET, LINDENBERGER WEG 80, D-13125 BERLIN, GERMANY.;PERROT, ANDREAS, LOSSIE, JANINE, LOHMANN, NADINE, SPERLING, SILKE R., OZCELIK, CEMIL, CHARITE, CARDIOVASC GENET EXPT \& CLIN RES CTR, D-13353 BERLIN, GERMANY.;TOMASOV, PAVOL, VESELKA, JOSEF, CHARLES UNIV PRAGUE, UNIV HOSP MOTOL, DEPT CARDIOL, SCH MED 2, PRAGUE, CZECH REPUBLIC.;VILLARD, ERIC, CHARRON, PHILIPPE, HOP LA PITIE SALPETRIERE, AP HP, DEPT GENET, PARIS, FRANCE.;VILLARD, ERIC, CHARRON, PHILIPPE, HOP LA PITIE SALPETRIERE, DEPT CARDIOL, PARIS, FRANCE.;VILLARD, ERIC, CHARRON, PHILIPPE, HOP LA PITIE SALPETRIERE, INSERM, UMR 1166, PARIS, FRANCE.;FALUDI, REKA, VARGA-SZEMES, AKOS, SIMOR, TAMAS, UNIV PECS, FAC MED, INST HEART, PECS, HUNGARY.;MELACINI, PAOLA, DE BORTOLI, MARZIA, ANGELINI, ANNALISA, UNIV PADUA, DEPT CARDIAC THORAC \& VASC SCI, PADUA, ITALY.;RICHARD, PASCALE, GRP HOSP PITIE SALPETRIERE, AP HP, SERV BIOCHIM METABOL, UF CARDIOGENET \& MYOGENET, F-75634 PARIS, FRANCE.;OZCELIK, CEMIL, KNAPPSCHAFTSKRANKENHAUS RECKLINGHAUSEN, MED KLIN KARDIOL GASTROENTEROL \& DIABETOL 1, RECKLINGHAUSEN, GERMANY.;CHARRON, PHILIPPE, UNIV VERSAILLES ST QUENTIN YVELINES, VERSAILLES, FRANCE.","10.5114/AOMS.2016.59250","KLEEBERGA ST 2, POZNAN, 61-615, POLAND",NA,NA,"CHARITE RESEARCH GRANT, ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (PHRC) [AOM95082], CONNY-MAEVA CHARITABLE FOUNDATION, LEDUCQ FOUNDATION (FONDATION LEDUCQ) (EUROGENE HEART FAILURE NETWORK), EUROPEAN UNION FP7 GRANT (INHERITANCE NETWORK), ITALIAN MINISTRY OF UNIVERSITY AND RESEARCH [20083EWHYR\_002], CZECH MINISTRY OF HEALTH [00064203]","THIS STUDY WAS SUPPORTED BY A CHARITE RESEARCH GRANT, ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (PHRC PROGRAMME HOSPITALIER DE RECHERCHE CLINIQUE AOM95082), THE CONNY-MAEVA CHARITABLE FOUNDATION, THE LEDUCQ FOUNDATION (FONDATION LEDUCQ) (EUROGENE HEART FAILURE NETWORK), A EUROPEAN UNION FP7 GRANT (INHERITANCE NETWORK), THE ITALIAN MINISTRY OF UNIVERSITY AND RESEARCH (GRANT 20083EWHYR\_002), AND THE CZECH MINISTRY OF HEALTH (PROJECT FOR CONCEPTUAL DEVELOPMENT OF RESEARCH ORGANIZATION 00064203). WE ARE GRATEFUL TO THE PATIENTS AND THEIR RELATIVES FOR THEIR PARTICIPATION IN THE STUDY. WE THANK ANDREA BEHM, UZMA ASLAM, LAETITIA DUBOSQ-BIDOT, AND PENG XU FOR EXCELLENT TECHNICAL SUPPORT.",NA,"1734-1922","2","263-278","TERMEDIA PUBLISHING HOUSE LTD","12",2016,"ISI000374510200004","35","GENERAL \& INTERNAL MEDICINE","0","MEDICINE, GENERAL \& INTERNAL","ANDREAS.PERROTCHARITE.DE",NA,"DJ9BY",NA,"PERROT, A (REPRINT AUTHOR), CHARITE, ECRC, CARDIOVASC GENET, LINDENBERGER WEG 80, D-13125 BERLIN, GERMANY","ISI","CARDIOVASC GENET EXPT AND CLIN RES CTR;CHARLES UNIV PRAGUE;UNIV PECS;UNIV PADUA;GRP HOSP PITIE SALPETRIERE;KNAPPSCHAFTSKRANKENHAUS RECKLINGHAUSEN;UNIV VERSAILLES ST QUENTIN YVELINES","NOTREPORTED",NA,"PERROT A, 2016, ARCH MED SCI","PERROT A, 2016, ARCH MED SCI"
"STRAUSS L, 2016, J CLIN MICROBIOL","STRAUSS L;RUFFING U;ABDULLA S;ALABI A;AKULENKO R;GARRINE M;GERMANN A;GROBUSCH MP;HELMS V;HERRMANN M;KAZIMOTO T;KERN W;MANDOMANDO I;PETERS G;SCHAUMBURG F;VON MUELLER L;MELLMANN A","DETECTING STAPHYLOCOCCUS AUREUS VIRULENCE AND RESISTANCE GENES: A COMPARISON OF WHOLE-GENOME SEQUENCING AND DNA MICROARRAY TECHNOLOGY","JOURNAL OF CLINICAL MICROBIOLOGY","J. CLIN. MICROBIOL.","STAPHYLOCOCCUS AUREUS IS A MAJOR BACTERIAL PATHOGEN CAUSING A VARIETY OF DISEASES RANGING FROM WOUND INFECTIONS TO SEVERE BACTEREMIA OR INTOXICATIONS. BESIDES HOST FACTORS, THE COURSE AND SEVERITY OF DISEASE IS ALSO WIDELY DEPENDENT ON THE GENOTYPE OF THE BACTERIUM. WHOLE-GENOME SEQUENCING (WGS), FOLLOWED BY BIOINFORMATIC SEQUENCE ANALYSIS, IS CURRENTLY THE MOST EXTENSIVE GENOTYPING METHOD AVAILABLE. TO IDENTIFY CLINICALLY RELEVANT STAPHYLOCOCCAL VIRULENCE AND RESISTANCE GENES IN WGS DATA, WE DEVELOPED AN IN SILICO TYPING SCHEME FOR THE SOFTWARE SEQSPHERE(+) (RIDOM GMBH, MUNSTER, GERMANY). THE IMPLEMENTED TARGET GENES (N=182) CORRESPOND TO THOSE QUERIED BY THE IDENTIBAC S. AUREUS GENOTYPING DNA MICROARRAY (ALERE TECHNOLOGIES, JENA, GERMANY). THE IN SILICO SCHEME WAS EVALUATED BY COMPARING THE TYPING RESULTS OF MICROARRAY AND OF WGS FOR 154 HUMAN S. AUREUS ISOLATES. A TOTAL OF 96.8\% (N=27,119) OF ALL TYPING RESULTS WERE EQUALLY IDENTIFIED WITH MICROARRAY AND WGS (40.6\% PRESENT AND 56.2\% ABSENT). DISCREPANCIES (3.2\% IN TOTAL) WERE CAUSED BY WGS ERRORS (1.7\%), MICROARRAY HYBRIDIZATION FAILURES (1.3\%), WRONG PREDICTION OF AMBIGUOUS MICROARRAY RESULTS (0.1\%), OR UNKNOWN CAUSES (0.1\%). SUPERIOR TO THE MICROARRAY, WGS ENABLED THE DISTINCTION OF ALLELIC VARIANTS, WHICH MAY BE ESSENTIAL FOR THE PREDICTION OF BACTERIAL VIRULENCE AND RESISTANCE PHENOTYPES. MULTILOCUS SEQUENCE TYPING CLONAL COMPLEXES AND STAPHYLOCOCCAL CASSETTE CHROMOSOME MEC ELEMENT TYPES INFERRED FROM MICROARRAY HYBRIDIZATION PATTERNS WERE EQUALLY DETERMINED BY WGS. IN CONCLUSION, WGS MAY SUBSTITUTE ARRAY-BASED METHODS DUE TO ITS UNIVERSAL METHODOLOGY, OPEN AND EXPANDABLE NATURE, AND RAPID PARALLEL ANALYSIS CAPACITY FOR DIFFERENT CHARACTERISTICS IN ONCE-GENERATED SEQUENCES.",NA,"METHICILLIN-RESISTANT; IDENTIFICATION; AFRICA; CLONES","ENGLISH","ARTICLE","ARTICLE",11,"ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;BECKER K, 1998, J CLIN MICROBIOL, V36, P2548.;BLETZ S, 2015, CLIN MICROBIOL INFEC, V21.;BUKOWSKI M, 2010, TOXINS, V2, P1148, DOI 10.3390/TOXINS2051148.;CANDES EJ, 2009, FOUND COMPUT MATH, V9, P717, DOI 10.1007/S10208-009-9045-5.;CLARKE J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/NNANO.2009.12].;CLARKE SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5.;DIDELOT X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/NRG3226.;EFRON B, 1983, AM STAT, V37, P36, DOI DOI 10.2307/2685844.;ENRIGHT MC, 2000, J CLIN MICROBIOL, V38, P1008.;HAMED M, 2015, INFECT GENET EVOL, V36, P475, DOI 10.1016/J.MEEGID.2015.08.020.;HERRMANN M, 2013, FUTURE MICROBIOL, V8, P17, DOI [10.2217/FMB.12.126, 10.2217/FMB.12.126].;HIRAMATSU K, 2013, INFECT CHEMOTHER, V45, P117, DOI 10.3947/IC.2013.45.2.117.;ITO T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09.;JUNEMANN S, 2013, NAT BIOTECHNOL, V31, P1148, DOI 10.1038/NBT1213-1148E.;KOREN Y., 2009, COMPUTER, V8, P30.;LEOPOLD SR, 2014, J CLIN MICROBIOL, V52, P2365, DOI 10.1128/JCM.00262-14.;LINDSAY JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006.;LOWY FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806.;MAIDEN MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/PNAS.95.6.3140.;MAYER S, 2001, J ANTIMICROB CHEMOTH, V47, P896, DOI 10.1093/JAC/47.6.896.;MONECKE S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/J.1574-695X.2008.00426.X.;MONECKE S, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0017936.;NOGUCHI N, 1999, FEMS MICROBIOL LETT, V172, P247, DOI 10.1111/J.1574-6968.1999.TB13475.X.;PANIAGUA-CONTRERAS G, 2014, FOLIA MICROBIOL, V59, P295, DOI 10.1007/S12223-013-0300-4.;ROCHE FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/MIC.0.25996-0.;RUFFING U, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0052487.;RUPPITSCH W, 2015, J CLIN MICROBIOL, V53, P2869, DOI 10.1128/JCM.01193-15.;SCHAUMBURG F, 2014, CLIN MICROBIOL INFEC, V20, P589, DOI 10.1111/1469-0691.12690.;SHITTU AO, 2015, FRONT MICROBIOL, V6, DOI 10.3389/FMICB.2015.01160.;TAMURA K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/MOLBEV/MSR121.;VAN WAMEL WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006.;XUE HP, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0020332.;ZHANG SK, 2015, J CLIN MICROBIOL, V53, P1685, DOI 10.1128/JCM.00323-15.","MELLMANN, A (REPRINT AUTHOR), UNIV MUNSTER, INST HYG, D-48149 MUNSTER, GERMANY.;STRAUSS, LENA, MELLMANN, ALEXANDER, UNIV MUNSTER, INST HYG, D-48149 MUNSTER, GERMANY.;RUFFING, ULLA, HERRMANN, MATHIAS, VON MUELLER, LUTZ, UNIV SAARLAND, INST MED MICROBIOL \& HYG, HOMBURG, GERMANY.;ABDULLA, SALIM, KAZIMOTO, THECKLA, IFAKARA HLTH RES \& DEV CTR, BAGAMOYO, TANZANIA.;ALABI, ABRAHAM, ALBERT SCHWEITZER HOSP, LAMBARENE, GABON.;ALABI, ABRAHAM, GROBUSCH, MARTIN PETER, UNIV TUBINGEN, INST TROP MED, TUBINGEN, GERMANY.;AKULENKO, RUSLAN, HELMS, VOLKHARD, UNIV SAARLAND, CTR BIOINFORMAT, D-66123 SAARBRUCKEN, GERMANY.;GARRINE, MARCELINO, MANDOMANDO, INACIO, MANHICA HLTH RES CTR, MANHICA, MOZAMBIQUE.;GERMANN, ANJA, FRAUNHOFER INST BIOMED ENGN, SULZBACH, GERMANY.;GROBUSCH, MARTIN PETER, UNIV AMSTERDAM, ACAD MED CTR, DIV INTERNAL MED, CTR TROP MED \& TRAVEL MED,DEPT INFECT DIS, MEIBERGDREEF 9, NL-1105 AZ AMSTERDAM, NETHERLANDS.;KERN, WINFRIED, UNIV FREIBURG, DEPT MED, DIV INFECT DIS, HUGSTETTER STR 55, D-79106 FREIBURG, GERMANY.;PETERS, GEORG, SCHAUMBURG, FRIEDER, UNIV MUNSTER, INST MED MICROBIOL, D-48149 MUNSTER, GERMANY.;VON MUELLER, LUTZ, CHRISTOPHORUS HOSP DULMEN, INST LAB MED MICROBIOL \& HYG, DULMEN, GERMANY.","10.1128/JCM.03022-15","1752 N ST NW, WASHINGTON, DC 20036-2904 USA",NA,NA,"DEUTSCHE FORSCHUNGSGEMEINSCHAFT (DFG) [ME 3205/4-1, HE1850/9-1, KE 700/2-1, EI 247/8-1]","DEUTSCHE FORSCHUNGSGEMEINSCHAFT (DFG) PROVIDED FUNDING TO ALEXANDER MELLMANN UNDER GRANT NUMBER ME 3205/4-1. DEUTSCHE FORSCHUNGSGEMEINSCHAFT (DFG) PROVIDED FUNDING TO MATHIAS J. HERRMANN UNDER GRANT NUMBER HE1850/9-1. DEUTSCHE FORSCHUNGSGEMEINSCHAFT (DFG) PROVIDED FUNDING TO WINFRIED V. KERN UNDER GRANT NUMBER KE 700/2-1. DEUTSCHE FORSCHUNGSGEMEINSCHAFT (DFG) PROVIDED FUNDING TO GEORG PETERS UNDER GRANT NUMBER EI 247/8-1.",NA,"0095-1137","4","1008-1016","AMER SOC MICROBIOLOGY","54",2016,"ISI000373337100022","34","MICROBIOLOGY","14","MICROBIOLOGY","MELLMANNUNI-MUENSTER.DE",NA,"DI2OX",NA,"MELLMANN, A (REPRINT AUTHOR), UNIV MUNSTER, INST HYG, D-48149 MUNSTER, GERMANY","ISI","UNIV MUNSTER;UNIV SAARLAND;IFAKARA HLTH RES AND DEV CTR;ALBERT SCHWEITZER HOSP;UNIV TUBINGEN;UNIV SAARLAND;MANHICA HLTH RES CTR;FRAUNHOFER INST BIOMED ENGN;UNIV AMSTERDAM;UNIV FREIBURG;UNIV MUNSTER;INST LAB MED MICROBIOL AND HYG","UNIV MUNSTER",NA,"STRAUSS L, 2016, J CLIN MICROBIOL","STRAUSS L, 2016, J CLIN MICROBIOL"
"EMAMEH RZ, 2016, MICROB BIOTECHNOL","EMAMEH RZ;KUUSLAHTI M;NAREAHO A;SUKURA A;PARKKILA S","INNOVATIVE MOLECULAR DIAGNOSIS OF TRICHINELLA SPECIES BASED ON BETA-CARBONIC ANHYDRASE GENOMIC SEQUENCE","MICROBIAL BIOTECHNOLOGY","MICROB. BIOTECHNOL.","TRICHINELLOSIS IS A HELMINTHIC INFECTION WHERE DIFFERENT SPECIES OF TRICHINELLA NEMATODES ARE THE CAUSATIVE AGENTS. SEVERAL MOLECULAR ASSAYS HAVE BEEN DESIGNED TO AID DIAGNOSTICS OF TRICHINELLOSIS. THESE ASSAYS ARE MOSTLY COMPLEX AND EXPENSIVE. THE GENOMES OF TRICHINELLA SPECIES CONTAIN CERTAIN PARASITE-SPECIFIC GENES, WHICH CAN BE DETECTED BY POLYMERASE CHAIN REACTION (PCR) METHODS. WE SELECTED -CARBONIC ANHYDRASE (-CA) GENE AS A TARGET, BECAUSE IT IS PRESENT IN MANY PARASITES GENOMES BUT ABSENT IN VERTEBRATES. WE DEVELOPED A NOVEL -CA GENE-BASED METHOD FOR DETECTION OF TRICHINELLA LARVAE IN BIOLOGICAL SAMPLES. WE FIRST IDENTIFIED A -CA PROTEIN SEQUENCE FROM TRICHINELLA SPIRALIS BY BIOINFORMATIC TOOLS USING -CAS FROM CAENORHABDITIS ELEGANS AND DROSOPHILA MELANOGASTER. THEREAFTER, 16 SETS OF DESIGNED PRIMERS WERE TESTED TO DETECT -CA GENOMIC SEQUENCES FROM THREE SPECIES OF TRICHINELLA, INCLUDING T.SPIRALIS, TRICHINELLAPSEUDOSPIRALIS AND TRICHINELLANATIVA. AMONG ALL 16 SETS OF DESIGNED PRIMERS, THE PRIMER SET NO. 2 EFFICIENTLY AMPLIFIED -CA GENOMIC SEQUENCES FROM T.SPIRALIS, T.PSEUDOSPIRALIS AND T.NATIVA WITHOUT ANY FALSE-POSITIVE AMPLICONS FROM OTHER PARASITE SAMPLES INCLUDING TOXOPLASMA GONDII, TOXOCARA CATI AND PARASCARIS EQUORUM. THIS ROBUST AND STRAIGHTFORWARD METHOD COULD BE USEFUL FOR MEAT INSPECTION IN SLAUGHTERHOUSES, QUALITY CONTROL BY FOOD AUTHORITIES AND MEDICAL LABORATORIES.",NA,"POLYMERASE-CHAIN-REACTION; MULTIPLEX PCR; TRICHINOSIS; INHIBITORS; SPIRALIS; IDENTIFICATION; INFECTION; ANIMALS; TARGET; ENZYME","ENGLISH","ARTICLE","ARTICLE",0,"AGUILERA J, 2005, BIOCHEM J, V391, P311, DOI 10.1042/BJ20050556.;AIRAS N, 2010, J PARASITOL, V96, P67, DOI 10.1645/GE-2202.1.;ALBAN L, 2011, PREV VET MED, V99, P148, DOI 10.1016/J.PREVETMED.2011.02.008.;ALTERIO V, 2006, J AM CHEM SOC, V128, P8329, DOI 10.1021/JA061574S.;ANCELLE T, 1998, EUROSURVEILLANCE, V3, P86.;BLAGA R, 2009, J HELMINTHOL, V83, P121, DOI 10.1017/S0022149X09359830.;BORSUK P, 2003, PARASITOL RES, V91, P374, DOI 10.1007/S00436-003-0971-X.;CLAUSEN MR, 1996, QJM-MON J ASSOC PHYS, V89, P631.;DEL PRETE S, 2014, BIOORG MED CHEM LETT, V24, P4389, DOI 10.1016/J.BMCL.2014.08.015.;DUPLESSIS M, 2001, MOL MICROBIOL, V41, P325, DOI 10.1046/J.1365-2958.2001.02521.X.;EMAMEH RZ, 2015, J ENZYM INHIB MED CH, V30, P505, DOI 10.3109/14756366.2014.944178.;EMAMEH RZ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-38.;FASSEAS MK, 2010, MOL BIOL REP, V37, P2941, DOI 10.1007/S11033-009-9857-Z.;FAWCETT TW, 1990, J BIOL CHEM, V265, P5414.;FERRY JG, 2010, BBA-PROTEINS PROTEOM, V1804, P374, DOI 10.1016/J.BBAPAP.2009.08.026.;FROSCHER W, 1988, EUR NEUROL, V28, P221, DOI 10.1159/000116271.;FUNKE RP, 1997, PLANT PHYSIOL, V114, P237, DOI 10.1104/PP.114.1.237.;GAJADHAR AA, 2009, VET PARASITOL, V159, P197, DOI 10.1016/J.VETPAR.2008.10.063.;GAMBLE HR, 2000, VET PARASITOL, V93, P393, DOI 10.1016/S0304-4017(00)00354-X.;GOTTSTEIN B, 2009, CLIN MICROBIOL REV, V22, P127, DOI 10.1128/CMR.00026-08.;GUENTHER S, 2008, J MICROBIOL METH, V75, P75, DOI 10.1016/J.MIMET.2008.05.008.;KIBBE WA, 2007, NUCLEIC ACIDS RES, V35, PW43, DOI 10.1093/NAR/GKM234.;KORINKOVA K, 2008, PARASITOL RES, V102, P1317, DOI 10.1007/S00436-008-0911-X.;KRIVOKAPICH SJ, 2012, INT J PARASITOL, V42, P903, DOI 10.1016/J.IJPARA.2012.07.009.;KUMAR V, 1990, ANN SOC BELG MED TR, V70, P131.;LA ROSA G, 2001, INT J PARASITOL, V31, P297, DOI 10.1016/S0020-7519(01)00110-2.;LANE TW, 2005, NATURE, V435, P42, DOI 10.1038/435042A.;LEROUX LP, 2015, INT J PARASITOL, V45, P319, DOI 10.1016/J.IJPARA.2015.01.003.;LI F, 2010, FOODBORNE PATHOG DIS, V7, P887, DOI 10.1089/FPD.2009.0472.;LI LZ, 2011, KOREAN J PARASITOL, V49, P381, DOI 10.3347/KJP.2011.49.4.381.;LIN ZB, 2013, PARASITOL RES, V112, P2087, DOI 10.1007/S00436-012-3267-1.;MARUCCI G, 2009, VET PARASITOL, V159, P225, DOI 10.1016/J.VETPAR.2008.10.041.;MERLIN C, 2003, J BACTERIOL, V185, P6415, DOI 10.1128/JB.185.21.6415-6424.2003.;MITSUHASHI S, 2004, APPL MICROBIOL BIOT, V63, P592, DOI 10.1007/S00253-003-1402-8.;NELSON M, 2003, J ENVIRON HEALTH, V65, P16.;DE NV, 2012, KOREAN J PARASITOL, V50, P339, DOI 10.3347/KJP.2012.50.4.339.;NISHIMORI I, 2007, J MED CHEM, V50, P381, DOI 10.1021/JM0612057.;NOCKLER K, 2000, VET PARASITOL, V93, P335, DOI 10.1016/S0304-4017(00)00350-2.;PEARSON WR, 2014, METHODS MOL BIOL, V1079, P75, DOI 10.1007/978-1-62703-646-7\_5.;POZIO E, 2005, VET PARASITOL, V127, P245, DOI 10.1016/J.VETPAR.2004.09.029.;POZIO E, 2002, INT J PARASITOL, V32, P1787, DOI 10.1016/S0020-7519(02)00139-X.;POZIO E, 2007, VET PARASITOL, V149, P3, DOI 10.1016/J.VETPAR.2007.07.002.;POZIO E, 2006, ADV PARASIT, V63, P367, DOI 10.1016/S0065-308X(06)63005-4.;ROMBOUT YB, 2001, J CLIN MICROBIOL, V39, P642, DOI 10.1128/JCM.39.2.642-646.2001.;SIEVERS F, 2011, MOL SYST BIOL, V7, DOI 10.1038/MSB.2011.75.;SMITH KS, 2000, J BACTERIOL, V182, P6605, DOI 10.1128/JB.182.23.6605-6613.2000.;SUPURAN CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/NRD2467.;SYRJANEN L, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-28.;TANTRAWATPAN C, 2012, VET PARASITOL, V185, P210, DOI 10.1016/J.VETPAR.2011.09.043.;VULLO D, 2004, J MED CHEM, V47, P1272, DOI 10.1021/JM031057+.;VULLO D, 2005, BIOORG MED CHEM LETT, V15, P963, DOI 10.1016/J.BMCL.2004.053.;WANG L, 2014, ARS MATH CONTEMP, V7, P40.;XU Y, 2008, NATURE, V452, P56, DOI 10.1038/NATURE06636.;YE J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134.;ZARLENGA DS, 2006, P NATL ACAD SCI USA, V103, P7354, DOI 10.1073/PNAS.0602466103.;ZARLENGA DS, 1999, INT J PARASITOL, V29, P1859, DOI 10.1016/S0020-7519(99)00107-1.;ZHANG YL, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-246.","EMAMEH, RZ (REPRINT AUTHOR), UNIV TAMPERE, SCH MED, FI-33520 TAMPERE, FINLAND.;EMAMEH, RZ (REPRINT AUTHOR), UNIV TAMPERE, BIOMEDITECH, FI-33520 TAMPERE, FINLAND.;EMAMEH, RZ (REPRINT AUTHOR), FIMLAB LABS LTD, BIOKATU 4, FI-33520 TAMPERE, FINLAND.;EMAMEH, RZ (REPRINT AUTHOR), TAMPERE UNIV HOSP, BIOKATU 4, FI-33520 TAMPERE, FINLAND.;EMAMEH, REZA ZOLFAGHARI, KUUSLAHTI, MARIANNE, PARKKILA, SEPPO, UNIV TAMPERE, SCH MED, FI-33520 TAMPERE, FINLAND.;EMAMEH, REZA ZOLFAGHARI, UNIV TAMPERE, BIOMEDITECH, FI-33520 TAMPERE, FINLAND.;EMAMEH, REZA ZOLFAGHARI, PARKKILA, SEPPO, FIMLAB LABS LTD, BIOKATU 4, FI-33520 TAMPERE, FINLAND.;EMAMEH, REZA ZOLFAGHARI, PARKKILA, SEPPO, TAMPERE UNIV HOSP, BIOKATU 4, FI-33520 TAMPERE, FINLAND.;NAREAHO, ANU, SUKURA, ANTTI, UNIV HELSINKI, FAC VET MED, DEPT VET BIOSCI, FI-00014 HELSINKI, FINLAND.","10.1111/1751-7915.12327","111 RIVER ST, HOBOKEN 07030-5774, NJ USA",NA,NA,"MINISTRY OF SCIENCE, RESEARCH AND TECHNOLOGY, NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY OF ISLAMIC REPUBLIC OF IRAN, ACADEMY OF FINLAND, FINNISH CULTURAL FOUNDATION (PIRKANMAA REGIONAL FUND), SIGRID JUSELIUS FOUNDATION, JANE AND AATOS ERKKO FOUNDATION, TAMPERE TUBERCULOSIS FOUNDATION, COMPETITIVE RESEARCH FUNDING OF THE TAMPERE UNIVERSITY HOSPITAL","TO PERFORM THESE STUDIES RZE RECEIVED A SCHOLARSHIP SUPPORT FROM THE MINISTRY OF SCIENCE, RESEARCH AND TECHNOLOGY, AND NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY OF ISLAMIC REPUBLIC OF IRAN. THIS STUDY WAS ALSO FUNDED BY ACADEMY OF FINLAND, FINNISH CULTURAL FOUNDATION (PIRKANMAA REGIONAL FUND), SIGRID JUSELIUS FOUNDATION, JANE AND AATOS ERKKO FOUNDATION, TAMPERE TUBERCULOSIS FOUNDATION, AND COMPETITIVE RESEARCH FUNDING OF THE TAMPERE UNIVERSITY HOSPITAL.",NA,"1751-7915","2","172-179","WILEY","9",2016,"ISI000371234500004","57","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, MICROBIOLOGY","4","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, MICROBIOLOGY","ZOLFAGHARI.EMAMEH.REZA.XSTUDENT.UTA.FI",NA,"DF3HJ",NA,"EMAMEH, RZ (REPRINT AUTHOR), UNIV TAMPERE, SCH MED, FI-33520 TAMPERE, FINLAND","ISI","UNIV TAMPERE;UNIV TAMPERE;FIMLAB LABS LTD;TAMPERE UNIV HOSP;UNIV HELSINKI","UNIV TAMPERE",NA,"EMAMEH RZ, 2016, MICROB BIOTECHNOL","EMAMEH RZ, 2016, MICROB BIOTECHNOL"
"MULCAHY-O'GRADY H, 2016, FRONT IMMUNOL","MULCAHY O GRADY H;WORKENTINE ML","THE CHALLENGE AND POTENTIAL OF METAGENOMICS IN THE CLINIC","FRONTIERS IN IMMUNOLOGY","FRONT. IMMUNOL.","THE BACTERIA, FUNGI, AND VIRUSES THAT LIVE ON AND IN US HAVE A TREMENDOUS IMPACT ON OUR DAY-TO-DAY HEALTH AND ARE OFTEN LINKED TO MANY DISEASES, INCLUDING AUTOIMMUNE DISORDERS AND INFECTIONS. DIAGNOSING AND TREATING THESE DISORDERS RELIES ON ACCURATE IDENTIFICATION AND CHARACTERIZATION OF THE MICROBIAL COMMUNITY. CURRENT SEQUENCING TECHNOLOGIES ALLOW THE SEQUENCING OF THE ENTIRE NUCLEIC ACID COMPLEMENT OF A SAMPLE PROVIDING AN ACCURATE SNAPSHOT OF THE COMMUNITY MEMBERS PRESENT IN ADDITION TO THE FULL GENETIC POTENTIAL OF THAT MICROBIAL COMMUNITY. THERE ARE A NUMBER OF CLINICAL APPLICATIONS THAT STAND TO BENEFIT FROM THESE DATA SETS, SUCH AS THE RAPID IDENTIFICATION OF PATHOGENS PRESENT IN A SAMPLE. OTHER APPLICATIONS INCLUDE THE IDENTIFICATION OF ANTIBIOTIC-RESISTANCE GENES, DIAGNOSIS AND TREATMENT OF GASTROINTESTINAL DISORDERS, AND MANY OTHER DISEASES ASSOCIATED WITH BACTERIAL, VIRAL, AND FUNGAL MICROBIOMES. METAGENOMICS ALSO ALLOWS THE PHYSICIAN TO PROBE MORE COMPLEX PHENOTYPES SUCH AS MICROBIAL DYSBIOSIS WITH INTESTINAL DISORDERS AND DISRUPTIONS OF THE SKIN MICROBIOME THAT MAY BE ASSOCIATED WITH SKIN DISORDERS. MANY OF THESE DISORDERS ARE NOT ASSOCIATED WITH A SINGLE PATHOGEN BUT EMERGE AS A RESULT OF COMPLEX ECOLOGICAL INTERACTIONS WITHIN MICROBIOTA. CURRENTLY, WE UNDERSTAND VERY LITTLE ABOUT THESE COMPLEX PHENOTYPES, YET CLEARLY THEY ARE IMPORTANT AND IN SOME CASES, AS WITH FECAL MICROBIOTA TRANSPLANTS IN CLOSTRIDIUM DIFFICILE INFECTIONS, TREATING THE MICROBIOME OF THE PATIENT IS EFFECTIVE. HERE, WE GIVE AN OVERVIEW OF METAGENOMICS AND DISCUSS A NUMBER OF AREAS WHERE METAGENOMICS IS APPLICABLE IN THE CLINIC, AND PROGRESS BEING MADE IN THESE AREAS. THIS INCLUDES (1) THE IDENTIFICATION OF UNKNOWN PATHOGENS, AND THOSE PATHOGENS PARTICULARLY HARD TO CULTURE, (2) UTILIZING FUNCTIONAL INFORMATION AND GENE CONTENT TO UNDERSTAND COMPLEX INFECTIONS SUCH AS CLOSTRIDIUM DIFFICILE, AND (3) PREDICTING ANTIMICROBIAL RESISTANCE OF THE COMMUNITY USING GENETIC DETERMINANTS OF RESISTANCE IDENTIFIED FROM THE SEQUENCING DATA. ALL OF THESE APPLICATIONS RELY ON SOPHISTICATED COMPUTATIONAL TOOLS, AND WE ALSO DISCUSS THE IMPORTANCE OF SKILLED BIOINFORMATIC SUPPORT FOR THE IMPLEMENTATION AND USE OF METAGENOMICS IN THE CLINIC.","METAGENOMICS; DIAGNOSITICS; PATHOGEN DETECTION; CLOSTRIDIUM DIFFICILE; ANTIBIOTIC RESISTANCE; BIOINFORMATICS; MICROBIOME; CLINICAL RESEARCH","CLOSTRIDIUM-DIFFICILE INFECTION; ANTIBIOTIC-RESISTANCE GENES; HUMAN GUT MICROBIOTA; INTESTINAL MICROBIOTA; SKIN MICROBIOME; DISEASE; CULTURE; METABOLISM; VANCOMYCIN; DISCOVERY","ENGLISH","REVIEW","ARTICLE",12,"ABUBUCKER S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/JOURNAL.PCBI.1002358.;ALNEBERG J, 2014, NAT METHODS, V11, P1144, DOI [10.1038/NMETH.3103, 10.1038/NMETH.3103].;ANTHARAM VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13.;BHADURI A, 2012, BIOINFORMATICS, V28, P1174, DOI 10.1093/BIOINFORMATICS/BTS100.;BHALLA A, 2003, INFECT CONT HOSP EP, V24, P644, DOI 10.1086/502267.;BHATT AS, 2013, NEW ENGL J MED, V369, P517, DOI 10.1056/NEJMOA1211115.;BOUILLAUT L, 2015, RES MICROBIOL, V166, P375, DOI 10.1016/J.RESMIC.2014.10.002.;BRADLEY P, 2015, RAPID ANTIBIOTIC RES, DOI [10.1101/018564, DOI 10.1101/018564].;BULTMAN SJ, 2014, CARCINOGENESIS, V35, P249, DOI 10.1093/CARCIN/BGT392.;BYRD AL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-262.;CAMMAROTA G, 2015, PHARMACOL THERAPEUT, V149, P191, DOI 10.1016/J.PHARMTHERA.2014.12.006.;CHO I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/NRG3182.;CRYAN JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/NRN3346.;DE LA COCHETIERE MF, 2008, MICROB ECOL, V56, P395, DOI 10.1007/S00248-007-9356-5.;DEAKIN LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12.;DREIER J, 2008, DIAGN MICR INFEC DIS, V61, P476, DOI 10.1016/J.DIAGMICROBIO.2008.03.008.;EREN AM, 2015, PEERJ, V3, DOI 10.7717/PEERJ.1319.;FERREYRA JA, 2014, CELL HOST MICROBE, V16, P770, DOI 10.1016/J.CHOM.2014.11.003.;FORSLUND K, 2014, BIOESSAYS, V36, P316, DOI 10.1002/BIES.201300143.;FUENTES S, 2014, ISME J, V8, P1621, DOI 10.1038/ISMEJ.2014.13.;GARRETT WS, 2015, SCIENCE, V348, P80, DOI 10.1126/SCIENCE.AAA4972.;GOODMAN AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/PNAS.1102938108.;GOODRICH JK, 2014, CELL, V158, P250, DOI 10.1016/J.CELL.2014.06.037.;GOUGH E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/CID/CIR632.;HOPKINS MJ, 2001, GUT, V48, P198, DOI 10.1136/GUT.48.2.198.;HU YF, 2013, NAT COMMUN, V4, DOI 10.1038/NCOMMS3151.;HUANG YVONNE J, 2014, ANN AM THORAC SOC, V11 SUPPL 1, PS48, DOI 10.1513/ANNALSATS.201306-187MG.;HUSON DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/GR.120618.111.;JOHNSON S, 2014, CLIN INFECT DIS, V59, P345, DOI 10.1093/CID/CIU313.;KNIGHT R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/NBT.2235.;KOSTIC AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/NBT.1868.;LAGIER JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023.;LAWLEY TD, 2012, PLOS PATHOG, V8, DOI 10.1371/JOURNAL.PPAT.1002995.;LEEK JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/NRG2825.;LIU B, 2009, NUCLEIC ACIDS RES, V37, PD443, DOI 10.1093/NAR/GKN656.;LOMAN NJ, 2013, JAMA-J AM MED ASSOC, V309, P1502, DOI 10.1001/JAMA.2013.3231.;LOUIE TJ, 2015, CLIN INFECT DIS, V60, PS91, DOI 10.1093/CID/CIV252.;LOUIE TJ, 2012, CLIN INFECT DIS, V55, PS132, DOI 10.1093/CID/CIS338.;LOUIE TJ, 2013, NEW CONS C DIFF PREV.;LUO CW, 2015, NAT BIOTECHNOL, V33, P1045, DOI 10.1038/NBT.3319.;MAY T, 1994, SCAND J GASTROENTERO, V29, P916, DOI 10.3109/00365529409094863.;MCARTHUR AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13.;MEYER F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386.;MILLER RR, 2013, GENOME MED, V5, DOI 10.1186/GM485.;MOKILI JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/J.COVIRO.2011.12.004.;NACCACHE SN, 2015, CLIN INFECT DIS, V60, P919, DOI 10.1093/CID/CIU912.;NACCACHE SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/GR.171934.113.;NAEEM R, 2013, BIOINFORMATICS, V29, P391, DOI 10.1093/BIOINFORMATICS/BTS684.;NAKAMURA S, 2008, EMERG INFECT DIS, V14, P1784, DOI 10.3201/EID1411.080589.;NI JJ, 2013, SCI REP-UK, V3, DOI 10.1038/SREP01968.;O'KEEFE SJD, 2010, WORLD J GASTROENTERO, V16, P139, DOI 10.3748/WJG.V16.I2.139.;OH J, 2014, NATURE, V514, P59, DOI 10.1038/NATURE13786.;ORDOVAS JM, 2006, CURR OPIN LIPIDOL, V17, P157, DOI 10.1097/01.MOL.0000217897.75068.BA.;PALLEN MJ, 2010, CURR OPIN MICROBIOL, V13, P625, DOI 10.1016/J.MIB.2010.08.003.;PENG Y, 2011, BIOINFORMATICS, V27, PI94, DOI 10.1093/BIOINFORMATICS/BTR216.;PETROF EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3.;POLLARD KS, 2015, POPULATION GENETIC A, DOI [10.1101/031757, DOI 10.1101/031757].;POWER ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990.;REA MC, 2012, J CLIN MICROBIOL, V50, P867, DOI 10.1128/JCM.05176-11.;REEVES AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12.;RICHARDSON DC, 2003, J INFECTION, V47, P170, DOI 10.1016/S0163-4453(03)00015-X.;SALTER SJ, 2014, BMC BIOL, V12, DOI 10.1186/S12915-014-0087-Z.;SANMIGUEL A, 2015, CELL MOL LIFE SCI, V72, P1499, DOI 10.1007/S00018-014-1812-Z.;SCHLOSS PD, 2014, NATURE, V514, P44, DOI 10.1038/514044A.;SCHMIEDER R, 2012, FUTURE MICROBIOL, V7, P73, DOI [10.2217/FMB.11.135, 10.2217/FMB.11.135].;SCHUBERT A. M., 2014, MBIO, V5, PE01021.;SEGATA N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/NMETH.2066].;SIBLEY CD, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0022702.;SMITH DR, 2015, FRONT GENET, V6, DOI 10.3389/FGENE.2015.00258.;SONG Y, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0081330.;STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/ANNUREV.MI.39.100185.001541.;STEWART EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12.;THOMAS TORSTEN, 2012, MICROB INFORM EXP, V2, P3, DOI 10.1186/2042-5783-2-3.;THURBER RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/NPROT.2009.10.;TREMAROLI V, 2012, NATURE, V489, P242, DOI 10.1038/NATURE11552.;TROMPETTE A, 2014, NAT MED, V20, P159, DOI 10.1038/NM.3444.;TURNER P, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0038271.;TVEDE M, 1989, LANCET, V1, P1156.;UBEDA C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918.;VIAUD S, 2013, SCIENCE, V342, P971, DOI 10.1126/SCIENCE.1240537.;VINCENT AT, 2015, FRONT GENET, V6, DOI 10.3389/FGENE.2015.00164.;VO ATE, 2014, MOL ECOL RESOUR, V14, P1183, DOI 10.1111/1755-0998.12269.;WEINGARDEN AR, 2014, AM J PHYSIOL-GASTR L, V306, PG310, DOI 10.1152/AJPGI.00282.2013.;WESOLOWSKA-ANDERSEN A, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-19.;WEYRICH LS, 2015, AUSTRALAS J DERMATOL, V56, P268, DOI 10.1111/AJD.12253.;WOOD DE, 2014, GENOME BIOL, V15, DOI 10.1186/GB-2014-15-3-R46.;WRIGHT GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/NRMICRO1614.","WORKENTINE, ML (REPRINT AUTHOR), UNIV CALGARY, FAC VET MED, CALGARY, AB, CANADA.;MULCAHY-O'GRADY, HEIDI, ALBERTA HLTH SERV, INFECT PREVENT \& CONTROL, CALGARY, AB, CANADA.;MULCAHY-O'GRADY, HEIDI, UNIV CALGARY, FAC MED, CALGARY, AB, CANADA.;WORKENTINE, MATTHEW L., UNIV CALGARY, FAC VET MED, CALGARY, AB, CANADA.","10.3389/FIMMU.2016.00029","PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND","29",NA,NA,NA,NA,"1664-3224",NA,NA,"FRONTIERS MEDIA SA","7",2016,"ISI000369129500001","87","IMMUNOLOGY","55","IMMUNOLOGY","MATTHEW.WORKENTINEUCALGARY.CA",NA,"DC3OV",NA,"WORKENTINE, ML (REPRINT AUTHOR), UNIV CALGARY, FAC VET MED, CALGARY, AB, CANADA","ISI","UNIV CALGARY;UNIV CALGARY","UNIV CALGARY",NA,"MULCAHY-O'GRADY H, 2016, FRONT IMMUNOL","MULCAHY-O'GRADY H, 2016, FRONT IMMUNOL"
"YIN L, 2016, VIRUSES-BASEL","YIN L;YAO J;CHANG K;GARDNER BP;YU F;GIULIANO AR;GOODENOW MM","HPV POPULATION PROFILING IN HEALTHY MEN BY NEXT-GENERATION DEEP SEQUENCING COUPLED WITH HPV-QUEST","VIRUSES-BASEL","VIRUSES-BASEL","MULTIPLE-TYPE HUMAN PAPILLOMAVIRUSES (HPV) INFECTION PRESENTS A GREATER RISK FOR PERSISTENCE IN ASYMPTOMATIC INDIVIDUALS AND MAY ACCELERATE CANCER DEVELOPMENT. TO EXTEND THE SCOPE OF HPV TYPES DEFINED BY PROBE-BASED ASSAYS, MULTIPLEXING DEEP SEQUENCING OF HPV L1, COUPLED WITH AN HPV-QUEST GENOTYPING SERVER AND A BIOINFORMATIC PIPELINE, WAS ESTABLISHED AND APPLIED TO SURVEY THE DIVERSITY OF HPV GENOTYPES AMONG A SUBSET OF HEALTHY MEN FROM THE HPV IN MEN (HIM) MULTINATIONAL STUDY. TWENTY-ONE HPV GENOTYPES (12 HIGH-RISK AND 9 LOW-RISK) WERE DETECTED IN THE GENITAL AREA FROM 18 ASYMPTOMATIC INDIVIDUALS. A SINGLE HPV TYPE, EITHER HPV16, HPV6B OR HPV83, WAS DETECTED IN 7 INDIVIDUALS, WHILE COINFECTION BY 2 TO 5 HIGH-RISK AND/OR LOW-RISK GENOTYPES WAS IDENTIFIED IN THE OTHER 11 PARTICIPANTS. IN TWO INDIVIDUALS STUDIED FOR OVER ONE YEAR, HPV16 PERSISTED, WHILE FLUCTUATIONS OF COINFECTING GENOTYPES OCCURRED. HPV L1 REGIONS WERE GENERALLY IDENTICAL BETWEEN QUERY AND REFERENCE SEQUENCES, ALTHOUGH NONSYNONYMOUS AND SYNONYMOUS NUCLEOTIDE POLYMORPHISMS OF HPV16, 18, 31, 35H, 59, 70, 73, CAND85, 6B, 62, 81, 83, CAND89 OR JEB2 L1 GENOTYPES, MOSTLY UNIDENTIFIED BY LINEAR ARRAY, WERE EVIDENT. DEEP SEQUENCING COUPLED WITH HPV-QUEST PROVIDES EFFICIENT AND UNAMBIGUOUS CLASSIFICATION OF HPV GENOTYPES IN MULTIPLE-TYPE HPV INFECTION IN HOST ECOSYSTEMS.","HPV; MULTIPLE-TYPE HPV INFECTION; ASYMPTOMATIC MEN; DEEP SEQUENCING; HPV-QUEST; LINEAR ARRAY; PAPILLOMAVIRUS EPISTEME","HUMAN-PAPILLOMAVIRUS INFECTION; POLYMERASE-CHAIN-REACTION; SQUAMOUS-CELL CARCINOMAS; CERVICAL-CANCER PATIENTS; LOWER GENITAL-TRACT; FINNISH FAMILY HPV; HIGH-RISK; NUCLEOTIDE-SEQUENCE; GENOTYPING METHODS; MULTIPLE TYPES","ENGLISH","ARTICLE","ARTICLE",1,"AL-SHABANAH OA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-343.;[ANONYMOUS], 2009, ROCH AMPL FUS PRIM D, P1.;ANWAR K, 1992, CANCER, V70, P1967, DOI 10.1002/1097-0142(19921001)70:7<1967::AID-CNCR2820700726>3.0.CO,2-8.;ARROYO LS, 2013, J CLIN VIROL, V58, P437, DOI 10.1016/J.JCV.2013.07.013.;BACHTIARY B, 2002, INT J CANCER, V102, P237, DOI 10.1002/IJC.10708.;BARZON L, 2011, INT J MOL SCI, V12, P7861, DOI 10.3390/IJMS12117861.;BENKI S, 2006, J CLIN MICROBIOL, V44, P4357, DOI 10.1128/JCM.01481-06.;BERNARD HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/IJC.21655.;BERNARD HU, 1994, J INFECT DIS, V170, P1077, DOI 10.1093/INFDIS/170.5.1077.;BRIOLAT J, 2007, INT J CANCER, V121, P2198, DOI 10.1002/IJC.22959.;CARVALHO ND, 2010, MEM I OSWALDO CRUZ, V105, P73, DOI 10.1590/S0074-02762010000100011.;CASTLE PE, 2008, J CLIN MICROBIOL, V46, P3437, DOI 10.1128/JCM.00620-08.;CHAN PKS, 2006, INT J CANCER, V118, P243, DOI 10.1002/IJC.21299.;CHAN SY, 1995, J VIROL, V69, P3074.;CHATURVEDI AK, 2011, J INFECT DIS, V203, P910, DOI 10.1093/INFDIS/JIQ139.;CHUA KL, 1996, CANCER, V77, P121, DOI 10.1002/(SICI)1097-0142(19960101)77:1<121::AID-CNCR20>3.0.CO,2-6.;CRICCA M, 2007, GYNECOL ONCOL, V106, P549, DOI 10.1016/J.YGYTIO.2007.05.004.;D'SOUZA G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMOA065497.;DAYYANI F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15.;DE VILLIERS EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/J.VIROL.2004.03.033.;DELIUS H, 1994, CURR TOP MICROBIOL IMMUNOL, V186, P13.;EKLUND C, 2012, J CLIN MICROBIOL, V50, P2289, DOI 10.1128/JCM.00840-12.;EKSTROM J, 2011, INT J CANCER, V129, P2643, DOI 10.1002/IJC.26204.;FIFE KH, 2001, J MED VIROL, V64, P550, DOI 10.1002/JMV.1085.;FLORES R, 2008, J VIROL METHODS, V149, P136, DOI 10.1016/J.JVIROMET.2007.12.010.;GALLEGOS-HERNANDEZ JF, 2007, CIR CIR, V75, P147.;GHARIZADEH B, 2005, J MOL DIAGN, V7, P198, DOI 10.1016/S1525-1578(10)60546-6.;GHARIZADEH B, 2001, LAB INVEST, V81, P673, DOI 10.1038/LABINVEST.3780276.;GIULIANO AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151.;GIULIANO AR, 2015, INT J CANCER, V136, P2752, DOI 10.1002/IJC.29082.;GIULIANO AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2.;GRAVITT PE, 2000, J CLIN MICROBIOL, V38, P357.;HAWS ALF, 2004, J VIROL METHODS, V122, P87, DOI 10.1016/J.JVIROMET.2004.08.007.;HO CM, 2011, VIRUS RES, V161, P124, DOI 10.1016/J.VIRUSRES.2011.06.012.;HO L, 1993, J VIROL, V67, P6413.;HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057.;HWANG TS, 2003, GYNECOL ONCOL, V90, P51, DOI 10.1016/S0090-8258(03)00201-4.;JACOBS MV, 1999, J CLIN PATHOL, V52, P498, DOI 10.1136/JCP.52.7.498.;JOHANSSON H, 2013, VIROLOGY, V440, P1, DOI 10.1016/J.VIROL.2013.01.023.;KJAER SK, 2005, CANCER EPIDEM BIOMAR, V14, P1528, DOI 10.1158/1055-9965.EPI-04-0754.;KLEIN F, 2009, LUNG CANCER, V65, P13, DOI 10.1016/J.LUNGCAN.2008.10.003.;KLETER B, 1998, AM J PATHOL, V153, P1731, DOI 10.1016/S0002-9440(10)65688-X.;KLETER B, 1999, J CLIN MICROBIOL, V37, P2508.;KLUG SJ, 2008, J MED VIROL, V80, P1264, DOI 10.1002/JMV.21191.;KORNEGAY JR, 2003, J CLIN MICROBIOL, V41, P1080, DOI 10.1128/JCM.41.3.1080-1086.2003.;KOVACS K, 2009, EUR J CANCER PREV, V18, P307, DOI 10.1097/CEJ.0B013E328324061A.;KUMAR R, 2002, J VIROL METHODS, V105, P233, DOI 10.1016/S0166-0934(02)00105-2.;LEI YJ, 2011, J MED VIROL, V83, P1230, DOI 10.1002/JMV.22034.;LI N, 2011, J INFECT DIS, V204, P217, DOI 10.1093/INFDIS/JIR248.;LICHTIG H, 2006, VIROLOGY, V350, P216, DOI 10.1016/J.VIROL.2006.01.038.;LOUVANTO K, 2010, J CLIN MICROBIOL, V48, P2665, DOI 10.1128/JCM.00783-10.;LOUVANTO K, 2010, J INFECT DIS, V202, P436, DOI 10.1086/653826.;LU BB, 2011, CANCER EPIDEM BIOMAR, V20, P990, DOI 10.1158/1055-9965.EPI-10-1160.;MARUR S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6.;MEIRING TL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-164.;MELSHEIMER P, 2004, CLIN CANCER RES, V10, P3059, DOI 10.1158/1078-0432.CCR-03-0565.;MILITELLO V, 2013, CLIN MICROBIOL INFEC, V19, PE428, DOI 10.1111/1469-0691.12219.;MIRGHANI H, 2014, ORAL ONCOL, V50, P1, DOI 10.1016/J.ORALONCOLOGY.2013.10.008.;MONTOYA JG, 1993, J CLIN MICROBIOL, V31, P2692.;MUNAGALA R, 2009, INT J ONCOL, V34, P263, DOI 10.3892/IJO\_00000148.;NIELSON CM, 2009, CANCER EPIDEM BIOMAR, V18, P1077, DOI 10.1158/1055-9965.EPI-08-0447.;ONG CK, 1993, J VIROL, V67, P6424.;PETT M, 2007, J PATHOL, V212, P356, DOI 10.1002/PATH.2192.;PILLAI MR, 2009, INT J CANCER, V125, P91, DOI 10.1002/IJC.24322.;PLUMMER M, 2011, J INFECT DIS, V203, P891, DOI 10.1093/INFDIS/JIQ146.;POLZ MF, 1998, APPL ENVIRON MICROB, V64, P3724.;QU WM, 1997, J CLIN MICROBIOL, V35, P1304.;RAGIN CCR, 2007, INT J CANCER, V121, P1813, DOI 10.1002/IJC.22851.;RAUTAVA J, 2012, J CLIN VIROL, V53, P116, DOI 10.1016/J.JCV.2011.11.005.;ROBINSON M, 2010, ORAL ONCOL, V46, P492, DOI 10.1016/J.ORALONCOLOGY.2010.02.013.;SASAGAWA T, 2001, CANCER EPIDEM BIOMAR, V10, P45.;SCHWARZ E, 1983, EMBO J, V2, P2341, DOI 10.1002/J.1460-2075.1983.TB01744.X.;SHIN HJ, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0078995.;SPEICH N, 2004, J MED MICROBIOL, V53, P125, DOI 10.1099/JMM.0.05447-0.;SUN YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/NAR/GKP285.;SUZUKI MT, 1996, APPL ENVIRON MICROB, V62, P625.;SYRJANEN S, 2010, ANN ONCOL, V21, P243, DOI 10.1093/ANNONC/MDQ454.;TRAVASSO CM, 2008, J BIOSCIENCES, V33, P73, DOI 10.1007/S12038-008-0023-X.;TROTTIER H, 2006, CANCER EPIDEM BIOMAR, V15, P1274, DOI 10.1158/1055-9965.EPI-06-0129.;VACCARELLA S, 2011, J INFECT DIS, V204, P1500, DOI 10.1093/INFDIS/JIR595.;VAN DEN BRULE AJC, 2002, J CLIN MICROBIOL, V40, P779, DOI 10.1128/JCM.40.3.779-787.2002.;VANDEGRAAFF N, 2001, J VIROL, V75, P11253, DOI 10.1128/JVI.75.22.11253-11260.2001.;VERNON SD, 2000, J CLIN MICROBIOL, V38, P651.;WALBOOMERS JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO,2-F.;WANG CC, 2010, INT J RADIAT ONCOL, V78, P1111, DOI 10.1016/J.IJROBP.2009.09.021.;WENTZENSEN N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009.;WESTRA WH, 2014, ORAL ONCOL, V50, P771, DOI 10.1016/J.ORALONCOLOGY.2014.05.004.;WINDER DM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-440.;XU B, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0066693.;YAMADA T, 1995, J VIROL, V69, P7743.;YANG Y, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0035983.;YANG ZH, 2014, AM J EPIDEMIOL, V180, P1066, DOI 10.1093/AJE/KWU267.;YEE C, 1985, AM J PATHOL, V119, P361.;YIN LI, 2012, BIOINFORMATION, V8, P388, DOI 10.6026/97320630008388.;ZIEGERT C, 2003, ONCOGENE, V22, P3977, DOI 10.1038/SJ.ONC.1206629.","YIN, L (REPRINT AUTHOR), UNIV FLORIDA, DEPT PATHOL IMMUNOL \& LAB MED, GAINESVILLE, FL 32610 USA.;YIN, L (REPRINT AUTHOR), UNIV FLORIDA, UF HLTH CANC CTR, GAINESVILLE, FL 32610 USA.;YIN, LI, CHANG, KAIFEN, GARDNER, BRENT P., GOODENOW, MAUREEN M., UNIV FLORIDA, DEPT PATHOL IMMUNOL \& LAB MED, GAINESVILLE, FL 32610 USA.;YIN, LI, CHANG, KAIFEN, GARDNER, BRENT P., GOODENOW, MAUREEN M., UNIV FLORIDA, UF HLTH CANC CTR, GAINESVILLE, FL 32610 USA.;YAO, JIN, YU, FAHONG, UNIV FLORIDA, INTERDISCIPLINARY CTR BIOTECHNOL RES, GAINESVILLE, FL 33612 USA.;GIULIANO, ANNA R., H LEE MOFFITT CANC CTR \& RES INST, CTR INFECT RES CANC, TAMPA, FL 33612 USA.","10.3390/V8020028","ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND","28",NA,"UF CANCER CENTER/MOFFITT COLLABORATIVE INITIATIVE, [R01 CA098803]","THE AUTHORS THANK THE STUDY VOLUNTEERS FOR PARTICIPATING, CARLA MAVIAN FOR CRITICAL REVIEW OF THE MANUSCRIPT, AND DANELLE SMITH AND DONNA INGLES FOR SAMPLE SHIPMENT AND DATA EXCHANGE. RESEARCH WAS SUPPORTED BY R01 CA098803 (ANNA R. GIULIANO) AND UF CANCER CENTER/MOFFITT COLLABORATIVE INITIATIVE (MAUREEN M. GOODENOW AND ANNA R. GIULIANO).",NA,"1999-4915","2",NA,"MDPI AG","8",2016,"ISI000371831800010","95","VIROLOGY","4","VIROLOGY","YINPATHOLOGY.UFL.EDU JIN.YAO2009GMAIL.COM KAIFENPATHOLOGY.UFL.EDU BRENTGAPCOM.EDU FYUUFL.EDU ANNA.GIULIANOMOFFITT.ORG GOODENOWUFL.EDU",NA,"DG1MI",NA,"YIN, L (REPRINT AUTHOR), UNIV FLORIDA, DEPT PATHOL IMMUNOL \& LAB MED, GAINESVILLE, FL 32610 USA","ISI","UNIV FLORIDA;UNIV FLORIDA;UNIV FLORIDA;H LEE MOFFITT CANC CTR AND RES INST","UNIV FLORIDA",NA,"YIN L, 2016, VIRUSES-BASEL","YIN L, 2016, VIRUSES-BASEL"
"DUDEKULAY DB, 2016, RNA BIOL","DUDEKULAY DB;PANDA AC;GRAMMATIKAKIS I;DE S;ABDELMOHSEN K;GOROSPE M","CIRCINTERACTOME: A WEB TOOL FOR EXPLORING CIRCULAR RNAS AND THEIR INTERACTING PROTEINS AND MICRORNAS","RNA BIOLOGY","RNA BIOL.","CIRCULAR RNAS (CIRCRNAS) ARE WIDELY EXPRESSED IN ANIMAL CELLS, BUT THEIR BIOGENESIS AND FUNCTIONS ARE POORLY UNDERSTOOD. CIRCRNAS HAVE BEEN SHOWN TO ACT AS SPONGES FOR MIRNAS AND MAY ALSO POTENTIALLY SPONGE RNA-BINDING PROTEINS (RBPS) AND ARE THUS PREDICTED TO FUNCTION AS ROBUST POSTTRANSCRIPTIONAL REGULATORS OF GENE EXPRESSION. THE JOINT ANALYSIS OF LARGE-SCALE TRANSCRIPTOME DATA COUPLED WITH COMPUTATIONAL ANALYSES REPRESENTS A POWERFUL APPROACH TO ELUCIDATE POSSIBLE BIOLOGICAL ROLES OF RIBONUCLEOPROTEIN (RNP) COMPLEXES. HERE, WE PRESENT A NEW WEB TOOL, CIRCINTERACTOME (CIRCRNA INTERACTOME), FOR MAPPING RBP- AND MIRNA-BINDING SITES ON HUMAN CIRCRNAS. CIRCINTERACTOME SEARCHES PUBLIC CIRCRNA, MIRNA, AND RBP DATABASES TO PROVIDE BIOINFORMATIC ANALYSES OF BINDING SITES ON CIRCRNAS AND ADDITIONALLY ANALYZES MIRNA AND RBP SITES ON JUNCTION AND JUNCTION-FLANKING SEQUENCES. CIRCINTERACTOME ALSO ALLOWS THE USER THE ABILITY TO (1) IDENTIFY POTENTIAL CIRCRNAS WHICH CAN ACT AS RBP SPONGES, (2) DESIGN JUNCTION-SPANNING PRIMERS FOR SPECIFIC DETECTION OF CIRCRNAS OF INTEREST, (3) DESIGN SIRNAS FOR CIRCRNA SILENCING, AND (4) IDENTIFY POTENTIAL INTERNAL RIBOSOMAL ENTRY SITES (IRES). IN SUM, THE WEB TOOL CIRCINTERACTOME, FREELY ACCESSIBLE AT HTTP://CIRCINTERACTOME.NIA.NIH.GOV, FACILITATES THE ANALYSIS OF CIRCRNAS AND CIRCRNP BIOLOGY.","CIRCRNA-MIRNA; TRANSCRIPTOME; CIRCRNA IRES; CLIP-SEQ; DIVERGENT PRIMER DESIGN; RNA-BINDING PROTEINS; CIRCRNA SIRNA; SPONGE CIRCRNAS","POSTTRANSCRIPTIONAL GENE-REGULATION; BINDING PROTEINS; MESSENGER-RNA; EVOLUTIONARY CONSERVATION; TRANSLATION; EXPRESSION; DISEASE; CLIP; HUR; REVEALS","ENGLISH","ARTICLE","ARTICLE",72,"ABDELMOHSEN K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022.;ABDELMOHSEN K, 2012, RNA BIOL, V9, P799, DOI 10.4161/RNA.19718.;ABDELMOHSEN K, 2010, WIRES RNA, V1, P214, DOI 10.1002/WRNA.4.;ABDELMOHSEN K, 2010, MOL CELL BIOL, V30, P4197, DOI 10.1128/MCB.00316-10.;ABOUHAIDAR MG, 2014, P NATL ACAD SCI USA, V111, P14542, DOI 10.1073/PNAS.1402814111.;AGAMI R, 2010, EUR J CLIN INVEST, V40, P370, DOI 10.1111/J.1365-2362.2010.02279.X.;ANDERSON DM, 2015, CELL, V160, P595, DOI 10.1016/J.CELL.2015.01.009.;BARTEL DP, 2009, CELL, V136, P215, DOI 10.1016/J.CELL.2009.01.002.;BAZZINI AA, 2014, EMBO J, V33, P981, DOI 10.1002/EMBJ.201488411.;BLENCOWE BJ, 2006, CELL, V126, P37, DOI 10.1016/J.CELL.2006.06.023.;BORCHERT GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/NSMB1174.;NGOC BT, 2013, LECT NOTES COMPUT SC, V7803, P196, DOI 10.1007/978-3-642-36543-0\_21.;CASTELLO A, 2013, TRENDS GENET, V29, P318, DOI 10.1016/J.TIG.2013.01.004.;CIAFRE SA, 2013, RNA BIOL, V10, P935, DOI 10.4161/RNA.24641.;FABIAN MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/ANNUREV-BIOCHEM-060308-103103.;GAO FB, 2012, BRAIN RES, V1462, P1, DOI 10.1016/J.BRAINRES.2012.05.038.;GERSTBERGER S, 2014, ADV EXP MED BIOL, V825, P1, DOI 10.1007/978-1-4939-1221-6\_1.;GLAZAR P, 2014, RNA, V20, P1666, DOI 10.1261/RNA.043687.113.;GLISOVIC T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/J.FEBSLET.2008.03.004.;GRIGULL J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004.;GRIMSON A, 2007, MOL CELL, V27, P91, DOI 10.1016/J.MOLCEL.2007.06.017.;HAFNER M, 2010, CELL, V141, P129, DOI 10.1016/J.CELL.2010.03.009.;HANSEN TB, 2013, NATURE, V495, P384, DOI 10.1038/NATURE11993.;HENTZE MW, 2013, EMBO J, V32, P923, DOI 10.1038/EMBOJ.2013.53.;JECK WR, 2013, RNA, V19, P141, DOI 10.1261/RNA.035667.112.;KIM HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/GAD.1812509.;KIM VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/NRM2632.;KONIG J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/NSMB.1838.;KOZOMARA A, 2014, NUCLEIC ACIDS RES, V42, PD68, DOI 10.1093/NAR/GKT1181.;KUHN RM, 2009, NUCLEIC ACIDS RES, V37, PD755, DOI 10.1093/NAR/GKN875.;LASDA E, 2014, RNA, V20, P1829, DOI 10.1261/RNA.047126.114.;LECUYER E, 2007, CELL, V131, P174, DOI 10.1016/J.CELL.2007.08.003.;LEE Y, 2004, EMBO J, V23, P4051, DOI 10.1038/SJ.EMBOJ.7600385.;LEWIS BP, 2005, CELL, V120, P15, DOI 10.1016/J.CELL.2004.12.035.;LI JH, 2014, NUCLEIC ACIDS RES, V42, PD92, DOI 10.1093/NAR/GKT1248.;LICATALOSI DD, 2008, NATURE, V456, P464, DOI 10.1038/NATURE07488.;MARTINEZ-SALAS E, 2013, INT J MOL SCI, V14, P21705, DOI 10.3390/IJMS141121705.;MEMCZAK S, 2013, NATURE, V495, P333, DOI 10.1038/NATURE11928.;MOKREJS M, 2010, NUCLEIC ACIDS RES, V38, PD131, DOI 10.1093/NAR/GKP981.;NAITO Y, 2004, NUCLEIC ACIDS RES, V32, PW124, DOI 10.1093/NAR/GKH442.;NEWMAN MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/GAD.1919710.;PANDA AC, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0101084.;SALZMAN J, 2013, PLOS GENET, V9, DOI 10.1371/JOURNAL.PGEN.1003777.;SALZMAN J, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0030733.;SRIKANTAN S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394.;TOMINAGA K, 2011, MOL CELL BIOL, V31, P4219, DOI 10.1128/MCB.05955-11.;ULE J, 2003, SCIENCE, V302, P1212, DOI 10.1126/SCIENCE.1090095.;UNTERGASSER A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/NAR/GKS596.;VASUDEVAN S, 2007, SCIENCE, V318, P1931, DOI 10.1126/SCIENCE.1149460.;WITTEN JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/J.TIG.2010.12.001.;YEKTA S, 2004, SCIENCE, V304, P594, DOI 10.1126/SCIENCE.1097434.","ABDELMOHSEN, K (REPRINT AUTHOR), NIA, GENET LAB, INTRAMURAL RES PROGRAM, NIH, BALTIMORE, MD 21224 USA.;DUDEKULAY, DAWOOD B., PANDA, AMARESH C., GRAMMATIKAKIS, IOANNIS, DE, SUPRIYO, ABDELMOHSEN, KOTB, GOROSPE, MYRIAM, NIA, GENET LAB, INTRAMURAL RES PROGRAM, NIH, BALTIMORE, MD 21224 USA.","10.1080/15476286.2015.1128065","530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",NA,NA,"NATIONAL INSTITUTE ON AGING INTRAMURAL RESEARCH PROGRAM OF THE NATIONAL INSTITUTES OF HEALTH","THIS RESEARCH WAS SUPPORTED IN FULL BY THE NATIONAL INSTITUTE ON AGING INTRAMURAL RESEARCH PROGRAM OF THE NATIONAL INSTITUTES OF HEALTH.",NA,"1547-6286","1","34-42","TAYLOR \& FRANCIS INC","13",2016,"ISI000370963300005","51","BIOCHEMISTRY \& MOLECULAR BIOLOGY","42","BIOCHEMISTRY \& MOLECULAR BIOLOGY","ABDELMOHSENKMAIL.NIH.GOV",NA,"DE9NA",NA,"ABDELMOHSEN, K (REPRINT AUTHOR), NIA, GENET LAB, INTRAMURAL RES PROGRAM, NIH, BALTIMORE, MD 21224 USA","ISI","GENET LAB","GENET LAB",NA,"DUDEKULAY DB, 2016, RNA BIOL","DUDEKULAY DB, 2016, RNA BIOL"
"SERRATI S, 2016, ONCOTARGETS THER","SERRATI S;DE SUMMA S;PILATO B;PETRIELLA D;LACALAMITA R;TOMMASI S;PINTO R","NEXT-GENERATION SEQUENCING: ADVANCES AND APPLICATIONS IN CANCER DIAGNOSIS","ONCOTARGETS AND THERAPY","ONCOTARGETS THER.","TECHNOLOGICAL ADVANCES HAVE LED TO THE INTRODUCTION OF NEXT-GENERATION SEQUENCING (NGS) PLATFORMS IN CANCER INVESTIGATION. NGS ALLOWS MASSIVE PARALLEL SEQUENCING THAT AFFORDS MAXIMAL TUMOR GENOMIC ASSESSMENT. NGS APPROACHES ARE DIFFERENT, AND CONCERN DNA AND RNA ANALYSIS. DNA SEQUENCING INCLUDES WHOLE-GENOME, WHOLE-EXOME, AND TARGETED SEQUENCING, WHICH FOCUSES ON A SELECTION OF GENES OF INTEREST FOR A SPECIFIC DISEASE. RNA SEQUENCING FACILITATES THE DETECTION OF ALTERNATIVE GENE-SPLICED TRANSCRIPTS, POSTTRANSCRIPTIONAL MODIFICATIONS, GENE FUSION, MUTATIONS/SINGLE-NUCLEOTIDE POLYMORPHISMS, SMALL AND LONG NONCODING RNAS, AND CHANGES IN GENE EXPRESSION. MOST APPLICATIONS ARE IN THE CANCER RESEARCH FIELD, BUT LATELY NGS TECHNOLOGY HAS BEEN REVOLUTIONIZING CANCER MOLECULAR DIAGNOSTICS, DUE TO THE MANY ADVANTAGES IT OFFERS COMPARED TO TRADITIONAL METHODS. THERE IS GREATER KNOWLEDGE ON SOLID CANCER DIAGNOSTICS, AND RECENT INTEREST HAS BEEN SHOWN ALSO IN THE FIELD OF HEMATOLOGIC CANCER. IN THIS REVIEW, WE REPORT THE LATEST DATA ON NGS DIAGNOSTIC/PREDICTIVE CLINICAL APPLICATIONS IN SOLID AND HEMATOLOGIC CANCERS. MOREOVER, SINCE THE AMOUNT OF NGS DATA PRODUCED IS VERY LARGE AND THEIR INTERPRETATION IS VERY COMPLEX, WE BRIEFLY DISCUSS TWO BIOINFORMATIC ASPECTS, VARIANT-CALLING ACCURACY AND COPY-NUMBER VARIATION DETECTION, WHICH ARE GAINING A LOT OF IMPORTANCE IN CANCER-DIAGNOSTIC ASSESSMENT.","HEREDITARY BREAST CANCER; MELANOMA; PROSTATE CANCER; THYROID CANCER; LUNG CANCER; COLORECTAL CANCER; HEMATOLOGIC CANCER","METASTATIC COLORECTAL-CANCER; RESIDUAL DISEASE DETECTION; COPY NUMBER ALTERATIONS; LUNG-CANCER; ION TORRENT; MULTIPLE-MYELOMA; EGFR-TKI; ACTIONABLE MUTATIONS; THYROID-NODULES; BREAST-CANCER","ENGLISH","REVIEW","ARTICLE",29,"BELARDINILLI F, 2015, CLIN BIOCHEM, V48, P908, DOI 10.1016/J.CLINBIOCHEM.2015.04.003.;BLACK JS, 2015, PATHOGENESIS, V2, P9, DOI [10.1016/J.PATHOG.2015.05.004, DOI 10.1016/J.PATHOG.2015.05.004].;BOLLI N, 2014, NAT COMMUN, V5, DOI 10.1038/NCOMMS3997.;BUDCZIES J, 2016, ONCOTARGET, V7, P13236, DOI 10.18632/ONCOTARGET.7451.;CHAPMAN MA, 2011, NATURE, V471, P467, DOI 10.1038/NATURE09837.;CHEN J, 2013, BIOMED RES INT, V2013.;COSTA JL, 2013, HUM MUTAT, V34, P629, DOI 10.1002/HUMU.22272.;CROSS DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337.;D'ARGENIO V, 2015, CLIN CHIM ACTA, V446, P221, DOI 10.1016/J.CCA.2015.03.045.;D'HAENE N, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0138245.;FAHAM M, 2012, BLOOD, V120, P5173, DOI 10.1182/BLOOD-2012-07-444042.;GAO J, 2016, BMJ OPEN, V6, DOI 10.1136/BMJOPEN-2015-009532.;GRASSO C, 2015, J MOL DIAGN, V17, P53, DOI 10.1016/J.JMOLDX.2014.09.008.;HALEY L, 2015, MODERN PATHOL, V28, P1390, DOI 10.1038/MODPATHOL.2015.86.;HALLEK M, 2008, BLOOD, V111, P5446, DOI 10.1182/BLOOD-2007-06-093906.;HOOGSTRAAT M, 2015, J MOL DIAGN, V17, P10, DOI 10.1016/J.JMOLDX.2014.09.004.;HSU HC, 2016, ONCOTARGET, V7, P22257, DOI 10.18632/ONCOTARGET.8076.;HUSSAINI M, 2015, CANCER CONTROL, V22, P158, DOI 10.1177/107327481502200206.;IACONO ML, 2016, ONCOTARGET, V7, P14394.;IHLE MA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-13.;JESINGHAUS M, 2016, GENE CHROMOSOME CANC, V55, P505, DOI 10.1002/GCC.22352.;KORTUM KM, 2015, ANN HEMATOL, V94, P1205, DOI 10.1007/S00277-015-2344-9.;LADETTO M, 2014, LEUKEMIA, V28, P1299, DOI 10.1038/LEU.2013.375.;LHOTA F, 2016, CLIN GENET, V90, P324, DOI 10.1111/CGE.12748.;LI W, 2015, CELL MOL BIOL, V61, P91.;LIM SM, 2016, ONCOTARGET, V7, P24172, DOI 10.18632/ONCOTARGET.8138.;LIN PH, 2016, ONCOTARGET, V7, P8310, DOI 10.18632/ONCOTARGET.7027.;LIU BA, 2013, ONCOTARGET, V4, P1868, DOI 10.18632/ONCOTARGET.1537.;MALAPELLE U, 2016, J CLIN PATHOL, V69, P767, DOI 10.1136/JCLINPATH-2015-203403.;MANSON-BAHR D, 2015, J CLIN PATHOL, V68, P212, DOI 10.1136/JCLINPATH-2014-202754.;MARCHETTI A, 2015, J THORAC ONCOL, V10, P1437, DOI 10.1097/JTO.0000000000000643.;MASAGO K, 2015, BMC CANCER, V15, DOI 10.1186/S12885-015-1925-2.;MORGAN GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/NRC3257.;NIELSEN R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/NRG2986.;NIKIFOROV YE, 2015, THYROID, V25, P1217, DOI 10.1089/THY.2015.0305.;NIKIFOROV YE, 2014, CANCER-AM CANCER SOC, V120, P3627, DOI 10.1002/CNCR.29038.;NIKIFOROVA MN, 2013, J CLIN ENDOCR METAB, V98, PE1852, DOI 10.1210/JC.2013-2292.;PILATO B, 2016, GENE CHROMOSOME CANC, V55, P803, DOI 10.1002/GCC.22383.;PINTO R, 2016, ONCOTARGET, V7, P25135, DOI 10.18632/ONCOTARGET.7175.;QIU T, 2015, SCI REP-UK, V5, DOI 10.1038/SREP11317.;QUAIL MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341.;QUE D, 2016, CANCER BIOL THER, V17, P320, DOI 10.1080/15384047.2016.1139238.;QUESADA V, 2012, NAT GENET, V44, P47, DOI 10.1038/NG.1032.;RANGACHARI DEEPA, 2015, CANCER TREAT COMMUN, V4, P174.;ROSS MG, 2013, GENOME BIOL, V14, DOI 10.1186/GB-2013-14-5-R51.;ROTHBERG JM, 2011, NATURE, V475, P348, DOI 10.1038/NATURE10242.;SCARPA A, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0080478.;SCHWAEDERLE M, 2016, ONCOTARGET, V7, P9707, DOI 10.18632/ONCOTARGET.7110.;SEQUIST LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/SCITRANSLMED.3002003.;SHAO D, 2016, SCI REP-UK, V6, DOI 10.1038/SREP22338.;SIMBOLO M, 2014, VIRCHOWS ARCH, V465, P73, DOI 10.1007/S00428-014-1589-3.;STADLER ZK, 2016, J CLIN ONCOL, V34, P2141, DOI 10.1200/JCO.2015.65.1067.;STROM CM, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0136419.;TARABEUX J, 2014, EUR J HUM GENET, V22, P535, DOI 10.1038/EJHG.2013.181.;THERKILDSEN C, 2014, ACTA ONCOL, V53, P852, DOI 10.3109/0284186X.2014.895036.;TOPS BBJ, 2015, BMC CANCER, V15, DOI 10.1186/S12885-015-1015-5.;TREECE AL, 2016, CANCER CYTOPATHOL, V124, P406, DOI 10.1002/CNCY.21699.;TUNG N, 2015, CANCER-AM CANCER SOC, V121, P25, DOI 10.1002/CNCR.29010.;UCHIDA J, 2015, CLIN CHEM, V61, P1191, DOI 10.1373/CLINCHEM.2015.241414.;VAN ENGEN-VAN GRUNSVEN ADRIANA C H, 2014, FRONT MED (LAUSANNE), V1, P39, DOI 10.3389/FMED.2014.00039.;VANNI I, 2015, INT J MOL SCI, V16, P28765, DOI 10.3390/IJMS161226129.;WALKER BA, 2014, LEUKEMIA, V28, P384, DOI 10.1038/LEU.2013.199.;WALTER AO, 2013, CANCER DISCOV, V3, P1404, DOI 10.1158/2159-8290.CD-13-0314.;WANG SR, 2016, J MOL DIAGN, V18, P416, DOI 10.1016/J.JMOLDX.2016.01.006.;XU S, 2016, CANCER LETT, V370, P324, DOI 10.1016/J.CANLET.2015.11.005.;YU HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246.;ZOOK JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/NBT.2835.","TOMMASI, S (REPRINT AUTHOR), IRCCS IST TUMORI GIOVANNI PAOLO II, MOL GENET LAB, 65 VIALE ORAZIO FLACCO, I-70124 BARI, PUGLIA, ITALY.;SERRATI, SIMONA, DE SUMMA, SIMONA, PILATO, BRUNELLA, PETRIELLA, DANIELA, LACALAMITA, ROSANNA, TOMMASI, STEFANIA, PINTO, ROSAMARIA, IRCCS IST TUMORI GIOVANNI PAOLO II, MOL GENET LAB, 65 VIALE ORAZIO FLACCO, I-70124 BARI, PUGLIA, ITALY.","10.2147/OTT.S99807","PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND",NA,NA,NA,NA,NA,"1178-6930",NA,"7355-7365","DOVE MEDICAL PRESS LTD","9",2016,"ISI000389274500002","67","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, ONCOLOGY","12","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, ONCOLOGY","S.TOMMASIONCOLOGICO.BARI.IT",NA,"EE0NS",NA,"TOMMASI, S (REPRINT AUTHOR), IRCCS IST TUMORI GIOVANNI PAOLO II, MOL GENET LAB, 65 VIALE ORAZIO FLACCO, I-70124 BARI, PUGLIA, ITALY","ISI","MOL GENET LAB","MOL GENET LAB",NA,"SERRATI S, 2016, ONCOTARGETS THER","SERRATI S, 2016, ONCOTARGETS THER"
"EIDINGER O, 2015, MOL VIS","EIDINGER O;LEIBU R;NEWMAN H;RIZEL L;PERLMAN I;BEN YOSEF T","AN INTRONIC DELETION IN THE PROM1 GENE LEADS TO AUTOSOMAL RECESSIVE CONE-ROD DYSTROPHY","MOLECULAR VISION","MOL. VIS.","PURPOSE: TO INVESTIGATE THE GENETIC BASIS FOR AUTOSOMAL RECESSIVE CONE-ROD DYSTROPHY (CRD) IN A CONSANGUINEOUS ISRAELI JEWISH FAMILY. METHODS: PATIENTS UNDERWENT A DETAILED OPHTHALMIC EVALUATION, INCLUDING EYE EXAMINATION, VISUAL FIELD TESTING, OPTICAL COHERENCE TOMOGRAPHY (OCT), AND ELECTROPHYSIOLOGICAL TESTS, ELECTRORETINOGRAPHY (ERG) AND VISUAL EVOKED POTENTIAL (VEP). GENOME-WIDE HOMOZYGOSITY MAPPING USING A SINGLE NUCLEOTIDE POLYMORPHISM (SNP) ARRAY WAS PERFORMED TO IDENTIFY HOMOZYGOUS REGIONS SHARED AMONG TWO OF THE AFFECTED INDIVIDUALS. MUTATION SCREENING OF THE UNDERLYING GENE WAS PERFORMED WITH DIRECT SEQUENCING. IN SILICO AND IN VITRO ANALYSES WERE USED TO PREDICT THE EFFECT OF THE IDENTIFIED MUTATION ON SPLICING. RESULTS: THE AFFECTED FAMILY MEMBERS ARE THREE SIBLINGS WHO HAVE VARIOUS DEGREES OF PROGRESSIVE VISUAL DETERIORATION, GLARE, COLOR VISION ABNORMALITIES, AND NIGHT VISION DIFFICULTIES. VISUAL FIELD TESTS REVEALED CENTRAL SCOTOMAS OF DIFFERENT EXTENSION. CONE AND ROD ERG RESPONSES WERE REDUCED, WITH CONES MORE SEVERELY AFFECTED. HOMOZYGOSITY MAPPING REVEALED SEVERAL HOMOZYGOUS INTERVALS SHARED AMONG TWO OF THE AFFECTED INDIVIDUALS. ONE INCLUDED THE PROM1 GENE. SEQUENCE ANALYSIS OF THE 26 CODING EXONS OF PROM1 IN ONE AFFECTED INDIVIDUAL REVEALED NO MUTATIONS IN THE CODING SEQUENCE OR IN INTRONIC SPLICE SITES. HOWEVER, IN INTRON 21, PROXIMATE TO THE INTRON-EXON JUNCTION, WE OBSERVED A HOMOZYGOUS 10 BP DELETION BETWEEN POSITIONS -26 AND -17 (C.2281-26\_-17DEL). THE DELETION WAS LINKED TO A KNOWN SNP, C.2281-6C>G. THE DELETION COSEGREGATED WITH THE DISEASE IN THE FAMILY, AND WAS NOT DETECTED IN PUBLIC DATABASES OR IN 101 ETHNICALLY-MATCHED CONTROL INDIVIDUALS. IN SILICO ANALYSIS PREDICTED THAT THIS DELETION WOULD LEAD TO ALTERED INTRON 21 SPLICING. BIOINFORMATIC ANALYSIS PREDICTED THAT A RECOGNITION SITE FOR THE SRSF2 SPLICING FACTOR IS LOCATED WITHIN THE DELETED SEQUENCE. THE IN VITRO SPLICING ASSAY DEMONSTRATED THAT C.2281-26\_-17DEL LEADS TO COMPLETE EXON 22 SKIPPING. CONCLUSIONS: A NOVEL AND UNIQUE INTRONIC MUTATION OF PROM1, UNDERLYING AUTOSOMAL RECESSIVE CRD IN A CONSANGUINEOUS ISRAELI FAMILY, WAS FOUND. THIS REPORT EXPANDS THE SPECTRUM OF PATHOGENIC MUTATIONS OF PROM1 AND FURTHER DEMONSTRATES THE IMPORTANCE OF INTRONIC MUTATIONS.",NA,"RETINITIS-PIGMENTOSA; FRAMESHIFT MUTATION; HEMATOPOIETIC STEM; DEGENERATION; PROMININ; CELLS; SC35","ENGLISH","ARTICLE","ARTICLE",5,"ALMEIDA JL, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-102.;AYUSO C, 2010, GENOME MED, V2, DOI 10.1186/GM155.;BERYOZKIN A, 2014, INVEST OPHTH VIS SCI, V55, P1149, DOI 10.1167/IOVS.13-13625.;BOULANGER-SCEMAMA E, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/S13023-015-0300-3.;CORBEIL D, 2013, ADV EXP MED BIOL, V777, P3, DOI 10.1007/978-1-4614-5894-4\_1.;EISENBERGER T, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0078496.;FU XD, 1992, P NATL ACAD SCI USA, V89, P1725, DOI 10.1073/PNAS.89.5.1725.;GALLEGO ME, 1997, EMBO J, V16, P1772, DOI 10.1093/EMBOJ/16.7.1772.;GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/NAR/17.20.8390.;HAMEL CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7.;JINDA W, 2014, INVEST OPHTH VIS SCI, V55, P2259, DOI 10.1167/IOVS.13-13567.;KHAN AO, 2015, OPHTHALMIC GENET.;LITTINK KW, 2010, INVEST OPHTH VIS SCI, V51, P5943, DOI 10.1167/IOVS.10-5797.;MAW MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/HMG/9.1.27.;MAYER AK, 2015, EUR J HUM GENET.;MCCULLOCH DL, 2015, DOC OPHTHALMOL, V130, P1, DOI 10.1007/S10633-014-9473-7.;MIRAGLIA S, 1997, BLOOD, V90, P5013.;PERMANYER J, 2010, INVEST OPHTH VIS SCI, V51, P2656, DOI 10.1167/IOVS.09-4857.;PRAS E, 2009, MOL VIS, V15, P1709.;SEELOW D, 2009, NUCLEIC ACIDS RES, V37, PW593, DOI 10.1093/NAR/GKP369.;WEIGMANN A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/PNAS.94.23.12425.;YANG ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891.;YIN AH, 1997, BLOOD, V90, P5002.;ZHANG QJ, 2007, HUM GENET, V122, P293, DOI 10.1007/S00439-007-0395-2.;ZHANG X, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0095528.;ZHAO L, 2015, HUM GENET, V134, P217, DOI 10.1007/S00439-014-1512-7.","BEN-YOSEF, T (REPRINT AUTHOR), TECHNION ISRAEL INST TECHNOL, RAPPAPORT FAC MED, DEPT GENET, POB 9649, IL-31096 HAIFA, ISRAEL.;EIDINGER, OSNAT, RIZEL, LEAH, PERLMAN, IDO, BEN-YOSEF, TAMAR, TECHNION ISRAEL INST TECHNOL, RUTH \& BRUCE RAPPAPORT FAC MED, HAIFA, ISRAEL.;LEIBU, RINA, RAMBAM HLTH CARE CTR, ALBERTO MOSCONA DEPT OPHTHALMOL, HAIFA, ISRAEL.;NEWMAN, HADAS, PERLMAN, IDO, TEL AVIV SOURASKY MED CTR, DEPT OPHTHALMOL, TEL AVIV, ISRAEL.;NEWMAN, HADAS, TEL AVIV UNIV, SACKLER FAC MED, IL-69978 TEL AVIV, ISRAEL.",NA,"C/O JEFF BOATRIGHT, LAB B, 5500 EMORY EYE CENTER, 1327 CLIFTON RD, N E, ATLANTA, GA 30322 USA",NA,NA,"FOUNDATION FIGHTING BLINDNES (FFB) [BR-GE-0214-0639-TECH]","WE ARE GRATEFUL TO THE FAMILY MEMBERS FOR THEIR PARTICIPATION IN THIS STUDY. THIS WORK WAS SUPPORTED BY A RESEARCH GRANT FROM THE FOUNDATION FIGHTING BLINDNES (FFB, BR-GE-0214-0639-TECH) TO TB, RL, HN AND IP.",NA,"1090-0535",NA,"1295-1306","MOLECULAR VISION","21",2015,"ISI000369175600001","26","BIOCHEMISTRY \& MOLECULAR BIOLOGY, OPHTHALMOLOGY","1","BIOCHEMISTRY \& MOLECULAR BIOLOGY, OPHTHALMOLOGY","BENYOSEFTX.TECHNION.AC.IL",NA,"DC4FJ",NA,"BEN-YOSEF, T (REPRINT AUTHOR), TECHNION ISRAEL INST TECHNOL, RAPPAPORT FAC MED, DEPT GENET, POB 9649, IL-31096 HAIFA, ISRAEL","ISI","TECHNION ISRAEL INST TECHNOL;RAMBAM HLTH CARE CTR;TEL AVIV SOURASKY MED CTR;TEL AVIV UNIV","TECHNION ISRAEL INST TECHNOL",NA,"EIDINGER O, 2015, MOL VIS","EIDINGER O, 2015, MOL VIS"
"VANNI I, 2015, INT J MOL SCI","VANNI I;COCO S;TRUINI A;RUSMINI M;DAL BELLO MG;ALAMA A;BANELLI B;MORA M;RIJAVEC E;BARLETTA G;GENOVA C;BIELLO F;MAGGIONI C;GROSSI F","NEXT-GENERATION SEQUENCING WORKFLOW FOR NSCLC CRITICAL SAMPLES USING A TARGETED SEQUENCING APPROACH BY ION TORRENT PGM (TM) PLATFORM","INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES","INT. J. MOL. SCI.","NEXT-GENERATION SEQUENCING (NGS) IS A COST-EFFECTIVE TECHNOLOGY CAPABLE OF SCREENING SEVERAL GENES SIMULTANEOUSLY, HOWEVER, ITS APPLICATION IN A CLINICAL CONTEXT REQUIRES AN ESTABLISHED WORKFLOW TO ACQUIRE RELIABLE SEQUENCING RESULTS. HERE, WE REPORT AN OPTIMIZED NGS WORKFLOW ANALYZING 22 LUNG CANCER-RELATED GENES TO SEQUENCE CRITICAL SAMPLES SUCH AS DNA FROM FORMALIN-FIXED PARAFFIN-EMBEDDED (FFPE) BLOCKS AND CIRCULATING FREE DNA (CFDNA). SNAP FROZEN AND MATCHED FFPE GDNA FROM 12 NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS, WHOSE GDNA FRAGMENTATION STATUS WAS PREVIOUSLY EVALUATED USING A MULTIPLEX PCR-BASED QUALITY CONTROL, WERE SUCCESSFULLY SEQUENCED WITH ION TORRENT PGM (TM). THE ROBUST BIOINFORMATIC PIPELINE ALLOWED US TO CORRECTLY CALL BOTH SINGLE NUCLEOTIDE VARIANTS (SNVS) AND INDELS WITH A DETECTION LIMIT OF 5\%, ACHIEVING 100\% SPECIFICITY AND 96\% SENSITIVITY. THIS WORKFLOW WAS ALSO VALIDATED IN 13 FFPE NSCLC BIOPSIES. FURTHERMORE, A SPECIFIC PROTOCOL FOR LOW INPUT GDNA CAPABLE OF PRODUCING GOOD SEQUENCING DATA WITH HIGH COVERAGE, HIGH UNIFORMITY, AND A LOW ERROR RATE WAS ALSO OPTIMIZED. IN CONCLUSION, WE DEMONSTRATE THE FEASIBILITY OF OBTAINING GDNA FROM FFPE SAMPLES SUITABLE FOR NGS BY PERFORMING APPROPRIATE QUALITY CONTROLS. THE OPTIMIZED WORKFLOW, CAPABLE OF SCREENING LOW INPUT GDNA, HIGHLIGHTS NGS AS A POTENTIAL TOOL IN THE DETECTION, DISEASE MONITORING, AND TREATMENT OF NSCLC.","NEXT-GENERATION SEQUENCING; NGS WORKFLOW; NSCLC; ION TORRENT PGM; FFPE; CFDNA","WHOLE-GENOME AMPLIFICATION; CELL LUNG-CANCER; INTRATUMOR HETEROGENEITY; DNA QUANTIFICATION; MUTATION DETECTION; TUMOR SPECIMENS; GENE-MUTATIONS; POLYMORPHISMS; BIOPSIES; PCR","ENGLISH","ARTICLE","ARTICLE",14,"BARKER DL, 2004, GENOME RES, V14, P901, DOI 10.1101/GR.1949704.;BERGEN AW, 2005, HUM MUTAT, V26, P262, DOI 10.1002/HUMU.20213.;BERGEN AW, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-24.;BETTEGOWDA C, 2014, SCI TRANSL MED, V6, DOI 10.1126/SCITRANSLMED.3007094.;BOLAND JF, 2013, HUM GENET, V132, P1153, DOI 10.1007/S00439-013-1321-4.;CHOUDHARY A., 2014, BMC MED GENOM, V7.;CINGOLANI P, 2012, FLY, V6, P80, DOI 10.4161/FLY.19695.;COCO S, 2015, TARGET ONCOL, V10, P393, DOI 10.1007/S11523-014-0344-7.;COCO S, 2015, CURR DRUG TARGETS, V16, P47, DOI 10.2174/1389450116666141210094640.;COCO S, 2012, J HUM GENET, V57, P682, DOI 10.1038/JHG.2012.87.;SEBASTIEN S, 2014, CLIN CANCER RES, V20, P4613, DOI 10.1158/1078-0432.CCR-13-3063.;CRONIN M, 2011, BIOMARK MED, V5, P293, DOI [10.2217/BMM.11.37, 10.2217/BMM.11.37].;D'HAENE N, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0138245.;DE BRUIN EC, 2014, SCIENCE, V346, P251, DOI 10.1126/SCIENCE.1253462.;DEAN FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/PNAS.082089499.;DEN DUNNEN JT, 2000, HUM MUTAT, V15, P7.;DIAZ LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011.;DIEHL F, 2008, NAT MED, V14, P985, DOI 10.1038/NM.1789.;GERLINGER M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMOA1113205.;GOVINDAN R, 2012, CELL, V150, P1121, DOI 10.1016/J.CELL.2012.08.024.;HADD AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/J.JMOLDX.2012.11.006.;HAGEMANN IS, 2015, CANCER-AM CANCER SOC, V121, P631, DOI 10.1002/CNCR.29089.;HAMMERMAN PS, 2012, NATURE, V489, P519, DOI 10.1038/NATURE11404.;HANSEN HM, 2007, CANCER EPIDEM BIOMAR, V16, P1686, DOI 10.1158/1055-9965.EPI-06-1024.;HANTSON I., 2014, TRANSL RESP MED, V2.;HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/NBT0993-1026.;HOSONO S, 2003, GENOME RES, V13, P954, DOI 10.1101/GR.816903.;IMIELINSKI M, 2012, CELL, V150, P1107, DOI 10.1016/J.CELL.2012.08.029.;KAMBEROV E, 2002, P SOC PHOTO-OPT INS, V4626, P340, DOI 10.1117/12.472062.;LANGMORE JP, 2002, PHARMACOGENOMICS, V3, P557, DOI 10.1517/14622416.3.4.557.;LIM EH, 2009, J THORAC ONCOL, V4, P12, DOI 10.1097/JTO.0B013E3181913E28.;LIZARDI PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898.;PAEZ J.G., 2004, NUCL ACIDS RES, V32.;PAO W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/PNAS.0405220101.;PARK JW, 2005, CLIN CHEM, V51, P1520, DOI 10.1373/CLINCHEM.2004.047076.;PASK R, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-15.;PINARD R., 2006, BMC GENOM, V7.;REHM HL, 2013, GENET MED, V15, P733, DOI 10.1038/GIM.2013.92.;RICHARDS S, 2015, GENET MED, V17, P405, DOI 10.1038/GIM.2015.30.;RONAGHI M, 1998, SCIENCE, V281, P363, DOI 10.1126/SCIENCE.281.5375.363.;ROSS MG, 2013, GENOME BIOL, V14, DOI 10.1186/GB-2013-14-5-R51.;SAH S, 2013, GENOME MED, V5, DOI 10.1186/GM481.;SAKURADA A, 2008, J THORAC ONCOL, V3, P527, DOI 10.1097/JTO.0B013E318168BE93.;SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/PNAS.74.12.5463.;SIEGEL R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/CAAC.21208.;SIMBOLO M, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0062692.;TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K.;THORVALDSDOTTIR H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/BIB/BBS017.;VAN BEERS EH, 2006, BRIT J CANCER, V94, P333, DOI 10.1038/SJ.BJC.6602889.;VOGELSTEIN B, 2013, SCIENCE, V339, P1546, DOI 10.1126/SCIENCE.1235122.;WILM A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/NAR/GKS918.;YILMAZ S., 2011, CURR OPIN BIOTECH, V23, P1.;ZHANG JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/SCIENCE.1256930.;ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/PNAS.89.13.5847.;ZHANG LX, 2014, ONCOLOGIST, V19, P336, DOI 10.1634/THEONCOLOGIST.2013-0180.;ZHANG XM, 2006, HUM MUTAT, V27, P110, DOI 10.1002/HUMU.20277.;ZHENG DT, 2014, CANCER BIOL THER, V15, P1542, DOI 10.4161/15384047.2014.956599.","VANNI, I (REPRINT AUTHOR), IRCCS AOU SAN MARTINO IST, NATL INST CANC RES, LUNG CANC UNIT, LGO R BENZI 10, I-16132 GENOA, ITALY.;VANNI, IRENE, COCO, SIMONA, TRUINI, ANNA, DAL BELLO, MARIA GIOVANNA, ALAMA, ANGELA, RIJAVEC, ERIKA, BARLETTA, GIULIA, GENOVA, CARLO, BIELLO, FEDERICA, MAGGIONI, CLAUDIA, GROSSI, FRANCESCO, IRCCS AOU SAN MARTINO IST, NATL INST CANC RES, LUNG CANC UNIT, I-16132 GENOA, ITALY.;TRUINI, ANNA, UNIV GENOA, IRCCS AOU SAN MARTINO IST, NATL INST CANC RES, DEPT INTERNAL MED \& MED SPECIALTIES DIMI, I-16132 GENOA, ITALY.;RUSMINI, MARTA, GIANNINA GASLINI INST, IRCCS, MOL GENET LAB, I-16148 GENOA, ITALY.;BANELLI, BARBARA, IRCCS AOU SAN MARTINO IST, NATL INST CANC RES, LAB TUMOR EPIGENET, I-16132 GENOA, ITALY.;MORA, MARCO, IRCCS AOU SAN MARTINO IST, NATL INST CANC RES, DEPT PATHOL, I-16132 GENOA, ITALY.","10.3390/IJMS161226129","ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",NA,NA,"ITALIAN MINISTRY OF HEALTH [02350922], BANCA CARIGE ITALIA [2013.0277-12]","WE KINDLY THANK CRISTINA BRUZZO AND ZITA CAVALIERI FOR TECHNICAL SUPPORT. WE ARE GRATEFUL TO THE BIOLOGICAL RESOURCE CENTER (CRB) OF IRCCS AOU SAN MARTINO-IST NATIONAL CANCER RESEARCH INSTITUTE FOR PROVIDING THE SAMPLES. THE PRESENT STUDY WAS SUPPORTED BY ITALIAN MINISTRY OF HEALTH (GR 2011-12, 02350922) AND BANCA CARIGE ITALIA (2013.0277-12).",NA,"1422-0067","12","28765-28782","MDPI","16",2015,"ISI000367535600053","57","BIOCHEMISTRY \& MOLECULAR BIOLOGY, CHEMISTRY","10","BIOCHEMISTRY \& MOLECULAR BIOLOGY, CHEMISTRY, MULTIDISCIPLINARY","IRENE.VANNIHSANMARTINO.IT SIMONA.COCOHSANMARTINO.IT ANNA.TRUINIHSANMARTINO.IT MARTA.RUSMINIGMAIL.COM MARIAGIOVANNA.DALBELLOHSANMARTINO.IT ANGELA.ALAMAHSANMARTINO.IT BARBARA.BANELLIHSANMARTINO.IT MARCO.MORAHSANMARTINO.IT FEBIELLOGMAIL.COM GIULIA.BARLETTAYAHOO.IT CARLO.GENOVA1985GMAIL.COM FEBIELLOGMAIL.COM CLAUDIA\_87MYAHOO.IT FRANCESCO.GROSSIHSANMARTINO.IT",NA,"DA1DD",NA,"VANNI, I (REPRINT AUTHOR), IRCCS AOU SAN MARTINO IST, NATL INST CANC RES, LUNG CANC UNIT, LGO R BENZI 10, I-16132 GENOA, ITALY","ISI","NATL INST CANC RES;UNIV GENOA;GIANNINA GASLINI INST;NATL INST CANC RES;NATL INST CANC RES","NATL INST CANC RES",NA,"VANNI I, 2015, INT J MOL SCI","VANNI I, 2015, INT J MOL SCI"
"ROUTH A, 2015, METHODS","ROUTH A;CHANG MW;OKULICZ JF;JOHNSON JE;TORBETT BE","COVAMA: CO-VARIATION MAPPER FOR DISEQUILIBRIUM ANALYSIS OF MUTANT LOCI IN VIRAL POPULATIONS USING NEXT-GENERATION SEQUENCE DATA","METHODS","METHODS","NEXT-GENERATION SEQUENCING (NGS) HAS TRANSFORMED OUR UNDERSTANDING OF THE DYNAMICS AND DIVERSITY OF VIRUS POPULATIONS FOR HUMAN PATHOGENS AND MODEL SYSTEMS ALIKE. DUE TO THE SENSITIVITY AND DEPTH OF COVERAGE IN NGS, IT IS POSSIBLE TO MEASURE THE FREQUENCY OF MUTATIONS THAT MAY BE PRESENT EVEN AT VANISHINGLY LOW FREQUENCIES WITHIN THE VIRAL POPULATION. HERE, WE DESCRIBE A SIMPLE BIOINFORMATIC PIPELINE CALLED COVAMA (CO-VARIATION MAPPER) SCRIPTED IN PYTHON THAT DETECTS CORRELATED PATTERNS OF MUTATIONS IN A VIRAL SAMPLE. OUR ALGORITHM TAKES NGS ALIGNMENT DATA AND POPULATES LARGE MATRICES OF CONTINGENCY TABLES THAT CORRESPOND TO EVERY POSSIBLE PAIRWISE INTERACTION OF NUCLEOTIDES IN THE VIRAL GENOME OR AMINO ACIDS IN THE CHOSEN OPEN READING FRAME. THESE TABLES ARE THEN ANALYSED USING CLASSICAL LINKAGE DISEQUILIBRIUM TO DETECT AND REPORT EVIDENCE OF EPISTASIS. WE TEST OUR ANALYSIS WITH SIMULATED DATA AND THEN APPLY THE APPROACH TO FIND EPISTATICALLY LINKED LOCI IN FLOCK HOUSE VIRUS GENOMIC RNA GROWN UNDER CONTROLLED CELL CULTURE CONDITIONS. WE ALSO REANALYZE NGS DATA FROM A LARGE COHORT OF HIV INFECTED PATIENTS AND FIND CORRELATED AMINO ACID SUBSTITUTION EVENTS IN THE PROTEASE GENE THAT HAVE ARISEN IN RESPONSE TO ANTI-VIRAL THERAPY. THIS BOTH CONFIRMS PREVIOUS FINDINGS AND SUGGESTS NEW PAIRS OF INTERACTIONS WITHIN HIV PROTEASE. THE SCRIPT IS PUBLICALLY AVAILABLE AT HTTP://SOURCEFORGE.NET/PROJECTS/COVAMA. (C) 2015 ELSEVIER INC. ALL RIGHTS RESERVED.","LINKAGE DISEQUILIBRIUM; FLOCK HOUSE VIRUS; HUMAN IMMUNODEFICIENCY VIRUS PROTEASE; COVARIATION; RNASEQ","LINKAGE DISEQUILIBRIUM; HIV-1 PROTEASE; VIRUS; RECOMBINATION; GENOME; COVARIATION; CHALLENGES; INFERENCE","ENGLISH","ARTICLE","ARTICLE",3,"ACEVEDO A, 2014, NATURE, V505, P686, DOI 10.1038/NATURE12861.;BEERENWINKEL N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/FMICB.2012.00329.;BROWNING SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/NRG3054.;CHANG MW, 2013, J VIROL METHODS, V189, P232, DOI 10.1016/J.JVIROMET.2013.01.019.;COUNTS CJ, 2015, PLOS ONE, V10, DOI 10.1371/JOURNAL.PONE.0123561.;FLYNN WF, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/JOURNAL.PCBI.1004249.;HOFFMAN NG, 2003, VIROLOGY, V314, P536, DOI 10.1016/S0042-6822(03)00484-7.;HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/SCIENCE.7041255.;JABARA CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/PNAS.1110064108.;JOHNSON VICTORIA A, 2013, TOP ANTIVIR MED, V21, P6.;LANGMEAD B, 2009, GENOME BIOL, V10, DOI 10.1186/GB-2009-10-3-R25.;LI H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/BIOINFORMATICS/BTP324.;LOU DI, 2013, P NATL ACAD SCI USA, V110, P19872, DOI 10.1073/PNAS.1319590110.;MACALALAD AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/JOURNAL.PCBI.1002417.;MARTIN M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200.;MINOCHE AE, 2011, GENOME BIOL, V12, DOI 10.1186/GB-2011-12-11-R112.;PROSPERI MCF, 2013, SCI REP-UK, V3, DOI 10.1038/SREP02837.;RHEE SY, 2007, PLOS COMPUT BIOL, V3, P836, DOI 10.1371/JOURNAL.PCBI.0030087.;ROUTH A., 2015, J MOL BIOL.;ROUTH A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/NAR/GKT916.;ROUTH A, 2012, J MOL BIOL, V424, P257, DOI 10.1016/J.JMB.2012.10.005.;SCHNEEMANN A, 1998, J VIROL, V72, P8738.;SHARMA D, 2015, J VIROL, V89, P1489, DOI 10.1128/JVI.02027-14.;SLATKIN M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/NRG2361.;SMIRNOV N.V.E., 1969, MATH STAT TECHNIK KU.;TOPFER A, 2013, J COMPUT BIOL, V20, P113, DOI 10.1089/CMB.2012.0232.;VAN WYNSBERGHE PM, 2009, J VIROL, V83, P2976, DOI 10.1128/JVI.02040-08.;WANG Q, 2007, PLOS ONE, V2, DOI 10.1371/JOURNAL.PONE.0000814.;WU TD, 2003, J VIROL, V77, P4836, DOI 10.1128/JVI.77.8.4836-4847.2003.;YANG X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-674.","ROUTH, A (REPRINT AUTHOR), SCRIPPS RES INST, DEPT MOL \& EXPT MED, 10550 NORTH TORREY PINES RD, LA JOLLA, CA 92037 USA.;ROUTH, ANDREW, TORBETT, BRUCE E., SCRIPPS RES INST, DEPT MOL \& EXPT MED, LA JOLLA, CA 92037 USA.;ROUTH, ANDREW, JOHNSON, JOHN E., SCRIPPS RES INST, DEPT INTEGRAT STRUCT \& COMPUTAT BIOL, LA JOLLA, CA 92037 USA.;ROUTH, ANDREW, UNIV TEXAS MED BRANCH, DEPT BIOCHEM \& MOL BIOL, GALVESTON, TX 77555 USA.;CHANG, MAX W., SALK INST BIOL STUDIES, INTEGRAT GENOM \& BIOINFORMAT CORE, LA JOLLA, CA 92037 USA.;OKULICZ, JASON F., SAN ANTONIO MIL MED CTR, INFECT DIS SERV, FT SAM HOUSTON, TX 78234 USA.;OKULICZ, JASON F., UNIFORMED SERV UNIV HLTH SCI, INFECT DIS CLIN RES PROGRAM, BETHESDA, MD 20814 USA.","10.1016/J.YMETH.2015.09.021","525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA",NA,NA,"SEED GRANT FROM THE SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE [5UL1TR001114], HIVE CENTER [1P50GM103368], NATIONAL INSTITUTES OF HEALTH [5R01-GM54076, T32AI007354], INFECTIOUS DISEASE CLINICAL RESEARCH PROGRAM (IDCRP) [IDCRP-000-03], FEDERAL FUNDS FROM THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NATIONAL INSTITUTES OF HEALTH (NIH), UNDER INTER-AGENCY AGREEMENT [Y1-AI-5072]","THIS WORK WAS FUNDED BY A SEED GRANT FROM THE SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE 5UL1TR001114 TO B.E.T, BY THE HIVE CENTER GRANT 1P50GM103368 TO B.E.T. AND BY THE NATIONAL INSTITUTES OF HEALTH 5R01-GM54076 TO J.E.J. M.W.C. WAS SUPPORTED BY THE NATIONAL INSTITUTES OF HEALTH T32AI007354., SUPPORT FOR THIS WORK (IDCRP-000-03) WAS ALSO PROVIDED BY THE INFECTIOUS DISEASE CLINICAL RESEARCH PROGRAM (IDCRP), A DEPARTMENT OF DEFENSE (DOD) PROGRAM EXECUTED THROUGH THE UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES. THIS PROJECT HAS BEEN FUNDED IN WHOLE, OR IN PART, WITH FEDERAL FUNDS FROM THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NATIONAL INSTITUTES OF HEALTH (NIH), UNDER INTER-AGENCY AGREEMENT Y1-AI-5072.",NA,"1046-2023",NA,"40-47","ACADEMIC PRESS INC ELSEVIER SCIENCE","91",2015,"ISI000366783100006","30","BIOCHEMISTRY \& MOLECULAR BIOLOGY","3","BIOCHEMICAL RESEARCH METHODS, BIOCHEMISTRY \& MOLECULAR BIOLOGY","AROUTHSCRIPPS.EDU BETORBETSCRIPPS.EDU",NA,"CZ0GM",NA,"ROUTH, A (REPRINT AUTHOR), SCRIPPS RES INST, DEPT MOL \& EXPT MED, 10550 NORTH TORREY PINES RD, LA JOLLA, CA 92037 USA","ISI","SCRIPPS RES INST;SCRIPPS RES INST;UNIV TEXAS MED BRANCH;SALK INST BIOL STUDIES;SAN ANTONIO MIL MED CTR;UNIFORMED SERV UNIV HLTH SCI","SCRIPPS RES INST",NA,"ROUTH A, 2015, METHODS","ROUTH A, 2015, METHODS"
"SONG Y, 2015, VET J","SONG Y;LA T;PHILLIPS ND;HAMPSON DJ","DEVELOPMENT OF A SEROLOGICAL ELISA USING A RECOMBINANT PROTEIN TO IDENTIFY PIG HERDS INFECTED WITH BRACHYSPIRA HYODYSENTERIAE","VETERINARY JOURNAL","VET. J.","BRACHYSPIRA HYODYSENTERIAE IS AN ANAEROBIC SPIROCHAETE THAT CAN INDUCE SWINE DYSENTERY (SD), A SEVERE MUCOHAEMORRHAGIC COLITIS IN GROWER AND FATTENER PIGS. THE AIM OF THIS STUDY WAS TO DEVELOP A SEROLOGICAL ELISA FOR USE AS A SCREENING METHOD TO DETECT EVIDENCE OF HERD INFECTION. BIOINFORMATIC ANALYSIS OF THE COMPLETE GENOME SEQUENCE OF STRAIN WA1 WAS USED TO IDENTIFY GENES PREDICTED TO ENCODE OUTER MEMBRANE PROTEINS. TWENTY CANDIDATE GENES WERE EXPRESSED IN AN ESCHERICHIA COLI MEDIATED SYSTEM, AND PURIFIED AS HISTIDINE-TAGGED RECOMBINANT PROTEINS. SELECTION OF OPTIMAL ANTIGENS UNDER DIFFERENT CONDITIONS WAS CONDUCTED USING WESTERN BLOT AND ELISA WITH A RANGE OF PIG SERA FROM INFECTED AND UNINFECTED PIGS. FROM THIS ANALYSIS, THREE RECOMBINANT PROTEINS WERE SELECTED AS BEING MOST SUITABLE FOR USE AS ANTIGENS. THESE ANTIGENS THEN WERE TESTED UNDER OPTIMIZED CONDITIONS IN AN INDIRECT ELISA DETECTING IGG2 USING 1551 SERA FROM HEALTHY PIGS AT SLAUGHTER, COMPRISING 896 FROM 18 HERDS CONSIDERED TO BE FREE FROM SD AND 655 FROM 12 INFECTED HERDS. USING A CUT-OFF VALUE FOR POSITIVITY OF THE MEAN PLUS FIVE STANDARD DEVIATIONS OF THE MEAN FOR THE NEGATIVE SERA, THE BEST OVERALL RESULTS WERE OBTAINED WITH THE ELISA USING ANTIGEN H114, WHICH WAS 100\% SPECIFIC AND 91.7\% SENSITIVE AT DETECTING THE REPORTED STATUS OF THE HERDS. THIS NEW ELISA SHOULD BE A USEFUL ADJUNCT FOR DETECTING AND MONITORING THE STATUS OF HERDS WITH RESPECT TO THE PRESENCE OF B. HYODYSENTERIAE, AND SHOULD PROVE USEFUL FOR UNDERSTANDING THE DYNAMICS OF INFECTION IN HERDS WHERE THE SPIROCHAETE IS PRESENT. (C) 2015 ELSEVIER LTD. ALL RIGHTS RESERVED.","BRACHYSPIRA HYODYSENTERIAE; DIAGNOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; SPIROCHAETE; SWINE DYSENTERY","LINKED-IMMUNOSORBENT-ASSAY; TREPONEMA-HYODYSENTERIAE; SWINE-DYSENTERY; VIRULENCE; FECES","ENGLISH","ARTICLE","ARTICLE",1,"BARTH S, 2012, VET MICROBIOL, V155, P438, DOI 10.1016/J.VETMIC.2011.09.032.;BURROUGH ER, 2012, J VET DIAGN INVEST, V24, P1025, DOI 10.1177/1040638712457927.;CHANDER Y., 2012, J VET DIAGNOSTIC INV, V4, P903.;HAMPSON DAVID J, 2015, PORCINE HEALTH MANAG, V1, P8, DOI 10.1186/S40813-015-0002-1.;HAMPSON DJ, 2012, DIS SWINE, P680.;HONTECILLAS R, 2005, IMMUNOLOGY, V115, P127, DOI 10.1111/J.1365-2567.2005.02124.X.;JOENS LA, 1982, J CLIN MICROBIOL, V15, P249.;LA T, 2005, VET MICROBIOL, V107, P249, DOI 10.1016/J.VETMIC.2005.01.016.;LA T., 2001, ANIMAL HEALTH RESEARCH REVIEWS, V2, P45.;LA T, 2003, J CLIN MICROBIOL, V41, P3372, DOI 10.1128/JCM.41.7.3372-3375.2003.;LA T., 2014, VET RES, V2014, P45, DOI DOI 10.1186/S13567-014-0131-6.;LA T, 2009, VET MICROBIOL, V133, P98, DOI 10.1016/J.VETMIC.2008.06.003.;MHOMA JRL, 1992, AUST VET J, V69, P81, DOI 10.1111/J.1751-0813.1992.TB15555.X.;OSORIO J, 2013, RES VET SCI, V95, P861, DOI 10.1016/J.RVSC.2013.07.014.;RUBIN JE, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0057146.;SMITH SC, 1991, EPIDEMIOL INFECT, V107, P285, DOI 10.1017/S0950268800048937.;SONG Y, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-6.;SONG Y, 2009, VET MICROBIOL, V137, P129, DOI 10.1016/J.VETMIC.2008.12.020.;SONG Y, 2009, VET MICROBIOL, V137, P111, DOI 10.1016/J.VETMIC.2008.12.018.;WRIGHT JC, 1989, J CLIN MICROBIOL, V27, P411.","HAMPSON, DJ (REPRINT AUTHOR), MURDOCH UNIV, SCH VET \& LIFE SCI, MURDOCH, WA 6150, AUSTRALIA.;SONG, YONG, LA, TOM, PHILLIPS, NYREE D., HAMPSON, DAVID J., MURDOCH UNIV, SCH VET \& LIFE SCI, MURDOCH, WA 6150, AUSTRALIA.","10.1016/J.TVJL.2015.08.021","THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",NA,NA,"AUSTRALIAN COOPERATIVE RESEARCH CENTRE FOR HIGH INTEGRITY AUSTRALIAN PORK (THE PORK CRC) [2C-106 0708]","THIS STUDY WAS FUNDED BY THE AUSTRALIAN COOPERATIVE RESEARCH CENTRE FOR HIGH INTEGRITY AUSTRALIAN PORK (THE PORK CRC) UNDER PROJECT NUMBER 2C-106 0708. WE THANK THE AUSTRALIAN VETERINARIANS AND PIG PRODUCERS WHO PROVIDED THE SERA THAT WERE USED IN THE STUDY.",NA,"1090-0233","3","365-370","ELSEVIER SCI LTD","206",2015,"ISI000366874100023","20","VETERINARY SCIENCES","4","VETERINARY SCIENCES","D.HAMPSONMURDOCH.EDU.AU",NA,"CZ1OB",NA,"HAMPSON, DJ (REPRINT AUTHOR), MURDOCH UNIV, SCH VET \& LIFE SCI, MURDOCH, WA 6150, AUSTRALIA","ISI","MURDOCH UNIV","MURDOCH UNIV",NA,"SONG Y, 2015, VET J","SONG Y, 2015, VET J"
"EIRIN ME, 2015, TUBERCULOSIS","EIRIN ME;MACIAS A;MAGNANO G;MORSELLA C;MENDEZ L;BLANCO FC;BIANCO MV;SEVERINA W;ALITO A;DE LOS ANGELES PANDO M;SINGH M;SPALLEK R;PAOLICCHI FA;BIGI F;CATALDI AA","IDENTIFICATION AND EVALUATION OF NEW MYCOBACTERIUM BOVIS ANTIGENS IN THE IN VITRO INTERFERON GAMMA RELEASE ASSAY FOR BOVINE TUBERCULOSIS DIAGNOSIS","TUBERCULOSIS","TUBERCULOSIS","BOVINE TUBERCULOSIS (BTB) IS A COMMON ZOONOTIC DISEASE, CAUSED BY MYCOBACTERIUM BOVIS (M. BOVIS), RESPONSIBLE FOR SIGNIFICANT ECONOMIC LOSSES WORLDWIDE. ITS DIAGNOSIS IS BASED ON THE DETECTION OF CELL MEDIATED IMMUNITY UNDER THE EXPOSURE TO PROTEIN PURIFIED DERIVATIVE TUBERCULIN (PPD), A COMPLEX AND POORLY CHARACTERIZED REAGENT. THE CROSS-REACTIVITY TO NON-TUBERCULOUS MYCOBACTERIUM SPECIES (FALSE-POSITIVE RESULTS) HAS BEEN CRUCIAL TO DEVELOP A MORE PROPER ANTIGEN. IN THE PRESENT STUDY, WE SELECTED SIX M. BOVIS OPEN READING FRAMES (MB1992, MB2031C, MB2319, MB2843C, MB2845C AND MB3212C) BY INSILICO ANALYSIS AND EVALUATED THEM IN EXPERIMENTAL AND NATURAL INFECTION, NONE OF THESE ANTIGENS HAD BEEN PREVIOUSLY ASSESSED AS DIAGNOSTIC ANTIGENS FOR BTB. THE REACTIVITY PERFORMANCE WAS TESTED IN ANIMALS WITH BOTH POSITIVE AND NEGATIVE TUBERCULIN SKIN TEST (TST) RESULTS AS WELL AS IN CATTLE INFECTED WITH MYCOBACTERIUM AVIUM SUBESP. PARATUBERCULOSIS (MAP). THE SIX RECOMBINANT ANTIGENS INDIVIDUALLY INDUCED AN IFN-G RESPONSE, WITH OVERALL RESPONDER FREQUENCY RANGING FROM 18.3 TO 31\%. MB2845C WAS THE MOST VALUABLE ANTIGEN WITH THE POTENTIAL TO DISCRIMINATE TST-POSITIVE CATTLE FROM EITHER TST-NEGATIVE OR MAP INFECTED ANIMALS. MB2845C SHOWED SIMILAR PERFORMANCE TO THAT OBSERVED WITH ESAT-6 AND PPD-B AMONG TST AND MTC SPECIFIC-PCR POSITIVE ANIMALS, ALTHOUGH THIS RESULT NEEDS TO BE PROVEN IN FURTHER STUDIES WITH A HIGHER SAMPLE SIZE. OUR DATA CONFIRM THE FEACIBILITY TO IMPLEMENT BIOINFORMATIC SCREENING TOOLS AND SUGGEST MB2845C AS A POTENTIAL DIAGNOSTIC ANTIGEN TO BE TESTED IN PROTEIN COCKTAILS TO EVALUATE THEIR CONTRIBUTION TO BTB DIAGNOSIS. (C) 2015 ELSEVIER LTD. ALL RIGHTS RESERVED.","BOVINE; TUBERCULOSIS; DIAGNOSIS; NEW ANTIGENS; IGRA","INFECTED CATTLE; PARATUBERCULOSIS; COCKTAILS; SEQUENCE; IRELAND; COMPLEX; TESTS; HERD","ENGLISH","ARTICLE","ARTICLE",2,"AAGAARD C, 2010, PREV VET MED, V96, P161, DOI 10.1016/J.PREVETMED.2010.06.007.;AAGAARD C, 2006, J CLIN MICROBIOL, V44, P4326, DOI 10.1128/JCM.01184-06.;ABERNETHY DA, 2013, VET REC, V172, DOI 10.1136/VR.100969.;ARANAZ A, 2006, VET RES, V37, P593, DOI 10.1051/VETRES:2006021.;AUSUBEL F M, 1981, COLD SPRING HARB SYMP QUANT BIOL, V45 PT 2, P487.;BYRNE AW, 2014, VET RES, V45, DOI 10.1186/S13567-014-0109-4.;BLANCO FC, 2013, TUBERCULOSIS, V93, P363, DOI 10.1016/J.TUBE.2013.02.004.;CASAL C, 2012, PREV VET MED, V105, P149, DOI 10.1016/J.PREVETMED.2012.02.007.;CHO YS, 2012, PROTEOMICS, V12, P979, DOI 10.1002/PMIC.201100544.;COLLINS DM, 1993, VET MICROBIOL, V36, P289, DOI 10.1016/0378-1135(93)90095-O.;DE KANTOR IN, 2006, VET MICROBIOL, V112, P111, DOI 10.1016/J.VETMIC.2005.11.033.;DE LA RUA-DOMENECH R, 2006, RES VET SCI, V81, P190, DOI 10.1016/J.RVSC.2005.11.005.;GARNIER T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/PNAS.1130426100.;GIDEON HP, 2012, J IMMUNOL, V189, P5867, DOI 10.4049/JIMMUNOL.1202281.;HE LM, 2012, J CELL BIOCHEM, V113, P2464, DOI 10.1002/JCB.24121.;LECHAT P, 2008, NUCLEIC ACIDS RES, V36, PD469, DOI 10.1093/NAR/GKM1042.;DE LA CRUZ ML, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0115632.;MICHEL AL, 2008, J VET DIAGN INVEST, V20, P501, DOI 10.1177/104063870802000415.;MONAGHAN ML, 1994, VET MICROBIOL, V40, P111, DOI 10.1016/0378-1135(94)90050-7.;PAOLICCHI FA, 2003, J VET MED B, V50, P20, DOI 10.1046/J.1439-0450.2003.00606.X.;PRASAD TSK, 2013, CLIN PROTEOM, V10, DOI 10.1186/1559-0275-10-8.;RINDI L, 2001, NEW MICROBIOL, V24, P289.;ROTHEL JS, 1990, AUST VET J, V67, P134, DOI 10.1111/J.1751-0813.1990.TB07730.X.;SCHILLER I, 2009, CLIN VACCINE IMMUNOL, V16, P1196, DOI 10.1128/CVI.00150-09.;SIDDERS B, 2008, INFECT IMMUN, V76, P3932, DOI 10.1128/IAI.00150-08.;THIERRY D, 1990, J CLIN MICROBIOL, V28, P2668.;TORRES-GONZALEZ P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/JOURNAL.PNTD.0002177.;VAN INGEN J, 2012, EMERG INFECT DIS, V18, P653, DOI 10.3201/EID1804.110888.;VORDERMEIER M, 2011, VET MICROBIOL, V151, P8, DOI 10.1016/J.VETMIC.2011.02.020.;WHELAN AO, 2010, J CLIN MICROBIOL, V48, P3176, DOI 10.1128/JCM.00420-10.","EIRIN, ME (REPRINT AUTHOR), INTA, CICVYA, INST BIOTECNOL, DE LOS RESEROS \& LAS CABANAS S-N, RA-1686 BUENOS AIRES, DF, ARGENTINA.;EIRIN, MARIA E., BLANCO, FEDERICO C., BIANCO, MARIA V., ALITO, ALICIA, BIGI, FABIANA, CATALDI, ANGEL A., INTA CASTELAR, CICVYA, INST BIOTECNOL, LABORATORIO TB BOVINA, BUENOS AIRES, DF, ARGENTINA.;MACIAS, ANALIA, MAGNANO, GABRIEL, UNIV NACL RIO CUARTO, FAC AGRON \& VET, DEPT PATOL ANIM, CORDOBA, ARGENTINA.;MORSELLA, CLAUDIA, MENDEZ, LAURA, PAOLICCHI, FERNANDO A., INTA, EEA BALCARCE, LAB BACTERIOL, BUENOS AIRES, DF, ARGENTINA.;SEVERINA, WALTER, PRIVATE ACT, RA-5917 CORDOBA, ARGENTINA.;DE LOS ANGELES PANDO, MARIA, UBA CONICET, FAC MED, INST INVEST BIOMED RETROVIRUS \& SIDA INBIRS, BUENOS AIRES, DF, ARGENTINA.;SINGH, MAHAVIR, SPALLEK, RALPH, LIONEX GMBH, BRAUNSCHWEIG, GERMANY.","10.1016/J.TUBE.2015.07.009","JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND",NA,NA,"INSTITUTO NACIONAL DE TECNOLOGIA AGROPECUARIA [AEBIO243512, PNBIO1131034], UNMDP AGR [422/13]","THE PRESENT STUDY WAS SUPPORTED BY THE FOLLOWING FUNDINGS SOURCES: INSTITUTO NACIONAL DE TECNOLOGIA AGROPECUARIA AEBIO243512, PNBIO1131034 AND UNMDP AGR 422/13.",NA,"1472-9792","6","795-801","CHURCHILL LIVINGSTONE","95",2015,"ISI000365626300022","30","IMMUNOLOGY, MICROBIOLOGY, RESPIRATORY SYSTEM","15","IMMUNOLOGY, MICROBIOLOGY, RESPIRATORY SYSTEM","EIRIN.MARIAINTA.GOB.AR AMACIASAYV.UNRC.EDU.AR GMAGNANOAYV.UNRC.EDU.AR MORSELLA.CLAUDIAINTA.GOB.AR MENDEZ.LAURAINTA.GOB.AR BLANCO.FEDERICOINTA.GOB.AR BIANCO.MARIAINTA.GOB.AR WALTERSEVERINAHOTMAIL.COM ALICIA.ALITOGMAIL.COM MPANDOFMED.UBA.AR INFOLIONEX.DE RSPLIONEX.DE PAOLICCHI.FERNANDOINTA.GOB.AR BIGI.FABIANAINTA.GOB.AR CATALDI.ANGELADRIANINTA.GOB.AR",NA,"CX3UZ",NA,"EIRIN, ME (REPRINT AUTHOR), INTA, CICVYA, INST BIOTECNOL, DE LOS RESEROS \& LAS CABANAS S-N, RA-1686 BUENOS AIRES, DF, ARGENTINA","ISI","INST BIOTECNOL;UNIV NACL RIO CUARTO;LAB BACTERIOL;INST INVEST BIOMED RETROVIRUS AND SIDA INBIRS;BRAUNSCHWEIG","INST BIOTECNOL",NA,"EIRIN ME, 2015, TUBERCULOSIS","EIRIN ME, 2015, TUBERCULOSIS"
"MCINERNEY-LEO AM, 2015, CLIN GENET","MCINERNEY LEO AM;HARRIS JE;LEO PJ;MARSHALL MS;GARDINER B;KINNING E;LEONG HY;MCKENZIE F;ONG WP;VODOPIUTZ J;WICKING C;BROWN MA;ZANKL A;DUNCAN EL","WHOLE EXOME SEQUENCING IS AN EFFICIENT, SENSITIVE AND SPECIFIC METHOD FOR DETERMINING THE GENETIC CAUSE OF SHORT-RIB THORACIC DYSTROPHIES","CLINICAL GENETICS","CLIN. GENET.","SHORT-RIB THORACIC DYSTROPHIES (SRTDS) ARE CONGENITAL DISORDERS DUE TO DEFECTS IN PRIMARY CILIUM FUNCTION. SRTDS ARE RECESSIVELY INHERITED WITH MUTATIONS IDENTIFIED IN 14 GENES TO DATE (COMPRISING 398 EXONS). CONVENTIONAL MUTATION DETECTION (USUALLY BY ITERATIVE SANGER SEQUENCING) IS INEFFICIENT AND EXPENSIVE, AND OFTEN NOT UNDERTAKEN. WHOLE EXOME MASSIVE PARALLEL SEQUENCING HAS BEEN USED TO IDENTIFY NEW GENES FOR SRTD (WDR34, WDR60 AND IFT172), HOWEVER, THE CLINICAL UTILITY OF WHOLE EXOME SEQUENCING (WES) HAS NOT BEEN ESTABLISHED. WES WAS PERFORMED IN 11 INDIVIDUALS WITH SRTDS. COMPOUND HETEROZYGOUS OR HOMOZYGOUS MUTATIONS WERE IDENTIFIED IN SIX CONFIRMED SRTD GENES IN 10 INDIVIDUALS (IFT172, DYNC2H1, TTC21B, WDR60, WDR34 AND NEK1), GIVING OVERALL SENSITIVITY OF 90.9\%. WES DATA FROM 993 UNAFFECTED INDIVIDUALS SEQUENCED USING SIMILAR TECHNOLOGY SHOWED TWO INDIVIDUALS WITH RARE (MINOR ALLELE FREQUENCY <0.005) COMPOUND HETEROZYGOUS VARIANTS OF UNKNOWN SIGNIFICANCE IN SRTD GENES (SPECIFICITY >99\%). COSTS FOR CONSUMABLES, LABORATORY PROCESSING AND BIOINFORMATIC ANALYSIS WERE <AU\$850 PER SAMPLE. WES IS SENSITIVE, SPECIFIC, EFFICIENT AND COST-EFFECTIVE FOR MUTATION SCREENING AS WELL AS GENE DISCOVERY IN SRTDS AND CAN BE CONSIDERED A FIRST-LINE METHODOLOGY FOR MUTATION IDENTIFICATION IN AFFECTED INDIVIDUALS.","CILIOPATHY; EXOME SEQUENCING; JEUNE SYNDROME; PRIMARY CILIA; SHORT-RIB POLYDACTYLY","VAN-CREVELD-SYNDROME; RETROGRADE INTRAFLAGELLAR TRANSPORT; SENSENBRENNER SYNDROME; POLYDACTYLY SYNDROME; CRANIOECTODERMAL DYSPLASIA; DYNC2H1 MUTATIONS; CAUSE JEUNE; CILIOPATHIES; DISEASE; DYSOSTOSIS","ENGLISH","ARTICLE","ARTICLE",13,"ARTS HH, 2011, J MED GENET, V48, P390, DOI 10.1136/JMG.2011.088864.;BACINO CA, 2012, AM J MED GENET A, V158A, P2917, DOI 10.1002/AJMG.A.35608.;BAUJAT G, 2013, J MED GENET, V50, P91, DOI 10.1136/JMEDGENET-2012-101282.;BEALES PL, 2007, NAT GENET, V39, P727, DOI 10.1038/NG2038.;BREDRUP C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/J.AJHG.2011.10.001.;CAVALCANTI DP, 2011, J MED GENET, V48, P88, DOI 10.1136/JMG.2009.069468.;COOPER D, 1995, METABOLIC MOL BASES, P259.;D'ASDIA MC, 2013, EUR J MED GENET, V56, P80, DOI 10.1016/J.EJMG.2012.11.005.;DAGONEAU N, 2009, AM J HUM GENET, V84, P706, DOI 10.1016/J.AJHG.2009.04.016.;DAVIS EE, 2012, CURR OPIN GENET DEV, V22, P290, DOI 10.1016/J.GDE.2012.04.006.;DAVIS EE, 2011, NAT GENET, V43, P189, DOI 10.1038/NG.756.;EL HOKAYEM J, 2012, J MED GENET, V49, P227, DOI 10.1136/JMEDGENET-2011-100717.;FILGES I, 2014, CLIN GENET, V86, P220, DOI 10.1111/CGE.12301.;GILISSEN C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/J.AJHG.2010.08.004.;GREEN RC, 2013, GENET MED, V15, P565, DOI 10.1038/GIM.2013.73.;HALBRITTER J, 2013, AM J HUM GENET, V93, P915, DOI 10.1016/J.AJHG.2013.09.012.;HILDEBRANDT F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMRA1010172.;HOFFER JL, 2013, CLIN GENET, V83, P92, DOI 10.1111/J.1399-0004.2012.01880.X.;HUBER C, 2013, AM J HUM GENET, V93, P926, DOI 10.1016/J.AJHG.2013.10.007.;HUBER C, 2012, AM J MED GENET C, V160C, P165, DOI 10.1002/AJMG.C.31336.;INGLIS PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/J.TIG.2006.07.006.;LAZARUS S, 2014, OSTEOPOROSIS INT, V25, P407, DOI 10.1007/S00198-013-2443-1.;LIN AE, 2013, AM J MED GENET A, V161, P2762, DOI 10.1002/AJMG.A.36265.;MCINERNEY-LEO AIDEEN M, 2013, BONEKEY REP, V2, P456, DOI 10.1038/BONEKEY.2013.190.;MCINERNEY-LEO AM, 2014, CLIN ENDOCRINOL, V80, P25, DOI 10.1111/CEN.12331.;MCINERNEY-LEO AM, 2013, AM J HUM GENET, V93, P515, DOI 10.1016/J.AJHG.2013.06.022.;MERRILL AE, 2009, AM J HUM GENET, V84, P542, DOI 10.1016/J.AJHG.2009.03.015.;MILL P, 2011, AM J HUM GENET, V88, P508, DOI 10.1016/J.AJHG.2011.03.015.;NG SB, 2009, NATURE, V461, P272, DOI 10.1038/NATURE08250.;PATEL-KING RS, 2013, MOL BIOL CELL, V24, P2668, DOI 10.1091/MBC.E13-05-0266.;PLAGNOL V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/BIOINFORMATICS/BTS526.;ROMPOLAS P, 2007, J CELL SCI, V120, P3653, DOI 10.1242/JCS.012773.;RUIZ-PEREZ VL, 2003, AM J HUM GENET, V72, P728, DOI 10.1086/368063.;RUIZ-PEREZ VL, 2000, NAT GENET, V24, P283, DOI 10.1038/73508.;SCHMIDTS M, 2013, AM J HUM GENET, V93, P932, DOI 10.1016/J.AJHG.2013.10.003.;SCHMIDTS M, 2013, J MED GENET, V50, P309, DOI 10.1136/JMEDGENET-2012-101284.;SCHMIDTS M, 2013, HUM MUTAT, V34, P714, DOI 10.1002/HUMU.22294.;THIEL C, 2011, AM J HUM GENET, V88, P106, DOI 10.1016/J.AJHG.2010.12.004.;WALCZAK-SZTULPA J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/J.AJHG.2010.04.012.;WANG JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/NMETH.1628, 10.1038/NMETH.1628].;YE XQ, 2006, HUM GENET, V119, P199, DOI 10.1007/S00439-005-0129-2.","DUNCAN, EL (REPRINT AUTHOR), ROYAL BRISBANE \& WOMENS HOSP, DEPT ENDOCRINOL, JAMES MAYNE BLDG,BUTTERFIELD RD, HERSTON, QLD 4029, AUSTRALIA.;MCINERNEY-LEO, A. M., HARRIS, J. E., LEO, P. J., MARSHALL, M. S., GARDINER, B., BROWN, M. A., DUNCAN, E. L., UNIV QUEENSLAND, DIAMANTINA INST, TRANSLAT RES INST, PRINCESS ALEXANDRA HOSP, WOOLLOONGABBA, QLD 4102, AUSTRALIA.;KINNING, E., SO GEN HOSP, WEST SCOTLAND GENET SERV, GLASGOW G51 4TF, LANARK, SCOTLAND.;LEONG, H. Y., ONG, W. P., HOSP KUALA LUMPUR, DEPT GENET, KUALA LUMPUR, MALAYSIA.;MCKENZIE, F., GENET SERV WESTERN AUSTRALIA, SUBIACO, WA 6008, AUSTRALIA.;MCKENZIE, F., UNIV WESTERN AUSTRALIA, SCH PAEDIAT \& CHILD HLTH, CRAWLEY, WA 6009, AUSTRALIA.;VODOPIUTZ, J., MED UNIV VIENNA, DEPT PEDIAT \& ADOLESCENT MED, A-1090 VIENNA, AUSTRIA.;WICKING, C., UNIV QUEENSLAND, INST MOL BIOSCI, BRISBANE, QLD 4072, AUSTRALIA.;ZANKL, A., UNIV SYDNEY, DISCIPLINE GENET MED, SYDNEY, NSW 2006, AUSTRALIA.;ZANKL, A., SYDNEY CHILDRENS HOSP NETWORK WESTMEAD, ACAD DEPT MED GENET, SYDNEY, NSW, AUSTRALIA.;DUNCAN, E. L., ROYAL BRISBANE \& WOMENS HOSP, DEPT ENDOCRINOL, HERSTON, QLD 4029, AUSTRALIA.;DUNCAN, E. L., UNIV QUEENSLAND, CLIN RES CTR, HERSTON, QLD 4029, AUSTRALIA.","10.1111/CGE.12550","111 RIVER ST, HOBOKEN 07030-5774, NJ USA",NA,NA,"NHMRC, REBECCA COOPER MEDICAL RESEARCH FOUNDATION, UNIVERSITY OF QUEENSLAND (UQ) POSTGRADUATE SCHOLARSHIP, UQ VICE CHANCELLOR'S SENIOR RESEARCH FELLOWSHIP","THE AUTHORS WOULD LIKE TO THANK THE FAMILIES FOR THEIR COOPERATION AND INTEREST IN THE STUDY. THE AUTHORS ALSO WISH TO THANK LINDA BRADBURY FOR COLLECTING INITIAL SAMPLES FROM FAMILY SKDP-24 AND SKDP-42, AND SHARON SONG AND LISA ANDERSON FOR TECHNICAL SUPPORT. M. A. B. WAS FUNDED BY AN NHMRC SENIOR PRINCIPAL RESEARCH FELLOWSHIP, AND WAS ALSO RECEIVED SUPPORT FROM THE REBECCA COOPER MEDICAL RESEARCH FOUNDATION. A. M. M. L. IS SUPPORTED BY A UNIVERSITY OF QUEENSLAND (UQ) POSTGRADUATE SCHOLARSHIP, AND C. W. BY A UQ VICE CHANCELLOR'S SENIOR RESEARCH FELLOWSHIP.",NA,"0009-9163","6","550-557","WILEY-BLACKWELL","88",2015,"ISI000364637900009","41","GENETICS \& HEREDITY","7","GENETICS \& HEREDITY","EMMA.DUNCANUQ.EDU.AU",NA,"CV9WI",NA,"DUNCAN, EL (REPRINT AUTHOR), ROYAL BRISBANE \& WOMENS HOSP, DEPT ENDOCRINOL, JAMES MAYNE BLDG,BUTTERFIELD RD, HERSTON, QLD 4029, AUSTRALIA","ISI","UNIV QUEENSLAND;SO GEN HOSP;HOSP KUALA LUMPUR;UNIV WESTERN AUSTRALIA;MED UNIV VIENNA;UNIV QUEENSLAND;UNIV SYDNEY;ACAD DEPT MED GENET;ROYAL BRISBANE AND WOMENS HOSP;UNIV QUEENSLAND","ROYAL BRISBANE AND WOMENS HOSP",NA,"MCINERNEY-LEO AM, 2015, CLIN GENET","MCINERNEY-LEO AM, 2015, CLIN GENET"
"FURSOVA NK, 2015, ANN CLIN MICROBIOL ANTIMICROB","FURSOVA NK;ASTASHKIN EI;KNYAZEVA AI;KARTSEV NN;LEONOVA ES;ERSHOVA ON;ALEXANDROVA IA;KURDYUMOVA NV;SAZIKINA SY;VOLOZHANTSEV NV;SVETOCH EA;DYATLOV IA","THE SPREAD OF BLA(OXA-48) AND BLA(OXA-244) CARBAPENEMASE GENES AMONG KLEBSIELLA PNEUMONIAE, PROTEUS MIRABILIS AND ENTEROBACTER SPP. ISOLATED IN MOSCOW, RUSSIA","ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS","ANN. CLIN. MICROBIOL. ANTIMICROB.","BACKGROUND: THE SPREAD OF CARBAPENEMASE-PRODUCING ENTEROBACTERIACEAE (CPE) IS A GREAT PROBLEM OF HEALTHCARE WORLDWIDE. STUDY OF THE SPREAD FOR BLA(OXA-48-LIKE) GENES CODING EPIDEMICALLY SIGNIFICANT CARBAPENEMASES AMONG HOSPITAL PATHOGENS IS IMPORTANT FOR THE REGIONAL AND GLOBAL EPIDEMIOLOGY OF ANTIMICROBIAL RESISTANCE. METHODS: ANTIBACTERIAL RESISTANT ISOLATES OF KLEBSIELLA PNEUMONIAE (N = 95) FROM 54 PATIENTS, P. MIRABILIS (N=32) FROM 20 PATIENTS, ENTEROBACTER AEROGENES (N=6) FROM FOUR PATIENTS, AND ENTEROBACTER CLOACAE (N=4) FROM FOUR PATIENTS WERE COLLECTED FROM JANUARY, 2013 TO OCTOBER, 2014 IN NEUROSURGICAL INTENSIVE CARE UNIT (ICU) OF THE BURDENKO NEUROSURGERY INSTITUTE, MOSCOW. CHARACTERISTICS OF THE ISOLATES WERE DONE USING SUSCEPTIBILITY TESTS, PCR DETECTION OF THE RESISTANCE GENES, GENOTYPING, CONJUGATION, DNA SEQUENCING, AND BIOINFORMATIC ANALYSIS. RESULTS: MAJOR STRAINS UNDER STUDY WERE MULTI DRUG RESISTANT (MDR), RESISTANT TO THREE OR MORE FUNCTIONAL CLASSES OF DRUGS SIMULTANEOUSLY-98.9 \% K. PNEUMONIAE, 100 \% P. MIRABILIS, ONE E. AEROGENES ISOLATE, AND ONE E. CLOACAE ISOLATE. MOLECULAR-GENETIC MECHANISM OF MDR IN K. PNEUMONIAE AND P. MIRABILIS ISOLATES WERE BASED ON CARRYING OF EPIDEMIC EXTENDED-SPECTRUM BETA-LACTAMASE BLA(CTX-M-15) GENE (87.2 AND 90.6 \% ACCORDINGLY), CARBAPENEMASE BLA(OXA-48-LIKE) GENE (55.3 AND 23.3 \% ACCORDINGLY), AND CLASS 1 (54.8 AND 31.3 \% ACCORDINGLY) AND CLASS 2 (90.6 \% P. MIRABILIS) INTEGRONS. THE BLA(OXA-48-LIKE)-POSITIVE K. PNEUMONIAE WERE COLLECTED DURING WHOLE TWO-YEAR SURVEILLANCE PERIOD, WHILE P. MIRABILIS AND ENTEROBACTER SPP. CARRYING BLA(OXA-48-LIKE) GENES WERE DETECTED ONLY AFTER FOUR AND 18 MONTHS AFTER THE RESEARCH START, RESPECTIVELY. THE BLAOXA-48-LIKE GENE ACQUISITION WAS SHOWN FOR P. MIRABILIS ISOLATES COLLECTED FROM FIVE PATIENTS AND FOR E. CLOACAE ISOLATE COLLECTED FROM ONE PATIENT DURING THEIR STAY IN THE ICU, PRESUMABLY FROM BLA(OXA-48-LIKE)-POSITIVE K. PNEUMONIAE. THE SOURCE OF THE BLA(OXA-244) GENE ACQUIRED BY E. AEROGENES ISOLATES AND THE TIME OF THIS EVENT WERE NOT RECOGNIZED. CONCLUSIONS: THE EXPANDING OF CPE IN THE SURVEYED ICU WAS ASSOCIATED WITH THE SPREAD OF BLA(OXA-48) AND BLAOXA-244 CARBAPENEMASE GENES DOCUMENTED NOT ONLY AMONG K. PNEUMONIAE, WELL-KNOWN BACTERIAL HOST FOR SUCH GENES, BUT AMONG P. MIRABILIS, E. AEROGENES, AND E. CLOACAE.","ENTEROBACTERIACEAE; KLEBSIELLA PNEUMONIAE; PROTEUS MIRABILIS; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; OXA-48-LIKE CARBAPENEMASE; HOSPITAL PATHOGENS; ANTIBACTERIAL RESISTANCE; HORIZONTAL GENE TRANSFER","BLA(CTX-M) GENES; RESISTANCE; EMERGENCE; PLASMID; OXA-48; HOSPITALS; CASSETTES; INTEGRONS; BACTERIA","ENGLISH","ARTICLE","ARTICLE",17,"AGEEVETS VA, 2014, INT J ANTIMICROB AG, V44, P152, DOI 10.1016/J.IJANTIMICAG.2014.05.004.;AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/RSTB.1980.0049.;ARANA DM, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/J.CMI.2014.07.008.;BIRGAND G, 2014, CLIN MICROBIOL INFEC, V20, PO887, DOI 10.1111/1469-0691.12604.;CHEN JH, 2010, J ANTIMICROB CHEMOTH, V65, P986, DOI 10.1093/JAC/DKQ056.;CHEN L, 2015, ANTIMICROB AGENTS CH, V59, P4305, DOI 10.1128/AAC.00565-15.;ECKERT C, 2006, J ANTIMICROB CHEMOTH, V57, P14, DOI 10.1093/JAC/DKI398.;EDELSTEIN M, 2003, ANTIMICROB AGENTS CH, V47, P3724, DOI 10.1128/AAC.47.12.3724-3732.2003.;FURSOVA N. K., 2010, ANTIBIOTIKI I KHIMIOTERAPIYA, V55, P3.;GLASNER C., 2013, EURP SURVEILL, P18, DOI DOI 10.2807/1560-7917.ES2013.18.28.20525.;HAMMOUDI D, 2014, INT J INFECT DIS, V29, P139, DOI 10.1016/J.IJID.2014.07.017.;HUJER KM, 2006, ANTIMICROB AGENTS CH, V50, P4114, DOI 10.1128/AAC.00778-06.;MAGIORAKOS AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/J.1469-0691.2011.03570.X.;MARTINEZ-MARTINEZ LUIS, 2014, ENFERM INFECC MICROBIOL CLIN, V32 SUPPL 4, P4, DOI 10.1016/S0213-005X(14)70168-5.;MOURA A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/BIOINFORMATICS/BTP105.;NORDMANN P, 2014, CLIN MICROBIOL INFEC, V20, P821, DOI 10.1111/1469-0691.12719.;OTEO J, 2013, J ANTIMICROB CHEMOTH, V68, P317, DOI 10.1093/JAC/DKS383.;PARTRIDGE SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/J.1574-6976.2009.00175.X.;POIREL L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004.;POIREL L, 2012, ANTIMICROB AGENTS CH, V56, P559, DOI 10.1128/AAC.05289-11.;POIREL L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08.;POTRON A, 2014, ANTIMICROB AGENTS CH, V58, P467, DOI 10.1128/AAC.01344-13.;PRYAMCHUK S. D., 2010, ANTIBIOTIKI I KHIMIOTERAPIYA, V55, P3.;RASHEED JK, 2008, J CLIN MICROBIOL, V46, P2066, DOI 10.1128/JCM.02038-07.;ROSENTHAL VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/J.AJIC.2011.05.020.;YANG J, 2012, CLIN MICROBIOL INFEC, V18, PE506, DOI 10.1111/1469-0691.12035.;ZIMMER M, 2003, AVIAN DIS, V47, P101, DOI 10.1637/0005-2086(2003)047[0101:DOCJSI]2.0.CO,2.","FURSOVA, NK (REPRINT AUTHOR), STATE RES CTR APPL MICROBIOL \& BIOTECHNOL, OBOLENSK 142279, MOSCOW REGION, RUSSIA.;FURSOVA, NADEZHDA K., ASTASHKIN, EUGENY I., KNYAZEVA, ANASTASIA I., KARTSEV, NIKOLAY N., LEONOVA, EKATERINA S., VOLOZHANTSEV, NIKOLAY V., SVETOCH, EDWARD A., DYATLOV, IVAN A., STATE RES CTR APPL MICROBIOL \& BIOTECHNOL, OBOLENSK 142279, MOSCOW REGION, RUSSIA.;ERSHOVA, OLGA N., ALEXANDROVA, IRINA A., KURDYUMOVA, NATALIA V., SAZIKINA, SVETLANA YU., NN BURDENKO INST NEUROSURG, MOSCOW 125047, RUSSIA.","10.1186/S12941-015-0108-Y","CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND","46",NA,"STATE RESEARCH CENTER FOR APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, OBOLENSK, BURDENKO NEUROSURGERY INSTITUTE, MOSCOW, RUSSIAN SCIENCE FOUNDATION [15-15-00058]","THE STUDY WAS FINANCIALLY SUPPORTED BY THE STATE RESEARCH CENTER FOR APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, OBOLENSK, AND THE BURDENKO NEUROSURGERY INSTITUTE, MOSCOW. THE WORK OF NKF, AIK, EAS, AND NVV CONSISTING IN GENOTYPING KLEBSIELLA PNEUMONIAE WAS ALSO SUPPORTED BY THE RUSSIAN SCIENCE FOUNDATION (GRANT NO. 15-15-00058).",NA,"1476-0711",NA,NA,"BMC","14",2015,"ISI000363840000001","27","MICROBIOLOGY","14","MICROBIOLOGY","N-FURSOVAYANDEX.RU",NA,"CU9CI",NA,"FURSOVA, NK (REPRINT AUTHOR), STATE RES CTR APPL MICROBIOL \& BIOTECHNOL, OBOLENSK 142279, MOSCOW REGION, RUSSIA","ISI","STATE RES CTR APPL MICROBIOL AND BIOTECHNOL;NN BURDENKO INST NEUROSURG","STATE RES CTR APPL MICROBIOL AND BIOTECHNOL",NA,"FURSOVA NK, 2015, ANN CLIN MICROBIOL ANTIMICROB","FURSOVA NK, 2015, ANN CLIN MICROBIOL ANTIMICROB"
"HAJJI H, 2015, J MED VIROL","HAJJI H;AHERFI S;MOTTE A;RAVAUX I;MOKHTARI S;RUIZ JM;POIZOT MARTIN I;TOURRES C;TIVOLI N;GEROLAMI R;TAMALET C;COLSON P","DIVERSITY OF 1,213 HEPATITIS C VIRUS NS3 PROTEASE SEQUENCES FROM A CLINICAL VIROLOGY LABORATORY DATABASE IN MARSEILLE UNIVERSITY HOSPITALS, SOUTHEASTERN FRANCE","JOURNAL OF MEDICAL VIROLOGY","J. MED. VIROL.","INFECTION WITH HEPATITIS C VIRUS (HCV) REPRESENTS A MAJOR PUBLIC HEALTH CONCERN WORLDWIDE. RECENT THERAPEUTIC ADVANCES HAVE BEEN CONSIDERABLE, HCV GENOTYPE CONTINUING TO GUIDE THERAPEUTIC MANAGEMENT. SINCE 2008, HCV GENOTYPING IN OUR CLINICAL MICROBIOLOGY LABORATORY AT UNIVERSITY HOSPITALS OF MARSEILLE, SOUTHEASTERN FRANCE, HAS BEEN BASED ON NS3 PROTEASE GENE POPULATION SEQUENCING, TO ALLOW CONCURRENT HCV GENOTYPE AND PROTEASE INHIBITOR (PI) GENOTYPIC RESISTANCE DETERMINATIONS. WE AIMED, FIRST, TO ANALYZE THE GENETIC DIVERSITY OF HCV NS3 PROTEASE OBTAINED FROM BLOOD SAMPLES COLLECTED BETWEEN 2003 AND 2013 FROM PATIENTS MONITORED AT UNIVERSITY HOSPITALS OF MARSEILLE AND DETECT POSSIBLE ATYPICAL SEQUENCES, AND, SECOND, TO IDENTIFY NS3 PROTEASE AMINO ACID PATTERNS ASSOCIATED WITH DECREASED SUSCEPTIBILITY TO HCV PIS. A TOTAL OF 1,213 HCV NS3 PROTEASE SEQUENCES WERE AVAILABLE IN OUR LABORATORY SEQUENCE DATABASE. WE IMPLEMENTED A STRATEGY BASED ON BIOINFORMATIC TOOLS TO DETERMINE WHETHER HCV SEQUENCES ARE REPRESENTATIVE OF OUR LOCAL HCV GENETIC DIVERSITY, OR DIVERGENT. IN OUR 2003-2012 HCV NS3 PROTEASE SEQUENCE DATABASE, WE DELINEATED 32 CLUSTERS REPRESENTATIVE OF THE MAJORITY HCV GENETIC DIVERSITY, AND 61 DIVERGENT SEQUENCES. FIVE OF THESE DIVERGENT SEQUENCES SHOWED LESS THAN 85\% NUCLEOTIDE IDENTITY WITH THEIR TOP GENBANK HIT. IN ADDITION, AMONG THE 294 SEQUENCES OBTAINED IN 2013, THREE WERE DIVERGENT RELATIVE TO THESE 32 PREVIOUSLY DELINEATED CLUSTERS. FINALLY, WE DETECTED BOTH NATURAL AND ON-TREATMENT GENOTYPIC RESISTANCE TO HCV NS3 PIS, INCLUDING A SUBSTANTIAL PREVALENCE OF Q80K SUBSTITUTIONS ASSOCIATED WITH DECREASED SUSCEPTIBILITY TO SIMEPREVIR, A SECOND GENERATION PI. J. MED. VIROL. 87:1921-1933, 2015. (C) 2015 WILEY PERIODICALS, INC.","HEPATITIS C VIRUS; NS3 PROTEASE; GENOTYPE; DIVERSITY; RESISTANCE MUTATIONS; THERAPY","DECREASED SENSITIVITY; RESISTANCE MUTATIONS; NATURAL-RESISTANCE; ANTIVIRAL THERAPY; INTERFERON-ALPHA; DRUG-RESISTANCE; NAIVE PATIENTS; IN-VIVO; HCV; INHIBITORS","ENGLISH","ARTICLE","ARTICLE",2,"AHERFI S, 2014, J MED VIROL, V86, P1868, DOI 10.1002/JMV.24016.;AKHAVAN S, 2009, J INFECT DIS, V200, P524, DOI 10.1086/600893.;BARTELS DJ, 2008, J INFECT DIS, V198, P800, DOI 10.1086/591141.;BARTELS DJ, 2013, J VIROL, V87, P1544, DOI 10.1128/JVI.02294-12.;BOUCHARDEAU F, 2007, J CLIN MICROBIOL, V45, P1140, DOI 10.1128/JCM.01982-06.;CANTALOUBE JF, 2005, J CLIN MICROBIOL, V43, P3624, DOI 10.1128/JCM.43.8.3624-3629.2005.;CHEVALIEZ S, 2011, CLIN MICROBIOL INFEC, V17, P116, DOI 10.1111/J.1469-0691.2010.03418.X.;COLSON P, 2008, HEPATOLOGY, V47, P766, DOI 10.1002/HEP.22122.;COLSON P, 2012, J CLIN VIROL, V53, P178, DOI 10.1016/J.JCV.2011.10.005.;COLSON P, 2011, ANTIVIR THER, V16, P615, DOI 10.3851/IMP1765.;CROOKS GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/GR.849004.;DONLIN MJ, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0103748.;EDGAR RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/NAR/GKH340.;EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER: EASL, 2014, J HEPATOL, V60, P392, DOI DOI 10.1016/J.JHEP.2013.11.003.;GAUDIERI S, 2009, HEPATOLOGY, V49, P1069, DOI 10.1002/HEP.22773.;HALDEDA M, 2013, ALBANIA INT J INFECT, V18, P90.;HIRAGA N, 2011, HEPATOLOGY, V54, P781, DOI 10.1002/HEP.24460.;JACKOWIAK P, 2014, INFECT GENET EVOL, V21, P67, DOI 10.1016/J.MEEGID.2013.10.021.;JORDIER F, 2013, J MED VIROL, V85, P1754, DOI 10.1002/JMV.23674.;KIEFFER TL, 2014, CURR OPIN VIROL, V8, P16, DOI 10.1016/J.COVIRO.2014.04.008.;KIM JJ, 2012, AM J HEALTH-SYST PH, V69, P19, DOI 10.2146/AJHP110123.;KRONENBERGER B, 2012, J VIRAL HEPATITIS, V19, P48, DOI 10.1111/J.1365-2893.2011.01526.X.;KUNTZEN T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/HEP.22549.;LAVANCHY D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/J.1469-0691.2010.03432.X.;LI CH, 2006, J MED VIROL, V78, P1061, DOI 10.1002/JMV.20663.;LI CH, 2012, J GEN VIROL, V93, P1173, DOI 10.1099/VIR.0.038315-0.;LOPEZ-LABRADOR FX, 2008, ANTIVIR THER, V13, P481.;MARCELLIN P, 2008, J HEPATOL, V48, P200, DOI 10.1016/J.JHEP.2007.09.010.;MEFFRE C, 2010, J MED VIROL, V82, P546, DOI 10.1002/JMV.21734.;MORSICA G, 2009, JAIDS-J ACQ IMM DEF, V51, P106, DOI 10.1097/QAI.0B013E3181A02FDA.;NEUMANN AU, 1998, SCIENCE, V282, P103, DOI 10.1126/SCIENCE.282.5386.103.;NEWMAN RM, 2013, J INFECT DIS, V208, P17, DOI 10.1093/INFDIS/JIS679.;NOPPORNPATH S, 2008, J GEN VIROL, V89, P1276, DOI 10.1099/VIR.0.83593-0.;PALANISAMY N, 2013, ANTIVIR RES, V99, P12, DOI 10.1016/J.ANTIVIRAL.2013.04.018.;PAWLOTSKY JM, 2009, NAT REV GASTRO HEPAT, V6, P383, DOI 10.1038/NRGASTRO.2009.102.;PAYAN C, 2005, J VIRAL HEPATITIS, V12, P405, DOI 10.1111/J.1365-2893.2005.00605.X.;PERES-DA-SILVA A, 2010, ARCH VIROL, V155, P807.;POORDAD F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMOA1010494.;POVEDA E, 2014, ANTIVIR RES, V108, P181, DOI 10.1016/J.ANTIVIRAL.2014.05.015.;QIU P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/NAR/GKP251.;REHERMANN B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/NRI1573.;RICE CM, 2014, NATURE, V510, P43, DOI 10.1038/510043A.;ROSEN HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMCP1006613.;ROUDOT-THORAVAL F, 2002, GASTROEN CLIN BIOL, V26, PB138.;SARRAZIN C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/J.GASTRO.2009.11.055.;SIMMONDS P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/HEP.20819.;SMITH DB, 2013, HEPATOLOGY, V1, P318, DOI DOI 10.1002/HEP.26744.;TAMURA K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/MOLBEV/MSR121.;VALLET S, 2005, J MED VIROL, V75, P528, DOI 10.1002/JMV.20302.;VALLET S, 2011, ANTIVIR THER, V16, P1093, DOI 10.3851/IMP1900.;ZENG YL, 2012, ARCH VIROL, V157, P1113, DOI 10.1007/S00705-012-1283-1.;ZHOU Y, 2007, J BIOL CHEM, V282, P22619, DOI 10.1074/JBC.M610207200.","COLSON, P (REPRINT AUTHOR), CHU TIMONE, INST HOSP UNIV IHU MEDITERRANEE INFECT, ASSISTANCE PUBL HOP MARSEILLE, POLE MALAD INFECT \& TROP CLIN \& BIOLOG,FEDERAT BA, F-13385 MARSEILLE, FRANCE.;HAJJI, HIND, AHERFI, SARAH, MOTTE, ANNE, TOURRES, CHRISTIAN, TIVOLI, NATACHA, TAMALET, CATHERINE, COLSON, PHILIPPE, CHU TIMONE, INST HOSP UNIV IHU MEDITERRANEE INFECT, ASSISTANCE PUBL HOP MARSEILLE, POLE MALAD INFECT \& TROP CLIN \& BIOLOG,FEDERAT BA, F-13385 MARSEILLE, FRANCE.;AHERFI, SARAH, TAMALET, CATHERINE, COLSON, PHILIPPE, AIX MARSEILLE UNIV, FAC MED \& PHARM, URMITE UM CNRS IRD 63 7278 198, INSERM,U1905, MARSEILLE, FRANCE.;RAVAUX, ISABELLE, CTR HOSP UNIV CONCEPT, IHU MEDITERRANEE INFECT, POLE MALAD INFECT \& TROP CLIN \& BIOLOG, SERV MALAD INFECT,ASSIST PUBL HOP MARSEILLE, MARSEILLE, FRANCE.;MOKHTARI, SAADIA, CTR HOSP UNIV NORD, IHU MEDITERRANEE INFECT, POLE MALAD INFECT \& TROP CLIN \& BIOLOG, SERV MALAD INFECT, MARSEILLE, FRANCE.;RUIZ, JEAN-MARIE, HOP SUD, CTR PENITENTIAIRE MARSEILLE, SERV MED MILIEU PENITENTIAIRE, ASSIST PUBL HOP MARSEILLE, MARSEILLE, FRANCE.;POIZOT-MARTIN, ISABELLE, AP HM ST MARGUERITE, SERV DIMMUNO HEMATOL CLIN, MARSEILLE, FRANCE.;POIZOT-MARTIN, ISABELLE, AIX MARSEILLE UNIV, INSERM, UMR 912, SESSTIM, MARSEILLE, FRANCE.;GEROLAMI, RENE, CTR HOSP UNIV CONCEPT, SERV HEPATOGASTROENTEROL, MARSEILLE, FRANCE.","10.1002/JMV.24261","111 RIVER ST, HOBOKEN 07030-5774, NJ USA",NA,NA,NA,NA,NA,"0146-6615","11","1921-1933","WILEY-BLACKWELL","87",2015,"ISI000360726600016","52","VIROLOGY","5","VIROLOGY","PHILIPPE.COLSONAP-HM.FR",NA,"CQ6PO",NA,"COLSON, P (REPRINT AUTHOR), CHU TIMONE, INST HOSP UNIV IHU MEDITERRANEE INFECT, ASSISTANCE PUBL HOP MARSEILLE, POLE MALAD INFECT \& TROP CLIN \& BIOLOG,FEDERAT BA, F-13385 MARSEILLE, FRANCE","ISI","INST HOSP UNIV IHU MEDITERRANEE INFECT;AIX MARSEILLE UNIV;CTR HOSP UNIV CONCEPT;CTR HOSP UNIV NORD;CTR PENITENTIAIRE MARSEILLE;SERV DIMMUNO HEMATOL CLIN;AIX MARSEILLE UNIV;CTR HOSP UNIV CONCEPT","INST HOSP UNIV IHU MEDITERRANEE INFECT",NA,"HAJJI H, 2015, J MED VIROL","HAJJI H, 2015, J MED VIROL"
"AKHTARKHAVARI T, 2015, ARCH IRAN MED","AKHTARKHAVARI T;JOGHATAEI MT;FATTAHI Z;AKBARI MR;LARD F;NAJMABADI H;KAHRIZI K","GENETIC INVESTIGATION OF AN IRANIAN SUPERCENTENARIAN BY WHOLE EXOME SEQUENCING","ARCHIVES OF IRANIAN MEDICINE","ARCH. IRAN. MED.","BACKGROUND: THE GENETIC BASIS OF LONGEVITY IS AN IMPORTANT FIELD OF STUDY BECAUSE THE MAJORITY OF SUPERCENTENARIEN CASES EXPERIENCE HEALTHY AGING AND MAY ONLY SHOW AGE-RELATED DISEASES IN THEIR LAST FEW YEARS OF LIFE. IT IS CLEAR THAT GENETIC FACTORS PLAY AN IMPORTANT ROLE IN SURVIVAL BEYOND 90 YEARS OF AGE, BUT THE EXACT RELATIONSHIP OF GENETIC VARIANTS TO THIS PHENOMENON REMAINS UNKNOWN. OBJECTIVE: THE AIM OF THIS PROJECT WAS TO INVESTIGATE DIFFERENT HYPOTHESES THAT DESCRIBE THE RELATIONSHIP BETWEEN GENETIC VARIANTS AND HUMAN LONGEVITY IN A LIVING IRANIAN MAN BY WHOLE EXOME SEQUENCING (WES). METHODS: INITIALLY, WE CONDUCTED HIGH QUALITY DNA EXTRACTION ON A PERIPHERAL BLOOD SAMPLE. THEN, WES WAS PERFORMED ON THE DNA AND DIFFERENT BIOINFORMATIC SOFTWARE PACKAGES AND DATABASES WERE USED TO ANALYZE THE DATA. TERTIARY ANALYSIS WAS PERFORMED ON FOUR GENETIC HYPOTHESES FOR LONGEVITY. RESULTS: ANALYSIS SHOWED THAT AMONG 27 METABOLIC VARIANTS WHICH ARE RELATED TO LONGEVITY, 18 VARIANTS ENCOMPASSED THE EXCEPTIONAL LONGEVITY ALLELE. IN COMPARISON WITH THE NHGRI GWAS CATALOG, THE CASE HAD 58 TRAIT-ASSOCIATED VARIANTS OF WHICH 11 WERE HOMOZYGOUS FOR THE RISK ALLELE. WE ALSO DISCOVERED 25 NOVEL VARIANTS WITHIN CANDIDATE GENES FOR AGING AND LONGEVITY AND WE DETECTED SEVEN LONGEVITY-ASSOCIATED VARIANTS IN THE SAMPLE. CONCLUSION: THIS STUDY WAS PERFORMED ON JUST ONE SAMPLE AND SO THE RESULTS CANNOT BE INTERPRETED AS A GENERALIZED PRINCIPLE FOR OTHER ELDERLY SOCIETIES, BUT THIS IS THE FIRST STEP TOWARDS INVESTIGATION OF THE GENETIC BASIS OF LONGEVITY IN IRAN AND PROVIDES AN INSIGHT FOR FURTHER STUDIES IN THE FIELD OF LONGEVITY.","AGING; COMPUTATIONAL BIOLOGY; WHOLE EXOME SEQUENCING; IRAN; LONGEVITY","GENOME-WIDE ASSOCIATION; QT INTERVAL DURATION; COMMON VARIANTS; JAPANESE POPULATION; SUSCEPTIBILITY LOCI; HUMAN LONGEVITY; RISK LOCI; IDENTIFIES LOCI; DISEASE SUSCEPTIBILITY; EXCEPTIONAL LONGEVITY","ENGLISH","ARTICLE","ARTICLE",1,"ABERG KA, 2013, JAMA PSYCHIAT, V70, P573, DOI 10.1001/JAMAPSYCHIATRY.2013.288.;ALBANI DIEGO, 2011, AGING MALE, V14, P257, DOI 10.3109/13685538.2011.607521.;ALLEN HL, 2010, NATURE, V467, P832, DOI 10.1038/NATURE09410.;ATMON G, 2005, MECH AGEING DEV, V126, P341, DOI 10.1016/J.MAD.2004.08.026.;BALISTRERI CR, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-8.;BARBIERI M, 2012, AGE, V34, P235, DOI 10.1007/S11357-011-9210-Z.;BARZILAI N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/JAMA.290.15.2030.;BEEKMAN M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/PNAS.1003540107.;BENYAMIN B, 2011, HUM MOL GENET, V20, P4504, DOI 10.1093/HMG/DDR375.;BENYAMIN B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/J.AJHG.2008.11.011.;BERNDT SI, 2013, NAT GENET, V45, P501, DOI 10.1038/NG.2606.;BOZAOGLU K, 2010, J CLIN ENDOCR METAB, V95, P2476, DOI 10.1210/JC.2010-0042.;BROOKS-WILSON AR, 2013, HUM GENET, V132, P1323, DOI 10.1007/S00439-013-1342-Z.;BUDOVSKY A, 2013, TRENDS GENET, V29, P559, DOI 10.1016/J.TIG.2013.08.003.;BURTON PR, 2007, NATURE, V447, P661, DOI 10.1038/NATURE05911.;CHAMBERS JC, 2008, NAT GENET, V40, P716, DOI 10.1038/NG.156.;CHAMBERS JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/NG.970.;CHAMBERS JC, 2010, NAT GENET, V42, P149, DOI 10.1038/NG.516.;CHASMAN DI, 2009, PLOS GENET, V5, DOI 10.1371/JOURNAL.PGEN.1000730.;CHU AY, 2012, CIRC-CARDIOVASC GENE, V5, P676, DOI 10.1161/CIRCGENETICS.112.963314.;COMUZZIE AG, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0051954.;CROSSLIN DR, 2013, HUM MOL GENET, V22, P2119, DOI 10.1093/HMG/DDT010.;DE MAGALHAES JP, 2004, FEBS LETT, V571, P243, DOI 10.1016/J.FEBSLET.2004.07.006.;DEHGHAN A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570.;DEPRISTO MA, 2011, NAT GENET, V43, P491, DOI 10.1038/NG.806.;DIVARIS K, 2012, J DENT RES, V91, PS21, DOI 10.1177/0022034512447951.;DUBOIS PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/NG.543.;EVANS DM, 2011, NAT GENET, V43, P761, DOI 10.1038/NG.873.;FATEMIFAR G, 2013, HUM MOL GENET, V22, P3807, DOI 10.1093/HMG/DDT231.;FERRARIO A, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-7.;FINGERLIN TE, 2013, NAT GENET, V45, P613, DOI 10.1038/NG.2609.;FIUZA-LUCES C, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0017558.;FRANCESCHINI N, 2012, AM J HUM GENET, V91, P744, DOI 10.1016/J.AJHG.2012.08.021.;FRANKE A, 2010, NAT GENET, V42, P1118, DOI 10.1038/NG.717.;FREUDENBERG J, 2011, ARTHRITIS RHEUM-US, V63, P884, DOI 10.1002/ART.30235.;GIEGER C, 2011, NATURE, V480, P201, DOI 10.1038/NATURE10659.;GRALLERT H, 2012, EUR HEART J, V33, P238, DOI 10.1093/EURHEARTJ/EHR372.;HANCOCK DB, 2012, PLOS GENET, V8, DOI 10.1371/JOURNAL.PGEN.1003098.;HARA K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/HMG/DDT399.;HAYES MG, 2013, DIABETES, V62, P3282, DOI 10.2337/DB12-1692.;HERSKIND AM, 1996, HUM GENET, V97, P319, DOI 10.1007/S004390050042.;HOLM H, 2010, NAT GENET, V42, P117, DOI 10.1038/NG.511.;ILLIG T, 2010, NAT GENET, V42, P137, DOI 10.1038/NG.507.;INOUYE M, 2012, PLOS GENET, V8, DOI 10.1371/JOURNAL.PGEN.1002907.;JOHANSEN CT, 2010, NAT GENET, V42, P684, DOI 10.1038/NG.628.;KAMATANI Y, 2010, NAT GENET, V42, P210, DOI 10.1038/NG.531.;KAPOOR M, 2013, HUM GENET, V132, P1141, DOI 10.1007/S00439-013-1318-Z.;KATHIRESAN S, 2009, NAT GENET, V41, P56, DOI 10.1038/NG.291.;KATHIRESAN S, 2008, NAT GENET, V40, P189, DOI 10.1038/NG.75.;KETTUNEN J, 2012, NAT GENET, V44, P269, DOI 10.1038/NG.1073.;KOTTGEN A, 2013, NAT GENET, V45, P145, DOI 10.1038/NG.2500.;KOTTGEN A, 2010, NAT GENET, V42, P376, DOI 10.1038/NG.568.;KRAJA AT, 2011, DIABETES, V60, P1329, DOI 10.2337/DB10-1011.;KULMINSKI AM, 2010, MECH AGEING DEV, V131, P338, DOI 10.1016/J.MAD.2010.04.001.;LETTRE G, 2011, PLOS GENET, V7, DOI 10.1371/JOURNAL.PGEN.1001300.;LI H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/BIOINFORMATICS/BTP698.;MASNAVI A, 2007, IRAN J AGEING, V2, P280.;MATARIN M, 2007, LANCET NEUROL, V6, P414, DOI 10.1016/S1474-4422(07)70081-9.;MATTEINI AM, 2014, CYTOKINE, V65, P10, DOI 10.1016/J.CYTO.2013.10.002.;MCCLAY JL, 2011, NEUROPSYCHOPHARMACOL, V36, P616, DOI 10.1038/NPP.2010.193.;MCKAY JD, 2011, PLOS GENET, V7, DOI 10.1371/JOURNAL.PGEN.1001333.;MCKENNA A, 2010, GENOME RES, V20, P1297, DOI 10.1101/GR.107524.110.;MCLAREN W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/BIOINFORMATICS/BTQ330.;MCMAHON FJ, 2010, NAT GENET, V42, P128, DOI 10.1038/NG.523.;MELZER D, 2008, PLOS GENET, V4, DOI 10.1371/JOURNAL.PGEN.1000072.;MENG WH, 2012, INVEST OPHTH VIS SCI, V53, P7983, DOI 10.1167/IOVS.12-10409.;MEYER TE, 2010, PLOS GENET, V6, DOI 10.1371/JOURNAL.PGEN.1001045.;MIDDELBERG RPS, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-123.;NEED AC, 2009, HUM MOL GENET, V18, P4650, DOI 10.1093/HMG/DDP413.;NEWTON-CHEH C, 2009, NAT GENET, V41, P399, DOI 10.1038/NG.364.;NYHOLT DR, 2012, NAT GENET, V44, P1355, DOI 10.1038/NG.2445.;OTOWA T, 2009, J HUM GENET, V54, P122, DOI 10.1038/JHG.2008.17.;PARK BL, 2013, HUM GENET, V132, P657, DOI 10.1007/S00439-013-1281-8.;PEDEN JF, 2011, NAT GENET, V43, P339, DOI 10.1038/NG.782.;PERLS TT, 2006, AM J CLIN NUTR, V83, P484S.;PERLS TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/PNAS.122587599.;PFEUFER A, 2009, NAT GENET, V41, P407, DOI 10.1038/NG.362.;REINER AP, 2012, AM J HUM GENET, V91, P502, DOI 10.1016/J.AJHG.2012.07.023.;REPAPI E, 2010, NAT GENET, V42, P36, DOI 10.1038/NG.501.;REVEILLE JD, 2010, NAT GENET, V42, P123, DOI 10.1038/NG.513.;RITCHIE MD, 2013, CIRCULATION, V127, P1377, DOI 10.1161/CIRCULATIONAHA.112.000604.;ROBINSON JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/NBT.1754.;RUNG J, 2009, NAT GENET, V41, P1110, DOI 10.1038/NG.443.;SAXENA R, 2007, SCIENCE, V316, P1331, DOI 10.1126/SCIENCE.1142358.;SAXENA R, 2010, NAT GENET, V42, P142, DOI 10.1038/NG.521.;SCOTT LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/SCIENCE.1142382.;SCOTT LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/PNAS.0813386106.;SEBASTIANI P., 2012, PLOS ONE SAN FRANCIS, V7, P1, DOI DOI 10.1371/J0URNAL.P0NE.0029848.;SEBASTIANI PAOLA, 2011, FRONT GENET, V2, P90, DOI 10.3389/FGENE.2011.00090.;SIM X, 2011, PLOS GENET, V7, DOI 10.1371/JOURNAL.PGEN.1001363.;SLADEK R, 2007, NATURE, V445, P881, DOI 10.1038/NATURE05616.;SOERENSEN M, 2012, DAN MED J, V59.;SOERENSEN M, 2009, MECH AGEING DEV, V130, P308, DOI 10.1016/J.MAD.2009.01.005.;SOTOODEHNIA N, 2010, NAT GENET, V42, P1068, DOI 10.1038/NG.716.;STEINTHORSDOTTIR V, 2007, NAT GENET, V39, P770, DOI 10.1038/NG2043.;SUCHINDRAN S, 2010, PLOS GENET, V6, DOI 10.1371/JOURNAL.PGEN.1000928.;TAKEUCHI F, 2009, DIABETES, V58, P1690, DOI 10.2337/DB08-1494.;TAN AH, 2012, HUM MOL GENET, V21, P1658, DOI 10.1093/HMG/DDR587.;TANG WH, 2012, AM J HUM GENET, V91, P152, DOI 10.1016/J.AJHG.2012.05.009.;TERAO C, 2011, HUM MOL GENET, V20, P2680, DOI 10.1093/HMG/DDR161.;TESLOVICH TM, 2010, NATURE, V466, P707, DOI 10.1038/NATURE09270.;THORVALDSDOTTIR H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/BIB/BBS017.;TIMPSON NJ, 2009, DIABETES, V58, P505, DOI 10.2337/DB08-0906.;VAUPEL JW, 1998, SCIENCE, V280, P855, DOI 10.1126/SCIENCE.280.5365.855.;VOIGHT BF, 2010, NAT GENET, V42, P579, DOI 10.1038/NG.609.;WAIN LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/NG.922.;WANG K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/NAR/GKQ603.;WEISSGLAS-VOLKOV D, 2013, J MED GENET, V50, P298, DOI 10.1136/JMEDGENET-2012-101461.;WELTER D, 2014, NUCLEIC ACIDS RES, V42, PD1001, DOI 10.1093/NAR/GKT1229.;WHEELER E, 2013, NAT GENET, V45, P513, DOI 10.1038/NG.2607.;WILLER CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/NG.2797.;YANG WL, 2013, AM J HUM GENET, V92, P41, DOI 10.1016/J.AJHG.2012.11.018.;YOUNG RD, 2010, CURR GERONTOL GERIAT, V2010.;ZEGGINI E, 2007, SCIENCE, V316, P1336, DOI 10.1126/SCIENCE.1142364.;ZHAO L, 2012, AGING CELL, V11, P1094, DOI 10.1111/ACEL.12011.","KAHRIZI, K (REPRINT AUTHOR), UNIV SOCIAL WELF \& REHABIL SCI, GENET RES CTR, TEHRAN, IRAN.;AKHTARKHAVARI, TARA, FATTAHI, ZOHREH, LARD, FARZANEH, NAJMABADI, HOSSEIN, KAHRIZI, KIMIA, UNIV SOCIAL WELF \& REHABIL SCI, GENET RES CTR, TEHRAN, IRAN.;JOGHATAEI, MOHAMMAD TAGHI, IRAN UNIV MED SCI, CELLULAR \& MOL RES CTR, DIV NEUROSCI, TEHRAN, IRAN.;AKBARI, MOHAMMAD REZA, UNIV TORONTO, WOMENS COLL RES INST, TORONTO, ON, CANADA.",NA,"PO BOX 19395-5655, TEHRAN, 00000, IRAN",NA,NA,NA,NA,NA,"1029-2977","10","688-697","ACAD MEDICAL SCIENCES I R IRAN","18",2015,"ISI000364729100007","115","GENERAL \& INTERNAL MEDICINE","6","MEDICINE, GENERAL \& INTERNAL","KAHRIZIYAHOO.COM",NA,"CW1DF",NA,"KAHRIZI, K (REPRINT AUTHOR), UNIV SOCIAL WELF \& REHABIL SCI, GENET RES CTR, TEHRAN, IRAN","ISI","UNIV SOCIAL WELF AND REHABIL SCI;IRAN UNIV MED SCI;UNIV TORONTO","UNIV SOCIAL WELF AND REHABIL SCI",NA,"AKHTARKHAVARI T, 2015, ARCH IRAN MED","AKHTARKHAVARI T, 2015, ARCH IRAN MED"
"MULLER E, 2015, CANCER MED","MULLER E;BRAULT B;HOLMES A;LEGROS A;JEANNOT E;CAMPITELLI M;ROUSSELIN A;GOARDON N;FREBOURG T;KRIEGER S;CROUET H;NICOLAS A;SASTRE X;VAUR D;CASTERA L","GENETIC PROFILES OF CERVICAL TUMORS BY HIGH-THROUGHPUT SEQUENCING FOR PERSONALIZED MEDICAL CARE","CANCER MEDICINE","CANCER MED.","CANCER TREATMENT IS FACING MAJOR EVOLUTION SINCE THE ADVENT OF TARGETED THERAPIES. BUILDING GENETIC PROFILES COULD PREDICT SENSITIVITY OR RESISTANCE TO THESE THERAPIES AND HIGHLIGHT DISEASE-SPECIFIC ABNORMALITIES, SUPPORTING PERSONALIZED PATIENT CARE. IN THE CONTEXT OF BIOMEDICAL RESEARCH AND CLINICAL DIAGNOSIS, OUR LABORATORY HAS DEVELOPED AN ONCOGENIC PANEL COMPRISED OF 226 GENES AND A DEDICATED BIOINFORMATIC PIPELINE TO EXPLORE SOMATIC MUTATIONS IN CERVICAL CARCINOMAS, USING HIGH-THROUGHPUT SEQUENCING. TWENTY-NINE TUMORS WERE SEQUENCED FOR EXONS WITHIN 226 GENES. THE AUTOMATED PIPELINE USED INCLUDES A DATABASE AND A FILTRATION SYSTEM DEDICATED TO IDENTIFYING MUTATIONS OF INTEREST AND EXCLUDING FALSE POSITIVE AND GERMLINE MUTATIONS. ONE-HUNDRED AND SEVENTY-SIX TOTAL MUTATIONAL EVENTS WERE FOUND AMONG THE 29 TUMORS. OUR CERVICAL TUMOR MUTATIONAL LANDSCAPE SHOWS THAT MOST MUTATIONS ARE FOUND IN PIK3CA (E545K, E542K) AND KRAS (G12D, G13D) AND OTHERS IN FBXW7 (R465C, R505G, R479Q). MUTATIONS HAVE ALSO BEEN FOUND IN ALK (V1149L, A1266T) AND EGFR (T259M). THESE RESULTS SHOWED THAT 48\% OF PATIENTS DISPLAY AT LEAST ONE DELETERIOUS MUTATION IN GENES THAT HAVE BEEN ALREADY TARGETED BY THE FOOD AND DRUG ADMINISTRATION APPROVED THERAPIES. CONSIDERING DELETERIOUS MUTATIONS, 59\% OF PATIENTS COULD BE ELIGIBLE FOR CLINICAL TRIALS. SEQUENCING HUNDREDS OF GENES IN A CLINICAL CONTEXT HAS BECOME FEASIBLE, IN TERMS OF TIME AND COST. IN THE NEAR FUTURE, SUCH AN ANALYSIS COULD BE A PART OF A BATTERY OF EXAMINATIONS ALONG THE DIAGNOSIS AND TREATMENT OF CANCER, HELPING TO DETECT SENSITIVITY OR RESISTANCE TO TARGETED THERAPIES AND ALLOW ADVANCEMENTS TOWARDS PERSONALIZED ONCOLOGY.","CERVIX; DIAGNOSIS; NGS; PANEL; TARGETED THERAPIE","COPY NUMBER ALTERATION; CELL LUNG-CANCER; SOMATIC MUTATION; HETEROGENEITY; RECEPTOR; GROWTH; RESISTANCE; DISCOVERY; DIAGNOSIS; VARIANTS","ENGLISH","ARTICLE","ARTICLE",10,"ADZHUBEI IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/NMETH0410-248.;AMADO RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116.;AUWERA G. A., 2013, CURR PROTOC BIOINFOR, V11, DOI DOI 10.1002/0471250953.BILL10S43.;CARLSON JJ, 2009, VALUE HEALTH, V12, P20, DOI 10.1111/J.1524-4733.2008.00415.X.;CARREIRA A, 2011, P NATL ACAD SCI USA, V108, P10448, DOI 10.1073/PNAS.1106971108.;CASTERA L, 2014, EUR J HUM GENET, V22, P1305, DOI 10.1038/EJHG.2014.16.;CIBULSKIS K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/NBT.2514.;DEPRISTO MA, 2011, NAT GENET, V43, P491, DOI 10.1038/NG.806.;FORBES SA, 2010, NUCLEIC ACIDS RES, V38, PD652, DOI 10.1093/NAR/GKP995.;FUTREAL PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/NRC1299.;GHERARDI E, 2003, P NATL ACAD SCI USA, V100, P12039, DOI 10.1073/PNAS.2034936100.;HOUDAYER C, 2012, HUM MUTAT, V33, P1228, DOI 10.1002/HUMU.22101.;HOWLADER N, 2014, SEER CANC STAT REV, P1975.;HUDSON TJ, 2010, NATURE, V464, P993, DOI 10.1038/NATURE08987.;HUNTER S, 2012, NUCLEIC ACIDS RES, V40, PD306, DOI 10.1093/NAR/GKR948.;JEMAL A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/CAAC.20107.;KANG S, 2007, GYNECOL ONCOL, V105, P662, DOI 10.1016/J.YGYNO.2007.01.045.;KIM S, 2013, J THORAC ONCOL, V8, P415, DOI 10.1097/JTO.0B013E318283DCC0.;KOBOLDT DC, 2012, GENOME RES, V22, P568, DOI 10.1101/GR.129684.111.;LANGE A, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-192.;LEE JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/JOURNAL.PMED.0030485.;LEITAO MARIO M JR, 2002, CURR TREAT OPTIONS ONCOL, V3, P105, DOI 10.1007/S11864-002-0056-6.;LI H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/BIOINFORMATICS/BTP324.;MCCLELLAN J, 2010, CELL, V141, P210, DOI 10.1016/J.CELL.2010.03.032.;MCINTYRE JB, 2013, GYNECOL ONCOL, V128, P409, DOI 10.1016/J.YGYNO.2012.12.019.;METZKER ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/NRG2626.;NG PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/NAR/GKG509.;OGISO H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7.;OJESINA AI, 2014, NATURE, V506, P371, DOI 10.1038/NATURE12881.;PAEZ JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/SCIENCE.1099314.;REHM HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/NRG3463.;SAMUELS Y, 2004, SCIENCE, V304, P554, DOI 10.1126/SCIENCE.1096502.;SASAKI T, 2011, CANCER RES, V71, P6051, DOI 10.1158/0008-5472.CAN-11-1340.;SAWYERS CL, 2008, NATURE, V452, P548, DOI 10.1038/NATURE06913.;SHANKARAN V., 2009, EC IMPLICATIONS KRAS.;SHERRY ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/NAR/29.1.308.;TOMMASINO M, 2003, HUM MUTAT, V21, P307, DOI 10.1002/HUMU.10178.;VAN ALLEN EM, 2014, NAT MED, V20, P682, DOI 10.1038/NM.3559.;VOGELSTEIN B, 2013, SCIENCE, V339, P1546, DOI 10.1126/SCIENCE.1235122.;WELCKER M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/NRC2290.;WICKRAMASINGHE D, 2005, CELL CYCLE, V4, P683, DOI 10.4161/CC.4.5.1688.;WILM A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/NAR/GKS918.;WU KJ, 2005, CANCER RES, V65, P417.;XU HL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-244.;ZACK TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/NG.2760.;ZUR HAUSEN H, 2009, VIROLOGY, V384, P260, DOI 10.1016/J.VIROL.2008.11.046.","CASTERA, L (REPRINT AUTHOR), CTR FRANCOIS BACLESSE, DEPT CANC BIOL \& GENET, 3 AVE GEN HARRIS, F-14076 CAEN, FRANCE.;MULLER, ETIENNE, BRAULT, BAPTISTE, LEGROS, ANGELINA, ROUSSELIN, ANTOINE, GOARDON, NICOLAS, KRIEGER, SOPHIE, VAUR, DOMINIQUE, CASTERA, LAURENT, CCC FRANCOIS BACLESSE, DEPT CANC BIOL \& GENET, CAEN, FRANCE.;MULLER, ETIENNE, FREBOURG, THIERRY, KRIEGER, SOPHIE, VAUR, DOMINIQUE, CASTERA, LAURENT, INSERM, U1079, ROUEN, FRANCE.;HOLMES, ALLYSON, NICOLAS, ALAIN, INST CURIE, RECOMBINAT \& GENET INSTABIL, UMR 3244, PARIS, FRANCE.;JEANNOT, EMMANUELLE, SASTRE, XAVIER, INST CURIE, BIOPATHOL DEPT, PARIS, FRANCE.;CAMPITELLI, MAURA, INST CURIE, DEPT RADIOTHERAPY, PARIS, FRANCE.;FREBOURG, THIERRY, UNIV HOSP, DEPT GENET, ROUEN, FRANCE.;KRIEGER, SOPHIE, UNIV CAEN, F-14032 CAEN, FRANCE.;CROUET, HUBERT, CCC FRANCOIS BACLESSE, DEPT GYNECOL ONCOL, CAEN, FRANCE.","10.1002/CAM4.492","111 RIVER ST, HOBOKEN 07030-5774, NJ USA",NA,NA,"INCA (FRENCH CANCER NATIONAL INSTITUTE), FONDATION ARC (ASSOCIATION POUR LA RECHERCHE SUR LE CANCER), LIGUE CONTRE LE CANCER, FRENCH NATIONAL LEAGUE AGAINST CANCER (LNCC)","THIS WORK WAS CONDUCTED AS A PART OF THE INTEGRATED ACTIONS FOR RESEARCH PROGRAM (PAIR-HPV) AND WAS SUPPORTED BY GRANTS FROM INCA (FRENCH CANCER NATIONAL INSTITUTE), FONDATION ARC (ASSOCIATION POUR LA RECHERCHE SUR LE CANCER) AND THE LIGUE CONTRE LE CANCER AND THE FRENCH NATIONAL LEAGUE AGAINST CANCER (LNCC).",NA,"2045-7634","10","1484-1493","WILEY","4",2015,"ISI000362794000003","46","ONCOLOGY","11","ONCOLOGY","L.CASTERABACLESSE.UNICANCER.FR",NA,"CT4RI",NA,"CASTERA, L (REPRINT AUTHOR), CTR FRANCOIS BACLESSE, DEPT CANC BIOL \& GENET, 3 AVE GEN HARRIS, F-14076 CAEN, FRANCE","ISI","INST CURIE;INST CURIE;INST CURIE;UNIV HOSP;UNIV CAEN","CTR FRANCOIS BACLESSE",NA,"MULLER E, 2015, CANCER MED","MULLER E, 2015, CANCER MED"
"POOLE CB, 2015, PLOS ONE","POOLE CB;ETTWILLER L;TANNER NA;EVANS TC;WANJI S;CARLOW CKS","GENOME FILTERING FOR NEW DNA BIOMARKERS OF LOA LOA INFECTION SUITABLE FOR LOOP-MEDIATED ISOTHERMAL AMPLIFICATION","PLOS ONE","PLOS ONE","LOA LOA INFECTIONS HAVE EMERGED AS A SERIOUS PUBLIC HEALTH PROBLEM IN PATIENTS CO-INFECTED WITH ONCHOCERCA VOLVULUS OR WUCHERERIA BANCROFTI BECAUSE OF SEVERE ADVERSE NEUROLOGICAL REACTIONS AFTER TREATMENT WITH IVERMECTIN. ACCURATE DIAGNOSTIC TESTS ARE NEEDED FOR CAREFUL MAPPING IN REGIONS WHERE MASS DRUG ADMINISTRATION IS UNDERWAY. LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) HAS BECOME A WIDELY ADOPTED SCREENING METHOD BECAUSE OF ITS OPERATIONAL SIMPLICITY, RAPIDITY AND VERSATILITY OF VISUAL DETECTION READOUT OPTIONS. HERE, WE PRESENT A MULTI-STEP BIOINFORMATIC PIPELINE TO GENERATE DIAGNOSTIC CANDIDATES SUITABLE FOR LAMP AND EXPERIMENTALLY VALIDATE THIS APPROACH USING ONE OF THE IDENTIFIED CANDIDATES TO DEVELOP A SPECIES-SPECIFIC LAMP ASSAY FOR L. LOA. THE PIPELINE IDENTIFIED SIMILAR TO 140 NEW L. LOA SPECIFIC DNA REPEAT FAMILIES AS PUTATIVE BIOMARKERS OF INFECTION. THE CONSENSUS SEQUENCE OF ONE FAMILY, REPEAT FAMILY 4 (RF4), WAS COMPILED FROM SIMILAR TO 350 SEQUENCES DISPERSED THROUGHOUT THE L. LOA GENOME AND MAPS TO A L. LOA-SPECIFIC REGION OF THE LONG TERMINAL REPEATS FOUND AT THE BOUNDARIES OF BEL/PAO RETROTRANSPOSONS. PCR AND LAMP PRIMER SETS TARGETING RF4 SPECIFICALLY AMPLIFIED L. LOA BUT NOT W. BANCROFTI, O. VOLVULUS, BRUGIA MALAYI, HUMAN OR MOSQUITO DNA. RF4 LAMP DETECTS THE DNA EQUIVALENT OF ONE MICROFILARIA (100 PG) IN 25-30 MINUTES AND AS LITTLE AS 0.060 PG OF L. LOA DNA (SIMILAR TO 1/1600TH OF A MICROFILARIA) PURIFIED FROM SPIKED BLOOD SAMPLES IN APPROXIMATELY 50 MINUTES. IN SUMMARY, WE HAVE SUCCESSFULLY EMPLOYED A BIOINFORMATIC APPROACH TO MINE THE L. LOA GENOME FOR SPECIES-SPECIFIC REPEAT FAMILIES THAT CAN SERVE AS NEW DNA BIOMARKERS FOR LAMP. THE RF4 LAMP ASSAY SHOWS PROMISE AS A FIELD TOOL FOR THE IMPLEMENTATION AND MANAGEMENT OF MASS DRUG ADMINISTRATION PROGRAMS AND WARRANTS FURTHER TESTING ON CLINICAL SAMPLES AS THE NEXT STAGE IN DEVELOPMENT TOWARDS THIS GOAL.",NA,"POLYMERASE-CHAIN-REACTION; WUCHERERIA-BANCROFTI INFECTION; RAPID ASSESSMENT PROCEDURE; REPETITIVE DNA; BRUGIA-MALAYI; HUMAN BLOOD; DIAGNOSTIC SENSITIVITY; FILARIAL PARASITE; LOIASIS RAPLOA; OCCULT LOIASIS","ENGLISH","ARTICLE","ARTICLE",4,"ABBASI I, 1999, PARASITOL RES, V85, P844, DOI 10.1007/S004360050643.;AEBY P, 1986, EMBO J, V5, P3353, DOI 10.1002/J.1460-2075.1986.TB04650.X.;ALHASSAN A, 2015, TRENDS PARASITOL, V31, P391, DOI 10.1016/J.PT.2015.04.006.;AZZIBROUCK GB, 2010, PARASITOLOGY, V137, P1119, DOI 10.1017/S0031182009991740.;BENNURU S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/JOURNAL.PNTD.0003180.;BENSON G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/NAR/27.2.573.;BOUSSINESQ M, 2006, ANN TROP MED PARASIT, V100, P715, DOI 10.1179/136485906X112194.;BOUSSINESQ M, 2001, J TOXICOL ENV HEAL A, V63, P495.;BOWEN NJ, 1999, GENOME RES, V9, P924, DOI 10.1101/GR.9.10.924.;BURBELO PD, 2008, J CLIN MICROBIOL, V46, P2298, DOI 10.1128/JCM.00490-08.;CHAKRABARTI R, 2001, NUCLEIC ACIDS RES, V29, P2377, DOI 10.1093/NAR/29.11.2377.;CHIPPAUX JP, 1996, PARASITOL TODAY, V12, P448, DOI 10.1016/0169-4758(96)40006-0.;CHULARERK P, 1970, J PARASITOL, V56, P623, DOI 10.2307/3277640.;COPELAND CS, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-20.;D'AMBROSIO MV, 2015, SCI TRANSL MED, V7, DOI 10.1126/SCITRANSLMED.AAA3480.;DAVIS PS, 1995, DROSOPH INF SERV, V76, P134.;DESJARDINS CA, 2013, NAT GENET, V45, P495, DOI 10.1038/NG.2585.;DRAME PM, 2014, J CLIN MICROBIOL, V52, P2071, DOI 10.1128/JCM.00525-14.;FERNANDEZ-SOTO P, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0094664.;FINK DL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/JOURNAL.PNTD.0001299.;FINK DL, 2011, J CLIN MICROBIOL, V49, P42, DOI 10.1128/JCM.01697-10.;FISCHER P, 2000, AM J TROP MED HYG, V62, P291, DOI 10.4269/AJTMH.2000.62.291.;GARDON J, 1997, T ROY SOC TROP MED H, V91, P593, DOI 10.1016/S0035-9203(97)90041-9.;GARDON J, 1997, LANCET, V350, P18, DOI 10.1016/S0140-6736(96)11094-1.;GONZALEZ A, 1984, P NATL ACAD SCI-BIOL, V81, P3356, DOI 10.1073/PNAS.81.11.3356.;GOTO M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072.;HAN ET, 2013, EXPERT REV MOL DIAGN, V13, P205, DOI [10.1586/ERM.12.144, 10.1586/ERM.12.144].;HOERAUF A, 2011, CLIN MICROBIOL INFEC, V17, P977, DOI 10.1111/J.1469-0691.2011.03586.X.;JIMENEZ M, 2011, EXP PARASITOL, V127, P282, DOI 10.1016/J.EXPPARA.2010.06.019.;KELLY-HOPE LA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/JOURNAL.PNTD.0001605.;KLION AD, 2003, J INFECT DIS, V187, P128, DOI 10.1086/345873.;KLION AD, 1994, J INFECT DIS, V169, P604, DOI 10.1093/INFDIS/169.3.604.;KLION AD, 1993, J INFECT DIS, V168, P202, DOI 10.1093/INFDIS/168.1.202.;KLION AD, 1991, MOL BIOCHEM PARASIT, V45, P297, DOI 10.1016/0166-6851(91)90098-Q.;KOHANY O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474.;LIZOTTE MR, 1994, AM J TROP MED HYG, V51, P314, DOI 10.4269/AJTMH.1994.51.314.;MALIK HS, 2000, GENOME RES, V10, P1307, DOI 10.1101/GR.145000.;MCREYNOLDS LA, 1986, P NATL ACAD SCI USA, V83, P797, DOI 10.1073/PNAS.83.3.797.;MOLYNEUX DH, 2009, T ROY SOC TROP MED H, V103, P338, DOI 10.1016/J.TRSTMH.2008.12.016.;NOTOMI T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/S12275-015-4656-9.;NOTOMI T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/NAR/28.12.E63.;OKORIE PN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/JOURNAL.PNTD.0002416.;PION D S S, 2004, PARASITOLOGY, V129, P613.;PION SDS, 2005, ANN TROP MED PARASIT, V99, P491, DOI 10.1179/136485905X51300.;POOLE CB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/JOURNAL.PNTD.0001948.;PRICE AL, 2005, BIOINFORMATICS, V21, PI351, DOI 10.1093/BIOINFORMATICS/BTI1018.;SAMBROOK J, 1989, MOL CLONING LAB MANU.;SIRIDEWA K, 1994, AM J TROP MED HYG, V51, P495, DOI 10.4269/AJTMH.1994.51.495.;TAKAGI H, 2011, PARASITOL INT, V60, P493, DOI 10.1016/J.PARINT.2011.08.018.;TALLON LJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-788.;TANNER N, 2013, COMPOSITIONS METHODS.;TANNER NA, 2015, BIOTECHNIQUES, V58, P59, DOI 10.2144/000114253.;TOURE FS, 1998, AM J TROP MED HYG, V59, P144, DOI 10.4269/AJTMH.1998.59.144.;TOURE FS, 1999, B SOC PATHOL EXOT, V92, P167.;TOURE FS, 1997, AM J TROP MED HYG, V56, P57, DOI 10.4269/AJTMH.1997.56.57.;UTTAH E, 2011, J VECTOR DIS, V48, P197.;VASUKI V, 2003, ACTA TROP, V86, P109, DOI 10.1016/S0001-706X(02)00267-X.;WANJI S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-25.;WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X.;XIONG Y, 1993, NUCLEIC ACIDS RES, V21, P2117, DOI 10.1093/NAR/21.9.2117.;ZHONG M, 1996, AM J TROP MED HYG, V54, P357, DOI 10.4269/AJTMH.1996.54.357.;ZOURE HGM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/JOURNAL.PNTD.0001210.","CARLOW, CKS (REPRINT AUTHOR), NEW ENGLAND BIOLABS INC, IPSWICH, MA 01938 USA.;POOLE, CATHERINE B., ETTWILLER, LAURENCE, TANNER, NATHAN A., EVANS, THOMAS C., JR., CARLOW, CLOTILDE K. S., NEW ENGLAND BIOLABS INC, IPSWICH, MA 01938 USA.;WANJI, SAMUEL, RES FDN TROP DIS \& ENVIRONM, BUEA, CAMEROON.","10.1371/JOURNAL.PONE.0139286","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E0139286",NA,"NEW ENGLAND BIOLABS","THE FUNDER, NEW ENGLAND BIOLABS, PROVIDED SUPPORT IN THE FORM OF SALARIES FOR AUTHORS CKSC, CBP, NAT, LE AND TCE, BUT DID NOT HAVE ANY ADDITIONAL ROLE IN THE STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT. THE SPECIFIC ROLES OF THESE AUTHORS ARE ARTICULATED IN THE `AUTHOR CONTRIBUTIONS' SECTION.",NA,"1932-6203","9",NA,"PUBLIC LIBRARY SCIENCE","10",2015,"ISI000362170700053","62","SCIENCE \& TECHNOLOGY - OTHER TOPICS","8","MULTIDISCIPLINARY SCIENCES","CARLOWNEB.COM",NA,"CS6EO",NA,"CARLOW, CKS (REPRINT AUTHOR), NEW ENGLAND BIOLABS INC, IPSWICH, MA 01938 USA","ISI","NEW ENGLAND BIOLABS INC;RES FDN TROP DIS AND ENVIRONM","NEW ENGLAND BIOLABS INC",NA,"POOLE CB, 2015, PLOS ONE","POOLE CB, 2015, PLOS ONE"
"DEVI SM, 2015, PROBIOTICS ANTIMICROB PROTEINS","DEVI SM;ARCHER AC;HALAMI PM","SCREENING, CHARACTERIZATION AND IN VITRO EVALUATION OF PROBIOTIC PROPERTIES AMONG LACTIC ACID BACTERIA THROUGH COMPARATIVE ANALYSIS","PROBIOTICS AND ANTIMICROBIAL PROTEINS","PROBIOTICS ANTIMICROB. PROTEINS","THE PRESENT WORK AIMED TO IDENTIFY PROBIOTIC BACTERIA FROM HEALTHY HUMAN INFANT FAECAL AND DAIRY SAMPLES. SUBSEQUENTLY, AN ASSAY WAS DEVELOPED TO EVALUATE THE PROBIOTIC PROPERTIES USING COMPARATIVE GENETIC APPROACH FOR MARKER GENES INVOLVED IN ADHESION TO THE INTESTINAL EPITHELIAL LAYER. SEVERAL IN VITRO PROPERTIES INCLUDING TOLERANCE TO BIOLOGICAL BARRIERS (SUCH AS ACID AND BILE), ANTIMICROBIAL SPECTRUM, RESISTANCE TO SIMULATED DIGESTIVE FLUIDS AND CELLULAR HYDROPHOBICITY WERE ASSESSED. THE POTENTIAL PROBIOTIC CULTURES WERE RAPIDLY CHARACTERIZED BY MORPHOLOGICAL, PHYSIOLOGICAL AND MOLECULAR-BASED METHODS [SUCH AS RFLP, ITS, RAPD AND (GTG)(5)]. FURTHER ANALYSIS BY 16S RDNA SEQUENCING REVEALED THAT THE SELECTED ISOLATES BELONG TO LACTOBACILLUS, PEDIOCOCCUS AND ENTEROCOCCUS SPECIES. TWO CULTURES OF NON-LACTIC, NONPATHOGENIC STAPHYLOCOCCUS SPP. WERE ALSO ISOLATED. THE NATIVE ISOLATES WERE ABLE TO SURVIVE UNDER ACIDIC, BILE AND SIMULATED INTESTINAL CONDITIONS. IN ADDITION, THESE CULTURES INHIBITED THE GROWTH OF TESTED BACTERIAL PATHOGENS. FURTHER, NO CORRELATION WAS OBSERVED BETWEEN HYDROPHOBICITY AND ADHESION ABILITY. SEQUENCING OF PROBIOTIC MARKER GENES SUCH AS BILE SALT HYDROLASE (BSH), FIBRONECTIN-BINDING PROTEIN (FBP) AND MUCIN-BINDING PROTEIN (MUB) FOR SELECTED ISOLATES REVEALED NUCLEOTIDE VARIATION. THE PROBIOTIC BINDING DOMAINS WERE DETECTED BY SEVERAL BIOINFORMATIC TOOLS. THE APPROACH USED IN THE STUDY ENABLED THE IDENTIFICATION OF POTENTIAL PROBIOTIC DOMAINS RESPONSIBLE FOR ADHESION OF BACTERIA TO INTESTINAL EPITHELIAL LAYER, WHICH MAY FURTHER ASSIST IN SCREENING OF NOVEL PROBIOTIC BACTERIA. THE RAPID DETECTION OF BINDING DOMAINS WILL HELP IN REVEALING THE BENEFICIAL PROPERTIES OF THE PROBIOTIC CULTURES. FURTHER, STUDIES WILL BE PERFORMED TO DEVELOP A NOVEL PROBIOTIC PRODUCT WHICH WILL CONTRIBUTE IN FOOD AND FEED INDUSTRY.","PROBIOTICS; LACTIC ACID BACTERIA; BINDING PROTEINS; BILE SALT HYDROLASE; PHYLOGENY; GENETIC COMPARISON","LACTOBACILLUS-ACIDOPHILUS NCFM; ADHESION; STRAINS; IDENTIFICATION; MUCUS; AGGREGATION; PROTEINS; SEQUENCE; ABILITY; SURFACE","ENGLISH","ARTICLE","ARTICLE",7,"ADIMPONG D.B., 2012, BMC MICROBIOL, V12, P1.;ALBRIGHT S.C., 1999, DATA ANAL DECISION M.;ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/NAR/25.17.3389.;BARROS ROSANA R., 2001, JOURNAL OF CLINICAL MICROBIOLOGY, V39, P1241, DOI 10.1128/JCM.39.4.1241-1246.2001.;BOEKHORST J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/MIC.0.28415-0.;BOONAERT CJP, 2000, APPL ENVIRON MICROB, V66, P2548, DOI 10.1128/AEM.66.6.2548-2554.2000.;BUCK BL, 2005, APPL ENVIRON MICROB, V71, P8344, DOI 10.1128/AEM.71.12.8344-8351.2005.;DE ANGELIS MA, 2001, APPL ENVIRON MICROB, V65, P2011.;DEVI SM, 2011, CURR MICROBIOL, V62, P181.;DUARY RAJ KUMAR, 2011, INDIAN J MED RES, V134, P664, DOI 10.4103/0971-5916.90992.;FUKAO M, 2013, PLOS ONE, V8, P1.;GEVERS D, 2001, FEMS MICROBIOL LETT, V205, P31, DOI 10.1016/S0378-1097(01)00439-6.;GRIMOUD J, 2010, ANAEROBE, V16, P493, DOI 10.1016/J.ANAEROBE.2010.07.005.;GROSU-TUDOR SS, 2012, ANN ROM SOC CELL BIO, V17, P234.;GUSILS C, 1999, CAN J MICROBIOL, V45, P981, DOI 10.1139/CJM-45-12-981.;JACOBSEN CN, 1999, APPL ENVIRON MICROB, V65, P4949.;JEYARAM K, 2010, INT J FOOD MICROBIOL, V143, P1, DOI 10.1016/J.IJFOODMICRO.2010.07.008.;KANMANI P, 2013, CRIT REV FOOD SCI, V53, P641, DOI 10.1080/10408398.2011.553752.;KARNA BKL, 2007, SCI DILIMAN, V19, P23.;KAUSHIK JK, 2009, PLOS ONE, V4, P1.;KOS B, 2003, J APPL MICROBIOL, V94, P981, DOI 10.1046/J.1365-2672.2003.01915.X.;MACIAS-RODRIGUEZ ME, 2009, J APPL MICROBIOL, V107, P1866, DOI 10.1111/J.1365-2672.2009.04368.X.;MAKAROVA K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/PNAS.0607117103.;MCAULIFFE O, 2005, APPL ENVIRON MICROB, V71, P4925, DOI 10.1128/AEM.71.8.4925-4929.2005.;MOHANIA D, 2008, J DIGEST DIS, V9, P190, DOI 10.1111/J.1751-2980.2008.00345.X.;MORA D, 2000, MICROBIOL-SGM, V146, P2027, DOI 10.1099/00221287-146-8-2027.;NARAIDA L, 2012, INT J FOOD NUT PUBLI, V5, P33.;NITHYA V, 2013, ANN MICROBIOL, V63, P129, DOI 10.1007/S13213-012-0453-4.;ONGOL M. P., 2012, RWANDA J HLTH SCI, V1, P39.;OSMANAGAOGLU O, 2010, PROBIOTICS ANTIMICRO, V2, P162, DOI 10.1007/S12602-010-9050-7.;PADMAJA RJ, 2013, INDIAN J MICROBIOL, V53, P276, DOI 10.1007/S12088-013-0359-2.;PRIDMORE RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/PNAS.0307327101.;ROSS S, 2000, INT J SYST EVOL MICR, V50, P251.;SCHILLINGER U, 2003, CURR MICROBIOL, V47, P453, DOI 10.1007/S00284-003-4067-8.;SENGUPTA R, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/237921.;SIELADIE DV, 2011, INNOV ROM FOOD BIOTE, V19, P12.;SUSKOVIC J, 2010, FOOD TECHNOL BIOTECH, V48, P296.;SVEC P, 2005, FEMS MICROBIOL LETT, V247, P59, DOI 10.1016/J.FEMSLE.2005.04.030.;TAMURA K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/MOLBEV/MSM092.;THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/NAR/22.22.4673.;THUMU SCR, 2013, J APPL MICROBIOL, V116, P689.;TUO YF, 2013, J DAIRY SCI, V96, P4252, DOI 10.3168/JDS.2013-6547.;TURPIN W., 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/J0URNAL.P0NE.0038034.;TURPIN W, 2011, APPL ENVIRON MICROB, V77, P8722, DOI 10.1128/AEM.05988-11.;VAN TASSELL ML, 2011, NUTRIENTS, V3, P613, DOI 10.3390/NU3050613.;VENTON D, 2012, GENOME BIOL EVOL, V4, P28, DOI 10.1093/GBE/EVR135.;ZHOU M, 2010, BMC GENOMICS, V11, P1.","HALAMI, PM (REPRINT AUTHOR), CSIR CENT FOOD TECHNOL RES INST, MICROBIOL \& FERMENTAT TECHNOL DEPT, MYSORE 570020, KARNATAKA, INDIA.;DEVI, SUNDRU MANJULATA, ARCHER, ANN CATHERINE, HALAMI, PRAKASH M., CSIR CENT FOOD TECHNOL RES INST, MICROBIOL \& FERMENTAT TECHNOL DEPT, MYSORE 570020, KARNATAKA, INDIA.","10.1007/S12602-015-9195-5","233 SPRING ST, NEW YORK, NY 10013 USA",NA,NA,"ICMR, NEW DELHI [5/9/1029/2011-RHN]","WE EXTEND OUR GRATITUDE TO PROF. RAM RAJASEKHARAN, DIRECTOR, CSIR-CFTRI, MYSORE, FOR ENCOURAGEMENT AND SUPPORT. THIS WORK WAS CARRIED OUT IN THE ICMR, NEW DELHI, FUNDED PROJECT ON PROBIOTICS (NO. 5/9/1029/2011-RHN).",NA,"1867-1306","3","181-192","SPRINGER","7",2015,"ISI000363376800001","47","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, MICROBIOLOGY","35","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, MICROBIOLOGY","PRAKASHALAMICFTRI.RES.IN",NA,"CU2TP",NA,"HALAMI, PM (REPRINT AUTHOR), CSIR CENT FOOD TECHNOL RES INST, MICROBIOL \& FERMENTAT TECHNOL DEPT, MYSORE 570020, KARNATAKA, INDIA","ISI","CSIR CENT FOOD TECHNOL RES INST","CSIR CENT FOOD TECHNOL RES INST",NA,"DEVI SM, 2015, PROBIOTICS ANTIMICROB PROTEINS","DEVI SM, 2015, PROBIOTICS ANTIMICROB PROTEINS"
"KNOWLES M, 2015, J FOOD PROT","KNOWLES M;LAMBERT D;HUSZCZYNSKI G;GAUTHIER M;BLAIS BW","PCR FOR THE SPECIFIC DETECTION OF AN ESCHERICHIA COLI O157:H7 LABORATORY CONTROL STRAIN","JOURNAL OF FOOD PROTECTION","J. FOOD PROT.","CONTROL STRAINS OF BACTERIAL PATHOGENS SUCH AS ESCHERICHIA COLI O157:H7 ARE COMMONLY PROCESSED IN PARALLEL WITH TEST SAMPLES IN FOOD MICROBIOLOGY LABORATORIES AS A QUALITY CONTROL MEASURE TO ASSURE THE SATISFACTORY PERFORMANCE OF MATERIALS USED IN THE ANALYTICAL PROCEDURE. BEFORE POSITIVE FINDINGS CAN BE REPORTED FOR RISK MANAGEMENT PURPOSES, ANALYSTS MUST HAVE A MEANS OF VERIFYING THAT PATHOGENIC BACTERIA (E.G., E. COLI O157:H7) RECOVERED FROM TEST SAMPLES ARE NOT DUE TO INADVERTENT CONTAMINATION WITH THE CONTROL STRAIN ROUTINELY HANDLED IN THE LABORATORY ENVIRONMENT. HERE, WE REPORT ON THE APPLICATION OF AN IN-HOUSE BIOINFORMATIC PIPELINE FOR THE IDENTIFICATION OF UNIQUE GENOMIC SIGNATURE SEQUENCES IN THE DEVELOPMENT OF SPECIFIC OLIGONUCLEOTIDE PRIMERS ENABLING THE IDENTIFICATION OF A COMMON POSITIVE CONTROL STRAIN, E. COLI O157:H7 (ATCC 35150), USING A SIMPLE PCR PROCEDURE.",NA,"BACTERIA; IDENTIFICATION; RESISTANCE; SYSTEM; TOOL","ENGLISH","ARTICLE","ARTICLE",2,"ACLAND A, 2014, NUCLEIC ACIDS RES, V42, PD7, DOI 10.1093/NAR/GKT1146.;ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;[ANONYMOUS], 2014, COMPENDIUM ANAL METH, V2.;BANKEVICH A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/CMB.2012.0021.;BIAIS BW, 2008, J FOOD PROTECT, V71, P2301.;BLAIS B. W., 2013, COMPENDIUM ANAL METH, V3.;BLAIS BW, 2011, J FOOD PROTECT, V74, P365, DOI 10.4315/0362-028X.JFP-10-450.;BONYADIAN MOJTABA, 2014, VET RES FORUM, V5, P29.;COCK PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/BIOINFORMATICS/BTP163.;HO CC, 2012, J CLIN MICROBIOL, V50, P1905, DOI 10.1128/JCM.06843-11.;JAHNE MA, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/S10661-014-4168-9.;JOLLEY KA, 2012, MICROBIOL-SGM, V158, P1005, DOI 10.1099/MIC.0.055459-0.;KELLEY DR, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-11-R116.;MARTINEZ-PEREZ A, 2010, FOOD CONTROL, V21, P1354, DOI 10.1016/J.FOODCONT.2010.04.009.;NAWAZ M, 2015, INT J ANTIMICROB AG, V45, P471, DOI 10.1016/J.IJANTIMICAG.2014.11.010.;YE J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134.","BLAIS, BW (REPRINT AUTHOR), CANADIAN FOOD INSPECT AGCY, OTTAWA LAB CARLING, RES \& DEV SECT, OTTAWA, ON K1A 0Y9, CANADA.;KNOWLES, MICHAEL, LAMBERT, DOMINIC, HUSZCZYNSKI, GEORGE, GAUTHIER, MARTINE, BLAIS, BURTON W., CANADIAN FOOD INSPECT AGCY, OTTAWA LAB CARLING, RES \& DEV SECT, OTTAWA, ON K1A 0Y9, CANADA.","10.4315/0362-028X.JFP-15-147","6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA",NA,NA,NA,NA,NA,"0362-028X","9","1738-1744","INT ASSOC FOOD PROTECTION","78",2015,"ISI000361154300015","16","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, FOOD SCIENCE \& TECHNOLOGY","5","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, FOOD SCIENCE \& TECHNOLOGY","BURTON.BLAISINSPECTION.GC.CA",NA,"CR2JE",NA,"BLAIS, BW (REPRINT AUTHOR), CANADIAN FOOD INSPECT AGCY, OTTAWA LAB CARLING, RES \& DEV SECT, OTTAWA, ON K1A 0Y9, CANADA","ISI","OTTAWA LAB CARLING","OTTAWA LAB CARLING",NA,"KNOWLES M, 2015, J FOOD PROT","KNOWLES M, 2015, J FOOD PROT"
"CUYVERS E, 2015, LANCET NEUROL","CUYVERS E;DE ROECK A;VAN DEN BOSSCHE T;VAN CAUWENBERGHE C;BETTENS K;VERMEULEN S;MATTHEIJSSENS M;PEETERS K;ENGELBORGHS S;VANDENBULCKE M;VANDENBERGHE R;DE DEYN PP;VAN BROECKHOVEN C;SLEEGERS K","MUTATIONS IN ABCA7 IN A BELGIAN COHORT OF ALZHEIMER'S DISEASE PATIENTS: A TARGETED RESEQUENCING STUDY","LANCET NEUROLOGY","LANCET NEUROL.","BACKGROUND ABCA7 WAS IDENTIFIED AS A RISK GENE FOR ALZHEIMER'S DISEASE IN GENOME-WIDE ASSOCIATION STUDIES (GWAS). IT WAS ONE OF THE GENES MOST STRONGLY ASSOCIATED WITH RISK OF ALZHEIMER'S DISEASE IN A BELGIAN COHORT. USING TARGETED RESEQUENCING, WE INVESTIGATED ABCA7 IN THIS COHORT WITH THE AIM TO DIRECTLY DETECT RARE AND COMMON VARIATIONS IN THIS GENE ASSOCIATED WITH ALZHEIMER'S DISEASE PATHOGENESIS. METHODS WE DID MASSIVE PARALLEL RESEQUENCING OF ABCA7 AFTER HALOPLEX TARGET ENRICHMENT OF THE EXONS, INTRONS, AND REGULATORY REGIONS IN 772 UNRELATED PATIENTS WITH ALZHEIMER'S DISEASE (MEAN AGE AT ONSET 74.6 YEARS [SD 8.9]) RECRUITED AT TWO MEMORY CLINICS IN FLANDERS, BELGIUM, AND 757 GEOGRAPHICALLY MATCHED COMMUNITY-DWELLING CONTROLS (MEAN AGE AT INCLUSION 73.9 YEARS [8.0]). AFTER BIOINFORMATIC PROCESSING, COMMON VARIANTS WERE ANALYSED WITH CONDITIONAL LOGISTIC REGRESSION AND RARE VARIANT ASSOCIATION ANALYSIS WAS DONE IN VARIANT ASSOCIATION TOOLS. TO EXPLORE AN OBSERVED FOUNDER EFFECT, ADDITIONAL UNRELATED PATIENTS WITH ALZHEIMER'S DISEASE (N=183, MEAN AGE AT ONSET 78.8 YEARS [SD 6.0]) AND CONTROL INDIVIDUALS (N=265, MEAN AGE AT INCLUSION 56.9 YEARS [10.8]) FROM THE SAME COHORT WHO HAD NOT BEEN INCLUDED IN MASSIVE PARALLEL RESEQUENCING BECAUSE OF INSUFFICIENT BIOSAMPLES WERE SCREENED FOR THE ABCA7 FRAMESHIFT MUTATION GLU709FS WITH SANGER SEQUENCING. THE EFFECT OF LOSS-OF-FUNCTION MUTATIONS ON ABCA7 EXPRESSION WAS INVESTIGATED WITH QUANTITATIVE REAL-TIME PCR IN POST-MORTEM BRAINS OF PATIENTS (N=3) AND CONTROL INDIVIDUALS (N=4), NONSENSE MEDIATED MRNA DECAY WAS INVESTIGATED IN LYMPHOBLAST CELL LINES FROM THREE PREDICTED LOSS-OF-FUNCTION MUTATION CARRIERS FROM THE COHORT OF 772 PATIENTS WITH ALZHEIMER'S DISEASE. FINDINGS AN INTRONIC LOW-FREQUENCY VARIANT RS78117248 (MINOR ALLELE FREQUENCY 3.8\% IN 58 PATIENTS WITH ALZHEIMER'S DISEASE AND IN CONTROLS 1.8\% IN 28 CONTROLS) SHOWED STRONGEST ASSOCIATION WITH ALZHEIMER'S DISEASE (ODDS RATIO 2.07, 95\% CI 1.31-3.27, P=0.0016), AND REMAINED SIGNIFICANT AFTER CONDITIONING FOR THE GWAS TOP SINGLE NUCLEOTIDE POLYMORPHISMS RS3764650, RS4147929, AND RS3752246 (2.00, 1.22-3.26, P=0.006). WE IDENTIFIED AN INCREASED FREQUENCY OF PREDICTED LOSS-OF-FUNCTION MUTATIONS IN THE PATIENTS COMPARED WITH THE CONTROLS (RELATIVE RISK 4.03, 95\% CI 1.75-9.29, P=0.0002). ONE FRAMESHIFT MUTATION (GLU709FS) SHOWED A FOUNDER EFFECT IN THE STUDY POPULATION, AND WAS FOUND TO SEGREGATE WITH DISEASE IN A FAMILY WITH AUTOSOMAL DOMINANT INHERITANCE OF ALZHEIMER'S DISEASE. EXPRESSION OF ABCA7 WAS REDUCED IN THE TWO CARRIERS OF LOSS-OF-FUNCTION MUTATIONS FOUND ONLY IN PATIENTS WITH ALZHEIMER'S DISEASE (GLU709FS AND TRP1214*) COMPARED WITH FOUR",NA,"GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; NATIONAL INSTITUTE; GENE-EXPRESSION; COMMON VARIANTS; CELLS; LOCI; CLU; GUIDELINES; DIAGNOSIS","ENGLISH","ARTICLE","ARTICLE",44,"ALLEN M, 2012, NEUROLOGY, V79, P221, DOI 10.1212/WNL.0B013E3182605801.;BETTENS K, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-3.;BOYLE AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/GR.137323.112.;CHAN SL, 2008, J NEUROCHEM, V106, P793, DOI 10.1111/J.1471-4159.2008.05433.X.;CHUNG HY, 1999, J BIOL CHEM, V274, P32301, DOI 10.1074/JBC.274.45.32301.;CUYVERS E., 2014, NEUROBIOL AGING, V35, P726.;FANG YW, 2013, J CELL SCI, V126, P2551, DOI 10.1242/JCS.120220.;FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6.;FRACKOWIAK J, 1992, ACTA NEUROPATHOL, V84, P225.;HAROLD D, 2009, NAT GENET, V41, P1088, DOI 10.1038/NG.440.;HIRSCHHORN JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/NRG1521.;HOLLINGWORTH P, 2011, NAT GENET, V43, P429, DOI 10.1038/NG.803.;HYMAN BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/J.JALZ.2011.10.007.;JEHLE AW, 2006, J CELL BIOL, V174, P547, DOI 10.1083/JCB.200601030.;KIM WS, 2006, NEUROREPORT, V17, P891, DOI 10.1097/01.WNR.0000221833.41340.CD.;KIM WS, 2013, J NEUROSCI, V33, P4387, DOI 10.1523/JNEUROSCI.4165-12.2013.;LAMBERT JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/NG.2802.;LAMBERT JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/NG.439.;LEE S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/J.AJHG.2014.06.009.;MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939.;MCKHANN GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/J.JALZ.2011.03.005.;NAJ AC, 2011, NAT GENET, V43, P436, DOI 10.1038/NG.801.;PHILLIPSJONES MK, 1995, MOL CELL BIOL, V15, P6593.;PURCELL S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795.;SESHADRI S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/JAMA.2010.574.;SLEEGERS K, ALZHEIMERS IN PRESS.;STEINBERG S, 2015, NAT GENET, V47, P445, DOI 10.1038/NG.3246.;TAKAHASHI KEI, 2005, MEDICAL MOLECULAR MORPHOLOGY, V38, P2, DOI 10.1007/S00795-004-0278-8.;TER BEEK J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/JGP.201411164.;VASQUEZ JB, 2013, NEUROSCI LETT, V556, P58, DOI 10.1016/J.NEULET.2013.09.058.;WANG GT, 2014, AM J HUM GENET, V94, P770, DOI 10.1016/J.AJHG.2014.04.004.;WU CA, 2013, CHINESE MED J-PEKING, V126, P306, DOI 10.3760/CMA.J.ISSN.0366-6999.20123502.","SLEEGERS, K (REPRINT AUTHOR), UNIV ANTWERP, VIB DEPT MOL GENET, NEURODEGENERAT BRAIN DIS GRP, CAMPUS DRIE EIKEN,UNIV PL 1, B-2610 ANTWERP, BELGIUM.;CUYVERS, ELISE, DE ROECK, ARNE, VAN DEN BOSSCHE, TOBI, VAN CAUWENBERGHE, CAROLINE, BETTENS, KAROLIEN, VERMEULEN, STEVEN, MATTHEIJSSENS, MARIA, PEETERS, KARIN, VAN BROECKHOVEN, CHRISTINE, SLEEGERS, KRISTEL, VIB, DEPT MOL GENET, NEURODEGENERAT BRAIN DIS GRP, ANTWERP, BELGIUM.;CUYVERS, ELISE, DE ROECK, ARNE, VAN DEN BOSSCHE, TOBI, VAN CAUWENBERGHE, CAROLINE, BETTENS, KAROLIEN, VERMEULEN, STEVEN, MATTHEIJSSENS, MARIA, PEETERS, KARIN, ENGELBORGHS, SEBASTIAAN, DE DEYN, PETER P., VAN BROECKHOVEN, CHRISTINE, SLEEGERS, KRISTEL, UNIV ANTWERP, INST BORN BUNGE, B-2610 ANTWERP, BELGIUM.;VAN DEN BOSSCHE, TOBI, UNIV ANTWERP HOSP, DEPT NEUROL, EDEGEM, BELGIUM.;VAN DEN BOSSCHE, TOBI, ENGELBORGHS, SEBASTIAAN, DE DEYN, PETER P., HOSP NETWORK ANTWERP MIDDELHEIM \& HOGE BEUKEN, DEPT NEUROL, ANTWERP, BELGIUM.;VAN DEN BOSSCHE, TOBI, ENGELBORGHS, SEBASTIAAN, DE DEYN, PETER P., HOSP NETWORK ANTWERP MIDDELHEIM \& HOGE BEUKEN, MEMORY CLIN, ANTWERP, BELGIUM.;VANDENBULCKE, MATHIEU, UNIV LEUVEN, DEPT OLD AGE PSYCHIAT, LEUVEN, BELGIUM.;VANDENBULCKE, MATHIEU, UNIV LEUVEN, MEMORY CLIN, LEUVEN, BELGIUM.;VANDENBULCKE, MATHIEU, VANDENBERGHE, RIK, UNIV HOSP LEUVEN GASTHUISBERG, LEUVEN, BELGIUM.;VANDENBERGHE, RIK, UNIV LEUVEN, DEPT NEUROL, LAB COGNIT NEUROL, LEUVEN, BELGIUM.","10.1016/S1474-4422(15)00133-7","360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",NA,NA,"BELGIAN SCIENCE POLICY OFFICE INTERUNIVERSITY ATTRACTION POLES PROGRAM [P7/16], ALZHEIMER RESEARCH FOUNDATION, KING BAUDOUIN FOUNDATION AB FUND, METHUSALEM EXCELLENCE PROGRAM INITIATIVE OF THE FLEMISH GOVERNMENT, FLANDERS IMPULSE PROGRAM ON NETWORKS FOR DEMENTIA RESEARCH, RESEARCH FOUNDATION FLANDERS, AGENCY FOR INNOVATION BY SCIENCE AND TECHNOLOGY FLANDERS, UNIVERSITY OF ANTWERP RESEARCH FUND, EUROPEAN UNION'S SEVENTH FRAMEWORK PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION (AGEDBRAINSYSBIO)","BELGIAN SCIENCE POLICY OFFICE INTERUNIVERSITY ATTRACTION POLES PROGRAM P7/16, ALZHEIMER RESEARCH FOUNDATION, KING BAUDOUIN FOUNDATION AB FUND, METHUSALEM EXCELLENCE PROGRAM INITIATIVE OF THE FLEMISH GOVERNMENT, FLANDERS IMPULSE PROGRAM ON NETWORKS FOR DEMENTIA RESEARCH, RESEARCH FOUNDATION FLANDERS, AGENCY FOR INNOVATION BY SCIENCE AND TECHNOLOGY FLANDERS, UNIVERSITY OF ANTWERP RESEARCH FUND, AND EUROPEAN UNION'S SEVENTH FRAMEWORK PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION (AGEDBRAINSYSBIO).",NA,"1474-4422","8","814-822","ELSEVIER SCIENCE INC","14",2015,"ISI000357879200011","32","NEUROSCIENCES \& NEUROLOGY","10","CLINICAL NEUROLOGY","KRISTEL.SLEEGERSMOLGEN.VIB-UA.BE",NA,"CM7MZ",NA,"SLEEGERS, K (REPRINT AUTHOR), UNIV ANTWERP, VIB DEPT MOL GENET, NEURODEGENERAT BRAIN DIS GRP, CAMPUS DRIE EIKEN,UNIV PL 1, B-2610 ANTWERP, BELGIUM","ISI","VAN DEN BOSSCHE;UNIV ANTWERP;UNIV ANTWERP HOSP;VAN DEN BOSSCHE;VAN DEN BOSSCHE;UNIV LEUVEN;UNIV LEUVEN;UNIV HOSP LEUVEN GASTHUISBERG;UNIV LEUVEN","UNIV ANTWERP",NA,"CUYVERS E, 2015, LANCET NEUROL","CUYVERS E, 2015, LANCET NEUROL"
"ROOSSINCK MJ, 2015, PHYTOPATHOLOGY","ROOSSINCK MJ;MARTIN DP;ROUMAGNAC P","PLANT VIRUS METAGENOMICS: ADVANCES IN VIRUS DISCOVERY","PHYTOPATHOLOGY","PHYTOPATHOLOGY","IN RECENT YEARS PLANT VIRUSES HAVE BEEN DETECTED FROM MANY ENVIRONMENTS, INCLUDING DOMESTIC AND WILD PLANTS AND INTERFACES BETWEEN THESE SYSTEMS-AQUATIC SOURCES, FECES OF VARIOUS ANIMALS, AND INSECTS. A VARIETY OF METHODS HAVE BEEN EMPLOYED TO STUDY PLANT VIRUS BIODIVERSITY, INCLUDING ENRICHMENT FOR VIRUS-LIKE PARTICLES OR VIRUS-SPECIFIC RNA OR DNA, OR THE EXTRACTION OF TOTAL NUCLEIC ACIDS, FOLLOWED BY NEXT-GENERATION DEEP SEQUENCING AND BIOINFORMATIC ANALYSES. ALL OF THE METHODS HAVE SOME SHORTCOMINGS, BUT TAKEN TOGETHER THESE STUDIES REVEAL OUR SURPRISING LACK OF KNOWLEDGE ABOUT PLANT VIRUSES AND POINT TO THE NEED FOR MORE COMPREHENSIVE STUDIES. IN ADDITION, MANY NEW VIRUSES HAVE BEEN DISCOVERED, WITH MOST VIRUS INFECTIONS IN WILD PLANTS APPEARING ASYMPTOMATIC, SUGGESTING THAT VIRUS DISEASE MAY BE A BYPRODUCT OF DOMESTICATION. FOR PLANT PATHOLOGISTS THESE STUDIES ARE PROVIDING USEFUL TOOLS TO DETECT VIRUSES, AND PERHAPS TO PREDICT FUTURE PROBLEMS THAT COULD THREATEN CULTIVATED PLANTS.",NA,"TALLGRASS PRAIRIE PRESERVE; COMPLETE GENOME SEQUENCES; MILD MOTTLE VIRUS; MOLECULAR CHARACTERIZATION; DNA VIRUSES; SMALL RNAS; TERRESTRIAL ORCHIDS; WESTERN-AUSTRALIA; OSAGE COUNTY; WILD PLANT","ENGLISH","REVIEW","ARTICLE",51,"ADAMS IP, 2014, ARCH VIROL, V159, P3463, DOI 10.1007/S00705-014-2215-Z.;ADAMS IP, 2013, PLANT PATHOL, V62, P741, DOI 10.1111/J.1365-3059.2012.02690.X.;ADAMS IP, 2013, ARCH VIROL, V158, P909, DOI 10.1007/S00705-012-1546-X.;ADAMS IP, 2014, PLOS ONE, V9, DOI [10.1371/JOURNAL.PONE.109125, 10.1371/JOURNAL.PONE.0109125].;ADAMS IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/J.1364-3703.2009.00545.X].;AL RWAHNIH M, 2009, VIROLOGY, V387, P395, DOI 10.1016/J.VIROL.2009.02.028.;ALLANDER T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/PNAS.211424698.;BAO XD, 2013, CURR OPIN MICROBIOL, V16, P514, DOI 10.1016/J.MIB.2013.05.007.;BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467A0.;BERNARDO P., 2014, THESIS U MONTELLIER.;BERNARDO P, 2013, VIRUS RES, V177, P35, DOI 10.1016/J.VIRUSRES.2013.07.006.;BI YQ, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0042758.;BREITBART M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/J.TIM.2005.04.003.;BREITBART M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/PNAS.202488399.;CANDRESSE T., 2014, PLOS ONE, V7.;VIVES MC, 2013, PHYTOPATHOLOGY, V103, P1077, DOI 10.1094/PHYTO-03-13-0068-R.;DAYARAM A, 2012, VIRUS RES, V166, P130, DOI 10.1016/J.VIRUSRES.2012.03.009.;DE SOUZA J, 2013, ARCH VIROL, V158, P1393, DOI 10.1007/S00705-013-1614-X.;DIAZRUIZ JR, 1978, PREP BIOCHEM, V8, P1, DOI 10.1080/00327487808068215.;DIEMER GS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-13.;DODDS JA, 1984, ANNU REV PHYTOPATHOL, V22, P151, DOI 10.1146/ANNUREV.PY.22.090184.001055.;DOMBROVSKY A, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0070722.;DONAIRE L, 2009, VIROLOGY, V392, P203, DOI 10.1016/J.VIROL.2009.07.005.;DONALDSON EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10.;DUTTA M, 2014, ARCH VIROL, V159, P1755, DOI 10.1007/S00705-014-1985-7.;FRANCOIS S., 2015, GENOME ANNOUNCEMENTS, V2.;GIAMPETRUZZI A, 2012, VIRUS RES, V163, P262, DOI 10.1016/J.VIRUSRES.2011.10.010.;HAGEN C, 2011, ARCH VIROL, V156, P1209, DOI 10.1007/S00705-011-0979-Y.;HALL RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/J.JVIROMET.2013.08.035.;HAMZA IA, 2011, WATER RES, V45, P1358, DOI 10.1016/J.WATRES.2010.10.021.;HANDELSMAN J, 1998, CHEM BIOL, V5, PR245, DOI 10.1016/S1074-5521(98)90108-9.;HANDELSMAN J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004.;HARAMOTO E, 2013, APPL ENVIRON MICROB, V79, P7413, DOI 10.1128/AEM.02354-13.;HWANG YT, 2013, VIROLOGY, V438, P61, DOI 10.1016/J.VIROL.2012.12.012.;JONES MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005.;KREUZE J, 2013, VIRUS RES, V173, P431, DOI 10.1016/J.VIRUSRES.2013.01.014.;KREUZE JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/J.VIROL.2009.03.024.;LI RG, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0037127.;LIU H., 2012, PLOS ONE, V7.;LOCONSOLE G, 2012, PHYTOPATHOLOGY, V102, P1168, DOI 10.1094/PHYTO-06-12-0140-R.;MACDIARMID R., 2013, PLOS PATHOG, V7.;MAMBOLE IA, 2014, ARCH VIROL, V159, P3421, DOI 10.1007/S00705-014-2211-3.;MARTIN DP, 2011, MOL ECOL RESOUR, V11, P943, DOI 10.1111/J.1755-0998.2011.03026.X.;MARTIN-HERNANDEZ AM, 2008, J VIROL, V82, P4064, DOI 10.1128/JVI.02438-07.;MASSART S, 2014, VIRUS RES, V188, P90, DOI 10.1016/J.VIRUSRES.2014.03.029.;MBANZIBWA DR, 2014, ANN APPL BIOL, V165, P329, DOI 10.1111/AAB.12136.;MELCHER U, 2008, J VIROL METHODS, V152, P49, DOI 10.1016/J.JVIROMET.2008.05.030.;MIN BE, 2012, PHYTOPATHOLOGY, V102, P166, DOI 10.1094/PHYTO-05-11-0154.;MONGER WA, 2010, ARCH VIROL, V155, P429, DOI 10.1007/S00705-009-0581-8.;MUTHUKUMAR V, 2009, VIRUS RES, V141, P169, DOI 10.1016/J.VIRUSRES.2008.06.016.;NG TFF, 2014, P NATL ACAD SCI USA, V111, P16842, DOI 10.1073/PNAS.1410429111.;NG TFF, 2009, J VIROL, V83, P2500, DOI 10.1128/JVI.01946-08.;PACE NR, 1985, ASM NEWS, V51, P4.;PHAN TG, 2011, PLOS PATHOG, V7, DOI 10.1371/JOURNAL.PPAT.1002218.;POOJARI S, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0064194.;PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060A0.;RICHARDS RS, 2014, ARCH VIROL, V159, P811, DOI 10.1007/S00705-013-1871-8.;RIESENFELD CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/ANNUREV.GENET.38.072902.091216.;ROOSSINCK MJ, 2015, MOL PLANT PATHOL, V16, P331, DOI 10.1111/MPP.12241.;ROOSSINCK MARILYN J, 2014, FRONT MICROBIOL, V5, P767, DOI 10.3389/FMICB.2014.00767.;ROOSSINCK MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/JOURNAL.PPAT.1003304.;ROOSSINCK MJ, 2012, ANNU REV GENET, V46, P359, DOI 10.1146/ANNUREV-GENET-110711-155600.;ROOSSINCK MJ, 2011, J GEN VIROL, V92, P2674, DOI 10.1099/VIR.0.034702-0.;ROOSSINCK MJ, 2011, NAT REV MICROBIOL, V9, P99, DOI 10.1038/NRMICRO2491.;ROOSSINCK MJ, 2010, MOL ECOL, V19, P81, DOI 10.1111/J.1365-294X.2009.04470.X.;ROOSSINCK MJ, 2012, VIRUSES ESSENTIAL AG, P177.;ROSARIO K, 2009, APPL ENVIRON MICROB, V75, P7261, DOI 10.1128/AEM.00410-09.;ROSARIO K, 2009, ENVIRON MICROBIOL, V11, P2806, DOI 10.1111/J.1462-2920.2009.01964.X.;ROUX S, 2013, NAT COMMUN, V4, DOI 10.1038/NCOMMS3700.;ROY A., 2013, J DATA MIN GENOMICS, V4.;RUSCH DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/JOURNAL.PBIO.0050077.;SAFARI M, 2014, CURR OPIN VIROL, V9, P39, DOI 10.1016/J.COVIRO.2014.09.004.;SCHEETS K, 2013, VIRUS RES, V176, P161, DOI 10.1016/J.VIRUSRES.2013.06.001.;SCHEETS K, 2011, VIRUS RES, V160, P256, DOI 10.1016/J.VIRUSRES.2011.06.023.;SCHMIDT TM, 1991, J BACTERIOL, V173, P4371.;SEGUIN J, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0088513.;SELA N, 2012, J VIROL, V86, P7721, DOI 10.1128/JVI.00983-12.;SHARPTON TJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/FPLS.2014.00209.;STOBBE AH, 2014, FRONT PLANT SCI, V5, DOI 10.3389/FPLS.2014.00150.;STOBBE AH, 2013, J MICROBIOL METH, V94, P356, DOI 10.1016/J.MIMET.2013.07.002.;SUTTLE CA, 2005, NATURE, V437, P356, DOI 10.1038/NATURE04160.;TERRY FFN, 2012, J VIROL, V86, P12161, DOI 10.1128/JVI.00869-12.;THAPA V, 2012, VIRUS RES, V167, P34, DOI 10.1016/J.VIRUSRES.2012.03.016.;TSENG CH, 2014, INT J MOL SCI, V15, P8878, DOI 10.3390/IJMS15058878.;WHON TW, 2012, J VIROL, V86, P8221, DOI 10.1128/JVI.00293-12.;WREN JD, 2006, PLOS BIOL, V4, P314, DOI 10.1371/JOURNAL.PBIO.0040080.;WYLIE SJ, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0105044.;WYLIE SJ, 2014, ARCH VIROL, V159, P1521, DOI 10.1007/S00705-013-1969-Z.;WYLIE SJ, 2014, ARCH VIROL, V159, P791, DOI 10.1007/S00705-013-1891-4.;WYLIE SJ, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0079587.;WYLIE SJ, 2013, VIRUS RES, V171, P22, DOI 10.1016/J.VIRUSRES.2012.10.003.;WYLIE SJ, 2012, ARCH VIROL, V157, P2447, DOI 10.1007/S00705-012-1452-2.;WYLIE SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/S00705-011-1166-X.;WYLIE SJ, 2011, ARCH VIROL, V156, P1251, DOI 10.1007/S00705-011-0965-4.;WYLIE SJ, 2011, ARCH VIROL, V156, P479, DOI 10.1007/S00705-010-0845-3.;ZHANG T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/JOURNAL.PBIO.0040003.;ZHANG Y, 2011, PHYTOPATHOLOGY, V101, P1081, DOI 10.1094/PHYTO-02-11-0034.","ROOSSINCK, MJ (REPRINT AUTHOR), PENN STATE UNIV, DEPT PLANT PATHOL \& ENVIRONM MICROBIOL, CTR INFECT DIS DYNAM, UNIVERSITY PK, PA 16802 USA.;ROOSSINCK, MARILYN J., PENN STATE UNIV, DEPT PLANT PATHOL \& ENVIRONM MICROBIOL, CTR INFECT DIS DYNAM, UNIVERSITY PK, PA 16802 USA.;MARTIN, DARREN P., UNIV CAPE TOWN, COMPUTAT BIOL GRP, INST INFECT DIS \& MOL MED, ZA-7925 CAPE TOWN, SOUTH AFRICA.;ROUMAGNAC, PHILIPPE, CIRAD, UMR BGPI, F-34398 MONTPELLIER 5, FRANCE.","10.1094/PHYTO-12-14-0356-RVW","3340 PILOT KNOB ROAD, ST PAUL, MN 55121 USA",NA,NA,"NATIONAL SCIENCE FOUNDATION [EF-0627108, EPS-0447262, IOS-0950579, IOS-1157148], UNITED STATES DEPARTMENT OF AGRICULTURE [OKLR-2007-01012], PENNSYLVANIA STATE UNIVERSITY","WE THANK P. BERNARDO, E. FERNANDEZ, AND D. FILLOUX FOR THEIR INVALUABLE HELP IN ACHIEVING THE LARGE-SCALE VANA-BASED ECOGENOMIC STUDIES CONDUCTED IN CAMARGUE AND WESTERN CAPE REGIONS. M. J. ROOSSINCK ACKNOWLEDGES THE NATIONAL SCIENCE FOUNDATION GRANT NUMBERS EF-0627108, EPS-0447262, IOS-0950579, AND IOS-1157148 AND THE UNITED STATES DEPARTMENT OF AGRICULTURE GRANT NUMBER OKLR-2007-01012 FOR PREVIOUS AND CONTINUING RESEARCH SUPPORT, AND THE PENNSYLVANIA STATE UNIVERSITY.",NA,"0031-949X","6","716-727","AMER PHYTOPATHOLOGICAL SOC","105",2015,"ISI000356955500001","97","PLANT SCIENCES","67","PLANT SCIENCES","MJR25PSU.EDU",NA,"CL4VY",NA,"ROOSSINCK, MJ (REPRINT AUTHOR), PENN STATE UNIV, DEPT PLANT PATHOL \& ENVIRONM MICROBIOL, CTR INFECT DIS DYNAM, UNIVERSITY PK, PA 16802 USA","ISI","PENN STATE UNIV;UNIV CAPE TOWN","PENN STATE UNIV",NA,"ROOSSINCK MJ, 2015, PHYTOPATHOLOGY","ROOSSINCK MJ, 2015, PHYTOPATHOLOGY"
"WANG W, 2015, INFLAMM BOWEL DIS","WANG W;JOVEL J;HALLORAN B;WINE E;PATTERSON J;FORD G;O KEEFE S;MENG B;SONG D;ZHANG Y;TIAN Z;WASILENKO ST;RAHBARI M;REZA S;MITCHELL T;JORDAN T;CARPENTER E;MADSEN K;FEDORAK R;DIELEMANN LA;WONG GKS;MASON AL","METAGENOMIC ANALYSIS OF MICROBIOME IN COLON TISSUE FROM SUBJECTS WITH INFLAMMATORY BOWEL DISEASES REVEALS INTERPLAY OF VIRUSES AND BACTERIA","INFLAMMATORY BOWEL DISEASES","INFLAMM. BOWEL DIS.","INFLAMMATORY BOWEL DISEASES (IBD), CROHN'S DISEASE AND ULCERATIVE COLITIS, ARE POORLY UNDERSTOOD DISORDERS AFFECTING THE INTESTINAL TRACT. THE CURRENT MODEL FOR DISEASE SUGGESTS THAT GENETICALLY SUSCEPTIBLE PATIENTS DEVELOP INTOLERANCE TO GUT MICROFLORA, AND CHRONIC INFLAMMATION DEVELOPS AS A RESULT OF ENVIRONMENTAL INSULTS. ALTHOUGH INTEREST HAS MAINLY FOCUSED ON STUDYING GENETIC VARIANTS AND GUT BACTERIAL FLORA, LITTLE IS KNOWN ABOUT THE POTENTIAL OF VIRAL INFECTION TO CONTRIBUTE TO DISEASE. ACCORDINGLY, WE CONDUCTED A METAGENOMIC ANALYSIS TO DOCUMENT THE BASELINE VIROME IN COLONIC BIOPSY SAMPLES FROM PATIENTS WITH IBD IN ORDER TO ASSESS THE CONTRIBUTION OF VIRAL INFECTION TO IBD. LIBRARIES WERE GENERATED FROM COLON RNA TO CREATE APPROXIMATELY 2 GB SEQUENCE DATA PER LIBRARY. USING A BIOINFORMATIC PIPELINE DESIGNED TO DETECT VIRAL SEQUENCES, MORE THAN 1000 VIRAL READS WERE DERIVED DIRECTLY FROM TISSUE WITHOUT ANY COCULTURE OR ISOLATION PROCEDURE. HEREIN, WE DESCRIBE THE COMPLEXITY AND ABUNDANCE OF VIRUSES, BACTERIA/BACTERIOPHAGE, AND HUMAN ENDOGENOUS RETROVIRAL SEQUENCES FROM 10 PATIENTS WITH IBD AND 5 HEALTHY SUBJECTS UNDERGOING SURVEILLANCE COLONOSCOPY. DIFFERENCES IN GUT MICROFLORA AND THE ABUNDANCE OF MAMMALIAN VIRUSES AND HUMAN ENDOGENOUS RETROVIRUSES WERE READILY DETECTED IN THE METAGENOMIC ANALYSES. SPECIFICALLY, PATIENTS WITH HERPESVIRIDAE SEQUENCES IN THEIR COLON DEMONSTRATED INCREASED EXPRESSION OF HUMAN ENDOGENOUS VIRAL SEQUENCES AND DIFFERENCES IN THE DIVERSITY OF THEIR MICROBIOME. THIS STUDY PROVIDES A PROMISING METAGENOMIC APPROACH TO DESCRIBE THE COLONIC MICROBIOME THAT CAN BE USED TO BETTER UNDERSTAND VIRUS-HOST AND PHAGE-BACTERIA INTERACTIONS IN IBD.","INFLAMMATORY BOWEL DISEASE; VIRAL METAGENOMICS; MICROBIOME","ENDOGENOUS RETROVIRUS HERV-K18; PARVOVIRUS B19 INFECTION; LONG TERMINAL REPEAT; ULCERATIVE-COLITIS; CYTOMEGALOVIRUS-INFECTION; GUT MICROBIOTA; INTESTINAL MICROBIOME; MULTIPLE-SCLEROSIS; VIRAL COMMUNITY; HUMAN FECES","ENGLISH","ARTICLE","ARTICLE",29,"ANTONY JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/NN1319.;ANTONY JM, 2007, AIDS RES HUM RETROV, V23, P1251, DOI 10.1089/AID.2006.0274.;ARUMUGAM M, 2011, NATURE, V473, P174, DOI 10.1038/NATURE09944.;BERNARDIN F, 2010, TRANSFUSION, V50, P2474, DOI 10.1111/J.1537-2995.2010.02699.X.;BERNSTEIN CN, 2007, INFLAMM BOWEL DIS, V13, P759, DOI 10.1002/IBD.20089.;BERNSTEIN CN, 2000, INFLAMM BOWEL DIS, V6, P34, DOI 10.1097/00054725-200002000-00005.;BREITBART M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003.;CADWELL K, 2010, CELL, V141, P1135, DOI 10.1016/J.CELL.2010.05.009.;CHICHLOWSKI M, 2008, AM J PHYSIOL-GASTR L, V295, PG1139, DOI 10.1152/AJPGI.90516.2008.;CRISCUOLI V, 2006, WORLD J GASTROENTERO, V12, P4813.;DAVENPORT M, 2014, INFLAMM BOWEL DIS, V20, P723, DOI 10.1097/MIB.0000000000000011.;DIMITROV DV, 2011, OMICS, V15, P419, DOI 10.1089/OMI.2010.0109.;FENG HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/SCIENCE.1152586.;GREENBERG R, 2008, DIGEST DIS SCI, V53, P760, DOI 10.1007/S10620-007-9935-9.;HUSSEIN K, 2006, AM J MED SCI, V331, P40, DOI 10.1097/00000441-200601000-00012.;JONES MK, 2014, SCIENCE, V346, P755, DOI 10.1126/SCIENCE.1257147.;GOSALBES MJ, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0017447.;KAMBHAM N, 2004, AM J SURG PATHOL, V28, P365, DOI 10.1097/00000478-200403000-00009.;KANDIEL A, 2006, AM J GASTROENTEROL, V101, P2857, DOI 10.1111/J.1572-0241.2006.00869.X.;KIM JJ, 2010, DIGEST DIS SCI, V55, P1059, DOI 10.1007/S10620-010-1126-4.;KNIGHT P, 2008, BRIT MED BULL, V88, P95, DOI 10.1093/BMB/LDN038.;KOJIMA T, 2006, SCAND J GASTROENTERO, V41, P706, DOI 10.1080/00365520500408584.;KONG CS, 2007, AM J SURG PATHOL, V31, P919, DOI 10.1097/01.PAS.0000213441.86030.FC.;KWUN HJ, 2002, VIRUS RES, V86, P93, DOI 10.1016/S0168-1702(02)00058-8.;LARSSON E, 1989, CURR TOP MICROBIOL, V148, P115.;LAW J, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0060595.;LEE WJ, 2003, MOL CELLS, V15, P75.;LEPAGE P, 2013, GUT, V62, P146, DOI 10.1136/GUTJNL-2011-301805.;LI J, 2015, INFLAMM BOWEL DIS, V21, P139, DOI 10.1097/MIB.0000000000000215.;LI RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/BIOINFORMATICS/BTN025.;LI RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/BIOINFORMATICS/BTP336.;LIDAR M, 2009, ISR MED ASSOC J, V11, P558.;MACFARLANE S, 2009, CRIT REV CL LAB SCI, V46, P25, DOI [10.1080/10408360802485792 , 10.1080/10408360802485792].;MASON ANDREW L., 1999, ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, V47, P289.;MATRICON JULIEN, 2010, SELF NONSELF, V1, P299, DOI 10.4161/SELF.1.4.13560.;MINOT S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/PNAS.1300833110.;MONTANARI M, 2009, AM J GASTROENTEROL, V104, P537, DOI 10.1038/AJG.2008.93.;MORGAN XC, 2012, GENOME BIOL, V13, DOI 10.1186/GB-2012-13-9-R79.;MORGULIS A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/BIOINFORMATICS/BIT774.;NELLAKER C, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-44.;PALACIOS G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMOA073785.;PEREZ-BROCAL V, 2013, CLIN TRANSL GASTROEN, V4, DOI 10.1038/CTG.2013.9.;PIRONI L, 2009, J CLIN MICROBIOL, V47, P1591, DOI 10.1128/JCM.00706-08.;QIN JJ, 2010, NATURE, V464, P59, DOI 10.1038/NATURE08821.;RICANEK P, 2012, CLIN EXP GASTROENTER, V5, P173, DOI 10.2147/CEG.S33858.;RIESENFELD CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/ANNUREV.GENET.38.072902.091216.;RUPRECHT K, 2006, J NEUROVIROL, V12, P65, DOI 10.1080/13550280600614973.;SANKARAN-WALTERS S, 2011, J CLIN VIROL, V50, P31, DOI 10.1016/J.JCV.2010.09.011.;SARTOR RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/J.GASTRO.2007.11.059.;SAUL SH, 1987, HUM PATHOL, V18, P1120, DOI 10.1016/S0046-8177(87)80379-9.;SCHUNTER MO, 2007, J CROHNS COLITIS, V1, P41, DOI 10.1016/J.CROHNS.2007.06.004.;SICAT J, 2005, J RHEUMATOL, V32, P1821.;SILVERBERG MS, 2005, CAN J GASTROENTEROL, V19, P5A, DOI 10.1155/2005/269076.;SLEATOR RD, 2008, LETT APPL MICROBIOL, V47, P361, DOI 10.1111/J.1472-765X.2008.02444.X.;SPIEKER T, 2000, AM J PATHOL, V157, P51, DOI 10.1016/S0002-9440(10)64516-6.;STAUFFER YVES, 2004, CANCER IMMUN, V4, P2.;SUTKOWSKI N, 2001, IMMUNITY, V15, P579, DOI 10.1016/S1074-7613(01)00210-2.;TAMBOLI CP, 2004, GUT, V53, P1, DOI 10.1136/GUT.53.1.1.;TIENG V, 2002, P NATL ACAD SCI USA, V99, P2977, DOI 10.1073/PNAS.032668099.;TUOHY KM, 2009, CURR PHARM DESIGN, V15, P1415, DOI 10.2174/138161209788168182.;VACHARAKSA A, 2010, CURR BIOL, V20, PR569, DOI 10.1016/J.CUB.2010.05.020.;VAISHAMPAYAN PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/GBE/EVP057.;VANDERPLOEG R, 2010, INFECT DIS CLIN N AM, V24, P977, DOI 10.1016/J.IDC.2010.07.008.;WAKEFIELD AJ, 1992, J MED VIROL, V38, P183, DOI 10.1002/JMV.1890380306.;YANAI H, 1999, AM J GASTROENTEROL, V94, P1582.;YOLKEN RH, 2014, P NATL ACAD SCI USA, V111, P16106, DOI 10.1073/PNAS.1418895111.;ZHANG T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/JOURNAL.PBIO.0040003.","MASON, AL (REPRINT AUTHOR), UNIV ALBERTA, DIV GASTROENTEROL \& HEPATOL, CTR EXCELLENCE GASTROINTESTINAL INFLAMMAT \& IMMUN, 7-142 KGR, EDMONTON, AB T6G 2E1, CANADA.;WANG, WEIWEI, JOVEL, JUAN, HALLORAN, BRENDAN, WINE, EYTAN, PATTERSON, JORDAN, FORD, GLENN, O'KEEFE, SANDRA, MENG, BO, WASILENKO, SHAWN T., RAHBARI, MANDANA, REZA, SALMAN, MITCHELL, TROY, JORDAN, TRACY, CARPENTER, ERIC, MADSEN, KAREN, FEDORAK, RICHARD, DIELEMANN, LEVINUS A., WONG, GANE KA-SHU, MASON, ANDREW L., UNIV ALBERTA, DEPT MED, CTR EXCELLENCE GASTROINTESTINAL INFLAMMAT \& IMMUN, EDMONTON, AB T6G 2E1, CANADA.;SONG, DEYONG, ZHANG, YONG, TIAN, ZHIJIAN, WONG, GANE KA-SHU, BEIJING GENOM INST, SHENZHEN, PEOPLES R CHINA.","10.1097/MIB.0000000000000344","JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA",NA,NA,"ALBERTA INNOVATES HEALTH SOLUTIONS, BROAD FOUNDATION, CANADIAN CROHN'S AND COLITIS FOUNDATION, CANADIAN INSTITUTES FOR HEALTH RESEARCH, ALBERTA INNOVATES TECHNOLOGY FUTURES, JANSSEN, ABBVIE, ALBA, BRISTOL-MYERS SQUIBB, CENTOCOR, GSK, GENENTECH, MERCK, MILLENNIUM, NOVARTIS, PFIZER, PROCTER GAMBLE, ROCHE, VSL [3], CELLTRION, BENEO-ORAFTI, ABBOTT, GILEAD","SUPPORTED IN PART BY THE ALBERTA INNOVATES HEALTH SOLUTIONS (A.L.M., L.A.D., AND W.W.), THE BROAD FOUNDATION (A.L.M. AND G.K.-S.W.), THE CANADIAN CROHN'S AND COLITIS FOUNDATION (A.L.M.), THE CANADIAN INSTITUTES FOR HEALTH RESEARCH (L.A.D.), AND ALBERTA INNOVATES TECHNOLOGY FUTURES (G.K.-S.W.). E.W. HAS BEEN AN ADVISORY BOARD MEMBER FOR ABBVIE AND JANSSEN AND RECEIVED RESEARCH SUPPORT FROM JANSSEN, R.F. HAS BEEN AN ADVISORY BOARD MEMBER FOR ABBVIE, FERRING, JANSSEN, SHIRE, VSL\#3, AND CELLTRION AND RECEIVED RESEARCH SUPPORT FROM ABBVIE, ALBA, BRISTOL-MYERS SQUIBB, CENTOCOR, GSK, GENENTECH, JANSSEN, MERCK, MILLENNIUM, NOVARTIS, PFIZER, PROCTER \& GAMBLE, ROCHE, VSL\#3, AND CELLTRION. L.A.D. HAS BEEN AN ADVISORY BOARD MEMBER FOR ABBVIE, FERRING, JANSSEN, AND SHIRE AND RECEIVED RESEARCH SUPPORT FROM BENEO-ORAFTI. A.L.M. HAS BEEN AN ADVISORY BOARD MEMBER FOR INTERCEPT AND NOVARTIS AND RECEIVED RESEARCH SUPPORT IN KIND FROM ABBOTT AND GILEAD. THE REMAINING AUTHORS HAVE NO CONFLICTS OF INTEREST TO DISCLOSE.",NA,"1078-0998","6","1419-1427","OXFORD UNIV PRESS INC","21",2015,"ISI000355315800027","67","GASTROENTEROLOGY \& HEPATOLOGY","47","GASTROENTEROLOGY \& HEPATOLOGY","GANEUALBERTA.CA ANDREW.MASONUALBERTA.CA",NA,"CJ2LI",NA,"MASON, AL (REPRINT AUTHOR), UNIV ALBERTA, DIV GASTROENTEROL \& HEPATOL, CTR EXCELLENCE GASTROINTESTINAL INFLAMMAT \& IMMUN, 7-142 KGR, EDMONTON, AB T6G 2E1, CANADA","ISI","UNIV ALBERTA;BEIJING GENOM INST","UNIV ALBERTA",NA,"WANG W, 2015, INFLAMM BOWEL DIS","WANG W, 2015, INFLAMM BOWEL DIS"
"GREIFF V, 2015, GENOME MED","GREIFF V;BHAT P;COOK SC;MENZEL U;KANG W;REDDY ST","A BIOINFORMATIC FRAMEWORK FOR IMMUNE REPERTOIRE DIVERSITY PROFILING ENABLES DETECTION OF IMMUNOLOGICAL STATUS","GENOME MEDICINE","GENOME MED.","BACKGROUND: LYMPHOCYTE RECEPTOR REPERTOIRES ARE CONTINUALLY SHAPED THROUGHOUT THE LIFETIME OF AN INDIVIDUAL IN RESPONSE TO ENVIRONMENTAL AND PATHOGENIC EXPOSURE. THUS, THEY MAY SERVE AS A FINGERPRINT OF AN INDIVIDUAL'S ONGOING IMMUNOLOGICAL STATUS (E.G., HEALTHY, INFECTED, VACCINATED), WITH FAR-REACHING IMPLICATIONS FOR IMMUNODIAGNOSTICS APPLICATIONS. THE ADVENT OF HIGH-THROUGHPUT IMMUNE REPERTOIRE SEQUENCING NOW ENABLES THE INTERROGATION OF IMMUNE REPERTOIRE DIVERSITY IN AN UNPRECEDENTED AND QUANTITATIVE MANNER. HOWEVER, STEADILY INCREASING SEQUENCING DEPTH HAS REVEALED THAT IMMUNE REPERTOIRES VARY GREATLY AMONG INDIVIDUALS IN THEIR COMPOSITION, CORRESPONDINGLY, IT HAS BEEN REPORTED THAT THERE ARE FEW SHARED SEQUENCES INDICATIVE OF IMMUNOLOGICAL STATUS ('PUBLIC CLONES'). DISCONCERTINGLY, THIS MEANS THAT THE WEALTH OF INFORMATION GAINED FROM REPERTOIRE SEQUENCING REMAINS LARGELY UNUSED FOR DETERMINING THE CURRENT STATUS OF IMMUNE RESPONSES, THEREBY HAMPERING THE IMPLEMENTATION OF IMMUNE-REPERTOIRE-BASED DIAGNOSTICS. METHODS: HERE, WE INTRODUCE A BIOINFORMATICS REPERTOIRE-PROFILING FRAMEWORK THAT POSSESSES THE ADVANTAGE OF CAPTURING THE DIVERSITY AND DISTRIBUTION OF ENTIRE IMMUNE REPERTOIRES, AS OPPOSED TO SINGULAR PUBLIC CLONES. THE FRAMEWORK RELIES ON HILL-BASED DIVERSITY PROFILES COMPOSED OF A CONTINUUM OF SINGLE DIVERSITY INDICES, WHICH ENABLE THE QUANTIFICATION OF THE EXTENT OF IMMUNOLOGICAL INFORMATION CONTAINED IN IMMUNE REPERTOIRES. RESULTS: WE COUPLED DIVERSITY PROFILES WITH UNSUPERVISED (HIERARCHICAL CLUSTERING) AND SUPERVISED (SUPPORT VECTOR MACHINE AND FEATURE SELECTION) MACHINE LEARNING APPROACHES IN ORDER TO CORRELATE PATIENTS' IMMUNOLOGICAL STATUSES WITH THEIR B-AND T-CELL REPERTOIRE DATA. WE COULD PREDICT WITH HIGH ACCURACY (GREATER THAN OR EQUAL TO 80 \%) A WIDE RANGE OF IMMUNOLOGICAL STATUSES SUCH AS HEALTHY, TRANSPLANTATION RECIPIENT, AND LYMPHOID CANCER, SUGGESTING AS A PROOF OF PRINCIPLE THAT DIVERSITY PROFILING CAN RECOVER A LARGE AMOUNT OF IMMUNODIAGNOSTIC FINGERPRINTS FROM IMMUNE REPERTOIRE DATA. OUR FRAMEWORK IS HIGHLY SCALABLE AS IT EASILY ALLOWED FOR THE ANALYSIS OF 1000 SIMULATED IMMUNE REPERTOIRES, THIS EXCEEDS THE SIZE OF PUBLISHED IMMUNE REPERTOIRE DATASETS BY ONE TO TWO ORDERS OF MAGNITUDE. CONCLUSIONS: OUR FRAMEWORK OFFERS THE POSSIBILITY TO ADVANCE IMMUNE-REPERTOIRE-BASED FINGERPRINTING, WHICH MAY IN THE FUTURE ENABLE A SYSTEMS IMMUNOGENOMICS APPROACH FOR VACCINE PROFILING AND THE ACCURATE AND EARLY DETECTION OF DISEASE AND INFECTION.",NA,"T-CELL REPERTOIRE; IMMUNOGLOBULIN HEAVY; RECEPTOR REPERTOIRES; ANTIBODY REPERTOIRE; GENERATION; DEEP; SELECTION; SIGNATURES; DIAGNOSIS; EVENNESS","ENGLISH","ARTICLE","ARTICLE",31,"ABBAS AK, 2005, CELLULAR MOL IMMUNOL.;BASHFORD-ROGERS RJM, 2013, GENOME RES, V23, P1874, DOI 10.1101/GR.154815.113.;BAUM PD, 2012, EUR J IMMUNOL, V42, P2834, DOI 10.1002/EJI.201242999.;BECATTINI S, 2014, SCIENCE, V2015, P400.;BENICHOU J, 2012, IMMUNOLOGY, V135, P183, DOI 10.1111/J.1365-2567.2011.03527.X.;BERGER CT, 2015, HUM VACC IMMUNOTHER, V11, P391, DOI 10.1080/21645515.2015.1008930.;BERGER WH, 1970, SCIENCE, V168, P1345, DOI 10.1126/SCIENCE.168.3937.1345.;BOLOTIN DA, 2012, EUR J IMMUNOL, V42, P3073, DOI 10.1002/EJI.201242517.;BOYD SD, 2014, GENES-BASEL, V5, P748, DOI 10.3390/GENES5030748.;BRITANOVA OV, 2014, J IMMUNOL, V192, P2689, DOI 10.4049/JIMMUNOL.1302064.;BUSSE CE, 2014, EUR J IMMUNOL, V44, P597, DOI 10.1002/EJI.201343917.;CALIS JJA, 2015, TRENDS IMMUNOL, V24, P112.;CHAO A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727.;CHAUSSABEL D, 2015, SEMIN IMMUNOL, V27, P58, DOI 10.1016/J.SMIM.2015.03.002.;DAY A., 2012, HEATMAP PLUS HEATMAP.;DE VRIES A., 2013, GGDENDRO TOOLS EXTRA.;DEAKIN CT, 2014, NUCLEIC ACIDS RES, V42.;DEKOSKY BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/NBT.2492.;DZIUBIANAU M, 2013, AM J TRANSPLANT, V13, P2842, DOI 10.1111/AJT.12431.;ELHANATI Y, 2014, P NATL ACAD SCI USA, V111, P9875, DOI 10.1073/PNAS.1409572111.;ESTORNINHO M, 2013, J IMMUNOL, V191, P5430, DOI 10.4049/JIMMUNOL.1300622.;ETIENNE RS, 2011, P ROY SOC LOND B BIO, V279.;EVERT S, 2007, P 45 ANN M ASS COMP, P29.;EVERT S., 2005, STAT WORD COOCCURREN.;GALILI T., 2014, DENDEXTEND EXTENDING.;GALSON JD, 2014, TRENDS IMMUNOL, V35, P319, DOI 10.1016/J.IT.2014.04.005.;GAUJOUX R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367.;GEORGIOU G, 2014, NAT BIOTECHNOL, V32, P156.;GOTELLI NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/J.1461-0248.2001.00230.X.;GREIFF V, 2012, EXPLORING GENESIS SP, VI.;GREIFF V, 2014, BMC IMMUNOL, V15, DOI 10.1186/S12865-014-0040-5.;GREIFF V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-79.;GRUPP SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMOA1215134.;GULLAPALLI RAMA R, 2012, J PATHOL INFORM, V3, P40, DOI 10.4103/2153-3539.103013.;HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352.;HOCHREITER S, 2006, NEURAL COMPUT, V18, P1472, DOI 10.1162/NECO.2006.18.6.1472.;JABARA CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/PNAS.1110064108.;JACKSON KJL, 2014, CELL HOST MICROBE, V16, P105, DOI 10.1016/J.CHOM.2014.05.013.;JACKSON KJL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/FIMMU.2013.00263.;JANEWAY C. A., 2004, IMMUNOBIOLOGY.;JOST L, 2006, OIKOS, V113, P363, DOI 10.1111/J.2006.0030-1299.14714.X.;JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI DOI 10.3390/D2020207.;LAVINDER JJ, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0101322.;LAYDON DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/JOURNAL.PCBI.1003646.;LEFRANC MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/NAR/27.1.209.;LEINSTER T, 2011, ECOLOGY, V93, P477.;LI S, 2014, NAT BIOTECHNOL, V32, P888, DOI 10.1038/NBT.3000.;LI S, 2013, NAT COMMUN, V4, DOI 10.1038/NCOMMS3333.;MASELLA AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31.;MAYER A, 2015, P NATL ACAD SCI USA, V112, P5950, DOI 10.1073/PNAS.1421827112.;MEHR R, 2012, IMMUNOL LETT, V148, P11, DOI 10.1016/J.IMLET.2012.08.002.;MENZEL U, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0096727.;MORA T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/PNAS.1001705107.;MORGAN M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/BIOINFORMATICS/BTP450.;MURARO PA, 2014, J CLIN INVEST, V124, P1168, DOI 10.1172/JCI71691.;NEWELL EW, 2014, NAT BIOTECHNOL, V32, P149, DOI 10.1038/NBT.2783.;PARAMESWARAN P, 2013, CELL HOST MICROBE, V13, P691, DOI 10.1016/J.CHOM.2013.05.008.;QI Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/PNAS.1409155111.;REDDY ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/NBT.1673.;REMPALA GA, 2013, J MATH BIOL, V67, P1.;RENYI A., 1961, 4TH P BERK S MATH ST, P547.;ROBINS H, 2013, CURR OPIN IMMUNOL, V25, P646, DOI 10.1016/J.COI.2013.09.017.;ROBINS HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/SCITRANSLMED.3001442.;ROBINSON WH, 2015, NAT REV RHEUMATOL, V11, P171, DOI 10.1038/NRRHEUM.2014.220.;SCHIRMER M, 2015, NUCLEIC ACIDS RES, V43, PU1341.;SCHWAB DJ, 2014, PHYS REV LETT, V113, DOI 10.1103/PHYSREVLETT.113.068102.;SEPULVEDA N, 2010, J IMMUNOL METHODS, V353, P124, DOI 10.1016/J.JIM.2009.11.009.;SHANNON CE, 2001, ACM SIGMOBILE MOBILE, V5, P3, DOI DOI 10.1145/584091.584093.;SHUGAY M, 2014, NAT METHODS, V11, P653, DOI [10.1038/NMETH.2960, 10.1038/NMETH.2960].;SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688A0.;SOKAL ROBERT R., 1962, TAXON, V11, P33, DOI 10.2307/1217208.;SOLOMON DL, 1975, BIOMETRICS UNIT TECH.;SU ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/NBT.2957.;TEAM RDC, 2009, R LANG ENV STAT COMP.;TOTHMERESZ B, 1995, J VEG SCI, V6, P283, DOI 10.2307/3236223.;TRUCK J, 2014, J IMMUNOL, V194, P252, DOI DOI 10.4049/JIMMUNOL.1401405.;VENTURI V, 2007, J IMMUNOL METHODS, V321, P182, DOI 10.1016/J.JIM.2007.01.019.;VOLLMERS C, 2013, P NATL ACAD SCI USA, V110, P13463, DOI 10.1073/PNAS.1312146110.;WANG C., 2013, J IMMUNOL, V192, P603, DOI DOI 10.4049/JIMMUNOL.1301384.;WANG GC, 2012, SCI TRANSL MED, V4.;WARNES GR, 2014, GPLOTS VARIOUS R PRO.;WEISS-OTTOLENGHI Y, 2014, FEBS LETT, V588, P318, DOI 10.1016/J.FEBSLET.2013.11.005.;WU D, 2012, SCI TRANSL MED, V4, DOI DOI 10.1126/SCITRANSLMED.3003656.;XU JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6.","REDDY, ST (REPRINT AUTHOR), SWISS FED INST TECHNOL, DEPT BIOSYST SCI \& ENGN, CH-4058 BASEL, SWITZERLAND.;GREIFF, VICTOR, BHAT, POOJA, COOK, SKYLAR C., MENZEL, ULRIKE, KANG, WENJING, REDDY, SAI T., SWISS FED INST TECHNOL, DEPT BIOSYST SCI \& ENGN, CH-4058 BASEL, SWITZERLAND.","10.1186/S13073-015-0169-8","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","49",NA,"MISROCK FOUNDATION, SWISS NATIONAL SCIENCE FOUNDATION","THIS WORK WAS SUPPORTED BY THE THE MISROCK FOUNDATION (WWW.MISROCKFOUNDATION.COM, TO STR) AND SWISS NATIONAL SCIENCE FOUNDATION (SYSTEMSX.CH RTD PROJECT ANTIBODYX). WE THANK DR CHRISTIAN BEISEL, MANUEL KOHLER, AND INA NISSEN FROM THE QUANTITATIVE GENOMICS FACILITY AND VERENA JAGGIN FROM THE SINGLE CELL FACILITY AT THE ETH ZURICH DEPARTMENT OF BIOSYSTEMS SCIENCE AND ENGINEERING FOR THEIR EXPERT TECHNICAL ASSISTANCE WITH HIGH-THROUGHPUT SEQUENCING AND FLOW CYTOMETRY, RESPECTIVELY. THE AUTHORS WISH TO THANK RENE RIEDEL (DEUTSCHES RHEUMA-FORSCHUNGSZENTRUM, BERLIN, GERMANY) FOR HELP WITH ESTABLISHING SORTING PROTOCOLS FOR NAIVE FOLLICULAR B CELLS AND ANTIBODY-SECRETING CELLS.",NA,"1756-994X",NA,NA,"BIOMED CENTRAL LTD","7",2015,"ISI000357376900001","84","GENETICS \& HEREDITY","12","GENETICS \& HEREDITY","SAI.REDDYETHZ.CH",NA,"CM0OD",NA,"REDDY, ST (REPRINT AUTHOR), SWISS FED INST TECHNOL, DEPT BIOSYST SCI \& ENGN, CH-4058 BASEL, SWITZERLAND","ISI","SWISS FED INST TECHNOL","SWISS FED INST TECHNOL",NA,"GREIFF V, 2015, GENOME MED","GREIFF V, 2015, GENOME MED"
"JIANG W, 2015, PLOS ONE","JIANG W;HU Y;GAO L;HE Z;ZHU C;MA R;HUANG Z","THE IMPACT OF VARIOUS TIME INTERVALS ON THE SUPRAGINGIVAL PLAQUE DYNAMIC CORE MICROBIOME","PLOS ONE","PLOS ONE","OBJECTIVE THE AIM OF THIS STUDY WAS TO EXAMINE THE INFLUENCE OF VARIOUS TIME INTERVALS ON THE COMPOSITION OF THE SUPRAGINGIVAL PLAQUE MICROBIOME, ESPECIALLY THE DYNAMIC CORE MICROBIOME, AND TO FIND A SUITABLE OBSERVATION INTERVAL FOR FURTHER STUDIES ON ORAL MICROBIOTA. METHODS AND MATERIALS EIGHT QUALIFIED VOLUNTEERS WHOSE RESPECTIVE AGE RANGES FROM 25 TO 28 YEARS PARTICIPATED IN THE PRESENT STUDY. THE SUPRAGINGIVAL PLAQUE WAS COLLECTED FROM THE BUCCOGINGIVAL SURFACE OF THE MAXILLARY FIRST MOLAR AT EIGHT TIME SLOTS WITH DIFFERENT INTERVALS (DAY 0, 1 DAY, 3 DAYS, 1 WEEK, 2 WEEKS, 3 WEEKS, 1 MONTH, AND 3 MONTHS). BIOINFORMATIC ANALYSES WAS PERFORMED BASED ON 16S RDNA PYROSEQUENCING (454 SEQUENCING PLATFORM) TARGETING AT THE HYPERVARIABLE V4-V5 REGION, IN ORDER TO ASSESS THE DIVERSITY AND VARIATION OF THE SUPRAGINGIVAL PLAQUE MICROBIOME. RESULTS A TOTAL OF 359,565 QUALIFIED READS FOR 64 SAMPLES WERE GENERATED FOR SUBSEQUENT ANALYSES, WHICH REPRESENTS 8,452 OPERATIONAL TAXONOMIC UNITS IDENTIFIED AT 3\% DISSIMILARITY. THE DYNAMIC CORE MICROBIOME DETECTED IN THE CURRENT STUDY INCLUDED FIVE PHYLA, 12 GENERA AND 13 SPECIES. AT THE GENUS LEVEL, THE RELATIVE ABUNDANCE OF BACTERIAL COMMUNITIES UNDER THE ``1 DAY,'' ``1 MONTH,'' AND ``3 MONTHS'' INTERVALS WAS CLUSTERED",NA,"PYROSEQUENCING ANALYSIS; BACTERIAL IDENTIFICATION; ORAL MICROBIOTA; DIVERSITY; DISEASE; CHILDREN; HEALTH; CARIES","ENGLISH","ARTICLE","ARTICLE",6,"BELDA-FERRE P, 2012, ISME J, V6, P46, DOI 10.1038/ISMEJ.2011.85.;CAPORASO JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/NMETH.F.303.;CONLAN S, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0047075.;GRICE EA, 2012, ANNU REV GENOM HUM G, V13, P151, DOI 10.1146/ANNUREV-GENOM-090711-163814.;HAMADY M, 2009, GENOME RES, V19, P1141, DOI 10.1101/GR.085464.108.;HE XS, 2009, INT J ORAL SCI, V1, P47, DOI 10.4248/IJOS.09029.;HU YJ, 2013, INT J ORAL SCI, V5, P21, DOI 10.1038/IJOS.2013.15.;HU YJ, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0056343.;HUSE SM, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0034242.;JIANG W, 2011, MICROB ECOL, V61, P342, DOI 10.1007/S00248-010-9753-Z.;JIANG W, 2013, CURR MICROBIOL, V67, P537, DOI 10.1007/S00284-013-0393-7.;KEIJSER BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104.;LAZAREVIC V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523.;LI KR, 2013, PLOS ONE, V8, DOI [10.1371/JOURNAL.PONE.0084171, 10.1371/JOURNAL.PONE.0058057].;LING ZX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-390.;MIGNARD S, 2006, J MICROBIOL METH, V67, P574, DOI 10.1016/J.MIMET.2006.05.009.;MUKHERJEE PK, 2014, PLOS PATHOG, V10, DOI 10.1371/JOURNAL.PPAT.1003996.;PASTER BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/J.1600-0757.2006.00174.X.;PETERSON SN, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0058487.;PUSHALKAR S, 2014, INT J ORAL SCI, V6, P219, DOI 10.1038/IJOS.2014.46.;SEGATA N, 2012, GENOME BIOL, V13, DOI 10.1186/GB-2012-13-6-R42.;SHADE A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/J.1462-2920.2011.02585.X.;TAO Y, 2013, ARCH ORAL BIOL, V58, P1129, DOI 10.1016/J.ARCHORALBIO.2013.04.005.;TURNBAUGH PJ, 2007, NATURE, V449, P804, DOI 10.1038/NATURE06244.;URSELL LK, 2012, NUTR REV, V70, PS38, DOI 10.1111/J.1753-4887.2012.00493.X.;WADE WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/J.PHRS.2012.11.006.;WANG JF, 2013, SCI REP-UK, V3, DOI 10.1038/SREP01843.;WANG Y, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0102116.;WOO PCY, 2008, CLIN MICROBIOL INFEC, V14, P908, DOI 10.1111/J.1469-0691.2008.02070.X.;XIN BC, 2013, ORAL DIS, V19, P401, DOI 10.1111/ODI.12018.;XU X, 2014, ORAL CAVITY CONTAINS.;YAMANAKA W, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0042806.;YANG F, 2013, J DENT RES, V92, P1106, DOI 10.1177/0022034513507065.;YE Y, 2013, CLIN MICROBIOL INFEC, V19, PE559, DOI 10.1111/1469-0691.12287.;ZAURA E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259.","HUANG, ZW (REPRINT AUTHOR), SHANGHAI JIAO TONG UNIV, DEPT ENDODONT, PEOPLES HOSP 9, SCH MED,SHANGHAI KEY LAB STOMATOL, SHANGHAI 200030, PEOPLES R CHINA.;JIANG, WEN-XIN, HU, YUE-JIAN, GAO, LI, HE, ZHI-YAN, ZHU, CAI-LIAN, MA, RUI, HUANG, ZHENG-WEI, SHANGHAI JIAO TONG UNIV, DEPT ENDODONT, PEOPLES HOSP 9, SCH MED,SHANGHAI KEY LAB STOMATOL, SHANGHAI 200030, PEOPLES R CHINA.","10.1371/JOURNAL.PONE.0124631","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","UNSP E0124631",NA,"NATIONAL SCIENCE \& TECHNOLOGY POLLAR PROGRAM [2012BAL07B03], NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA [81070826/81371143], SHANGHAI RISING-STAR PROGRAM [12QH1401400]","THIS WORK WAS SUPPORTED BY THE NATIONAL SCIENCE \& TECHNOLOGY POLLAR PROGRAM DURING THE 12TH FIVE-YEAR PLAN PERIOD (GRANT NO. 2012BAL07B03). THIS WORK WAS ALSO SUPPORTED BY GRANT NO. 81070826/81371143 FROM THE NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA AND WAS PARTLY SUPPORTED BY SHANGHAI RISING-STAR PROGRAM NO. 12QH1401400. ZWH RECEIVED THE FUNDING.",NA,"1932-6203","5",NA,"PUBLIC LIBRARY SCIENCE","10",2015,"ISI000353943400019","35","SCIENCE \& TECHNOLOGY - OTHER TOPICS","14","MULTIDISCIPLINARY SCIENCES","HUANGZHENGWEISHSMU.EDU.CN",NA,"CH3PT",NA,"HUANG, ZW (REPRINT AUTHOR), SHANGHAI JIAO TONG UNIV, DEPT ENDODONT, PEOPLES HOSP 9, SCH MED,SHANGHAI KEY LAB STOMATOL, SHANGHAI 200030, PEOPLES R CHINA","ISI","SHANGHAI JIAO TONG UNIV","SHANGHAI JIAO TONG UNIV",NA,"JIANG W, 2015, PLOS ONE","JIANG W, 2015, PLOS ONE"
"DAVARE MA, 2015, BIOL CELL","DAVARE MA;TOGNON CE","DETECTING AND TARGETTING ONCOGENIC FUSION PROTEINS IN THE GENOMIC ERA","BIOLOGY OF THE CELL","BIOL. CELL","THE ADVENT OF WIDESPREAD CANCER GENOME SEQUENCING HAS ACCELERATED OUR UNDERSTANDING OF THE MOLECULAR ABERRATIONS UNDERLYING MALIGNANT DISEASE AT AN UNPRECEDENTED RATE. COUPLING THE LARGE NUMBER OF BIOINFORMATIC METHODS DEVELOPED TO LOCATE GENOMIC BREAKPOINTS WITH INCREASED SEQUENCE READ LENGTH AND A DEEPER UNDERSTANDING OF CODING REGION FUNCTION HAS ENABLED RAPID IDENTIFICATION OF NOVEL ACTIONABLE ONCOGENIC FUSION GENES. USING EXAMPLES OF KINASE FUSIONS FOUND IN LIQUID AND SOLID TUMOURS, THIS REVIEW HIGHLIGHTS MAJOR CONCEPTS THAT HAVE ARISEN IN OUR UNDERSTANDING OF CANCER PATHOGENESIS THROUGH THE STUDY OF FUSION PROTEINS. WE PROVIDE AN OVERVIEW OF RECENTLY DEVELOPED METHODS TO IDENTIFY POTENTIAL FUSION PROTEINS FROM NEXT-GENERATION SEQUENCING DATA, DESCRIBE THE VALIDATION OF THEIR ONCOGENIC POTENTIAL AND DISCUSS THE ROLE OF TARGETTED THERAPIES IN TREATING CANCERS DRIVEN BY FUSION ONCOPROTEINS.","CANCER; ONCOLOGY; CANCER; OTHER RECEPTORS; PROTEIN KINASES; PHOSPHATASES; TARGETED THERAPY","INFLAMMATORY MYOFIBROBLASTIC TUMOR; LARGE-CELL LYMPHOMA; CHRONIC MYELOID-LEUKEMIA; ETV6-NTRK3 GENE FUSION; POSITIVE LUNG-CANCER; RNA-SEQ DATA; ACUTE PROMYELOCYTIC LEUKEMIA; RECEPTOR TYROSINE KINASES; LOCALIZED PROSTATE-CANCER; BCR-ABL","ENGLISH","REVIEW","ARTICLE",10,"ABATE F, 2014, BMC SYST BIOL, V8, DOI 10.1186/S12918-014-0097-Z.;ABATE F, 2012, BIOINFORMATICS, V28, P2114, DOI 10.1093/BIOINFORMATICS/BTS334.;ARDINI E, 2014, MOL ONCOL, V8, P1495, DOI 10.1016/J.MOLONC.2014.06.001.;ASMANN YW, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/NAR/GKR362.;AWAD MARK M, 2014, CLIN ADV HEMATOL ONCOL, V12, P429.;AWAD MM, 2013, NEW ENGL J MED, V368, P2395, DOI 10.1056/NEJMOA1215530.;BECCUTI M., 2013, GENOME BIOINFORMATIC, V1, P2.;BENELLI M, 2012, BIOINFORMATICS, V28, P3232, DOI 10.1093/BIOINFORMATICS/BTS617.;BIRCH AH, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0028250.;BIRCHMEIER C, 1987, P NATL ACAD SCI USA, V84, P9270, DOI 10.1073/PNAS.84.24.9270.;BOEHM JS, 2011, NAT REV GENET, V12, P487, DOI 10.1038/NRG3013.;BRADEEN HA, 2006, BLOOD, V108, P2332, DOI 10.1182/BLOOD-2006-02-004580.;BRIDGE JA, 2001, AM J PATHOL, V159, P411, DOI 10.1016/S0002-9440(10)61711-7.;CAMIDGE DR, 2014, NAT REV CLIN ONCOL, V11, P473, DOI 10.1038/NRCLINONC.2014.104.;CARRARA M, 2013, BIOMED RES INT, DOI 10.1155/2013/340620.;CASALUCE F, 2013, TARGET ONCOL, V8, P55, DOI 10.1007/S11523-012-0250-9.;CHAREST A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/GCC.10207.;CHAREST A, 2003, P NATL ACAD SCI USA, V100, P916, DOI 10.1073/PNAS.242741799.;CHIARI R, 2014, CLIN LUNG CANCER, V15, P470, DOI 10.1016/J.CLLC.2014.06.004.;CHU HT, 2013, BIOINFORMATICS, V29, P1004, DOI 10.1093/BIOINFORMATICS/BTT092.;COLLEONI GWB, 2000, AM J PATHOL, V156, P781, DOI 10.1016/S0002-9440(10)64945-0.;COOLS J, 2002, GENE CHROMOSOME CANC, V34, P354, DOI 10.1002/GCC.10033.;CUNHA SI, 2011, BLOOD, V117, P6999, DOI 10.1182/BLOOD-2011-01-330142.;DAVARE MA, 2013, P NATL ACAD SCI USA, V110, P19519, DOI 10.1073/PNAS.1319583110.;DAVIES KD, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0082236.;DAVIES KD, 2013, CLIN CANCER RES, V19, P4040, DOI 10.1158/1078-0432.CCR-12-2851.;DE BRAEKELEER E, 2014, EXPERT REV HEMATOL, V7, P347, DOI 10.1586/17474086.2014.903794.;DE PAEPE P, 2003, BLOOD, V102, P2638, DOI 10.1182/BLOOD-2003-04-1050.;DEBELENKO LV, 2011, MODERN PATHOL, V24, P430, DOI 10.1038/MODPATHOL.2010.213.;DEBELENKO LV, 2003, LAB INVEST, V83, P1255, DOI 10.1097/01.LAB.0000088856.49388.EA.;DOEBELE RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906.;DREXLER HG, 2000, LEUKEMIA, V14, P1533, DOI 10.1038/SJ.LEU.2401878.;DRILON A, 2013, CANCER DISCOV, V3, P630, DOI 10.1158/2159-8290.CD-13-0035.;DRUKER BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMOA062867.;DRUKER BJ, 2009, NAT MED, V15, P1149, DOI 10.1038/NM1009-1149.;EDGREN H, 2011, GENOME BIOL, V12, DOI 10.1186/GB-2011-12-1-R6.;FEHR A, 2011, AM J SURG PATHOL, V35, P1600, DOI 10.1097/PAS.0B013E31822832C7.;FRAMPTON GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/NBT.2696.;FRANCIS RW, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0039987.;GAINOR JF, 2013, ONCOLOGIST, V18, P865, DOI 10.1634/THEONCOLOGIST.2013-0095.;GE HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/BIOINFORMATICS/BTR310.;GIACOMINI CP, 2013, PLOS GENET, V9, DOI 10.1371/JOURNAL.PGEN.1003464.;GIBBONS DL, 2012, CANCER-AM CANCER SOC, V118, P293, DOI 10.1002/CNCR.26225.;GRANDE E, 2011, MOL CANCER THER, V10, P569, DOI 10.1158/1535-7163.MCT-10-0615.;GRECO A, 1993, GENOMICS, V18, P397, DOI 10.1006/GENO.1993.1482.;GU TL, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0015640.;HANAHAN D, 2011, CELL, V144, P646, DOI 10.1016/J.CELL.2011.02.013.;HANTSCHEL O, 2012, CANCER RES, V72, P4890, DOI 10.1158/0008-5472.CAN-12-1276.;HERNANDEZ L, 1999, BLOOD, V94, P3265.;HESSELS D, 2007, CLIN CANCER RES, V13, P5103, DOI 10.1158/1078-0432.CCR-07-0700.;HEUCKMANN JM, 2011, CLIN CANCER RES, V17, P7394, DOI 10.1158/1078-0432.CCR-11-1648.;CHI HT, 2012, BIOCHEM BIOPH RES CO, V429, P87, DOI 10.1016/J.BBRC.2012.10.087.;HUANG EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/ANNUREV.NEURO.24.1.677.;HUANG ME, 1988, BLOOD, V72, P567.;IYER MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/BIOINFORMATICS/BTR467.;JIA WL, 2013, GENOME BIOL, V14, DOI 10.1186/GB-2013-14-2-R12.;JONES DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/NG.2682.;JUNG Y, 2012, GENE CHROMOSOME CANC, V51, P590, DOI 10.1002/GCC.21945.;KATAYAMA R, 2014, CLIN CANCER RES, V20, P5686, DOI 10.1158/1078-0432.CCR-14-1511.;KIM D, 2011, GENOME BIOL, V12, DOI 10.1186/GB-2011-12-8-R72.;KIM J, 2014, ONCOGENE, V33, P5183, DOI 10.1038/ONC.2013.461.;KINSELLA M, 2011, BIOINFORMATICS, V27, P1068, DOI 10.1093/BIOINFORMATICS/BTR085.;KNEZEVICH SR, 1998, NAT GENET, V18, P184, DOI 10.1038/NG0298-184.;KNEZEVICH SR, 1998, CANCER RES, V58, P5046.;KOHNO T, 2013, CANCER SCI, V104, P1396, DOI 10.1111/CAS.12275.;KRALIK JM, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-19.;KWAK EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMOA1006448.;LAMANT L, 2003, GENE CHROMOSOME CANC, V37, P427, DOI 10.1002/GCC.10232.;LARRIVEE B, 2012, DEV CELL, V22, P489, DOI 10.1016/J.DEVCEL.2012.02.005.;LAWRENCE B, 2000, AM J PATHOL, V157, P377, DOI 10.1016/S0002-9440(10)64550-6.;LEE J, 2013, CANCER-AM CANCER SOC, V119, P1627, DOI 10.1002/CNCR.27967.;LEEMAN-NEILL RJ, 2014, CANCER-AM CANCER SOC, V120, P799, DOI 10.1002/CNCR.28484.;LI Y, 2011, BIOINFORMATICS, V27, P1708, DOI 10.1093/BIOINFORMATICS/BTR265.;LI Z, 2007, CANCER CELL, V12, P542, DOI 10.1016/J.CCR.2007.11.012.;LIN E, 2009, MOL CANCER RES, V7, P1466, DOI 10.1158/1541-7786.MCR-08-0522.;LIPSON D, 2012, NAT MED, V18, P382, DOI 10.1038/NM.2673.;LIU H, 2014, CANCER CELL, V25, P530, DOI 10.1016/J.CCR.2014.03.008.;LOVLY C. M., 2012, SCI TRANSL MED, V4.;LU XY, 2011, CURR MED CHEM, V18, P2146.;MA ZG, 2003, GENE CHROMOSOME CANC, V37, P98, DOI 10.1002/GCC.10177.;MARTIN MJ, 2006, MOL CELL BIOL, V26, P1754, DOI 10.1128/MCB.26.5.1754-1769.2006.;MCDONALD J, 2011, GENET MED, V13, P607, DOI 10.1097/GIM.0B013E3182136D32.;MCPHERSON A, 2012, GENOME RES, V22, P2250, DOI 10.1101/GR.136572.111.;MCPHERSON A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/JOURNAL.PCBI.1001138.;MCPHERSON A, 2011, BIOINFORMATICS, V27, P1481, DOI 10.1093/BIOINFORMATICS/BTR184.;MEECH SJ, 2001, BLOOD, V98, P1209, DOI 10.1182/BLOOD.V98.4.1209.;MEHRA R, 2007, MODERN PATHOL, V20, P538, DOI 10.1038/MODPATHOL.3800769.;MIAN AA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-411.;MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/SCIENCE.8122112.;MOUNIR Z, 2015, ONCOGENE, V34, P3815, DOI 10.1038/ONC.2014.308.;NAKAGAWARA A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4.;NAM RK, 2007, BRIT J CANCER, V97, P1690, DOI 10.1038/SJ.BJC.6604054.;NAM RK, 2007, CANCER BIOL THER, V6, P40, DOI 10.4161/CBT.6.1.3489.;NITA-LAZAR A, 2008, PROTEOMICS, V8, P4433, DOI 10.1002/PMIC.200800231.;NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85.;O'HARE T, 2007, BLOOD, V110, P2242, DOI 10.1182/BLOOD-2007-03-066936.;O'HARE T, 2007, CLIN LYMPHOMA MYELOM, V7, PS120, DOI 10.3816/CLM.2007.S.012.;O'HARE T, 2009, CANCER CELL, V16, P401, DOI 10.1016/J.CCR.2009.09.028.;PANAGOPOULOS I, 2006, INT J CANCER, V118, P1181, DOI 10.1002/IJC.21490.;PARKER BC, 2013, CHIN J CANCER, V32, P594, DOI 10.5732/CJC.013.10178.;PEROT G, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0087170.;PETROVICS G, 2005, ONCOGENE, V24, P3847, DOI 10.1038/SJ.ONC.1208518.;PIAZZA R, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/NAR/GKS394.;PULFORD K, 1997, BLOOD, V89, P1394.;QADIR MA, 2014, J MOL DIAGN, V16, P361, DOI 10.1016/J.JMOLDX.2014.01.002.;REDMOND AISLING M, 2009, GENOME BIOL, V10, P311, DOI 10.1186/GB-2009-10-7-311.;REN H, 2012, CANCER RES, V72, P3312, DOI 10.1158/0008-5472.CAN-11-3931.;RIKOVA K, 2007, CELL, V131, P1190, DOI 10.1016/J.CELL.2007.11.025.;RIMKUNAS VM, 2012, CLIN CANCER RES, V18, P4449, DOI 10.1158/1078-0432.CCR-11-3351.;ROBERTS KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMOA1403088.;RODIG SJ, 2010, CURR OPIN INVEST DR, V11, P1477.;ROSS JS, 2014, ONCOLOGIST, V19, P235, DOI 10.1634/THEONCOLOGIST.2013-0352.;RUBIN BP, 1998, AM J PATHOL, V153, P1451, DOI 10.1016/S0002-9440(10)65732-X.;SAKARYA O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/JOURNAL.PCBI.1002464.;SARAMAKI OR, 2008, CLIN CANCER RES, V14, P3395, DOI 10.1158/1078-0432.CCR-07-2051.;SBONER A, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-10-R104.;SHAH N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-818.;SHARMA S, 1989, ONCOGENE RES, V5, P91.;SHAW AT, 2014, NEW ENGL J MED, V371, P1963, DOI 10.1056/NEJMOA1406766.;SHAW AT, 2013, NAT REV CANCER, V13, P772, DOI 10.1038/NRC3612.;SHAW AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMOA1214886.;SHIOTA M, 1994, ONCOGENE, V9, P1567.;SKALOVA A, 2010, AM J SURG PATHOL, V34, P599, DOI 10.1097/PAS.0B013E3181D9EFCC.;SODA M, 2007, NATURE, V448, P561, DOI 10.1038/NATURE05945.;SOLOMON BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMOA1408440, 10.1056/NEJMX150034].;STRANSKY N, 2014, NAT COMMUN, V5, DOI 10.1038/NCOMMS5846.;SUEHARA Y, 2012, CLIN CANCER RES, V18, P6599, DOI 10.1158/1078-0432.CCR-12-0838.;SUN RP, 2012, BIOINFORMATICS, V28, P1024, DOI 10.1093/BIOINFORMATICS/BTS064.;TAIPALE M, 2013, NAT BIOTECHNOL, V31, P630, DOI 10.1038/NBT.2620.;TAKASHIMA T., 1992, JAP J CLIN MED, V50, P1363.;TAKEUCHI K, 2008, CLIN CANCER RES, V14, P6618, DOI 10.1158/1078-0432.CCR-08-1018.;TAKEUCHI K, 2012, NAT MED, V18, P378, DOI 10.1038/NM.2658.;TAKEUCHI K, 2011, HAEMATOL-HEMATOL J, V96, P464, DOI 10.3324/HAEMATOL.2010.033514.;TAKEUCHI K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248.;TARIS M, 2014, PROSTATE, V74, P1481, DOI 10.1002/PROS.22863.;THIELE CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651.;TOGASHI Y, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0031323.;TOGNON C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0.;TOGNON CE, 2012, ONCOGENE, V31, P1334, DOI 10.1038/ONC.2011.323.;TOGNON CE, 2011, CANCER RES, V71, P1060, DOI 10.1158/0008-5472.CAN-10-3096.;TOMLINS SA, 2005, SCIENCE, V310, P644, DOI 10.1126/SCIENCE.1117679.;TORT F, 2001, LAB INVEST, V81, P419, DOI 10.1038/LABINVEST.3780249.;VAISHNAVI A, 2013, NAT MED, V19, P1469, DOI 10.1038/NM.3352.;WANG K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/NAR/GKQ622.;WANG QG, 2013, BRIEF BIOINFORM, V14, P506, DOI 10.1093/BIB/BBS044.;WIESNER T, 2014, NAT COMMUN, V5, DOI 10.1038/NCOMMS4116.;WINNES M, 2007, ONCOL REP, V17, P1033.;WU G, 2014, NAT GENET, V46, P444, DOI 10.1038/NG.2938.;YORUKOGLU D, 2012, BIOINFORMATICS, V28, PI179, DOI 10.1093/BIOINFORMATICS/BTS214.;YOSHIDA A, 2013, HISTOPATHOLOGY, V63, P881, DOI 10.1111/HIS.12218.;ZABRISKIE MS, 2014, CANCER CELL, V26, P428, DOI 10.1016/J.CCR.2014.07.006.;ZHANG JH, 2013, NAT GENET, V45, P602, DOI 10.1038/NG.2611.","DAVARE, MA (REPRINT AUTHOR), OREGON HLTH \& SCI UNIV, KNIGHT CANC INST, PORTLAND, OR 97239 USA.;DAVARE, MONIKA A., TOGNON, CRISTINA E., OREGON HLTH \& SCI UNIV, KNIGHT CANC INST, PORTLAND, OR 97239 USA.;DAVARE, MONIKA A., OREGON HLTH \& SCI UNIV, DEPT PEDIAT, PORTLAND, OR 97239 USA.;TOGNON, CRISTINA E., HOWARD HUGHES MED INST, PORTLAND, OR 97239 USA.","10.1111/BOC.201400096","111 RIVER ST, HOBOKEN 07030-5774, NJ USA",NA,NA,"HYUNDAI HOPE ON WHEELS, HOWARD HUGHES FOUNDATION","THIS WORK WAS SUPPORTED IN PART BY A HYUNDAI HOPE ON WHEELS GRANT TO M.D. C.T. IS SUPPORTED THROUGH HOWARD HUGHES FOUNDATION INVESTIGATOR SUPPORT AWARDED TO B.J. DRUKER.",NA,"0248-4900","5","111-129","WILEY-BLACKWELL","107",2015,"ISI000354209900001","152","CELL BIOLOGY","16","CELL BIOLOGY","DAVAREMOHSU.EDU TOGNONOHSU.EDU",NA,"CH7IQ",NA,"DAVARE, MA (REPRINT AUTHOR), OREGON HLTH \& SCI UNIV, KNIGHT CANC INST, PORTLAND, OR 97239 USA","ISI","OREGON HLTH AND SCI UNIV;OREGON HLTH AND SCI UNIV;HOWARD HUGHES MED INST","OREGON HLTH AND SCI UNIV",NA,"DAVARE MA, 2015, BIOL CELL","DAVARE MA, 2015, BIOL CELL"
"KAITETZIDOU E, 2015, PHYSIOL GENOMICS","KAITETZIDOU E;XIANG J;ANTONOPOULOU E;TSIGENOPOULOS CS;SARROPOULOU E","DYNAMICS OF GENE EXPRESSION PATTERNS DURING EARLY DEVELOPMENT OF THE EUROPEAN SEABASS (DICENTRARCHUS LABRAX)","PHYSIOLOGICAL GENOMICS","PHYSIOL. GENOMICS","LARVAL AND EMBRYONIC STAGES ARE THE MOST CRITICAL PERIOD IN THE LIFE CYCLE OF MARINE FISH. KEY DEVELOPMENTAL EVENTS OCCUR EARLY IN DEVELOPMENT AND ARE INFLUENCED BY EXTERNAL PARAMETERS LIKE STRESS, TEMPERATURE, SALINITY, AND PHOTOPERIODISM. ANY FAILURE MAY CAUSE MALFORMATIONS, DEVELOPMENTAL DELAYS, POOR GROWTH, AND MASSIVE MORTALITIES. ADVANCED UNDERSTANDING OF MOLECULAR PROCESSES UNDERLYING MARINE LARVAL DEVELOPMENT MAY LEAD TO SUPERIOR LARVAL REARING CONDITIONS. TODAY, THE NEW SEQUENCING AND BIOINFORMATIC METHODS ALLOW TRANSCRIPTOME SCREENS COMPRISING MESSENGER (MRNA) AND MICRORNA (MIRNA) WITH THE SCOPE OF DETECTING DIFFERENTIAL EXPRESSION FOR ANY SPECIES OF INTEREST. IN THE PRESENT STUDY, WE APPLIED ILLUMINA TECHNOLOGY TO INVESTIGATE THE TRANSCRIPTOME OF EARLY DEVELOPMENTAL STAGES OF THE EUROPEAN SEABASS (DICENTRARCHUS LABRAX). THE EUROPEAN SEABASS, IN ITS NATURAL ENVIRONMENT, IS A EURYHALINE SPECIES AND HAS SHOWN HIGH ADAPTATION PROCESSES IN EARLY LIFE PHASES. DURING ITS EMBRYONIC AND LARVAL PHASES THE EUROPEAN SEABASS LIVES IN A MARINE ENVIRONMENT AND AS A JUVENILE IT MIGRATES TO COASTAL ZONES, ESTUARIES, AND LAGOONS. INVESTIGATING THE DYNAMICS OF GENE EXPRESSION IN ITS EARLY DEVELOPMENT MAY SHED LIGHT ON FACTORS PROMOTING PHENOTYPIC PLASTICITY AND MAY ALSO CONTRIBUTE TO THE IMPROVEMENT AND ADVANCEMENT OF REARING METHODS OF THE EUROPEAN SEABASS, A SPECIES OF HIGH ECONOMIC IMPORTANCE IN EUROPEAN AND MEDITERRANEAN AQUACULTURE. WE PRESENT THE IDENTIFICATION, CHARACTERIZATION, AND EXPRESSION OF MRNA AND MIRNA, COMPRISING PARALOGOUS GENES AND DIFFERENTIALLY SPLICED TRANSCRIPTS FROM EARLY DEVELOPMENTAL STAGES OF THE EUROPEAN SEABASS. WE FURTHER INVESTIGATED THE DETECTION OF POSSIBLE INTERACTIONS OF MIRNA WITH MRNA.","RNA-SEQ; TRANSCRIPTOMICS; AQUACULTURE; EUROPEAN SEABASS; DICENTRARCHUS LABRAX; MIRNA; MRNA; DEVELOPMENT","RNA-SEQ; EMBRYONIC-DEVELOPMENT; SKELETAL-MUSCLE; MICRORNA EXPRESSION; GENOME DUPLICATION; ANIMAL DEVELOPMENT; ORYZIAS-LATIPES; HUMAN-DISEASE; ZEBRAFISH; TRANSCRIPTOME","ENGLISH","ARTICLE","ARTICLE",7,"ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;ALVAREZ-GARCIA I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/DEV.02073.;ANDERS S, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-10-R106.;BARDOU P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293.;BEKAERT M, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0070136.;BIZUAYEHU TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-11.;BIZUAYEHU TT, 2014, GENOME BIOL EVOL, V6, P1911, DOI 10.1093/GBE/EVU151.;BOLGER AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/BIOINFORMATICS/BTU170.;BOUTET I, 2006, GENE, V379, P40, DOI 10.1016/J.GENE.2006.04.011.;CALDUCH-GINER JA, 2013, BMC GENOMICS, V13, P470.;LANES CFC, 2013, MAR BIOTECHNOL, V15, P677, DOI 10.1007/S10126-013-9527-Y.;CHANG S, 2004, NATURE, V430, P785, DOI 10.1038/NATURE02752.;CHEN PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/GAD.1310605.;CHISTIAKOV DA, 2004, ANIM GENET, V35, P53, DOI 10.1046/J.1365-2052.2003.01076.X.;COLLIGNON J, 1996, NATURE, V381, P155, DOI 10.1038/381155A0.;CONESA ANA, 2008, INT J PLANT GENOMICS, V2008, P619832, DOI 10.1155/2008/619832.;CUCCHI P, 2012, HELGOLAND MAR RES, V66, P199, DOI 10.1007/S10152-011-0262-3.;DARIAS MJ, 2008, MAR BIOTECHNOL, V10, P416, DOI 10.1007/S10126-007-9078-1.;DE LA SERRANA DG, 2014, GENOME BIOL EVOL, V6, P981, DOI 10.1093/GBE/EVU074.;DE LA SERRANA DG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-181.;DIVANACH P, 1985, THESIS U SCI TECHNIQ.;DOOLEY K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5.;ENRIGHT ANTON J, 2003, GENOME BIOL, V5, PR1, DOI 10.1186/GB-2003-5-1-R1.;FERNANDES AM, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0075002.;FJOSE A, 2010, NEW BIOTECHNOL, V27, P250, DOI 10.1016/J.NBT.2010.02.017.;FORCE A, 1999, GENETICS, V151, P1531.;FU YS, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0022957.;GAGAN J, 2012, CURR OPIN PHARMACOL, V12, P383, DOI 10.1016/J.COPH.2012.02.001.;GEAY F, 2011, AQUACULTURE EUROPE 1, V2020, P377.;GRABHERR MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/NBT.1883.;GUYON R, 2010, GENOMICS, V96, P228, DOI 10.1016/J.YGENO.2010.07.007.;HAAS BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/NBT0510-421.;HAND NJ, 2009, GASTROENTEROLOGY, V136, P1081, DOI 10.1053/J.GASTRO.2008.12.006.;HARTIGAN J. A., 1979, APPLIED STATISTICS, V28, P100, DOI 10.2307/2346830.;HE L, 2004, NAT REV GENET, V5, P522.;HORI H, 2007, J GASTROENTEROL, V42, P567, DOI 10.1007/S00535-007-2055-7.;IWAMATSU T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/J.MOD.2004.03.012.;JANSSON MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/J.MOLONC.2012.09.006.;JIN ZG, 2006, CURR BIOL, V16, PR966, DOI 10.1016/J.CUB.2006.10.018.;KASSAHN KS, 2009, GENOME RES, V19, P1404, DOI 10.1101/GR.086827.108.;KENT WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/GR.229202, 10.1101/GR.229202. ARTICLE PUBLISHED ONLINE BEFORE MARCH 2002].;KETLEY A, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0065170.;KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/AJA.1002030302.;KITANO J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-214.;KRUGER J, 2006, NUCLEIC ACIDS RES, V34, PW451, DOI 10.1093/NAR/GKL243.;LANGMEAD B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/NMETH.1923].;LANGMEAD B, 2009, GENOME BIOL, V10, DOI 10.1186/GB-2009-10-3-R25.;LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y.;LI B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323.;LI P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-177.;LI SC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S8.;LI WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/BIOINFORMATICS/BTL158.;LIU L, 2012, BMC PUBLIC HEALTH, V12, DOI [10.1186/1471-2458-12-219, 10.1155/2012/251364].;LIU SHIKAI, 2012, BMC GENOMICS, V13, P595, DOI 10.1186/1471-2164-13-595.;LUO GZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-727.;MCGETTIGAN PA, 2013, CURR OPIN CHEM BIOL, V17, P4, DOI 10.1016/J.CBPA.2012.12.008.;MERCIER P, 1995, INT J DEV BIOL, V39, P559.;MICHIBATA H, 1987, ENVIRON RES, V42, P321, DOI 10.1016/S0013-9351(87)80197-4.;MICHOEL T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S5.;MISHRA N. S., 2007, OPEN PLANT SCIENCE JOURNAL, V1, P1.;OSHLACK A, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-12-220.;PAULI A, 2012, GENOME RES, V22, P577, DOI 10.1101/GR.133009.111.;PITTMAN K, 2013, REV AQUACULT, V5, PS224, DOI 10.1111/RAQ.12034.;POWELL GT, 2011, PLOS BIOL, V9, DOI 10.1371/JOURNAL.PBIO.1001216.;RAMACHANDRA RK, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-41.;RAPAPORT F, 2013, GENOME BIOL, V14, DOI 10.1186/GB-2013-14-9-R95.;SALEM M, 2010, MAR BIOTECHNOL, V12, P410, DOI 10.1007/S10126-009-9232-Z.;SARROPOULOU E, 2008, MAR BIOTECHNOL, V10, P227, DOI 10.1007/S10126-007-9066-5.;SARROPOULOU E, 2005, PHYSIOL GENOMICS, V23, P182, DOI 10.1152/PHYSIOLGENOMICS.00139.2005.;SARROPOULOU E, 2012, MAR BIOTECHNOL, V14, P634, DOI 10.1007/S10126-012-9466-Z.;SARROPOULOU E, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0087744.;SARROPOULOU E, 2011, MAR BIOTECHNOL, V13, P1115, DOI 10.1007/S10126-011-9375-6.;SARROPOULOU E, 2010, MOL PHYLOGENET EVOL, V55, P640, DOI 10.1016/J.YMPEV.2009.10.001.;SHANNON P, 2003, GENOME RES, V13, P2498, DOI 10.1101/GR.1239303.;SOARES AR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-195.;STEINER E, 2006, CURR DRUG TARGETS, V7, P923, DOI 10.2174/138945006778019345.;STERN-GINOSSAR N, 2007, SCIENCE, V317, P376, DOI 10.1126/SCIENCE.1140956.;TAYLOR JS, 2003, GENOME RES, V13, P382, DOI 10.1101/GR.640303.;TINE M, 2014, NAT COMMUN, V5, DOI 10.1038/NCOMMS6770.;TON C, 2000, GENOME RES, V10, P1915, DOI 10.1101/GR.10.12.1915.;VESTERLUND L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30.;VON WESTERNHAGEN H, 1988, FISH PHYSL A, VXI, P254.;WAGNER A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/J.1558-5646.1996.TB02342.X.;WANG Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/NRG2484.;WIENHOLDS E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/J.FEBSLET.2005.07.070.;WIENHOLDS E, 2003, NAT GENET, V35, P217, DOI 10.1038/NG1251.;WIENHOLDS E, 2005, SCIENCE, V309, P310, DOI 10.1126/SCIENCE.1114519.;WIGHTMAN B, 1991, GENE DEV, V5, P1813, DOI 10.1101/GAD.5.10.1813.;WONG L, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-100.;XIA JH, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0017537.;YAN B, 2013, J EXP BIOL, V216, P447, DOI 10.1242/JEB.076315.;YAN B, 2012, AQUACULTURE, V364, P240, DOI 10.1016/J.AQUACULTURE.2012.08.018.;YAN XC, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0030925.;YEKTA S, 2004, SCIENCE, V304, P594, DOI 10.1126/SCIENCE.1097434.;YING SY, 2005, BIOCHEM BIOPH RES CO, V335, P1, DOI 10.1016/J.BBRC.2005.06.130.;YOSHINARI N, 2009, DEV BIOL, V325, P71, DOI 10.1016/J.YDBIO.2008.09.028.","SARROPOULOU, E (REPRINT AUTHOR), INST MARINE BIOL BIOTECHNOL \& AQUACULTURE, HELLEN CTR MARINE RES, POB 2214, IRAKLION 71003, GREECE.;KAITETZIDOU, E., TSIGENOPOULOS, C. S., SARROPOULOU, E., INST MARINE BIOL BIOTECHNOL \& AQUACULTURE, HELLEN CTR MARINE RES, IRAKLION 71003, GREECE.;KAITETZIDOU, E., ANTONOPOULOU, E., ARISTOTLE UNIV THESSALONIKI, FAC SCI, SCH BIOL, THESSALONIKI, GREECE.;XIANG, J., WEILL CORNELL MED COLL, GENOM RESOURCES CORE FACIL, NEW YORK, NY USA.","10.1152/PHYSIOLGENOMICS.00001.2015","9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA",NA,NA,"MINISTRY OF EDUCATION AND RELIGIOUS AFFAIRS, UNDER THE CALL ``ARISTEIA I'' OF THE NATIONAL STRATEGIC REFERENCE FRAMEWORK (ANNOTATE), EU,","FINANCIAL SUPPORT FOR THIS STUDY HAS BEEN PROVIDED BY THE MINISTRY OF EDUCATION AND RELIGIOUS AFFAIRS, UNDER THE CALL ``ARISTEIA I'' OF THE",NA,"1094-8341","5","158-169","AMER PHYSIOLOGICAL SOC","47",2015,"ISI000353926600003","96","CELL BIOLOGY, GENETICS \& HEREDITY, PHYSIOLOGY","38","CELL BIOLOGY, GENETICS \& HEREDITY, PHYSIOLOGY","SARRISHCMR.GR",NA,"CH3JI",NA,"SARROPOULOU, E (REPRINT AUTHOR), INST MARINE BIOL BIOTECHNOL \& AQUACULTURE, HELLEN CTR MARINE RES, POB 2214, IRAKLION 71003, GREECE","ISI","INST MARINE BIOL BIOTECHNOL AND AQUACULTURE;ARISTOTLE UNIV THESSALONIKI;WEILL CORNELL MED COLL","INST MARINE BIOL BIOTECHNOL AND AQUACULTURE",NA,"KAITETZIDOU E, 2015, PHYSIOL GENOMICS","KAITETZIDOU E, 2015, PHYSIOL GENOMICS"
"LAMBERT D, 2015, PLOS ONE","LAMBERT D;CARRILLO CD;KOZIOL AG;MANNINGER P;BLAIS BW","GENESIPPR: A RAPID WHOLE-GENOME APPROACH FOR THE IDENTIFICATION AND CHARACTERIZATION OF FOODBORNE PATHOGENS SUCH AS PRIORITY SHIGA TOXIGENIC ESCHERICHIA COLI","PLOS ONE","PLOS ONE","THE TIMELY IDENTIFICATION AND CHARACTERIZATION OF FOODBORNE BACTERIA FOR RISK ASSESSMENT PURPOSES IS A KEY OPERATION IN OUTBREAK INVESTIGATIONS. CURRENT METHODS REQUIRE SEVERAL DAYS AND/OR PROVIDE LOW-RESOLUTION CHARACTERIZATION. HERE WE DESCRIBE A WHOLE-GENOME-SEQUENCING (WGS) APPROACH (GENESIPPR) ENABLING SAME-DAY IDENTIFICATION OF COLONY ISOLATES RECOVERED FROM INVESTIGATIVE FOOD SAMPLES. THE IDENTIFICATION OF COLONIES OF PRIORITY SHIGA-TOXIGENIC ESCHERICHIA COLI (STEC) (I.E., SEROGROUPS O26, O45, O103, O111, O121, O145 AND O157) SERVED AS A PROOF OF CONCEPT. GENOMIC DNA WAS ISOLATED FROM SINGLE COLONIES AND SEQUENCING WAS CONDUCTED ON THE ILLUMINA MISEQ INSTRUMENT WITH RAW DATA SAMPLING FROM THE INSTRUMENT FOLLOWING 4.5 HRS OF SEQUENCING. MODELING EXPERIMENTS INDICATED THAT DATASETS COMPRISED OF 21-NT READS REPRESENTING APPROXIMATELY 4-FOLD COVERAGE OF THE GENOME WERE SUFFICIENT TO AVOID SIGNIFICANT GAPS IN SEQUENCE DATA. A NOVEL BIOINFORMATIC PIPELINE WAS USED TO IDENTIFY THE PRESENCE OF SPECIFIC MARKER GENES BASED ON MAPPING OF THE SHORT READS TO REFERENCE SEQUENCE LIBRARIES, ALONG WITH THE DETECTION OF DISPERSED CONSERVED GENOMIC MARKERS AS A QUALITY CONTROL METRIC TO ASSURE THE VALIDITY OF THE ANALYSIS. STEC VIRULENCE MARKERS WERE CORRECTLY IDENTIFIED IN ALL ISOLATES TESTED, AND SINGLE COLONIES WERE IDENTIFIED WITHIN 9 HRS. THIS METHOD HAS THE POTENTIAL TO PRODUCE HIGH-RESOLUTION CHARACTERIZATION OF STEC ISOLATES, AND WHOLE-GENOME SEQUENCE DATA GENERATED FOLLOWING THE GENESIPPR ANALYSIS COULD BE USED FOR ISOLATE IDENTIFICATION IN PLACE OF LENGTHY BIOCHEMICAL CHARACTERIZATION AND TYPING METHODOLOGIES. SIGNIFICANT ADVANTAGES OF THIS PROCEDURE INCLUDE EASE OF ADAPTATION TO THE DETECTION OF ANY GENE MARKER OF INTEREST, AS WELL AS TO THE IDENTIFICATION OF OTHER FOODBORNE PATHOGENS FOR WHICH GENOMIC MARKERS HAVE BEEN DEFINED.",NA,"VIRULENCE; SEQUENCE; SURVEILLANCE; OUTBREAK; STRAINS; SYSTEM; FOOD; O26","ENGLISH","ARTICLE","ARTICLE",15,"AURASS P, 2011, ENVIRON MICROBIOL, V13, P3139, DOI 10.1111/J.1462-2920.2011.02604.X.;BANKEVICH A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/CMB.2012.0021.;BIELASZEWSKA M, 2013, CLIN INFECT DIS, V56, P1373, DOI 10.1093/CID/CIT055.;BLAIS BW, 2012, J FOOD PROTECT, V75, P1691, DOI 10.4315/0362-028X.JFP-12-116.;DEER DM, 2010, LETT APPL MICROBIOL, V50, P366, DOI 10.1111/J.1472-765X.2010.02804.X.;DELANNOY S, 2013, J CLIN MICROBIOL, V51, P1083, DOI 10.1128/JCM.02864-12.;DEN BAKKER HC, 2014, EMERG INFECT DIS, V20, P1306, DOI 10.3201/EID2008.131399.;DINGLE KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001.;EKLUND M, 2002, J CLIN MICROBIOL, V40, P4585, DOI 10.1128/JCM.40.12.4585-4593.2002.;EPPINGER M, 2014, GUT MICROBES, V5, DOI [10.4161/19490976.2014.969979, DOI 10.4161/19490976.2014.969979].;EVANS PETER S, 2014, GENOME ANNOUNC, V2, DOI 10.1128/GENOMEA.01154-13.;EYRE DW, 2012, BMJ OPEN, V2, DOI 10.1136/BMJOPEN-2012-001124.;FRANZ E, 2014, INT J FOOD MICROBIOL, V187, P57, DOI 10.1016/J.IJFOODMICRO.2014.07.002.;FSIS, 2011, FED REGISTER, V76.;GILL A, 2012, J FOOD PROTECT, V75, P827, DOI 10.4315/0362-028X.JFP-11-395.;GILMOUR MW, 2006, J CLIN MICROBIOL, V44, P449, DOI 10.1128/JCM.44.2.449-458.2006.;GORDON A., 2010, FASTX TOOLKIT FASTQ.;HAYASHI T, 2001, DNA RES, V8, P11, DOI 10.1093/DNARES/8.1.11.;HUANG WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/BIOINFORMATICS/BTR708.;HUSZCZYNSKI G, 2013, J FOOD PROTECT, V76, P1689, DOI 10.4315/0362-028X.JFP-13-059.;JAUREGUY F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560.;JOENSEN KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13.;KELLEY DR, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-11-R116.;LAMBLE S, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-104.;LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/BIOINFORMATICS/BTM404.;LEEKITCHAROENPHON P, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0087991.;LI H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/BIOINFORMATICS/BTP352.;MARTINEZ-PEREZ A, 2010, FOOD CONTROL, V21, P1354, DOI 10.1016/J.FOODCONT.2010.04.009.;MELLMANN A, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0022751.;POSTINGL H., SEQUENCE MAPPING ALI.;PRAGER R, 2005, INT J MED MICROBIOL, V295, P29, DOI 10.1016/J.IJMM.2004.12.009.;PRAGER R, 2014, PLOS ONE, V9, DOI 10.1371/JOURNAL.PONE.0095379.;SCHMID D, 2014, CLIN MICROBIOL INFEC, V20, P431, DOI 10.1111/1469-0691.12638.;SHRINGI S, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0051572.;SHRINGI S, 2012, INFECT IMMUN, V80, P369, DOI 10.1128/IAI.05470-11.;TREES EIJA, 2014, GENOME ANNOUNC, V2, DOI 10.1128/GENOMEA.00718-14.;WIRTH T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/J.1365-2958.2006.05172.X.","BLAIS, BW (REPRINT AUTHOR), CANADIAN FOOD INSPECT AGCY, SCI BRANCH, OTTAWA LAB CARLING, RES \& DEV, OTTAWA, ON, CANADA.;LAMBERT, DOMINIC, CARRILLO, CATHERINE D., KOZIOL, ADAM G., MANNINGER, PAUL, BLAIS, BURTON W., CANADIAN FOOD INSPECT AGCY, SCI BRANCH, OTTAWA LAB CARLING, RES \& DEV, OTTAWA, ON, CANADA.","10.1371/JOURNAL.PONE.0122928","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E0122928",NA,"CANADIAN SAFETY AND SECURITY PROGRAM [CSSP-2013-TI-1145]","THE SEQUENCING INSTRUMENT WAS PURCHASED THROUGH FUNDING PROVIDED BY THE CANADIAN SAFETY AND SECURITY PROGRAM (CSSP-2013-TI-1145). BUDGET FOR MATERIALS AND REAGENTS WAS PROVIDED BY THE CANADIAN FOOD INSPECTION AGENCY, TECHNOLOGY DEVELOPMENT FUNDS.",NA,"1932-6203","4",NA,"PUBLIC LIBRARY SCIENCE","10",2015,"ISI000352590300068","37","SCIENCE \& TECHNOLOGY - OTHER TOPICS","15","MULTIDISCIPLINARY SCIENCES","BURTON.BLAISINSPECTION.GC.CA",NA,"CF5II",NA,"BLAIS, BW (REPRINT AUTHOR), CANADIAN FOOD INSPECT AGCY, SCI BRANCH, OTTAWA LAB CARLING, RES \& DEV, OTTAWA, ON, CANADA","ISI","SCI BRANCH","SCI BRANCH",NA,"LAMBERT D, 2015, PLOS ONE","LAMBERT D, 2015, PLOS ONE"
"PANG Y, 2015, IMMUNOL LETT","PANG Y;LIU S;ZHENG Z;LIU X;LI Q","IDENTIFICATION AND CHARACTERIZATION OF THE LAMPREY IRF GENE","IMMUNOLOGY LETTERS","IMMUNOL. LETT.","INTERFERON REGULATORY FACTORS (IRFS) ARE NAMED FOR THEIR ABILITY TO BIND TO AND REGULATE INTERFERON GENES WHEN AN ORGANISM BECOMES INFECTED WITH A VIRUS. NUMEROUS STUDIES HAVE REVEALED THE VERSATILE AND CRITICAL FUNCTIONS OF IRFS. IN THIS STUDY, AN IRF GENE FROM LAMPETRA JAPONICA WAS IDENTIFIED AND ANALYZED USING BIOINFORMATIC METHODS. THE L. JAPONICA IRF (LJ-IRF) SHARES HIGH SEQUENCE HOMOLOGY WITH OTHER VERTEBRATE IRFS BUT LOW SEQUENCE HOMOLOGY WITH AN ASCIDIAN IRF-LIKE PROTEIN. WE ALSO USED RECOMBINANT LJ-IRF PROTEIN (RLJ-IRF) TO IMMUNIZE NEW ZEALAND RABBITS TO PREPARE SPECIFIC ANTI-RLJ-IRF POLYCLONAL ANTIBODIES. ENZYME-LINKED IMMUNOSORBENT ASSAYS (ELISAS) AND WESTERN BLOTTING ASSAYS WERE PERFORMED TO DETECT THE VALENCE AND SPECIFICITY OF THE ANTIBODY. FACS ANALYSIS REVEALED THAT THE LJ-IRF PROTEIN WAS EXPRESSED IN APPROXIMATELY 21.14\% OF LEUKOCYTES AND 9.60\% OF SUPRANEURAL BODY CELLS IN L. JAPONICA, WITH IMMUNOFLUORESCENCE STAINING INDICATING A CYTOPLASMIC LOCATION. THE IMMUNOHISTOCHEMISTRY RESULTS DEMONSTRATED THAT IRF IS DISTRIBUTED IN THE EPITHELIAL CELLS OF THE HEART, SUPRANEURAL BODY, KIDNEYS AND GILLS BUT IS NOT DETECTABLE IN INTESTINALS OR ORAL GLAND TISSUES. HOWEVER, THE EXPRESSION OF IRF WAS UPREGULATED IN LAMPREY INTESTINAL TISSUES UPON STIMULATION WITH THE RLJ-HMGB1 PROTEIN. LJ-IRF GENE EXPRESSION LEVELS WERE HIGHER IN THE RLJ-HMGB1-STIMULATED GROUP THAN THE CONTROL GROUP, AND THE EXPRESSION LEVEL OF LJ-IRF WAS SIGNIFICANTLY INCREASED IN THE INTESTINES AS DETERMINED BY QUANTITATIVE REAL-TIME PCR. THESE RESULTS PROVIDE A FOUNDATION FOR STUDYING THE ORIGIN AND EVOLUTION OF THE INNATE IMMUNE SYSTEM IN LAMPREYS. (C) 2015 EUROPEAN FEDERATION OF IMMUNOLOGICAL SOCIETIES. PUBLISHED BY ELSEVIER B.V. ALL RIGHTS RESERVED.","IRF; LAMPETRA JAPONICA; EVOLUTION; IMMUNE RESPONSE","TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION RECEPTORS; REGULATORY FACTOR FAMILY; TRANSCRIPTION FACTORS; IMMUNE-RESPONSE; HOST-DEFENSE; ONCOGENESIS; EXPRESSION; INFECTION; EVOLUTION","ENGLISH","ARTICLE","ARTICLE",4,"ALTMANN SM, 2003, J VIROL, V77, P1992, DOI 10.1128/JVI.77.3.1992-2002.2003.;BLASIUS AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/J.IMMUNI.2010.03.012.;COCCIA EM, 2001, BIOCHEM J, V360, P285, DOI 10.1042/0264-6021:3600285.;DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/SCIENCE.8197455.;HARADA H, 1994, MOL CELL BIOL, V14, P1500, DOI 10.1128/MCB.14.2.1500.;HONDA K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/NRI1900.;HUANG B, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-22.;IKUSHIMA H, 2013, COLD SPRING HARB SYM, VLXXVIII, P1.;JANEWAY CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/ANNUREV.IMMUNOL.20.083001.084359.;KAWAI T, 2011, IMMUNITY, V34, P637, DOI 10.1016/J.IMMUNI.2011.05.006.;LANGEVIN C, 2013, J MOL BIOL, V425, P4904, DOI 10.1016/J.JMB.2013.09.033.;LIN RT, 2005, J BIOL CHEM, V280, P3088, DOI 10.1074/JBC.M408452200.;LIU XJ, 2009, DEV COMP IMMUNOL, V33, P257, DOI 10.1016/J.DCI.2008.09.008.;MA LIJUAN, 2012, IMMUNE NETW, V12, P148, DOI 10.4110/IN.2012.12.4.148.;MAMANE Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0.;MERARO D, 1999, J IMMUNOL, V163, P6468.;MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4.;NEHYBA J, 2009, MOL BIOL EVOL, V26, P2539, DOI 10.1093/MOLBEV/MSP167.;OZATO K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/JBC.R700003200.;PANG Y, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0035755.;PITHA PM, 2011, VIRUSES-BASEL, V3, P1179, DOI 10.3390/V3071179.;SANCHO D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/ANNUREV-IMMUNOL-031210-101352.;SAVITSKY D, 2010, CANCER IMMUNOL IMMUN, V59, P489, DOI 10.1007/S00262-009-0804-6.;TAKAOKA A, 2008, CANCER SCI, V99, P467, DOI 10.1111/J.1349-7006.2007.00720.X.;TAKEUCHI O, 2010, CELL, V140, P805, DOI 10.1016/J.CELL.2010.01.022.;TAMURA T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/ANNUREV.IMMUNOL.26.021607.090400.;TANIGUCHI T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/ANNUREV.IMMUNOL.19.1.623.;WU FF, 2010, FISH SHELLFISH IMMUN, V29, P407, DOI 10.1016/J.FSI.2010.04.019.;YANAI H, 2012, ONCOIMMUNOLOGY, V1, P1376, DOI 10.4161/ONCI.22475.","LI, QW (REPRINT AUTHOR), LIAONING NORMAL UNIV, COLL LIFE SCI, DALIAN 116081, PEOPLES R CHINA.;PANG, YUE, LIU, SHUANG, ZHENG, ZHEN, LIU, XIN, LI, QINGWEI, LIAONING NORMAL UNIV, COLL LIFE SCI, DALIAN 116081, PEOPLES R CHINA.;PANG, YUE, LIU, SHUANG, ZHENG, ZHEN, LIU, XIN, LI, QINGWEI, LIAONING NORMAL UNIV, CTR LAMPREY RES, DALIAN 116081, PEOPLES R CHINA.","10.1016/J.IMLET.2015.02.006","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"CHINESE MAJOR STATE BASIC RESEARCH DEVELOPMENT PROGRAM (973 PROGRAM) [2013CB835304], MARINE PUBLIC WELFARE PROJECT OF STATE OCEANIC ADMINISTRATION [201305016], CHINESE NATIONAL NATURAL SCIENCE FOUNDATION [31170353, 31202020], RESEARCH PROJECT OF LIAONING PROVINCIAL DEPARTMENT OF EDUCATION [LJQ2014117], SCIENCE AND TECHNOLOGY PROJECT OF DALIAN [2013E11SF056]","THIS WORK WAS SUPPORTED BY THE CHINESE MAJOR STATE BASIC RESEARCH DEVELOPMENT PROGRAM (973 PROGRAM, GRANT 2013CB835304), MARINE PUBLIC WELFARE PROJECT OF STATE OCEANIC ADMINISTRATION (NO. 201305016), CHINESE NATIONAL NATURAL SCIENCE FOUNDATION GRANTS 31170353 AND 31202020, THE RESEARCH PROJECT OF LIAONING PROVINCIAL DEPARTMENT OF EDUCATION (LJQ2014117) AND THE SCIENCE AND TECHNOLOGY PROJECT OF DALIAN (NO. 2013E11SF056).",NA,"0165-2478","2","55-64","ELSEVIER SCIENCE BV","164",2015,"ISI000353094900001","29","IMMUNOLOGY","5","IMMUNOLOGY","LIQW263.NET",NA,"CG2HG",NA,"LI, QW (REPRINT AUTHOR), LIAONING NORMAL UNIV, COLL LIFE SCI, DALIAN 116081, PEOPLES R CHINA","ISI","LIAONING NORMAL UNIV;LIAONING NORMAL UNIV","LIAONING NORMAL UNIV",NA,"PANG Y, 2015, IMMUNOL LETT","PANG Y, 2015, IMMUNOL LETT"
"PIRONTI A, 2015, J CLIN VIROL","PIRONTI A;SIERRA S;KAISER R;LENGAUER T;PFEIFER N","EFFECTS OF SEQUENCE ALTERATIONS ON RESULTS FROM GENOTYPIC TROPISM TESTING","JOURNAL OF CLINICAL VIROLOGY","J. CLIN. VIROL.","BACKGROUND: GENO2PHENO([CORECEPTOR]) IS A BIOINFORMATIC METHOD FOR GENOTYPIC TROPISM DETERMINATION (GTD) WHICH HAS BEEN EXTENSIVELY VALIDATED. OBJECTIVES: GTD CAN BE AFFECTED BY SEQUENCING/BASE-CALLING VARIABILITY AND UNRELIABLE REPRESENTATION OF MINORITY POPULATIONS IN SANGER BULK SEQUENCING. THIS STUDY AIMS AT QUANTIFYING THE ROBUSTNESS OF GENO2PHENO([CORECEPTOR]) WITH RESPECT TO THESE ISSUES. GTD WITH A SINGLE AMPLIFICATION OR IN TRIPLICATE (HENCEFORTH SINGLETON/TRIPLICATE) IS CONSIDERED. STUDY DESIGN: FROM A DATASET CONTAINING 67,997HIV-1 V3 NUCLEOTIDE SEQUENCES, TWO DATASETS SIMULATING SEQUENCING VARIABILITY WERE CREATED. FURTHER TWO DATASETS WERE CREATED TO SIMULATE UNRELIABLE REPRESENTATION OF MINORITY VARIANTS. AFTER INTERPRETATION OF ALL SEQUENCES WITH GENO2PHENO[CORECEPTOR], PROBABILITIES OF CHANGE OF PREDICTED TROPISM WERE CALCULATED. RESULTS: GENO2PHENO([CORECEPTOR]) TENDS TO REPORT REDUCED FALSE-POSITIVE RATES (FPRS) WHEN SEQUENCE ALTERATIONS ARE PRESENT. TRIPLICATE FPRS TEND TO BE LOWER THAN SINGLETON FPRS, RESULTING IN A BIAS TOWARDS CLASSIFYING VIRUSES AS X4-CAPABLE. ALTERATIONS INTRODUCED INTO NUCLEOTIDE SEQUENCES BY SIMULATION CHANGE SINGLETON PREDICTED TROPISM WITH A PROBABILITY <= 2\%. TRIPLICATE PREDICTION LOWERS THIS PROBABILITY FOR PREDICTED X4 TROPISM, BUT RAISES IT FOR PREDICTED R5 TROPISM <= 6\%. SIMULATED LIMITED DETECTION OF MINORITY VARIANTS IN X4 SEQUENCES RESULTED IN UNCHANGED PREDICTED TROPISM WITH PROBABILITY ABOVE 90\% AS COMPARED TO PROBABILITY ABOVE 98\% WITH TRIPLICATE FPRS. CONCLUSIONS: GENO2PHENO([CORECEPTOR]) PROVED TO BE ROBUST WHEN SEQUENCE ALTERATIONS ARE PRESENT AND WHEN DETECTABLE MINORITIES ARE MISSED BY BULK SEQUENCING. CHANGES IN TROPISM PREDICTION DUE TO SEQUENCE ALTERATIONS AS WELL AS TRIPLICATE PREDICTION ARE MUCH MORE LIKELY TO RESULT IN FALSE X4-CAPABLE PREDICTIONS THAN IN FALSE R5 PREDICTIONS. (C) 2015 PUBLISHED BY ELSEVIER B.V.","HIV-1; TROPISM; GENOTYPIC TROPISM DETERMINATION; GENO2PHENO; TRIPLICATE; SIMULATION OF SANGER BULK-SEQUENCING ERRORS","CLINICAL-PRACTICE; HIV; PREDICTION; TROFILE; USAGE; ASSAY","ENGLISH","ARTICLE","ARTICLE",1,"BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289.;EWING B, 1998, GENOME RES, V8, P186, DOI 10.1101/GR.8.3.186.;JOHNSON AD, 2010, BIOINFORMATICS, V26, P1386, DOI 10.1093/BIOINFORMATICS/BTQ098.;LENGAUER T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/NBT1207-1405.;LEVY JA, 2007, HIV AND THE PATHOGENESIS OF AIDS, 3RD EDITION, P1.;MCGOVERN R. A., 2010, J VIS EXP JOVE.;MCGOVERN R. A., 2012, J ACQ IMMUN DEF SYND, V61, P9.;MCGOVERN RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0B013E32833E6CFB.;MCLAUGHLIN S, 2013, AIDS RES HUM RETROV, V29, P814, DOI [10.1089/AID.2012.0024, 10.1089/AID.2012.0024].;MYERS G, 1999, PROC INT CONF INTELL SYST MOL BIOL, P202.;PERRY C. M., 2010, DRUGS, V118, P9.;PINEDA-PENA N. R., 2013, INFECT GENET EVOL J.;POVEDA E, 2012, AIDS REV, V14, P208.;PROSPERI MCF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-56.;RECORDON-PINSON P, 2010, ANTIMICROB AGENTS CH, V54, P3335, DOI 10.1128/AAC.00148-10.;SIERRA S., 2011, J VIS EXP JOVE.;SVICHER V, 2010, NEW MICROBIOL, V33, P195.;SYMONS J, 2012, CLIN MICROBIOL INFEC, V18, P606, DOI 10.1111/J.1469-0691.2011.03631.X.;VANDEKERCKHOVE A., 2010, J INT AIDS SOC, V13, PO7.;VANDEKERCKHOVE LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4.;WALTER H., 2013, EMPFEHLUNG BESTIMMUN.;WOODS CK, 2012, J CLIN MICROBIOL, V50, P1936, DOI 10.1128/JCM.06689-11.","PIRONTI, A (REPRINT AUTHOR), MAX PLANCK INST INFORMAT, DEPT COMPUTAT BIOL \& APPL ALGORITHM, CAMPUS E 14, D-66123 SAARBRUCKEN, GERMANY.;PIRONTI, ALEJANDRO, LENGAUER, THOMAS, PFEIFER, NICO, MAX PLANCK INST INFORMAT, DEPT COMPUTAT BIOL \& APPL ALGORITHM, D-66123 SAARBRUCKEN, GERMANY.;SIERRA, SALETA, KAISER, ROLF, UNIV COLOGNE, INST VIROL, D-50935 COLOGNE, GERMANY.","10.1016/J.JCV.2015.02.006","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"CHAIN (EU) [223131, HEALTH-F3-2009-223131], RESINA (GERMAN HEALTH MINISTRY) [310/4476]","THIS WORK WAS PARTIALLY FUNDED BY CHAIN (EU GRANT NUMBER 223131, HEALTH-F3-2009-223131), AND PERFORMED IN THE CONTEXT OF MASTER/HIV-HEP (GERMAN HEALTH MINISTRY), EUCOHIV (WWW.EUCOHIV.ORG) AND RESINA (GERMAN HEALTH MINISTRY GRANT NUMBER 310/4476).",NA,"1386-6532",NA,"68-73","ELSEVIER SCIENCE BV","65",2015,"ISI000352701500015","22","VIROLOGY","4","VIROLOGY","APIRONTIMPI-INF.MPG.DE",NA,"CF6XZ",NA,"PIRONTI, A (REPRINT AUTHOR), MAX PLANCK INST INFORMAT, DEPT COMPUTAT BIOL \& APPL ALGORITHM, CAMPUS E 14, D-66123 SAARBRUCKEN, GERMANY","ISI","MAX PLANCK INST INFORMAT;UNIV COLOGNE","MAX PLANCK INST INFORMAT",NA,"PIRONTI A, 2015, J CLIN VIROL","PIRONTI A, 2015, J CLIN VIROL"
"NAM YR, 2015, J VIROL METHODS","NAM YR;LEE U;CHOI HS;LEE KJ;KIM N;JANG YJ;JOO CH","DEGENERATE PCR PRIMER DESIGN FOR THE SPECIFIC IDENTIFICATION OF RHINOVIRUS C","JOURNAL OF VIROLOGICAL METHODS","J. VIROL. METHODS","HUMAN RHINOVIRUS (HRV)-A AND -B IS A COMMON CAUSE OF UPPER RESPIRATORY TRACT INFECTIONS. RECENTLY, A THIRD SPECIES, HRV-C, WAS CATEGORIZED BASED ON MOLECULAR TYPING STUDIES. THE RESULTS SHOWED THAT THE HRV-C GENOME HAD DIVERGED FROM THAT OF HRV-A AND -B. DESPITE ITS LATE IDENTIFICATION, INCREASING EVIDENCE SUGGESTS THAT HRV-C CAUSES MORE SEVERE PATHOGENIC INFECTIONS THAN HRV-A OR -B, HOWEVER, A LARGE AMOUNT OF EPIDEMIOLOGICAL DATA IS REQUIRED TO CONFIRM THIS ASSOCIATION IN DIFFERENT CLINICAL SETTINGS. CONSEQUENTLY, A SIMPLE AND RAPID METHOD FOR IDENTIFYING HRV-C IS REQUIRED TO EXPEDITE SUCH EPIDEMIOLOGICAL STUDIES. HERE, TWO DEGENERATE PRIMER SETS (HEV AND HRVC) WERE DESIGNED BASED ON BIOINFORMATIC ANALYSES. THE HEV SET TARGETING THE FIFTH IRES DOMAIN SEQUENCE WITHIN THE 5'-UTR, WHICH IS HIGHLY CONSERVED AMONG ENTEROVIRUSES, WAS DESIGNED TO DETECT ALL ENTEROVIRUSES, WHEREAS THE HRVC SET, WHICH TARGETED THE VP2 CODING REGION, WAS DESIGNED TO DETECT HRV-C ALONE. BOTH PRIMER SETS WERE TESTED AGAINST A PANEL OF STANDARD ENTEROVIRUSES AND CLINICAL LAVAGE SAMPLES. HEV DETECTED ALL ENTEROVIRUSES TESTED WHEREAS HRVC WAS SPECIFIC FOR HRV-C. ALTHOUGH THE PRIMER DESIGN STRATEGY WAS CONFIRMED WITH A LIMITED NUMBER OF SAMPLES, EXTENSIVE TESTS ARE REQUIRED TO BE APPLIED IN CLINICAL SETTINGS. (C) 2014 ELSEVIER B.V. ALL RIGHTS RESERVED.","RHINOVIRUS C; DEGENERATE PCR PRIMER; RT-PCR","RESPIRATORY-TRACT INFECTIONS; POLYMERASE-CHAIN-REACTION; YOUNG-CHILDREN; ASTHMA; ILLNESS; RNA; SEVERITY; INFANTS; PROTEIN; VIRUS","ENGLISH","ARTICLE","ARTICLE",2,"ADAMS MJ, 2013, ARCH VIROL, V158, P2023, DOI 10.1007/S00705-013-1688-5.;AHN JH, 2003, INTERVIROLOGY, V46, P245, DOI 10.1159/000072435.;BIZZINTINO J, 2011, EUR RESPIR J, V37, P1037, DOI 10.1183/09031936.00092410.;DENLINGER LC, 2011, AM J RESP CRIT CARE, V184, P1007, DOI 10.1164/RCCM.201103-0585OC.;ERDMAN DD, 2003, J CLIN MICROBIOL, V41, P4298, DOI 10.1128/JCM.41.9.4298-4303.2003.;FERREIRA A, 2002, RESPIRATION, V69, P136, DOI 10.1159/000056316.;HAYDEN FG, 2004, REV MED VIROL, V14, P17, DOI 10.1002/RMV.406.;JARTTI T, 2004, EMERG INFECT DIS, V10, P1095, DOI 10.3201/EID1006.030629.;JENNINGS LC, 2004, PEDIATR INFECT DIS J, V23, P1003, DOI 10.1097/01.INF.0000143648.04673.6C.;JOO CH, 2010, ANTIMICROB AGENTS CH, V54, P5048, DOI 10.1128/AAC.00682-10.;KAIDA A, 2011, JPN J INFECT DIS, V64, P488.;LAINE P, 2005, J GEN VIROL, V86, P697, DOI 10.1099/VIR.0.80445-0.;LAU SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07.;LEDFORD RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004.;LEE WM, 2007, PLOS ONE, V2, DOI 10.1371/JOURNAL.PONE.0000966.;LEMANSKE RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/J.JACI.2005.06.024.;LINDER JE, 2013, J ALLERGY CLIN IMMUN, V131, P69, DOI 10.1016/J.JACI.2012.09.033.;MCERLEAN P, 2007, J CLIN VIROL, V39, P67, DOI 10.1016/J.JCV.2007.03.012.;MCINTYRE CL, 2013, J GEN VIROL, V94, P1791, DOI 10.1099/VIR.0.053686-0.;MCINTYRE CL, 2013, ARCH VIROL, V158, P1497, DOI 10.1007/S00705-013-1634-6.;MCLEISH NJ, 2012, J CLIN MICROBIOL, V50, P2910, DOI 10.1128/JCM.01172-12.;MILLER EK, 2007, J INFECT DIS, V195, P773, DOI 10.1086/511821.;MILLER EK, 2011, J ALLERGY CLIN IMMUN, V127, P883, DOI 10.1016/J.JACI.2010.11.041.;MILLER EK, 2009, J CLIN VIROL, V46, P85, DOI 10.1016/J.JCV.2009.06.007.;MORI J, 1994, J MED VIROL, V44, P323, DOI 10.1002/JMV.1890440403.;SAVOLAINEN C, 2004, J GEN VIROL, V85, P2271, DOI 10.1099/VIR.0.79897-0.;SAVOLAINEN C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333.;SAVOLAINEN-KOPRA C, 2009, VIRUSES-BASEL, V1, P1178, DOI 10.3390/V1031178.;TAKEYAMA A, 2012, J MED VIROL, V84, P1135, DOI 10.1002/JMV.23306.;WEINBERG GA, 2004, J INFECT DIS, V189, P706, DOI 10.1086/381456.;WISDOM A, 2009, J CLIN MICROBIOL, V47, P3958, DOI 10.1128/JCM.00993-09.;ZAMBRANO JC, 2003, J ALLERGY CLIN IMMUN, V111, P1008, DOI 10.1067/MAI.2003.1396.","JOO, CH (REPRINT AUTHOR), UNIV ULSAN, COLL MED, DEPT MICROBIOL, ASANBYEONGWON GIL 86, SEOUL 138736, SOUTH KOREA.;NAM, YOUNG RAN, LEE, UK, CHOI, HAN SEOK, LEE, KYOUNG JIN, KIM, NARI, JOO, CHUL HYUN, UNIV ULSAN, COLL MED, DEPT MICROBIOL, SEOUL 138736, SOUTH KOREA.;JANG, YONG JU, ASAN MED CTR, DEPT OTOLARYNGOL, SEOUL, SOUTH KOREA.;JOO, CHUL HYUN, UNIV ULSAN, COLL MED, CELL DYSFUNCT RES CTR, SEOUL 138736, SOUTH KOREA.","10.1016/J.JVIROMET.2014.10.021","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"KOREA HEALTH TECHNOLOGY R\&D PROJECT, MINISTRY OF HEALTH \&WELFARE, REPUBLIC OF KOREA [A110893]","THIS STUDY WAS SUPPORTED BY A GRANT OF THE KOREA HEALTH TECHNOLOGY R\&D PROJECT, MINISTRY OF HEALTH \&WELFARE, REPUBLIC OF KOREA (A110893).",NA,"0166-0934",NA,"15-24","ELSEVIER SCIENCE BV","214",2015,"ISI000351654800003","32","BIOCHEMISTRY \& MOLECULAR BIOLOGY, BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, VIROLOGY","14","BIOCHEMICAL RESEARCH METHODS, BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, VIROLOGY","CHJOOAMC.SEOUL.KR",NA,"CE2OL",NA,"JOO, CH (REPRINT AUTHOR), UNIV ULSAN, COLL MED, DEPT MICROBIOL, ASANBYEONGWON GIL 86, SEOUL 138736, SOUTH KOREA","ISI","UNIV ULSAN;ASAN MED CTR;UNIV ULSAN","UNIV ULSAN",NA,"NAM YR, 2015, J VIROL METHODS","NAM YR, 2015, J VIROL METHODS"
"MARTINEZ-DEL CAMPO A, 2015, MBIO","MARTINEZ DEL CAMPO A;BODEA S;HAMER HA;MARKS JA;HAISER HJ;TURNBAUGH PJ;BALSKUS EP","CHARACTERIZATION AND DETECTION OF A WIDELY DISTRIBUTED GENE CLUSTER THAT PREDICTS ANAEROBIC CHOLINE UTILIZATION BY HUMAN GUT BACTERIA","MBIO","MBIO","ELUCIDATION OF THE MOLECULAR MECHANISMS UNDERLYING THE HUMAN GUT MICROBIOTA'S EFFECTS ON HEALTH AND DISEASE HAS BEEN COMPLICATED BY DIFFICULTIES IN LINKING METABOLIC FUNCTIONS ASSOCIATED WITH THE GUT COMMUNITY AS A WHOLE TO INDIVIDUAL MICROORGANISMS AND ACTIVITIES. ANAEROBIC MICROBIAL CHOLINE METABOLISM, A DISEASE-ASSOCIATED METABOLIC PATHWAY, EXEMPLIFIES THIS CHALLENGE, AS THE SPECIFIC HUMAN GUT MICROORGANISMS RESPONSIBLE FOR THIS TRANSFORMATION HAVE NOT YET BEEN CLEARLY IDENTIFIED. IN THIS STUDY, WE ESTABLISHED THE LINK BETWEEN A BACTERIAL GENE CLUSTER, THE CHOLINE UTILIZATION (CUT) CLUSTER, AND ANAEROBIC CHOLINE METABOLISM IN HUMAN GUT ISOLATES BY COMBINING TRANSCRIPTIONAL, BIOCHEMICAL, BIOINFORMATIC, AND CULTIVATION-BASED APPROACHES. QUANTITATIVE REVERSE TRANSCRIPTION-PCR ANALYSIS AND IN VITRO BIOCHEMICAL CHARACTERIZATION OF TWO CUT GENE PRODUCTS LINKED THE ENTIRE CLUSTER TO GROWTH ON CHOLINE AND SUPPORTED A MODEL FOR THIS PATHWAY. ANALYSES OF SEQUENCED BACTERIAL GENOMES REVEALED THAT THE CUT CLUSTER IS PRESENT IN MANY HUMAN GUT BACTERIA, IS PREDICTIVE OF CHOLINE UTILIZATION IN SEQUENCED ISOLATES, AND IS WIDELY BUT DISCONTINUOUSLY DISTRIBUTED ACROSS MULTIPLE BACTERIAL PHYLA. GIVEN THAT BACTERIAL PHYLOGENY IS A POOR MARKER FOR CHOLINE UTILIZATION, WE WERE PROMPTED TO DEVELOP A DEGENERATE PCR-BASED METHOD FOR DETECTING THE KEY FUNCTIONAL GENE CHOLINE TMA-LYASE (CUTC) IN GENOMIC AND METAGENOMIC DNA. USING THIS TOOL, WE FOUND THAT NEW CHOLINE-METABOLIZING GUT ISOLATES UNIVERSALLY POSSESSED CUTC. WE ALSO DEMONSTRATED THAT THIS GENE IS WIDESPREAD IN STOOL METAGENOMIC DATA SETS. OVERALL, THIS WORK REPRESENTS A CRUCIAL STEP TOWARD UNDERSTANDING ANAEROBIC CHOLINE METABOLISM IN THE HUMAN GUT MICROBIOTA AND UNDERSCORES THE IMPORTANCE OF EXAMINING THIS MICROBIAL COMMUNITY FROM A FUNCTION-ORIENTED PERSPECTIVE. IMPORTANCE ANAEROBIC CHOLINE UTILIZATION IS A BACTERIAL METABOLIC ACTIVITY THAT OCCURS IN THE HUMAN GUT AND IS LINKED TO MULTIPLE DISEASES. WHILE BACTERIAL GENES RESPONSIBLE FOR CHOLINE FERMENTATION (THE CUT GENE CLUSTER) HAVE BEEN RECENTLY IDENTIFIED, THERE HAS BEEN NO CHARACTERIZATION OF THESE GENES IN HUMAN GUT ISOLATES AND MICROBIAL COMMUNITIES. IN THIS WORK, WE USE MULTIPLE APPROACHES TO DEMONSTRATE THAT THE PATHWAY ENCODED BY THE CUT GENES IS PRESENT AND FUNCTIONAL IN A DIVERSE RANGE OF HUMAN GUT BACTERIA AND IS ALSO WIDESPREAD IN STOOL METAGENOMES. WE ALSO DEVELOPED A PCR-BASED STRATEGY TO DETECT A KEY FUNCTIONAL GENE (CUTC) INVOLVED IN THIS PATHWAY AND APPLIED IT TO CHARACTERIZE NEWLY ISOLATED CHOLINE-UTILIZING STRAINS. BOTH OUR ANALYSES OF THE CUT GENE CLUSTER AND THIS MOLECULAR TOOL WILL AID EFFORTS TO FURTHER UNDERSTAND THE ROLE OF CHOLINE METABOLISM IN THE HUMAN GUT MICROBIOTA AND ITS LINK TO DISEASE.",NA,"TRIMETHYLAMINE-N-OXIDE; GLYCYL RADICAL ENZYMES; HUMAN COLONIC BACTERIA; CELL-FREE EXTRACTS; ESCHERICHIA-COLI; VIBRIO-CHOLINICUS; SALMONELLA-TYPHIMURIUM; HUMAN MICROBIOME; DIETARY CHOLINE; DOSE-RESPONSE","ENGLISH","ARTICLE","ARTICLE",16,"ALWAIZ M, 1992, METABOLISM, V41, P135, DOI 10.1016/0026-0495(92)90140-6.;BAE S, 2014, CANCER RES, V74, P7442, DOI 10.1158/0008-5472.CAN-14-1835.;BAIN MA, 2005, CURR DRUG METAB, V6, P227, DOI 10.2174/1389200054021807.;BERTIN Y, 2011, ENVIRON MICROBIOL, V13, P365, DOI 10.1111/J.1462-2920.2010.02334.X.;BOBIK TA, 1992, J BACTERIOL, V174, P2253.;BOBIK TA, 1999, J BACTERIOL, V181, P5967.;BRADBEER C, 1965, J BIOL CHEM, V240, P4669.;BROWN SA, 2008, NAT REV MICROBIOL, V6, P657, DOI 10.1038/NRMICRO1955.;BRUGERE JEAN-FRANCOIS, 2014, GUT MICROBES, V5, P5, DOI 10.4161/GMIC.26749.;CABISCOL E, 1994, J BIOL CHEM, V269, P6592.;CAI F, 2008, ARCH MICROBIOL, V189, P141, DOI 10.1007/S00203-007-0305-Y.;CAMACHO C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421.;CHAO CK, 1990, J NUTR BIOCHEM, V1, P89, DOI 10.1016/0955-2863(90)90055-P.;CHENG SQ, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0047144.;CHRISTODOULOU J, 2012, J PAEDIATR CHILD H, V48, PE153, DOI 10.1111/J.1440-1754.2010.01978.X.;CRACIUN S, 2014, ACS CHEM BIOL, V9, P1408, DOI 10.1021/CB500113P.;CRACIUN S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/PNAS.1215689109.;DABEK M, 2008, FEMS MICROBIOL ECOL, V66, P487, DOI 10.1111/J.1574-6941.2008.00520.X.;DOBRINDT U, 2002, INFECT IMMUN, V70, P6365, DOI 10.1128/IAI.70.11.6365-6372.2002.;DUMAS ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/PNAS.0601056103.;HAYWARD HR, 1960, J BIOL CHEM, V235, P3592.;HAYWARD HR, 1960, J BIOL CHEM, V235, P538.;HAYWARD HR, 1959, J BACTERIOL, V78, P557.;HEHEMANN JH, 2010, NATURE, V464, P908, DOI 10.1038/NATURE08937.;HOLMES E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/J.TIM.2011.05.006.;HUTTENHOWER C, 2012, NATURE, V486, P207, DOI 10.1038/NATURE11234.;JONES BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/PNAS.0804437105.;JORDA J, 2013, PROTEIN SCI, V22, P179, DOI 10.1002/PRO.2196.;KARLSSON FH, 2012, NAT COMMUN, V3, DOI 10.1038/NCOMMS2266.;KERFELD CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/ANNUREV.MICRO.112408.134211.;KOETH RA, 2013, NAT MED, V19, P576, DOI 10.1038/NM.3145.;KOFOID E, 1999, J BACTERIOL, V181, P5317.;KRUEGER SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/J.PHARMTHERA.2005.01.001.;KUEHL JV, 2014, MBIO, V5, DOI 10.1128/MBIO.01041-14.;LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/BIOINFORMATICS/BTM404.;LETUNIC I, 2011, NUCLEIC ACIDS RES, V39, PW475, DOI 10.1093/NAR/GKR201.;LIVAK KJ, 2001, METHODS, V25, P402, DOI 10.1006/METH.2001.1262.;LOUIS P, 2007, FEMS MICROBIOL LETT, V269, P240, DOI 10.1111/J.1574-6968.2006.00629.X.;MARTIN FPJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/FPHYS.2012.00113.;MCINTOSH FM, 2012, ENVIRON MICROBIOL, V14, P1876, DOI 10.1111/J.1462-2920.2012.02711.X.;MILLER CA, 2014, AM J CLIN NUTR, V100, P778, DOI 10.3945/AJCN.114.087692.;MONTELLA C, 2005, J BACTERIOL, V187, P4957, DOI 10.1128/JB.187.14.4957-4966.2005.;MULLER E, 1981, APPL ENVIRON MICROB, V42, P439.;NADKARNI MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257.;NEILL AR, 1978, BIOCHEM J, V170, P529, DOI 10.1042/BJ1700529.;NICHOLSON JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/SCIENCE.1223813.;NIIZEKI N, 2002, COMP BIOCHEM PHYS B, V131, P371, DOI 10.1016/S1096-4959(01)00508-5.;PENROD JT, 2006, J BACTERIOL, V188, P2865, DOI 10.1128/JB.188.8.2865-2874.2006.;QIN JJ, 2010, NATURE, V464, P59, DOI 10.1038/NATURE08821.;REICHARDT N, 2014, ISME J, V8, P1323, DOI 10.1038/ISMEJ.2014.14.;REID MF, 1994, CRIT REV MICROBIOL, V20, P13, DOI 10.3109/10408419409113545.;ROOF DM, 1988, J BACTERIOL, V170, P3855, DOI 10.1128/JB.170.9.3855-3863.1988.;ROZEN S, 2000, METHODS MOL BIOL, V132, P365.;SANDHU SS, 1986, CAN J MICROBIOL, V32, P743, DOI 10.1139/M86-135.;SCHICHO R, 2012, J PROTEOME RES, V11, P3344, DOI 10.1021/PR300139Q.;SELMER T, 2005, BIOL CHEM, V386, P981, DOI 10.1515/BC.2005.114.;SHARON G, 2014, CELL METAB, V20, P719, DOI 10.1016/J.CMET.2014.10.016.;SIEVERS F, 2011, MOL SYST BIOL, V7, DOI 10.1038/MSB.2011.75.;SMILLIE CS, 2011, NATURE, V480, P241, DOI 10.1038/NATURE10571.;SOMMER MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/SCIENCE.1176950.;TAMURA K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/MOLBEV/MSR121.;TANG WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMOA1109400.;VITAL M, 2014, MBIO, V5, DOI 10.1128/MBIO.00889-14.;WACKETT LP, 2007, APPL ENVIRON MICROB, V73, P7192, DOI 10.1128/AEM.01785-07.;WANG ZN, 2014, EUR HEART J, V35, P904, DOI 10.1093/EURHEARTJ/EHU002.;WANG ZN, 2011, NATURE, V472, P57, DOI 10.1038/NATURE09922.;WARGO MJ, 2013, APPL ENVIRON MICROB, V79, P2112, DOI 10.1128/AEM.03565-12.;YATSUNENKO T, 2012, NATURE, V486, P222, DOI 10.1038/NATURE11053.;YEATES TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/NRMICRO1913.;ZEISEL SH, 1989, J NUTR, V119, P800.;ZEISEL SH, 1983, J PHARMACOL EXP THER, V225, P320.;ZHANG AQ, 1999, FOOD CHEM TOXICOL, V37, P515, DOI 10.1016/S0278-6915(99)00028-9.","BALSKUS, EP (REPRINT AUTHOR), HARVARD UNIV, DEPT CHEM \& CHEM BIOL, CAMBRIDGE, MA 02138 USA.;MARTINEZ-DEL CAMPO, ANA, BODEA, SMARANDA, HAMER, HILARY A., MARKS, JONATHAN A., BALSKUS, EMILY P., HARVARD UNIV, DEPT CHEM \& CHEM BIOL, CAMBRIDGE, MA 02138 USA.;HAISER, HENRY J., NOVARTIS INST BIOMED RES, CAMBRIDGE, MA USA.;TURNBAUGH, PETER J., UNIV CALIF SAN FRANCISCO, SAN FRANCISCO, CA 94143 USA.","10.1128/MBIO.00042-15","1752 N ST NW, WASHINGTON, DC 20036-2904 USA","E00042-15",NA,"SMITH FAMILY AWARD FOR EXCELLENCE IN BIOMEDICAL RESEARCH, PACKARD FELLOWSHIP FOR SCIENCE AND ENGINEERING, MILTON FUND, CORNING FOUNDATION, ELI LILLY NEW FACULTY AWARD, AMGEN, HOWARD HUGHES MEDICAL INSTITUTE","FINANCIAL SUPPORT WAS PROVIDED BY THE SMITH FAMILY AWARD FOR EXCELLENCE IN BIOMEDICAL RESEARCH, THE PACKARD FELLOWSHIP FOR SCIENCE AND ENGINEERING, THE MILTON FUND, THE CORNING FOUNDATION, THE ELI LILLY NEW FACULTY AWARD, AND AMGEN. S. BODEA ACKNOWLEDGES A GRADUATE FELLOWSHIP FROM THE HOWARD HUGHES MEDICAL INSTITUTE.",NA,"2150-7511","2",NA,"AMER SOC MICROBIOLOGY","6",2015,"ISI000355312400060","72","MICROBIOLOGY","40","MICROBIOLOGY","BALSKUSCHEMISTRY.HARVARD.EDU",NA,"CJ2KE",NA,"BALSKUS, EP (REPRINT AUTHOR), HARVARD UNIV, DEPT CHEM \& CHEM BIOL, CAMBRIDGE, MA 02138 USA","ISI","HARVARD UNIV;NOVARTIS INST BIOMED RES;UNIV CALIF SAN FRANCISCO","HARVARD UNIV",NA,"MARTINEZ-DEL CAMPO A, 2015, MBIO","MARTINEZ-DEL CAMPO A, 2015, MBIO"
"COZZI-LEPRI A, 2015, J ANTIMICROB CHEMOTHER","COZZI LEPRI A;NOGUERA JULIAN M;DI GIALLONARDO F;SCHUURMAN R;DAEUMER M;AITKEN S;CECCHERINI SILBERSTEIN F;MONFORTE ADA;GERETTI AM;BOOTH CL;KAISER R;MICHALIK C;JANSEN K;MASQUELIER B;BELLECAVE P;KOUYOS RD;CASTRO E;FURRER H;SCHULTZE A;GUENTHARD HF;BRUN VEZINET F;PAREDES R;METZNER KJ;CHAIN MINORITY HIV 1 VARIANTS CHAINMHIVV","LOW-FREQUENCY DRUG-RESISTANT HIV-1 AND RISK OF VIROLOGICAL FAILURE TO FIRST-LINE NNRTI-BASED ART: A MULTICOHORT EUROPEAN CASE-CONTROL STUDY USING CENTRALIZED ULTRASENSITIVE 454 PYROSEQUENCING","JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY","J. ANTIMICROB. CHEMOTHER.","OBJECTIVES: IT IS STILL DEBATED IF PRE-EXISTING MINORITY DRUG-RESISTANT HIV-1 VARIANTS (MVS) AFFECT THE VIROLOGICAL OUTCOMES OF FIRST-LINE NNRTI-CONTAINING ART. METHODS: THIS EUROPE-WIDE CASE-CONTROL STUDY INCLUDED ART-NAIVE SUBJECTS INFECTED WITH DRUG-SUSCEPTIBLE HIV-1 AS REVEALED BY POPULATION SEQUENCING, WHO ACHIEVED VIROLOGICAL SUPPRESSION ON FIRST-LINE ART INCLUDING ONE NNRTI. CASES EXPERIENCED VIROLOGICAL FAILURE AND CONTROLS WERE SUBJECTS FROM THE SAME COHORT WHOSE VIRAEMIA REMAINED SUPPRESSED AT A MATCHED TIME SINCE INITIATION OF ART. BLINDED, CENTRALIZED 454 PYROSEQUENCING WITH PARALLEL BIOINFORMATIC ANALYSIS IN TWO LABORATORIES WAS USED TO IDENTIFY MVS IN THE 1\%-25\% FREQUENCY RANGE. ORS OF VIROLOGICAL FAILURE ACCORDING TO MV DETECTION WERE ESTIMATED BY LOGISTIC REGRESSION. RESULTS: TWO HUNDRED AND SIXTY SAMPLES (76 CASES AND 184 CONTROLS), MOSTLY SUBTYPE B (73.5\%), WERE USED FOR THE ANALYSIS. IDENTICAL MVS WERE DETECTED IN THE TWO LABORATORIES. 31.6\% OF CASES AND 16.8\% OF CONTROLS HARBOURED PRE-EXISTING MVS. DETECTION OF AT LEAST ONE MV VERSUS NO MVS WAS ASSOCIATED WITH AN INCREASED RISK OF VIROLOGICAL FAILURE (OR = 2.75, 95\% CI=1.35-5.60, P=0.005), SIMILAR ASSOCIATIONS WERE OBSERVED FOR AT LEAST ONE MV VERSUS NO NRTIMVS (OR=2.27, 95\% CI = 0.76-6.77, P=0.140) AND AT LEAST ONE MV VERSUS NO NNRTI MVS (OR = 2.41, 95\% CI=1.12-5.18, P=0.024). A DOSE-EFFECT RELATIONSHIP BETWEEN VIROLOGICAL FAILURE AND MUTATIONAL LOAD WAS FOUND. CONCLUSIONS: PRE-EXISTING MVS MORE THAN DOUBLE THE RISK OF VIROLOGICAL FAILURE TO FIRST-LINE NNRTI-BASED ART.","MINORITY DRUG-RESISTANT HIV-1 VARIANTS; CHAIN; ANTIRETROVIRAL THERAPY; EUROPEAN MULTICENTRE STUDY","IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE; ANTIRETROVIRAL TREATMENT; BASIC CONCEPTS; MUTATIONS; EFAVIRENZ; VARIANTS; THERAPY; POLYMORPHISMS; NEVIRAPINE","ENGLISH","ARTICLE","ARTICLE",49,"[ANONYMOUS], 2012, TECHN UPD TREATM OPT.;BACHELER L, 2001, J VIROL, V75, P4999, DOI 10.1128/JVI.75.11.4999-5008.2001.;BUCKHEIT RW, 1995, ANTIVIR RES, V26, P117, DOI 10.1016/0166-3542(94)00069-K.;CASTRO H, 2013, J INFECT DIS, V208, P1459, DOI 10.1093/INFDIS/JIT345.;DI GIALLONARDO F, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0074249.;DOMINGO E, 1996, FASEB J, V10, P859.;FOURATI S, 2012, AIDS, V26, P1619, DOI 10.1097/QAD.0B013E3283560703.;FRASCO MA, 2012, AIDS, V26, P2097, DOI 10.1097/QAD.0B013E3283593602.;GADHAMSETTY S, 2010, J VIROL, V84, P10230, DOI 10.1128/JVI.01010-10.;GILKS CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7.;HALVAS EK, 2006, J CLIN MICROBIOL, V44, P2612, DOI 10.1128/JCM.00449-06.;JOHNSON VICTORIA A, 2013, TOP ANTIVIR MED, V21, P6.;KIM EY, 2010, J VIROL, V84, P10402, DOI 10.1128/JVI.01223-10.;LI JZ, 2013, J INFECT DIS, V207, P893, DOI 10.1093/INFDIS/JIS925.;LI JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0B013E32834E9D7D.;LI JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/JAMA.2011.375.;MACKIE NE, 2013, AIDS, V27, P2245, DOI 10.1097/QAD.0B013E3283636179.;METZNER KJ, 2013, J INFECT DIS, V208, P1102, DOI 10.1093/INFDIS/JIT310.;METZNER KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703.;PAREDES R, 2007, J VIROL METHODS, V146, P136, DOI 10.1016/J.JVIROMET.2007.06.012.;PAREDES R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543.;RIBAUDO HJ, 2010, J INFECT DIS, V202, P717, DOI 10.1086/655470.;SCHACKMAN BR, 2007, JAIDS-J ACQ IMM DEF, V46, P547, DOI 10.1097/QAI.0B013E31815AC499.;SCHUURMAN R, 1999, J CLIN MICROBIOL, V37, P2291.;SNEDECOR SJ, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0072784.;THOMPSON MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/JAMA.2012.7961.;VANDENBROUCKE JP, 2012, INT J EPIDEMIOL, V41, P1480, DOI 10.1093/IJE/DYS147.;VARGHESE V, 2009, JAIDS-J ACQ IMM DEF, V52, P309, DOI 10.1097/QAI.0B013E3181BCA669.;WHO, HIV DRUG RES REP 201.;WITTKOP L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9.","METZNER, KJ (REPRINT AUTHOR), UNIV ZURICH, UNIV ZURICH HOSP, DIV INFECT DIS \& HOSP EPIDEMIOL, ZURICH, SWITZERLAND.;COZZI-LEPRI, ALESSANDRO, SCHULTZE, ANNA, UCL, LONDON, ENGLAND.;NOGUERA-JULIAN, MARC, PAREDES, ROGER, UNIV VIC, UNIV AUTONOMA BARCELONA, INST RECERCA, SIDA IRSICAIXA, CATALONIA, SPAIN.;NOGUERA-JULIAN, MARC, PAREDES, ROGER, UNIV VIC, UNIV AUTONOMA BARCELONA, UNITAT VIH, CATALONIA, SPAIN.;DI GIALLONARDO, FRANCESCA, KOUYOS, ROGER D., GUENTHARD, HULDRYCH F., METZNER, KARIN J., UNIV ZURICH, UNIV ZURICH HOSP, DIV INFECT DIS \& HOSP EPIDEMIOL, ZURICH, SWITZERLAND.;SCHUURMAN, ROB, AITKEN, SUE, UNIV MED CTR, DEPT VIROL, UTRECHT, NETHERLANDS.;DAEUMER, MARTIN, INST IMMUNOL \& GENET, KAISERSLAUTERN, GERMANY.;CECCHERINI-SILBERSTEIN, FRANCESCA, UNIV ROMA TOR VERGATA, DEPT EXPT MED \& SURG, ROME, ITALY.;MONFORTE, ANTONELLA D'ARMINIO, UNIV MILAN, DEPT HLTH SCI, CLIN INFECT DIS, SAN PAOLO HOSP, MILAN, ITALY.;GERETTI, ANNA MARIA, UNIV LIVERPOOL, INST INFECT \& GLOBAL HLTH, LIVERPOOL L69 3BX, MERSEYSIDE, ENGLAND.;BOOTH, CLARE L., ROYAL FREE LONDON NHS FDN TRUST, DEPT VIROL, LONDON, ENGLAND.;KAISER, ROLF, UNIV COLOGNE, INST VIROL, D-50931 COLOGNE, GERMANY.;MICHALIK, CLAUDIA, JANSEN, KLAUS, COMPETENCE NETWORK HIV AIDS, BOCHUM, GERMANY.;MICHALIK, CLAUDIA, JANSEN, KLAUS, RUHR UNIV BOCHUM, CLIN DERMATOL VENEROL \& ALLERGOL, BOCHUM, GERMANY.;MICHALIK, CLAUDIA, UNIV COLOGNE, CLIN TRIAL CTR ZKS, D-50931 COLOGNE, GERMANY.;MASQUELIER, BERNARD, BELLECAVE, PANTXIKA, CHU BORDEAUX, VIROL LAB, BORDEAUX, FRANCE.;MASQUELIER, BERNARD, BELLECAVE, PANTXIKA, UNIV BORDEAUX 2, MFP UMR5234, F-33076 BORDEAUX, FRANCE.;CASTRO, ERIKA, CHU VAUDOIS, ADDICT MED, SERV COMMUNITY PSYCHIAT, CH-1011 LAUSANNE, SWITZERLAND.;FURRER, HANSJAKOB, UNIV HOSP BERN, DEPT INFECT DIS, CH-3010 BERN, SWITZERLAND.;FURRER, HANSJAKOB, UNIV BERN, BERN, SWITZERLAND.;BRUN-VEZINET, FRANCOISE, HOP XAVIER BICHAT, DEPT VIROL, PARIS, FRANCE.","10.1093/JAC/DKU426","GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND",NA,NA,"`CHAIN, COLLABORATIVE HIV AND ANTI-HIV DRUG RESISTANCE NETWORK', INTEGRATED PROJECT, EUROPEAN COMMISSION [223131], GILEAD SCIENCES, ROCHE DIAGNOSTICS GMBH, SWISS NATIONAL SCIENCE FOUNDATION (SNF) [33CS30-134277, 33CS30-148522, 108787], SWISS HIV COHORT STUDY RESEARCH FOUNDATION, EUROPEAN COMMISSION [CT94-1637, CT97-2713, QLK2-2000-00773, LSHP-CT-2006-018632, 260694], BRISTOL-MYERS SQUIBB, JANSSEN RD, MERCK AND CO. INC., PFIZER INC., GLAXOSMITHKLINE LLC","THIS STUDY WAS SUPPORTED BY `CHAIN, COLLABORATIVE HIV AND ANTI-HIV DRUG RESISTANCE NETWORK', INTEGRATED PROJECT NO. 223131, EUROPEAN COMMISSION FRAMEWORK 7 PROGRAM, GILEAD SCIENCES AND ROCHE DIAGNOSTICS GMBH. THE SWISS HIV COHORT STUDY IS SUPPORTED BY THE SWISS NATIONAL SCIENCE FOUNDATION (SNF GRANT \#33CS30-134277, -148522 AND \#108787) AND THE SWISS HIV COHORT STUDY RESEARCH FOUNDATION. PRIMARY SUPPORT FOR EUROSIDA IS PROVIDED BY THE EUROPEAN COMMISSION BIOMED 1 (CT94-1637) AND BIOMED 2 (CT97-2713) AND THE 5TH FRAMEWORK (QLK2-2000-00773), THE 6TH FRAMEWORK (LSHP-CT-2006-018632) AND THE 7TH FRAMEWORK (FP7/2007-2013, EUROCOORD NO. 260694) PROGRAMMES. CURRENT SUPPORT ALSO INCLUDES UNRESTRICTED GRANTS FROM BRISTOL-MYERS SQUIBB, JANSSEN R\&D, MERCK AND CO. INC., PFIZER INC. AND GLAXOSMITHKLINE LLC.",NA,"0305-7453","3","930-940","OXFORD UNIV PRESS","70",2015,"ISI000350214700041","30","INFECTIOUS DISEASES, MICROBIOLOGY, PHARMACOLOGY \& PHARMACY","14","INFECTIOUS DISEASES, MICROBIOLOGY, PHARMACOLOGY \& PHARMACY","KARIN.METZNERUSZ.CH",NA,"CC2ZV",NA,"METZNER, KJ (REPRINT AUTHOR), UNIV ZURICH, UNIV ZURICH HOSP, DIV INFECT DIS \& HOSP EPIDEMIOL, ZURICH, SWITZERLAND","ISI","SCHULTZE;UNIV VIC;UNIV VIC;UNIV ZURICH;UNIV MED CTR;INST IMMUNOL AND GENET;UNIV ROMA TOR VERGATA;UNIV MILAN;UNIV LIVERPOOL;ROYAL FREE LONDON NHS FDN TRUST;UNIV COLOGNE;RUHR UNIV BOCHUM;UNIV COLOGNE;VIROL LAB;UNIV HOSP BERN;UNIV BERN","UNIV ZURICH",NA,"COZZI-LEPRI A, 2015, J ANTIMICROB CHEMOTHER","COZZI-LEPRI A, 2015, J ANTIMICROB CHEMOTHER"
"LIN J, 2015, PARASITES VECTORS","LIN J;QU H;CHEN G;HE L;XU Y;XIE Z;REN M;SUN J;LI S;CHEN W;CHEN X;WANG X;LI X;LIANG C;HUANG Y;YU X","CLONORCHIS SINENSIS ACETOACETYL-COA THIOLASE: IDENTIFICATION AND CHARACTERIZATION OF ITS POTENTIAL ROLE IN SURVIVING IN THE BILE DUCT","PARASITES \& VECTORS","PARASITES VECTORS","BACKGROUND: CLONORCHIS SINENSIS (C. SINENSIS) INHABITS IN BILE DUCT OF THE HOST. HOWEVER, THE MECHANISMS INVOLVED IN WHY C. SINENSIS CAN SURVIVE IN THE BILE ENVIRONMENT CONTAINING LIPIDS HAVE NOT YET BEEN EXPLORED. IN THIS STUDY, C. SINENSIS ACETOACETYL-COA THIOLASE (CSACAT), A MEMBER OF THE THIOLASE FAMILY WHICH HAS A KEY ROLE IN THE BETA OXIDATION PATHWAY OF FATTY ACID PRODUCTION, WAS IDENTIFIED AND CHARACTERIZED TO UNDERSTAND ITS POTENTIAL ROLE IN ADAPTING TO THE BILE ENVIRONMENT. METHODS: THE ENCODING SEQUENCE, CONSERVED DOMAINS AND SPATIAL STRUCTURE OF CSACAT WERE IDENTIFIED AND ANALYZED BY BIOINFORMATIC TOOLS. RECOMBINANT CSACAT (RCSACAT) WAS OBTAINED USING A PROCARYOTIC EXPRESSION SYSTEM. THE EXPRESSION PATTERN OF CSACAT WAS CONFIRMED BY QUANTITATIVE REAL-TIME PCR, WESTERN BLOTTING, AND IMMUNOFLUORESCENCE. GRADIENTS OF LECITHIN WERE THEN SET TO CULTURE C. SINENSIS ADULTS IN VITRO AND THE SURVIVAL RATE OF C. SINENSIS WAS ANALYZED, AS WELL AS THE EXPRESSION LEVEL AND ENZYMATIC ACTIVITY OF CSACAT IN DIFFERENT LIPID ENVIRONMENTS. HYPERCHOLESTEREMIA RABBIT MODELS WERE ESTABLISHED BY FEEDING WITH A HYPERLIPIDEMIC DIET AND THEN INFECTED INTRAGASTRICALLY WITH C. SINENSIS. ONE AND A HALF MONTHS LATER, THE WORM BURDENS AND THE EXPRESSION LEVEL OF CSACAT WAS DETECTED. RESULTS: CSACAT WAS CONFIRMED TO BE A MEMBER OF THE THIOLASE FAMILY AND PRESENT IN THE EXCRETORY/SECRETORY PROTEINS OF C. SINENSIS. CSACAT WAS SPECIFICALLY LOCALIZED AT THE VITELLARIUM AND SUB-TEGUMENTAL MUSCLE LAYER IN ADULT WORMS. THE MRNA LEVEL OF CSACAT IN EGGS WAS HIGHER THAN THOSE IN ADULT WORMS AND METACERCARIAE. WHEN ADULT WORMS WERE CULTURED WITH HIGHER CONCENTRATION OF LECITHIN, THE EXPRESSION LEVEL AND ENZYME ACTIVITY OF CSACAT WERE UP-REGULATED. THE SURVIVAL RATE OF ADULT WORMS WAS HIGHER THAN CONTROL GROUP. MORE ADULT WORMS WERE RECOVERED FROM HYPERCHOLESTEREMIA RABBIT MODELS. THE EXPRESSION LEVEL OF CSACAT IN THESE WORMS WAS HIGHER THAN CONTROL GROUP. CONCLUSIONS: OUR RESULTS IMPLIED THAT C. SINENSIS MIGHT SENSE LIPID LEVELS AND SURVIVE BETTER IN THE BILE ENVIRONMENT WITH HIGHER LIPID LEVELS. C. SINENSIS MIGHT MODULATE THE EXPRESSION AND ENZYMATIC ACTIVITY OF CSACAT, AN ENZYME INVOLVED IN FATTY ACID METABOLISM, FOR ENERGY OR PHYSICAL REQUIREMENTS TO ADAPT TO THE HOST.","CLONORCHIS SINENSIS; ACETOACETYL-COA THIOLASE; ENZYMATIC ACTIVITY; SURVIVAL RATE; LECITHIN; HYPERCHOLESTEREMIA","CAENORHABDITIS-ELEGANS; LIFE-SPAN; MOLECULAR CHARACTERIZATION; GENE-EXPRESSION; LECITHIN; LYSOPHOSPHOLIPASE; SCHISTOSOMA; INFECTION; GENOME; CELLS","ENGLISH","ARTICLE","ARTICLE",3,"BALINT JA, 1965, J LIPID RES, V6, P96.;BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/SCIENCE.2006412.;BERDICHEVSKY A, 2010, P NATL ACAD SCI USA, V107, P18927, DOI 10.1073/PNAS.1013854107.;BUNYA M, 1997, EUR J BIOCHEM, V245, P252, DOI 10.1111/J.1432-1033.1997.T01-1-00252.X.;CAO W, 2008, BBA-GEN SUBJECTS, V1780, P873, DOI 10.1016/J.BBAGEN.2008.02.007.;HAAPALAINEN AM, 2007, BIOCHEMISTRY-US, V46, P4305, DOI 10.1021/BI6026192.;HONG ST, 2012, PARASITOL INT, V61, P17, DOI 10.1016/J.PARINT.2011.06.007.;HOU Y, 2009, EXP GERONTOL, V44, P434, DOI 10.1016/J.EXGER.2009.03.007.;HUANG C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/PNAS.0400848101.;HUANG LS, 2012, MOL CELL BIOCHEM, V363, P367, DOI 10.1007/S11010-011-1189-3.;IGUAL JC, 1992, J MOL EVOL, V35, P147.;IWATA F, 2008, PARASITOL INT, V57, P54, DOI 10.1016/J.PARINT.2007.08.002.;KIM TI, 2009, KOREAN J PARASITOL, V47, PS59, DOI 10.3347/KJP.2009.47.S.S59.;KITA K, 2003, CURR MED CHEM, V10, P2535, DOI 10.2174/0929867033456549.;LEGIDO-QUIGLEY C, 2010, PARASITOLOGY, V137, P1425, DOI 10.1017/S0031182010000545.;LIANG CHI, 2009, ZHONGGUO JI SHENG CHONG XUE YU JI SHENG CHONG BING ZA ZHI, V27, P148.;LIANG P, 2013, PARASITOL RES, V112, P1719, DOI 10.1007/S00436-013-3330-6.;LIM MK, 2006, AM J TROP MED HYG, V75, P93, DOI 10.4269/AJTMH.2006.75.93.;LIVAK KJ, 2001, METHODS, V25, P402, DOI 10.1006/METH.2001.1262.;MA CL, 2007, PARASITOL RES, V101, P419, DOI 10.1007/S00436-007-0481-3.;MAK HY, 2006, NAT GENET, V38, P363, DOI 10.1038/NG1739.;MIDDLETON B, 1973, BIOCHEM J, V132, P717, DOI 10.1042/BJ1320717.;SANTHANAM S, 2007, GUT, V56, P1543, DOI 10.1136/GUT.2006.108449.;SODERLIND E, 2010, MOL PHARMACEUT, V7, P1498, DOI 10.1021/MP100144V.;SUGAWARA S, 2013, J CLIN BIOCHEM NUTR, V52, P139, DOI 10.3164/JCBN.12-88.;TAN YN, 2013, TOXICOL IN VITRO, V27, P714, DOI 10.1016/J.TIV.2012.11.018.;TSO P, 2012, MED PHYSL PRINCIPLES, P481.;UDDIN MH, 2012, KOREAN J PARASITOL, V50, P309, DOI 10.3347/KJP.2012.50.4.309.;VAN ERPECUM KJ, 2005, BIOL CELL, V97, P815, DOI 10.1042/BC20040088.;WANG MC, 2008, SCIENCE, V322, P957, DOI 10.1126/SCIENCE.1162011.;WANG XY, 2011, GENOME BIOL, V12, DOI 10.1186/GB-2011-12-10-R107.;WU W, 2012, PARASITOL RES, V111, P1879, DOI 10.1007/S00436-012-3152-Y.;XU YQ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-360.;YOO WG, 2009, PARASITOL RES, V104, P321, DOI 10.1007/S00436-008-1195-X.;ZHANG F, 2013, PARASITOL RES, V112, P737, DOI 10.1007/S00436-012-3194-1.;ZHENG MH, 2013, PARASITOL RES, V112, P1287, DOI 10.1007/S00436-012-3264-4.;ZHOU Y, 2009, NATURE, V460, P345, DOI 10.1038/NATURE08140.","HUANG, Y (REPRINT AUTHOR), SUN YAT SEN UNIV, ZHONGSHAN SCH MED, DEPT PARASITOL, 74 ZHONGSHAN 2ND RD, GUANGZHOU 510080, GUANGDONG, PEOPLES R CHINA.;LIN, JINSI, QU, HONGLING, CHEN, GUISHAN, HE, LEI, XU, YANQUAN, XIE, ZHIZHI, REN, MENGYU, SUN, JIUFENG, LI, SHAN, CHEN, WENJUN, CHEN, XUEQING, WANG, XIAOYUN, LI, XUERONG, LIANG, CHI, HUANG, YAN, YU, XINBING, SUN YAT SEN UNIV, ZHONGSHAN SCH MED, DEPT PARASITOL, GUANGZHOU 510080, GUANGDONG, PEOPLES R CHINA.;LIN, JINSI, QU, HONGLING, CHEN, GUISHAN, HE, LEI, XU, YANQUAN, XIE, ZHIZHI, REN, MENGYU, SUN, JIUFENG, LI, SHAN, CHEN, WENJUN, CHEN, XUEQING, WANG, XIAOYUN, LI, XUERONG, LIANG, CHI, HUANG, YAN, YU, XINBING, SUN YAT SEN UNIV, KEY LAB TROP DIS CONTROL, MINIST EDUC, GUANGZHOU 510080, GUANGDONG, PEOPLES R CHINA.","10.1186/S13071-015-0728-2","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","125",NA,"NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA [81101270, 81171602], NATIONAL IMPORTANT SCI-TECH SPECIAL PROJECTS [2012ZX10004220], NATIONAL KEY BASIC RESEARCH AND DEVELOPMENT PROJECT (973 PROJECT) [2010CB530000]","THIS WORK WAS SUPPORTED BY THE NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA (NO. 81101270 AND NO. 81171602), THE NATIONAL IMPORTANT SCI-TECH SPECIAL PROJECTS (2012ZX10004220), AND THE NATIONAL KEY BASIC RESEARCH AND DEVELOPMENT PROJECT (973 PROJECT, NO. 2010CB530000).",NA,"1756-3305",NA,NA,"BIOMED CENTRAL LTD","8",2015,"ISI000351039700001","37","PARASITOLOGY, TROPICAL MEDICINE","2","PARASITOLOGY, TROPICAL MEDICINE","HUANG66MAIL.SYSU.EDU.CN YUHXTEAM163.COM",NA,"CD4GD",NA,"HUANG, Y (REPRINT AUTHOR), SUN YAT SEN UNIV, ZHONGSHAN SCH MED, DEPT PARASITOL, 74 ZHONGSHAN 2ND RD, GUANGZHOU 510080, GUANGDONG, PEOPLES R CHINA","ISI","SUN YAT SEN UNIV;SUN YAT SEN UNIV","SUN YAT SEN UNIV",NA,"LIN J, 2015, PARASITES VECTORS","LIN J, 2015, PARASITES VECTORS"
"EISENBERGER T, 2015, PLOS ONE","EISENBERGER T;DECKER C;HIERSCHE M;HAMANN RC;DECKER E;NEUBER S;FRANK V;BOLZ HJ;FEHRENBACH H;PAPE L;TOENSHOFF B;MACHE C;LATTA K;BERGMANN C","AN EFFICIENT AND COMPREHENSIVE STRATEGY FOR GENETIC DIAGNOSTICS OF POLYCYSTIC KIDNEY DISEASE","PLOS ONE","PLOS ONE","RENAL CYSTS ARE CLINICALLY AND GENETICALLY HETEROGENEOUS CONDITIONS. AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) IS THE MOST FREQUENT LIFE-THREATENING GENETIC DISEASE AND MAINLY CAUSED BY MUTATIONS IN PKD1. THE PRESENCE OF SIX PKD1 PSEUDOGENES AND TREMENDOUS ALLELIC HETEROGENEITY MAKE MOLECULAR GENETIC TESTING CHALLENGING REQUIRING LABORIOUS LOCUS-SPECIFIC AMPLIFICATION. INCREASING EVIDENCE SUGGESTS A MAJOR ROLE FOR PKD1 IN EARLY AND SEVERE CASES OF ADPKD AND SOME PATIENTS WITH A RECESSIVE FORM. FURTHERMORE IT IS BECOMING OBVIOUS THAT CLINICAL MANIFESTATIONS CAN BE MIMICKED BY MUTATIONS IN A NUMBER OF OTHER GENES WITH THE NECESSITY FOR BROADER GENETIC TESTING. WE ESTABLISHED AND VALIDATED A SEQUENCE CAPTURE BASED NGS TESTING APPROACH FOR ALL GENES KNOWN FOR CYSTIC AND POLYCYSTIC KIDNEY DISEASE INCLUDING PKD1. THEREBY, WE DEMONSTRATE THAT THE APPLIED STANDARD MAPPING ALGORITHM SPECIFICALLY ALIGNS READS TO THE PKD1 LOCUS AND OVERCOMES THE COMPLICATION OF UNSPECIFIC CAPTURE OF PSEUDOGENES. EMPLOYING CAREFUL AND EXPERIENCED ASSESSMENT OF NGS DATA, THE METHOD IS SHOWN TO BE VERY SPECIFIC AND EQUALLY SENSITIVE AS ESTABLISHED METHODS. AN ADDITIONAL ADVANTAGE OVER CONVENTIONAL SANGER SEQUENCING IS THE DETECTION OF COPY NUMBER VARIATIONS (CNVS). SOPHISTICATED BIOINFORMATIC READ SIMULATION INCREASED THE HIGH ANALYTICAL DEPTH OF THE VALIDATION STUDY AND FURTHER DEMONSTRATED THE STRENGTH OF THE APPROACH. WE FURTHER RAISE SOME AWARENESS OF LIMITATIONS AND PITFALLS OF COMMON NGS WORK-FLOWS WHEN APPLIED IN COMPLEX REGIONS LIKE PKD1 DEMONSTRATING THAT QUALITY OF NGS NEEDS MORE THAN HIGH COVERAGE OF THE TARGET REGION. BY THIS, WE PROPOSE A TIME- AND COST-EFFICIENT DIAGNOSTIC STRATEGY FOR COMPREHENSIVE MOLECULAR GENETIC TESTING OF POLYCYSTIC KIDNEY DISEASE WHICH IS HIGHLY AUTOMATABLE AND WILL BE OF PARTICULAR VALUE WHEN THERAPEUTIC OPTIONS FOR PKD EMERGE AND GENETIC TESTING IS NEEDED FOR LARGER NUMBERS OF PATIENTS.",NA,"AUTOSOMAL-DOMINANT; PRIMARY CILIUM; MUTATIONS; NEPHRONOPHTHISIS; CILIOPATHIES; ALIGNMENT; PKD1; NEK8","ENGLISH","ARTICLE","ARTICLE",22,"ARTS HH, 2013, PEDIATR NEPHROL, V28, P863, DOI 10.1007/S00467-012-2259-9.;AUDREZET MP, 2012, HUM MUTAT, V33, P1239, DOI 10.1002/HUMU.22103.;BERGMANN C., 2014, AUTOSOMAL RECESSIVE.;BERGMANN C., 2014, PEDIAT NEPHROL.;BERGMANN C, 2008, NEW ENGL J MED, V359, P318, DOI 10.1056/NEJMC0801868.;BERGMANN C, 2011, J AM SOC NEPHROL, V22, P2047, DOI 10.1681/ASN.2010101080.;BOGDANOVA N, 2001, GENOMICS, V74, P333, DOI 10.1006/GENO.2001.6568.;CONSUGAR MB, 2008, KIDNEY INT, V74, P1468, DOI 10.1038/KI.2008.485.;DE LIGT J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMOA1206524.;EISENBERGER T, 2014, HUM MUTAT, V35, P565, DOI 10.1002/HUMU.22532.;EISENBERGER T, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0078496.;FEHRENBACH H, 2014, PEDIAT NEPHROL, P99451.;FRANK V, 2013, HUM MOL GENET, V22, P2177, DOI 10.1093/HMG/DDT070.;GERDES JM, 2009, CELL, V137, P32, DOI 10.1016/J.CELL.2009.03.023.;GOETZ SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/NRG2774.;HARRIS PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/ANNUREV.MED.60.101707.125712.;HOFF S, 2013, NAT GENET, V45, P951, DOI 10.1038/NG.2681.;KOBOLDT DC, 2012, GENOME RES, V22, P568, DOI 10.1101/GR.129684.111.;LANDSVERK ML, 2012, GENET MED, V14, P877, DOI 10.1038/GIM.2012.58.;LI H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/BIOINFORMATICS/BTP352.;LI H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/BIOINFORMATICS/BTP324.;MCKENNA A, 2010, GENOME RES, V20, P1297, DOI 10.1101/GR.107524.110.;NIX DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-9.;OTT E, 2014, J MED GENET, P91.;ROSSETTI S, 2002, KIDNEY INT, V61, P1588, DOI 10.1046/J.1523-1755.2002.00326.X.;ROSSETTI S, 2007, J AM SOC NEPHROL, V18, P2143, DOI 10.1681/ASN.2006121387.;ROSSETTI S, 2007, J AM SOC NEPHROL, V18, P1374, DOI 10.1681/ASN.2007010125.;ROSSETTI S, 2012, J AM SOC NEPHROL, V23, P915, DOI 10.1681/ASN.2011101032.;SAFRAN M., 2010, DATABASE-OXFORD, V2010, DOI DOI 10.1093/DATABASE/BAQ020.;SALOMON R, 2009, PEDIATR NEPHROL, V24, P2333, DOI 10.1007/S00467-008-0840-Z.;SCHMIDTS M, 2013, HUM MUTAT, V34, P714, DOI 10.1002/HUMU.22294.;SUZUKI S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S7.;SYMMONS O, 2008, MOL BIOL EVOL, V25, P2601, DOI 10.1093/MOLBEV/MSN202.;TRUJILLANO D, 2014, MOL GENETIC GENETIC, V5, P99451, DOI DOI 10.1093/BRAIN/AWQ331.;TURNER EH, 2009, ANNU REV GENOM HUM G, V10, P263, DOI 10.1146/ANNUREV-GENOM-082908-150112.;VOELKERDING KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/CLINCHEM.2008.112789.","BERGMANN, C (REPRINT AUTHOR), BIOSCIENTIA CTR HUMAN GENET, INGELHEIM, GERMANY.;EISENBERGER, TOBIAS, DECKER, CHRISTIAN, HIERSCHE, MILAN, HAMANN, RUBEN C., DECKER, EVA, NEUBER, STEFFEN, FRANK, VALESKA, BOLZ, HANNO J., BERGMANN, CARSTEN, BIOSCIENTIA CTR HUMAN GENET, INGELHEIM, GERMANY.;FEHRENBACH, HENRY, CHILDRENS HOSP MEMMINGEN, DEPT PEDIAT, MEMMINGEN, GERMANY.;PAPE, LARS, MHH HANNOVER, CLIN PEDIAT KIDNEY LIVER \& METAB DIS, HANNOVER, GERMANY.;TOENSHOFF, BURKHARD, UNIV CHILDRENS HOSP HEIDELBERG, DEPT PEDIAT 1, HEIDELBERG, GERMANY.;MACHE, CHRISTOPH, MED UNIV GRAZ, DEPT PEDIAT, GRAZ, AUSTRIA.;LATTA, KAY, CLEMENTINE CHILDRENS HOSP, FRANKFURT, GERMANY.;BERGMANN, CARSTEN, UNIV FREIBURG, MED CTR, DEPT MED, DIV RENAL, D-79106 FREIBURG, GERMANY.","10.1371/JOURNAL.PONE.0116680","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","UNSP E0116680",NA,NA,NA,NA,"1932-6203","2",NA,"PUBLIC LIBRARY SCIENCE","10",2015,"ISI000348822600032","36","SCIENCE \& TECHNOLOGY - OTHER TOPICS","11","MULTIDISCIPLINARY SCIENCES","CARSTEN.BERGMANNBIOSCIENTIA.DE",NA,"CA3QZ",NA,"BERGMANN, C (REPRINT AUTHOR), BIOSCIENTIA CTR HUMAN GENET, INGELHEIM, GERMANY","ISI","HIERSCHE;CHILDRENS HOSP MEMMINGEN;CLIN PEDIAT KIDNEY LIVER AND METAB DIS;UNIV CHILDRENS HOSP HEIDELBERG;MED UNIV GRAZ;CLEMENTINE CHILDRENS HOSP;UNIV FREIBURG","BIOSCIENTIA CTR HUMAN GENET",NA,"EISENBERGER T, 2015, PLOS ONE","EISENBERGER T, 2015, PLOS ONE"
"LUXEMBOURG B, 2015, THROMB RES","LUXEMBOURG B;D SOUZA M;KOERBER S;SEIFRIED E","PREDICTION OF THE PATHOGENICITY OF ANTITHROMBIN SEQUENCE VARIATIONS BY IN SILICO METHODS","THROMBOSIS RESEARCH","THROMB. RES.","COMPUTATIONAL PREDICTION TOOLS HAVE BEEN DEVELOPED TO AID IN THE INTERPRETATION OF NOVEL SEQUENCE VARIATIONS, BUT THEIR UTILITY WITHIN THE DIAGNOSTIC SETTING OF ANTITHROMBIN (AT) DEFICIENCY HAS NOT BEEN EVALUATED TO DATE. THE AIM OF OUR STUDY WAS TO TEST THE PERFORMANCE OF DIFFERENT BIOINFORMATIC TOOLS (META-SNP, MUTPRED, NSSNPANALYZER, PANTHER, PHD-SNP, PMUT, SIFT, SNAP, SNPS\&GO, POLYPHEN-2, PON-P2, AND PREDICTSNP) IN PREDICTING THE PATHOGENICITY OF AT SEQUENCE VARIATIONS. WE ANALYSED ALL NATURALLY OCCURRING SERPINC1 MISSENSE MUTATIONS THAT HAVE BEEN PREVIOUSLY CHARACTERISED TO BE DAMAGING WITH REGARD TO THE SECRETION OR FUNCTION OF THE AT MOLECULE. ADDITIONALLY, WE ANALYSED ALL REPORTED NON-SYNONYMOUS EXONIC POLYMORPHISMS WITHIN SERPINC1 WITH A POPULATION ALLELE FREQUENCY > 1.0\%. THE IN SILICO TOOLS HAD ACCURACIES OF 62-96\%, SENSITIVITIES OF 59-98\%, AND SPECIFICITIES OF 33-100\% FOR THE PREDICTION OF THE PATHOGENICITY OF AT SEQUENCE VARIATIONS, RECEIVER OPERATING CHARACTERISTIC ANALYSIS HAD AREA UNDER THE CURVES BETWEEN 0.54-0.97. WHEN MUTATIONS WERE GROUPED ACCORDING TO THEIR EFFECT ON THE PHENOTYPE OF AT DEFICIENCY [TYPE I OR TYPE II WITH A THROMBIN (IIRS) OR HEPARIN (IIHBS) BINDING DEFECT OR PLEIOTROPIC EFFECTS (IIPE)], WE OBSERVED THE LOWEST PERFORMANCE CHARACTERISTICS OF THE TOOLS FOR MUTATIONS CAUSING AT DEFICIENCY TYPE IIHBS. ONLY THREE TOOLS (MUTPRED, PHD-SNP, POLYPHEN-2) DETECTED MUTANTS CAUSING TYPE IIHBS AT DEFICIENCY WITH HIGH SENSITIVITY (93\%), THE SENSITIVITIES OF THE OTHER TOOLS RANGED BETWEEN 36\% AND 79\%. THIS STUDY DEMONSTRATES THAT BIOINFORMATIC TOOLS ARE USEFUL FOR PATHOGENICITY PREDICTION FOR AT SEQUENCE VARIATIONS, BUT THEY HAVE SUBSTANTIALLY DIFFERENT PERFORMANCE CHARACTERISTICS, PARTICULARLY FOR TYPE IIHBS AT DEFICIENCY. (C) 2014 ELSEVIER LTD. ALL RIGHTS RESERVED.","ANTITHROMBIN; SERPINC1; MUTATION; SEQUENCE VARIATION; IN SILICO","AMINO-ACID SUBSTITUTIONS; NUCLEOTIDE POLYMORPHISMS; MOLECULAR-MECHANISMS; MUTATIONS; DEFICIENCY; DISEASE; VARIANTS; THROMBOEMBOLISM; ANNOTATION; EVOLUTION","ENGLISH","ARTICLE","ARTICLE",5,"ADZHUBEI I, 2013, CURR PROTOC HUM GENE, V76, DOI 10.1002/0471142905.HG0720S76.;ADZHUBEI IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/NMETH0410-248.;BACKOVIC M, 2002, J PROTEOME RES, V1, P367, DOI 10.1021/PR025515Z.;BAO L, 2005, NUCLEIC ACIDS RES, V33, PW480, DOI 10.1093/NAR/GKI372.;BAYTON T, 2003, ANTITHROMBIN MUTATIO.;BENDL J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/JOURNAL.PCBI.1003440.;BREIMAN L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324.;BROMBERG Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/NAR/GKM238.;CAPRIOTTI E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/BIOINFORMATICS/BTL423.;CAPRIOTTI E, 2004, BIOINFORMATICS, V20, P63, DOI 10.1093/BIOINFORMATICS/BTH928.;CAPRIOTTI E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S6.;CAPRIOTTI E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S2.;CAPRIOTTI E, 2012, BRIEF BIOINFORM, V13, P495, DOI 10.1093/BIB/BBR070.;CLINICAL MOLECULAR GENETICS SOCIETY, BEST PRACT GUID.;DE LA MORENA-BARRIO ME, 2012, THROMB HAEMOSTASIS, V107, P430.;FERRER-COSTA C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/BIOINFORMATICS/BIT486.;FINAZZI G, 1987, THROMB HAEMOSTASIS, V58, P1094.;HUNTINGTON JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/J.1538-7836.2011.04360.X.;KUHLE S, 2001, THROMB HAEMOSTASIS, V86, P1007.;KUMAR A, 2013, BIOCHEM BIOPH RES CO, V440, P714, DOI 10.1016/J.BBRC.2013.09.134.;LI B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/BIOINFORMATICS/BTP528.;LUXEMBOURG B, 2014, THROMB HAEMOSTASIS, V111, P249, DOI 10.1160/TH13-05-0402.;LUXEMBOURG B, 2011, THROMB HAEMOSTASIS, V105, P635, DOI 10.1160/TH10-08-0538.;MARTINEZ-MARTINEZ I, 2010, HAEMATOL-HEMATOL J, V95, P1358, DOI 10.3324/HAEMATOL.2009.015487.;MI HY, 2013, NUCLEIC ACIDS RES, V41, PD377, DOI 10.1093/NAR/GKS1118.;NG PC, 2001, GENOME RES, V11, P863, DOI 10.1101/GR.176601.;OLATUBOSUN A, 2012, HUM MUTAT, V33, P1166, DOI 10.1002/HUMU.22102.;OLDS RJ, 1993, BIOCHEMISTRY-US, V32, P4216, DOI 10.1021/BI00067A008.;OLSON ST, 2010, BIOCHIMIE, V92, P1587, DOI 10.1016/J.BIOCHI.2010.05.011.;SHEN BR, 2008, PROTEIN ENG DES SEL, V21, P37, DOI 10.1093/PROTEIN/GZM084.;SILVERMAN GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/JBC.R100016200.;TANAKA Y, 2002, J BIOL CHEM, V277, P51058, DOI 10.1074/JBC.M210231200.;THOMAS PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/PNAS.0404380101.;THUSBERG J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/HUMU.21445.","LUXEMBOURG, B (REPRINT AUTHOR), DRK BLOOD DONOR SERV BADEN WRUTTEMBERG HESSEN, INST TRANSFUS MED \& IMMUNOHAEMATOL, SANDHOFSTR 1, D-60528 FRANKFURT, GERMANY.;LUXEMBOURG, BEATE, D'SOUZA, MATHIAS, KOERBER, STEPHANIE, SEIFRIED, ERHARD, UNIV HOSP FRANKFURT, DRK BLOOD DONOR SERV BADEN WRTTEMBERG HESSEN, INST TRANSFUS MED \& IMMUNOHAEMATOL, D-60528 FRANKFURT, GERMANY.;LUXEMBOURG, BEATE, UNIV HOSP FRANKFURT, DEPT INTERNAL MED, D-60590 FRANKFURT, GERMANY.;DRK BLOOD DONOR SERV BADEN WRUTTEMBERG HESSEN, INST TRANSFUS MED \& IMMUNOHAEMATOL, D-60528 FRANKFURT, GERMANY.","10.1016/J.THROMRES.2014.11.022","THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND",NA,NA,NA,NA,NA,"0049-3848","2","404-409","PERGAMON-ELSEVIER SCIENCE LTD","135",2015,"ISI000348196900030","34","HEMATOLOGY, CARDIOVASCULAR SYSTEM \& CARDIOLOGY","1","HEMATOLOGY, PERIPHERAL VASCULAR DISEASE","BEATE.LUXEMBOURGKGU.DE",NA,"AZ4MY",NA,"LUXEMBOURG, B (REPRINT AUTHOR), DRK BLOOD DONOR SERV BADEN WRUTTEMBERG HESSEN, INST TRANSFUS MED \& IMMUNOHAEMATOL, SANDHOFSTR 1, D-60528 FRANKFURT, GERMANY","ISI","UNIV HOSP FRANKFURT;UNIV HOSP FRANKFURT;INST TRANSFUS MED AND IMMUNOHAEMATOL","INST TRANSFUS MED AND IMMUNOHAEMATOL",NA,"LUXEMBOURG B, 2015, THROMB RES","LUXEMBOURG B, 2015, THROMB RES"
"LEYTON Y, 2015, BMC CANCER","LEYTON Y;GONZALEZ HORMAZABAL P;BLANCO R;BRAVO T;FERNANDEZ RAMIRES R;MORALES S;LANDEROS N;REYES JM;PERALTA O;TAPIA JC;GOMEZ F;WAUGH E;IBANEZ G;PAKOMIO J;GRAU G;JARA L","ASSOCIATION OF PALB2 SEQUENCE VARIANTS WITH THE RISK OF FAMILIAL AND EARLY-ONSET BREAST CANCER IN A SOUTH-AMERICAN POPULATION","BMC CANCER","BMC CANCER","BACKGROUND: GERMLINE MUTATIONS IN PALB2 HAVE BEEN IDENTIFIED IN APPROXIMATELY 1\% OF FAMILIAL BREAST CANCER (BC) IN SEVERAL POPULATIONS. NEVERTHELESS ITS CONTRIBUTION IN THE SOUTH-AMERICAN POPULATION IS UNKNOWN. THE GOAL OF THIS STUDY WAS TO DETERMINE THE PREVALENCE OF PALB2 MUTATIONS IN THE CHILEAN POPULATION. METHODS: 100 CHILEAN BRCA1/2-NEGATIVES FAMILIAL BC CASES WERE INCLUDED FOR THE PALB2 MUTATION ANALYSIS. WE USE CONFORMATIONAL SENSITIVE GEL ELECTROPHORESIS AND DIRECT SEQUENCING. USING A CASE-CONTROL DESIGN, WE STUDIED THE IDENTIFIED VARIANTS IN 436 BC CASES AND 809 CONTROLS TO EVALUATE THEIR POSSIBLE ASSOCIATION WITH BC RISK. RESULTS: NO PATHOGENIC MUTATIONS WERE DETECTED. WE IDENTIFIED THREE VARIANTS, THE VARIANT C.1861C > A NOT PREVIOUSLY DESCRIBED WAS FOUND IN ONE OF THE 436 CASES AND NONE OF THE 809 CONTROLS. THE BIOINFORMATIC ANALYSES INDICATE THAT THIS VARIANT PROBABLY IS NOT PATHOGENIC.PALB2 C.1676A > G (RS152451A/G) AND C.2993C > T (RS45551636C/T) VARIANTS WERE SIGNIFICANTLY ASSOCIATED WITH INCREASED BC RISK ONLY IN CASES WITH A STRONG FAMILY HISTORY OF BC (OR=1.9 [CI 95\% 1.3-2.8] P < 0.01 AND OR=3.3 [CI 95\% 1.4-7.3] P < 0.01, RESPECTIVELY). THE RS152451A/G-RS45551636C/T COMPOSITE GENOTYPE PRODUCE INCREASE OF THE BC RISK IN CASES WITH A STRONG FAMILY HISTORY OF BC (OR=3.6 [CI 95\% 1.7-8.0] P=0.003). THE RS152451-G/RS45551636-C AND RS152451-G/RS45551636-T HAPLOTYPES WERE ASSOCIATED WITH AN INCREASED BC RISK ONLY IN CASES WITH A STRONG FAMILY HISTORY OF BC (OR=1.6 [CI 95\% 1.0-2.5] P=0.05 AND OR=3.7 [CI 95\% 1.8-7.5] P < 0.001, RESPECTIVELY). CONCLUSION: OUR RESULTS SUGGEST THAT PALB2 C.1676A > G AND C.2993C > T PLAY ROLES IN BC RISK IN WOMEN WITH A STRONG FAMILY HISTORY OF BC.","FAMILIAL BREAST CANCER; PALB2; BRCA1/2-NEGATIVE FAMILIES; SOUTH-AMERICAN POPULATION","FRENCH-CANADIAN WOMEN; ABO-BLOOD-GROUPS; GERMLINE MUTATIONS; BRCA2-INTERACTING PROTEIN; HOMOLOGOUS RECOMBINATION; CHILEAN POPULATION; FOUNDER MUTATION; GENES; BRCA2; PREVALENCE","ENGLISH","ARTICLE","ARTICLE",5,"ADANK MA, 2011, BREAST CANCER RES TR, V127, P357, DOI 10.1007/S10549-010-1001-1.;ADZHUBEI IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/NMETH0410-248.;BALIA C, 2010, FAM CANCER, V9, P531, DOI 10.1007/S10689-010-9382-1.;BLANCO A, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0067538.;BOGDANOVA N, 2011, BREAST CANCER RES TR, V126, P545, DOI 10.1007/S10549-010-1290-4.;CAO AY, 2009, BREAST CANCER RES TR, V114, P457, DOI 10.1007/S10549-008-0036-Z.;CASADEI S, 2011, CANCER RES, V71, P2222, DOI 10.1158/0008-5472.CAN-10-3958.;CATUCCI I, 2012, FAM CANCER, V11, P483, DOI 10.1007/S10689-012-9540-8.;CHEN PZ, 2008, CLIN CANCER RES, V14, P5931, DOI 10.1158/1078-0432.CCR-08-0429.;CHOI Y, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0046688.;CHOMCZYNSKI P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/NPROT.2006.83.;CRUZCOKE R, 1976, REV MED CHILE, V104, P365.;DANSONKA-MIESZKOWSKA A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-20.;DING YC, 2011, BREAST CANCER RES TR, V126, P771, DOI 10.1007/S10549-010-1195-2.;DING YC, 2011, BREAST CANCER RES TR, V126, P227, DOI 10.1007/S10549-010-1271-7.;DUDBRIDGE F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108.;ERKKO H, 2008, CLIN CANCER RES, V14, P4667, DOI 10.1158/1078-0432.CCR-08-0210.;ERKKO H, 2007, NATURE, V446, P316, DOI 10.1038/NATURE05609.;FOULKES WD, 2007, BREAST CANCER RES, V9, DOI 10.1186/BCR1828.;GARCIA MJ, 2009, BREAST CANCER RES TR, V113, P545, DOI 10.1007/S10549-008-9945-0.;GHADIRIAN P, 2009, CLIN GENET, V76, P421, DOI 10.1111/J.1399-0004.2009.01277.X.;GONZALEZ-HORMAZABAL P, 2011, BREAST CANCER RES TR, V126, P705, DOI 10.1007/S10549-010-1170-Y.;GUNNARSSON H, 2008, J NEGAT RESULTS BIOM, V7, DOI 10.1186/1477-5751-7-5.;HELLEBRAND H, 2011, HUM MUTAT, V32, PE2176, DOI 10.1002/HUMU.21478.;HOFSTATTER EW, 2011, FAM CANCER, V10, P225, DOI 10.1007/S10689-011-9426-1.;HOLLESTELLE A, 2010, CURR OPIN GENET DEV, V20, P268, DOI 10.1016/J.GDE.2010.02.009.;KORKKO J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/PNAS.95.4.1681.;KUMAR P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/NPROT.2009.86.;PAPI L, 2010, FAM CANCER, V9, P181, DOI 10.1007/S10689-009-9295-Z.;PETERLONGO P, 2011, BREAST CANCER RES TR, V126, P825, DOI 10.1007/S10549-010-1305-1.;PHUAH SY, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0073638.;RAHMAN N, 2007, NAT GENET, V39, P165, DOI 10.1038/NG1959.;REID S, 2007, NAT GENET, V39, P162, DOI 10.1038/NG1947.;SLUITER M, 2009, FAM CANCER, V8, P347, DOI 10.1007/S10689-009-9241-0.;SOPIK V, 2014, NEW ENGL J MED, V371, P1650, DOI [10.1056/NEJMC1410673, 10.1056/NEJMC1410673\#SA1].;SOUTHEY MC, 2013, APPL CLIN GENET, V6, P43, DOI 10.2147/TACG.S34116.;SOUTHEY MC, 2010, BREAST CANCER RES, V12, DOI 10.1186/BCR2796.;STRATTON MR, 2009, NATURE, V458, P719, DOI 10.1038/NATURE07943.;SY SMH, 2009, J BIOL CHEM, V284, P21127, DOI 10.1074/JBC.C109.023937.;SY SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/PNAS.0811159106.;TEO ZL, 2013, FAM CANCER, V12, P587, DOI 10.1007/S10689-013-9620-4.;TEO ZL, 2013, BREAST CANCER RES, V15, DOI 10.1186/BCR3392.;TISCHKOWITZ M, 2007, P NATL ACAD SCI USA, V104, P6788, DOI 10.1073/PNAS.0701724104.;TISCHKOWITZ M, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-5.;TISCHKOWITZ M, 2012, HUM MUTAT, V33, P674, DOI 10.1002/HUMU.22022.;TISCHKOWITZ MD, 2009, GASTROENTEROLOGY, V137, P1183, DOI 10.1053/J.GASTRO.2009.06.055.;UNTERGASSER A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/NAR/GKS596.;VALENZUELA CY, 1988, REV MED CHILE, V116, P981.;VALENZUELA CY, 1977, SOC BIOL, V24, P225, DOI 10.1080/19485565.1977.9988285.;VALENZUELA CY, 1987, REV MED CHILE, V115, P295.;WALSH T, 2007, CANCER CELL, V11, P103, DOI 10.1016/J.CCR.2007.01.010.;WONG MW, 2011, BREAST CANCER RES TR, V127, P853, DOI 10.1007/S10549-011-1443-0.;XIA B, 2006, MOL CELL, V22, P719, DOI 10.1016/J.MOLCEL.2006.05.022.;ZHANG F, 2009, MOL CANCER RES, V7, P1110, DOI 10.1158/1541-7786.MCR-09-0123.;ZHANG F, 2009, CURR BIOL, V19, P524, DOI 10.1016/J.CUB.2009.02.018.;ZHENG YL, 2012, CANCER-AM CANCER SOC, V118, P1362, DOI 10.1002/CNCR.26388.","JARA, L (REPRINT AUTHOR), UNIV CHILE, SCH MED, INST BIOMED SCI ICBM, HUMAN GENET PROGRAM, AVE INDEPENDENCIA 1027, SANTIAGO, CHILE.;LEYTON, YESSICA, GONZALEZ-HORMAZABAL, PATRICIO, BLANCO, RAFAEL, MORALES, SEBASTIAN, LANDEROS, NATALIA, PAKOMIO, JANARA, GRAU, GILBERTO, JARA, LILIAN, UNIV CHILE, SCH MED, INST BIOMED SCI ICBM, HUMAN GENET PROGRAM, SANTIAGO, CHILE.;BRAVO, TERESA, NATL CANC SOC, CORP NACL CANC CONAC, SANTIAGO, CHILE.;FERNANDEZ-RAMIRES, RICARDO, UNIV CHILE, SCH ODONTOL, RES INST DENT SCI, SANTIAGO, CHILE.;REYES, JOSE M., PERALTA, OCTAVIO, CLINCA LAS CONDES, SANTIAGO, CHILE.;PERALTA, OCTAVIO, UNIV CHILE, DEPT GYNEACOL \& OBSTET, SCH MED, SANTIAGO, CHILE.;TAPIA, JULIO C., UNVERS CHILE, SCH MED, INST BIOMED SCI ICBM, CELL TRANSFORMAT LAB, SANTIAGO, CHILE.;GOMEZ, FERNANDO, WAUGH, ENRIQUE, CLIN SANTA MARIA, SANTIAGO, CHILE.;IBANEZ, GLADYS, CLIN DAVILA, SANTIAGO, CHILE.;IBANEZ, GLADYS, HOSP SAN JOSE, SANTIAGO, CHILE.","10.1186/S12885-015-1033-3","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","30",NA,"FONDO NACIONAL DE DESARROLLO CIENTIFICO Y TECNOLOGICO (FONDECYT) [1110081], CORPORACION NACIONAL DEL CANCER","THE AUTHORS THANK THE MANY FAMILIES WHO PARTICIPATED IN THE RESEARCH STUDIES DESCRIBED IN THIS ARTICLE. WE ACKNOWLEDGE THE BREAST CANCER GROUP OF CONAC: MARIA TERESA BARRIOS, ANGELICA SOTO, ROSSANA RECABARREN, LETICIA GARCIA, KAREN OLMOS AND PAOLA CARRASCO, AND LORENA SECCIA FOR HER TECHNICAL ASSISTANCE. GRANT SPONSOR: FONDO NACIONAL DE DESARROLLO CIENTIFICO Y TECNOLOGICO (FONDECYT). GRANT NUMBER: 1110081. GRANT SPONSOR: CORPORACION NACIONAL DEL CANCER.",NA,"1471-2407",NA,NA,"BIOMED CENTRAL LTD","15",2015,"ISI000349635300001","56","ONCOLOGY","10","ONCOLOGY","LJARAMED.UCHILE.CL",NA,"CB4YT",NA,"JARA, L (REPRINT AUTHOR), UNIV CHILE, SCH MED, INST BIOMED SCI ICBM, HUMAN GENET PROGRAM, AVE INDEPENDENCIA 1027, SANTIAGO, CHILE","ISI","UNIV CHILE;TERESA;UNIV CHILE;CLINCA LAS CONDES;UNIV CHILE;SCH MED;CLIN SANTA MARIA;CLIN DAVILA;HOSP SAN JOSE","UNIV CHILE",NA,"LEYTON Y, 2015, BMC CANCER","LEYTON Y, 2015, BMC CANCER"
"GUO Y, 2015, OPHTHALMIC GENET","GUO Y;PROKUDIN I;YU C;LIANG J;XIE Y;FLAHERTY M;TIAN L;CROFTS S;WANG F;SNYDER J;DONALDSON C;ABDEL MAGID N;VAZQUEZ L;KEATING B;HAKONARSON H;WANG J;JAMIESON RV","ADVANTAGE OF WHOLE EXOME SEQUENCING OVER ALLELE-SPECIFIC AND TARGETED SEGMENT SEQUENCING IN DETECTION OF NOVEL TULP1 MUTATION IN LEBER CONGENITAL AMAUROSIS","OPHTHALMIC GENETICS","OPHTHALMIC GENET.","BACKGROUND: LEBER CONGENITAL AMAUROSIS (LCA) IS A SEVERE FORM OF RETINAL DYSTROPHY WITH MARKED UNDERLYING GENETIC HETEROGENEITY. UNTIL RECENTLY, ALLELE-SPECIFIC ASSAYS AND SANGER SEQUENCING OF TARGETED SEGMENTS WERE THE ONLY AVAILABLE APPROACHES FOR ATTEMPTED GENETIC DIAGNOSIS IN THIS CONDITION. A BROADER NEXT-GENERATION SEQUENCING (NGS) STRATEGY, SUCH AS WHOLE EXOME SEQUENCING, PROVIDES AN IMPROVED MOLECULAR GENETIC DIAGNOSTIC CAPACITY FOR PATIENTS WITH THESE CONDITIONS. MATERIALS AND METHODS: IN A CHILD WITH LCA, AN ALLELE-SPECIFIC ASSAY ANALYZING 135 KNOWN LCA-CAUSING VARIATIONS, FOLLOWED BY TARGETED SEGMENT SEQUENCING OF 61 REGIONS IN 14 CAUSATIVE GENES WAS PERFORMED. SUBSEQUENTLY, EXOME SEQUENCING WAS UNDERTAKEN IN THE PROBAND, UNAFFECTED CONSANGUINEOUS PARENTS AND TWO UNAFFECTED SIBLINGS. BIOINFORMATIC ANALYSIS USED TWO INDEPENDENT PIPELINES, BWA-GATK AND SOAP, FOLLOWED BY ANNOVAR AND SNPEFF TO ANNOTATE THE VARIANTS. RESULTS: NO DISEASE-CAUSING VARIANTS WERE FOUND USING THE ALLELE-SPECIFIC OR TARGETED SEGMENT SANGER SEQUENCING ASSAYS. ANALYSIS OF VARIANTS IN THE EXOME SEQUENCE DATA REVEALED A NOVEL HOMOZYGOUS NONSENSE MUTATION (C.1081C4T, P.ARG361*) IN TULP1, A GENE WITH ROLES","LEBER CONGENITAL AMAUROSIS; RETINITIS PIGMENTOSA; TULP1; WHOLE EXOME SEQUENCING","TUBBY-LIKE PROTEIN-1; ONSET RETINITIS-PIGMENTOSA; RETINAL DEGENERATION; READ ALIGNMENT; GENE-THERAPY; GENOME; MICE; DYSTROPHIES; FAMILY","ENGLISH","ARTICLE","ARTICLE",4,"ABBASI AH, 2008, MOL VIS, V14, P675.;ADZHUBEI I, 2013, CURR PROTOC HUM GENE, DOI [10. 1002/0471142905. HG0720S76, 10.1002/0471142905.HG0720S76, DOI 10.1002/0471142905.HG0720S76].;BOGGON TJ, 1999, SCIENCE, V286, P2119, DOI 10.1126/SCIENCE.286.5447.2119.;CABEROY NB, 2010, EMBO J, V29, P3898, DOI 10.1038/EMBOJ.2010.265.;CINGOLANI P, 2012, FLY, V6, P80, DOI 10.4161/FLY.19695.;DEN HOLLANDER AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/J.PRETEYERES.2008.05.003.;DEN HOLLANDER AI, 2007, INVEST OPHTH VIS SCI, V48, P5690, DOI 10.1167/IOVS.07-0610.;DEN HOLLANDER AI, 2007, ARCH OPHTHALMOL-CHIC, V125, P932, DOI 10.1001/ARCHOPHT.125.7.932.;DEN HOLLANDER AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258.;GROSSMAN GH, 2009, INVEST OPHTH VIS SCI, V50, P3074, DOI 10.1167/IOVS.08-3190.;GU SM, 1998, LANCET, V351, P1103, DOI 10.1016/S0140-6736(05)79384-3.;HAGSTROM SA, 1999, INVEST OPHTH VIS SCI, V40, P2795.;HAGSTROM SA, 1998, NAT GENET, V18, P174, DOI 10.1038/NG0298-174.;HAGSTROM SA, 2001, INVEST OPHTH VIS SCI, V42, P1955.;HANEIN S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/HUMU.20010.;JACOBSON SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/ARCHOPHTHALMOL.2011.298.;LI H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/BIOINFORMATICS/BTP324.;LI RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/GR.088013.108.;LI YM, 2009, INVEST OPHTH VIS SCI, V50, P1336, DOI 10.1167/IOVS.08-2589.;MADDOX DM, 2012, INVEST OPHTH VIS SCI, V53, P1663, DOI 10.1167/IOVS.11-8871.;MATAFTSI A, 2007, INVEST OPHTH VIS SCI, V48, P5160, DOI 10.1167/IOVS.06-1013.;MCKENNA A, 2010, GENOME RES, V20, P1297, DOI 10.1101/GR.107524.110.;NG PC, 2001, GENOME RES, V11, P863, DOI 10.1101/GR.176601.;O'RAWE J, 2013, GENOME MED, V5, DOI 10.1186/GM432.;PERTEA M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-274.;RUFFALO M, 2011, BIOINFORMATICS, V27, P2790, DOI 10.1093/BIOINFORMATICS/BTR477.;STONE EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/J.AJO.2007.08.022.;VALLESPIN E, 2007, INVEST OPHTH VIS SCI, V48, P5653, DOI 10.1167/IOVS.07-0007.;WANG K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/NAR/GKQ603.;WANG X, 2011, HUM MUTAT, V32, P1450, DOI 10.1002/HUMU.21587.","JAMIESON, RV (REPRINT AUTHOR), CHILDRENS HOSP WESTMEAD, WESTERN SYDNEY GENET PROGRAM, EYE \& DEV GENET RES GRP, SYDNEY, NSW, AUSTRALIA.;GUO, YIRAN, TIAN, LIFENG, WANG, FENGXIANG, SNYDER, JAMES, ABDEL-MAGID, NADA, VAZQUEZ, LYAM, KEATING, BRENDAN, HAKONARSON, HAKON, CHILDRENS HOSP PHILADELPHIA, CTR APPL GENOM, PHILADELPHIA, PA 19104 USA.;PROKUDIN, IVAN, JAMIESON, ROBYN V., CHILDRENS HOSP WESTMEAD, WESTERN SYDNEY GENET PROGRAM, EYE \& DEV GENET RES GRP, SYDNEY, NSW, AUSTRALIA.;PROKUDIN, IVAN, JAMIESON, ROBYN V., CHILDRENS MED RES INST, SYDNEY, NSW, AUSTRALIA.;YU, CONG, SICHUAN UNIV, KEY LAB BIORESOURCES \& ECOENVIRONM, SICHUAN KEY LAB MOL BIOL \& BIOTECHNOL, COLL LIFE SCI,MINIST EDUC, CHENGDU 610064, PEOPLES R CHINA.;YU, CONG, LIANG, JINLONG, XIE, YI, WANG, JUN, BGI SHENZHEN, SHENZHEN, PEOPLES R CHINA.;FLAHERTY, MAREE, CROFTS, STEPHANIE, DONALDSON, CRAIG, CHILDRENS HOSP WESTMEAD, DEPT OPHTHALMOL, SYDNEY, NSW, AUSTRALIA.;KEATING, BRENDAN, HAKONARSON, HAKON, CHILDRENS HOSP PHILADELPHIA, DIV HUMAN GENET, PHILADELPHIA, PA 19104 USA.;KEATING, BRENDAN, HAKONARSON, HAKON, UNIV PENN, DEPT PEDIAT, PERELMAN SCH MED, PHILADELPHIA, PA 19104 USA.;WANG, JUN, UNIV COPENHAGEN, DEPT BIOL, COPENHAGEN, DENMARK.;WANG, JUN, KING ABDULAZIZ UNIV, JEDDAH 21413, SAUDI ARABIA.;JAMIESON, ROBYN V., UNIV SYDNEY, DISCIPLINE OPHTHALMOL, SYDNEY, NSW 2006, AUSTRALIA.;JAMIESON, ROBYN V., UNIV SYDNEY, SAVE SIGHT INST, SYDNEY, NSW 2006, AUSTRALIA.;JAMIESON, ROBYN V., UNIV SYDNEY, DISCIPLINE PAEDIAT \& CHILD HLTH, SYDNEY, NSW 2006, AUSTRALIA.;JAMIESON, ROBYN V., UNIV SYDNEY, DISCIPLINE GENET MED, SYDNEY, NSW 2006, AUSTRALIA.","10.3109/13816810.2014.886269","530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",NA,NA,"RETINA AUSTRALIA, NHMRC","WE THANK THE FAMILY FOR THEIR INTEREST IN THIS RESEARCH. WE THANK REBECCA STOREN FOR INITIAL ASSISTANCE WITH SANGER SEQUENCING. WE THANK JOHN GRIGG FOR ASSISTANCE WITH FIGURE 1. WE ACKNOWLEDGE SUPPORT FROM RETINA AUSTRALIA AND THE NHMRC IN THIS PROJECT.",NA,"1381-6810","4","333-338","TAYLOR \& FRANCIS INC","36",2015,"ISI000369858800008","30","GENETICS \& HEREDITY, OPHTHALMOLOGY","1","GENETICS \& HEREDITY, OPHTHALMOLOGY","HAKONARSONEMAIL.CHOP.EDU WANGJGENOMICS.CN RJAMIESONCMRI.ORG.AU",NA,"DD3YG",NA,"JAMIESON, RV (REPRINT AUTHOR), CHILDRENS HOSP WESTMEAD, WESTERN SYDNEY GENET PROGRAM, EYE \& DEV GENET RES GRP, SYDNEY, NSW, AUSTRALIA","ISI","CTR APPL GENOM;CHILDRENS HOSP WESTMEAD;CHILDRENS MED RES INST;SICHUAN UNIV;CHILDRENS HOSP WESTMEAD;CHILDRENS HOSP PHILADELPHIA;UNIV PENN;UNIV COPENHAGEN;KING ABDULAZIZ UNIV;UNIV SYDNEY;UNIV SYDNEY;UNIV SYDNEY;UNIV SYDNEY","CHILDRENS HOSP WESTMEAD",NA,"GUO Y, 2015, OPHTHALMIC GENET","GUO Y, 2015, OPHTHALMIC GENET"
"ROSE G, 2015, INT J GENOMICS","ROSE G;WOOLDRIDGE DJ;ANSCOMBE C;MEE ET;MISRA RV;GHARBIA S","CHALLENGES OF THE UNKNOWN: CLINICAL APPLICATION OF MICROBIAL METAGENOMICS","INTERNATIONAL JOURNAL OF GENOMICS","INT. J. GENOMICS","AVAILABILITY OF FAST, HIGH THROUGHPUT AND LOW COST WHOLE GENOME SEQUENCING HOLDS GREAT PROMISE WITHIN PUBLIC HEALTH MICROBIOLOGY, WITH APPLICATIONS RANGING FROM OUTBREAK DETECTION AND TRACKING TRANSMISSION EVENTS TO UNDERSTANDING THE ROLE PLAYED BY MICROBIAL COMMUNITIES IN HEALTH AND DISEASE. WITHIN CLINICAL METAGENOMICS, IDENTIFYING MICROORGANISMS FROM A COMPLEX AND HOST ENRICHED BACKGROUND REMAINS A CENTRAL COMPUTATIONAL CHALLENGE. AS PROOF OF PRINCIPLE, WE SEQUENCED TWO METAGENOMIC SAMPLES, A KNOWN VIRAL MIXTURE OF 25 HUMAN PATHOGENS AND AN UNKNOWN COMPLEX BIOLOGICAL MODEL USING BENCHTOP TECHNOLOGY. THE DATASETS WERE THEN ANALYSED USING A BIOINFORMATIC PIPELINE DEVELOPED AROUND RECENT FAST CLASSIFICATION METHODS. A TARGETED APPROACH WAS ABLE TO DETECT 20 OF THE VIRUSES AGAINST A BACKGROUND OF HOST CONTAMINATION FROM MULTIPLE SOURCES AND BACTERIAL CONTAMINATION. AN ALTERNATIVE UNTARGETED IDENTIFICATION METHOD WAS HIGHLY CORRELATED WITH THESE CLASSIFICATIONS, AND OVER 1,600 SPECIES WERE IDENTIFIED WHEN APPLIED TO THE COMPLEX BIOLOGICAL MODEL, INCLUDING SEVERAL SPECIES CAPTURED AT OVER 50\% GENOME COVERAGE. IN SUMMARY, THIS STUDY DEMONSTRATES THE GREAT POTENTIAL OF APPLYING METAGENOMICS WITHIN THE CLINICAL LABORATORY SETTING AND THAT THIS CAN BE ACHIEVED USING INFRASTRUCTURE AVAILABLE TO NONDEDICATED SEQUENCING CENTRES.",NA,"READ ALIGNMENT; DNA-SEQUENCES; CLASSIFICATION; TOOL; BACTERIAL; DATABASE; ORIGIN; SUITE","ENGLISH","ARTICLE","ARTICLE",5,"ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;AMES SK, 2013, BIOINFORMATICS, V29, P2253, DOI 10.1093/BIOINFORMATICS/BTT389.;ANDREWS S., 2010, FASTQC QUALITY CONTR.;BALZOLA F., 2010, NATURE, V11, P59.;BOISVERT S, 2012, GENOME BIOL, V13, DOI 10.1186/GB-2012-13-12-R122.;BOLGER AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/BIOINFORMATICS/BTU170.;BRADY A., 2009, NATURE METHODS, V6, P673.;CUNNINGHAM SA, 2010, J CLIN MICROBIOL, V48, P2929, DOI 10.1128/JCM.00339-10.;DIDELOT X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/NRG3226.;DROGE J, 2015, BIOINFORMATICS, V31, P817, DOI 10.1093/BIOINFORMATICS/BTU745.;EYRE DW, 2012, BMJ OPEN, V2, DOI 10.1136/BMJOPEN-2012-001124.;FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/SCIENCE.7542800.;GORI F, 2011, BIOINFORMATICS, V27, P196, DOI 10.1093/BIOINFORMATICS/BTQ649.;HANDELSMAN J, 1998, CHEM BIOL, V5, PR245, DOI 10.1016/S1074-5521(98)90108-9.;HAQUE MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/BIOINFORMATICS/BTP317.;HORTON M, 2010, BIOINFORMATICS, V26, P568, DOI 10.1093/BIOINFORMATICS/BTP682.;HUSON DH, 2007, GENOME RES, V17, P377, DOI 10.1101/GR.5969107.;HUSON DH, 2014, BIOINFORMATICS, V30, P38, DOI 10.1093/BIOINFORMATICS/BTT254.;KIM H. B., 2011, VET MICROBIOL, V153, P24.;KOSER CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMOA1109910.;KRAUSE L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/NAR/GKN038.;LANGMEAD B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/NMETH.1923].;LECUIT M., 2014, FRONTIERS CELLULAR I, V4, P1.;LI H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/BIOINFORMATICS/BTP324.;LI L, 2015, J VIROL METHODS, V213, P139, DOI 10.1016/J.JVIROMET.2014.12.002.;LIU B, 2010, P 2010 IEEE INT C BI, P95.;LIU B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4.;MALBOEUF CM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/NAR/GKS794.;MEYER F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386.;MOHAMMED MH, 2011, BIOINFORMATICS, V27, P22, DOI 10.1093/BIOINFORMATICS/BTQ608.;NACCACHE SN, 2014, P NATL ACAD SCI USA, V111, PE976, DOI 10.1073/PNAS.1317064111.;NACCACHE SN, 2013, J VIROL, V87, P11966, DOI 10.1128/JVI.02323-13.;NAPOLITANO F, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-201.;NI JJ, 2013, SCI REP-UK, V3, DOI 10.1038/SREP01968.;ONDOV BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385.;PALLEN MJ, 2014, PARASITOLOGY, V141, P1856, DOI 10.1017/S0031182014000134.;PASQUALINI L, 2012, J CLIN MICROBIOL, V50, P1285, DOI 10.1128/JCM.06793-11.;PATI A, 2011, STAND GENOMIC SCI, V5, P248, DOI 10.4056/SIGS.2075298.;QUINLAN AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/BIOINFORMATICS/BTQ033.;ROSEN GL, 2011, BIOINFORMATICS, V27, P127, DOI 10.1093/BIOINFORMATICS/BTQ619.;SADEDIN SP, 2012, BIOINFORMATICS, V28, P1525, DOI 10.1093/BIOINFORMATICS/BTS167.;SALTER SJ, 2014, BMC BIOL, V12, DOI 10.1186/S12915-014-0087-Z.;SCHREIBER F, 2010, BIOINFORMATICS, V26, P960, DOI 10.1093/BIOINFORMATICS/BTQ070.;SEGATA N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/NMETH.2066].;STARK M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-461.;STRANNEHEIM H, 2010, BIOINFORMATICS, V26, P1595, DOI 10.1093/BIOINFORMATICS/BTQ230.;TREMAROLI V, 2012, NATURE, V489, P242, DOI 10.1038/NATURE11552.;WALKER TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3.;WOOD DE, 2014, GENOME BIOL, V15, DOI 10.1186/GB-2014-15-3-R46.;ZHOU Q, 2014, SCI REP-UK, V4, DOI 10.1038/SREP06957.","ROSE, G (REPRINT AUTHOR), MICROBIOL SERV, PUBL HLTH ENGLAND, GENOM RES UNIT, 61 COLINDALE AVE, LONDON NW9 5HT, ENGLAND.;ROSE, GRAHAM, WOOLDRIDGE, DAVID J., ANSCOMBE, CATHERINE, MISRA, RAJU V., GHARBIA, SAHEER, MICROBIOL SERV, PUBL HLTH ENGLAND, GENOM RES UNIT, LONDON NW9 5HT, ENGLAND.;MEE, EDWARD T., MED \& HEALTHCARE PROD REGULATORY AGCY, NATL INST BIOL STAND \& CONTROL, DIV VIROL, S MIMMS EN6 3QG, HERTS, ENGLAND.","10.1155/2015/292950","315 MADISON AVE 3RD FLR, STE 3070, NEW YORK, NY 10017 USA","292950",NA,NA,NA,NA,"2314-436X",NA,NA,"HINDAWI PUBLISHING CORP",NA,2015,"ISI000361962600001","50","BIOCHEMISTRY \& MOLECULAR BIOLOGY, BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","5","BIOCHEMISTRY \& MOLECULAR BIOLOGY, BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","GRAHAM.ROSEPHE.GOV.UK",NA,"CS3HJ",NA,"ROSE, G (REPRINT AUTHOR), MICROBIOL SERV, PUBL HLTH ENGLAND, GENOM RES UNIT, 61 COLINDALE AVE, LONDON NW9 5HT, ENGLAND","ISI","GENOM RES UNIT;NATL INST BIOL STAND AND CONTROL","GENOM RES UNIT",NA,"ROSE G, 2015, INT J GENOMICS","ROSE G, 2015, INT J GENOMICS"
"TUTTLE MS, 2015, ADV WOUND CARE","TUTTLE MS","ASSOCIATION BETWEEN MICROBIAL BIOBURDEN AND HEALING OUTCOMES IN VENOUS LEG ULCERS: A REVIEW OF THE EVIDENCE","ADVANCES IN WOUND CARE","ADV. WOUND CARE","SIGNIFICANCE: VENOUS LEG ULCERS (VLUS) ARE SUSCEPTIBLE TO MICROBIAL INVASION, AND SERIOUS COMPLICATIONS CAN RESULT WITHOUT THE TIMELY CONTROL OF INFECTION. DIAGNOSIS OF WOUND INFECTION IS PRIMARILY BASED ON SUBJECTIVE CLINICAL CHARACTERISTICS AND PATIENT-REPORTED SYMPTOMS, AND THE TREATMENT WITH ANTIMICROBIALS HAS NOT CONSISTENTLY SHOWN IMPROVEMENT IN HEALING OUTCOMES. THIS IS A REVIEW OF STUDIES USING BACTERIAL CULTURES AND/OR NEW MOLECULAR-BASED METHODS ASSOCIATING MICROBIAL BIOBURDEN WITH HEALING OUTCOMES IN VLU PATIENTS, WITH THE GOAL OF GUIDING FUTURE STUDIES TO BETTER DETERMINE SIGNIFICANT PATTERNS OF MICROBIAL INVOLVEMENT IN CHRONIC WOUNDS. RECENT ADVANCES: STUDIES REVIEWED HERE USE CULTIVATION-BASED IDENTIFICATION OF BACTERIA AND NEXT-GENERATION SEQUENCING OF THE BACTERIAL 16S RRNA GENE TO GAIN INSIGHT INTO MICROBIAL BIOBURDEN IN VLUS. FURTHER APPLICATION OF SOPHISTICATED DNA SEQUENCING AND BIOINFORMATIC ANALYSES HAS THE POTENTIAL TO REVOLUTIONIZE OUR ABILITY TO FURTHER DISCERN, WITH HIGH RESOLUTION, COMPLEX MICROBIAL COMMUNITIES IN CHRONIC WOUNDS. CRITICAL ISSUES: FEW PREVIOUS STUDIES OF MICROBIAL BIOBURDEN IN VLUS HAVE INCORPORATED THE KNOWLEDGE OF CLINICAL TREATMENTS, WHICH INCLUDES CLOSE MONITORING OF PATIENTS' SYMPTOMS AND RESPONSES TO THERAPY. THUS, WOUND CARE PRACTITIONERS ARE CURRENTLY WITHOUT EVIDENCE-BASED GUIDANCE FOR THE DIAGNOSIS AND TREATMENT OF WOUND INFECTIONS. FUTURE DIRECTIONS: CLINICALLY RELEVANT BREAKTHROUGHS ARE POSSIBLE BY COMBINING ADVANCED MICROBIAL DETECTION TECHNIQUES WITH IMPROVED STUDY DESIGNS THAT REFLECT CLINICAL PRACTICES. WELL-DESIGNED LONGITUDINAL STUDIES HAVE GREAT POTENTIAL TO LEAD TO BETTER EVIDENCE-BASED DIAGNOSIS OF CHRONIC WOUNDS. A GREATER UNDERSTANDING OF MICROBIAL BIOBURDEN IN CHRONIC WOUNDS IS LIKELY TO LEAD TO BETTER THERAPIES THAT SPEED HEALING AND PREVENT WOUND INFECTION WITHOUT RISKING THE DEVELOPMENT OF ANTIMICROBIAL RESISTANCE.",NA,"CHRONIC WOUND MICROBIOTA; BACTERIAL DIVERSITY; CONTROLLED-TRIAL; CLINICAL SIGNS; INFECTION; CULTURE; IDENTIFICATION; KERATINOCYTES; FIBROBLASTS; BIOPSIES","ENGLISH","REVIEW","ARTICLE",12,"BAKER SR, 1991, BRIT J SURG, V78, P864, DOI 10.1002/BJS.1800780729.;BAMBERG R, 2002, WOUNDS, V14, P314.;BILL T J, 2001, OSTOMY WOUND MANAGE, V47, P34.;COOPER RA, 2009, INT WOUND J, V6, P453, DOI 10.1111/J.1742-481X.2009.00640.X.;DAVIES CE, 2004, J CLIN MICROBIOL, V42, P3549, DOI 10.1128/JCM.42.8.3549-3557.2004.;DAVIES CE, 2007, WOUND REPAIR REGEN, V15, P17, DOI 10.1111/J.1524-475X.2006.00180.X.;DOWD SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43.;ERIKSSON G, 1984, SCAND J INFECT DIS, V16, P175, DOI 10.3109/00365548409087138.;FAZLI M, 2009, J CLIN MICROBIOL, V47, P4084, DOI 10.1128/JCM.01395-09.;GARDNER SE, 2001, WOUND REPAIR REGEN, V9, P178, DOI 10.1046/J.1524-475X.2001.00178.X.;GARDNER SE, 2006, WOUND REPAIR REGEN, V14, P548, DOI 10.1111/J.1743-6109.2006.00162.X.;GARDNER SE, 2013, DIABETES, V62, P923, DOI [10.2337/DB12-0771, 10.2337/DB12-0771/-/DC1].;GILCHRIST B, 1989, BRIT J DERMATOL, V121, P337, DOI 10.1111/J.1365-2133.1989.TB01427.X.;GJODSBOL KRISTINE, 2006, INT WOUND J, V3, P225, DOI 10.1111/J.1742-481X.2006.00159.X.;GJODSBOL K, 2012, INT WOUND J, V9, P295, DOI 10.1111/J.1742-481X.2011.00883.X.;GRICE EA, 2012, ADV EXP MED BIOL, V946, P55, DOI 10.1007/978-1-4614-0106-3\_4.;HALBERT A.R., 1992, AUSTRALAS J DERMATOL, V33, P75, DOI DOI 10.1111/J.1440-0960.1992.TB00083.X.;HAN A, 2011, WOUND REPAIR REGEN, V19, P532, DOI 10.1111/J.1524-475X.2011.00720.X.;HANSSON C, 1995, ACTA DERM-VENEREOL, V75, P24.;KIRKETERP-MOLLER K, 2008, J CLIN MICROBIOL, V46, P2717, DOI 10.1128/JCM.00501-08.;KIRSNER RS, 2012, LANCET, V380, P977, DOI 10.1016/S0140-6736(12)60644-8.;KRIZEK TJ, 1967, SURG FORUM, V18, P518.;LANTIS JC, 2013, J VASC SURG, V58, P433, DOI 10.1016/J.JVS.2012.12.055.;LEVINE NS, 1976, J TRAUMA, V16, P89, DOI 10.1097/00005373-197602000-00002.;LOOKINGBILL DP, 1978, ARCH DERMATOL, V114, P1765, DOI 10.1001/ARCHDERM.114.12.1765.;MADSEN SM, 1996, APMIS, V104, P895, DOI 10.1111/J.1699-0463.1996.TB04955.X.;MALIC S, 2009, MICROBIOL-SGM, V155, P2603, DOI 10.1099/MIC.0.028712-0.;MARGOLIS DJ, 2002, J AM ACAD DERMATOL, V46, P381, DOI 10.1067/MJD.2002.121739.;MELENDEZ JH, 2010, CLIN MICROBIOL INFEC, V16, P1762, DOI 10.1111/J.1469-0691.2010.03158.X.;MILIC DJ, 2009, J VASC SURG, V49, P1242, DOI 10.1016/J.JVS.2008.11.069.;MOFFATT CJ, 2010, BRIT J DERMATOL, V162, P51, DOI 10.1111/J.1365-2133.2009.09397.X.;MOORE K, 2010, J CLIN PATHOL, V63, P830, DOI 10.1136/JCP.2010.077032.;NELZEN O, 1997, EUR J VASC ENDOVASC, V13, P500, DOI 10.1016/S1078-5884(97)80179-7.;NELZEN O, 1994, BRIT J SURG, V81, P182, DOI 10.1002/BJS.1800810206.;O'MEARA S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003557.PUB3.;PRICE LB, 2011, WOUND REPAIR REGEN, V19, P80, DOI 10.1111/J.1524-475X.2010.00628.X.;PRICE LB, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0006462.;REDDY M, 2012, JAMA-J AM MED ASSOC, V307, P605, DOI 10.1001/JAMA.2012.98.;RHOADS DD, 2012, INT J MOL SCI, V13, P2535, DOI 10.3390/IJMS13032535.;ROBSON M C, 1968, SURG FORUM, V19, P501.;ROBSON M C, 1970, J SURG ONCOL, V2, P379, DOI 10.1002/JSO.2930020410.;SIBBALD RG, 2011, ADV SKIN WOUND CARE, V24, P415, DOI 10.1097/01.ASW.0000405216.27050.97.;SINDRILARU A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490.;SKENE AI, 1992, BRIT MED J, V305, P1119, DOI 10.1136/BMJ.305.6862.1119.;TRENGOVE N J, 1996, J WOUND CARE, V5, P277.;TUTTLE MS, 2011, J CLIN MICROBIOL, V49, P3812, DOI 10.1128/JCM.00847-11.;WOLCOTT RD, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-226.;WOO KY, 2009, OSTOMY WOUND MANAG, V55, P40.;YIM E, 2014, JAMA DERMATOL, V150, P385, DOI 10.1001/JAMADERMATOL.2013.6723.","TUTTLE, MS (REPRINT AUTHOR), CASE WESTERN RESERVE UNIV, UNIV HOSP CASE MED CTR, DEPT DERMATOL, 11100 EUCLID AVE,LAKESIDE 3500, CLEVELAND, OH 44106 USA.;CASE WESTERN RESERVE UNIV, UNIV HOSP CASE MED CTR, DEPT DERMATOL, CLEVELAND, OH 44106 USA.","10.1089/WOUND.2014.0535","140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA",NA,NA,NA,NA,NA,"2162-1918","1","1-11","MARY ANN LIEBERT, INC","4",2015,"ISI000357257600001","49","DERMATOLOGY","3","DERMATOLOGY","MARIE.TUTTLECASE.EDU",NA,"CL8XN",NA,"TUTTLE, MS (REPRINT AUTHOR), CASE WESTERN RESERVE UNIV, UNIV HOSP CASE MED CTR, DEPT DERMATOL, 11100 EUCLID AVE,LAKESIDE 3500, CLEVELAND, OH 44106 USA","ISI","CASE WESTERN RESERVE UNIV","CASE WESTERN RESERVE UNIV",NA,"TUTTLE MS, 2015, ADV WOUND CARE","TUTTLE MS, 2015, ADV WOUND CARE"
"SALMANINEJAD A, 2015, CLIN LAB","SALMANINEJAD A;GHADAMI S;DIZAJI MZ;GOLCHEHRE Z;ESTIAR MA;ZAMANI MR;EBRAHIMZADEH VESAL R;NOWROOZI MR;SHAKOORI A","MOLECULAR CHARACTERIZATION OF KRAS, BRAF, AND EGFR GENES IN CASES WITH PROSTATIC ADENOCARCINOMA, REPORTING BIOINFORMATICS DESCRIPTION AND RECURRENT MUTATIONS","CLINICAL LABORATORY","CLIN. LAB.","BACKGROUND: PROSTATE CANCER IS ONE OF THE MOST COMMON CANCERS WHICH DEVELOPS BY MUTATIONS AND/OR OTHER GENETIC ALTERATIONS IN SPECIFIC GENES. REGARDING THE PREVIOUS STUDIES IN LITERATURE PREDOMINANT MUTATIONS TAKE PLACE IN KRAS, BRAF, AND EGFR GENES IN SPECIAL TYPES OF CANCERS. IN THIS RESEARCH, WE ATTEMPT TO IDENTIFY THE PREVALENCE AND SIGNIFICANT ROLE OF THE POSSIBLE MUTATIONS IN EGFR EXONS 18 - 21, KRAS CODON 12, 13, AND 61, AND BRAF CODON 600 MUTATIONS IN TUMORAL TISSUE SPECIMENS FROM PATIENTS WITH PROSTATIC ADENOCARCINOMA. FURTHERMORE, IN THIS RESEARCH, IT HAS BEEN ATTEMPTED TO INVESTIGATE THE MOLECULAR CHARACTERISTICS OF THESE GENES IN TERMS OF BIOINFORMATIC ASPECTS. METHODS: A TOTAL OF 35 PROSTATIC ADENOCARCINOMA FRESH TISSUE SAMPLES, ENRICHED IN NEOPLASTIC CELLS, WERE OBTAINED FROM THE CANCER INSTITUTE OF IRAN. THE PRESENCE OF MUTATIONS AT CODONS 12, 13 AND 61 OF KRAS, CODON 600 OF BRAF AND EGFR EXONS 18 - 21 WERE DETERMINED BY DIRECT SANGER SEQUENCING. TO EVALUATE THE MOLECULAR FEATURES, STRUCTURE, AND POST-TRANSLATION MODIFICATION OF THOSE GENES, A BIOINFORMATICS SURVEY WAS PERFORMED USING THE SWISS-MODEL (HTTP://SWISSMODEL.EXPASY.ORG) AND NETPHOS 2.0 (HTTP://WWW.CBS.DTU.DK/SERVICES/NETPHOS/) SERVER. ALSO, USING BIOINFORMATICS SOFTWARE, THE PHYLOGENY TREE OF THE MUTATIONS WAS DRAWN. RESULTS: MUTATIONS OF CODONS 12 AND 13 OF KRAS WERE FOUND IN 2 OF THE 35 PROSTATIC ADENOCARCINOMAS. TWO CASES CARRIED HOMOZYGOUS MUTATIONS ON EXON 2 IN CODON 12 (G12V) AND CODON 13 (G13D). ALSO, NO MUTATION WAS DETECTED AT BRAF CODON 600 AND EGFR EXONS 18 - 21 IN ANY OF THE SAMPLES. CONCLUSIONS: BASED ON THE GROUP OF PATIENTS WITH PROSTATE ADENOCARCINOMA, OUR RESEARCH SHOWS THAT THE MUTATIONS IN CODONS 12 AND 13 OF KRAS ARE THE MOST COMMON IN PROSTATE CARCINOMAS. NOTING THESE RESULTS AND THE MOLECULAR PATHWAY OF THIS GENE, THERE IS A POSSIBLE MORE PERCEPTIBLE ROLE FOR THIS GENE IN THE PATHOGENESIS OF PROSTATIC CARCINOMA. HOWEVER, ACCORDING TO OUR FINDING, AS IN PREVIOUS STUDIES, THE ROLE OF BRAF AND EGFR GENE MUTATIONS IN PROSTATE ADENOCARCINOMA ARE LESS THAN IN THE KRAS GENE AND, THEREFORE, WE ASSUME THAT THESE COMMON MUTATIONS OF THE KRAS GENE CAN BE USED AS AN EARLY DETERMINING MARKER FOR EARLY DIAGNOSIS OF PROSTATE ADENOCARCINOMA. IN THE FUTURE, DUE TO THE COMPLEXITY OF ETIOLOGICAL PARAMETERS IN PROSTATE CANCER DEVELOPMENT, THE CASE SPECIFIC TUMOR MOLECULAR IDENTIFICATION AND TREATMENT FOR EACH AFFECTED SUBJECT ARE URGENTLY NEEDED.","PROSTATE CANCER; KRAS; EGFR; BRAF; BIOINFORMATICS; MUTATION","GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; CHINESE PATIENTS; SOMATIC EGFR; EXPRESSION; PROGRESSION; CARCINOMAS; RAS; ACTIVATION; ONCOGENE","ENGLISH","ARTICLE","ARTICLE",2,"AGELL L, 2011, MODERN PATHOL, V24, P443, DOI 10.1038/MODPATHOL.2010.208.;BOYD LK, 2012, NAT REV UROL, V9, P652, DOI 10.1038/NRUROL.2012.185.;BRATT O, 2010, J NATL CANCER I, V102, P1336, DOI 10.1093/JNCI/DJQ265.;CHO NY, 2006, INT J CANCER, V119, P1858, DOI 10.1002/IJC.22071.;DAHABREH IJ, 2010, CLIN CANCER RES, V16, P291, DOI 10.1158/1078-0432.CCR-09-1660.;DAVIES H, 2002, NATURE, V417, P949, DOI 10.1038/NATURE00766.;DE MUGA S, 2010, MODERN PATHOL, V23, P703, DOI 10.1038/MODPATHOL.2010.45.;DELONGCHAMPS NICOLAS B, 2007, CURR PROBL CANCER, V31, P226, DOI 10.1016/J.CURRPROBLCANCER.2007.01.004.;DEREEPER A, 2008, NUCLEIC ACIDS RES, V36, PW465, DOI 10.1093/NAR/GKN180.;DI LORENZO G, 2002, CLIN CANCER RES, V8, P3438.;EBERHARD DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857.;FLAHERTY KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMOA1002011.;FU M, 2014, VIRCHOWS ARCH, V464, P575, DOI 10.1007/S00428-014-1566-X.;FUKUSHIMA TOSHIHIKO, 2005, FUKUSHIMA J MED SCI, V51, P67.;GARNETT MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/J.CCR.2004.09.022.;GLEASON DF, 2002, J UROLOGY, V167, P953, DOI 10.1016/S0022-5347(02)80309-3.;HAAS GP, 2008, CAN J UROL, V15, P3866.;HEIDENREICH A, 2014, EUR UROL, V65, P124, DOI 10.1016/J.EURURO.2013.09.046.;HEIDENREICH A, 2011, EUR UROL, V59, P61, DOI 10.1016/J.EURURO.2010.10.039.;HERMANEK P, 1997, TNM ATLAS, V4, P272.;HOSSEINI MOSTAFA, 2010, ACTA MED IRAN, V48, P61.;IMMERVOLL H, 2006, VIRCHOWS ARCH, V448, P788, DOI 10.1007/S00428-006-0191-8.;JEONG JH, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0003949.;KARANTANOS T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/ONC.2013.206.;LIU T, 2009, APPL IMMUNOHISTO M M, V17, P121, DOI 10.1097/PAI.0B013E31818816B9.;MA CHUN-GUANG, 2010, ZHONGHUA WAI KE ZA ZHI, V48, P1166.;MIMEAULT M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/CARCIN/BGI229.;MISALE S, 2012, NATURE.;MOUSAVI SM, 2009, ANN ONCOL, V20, P556, DOI 10.1093/ANNONC/MDN642.;NORMANNO N, 2006, GENE, V366, P2, DOI 10.1016/J.GENE.2005.10.018.;PERALDO-NEIA C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-31.;PERGOLIZZI RG, 1993, CANCER INVEST, V11, P25, DOI 10.3109/07357909309020257.;PIGNON JC, 2009, CANCER RES, V69, P2941, DOI 10.1158/0008-5472.CAN-08-3760.;RADICH JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/PNAS.0510423103.;REN GP, 2012, GENE CHROMOSOME CANC, V51, P1014, DOI 10.1002/GCC.21984.;SADJADI A, 2007, ARCH IRAN MED, V10, P481.;SHEN YY, 2010, CANCER GENET CYTOGEN, V198, P35, DOI 10.1016/J.CANCERGENCYTO.2009.12.003.;SHIBATA D, 1990, BAILLIERE CLIN GASTR, V4, P151, DOI 10.1016/0950-3528(90)90044-H.;SIEGEL R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/CAAC.21208.;SILAN F, 2012, MOL BIOL REP, V39, P1595, DOI 10.1007/S11033-011-0898-8.;SINGH D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2.;SOSMAN JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMOA1112302.;TRAISH AM, 2009, BRIT J CANCER, V101, P1949, DOI 10.1038/SJ.BJC.6605376.;XU B, 2011, MOL CELL BIOCHEM, V350, P207, DOI 10.1007/S11010-010-0700-6.","SHAKOORI, A (REPRINT AUTHOR), UNIV TEHRAN MED SCI, DEPT MED GENET, SCH MED, TEHRAN, IRAN.;SALMANINEJAD, ARASH, GHADAMI, SHIRIN, DIZAJI, MAJID ZAKI, GOLCHEHRE, ZAHRA, ESTIAR, MEHRDAD ASGHARI, SHAKOORI, ABBAS, UNIV TEHRAN MED SCI, DEPT MED GENET, SCH MED, TEHRAN, IRAN.;SALMANINEJAD, ARASH, SHAKOORI, ABBAS, UNIV TEHRAN MED SCI, DEPT MED GENET, CANC INST IRAN, TEHRAN, IRAN.;GHADAMI, SHIRIN, PASTEUR INST IRAN, BIOTECHNOL RES CTR, DEPT MOL MED, TEHRAN, IRAN.;ZAMANI, MOHAMMAD REZA, UNIV TEHRAN MED SCI, DEPT IMMUNOL, SCH MED, TEHRAN, IRAN.;EBRAHIMZADEH-VESAL, REZA, NEYSHABUR UNIV MED SCI, DEPT BASIC MED SCI, FAC MED, NEYSHABUR, IRAN.;NOWROOZI, MOHAMMAD REZA, UNIV TEHRAN MED SCI, URO ONCOL RES CTR, TEHRAN, IRAN.","10.7754/CLIN.LAB.2014.141210","IM BREITSPIEL 15, HEIDELBERG, D-69126, GERMANY",NA,NA,"TEHRAN UNIVERSITY OF MEDICAL SCIENCES","THE AUTHORS WOULD LIKE TO ANNOUNCE THEIR GRATITUDE TO ALL CONTRIBUTORS WHO HAVE MADE THE ACHIEVEMENT OF THIS RESEARCH POSSIBLE. THE STUDY REPORTED IN THIS PAPER WAS SUPPORTED BY A RESEARCH GRANT FROM THE DEPUTY OF TEHRAN UNIVERSITY OF MEDICAL SCIENCES.",NA,"1433-6510","7","749-759","CLIN LAB PUBL","61",2015,"ISI000358180700013","44","MEDICAL LABORATORY TECHNOLOGY","4","MEDICAL LABORATORY TECHNOLOGY","MMOWROOZIYAHOO.COM SHAKOORIATUMS.AC.IR",NA,"CN1LE",NA,"SHAKOORI, A (REPRINT AUTHOR), UNIV TEHRAN MED SCI, DEPT MED GENET, SCH MED, TEHRAN, IRAN","ISI","UNIV TEHRAN MED SCI;UNIV TEHRAN MED SCI;PASTEUR INST IRAN;UNIV TEHRAN MED SCI;NEYSHABUR UNIV MED SCI;UNIV TEHRAN MED SCI","UNIV TEHRAN MED SCI",NA,"SALMANINEJAD A, 2015, CLIN LAB","SALMANINEJAD A, 2015, CLIN LAB"
"ESPINDOLA A, 2015, INT J DATA MIN BIOINFORM","ESPINDOLA A;SCHNEIDER W;HOYT PR;MAREK SM;GARZON C","A NEW APPROACH FOR DETECTING FUNGAL AND OOMYCETE PLANT PATHOGENS IN NEXT GENERATION SEQUENCING METAGENOME DATA UTILISING ELECTRONIC PROBES","INTERNATIONAL JOURNAL OF DATA MINING AND BIOINFORMATICS","INT. J. DATA MIN. BIOINFORM.","EARLY STAGE INFECTIONS CAUSED BY FUNGAL/OOMYCETE SPORES MAY NOT BE DETECTED UNTIL SIGNS OR SYMPTOMS DEVELOP. SEROLOGICAL AND MOLECULAR TECHNIQUES ARE CURRENTLY USED FOR DETECTING THESE PATHOGENS. NEXT-GENERATION SEQUENCING (NGS) HAS POTENTIAL AS A DIAGNOSTIC TOOL, DUE TO THE CAPACITY TO TARGET MULTIPLE UNIQUE SIGNATURE LOCI OF PATHOGENS IN AN INFECTED PLANT METAGENOME. NGS HAS SIGNIFICANT POTENTIAL FOR DIAGNOSIS OF IMPORTANT EUKARYOTIC PLANT PATHOGENS. HOWEVER, THE ASSEMBLY AND ANALYSIS OF HUGE AMOUNTS OF SEQUENCE IS LABORIOUS, TIME CONSUMING, AND NOT NECESSARY FOR DIAGNOSTIC PURPOSES. PREVIOUS WORK DEMONSTRATED THAT A BIOINFORMATIC TOOL TERMED ELECTRONIC PROBE DIAGNOSTIC NUCLEIC ACID ANALYSIS (EDNA) HAD POTENTIAL FOR GREATLY SIMPLIFYING DETECTING FUNGAL AND OOMYCETE PLANT PATHOGENS IN SIMULATED METAGENOMES. THE INITIAL STUDY DEMONSTRATED LIMITATIONS FOR DETECTION ACCURACY RELATED TO THE ANALYSIS OF MATCHES BETWEEN QUERIES AND METAGENOME READS. THIS STUDY IS A MODIFICATION OF EDNA DEMONSTRATING A BETTER ACCURACY FOR DETECTING FUNGAL AND OOMYCETE PLANT PATHOGENS.","SEQUENCING; EDNA; ELECTRONIC PROBE; E-PROBE; PUCCINIA GRAMINIS; PYTHIUM ULTIMUM; PHAKOPSORA PACHYRHIZI; PHYTOPHTHORA RAMORUM; 454 ROCHE; DIAGNOSTICS; FUNGI; PUCCINIOMYCETES; CHROMALVEOLATA; OOMYCETES","GENOME; INVASIONS; PATTERNS","ENGLISH","ARTICLE","ARTICLE",4,"ADAMS IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/J.1364-3703.2009.00545.X].;CAMACHO C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421.;CASTELLO JD, 1995, BIOSCIENCE, V45, P16, DOI 10.2307/1312531.;COX-FOSTER DL, 2007, SCIENCE, V318, P283, DOI 10.1126/SCIENCE.1146498.;ENSERINK M, 1999, SCIENCE, V285, P1834, DOI 10.1126/SCIENCE.285.5435.1834.;EVERETT RA, 2000, TRENDS ECOL EVOL, V15, P177, DOI 10.1016/S0169-5347(00)01835-8.;HANE JK, 2011, GENOME BIOL, V12, DOI 10.1186/GB-2011-12-5-R45.;HUSON DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/GR.120618.111.;JONES WJ, 2010, ESTUAR COAST, V33, P944, DOI 10.1007/S12237-009-9182-8.;LEVESQUE C.A., 2010, GENOME BIOL, V11.;MAGI A, 2010, GENES-BASEL, V1, P294, DOI 10.3390/GENES1020294.;MARGULIES M, 2005, NATURE, V437, P376, DOI 10.1038/NATURE03959.;PALACIOS G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMOA073785.;RICHTER DC, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0003373.;RONAGHI M, 2001, GENOME RES, V11, P3, DOI 10.1101/GR.11.1.3.;SEGATA N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/NMETH.2066].;STOBBE AH, 2013, J MICROBIOL METH, V94, P356, DOI 10.1016/J.MIMET.2013.07.002.;STRANGE RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/ANNUREV.PHYTO.43.113004.133839.;TEMBE W, 2007, BIOINFORMATICS, V23, P5, DOI 10.1093/BIOINFORMATICS/BTL549.;TYLER BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/SCIENCE.1128796.;TYSON GW, 2004, NATURE, V428, P37, DOI 10.1038/NATURE02340.;VELASCO R, 2007, PLOS ONE, V2, DOI 10.1371/JOURNAL.PONE.0001326.;VIJAYA SR, 2008, BMC BIOINFORMATICS, V9, P185.","ESPINDOLA, A (REPRINT AUTHOR), OKLAHOMA STATE UNIV, ENTOMOL \& PLANT PATHOL DEPT, 127 NOBLE RES CTR, STILLWATER, OK 74078 USA.;ESPINDOLA, ANDRES, OKLAHOMA STATE UNIV, ENTOMOL \& PLANT PATHOL DEPT, STILLWATER, OK 74078 USA.;SCHNEIDER, WILLIAM, USDA ARS, FDWSRU, FT DETRICK, MD 21702 USA.;HOYT, PETER R., DEPT BIOCHEM \& MOL BIOL, STILLWATER, OK 74078 USA.;MAREK, STEPHEN M., OKLAHOMA STATE UNIV, DEPT ENTOMOL \& PLANT PATHOL, STILLWATER, OK 74078 USA.;GARZON, CARLA, DEPT ENTOMOL \& PLANT PATHOL, STILLWATER, OK 74078 USA.","10.1504/IJDMB.2015.069422","WORLD TRADE CENTER BLDG, 29 ROUTE DE PRE-BOIS, CASE POSTALE 856, CH-1215 GENEVA, SWITZERLAND",NA,NA,NA,NA,NA,"1748-5673","2","115-128","INDERSCIENCE ENTERPRISES LTD","12",2015,"ISI000354888900001","23","MATHEMATICAL \& COMPUTATIONAL BIOLOGY","23","MATHEMATICAL \& COMPUTATIONAL BIOLOGY","ANDRES.ESPINDOLAOKSTATE.EDU WILLIAM.SCHNEIDERARS.USDA.GOV PETER.R.HOYTOKSTATE.EDU STEPHEN.MAREKOKSTATE.EDU CARLA.GARZONOKSTATE.EDU",NA,"CI6RO",NA,"ESPINDOLA, A (REPRINT AUTHOR), OKLAHOMA STATE UNIV, ENTOMOL \& PLANT PATHOL DEPT, 127 NOBLE RES CTR, STILLWATER, OK 74078 USA","ISI","OKLAHOMA STATE UNIV;SCHNEIDER;OKLAHOMA STATE UNIV","OKLAHOMA STATE UNIV",NA,"ESPINDOLA A, 2015, INT J DATA MIN BIOINFORM","ESPINDOLA A, 2015, INT J DATA MIN BIOINFORM"
"BAHN JH, 2015, CLIN CHEM","BAHN JH;ZHANG Q;LI F;CHAN TM;LIN X;KIM Y;WONG DTW;XIAO X","THE LANDSCAPE OF MICRORNA, PIWI-INTERACTING RNA, AND CIRCULAR RNA IN HUMAN SALIVA","CLINICAL CHEMISTRY","CLIN. CHEM.","BACKGROUND: EXTRACELLULAR RNAS (EXRNAS) IN HUMAN BODY FLUIDS ARE EMERGING AS EFFECTIVE BIOMARKERS FOR DETECTION OF DISEASES. SALIVA, AS THE MOST ACCESSIBLE AND NON-INVASIVE BODY FLUID, HAS BEEN SHOWN TO HARBOR EXRNA BIOMARKERS FOR SEVERAL HUMAN DISEASES. HOWEVER, THE ENTIRE SPECTRUM OF EXRNA FROM SALIVA HAS NOT BEEN FULLY CHARACTERIZED. METHODS: USING HIGH-THROUGHPUT RNA SEQUENCING (RNA-SEQ), WE CONDUCTED AN IN-DEPTH BIOINFORMATIC ANALYSIS OF NONCODING RNAS (NCRNAS) IN HUMAN CELL-FREE SALIVA (CFS) FROM HEALTHY INDIVIDUALS, WITH A FOCUS ON MICRORNAS (MIRNAS), PIWI-INTERACTING RNAS (PIRNAS), AND CIRCULAR RNAS (CIRCRNAS). RESULTS: OUR DATA DEMONSTRATED ROBUST REPRODUCIBILITY OF MIRNA AND PIRNA PROFILES ACROSS INDIVIDUALS. FURTHERMORE, INDIVIDUAL VARIABILITY OF THESE SALIVARY RNA SPECIES WAS HIGHLY SIMILAR TO THOSE IN OTHER BODY FLUIDS OR CELLULAR SAMPLES, DESPITE THE DIRECT EXPOSURE OF SALIVA TO ENVIRONMENTAL IMPACTS. BY COMPARATIVE ANALYSIS OF >90 RNA-SEQ DATA SETS OF DIFFERENT ORIGINS, WE OBSERVED THAT PIRNAS WERE SURPRISINGLY ABUNDANT IN CFS COMPARED WITH OTHER BODY FLUID OR INTRACELLULAR SAMPLES, WITH EXPRESSION LEVELS IN CFS COMPARABLE TO THOSE FOUND IN EMBRYONIC STEM CELLS AND SKIN CELLS. CONVERSELY, MIRNA EXPRESSION PROFILES IN CFS WERE HIGHLY SIMILAR TO THOSE IN SERUM AND CEREBROSPINAL FLUID. USING A CUSTOMIZED BIOINFORMATICS METHOD, WE IDENTIFIED >400 CIRCRNAS IN CFS. THESE DATA REPRESENT THE FIRST GLOBAL CHARACTERIZATION AND EXPERIMENTAL VALIDATION OF CIRCRNAS IN ANY TYPE OF EXTRACELLULAR BODY FLUID. CONCLUSIONS: OUR STUDY PROVIDES A COMPREHENSIVE LANDSCAPE OF NCRNA SPECIES IN HUMAN SALIVA THAT WILL FACILITATE FURTHER BIOMARKER DISCOVERIES AND LAY A FOUNDATION FOR FUTURE STUDIES RELATED TO NCRNAS IN HUMAN SALIVA. (C) 2014 AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY",NA,"PANCREATIC-CANCER; SJOGRENS-SYNDROME; BIOMARKERS; EXPRESSION; EXOSOMES; REVEALS; CARCINOMA; SERUM; MIRNA","ENGLISH","ARTICLE","ARTICLE",130,"ANDERS S, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-10-R106.;BURGOS KL, 2013, RNA, V19, P712, DOI 10.1261/RNA.036863.112.;CHEN T, 2010, DATABASE-OXFORD, DOI 10.1093/DATABASE/BAQ013.;CHEN X, 2008, CELL RES, V18, P997, DOI 10.1038/CR.2008.282.;FARID WRR, 2012, LIVER TRANSPLANT, V18, P290, DOI 10.1002/LT.22438.;GALLO A, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0030679.;HANSEN TB, 2013, NATURE, V495, P384, DOI 10.1038/NATURE11993.;HU L, 2014, CLIN BIOCHEM, V47, P967, DOI 10.1016/J.CLINBIOCHEM.2013.11.009.;HU S, 2007, ARTHRITIS RHEUM-US, V56, P3588, DOI 10.1002/ART.22954.;HUANG XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319.;JECK WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/NBT.2890.;JECK WR, 2013, RNA, V19, P141, DOI 10.1261/RNA.035667.112.;JOYCE CE, 2011, HUM MOL GENET, V20, P4025, DOI 10.1093/HMG/DDR331.;KIM SY, 2013, J MOL DIAGN, V15, P661, DOI 10.1016/J.JMOLDX.2013.04.004.;KUCHEN S, 2010, IMMUNITY, V32, P828, DOI 10.1016/J.IMMUNI.2010.05.009.;LAKSHMI SS, 2008, NUCLEIC ACIDS RES, V36, PD173, DOI 10.1093/NAR/GKM696.;LANGMEAD B, 2009, GENOME BIOL, V10, DOI 10.1186/GB-2009-10-3-R25.;LAU C, 2013, J BIOL CHEM, V288, P26888, DOI 10.1074/JBC.M113.452458.;LEE YH, 2012, J MOL MED, V90, P427, DOI 10.1007/S00109-011-0829-0.;LEE YH, 2011, CLIN CHEM, V57, P1295, DOI 10.1373/CLINCHEM.2010.159210.;LI BS, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0041629.;LI Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167.;MEMCZAK S, 2013, NATURE, V495, P333, DOI 10.1038/NATURE11928.;OGAWA Y, 2013, BIOL PHARM BULL, V36, P66, DOI 10.1248/BPB.B12-00607.;PARK NJ, 2006, CLIN CHEM, V52, P988, DOI 10.1373/CLINCHEM.2005.063206.;PARK NJ, 2007, ARCH ORAL BIOL, V52, P30, DOI 10.1016/J.ARCHORALBIO.2006.08.014.;SALZMAN J, 2013, PLOS GENET, V9, DOI 10.1371/JOURNAL.PGEN.1003777.;SALZMAN J, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0030733.;SHARMA S, 2010, ACS NANO, V4, P1921, DOI 10.1021/NN901824N.;SOMEL M, 2010, GENOME RES, V20, P1207, DOI 10.1101/GR.106849.110.;SPIELMANN N, 2012, CLIN CHEM, V58, P1314, DOI 10.1373/CLINCHEM.2011.176941.;ST JOHN MAR, 2004, ARCH OTOLARYNGOL, V130, P929, DOI 10.1001/ARCHOTOL.130.8.929.;TANDON M, 2012, ORAL DIS, V18, P127, DOI 10.1111/J.1601-0825.2011.01849.X.;THERY CLOTILDE, 2006, CURR PROTOC CELL BIOL, VCHAPTER 3, DOI 10.1002/0471143030.CB0322S30.;WALZ A, 2006, PROTEOMICS, V6, P1631, DOI 10.1002/PMIC.200500125.;WANG JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/J.BBRC.2010.02.145.;WILLIAMS Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/PNAS.1214046110.;WONG DAVID T W, 2012, J AM DENT ASSOC, V143, P19S.;XU JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/MC.20712.;ZHANG L, 2012, CELL MOL LIFE SCI, V69, P3341, DOI 10.1007/S00018-012-1027-0.;ZHANG L, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0015573.;ZHANG L, 2010, GASTROENTEROLOGY, V138, P949, DOI 10.1053/J.GASTRO.2009.11.010.;ZHANG Y, 2013, MOL CELL, V51, P792, DOI 10.1016/J.MOLCEL.2013.08.017.;ZHOU X, 2012, ONCOL REP, V27, P447, DOI 10.3892/OR.2011.1482.","WONG, DTW (REPRINT AUTHOR), UCLA, DEPT INTEGRAT BIOL \& PHYSIOL, 611 CHARLES YOUNG DR, LOS ANGELES, CA 90095 USA.;BAHN, JAE HOON, ZHANG, QING, CHAN, TAK-MING, LIN, XIANZHI, XIAO, XINSHU, UCLA, DEPT INTEGRAT BIOL \& PHYSIOL, LOS ANGELES, CA 90095 USA.;BAHN, JAE HOON, ZHANG, QING, CHAN, TAK-MING, LIN, XIANZHI, WONG, DAVID T. W., XIAO, XINSHU, UCLA, INST MOL BIOL, LOS ANGELES, CA 90095 USA.;LI, FENG, KIM, YONG, WONG, DAVID T. W., UCLA, SCH DENT, LOS ANGELES, CA 90095 USA.;KIM, YONG, WONG, DAVID T. W., XIAO, XINSHU, UCLA, JONSSON COMPREHENS CANC CTR, LOS ANGELES, CA 90095 USA.;KIM, YONG, UCLA, BROAD STEM CELL RES CTR, LOS ANGELES, CA 90095 USA.;WONG, DAVID T. W., XIAO, XINSHU, UCLA, SCH ENGN, LOS ANGELES, CA 90095 USA.;WONG, DAVID T. W., UCLA, DEPT OTOLARYNGOL HEAD \& NECK SURG, LOS ANGELES, CA 90095 USA.","10.1373/CLINCHEM.2014.230433","2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA",NA,NA,"NIH [R01HG006264, U01HG007013], NIH FROM THE DEPARTMENT OF DEFENSE [LC110207], NIH FROM THE TOBACCO-RELATED DISEASE RESEARCH PROGRAM [20PT-0032]","D.T. WONG, NIH GRANTS UH2 TR000923-01, LC110207 FROM THE DEPARTMENT OF DEFENSE, AND 20PT-0032 FROM THE TOBACCO-RELATED DISEASE RESEARCH PROGRAM, X. XIAO, NIH GRANTS R01HG006264 AND U01HG007013.",NA,"0009-9147","1","221-230","AMER ASSOC CLINICAL CHEMISTRY","61",2015,"ISI000352133500032","44","MEDICAL LABORATORY TECHNOLOGY","91","MEDICAL LABORATORY TECHNOLOGY","DTWWUCLA.EDU GXXIAOUCLA.EDU",NA,"CE8ZS",NA,"WONG, DTW (REPRINT AUTHOR), UCLA, DEPT INTEGRAT BIOL \& PHYSIOL, 611 CHARLES YOUNG DR, LOS ANGELES, CA 90095 USA","ISI","INST MOL BIOL;SCH DENT;JONSSON COMPREHENS CANC CTR;BROAD STEM CELL RES CTR;SCH ENGN","NOTREPORTED",NA,"BAHN JH, 2015, CLIN CHEM","BAHN JH, 2015, CLIN CHEM"
"FENG Z, 2014, NUCLEIC ACIDS RES","FENG Z;LI J;ZHANG JR;ZHANG X","QDNAMOD: A STATISTICAL MODEL-BASED TOOL TO REVEAL INTERCELLULAR HETEROGENEITY OF DNA MODIFICATION FROM SMRT SEQUENCING DATA","NUCLEIC ACIDS RESEARCH","NUCLEIC ACIDS RES.","IN AN ISOGENIC CELL POPULATION, PHENOTYPIC HETEROGENEITY AMONG INDIVIDUAL CELLS IS COMMON AND CRITICAL FOR SURVIVAL OF THE POPULATION UNDER DIFFERENT ENVIRONMENT CONDITIONS. DNA MODIFICATION IS AN IMPORTANT EPIGENETIC FACTOR THAT CAN REGULATE PHENOTYPIC HETEROGENEITY. THE SINGLE MOLECULE REAL-TIME (SMRT) SEQUENCING TECHNOLOGY PROVIDES A UNIQUE PLATFORM FOR DETECTING A WIDE RANGE OF DNA MODIFICATIONS, INCLUDING N6-METHYLADENINE (6-MA), N4-METHYLCYTOSINE (4-MC) AND 5-METHYLCYTOSINE (5-MC). HERE WE PRESENT QDNAMOD, A NOVEL BIOINFORMATIC TOOL FOR GENOME-WIDE QUANTITATIVE PROFILING OF INTERCELLULAR HETEROGENEITY OF DNA MODIFICATION FROM SMRT SEQUENCING DATA. IT IS CAPABLE OF ESTIMATING PROPORTION OF ISOGENIC HAPLOID CELLS, IN WHICH THE SAME LOCI OF THE GENOME ARE DIFFERENTIALLY MODIFIED. WE TESTED THE RELIABILITY OF QDNAMOD WITH THE SMRT SEQUENCING DATA OF STREPTOCOCCUS PNEUMONIAE STRAIN ST556. QDNAMOD DETECTED EXTENSIVE INTERCELLULAR HETEROGENEITY OF DNA METHYLATION (6-MA) IN A CLONAL POPULATION OF ST556. SUBSEQUENT BIOCHEMICAL ANALYSES REVEALED THAT THE RECOGNITION SEQUENCES OF TWO TYPE I RESTRICTION-MODIFICATION (R-M) SYSTEMS ARE RESPONSIBLE FOR THE INTERCELLULAR HETEROGENEITY OF DNA METHYLATION INITIALLY IDENTIFIED BY QDNAMOD. QDNAMOD THUS REPRESENTS A VALUABLE TOOL FOR STUDYING INTERCELLULAR PHENOTYPIC HETEROGENEITY FROM GENOME-WIDE DNA MODIFICATION.",NA,"SINGLE-MOLECULE; STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI; MULTIPLE GENES; METHYLATION; RESTRICTION; EXPRESSION; PHASEVARION; INFECTION; DISCOVERY","ENGLISH","ARTICLE","ARTICLE",8,"BLAKEWAY L., 2014, FASEB J.;CASADESUS J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06.;CASADESUS J, 2013, J BIOL CHEM, V288, P13929, DOI 10.1074/JBC.R113.472274.;CHAISSON MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238.;CHEN HQ, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0002950.;CLARK TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/NAR/GKR1146.;CLARK TYSON A, 2011, GENOME INTEGR, V2, P10, DOI 10.1186/2041-9414-2-10.;DAVIES DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/PNAS.0408782102.;EID J, 2009, SCIENCE, V323, P133, DOI 10.1126/SCIENCE.1162986.;FANG G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/NBT.2432.;FENG ZX, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/JOURNAL.PCBI.1002935.;FLUSBERG BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/NMETH.1459].;FOX KL, 2007, NUCLEIC ACIDS RES, V35, P5242, DOI 10.1093/NAR/GKM571.;HERNDAY AD, 2003, MOL CELL, V12, P947, DOI 10.1016/S1097-2765(03)00383-6.;KREBES J, 2014, NUCLEIC ACIDS RES, V42, P2415, DOI 10.1093/NAR/GKT1201.;LASZLO AH, 2013, P NATL ACAD SCI USA, V110, P18904, DOI 10.1073/PNAS.1310240110.;LI GL, 2012, J BACTERIOL, V194, P3294, DOI 10.1128/JB.00363-12.;LISTER R, 2009, GENOME RES, V19, P959, DOI 10.1101/GR.083451.108.;LU L, 2006, J BIOL CHEM, V281, P15464, DOI 10.1074/JBC.M602404200.;MA Z, 2007, J BACTERIOL, V189, P2497, DOI 10.1128/JB.01429-06.;MARIA L., 2013, PLOS GENET, V9.;MARSCHALL T, 2009, BIOINFORMATICS, V25, PI356, DOI 10.1093/BIOINFORMATICS/BTP188.;MURRAY IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/NAR/GKS891.;OWEN P, 1996, FEMS IMMUNOL MED MIC, V16, P63.;ROBERTS RJ, 2010, NUCLEIC ACIDS RES, V38, PD234, DOI 10.1093/NAR/GKP874.;SCHADT EE, 2013, GENOME RES, V23, P129, DOI 10.1101/GR.136739.111.;SCHREIBER J, 2013, P NATL ACAD SCI USA, V110, P18910, DOI 10.1073/PNAS.1310615110.;SHIM J, 2013, SCI REP-UK, V3, DOI 10.1038/SREP01389.;SMITH ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/NRG3354.;SONG CX, 2012, NAT METHODS, V9, P75, DOI [10.1038/NMETH.1779, 10.1038/NMETH.1779].;SRIKHANTA YN, 2005, P NATL ACAD SCI USA, V102, P5547, DOI 10.1073/PNAS.0501169102.;SRIKHANTA YN, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0027569.;SRIKHANTA YN, 2010, NAT REV MICROBIOL, V8, P196, DOI 10.1038/NRMICRO2283.;SRIKHANTA YN, 2009, PLOS PATHOG, V5, DOI 10.1371/JOURNAL.PPAT.1000400.;TRAVERS KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/NAR/GKQ543.;VAN DER WOUDE MW, 2008, ANNU REV MICROBIOL, V62, P153, DOI 10.1146/ANNUREV.MICRO.62.081307.162938.;VAN OPIJNEN T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/NMETH.1377].;VANDERWOUDE MW, 1992, MOL MICROBIOL, V6, P2429.;WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/ANNUREV.GE.25.120191.003101.;YOTHER J, 2006, GRAM POSITIVE PATHOG, P275.","ZHANG, XG (REPRINT AUTHOR), TSINGHUA UNIV, TNLIST, BIOINFORMAT DIV, MOE KEY LAB BIOINFORMAT, BEIJING 100084, PEOPLES R CHINA.;FENG, ZHIXING, ZHANG, XUEGONG, TSINGHUA UNIV, TNLIST, BIOINFORMAT DIV, MOE KEY LAB BIOINFORMAT, BEIJING 100084, PEOPLES R CHINA.;FENG, ZHIXING, ZHANG, XUEGONG, TSINGHUA UNIV, DEPT AUTOMAT, BEIJING 100084, PEOPLES R CHINA.;FENG, ZHIXING, LI, JING, ZHANG, JING-REN, TSINGHUA UNIV, CTR INFECT DIS RES, SCH MED, BEIJING 100084, PEOPLES R CHINA.;ZHANG, JING-REN, TSINGHUA UNIV, COLLABORAT INNOVAT CTR BIOTHERAPY, BEIJING 100084, PEOPLES R CHINA.;ZHANG, JING-REN, SICHUAN UNIV, WEST CHINA HOSP, WEST CHINA MED SCH, COLLABORAT INNOVAT CTR BIOTHERAPY,STATE KEY LAB B, CHENGDU 610064, PEOPLES R CHINA.;ZHANG, JING-REN, SICHUAN UNIV, WEST CHINA HOSP, WEST CHINA MED SCH, CTR CANC, CHENGDU 610064, PEOPLES R CHINA.","10.1093/NAR/GKU1097","GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND",NA,NA,"NATIONAL BASIC RESEARCH PROGRAM OF CHINA [2012CB316504, 2012CB518702], NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA [91010016], TSINGHUA UNIVERSITY COLLABORATIVE RESEARCH PROGRAM [2011Z23153], CENTER FOR MARINE MEDICINE AND RESCUE OF TSINGHUA UNIVERSITY [20124812029], BILL AND MELINDA GATES FOUNDATION [OPP1021992]","NATIONAL BASIC RESEARCH PROGRAM OF CHINA [2012CB316504, 2012CB518702], NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA [91010016], TSINGHUA UNIVERSITY COLLABORATIVE RESEARCH PROGRAM [2011Z23153], CENTER FOR MARINE MEDICINE AND RESCUE OF TSINGHUA UNIVERSITY [20124812029], GRAND CHALLENGES EXPLORATION GRANT OF THE BILL AND MELINDA GATES FOUNDATION [OPP1021992]. FUNDING FOR OPEN ACCESS CHARGE: NATIONAL BASIC RESEARCH PROGRAM OF CHINA [2012CB316504, 2012CB518702].",NA,"0305-1048","22","13488-13499","OXFORD UNIV PRESS","42",2014,"ISI000347916900012","40","BIOCHEMISTRY \& MOLECULAR BIOLOGY","15","BIOCHEMISTRY \& MOLECULAR BIOLOGY","ZHANGLABTSINGHUA.EDU.CN ZHANGXGTSINGHUA.EDU.CN",NA,"AZ0DQ",NA,"ZHANG, XG (REPRINT AUTHOR), TSINGHUA UNIV, TNLIST, BIOINFORMAT DIV, MOE KEY LAB BIOINFORMAT, BEIJING 100084, PEOPLES R CHINA","ISI","TSINGHUA UNIV;TSINGHUA UNIV;TSINGHUA UNIV;TSINGHUA UNIV;SICHUAN UNIV;SICHUAN UNIV","TSINGHUA UNIV",NA,"FENG Z, 2014, NUCLEIC ACIDS RES","FENG Z, 2014, NUCLEIC ACIDS RES"
"SWANSON B, 2014, CANCER EPIDEMIOL BIOMARKERS PREV","SWANSON B;HARRISON S;DUKKA KC;MUGANDA P","COMPARATIVE ANALYSIS OF BIOINFORMATIC TOOLS FOR THE DETECTION OF VIRAL DNA SEQUENCES IN TUMOR CELLS","CANCER EPIDEMIOLOGY BIOMARKERS \& PREVENTION","CANCER EPIDEMIOL. BIOMARKERS PREV.",NA,NA,NA,"ENGLISH","MEETING ABSTRACT","ARTICLE",0,NA,"SWANSON, BARBARA, HARRISON, SCOTT, DUKKA, K. C., MUGANDA, PERPETUA, N CAROLINA AGR \& TECH STATE UNIV, GREENSBORO, NC 27411 USA.","10.1158/1538-7755.DISP13-C04","615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA",NA,NA,NA,NA,NA,"1055-9965","11",NA,"AMER ASSOC CANCER RESEARCH","23",2014,"ISI000359846600141","0","ONCOLOGY, PUBLIC, ENVIRONMENTAL \& OCCUPATIONAL HEALTH","1","ONCOLOGY, PUBLIC, ENVIRONMENTAL \& OCCUPATIONAL HEALTH",NA,NA,"CP4JA",NA,"SWANSON, BARBARA, HARRISON, SCOTT, DUKKA, K","ISI","N CAROLINA AGR AND TECH STATE UNIV","NOTREPORTED",NA,"SWANSON B, 2014, CANCER EPIDEMIOL BIOMARKERS PREV","SWANSON B, 2014, CANCER EPIDEMIOL BIOMARKERS PREV"
"WEHNER S, 2014, PLOS ONE","WEHNER S;MANNALA GK;QING X;MADHUGIRI R;CHAKRABORTY T;MRAHEIL MA;HAIN T;MARZ M","DETECTION OF VERY LONG ANTISENSE TRANSCRIPTS BY WHOLE TRANSCRIPTOME RNA-SEQ ANALYSIS OF LISTERIA MONOCYTOGENES BY SEMICONDUCTOR SEQUENCING TECHNOLOGY","PLOS ONE","PLOS ONE","THE GRAM-POSITIVE BACTERIUM LISTERIA MONOCYTOGENES IS THE CAUSATIVE AGENT OF LISTERIOSIS, A SEVERE FOOD-BORNE INFECTION CHARACTERISED BY ABORTION, SEPTICAEMIA, OR MENINGOENCEPHALITIS. L. MONOCYTOGENES CAUSES OUTBREAKS OF FEBRILE GASTROENTERITIS AND ACCOUNTS FOR COMMUNITY-ACQUIRED BACTERIAL MENINGITIS IN HUMANS. LISTERIOSIS HAS ONE OF THE HIGHEST MORTALITY RATES (UP TO 30\%) OF ALL FOOD-BORNE INFECTIONS. THIS HUMAN PATHOGENIC BACTERIUM IS AN IMPORTANT MODEL ORGANISM FOR BIOMEDICAL RESEARCH TO INVESTIGATE CELL-MEDIATED IMMUNITY. L. MONOCYTOGENES IS ALSO ONE OF THE BEST CHARACTERISED BACTERIAL SYSTEMS FOR THE MOLECULAR ANALYSIS OF INTRACELLULAR PARASITISM. RECENTLY SEVERAL TRANSCRIPTOMIC STUDIES HAVE ALSO MADE THE UBIQUITOUS DISTRIBUTED BACTERIUM AS A MODEL TO UNDERSTAND MECHANISMS OF GENE REGULATION FROM THE ENVIRONMENT TO THE INFECTED HOST ON THE LEVEL OF MRNA AND NON-CODING RNAS (NCRNAS). WE HAVE USED SEMICONDUCTOR SEQUENCING TECHNOLOGY FOR RNA-SEQ TO INVESTIGATE THE REPERTOIRE OF LISTERIAL NCRNAS UNDER EXTRA-AND INTRACELLULAR GROWTH CONDITIONS. FURTHERMORE, WE APPLIED A NEW BIOINFORMATIC ANALYSIS PIPELINE FOR DETECTION, COMPARATIVE GENOMICS AND STRUCTURAL CONSERVATION TO IDENTIFY NCRNAS. WITH THIS WORK, IN TOTAL, 741 NCRNA LOCATIONS OF POTENTIAL NCRNA CANDIDATES ARE NOW KNOWN FOR L. MONOCYTOGENES, OF WHICH 611 NCRNA CANDIDATES WERE IDENTIFIED BY RNA-SEQ. 441 TRANSCRIBED NCRNAS HAVE NEVER BEEN DESCRIBED BEFORE. AMONG THESE, WE IDENTIFIED NOVEL LONG NON-CODING ANTISENSE RNAS WITH A LENGTH OF UP TO 5,400 NT E.G. OPPOSITE TO GENES CODING FOR INTERNALINS, METHYLASES OR A HIGH-AFFINITY POTASSIUM UPTAKE SYSTEM, NAMELY THE KDPABC OPERON, WHICH WERE CONFIRMED BY QRT-PCR ANALYSIS. RNA-SEQ, COMPARATIVE GENOMICS AND STRUCTURAL CONSERVATION OF L. MONOCYTOGENES NCRNAS ILLUSTRATE THAT THIS HUMAN PATHOGEN USES A LARGE NUMBER AND REPERTOIRE OF NCRNA INCLUDING NOVEL LONG ANTISENSE RNAS, WHICH COULD BE IMPORTANT FOR INTRACELLULAR SURVIVAL WITHIN THE INFECTED EUKARYOTIC HOST.",NA,"COMPARATIVE GENOMICS; BACILLUS-SUBTILIS; NONCODING RNAS; MESSENGER-RNA; VIRULENCE; GENES; EXPRESSION; ADAPTATION; PREDICTION; DATABASE","ENGLISH","ARTICLE","ARTICLE",6,"ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;ARNVIG KB, 2011, PLOS PATHOG, V7, DOI 10.1371/JOURNAL.PPAT.1002342.;BECAVIN C, 2014, MBIO, V5, P00969.;BERTSCH D, 2013, INT J SYST EVOL MICR, V63, P526, DOI 10.1099/IJS.0.036947-0.;BRONDSTED L, 2003, FEMS MICROBIOL LETT, V219, P233, DOI 10.1016/S0378-1097(03)00052-1.;CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/JB.174.2.568-574.1992.;CHATTERJEE SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006.;CHRISTIANSEN JK, 2006, RNA, V12, P1383, DOI 10.1261/RNA.49706.;DE LAS HA, 2011, CURROPINMICROBIOL, V14, P118, DOI DOI 10.1016/J.MIB.2011.01.005.;DEN BAKKER HC, 2013, INT J SYST EVOL MICR, V63, P3257, DOI 10.1099/IJS.0.048587-0.;DORTET L, 2011, PLOS PATHOG, V7, DOI 10.1371/JOURNAL.PPAT.1002168.;FREEMAN ZN, 2013, PLOS PATHOG, V9, DOI 10.1371/JOURNAL.PPAT.1003201.;GARDNER PP, 2009, NUCLEIC ACIDS RES, V37, PD136, DOI 10.1093/NAR/GKN766.;GLASER P, 2001, SCIENCE, V294, P849, DOI 10.1126/SCIENCE.1063447.;GOUIN E, 2010, P NATL ACAD SCI USA, V107, P17333, DOI 10.1073/PNAS.1007765107.;GRAVES LM, 2010, INT J SYST EVOL MICR, V60, P1280, DOI 10.1099/IJS.0.014118-0.;GRIFFITHS-JONES S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/NAR/GKG006.;HAIN T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-20.;HAIN T, 2007, INT J MED MICROBIOL, V297, P541, DOI 10.1016/J.IJMM.2007.03.016.;HAIN T, 2006, J BACTERIOL, V188, P7405, DOI 10.1128/JB.00578-06.;HAIN T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-144.;HOFACKER IL, 2004, BIOINFORMATICS, V20, P186, DOI 10.1093/BIOINFORMATICS/BTG388.;HOFFMANN S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/JOURNAL.PCBI.1000502.;HOLTMANN G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003.;KAZMIERCZAK MJ, 2003, J BACTERIOL, V185, P5722, DOI 10.1128/JB.185.19.5722-5734.2003.;KUENNE C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-47.;LAGESEN K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/NAR/GKM160.;LANG HE, 2013, INTJSYSTEVOLMICROBIO, V63, P641.;LECHNER M, 2013, BACPROT PRO IN PRESS.;LECLERCQ A, 2010, INT J SYST EVOL MICR, V60, P2210, DOI 10.1099/IJS.0.017376-0.;LOWE TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/NAR/25.5.955.;MELLIN JR, 2013, P NATL ACAD SCI USA, V110, P13132, DOI 10.1073/PNAS.1304795110.;MRAHEIL MA, 2011, NUCLEIC ACIDS RES, V39, P4235, DOI 10.1093/NAR/GKR033.;NAWROCKI EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/BIOINFORMATICS/BTP157.;NICOLAS P, 2012, SCIENCE, V335, P1103, DOI 10.1126/SCIENCE.1206848.;OLIVER HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641.;PFAFFL MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/NAR/29.9.E45.;PIZARRO-CERDA J, 2012, COLD SPRING HARBPERS, V2.;POLAREK JW, 1992, J BACTERIOL, V174, P2145.;RAGHAVAN R, 2012, MBIO, V3.;SABET C, 2005, INFECT IMMUN, V73, P6912, DOI 10.1128/IAI.73.10.6912-6922.2005.;STAZIC D, 2011, NUCLEIC ACIDS RES, V39, P4890, DOI 10.1093/NAR/GKR037.;SWAMINATHAN B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/J.MICINF.2007.05.011.;TASARA T, 2007, FEMS MICROBIOL LETT, V269, P265, DOI 10.1111/J.1574-6968.2007.00633.X.;TOLEDO-ARANA A, 2009, NATURE, V459, P950, DOI 10.1038/NATURE08080.;VAZQUEZ-BOLAND JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001.;WASHIETL S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/PNAS.0409169102.;WIESEKE N, 2013, LECT NOTES COMPUTER, P249.;WILLIAMS T, 2005, INFECT IMMUN, V73, P3152, DOI 10.1128/IAI.73.5.3152-3159.2005.;WURTZEL O, 2012, MOL SYST BIOL, V8, DOI 10.1038/MSB.2012.11.","HAIN, T (REPRINT AUTHOR), UNIV GIESSEN, INST MED MICROBIOL, D-35390 GIESSEN, GERMANY.;WEHNER, STEFANIE, MARZ, MANJA, UNIV JENA, FAC MATH \& COMP SCI, JENA, GERMANY.;MANNALA, GOPALA K., QING, XIAOXING, CHAKRABORTY, TRINAD, MRAHEIL, MOBARAK A., HAIN, TORSTEN, UNIV GIESSEN, INST MED MICROBIOL, D-35390 GIESSEN, GERMANY.;CHAKRABORTY, TRINAD, HAIN, TORSTEN, GERMAN CTR INFECT RES DZIF, GIESSEN, GERMANY.;MADHUGIRI, RAMAKANTH, UNIV GIESSEN, INST MED VIROL, D-35390 GIESSEN, GERMANY.","10.1371/JOURNAL.PONE.0108639","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E108639",NA,"GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH THROUGH ERA-NET PROGRAM, GERMAN CENTRE FOR INFECTION RESEARCH, JUSTUS-LIEBIG UNIVERSITY GIESSEN, CARL-ZEISS-STIFTUNG, DFG [MA5082/1-1]","THIS PROJECT WAS FUNDED BY THE GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH THROUGH ERA-NET PROGRAM GRANTS SNCRNAOMICS TO T. H. AND THE GERMAN CENTRE FOR INFECTION RESEARCH, JUSTUS-LIEBIG UNIVERSITY GIESSEN TO T. H. AND T. C. THIS WORK WAS FUNDED IN PART BY THE CARL-ZEISS-STIFTUNG, AND DFG MA5082/1-1. THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT.",NA,"1932-6203","10",NA,"PUBLIC LIBRARY SCIENCE","9",2014,"ISI000345743700025","50","SCIENCE \& TECHNOLOGY - OTHER TOPICS","19","MULTIDISCIPLINARY SCIENCES","TORSTEN.HAINMIKROBIO.MED.UNI-GIESSEN.DE MANJAUNI-JENA.DE",NA,"AU6XC",NA,"HAIN, T (REPRINT AUTHOR), UNIV GIESSEN, INST MED MICROBIOL, D-35390 GIESSEN, GERMANY","ISI","UNIV JENA;UNIV GIESSEN;GERMAN CTR INFECT RES DZIF;UNIV GIESSEN","UNIV GIESSEN",NA,"WEHNER S, 2014, PLOS ONE","WEHNER S, 2014, PLOS ONE"
"LIU W, 2014, PLANT BIOTECHNOL J","LIU W;MAZAREI M;PENG Y;FETHE MH;RUDIS MR;LIN J;MILLWOOD RJ;ARELLI PR;STEWART CN","COMPUTATIONAL DISCOVERY OF SOYBEAN PROMOTER CIS-REGULATORY ELEMENTS FOR THE CONSTRUCTION OF SOYBEAN CYST NEMATODE-INDUCIBLE SYNTHETIC PROMOTERS","PLANT BIOTECHNOLOGY JOURNAL","PLANT BIOTECHNOL. J.","COMPUTATIONAL METHODS OFFER GREAT HOPE BUT LIMITED ACCURACY IN THE PREDICTION OF FUNCTIONAL CIS-REGULATORY ELEMENTS, IMPROVEMENTS ARE NEEDED TO ENABLE SYNTHETIC PROMOTER DESIGN. WE APPLIED AN ENSEMBLE STRATEGY FOR DE NOVO SOYBEAN CYST NEMATODE (SCN)-INDUCIBLE MOTIF DISCOVERY AMONG PROMOTERS OF 18 CO-EXPRESSED SOYBEAN GENES THAT WERE SELECTED FROM SIX REPORTED MICROARRAY STUDIES INVOLVING A COMPATIBLE SOYBEAN-SCN INTERACTION. A TOTAL OF 116 OVERLAPPING MOTIF REGIONS (OMRS) WERE DISCOVERED BIOINFORMATICALLY THAT WERE IDENTIFIED BY AT LEAST FOUR OUT OF SEVEN BIOINFORMATIC TOOLS. USING SYNTHETIC PROMOTERS, THE INDUCIBILITY OF EACH OMR OR MOTIF ITSELF WAS EVALUATED BY CO-LOCALIZATION OF GAIN OF FUNCTION OF AN ORANGE FLUORESCENT PROTEIN REPORTER AND THE PRESENCE OF SCN IN TRANSGENIC SOYBEAN HAIRY ROOTS. AMONG 16 OMRS DETECTED FROM TWO EXPERIMENTALLY CONFIRMED SCN-INDUCIBLE PROMOTERS, 11 OMRS (I. E. 68.75\%) WERE EXPERIMENTALLY CONFIRMED TO BE SCN-INDUCIBLE, LEADING TO THE DISCOVERY OF 23 CORE MOTIFS OF 5- TO 7-BP LENGTH, OF WHICH 14 ARE NOVEL IN PLANTS. WE FOUND THAT A COMBINATION OF THE THREE BEST TOOLS (I. E. SCOPE, W-ALIGNACE AND WEEDER) COULD DETECT ALL 23 CORE MOTIFS. THUS, THIS STRATEGY IS A HIGH-THROUGHPUT APPROACH FOR DE NOVO MOTIF DISCOVERY IN SOYBEAN AND OFFERS GREAT POTENTIAL FOR NOVEL MOTIF DISCOVERY AND SYNTHETIC PROMOTER ENGINEERING FOR ANY PLANT AND TRAIT IN CROP BIOTECHNOLOGY.","DE NOVO MOTIF DISCOVERY; PLANT SYNTHETIC BIOLOGY; PPORRFP; TRANSGENIC SOYBEAN HAIRY SYSTEM; SOYBEAN CYST NEMATODE; SOYBEAN","FACTOR-BINDING SITES; HETERODERA-GLYCINES; MOTIF DISCOVERY; FLUORESCENT PROTEINS; EXPRESSION ANALYSIS; ARABIDOPSIS PLANTS; DNA; SEQUENCES; PATHOGEN; ROOTS","ENGLISH","ARTICLE","ARTICLE",17,"ALIEVA NO, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0002680.;ALTARAWY D, 2009, LECT N BIOINFORMAT, V5780, P13.;ALTMAN RB, 2001, CURR OPIN STRUC BIOL, V11, P340, DOI 10.1016/S0959-440X(00)00212-8.;AO W, 2004, SCIENCE, V305, P1743, DOI 10.1126/SCIENCE.1102216.;ARELLI PR, 2000, CROP SCI, V40, P824, DOI 10.2135/CROPSCI2000.403824X.;BAILEY TL, 2006, NUCLEIC ACIDS RES, V34, PW369, DOI 10.1093/NAR/GKL198.;BYRD D.W., 1983, J NEMATOL, V15, P142.;CARLSON JM, 2007, NUCLEIC ACIDS RES, V35, PW259, DOI 10.1093/NAR/GKM310.;CHAKRAVARTY A, 2007, BMC BIOINFORMATICS, V8, P249, DOI DOI 10.1186/1471-2105-8-249.;CHEN X, 2008, BIOINFORMATICS, V24, P1121, DOI 10.1093/BIOINFORMATICS/BTN088.;D'HAESELEER P, 2006, NAT BIOTECHNOL, V24, P959, DOI 10.1038/NBT0806-959.;DAVIS EL, 2004, TRENDS PARASITOL, V20, P134, DOI 10.1016/J.PT.2004.01.005.;ENDO B Y, 1991, REVUE DE NEMATOLOGIE, V14, P73.;FETHE MH, 2014, PLANT BIOTECHNOL J, V12, P755, DOI 10.1111/PBI.12180.;GHEYSEN GODELIEVE, 2009, V15, P45, DOI 10.1007/7089\_2008\_35.;HARTWIG EE, 1971, CROP SCI, V11, P603, DOI 10.2135/CROPSCI1971.0011183X001100040063X.;HASELOFF J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/PNAS.94.6.2122.;HERTZ GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/BIOINFORMATICS/15.7.563.;HIGO K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/NAR/27.1.297.;HU JJ, 2005, NUCLEIC ACIDS RES, V33, P4899, DOI 10.1093/NAR/GKI791.;ITHAL N, 2007, MOL PLANT MICROBE IN, V20, P510, DOI 10.1094/MPMI-20-5-0510.;ITHAL N, 2007, MOL PLANT MICROBE IN, V20, P293, DOI 10.1094/MPMI-20-3-0293.;KERESZT A, 2007, NAT PROTOC, V2, P948, DOI 10.1038/NPROT.2007.141.;KIM YH, 1987, J NEMATOL, V19, P177.;KLINK VP, 2007, PLANTA, V226, P1423, DOI 10.1007/S00425-007-0581-4.;KLINK VP, 2007, PLANTA, V226, P1389, DOI 10.1007/S00425-007-0578-Z.;KOSCHMANN J, 2012, PLANT PHYSIOL, V160, P178, DOI 10.1104/PP.112.198259.;LESCOT M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/NAR/30.1.325.;LI N, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-8.;LIN JY, 2013, PLANT BIOTECHNOL J, V11, P1135, DOI 10.1111/PBI.12108.;LIU W., 2013, PLANT BIOTECHNOL J, V12, P436.;LIU WS, 2013, NAT REV GENET, V14, P781, DOI 10.1038/NRG3583.;LIU WS, 2013, PLANT BIOTECHNOL J, V11, P43, DOI 10.1111/PBI.12005.;LIU WS, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-108.;LIU X, 2001, PAC S BIOCOMPUT, P127.;LIU XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/NBT717.;MANN DGJ, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-17.;MATYS V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/NAR/GKG108.;MAZAREI M, 2008, SENSORS-BASEL, V8, P2628, DOI 10.3390/S8042628.;MAZAREI M, 2011, THEOR APPL GENET, V123, P1193, DOI 10.1007/S00122-011-1659-8.;PAVESI G, 2004, NUCLEIC ACIDS RES, V32, PW199, DOI 10.1093/NAR/GKH465.;PUTHOFF DP, 2007, J EXP BOT, V58, P3407, DOI 10.1093/JXB/ERM211.;QUEST D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S6.;RUSHTON PJ, 2002, PLANT CELL, V14, P749, DOI 10.1105/TPC.010412.;SCHULZE A, 2001, NAT CELL BIOL, V3, PE190, DOI 10.1038/35087138.;SINHA S, 2003, NUCLEIC ACIDS RES, V31, P3586, DOI 10.1093/NAR/GKG618.;THIJS G, 2002, J COMPUT BIOL, V9, P447, DOI 10.1089/10665270252935566.;TOMPA M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/NBT1053.;VAN HELDEN J, 2000, NUCLEIC ACIDS RES, V28, P1808, DOI 10.1093/NAR/28.8.1808.;VAN HELDEN J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/JMBI.1998.1947.;VENTER M, 2007, TRENDS PLANT SCI, V12, P118, DOI 10.1016/J.TPLANTS.2007.01.002.;WIJAYA E, 2008, BIOINFORMATICS, V24, P2288, DOI 10.1093/BIOINFORMATICS/BTN420.;WORKMAN C T, 2000, PAC SYMP BIOCOMPUT, P467.;WRATHER JA, 2006, J NEMATOL, V38, P173.;YANOVER C, 2009, BIOINFORMATICS, V25, P868, DOI 10.1093/BIOINFORMATICS/BTP090.;YU HY, 2003, TRENDS GENET, V19, P422, DOI 10.1016/S0168-9525(03)00175-6.;ZHOU Q, 2004, P NATL ACAD SCI USA, V101, P12114, DOI 10.1073/PNAS.0402858101.","STEWART, CN (REPRINT AUTHOR), UNIV TENNESSEE, DEPT PLANT SCI, KNOXVILLE, TN 37996 USA.;LIU, WUSHENG, MAZAREI, MITRA, PENG, YANHUI, FETHE, MICHAEL H., RUDIS, MARY R., LIN, JINGYU, MILLWOOD, REGINALD J., STEWART, CHARLES NEAL, JR., UNIV TENNESSEE, DEPT PLANT SCI, KNOXVILLE, TN 37996 USA.;ARELLI, PRAKASH R., ARS, CROP GENET RES UNIT, USDA, MRS, JACKSON, TN USA.","10.1111/PBI.12206","111 RIVER ST, HOBOKEN 07030-5774, NJ USA",NA,NA,"USDA-NIFA","WE GRATEFULLY ACKNOWLEDGE FUNDING BY GRANTS FROM USDA-NIFA. WE THANK DR. PRIYA RANJAN FOR DOWNLOADING THE WHOLE INTERGENIC SEQUENCES OF SOYBEAN, DR. ROBERT GROSS FOR CREATING THE SOYBEAN BACKGROUND FOR SCOPE AND DR. GIULIO PAVESI FOR CREATING THE SOYBEAN BACKGROUND FOR WEEDER.",NA,"1467-7644","8","1015-1026","WILEY-BLACKWELL","12",2014,"ISI000342843000003","57","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, PLANT SCIENCES","50","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, PLANT SCIENCES","NEALSTEWARTUTK.EDU",NA,"AQ5JB",NA,"STEWART, CN (REPRINT AUTHOR), UNIV TENNESSEE, DEPT PLANT SCI, KNOXVILLE, TN 37996 USA","ISI","UNIV TENNESSEE;CROP GENET RES UNIT","UNIV TENNESSEE",NA,"LIU W, 2014, PLANT BIOTECHNOL J","LIU W, 2014, PLANT BIOTECHNOL J"
"AIAMKITSUMRIT B, 2014, PLOS ONE","AIAMKITSUMRIT B;DAMPIER W;MARTIN GARCIA J;NONNEMACHER MR;PIRRONE V;IVANOVA T;ZHONG W;KILARESKI E;ALDIGUN H;FRANTZ B;RIMBEY M;WOJNO A;PASSIC S;WILLIAMS JW;SHAH S;BLAKEY B;PARIKH N;JACOBSON JM;MOLDOVER B;WIGDAHL B","DEFINING DIFFERENTIAL GENETIC SIGNATURES IN CXCR4-AND THE CCR5-UTILIZING HIV-1 CO-LINEAR SEQUENCES","PLOS ONE","PLOS ONE","THE ADAPTATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HIV-1) TO AN ARRAY OF PHYSIOLOGIC NICHES IS ADVANTAGED BY THE PLASTICITY OF THE VIRAL GENOME, ENCODED PROTEINS, AND PROMOTER. CXCR4-UTILIZING (X4) VIRUSES PREFERENTIALLY, BUT NOT UNIVERSALLY, INFECT CD4(+) T CELLS, GENERATING HIGH LEVELS OF VIRUS WITHIN ACTIVATED HIV-1-INFECTED T CELLS THAT CAN BE DETECTED IN REGIONAL LYMPH NODES AND PERIPHERAL BLOOD. BY COMPARISON, THE CCR5-UTILIZING (R5) VIRUSES HAVE A GREATER PREFERENCE FOR CELLS OF THE MONOCYTE-MACROPHAGE LINEAGE, HOWEVER, WHILE R5 VIRUSES ALSO DISPLAY A PROPENSITY TO ENTER AND REPLICATE IN T CELLS, THEY INFECT A SMALLER PERCENTAGE OF CD4(+) T CELLS IN COMPARISON TO X4 VIRUSES. ADDITIONALLY, R5 VIRUSES HAVE BEEN ASSOCIATED WITH VIRAL TRANSMISSION AND CNS DISEASE AND ARE ALSO MORE PREVALENT DURING HIV-1 DISEASE. SPECIFIC ADAPTIVE CHANGES ASSOCIATED WITH X4 AND R5 VIRUSES WERE IDENTIFIED IN CO-LINEAR VIRAL SEQUENCES BEYOND THE ENV-V3. THE IN SILICO POSITION-SPECIFIC SCORING MATRIX (PSSM) ALGORITHM WAS USED TO DEFINE DISTINCT GROUPS OF X4 AND R5 SEQUENCES BASED SOLELY ON SEQUENCES IN ENV-V3. BIOINFORMATIC TOOLS WERE USED TO IDENTIFY GENETIC SIGNATURES INVOLVING SPECIFIC PROTEIN DOMAINS OR LONG TERMINAL REPEAT (LTR) TRANSCRIPTION FACTOR SITES WITHIN CO-LINEAR VIRAL PROTEIN R (VPR), TRANS-ACTIVATOR OF TRANSCRIPTION (TAT), OR LTR SEQUENCES THAT WERE PREFERENTIALLY ASSOCIATED WITH X4 OR R5 ENV-V3 SEQUENCES. A NUMBER OF DIFFERENTIAL AMINO ACID AND NUCLEOTIDE CHANGES WERE IDENTIFIED ACROSS THE CO-LINEAR VPR, TAT, AND LTR SEQUENCES, SUGGESTING THE PRESENCE OF SPECIFIC GENETIC SIGNATURES THAT PREFERENTIALLY ASSOCIATE WITH X4 OR R5 VIRUSES. INVESTIGATION OF THE GENETIC RELATEDNESS BETWEEN X4 AND R5 VIRUSES UTILIZING PHYLOGENETIC ANALYSES OF COMPLETE SEQUENCES COULD NOT BE USED TO DEFINITIVELY AND UNIQUELY IDENTIFY GROUPS OF R5 OR X4 SEQUENCES, IN CONTRAST, DIFFERENCES IN THE GENETIC DIVERSITIES BETWEEN X4 AND R5 WERE READILY IDENTIFIED WITHIN THESE CO-LINEAR SEQUENCES IN HIV-1-INFECTED PATIENTS.",NA,"HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; VIRAL PROTEIN R; DISEASE PROGRESSION; CORECEPTOR USAGE; IN-VITRO; SUBTYPE-B; ENVELOPE GLYCOPROTEINS; REPLICATION CAPACITY; MACROPHAGE TROPISM","ENGLISH","ARTICLE","ARTICLE",4,"ALKHATIB G, 1996, SCIENCE, V272, P1955, DOI 10.1126/SCIENCE.272.5270.1955.;AMBROSINO C, 1997, J BIOL CHEM, V272, P14883, DOI 10.1074/JBC.272.23.14883.;AZAD AA, 2000, BIOCHEM BIOPH RES CO, V267, P677, DOI 10.1006/BBRC.1999.1708.;BANO AS, 2007, OLIGONUCLEOTIDES, V17, P465, DOI 10.1089/OLI.2007.0091.;BANO AS, 2007, AIDS, V21, P1832, DOI 10.1097/QAD.0B013E328277F16B.;BANO AS, 2009, J GEN VIROL, V90, P2768, DOI 10.1099/VIR.0.011080-0.;BRULAND T, 2003, J GEN VIROL, V84, P907, DOI 10.1099/VIR.0.18625-0.;BUKRINSKY M, 1999, REV MED VIROL, V9, P39, DOI 10.1002/(SICI)1099-1654(199901/03)9:1<39::AID-RMV235>3.0.CO,2-3.;BURDO TH, 2004, J NEUROVIROL, V10, P7, DOI 10.1080/13550280490270789.;BUTTO S, 2003, J INFECT DIS, V188, P1171, DOI 10.1086/378412.;CANONNEHERGAUX F, 1995, J VIROL, V69, P6634.;CARRILLO A, 1996, J VIROL, V70, P1301.;CHOHAN B, 2005, J VIROL, V79, P6528, DOI 10.1128/JVI.79.10.6528-6531.2005.;CONAWAY JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7.;CONNOR RI, 1997, J EXP MED, V185, P621, DOI 10.1084/JEM.185.4.621.;COONEY AJ, 1991, J VIROL, V65, P2853.;COWLEY D, 2011, J NEUROVIROL, V17, P70, DOI 10.1007/S13365-010-0002-5.;CULLEN BR, 1991, FASEB J, V5, P2361.;DEJONG JJ, 1992, J VIROL, V66, P6777.;DENG HK, 1996, NATURE, V381, P661, DOI 10.1038/381661A0.;DERDEYN CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/SCIENCE.1093137.;DIMONTE S, 2012, VIRUS RES, V168, P73, DOI 10.1016/J.VIRUSRES.2012.06.019.;DORANZ BJ, 1999, J VIROL, V73, P2752.;DUNCAN CJA, 2011, VIRUSES-BASEL, V3, P2255, DOI 10.3390/V3112255.;ECKERT DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/ANNUREV.BIOCHEM.70.1.777.;EMERMAN M, 1996, CURR BIOL, V6, P1096, DOI 10.1016/S0960-9822(02)00676-0.;EMERMAN M, 1998, SCIENCE, V280, P1880, DOI 10.1126/SCIENCE.280.5371.1880.;EUGENIN EA, 2007, P NATL ACAD SCI USA, V104, P3438, DOI 10.1073/PNAS.0611699104.;FASSATI A, 2001, J VIROL, V75, P3626, DOI 10.1128/JVI.75.8.3626-3635.2001.;FERRUCCI A, 2011, ADV VIRUS RES, V81, P165, DOI 10.1016/B978-0-12-385885-6.00010-9.;FIELDS BN, 2007, FIELDS VIROLOGY, P2664.;FU YX, 2001, MOL BIOL EVOL, V18, P620, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A003842.;GALLO RC, 1986, PROG ALLERGY, V37, P1.;GARCIABLANCO MA, 1991, SCIENCE, V254, P815, DOI 10.1126/SCIENCE.1658933.;GNANAKARAN S, 2011, PLOS PATHOG, V7, DOI 10.1371/JOURNAL.PPAT.1002209.;HAHN BH, 1986, SCIENCE, V232, P1548, DOI 10.1126/SCIENCE.3012778.;HENDERSON AJ, 1997, P NATL ACAD SCI USA, V94, P8714, DOI 10.1073/PNAS.94.16.8714.;HENDERSON AJ, 1995, J VIROL, V69, P5337.;HENDERSON AJ, 1996, IMMUNITY, V5, P91, DOI 10.1016/S1074-7613(00)80313-1.;HOGAN TH, 2003, J NEUROVIROL, V9, P55, DOI 10.1080/13550280390173292.;HOGAN TH, 2002, J NEUROVIROL, V8, P21, DOI 10.1080/13550280290167911.;HOLZMEISTER J, 1993, BIOCHEM BIOPH RES CO, V197, P1229, DOI 10.1006/BBRC.1993.2608.;HUANG YX, 1996, NAT MED, V2, P1240, DOI 10.1038/NM1196-1240.;HUTTO C, 1996, J VIROL, V70, P3589.;JENSEN M, 2007, PSSM.;JENSEN MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003.;JENSEN MARK A., 2003, AIDS REVIEWS, V5, P104.;JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275.;JONES E., 2001, SCIPY OPEN SOURCE SC.;JOOS B, 2005, J VIROL, V79, P9026, DOI 10.1128/JVI.79.14.9026-9037.2005.;KALANTARI P, 2008, J BIOL CHEM, V283, P33183, DOI 10.1074/JBC.M807403200.;KEELE BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/PNAS.0802203105.;KILARESKI EM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-118.;KING JE, 2006, MICROBES INFECT, V8, P1347, DOI 10.1016/J.MICINF.2005.11.014.;KITAYAMA H, 2008, J VIROL, V82, P2528, DOI 10.1128/JVI.02094-07.;KOGAN M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-25.;LI L., 2012, ADV VIROL, V2012, DOI DOI 10.1155/2012/123605.;LI LN, 2011, J NEUROVIROL, V17, P92, DOI 10.1007/S13365-010-0014-1.;LIU Y, 2008, VIROLOGY, V374, P229, DOI 10.1016/J.VIROL.2008.01.029.;LU YC, 1989, J VIROL, V63, P4115.;MACIAN F, 1999, MOL CELL BIOL, V19, P3645.;MANCEBO HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/GAD.11.20.2633.;MARKHAM RB, 1998, P NATL ACAD SCI USA, V95, P12568, DOI 10.1073/PNAS.95.21.12568.;MARKHAM RB, 1996, J VIROL, V70, P6947.;MASCIOTRA S, 2002, AIDS, V16, P1887, DOI 10.1097/00002030-200209270-00005.;MATHELIER A, 2014, NUCLEIC ACIDS RES, V42, PD142, DOI 10.1093/NAR/GKT997.;MAX PLANCK INSTITUT FUR INFORMATIK, 2011, GENO2PHENO.;MAYNE M, 1998, NEUROIMMUNOMODULAT, V5, P184, DOI 10.1159/000026336.;MBONYE U, 2011, CURR HIV RES, V9, P554, DOI 10.2174/157016211798998736.;MCALLISTER JJ, 2000, VIROLOGY, V274, P262, DOI 10.1006/VIRO.2000.0476.;MEFFORD ME, 2008, AIDS RES HUM RETROV, V24, P1215, DOI 10.1089/AID.2008.0009.;MELTZER MS, 1990, IMMUNOL TODAY, V11, P217, DOI 10.1016/0167-5699(90)90086-O.;MOLOGNI D, 2006, AIDS, V20, P567, DOI 10.1097/01.AIDS.0000210611.60459.0E.;MONNO L, 2011, ANTIMICROB AGENTS CH, V55, P5078, DOI 10.1128/AAC.00743-11.;MOORE JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567.;NEI M, 2000, MOL EVOLUTION PHYLOG.;NEOGI UJJWAL, 2012, AIDS RES HUM RETROVIRUSES, V28, P1152, DOI 10.1089/AID.2011.0380.;NONNEMACHER MR, 2004, J NEUROIMMUNOL, V157, P39, DOI 10.1016/J.JNEUROIM.2004.08.021.;NORA T, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-23.;OCHSENBAUER C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11.;PARKER ZF, 2013, J VIROL, V87, P2401, DOI 10.1128/JVI.02964-12.;PARRISH NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/PNAS.1304288110.;PILLAI S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658.;POSS M, 1995, J VIROL, V69, P8118.;PROSPERI MCF, 2009, AIDS RES HUM RETROV, V25, P305, DOI 10.1089/AID.2008.0039.;RAO VR, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-61.;ROEBUCK KA, 1999, GENE EXPRESSION, V8, P67.;ROSS HL, 2001, J NEUROVIROL, V7, P235.;ROSSI F, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-89.;SAGAR M, 2006, AIDS RES HUM RETROV, V22, P430, DOI 10.1089/AID.2006.22.430.;SALZWEDEL K, 2000, J VIROL, V74, P326, DOI 10.1128/JVI.74.1.326-333.2000.;SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/JEM.174.2.407.;SATTENTAU QJ, 1993, J VIROL, V67, P7383.;SAWAYA BE, 2000, J BIOL CHEM, V275, P35209, DOI 10.1074/JBC.M005197200.;SCHMIDTMAYEROVA H, 1998, J VIROL, V72, P4633.;SCHUITEMAKER H, 1992, J VIROL, V66, P1354.;SCHUITEMAKER H, 1995, SCIENCE, V268, P115, DOI 10.1126/SCIENCE.7755774.;SCHWEIGHARDT B, 2004, J VIROL, V78, P9164, DOI 10.1128/JVI.78.17.9164-9173.2004.;SHARON M, 2003, STRUCTURE, V11, P225, DOI 10.1016/S0969-2126(03)00011-X.;SIERRA S, 2007, EUR J MED RES, V12, P453.;SING T, 2007, ANTIVIR THER, V12, P1097.;SOULIE C, 2008, HIV MED, V9, P1, DOI 10.1111/J.1468-1293.2008.00518.X.;SRINIVASAN A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-99.;TAMURA K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/MOLBEV/MSR121.;TROUPLIN V, 2001, J VIROL, V75, P251, DOI 10.1128/JVI.75.1.251-259.2001.;TUNGATURTHI PK, 2004, DNA CELL BIOL, V23, P207, DOI 10.1089/104454904773819798.;TYOR W, 2013, J NEUROVIROL, V19, P515, DOI 10.1007/S13365-013-0206-6.;VERHOFSTEDE C, 2011, HIV MED, V12, P544, DOI 10.1111/J.1468-1293.2011.00922.X.;WEI P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3.;WHITCOMB JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06.;WILEN CB, 2011, J VIROL, V85, P8514, DOI 10.1128/JVI.00736-11.;YEDAVALLI VRK, 2001, AIDS RES HUM RETROV, V17, P911, DOI 10.1089/088922201750290032.;ZHOU Y, 2001, VIROLOGY, V287, P133, DOI 10.1006/VIRO.2001.1031.;ZHU YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/GAD.11.20.2622.","WIGDAHL, B (REPRINT AUTHOR), DREXEL UNIV, DEPT MICROBIOL \& IMMUNOL, COLL MED, PHILADELPHIA, PA 19104 USA.;AIAMKITSUMRIT, BENJAMAS, DAMPIER, WILL, MARTIN-GARCIA, JULIO, NONNEMACHER, MICHAEL R., PIRRONE, VANESSA, IVANOVA, TATYANA, ZHONG, WEN, KILARESKI, EVELYN, ALDIGUN, HAZEEZ, FRANTZ, BRIAN, RIMBEY, MATTHEW, WOJNO, ADAM, PASSIC, SHENDRA, WILLIAMS, JEAN W., SHAH, SONIA, BLAKEY, BRANDON, PARIKH, NIRZARI, JACOBSON, JEFFREY M., WIGDAHL, BRIAN, DREXEL UNIV, DEPT MICROBIOL \& IMMUNOL, COLL MED, PHILADELPHIA, PA 19104 USA.;JACOBSON, JEFFREY M., DREXEL UNIV, DEPT MED, DIV INFECT DIS \& HIV MED, COLL MED, PHILADELPHIA, PA 19104 USA.;AIAMKITSUMRIT, BENJAMAS, DAMPIER, WILL, MARTIN-GARCIA, JULIO, NONNEMACHER, MICHAEL R., PIRRONE, VANESSA, IVANOVA, TATYANA, ZHONG, WEN, KILARESKI, EVELYN, ALDIGUN, HAZEEZ, FRANTZ, BRIAN, RIMBEY, MATTHEW, WOJNO, ADAM, PASSIC, SHENDRA, WILLIAMS, JEAN W., SHAH, SONIA, BLAKEY, BRANDON, PARIKH, NIRZARI, WIGDAHL, BRIAN, DREXEL UNIV, CTR MOL VIROL \& TRANSLAT NEUROSCI, INST MOL MED \& INFECT DIS, COLL MED, PHILADELPHIA, PA 19104 USA.;JACOBSON, JEFFREY M., DREXEL UNIV, CTR CLIN \& TRANSLAT MED, INST MOL MED \& INFECT DIS, COLL MED, PHILADELPHIA, PA 19104 USA.;MOLDOVER, BRIAN, B TECH CONSULTING LTD, PHILADELPHIA, PA USA.","10.1371/JOURNAL.PONE.0107389","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E107389",NA,"NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01 NS32092], NATIONAL INSTITUTE ON DRUG ABUSE [R01 DA19807], NATIONAL INSTITUTE OF MENTAL HEALTH [P30 MH092177, T32 MH079785]","RESEARCH WITHIN THIS MANUSCRIPT HAS BEEN SUPPORTED BY THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE, GRANT NUMBER R01 NS32092, WWW.NINDS.NIH.GOV, THE NATIONAL INSTITUTE ON DRUG ABUSE, GRANT NUMBER R01 DA19807, WWW.DRUGABUSE.GOV, THE NATIONAL INSTITUTE OF MENTAL HEALTH, GRANT NUMBER P30 MH092177, WWW.NIMH.NIH.GOV, AND THE NATIONAL INSTITUTE OF MENTAL HEALTH, GRANT NUMBER T32 MH079785, WWW.NIMH.NIH.GOV. THE FUNDERS HAD NO ROLE IN THE STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT.",NA,"1932-6203","9",NA,"PUBLIC LIBRARY SCIENCE","9",2014,"ISI000345745400021","114","SCIENCE \& TECHNOLOGY - OTHER TOPICS","4","MULTIDISCIPLINARY SCIENCES","BWIGDAHLDREXELMED.EDU",NA,"AU6XR",NA,"WIGDAHL, B (REPRINT AUTHOR), DREXEL UNIV, DEPT MICROBIOL \& IMMUNOL, COLL MED, PHILADELPHIA, PA 19104 USA","ISI","DREXEL UNIV;DREXEL UNIV;DREXEL UNIV;DREXEL UNIV;B TECH CONSULTING LTD","DREXEL UNIV",NA,"AIAMKITSUMRIT B, 2014, PLOS ONE","AIAMKITSUMRIT B, 2014, PLOS ONE"
"VINCENT AL, 2014, INVEST OPHTHALMOL VIS SCI","VINCENT AL;JORDAN CA;CADZOW MJ;MERRIMAN TR;MCGHEE CN","MUTATIONS IN THE ZINC FINGER PROTEIN GENE, ZNF469, CONTRIBUTE TO THE PATHOGENESIS OF KERATOCONUS","INVESTIGATIVE OPHTHALMOLOGY \& VISUAL SCIENCE","INVEST. OPHTHALMOL. VIS. SCI.","PURPOSE. MUTATIONS IN THE ZINC FINGER PROTEIN GENE ZNF469 CAUSE RECESSIVE BRITTLE CORNEA SYNDROME, CHARACTERIZED BY SPONTANEOUS CORNEAL PERFORATIONS. GENOME-WIDE ASSOCIATION STUDIES (GWAS) HAVE IMPLICATED COMMON VARIANTS IN THIS GENE AS A DETERMINANT FOR CENTRAL CORNEAL THICKNESS (CCT). WE INVESTIGATED THE CONTRIBUTION OF ZNF469 IN A SAMPLE SET OF KERATOCONUS PATIENTS. METHODS. FORTY-THREE PATIENTS WITH KERATOCONUS (49\% MAORI OR PACIFIC [POLYNESIAN]) WERE RECRUITED. IF A FAMILY HISTORY WAS PRESENT, FAMILY MEMBERS WERE RECRUITED. PARTICIPANTS UNDERWENT COMPREHENSIVE EXAMINATION, AND A DNA SAMPLE WAS COLLECTED. MUTATIONAL ANALYSIS OF ZNF469 WAS UNDERTAKEN USING SANGER SEQUENCING, INCLUDING AN ANCESTRALLY MATCHED POLYNESIAN CONTROL POPULATION. BIOINFORMATIC DATABASES OF EXOME VARIATION AND PROTEIN PREDICTION SOFTWARE WERE USED TO DETERMINE PRESENCE AND FREQUENCY AND THE PATHOGENICITY FOR EACH OBSERVED CHANGE. RESULTS. FOURTEEN NONSYNONYMOUS MISSENSE SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS) WERE OBSERVED IN ZNF469. OF THE 43 PROBANDS, AT LEAST ONE PROBABLE DISEASE-CAUSING VARIANT WAS DETECTED IN 20 (46\%) (16/32 SPORADIC, 4/11 FAMILIAL) AND TWO VARIANTS IN 5 (11.6\%) (3/32 SPORADIC, 2/11 FAMILIAL). ONLY HETEROZYGOUS CHANGES SEGREGATED WITH DISEASE. THREE ``DELETERIOUS'' CHANGES OBSERVED IN THE POLYNESIAN CONTROLS WERE","KERATOCONUS; GENETICS; ZNF469","BRITTLE CORNEA SYNDROME; NATIONAL EYE BANK; NEW-ZEALAND; BLUE SCLERA; PENETRATING KERATOPLASTY; THICKNESS; TRANSPLANTATION; TRENDS; FAMILY; TISSUE","ENGLISH","ARTICLE","ARTICLE",19,"ABU A, 2008, AM J HUM GENET, V82, P1217, DOI 10.1016/J.AJHG.2008.04.001.;ABU A, 2006, INVEST OPHTH VIS SCI, V47, P5283, DOI 10.1167/IOVS.06-0206.;AL-OWAIN M, 2012, GENE, V511, P447, DOI 10.1016/J.GENE.2012.09.022.;ALDAHMESH MA, 2012, CLIN GENET, V81, P198, DOI 10.1111/J.1399-0004.2011.01808.X.;BURDON KP, 2013, CLIN EXP OPTOM, V96, P146, DOI 10.1111/CXO.12024.;CHRISTENSEN AE, 2009, INVEST OPHTH VIS SCI, V51, P47.;COSAR CB, 2002, CORNEA, V21, P148, DOI 10.1097/00003226-200203000-00003.;CUNNINGHAM WJ, 2012, CLIN EXP OPHTHALMOL, V40, P141, DOI 10.1111/J.1442-9071.2011.02681.X.;DESMET FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/NAR/GKP215.;DOBBINS KRB, 2000, CORNEA, V19, P813, DOI 10.1097/00003226-200011000-00010.;EDWARDS M, 2002, CORNEA, V21, P152, DOI 10.1097/00003226-200203000-00004.;FULLERTON J, 2002, HUM GENET, V110, P462, DOI 10.1007/S00439-002-0705-7.;GREGORATOS ND, 1971, BRIT J OPHTHALMOL, V55, P424, DOI 10.1136/BJO.55.6.424.;HASELTINE SJ, 2012, ACTA OPHTHALMOL, V90, PE626, DOI 10.1111/J.1755-3768.2012.02509.X.;HOEHN R, 2012, HUM GENET, V131, P1783, DOI 10.1007/S00439-012-1201-3.;HOLLIS-MOFFATT JE, 2009, ARTHRITIS RHEUM-US, V60, P3485, DOI 10.1002/ART.24938.;JORDAN CA, 2011, J CATARACT REFR SURG, V37, P1493, DOI 10.1016/J.JCRS.2011.03.040.;KHAN AO, 2012, OPHTHALMIC GENET, V33, P257, DOI 10.3109/13816810.2012.670362.;KHAN AO, 2010, ARCH OPHTHALMOL-CHIC, V128, P1376, DOI 10.1001/ARCHOPHTHALMOL.2010.238.;LEGEAIS JM, 2001, CORNEA, V20, P603, DOI 10.1097/00003226-200108000-00009.;LU Y, 2013, NAT GENET, V45, P155, DOI 10.1038/NG.2506.;LU Y, 2010, PLOS GENET, V6, DOI 10.1371/JOURNAL.PGEN.1000947.;MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/NAR/16.3.1215.;OWENS H, 2007, CORNEA, V26, P312, DOI 10.1097/ICO.0B013E31802F8D87.;PATEL HY, 2005, CORNEA, V24, P576, DOI 10.1097/01.ICO.0000155035.55751.B2.;PATEL HY, 2005, BRIT J OPHTHALMOL, V89, P404, DOI 10.1136/BJO.2004.053116.;RABINOWITZ YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7.;ROBERTS RL, 2014, JOINT BONE SPINE, V81, P160, DOI 10.1016/J.JBSPIN.2013.07.006.;ROHRBACH M, 2013, MOL GENET METAB, V109, P289, DOI 10.1016/J.YMGME.2013.04.014.;STEIN R, 1968, AM J OPHTHALMOL, V66, P67, DOI 10.1016/0002-9394(68)91789-3.;TICHO U, 1980, BRIT J OPHTHALMOL, V64, P175, DOI 10.1136/BJO.64.3.175.;TYYNISMAA H, 2002, INVEST OPHTH VIS SCI, V43, P3160.;ULMER M, 2012, INVEST OPHTH VIS SCI, V53, P4468, DOI 10.1167/IOVS.12-9784.;VITART V, 2010, HUM MOL GENET, V19, P4304, DOI 10.1093/HMG/DDQ349.;VITHANA EN, 2011, HUM MOL GENET, V20, P649, DOI 10.1093/HMG/DDQ511.;WAGNER H, 2007, CONT LENS ANTERIOR EYE, V30, P223, DOI 10.1016/J.CLAE.2007.03.001.;WANG Y, 2000, AM J MED GENET, V93, P403, DOI 10.1002/1096-8628(20000828)93:5<403::AID-AJMG11>3.3.CO,2-1.;WRIGHT EMMB, 2011, AM J HUM GENET, V88, P767, DOI 10.1016/J.AJHG.2011.05.007.;ZLOTOGORA J, 1990, AM J MED GENET, V36, P269, DOI 10.1002/AJMG.1320360303.","VINCENT, AL (REPRINT AUTHOR), UNIV AUCKLAND, FMHS, DEPT OPHTHALMOL, PRIVATE BAG 92019, AUCKLAND 1, NEW ZEALAND.;VINCENT, ANDREA L., JORDAN, CHARLOTTE A., MCGHEE, CHARLES N., UNIV AUCKLAND, NEW ZEALAND NATL EYE CTR, DEPT OPHTHALMOL, AUCKLAND 1, NEW ZEALAND.;VINCENT, ANDREA L., JORDAN, CHARLOTTE A., MCGHEE, CHARLES N., AUCKLAND DIST HLTH BOARD, GREENLANE CLIN CTR, EYE DEPT, AUCKLAND, NEW ZEALAND.;CADZOW, MURRAY J., MERRIMAN, TONY R., UNIV OTAGO, DEPT BIOCHEM, DUNEDIN, NEW ZEALAND.","10.1167/IOVS.14-14532","12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA",NA,NA,"SAVE SIGHT SOCIETY OF NEW ZEALAND, MAURICE AND PHYLLIS PAYKEL TRUST, AUCKLAND MEDICAL RESEARCH FOUNDATION","SUPPORTED BY THE SAVE SIGHT SOCIETY OF NEW ZEALAND, THE MAURICE AND PHYLLIS PAYKEL TRUST, AND THE AUCKLAND MEDICAL RESEARCH FOUNDATION.",NA,"0146-0404","9","5629-5635","ASSOC RESEARCH VISION OPHTHALMOLOGY INC","55",2014,"ISI000343146900020","39","OPHTHALMOLOGY","1","OPHTHALMOLOGY","A.VINCENTAUCKLAND.AC.NZ",NA,"AQ9DX",NA,"VINCENT, AL (REPRINT AUTHOR), UNIV AUCKLAND, FMHS, DEPT OPHTHALMOL, PRIVATE BAG 92019, AUCKLAND 1, NEW ZEALAND","ISI","UNIV AUCKLAND;GREENLANE CLIN CTR;UNIV OTAGO","UNIV AUCKLAND",NA,"VINCENT AL, 2014, INVEST OPHTHALMOL VIS SCI","VINCENT AL, 2014, INVEST OPHTHALMOL VIS SCI"
"OZER EA, 2014, BMC GENOMICS","OZER EA;ALLEN JP;HAUSER AR","CHARACTERIZATION OF THE CORE AND ACCESSORY GENOMES OF PSEUDOMONAS AERUGINOSA USING BIOINFORMATIC TOOLS SPINE AND AGENT","BMC GENOMICS","BMC GENOMICS","BACKGROUND: PSEUDOMONAS AERUGINOSA IS AN IMPORTANT OPPORTUNISTIC PATHOGEN RESPONSIBLE FOR MANY INFECTIONS IN HOSPITALIZED AND IMMUNOCOMPROMISED PATIENTS. PREVIOUS REPORTS ESTIMATED THAT APPROXIMATELY 10\% OF ITS 6.6 MBP GENOME VARIES FROM STRAIN TO STRAIN AND IS THEREFORE REFERRED TO AS ``ACCESSORY GENOME''. ELEMENTS WITHIN","PSEUDOMONAS AERUGINOSA; CORE GENOME; ACCESSORY GENOME; COMPARATIVE GENOMICS; SPINE; AGENT; WHOLE-GENOME SEQUENCING","METALLO-BETA-LACTAMASE; III PROTEIN SECRETION; MICROBIAL PAN-GENOME; INTENSIVE-CARE-UNIT; PATHOGENICITY ISLANDS; BACTERIAL GENOMES; POPULATION GENOMICS; CLINICAL-OUTCOMES; SPECIES CONCEPT; IN-SILICO","ENGLISH","ARTICLE","ARTICLE",38,"AGUILAR-BARAJAS E, 2010, PSEUDOMONAS, VOL 6: MOLECULAR MICROBIOLOGY, INFECTION AND BIODIVERSITY, P255, DOI 10.1007/978-90-481-3909-5\_9.;ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/NAR/25.17.3389.;AZIZ RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75.;BATTLE SE, 2009, FEMS MICROBIOL LETT, V290, P70, DOI 10.1111/J.1574-6968.2008.01406.X.;BENTLEY S, 2009, NAT REV MICROBIOL, V7, P258, DOI 10.1038/NRMICRO2123.;BEZUIDT OKI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-416.;BI DX, 2012, NUCLEIC ACIDS RES, V40, PD621, DOI 10.1093/NAR/GKR846.;BODEY GP, 1983, REV INFECT DIS, V5, P279.;BOISVERT S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/CMB.2009.0238.;BROEKHUIJSEN M, 2003, J CLIN MICROBIOL, V41, P2924, DOI 10.1128/JCM.41.7.2924-2931.2003.;CAMACHO C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421.;CAMPOS-GARCIA J, 2010, PSEUDOMONAS, VOL 6: MOLECULAR MICROBIOLOGY, INFECTION AND BIODIVERSITY, P235, DOI 10.1007/978-90-481-3909-5\_8.;CHAIN PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/SCIENCE.1180614.;CHAN JZM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-302.;CHIAPELLO H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-171.;CHIAPELLO H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-498.;CHUN J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/PNAS.0907787106.;DANTAS G, 2008, SCIENCE, V320, P100, DOI 10.1126/SCIENCE.1155157.;DELCHER AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/NAR/30.11.2478.;DEN BAKKER HC, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0067511.;DETTMAN JR, 2013, P NATL ACAD SCI USA, V110, P21065, DOI 10.1073/PNAS.1307862110.;DI NOCERA PP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-224.;DOBRINDT U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/NRMICRO884.;EDGAR RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/BIOINFORMATICS/BTQ461.;EL-SOLH AA, 2012, CRIT CARE MED, V40, P1157, DOI 10.1097/CCM.0B013E3182377906.;FAGON JY, 1989, AM REV RESPIR DIS, V139, P877, DOI 10.1164/AJRCCM/139.4.877.;FELTMAN H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659.;FERRARA S, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0036553.;FINCKBARBANCON V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/J.1365-2958.1997.4891851.X.;GOEBEL BM, 1994, APPL ENVIRON MICROB, V60, P1614.;GORIS J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/IJS.0.64483-0.;HAUSER AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005.;HE JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/PNAS.0304622101.;HENTSCHEL U, 2001, MICROBES INFECT, V3, P545, DOI 10.1016/S1286-4579(01)01410-1.;HOWELL HA, 2013, MBIO, V4.;HSIAO W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/BIOINFORMATICS/BTG004.;IMPERI F, 2011, IUBMB LIFE, V63, P1068, DOI 10.1002/IUB.531.;JACOBS F, 2007, CLIN MICROBIOL INFEC, V13.;JARVIS WR, 2003, P C C I D, V7, P153.;JUHAS M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/J.1574-6976.2008.00136.X.;KIIL K, 2008, PSEUDOMONAS MODEL OR, V1, P1.;KINGSFORD C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21.;KITTICHOTIRAT W, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0022420.;KLOCKGETHER J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/FMICB.2011.00150.;KUNG VL, 2010, MICROBIOL MOL BIOL R, V74, P621, DOI 10.1128/MMBR.00027-10.;KURTZ S, 2004, GENOME BIOL, V5, DOI 10.1186/GB-2004-5-2-R12.;LAING C, 2011, INFECT GENET EVOL, V11, P2151, DOI 10.1016/J.MEEGID.2011.09.021.;LAING C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-461.;LANGILLE MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/BIOINFORMATICS/BTP030.;LANGILLE MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329.;LAWRENCE JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158.;LEE DG, 2006, GENOME BIOL, V7, DOI 10.1186/GB-2006-7-10-R90.;LINDSAY JODI A., 2006, FUNCTIONAL \& INTEGRATIVE GENOMICS, V6, P186, DOI 10.1007/S10142-005-0019-7.;LIU PV, 1966, J INFECT DIS, V116, P112, DOI 10.1093/INFDIS/116.1.112.;LUKJANCENKO O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/S00248-010-9717-3.;MATHEE K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/PNAS.0711982105.;MATZ C, 2008, ISME J, V2, P843, DOI 10.1038/ISMEJ.2008.47.;MEDINI D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/J.GDE.2005.09.006.;MORALES-ESPINOSA R, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0037459.;NICAS TI, 1985, CAN J MICROBIOL, V31, P387, DOI 10.1139/M85-074.;OBRITSCH MD, 2004, ANTIMICROB AGENTS CH, V48, P4606, DOI 10.1128/AAC.48.12.4606-4610.2004.;OU HY, 2007, NUCLEIC ACIDS RES, V35, PW97, DOI 10.1093/NAR/GKM380.;OZEN AI, 2012, MICROB ECOL, V63, P239, DOI 10.1007/S00248-011-9914-8.;PIER G. B., 2010, PRINCIPLES PRACTICE, V2, P2835.;PUKATZKI S, 2002, P NATL ACAD SCI USA, V99, P3159, DOI 10.1073/PNAS.052704399.;RAKHIMOVA E, 2009, J INFECT DIS, V200, P1928, DOI 10.1086/648404.;RICCIO ML, 2005, ANTIMICROB AGENTS CH, V49, P104, DOI 10.1128/AAC.49.1.104-110.2005.;RICHTER M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/PNAS.0906412106.;RILEY MARGARET A., 2009, V532, P367, DOI 10.1007/978-1-60327-853-9\_21.;ROY PH, 2010, PLOS ONE, V5, PE8842.;ROY-BURMAN A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737.;SATO H, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0018356.;SCHULERT GS, 2003, J INFECT DIS, V188.;SERRES MH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-46.;SHAO YC, 2010, NUCLEIC ACIDS RES, V38, PW194, DOI 10.1093/NAR/GKQ326.;SHAVER CM, 2004, INFECT IMMUN, V72, P6969, DOI 10.1128/IAI.72.12.6969-6977.2004.;SHAVER CM, 2006, MICROBIOL-SGM, V152, P143, DOI 10.1099/MIC.0.28368-0.;SHEN K, 2006, INFECT IMMUN, V74, P5272, DOI 10.1128/IAI.00546-06.;SIARKOU VI, 2009, ANTIMICROB AGENTS CH, V53, P1325, DOI 10.1128/AAC.01230-08.;SILBY MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/J.1574-6976.2011.00269.X.;SOARES SC, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0030848.;SPENCER DH, 2003, J BACTERIOL, V185, P1316, DOI 10.1128/JB.185.4.1316-1325.2003.;STALEY JT, 2006, PHILOS T R SOC B, V361, P1899, DOI 10.1098/RSTB.2006.1914.;STOTHARD P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/BIOINFORMATICS/BTI054.;STOVER CK, 2000, NATURE, V406, P959.;SUI SJH, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0008094.;TATUSOV RL, 1997, SCIENCE, V278, P631, DOI 10.1126/SCIENCE.278.5338.631.;TATUSOV RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/NAR/29.1.22.;TETTELIN H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/PNAS.0506758102.;TSAKRIS A, 2009, J CLIN MICROBIOL, V47, P3524, DOI 10.1128/JCM.01099-09.;TSENG SP, 2009, J ANTIMICROB CHEMOTH, V64, P1170, DOI 10.1093/JAC/DKP341.;TUMMLER B, 2006, PSEUDOMONAS, VOL 4: MOLECULAR BIOLOGY OF EMERGING ISSUES, P35.;VERNIKOS GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/BIOINFORMATICS/BTL369.;WAACK S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142.;WINSOR GL, 2011, NUCLEIC ACIDS RES, V39, PD596, DOI 10.1093/NAR/GKQ869.;WINSTANLEY C, 2009, GENOME RES, V19, P12, DOI 10.1101/GR.086082.108.;WOLFGANG MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/PNAS.0832438100.;WU DQ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-438.;ZHOU Y, 2011, NUCLEIC ACIDS RES, V39, PW347, DOI 10.1093/NAR/GKR485.","OZER, EA (REPRINT AUTHOR), NORTHWESTERN UNIV, DEPT MED, DIV INFECT DIS, 645 NORTH MICHIGAN AVE SUITE 900, CHICAGO, IL 60611 USA.;OZER, EGON A., HAUSER, ALAN R., NORTHWESTERN UNIV, DEPT MED, DIV INFECT DIS, CHICAGO, IL 60611 USA.;ALLEN, JONATHAN P., HAUSER, ALAN R., NORTHWESTERN UNIV, DEPT MICROBIOL IMMUNOL, CHICAGO, IL 60611 USA.","10.1186/1471-2164-15-737","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","737",NA,"AMERICAN CANCER SOCIETY [MRSG 13 220 01 - MPC], NATIONAL INSTITUTES OF HEALTH [F32AI089068, T32AI007476, F32AI108247-01, AI053674, AI075191, AI099269, AI04831, AI088286]","THE AUTHORS THANK MARK MANDEL AND SUDHIR PENUGONDA FOR DISCUSSIONS AND GUIDANCE. WE WOULD LIKE TO THANK LISA DESHONG SADZEWICZ, LUKE TALLON, AND STAFF AT THE UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE INSTITUTE FOR GENOME SCIENCES FOR NGS SEQUENCING, AS WELL AS SEBASTIEN BOISVERT AT THE UNIVERSITE LAVAL, QUEBEC, CANADA FOR ASSISTANCE WITH GENOMIC ASSEMBLY SOFTWARE. THESE STUDIES WERE SUPPORTED BY THE AMERICAN CANCER SOCIETY (MRSG 13 220 01 - MPC, E.O.) AND THE NATIONAL INSTITUTES OF HEALTH (F32AI089068 AND T32AI007476, E.O., T32AI007476 AND F32AI108247-01, J.P.A., AI053674, AI075191, AI099269, AI04831 AND AI088286, A.R.H.).",NA,"1471-2164",NA,NA,"BIOMED CENTRAL LTD","15",2014,"ISI000341041700002","99","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","19","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","E-OZERNORTHWESTERN.EDU",NA,"AO0ZO",NA,"OZER, EA (REPRINT AUTHOR), NORTHWESTERN UNIV, DEPT MED, DIV INFECT DIS, 645 NORTH MICHIGAN AVE SUITE 900, CHICAGO, IL 60611 USA","ISI","NORTHWESTERN UNIV;NORTHWESTERN UNIV","NORTHWESTERN UNIV",NA,"OZER EA, 2014, BMC GENOMICS","OZER EA, 2014, BMC GENOMICS"
"JANG HM, 2014, BMC GENOMICS","JANG HM;ERF GF;ROWLAND KC;KONG BW","GENOME RESEQUENCING AND BIOINFORMATIC ANALYSIS OF SNP CONTAINING CANDIDATE GENES IN THE AUTOIMMUNE VITILIGO SMYTH LINE CHICKEN MODEL","BMC GENOMICS","BMC GENOMICS","BACKGROUND: THE SMYTH LINE (SL) CHICKEN IS THE ONLY ANIMAL MODEL FOR AUTOIMMUNE VITILIGO THAT SPONTANEOUSLY DISPLAYS ALL CLINICAL AND BIOLOGICAL MANIFESTATIONS OF THE HUMAN DISORDER. TO UNDERSTAND THE GENETIC COMPONENTS UNDERLYING THE SUSCEPTIBILITY TO DEVELOP SL VITILIGO (SLV), WHOLE GENOME RESEQUENCING ANALYSIS WAS PERFORMED IN SLV CHICKENS COMPARED WITH NON-VITILIGINOUS PARENTAL BROWN LINE (BL) CHICKENS, WHICH MAINTAIN A VERY LOW INCIDENCE RATE OF VITILIGO. RESULTS: ILLUMINA SEQUENCING TECHNOLOGY AND REFERENCE BASED ASSEMBLY ON RED JUNGLE FOWL GENOME SEQUENCES WERE USED. RESULTS OF GENOME RESEQUENCING OF POOLED DNA OF EACH 10 BL AND SL CHICKENS REACHED 5.1X AND 7.0X COVERAGE, RESPECTIVELY. THE TOTAL NUMBER OF SNPS WAS 4.8 AND 5.5 MILLION IN BL AND SL GENOME, RESPECTIVELY. THROUGH A SERIES OF FILTERING PROCESSES, A TOTAL OF SIMILAR TO 1 MILLION UNIQUE SNPS WERE FOUND IN THE SL ALONE. EVENTUALLY OF THE 156 RELIABLE MARKER SNPS, WHICH CAN INDUCE NON-SYNONYMOUS-, FRAMESHIFT-, NONSENSE-, AND NO-START MUTATIONS IN AMINO ACID SEQUENCES IN PROTEINS, 139 GENES WERE CHOSEN FOR FURTHER ANALYSIS. OF THESE, 14 RANDOMLY CHOSEN SNPS WERE EXAMINED FOR SNP VERIFICATION BY PCR AND SANGER SEQUENCING TO DETECT SNP POSITIONS IN 20 BL AND 70 SL CHICKENS. THE RESULTS OF THE ANALYSIS OF THE 14 SNPS CLEARLY SHOWED DIFFERENTIAL FREQUENCIES OF NUCLEOTIDE BASES IN THE SNP POSITIONS BETWEEN BL AND SL CHICKENS. BIOINFORMATIC ANALYSIS SHOWED THAT THE 156 MOST RELIABLE MARKER SNPS INCLUDED GENES INVOLVED IN DERMATOLOGICAL DISEASES/CONDITIONS SUCH AS ADAMTS13, ASPM, ATP6V0A2, BRCA2, COL12A1, GRM5, LRP2, OBSCN, PLAU, RNF168, STAB2, AND XIRP1. INTERMOLECULAR GENE NETWORK ANALYSIS REVEALED THAT CANDIDATE GENES IDENTIFIED IN SLV PLAY A ROLE IN NETWORKS CENTERED ON PROTEIN KINASES (MAPK, ERK1/2, PKC, PRKDC), PHOSPHATASE (PPP1CA), UBIQUITINYLATION (UBC) AND AMYLOID PRODUCTION (APP). CONCLUSIONS: VARIOUS POTENTIAL GENETIC MARKERS SHOWING AMINO ACID CHANGES AND POTENTIAL ROLES IN VITILIGO DEVELOPMENT WERE IDENTIFIED IN THE SLV CHICKEN THROUGH GENOME RESEQUENCING. THE GENETIC MARKERS AND BIOINFORMATIC INTERPRETATIONS OF AMINO ACID MUTATIONS FOUND IN SLV CHICKENS MAY PROVIDE INSIGHT INTO THE GENETIC COMPONENT RESPONSIBLE FOR THE ONSET AND THE PROGRESSION OF AUTOIMMUNE VITILIGO AND SERVE AS VALUABLE MARKERS TO DEVELOP DIAGNOSTIC TOOLS TO DETECT VITILIGO SUSCEPTIBILITY.",NA,"SYSTEMIC-LUPUS-ERYTHEMATOSUS; CHINESE HAN POPULATION; GENERALIZED VITILIGO; WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; SIGNALING PATHWAY; IN-VIVO; PROTEIN; DNA; MUTATIONS","ENGLISH","ARTICLE","ARTICLE",4,"BAATEN BAS JG, 2010, COMMUN INTEGR BIOL, V3, P508, DOI 10.4161/CIB.3.6.13495.;BALAKRISHNAN A, 2007, CANCER RES, V67, P3545, DOI 10.1158/0008-5472.CAN-07-0065.;BOISSY RE, 1988, DERMATOL CLIN, V6, P161, DOI 10.1016/S0733-8635(18)30663-6.;BOISSY RE, 1986, J INVEST DERMATOL, V86, P149, DOI 10.1111/1523-1747.EP12284190.;BOLON I, 2004, AM J PATHOL, V164, P2299, DOI 10.1016/S0002-9440(10)63786-8.;BOWERS RR, 1999, CELL MOL BIOL, V45, P1065.;CHAN DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/GAD.1015202.;CHEONG KA, 2013, J KOREAN MED SCI, V28, P775, DOI 10.3346/JKMS.2013.28.5.775.;CHOI KY, 2011, P NATL ACAD SCI USA, V108, P15219, DOI 10.1073/PNAS.1107304108.;COLLAND F, 2004, GENOME RES, V14, P1324, DOI 10.1101/GR.2334104.;COLLINGWOOD TS, 2007, J BIOL CHEM, V282, P30920, DOI 10.1074/JBC.M706870200.;COTSAPAS C, 2013, TRENDS IMMUNOL, V34, P22, DOI 10.1016/J.IT.2012.09.001.;DANIELSEN JM, 2011, MOL CELL PROTEOMICS, V10, PM110, DOI DOI 10.1074/MCP.M110.003590.;ERF GF, 2010, VITILIGO, P205, DOI 10.1007/978-3-540-69361-1\_2.2.4.;ERF GF, 2008, AVIAN IMMUNOLOGY, P339, DOI 10.1016/B978-012370634-8.50021-4.;EUDY JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/SCIENCE.280.5370.1753.;GATEVA V, 2009, NAT GENET, V41, P1228, DOI 10.1038/NG.468.;HENDRICKX A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/J.CHEMBIOL.2009.02.012.;HINDORFF LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/PNAS.0903103106.;JENSEN RB, 2010, NATURE, V467, P678, DOI 10.1038/NATURE09399.;JIN Y, 2012, NAT GENET, V44, P676, DOI 10.1038/NG.2272.;JIN Y, 2012, J INVEST DERMATOL, V132, P1730, DOI 10.1038/JID.2012.37.;JIN Y, 2011, J INVEST DERMATOL, V131, P1308, DOI 10.1038/JID.2011.12.;KATO H, 2006, NATURE, V441, P101, DOI 10.1038/NATURE04734.;KIIAN I, 2003, THROMB HAEMOSTASIS, V89, P904.;KONG BW, 2011, BMC GENOMICS, V12.;KORNAK U, 2008, NAT GENET, V40, P32, DOI 10.1038/NG.2007.45.;KOUPRINA N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/HMG/DDI220.;LE POOLE IC, 2008, CURRENT DIRECTIONS A, V22, P566.;LEE KA, 2011, J BIOL CHEM, V286, P41530, DOI 10.1074/JBC.M111.248856.;LI YH, 2010, J INVEST DERMATOL, V130, P2768, DOI 10.1038/JID.2010.214.;MARTINEZ A, 2008, EUR J HUM GENET, V16, P861, DOI 10.1038/EJHG.2008.16.;MAURANO MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/SCIENCE.1222794.;MEDRANO EE, 1990, J INVEST DERMATOL, V95, P441.;MORI T, 2007, J BIOL CHEM, V282, P19884, DOI 10.1074/JBC.M700770200.;NIELSEN R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/NRG2986.;NIKOLAEV SI, 2012, NAT GENET, V44, P133, DOI 10.1038/NG.1026.;OLAH J, 2011, J BIOL CHEM, V286, P34088, DOI 10.1074/JBC.M111.243907.;OMRAN H, 2000, AM J RESP CELL MOL, V23, P696, DOI 10.1165/AJRCMB.23.5.4257.;OTTEN C, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0031041.;PATEL KG, 2001, J NEUROSCI, V21, P7954.;PIMANDA JE, 2004, BLOOD, V103, P627, DOI 10.1182/BLOOD-2003-04-1346.;RAMOS PS, 2011, ARTHRITIS RHEUM-US, V63, P2049, DOI 10.1002/ART.30356.;SHI F, 2012, BMC IMMUNOL, V13.;SMYTH DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/NG1800.;SPOELGEN R, 2005, DEVELOPMENT, V132, P405, DOI 10.1242/DEV.01580.;SPRITZ RA, 2012, J INVEST DERMATOL, V132, P268, DOI 10.1038/JID.2011.321.;SPRITZ RICHARD A, 2011, J INVEST DERMATOL, V131, PE18, DOI 10.1038/SKINBIO.2011.7.;STEWART GS, 2009, CELL, V136, P420, DOI 10.1016/J.CELL.2008.12.042.;SUTHERLAND A, 2007, J CLIN ENDOCR METAB, V92, P3338, DOI 10.1210/JC.2007-0173.;TAMURA Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/JBC.M210211200.;TANG J, 2013, MOL BIOL REP, V40, P4097, DOI 10.1007/S11033-013-2491-9.;TANG XF, 2013, J INVEST DERMATOL, V133, P403, DOI 10.1038/JID.2012.320.;THE BREAST CANCER LINKAGE CONSORTIUM. CANCER RISKS IN BRCA2 MUTATION CARRIERS, 1999, J NATL CANCER I, V91, P1310, DOI DOI 10.1093/JNCI/91.15.1310.;UDESHI ND, 2012, MOL CELL PROTEOMICS, V11, P148, DOI 10.1074/MCP.M111.016857.;WAGNER S.A., 2011, MOL CELL PROTEOMICS, V10.;WAGNER SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/MCP.M112.017905.;ZARIWALA MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/ANNUREV.PHYSIOL.69.040705.141301.","KONG, BW (REPRINT AUTHOR), UNIV ARKANSAS, CTR EXCELLENCE POULTRY SCI, DEPT POULTRY SCI, POSC O-404,1260 WEST MAPLE, FAYETTEVILLE, AR 72701 USA.;JANG, HYEON-MIN, ERF, GISELA F., ROWLAND, KAYLEE C., KONG, BYUNG-WHI, UNIV ARKANSAS, CTR EXCELLENCE POULTRY SCI, DEPT POULTRY SCI, FAYETTEVILLE, AR 72701 USA.","10.1186/1471-2164-15-707","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","707",NA,"ARKANSAS BIOSCIENCE INSTITUTE, ARKANSAS AGRICULTURAL EXPERIMENTAL STATION","THIS WORK WAS SUPPORTED BY ARKANSAS BIOSCIENCE INSTITUTE AND ARKANSAS AGRICULTURAL EXPERIMENTAL STATION.",NA,"1471-2164",NA,NA,"BIOMED CENTRAL LTD","15",2014,"ISI000341039500004","58","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","29","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","BKONGUARK.EDU",NA,"AO0YS",NA,"KONG, BW (REPRINT AUTHOR), UNIV ARKANSAS, CTR EXCELLENCE POULTRY SCI, DEPT POULTRY SCI, POSC O-404,1260 WEST MAPLE, FAYETTEVILLE, AR 72701 USA","ISI","UNIV ARKANSAS","UNIV ARKANSAS",NA,"JANG HM, 2014, BMC GENOMICS","JANG HM, 2014, BMC GENOMICS"
"SKEWES-COX P, 2014, PLOS ONE","SKEWES COX P;SHARPTON TJ;POLLARD KS;DERISI JL","PROFILE HIDDEN MARKOV MODELS FOR THE DETECTION OF VIRUSES WITHIN METAGENOMIC SEQUENCE DATA","PLOS ONE","PLOS ONE","RAPID, SENSITIVE, AND SPECIFIC VIRUS DETECTION IS AN IMPORTANT COMPONENT OF CLINICAL DIAGNOSTICS. MASSIVELY PARALLEL SEQUENCING ENABLES NEW DIAGNOSTIC OPPORTUNITIES THAT COMPLEMENT TRADITIONAL SEROLOGICAL AND PCR BASED TECHNIQUES. WHILE MASSIVELY PARALLEL SEQUENCING PROMISES THE BENEFITS OF BEING MORE COMPREHENSIVE AND LESS BIASED THAN TRADITIONAL APPROACHES, IT PRESENTS NEW ANALYTICAL CHALLENGES, ESPECIALLY WITH RESPECT TO DETECTION OF PATHOGEN SEQUENCES IN METAGENOMIC CONTEXTS. TO A FIRST APPROXIMATION, THE INITIAL DETECTION OF VIRUSES CAN BE ACHIEVED SIMPLY THROUGH ALIGNMENT OF SEQUENCE READS OR ASSEMBLED CONTIGS TO A REFERENCE DATABASE OF PATHOGEN GENOMES WITH TOOLS SUCH AS BLAST. HOWEVER, RECOGNITION OF HIGHLY DIVERGENT VIRAL SEQUENCES IS PROBLEMATIC, AND MAY BE FURTHER COMPLICATED BY THE INHERENTLY HIGH MUTATION RATES OF SOME VIRAL TYPES, ESPECIALLY RNA VIRUSES. IN THESE CASES, INCREASED SENSITIVITY MAY BE ACHIEVED BY LEVERAGING POSITION-SPECIFIC INFORMATION DURING THE ALIGNMENT PROCESS. HERE, WE CONSTRUCTED HMMER3-COMPATIBLE PROFILE HIDDEN MARKOV MODELS (PROFILE HMMS) FROM ALL THE VIRALLY ANNOTATED PROTEINS IN REFSEQ IN AN AUTOMATED FASHION USING A CUSTOM-BUILT BIOINFORMATIC PIPELINE. WE THEN TESTED THE ABILITY OF THESE VIRAL PROFILE HMMS (''VFAMS'') TO ACCURATELY CLASSIFY SEQUENCES AS",NA,"PROTEIN FAMILIES DATABASE; HOMOLOGY DETECTION; IDENTIFICATION; ALIGNMENT; VIROLOGY; ILLNESS; TRENDS; GENE; RNA","ENGLISH","ARTICLE","ARTICLE",35,"ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;BACCHETTI S, 1986, J VIROL, V57, P1177.;BEXFIELD N, 2010, VET J.;BOYER M, 2011, P NATL ACAD SCI USA, V108, P10296, DOI 10.1073/PNAS.1101118108.;BRENNER SE, 1998, P NATL ACAD SCI USA, V95, P6073, DOI 10.1073/PNAS.95.11.6073.;CAPOBIANCHI MR, 2013, CLIN MICROBIOL INFEC, V19, P15, DOI 10.1111/1469-0691.12056.;DELWART EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/RMV.532.;DONG J, 2008, J MOL DIAGN, V10, P185, DOI 10.2353/JMOLDX.2008.070063.;DUCKETT CS, 1996, EMBO J, V15, P2685, DOI 10.1002/J.1460-2075.1996.TB00629.X.;EDDY SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/BIOINFORMATICS/14.9.755.;EDGAR RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/NAR/GKH340.;ENRIGHT AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/NAR/30.7.1575.;ESPAGNE E, 2004, SCIENCE, V306, P286, DOI 10.1126/SCIENCE.1103066.;FELIX MA, 2011, PLOS BIOL, V9, DOI 10.1371/JOURNAL.PBIO.1000586.;FINN RD, 2008, NUCLEIC ACIDS RES, V36, PD281, DOI 10.1093/NAR/GKM960.;FINN RD, 2011, NUCLEIC ACIDS RES, V39, PW29, DOI 10.1093/NAR/GKR367.;FINN RD, 2010, NUCLEIC ACIDS RES, V38, PD211, DOI 10.1093/NAR/GKP985.;GRENINGER AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82.;IWAMOTO T, 2001, J GEN VIROL, V82, P2653, DOI 10.1099/0022-1317-82-11-2653.;JONES KE, 2008, NATURE, V451, P990, DOI 10.1038/NATURE06536.;KELLAM P, 1998, TRENDS MICROBIOL, V6, P160, DOI 10.1016/S0966-842X(98)01239-6.;KISTLER AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88.;KRISHNAMURTHY N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S12.;LANGMEAD B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/NMETH.1923].;LANGMEAD B, 2009, GENOME BIOL, V10, DOI 10.1186/GB-2009-10-3-R25.;LI WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/BIOINFORMATICS/BTL158.;LIPKIN WI, 2010, MICROBIOL MOL BIOL R, V74, P363, DOI 10.1128/MMBR.00007-10.;MADERA M, 2002, NUCLEIC ACIDS RES, V30, P4321, DOI 10.1093/NAR/GKF544.;PARK J, 1998, J MOL BIOL, V284, P1201, DOI 10.1006/JMBI.1998.2221.;PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/PNAS.85.8.2444.;PRESTON VG, 1984, VIROLOGY, V138, P58, DOI 10.1016/0042-6822(84)90147-8.;PRUITT KD, 2009, NUCLEIC ACIDS RES, V37, PD32, DOI 10.1093/NAR/GKN721.;RADFORD AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/VIR.0.043182-0.;REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/SCIENCE.8511586.;RUBY JG, 2013, PRICE SOFTWARE TARGE.;RUNCKEL C, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0020656.;SJOLANDER K, 1996, COMPUT APPL BIOSCI, V12, P327.;SODING J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/BIOINFORMATICS/BTI125.;STENGLEIN MD, 2012, MBIO, V3, DOI 10.1128/MBIO.00180-12.;SUETAKE T, 2000, J BIOL CHEM, V275, P17929, DOI 10.1074/JBC.C000184200.;WANG D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/JOURNAL.PBIO.0000002.;WOOLHOUSE MEJ, 2008, P ROY SOC B-BIOL SCI, V275, P2111, DOI 10.1098/RSPB.2008.0294.;YAMASHITA T, 1998, J VIROL, V72, P8408.;YOZWIAK NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/JOURNAL.PNTD.0001485.;YOZWIAK NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10.","DERISI, JL (REPRINT AUTHOR), UNIV CALIF SAN FRANCISCO, DEPT MED BIOCHEM \& BIOPHYS, SAN FRANCISCO, CA 94143 USA.;SKEWES-COX, PETER, UNIV CALIF SAN FRANCISCO, BIOL \& MED INFORMAT GRAD PROGRAM, SAN FRANCISCO, CA 94143 USA.;SKEWES-COX, PETER, DERISI, JOSEPH L., UNIV CALIF SAN FRANCISCO, DEPT MED BIOCHEM \& BIOPHYS, SAN FRANCISCO, CA 94143 USA.;SKEWES-COX, PETER, DERISI, JOSEPH L., UNIV CALIF SAN FRANCISCO, DEPT MICROBIOL, SAN FRANCISCO, CA 94143 USA.;SHARPTON, THOMAS J., POLLARD, KATHERINE S., UNIV CALIF SAN FRANCISCO, J DAVID GLADSTONE INST, SAN FRANCISCO, CA 94143 USA.;POLLARD, KATHERINE S., UNIV CALIF SAN FRANCISCO, INST HUMAN GENET, SAN FRANCISCO, CA 94143 USA.;POLLARD, KATHERINE S., UNIV CALIF SAN FRANCISCO, DIV BIOSTAT, SAN FRANCISCO, CA 94143 USA.;SKEWES-COX, PETER, DERISI, JOSEPH L., HOWARD HUGHES MED INST, BETHESDA, MD 20817 USA.","10.1371/JOURNAL.PONE.0105067","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E105067",NA,"HOWARD HUGHES MEDICAL INSTITUTE, GORDON AND BETTY MOORE FOUNDATION [1660, 3300], NATIONAL SCIENCE FOUNDATION [DMS-1069303], GLADSTONE INSTITUTES, SCLERODERMA RESEARCH FOUNDATION, PHRMA FOUNDATION PRE-DOCTORAL BIOINFORMATICS FELLOWSHIP PROGRAM","THIS WORK WAS SUPPORTED BY THE HOWARD HUGHES MEDICAL INSTITUTE (JLD), THE GORDON AND BETTY MOORE FOUNDATION (GRANTS \#1660 AND \#3300), THE NATIONAL SCIENCE FOUNDATION (GRANT \#DMS-1069303), AND GLADSTONE INSTITUTES (KSP, TJS), THE SCLERODERMA RESEARCH FOUNDATION AND THE PHRMA FOUNDATION PRE-DOCTORAL BIOINFORMATICS FELLOWSHIP PROGRAM (PS-C). THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT.",NA,"1932-6203","8",NA,"PUBLIC LIBRARY SCIENCE","9",2014,"ISI000342687200049","45","SCIENCE \& TECHNOLOGY - OTHER TOPICS","5","MULTIDISCIPLINARY SCIENCES","JOEDERISILAB.UCSF.EDU",NA,"AQ3JB",NA,"DERISI, JL (REPRINT AUTHOR), UNIV CALIF SAN FRANCISCO, DEPT MED BIOCHEM \& BIOPHYS, SAN FRANCISCO, CA 94143 USA","ISI","UNIV CALIF SAN FRANCISCO;UNIV CALIF SAN FRANCISCO;UNIV CALIF SAN FRANCISCO;UNIV CALIF SAN FRANCISCO;UNIV CALIF SAN FRANCISCO;UNIV CALIF SAN FRANCISCO;HOWARD HUGHES MED INST","UNIV CALIF SAN FRANCISCO",NA,"SKEWES-COX P, 2014, PLOS ONE","SKEWES-COX P, 2014, PLOS ONE"
"MAEBERT K, 2014, INT J RADIAT BIOL","MAEBERT K;COJOC M;PEITZSCH C;KURTH I;SOUCHELNYTSKYI S;DUBROVSKA A","CANCER BIOMARKER DISCOVERY: CURRENT STATUS AND FUTURE PERSPECTIVES","INTERNATIONAL JOURNAL OF RADIATION BIOLOGY","INT. J. RADIAT. BIOL.","PURPOSE : CANCER IS A MULTIGENE DISEASE WHICH ARISES AS A RESULT OF MUTATIONAL AND EPIGENETIC CHANGES COUPLED WITH ACTIVATION OF COMPLEX SIGNALING NETWORKS. THE USE OF BIOMARKERS FOR EARLY CANCER DETECTION, STAGING AND INDIVIDUALIZATION OF THERAPY MIGHT IMPROVE PATIENT CARE. A FEW FUNDAMENTAL ISSUES SUCH AS TUMOR HETEROGENEITY, A HIGHLY DYNAMIC NATURE OF THE INTRINSIC AND EXTRINSIC DETERMINANTS OF RADIO-AND CHEMORESISTANCE, ALONG WITH THE PLASTICITY AND DIVERSITY OF CANCER STEM CELLS (CSC) MAKE BIOMARKER DEVELOPMENT A CHALLENGING TASK. IN THIS REVIEW WE OUTLINE THE PRECLINICAL STRATEGIES OF CANCER BIOMARKER DISCOVERY INCLUDING GENOMIC, PROTEOMIC, METABOLOMIC AND MICRORNOMIC PROFILING, COMPARATIVE GENOME HYBRIDIZATION (CGH), SINGLE NUCLEOTIDE POLYMORPHISM (SNP) ANALYSIS, HIGH THROUGHPUT SCREENING (HTS) AND NEXT GENERATION SEQUENCING (NGS). OTHER PROMISING APPROACHES SUCH AS ASSESSMENT OF CIRCULATING TUMOR CELLS (CTC), ANALYSIS OF CSC-SPECIFIC MARKERS AND CELL-FREE CIRCULATING TUMOR DNA (CTDNA) ARE ALSO DISCUSSED. CONCLUSIONS : THE EMERGENCE OF POWERFUL PROTEOMIC AND GENOMIC TECHNOLOGIES IN CONJUNCTION WITH ADVANCED BIOINFORMATIC TOOLS ALLOWS THE SIMULTANEOUS ANALYSIS OF THOUSANDS OF BIOLOGICAL MOLECULES. THESE TECHNIQUES YIELD THE DISCOVERY OF NEW TUMOR SIGNATURES, WHICH ARE SENSITIVE AND SPECIFIC ENOUGH FOR EARLY CANCER DETECTION, FOR MONITORING DISEASE PROGRESSION AND FOR PROPER TREATMENT SELECTION, PAVING THE WAY TO INDIVIDUALIZED CANCER TREATMENT.","GENE EXPRESSION; RADIOSENSITIVITY; GENE THERAPY; GENOMIC INSTABILITY; CELLULAR RADIOBIOLOGY; CLINICAL RADIOBIOLOGY","COMPARATIVE GENOMIC HYBRIDIZATION; CIRCULATING TUMOR-CELLS; ACUTE MYELOID-LEUKEMIA; HUMAN PROSTATE-CANCER; DOUBLE-STRAND BREAKS; STEM-CELLS; COLORECTAL-CANCER; LUNG-CANCER; NASOPHARYNGEAL CARCINOMA; RADIATION-THERAPY","ENGLISH","ARTICLE","ARTICLE",37,"ABHOLD EL, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0032459.;ABRAMYUK A, 2009, RADIOTHER ONCOL, V91, P399, DOI 10.1016/J.RADONC.2009.01.003.;AERTS HJWL, 2009, RADIOTHER ONCOL, V91, P386, DOI 10.1016/J.RADONC.2009.03.006.;AKIYOSHI T, 2012, SURG TODAY, V42, P713, DOI 10.1007/S00595-012-0223-8.;AKTAS B, 2009, BREAST CANCER RES, V11, DOI 10.1186/BCR2333.;ALISON MR, 2012, CANCER TREAT REV, V38, P589, DOI 10.1016/J.CTRV.2012.03.003.;AMUNDADOTTIR LT, 2006, NAT GENET, V38, P652, DOI 10.1038/NG1808.;ARMITAGE EG, 2014, J PHARMACEUT BIOMED, V87, P1, DOI 10.1016/J.JPBA.2013.08.041.;ARMSTRONG AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490.;ASHWORTH A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/CSHPERSPECT.A003327.;ATTARHA S, 2013, BRIT J CANCER, V109, P704, DOI 10.1038/BJC.2013.359.;BACCELLI I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/NBT.2576.;BACCELLI I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/JCB.201202014.;BAUMANN M, 2003, INT J RADIAT BIOL, V79, P547, DOI 10.1080/0955300031000112839.;BAUMANN M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/NRC2419.;BEA S, 2013, P NATL ACAD SCI USA, V110, P18250, DOI 10.1073/PNAS.1314608110.;BERG M, 2012, DISCOV MED, V14, P207.;BERNS K, 2007, CANCER CELL, V12, P395, DOI 10.1016/J.CCR.2007.08.030.;BIBAULT JE, 2013, CANCER METAST REV, V32, P479, DOI 10.1007/S10555-013-9419-7.;BONNER JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMOA053422.;BONNET D, 1997, NAT MED, V3, P730, DOI 10.1038/NM0797-730.;BOTLING J, 2013, CLIN CANCER RES, V19, P194, DOI 10.1158/1078-0432.CCR-12-1139.;BRUMMELKAMP TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/NCHEMBIO774.;BRUNNER TB, 2012, SEMIN RADIAT ONCOL, V22, P151, DOI 10.1016/J.SEMRADONC.2011.12.003.;BUCHSTALLER J, 2012, CANCER CELL, V21, P240, DOI 10.1016/J.CCR.2011.12.027.;BUTOF R, 2013, RADIOTHER ONCOL, V108, P388, DOI 10.1016/J.RADONC.2013.06.002.;BUSH WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/JOURNAL.PCBI.1002822.;CAMPBELL PJ, 2010, NATURE, V467, P1109, DOI 10.1038/NATURE09460.;CARVALHO B, 2004, J CLIN PATHOL, V57, P644, DOI 10.1136/JCP.2003.013029.;CASHIN PH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-435.;CHAUDHRY MA, 2014, J CELL BIOCHEM, V115, P436, DOI 10.1002/JCB.24694.;CHEN K, 2013, ACTA PHARMACOL SIN, V34, P732, DOI 10.1038/APS.2013.27.;CONROTTO P., 2008, EXPERIMENTAL ONCOLOGY, V30, P171.;CUARON J, 2013, FRONT ONCOL, V2, DOI 10.3389/FONC.2012.00208.;DANG CV, 2012, GENE DEV, V26, P877, DOI 10.1101/GAD.189365.112.;DANILA DC, 2011, CANCER J, V17, P438, DOI 10.1097/PPO.0B013E31823E69AC.;DENG Q, 2012, CHEMOTHERAPY, V58, P445, DOI 10.1159/000345916.;DERISI JL, 1997, SCIENCE, V278, P680, DOI 10.1126/SCIENCE.278.5338.680.;DIAMANDIS EP, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-87.;DIAZ-CANO SJ, 2012, INT J MOL SCI, V13, P1951, DOI 10.3390/IJMS13021951.;DIEHN M, 2009, SEMIN RADIAT ONCOL, V19, P78, DOI 10.1016/J.SEMRADONC.2008.11.002.;DING L, 2012, STEM CELL REV REP, V8, P32, DOI 10.1007/S12015-011-9269-Z.;DUARTE CW, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0029653.;DUBROVSKA A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/PNAS.0810956106.;EHRLICH M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/SJ.ONC.1205651.;EICHHORN PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740.;EKE I, 2011, RADIOTHER ONCOL, V99, P271, DOI 10.1016/J.RADONC.2011.06.007.;EVANS SM, 2003, CANCER LETT, V195, P1, DOI 10.1016/S0304-3835(03)00012-0.;FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I.;FERRARINI M, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0071613.;FIRE A, 1998, NATURE, V391, P806, DOI 10.1038/35888.;FONG ELS, 2013, P NATL ACAD SCI USA, V110, P6500, DOI 10.1073/PNAS.1221403110.;FU SB, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0038465.;FUZERY AK, 2013, CLIN PROTEOM, V10, DOI 10.1186/1559-0275-10-13.;GERLINGER M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMOA1113205.;GINESTIER C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/J.STEM.2007.08.014.;GROSELJ B, 2013, BRIT J CANCER, V108, P748, DOI 10.1038/BJC.2013.21.;GROSSO S, 2013, CELL DEATH DIS, V4, DOI 10.1038/CDDIS.2013.71.;GUDMUNDSSON J, 2007, NAT GENET, V39, P977, DOI 10.1038/NG2062.;GUDMUNDSSON J, 2007, NAT GENET, V39, P631, DOI 10.1038/NG1999.;GUPTA PB, 2009, CELL, V138, P645, DOI 10.1016/J.CELL.2009.06.034.;GUPTA T, 2012, J NEURO-ONCOL, V109, P195, DOI 10.1007/S11060-012-0887-3.;HAIMAN CA, 2007, NAT GENET, V39, P638, DOI 10.1038/NG2015.;HEINRICHS S, 2007, GENOME BIOL, V8, DOI 10.1186/GB-2007-8-7-219.;HERMAN JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMRA023075.;HICKS C, 2011, CANCER INFORM, V10, P185, DOI 10.4137/CIN.S6837.;HIGGINS MJ, 2012, CLIN CANCER RES, V18, P3462, DOI 10.1158/1078-0432.CCR-11-2696.;HOEBEN BAW, 2013, ACTA ONCOL, V52, P1257, DOI 10.3109/0284186X.2013.812799.;HUGHES T, 2006, BLOOD, V108, P28, DOI 10.1182/BLOOD-2006-01-0092.;HWANG-VERSLUES WW, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0008377.;IDO T, 1978, J LABELLED COMPD RAD, V14, P175, DOI 10.1002/JLCR.2580140204.;IDRIS SF, 2013, EXPERT REV MOL DIAGN, V13, P167, DOI [10.1586/ERM.13.1, 10.1586/ERM.13.1].;IORNS E, 2008, CANCER CELL, V13, P91, DOI 10.1016/J.CCR.2008.01.001.;ISSAQ HJ, 2011, ELECTROPHORESIS, V32, P967, DOI 10.1002/ELPS.201000588.;JACOBSON O, 2011, THERANOSTICS, V1, P251, DOI 10.7150/THNO/V01P0251.;JACOBY MA, 2012, EXPERT REV MOL DIAGN, V12, P253, DOI [10.1586/ERM.12.18, 10.1586/ERM.12.18].;JANCIK S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/150960.;JANKOWITZ RC, 2011, BREAST CANCER RES, V13, DOI 10.1186/BCR3038.;KAKLAMANI V, 2006, EXPERT REV MOL DIAGN, V6, P803, DOI 10.1586/14737159.6.6.803.;KAMALAKARAN S, 2013, MOL ONCOL, V7, P743, DOI 10.1016/J.MOLONC.2013.04.008.;KANAGAL-SHAMANNA R, 2014, MODERN PATHOL, V27, P314, DOI 10.1038/MODPATHOL.2013.122.;KANG YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/J.CCR.2013.04.017.;KARLEY DUGESHWAR, 2011, WORLD J ONCOL, V2, P151, DOI 10.4021/WJON352W.;KASE M, 2011, RADIOTHER ONCOL, V101, P127, DOI 10.1016/J.RADONC.2011.06.024.;KHLEIF SN, 2010, CLIN CANCER RES, V16, P3299, DOI 10.1158/1078-0432.CCR-10-0880.;KIM H, 2004, J CLIN ONCOL, V22, P2363, DOI 10.1200/JCO.2004.10.077.;KIM JH, 2012, RADIAT RES, V178, P202, DOI 10.1667/RR2886.1.;KIM RJ, 2013, CANCER LETT, V333, P18, DOI 10.1016/J.CANLET.2012.11.026.;KLOTH JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-53.;KORKAYA H, 2013, CANCER RES, V73, P3489, DOI 10.1158/0008-5472.CAN-13-0260.;KRAUSE M, 2007, RADIOTHER ONCOL, V83, P316, DOI 10.1016/J.RADONC.2007.04.014.;KRESO A, 2013, SCIENCE, V339, P543, DOI 10.1126/SCIENCE.1227670.;KUHMANN C, 2011, RADIOTHER ONCOL, V101, P116, DOI 10.1016/J.RADONC.2011.05.048.;KUICK R, 2007, CANCER LETT, V249, P40, DOI 10.1016/J.CANLET.2006.12.032.;LAFRAMBOISE T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/NAR/GKP552.;LALLY BE, 2007, CANCER RES, V67, P8791, DOI 10.1158/0008-5472.CAN-07-0477.;LAM SW, 2014, CANCER TREAT REV, V40, P129, DOI 10.1016/J.CTRV.2013.06.006.;LAMMERING G, 2010, STRAHLENTHER ONKOL, V186, P471, DOI 10.1007/S00066-010-2150-1.;LEE P, 2013, INT J RADIAT ONCOL, V86, P609, DOI 10.1016/J.IJROBP.2013.01.009.;LI WT, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0033653.;LIU PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/NRD2926.;LIU R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMOA063994.;LIU SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388.;LIU XQ, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0054077.;LOMNYTSKA M, 2007, PROTEOM CLIN APPL, V1, P1090, DOI 10.1002/PRCA.200700179.;LUDWIG JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/NRC1739.;LUNDHOLM L, 2014, INT J RADIAT BIOL, V90, P718, DOI 10.3109/09553002.2014.905725.;MA L, 2013, FEBS J, V280, P2027, DOI 10.1111/FEBS.12226.;MADU CO, 2010, J CANCER, V1, P150.;MAHESWARAN S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/J.GDE.2009.12.002.;MAHIMKAR MB, 2012, MOL CARCINOGEN, V51, PE94, DOI 10.1002/MC.21868.;MANI SA, 2008, CELL, V133, P704, DOI 10.1016/J.CELL.2008.03.027.;MAO P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/PNAS.1221478110.;MEIJER TWH, 2012, CLIN CANCER RES, V18, P5585, DOI 10.1158/1078-0432.CCR-12-0858.;MELDRUM CLIFF, 2011, CLIN BIOCHEM REV, V32, P177.;MENEGAKIS A, 2011, RADIOTHER ONCOL, V100, P137, DOI 10.1016/J.RADONC.2011.07.001.;MENEGAKIS A, 2009, INT J RADIAT BIOL, V85, P1032, DOI 10.3109/09553000903242149.;MEYERSON M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/NRG2841.;MILLER MB, 2009, CLIN MICROBIOL REV, V22, P611, DOI 10.1128/CMR.00019-09.;MIQUELI AD, 2009, BRIT J CANCER, V100, P950, DOI 10.1038/SJ.BJC.6604943.;MISALE S, 2012, NATURE, V486, P532, DOI 10.1038/NATURE11156.;MISHRA ALOK, 2010, CANCERS (BASEL), V2, P190, DOI 10.3390/CANCERS2010190.;MOHR S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/ANNUREV-BIOCHEM-060408-092949.;MONETTI F, 2004, LUNG CANCER-J IASLC, V43, P71, DOI 10.1016/J.LUNGCAN.2003.07.005.;MOOK STELLA, 2007, CANCER GENOMICS \& PROTEOMICS, V4, P147.;NAKAO M, 2011, ONCOL REP, V25, P1603, DOI 10.3892/OR.2011.1246.;NARAYAN A, 2012, CANCER RES, V72, P3492, DOI 10.1158/0008-5472.CAN-11-4037.;NAVIN N, 2011, NATURE, V472, P90, DOI 10.1038/NATURE09807.;NOTTA F, 2011, NATURE, V469, P362, DOI 10.1038/NATURE09733.;OLIVIER M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/CSHPERSPECT.A001008.;PANTEL K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/NRC2375.;PANTEL K, 2013, CANCER RES, V73, P6384, DOI 10.1158/0008-5472.CAN-13-2030.;PEITZSCH C, 2014, INT J RADIAT BIOL, V90, P636, DOI 10.3109/09553002.2014.916841.;PEITZSCH C, 2013, RADIOTHER ONCOL, V108, P378, DOI 10.1016/J.RADONC.2013.06.003.;PETERSEN C, 2001, INT J RADIAT ONCOL, V51, P483, DOI 10.1016/S0360-3016(01)01686-8.;PIRNIA F, 2006, ANTICANCER RES, V26, P1765.;PISTOLLATO F, 2010, STEM CELLS, V28, P1918, DOI 10.1002/STEM.518.;PRAT A, 2012, NAT REV CLIN ONCOL, V9, P48, DOI 10.1038/NRCLINONC.2011.178.;PUNNOOSE EA, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0012517.;QIANG L, 2012, CELL DEATH DIFFER, V19, P284, DOI 10.1038/CDD.2011.95.;QU CJ, 2012, CELL CYCLE, V11, P785, DOI 10.4161/CC.11.4.19228.;QUINTANA E, 2008, NATURE, V456, P593, DOI 10.1038/NATURE07567.;RASPER M, 2010, NEURO-ONCOLOGY, V12, P1024, DOI 10.1093/NEUONC/NOQ070.;REN J, 2013, CURR PHARM DES.;RICHARDSON AL, 2012, CLIN CANCER RES, V18, P3209, DOI 10.1158/1078-0432.CCR-12-0871.;RICHMOND ELLEN S, 2012, SEMIN ONCOL NURS, V28, P87, DOI 10.1016/J.SONCN.2012.03.002.;ROBIN ED, 1984, J CELL PHYSIOL, V118, P287, DOI 10.1002/JCP.1041180311.;ROS S, 2012, CELL METAB, V16, P687, DOI 10.1016/J.CMET.2012.11.010.;ROSELL R, 2012, LANCET ONCOL, V13, P971, DOI 10.1016/S1470-2045(12)70369-8.;ROULHAC PL, 2011, COLD SPRING HARB PRO, V2011.;RYBAK AP, 2013, CELL SIGNAL, V25, P2734, DOI 10.1016/J.CELLSIG.2013.08.041.;SACHLOS E, 2012, CELL, V149, P1284, DOI 10.1016/J.CELL.2012.03.049.;SALARI K, 2012, EUR HEART J, V33, P1564, DOI 10.1093/EURHEARTJ/EHS112.;SATTLER UGA, 2010, RADIOTHER ONCOL, V94, P102, DOI 10.1016/J.RADONC.2009.11.007.;SCARTOZZI M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-71.;SCHEEL C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/J.SEMCANCER.2012.04.001.;SCHNECK H, 2013, MOL ONCOL, V7, P976, DOI 10.1016/J.MOLONC.2013.07.007.;SEYMOUR CB, 1986, INT J RADIAT BIOL, V50, P167, DOI 10.1080/09553008614550541.;SHAIB W, 2013, J GASTROINTEST ONCOL, V4, P308, DOI 10.3978/J.ISSN.2078-6891.2013.029.;SHIGDAR S, 2012, THER DELIV, V3, P227, DOI 10.4155/TDE.11.148.;SHU XO, 2012, CANCER RES, V72, P1182, DOI 10.1158/0008-5472.CAN-11-2561.;SIMS D, 2011, GENOME BIOL, V12, DOI 10.1186/GB-2011-12-10-R104.;SKVORTSOV S, 2014, INT J RADIAT BIOL, V90, P653, DOI 10.3109/09553002.2013.873559.;SKVORTSOVA I, 2008, PROTEOMICS, V8, P4521, DOI 10.1002/PMIC.200800113.;SOLIN LJ, 2012, BREAST CANCER RES TR, V134, P683, DOI 10.1007/S10549-012-2072-Y.;SOTTORIVA A, 2013, CANCER RES, V73, P41, DOI 10.1158/0008-5472.CAN-12-2273.;SULLIVAN JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881.;SVOBODA M, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-195.;TANG DG, 2012, CELL RES, V22, P457, DOI 10.1038/CR.2012.13.;TANG FQ, 2011, CLIN BIOCHEM, V44, P711, DOI 10.1016/J.CLINBIOCHEM.2011.03.025.;TINHOFER I, 2014, INT J RADIAT BIOL, V90, P622, DOI 10.3109/09553002.2014.886798.;TIRINO V, 2013, FASEB J, V27, P13, DOI 10.1096/FJ.12-218222.;TOMILO M, 2013, CANC RES S, V73.;TOMIOKA N, 2010, CANCER GENET CYTOGEN, V201, P6, DOI 10.1016/J.CANCERGENCYTO.2010.04.017.;TRACHOOTHAM D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/NRD2803.;TRAUTMANN F, 2014, INT J RADIAT BIOL, V90, P687, DOI 10.3109/09553002.2014.906766.;TSIMBERIDOU APOSTOLIA M, 2013, AM SOC CLIN ONCOL EDUC BOOK, P118, DOI 10.1200/EDBOOK\_AM.2013.33.118.;TSUCHIDA T, 2008, NUCL MED BIOL, V35, P171, DOI 10.1016/J.NUCMEDBIO.2007.11.004.;TSURUMI C, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0015605.;UNLU M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/ELPS.1150181133.;VAN DEN HOOGEN C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806.;VAUPEL P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/S10555-007-9055-1.;WALTHER TC, 2010, J CELL BIOL, V190, P491, DOI 10.1083/JCB.201004052.;WARBURG O, 1956, SCIENCE, V124, P269, DOI 10.1126/SCIENCE.124.3215.267.;WEIDHAAS JB, 2009, CLIN CANCER RES, V15, P4199, DOI 10.1158/1078-0432.CCR-08-2257.;WEIGEL MT, 2010, ENDOCR-RELAT CANCER, V17, PR245, DOI 10.1677/ERC-10-0136.;WEINSTEIN IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CA,N-07-3293.;WERBROUCK J, 2009, INT J RADIAT ONCOL, V73, P1187, DOI 10.1016/J.IJROBP.2008.08.073.;WEST CML, 1993, BRIT J CANCER, V68, P819, DOI 10.1038/BJC.1993.434.;WHITEHURST AW, 2007, NATURE, V446, P815, DOI 10.1038/NATURE05697.;WILSON WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/NRC3064.;WISZNIEWSKA J, 2014, EUR J HUM GENET, V22, P79, DOI 10.1038/EJHG.2013.77.;WITHERS HR, 1988, ACTA ONCOL, V27, P131, DOI 10.3109/02841868809090333.;WULFKUHLE JD, 2003, ADV EXP MED BIOL, V532, P59.;YACHIDA S, 2010, NATURE, V467, P1114, DOI 10.1038/NATURE09515.;YAN D, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0011397.;YAROMINA A, 2012, MOL ONCOL, V6, P211, DOI 10.1016/J.MOLONC.2012.01.007.;YEN LC, 2009, CLIN CANCER RES, V15, P4508, DOI 10.1158/1078-0432.CCR-08-3179.;YOUN A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/BIOINFORMATICS/BTQ630.;YU M, 2013, SCIENCE, V339, P580, DOI 10.1126/SCIENCE.1228522.;YUAN SQ, 2013, STEM CELLS, V31, P23, DOI 10.1002/STEM.1273.;ZAKHARCHENKO O, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0065163.;ZHENG M, 2008, CANCER RES, V68, P7570, DOI 10.1158/0008-5472.CAN-08-0632.","DUBROVSKA, A (REPRINT AUTHOR), TECH UNIV DRESDEN, MED FAC DRESDEN CARL GUSTAV CARUS, ONCORAY NATL CTR RADIAT RES ONCOL, FETSCHERSTR 74 PF41, D-01307 DRESDEN, GERMANY.;MAEBERT, KATRIN, COJOC, MONICA, PEITZSCH, CLAUDIA, KURTH, INA, DUBROVSKA, ANNA, TECH UNIV DRESDEN, MED FAC DRESDEN CARL GUSTAV CARUS, ONCORAY NATL CTR RADIAT RES ONCOL, D-01307 DRESDEN, GERMANY.;SOUCHELNYTSKYI, SERHIY, KAROLINSKA UNIV HOSP, KAROLINSKA INST, DEPT ONCOL PATHOL, KAROLINSKA BIOM CTR, STOCKHOLM, SWEDEN.","10.3109/09553002.2014.892229","2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",NA,NA,"GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH [03Z1NN11]","K.M., M. C., C. P., I. K. AND A. D. WISH TO ACKNOWLEDGE FUNDING FROM THE GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH (GRANT NO. 03Z1NN11).",NA,"0955-3002","8","659-677","TAYLOR \& FRANCIS LTD","90",2014,"ISI000340459800007","203","LIFE SCIENCES \& BIOMEDICINE - OTHER TOPICS, NUCLEAR SCIENCE \& TECHNOLOGY, RADIOLOGY, NUCLEAR MEDICINE \& MEDICAL IMAGING","85","BIOLOGY, NUCLEAR SCIENCE \& TECHNOLOGY, RADIOLOGY, NUCLEAR MEDICINE \& MEDICAL IMAGING","ANNA.DUBROVSKAONCORAY.DE",NA,"AN3BL",NA,"DUBROVSKA, A (REPRINT AUTHOR), TECH UNIV DRESDEN, MED FAC DRESDEN CARL GUSTAV CARUS, ONCORAY NATL CTR RADIAT RES ONCOL, FETSCHERSTR 74 PF41, D-01307 DRESDEN, GERMANY","ISI","TECH UNIV DRESDEN;KAROLINSKA UNIV HOSP","TECH UNIV DRESDEN",NA,"MAEBERT K, 2014, INT J RADIAT BIOL","MAEBERT K, 2014, INT J RADIAT BIOL"
"RIPP F, 2014, BMC GENOMICS","RIPP F;KROMBHOLZ CF;LIU Y;WEBER M;SCHAEFER A;SCHMIDT B;KOEPPEL R;HANKELN T","ALL-FOOD-SEQ (AFS): A QUANTIFIABLE SCREEN FOR SPECIES IN BIOLOGICAL SAMPLES BY DEEP DNA SEQUENCING","BMC GENOMICS","BMC GENOMICS","BACKGROUND: DNA-BASED METHODS LIKE PCR EFFICIENTLY IDENTIFY AND QUANTIFY THE TAXON COMPOSITION OF COMPLEX BIOLOGICAL MATERIALS, BUT ARE LIMITED TO DETECTING SPECIES TARGETED BY THE CHOICE OF THE PRIMER ASSAY. WE SHOW HERE HOW UNTARGETED DEEP SEQUENCING OF FOODSTUFF TOTAL GENOMIC DNA, FOLLOWED BY BIOINFORMATIC ANALYSIS OF SEQUENCE READS, FACILITATES HIGHLY ACCURATE IDENTIFICATION OF SPECIES FROM ALL KINGDOMS OF LIFE, AT THE SAME TIME ENABLING QUANTITATIVE MEASUREMENT OF THE MAIN INGREDIENTS AND DETECTION OF UNANTICIPATED FOOD COMPONENTS. RESULTS: SEQUENCE DATA SIMULATION AND REAL-CASE ILLUMINA SEQUENCING OF DNA FROM REFERENCE SAUSAGES COMPOSED OF MAMMALIAN (PIG, COW, HORSE, SHEEP) AND AVIAN (CHICKEN, TURKEY) SPECIES ARE ABLE TO QUANTIFY MATERIAL CORRECTLY AT THE 1\% DISCRIMINATION LEVEL VIA A READ COUNTING APPROACH. AN ADDITIONAL METAGENOMIC STEP FACILITATES IDENTIFICATION OF TRACES FROM ANIMAL, PLANT AND MICROBIAL DNA INCLUDING UNEXPECTED SPECIES, WHICH IS PROSPECTIVELY IMPORTANT FOR THE DETECTION OF ALLERGENS AND PATHOGENS. CONCLUSIONS: OUR DATA SUGGEST THAT DEEP SEQUENCING OF TOTAL GENOMIC DNA FROM SAMPLES OF HETEROGENEOUS TAXON COMPOSITION PROMISES TO BE A VALUABLE SCREENING TOOL FOR REFERENCE SPECIES IDENTIFICATION AND QUANTIFICATION IN BIOSURVEILLANCE APPLICATIONS LIKE FOOD TESTING, POTENTIALLY ALLEVIATING SOME OF THE PROBLEMS IN TAXON REPRESENTATION AND QUANTIFICATION ASSOCIATED WITH TARGETED PCR-BASED APPROACHES.","ILLUMINA; NEXT-GENERATION SEQUENCING; REAL-TIME PCR; SPECIES IDENTIFICATION; METAGENOMICS","REAL-TIME PCR; BURROWS-WHEELER TRANSFORM; POLYMERASE-CHAIN-REACTION; RNA-SEQ; TECHNOLOGY; GENOME; QUANTIFICATION; IDENTIFICATION; EVOLUTION; ALIGNMENT","ENGLISH","ARTICLE","ARTICLE",18,"ADEY A, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-12-R119.;ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;[ANONYMOUS], 2005, SWISS FOOD LEGISLATO, V23, P11.;ASENSIO L, 2008, FOOD CONTROL, V19, P1, DOI 10.1016/J.FOODCONT.2007.02.010.;BRODMANN PD, 2003, MEAT SCI, V65, P599, DOI 10.1016/S0309-1740(02)00253-X.;CHEN CC, 2011, J BACTERIOL, V193, P1788, DOI 10.1128/JB.00007-11.;CHIANG YC, 2012, J MICROBIOL METH, V88, P110, DOI 10.1016/J.MIMET.2011.10.021.;COGHLAN ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/JOURNAL.PGEN.1002657.;DALLOUL RA, 2010, PLOS BIOL, V8, DOI 10.1371/JOURNAL.PBIO.1000475.;DEAGLE BE, 2013, MOL ECOL RESOUR, V13, P620, DOI 10.1111/1755-0998.12103.;DUNHAM I, 2012, NATURE, V489, P57, DOI 10.1038/NATURE11247.;EUGSTER A, 2009, EUR FOOD RES TECHNOL, V230, P55, DOI 10.1007/S00217-009-1138-5.;FRANCIS OE, 2013, GENOME RES, V23, P1721, DOI 10.1101/GR.150151.112.;GREGORY TR, 2002, EVOLUTION, V56, P121.;HEBERT PDN, 2003, P ROY SOC B-BIOL SCI, V270, PS96, DOI 10.1098/RSBL.2003.0025.;HUSON DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/GR.120618.111.;KERSTENS HHD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-479.;KIJAS JW, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0004668.;KIJAS JW, 2006, ANIM GENET, V37, P171, DOI 10.1111/J.1365-2052.2005.01399.X.;KIRCHER M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/NAR/GKR771.;KOPPEL R, 2008, EUR FOOD RES TECHNOL, V227, P1199, DOI 10.1007/S00217-008-0837-7.;KOPPEL R, 2012, J AOAC INT, V95, P494, DOI 10.5740/JAOACINT.11-115.;KOPPEL R, 2011, EUR FOOD RES TECHNOL, V232, P151, DOI 10.1007/S00217-010-1371-Y.;LI H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/BIB/BBQ015.;LI H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/BIOINFORMATICS/BTP698.;LI H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/BIOINFORMATICS/BTP352.;LIU YC, 2012, BIOINFORMATICS, V28, P1830, DOI 10.1093/BIOINFORMATICS/BTS276.;MAFRA I, 2008, EUR FOOD RES TECHNOL, V227, P649, DOI 10.1007/S00217-007-0782-X.;MARGUERAT S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/S00018-009-0180-6.;MARIONI JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/GR.079558.108.;MEYER R, 1994, J AOAC INT, V77, P617.;MORTAZAVI A, 2008, NAT METHODS, V5, P621, DOI 10.1038/NMETH.1226.;NEWMASTER SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222.;OAKENFULL EA, 1998, J MOL EVOL, V47, P772, DOI 10.1007/PL00006436.;OZSOLAK F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/NRG2934.;PLOHL M, 2008, GENE, V409, P72, DOI 10.1016/J.GENE.2007.11.013.;POP M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/J.TIG.2007.12.006.;ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/JCP.1041360316.;SAWYER J, 2003, FOOD CONTROL, V14, P579, DOI 10.1016/S0956-7135(02)00148-2.;SCHNOES AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/JOURNAL.PCBI.1000605.;SCHUBERT-ULLRICH P, 2009, ANAL BIOANAL CHEM, V395, P69, DOI 10.1007/S00216-009-2715-Y.;SEGATA N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/NMETH.2066].;TELETCHEA F, 2008, J APPL ECOL, V45, P967, DOI 10.1111/J.1365-2664.2007.01415.X.;TILLMAR AO, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0083761.;VAN NIEUWERBURGH F, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0026969.;WADE CM, 2009, SCIENCE, V326, P865, DOI 10.1126/SCIENCE.1178158.;WIEDMANN RT, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-81.;WILLIAMS RBH, 2006, NAT GENET, V38, P855, DOI 10.1038/NG0806-855.;WOOD DE, 2014, GENOME BIOL, V15, DOI 10.1186/GB-2014-15-3-R46.;WOOLFE M, 2004, TRENDS BIOTECHNOL, V22, P222, DOI 10.1016/J.TIBTECH.2004.03.010.;ZHANG CL, 2007, FOOD CONTROL, V18, P1149, DOI 10.1016/J.FOODCONT.2006.07.018.;ZHOU X, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-4.","HANKELN, T (REPRINT AUTHOR), JOHANNES GUTENBERG UNIV MAINZ, INST MOL GENET, D-55099 MAINZ, GERMANY.;RIPP, FABIAN, KROMBHOLZ, CHRISTOPHER FELIX, WEBER, MATHIAS, SCHAEFER, ANNE, HANKELN, THOMAS, JOHANNES GUTENBERG UNIV MAINZ, INST MOL GENET, D-55099 MAINZ, GERMANY.;LIU, YONGCHAO, SCHMIDT, BERTIL, JOHANNES GUTENBERG UNIV MAINZ, INST COMP SCI, D-55099 MAINZ, GERMANY.;KOEPPEL, RENE, OFFICIAL FOOD CONTROL AUTHOR CANTON ZURICH, ZURICH, SWITZERLAND.","10.1186/1471-2164-15-639","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","639",NA,"JOHANNES GUTENBERG UNIVERSITY OF MAINZ CENTER FOR COMPUTATIONAL SCIENCES (SRFN), JGU MAINZ INTRAMURAL FUNDING PROGRAM, MINISTRY OF JUSTICE AND FOR CONSUMER SAFETY RHINELAND-PALATINATE, GERMANY","WE GRATEFULLY ACKNOWLEDGE FUNDING BY THE JOHANNES GUTENBERG UNIVERSITY OF MAINZ CENTER FOR COMPUTATIONAL SCIENCES (SRFN, TO TH AND BS), THE JGU MAINZ INTRAMURAL FUNDING PROGRAM AND THE MINISTRY OF JUSTICE AND FOR CONSUMER SAFETY RHINELAND-PALATINATE, GERMANY (TO TH). THE AUTHORS ALSO THANK DR. STEFFEN RAPP (JGU MAINZ) AND DR. SVEN BIKAR (GENTERPRISE \& STARSEQ GMBH, MAINZ) FOR OPERATION OF THE ILLUMINA SEQUENCERS.",NA,"1471-2164",NA,NA,"BIOMED CENTRAL LTD","15",2014,"ISI000340639000001","52","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","34","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","HANKELNUNI-MAINZ.DE",NA,"AN5NT",NA,"HANKELN, T (REPRINT AUTHOR), JOHANNES GUTENBERG UNIV MAINZ, INST MOL GENET, D-55099 MAINZ, GERMANY","ISI","JOHANNES GUTENBERG UNIV MAINZ;JOHANNES GUTENBERG UNIV MAINZ","JOHANNES GUTENBERG UNIV MAINZ",NA,"RIPP F, 2014, BMC GENOMICS","RIPP F, 2014, BMC GENOMICS"
"TO KKW, 2014, J INFECT","TO KKW;SONG W;LAU SY;QUE TL;LUNG DC;HUNG IFN;CHEN H;YUEN KY","UNIQUE REASSORTANT OF INFLUENZA A(H7N9) VIRUS ASSOCIATED WITH SEVERE DISEASE EMERGING IN HONG KONG","JOURNAL OF INFECTION","J. INFECT.","OBJECTIVE: HUMAN INFECTIONS CAUSED BY AVIAN INFLUENZA VIRUS A(H7N9) RE-EMERGED IN LATE 2013. WE REPORTED THE FIRST HONG KONG PATIENT WITHOUT RISK FACTORS FOR SEVERE A(H7N9) DISEASE. METHODS: DIRECT SEQUENCING WAS PERFORMED ON THE ENDOTRACHEAL ASPIRATE COLLECTED FROM A 36-YEAR-OLD FEMALE WITH HISTORY OF POULTRY CONTACT. BIOINFORMATIC ANALYSIS WAS PERFORMED TO COMPARE THE CURRENT STRAIN AND PREVIOUS A(H7N9) ISOLATES. RESULTS: THE INFLUENZA A/HONG KONG/470129/2013 VIRUS STRAIN WAS DETECTED IN A PATIENT WITH ACUTE RESPIRATORY DISTRESS SYNDROME, DERANGED LIVER FUNCTION AND COAGULATION PROFILE, CYTOPENIA, AND RHABDOMYOLYSIS. THE HA, NA AND MP GENES OF A/HONG KONG/470129/2013 CLUSTER WITH THOSE OF OTHER HUMAN A(H7N9) STRAINS. THE PB1, PB2 AND NS GENES ARE MOST CLOSELY RELATED TO THOSE OF A/GUANGDONG/1/2013 STRAIN IDENTIFIED IN AUGUST 2013, BUT ARE DISTINCT FROM THOSE OF OTHER HUMAN AND AVIAN A(H7N9) STRAINS. THE OTHER INTERNAL GENES NP AND PA GENES ARE MORE CLOSELY RELATED TO THOSE OF NON-A(H7N9) AVIAN INFLUENZA A VIRUSES. A UNIQUE PA L336M MUTATION, ASSOCIATED WITH INCREASED POLYMERASE ACTIVITY, WAS FOUND. THE PATIENT REQUIRED SALVAGE BY EXTRACORPOREAL MEMBRANE OXYGENATION. CONCLUSIONS: THE A/HONG KONG/470129/2013 VIRUS IS A NOVEL REASSORTANT DERIVED FROM A/GUANGDONG/1/2013 VIRUS. THE UNIQUE MUTATION PA L336M MAY ENHANCE VIRAL REPLICATION AND THEREFORE DISEASE SEVERITY. (C) 2014 THE BRITISH INFECTION ASSOCIATION. PUBLISHED BY ELSEVIER LTD. ALL RIGHTS RESERVED.","AVIAN INFLUENZA; H7N9; PHYLOGENETIC TREE; EVOLUTION; L336M; PA","A H7N9 VIRUS; HUMAN INFECTIONS; ORIGIN; CHINA; H5N1; TRANSMISSION; POLYMERASE; DIVERSITY; EMERGENCE; POULTRY","ENGLISH","ARTICLE","ARTICLE",23,"BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/AJRCCM.149.3.7509706.;BUSSEY KA, 2011, J VIROL, V85, P7020, DOI 10.1128/JVI.00522-11.;CHAN JFW, 2013, TRENDS MICROBIOL, V21, P544, DOI 10.1016/J.TIM.2013.05.005.;CHAN KH, 2013, J CLIN MICROBIOL, V51, P2592, DOI 10.1128/JCM.00785-13.;CHEN E, 2013, EURO SURVEILL, V18.;CHEN Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4.;CHENG VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07.;CHENG VCC, 2012, CLIN MICROBIOL REV, V25, P223, DOI 10.1128/CMR.05012-11.;COWLING BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X.;GAO HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMOA1305584.;GAO RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMOA1304459.;HERFST S, 2012, SCIENCE, V336, P1534, DOI 10.1126/SCIENCE.1213362.;HU YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3.;JONGES M, 2011, J VIROL, V85, P10598, DOI 10.1128/JVI.05369-11.;LAM TTY, 2013, NATURE, V502, P241, DOI 10.1038/NATURE12515.;LIN PH, 2014, CLIN INFECT DIS, V58, P242, DOI 10.1093/CID/CIT638.;LIU D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1.;MANZ B, 2013, J VIROL, V87, P7200, DOI 10.1128/JVI.00980-13.;QI X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/BMJ.F4752.;REN X, 2013, EMERG INFECT DIS, V19.;THE GOVERNMENT OF THE HONG KONG SPECIAL ADMINISTRATIVE REGION, SFH CONF HUM CAS AV.;TO KKW, 2013, LANCET INFECT DIS, V13, P809, DOI 10.1016/S1473-3099(13)70167-1.;TO KKW, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/EMI.2012.24.;WORLD HEALTH ORGANIZATION (WHO), NUMB CONF HUM CAS AV.;YANG SG, 2014, J INFECT DIS, V209, P265, DOI 10.1093/INFDIS/JIT430.;YU L, 2013, CLIN INFECT DIS, V57, P1449, DOI 10.1093/CID/CIT541.;YUAN J, 2013, CLIN INFECT DIS, V57, P1367, DOI 10.1093/CID/CIT479.;YUEN KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9.;ZHANG LS, 2013, CLIN INFECT DIS, V57, P1059, DOI 10.1093/CID/CIT414.","YUEN, KY (REPRINT AUTHOR), UNIV HONG KONG, QUEEN MARY HOSP, CAROL YU CTR INFECT, POKFULAM RD, POKFULAM, HONG KONG, PEOPLES R CHINA.;TO, KELVIN KAI-WANG, CHEN, HONGLIN, YUEN, KWOK-YUNG, STATE KEY LAB EMERGING INFECT DIS, HONG KONG, HONG KONG, PEOPLES R CHINA.;TO, KELVIN KAI-WANG, CHEN, HONGLIN, YUEN, KWOK-YUNG, CAROL YU CTR INFECT, HONG KONG, HONG KONG, PEOPLES R CHINA.;TO, KELVIN KAI-WANG, CHEN, HONGLIN, YUEN, KWOK-YUNG, RES CTR INFECT \& IMMUNOL, HONG KONG, HONG KONG, PEOPLES R CHINA.;TO, KELVIN KAI-WANG, SONG, WENJUN, LAU, SIU-YING, CHEN, HONGLIN, YUEN, KWOK-YUNG, UNIV HONG KONG, DEPT MICROBIOL, POKFULAM, HONG KONG, PEOPLES R CHINA.;QUE, TAK-LUN, LUNG, DAVID CHRISTOPHER, TUEN MUN HOSP, DEPT PATHOL, HONG KONG, HONG KONG, PEOPLES R CHINA.;HUNG, IVAN FAN-NGAI, UNIV HONG KONG, DEPT MED, POKFULAM, HONG KONG, PEOPLES R CHINA.","10.1016/J.JINF.2014.02.012","32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND",NA,NA,"PROVIDENCE FOUNDATION LIMITED, CONSULTANCY SERVICE FOR ENHANCING LABORATORY SURVEILLANCE OF EMERGING INFECTIOUS DISEASE FOR THE HKSAR DEPARTMENT OF HEALTH, RESEARCH GRANTS COUNCIL OF THE HKSAR [7620/10M, 7629/13M]","WE ARE GRATEFUL FOR THE GENEROUS SUPPORT OF HUI HOY, AND HUI MING IN THE GENOMIC SEQUENCING PLATFORM. THIS WORK WAS PARTLY SUPPORTED BY PROVIDENCE FOUNDATION LIMITED IN MEMORY OF THE LATE LUI HAC MINH, THE CONSULTANCY SERVICE FOR ENHANCING LABORATORY SURVEILLANCE OF EMERGING INFECTIOUS DISEASE FOR THE HKSAR DEPARTMENT OF HEALTH, AND RESEARCH GRANTS COUNCIL OF THE HKSAR (7620/10M AND 7629/13M). WE ACKNOWLEDGE YUELONG SHU FOR PERMITTING US TO USE THE DATA HE DEPOSITED IN GLOBAL INITIATIVE ON SHARING ALL INFLUENZA DATA (GISAID) EPIFLU (TM) DATABASE.",NA,"0163-4453","1","60-68","W B SAUNDERS CO LTD","69",2014,"ISI000339352100007","29","INFECTIOUS DISEASES","8","INFECTIOUS DISEASES","KYYUENHKU.HK",NA,"AL7YD",NA,"YUEN, KY (REPRINT AUTHOR), UNIV HONG KONG, QUEEN MARY HOSP, CAROL YU CTR INFECT, POKFULAM RD, POKFULAM, HONG KONG, PEOPLES R CHINA","ISI","STATE KEY LAB EMERGING INFECT DIS;CAROL YU CTR INFECT;RES CTR INFECT AND IMMUNOL;UNIV HONG KONG;TUEN MUN HOSP;UNIV HONG KONG","UNIV HONG KONG",NA,"TO KKW, 2014, J INFECT","TO KKW, 2014, J INFECT"
"GENILLOUD O, 2014, ANTONIE VAN LEEUWENHOEK","GENILLOUD O","THE RE-EMERGING ROLE OF MICROBIAL NATURAL PRODUCTS IN ANTIBIOTIC DISCOVERY","ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY","ANTONIE VAN LEEUWENHOEK","NEW CLASSES OF ANTIBACTERIAL COMPOUNDS ARE URGENTLY NEEDED TO RESPOND TO THE HIGH FREQUENCY OF OCCURRENCE OF RESISTANCES TO ALL MAJOR CLASSES OF KNOWN ANTIBIOTICS. MICROBIAL NATURAL PRODUCTS HAVE BEEN FOR DECADES ONE OF THE MOST SUCCESSFUL SOURCES OF DRUGS TO TREAT INFECTIOUS DISEASES BUT TODAY, THE EMERGING UNMET CLINICAL NEED POSES COMPLETELY NEW CHALLENGES TO THE DISCOVERY OF NOVEL CANDIDATES WITH THE DESIRED PROPERTIES TO BE DEVELOPED AS ANTIBIOTICS. WHILE NATURAL PRODUCTS DISCOVERY PROGRAMS HAVE BEEN GRADUALLY ABANDONED BY THE BIG PHARMA, SMALLER BIOTECHNOLOGY COMPANIES AND RESEARCH ORGANIZATIONS ARE TAKING OVER THE LEAD IN THE DISCOVERY OF NOVEL ANTIBACTERIALS. RECENT YEARS HAVE SEEN NEW APPROACHES AND TECHNOLOGIES BEING DEVELOPED AND INTEGRATED IN A MULTIDISCIPLINARY EFFORT TO FURTHER EXPLOIT MICROBIAL RESOURCES AND THEIR BIOSYNTHETIC POTENTIAL AS AN UNTAPPED SOURCE OF NOVEL MOLECULES. NEW STRATEGIES TO ISOLATE NOVEL SPECIES THOUGHT TO BE UNCULTIVABLE, AND SYNTHETIC BIOLOGY APPROACHES RANGING FROM GENOME MINING OF MICROBIAL STRAINS FOR CRYPTIC BIOSYNTHETIC PATHWAYS TO THEIR HETEROLOGOUS EXPRESSION HAVE BEEN EMERGING IN COMBINATION WITH HIGH THROUGHPUT SEQUENCING PLATFORMS, INTEGRATED BIOINFORMATIC ANALYSIS, AND ON-SITE ANALYTICAL DETECTION AND DEREPLICATION TOOLS FOR NOVEL COMPOUNDS. THESE DIFFERENT INNOVATIVE APPROACHES ARE DEFINING A COMPLETELY NEW FRAMEWORK THAT IS SETTING THE BASES FOR THE FUTURE DISCOVERY OF NOVEL CHEMICAL SCAFFOLDS THAT SHOULD FOSTER A RENEWED INTEREST IN THE IDENTIFICATION OF NOVEL CLASSES OF NATURAL PRODUCT ANTIBIOTICS FROM THE MICROBIAL WORLD.","ANTIBIOTICS; MICROBIAL NATURAL PRODUCTS; GENOME MINING; SCREENING; SECONDARY METABOLISM","BIOSYNTHETIC GENE CLUSTERS; STREPTOMYCES-COELICOLOR; ANTIBACTERIAL DISCOVERY; SECONDARY METABOLISM; STAPHYLOCOCCUS-AUREUS; ANTISENSE STRATEGY; DRUG DISCOVERY; ASPERGILLUS-NIDULANS; CHEMICAL DIVERSITY; MASS-SPECTROMETRY","ENGLISH","REVIEW","ARTICLE",33,"ANGELL S, 2006, CHEM BIOL, V13, P1349, DOI 10.1016/J.CHEMBIOL.2006.10.012.;BANIK JJ, 2010, CURR OPIN MICROBIOL, V13, P603, DOI 10.1016/J.MIB.2010.08.012.;BENTLEY SD, 2002, NATURE, V417, P141, DOI 10.1038/417141A.;BERDY J, 2012, J ANTIBIOT, V65, P385, DOI 10.1038/JA.2012.27.;BILLS GF, 2008, J APPL MICROBIOL, V104, P1644, DOI 10.1111/J.1365-2672.2008.03735.X.;BILLS G, 2009, MYCOL SER, V27, P257.;BILLS GF, 2013, CURR OPIN MICROBIOL, V16, P549, DOI 10.1016/J.MIB.2013.08.001.;BODE HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO,2-9.;BODE HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/J.CBPA.2009.02.037.;BOK JW, 2006, MOL MICROBIOL, V61, P1636, DOI 10.1111/J.1365-2958.2006.05330.X.;BOUCHER HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011.;BRAKHAGE AA, 2011, FUNGAL GENET BIOL, V48, P15, DOI 10.1016/J.FGB.2010.04.004.;BURGESS JG, 1999, J BIOTECHNOL, V70, P27, DOI 10.1016/S0168-1656(99)00054-1.;BUSH K, 2012, CURR OPIN PHARMACOL, V12, P527, DOI 10.1016/J.COPH.2012.06.003.;BUTLER MS, 2011, J ANTIBIOT, V64, P413, DOI 10.1038/JA.2011.44.;BUTLER MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/NP040106Y.;BUTLER MS, 2006, BIOCHEM PHARMACOL, V71, P919, DOI 10.1016/J.BCP.2005.10.012.;CHALLIS GL, 2008, MICROBIOL-SGM, V154, P1555, DOI 10.1099/MIC.0.2008/018523-0.;COREY GR, 2009, NAT REV DRUG DISCOV, V8, P929, DOI 10.1038/NRD3051.;CORRE C, 2008, P NATL ACAD SCI USA, V105, P17510, DOI 10.1073/PNAS.0805530105.;CORRE C, 2009, NAT PROD REP, V26, P977, DOI 10.1039/B713024B.;CRANEY A, 2012, CHEM BIOL, V19, P1020, DOI 10.1016/J.CHEMBIOL.2012.06.013.;CRAWFORD JM, 2011, CHEM COMMUN, V47, P7559, DOI 10.1039/C1CC11574J.;CUETO M, 2001, J NAT PROD, V64, P1444, DOI 10.1021/NP0102713.;DE LA CRUZ M, 2012, CHEM BIODIVERS, V9, P1095, DOI 10.1002/CBDV.201100362.;DOBSON CM, 2004, NATURE, V432, P824, DOI 10.1038/NATURE03192.;DONADIO S, 2010, J ANTIBIOT, V63, P423, DOI 10.1038/JA.2010.62.;DONALD RGK, 2009, CHEM BIOL, V16, P826, DOI 10.1016/J.CHEMBIOL.2009.07.004.;ESQUENAZI E, 2009, NAT PROD REP, V26, P1521, DOI 10.1039/B915674G.;FISCHBACH MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/SCIENCE.1176667.;FREEMAN MF, 2012, SCIENCE, V338, P387, DOI 10.1126/SCIENCE.1226121.;FUCHS SW, 2011, ORG BIOMOL CHEM, V9, P3130, DOI 10.1039/C1OB05097D.;GANESAN A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/J.CBPA.2008.03.016.;GENILLOUD O, 2013, ANTIMICROBIALS NEW O, P231.;GENILLOUD OLGA, 2012, RECENT PAT ANTIINFECT DRUG DISCOV, V7, P189.;GENILLOUD O, 2011, J IND MICROBIOL BIOT, V38, P375, DOI 10.1007/S10295-010-0882-7.;GOETZ MA, 2010, J ANTIBIOT, V63, P512, DOI 10.1038/JA.2010.86.;GOMEZ-ESCRIBANO JP, 2014, J IND MICROBIOL BIOT, V41, P425, DOI 10.1007/S10295-013-1348-5.;GROSS H, 2007, CHEM BIOL, V14, P53, DOI 10.1016/J.CHEMBIOL.2006.11.007.;GROSS H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/B817075B.;GROSS H, 2009, IDRUGS, V12, P207.;HANTKE K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3.;HENRIKSON JC, 2009, ORG BIOMOL CHEM, V7, P435, DOI 10.1039/B819208A.;HESKETH A, 2009, MOL MICROBIOL, V74, P1427, DOI 10.1111/J.1365-2958.2009.06941.X.;HOSAKA T, 2009, NAT BIOTECHNOL, V27, P462, DOI 10.1038/NBT.1538.;JENSEN PR, 2007, APPL ENVIRON MICROB, V73, P1146, DOI 10.1128/AEM.01891-06.;KAEBERLEIN T, 2002, SCIENCE, V296, P1127, DOI 10.1126/SCIENCE.1070633.;KALAITZIS JA, 2009, NAT PROD REP, V26, P1447, DOI 10.1039/B817074F.;KAWAI K, 2007, FEMS MICROBIOL LETT, V274, P311, DOI 10.1111/J.1574-6968.2007.00846.X.;KERSTEN RD, 2011, NAT CHEM BIOL, V7, P794, DOI 10.1038/NCHEMBIO.684.;KHALDI N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/J.FGB.2010.06.003.;KIRST HA, 2013, EXPERT OPIN DRUG DIS, V8, P479, DOI 10.1517/17460441.2013.779666.;KIRST HA, 2012, EXPERT OPIN THER PAT, V22, P15, DOI 10.1517/13543776.2012.642370.;KITANI S, 2011, P NATL ACAD SCI USA, V108, P16410, DOI 10.1073/PNAS.1113908108.;KOEHN FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/NRD1657.;KOMATSU M, 2013, ACS SYNTH BIOL, V2, P384, DOI 10.1021/SB3001003.;LAURETI L, 2011, P NATL ACAD SCI USA, V108, P6258, DOI 10.1073/PNAS.1019077108.;LEWIS K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/NRD3975.;LEWIS K, 2010, J ANTIBIOT, V63, P468, DOI 10.1038/JA.2010.87.;LINCKE T, 2010, ANGEW CHEM INT EDIT, V49, P2011, DOI 10.1002/ANIE.200906114.;LIVERMORE DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/JAC/DKP255.;MARINELLI F, 2013, ANTIMICROBIALS NEW O.;MCKENZIE NL, 2010, J ANTIBIOT, V63, P177, DOI 10.1038/JA.2010.13.;MEDEMA MH, 2011, NUCLEIC ACIDS RES, V39, PW339, DOI 10.1093/NAR/GKR466.;MONNERET C., 2013, ANNALES PHARMACEUTIQUES FRANCAISES, V71, P95, DOI 10.1016/J.PHARMA.2013.01.004.;MOORE JM, 2012, USE DISCOVERY CHEM E, V517, P368.;NETT M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/B817069J.;NEWMAN DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/NP200906S.;NISHIDA H, 2007, ENVIRON MICROBIOL, V9, P1986, DOI 10.1111/J.1462-2920.2007.01314.X.;NOVAK R, 2012, RSC DRUG DISCOV, V25, P326, DOI 10.1039/9781849734950-00326.;OH DC, 2007, J NAT PROD, V70, P515, DOI 10.1021/NP060381F.;ONAKA H, 2011, APPL ENVIRON MICROB, V77, P400, DOI 10.1128/AEM.01337-10.;ONDEYKA JG, 2007, J NAT PROD, V70, P668, DOI 10.1021/NP060557D.;PARISH CA, 2009, J NAT PROD, V72, P59, DOI 10.1021/NP800528A.;PAYNE D J, 2000, CURR OPIN DRUG DISCOV DEVEL, V3, P177.;PAYNE DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/NRD2201.;PEREZ J, 2011, MICROB BIOTECHNOL, V4, P175, DOI 10.1111/J.1751-7915.2010.00208.X.;PHILLIPS JW, 2011, CHEM BIOL, V18, P955, DOI 10.1016/J.CHEMBIOL.2011.06.011.;PIEL J, 2004, NAT PROD REP, V21, P519, DOI 10.1039/B310175B.;PIEL J, 2011, ANNU REV MICROBIOL, V65, P431, DOI 10.1146/ANNUREV-MICRO-090110-102805.;NGUYEN QT, 2012, FEBS LETT, V586, P2177, DOI 10.1016/J.FEBSLET.2012.02.008.;RAPPE MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/ANNUREV.MICRO.57.030502.090759.;RIGALI S, 2008, EMBO REP, V9, P670, DOI 10.1038/EMBOR.2008.83.;ROSEN J, 2009, J MED CHEM, V52, P1953, DOI 10.1021/JM801514W.;RUIZ B, 2010, CRIT REV MICROBIOL, V36, P146, DOI 10.3109/10408410903489576.;SCHARF DH, 2013, J BIOTECHNOL, V163, P179, DOI 10.1016/J.JBIOTEC.2012.06.027.;SCHERLACH K, 2009, ORG BIOMOL CHEM, V7, P1753, DOI 10.1039/B821578B.;SCHMITT EK, 2011, CURR OPIN CHEM BIOL, V15, P497, DOI 10.1016/J.CBPA.2011.05.018.;SCHOFIELD MM, 2013, CURR OPIN BIOTECH, V24, P1151, DOI 10.1016/J.COPBIO.2013.05.001.;SCHROECKH V, 2009, P NATL ACAD SCI USA, V106, P14558, DOI 10.1073/PNAS.0901870106.;SHWAB EK, 2007, EUKARYOT CELL, V6, P1656, DOI 10.1128/EC.00186-07.;SILVER LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10.;SINGH SB, 2007, CURR OPIN DRUG DISC, V10, P160.;SINGH SB, 2006, ORG LETT, V8, P5449, DOI 10.1021/OL062041R.;SINGH SB, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 2: NATURAL PRODUCTS STRUCTURAL DIVERSITY-II: SECONDARY METABOLITES: SOURCES, STRUCTURES AND CHEMICAL BIOLOGY, P109.;SINGH SB, 2011, EXPERT REV ANTI-INFE, V9, P589, DOI [10.1586/ERI.11.81, 10.1586/ERI.11.81].;STEWART EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12.;THOMASON LYNN, 2007, CURR PROTOC MOL BIOL, VCHAPTER 1, DOI 10.1002/0471142727.MB0116S78.;UEDA K, 2000, J ANTIBIOT, V53, P979, DOI 10.7164/ANTIBIOTICS.53.979.;VAN WEZEL GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/C1NP00003A.;VENUGOPAL AA, 2012, CLIN INFECT DIS, V54, P568, DOI 10.1093/CID/CIR830.;WALSH CT, 2010, J AM CHEM SOC, V132, P2469, DOI 10.1021/JA909118A.;WANG J, 2006, NATURE, V441, P358, DOI 10.1038/NATURE04784.;WANG J, 2007, P NATL ACAD SCI USA, V104, P7612, DOI 10.1073/PNAS.0700746104.;WATROUS J, 2010, ANAL CHEM, V82, P1598, DOI 10.1021/AC9027388.;WENZEL SC, 2009, NAT PROD REP, V26, P1385, DOI 10.1039/B817073H.;WILLIAMS RB, 2008, ORG BIOMOL CHEM, V6, P1895, DOI 10.1039/B804701D.;WILSON MC, 2014, NATURE, V506, P58, DOI 10.1038/NATURE12959.;WILSON MC, 2013, CHEM BIOL, V20, P636, DOI 10.1016/J.CHEMBIOL.2013.04.011.;WINTER JM, 2012, CURR OPIN BIOTECH, V23, P736, DOI 10.1016/J.COPBIO.2011.12.016.;WINTER JM, 2011, CURR OPIN CHEM BIOL, V15, P22, DOI 10.1016/J.CBPA.2010.10.020.;WRIGHT GD, 2012, CHEM BIOL, V19, P3, DOI 10.1016/J.CHEMBIOL.2011.10.019.;YAMANAKA K, 2005, MICROBIOL-SGM, V151, P2899, DOI 10.1099/MIC.0.28139-0.;YAMANAKA K, 2014, P NATL ACAD SCI USA, V111, P1957, DOI 10.1073/PNAS.1319584111.;ZERIKLY M, 2009, CHEMBIOCHEM, V10, P625, DOI 10.1002/CBIC.200800389.;ZHANG CW, 2008, J NAT PROD, V71, P1304, DOI 10.1021/NP8001833.;ZHANG CW, 2009, BIOORGAN MED CHEM, V17, P2162, DOI 10.1016/J.BMC.2008.04.018.;ZIEMERT N, 2014, P NATL ACAD SCI USA, V111, PE1130, DOI 10.1073/PNAS.1324161111.;ZOTCHEV SB, 2012, J BIOTECHNOL, V158, P168, DOI 10.1016/J.JBIOTEC.2011.06.002.","GENILLOUD, O (REPRINT AUTHOR), FDN MEDINA, AVDA CONOCIMIENTO 3,PARQUE TECNOL CIENCIAS SALUD, GRANADA 18016, SPAIN.;FDN MEDINA, GRANADA 18016, SPAIN.","10.1007/S10482-014-0204-6","VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS",NA,NA,NA,NA,NA,"0003-6072","1","173-188","SPRINGER","106",2014,"ISI000338321700011","119","MICROBIOLOGY","107","MICROBIOLOGY","OLGA.GENILLOUDMEDINAANDALUCIA.ES",NA,"AK3KG",NA,"GENILLOUD, O (REPRINT AUTHOR), FDN MEDINA, AVDA CONOCIMIENTO 3,PARQUE TECNOL CIENCIAS SALUD, GRANADA 18016, SPAIN","ISI","FDN MEDINA","FDN MEDINA",NA,"GENILLOUD O, 2014, ANTONIE VAN LEEUWENHOEK","GENILLOUD O, 2014, ANTONIE VAN LEEUWENHOEK"
"PORAZINSKA DL, 2014, PHYTOPATHOLOGY","PORAZINSKA DL;MORGAN MJ;GASPAR JM;COURT LN;HARDY CM;HODDA M","DISCRIMINATION OF PLANT-PARASITIC NEMATODES FROM COMPLEX SOIL COMMUNITIES USING ECOMETAGENETICS","PHYTOPATHOLOGY","PHYTOPATHOLOGY","MANY PLANT PATHOGENS ARE MICROSCOPIC, CRYPTIC, AND DIFFICULT TO DIAGNOSE. THE NEW APPROACH OF ECOMETAGENETICS, INVOLVING ULTRASEQUENCING, BIOINFORMATICS, AND BIOSTATISTICS, HAS THE POTENTIAL TO IMPROVE DIAGNOSES OF PLANT PATHOGENS SUCH AS NEMATODES FROM THE COMPLEX MIXTURES FOUND IN MANY AGRICULTURAL AND BIOSECURITY SITUATIONS. WE TESTED THIS APPROACH ON A GRADIENT OF COMPLEXITY RANGING FROM A FEW INDIVIDUALS FROM A FEW SPECIES OF KNOWN NEMATODE PATHOGENS IN A RELATIVELY DEFINED SUBSTRATE TO A COMPLEX AND POORLY KNOWN SUITE OF NEMATODE PATHOGENS IN A COMPLEX FOREST SOIL, INCLUDING ITS ASSOCIATED BIOTA OF UNKNOWN PROTISTS, FUNGI, AND OTHER MICROSCOPIC EUKARYOTES. WE ADDED THREE KNOWN BUT CONTRASTING SPECIES (PRATYLENCHUS NEGLECTUS, THE CLOSELY RELATED P. THORNEI, AND HETERODERA AVENAE) TO HALF THE SET OF SUBSTRATES, LEAVING THE OTHER HALF WITHOUT THEM. WE THEN TESTED WHETHER ALL NEMATODE PATHOGENS KNOWN AND UNKNOWN, INDIGENOUS, AND EXPERIMENTALLY ADDED WERE DETECTED CONSISTENTLY PRESENT OR ABSENT. WE ALWAYS DETECTED THE PRATYLENCHUS SPP. CORRECTLY AND WITH THE NUMBER OF SEQUENCE READS PROPORTIONAL TO THE NUMBERS ADDED. HOWEVER, A SINGLE CYST OF H. AVENAE WAS ONLY IDENTIFIED APPROXIMATELY HALF THE TIME IT WAS PRESENT. OTHER PLANT-PARASITIC NEMATODES AND NEMATODES FROM OTHER TROPHIC GROUPS WERE DETECTED WELL BUT OTHER EUKARYOTES WERE DETECTED LESS CONSISTENTLY. DNA SAMPLING ERRORS OR INFORMATIC ERRORS OR BOTH WERE INVOLVED IN MISIDENTIFICATION OF H. AVENAE, HOWEVER, THE PROPORTIONS OF EACH VARIED IN THE DIFFERENT BIOINFORMATIC PIPELINES AND WITH DIFFERENT PARAMETERS USED. TO A LARGE EXTENT, FALSE-POSITIVE AND FALSE-NEGATIVE ERRORS WERE COMPLEMENTARY: PIPELINES AND PARAMETERS WITH THE HIGHEST FALSE-POSITIVE RATES HAD THE LOWEST FALSE-NEGATIVE RATES AND VICE VERSA. SOURCES OF ERROR IDENTIFIED INCLUDED ASSUMPTIONS IN THE BIOINFORMATIC PIPELINES, SLIGHT DIFFERENCES IN PRIMER REGIONS, THE NUMBER OF SEQUENCE READS REGARDED AS THE MINIMUM THRESHOLD FOR INCLUSION IN ANALYSIS, AND INACCESSIBLE DNA IN RESISTANT LIFE STAGES. IDENTIFICATION OF THE SOURCES OF ERROR ALLOWS US TO SUGGEST WAYS TO IMPROVE IDENTIFICATION USING ECOMETAGENETICS.",NA,"HIGH-THROUGHPUT; HETERODERA-AVENAE; RIBOSOMAL DNA; DIVERSITY; BIODIVERSITY; MELOIDOGYNE; EXTRACTION; EVOLUTION; ALIGNMENT; BARCODE","ENGLISH","ARTICLE","ARTICLE",3,"ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/NAR/25.17.3389.;ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;BALDWIN DS, 2013, MOL ECOL, V22, P1746, DOI 10.1111/MEC.12190.;BIK HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/J.TREE.2011.11.010.;BLAXTER M, 2005, PHILOS T ROY SOC B, V360, P1935, DOI 10.1098/RSTB.2005.1725.;BLOEMERS GF, 1995, PEDOBIOLOGIA, V39, P331.;BLOK VC, 2010, ROOT-KNOT NEMATODES, P98.;CAPORASO JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/NMETH.F.303.;CASTAGNONE-SERENO P, 2013, ANNU REV PHYTOPATHOL, V51, P203, DOI 10.1146/ANNUREV-PHYTO-082712-102300.;CHARITON AA, 2010, FRONT ECOL ENVIRON, V8, P233, DOI 10.1890/090115.;CHOU HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/BIOINFORMATICS/17.12.1093.;CREER S, 2010, MOL ECOL, V19, P4, DOI 10.1111/J.1365-294X.2009.04473.X.;DE WAELE D, 2007, ANNU REV PHYTOPATHOL, V45, P457, DOI 10.1146/ANNUREV.PHYTO.45.062806.094438.;EASTWELL KC, 1995, PLANT DIS, V79, P822, DOI 10.1094/PD-79-0822.;EDGAR RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/NAR/GKH340.;FONSECA VG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/NAR/GKS002.;FOURNIER D, 2010, J NEMATOL, V42, P242.;FRECKMAN DW, 1977, J NEMATOL, V9, P176.;GASPAR JM, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0060458.;HOCKLAND S, 2006, PLANT NEMATOLOGY, P327, DOI 10.1079/9781845930561.0327.;HODDA M, 2006, FRESHWATER NEMATODES: ECOLOGY AND TAXONOMY, P31, DOI 10.1079/9780851990095.0031.;HODDA M, 2009, PHYTOPATHOLOGY, V99, P1387, DOI 10.1094/PHYTO-99-12-1387.;HOOPER D. J., 1986, LABORATORY METHODS FOR WORK WITH PLANT AND SOIL NEMATODES., P5.;HUGALL A, 1999, MOL BIOL EVOL, V16, P157, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A026098.;LEHMAN PS, 2004, NEMATOLOGY ADV PERSP, V2, P1133.;LIU W. H., 2012, BIOCHEM BIOPH RES CO, V294, P347.;MCSORLEY R, 1991, AGR ECOSYST ENVIRON, V34, P201, DOI 10.1016/0167-8809(91)90106-8.;MCSORLEY R., 1987, P13.;MCTAGGART S, 2007, GENETICS, V175, P311, DOI 10.1534/GENETICS.105.050229.;MEAGHER JW, 1977, J NEMATOL, V9, P9.;MORGAN MAJ, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0056738.;PARMENTIER I, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0054921.;PATTISON AB, 2008, APPL SOIL ECOL, V40, P155, DOI 10.1016/J.APSOIL.2008.04.002.;PATTISON AB, 2011, AUSTRALAS PLANT PATH, V40, P385, DOI 10.1007/S13313-011-0055-9.;PAUTASSO M, 2013, FUNGAL ECOL, V6, P129, DOI 10.1016/J.FUNECO.2012.04.004.;PORAZINSKA DL, 2010, ZOOTAXA, P55, DOI 10.11646/ZOOTAXA.2427.1.6.;PORAZINSKA DL, 2012, J NEMATOL, V44, P18.;PORAZINSKA DL, 2010, MOL ECOL RESOUR, V10, P666, DOI 10.1111/J.1755-0998.2009.02819.X.;PORAZINSKA DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/J.1755-0998.2009.02611.X.;POWERS T, 2011, J NEMATOL, V43, P35.;SASSER JN, 1983, ANNU REV PHYTOPATHOL, V21, P271, DOI 10.1146/ANNUREV.PY.21.090183.001415.;SCHLOSS PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09.;SHEPHERD A. M., 1986, LAB METHODS WORK PLA, P31.;SINGH SK, 2013, ANN APPL BIOL, V163, P323, DOI 10.1111/AAB.12065.;SINGH S. K., 2013, B OEPP EPPO B, V43, P3344.;SMILEY RW, 2005, J NEMATOL, V37, P297.;SMILEY RW, 2010, CEREAL CYST NEMATODE.;SOUTHEY J. F., 1986, LABORATORY METHODS FOR WORK WITH PLANT AND SOIL NEMATODES., P1.;STIRLING G., 1999, RIRDC PUBL.;STIRLING GR, 2011, NEMATROPICA, V41, P109.;SUBBOTIN SA, 2010, NEMATOL MONOGR PER B, V8, P1.;VSN INTERNATIONAL, 2011, GENSTAT WINDOWS.;WAEYENBERGE L., 2009, P 1 WORKSH INT CER C, P109.;WHITEHEAD A. G., 1998, PLANT NEMATODE CONTR.;WHITHAM TG, 2008, SCIENCE, V320, P492, DOI 10.1126/SCIENCE.1153918.;YANG CX, 2013, SCI CHINA LIFE SCI, V56, P73, DOI 10.1007/S11427-012-4423-7.;YEATES GW, 1993, J NEMATOL, V25, P315.;ZHANG Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478.;ZHANG ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/ZOOTAXA.3703.1.1.;ZHAO Y, 2005, MOL BIOTECHNOL, V31, P55, DOI 10.1385/MB:31:1:055.","HODDA, M (REPRINT AUTHOR), CSIRO ECOSYST SCI, GPO BOX 1700, CANBERRA, ACT 2601, AUSTRALIA.;PORAZINSKA, DOROTA L., UNIV FLORIDA, FT LAUDERDALE RES \& EDUC CTR, FT LAUDERDALE, FL 33314 USA.;PORAZINSKA, DOROTA L., MORGAN, MATTHEW J., COURT, LEON N., HARDY, CHRISTOPHER M., HODDA, MIKE, CSIRO ECOSYST SCI, CANBERRA, ACT 2601, AUSTRALIA.;GASPAR, JOHN M., UNIV NEW HAMPSHIRE, DEPT MOL CELLULAR \& BIOMED SCI, DURHAM, NH 03824 USA.","10.1094/PHYTO-08-13-0236-R","3340 PILOT KNOB ROAD, ST PAUL, MN 55121 USA",NA,NA,"OFFICE OF THE CHIEF EXECUTIVE CSIRO","WE THANK THE OFFICE OF THE CHIEF EXECUTIVE CSIRO FOR FUNDING THE DISTINGUISHED VISITING FELLOWSHIP THAT MADE THIS WORK POSSIBLE, THE CSIRO BIOSECURITY FLAGSHIP FOR OPERATING FUNDS, R. EICHNER (AUSTRALIAN DEPARTMENT OF AGRICULTURE FISHERIES \& FORESTRY, MELBOURNE), S. BUIYAN (BUREAU OF SUGAR EXPERIMENT STATIONS, BUNDABERG), T. PATTISON (DEPARTMENT OF AGRICULTURE FORESTRY \& FISHERIES QUEENSLAND, SOUTH JOHNSTONE), AND G. STIRLING (BIOLCROP, BRISBANE) FOR SUPPLYING SUBSTRATES, AND J. LEWIS (SARDI) FOR SUPPLYING NEMATODE CULTURES.",NA,"0031-949X","7","749-761","AMER PHYTOPATHOLOGICAL SOC","104",2014,"ISI000337849800008","60","PLANT SCIENCES","29","PLANT SCIENCES","MIKE.HODDACSIRO.AU",NA,"AJ7AQ",NA,"HODDA, M (REPRINT AUTHOR), CSIRO ECOSYST SCI, GPO BOX 1700, CANBERRA, ACT 2601, AUSTRALIA","ISI","UNIV FLORIDA;CSIRO ECOSYST SCI;UNIV NEW HAMPSHIRE","CSIRO ECOSYST SCI",NA,"PORAZINSKA DL, 2014, PHYTOPATHOLOGY","PORAZINSKA DL, 2014, PHYTOPATHOLOGY"
"YANG T, 2014, CLIN CHIM ACTA","YANG T;MENG Y;WEI X;SHEN J;ZHANG M;QI C;WANG C;LIU J;MA M;HUANG S","IDENTIFICATION OF NOVEL MUTATIONS OF PKD1 GENE IN CHINESE PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE BY TARGETED NEXT-GENERATION SEQUENCING","CLINICA CHIMICA ACTA","CLIN. CHIM. ACTA","BACKGROUND: MUTATIONS OF PKD1 AND PKD2 ACCOUNTED FOR THE MOST CASES OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD). THE PRESENCE OF THE LARGE TRANSCRIPT, NUMEROUS EXONS AND COMPLEX REITERATED REGIONS WITHIN THE GENE HAS SIGNIFICANTLY COMPLICATED THE ANALYSIS OF PKD1 WITH ROUTINE PCR-BASED APPROACHES. METHODS: WE DEVELOPED A STRATEGY TO ANALYZE BOTH THE PKD1/PKD2 GENES SIMULTANEOUSLY USING TARGETED NEXT-GENERATION SEQUENCING (NGS). ALL CODING EXONS PLUS THE FLANKING SEQUENCES OF PKD1 AND PKD2 GENES FROM PROBANDS WERE CAPTURED, INDIVIDUALLY BARCODED AND FOLLOWED BY HISEQ2000 SEQUENCING. THE CANDIDATE VARIANTS WERE VALIDATED BY USING CLASSIC SANGER SEQUENCING. PKD1-SPECIFIC PRIMERS WERE DESIGNED TO AMPLIFY THE REPLICATED AREAS OF PKD1 GENE. RESULTS: FIVE NOVEL VARIATIONS AND ONE KNOWN MUTATION IN PKD1 GENE WERE DETECTED IN FIVE FAMILIAL AND ONE SPORADIC CHINESE ADPKD PATIENTS. THROUGH PEDIGREE AND BIOINFORMATIC ANALYSIS, FIVE OF THEM WERE IDENTIFIED AS PATHOGENIC MUTATIONS (P.G1319R, P.Y3781* P.W4122*","ADPKD; MUTATION; PKD1; TARGETED NEXT-GENERATION SEQUENCING","I-TASSER; PROTEIN; PREDICTION; DIAGNOSIS; CRITERIA; ENCODES; REGION; SERVER; ADPKD","ENGLISH","ARTICLE","ARTICLE",12,"ADZHUBEI IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/NMETH0410-248.;BYCROFT M, 1999, EMBO J, V18, P297, DOI 10.1093/EMBOJ/18.2.297.;DALGAARD O Z, 1957, ACTA MED SCAND SUPPL, V328, P1.;DEN DUNNEN JT, 2000, HUM MUTAT, V15, P7.;GOUT AM, 2007, HUM MUTAT, V28, P654, DOI 10.1002/HUMU.20474.;GUEX N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/ELPS.1150181505.;HARRIS PC, 2006, J AM SOC NEPHROL, V17, P3013, DOI 10.1681/ASN.2006080835.;HATEBOER N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3.;HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/NG0695-151.;NG PC, 2001, GENOME RES, V11, P863, DOI 10.1101/GR.176601.;PEI Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507.;PERRICHOT RA, 1999, HUM GENET, V105, P231, DOI 10.1007/S004390051094.;PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128.;PHAKDEEKITCHAROEN B, 2000, KIDNEY INT, V58, P1400, DOI 10.1046/J.1523-1755.2000.00302.X.;QI XP, 2013, GENE, V516, P93, DOI 10.1016/J.GENE.2012.12.060.;RAVINE D, 1994, LANCET, V343, P824, DOI 10.1016/S0140-6736(94)92026-5.;ROSSETTI S, 2002, KIDNEY INT, V61, P1588, DOI 10.1046/J.1523-1755.2002.00326.X.;ROSSETTI S, 2002, J AM SOC NEPHROL, V13, P1230, DOI 10.1097/01.ASN.0000013300.11876.37.;ROSSETTI S, 2007, J AM SOC NEPHROL, V18, P2143, DOI 10.1681/ASN.2006121387.;ROSSETTI S, 2012, J AM SOC NEPHROL, V23, P915, DOI 10.1681/ASN.2011101032.;ROY A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/NPROT.2010.5.;SCHULZEGAHMEN U, 1996, J MED CHEM, V39, P4540, DOI 10.1021/JM960402A.;SHENDURE J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/NBT1486.;THOMAS R, 1999, AM J HUM GENET, V65, P39, DOI 10.1086/302460.;WARD CJ, 1994, CELL, V77, P881.;WATNICK TJ, 1998, HUM MOL GENET, V7, P1239, DOI 10.1093/HMG/7.8.1239.;WEI XM, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0029500.;YU CW, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-164.;ZHANG SZ, 2005, NEPHRON EXP NEPHROL, V100, P63, DOI 10.1159/000084572.;ZHANG Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40.","YANG, T (REPRINT AUTHOR), CHINESE ACAD MED SCI, INST BASIC MED SCI, DEPT MED GENET, 5 DONG DAN SAN TIAO, BEIJING 100005, PEOPLES R CHINA.;YANG, TAO, MENG, YAN, QI, CHEN, WANG, CHUNDAN, MA, MINRUI, HUANG, SHANGZHI, CHINESE ACAD MED SCI, INST BASIC MED SCI, SCH BASIC MED,PEKING UNION MED COLL,DEPT MED GENE, WHO COLLABORATING CTR COMMUNITY CONTROL HEREDITAR, BEIJING 100005, PEOPLES R CHINA.;WEI, XIAOMING, ZHANG, MINGRONG, BGI SHENZHEN, SHENZHEN, PEOPLES R CHINA.;SHEN, JIANDONG, LIU, JIAYIN, NANJING MED UNIV, AFFILIATED HOSP 1, CLIN CTR REPROD MED, STATE KEY LAB REPROD MED, NANJING, JIANGSU, PEOPLES R CHINA.","10.1016/J.CCA.2014.02.011","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"NATIONAL KEY TECHNOLOGY R\&D PROGRAM DURING THE TWELFTH FIVE-YEAR PLAN PERIOD FROM THE CHINESE MINISTRY OF SCIENCE AND TECHNOLOGY [2013BAI12B01-1], SCIENTIFIC RESEARCH FOUNDATION FOR OVERSEA-RETURNED CHINESE SCHOLARS FROM STATE HUMAN RESOURCE MINISTRY AND THE EDUCATION MINISTRY, CHINA [1139-42]","WE ARE GRATEFUL TO ALL PATIENTS AND THEIR FAMILIES, AS WELL AS THE NORMAL VOLUNTEERS FOR THEIR PARTICIPATION IN THIS RESEARCH. THIS WORK WAS SUPPORTED BY THE NATIONAL KEY TECHNOLOGY R\&D PROGRAM DURING THE TWELFTH FIVE-YEAR PLAN PERIOD FROM THE CHINESE MINISTRY OF SCIENCE AND TECHNOLOGY (2013BAI12B01-1) AND A PROJECT SUPPORTED BY THE SCIENTIFIC RESEARCH FOUNDATION FOR OVERSEA-RETURNED CHINESE SCHOLARS FROM THE STATE HUMAN RESOURCE MINISTRY AND THE EDUCATION MINISTRY, CHINA (2011-ISSUE 1139-42).",NA,"0009-8981",NA,"12-19","ELSEVIER SCIENCE BV","433",2014,"ISI000337992200003","30","MEDICAL LABORATORY TECHNOLOGY","0","MEDICAL LABORATORY TECHNOLOGY","TYANGIBMS.PUMC.EDU.CN HSZ\_PUMCIBMS.PUMC.EDU.CN",NA,"AJ8XU",NA,"YANG, T (REPRINT AUTHOR), CHINESE ACAD MED SCI, INST BASIC MED SCI, DEPT MED GENET, 5 DONG DAN SAN TIAO, BEIJING 100005, PEOPLES R CHINA","ISI","PEKING UNION MED COLL;NANJING MED UNIV","INST BASIC MED SCI",NA,"YANG T, 2014, CLIN CHIM ACTA","YANG T, 2014, CLIN CHIM ACTA"
"CUBRY P, 2014, PLANT BREED","CUBRY P;PUJADE RENAUD V;GARCIA D;ESPEOUT S;LE GUEN V;GRANET F;SEGUIN M","DEVELOPMENT AND CHARACTERIZATION OF A NEW SET OF 164 POLYMORPHIC EST-SSR MARKERS FOR DIVERSITY AND BREEDING STUDIES IN RUBBER TREE (HEVEA BRASILIENSIS MULL. ARG.)","PLANT BREEDING","PLANT BREED.","DESPITE ITS ECONOMIC IMPORTANCE AND RECENT GENOME RELEASE, THE NEED FOR MOLECULAR TOOLS FOR HEVEA BRASILIENSIS IS HIGH. IN THE FRAME OF A DISEASE RESISTANCE STUDY, EST SEQUENCES WERE RETRIEVED FROM PUBLIC DATABASE OR GENERATED BY SEQUENCING SSH LIBRARIES. SEQUENCES WERE TRIMMED AND MICROSATELLITE MOTIFS SEARCHED USING AN AD HOC BIOINFORMATIC PIPELINE, AND PAIRS OF PRIMERS FOR THE AMPLIFICATION OF CANDIDATE MARKERS WERE GENERATED. WE FOUND A TOTAL OF 10499 UNIGENES FROM BOTH SOURCES OF SEQUENCES, AND 673 MICROSATELLITES MOTIFS WERE DETECTED USING THE DEFAULT PARAMETERS OF THE PIPELINE. TWO HUNDRED SIXTY-FOUR PRIMER PAIRS WERE TESTED AND 226 (85.6\%) SUCCESSFULLY AMPLIFIED. OUT OF THE AMPLIFIED CANDIDATE MARKERS, 164 EXHIBITED POLYMORPHISM. RELATIONSHIPS BASED ON DENDROGRAMS USING SIMPLE MATCHING INDEX AND DIVERSITY STATISTICS BASED ON EST-SSRS WERE COMPARED WITH GENOMIC SSRS, SHOWING THE POTENTIALITIES OF EST-DERIVED MICROSATELLITES FOR RESISTANCE STUDIES BUT ALSO FOR POPULATION GENETICS APPROACHES.","EST-SSR; MICROSATELLITES; RUBBER TREE; HEVEA SPP; MICROCYCLUS ULEI","GENETIC-LINKAGE MAP; MICROSATELLITE MARKERS; DISEQUILIBRIUM; ASSOCIATION; POPULATIONS; SEQUENCES; PLANTS; RFLP; WILD","ENGLISH","ARTICLE","ARTICLE",10,"ARGOUT X, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-512.;BESSE P, 1994, THEOR APPL GENET, V88, P199, DOI 10.1007/BF00225898.;CONESA A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/BIOINFORMATICS/BTI610.;CUBRY P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-10.;ELLIS JR, 2007, HEREDITY, V99, P125, DOI 10.1038/SJ.HDY.6801001.;FENG SP, 2009, MOL BREEDING, V23, P85, DOI 10.1007/S11032-008-9216-0.;GARCIA D, 2011, PHYSIOL MOL PLANT P, V76, P126, DOI 10.1016/J.PMPP.2011.07.006.;GUPTA PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/S11103-005-0257-Z.;GUPTA S, 2013, PLANT BREEDING, V132, P367, DOI 10.1111/PBR.12070.;KUMAR YADAV H., 2010, TREE GENET GENOMES, V7, P207.;LE GUEN V, 2011, PLANT BREEDING, V130, P294, DOI 10.1111/J.1439-0523.2010.01774.X.;LE GUEN V, 2009, TREE GENET GENOMES, V5, P673, DOI 10.1007/S11295-009-0218-9.;LE GUEN V., 2008, EXPLORATION DIVERSIT.;LESPINASSE D, 2000, THEOR APPL GENET, V100, P127, DOI 10.1007/S001220050018.;LI DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192.;LIU KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/BIOINFORMATICS/BTI282.;OHYAMA A, 2009, MOL BREEDING, V23, P685, DOI 10.1007/S11032-009-9265-Z.;PEROVIC D, 2009, MOL BREEDING, V23, P641, DOI 10.1007/S11032-009-9262-2.;PERRIER X, 2006, DARWIN SOFTWARE.;PERRIER XAVIER, 2003, P31.;POOTAKHAM W, 2012, PLANT BREEDING, V131, P555, DOI 10.1111/J.1439-0523.2012.01982.X.;RAFALSKI JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/J.PBI.2009.12.004.;ROZEN S, 2000, METHODS MOL BIOL, V132, P365.;SAITOU N, 1987, MOL BIOL EVOL, V4, P406.;SEGUIN MARC, 2003, P277.;SOUZA LM, 2009, CONSERV GENET RESOUR, V1, P75, DOI 10.1007/S12686-009-9018-7.;TRIWITAYAKORN K, 2011, DNA RES, V18, P471, DOI 10.1093/DNARES/DSR034.;TYRKA M, 2008, J APPL GENET, V49, P127, DOI 10.1007/BF03195605.;VARSHNEY RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/J.TIBTECH.2004.11.005.;VIGOUROUX Y, 2005, GENETICS, V169, P1617, DOI 10.1534/GENETICS.104.032086.;WEN MINGFU, 2010, BMC RES NOTES, V3, P42, DOI 10.1186/1756-0500-3-42.","CUBRY, P (REPRINT AUTHOR), CIRAD, UMR AGAP, F-34398 MONTPELLIER, FRANCE.;CUBRY, PHILIPPE, GARCIA, DOMINIQUE, ESPEOUT, SANDRA, LE GUEN, VINCENT, SEGUIN, MARC, CIRAD, UMR AGAP, F-34398 MONTPELLIER, FRANCE.;CUBRY, PHILIPPE, GRANET, FRANCOISE, MANUFACTURE FRANCAISE PNEUMAT MICHELIN, F-63040 CLERMONT FERRAND, FRANCE.;PUJADE-RENAUD, VALERIE, CIRAD, UMR AGAP, F-63000 CLERMONT FERRAND, FRANCE.;PUJADE-RENAUD, VALERIE, UNIV CLERMONT FERRAND, CLERMONT UNIV, UMR PIAF 547, F-63000 CLERMONT FERRAND, FRANCE.","10.1111/PBR.12158","111 RIVER ST, HOBOKEN 07030-5774, NJ USA",NA,NA,"FRENCH NATIONAL RESEARCH AGENCY (AGENCE NATIONALE POUR LA RECHERCHE, CONTRAT ANR/GENOPLANTE) [GPLA07017C]","THIS WORK WAS PERFORMED AS PART OF THE CIRAD - MICHELIN COLLABORATIVE PROJECT `GENESALB' SUPPORTED BY A GRANT FROM THE FRENCH NATIONAL RESEARCH AGENCY (AGENCE NATIONALE POUR LA RECHERCHE, CONTRAT ANR/GENOPLANTE NO GPLA07017C). WE THANK THE MONTPELLIER LANGUEDOC-ROUSSILLON GRAND PLATEAU TECHNIQUE REGIONAL FOR HOSTING THE SSR GENOTYPING ACTIVITIES. ESTTIK DATABASE WAS MADE AVAILABLE BY THE SOUTHGREEN BIOINFORMATICS PLATFORM AT HTTP://SOUTHGREEN.CIRAD.FR/. WE THANK RONAN RIVALLAN FOR TECHNICAL HELP, XAVIER ARGOUT FOR COMPUTATIONAL PROCEDURES AND DATA RETRIEVING, GERALD OLIVER FOR KEEPING SOME VEGETAL MATERIAL IN A GREENHOUSE IN MONTPELLIER, JEAN-MARC THEVENIN AND FABIEN DOARE FOR PROVIDING US WITH SOME FRESH MATERIAL FROM CIRAD'S POINTE COMBI CENTRE (FRENCH GUYANA) COLLECTION.",NA,"0179-9541","3","419-426","WILEY-BLACKWELL","133",2014,"ISI000337680000015","31","AGRICULTURE, BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, PLANT SCIENCES","21","AGRONOMY, BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, PLANT SCIENCES","PHILIPPE.CUBRYHOTMAIL.FR",NA,"AJ4WP",NA,"CUBRY, P (REPRINT AUTHOR), CIRAD, UMR AGAP, F-34398 MONTPELLIER, FRANCE","ISI","MANUFACTURE FRANCAISE PNEUMAT MICHELIN;UNIV CLERMONT FERRAND","NOTREPORTED",NA,"CUBRY P, 2014, PLANT BREED","CUBRY P, 2014, PLANT BREED"
"ROMERO R, 2014, MICROBIOME","ROMERO R;HASSAN SS;GAJER P;TARCA AL;FADROSH DW;BIEDA J;CHAEMSAITHONG P;MIRANDA J;CHAIWORAPONGSA T;RAVEL J","THE VAGINAL MICROBIOTA OF PREGNANT WOMEN WHO SUBSEQUENTLY HAVE SPONTANEOUS PRETERM LABOR AND DELIVERY AND THOSE WITH A NORMAL DELIVERY AT TERM","MICROBIOME","MICROBIOME","BACKGROUND: THIS STUDY WAS UNDERTAKEN TO DETERMINE WHETHER THE VAGINAL MICROBIOTA OF PREGNANT WOMEN WHO SUBSEQUENTLY HAD A SPONTANEOUS PRETERM DELIVERY IS DIFFERENT FROM THAT OF WOMEN WHO HAD A TERM DELIVERY. RESULTS: THIS WAS A NESTED CASE-CONTROL STUDY OF PREGNANT WOMEN WHO HAD A TERM DELIVERY (CONTROLS) AND THOSE WHO HAD A SPONTANEOUS PRETERM DELIVERY BEFORE 34 WEEKS OF GESTATION (CASES). SAMPLES OF VAGINAL FLUID WERE COLLECTED LONGITUDINALLY AND STORED AT -70 DEGREES C UNTIL ASSAYED. A MICROBIAL SURVEY USING PYROSEQUENCING OF V1-V3 REGIONS OF 16S RRNA GENES WAS PERFORMED. WE TESTED THE HYPOTHESIS OF WHETHER THE RELATIVE ABUNDANCE OF INDIVIDUAL MICROBIAL SPECIES (PHYLOTYPES) WAS DIFFERENT BETWEEN WOMEN WHO HAD A TERM VERSUS PRETERM DELIVERY. A SUITE OF BIOINFORMATIC AND STATISTICAL TOOLS, INCLUDING LINEAR MIXED EFFECTS MODELS AND GENERALIZED ESTIMATING EQUATIONS, WAS USED. WE SHOW THAT: 1) THE COMPOSITION OF THE VAGINAL MICROBIOTA DURING NORMAL PREGNANCY CHANGED AS A FUNCTION OF GESTATIONAL AGE, WITH AN INCREASE IN THE RELATIVE ABUNDANCE OF FOUR LACTOBACILLUS SPP., AND DECREASED IN ANAEROBE OR STRICT-ANAEROBE MICROBIAL SPECIES AS PREGNANCY PROGRESSED, 2) NO BACTERIAL TAXA DIFFERED IN RELATIVE ABUNDANCE BETWEEN WOMEN WHO HAD A SPONTANEOUS PRETERM DELIVERY AND THOSE WHO DELIVERED AT TERM, AND 3) NO DIFFERENCES IN THE FREQUENCY OF THE VAGINAL COMMUNITY STATE TYPES (CST I, III, IV-B) BETWEEN WOMEN WHO DELIVERED AT TERM AND THOSE WHO DELIVERED PRETERM WERE DETECTED. CONCLUSIONS: THE BACTERIAL TAXA COMPOSITION AND ABUNDANCE OF VAGINAL MICROBIAL COMMUNITIES, CHARACTERIZED WITH 16S RRNA GENE SEQUENCE-BASED TECHNIQUES, WERE NOT DIFFERENT IN PREGNANT WOMEN WHO SUBSEQUENTLY DELIVERED A PRETERM NEONATE VERSUS THOSE WHO DELIVERED AT TERM.","INFECTION-INDUCED PRETERM DELIVERY; HISTOLOGIC CHORIOAMNIONITIS; PREMATURITY; VAGINAL FLORA; VAGINAL MICROBIOME","AMNIOTIC-FLUID INFECTION; LOW-BIRTH-WEIGHT; ASYMPTOMATIC BACTERIAL VAGINOSIS; POLYMERASE-CHAIN-REACTION; RIBOSOMAL-RNA GENES; INTRAAMNIOTIC INFECTION; UREAPLASMA-UREALYTICUM; INTACT MEMBRANES; PREMATURE LABOR; RISK-FACTOR","ENGLISH","ARTICLE","ARTICLE",79,"AAGAARD K, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0036466.;ANDREWS WW, 2006, AM J OBSTET GYNECOL, V194, P493, DOI 10.1016/J.AJOG.2005.08.054.;ANDREWS WW, 2000, AM J PERINAT, V17, P357, DOI 10.1055/S-2000-13448.;ANDREWS WW, 1995, INFECT AGENT DIS, V4, P196.;BACKHED F, 2005, SCIENCE, V307, P1915, DOI 10.1126/SCIENCE.1104816.;BECK S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554.;BEHRMAN RE, 2007, PRETERM BIRTH CAUSES, P398.;BENIRSCHKE K, 1960, AMA J DIS CHILD, V99, P714, DOI 10.1001/ARCHPEDI.1960.02070030716003.;BLANC WA, 1961, J PEDIATR-US, V59, P473, DOI 10.1016/S0022-3476(61)80232-1.;BLENCOWE H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4.;BOBITT JR, 1981, AM J OBSTET GYNECOL, V140, P947, DOI 10.1016/0002-9378(81)90090-9.;BROCKLEHURST P, 2013, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD000262.PUB4.;BROTMAN RM, 2008, CLIN INFECT DIS, V47, P44, DOI 10.1086/588662.;BRUNER JP, 1986, AM J PERINAT, V3, P213, DOI 10.1055/S-2007-999870.;CAPORASO JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/NMETH.F.303.;CAREY JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802.;CHAIM W, 1997, ARCH GYNECOL OBSTET, V259, P51, DOI 10.1007/BF02505309.;CHO I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/NRG3182.;CLARK P, 1994, INFECT DIS OBSTET GYNECOL, V2, P179, DOI 10.1155/S106474499400061X.;COTCH MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008.;DAMMANN O, 1997, DEV MED CHILD NEUROL, V39, P836.;DENNEY JM, 2009, SEMIN FETAL NEONAT M, V14, P200, DOI 10.1016/J.SINY.2009.01.008.;DEVILLARD ESTELLE, 2005, INFECT DIS OBSTET GYNECOL, V13, P25.;DIGIULIO DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/J.1600-0897.2010.00830.X.;DIGIULIO DB, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0003056.;DONDERS GG, 2009, BJOG-INT J OBSTET GY, V116, P1315, DOI 10.1111/J.1471-0528.2009.02237.X.;DONDERS G. G., 2010, ULTRASOUND OBST GYN, DOI [10.1002/UOG.7568, DOI 10.1002/UOG.7568].;DONDERS GGG, 2011, BJOG-INT J OBSTET GY, V118, P1163, DOI 10.1111/J.1471-0528.2011.03020.X.;DONDERS GGG, 2000, AM J OBSTET GYNECOL, V183, P431, DOI 10.1067/MOB.2000.105738.;DONDERS GGG, 2002, BJOG-INT J OBSTET GY, V109, P34, DOI 10.1016/S1470-0328(02)00432-9.;DONDERS GGG, 2000, ULTRASOUND OBST GYN, V16, P496, DOI 10.1046/J.1469-0705.2000.00275-3.X.;ECKBURG PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/SCIENCE.1110591.;EDGAR RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/BIOINFORMATICS/BTR381.;EDGAR RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/BIOINFORMATICS/BTQ461.;ELOVITZ M, 2014, AM J OBSTET GYNECOL, V210, PS16, DOI 10.1016/J.AJOG.2013.10.059.;ESCHENBACH D A, 1984, SCAND J UROL NEPHROL SUPPL, V86, P213.;FORNEY LJ, 2010, J CLIN MICROBIOL, V48, P1741, DOI 10.1128/JCM.01710-09.;FRANK JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07.;FREDRICKS DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07.;FREDRICKS DAVID N, 2005, CURR INFECT DIS REP, V7, P463, DOI 10.1007/S11908-005-0049-2.;FREDRICKS DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMOA043802.;GAJER P., 2012, SCI TRANSL MED, V4, DOI DOI 10.1126/SCITRANSLMED.3003605.;GENC MR, 2011, BJOG-INT J OBSTET GY, V118, P154, DOI 10.1111/J.1471-0528.2010.02772.X.;GIBBS RS, 1993, AM J OBSTET GYNECOL, V169, P460, DOI 10.1016/0002-9378(93)90341-F.;GOLDBERG R. L., 2010, PRETERM BIRTH PREVEN, P22 .;GOLDENBERG RL, 2005, CLIN PERINATOL, V32, P523, DOI 10.1016/J.CLP.2005.04.006.;GOLDENBERG RL, 1996, AM J OBSTET GYNECOL, V174, P1618, DOI 10.1016/S0002-9378(96)70617-8.;GOLDENBERG RL, 1996, OBSTET GYNECOL, V87, P656, DOI 10.1016/0029-7844(96)00034-S.;GOLDENBERG RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4.;GOMEZ LM, 2010, AM J OBSTET GYNECOL, V202, PE381.;GONCALVES LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/MRDD.10008.;GRAVETT MG, 1986, OBSTET GYNECOL, V67, P229, DOI 10.1097/00006250-198602000-00013.;GRAVETT MG, 1986, JAMA-J AM MED ASSOC, V256, P1899.;HAMILTON BRADY E, 2012, NATL VITAL STAT REP, V61, P1.;HAMILTON BE, 2013, PEDIATRICS, V131, P548, DOI 10.1542/PEDS.2012-3769.;HAUTH JC, 2003, AM J OBSTET GYNECOL, V188, P831, DOI 10.1067/MOB.2003.184.;HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/BMJ.308.6924.295.;HILL JE, 2005, AM J OBSTET GYNECOL, V193, P682, DOI 10.1016/J.AJOG.2005.02.094.;HILLIER SL, 1995, CLIN INFECT DIS, V20, PS276, DOI 10.1093/CLINIDS/20.SUPPLEMENT\_2.S276.;HILLIER SL, 1992, AM J OBSTET GYNECOL, V166, P938, DOI 10.1016/0002-9378(92)91368-K.;HILLIER SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604.;HITTI J, 2001, OBSTET GYNECOL, V97, P211, DOI 10.1016/S0029-7844(00)01146-7.;HOLST E, 1994, J CLIN MICROBIOL, V32, P176.;HOLST RM, 2006, ULTRASOUND OBST GYN, V28, P768, DOI 10.1002/UOG.3837.;HUTTENHOWER C, 2012, NATURE, V486, P207, DOI 10.1038/NATURE11234.;IAMS JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7.;JACOBSSON B, 2005, BJOG-INT J OBSTET GY, V112, P719, DOI 10.1111/J.1471-0528.2005.00536.X.;JACOBSSON B, 2003, ACTA OBSTET GYN SCAN, V82, P120, DOI 10.1034/J.1600-0412.2003.00047.X.;JACOBSSON B, 2002, ACTA OBSTET GYN SCAN, V81, P1006, DOI 10.1034/J.1600-0412.2002.811103.X.;KEKKI M, 2001, OBSTET GYNECOL, V97, P643, DOI 10.1016/S0029-7844(01)01321-7.;KINGDOM J, 2005, PLACENTA SA, V26, PS114.;KLEBANOFF MA, 2005, AM J OBSTET GYNECOL, V192, P470, DOI 10.1016/J.AJOG.2004.07.017.;KLEBANOFF MA, 2001, NEW ENGL J MED, V345, P487, DOI 10.1056/NEJMOA003329.;KROHN MA, 1995, J INFECT DIS, V171, P1475, DOI 10.1093/INFDIS/171.6.1475.;LAMBERT D, 1992, AM STAT ASS AM SOC Q, V34, P1, DOI DOI 10.2307/1269547.;LAMONT RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/J.1471-0528.2010.02840.X.;LAMONT RF, 2010, BJOG-INT J OBSTET GY, V117, P119, DOI 10.1111/J.1471-0528.2009.02403.X.;LAMONT RF, 2010, BJOG, V117, P120.;LAMONT RF, 2011, AM J OBSTET GYNECOL, V205, P177, DOI 10.1016/J.AJOG.2011.03.047.;LAXMI U, 2012, J MATERN-FETAL NEO M, V25, P64, DOI 10.3109/14767058.2011.565390.;LEE SE, 2009, J MATERN-FETAL NEO M, V22, P212, DOI 10.1080/14767050802616994.;LEIGH J, 1986, OBSTET GYNECOL, V67, P500.;LEITICH H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/MOB.2003.339.;LEITICH H, 2007, BEST PRACT RES CL OB, V21, P375, DOI 10.1016/J.BPOBGYN.2006.12.005.;LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115.;LITTELL CA, 2006, SAS MIXED MODELS, P567.;LLAHICAMP JM, 1996, HUM REPROD, V11, P1575.;MACONES GA, 2004, AM J OBSTET GYNECOL, V190, P1504, DOI 10.1016/AJOG.2004.01.001.;MARCH OF DIMES, IMP PREM BIRTH SOC.;MARRAZZO JM, 2008, ANN INTERN MED, V149, P20, DOI 10.7326/0003-4819-149-1-200807010-00006.;MARTIUS J, 1990, ARCH GYNECOL OBSTET, V247, P1, DOI 10.1007/BF02390649.;MATSEN FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538.;MCGREGOR J A, 1988, OBSTETRICAL AND GYNECOLOGICAL SURVEY, V43, P1.;MEIS PJ, 1995, AM J OBSTET GYNECOL, V173, P1231, DOI 10.1016/0002-9378(95)91360-2.;MENARD JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661.;MINKOFF H, 1987, INT J GYNECOL OBSTET, V25, P17, DOI 10.1016/0020-7292(87)90179-2.;MORGAN XC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/JOURNAL.PCBI.1002808.;MUGLIA LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMRA0904308.;NELSON DB, 2014, PAEDIATR PERINAT EP, V28, P88, DOI 10.1111/PPE.12106.;NELSON KE, 2010, SCIENCE, V328, P994, DOI 10.1126/SCIENCE.1183605.;NEWTON ER, 1997, AM J OBSTET GYNECOL, V176, P672, DOI 10.1016/S0002-9378(97)70568-4.;NEWTON ER, 1990, OBSTET GYNECOL, V75, P402.;NOVY MJ, 2009, REPROD SCI, V16, P56, DOI 10.1177/1933719108325508.;NYGREN P, 2008, ANN INTERN MED, V148, P220, DOI 10.7326/0003-4819-148-3-200802050-00008.;OAKESHOTT P, 2002, BRIT MED J, V325, P1334, DOI 10.1136/BMJ.325.7376.1334.;OAKLEY BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07.;OH KJ, 2010, J PERINAT MED, V38, P261, DOI 10.1515/JPM.2010.040.;PACORA P, 2002, J MATERN FETAL NEONATAL MED, V11, P18, DOI 10.1080/713605445.;PAVLOVA SI, 2002, J APPL MICROBIOL, V92, P451, DOI 10.1046/J.1365-2672.2002.01547.X.;PETERSON J, 2009, GENOME RES, V19, P2317, DOI 10.1101/GR.096651.109.;PETROSINO JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/CLINCHEM.2008.107565.;QIN JJ, 2010, NATURE, V464, P59, DOI 10.1038/NATURE08821.;RACICOT K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/JIMMUNOL.1300661.;RALPH SG, 1999, BRIT MED J, V319, P220, DOI 10.1136/BMJ.319.7204.220.;RAVEL J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/PNAS.1002611107.;REDLINE RW, 2006, SEMIN FETAL NEONAT M, V11, P296, DOI 10.1016/J.SINY.2006.02.011.;REDLINE RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/S10024-003-7070-Y.;RELMAN DA, 2012, NATURE, V486, P194, DOI 10.1038/486194A.;ROMERO P, 2009, CREASY RESNIKS MATER, P521.;ROMERO R, 1994, ANN NY ACAD SCI, V734, P414, DOI 10.1111/J.1749-6632.1994.TB21771.X.;ROMERO R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/J.1471-0528.2006.01120.X.;ROMERO R, 1992, AM J OBSTET GYNECOL, V166, P1382, DOI 10.1016/0002-9378(92)91609-E.;ROMERO R, 1988, SEMIN PERINATOL, V12, P262.;ROMERO R, 1988, AM J OBSTET GYNECOL, V159, P661, DOI 10.1016/S0002-9378(88)80030-9.;ROMERO R, 1988, CLIN OBSTET GYNECOL, V31, P553, DOI 10.1097/00003081-198809000-00006.;ROMERO R, 2004, AM J OBSTET GYNECOL, V190, P1509, DOI 10.1016/AJOG.2004.01.002.;ROMERO R, 1989, OBSTET GYNECOL, V73, P532.;ROMERO R, 2001, PAEDIATR PERINAT EP, V15, P41, DOI 10.1046/J.1365-3016.2001.00007.X.;ROMERO R, 1989, AM J OBSTET GYNECOL, V161, P817, DOI 10.1016/0002-9378(89)90409-2.;ROMERO R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4.;ROMERO R, 2013, J PERINAT MED, V41, P27, DOI 10.1515/JPM-2012-0272.;ROMERO ROBERTO, 2002, SEMIN NEONATOL, V7, P259, DOI 10.1016/S1084-2756(02)90121-1.;RUSSELL RB, 2007, PEDIATRICS, V120, PE1, DOI 10.1542/PEDS.2006-2386.;SHERMAN DJ, 1997, EUR J CLIN MICROBIOL, V16, P417, DOI 10.1007/BF02471905.;SILVER HM, 1989, AM J OBSTET GYNECOL, V161, P808, DOI 10.1016/0002-9378(89)90406-7.;TAMRAKAR R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-128.;TRAMA JP, 2008, MOL CELL PROBE, V22, P96, DOI 10.1016/J.MCP.2007.08.002.;TURNBAUGH PJ, 2007, NATURE, V449, P804, DOI 10.1038/NATURE06244.;VERHELST R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16.;VERSTRAELEN H, 2004, AM J OBSTET GYNECOL, V191, P1130, DOI 10.1016/J.AJOG.2004.04.013.;VERSTRAELEN H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116.;VOGEL I, 2006, ACTA OBSTET GYN SCAN, V85, P778, DOI 10.1080/00016340500442423.;WAHBEH CJ, 1984, AM J OBSTET GYNECOL, V148, P739, DOI 10.1016/0002-9378(84)90558-1.;WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063A0.;WATTS DH, 1989, OBSTET GYNECOL, V73, P52.;WATTS DH, 1992, OBSTET GYNECOL, V79, P351.;WATTS DH, 1990, OBSTET GYNECOL, V75, P52.;WEN A, 2014, J INFECT DIS, V209, P1087, DOI 10.1093/INFDIS/JIT632.;WHO, 2012, BORN TOO SOON GLOB A.;YAMAMOTO T, 2009, J PEDIATR ADOL GYNEC, V22, P11, DOI 10.1016/J.JPAG.2008.01.073.;YOON BH, 1998, OBSTET GYNECOL, V92, P77, DOI 10.1016/S0029-7844(98)00122-7.;YOON BH, 2001, AM J OBSTET GYNECOL, V185, P1130, DOI 10.1067/MOB.2001.117680.;YOON BH, 2000, AM J OBSTET GYNECOL, V183, P1130, DOI 10.1067/MOB.2000.109036.;YUAN SQ, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0033865.;ZHOU X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/MIC.0.26905-0.","ROMERO, R (REPRINT AUTHOR), NIH, PERINATOL RES BRANCH, PROGRAM PERINATAL RES \& OBSTET, DIV INTRAMURAL RES,EUNICE KENNEDY SHRIVER NATL IN, BLDG 10, BETHESDA, MD 20892 USA.;ROMERO, ROBERTO, HASSAN, SONIA S., TARCA, ADI L., BIEDA, JANINE, CHAEMSAITHONG, PIYA, MIRANDA, JEZID, CHAIWORAPONGSA, TINNAKORN, NIH, PERINATOL RES BRANCH, PROGRAM PERINATAL RES \& OBSTET, DIV INTRAMURAL RES,EUNICE KENNEDY SHRIVER NATL IN, BETHESDA, MD 20892 USA.;ROMERO, ROBERTO, UNIV MICHIGAN, DEPT OBSTET \& GYNAECOL, ANN ARBOR, MI 48109 USA.;ROMERO, ROBERTO, MICHIGAN STATE UNIV, DEPT EPIDEMIOL \& BIOSTAT, E LANSING, MI 48824 USA.;HASSAN, SONIA S., CHAIWORAPONGSA, TINNAKORN, WAYNE STATE UNIV, SCH MED, DEPT OBSTET \& GYNAECOL, DETROIT, MI 48201 USA.;GAJER, PAWEL, FADROSH, DOUGLAS W., RAVEL, JACQUES, UNIV MARYLAND, SCH MED, INST GENOME SCI, BALTIMORE, MD 21201 USA.;GAJER, PAWEL, RAVEL, JACQUES, UNIV MARYLAND, SCH MED, DEPT MICROBIOL \& IMMUNOL, BALTIMORE, MD 21201 USA.;BIEDA, JANINE, CHAIWORAPONGSA, TINNAKORN, HUTZEL WOMENS HOSP, DETROIT MED CTR, DETROIT, MI 48201 USA.","10.1186/2049-2618-2-18","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","18",NA,"EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT, NIH, DHHS","THIS WORK WAS FUNDED, IN PART, BY THE EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT, NIH, DHHS. THE AUTHORS WISH TO ACKNOWLEDGE THE CONTRIBUTIONS OF THE PATIENTS WHO VOLUNTEERED FOR THESE STUDIES, THE MEDICAL AND HEALTHCARE PERSONNEL INVOLVED IN THE RESEARCH EFFORT, AND COLLEAGUES WHO CONTRIBUTED TO THE DISCUSSIONS WHICH EVENTUALLY LED TO THE CONDUCT OF THE STUDY. WE ARE PARTICULARLY GRATEFUL TO DR. SHARON HILLIER OF THE UNIVERSITY OF PITTSBURGH, DR. JACK SOBEL OF WAYNE STATE UNIVERSITY, DR. RONALD LAMONT OF THE UNIVERSITY OF SOUTHERN DENMARK, DR. DAVID RELMAN OF STANFORD UNIVERSITY, DR. SORIN DRAGHICI OF WAYNE STATE UNIVERSITY.",NA,"2049-2618",NA,NA,"BIOMED CENTRAL LTD","2",2014,"ISI000363192200001","155","MICROBIOLOGY","16","MICROBIOLOGY","PRBCHIEFSTAFFMED.WAYNE.EDU PGAJERGMAIL.COM",NA,"CU0FT",NA,"ROMERO, R (REPRINT AUTHOR), NIH, PERINATOL RES BRANCH, PROGRAM PERINATAL RES \& OBSTET, DIV INTRAMURAL RES,EUNICE KENNEDY SHRIVER NATL IN, BLDG 10, BETHESDA, MD 20892 USA","ISI","PERINATOL RES BRANCH;UNIV MICHIGAN;MICHIGAN STATE UNIV;WAYNE STATE UNIV;UNIV MARYLAND;UNIV MARYLAND;DETROIT MED CTR","PERINATOL RES BRANCH",NA,"ROMERO R, 2014, MICROBIOME","ROMERO R, 2014, MICROBIOME"
"BIALASIEWICZ S, 2014, BMC INFECT DIS","BIALASIEWICZ S;MCVERNON J;NOLAN T;LAMBERT SB;ZHAO G;WANG D;NISSEN MD;SLOOTS TP","DETECTION OF A DIVERGENT PARAINFLUENZA 4 VIRUS IN AN ADULT PATIENT WITH INFLUENZA LIKE ILLNESS USING NEXT-GENERATION SEQUENCING","BMC INFECTIOUS DISEASES","BMC INFECT. DIS.","BACKGROUND: HUMAN PARAINFLUENZA VIRUSES ARE A COMMON CAUSE OF BOTH UPPER AND LOWER RESPIRATORY TRACT INFECTIONS, PARTICULARLY IN CHILDREN. OF THE FOUR PARAINFLUENZA VIRUS SEROTYPES, PARAINFLUENZA 4 IS LEAST WELL CHARACTERISED FROM BOTH THE CLINICAL, EPIDEMIOLOGICAL AND GENETIC PERSPECTIVES. METHODS: FLOCKED NOSE OR THROAT SWABS FROM A PREVIOUS STUDY INVESTIGATING VIRAL PREVALENCE IN COMMUNITY-BASED ADULTS SUFFERING FROM INFLUENZA LIKE ILLNESS WERE USED AS THE BASIS FOR THIS STUDY. SAMPLES IN WHICH NO VIRUS WAS DETECTED USING A 16 VIRAL RESPIRATORY PATHOGEN REAL-TIME PCR PANEL WERE BARCODED AND PYROSEQUENCED USING THE ROCHE 454 GS FLX TITANIUM CHEMISTRY. THE SEQUENCES WERE ANALYSED USING THE VIRUSHUNTER BIOINFORMATIC PIPELINE. SANGER SEQUENCING WAS USED TO COMPLETE THE DETECTED PARAINFLUENZA 4 CODING REGION. RESULTS: A VARIANT PARAINFLUENZA 4 SUBTYPE B STRAIN (QLD-01) WAS DISCOVERED IN AN OTHERWISE HEALTHY ADULT WHO PRESENTED WITH INFLUENZA LIKE ILLNESS. STRAIN QLD-01 SHARED GENOMIC SIMILARITIES WITH BOTH A AND B SUBTYPES. THE EXTENT OF DIVERGENCE OF THIS GENOME FROM THE 5 AVAILABLE WHOLE PARAINFLUENZA 4 GENOMES IMPACTED THE PREDICTED BINDING EFFICIENCIES OF THE MAJORITY OF PUBLISHED PARAINFLUENZA 4 PCR ASSAYS. CONCLUSIONS: THESE FINDINGS FURTHER SUPPORT A POSSIBLE ROLE FOR PARAINFLUENZA 4 IN THE AETIOLOGY OF ADULT RESPIRATORY DISEASE WITHIN THE COMMUNITY SETTING, AND HIGHLIGHT THE CAUTION NEEDED TO BE USED IN DESIGNING PCR ASSAYS FROM LIMITED SEQUENCE INFORMATION OR IN USING PROPRIETARY COMMERCIAL PCR ASSAYS.","PARAINFLUENZA 4; COMMUNITY INFECTION; RESPIRATORY TRACT INFECTION; INFLUENZA LIKE ILLNESS; NEXT GENERATION SEQUENCING; VIRUS DISCOVERY; PCR; FALSE NEGATIVE RESULTS; ADULT","REAL-TIME PCR; EPIDEMIOLOGY; INFECTIONS; SYMPTOMS; CHILDREN; SAMPLES","ENGLISH","ARTICLE","ARTICLE",3,"AGUILAR JC, 2000, J CLIN MICROBIOL, V38, P1191.;ALQUEZAR-PLANAS DE, 2013, SCI REP-UK, V3, DOI 10.1038/SREP02468.;CANCHOLA J, 1964, AM J HYG, V79, P357, DOI 10.1093/OXFORDJOURNALS.AJE.A120390.;CHIU CY, 2006, CLIN INFECT DIS, V43, PE71, DOI 10.1086/507896.;ETHERINGTON GJ, 2005, BIOINFORMATICS, V21, P278, DOI 10.1093/BIOINFORMATICS/BTH500.;FROST HM, 2014, J INFECT DIS, V209, P695, DOI 10.1093/INFDIS/JIT552.;HOLTZ LR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-86.;HOWARD PF, 2013, INFLUENZA OTHER RESP, V7, P330, DOI 10.1111/J.1750-2659.2012.00395.X.;LAU SKP, 2005, J CLIN MICROBIOL, V43, P4515, DOI 10.1128/JCM.43.9.4515-4521.2005.;LAU SKP, 2009, J CLIN MICROBIOL, V47, P1549, DOI 10.1128/JCM.00047-09.;LIU WK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-28.;REIJANS M, 2008, J CLIN MICROBIOL, V46, P1232, DOI 10.1128/JCM.02294-07.;REN LL, 2011, J CLIN VIROL, V51, P209, DOI 10.1016/J.JCV.2011.05.001.;TAMURA K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/MOLBEV/MSR121.;TEMPLETON KE, 2004, J CLIN MICROBIOL.;VAN DE POL AC, 2007, J CLIN MICROBIOL, V45, P2260, DOI 10.1128/JCM.00848-07.;WANG CYT, 2012, J CLIN VIROL, V54, P83, DOI 10.1016/J.JCV.2012.01.013.;ZHANG SW, 2013, J VIROL, V87, P12457, DOI 10.1128/JVI.01565-13.;ZHAO GY, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0078470.","BIALASIEWICZ, S (REPRINT AUTHOR), UNIV QUEENSLAND, QUEENSLAND CHILDRENS MED RES INST, BRISBANE, QLD, AUSTRALIA.;BIALASIEWICZ, SEWERYN, LAMBERT, STEPHEN B., NISSEN, MICHAEL D., SLOOTS, THEO P., UNIV QUEENSLAND, QUEENSLAND CHILDRENS MED RES INST, BRISBANE, QLD, AUSTRALIA.;BIALASIEWICZ, SEWERYN, NISSEN, MICHAEL D., SLOOTS, THEO P., ROYAL CHILDRENS HOSP, QUEENSLAND PAEDIAT INFECT DIS LAB, BRISBANE, QLD, AUSTRALIA.;MCVERNON, JODIE, NOLAN, TERRY, UNIV MELBOURNE, MURDOCH CHILDRENS RES INST, PARKVILLE, VIC 3052, AUSTRALIA.;MCVERNON, JODIE, NOLAN, TERRY, UNIV MELBOURNE, MELBOURNE SCH POPULAT HLTH, PARKVILLE, VIC 3052, AUSTRALIA.;ZHAO, GUOYAN, WANG, DAVID, WASHINGTON UNIV SCH MED, DEPT MOL MICROBIOL, ST LOUIS, MO USA.;ZHAO, GUOYAN, WANG, DAVID, WASHINGTON UNIV SCH MED, DEPT PATHOL \& IMMUNOL, ST LOUIS, MO USA.;BIALASIEWICZ, SEWERYN, SIR ALBERT SAKZEWSKI VIRUS RES CTR, HERSTON, QLD 4029, AUSTRALIA.","10.1186/1471-2334-14-275","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","275",NA,"NIH [U54 AI057160], ARC LINKAGE GRANT [LP0989464], QCMRI PROGRAM [50006], QCMRI EARLY CAREER RESEARCH FELLOWSHIP [50056]","THIS WORK WAS SUPPORTED IN PART BY: NIH GRANT U54 AI057160 TO THE MIDWEST REGIONAL CENTER OF EXCELLENCE FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASE RESEARCH, ARC LINKAGE GRANT LP0989464, AND QCMRI PROGRAM GRANT 50006. SB IS SUPPORTED BY THE QCMRI EARLY CAREER RESEARCH FELLOWSHIP 50056.",NA,"1471-2334",NA,NA,"BIOMED CENTRAL LTD","14",2014,"ISI000336754800003","19","INFECTIOUS DISEASES","3","INFECTIOUS DISEASES","SEWERYNUQ.EDU.AU",NA,"AI3IP",NA,"BIALASIEWICZ, S (REPRINT AUTHOR), UNIV QUEENSLAND, QUEENSLAND CHILDRENS MED RES INST, BRISBANE, QLD, AUSTRALIA","ISI","UNIV QUEENSLAND;ROYAL CHILDRENS HOSP;UNIV MELBOURNE;UNIV MELBOURNE;WASHINGTON UNIV SCH MED;WASHINGTON UNIV SCH MED;SIR ALBERT SAKZEWSKI VIRUS RES CTR","UNIV QUEENSLAND",NA,"BIALASIEWICZ S, 2014, BMC INFECT DIS","BIALASIEWICZ S, 2014, BMC INFECT DIS"
"GU Y, 2014, PLOS ONE","GU Y;LU K;YANG G;CEN Z;YU L;LIN L;HAO J;YANG Z;PENG J;CUI S;HUANG J","MUTATION SPECTRUM OF SIX GENES IN CHINESE PHENYLKETONURIA PATIENTS OBTAINED THROUGH NEXT-GENERATION SEQUENCING","PLOS ONE","PLOS ONE","BACKGROUND: THE IDENTIFICATION OF GENE VARIANTS PLAYS AN IMPORTANT ROLE IN THE DIAGNOSIS OF GENETIC DISEASES. METHODOLOGY/PRINCIPAL FINDINGS: TO DEVELOP A RAPID METHOD FOR THE DIAGNOSIS OF PHENYLKETONURIA (PKU) AND TETRAHYDROBIOPTERIN (BH4) DEFICIENCY, WE DESIGNED A MULTIPLEX, PCR-BASED PRIMER PANEL TO AMPLIFY ALL THE EXONS AND FLANKING REGIONS (50 BP AVERAGE) OF SIX PKU-ASSOCIATED GENES (PAH, PTS, GCH1, QDPR, PCBD1 AND GFRP). THE ION TORRENT PERSONAL GENOME MACHINE (PGM) SYSTEM WAS USED TO DETECT MUTATIONS IN ALL THE EXONS OF THESE SIX GENES. WE TESTED 93 DNA SAMPLES FROM BLOOD SPECIMENS FROM 35 PATIENTS AND THEIR PARENTS (32 FAMILIES) AND 26 HEALTHY ADULTS. USING STRICT BIOINFORMATIC CRITERIA, THIS SEQUENCING DATA PROVIDED, ON AVERAGE, 99.14\% COVERAGE OF THE 39 EXONS AT MORE THAN 70-FOLD MEAN DEPTH OF COVERAGE. WE FOUND 23 PREVIOUSLY DOCUMENTED VARIANTS IN THE PAH GENE AND SIX NOVEL MUTATIONS IN THE PAH AND PTS GENES. A DETAILED ANALYSIS OF THE MUTATION SPECTRUM OF THESE PATIENTS IS DESCRIBED IN THIS STUDY. CONCLUSIONS/SIGNIFICANCE: THESE RESULTS WERE CONFIRMED BY SANGER SEQUENCING. IN CONCLUSION, BENCHTOP NEXT-GENERATION SEQUENCING TECHNOLOGY CAN BE USED TO DETECT MUTATIONS IN MONOGENIC DISEASES AND CAN DETECT BOTH POINT MUTATIONS AND INDELS WITH HIGH SENSITIVITY, FIDELITY AND THROUGHPUT AT A LOWER COST THAN CONVENTIONAL METHODS IN CLINICAL APPLICATIONS.",NA,"PHENYLALANINE-HYDROXYLASE DEFICIENCY; GTP CYCLOHYDROLASE-I; DIAGNOSIS","ENGLISH","ARTICLE","ARTICLE",12,"BLAU N, 2004, MOL GENET METAB, V82, P101, DOI 10.1016/J.YMGME.2004.03.006.;BLAU N, 2011, MOL GENET METAB, V104, PS2, DOI 10.1016/J.YMGME.2011.08.017.;BOLAND JF, 2013, HUM GENET, V132, P1153, DOI 10.1007/S00439-013-1321-4.;CHEN GQ, 2006, J APPL CLIN PEDIAT, V21, P483.;CHIU YH, 2012, J HUM GENET, V57, P145, DOI 10.1038/JHG.2011.146.;COSTA JL, 2013, HUM MUTAT, V34, P629, DOI 10.1002/HUMU.22272.;DWORNICZAK B, 1991, GENOMICS, V11, P242, DOI 10.1016/0888-7543(91)90129-3.;ELLIOTT AARON M, 2012, J BIOMOL TECH, V23, P24, DOI 10.7171/JBT.12-2301-003.;GU XUE-FAN, 2004, ZHONGHUA YUFANG YIXUE ZAZHI, V38, P99.;KOBOLDT DC, 2012, GENOME RES, V22, P568, DOI 10.1101/GR.129684.111.;LI L, 2009, CHINESE J CHILD HLTH, V17, P464.;LI ZY, 2005, HEILONG JIANG MED J, V29, P554.;MITCHELL JJ, 2011, GENET MED, V13, P697, DOI 10.1097/GIM.0B013E3182141B48.;NIEDERWIESER A, 1984, EUR J PEDIATR, V141, P208, DOI 10.1007/BF00572762.;PALLES C, 2013, NAT GENET, V45, P136, DOI 10.1038/NG.2503.;ROTHBERG JM, 2011, NATURE, V475, P348, DOI 10.1038/NATURE10242.;SONG F, 2005, MOL GENET METAB, V86, PS107, DOI 10.1016/J.YMGME.2005.09.001.;THONY B, 2006, HUM MUTAT, V27, P870, DOI 10.1002/HUMU.20366.;TREFF NR, 2013, FERTIL STERIL, V99, P1377, DOI 10.1016/J.FERTNSTERT.2012.12.018.;WANG Z, 2006, CHINESE J BIRTH HLTH, V14, P111.;YOUSEM SA, 2013, CHEST, V143, P1679, DOI 10.1378/CHEST.12-1917.;ZHOU YA, 2012, GENET MOL BIOL, V35, P709, DOI 10.1590/S1415-47572012005000069.","HUANG, J (REPRINT AUTHOR), NATL ENGN CTR BIOCHIP SHANGHAI, SHANGHAI, PEOPLES R CHINA.;GU, YING, MATERNAL \& CHILD HLTH CARE HOSP, PRENATAL DIAG CTR, LIANYUNGANG, JIANGSU, PEOPLES R CHINA.;LU, KANGMO, CHENGDU WOMENS \& CHILDRENS HOSP, PRENATAL DIAG CTR, CHENGDU, JIANGSU, PEOPLES R CHINA.;YANG, GUANGHUI, CEN, ZHONG, LIN, LIN, HAO, JING, YANG, ZHIGANG, PENG, JIABAO, CUI, SHUJIAN, SHANGHAI FIND BIOTECH CO LTD, SHANGHAI, PEOPLES R CHINA.;YU, LI, LIFE TECHNOL CO, SHANGHAI, PEOPLES R CHINA.;HUANG, JIAN, NATL ENGN CTR BIOCHIP SHANGHAI, SHANGHAI, PEOPLES R CHINA.;HUANG, JIAN, CHINESE NATL HUMAN GENOME CTR SHANGHAI, SHANGHAI MOST KEY LAB DIS \& HLTH GENOM, SHANGHAI, PEOPLES R CHINA.","10.1371/JOURNAL.PONE.0094100","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E94100",NA,"NATIONAL HIGH TECHNOLOGY RESEARCH AND DEVELOPMENT PROGRAM OF CHINA (863 PROGRAM) [2012AA02A205], CHINESE NATIONAL KEY PROGRAM ON BASIC RESEARCH (973 PROGRAM) [2010CB529206, 2014CB965002], NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA [81272306], PROGRAM OF SHANGHAI SUBJECT CHIEF SCIENTIST [12XD1421400, 11JC1408800, 13431902000, 12DZ942500], SHANGHAI FIND BIO-TECH CO LTD., LIFE TECHNOLOGIES COMPANY, NATIONAL ENGINEERING CENTER FOR BIOCHIP AT SHANGHAI","THE AUTHORS GRATEFULLY ACKNOWLEDGE GRANT SUPPORT FROM THE NATIONAL HIGH TECHNOLOGY RESEARCH AND DEVELOPMENT PROGRAM OF CHINA (863 PROGRAM, 2012AA02A205), THE CHINESE NATIONAL KEY PROGRAM ON BASIC RESEARCH (973 PROGRAM, 2010CB529206 AND 2014CB965002), THE NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA (81272306) AND THE PROGRAM OF SHANGHAI SUBJECT CHIEF SCIENTIST (12XD1421400, 11JC1408800, 13431902000 AND 12DZ942500). SHANGHAI FIND BIO-TECH CO LTD., PROVIDED SUPPORT IN THE FORM OF SALARIES FOR AUTHORS GY, ZC, LL, JH, ZY, JP, \& SC. LIFE TECHNOLOGIES COMPANY PROVIDED SUPPORT IN THE FORM OF A SALARY FOR AUTHOR LY. NATIONAL ENGINEERING CENTER FOR BIOCHIP AT SHANGHAI PROVIDED SUPPORT IN THE FORM OF A SALARY FOR AUTHOR JH. OTHERWISE, THESE ORGANISATIONS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT. THE SPECIFIC ROLES OF THESE AUTHORS ARE ARTICULATED IN THE `AUTHOR CONTRIBUTIONS' SECTION.",NA,"1932-6203","4",NA,"PUBLIC LIBRARY SCIENCE","9",2014,"ISI000334107500123","22","SCIENCE \& TECHNOLOGY - OTHER TOPICS","12","MULTIDISCIPLINARY SCIENCES","HUANGJCHGCHOTMAIL.COM",NA,"AE6MJ",NA,"HUANG, J (REPRINT AUTHOR), NATL ENGN CTR BIOCHIP SHANGHAI, SHANGHAI, PEOPLES R CHINA","ISI","PRENATAL DIAG CTR;PRENATAL DIAG CTR;SHANGHAI FIND BIOTECH CO LTD;LIFE TECHNOL CO;NATL ENGN CTR BIOCHIP SHANGHAI;CHINESE NATL HUMAN GENOME CTR SHANGHAI","NATL ENGN CTR BIOCHIP SHANGHAI",NA,"GU Y, 2014, PLOS ONE","GU Y, 2014, PLOS ONE"
"LIN Z, 2014, J INFECT DEV CTRIES","LIN Z;FAROOQUI A;LI G;WONG GKS;MASON AL;BANNER D;KELVIN AA;KELVIN DJ;LEON AJ","NEXT-GENERATION SEQUENCING AND BIOINFORMATIC APPROACHES TO DETECT AND ANALYZE INFLUENZA VIRUS IN FERRETS","JOURNAL OF INFECTION IN DEVELOPING COUNTRIES","J. INFECT. DEV. CTRIES.","INTRODUCTION: CONVENTIONAL METHODS USED TO DETECT AND CHARACTERIZE INFLUENZA VIRUSES IN BIOLOGICAL SAMPLES FACE MULTIPLE CHALLENGES DUE TO THE DIVERSITY OF SUBTYPES AND HIGH DISSIMILARITY OF EMERGING STRAINS. NEXT-GENERATION SEQUENCING (NGS) IS A POWERFUL TECHNIQUE THAT CAN FACILITATE THE DETECTION AND CHARACTERIZATION OF INFLUENZA, HOWEVER, THE SEQUENCING STRATEGY AND THE PROCEDURES OF DATA ANALYSIS POSSESS DIFFERENT ASPECTS THAT REQUIRE CAREFUL CONSIDERATION. METHODOLOGY: THE RNA FROM THE LUNGS OF FERRETS INFECTED WITH INFLUENZA A/CALIFORNIA/07/2009 WAS ANALYZED BY NEXT-GENERATION SEQUENCING (NGS) WITHOUT USING SPECIFIC PCR AMPLIFICATION OF THE VIRAL SEQUENCES. SEVERAL BIOINFORMATIC APPROACHES WERE USED TO RESOLVE THE VIRAL GENES AND DETECT VIRAL QUASISPECIES. RESULTS: THE GENOMIC SEQUENCES OF INFLUENZA VIRUS WERE CHARACTERIZED TO A HIGH LEVEL OF DETAIL WHEN ANALYZING THE SHORT-READS WITH EITHER THE FAST ALIGNER BOWTIE2, THE GENERAL PURPOSE ALIGNER BLASTN OR DE NOVO ASSEMBLY WITH ABYSS. MOREOVER, WHEN USING DISTANT VIRAL SEQUENCES AS REFERENCE, THESE METHODS WERE STILL ABLE TO RESOLVE THE VIRAL SEQUENCES OF A BIOLOGICAL SAMPLE. FINALLY, DIRECT SEQUENCING OF RNA SAMPLES DID NOT PROVIDE SUFFICIENT COVERAGE OF THE VIRAL GENOME TO STUDY VIRAL QUASISPECIES, AND, THEREFORE, PRIOR AMPLIFICATION OF THE VIRAL SEGMENTS BY PCR WOULD BE REQUIRED TO PERFORM THIS TYPE OF ANALYSIS. CONCLUSIONS: THE INTRODUCTION OF NGS FOR VIRUS RESEARCH ALLOWS ROUTINE FULL CHARACTERIZATION OF VIRAL ISOLATES, HOWEVER, CAREFUL DESIGN OF THE SEQUENCING STRATEGY AND THE PROCEDURES FOR DATA ANALYSIS ARE STILL OF CRITICAL IMPORTANCE.","FERRET; INFLUENZA; NEXT GENERATION SEQUENCING; DEEP SEQUENCING; VIRUS","2009 PANDEMIC INFLUENZA; SHORT DNA-SEQUENCES; READ ALIGNMENT; EXPRESSION ANALYSIS; VIRAL PATHOGENS; RNA-SEQ; INFECTION; ULTRAFAST; RESPONSES; PACKAGE","ENGLISH","ARTICLE","ARTICLE",3,"ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;BIROL I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/BIOINFORMATICS/BTP367.;CAMERON CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08.;CHEVAL J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11.;DANESH A, 2011, VIROLOGY, V409, P102, DOI 10.1016/J.VIROL.2010.10.002.;FAROOQUI A, 2011, J INFECT DEV COUNTR, V5, P700.;GARTEN RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/SCIENCE.1176225.;GHEDIN E, 2011, J INFECT DIS, V203, P168, DOI 10.1093/INFDIS/JIQ040.;GRENINGER AL, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0013381.;HOPER D, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0019075.;KOBOLDT DC, 2012, GENOME RES, V22, P568, DOI 10.1101/GR.129684.111.;KURODA M, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0010256.;LANGMEAD B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/NMETH.1923].;LANGMEAD B, 2009, GENOME BIOL, V10, DOI 10.1186/GB-2009-10-3-R25.;LEON AJ, 2013, J VIROL, V87, P1957, DOI 10.1128/JVI.02476-12.;LI H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/BIOINFORMATICS/BTP698.;LI H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/BIOINFORMATICS/BTP324.;LI RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/BIOINFORMATICS/BTP336.;LI YINGRUI, 2010, HUMAN GENOMICS, V4, P271.;MCHARDY AC, 2009, PLOS PATHOG, V5, DOI 10.1371/JOURNAL.PPAT.1000566.;METZKER ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/NRG2626.;MILNE I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/BIOINFORMATICS/BTP666.;MORTAZAVI A, 2008, NAT METHODS, V5, P621, DOI 10.1038/NMETH.1226.;NAKAMURA S, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0004219.;NOWROUSIAN M, 2010, EUKARYOT CELL, V9, P1300, DOI 10.1128/EC.00123-10.;RAMAKRISHNAN MA, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0007105.;ROBINSON MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/BIOINFORMATICS/BTP616.;ROWE T, 2010, VIROLOGY, V401, P257, DOI 10.1016/J.VIROL.2010.02.020.;SUK JE, 2011, AM J PUBLIC HEALTH, V101, P2068, DOI 10.2105/AJPH.2011.300181.;WANG D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/PNAS.242579699.;WANG LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/BIOINFORMATICS/BTP612.;WANG ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726.;WARREN RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/BIOINFORMATICS/BTL629.;YONGFENG H, 2011, CLIN MICROBIOL INFEC, V17, P241, DOI 10.1111/J.1469-0691.2010.03246.X.;ZERBINO DR, 2010, CURRENT PROTOCOLS BI, DOI DOI 10.1002/0471250953.BI1105S31.","KELVIN, DJ (REPRINT AUTHOR), SHANTOU UNIV, COLL MED, INT INST INFECT \& IMMUN, DIV IMMUNOL, 22 XINLING RD, SHANTOU 515041, GUANGDONG, PEOPLES R CHINA.;LIN, ZHEN, FAROOQUI, AMBER, LI, GUISHUANG, KELVIN, DAVID J., LEON, ALBERTO J., SHANTOU UNIV, COLL MED, INT INST INFECT \& IMMUN, DIV IMMUNOL, SHANTOU 515041, GUANGDONG, PEOPLES R CHINA.;LIN, ZHEN, FAROOQUI, AMBER, LI, GUISHUANG, KELVIN, DAVID J., LEON, ALBERTO J., GUANGDONG PROV KEY LAB INFECT DIS \& MOL IMMUNOPAT, SHANTOU, GUANGDONG, PEOPLES R CHINA.;LIN, ZHEN, WONG, GANE KA-SHU, UNIV ALBERTA, DEPT MED, EDMONTON, AB T6G 2M7, CANADA.;WONG, GANE KA-SHU, MASON, ANDREW L., UNIV ALBERTA, DEPT BIOL SCI, EDMONTON, AB T6G 2M7, CANADA.;BANNER, DAVID, KELVIN, DAVID J., LEON, ALBERTO J., UNIV HLTH NETWORK, DIV EXPT THERAPEUT, TORONTO, ON, CANADA.;KELVIN, ALYSON A., IDR, TORONTO, ON, CANADA.;KELVIN, DAVID J., UNIV SASSARI, DIPARTIMENTO SCIENZE BIOMED, SASSARI, ITALY.","10.3855/JIDC.3749","JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY",NA,NA,"LI KA SHING FOUNDATION, GUANGDONG PROVINCIAL KEY LABORATORY OF INFECTIOUS DISEASES AND MOLECULAR IMMUNOPATHOLOGY, CANADIAN INSTITUTE OF HEALTH RESEARCH, IMMUNE DIAGNOSTICS RESEARCH","THIS STUDY WAS SUPPORTED BY GRANTS FROM THE LI KA SHING FOUNDATION, THE GUANGDONG PROVINCIAL KEY LABORATORY OF INFECTIOUS DISEASES AND MOLECULAR IMMUNOPATHOLOGY, THE CANADIAN INSTITUTE OF HEALTH RESEARCH, AND IMMUNE DIAGNOSTICS \& RESEARCH. WE WOULD LIKE TO THANK THOMAS ROWE FOR TECHNICAL ASSISTANCE. WE WOULD LIKE TO THANK TED ROSS FOR VALUABLE INSIGHT INTO PERFORMING THE FERRET STUDIES. WE WOULD LIKE TO THANK LONGSI RAN AND LUOLING XU FOR PROCESSING THE SAMPLES AND BGI-SHENZHEN FOR THE CONSTRUCTION OF THE CDNA LIBRARIES AND SEQUENCING. Z.L. IS ENROLLED IN THE LI KA SHING SINO-CANADIAN EXCHANGE PROGRAM.",NA,"1972-2680","4","498-509","J INFECTION DEVELOPING COUNTRIES","8",2014,"ISI000339927900015","35","INFECTIOUS DISEASES","8","INFECTIOUS DISEASES","DKELVINJIDC.ORG",NA,"AM5VA",NA,"KELVIN, DJ (REPRINT AUTHOR), SHANTOU UNIV, COLL MED, INT INST INFECT \& IMMUN, DIV IMMUNOL, 22 XINLING RD, SHANTOU 515041, GUANGDONG, PEOPLES R CHINA","ISI","SHANTOU UNIV;GUANGDONG PROV KEY LAB INFECT DIS AND MOL IMMUNOPAT;UNIV ALBERTA;UNIV ALBERTA;UNIV HLTH NETWORK;UNIV SASSARI","SHANTOU UNIV",NA,"LIN Z, 2014, J INFECT DEV CTRIES","LIN Z, 2014, J INFECT DEV CTRIES"
"YEN HC, 2014, PLOS ONE","YEN HC;LI SL;HSU WC;TANG P","INTERFERENCE OF CO-AMPLIFIED NUCLEAR MITOCHONDRIAL DNA SEQUENCES ON THE DETERMINATION OF HUMAN MTDNA HETEROPLASMY BY USING THE SURVEYOR NUCLEASE AND THE WAVE HS SYSTEM","PLOS ONE","PLOS ONE","HIGH-SENSITIVITY AND HIGH-THROUGHPUT MUTATION DETECTION TECHNIQUES ARE USEFUL FOR SCREENING THE HOMOPLASMY OR HETEROPLASMY STATUS OF MITOCHONDRIAL DNA (MTDNA), BUT MIGHT BE SUSCEPTIBLE TO INTERFERENCE FROM NUCLEAR MITOCHONDRIAL DNA SEQUENCES (NUMTS) CO-AMPLIFIED DURING POLYMERASE CHAIN REACTION (PCR). IN THIS STUDY, WE FIRST EVALUATED THE PLATFORM OF SURVEYOR NUCLEASE DIGESTION OF HETERODUPLEXED DNA FOLLOWED BY THE DETECTION OF CLEAVED DNA BY USING THE WAVE HS SYSTEM (SN/WAVE-HS) FOR DETECTING HUMAN MTDNA VARIANTS AND FOUND THAT ITS PERFORMANCE WAS SLIGHTLY BETTER THAN THAT OF DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (DHPLC). THE POTENTIAL INTERFERENCE FROM CO-AMPLIFIED NUMTS ON SCREENING MTDNA HETEROPLASMY WHEN USING THESE 2 HIGHLY SENSITIVE TECHNIQUES WAS FURTHER EXAMINED BY USING 2 PUBLISHED PRIMER SETS CONTAINING A TOTAL OF 65 PRIMER PAIRS, WHICH WERE ORIGINALLY DESIGNED TO BE USED WITH ONE OF THE 2 TECHNIQUES. WE CONFIRMED THAT 24 PRIMER PAIRS COULD AMPLIFY NUMTS BY CONDUCTING BIOINFORMATIC ANALYSIS AND PCR WITH THE DNA FROM 143B-RHO(0) CELLS. USING MTDNA EXTRACTED FROM THE MITOCHONDRIA OF HUMAN 143B CELLS AND A CYBRID LINE WITH THE NUCLEAR BACKGROUND OF 143B-RHO(0) CELLS, WE DEMONSTRATED THAT NUMTS COULD AFFECT THE PATTERNS OF CHROMATOGRAMS FOR CELL DNA DURING SN-WAVE/HS ANALYSIS OF MTDNA, LEADING TO INCORRECT JUDGMENT OF MTDNA HOMOPLASMY OR HETEROPLASMY STATUS. HOWEVER, WE OBSERVED SUCH INTERFERENCE ONLY IN 2 OF 24 PRIMER PAIRS SELECTED, AND DID NOT OBSERVE SUCH EFFECTS DURING DHPLC ANALYSIS. THESE RESULTS INDICATE THAT NUMTS CAN AFFECT THE SCREENING OF LOW-LEVEL MTDNA VARIANTS, BUT IT MIGHT NOT BE PREDICTED BY BIOINFORMATIC ANALYSIS OR THE AMPLIFICATION OF DNA FROM 143B-RHO(0) CELLS. THEREFORE, USING PURIFIED MTDNA FROM CULTURED CELLS WITH PROVEN PURITY TO EVALUATE THE EFFECTS OF NUMTS FROM A PRIMER PAIR ON MTDNA DETECTION BY USING PCR-BASED HIGH-SENSITIVITY METHODS PRIOR TO THE USE OF A PRIMER PAIR IN REAL STUDIES WOULD BE A MORE PRACTICAL STRATEGY.",NA,"RAPID IDENTIFICATION; MUTATIONS; GENOME; PSEUDOGENES; INSIGHTS; DISEASE; CANCER; PCR","ENGLISH","ARTICLE","ARTICLE",4,"ACINAS SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005.;BALLANA E, 2008, HUM MUTAT, V29, P248, DOI 10.1002/HUMU.20639.;BANNWARTH S, 2008, MITOCHONDRION, V8, P136, DOI 10.1016/J.MITO.2007.10.008.;BANNWARTH S, 2006, NAT PROTOC, V1, P2037, DOI 10.1038/NPROT.2006.318.;BENSASSON D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6.;BIGGIN A, 2005, MOL GENET METAB, V84, P61, DOI 10.1016/J.YMGME.2004.09.011.;CALVIGNAC S, 2011, MITOCHONDRION, V11, P246, DOI 10.1016/J.MITO.2010.10.004.;CHEN SW, 2013, MITOCHONDRION, V13, P143, DOI 10.1016/J.MITO.2013.01.007.;JANNE PA, 2006, CLIN CANCER RES, V12, P751, DOI 10.1158/1078-0432.CCR-05-2047.;KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/SCIENCE.2814477.;KULAWIEC M, 2010, ENVIRON MOL MUTAGEN, V51, P427, DOI 10.1002/EM.20582.;MEIERHOFER D, 2005, MITOCHONDRION, V5, P282, DOI 10.1016/J.MITO.2005.06.001.;MISHMAR D, 2004, HUM MUTAT, V23, P125, DOI 10.1002/HUMU.10304.;OLEYKOWSKI CA, 1998, NUCLEIC ACIDS RES, V26, P4597, DOI 10.1093/NAR/26.20.4597.;PARR RL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-185.;RAMOS A, 2011, MITOCHONDRION, V11, P946, DOI 10.1016/J.MITO.2011.08.009.;RAMOS A, 2009, ELECTROPHORESIS, V30, P1587, DOI 10.1002/ELPS.200800601.;RICCHETTI M, 2004, PLOS BIOL, V2, P1313, DOI 10.1371/JOURNAL.PBIO.0020273.;THOMPSON JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/NAR/30.9.2083.;TOURMEN Y, 2002, GENOMICS, V80, P71, DOI 10.1006/GENO.2002.6798.;TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/PNAS.91.18.8334.;VAMVAKAS SPIRIDON, 1993, V2, P453.;VENEGAS V, 2012, METHODS MOL BIOL, V837, P313, DOI 10.1007/978-1-61779-504-6\_21.;WALLACE DC, 1997, P NATL ACAD SCI USA, V94, P14900, DOI 10.1073/PNAS.94.26.14900.;WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/ANNUREV.BI.61.070192.005523.;WALLACE DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/EM.20586.;WHITE HE, 2005, GENET TEST, V9, P190, DOI 10.1089/GTE.2005.9.190.;WOISCHNIK M, 2002, GENOME RES, V12, P885, DOI 10.1101/GR.227202.;YAO YG, 2008, J MED GENET, V45, P769, DOI 10.1136/JMG.2008.059782.;YEN HC, 2010, ANN NY ACAD SCI, V1201, P13, DOI 10.1111/J.1749-6632.2010.05626.X.","YEN, HC (REPRINT AUTHOR), CHANG GUNG UNIV, COLL MED, DEPT \& GRAD INST MED BIOTECHNOL \& LAB SCI, TAO YUAN, TAIWAN.;YEN, HSIU-CHUAN, LI, SHIUE-LI, HSU, WEI-CHIEN, CHANG GUNG UNIV, COLL MED, DEPT \& GRAD INST MED BIOTECHNOL \& LAB SCI, TAO YUAN, TAIWAN.;TANG, PETRUS, CHANG GUNG UNIV, COLL MED, DEPT PUBL HLTH \& PARASITOL, TAO YUAN, TAIWAN.","10.1371/JOURNAL.PONE.0092817","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E92817",NA,"CHANG GUNG MEMORIAL HOSPITAL, TAIWAN [CMRPD180412, CMRPD1B0341]","THIS RESEARCH WAS SUPPORTED BY GRANTS CMRPD180412 AND CMRPD1B0341 TO HSIU-CHUAN YEN FROM CHANG GUNG MEMORIAL HOSPITAL, TAIWAN. THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT.",NA,"1932-6203","3",NA,"PUBLIC LIBRARY SCIENCE","9",2014,"ISI000333459900118","30","SCIENCE \& TECHNOLOGY - OTHER TOPICS","11","MULTIDISCIPLINARY SCIENCES","YENMAIL.CGU.EDU.TW",NA,"AD7QO",NA,"YEN, HC (REPRINT AUTHOR), CHANG GUNG UNIV, COLL MED, DEPT \& GRAD INST MED BIOTECHNOL \& LAB SCI, TAO YUAN, TAIWAN","ISI","CHANG GUNG UNIV;CHANG GUNG UNIV","CHANG GUNG UNIV",NA,"YEN HC, 2014, PLOS ONE","YEN HC, 2014, PLOS ONE"
"DICKINS B, 2014, BIOTECHNIQUES","DICKINS B;REBOLLEDO JARAMILLO B;SU MSW;PAUL IM;BLANKENBERG D;STOLER N;MAKOVA KD;NEKRUTENKO A","CONTROLLING FOR CONTAMINATION IN RE-SEQUENCING STUDIES WITH A REPRODUCIBLE WEB-BASED PHYLOGENETIC APPROACH","BIOTECHNIQUES","BIOTECHNIQUES","POLYMORPHISM DISCOVERY IS A ROUTINE APPLICATION OF NEXT-GENERATION SEQUENCING TECHNOLOGY WHERE MULTIPLE SAMPLES ARE SENT TO A SERVICE PROVIDER FOR LIBRARY PREPARATION, SUBSEQUENT SEQUENCING, AND BIOINFORMATIC ANALYSES. THE DECREASING COST AND ADVANCES IN MULTIPLEXING APPROACHES HAVE MADE IT POSSIBLE TO ANALYZE HUNDREDS OF SAMPLES AT A REASONABLE COST. HOWEVER, BECAUSE OF THE MANUAL STEPS INVOLVED IN THE INITIAL PROCESSING OF SAMPLES AND HANDLING OF SEQUENCING EQUIPMENT, CROSS-CONTAMINATION REMAINS A SIGNIFICANT CHALLENGE. IT IS ESPECIALLY PROBLEMATIC IN CASES WHERE POLYMORPHISM FREQUENCIES DO NOT ADHERE TO DIPLOID EXPECTATION, FOR EXAMPLE, HETEROGENEOUS TUMOR SAMPLES, ORGANELLAR GENOMES, AS WELL AS DURING BACTERIAL AND VIRAL SEQUENCING. IN THESE INSTANCES, LOW LEVELS OF CONTAMINATION MAY BE READILY MISTAKEN FOR POLYMORPHISMS, LEADING TO FALSE RESULTS. HERE WE DESCRIBE PRACTICAL STEPS DESIGNED TO RELIABLY DETECT CONTAMINATION AND UNCOVER ITS ORIGIN, AND ALSO PROVIDE NEW, GALAXY-BASED, READILY ACCESSIBLE COMPUTATIONAL TOOLS AND WORKFLOWS FOR QUALITY CONTROL. ALL RESULTS DESCRIBED IN THIS REPORT CAN BE REPRODUCED INTERACTIVELY ON THE WEB AS DESCRIBED AT HTTP://USEGALAXY.ORG/CONTAMINATION.","RE-SEQUENCING; CONTAMINATION; NEXT-GENERATION SEQUENCING; GALAXY; REPRODUCIBILITY","HUMAN MITOCHONDRIAL-DNA; RAPID SEGREGATION; HETEROPLASMY; REDUCTION; DYNAMICS; EXPLAINS; GENOMES; DRIFT; TREE","ENGLISH","ARTICLE","ARTICLE",7,"AVITAL G, 2012, HUM MOL GENET, V21, P4214, DOI 10.1093/HMG/DDS245.;BEHAR DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/J.AJHG.2012.03.002.;BOGENHAGEN DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/J.BBAGRM.2011.11.005.;CAO LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/NG1970.;CHINNERY PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X.;CREE LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/J.BBADIS.2009.03.002.;CREE LM, 2008, NAT GENET, V40, P249, DOI 10.1038/NG.2007.63.;DIMAURO S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/J.BBABIO.2004.03.014.;FREEMAN B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738.;GOTO H, 2011, GENOME BIOL, V12, DOI 10.1186/GB-2011-12-6-R59.;HOWELL N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264.;JACOBS HT, 2001, TRENDS GENET, V17, P653, DOI 10.1016/S0168-9525(01)02480-5.;JENUTH JP, 1996, NAT GENET, V14, P146, DOI 10.1038/NG1096-146.;KLOSS-BRANDSTATTER A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/HUMU.21382.;LEGROS F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/JCS.01134.;LI MK, 2012, GENOME BIOL, V13, DOI 10.1186/GB-2012-13-5-R34.;LI MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/J.AJHG.2010.07.014.;NEKRUTENKO A, 2012, NAT REV GENET, V13, P667, DOI 10.1038/NRG3305.;PARADIS E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/BIOINFORMATICS/BTG412.;RUIZ-PESINI E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/NAR/GKL927.;SAITOU N, 1987, MOL BIOL EVOL, V4, P406.;SUKUMARAN J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/BIOINFORMATICS/BTQ228.;TANAKA M, 1996, METHODS ENZYMOL, V264, P407, DOI 10.1016/S0076-6879(96)64037-3.;VAN OVEN M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/HUMU.20921.;WAI T, 2008, NAT GENET, V40, P1484, DOI 10.1038/NG.258.","MAKOVA, KD (REPRINT AUTHOR), PENN STATE UNIV, UNIVERSITY PK, PA 16802 USA.;DICKINS, BENJAMIN, REBOLLEDO-JARAMILLO, BORIS, BLANKENBERG, DANIEL, NEKRUTENKO, ANTON, PENN STATE UNIV, DEPT BIOCHEM \& MOL BIOL, UNIVERSITY PK, PA 16802 USA.;DICKINS, BENJAMIN, SU, MARCIA SHU-WEI, MAKOVA, KATERYNA D., PENN STATE UNIV, DEPT BIOL, UNIVERSITY PK, PA 16802 USA.;REBOLLEDO-JARAMILLO, BORIS, STOLER, NICHOLAS, PENN STATE UNIV, INTERDISCIPLINARY GRAD PROGRAM BIOSCI, UNIVERSITY PK, PA 16802 USA.;PAUL, IAN M., PENN STATE COLL MED, DEPT PEDIAT, HERSHEY, PA USA.","10.2144/000114146","52 VANDERBILT AVE, NEW YORK, NY 10017 USA",NA,NA,"NIH [GM07226405S2, HG004909], PENN STATE UNIVERSITY, HUCK INSTITUTES FOR THE LIFE SCIENCES, PENNSYLVANIA DEPARTMENT OF HEALTH USING TOBACCO SETTLEMENT FUNDS, PENN STATE CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE (CTSI)","THE AUTHORS ARE GRATEFUL TO JESSICA BEILER FOR COORDINATING SAMPLE COLLECTION, TO CLINICAL NURSES FROM PENN STATE COLLEGE OF MEDICINE'S PEDIATRIC CLINICAL RESEARCH OFFICE FOR COLLECTING THE SAMPLES, AND TO VOLUNTEERS FOR DONATING THE SAMPLES. EFFORTS OF THE GALAXY TEAM (ENIS AFGAN, DANNON BAKER, DAVE CLEMENTS, NATE CORAOR, CARL EBERHARD, DORINE FRANCHETEAU, JEREMY GOECKS, SAM GUERLER, GREG VON KUSTER, JENNIFER JACKSON, ROSS LAZARUS, AND JAMES TAYLOR) WERE INSTRUMENTAL FOR MAKING THIS WORK HAPPEN. SPECIAL THANKS TO DAVE BOUVIER FOR HELPING TO TUNE THE GALAXY TOOLS DESCRIBED IN THIS MANUSCRIPT. THIS WORK WAS FUNDED BY AN NIH GRANT, GM07226405S2 TO KDM AND AN NIH GRANT HG004909 TO AN, AS WELL AS FUNDS FROM PENN STATE UNIVERSITY AND THE HUCK INSTITUTES FOR THE LIFE SCIENCES TO AN, KDM. ADDITIONAL FUNDING WAS PROVIDED, IN PART, UNDER A GRANT WITH THE PENNSYLVANIA DEPARTMENT OF HEALTH USING TOBACCO SETTLEMENT FUNDS AND BY THE PENN STATE CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE (CTSI). THE DEPARTMENT SPECIFICALLY DISCLAIMS RESPONSIBILITY FOR ANY ANALYSES, INTERPRETATIONS OR CONCLUSIONS. THIS PAPER IS SUBJECT TO THE NIH PUBLIC ACCESS POLICY.",NA,"0736-6205","3","134+","BIOTECHNIQUES OFFICE","56",2014,"ISI000333477000005","25","BIOCHEMISTRY \& MOLECULAR BIOLOGY","8","BIOCHEMICAL RESEARCH METHODS, BIOCHEMISTRY \& MOLECULAR BIOLOGY","KMAKOVABX.PSU.EDU ANTONBX.PSU.EDU",NA,"AD7WG",NA,"MAKOVA, KD (REPRINT AUTHOR), PENN STATE UNIV, UNIVERSITY PK, PA 16802 USA","ISI","PENN STATE UNIV;PENN STATE UNIV;PENN STATE UNIV;PENN STATE COLL MED","PENN STATE UNIV",NA,"DICKINS B, 2014, BIOTECHNIQUES","DICKINS B, 2014, BIOTECHNIQUES"
"ZHANG ZH, 2014, PLOS ONE","ZHANG ZH;LIN WX;DENG M;ZHAO ST;ZENG HS;CHEN FP;SONG YZ","CLINICAL, MOLECULAR AND FUNCTIONAL INVESTIGATION ON AN INFANT WITH NEONATAL INTRAHEPATIC CHOLESTASIS CAUSED BY CITRIN DEFICIENCY (NICCD)","PLOS ONE","PLOS ONE","BACKGROUND AND OBJECTIVE: SLC25A13 ANALYSIS HAS PROVIDED RELIABLE EVIDENCES FOR THE DEFINITIVE DIAGNOSIS OF CITRIN DEFICIENCY (CD) IN THE PAST DECADE. MEANWHILE, THESE STUDIES GENERATED SOME ISSUES YET TO BE RESOLVED, INCLUDING THE PATHOGENICITY OF SLC25A13 MISSENSE MUTATIONS AND THE MRNA PRODUCT FROM THE MUTATION C.615+5G>A. THIS STUDY AIMS TO INVESTIGATE THE EFFECT OF A NOVEL MISSENSE MUTATION ON THE ASPARTATE/GLUTAMATE CARRIER (AGC) FUNCTION OF CITRIN PROTEIN, AND TO EXPLORE THE ABERRANT TRANSCRIPT FROM C.615+5G>A IN THE SAME CD INFANT. METHODS AND RESULTS: BY MEANS OF SCREENING FOR PREVALENT SLC25A13 MUTATIONS AND EXONS SEQUENCING, THE PATIENT PROVED A COMPOUND HETEROZYGOTE OF C.615+5G>A AND A NOVEL C.1064G>A (P.ARG355GLN) MUTATION. AN ABERRANT TRANSCRIPT WITH RETENTION OF THE ENTIRE INTRON 6, R.[615+1\_615+1789INS, 615+5 G>A] (GENBANK ACCESSION NUMBER KJ128074), WHICH WAS RESULTED FROM C.615+5G>A, WAS DETECTED BY RT-PCR AND CDNA SEQUENCING. AFTER BIOINFORMATIC ANALYSES OF THE NOVEL MISSENSE MUTATION C.1064G>A, THE GROWTH ABILITIES OF THREE AGC1D YEAST STRAINS WERE TESTED, WHICH HAD BEEN TRANSFORMED WITH RECOMBINANT OR EMPTY VECTORS, RESPECTIVELY. BESIDES THE BIOINFORMATICALLY PATHOGENIC EVIDENCES, THE GROWTH ABILITY OF THE AGC1 DELTA STRAINS TRANSFORMED WITH MUTANT RECOMBINANT WAS THE SAME AS WITH EMPTY VECTOR, BUT SIGNIFICANTLY LOWER THAN THAT WITH NORMAL CONTROL IN FUNCTIONAL ANALYSIS. CONCLUSIONS: A CD INFANT WAS DEFINITELY DIAGNOSED IN THIS PAPER BY A GENETIC, TRANSCRIPTIONAL AND FUNCTIONAL ANALYSIS OF SLC25A13 GENE. THIS STUDY PROVIDED DIRECT LABORATORY EVIDENCES SUPPORTING THE SPLICE-SITE NATURE OF THE C.615+5G>A MUTATION, AND THE NOVEL C.1064G>A VARIATION, WHICH PROVED A PATHOGENIC MUTATION BIOINFORMATICALLY AND FUNCTIONALLY, ENRICHED THE SLC25A13 MUTATION SPECTRUM.",NA,"ASPARTATE-GLUTAMATE CARRIER; MESSENGER-RNA DECAY; II CITRULLINEMIA; SLC25A13 GENE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; SWISS-MODEL; PROTEIN; MUTATIONS; IDENTIFICATION","ENGLISH","ARTICLE","ARTICLE",11,"ADZHUBEI IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/NMETH0410-248.;BACH A, 1982, AM J CLIN NUTR, V35, P950.;BORDOLI L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/NPROT.2008.197.;BOSCH AM, 2006, J INHERIT METAB DIS, V29, P516, DOI 10.1007/S10545-006-0382-0.;BROW DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/ANNUREV.GENET.36.043002.091635.;CAVERO S, 2003, MOL MICROBIOL, V50, P1257, DOI 10.1046/J.1365-2958.2003.03742.X.;CHANG YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/ANNUREV.BIOCHEM.76.050106.093909.;CHEN R, 2013, WORLD J GASTROENTERO, V19, P4545, DOI 10.3748/WJG.V19.I28.4545.;DIMMOCK D, 2007, PEDIATRICS, V119, PE773, DOI 10.1542/PEDS.2006-1950.;FIERMONTE G, 2011, MOL GENET METAB, V104, P501, DOI 10.1016/J.YMGME.2011.08.022.;FU HY, 2011, J GASTROENTEROL, V46, P510, DOI 10.1007/S00535-010-0329-Y.;GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/YEA.320110408.;GREEN RE, 2003, BIOINFORMATICS, V19, PI118, DOI 10.1093/BIOINFORMATICS/BTG1015.;GUELDENER U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/NAR/30.6.E23.;GULDENER U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/NAR/24.13.2519.;HASTINGS ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X.;HAYASAKA K, 2012, JIMD REP, V2, P37, DOI 10.1007/8904\_2011\_42.;HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2.;JIANG GUANG-YU, 2012, CHINESE JOURNAL OF PATHOLOGY, V41, P452, DOI 10.3760/CMA.J.ISSN.0529-5807.2012.07.005.;KOBAYASHI K, 1999, NAT GENET, V22, P159, DOI 10.1038/9667.;KOBAYASHI K., 2012, GENEREVIEWS.;KOBAYASHI K, 2003, MEMBRANE TRANSPORTER, P147.;LEHNER F, 2006, J LIPID RES, V47, P404, DOI 10.1194/JLR.M500423-JLR200.;LEWIS BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/PNAS.0136770100.;LIN WX, 2012, GENE, V505, P269, DOI 10.1016/J.GENE.2012.06.012.;LU YB, 2005, J HUM GENET, V50, P338, DOI 10.1007/S10038-005-0262-8.;NING C, 2000, PEDIATR RES, V48, P211, DOI 10.1203/00006450-200008000-00015.;NURY H, 2005, FEBS LETT, V579, P6031, DOI 10.1016/J.FEBSLET.2005.09.061.;OHURA T, 2007, J INHERIT METAB DIS, V30, P139, DOI 10.1007/S10545-007-0506-1.;OKANO Y, 2013, MOL GENET METAB, V109, P9, DOI 10.1016/J.YMGME.2013.01.020.;PALMIERI L, 2001, EMBO J, V20, P5060, DOI 10.1093/EMBOJ/20.18.5060.;ROCA X, 2013, GENE DEV, V27, P129, DOI 10.1101/GAD.209759.112.;ROMAN C, 2007, PEDIATR RES, V61, P83, DOI 10.1203/01.PDR.0000250199.24107.FB.;SAHEKI T, 2006, HEPATIC ENCEPHALOPATHY AND NITROGEN METABOLISM, P320, DOI 10.1007/1-4020-4456-9\_23.;SAHEKI T, 2005, HEPATOL RES, V33, P181, DOI 10.1016/J.HEPRES.2005.09.031.;SAHEKI T, 2004, MOL GENET METAB, V81, PS20, DOI 10.1016/J.YMGME.2004.01.006.;SAHEKI T, 2002, J HUM GENET, V47, P333, DOI 10.1007/S100380200046.;SAHEKI T, 2011, MOL GENET METAB, V104, P492, DOI 10.1016/J.YMGME.2011.08.015.;SAHEKI T, 2005, RECENT RES DEV LIFE, P59.;SCHWARZ JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/NMETH0810-575.;SCHWEDE T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/NAR/GKG520.;SHETH N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/NAR/GKL556.;SONG YZ, 2009, DIGEST LIVER DIS, V41, P683, DOI 10.1016/J.DLD.2008.11.014.;SONG Y. Z., 2010, JAPANESE J INHERITED, V26, P57.;SONG YZ, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0074544.;SONG YZ, 2011, INT J MOL MED, V28, P33, DOI 10.3892/IJMM.2011.653.;TABATA A, 2008, J HUM GENET, V53, P534, DOI 10.1007/S10038-008-0282-2.;TOKUHARA D, 2007, MOL GENET METAB, V90, P30, DOI 10.1016/J.YMGME.2006.09.009.;VITORIA I, 2013, MOL GENET METAB, V110, P181, DOI 10.1016/J.YMGME.2013.06.011.;WAHL MC, 2009, CELL, V136, P701, DOI 10.1016/J.CELL.2009.02.009.;WONGKITTICHOTE P, 2013, J INHERIT METAB DIS, V36, P821, DOI 10.1007/S10545-012-9543-5.;YAZAKI M, 2013, CLIN NEUROL NEUROSUR, V115, P1542, DOI 10.1016/J.CLINEURO.2012.12.027.;ZHANG ZH, 2012, GENE, V511, P227, DOI 10.1016/J.GENE.2012.09.049.","SONG, YZ (REPRINT AUTHOR), JINAN UNIV, DEPT PEDIAT, AFFILIATED HOSP 1, GUANGZHOU, GUANGDONG, PEOPLES R CHINA.;ZHANG, ZHAN-HUI, LIN, WEI-XIA, DENG, MEI, ZHAO, SHU-TAO, ZENG, HAN-SHI, SONG, YUAN-ZONG, JINAN UNIV, DEPT PEDIAT, AFFILIATED HOSP 1, GUANGZHOU, GUANGDONG, PEOPLES R CHINA.;ZHANG, ZHAN-HUI, JINAN UNIV, CENT LAB, AFFILIATED HOSP 1, GUANGZHOU, GUANGDONG, PEOPLES R CHINA.;CHEN, FENG-PING, JINAN UNIV, DEPT LAB SCI, AFFILIATED HOSP 1, GUANGZHOU, GUANGDONG, PEOPLES R CHINA.","10.1371/JOURNAL.PONE.0089267","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E89267",NA,"INNOVATION FUND OF JINAN UNIVERSITY [21612430], NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA [81070279, 81270957]","THE RESEARCH WAS FINANCIALLY SUPPORTED BY THE INNOVATION FUND OF JINAN UNIVERSITY NO. 21612430 (THE FUNDAMENTAL RESEARCH FUNDS FOR CENTRAL UNIVERSITIES) AND THE PROJECTS SUPPORTED BY THE NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA (NOS. 81070279 AND 81270957). THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT.",NA,"1932-6203","2",NA,"PUBLIC LIBRARY SCIENCE","9",2014,"ISI000331717900076","53","SCIENCE \& TECHNOLOGY - OTHER TOPICS","19","MULTIDISCIPLINARY SCIENCES","SONGYUANZONGVIP.TOM.COM",NA,"AB3VI",NA,"SONG, YZ (REPRINT AUTHOR), JINAN UNIV, DEPT PEDIAT, AFFILIATED HOSP 1, GUANGZHOU, GUANGDONG, PEOPLES R CHINA","ISI","JINAN UNIV;JINAN UNIV;JINAN UNIV","JINAN UNIV",NA,"ZHANG ZH, 2014, PLOS ONE","ZHANG ZH, 2014, PLOS ONE"
"NOURI N, 2014, GENE","NOURI N;FAZEL NAJAFABADI E;BEHNAM M;NOURI N;ARYANI O;GHASEMI M;NASIRI J;SEDGHI M","USE OF IN SILICO TOOLS FOR CLASSIFICATION OF NOVEL MISSENSE MUTATIONS IDENTIFIED IN DYSTROPHIN GENE IN DEVELOPING COUNTRIES","GENE","GENE","DMD GENE WHICH IS COMPOSED OF 79 EXONS IS THE LARGEST KNOWN GENE LOCATED ON X CHROMOSOME (XP21). POINT MUTATIONS IN THE DYSTROPHIN GENE ARE RESPONSIBLE FOR 30-35\% OF CASES WITH DMD/BMD. MUTATION ANALYSIS OF ALL THE EXONS OF THE DMD GENE IS COSTLY IN DEVELOPING COUNTRIES, THEREFORE, A FEW OF THE EXONS ARE SELECTED TO BE ANALYZED ROUTINELY IN CLINICAL LABORATORIES. IN THIS STUDY, DIRECT SEQUENCING WAS USED FOR DETECTION OF POINT MUTATIONS IN 10 EXONS OF DYSTROPHIN GENE IN PATIENTS AFFECTED WITH DMD WITHOUT DETECTABLE LARGE REARRANGEMENTS. FREELY AVAILABLE PROGRAMS WERE USED TO PREDICT THE DAMAGING EFFECTS OF THE MUTATIONS. POINT MUTATIONS WERE SUCCESSFULLY DETECTED IN THREE PATIENTS. THREE NOVEL MUTATIONS, TWO MISSENSE MUTATIONS LOCATED ON NONCONSERVATIVE DOMAINS AND A SINGLE NUCLEOTIDE DELETION, WERE DETECTED. MISSENSE MUTATIONS WERE PREDICTED TO CHANGE SPLICING EFFICIENCY. DETECTION OF POINT MUTATIONS BY DNA ANALYSIS FOLLOWED BY PREDICTION OF THE PATHOGENECITY BY USING BIOINFORMATIC TOOL MIGHT BE AN ASSET TO PROVIDE PROPER DIAGNOSIS OR GENETIC COUNSELING TO PATIENTS AND THEIR FAMILY. (C) 2013 ELSEVIER B.V. ALL RIGHTS RESERVED.","DUCHENNE MUSCULAR DYSTROPHY; DIRECT SEQUENCING; MISSENSE MUTATION; BIOINFORMATICS","DUCHENNE MUSCULAR-DYSTROPHY; DATABASE; DELETIONS; PROTEINS; DISEASE; EXON","ENGLISH","ARTICLE","ARTICLE",5,"AARTSMA-RUS A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/MUS.20586.;ADZHUBEI IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/NMETH0410-248.;ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/NAR/25.17.3389.;ALTSHULER D, 2010, NATURE, V467, P1061, DOI 10.1038/NATURE09534.;BEGGS AH, 1990, HUM GENET, V86, P45.;BLAKE DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/PHYSREV.00028.2001.;BROMBERG Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/NAR/GKM238.;COHN RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO,2-T.;DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835.;DESMET FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/NAR/GKP215.;EHMSEN J, 2002, J CELL SCI, V115, P2801.;FLANIGAN KM, 2011, HUM MUTAT, V32, P299, DOI 10.1002/HUMU.21426.;HICKS S., 2011, HUM MUTAT, V32.;HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4.;KUMAR P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/NPROT.2009.86.;LI B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/BIOINFORMATICS/BTP528.;MALUEKA RG, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-23.;MUNTONI F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4.;NISHIDA A, 2011, NAT COMMUN, V2, DOI 10.1038/NCOMMS1306.;PAUL D.T., 2004, PNAS, V101, P15398.;PUNTA M, 2012, NUCLEIC ACIDS RES, V40, PD290, DOI 10.1093/NAR/GKR1065.;ROBERTS RG, 1992, GENOMICS, V13, P942, DOI 10.1016/0888-7543(92)90005-D.;SCHWARTZ M, 2005, CLIN GENET, V67, P189, DOI 10.1111/J.1399-0004.2004.00382.X.;SCHWARZ JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/NMETH0810-575.;SEDLACKOVA J, 2009, NEUROMUSCULAR DISORD, V19, P749, DOI 10.1016/J.NMD.2009.08.011.;SHERRY ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/NAR/29.1.308.;THUSBERG J, 2006, HUM MUTAT, V27, P1230, DOI 10.1002/HUMU.20407.;THUSBERG J, 2009, HUM MUTAT, V30, P703, DOI 10.1002/HUMU.20938.;WATERHOUSE AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/BIOINFORMATICS/BTP033.","SEDGHI, M (REPRINT AUTHOR), ISFAHAN UNIV MED SCI, ALZAHRA UNIV HOSP, MED GENET LAB, ESFAHAN, IRAN.;NOURI, NARGES, NOURI, NAYEREH, SEDGHI, MARYAM, ISFAHAN UNIV MED SCI, PIDRC, ESFAHAN, IRAN.;FAZEL-NAJAFABADI, ESMAT, BEHNAM, MAHDIEH, NOURI, NAYEREH, SEDGHI, MARYAM, ISFAHAN UNIV MED SCI, ALZAHRA UNIV HOSP, MED GENET LAB, ESFAHAN, IRAN.;ARYANI, OMID, ESPECIAL MED CTR, DEPT GENET, TEHRAN, IRAN.;GHASEMI, MAJID, ISFAHAN UNIV MED SCI, ISFAHAN NEUROSCI RES CTR, DEPT NEUROL, ESFAHAN, IRAN.;NASIRI, JAFAR, ISFAHAN UNIV MED SCI, DEPT PEDIAT, ESFAHAN, IRAN.","10.1016/J.GENE.2013.11.022","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"ISFAHAN UNIVERSITY OF MEDICAL SCIENCES, ISFAHAN, IRAN [291018]","THIS WORK WAS FUNDED BY GRANT NUMBER 291018 FROM DEPUTY FOR RESEARCH, ISFAHAN UNIVERSITY OF MEDICAL SCIENCES, ISFAHAN, IRAN. THE AUTHORS WISH TO SINCERELY THANK THE PATIENTS AND THEIR FAMILY THAT PARTICIPATED IN THIS STUDY.",NA,"0378-1119","2","250-254","ELSEVIER SCIENCE BV","535",2014,"ISI000331672200024","29","GENETICS \& HEREDITY","7","GENETICS \& HEREDITY","M\_SEDGHIAZH.MUI.AC.IR",NA,"AB3DT",NA,"SEDGHI, M (REPRINT AUTHOR), ISFAHAN UNIV MED SCI, ALZAHRA UNIV HOSP, MED GENET LAB, ESFAHAN, IRAN","ISI","ISFAHAN UNIV MED SCI;ISFAHAN UNIV MED SCI;ESPECIAL MED CTR;ISFAHAN UNIV MED SCI;ISFAHAN UNIV MED SCI","ISFAHAN UNIV MED SCI",NA,"NOURI N, 2014, GENE","NOURI N, 2014, GENE"
"BET A, 2014, JAIDS","BET A;STERRETT S;SATO A;BANSAL A;GOEPFERT PA","CHARACTERIZATION OF T-CELL RESPONSES TO CRYPTIC EPITOPES IN RECIPIENTS OF A NONCODON-OPTIMIZED HIV-1 VACCINE","JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES","JAIDS","INTRODUCTION: CRYPTIC EPITOPES (CES) CAN BE ENCODED BY ANY OF THE 5 ALTERNATIVE READING FRAMES (ARFS, 2 SENSE AND 3 ANTISENSE) OF A KNOWN GENE. ALTHOUGH CE RESPONSES ARE COMMONLY DETECTED DURING HIV-1 INFECTION, IT IS NOT KNOWN WHETHER THESE RESPONSES ARE INDUCED AFTER VACCINATION. METHODS: USING A BIOINFORMATIC APPROACH, WE DETERMINED THAT VACCINES WITH CODON-OPTIMIZED HIV INSERTS SIGNIFICANTLY SKEWED CE SEQUENCES AND ARE NOT LIKELY TO INDUCE CROSSREACTIVE RESPONSES TO NATURAL HIV CE. WE THEN EVALUATED THE CE- AND PROTEIN-SPECIFIC T-CELL RESPONSES USING GAG, POL, AND ARF PEPTIDE POOLS AMONG PARTICIPANTS IMMUNIZED WITH A NON-CODON OPTIMIZED VACCINE REGIMEN OF 2 PGA2/JS7 DNA PRIMES FOLLOWED BY 2 MVA/HIV62 GAG-POL-ENV VECTOR BOOSTS OR 4 SALINE INJECTIONS. RESULTS: VACCINEES HAD SIGNIFICANTLY MORE INTERFERON GAMMA ENZYME-LINKED IMMUNOSORBENT SPOT (IFN GAMMA ELISPOT) RESPONSES TOWARD GAG (P=0.003) BUT NOT TOWARD POL PROTEIN THAN DID PLACEBO RECIPIENTS. HOWEVER, CE-SPECIFIC T-CELL RESPONSES WERE LOW IN MAGNITUDE, AND THEIR FREQUENCIES DID NOT DIFFER SIGNIFICANTLY BETWEEN VACCINE AND PLACEBO RECIPIENTS. ADDITIONALLY, MOST POSITIVE CE RESPONSES COULD NOT BE MAPPED TO INDIVIDUAL PEPTIDES. AFTER EXPANDING RESPONSES IN A CULTURED ASSAY, HOWEVER, THE FREQUENCY AND THE MEDIAN MAGNITUDE OF RESPONSES TO ARF PEPTIDES WERE SIGNIFICANTLY GREATER IN VACCINEES (P < 0.0001), INDICATING THAT CE-SPECIFIC T-CELL RESPONSES ARE PRESENT BUT BELOW AN EX VIVO ASSAY'S LIMIT OF DETECTION. CONCLUSIONS: OUR DATA DEMONSTRATE THAT HIV-1 VACCINES CURRENTLY IN CLINICAL TRIALS ARE POORLY IMMUNOGENIC WITH REGARD TO CE-SPECIFIC T-CELL RESPONSES. THEREFORE, THE CONTEXT OF HIV-1 IMMUNOGENS MAY NEED TO BE MODIFIED AS A COMPREHENSIVE STRATEGY TO BROADEN VACCINE-INDUCED T-CELL RESPONSES.","CRYPTIC EPITOPES; CODON OPTIMIZED; ALTERNATIVE READING FRAMES; HIV-1; CD8+T CELLS; HVTN 205 VACCINE TRIAL","IMMUNODEFICIENCY VIRUS-REPLICATION; DEFECTIVE RIBOSOMAL PRODUCTS; I-RESTRICTED EPITOPES; RHESUS-MONKEYS; CODON-OPTIMIZATION; ANTIGENIC PEPTIDES; READING FRAMES; IMMUNE CONTROL; ELISPOT ASSAY; MAJOR SOURCE","ENGLISH","ARTICLE","ARTICLE",3,"ABDULHAQQ SA, 2008, IMMUNOL RES, V42, P219, DOI 10.1007/S12026-008-8076-3.;BANSAL A, 2005, AIDS, V19, P241.;BANSAL A, 2007, AIDS, V21, P2387, DOI 10.1097/QAD.0B013E3282F13823.;BANSAL A, 2010, J EXP MED, V207, P51, DOI 10.1084/JEM.20092060.;BAROUCH DH, 2012, NATURE, V482, P89, DOI 10.1038/NATURE10766.;BERGER CT, 2010, J EXP MED, V207, P61, DOI 10.1084/JEM.20091808.;BRUCE AG, 1986, P NATL ACAD SCI USA, V83, P5062, DOI 10.1073/PNAS.83.14.5062.;BRUMME ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08.;BUCHBINDER SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3.;BULL M, 2007, J IMMUNOL METHODS, V322, P57, DOI 10.1016/J.JIM.2007.02.003.;BULLOCK TNJ, 1997, J EXP MED, V186, P1051, DOI 10.1084/JEM.186.7.1051.;CAMPION S, 2011, EUR J IMMUNOL, V41, P255, DOI 10.1002/EJI.201040296.;CANNARROZZI G, 2010, CELL, V141, P355, DOI 10.1016/J.CELL.2010.02.036.;CARDINAUD S, 2004, J EXP MED, V199, P1053, DOI 10.1084/JEM.20031869.;CHAMPIAT S, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0039311.;CHEVALIER MF, 2011, J VIROL, V85, P733, DOI 10.1128/JVI.02030-10.;DOLAN BP, 2010, J IMMUNOL, V184, P1419, DOI 10.4049/JIMMUNOL.0901907.;DRAENERT R, 2004, AIDS, V18, P871, DOI 10.1097/01.AIDS.0000111400.02002.DB.;DRUMMOND A., 2012, GENEIOUS.;EDWARDS BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002.;FILBERT H, 2013, CANCER IMMUNOL IMMUN, V62, P615, DOI 10.1007/S00262-012-1359-5.;FUKAZAWA Y, 2012, NAT MED, V18, P1673, DOI 10.1038/NM.2934.;GAUR A, 2005, J VIROL, V79, P4308, DOI 10.1128/JVI.79.7.4308-4315.2005.;GOEPFERT PA, 2011, J INFECT DIS, V203, P610, DOI 10.1093/INFDIS/JIQ105.;GOONETILLEKE N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006.;GOULDER PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/NRI2357.;GRAHAM BS, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0059340.;HANSEN SG, 2011, NATURE, V473, P523, DOI 10.1038/NATURE10003.;HARARI A, 2008, J EXP MED, V205, P63, DOI 10.1084/JEM.20071331.;HAYNES BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMOA1113425.;JANETZKI S, 2010, CANCER IMMUNOL IMMUN, V59, P609, DOI 10.1007/S00262-009-0788-2.;KEELE BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/PNAS.0802203105.;KOTLAR D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-67.;LETVIN NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/SCIENCE.1124226.;LIU JY, 2009, NATURE, V457, P87, DOI 10.1038/NATURE07469.;MALHOTRA I, 2008, J IMMUNOL, V180, P3383, DOI 10.4049/JIMMUNOL.180.5.3383.;MANESS NJ, 2007, J EXP MED, V204, P2505, DOI 10.1084/JEM.20071261.;MANESS NJ, 2010, J VIROL, V84, P11569, DOI 10.1128/JVI.01419-10.;MANESS NJ, 2010, J IMMUNOL, V184, P67, DOI 10.4049/JIMMUNOL.0903118.;MCELRATH MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5.;MICHAEL NL, 1994, J VIROL, V68, P979.;MUDD PA, 2012, NATURE, V491, P129, DOI 10.1038/NATURE11443.;MUTURI M, 2006, RETROVIROLOGY S1, V3, P44.;NAGATA T, 1999, BIOCHEM BIOPH RES CO, V261, P445, DOI 10.1006/BBRC.1999.1050.;OCHSENBAUER C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11.;OTTING N, 2005, P NATL ACAD SCI USA, V102, P1626, DOI 10.1073/PNAS.0409084102.;PICKER LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/ANNUREV-MED-042010-085643.;PRIDDY FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993.;RERKS-NGARM S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMOA0908492.;RITCHIE AJ, 2011, J VIROL, V85, P3507, DOI 10.1128/JVI.02444-10.;SCHIRMBECK R, 2005, J IMMUNOL, V174, P4647, DOI 10.4049/JIMMUNOL.174.8.4647.;SMITH JM, 2004, AIDS RES HUM RETROV, V20, P1335, DOI 10.1089/AID.2004.20.1335.;STEPHENSON KE, 2012, J VIROL, V86, P11434, DOI 10.1128/JVI.01779-12.;TAYLOR BS, 2008, NEW ENGL J MED, V359, P1965, DOI 10.1056/NEJMC086373.;WATTS JM, 2009, NATURE, V460, P711, DOI 10.1038/NATURE08237.;WILSON NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09.;WINSTONE N, 2009, EUR J IMMUNOL, V39, P975, DOI 10.1002/EJI.200839167.;YEWDELL JW, 2007, J EXP MED, V204, P2501, DOI 10.1084/JEM.20071986.;YEWDELL JW, 1996, J IMMUNOL, V157, P1823.","GOEPFERT, PA (REPRINT AUTHOR), UNIV ALABAMA BIRMINGHAM, DEPT MED, 908 20TH ST SOUTH CCB 328, BIRMINGHAM, AL 35294 USA.;BET, ANNE, STERRETT, SARAH, GOEPFERT, PAUL A., UNIV ALABAMA BIRMINGHAM, DEPT MICROBIOL, BIRMINGHAM, AL 35294 USA.;SATO, ALICIA, FRED HUTCHINSON CANC RES CTR, STAT CTR HIV AIDS RES \& PREVENT, SEATTLE, WA 98104 USA.;BANSAL, ANJU, GOEPFERT, PAUL A., UNIV ALABAMA BIRMINGHAM, DEPT MED, BIRMINGHAM, AL 35294 USA.","10.1097/QAI.0B013E3182A9917E","530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA",NA,NA,"HIV VACCINE TRIALS NETWORK, GEOVAX, INC","THE AUTHORS THANK ALL THE VOLUNTEERS WHO PARTICIPATED IN THE HVTN 205 STUDY. THE AUTHORS ALSO THANK THE HIV VACCINE TRIALS NETWORK AND GEOVAX, INC FOR THEIR COLLABORATION IN SUPPORTING THIS WORK.",NA,"1525-4135","2","142-150","LIPPINCOTT WILLIAMS \& WILKINS","65",2014,"ISI000335650300016","59","IMMUNOLOGY, INFECTIOUS DISEASES","2","IMMUNOLOGY, INFECTIOUS DISEASES","PAULGUAB.EDU",NA,"AG8DZ",NA,"GOEPFERT, PA (REPRINT AUTHOR), UNIV ALABAMA BIRMINGHAM, DEPT MED, 908 20TH ST SOUTH CCB 328, BIRMINGHAM, AL 35294 USA","ISI","UNIV ALABAMA BIRMINGHAM;FRED HUTCHINSON CANC RES CTR;UNIV ALABAMA BIRMINGHAM","UNIV ALABAMA BIRMINGHAM",NA,"BET A, 2014, JAIDS","BET A, 2014, JAIDS"
"VASEGHI A, 2014, WORLD J MICROBIOL BIOTECHNOL","VASEGHI A;BAKHSHINEJAD B;SAFAIE N;PARCHIN RA;SADEGHIZADEH M","PCR AMPLIFICATION OF THE HRCV GENE THROUGH SPECIFIC PRIMERS FOR DETECTING PSEUDOMONAS SYRINGAE PATHOVARS","WORLD JOURNAL OF MICROBIOLOGY \& BIOTECHNOLOGY","WORLD J. MICROBIOL. BIOTECHNOL.","PSEUDOMONAS SYRINGAE PATHOVARS ARE IMPORTANT PATHOGENS AMONG PHYTOPATHOGENIC BACTERIA CAUSING A VARIETY OF DISEASES IN PLANTS. THESE PATHOGENS CAN RAPIDLY DISSEMINATE IN A LARGE AREA LEADING TO INFECTION AND DESTRUCTION OF PLANTS. TO PREVENT THE INCIDENCE OF THE BACTERIA, APPROPRIATE DETECTION METHODS SHOULD BE EMPLOYED. ROUTINELY SEROLOGICAL TESTS, BEING TIME-CONSUMING AND COSTLY, ARE EXPLOITED TO DETECT THESE PATHOGENS IN PLANTS, SOIL, WATER AND OTHER RESOURCES. OVER THE RECENT YEARS, DNA-BASED DETECTION APPROACHES WHICH ARE STABLE, RAPID, SPECIFIC AND RELIABLE HAVE BEEN DEVELOPED AND SEQUENCE ANALYSIS OF VARIOUS GENES ARE WIDELY UTILIZED TO IDENTIFY DIFFERENT STRAINS OF P. SYRINGE. HOWEVER, THE GREATEST LIMITATION OF THESE GENES IS INABILITY TO DETECT NUMEROUS PATHOVARS OF P. SYRINGAE. HEREIN, BY USING BIOINFORMATIC ANALYSIS, WE FOUND THE HRCV GENE LOCATED AT PATHOGENICITY ISLANDS OF BACTERIAL GENOME WITH THE POTENTIAL OF BEING USED AS A NEW MARKER FOR PHYLOGENETIC DETECTION OF NUMEROUS PATHOVARS OF P. SYRINGAE. FOLLOWING DESIGN OF SPECIFIC PRIMERS TO HRCV, WE AMPLIFIED A 440 BP FRAGMENT. OF 13 ASSAYED PATHOVARS, 11 WERE DETECTED. ALSO, THROUGH EXPERIMENTAL PROCEDURES AND BIOINFORMATIC ANALYSIS IT WAS REVEALED THAT THE DESIGNED PRIMERS HAVE THE CAPACITY TO DETECT 19 PATHOVARS. OUR FINDINGS SUGGEST THAT HRCV COULD BE USED AS A GENE WITH THE MERIT OF DETECTING MORE PATHOVARS OF P. SYRINGAE IN COMPARISON WITH OTHER GENES USED FREQUENTLY FOR DETECTION PURPOSES.","BIOINFORMATIC ANALYSIS; DETECTION; HRCV GENE; PSEUDOMONAS SYRINGAE","III SECRETION; IDENTIFICATION; STRAINS; PHASEOLICOLA; SENSITIVITY; PROTOCOL; DISEASE; CLUSTER; PLANTS; HRP","ENGLISH","ARTICLE","ARTICLE",2,"ALMEIDA NF, 2010, PHYTOPATHOLOGY, V100, P208, DOI 10.1094/PHYTO-100-3-0208.;BASSAM BJ, 1993, BIOTECHNIQUES, V14, P30.;BENNASAR A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-118.;BERESWILL S, 1994, APPL ENVIRON MICROB, V60, P2924.;BERTOLINI E, 2003, J MICROBIOL METH, V52, P261, DOI 10.1016/S0167-7012(02)00163-X.;BULL CT, 2011, PHYTOPATHOLOGY, V101, P847, DOI 10.1094/PHYTO-11-10-0318.;CASANO FJ, 1987, EPPO B, V17, P173.;CHO MS, 2010, MICROBIOL RES, V165, P565, DOI 10.1016/J.MICRES.2009.11.001.;GARDAN L, 1997, DEV PLANT PATHOLOGY, V9, P445.;HE QS, 1994, BIOTECHNIQUES, V17, P82.;HE SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/J.BBAMCR.2004.03.011.;HORST RK., 1990, WESTCOTTS PLANT DIS.;HWANG MSH, 2005, APPL ENVIRON MICROB, V71, P5182, DOI 10.1128/AEM.71.9.5182-5191.2005.;JANSE JD, 1991, SYST APPL MICROBIOL, V14, P79, DOI 10.1016/S0723-2020(11)80365-6.;KONG H, 2004, BIOL CONTROL, V30, P83, DOI 10.1016/J.BIOCONTROL.2003.09.002.;LINDGREN PB, 1986, J BACTERIOL, V168, P512, DOI 10.1128/JB.168.2.512-522.1986.;LOPEZ MM, 1997, DEV PLANT PATHOL, V11, P117.;LOUWS FJ, 1999, ANNU REV PHYTOPATHOL, V37, P81, DOI 10.1146/ANNUREV.PHYTO.37.1.81.;LYDON J, 2001, LETT APPL MICROBIOL, V32, P166, DOI 10.1046/J.1472-765X.2001.00882.X.;PARKINSON N, 2011, PLANT PATHOL, V60, P338, DOI 10.1111/J.1365-3059.2010.02366.X.;PETERS BJ, 2004, PLANT PATHOL, V53, P73, DOI [10.1111/J.1365-3059.2004.00946.X, 10.1046/J.1365-3059.2003.00946.X].;RAMOS AR, 2007, J BACTERIOL, V189, P5773, DOI 10.1128/JB.00435-07.;RICO A, 2003, PHYTOPATHOLOGY, V93, P1553, DOI 10.1094/PHYTO.2003.93.12.1553.;SAWADA H, 1999, J MOL EVOL, V49, P627, DOI 10.1007/PL00006584.;SINGH VINAY K., 2001, MOLECULAR BIOLOGY TODAY, V2, P27.;SORENSEN KN, 1998, APPL ENVIRON MICROB, V64, P226.;TAGUCHI F, 2003, PLANT PHYSIOL BIOCH, V41, P165, DOI 10.1016/S0981-9428(02)00018-9.;TAMPAKAKI AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/J.1462-5822.2004.00432.X.;TAMURA K, 2002, PHYSIOL MOL PLANT P, V60, P207, DOI 10.1006/PMPP.2002.0405.;TAYEB LA, 2005, RES MICROBIOL, V156, P763, DOI 10.1016/J.RESMIC.2005.02.009.;TENOVER FC, 1997, INFECT CONT HOSP EP, V18, P426.;THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/NAR/22.22.4673.;VASEGHI A, 2013, SENSOR ACTUAT B-CHEM, V181, P644, DOI 10.1016/J.SNB.2013.02.018.;VINATZER BORIS A., 2009, P37.;WIDMER F, 1998, APPL ENVIRON MICROB, V64, P2545.;ZHAO YF, 2002, PLANT DIS, V86, P883, DOI 10.1094/PDIS.2002.86.8.883.","SADEGHIZADEH, M (REPRINT AUTHOR), TARBIAT MODARES UNIV, DEPT GENET, FAC BIOL SCI, TEHRAN, IRAN.;VASEGHI, AKBAR, BAKHSHINEJAD, BABAK, SADEGHIZADEH, MAJID, TARBIAT MODARES UNIV, DEPT GENET, FAC BIOL SCI, TEHRAN, IRAN.;VASEGHI, AKBAR, PARCHIN, REZA ASHRAFI, ISLAMIC AZAD UNIV, YOUNG RESEARCHER CLUB, SCI \& RESEARCHER BRANCH, ARDEBIL, IRAN.;SAFAIE, NASER, TARBIAT MODARES UNIV, DEPT PLANT PATHOL, FAC AGR, TEHRAN, IRAN.","10.1007/S11274-013-1438-6","233 SPRING ST, NEW YORK, NY 10013 USA",NA,NA,"RESEARCH COUNCIL OF TARBIAT MODARES UNIVERSITY","THE AUTHORS EXPRESS THEIR PROFOUND GRATITUDE TO THE RESEARCH COUNCIL OF TARBIAT MODARES UNIVERSITY FOR FUNDING THIS STUDY. THE AUTHORS DECLARE THAT THERE IS NO CONFLICT OF INTERESTS.",NA,"0959-3993","2","413-421","SPRINGER","30",2014,"ISI000330829900007","36","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY","10","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY","SADEGHMAMODARES.AC.IR",NA,"AA1AZ",NA,"SADEGHIZADEH, M (REPRINT AUTHOR), TARBIAT MODARES UNIV, DEPT GENET, FAC BIOL SCI, TEHRAN, IRAN","ISI","TARBIAT MODARES UNIV;ISLAMIC AZAD UNIV;TARBIAT MODARES UNIV","TARBIAT MODARES UNIV",NA,"VASEGHI A, 2014, WORLD J MICROBIOL BIOTECHNOL","VASEGHI A, 2014, WORLD J MICROBIOL BIOTECHNOL"
"VAZQUEZ-CASTELLANOS JF, 2014, BMC GENOMICS","VAZQUEZ CASTELLANOS JF;GARCIA LOPEZ R;PEREZ BROCAL V;PIGNATELLI M;MOYA A","COMPARISON OF DIFFERENT ASSEMBLY AND ANNOTATION TOOLS ON ANALYSIS OF SIMULATED VIRAL METAGENOMIC COMMUNITIES IN THE GUT","BMC GENOMICS","BMC GENOMICS","BACKGROUND: THE MAIN LIMITATIONS IN THE ANALYSIS OF VIRAL METAGENOMES ARE PERHAPS THE HIGH GENETIC VARIABILITY AND THE LACK OF INFORMATION IN EXTANT DATABASES. TO ADDRESS THESE ISSUES, SEVERAL BIOINFORMATIC TOOLS HAVE BEEN SPECIFICALLY DESIGNED OR ADAPTED FOR METAGENOMICS BY IMPROVING READ ASSEMBLY AND CREATING MORE SENSITIVE METHODS FOR HOMOLOGY DETECTION. THIS STUDY COMPARES THE PERFORMANCE OF DIFFERENT AVAILABLE ASSEMBLERS AND TAXONOMIC ANNOTATION SOFTWARE USING SIMULATED VIRAL-METAGENOMIC DATA. RESULTS: WE SIMULATED TWO 454 VIRAL METAGENOMES USING GENOMES FROM NCBI'S REFSEQ DATABASE BASED ON THE LIST OF ACTUAL VIRUSES FOUND IN PREVIOUSLY PUBLISHED METAGENOMES. THREE DIFFERENT ASSEMBLY STRATEGIES, SPANNING SIX ASSEMBLERS, WERE TESTED FOR PERFORMANCE: OVERLAP-LAYOUT-CONSENSUS ALGORITHMS NEWBLER, CELERA AND MINIMO, DE BRUIJN GRAPHS ALGORITHMS VELVET AND METAVELVET, AND READ PROBABILISTIC MODEL GENOVO. THE PERFORMANCE OF THE ASSEMBLIES WAS MEASURED BY THE LENGTH OF RESULTING CONTIGS (USING N50), THE PERCENTAGE OF READS ASSEMBLED AND THE OVERALL ACCURACY WHEN COMPARING AGAINST CORRESPONDING REFERENCE GENOMES. ADDITIONALLY, THE NUMBER OF CHIMERAS PER CONTIG AND THE LOWEST COMMON ANCESTOR WERE ESTIMATED IN ORDER TO ASSESS THE EFFECT OF ASSEMBLING ON TAXONOMIC AND FUNCTIONAL ANNOTATION. THE FUNCTIONAL CLASSIFICATION OF THE READS WAS EVALUATED BY COUNTING THE READS THAT CORRECTLY MATCHED THE FUNCTIONAL DATA PREVIOUSLY REPORTED FOR THE ORIGINAL GENOMES AND CALCULATING THE NUMBER OF OVER-REPRESENTED FUNCTIONAL CATEGORIES IN CHIMERIC CONTIGS. THE SENSITIVITY AND SPECIFICITY OF TBLASTX, PHYMMBL AND THE K MER FREQUENCIES WERE MEASURED BY ACCURATE PREDICTIONS WHEN COMPARING SIMULATED READS AGAINST THE NCBI VIRUS GENOMES REFSEQ DATABASE. CONCLUSIONS: ASSEMBLING IMPROVES FUNCTIONAL ANNOTATION BY INCREASING ACCURATE ASSIGNATIONS AND DECREASING AMBIGUOUS HITS BETWEEN VIRUSES AND BACTERIA. HOWEVER, THE SUCCESS IS LIMITED BY THE CHIMERIC CONTIGS OCCURRING AT ALL TAXONOMIC LEVELS. THE ASSEMBLER AND ITS PARAMETERS SHOULD BE SELECTED BASED ON THE FOCUS OF EACH STUDY. MINIMO'S NON-CHIMERIC CONTIGS AND GENOVO'S LONG CONTIGS EXCELLED IN TAXONOMY ASSIGNATION AND FUNCTIONAL ANNOTATION, RESPECTIVELY. TBLASTX STOOD OUT AS THE BEST APPROACH FOR TAXONOMIC ANNOTATION FOR VIRUS IDENTIFICATION. PHYMMBL PROVED USEFUL IN DATASETS IN WHICH NO RELATED SEQUENCES ARE PRESENT AS IT USES GENOMIC FEATURES THAT MAY HELP IDENTIFY DISTANT TAXA. THE K-FREQUENCIES UNDERPERFORMED IN ALL VIRAL DATASETS.","VIRAL METAGENOME; ASSEMBLER PERFORMANCE; TAXONOMIC CLASSIFICATION; CHIMERA IDENTIFICATION; FUNCTIONAL ANNOTATION","GENE-TRANSFER AGENTS; PHYLOGENETIC CLASSIFICATION; FECAL MICROBIOTA; CROHNS-DISEASE; GENOME; PHAGE; SEQUENCE; EVOLUTION; VIRUSES; SEARCH","ENGLISH","ARTICLE","ARTICLE",38,"ALLEN HK, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-5.;ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/NAR/25.17.3389.;ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;ANGLY F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41.;ARUMUGAM M, 2011, NATURE, V473, P174, DOI 10.1038/NATURE09944.;BACKHAUS H, 1985, J VIROL, V55, P458.;BAO QY, 2002, GENOME RES, V12, P689, DOI 10.1101/GR.219302.;BOISVERT S, 2012, GENOME BIOL, V13, DOI 10.1186/GB-2012-13-12-R122.;BOTSTEIN D, 1980, ANN N Y ACAD SCI, V354, P484, DOI 10.1111/J.1749-6632.1980.TB27987.X.;BRADY A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/NMETH.1358].;BREITBART M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003.;BREITBART M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/PNAS.202488399.;BREITBART M, 2008, RES MICROBIOL, V159, P367, DOI 10.1016/J.RESMIC.2008.04.006.;BRUSSOW H, 2001, MOL MICROBIOL, V39, P213, DOI 10.1046/J.1365-2958.2001.02228.X.;CANCHAYA C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9.;CASJENS S, 1992, SEMINARS VIROLOGY, V3, P383.;CHARLES TC, 2010, METAGENOMICS: THEORY, METHODS AND APPLICATIONS, P107.;CHARUVAKA A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S8.;CLARK AJ, 2001, J MOL BIOL, V311, P657, DOI 10.1006/JMBI.2001.4868.;DAY JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-313.;EDWARDS RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/NRMICROL163.;EPPLER K, 1991, VIROLOGY, V183, P519, DOI 10.1016/0042-6822(91)90981-G.;FUJIMURA KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/ERI.10.14, 10.1586/ERI.10.14].;GEORGE I, 2010, METAGENOMICS: THEORY, METHODS AND APPLICATIONS, P119.;GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/NG0393-266.;GOECKS J, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-8-R86.;GROTH AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/J.JMB.2003.09.082.;GRUNDLING A, 2001, P NATL ACAD SCI USA, V98, P9348, DOI 10.1073/PNAS.151247598.;HANDELSMAN J, 1998, CHEM BIOL, V5, PR245, DOI 10.1016/S1074-5521(98)90108-9.;HENDRIX RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/PNAS.96.5.2192.;HUANG SK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-124.;HURWITZ BL, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0057355.;JANSSON J, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0006386.;KANEKO J, 2009, J BACTERIOL, V191, P4674, DOI 10.1128/JB.01793-08.;KENT WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/GR.229202, 10.1101/GR.229202. ARTICLE PUBLISHED ONLINE BEFORE MARCH 2002].;KRISTENSEN DM, 2013, J BACTERIOL, V195, P941, DOI 10.1128/JB.01801-12.;KRISTENSEN DM, 2011, J BACTERIOL, V193, P1806, DOI 10.1128/JB.01311-10.;LAI BB, 2012, BIOINFORMATICS, V28, P1455, DOI 10.1093/BIOINFORMATICS/BTS162.;LANG AS, 2012, NAT REV MICROBIOL, V10, P472, DOI 10.1038/NRMICRO2802.;LASERSON J, 2011, J COMPUT BIOL, V18, P429, DOI 10.1089/CMB.2010.0244.;LEPLAE R, 2010, NUCLEIC ACIDS RES, V38, PD57, DOI 10.1093/NAR/GKP938.;LUO CW, 2012, PLOS ONE, V7, DOI [10.1371/JOURNAL.PONE.0030087, 10.1371/JOURNAL.PONE.0036568].;MANICHANH C, 2006, GUT, V55, P205, DOI 10.1136/GUT.2005.073817.;MARGULIES M, 2005, NATURE, V437, P376, DOI 10.1038/NATURE03959.;MARTIN J, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0036427.;MCHARDY AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976.;MENDE DR, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0031386.;METHE BA, 2012, NATURE, V486, P215, DOI 10.1038/NATURE11209.;MILLER JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/BIOINFORMATICS/BTN548.;MYERS EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/SCIENCE.287.5461.2196.;NAMIKI T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/NAR/GKS678.;NARASINGARAO P, 2012, ISME J, V6, P81, DOI 10.1038/ISMEJ.2011.78.;NING ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/GR.194201.;PAGES H, BIOSTRINGS STRING OB.;PEDERSEN M, 2000, VIROLOGY, V276, P315, DOI 10.1006/VIRO.2000.0497.;PENG Y, 2011, BIOINFORMATICS, V27, PI94, DOI 10.1093/BIOINFORMATICS/BTR216.;PEREZ-BROCAL V, 2013, CLIN TRANSL GASTROEN, V4, DOI 10.1038/CTG.2013.9.;PIGNATELLI M, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0019984.;PONSTIGL H, 2013, SMALT.;POP M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/BIB/BBP026.;POWELL S, 2012, NUCLEIC ACIDS RES, V40, PD284, DOI 10.1093/NAR/GKR1060.;QIN JJ, 2010, NATURE, V464, P59, DOI 10.1038/NATURE08821.;R DEVELOPMENT CORE TEAM, 2012, R LANG ENV STAT COMP.;REN XW, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0051188.;REYES A, 2010, NATURE, V466, P334, DOI 10.1038/NATURE09199.;RICHTER DC, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0003373.;RUSCH DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/JOURNAL.PBIO.0050077.;SCHMIEDER R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/BIOINFORMATICS/BTR026.;SCHMIEDER R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341.;SOKOL H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/PNAS.0804812105.;TREANGEN TJ, 2011, CURR PROTOC BIOINFOR, V33.;TRIFONOV V, 2010, MBIO, V1, DOI 10.1128/MBIO.00156-10.;VENTER JC, 2004, SCIENCE, V304, P66, DOI 10.1126/SCIENCE.1093857.;VICTORIA JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08.;WEN L, 2008, NATURE, V455, P1109, DOI 10.1038/NATURE07336.;WILLIAMSON SJ, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0042047.;WILLNER D, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0007370.;WOMMACK KE, 2012, STAND GENOMIC SCI, V6, P421, DOI 10.4056/SIGS.2945050.;WONG DWS, 2010, METAGENOMICS: THEORY, METHODS AND APPLICATIONS, P141.;WOOLEY JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/JOURNAL.PCBI.1000667.;WYLIE KM, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0027735.;YANG X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-475.;YOSHIDA T, 2008, J BACTERIOL, V190, P1762, DOI 10.1128/JB.01534-07.;YU JM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-39.;ZERBINO DR, 2008, GENOME RES, V18, P821, DOI 10.1101/GR.074492.107.;ZHANG Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478.","MOYA, A (REPRINT AUTHOR), FDN FOMENTO INVEST SANIT \& BIOMED COMUNIDAD VALEN, AVE CATALUNA 21, VALENCIA 46020, SPAIN.;VAZQUEZ-CASTELLANOS, JORGE F., GARCIA-LOPEZ, RODRIGO, PEREZ-BROCAL, VICENTE, MOYA, ANDRES, FDN FOMENTO INVEST SANIT \& BIOMED COMUNIDAD VALEN, VALENCIA 46020, SPAIN.;VAZQUEZ-CASTELLANOS, JORGE F., GARCIA-LOPEZ, RODRIGO, PEREZ-BROCAL, VICENTE, MOYA, ANDRES, UNIV VALENCIA, INST CAVANILLES BIODIVERSITAT \& BIOL EVOLUT ICBIB, VALENCIA 46071, SPAIN.;PEREZ-BROCAL, VICENTE, MOYA, ANDRES, CIBER EPIDEMIOL \& SALUD PUBL CIBERESP, MADRID, SPAIN.;PIGNATELLI, MIGUEL, EUROPEAN BIOINFORMAT INST, EUROPEAN MOL BIOL LAB, CAMBRIDGE CB10 1SD, ENGLAND.","10.1186/1471-2164-15-37","CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND","37",NA,"MINISTRY OF ECONOMY AND COMPETITIVENESS (MINECO) [SAF-2012-31187], INSTITUTO DE SALUD CARLOS III, SPAIN, MICINN, SPAIN, ``INSTITUTO NACIONAL DE LA SALUD CARLOS III'' SPAIN [CD09/00101]","THIS WORK WAS SUPPORTED BY GRANT SAF-2012-31187 FROM THE MINISTRY OF ECONOMY AND COMPETITIVENESS (MINECO) TO AM. JFVC WAS ALSO SUPPORTED BY A FELLOWSHIP ``AYUDAS PREDOCTORALES DE FORMACION EN INVESTIGACION EN SALUD'' FROM THE INSTITUTO DE SALUD CARLOS III, SPAIN. RGL IS",NA,"1471-2164",NA,NA,"BMC","15",2014,"ISI000331095900001","86","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","51","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","ANDRES.MOYAUV.ES",NA,"AA4VY",NA,"MOYA, A (REPRINT AUTHOR), FDN FOMENTO INVEST SANIT \& BIOMED COMUNIDAD VALEN, AVE CATALUNA 21, VALENCIA 46020, SPAIN","ISI","ANDRES;UNIV VALENCIA;ANDRES;EUROPEAN BIOINFORMAT INST","FDN FOMENTO INVEST SANIT AND BIOMED COMUNIDAD VALEN",NA,"VAZQUEZ-CASTELLANOS JF, 2014, BMC GENOMICS","VAZQUEZ-CASTELLANOS JF, 2014, BMC GENOMICS"
"PARCERISAS A, 2014, J ALZHEIMERS DIS","PARCERISAS A;RUBIO SE;MUHAISEN A;GOMEZ RAMOS A;PUJADAS L;PUIGGROS M;ROSSI D;URENA J;BURGAYA F;PASCUAL M;TORRENTS D;RABANO A;AVILA J;SORIANO E","SOMATIC SIGNATURE OF BRAIN-SPECIFIC SINGLE NUCLEOTIDE VARIATIONS IN SPORADIC ALZHEIMER'S DISEASE","JOURNAL OF ALZHEIMERS DISEASE","J. ALZHEIMERS DIS.","BACKGROUND: ALTHOUGH GENOME-WIDE ASSOCIATION STUDIES HAVE SHOWN THAT GENETIC FACTORS INCREASE THE RISK OF SUFFERING LATE-ONSET, SPORADIC ALZHEIMER'S DISEASE (SAD), THE MOLECULAR MECHANISMS RESPONSIBLE REMAIN LARGELY UNKNOWN. OBJECTIVE: THE AIM OF THE STUDY WAS TO INVESTIGATE THE PRESENCE OF SOMATIC, BRAIN-SPECIFIC SINGLE NUCLEOTIDE VARIATIONS (SNV) IN THE HIPPOCAMPUS OF SAD SAMPLES. METHODS: BY USING BIOINFORMATIC TOOLS, WE COMPARED WHOLE EXOME SEQUENCES IN PAIRED BLOOD AND HIPPOCAMPAL GENOMIC DNAS FROM 17 SAD PATIENTS AND FROM 2 CONTROLS AND 2 VASCULAR DEMENTIA PATIENTS. RESULTS: WE FOUND A REMARKABLE NUMBER OF SNVS IN SAD BRAINS (SIMILAR TO 575 PER PATIENT) THAT WERE NOT DETECTED IN BLOOD. LOCI WITH HIPPOCAMPUS-SPECIFIC (HS)-SNVS WERE COMMON TO SEVERAL PATIENTS, WITH 38 GENES BEING PRESENT IN 6 OR MORE PATIENTS OUT OF THE 17. WHILE SOME OF THESE SNVS WERE IN GENES PREVIOUSLY RELATED TO SAD (E.G., CSMD1, LRP2), MOST HS-SNVS OCCURRED IN LOCI PREVIOUSLY UNRELATED TO SAD. THE MOST FREQUENT GENES WITH HS-SNVS WERE ASSOCIATED WITH NEUROTRANSMISSION, DNA METABOLISM, NEURONAL TRANSPORT, AND MUSCULAR FUNCTION. INTERESTINGLY, 19 RECURRENT HS-SNVS WERE COMMON TO 3 SAD PATIENTS. REPETITIVE LOCI OR HS-SNVS WERE UNDERREPRESENTED IN THE HIPPOCAMPUS OF CONTROL OR VASCULAR DEMENTIA DONORS, OR IN THE CEREBELLUM OF SAD PATIENTS. CONCLUSION: OUR DATA SUGGEST THAT ADULT BLOOD AND BRAIN HAVE DIFFERENT DNA GENOMIC VARIATIONS, AND THAT SOMATIC GENETIC MOSAICISM AND BRAIN-SPECIFIC GENOME RESHAPING MAY CONTRIBUTE TO SAD PATHOGENESIS AND COGNITIVE DIFFERENCES BETWEEN INDIVIDUALS.","ALZHEIMER'S DISEASE; EXOME SEQUENCING; SOMATIC VARIATIONS","GENOME-WIDE ASSOCIATION; A-BETA-PP; SECRETASE ACTIVATING PROTEIN; DREIFUSS MUSCULAR-DYSTROPHY; SQUAMOUS-CELL CARCINOMA; COPY NUMBER VARIATION; DNA-SEQUENCING DATA; AMYLOID-BETA; SUSCEPTIBILITY GENES; MACULAR DEGENERATION","ENGLISH","ARTICLE","ARTICLE",10,"ALIEV G., 2003, JOURNAL OF SUBMICROSCOPIC CYTOLOGY AND PATHOLOGY, V35, P253.;ALVIRA-BOTERO X, CURR AGING SCI, V3, P219.;ALVIRA-BOTERO XIMENA, 2010, CURR AGING SCI, V3, P219.;ARIMURA T, 2007, BIOCHEM BIOPH RES CO, V362, P281, DOI 10.1016/J.BBRC.2007.07.183.;BAILLIE JK, 2011, NATURE, V479, P534, DOI 10.1038/NATURE10531.;BALLARD C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9.;BARANZINI SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/HMG/DDN388.;BARNES DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2.;BARNETT DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/BIOINFORMATICS/BTR174.;BARRETT JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/NG.959.;BASHIR R, 1998, NAT GENET, V20, P37.;BENOIT ME, 2013, J BIOL CHEM, V288, P654, DOI 10.1074/JBC.M112.400168.;BERTRAM L, 2010, NEURON, V68, P270, DOI 10.1016/J.NEURON.2010.10.013.;BOND J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/J.CEB.2005.11.004.;BRADSHAW EM, 2013, NAT NEUROSCI, V16, P848, DOI 10.1038/NN.3435.;BRUNO AM, NEUROBIOL AGING, V33.;CARLSSON L, 2008, HISTOCHEM CELL BIOL, V130, P91, DOI 10.1007/S00418-008-0413-Z.;CAVANILLAS ML, 2011, GENES IMMUN, V12, P110, DOI 10.1038/GENE.2010.52.;CHAKROBORTY S, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0052056.;CHARIZANIS K, 2012, NEURON, V75, P437, DOI 10.1016/J.NEURON.2012.05.029.;CINGOLANI P., 2012, SNPEFF VARIANT EFFEC.;CINGOLANI P, 2012, FLY, V6, P80, DOI 10.4161/FLY.19695.;COLTON CA, 2008, J ALZHEIMERS DIS, V15, P571.;COST GJ, 2001, NUCLEIC ACIDS RES, V29, P573, DOI 10.1093/NAR/29.2.573.;DABORG J, 2012, J NEURAL TRANSM, V119, P789, DOI 10.1007/S00702-012-0797-8.;DE BAETS G, 2012, NUCLEIC ACIDS RES, V40, PD935, DOI 10.1093/NAR/GKR996.;DEPRISTO MA, 2011, NAT GENET, V43, P491, DOI 10.1038/NG.806.;DJUROVIC S, 2009, PSYCHIAT RES, V168, P256, DOI 10.1016/J.PSYCHRES.2008.08.007.;DREW KL, 2002, COMP BIOCHEM PHYS C, V133, P483, DOI 10.1016/S1532-0456(02)00118-7.;DUPRE N, 1993, GENEREVIEWS.;DURSUN E, 2008, J GERIATR PSYCH NEUR, V21, P268, DOI 10.1177/0891988708324941.;EDVARDSON S, 2012, ANN NEUROL, V71, P569, DOI 10.1002/ANA.23524.;EVRONY GD, 2012, CELL, V151, P483, DOI 10.1016/J.CELL.2012.09.035.;FESCHOTTE C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/NRG2337.;FISHEL ML, 2007, MUTAT RES-FUND MOL M, V614, P24, DOI 10.1016/J.MRFMMM.2006.06.007.;FOULKES WD, 2008, NEW ENGL J MED, V359, P2143, DOI 10.1056/NEJMRA0802968.;FRANC DT, 2012, NEUROMUSCULAR DISORD, V22, P483, DOI 10.1016/J.NMD.2012.01.003.;FUJITA PA, 2011, NUCLEIC ACIDS RES, V39, PD876, DOI 10.1093/NAR/GKQ963.;FURNEY SJ, MOL PSYCHIAT, V16, P1130.;GALVIN JE, 2006, ACTA NEUROPATHOL, V112, P665, DOI 10.1007/S00401-006-0147-8.;GARBETT K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/J.NBD.2008.01.012.;GERSTEIN M, 2012, NATURE, V489, P208, DOI 10.1038/489208B.;GHERSI E, 2004, J BIOL CHEM, V279, P49105, DOI 10.1074/JBC.M405329200.;GHERSI E, 2004, J ALZHEIMERS DIS, V6, P67.;GRATACOS M, 2009, AM J MED GENET B, V150B, P808, DOI 10.1002/AJMG.B.30902.;GRICIUC A, 2013, NEURON, V78, P631, DOI 10.1016/J.NEURON.2013.04.014.;GROS-LOUIS F, 2007, NAT GENET, V39, P80, DOI 10.1038/NG1927.;GRUPE A, 2006, AM J HUM GENET, V78, P78, DOI 10.1086/498851.;GRUPE A, 2007, HUM MOL GENET, V16, P865, DOI 10.1093/HMG/DDM031.;GUERREIRO R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMOA1211851.;HAGIKURA M, 2010, PATHOL INT, V60, P735, DOI 10.1111/J.1440-1827.2010.02592.X.;HALDEMAN-ENGLERT CR, 2010, AM J MED GENET A, V152A, P196, DOI 10.1002/AJMG.A.33176.;HAN MR, 2011, BMC NEUROL, V10, P90.;HAROLD D, 2009, NAT GENET, V41, P1088, DOI 10.1038/NG.440.;HASEGAWA M, 2007, PATHOL INT, V57, P245, DOI 10.1111/J.1440-1827.2007.02097.X.;HAVIK B, 2011, BIOL PSYCHIAT, V70, P35, DOI 10.1016/J.BIOPSYCH.2011.01.030.;HE G, 2010, NATURE, V467, P95, DOI 10.1038/NATURE09325.;HE ZQ, 2008, MED HYPOTHESES, V70, P92, DOI 10.1016/J.MEHY.2007.04.022.;HEINZEN EL, 2010, J ALZHEIMERS DIS, V19, P69, DOI 10.3233/JAD-2010-1212.;HOLASEK SS, 2005, BRAIN RES, V1045, P185, DOI 10.1016/J.BRAINRES.2005.03.037.;HOLLINGWORTH P, 2011, NAT GENET, V43, P429, DOI 10.1038/NG.803.;HUIJSMANS CJJ, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0038362.;ILLA I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO,2-0.;ISHIGURO H, 2008, AM J MED GENET B, V147B, P1167, DOI 10.1002/AJMG.B.30742.;IZUMI Y, 2013, NEUROLOGY, V80, P600, DOI 10.1212/WNL.0B013E3182815529.;JAEGER S, 2008, CURR ALZHEIMER RES, V5, P15.;JELCIC I, MULT SCLER, V18, P951.;JONSSON T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMOA1211103.;KALLIO SP, 2009, HUM MOL GENET, V18, P1670, DOI 10.1093/HMG/DDP073.;KAMAL M, BREAST CANC RES TREA, V121, P555.;KAMAL M, 2010, BREAST CANCER RES TR, V121, P555, DOI 10.1007/S10549-009-0500-4.;KAMBOH MI, 2012, MOL PSYCHIATR, V17, P1340, DOI 10.1038/MP.2011.135.;KANTARCI S, 2007, NAT GENET, V39, P957, DOI 10.1038/NG2063.;KIM S, 2010, CLIN J AM SOC NEPHRO, V5, P1072, DOI 10.2215/CJN.06550909.;KLIMOWICZ AC, 2012, EUR J CANCER, V48, P2166, DOI 10.1016/J.EJCA.2012.04.010.;KNIGHT HM, 2009, AM J HUM GENET, V85, P833, DOI 10.1016/J.AJHG.2009.11.003.;KRUG T, 2010, HUM GENET, V127, P513, DOI 10.1007/S00439-010-0790-Y.;KUSHIMA I, SCHIZOPHR B, V38, P552.;LABEIT S, 2011, FASEB J, V25, P822, DOI 10.1096/FJ.10-157412.;LAFERLA FM, 1997, J CLIN INVEST, V100, P310, DOI 10.1172/JCI119536.;LAMBERT JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/NG.2802.;LAMBERT JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/NG.439.;LANDER ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062.;LEHTOKARI VL, 2011, NEUROMUSCULAR DISORD, V21, P556, DOI 10.1016/J.NMD.2011.05.012.;LESCH KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/S00702-008-0119-3.;LI H, 2009, BIOINFORMATICS, V26, P589, DOI DOI 10.1093/BIOINFORMATICS/BTP698.;LIU J, 1998, NAT GENET, V20, P31.;LU T, 2004, NATURE, V429, P883, DOI 10.1038/NATURE02661.;LYNCH SM, 1997, BBA-LIPID LIPID MET, V1345, P215, DOI 10.1016/S0005-2760(96)00182-8.;MA CQ, 2009, CANCER BIOL THER, V8, P907, DOI 10.4161/CBT.8.10.8132.;MACHIDA T, 2006, ONCOGENE, V25, P1931, DOI 10.1038/SJ.ONC.1209225.;MAEDA N, 2012, MOL ASPECTS MED, V33, P665, DOI 10.1016/J.MAM.2012.02.004.;MAHER B, 2012, NATURE, V489, P46, DOI 10.1038/489046A.;MAHON PB, 2011, AM J MED GENET B, V156B, P370, DOI 10.1002/AJMG.B.31172.;MANN DMA, 1989, J NEUROL SCI, V89, P169, DOI 10.1016/0022-510X(89)90019-1.;MARCHESI VT, 2011, FASEB J, V25, P5, DOI 10.1096/FJ.11-0102UFM.;MAYDAN G, 2011, J MED GENET, V48, P383, DOI 10.1136/JMG.2010.087114.;MCCONNELL MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/SCIENCE.1243472.;MCELHINNY AS, 2003, TRENDS CARDIOVAS MED, V13, P195, DOI 10.1016/S1050-1738(03)00076-8.;MCGREGOR L, 2003, NAT GENET, V34, P203, DOI 10.1038/NG1142.;MCKENNA A, 2010, GENOME RES, V20, P1297, DOI 10.1101/GR.107524.110.;MENDOZA-NARANJO A, 2007, J CELL SCI, V120, P279, DOI 10.1242/JCS.03323.;MEYER LR, 2013, NUCLEIC ACIDS RES, V41, PD64, DOI 10.1093/NAR/GKS1048.;MILLER MB, 2013, NEUROSCIENTIST, V19, P255, DOI 10.1177/1073858413475486.;MIRANDA M, 2009, METABOLISM, V58, P1762, DOI 10.1016/J.METABOL.2009.06.004.;NAJ AC, 2011, NAT GENET, V43, P436, DOI 10.1038/NG.801.;NEALE BM, 2008, AM J MED GENET B, V147B, P1337, DOI 10.1002/AJMG.B.30866.;NICOT AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/NG2086.;NIE HZ, 2010, BRAIN RES, V1356, P112, DOI 10.1016/J.BRAINRES.2010.07.110.;NUNOMURA A, 2002, NEUROREPORT, V13, P2035, DOI 10.1097/00001756-200211150-00009.;OHLSSON M, 2012, BRAIN, V135, P1682, DOI 10.1093/BRAIN/AWS103.;OHSHIMA Y, 2010, J DERMATOL SCI, V57, P140, DOI 10.1016/J.JDERMSCI.2009.11.004.;OULES B, 2012, J NEUROSCI, V32, P11820, DOI 10.1523/JNEUROSCI.0875-12.2012.;OVERLACK N, BIOCH BIOPHYS ACTA, V1813, P1883.;OVERLACK N, 2011, BBA-MOL CELL RES, V1813, P1883, DOI 10.1016/J.BBAMCR.2011.05.015.;PARADAS C, 2010, NEUROLOGY, V75, P316, DOI 10.1212/WNL.0B013E3181EA1564.;PELTOMAKI P, 2012, EXP CELL RES, V318, P299, DOI 10.1016/J.YEXCR.2011.12.001.;PERRONNET C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/849426.;PODURI A, 2012, NEURON, V74, P41, DOI 10.1016/J.NEURON.2012.03.010.;POTKIN SG, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0006501.;PRASHER VP, 1993, LANCET, V342, P686, DOI 10.1016/0140-6736(93)91801-R.;PUENTE XS, 2011, NATURE, V475, P101, DOI 10.1038/NATURE10113.;QUERFURTH HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMRA0909142.;REIS CA, 2011, EXPERT REV PROTEOMIC, V8, P435, DOI 10.1586/EPR.11.30.;REITZ C, 2011, NAT REV NEUROL, V7, P137, DOI 10.1038/NRNEUROL.2011.2.;REYNOLDS R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/IOVS.09-3928.;RIPKE S, 2011, NAT GENET, V43, P969, DOI 10.1038/NG.940.;RODRIGUEZ-ESCUDERO I, 2011, HUM MOL GENET, V20, P4132, DOI 10.1093/HMG/DDR337.;ROVELET-LECRUX A, 2006, NAT GENET, V38, P24, DOI 10.1038/NG1718.;SATOH J, 2012, NEUROPATH APPL NEURO, V38, P132, DOI 10.1111/J.1365-2990.2011.01206.X.;SCHARF JM, MOL PSYCHIAT, V18, P721.;SCHELLENBERG GD, 2012, ACTA NEUROPATHOL, V124, P305, DOI 10.1007/S00401-012-0996-2.;SCHMIDT WM, 2011, PLOS GENET, V7, DOI 10.1371/JOURNAL.PGEN.1002042.;SCHMITT-ULMS G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/NBT969.;SCOTT LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/SCIENCE.1142382.;SELKOE DJ, 2011, COLD SPRING HARB PER, V3.;SHAW SW, 2008, J HUM GENET, V53, P136, DOI 10.1007/S10038-007-0229-Z.;SHERRY ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/NAR/29.1.308.;SHINAWI M, 2009, NAT GENET, V41, P1269, DOI 10.1038/NG.481.;SMITH EN, 2011, PLOS GENET, V7, DOI 10.1371/JOURNAL.PGEN.1002134.;STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/PNAS.90.5.1977.;SUBERBIELLE E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/NN.3356.;SUIZU F, 2009, DEV CELL, V17, P800, DOI 10.1016/J.DEVCEL.2009.09.007.;SULTAN A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/JBC.M110.199976.;SWAMINATHAN S, 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/729478.;TAJSHARGHI H, 2013, ACTA NEUROPATHOL, V125, P3, DOI 10.1007/S00401-012-1024-2.;TANZI R.E., 2012, COLD SPRING HARB PER, V2.;TAPPAREL C, 2003, GENE, V323, P189, DOI 10.1016/J.GENE.2003.09.038.;THOMPSON CL, 2007, HUM MOL GENET, V16, P2135, DOI 10.1093/HMG/DDM164.;TOOMES C, 2003, GENE CHROMOSOME CANC, V37, P132, DOI 10.1002/GCC.10191.;VERBEEK EC, PLOS ONE, V7.;VERBEEK EC, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0037384.;WALKER SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277.;WANG LL, CLIN CHIM ACTA, V412, P268.;WEISSMAN L, 2007, NUCLEIC ACIDS RES, V35, P5545, DOI 10.1093/NAR/GKM605.;WHEELER HE, 2013, NAT REV GENET, V14, P23, DOI 10.1038/NRG3352.;WHEELER MA, 2007, EXP CELL RES, V313, P2845, DOI 10.1016/J.YEXCR.2007.03.025.;WILCOCK DM, 2008, J NEUROSCI, V28, P1537, DOI 10.1523/JNEUROSCI.5066-07.2008.;WYATT L, 2008, CELL CYCLE, V7, P2290, DOI 10.4161/CC.6443.;XIN YR, 2012, NUCLEIC ACIDS RES, V40, PD1245, DOI 10.1093/NAR/GKR1193.;YANG Y, 2013, LIFE SCI, V92, P149, DOI 10.1016/J.LFS.2012.11.010.;YASHIN AI, 2010, AGING-US, V2, P612, DOI 10.18632/AGING.100191.;YATSULA B, 2006, LEUKEMIA, V20, P162, DOI 10.1038/SJ.LEU.2404034.;YOUN HS, 2007, J ALZHEIMERS DIS, V11, P385.;YU TW, 2013, NEURON, V77, P259, DOI 10.1016/J.NEURON.2012.11.002.;ZHANG QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/HMG/DDM238.;ZHU XW, 2004, J NEUROCHEM, V89, P1233, DOI 10.1111/J.1471-4159.2004.02416.X.;ZHU YH, 2003, STROKE, V34, P2483, DOI 10.1161/01.STR.0000088644.60368.ED.","SORIANO, E (REPRINT AUTHOR), UNIV BARCELONA, DEPT CELL BIOL, E-08028 BARCELONA, SPAIN.;PARCERISAS, ANTONI, RUBIO, SARA E., MUHAISEN, ASHRAF, PUJADAS, LLUIS, ROSSI, DANIELA, URENA, JESUS, BURGAYA, FERRAN, PASCUAL, MARTA, TORRENTS, DAVID, SORIANO, EDUARDO, UNIV BARCELONA, DEPT CELL BIOL, E-08028 BARCELONA, SPAIN.;PARCERISAS, ANTONI, RUBIO, SARA E., MUHAISEN, ASHRAF, GOMEZ-RAMOS, ALBERTO, PUJADAS, LLUIS, ROSSI, DANIELA, URENA, JESUS, BURGAYA, FERRAN, PASCUAL, MARTA, AVILA, JESUS, SORIANO, EDUARDO, CTR INVEST BIOMED RED ENFERMEDADES NEURODEGENERAT, SANTANDER, SPAIN.;GOMEZ-RAMOS, ALBERTO, AVILA, JESUS, UAM, CSIC, CTR BIOL MOL SEVERO OCHOA, MADRID, SPAIN.;PUIGGROS, MONTSERRAT, BARCELONA SUPERCOMP CTR, JOINT IRB BSC PROGRAM COMPUTAT BIOL, BARCELONA, SPAIN.;TORRENTS, DAVID, ICREA, BARCELONA, SPAIN.;RABANO, ALBERTO, SORIANO, EDUARDO, FUNDAC CIEN, MADRID, SPAIN.;SORIANO, EDUARDO, VHIR, BARCELONA, SPAIN.","10.3233/JAD-140891","NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS",NA,NA,"BBVA FOUNDATION, MICINN-MINECO, REINA SOFIA FOUNDATION, CIEN FOUNDATION, CIBERNED (ISCIII), MICINNN-MINECO [BFU2008-3980, SAF2006-02424], ICREA","THIS STUDY WAS SUPPORTED BY GRANTS FROM BBVA FOUNDATION AND MICINN-MINECO. WE ALSO LIKE TO THANK THE SUPPORT OF THE REINA SOFIA FOUNDATION, THE CIEN FOUNDATION, CIBERNED (ISCIII), AND GRANTS BFU2008-3980 (ES) AND SAF2006-02424 (JA) FROM MICINNN-MINECO. DR HELD A FELLOWSHIP FROM MICINN-MINECO.",NA,"1387-2877","4","1357-1382","IOS PRESS","42",2014,"ISI000343763000023","168","NEUROSCIENCES \& NEUROLOGY","14","NEUROSCIENCES","JAVILACBM.UAM.ES ESORIANOUB.EDU",NA,"AR7ME",NA,"SORIANO, E (REPRINT AUTHOR), UNIV BARCELONA, DEPT CELL BIOL, E-08028 BARCELONA, SPAIN","ISI","UNIV BARCELONA;CTR INVEST BIOMED RED ENFERMEDADES NEURODEGENERAT;CTR BIOL MOL SEVERO OCHOA;BARCELONA SUPERCOMP CTR","UNIV BARCELONA",NA,"PARCERISAS A, 2014, J ALZHEIMERS DIS","PARCERISAS A, 2014, J ALZHEIMERS DIS"
"HINCHCLIFFE M, 2014, PATHOLOGY","HINCHCLIFFE M;LE H;FIMMEL A;MOLLOY L;FREEMAN L;SULLIVAN D;TRENT RJ","DIAGNOSTIC VALIDATION OF A FAMILIAL HYPERCHOLESTEROLAEMIA COHORT PROVIDES A MODEL FOR USING TARGETED NEXT GENERATION DNA SEQUENCING IN THE CLINICAL SETTING","PATHOLOGY","PATHOLOGY","OUR AIM WAS TO ASSESS THE SENSITIVITY AND SPECIFICITY OF A NEXT GENERATION DNA SEQUENCING (NGS) PLATFORM USING A CAPTURE BASED DNA LIBRARY PREPARATION METHOD. DATA AND EXPERIENCE GAINED FROM THIS DIAGNOSTIC VALIDATION CAN BE USED TO PROGRESS THE APPLICATIONS OF NGS IN THE WIDER MOLECULAR DIAGNOSTIC SETTING. A TECHNICAL CROSS-VALIDATION COMPARING THE CURRENT MOLECULAR DIAGNOSTIC GOLD STANDARD METHODS OF SANGER DNA SEQUENCING AND MULTIPLEX LIGATION-DEPENDANT PROBE AMPLIFICATION (MLPA) VERSUS A CUSTOMISED CAPTURE BASED TARGETED RE-SEQUENCING METHOD ON A SOLID 5500 SEQUENCING PLATFORM WAS CARRIED OUT USING A COHORT OF 96 FAMILIAL HYPERCHOLESTEROLAEMIA (FH) SAMPLES. WE COMPARED A TOTAL OF 595 DNA VARIATIONS (488 COMMON SINGLE NUCLEOTIDE POLYMORPHISMS, 73 MISSENSE MUTATIONS, 9 NONSENSE MUTATIONS, 3 SPLICE SITE POINT MUTATIONS, 13 SMALL INDELS, 2 MULTI-EXONIC DUPLICATIONS AND 7 MULTI-EXONIC DELETIONS) FOUND PREVIOUSLY IN THE 96 FH SAMPLES. DNA VARIATION DETECTION SENSITIVITY AND SPECIFICITY WERE BOTH 100\% FOR THE SOLID 5500 NGS PLATFORM COMPARED WITH SANGER SEQUENCING AND MLPA ONLY WHEN BOTH LIFESCOPE AND INTEGRATIVE GENOMICS VIEWER SOFTWARES WERE UTILISED. THE METHODS DESCRIBED HERE OFFER A HIGH-QUALITY STRATEGY FOR THE DETECTION OF A WIDE RANGE OF DNA MUTATIONS IN DISEASES WITH A MODERATE NUMBER OF WELL DESCRIBED CAUSATIVE GENES. HOWEVER, THERE ARE IMPORTANT ISSUES RELATED TO THE BIOINFORMATIC ALGORITHMS EMPLOYED TO DETECT SMALL INDELS.","FAMILIAL HYPERCHOLESTEROLAEMIA; FH; INDEL; MLPA; NEXT GENERATION DNA SEQUENCING; NGS; SNP; SNV","TOOL","ENGLISH","ARTICLE","ARTICLE",6,"ASAN, 2011, GENOME BIOL, V12, DOI 10.1186/GB-2011-12-9-R95.;ASHLEY EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7.;FUTEMA M, 2012, J MED GENET, V49, P644, DOI 10.1136/JMEDGENET-2012-101189.;HAN J., 2013, MECH AGEING DEV.;HOLLANTS S, 2012, CLIN CHEM, V58, P717, DOI 10.1373/CLINCHEM.2011.173963.;KIRKE A, 2012, AUST FAM PHYSICIAN, V41, P965.;KWITEROVICH PO, 2012, CLIN CARDIOL, V35, P662, DOI 10.1002/CLC.22050.;OZCELIK H, 2012, J MOL DIAGN, V14, P467, DOI 10.1016/J.JMOLDX.2012.03.006.;VAN NIEUWERBURGH F, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0026969.;WATTS GF, 2011, ATHEROSCLEROSIS SUPP, V12, P221, DOI 10.1016/J.ATHEROSCLEROSISSUP.2011.06.001.;WOODERCHAK-DONAHUE WL, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-50.;WORLD HEALTH ORGANIZATION, 1999, REP 2 WHO CONS.;YOUSEM SA, 2013, CHEST, V143, P1679, DOI 10.1378/CHEST.12-1917.","HINCHCLIFFE, M (REPRINT AUTHOR), ROYAL PRINCE ALFRED HOSP, DEPT MOL \& CLIN GENET, CAMPERDOWN, NSW 2050, AUSTRALIA.;HINCHCLIFFE, MARCUS, LE, HUONG, FIMMEL, ANTHONY, MOLLOY, LAURA, FREEMAN, LUCINDA, TRENT, RONALD J., ROYAL PRINCE ALFRED HOSP, DEPT MOL \& CLIN GENET, CAMPERDOWN, NSW 2050, AUSTRALIA.;SULLIVAN, DAVID, ROYAL PRINCE ALFRED HOSP, DEPT CLIN BIOCHEM, CAMPERDOWN, NSW 2050, AUSTRALIA.;TRENT, RONALD J., UNIV SYDNEY, SYDNEY MED SCH, SYDNEY, NSW 2006, AUSTRALIA.","10.1097/PAT.0000000000000026","530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA",NA,NA,NA,NA,NA,"0031-3025","1","60-68","LIPPINCOTT WILLIAMS \& WILKINS","46",2014,"ISI000338694800011","13","PATHOLOGY","0","PATHOLOGY","MHIN9872UNI.SYDNEY.EDU.AU",NA,"AK8RD",NA,"HINCHCLIFFE, M (REPRINT AUTHOR), ROYAL PRINCE ALFRED HOSP, DEPT MOL \& CLIN GENET, CAMPERDOWN, NSW 2050, AUSTRALIA","ISI","ROYAL PRINCE ALFRED HOSP;ROYAL PRINCE ALFRED HOSP;UNIV SYDNEY","ROYAL PRINCE ALFRED HOSP",NA,"HINCHCLIFFE M, 2014, PATHOLOGY","HINCHCLIFFE M, 2014, PATHOLOGY"
"LU Z, 2014, NUCLEIC ACIDS RES","LU Z;MATERA AG","VICINAL: A METHOD FOR THE DETERMINATION OF NCRNA ENDS USING CHIMERIC READS FROM RNA-SEQ EXPERIMENTS","NUCLEIC ACIDS RESEARCH","NUCLEIC ACIDS RES.","NON-CODING (NC)RNAS ARE IMPORTANT STRUCTURAL AND REGULATORY MOLECULES. ACCURATE DETERMINATION OF THE PRIMARY SEQUENCE AND SECONDARY STRUCTURE OF NCRNAS IS IMPORTANT FOR UNDERSTANDING THEIR FUNCTIONS. DURING CDNA SYNTHESIS, RNA 3' END STEM-LOOPS CAN SELF-PRIME REVERSE TRANSCRIPTION, CREATING RNA-CDNA CHIMERAS. WE FOUND THAT CHIMERIC RNA-CDNA FRAGMENTS CAN ALSO BE DETECTED AT 5' END STEM-LOOPS, ALTHOUGH AT MUCH LOWER FREQUENCY. USING THE GUBLER-HOFFMAN METHOD, BOTH TYPES OF CHIMERIC FRAGMENTS CAN BE CONVERTED TO CDNA DURING LIBRARY CONSTRUCTION, AND THEY ARE READILY DETECTABLE IN HIGH-THROUGHPUT RNA SEQUENCING (RNA-SEQ) EXPERIMENTS. HERE, WE SHOW THAT THESE CHIMERIC READS CONTAIN VALUABLE INFORMATION ABOUT THE BOUNDARIES OF NCRNAS. WE DEVELOPED A BIOINFORMATIC METHOD, CALLED VICINAL, TO PRECISELY MAP THE ENDS OF NUMEROUS FRUITFLY, MOUSE AND HUMAN NCRNAS. USING THIS METHOD, WE ANALYZED CHIMERIC READS FROM OVER 100 RNA-SEQ DATASETS, THE RESULTS OF WHICH WE MAKE AVAILABLE FOR USERS TO FIND RNAS OF INTEREST. IN SUMMARY, WE SHOW THAT VICINAL IS A USEFUL TOOL FOR DETERMINATION OF THE PRECISE BOUNDARIES OF UNCHARACTERIZED NCRNAS, FACILITATING FURTHER STRUCTURE/FUNCTION STUDIES.",NA,"SMALL NUCLEAR; DROSOPHILA-MELANOGASTER; SECONDARY STRUCTURE; NONCODING RNAS; CLASSIC RACE; TRANSCRIPTION; GENOME; VIRUS; DNA; EXPRESSION","ENGLISH","ARTICLE","ARTICLE",6,"BERNSTEIN LB, 1983, CELL, V32, P461, DOI 10.1016/0092-8674(83)90466-X.;BOURGUIGNON GJ, 1976, J VIROL, V20, P290.;CHEN CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/NAR/GNI178.;CROUCHER NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/J.MIB.2010.09.009.;DARTY K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/BIOINFORMATICS/BTP250.;DERYUSHEVA S, 2013, RNA, V19, P1802, DOI 10.1261/RNA.042028.113.;GRAVELEY BR, 2011, NATURE, V471, P473, DOI 10.1038/NATURE09715.;GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5.;HOFACKER IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/NAR/GKG599.;HU DQ, 2013, NAT STRUCT MOL BIOL, V20, P1093, DOI 10.1038/NSMB.2653.;HU DQ, 2013, MOL CELL, V51, P493, DOI 10.1016/J.MOLCEL.2013.07.003.;JUNG CH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-77.;KONDRASHOV AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/J.JMB.2005.07.049.;LANGMEAD B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/NMETH.1923].;LANGMEAD B, 2009, GENOME BIOL, V10, DOI 10.1186/GB-2009-10-3-R25.;LI H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/BIOINFORMATICS/BTP324.;LO PCH, 1990, NUCLEIC ACIDS RES, V18, P6971, DOI 10.1093/NAR/18.23.6971.;LU ZP, 2014, GENOME BIOL, V15, DOI 10.1186/GB-2014-15-1-R7.;MARKHAM NICHOLAS R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6\_1.;MARQUEZ SM, 2005, RNA, V11, P739, DOI 10.1261/RNA.7211705.;MATERA AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/NRM2124.;MATTICK JS, 2006, HUM MOL GENET, V15, PR17, DOI 10.1093/HMG/DDL046.;MOUSAVI K, 2013, MOL CELL, V51, P606, DOI 10.1016/J.MOLCEL.2013.07.022.;NAKAMURA R, 2008, MOL CELL BIOL, V28, P6620, DOI 10.1128/MCB.00448-08.;PEDERSEN JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/JOURNAL.PCBI.0020033.;RUAN XA, 2012, METHODS MOL BIOL, V809, P535, DOI 10.1007/978-1-61779-376-9\_35.;SALZMAN LA, 1979, J VIROL, V30, P946.;SCOTTO-LAVINO E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/NPROT.2006.481.;SCOTTO-LAVINO E, 2006, NAT PROTOC, V1, P2555, DOI 10.1038/NPROT.2006.480.;SMITH ER, 2011, MOL CELL, V44, P954, DOI 10.1016/J.MOLCEL.2011.12.008.;TAKAHASHI H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/NPROT.2012.005.;TUISKUNEN A, 2010, J GEN VIROL, V91, P1019, DOI 10.1099/VIR.0.016667-0.;WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691A0.;WANG Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/NRG2484.;WASHIETL S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/PNAS.0409169102.;WILL S, 2007, PLOS COMPUT BIOL, V3, P680, DOI 10.1371/JOURNAL.PCBI.0030065.;WILL S, 2012, RNA, V18, P900, DOI 10.1261/RNA.029041.111.;YANG Z., 2001, 7SK SMALL NUCL RNA I.","MATERA, AG (REPRINT AUTHOR), UNIV N CAROLINA, DEPT BIOL, CB 3280, CHAPEL HILL, NC 27599 USA.;LU, ZHIPENG, MATERA, A. GREGORY, UNIV N CAROLINA, DEPT BIOL, CHAPEL HILL, NC 27599 USA.;MATERA, A. GREGORY, UNIV N CAROLINA, DEPT GENET, CHAPEL HILL, NC 27599 USA.;LU, ZHIPENG, MATERA, A. GREGORY, UNIV N CAROLINA, INTEGRAT PROGRAM BIOL \& GENOME SCI, CHAPEL HILL, NC 27599 USA.","10.1093/NAR/GKU207","GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND","E79",NA,"NATIONAL INSTITUTES OF HEALTH (NIH) [R01-GM053034], NIH [R01-GM053034]","NATIONAL INSTITUTES OF HEALTH (NIH) [R01-GM053034 TO A.G.M.]. SOURCE OF OPEN ACCESS FUNDING: NIH [R01-GM053034].",NA,"0305-1048","9",NA,"OXFORD UNIV PRESS","42",2014,"ISI000336495400006","38","BIOCHEMISTRY \& MOLECULAR BIOLOGY","5","BIOCHEMISTRY \& MOLECULAR BIOLOGY","ZHIPENGLUCHINAGMAIL.COM MATERAUNC.EDU",NA,"AH9WI",NA,"MATERA, AG (REPRINT AUTHOR), UNIV N CAROLINA, DEPT BIOL, CB 3280, CHAPEL HILL, NC 27599 USA","ISI","UNIV N CAROLINA;UNIV N CAROLINA;UNIV N CAROLINA","UNIV N CAROLINA",NA,"LU Z, 2014, NUCLEIC ACIDS RES","LU Z, 2014, NUCLEIC ACIDS RES"
"HUA Y, 2014, GENET MOL RES","HUA Y;HUI DY;RONG ZH;CHENG T","MOLECULAR CLONING AND CHARACTERIZATION OF A NOVEL CHICKEN GENE NAMED GRNI","GENETICS AND MOLECULAR RESEARCH","GENET. MOL. RES.","THE FULL-LENGTH CDNA SEQUENCE OF A NOVEL EXPRESSED SEQUENCE TAG (GENBANK ACCESSION NO. HQ184338) THAT WAS DIFFERENTIALLY EXPRESSED DURING NEWCASTLE DISEASE VIRUS (NDV) INFECTION IN CHICKENS WAS CLONED FROM THE CHICKEN SPLEEN BY A RAPID AMPLIFICATION OF CDNA ENDS ASSAY. THIS GENE WAS FURTHER ANALYZED USING BIOINFORMATIC METHODS AND NAMED GRNI. THE FULL-LENGTH CDNA SEQUENCE WAS 1698 BP WITHOUT INTRONS, LOCATING BETWEEN 104,691,934 AND 104,693,618 IN GALGAL4 ON CHROMOSOME 2. THE OPEN READING FRAME (ORF) CONTAINED 261 BP AND ENCODED A DEDUCED PROTEIN OF 86 AMINO ACID RESIDUES. FURTHERMORE, THE ENCODED PROTEIN CONTAINED TWO TRANSMEMBRANE REGIONS WITHOUT SIGNAL PEPTIDES, INDICATING THAT THIS PROTEIN IS LOCATED IN THE MITOCHONDRIAL MEMBRANE. MOREOVER, ITS HOMOLOGOUS PROTEIN WAS NOT IDENTIFIED. REAL-TIME POLYMERASE CHAIN REACTION WAS USED TO DETECT THE DYNAMIC MRNA EXPRESSION OF THIS GENE IN THE SPLEEN, THYMUS, BURSA OF FABRICIUS, AND TRACHEA OF NDV-INFECTED CHICKENS. RESULTS SUGGESTED THAT THE GENE WAS INVOLVED IN THE TRANSCRIPTIONAL RESPONSE OF CHICKEN TO NDV INFECTION. TO OBTAIN A FUSION PROTEIN AND PREPARE RABBIT ANTI-SERUM, THE PREDICTED ORF OF THIS GENE WAS EXPRESSED IN ESCHERICHIA COLI. THE EXPRESSION OF THIS GENE AT THE PROTEIN LEVEL WAS FURTHER CONFIRMED IN THE SPLEEN, THYMUS, AND BURSA OF FABRICIUS OF NDV-INFECTED CHICKENS USING WESTERN BLOT ANALYSIS. IN CONCLUSION, A NOVEL PROTEIN-CODING GENE NAMED GRNI WAS SUCCESSFULLY CLONED AND IDENTIFIED IN CHICKENS. FURTHERMORE, THIS GENE WAS FOUND TO BE INVOLVED IN THE RESPONSE OF CHICKENS TO NDV INFECTION.","CHICKEN; NOVEL GENE; SEQUENCE CHARACTERIZATION; TRANSCRIPT EXPRESSION; NEWCASTLE DISEASE VIRUS","EXPRESSED SEQUENCE TAGS; NEWCASTLE-DISEASE VIRUS; NORMALIZATION; AMPLIFICATION; EVOLUTION; DATABASE; GENOME; CDNAS; PCR","ENGLISH","ARTICLE","ARTICLE",0,"BOARDMAN PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4.;BOWER NI, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/NAR/GKQ816.;BURT DW, 2007, POULTRY SCI, V86, P1460, DOI 10.1093/PS/86.7.1460.;CLIFTON SANDRA W., 2009, V533, P13, DOI 10.1007/978-1-60327-136-3\_2.;EYRAS E, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-131.;FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/PNAS.85.23.8998.;HILLIER LW, 2004, NATURE, V432, P695, DOI 10.1038/NATURE03154.;JORGE EC, 2004, INT J DEV BIOL, V48, P333, DOI 10.1387/IJDB.031775EJ.;KIM H, 2006, GENOMICS, V88, P252, DOI 10.1016/J.YGENO.2006.03.015.;LAN DL, 2010, AVIAN PATHOL, V39, P151, DOI 10.1080/03079451003716383.;LI C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/PNAS.011404098.;LIVAK KJ, 2001, METHODS, V25, P402, DOI 10.1006/METH.2001.1262.;PARKINSON JOHN, 2009, V533, P1, DOI 10.1007/978-1-60327-136-3\_1.;SOARES MARCELO BENTO, 2009, V533, P109, DOI 10.1007/978-1-60327-136-3\_6.;TAN CSH, 2011, SCI SIGNAL, V4, DOI 10.1126/SCISIGNAL.2002093.;TIRUNAGARU VG, 2000, GENOMICS, V66, P144, DOI 10.1006/GENO.2000.6189.;YUE H, 2009, VIRUS GENES, V38, P143, DOI 10.1007/S11262-008-0309-Y.;YUE HUA, 2010, VIROLOGICA SINICA, V25, P425, DOI 10.1007/S12250-010-3114-4.","CHENG, T (REPRINT AUTHOR), SOUTHWEST UNIV NATIONALITIES, COLL LIFE SCI \& TECHNOL, CHENGDU, SICHUAN, PEOPLES R CHINA.;HUA, Y., HUI, D. Y., RONG, Z. H., CHENG, T., SOUTHWEST UNIV NATIONALITIES, COLL LIFE SCI \& TECHNOL, CHENGDU, SICHUAN, PEOPLES R CHINA.;HUA, Y., RONG, Z. H., CHENG, T., SICHUAN INST HIGHER LEARNING, KEY LAB, CHENGDU, SICHUAN, PEOPLES R CHINA.","10.4238/2014.JANUARY.21.6","RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000, BRAZIL",NA,NA,"VETERINARY MEDICINE DISCIPLINE PROGRAM, SOUTHWEST UNIVERSITY FOR NATIONALITIES [2011XWD-S0906]","RESEARCH SUPPORTED BY THE VETERINARY MEDICINE DISCIPLINE PROGRAM, SOUTHWEST UNIVERSITY FOR NATIONALITIES (\#2011XWD-S0906).",NA,"1676-5680","1","386-395","FUNPEC-EDITORA","13",2014,"ISI000331846400041","18","BIOCHEMISTRY \& MOLECULAR BIOLOGY, GENETICS \& HEREDITY","1","BIOCHEMISTRY \& MOLECULAR BIOLOGY, GENETICS \& HEREDITY","TANGCHENG101163.COM",NA,"AB5RO",NA,"CHENG, T (REPRINT AUTHOR), SOUTHWEST UNIV NATIONALITIES, COLL LIFE SCI \& TECHNOL, CHENGDU, SICHUAN, PEOPLES R CHINA","ISI","SOUTHWEST UNIV NATIONALITIES;SICHUAN INST HIGHER LEARNING","SOUTHWEST UNIV NATIONALITIES",NA,"HUA Y, 2014, GENET MOL RES","HUA Y, 2014, GENET MOL RES"
"HASMAN H, 2014, J CLIN MICROBIOL","HASMAN H;SAPUTRA D;SICHERITZ PONTEN T;LUND O;SVENDSEN CA;FRIMODT MOLLER N;AARESTRUP FM","RAPID WHOLE-GENOME SEQUENCING FOR DETECTION AND CHARACTERIZATION OF MICROORGANISMS DIRECTLY FROM CLINICAL SAMPLES","JOURNAL OF CLINICAL MICROBIOLOGY","J. CLIN. MICROBIOL.","WHOLE-GENOME SEQUENCING (WGS) IS BECOMING AVAILABLE AS A ROUTINE TOOL FOR CLINICAL MICROBIOLOGY. IF APPLIED DIRECTLY ON CLINICAL SAMPLES, THIS COULD FURTHER REDUCE DIAGNOSTIC TIMES AND THEREBY IMPROVE CONTROL AND TREATMENT. A MAJOR BOTTLENECK IS THE AVAILABILITY OF FAST AND RELIABLE BIOINFORMATIC TOOLS. THIS STUDY WAS CONDUCTED TO EVALUATE THE APPLICABILITY OF WGS DIRECTLY ON CLINICAL SAMPLES AND TO DEVELOP EASY-TO-USE BIOINFORMATIC TOOLS FOR THE ANALYSIS OF SEQUENCING DATA. THIRTY-FIVE RANDOM URINE SAMPLES FROM PATIENTS WITH SUSPECTED URINARY TRACT INFECTIONS WERE EXAMINED USING CONVENTIONAL MICROBIOLOGY, WGS OF ISOLATED BACTERIA, AND DIRECT SEQUENCING ON PELLETS FROM THE URINE SAMPLES. A RAPID METHOD FOR ANALYZING THE SEQUENCE DATA WAS DEVELOPED. BACTERIA WERE CULTIVATED FROM 19 SAMPLES BUT IN PURE CULTURES FROM ONLY 17 SAMPLES. WGS IMPROVED THE IDENTIFICATION OF THE CULTIVATED BACTERIA, AND ALMOST COMPLETE AGREEMENT WAS OBSERVED BETWEEN PHENOTYPIC AND PREDICTED ANTIMICROBIAL SUSCEPTIBILITIES. COMPLETE AGREEMENT WAS OBSERVED BETWEEN SPECIES IDENTIFICATION, MULTILOCUS SEQUENCE TYPING, AND PHYLOGENETIC RELATIONSHIPS FOR ESCHERICHIA COLI AND ENTEROCOCCUS FAECALIS ISOLATES WHEN THE RESULTS OF WGS OF CULTURED ISOLATES AND URINE SAMPLES WERE DIRECTLY COMPARED. SEQUENCING DIRECTLY FROM THE URINE ENABLED BACTERIAL IDENTIFICATION IN POLYMICROBIAL SAMPLES. ADDITIONAL PUTATIVE PATHOGENIC STRAINS WERE OBSERVED IN SOME CULTURE-NEGATIVE SAMPLES. WGS DIRECTLY ON CLINICAL SAMPLES CAN PROVIDE CLINICALLY RELEVANT INFORMATION AND DRASTICALLY REDUCE DIAGNOSTIC TIMES. THIS MAY PROVE VERY USEFUL, BUT THE NEED FOR DATA ANALYSIS IS STILL A HURDLE TO CLINICAL IMPLEMENTATION. TO OVERCOME THIS PROBLEM, A PUBLICLY AVAILABLE BIOINFORMATIC TOOL WAS DEVELOPED IN THIS STUDY.",NA,"URINARY-TRACT-INFECTIONS; AEROCOCCUS-URINAE; CULTURE; OUTBREAK; IDENTIFICATION; MICROBIOLOGY; BACTERIA","ENGLISH","ARTICLE","ARTICLE",100,"AARESTRUP FRANK M, 2012, EMERG INFECT DIS, V18, PE1, DOI 10.3201/EID/1811.120453.;ANDERSSON P, 2013, CLIN MICROBIOL INFEC, V19, PE405, DOI 10.1111/1469-0691.12237.;CROXATTO A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/J.1574-6976.2011.00298.X.;CUNNINGHAM SA, 2010, J CLIN MICROBIOL, V48, P2929, DOI 10.1128/JCM.00339-10.;DIDELOT X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/NRG3226.;DOMANN E, 2003, J CLIN MICROBIOL, V41, P5500, DOI 10.1128/JCM.41.12.5500-5510.2003.;EYRE DW, 2012, BMJ OPEN, V2, DOI 10.1136/BMJOPEN-2012-001124.;HARRIS SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2.;HENDRIKSEN RS, 2011, MBIO, V2, DOI 10.1128/MBIO.00157-11.;IMIRZALIOGLU C, 2008, ANDROLOGIA, V40, P66, DOI 10.1111/J.1439-0272.2007.00830.X.;KOSER CU, 2012, PLOS PATHOG, V8, DOI 10.1371/JOURNAL.PPAT.1002824.;KOSER CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMOA1109910.;LAM MH, 1988, J CLIN MICROBIOL, V26, P1130.;LARSEN MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11.;LEEKITCHAROENPHON P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S6.;LOMAN NJ, 2013, JAMA-J AM MED ASSOC, V309, P1502, DOI 10.1001/JAMA.2013.3231.;MELLMANN A, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0022751.;PRICE LB, 2013, MBIO, V4, DOI 10.1128/MBIO.00520-12.;SETH-SMITH HMB, 2013, GENOME RES, V23, P855, DOI 10.1101/GR.150037.112.;SIDDIQUI H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-244.;SIERRA-HOFFMAN M, 2005, DIAGN MICR INFEC DIS, V53, P289, DOI 10.1016/J.DIAGMICROBIO.2005.06.021.;TOROK ME, 2013, J CLIN MICROBIOL, V51, P611, DOI 10.1128/JCM.02279-12.;WALKER TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3.;YOUNG BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/PNAS.1113219109.;ZANKARI E, 2013, J ANTIMICROB CHEMOTH, V68, P771, DOI 10.1093/JAC/DKS496.;ZANKARI E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/JAC/DKS261.;ZHANG Q, 2000, J CLIN MICROBIOL, V38, P1703.","AARESTRUP, FM (REPRINT AUTHOR), TECH UNIV DENMARK, NATL FOOD INST, DK-2800 LYNGBY, DENMARK.;HASMAN, HENRIK, SVENDSEN, CHRISTINA AABY, AARESTRUP, FRANK M., TECH UNIV DENMARK, NATL FOOD INST, DK-2800 LYNGBY, DENMARK.;SAPUTRA, DHANY, SICHERITZ-PONTEN, THOMAS, LUND, OLE, TECH UNIV DENMARK, DK-2800 LYNGBY, DENMARK.;FRIMODT-MOLLER, NIELS, UNIV COPENHAGEN, HVIDOVRE HOSP, DK-2650 HVIDOVRE, DENMARK.","10.1128/JCM.02452-13","1752 N ST NW, WASHINGTON, DC 20036-2904 USA",NA,NA,"CENTER FOR GENOMIC EPIDEMIOLOGY, DANISH COUNCIL FOR STRATEGIC RESEARCH [09-067103/DSF]","THIS STUDY WAS SUPPORTED BY THE CENTER FOR GENOMIC EPIDEMIOLOGY (WWW.GENOMICEPIDEMIOLOGY.ORG) AND GRANT 09-067103/DSF FROM THE DANISH COUNCIL FOR STRATEGIC RESEARCH.",NA,"0095-1137","1","139-146","AMER SOC MICROBIOLOGY","52",2014,"ISI000329222400022","27","MICROBIOLOGY","44","MICROBIOLOGY","FMAAFOOD.DTU.DK",NA,"283CM",NA,"AARESTRUP, FM (REPRINT AUTHOR), TECH UNIV DENMARK, NATL FOOD INST, DK-2800 LYNGBY, DENMARK","ISI","TECH UNIV DENMARK;TECH UNIV DENMARK;UNIV COPENHAGEN","TECH UNIV DENMARK",NA,"HASMAN H, 2014, J CLIN MICROBIOL","HASMAN H, 2014, J CLIN MICROBIOL"
"PEETERS N, 2013, BMC GENOMICS","PEETERS N;CARRERE S;ANISIMOVA M;PLENER L;CAZALE AC;GENIN S","REPERTOIRE, UNIFIED NOMENCLATURE AND EVOLUTION OF THE TYPE III EFFECTOR GENE SET IN THE RALSTONIA SOLANACEARUM SPECIES COMPLEX","BMC GENOMICS","BMC GENOMICS","BACKGROUND: RALSTONIA SOLANACEARUM IS A SOIL-BORNE BETA-PROTEOBACTERIUM THAT CAUSES BACTERIAL WILT DISEASE IN MANY FOOD CROPS AND IS A MAJOR PROBLEM FOR AGRICULTURE IN INTERTROPICAL REGIONS. R. SOLANACEARUM IS A HETEROGENEOUS SPECIES, BOTH PHENOTYPICALLY AND GENETICALLY, AND IS CONSIDERED AS A SPECIES COMPLEX. PATHOGENICITY OF R. SOLANACEARUM RELIES ON THE TYPE III SECRETION SYSTEM THAT INJECTS TYPE III EFFECTOR (T3E) PROTEINS INTO PLANT CELLS. T3E COLLECTIVELY PERTURB HOST CELL PROCESSES AND MODULATE PLANT IMMUNITY TO ENABLE BACTERIAL INFECTION. RESULTS: WE PROVIDE THE CATALOGUE OF T3E IN THE R. SOLANACEARUM SPECIES COMPLEX, AS WELL AS CANDIDATES IN NEWLY SEQUENCED STRAINS. 94 T3E ORTHOLOGOUS GROUPS WERE DEFINED ON PHYLOGENETIC BASES AND ORDERED USING A UNIFORM NOMENCLATURE. THIS CURATED T3E CATALOG IS AVAILABLE ON A PUBLIC WEBSITE AND A BIOINFORMATIC PIPELINE HAS BEEN DESIGNED TO RAPIDLY PREDICT T3E GENES IN NEWLY SEQUENCED STRAINS. SYSTEMATICAL ANALYSES WERE PERFORMED TO DETECT LATERAL T3E GENE TRANSFER EVENTS AND IDENTIFY T3E GENES UNDER POSITIVE SELECTION. OUR ANALYSES ALSO PINPOINT THE RIPF TRANSLOCON PROTEINS AS MAJOR DISCRIMINATING DETERMINANTS AMONG THE PHYLOGENETIC LINEAGES. CONCLUSIONS: ESTABLISHMENT OF T3E REPERTOIRES IN STRAINS REPRESENTATIVES OF THE R. SOLANACEARUM BIODIVERSITY ALLOWED DETERMINING A SET OF 22 T3E PRESENT IN ALL THE STRAINS BUT PROVIDED NO CLUES ON HOST SPECIFICITY DETERMINANTS. THE DEFINITION OF A STANDARDIZED NOMENCLATURE AND THE OPTIMIZATION OF PREDICTIVE TOOLS WILL PAVE THE WAY TO UNDERSTANDING HOW VARIATION OF THESE REPERTOIRES IS CORRELATED TO THE DIVERSIFICATION OF THIS SPECIES COMPLEX AND HOW THEY CONTRIBUTE TO THE DIFFERENT STRAIN PATHOTYPES.","TYPE III EFFECTOR; RALSTONIA SOLANACEARUM; SELECTION; HORIZONTAL GENE TRANSFER; HOST SPECIFICITY","MULTIPLE SEQUENCE ALIGNMENT; CODON-SUBSTITUTION MODELS; E3 UBIQUITIN LIGASES; AMINO-ACID SITES; SECRETION SYSTEM; PLANT PATHOGEN; BACTERIAL WILT; PSEUDOMONAS-SOLANACEARUM; FUNCTIONAL-ANALYSIS; POSITIVE SELECTION","ENGLISH","ARTICLE","ARTICLE",55,"ANGOT A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/JOURNAL.PPAT.0030003.;ANGOT A, 2006, P NATL ACAD SCI USA, V103, P14620, DOI 10.1073/PNAS.0509393103.;ANISIMOVA M, 2003, GENETICS, V164, P1229.;ANISIMOVA M, 2011, SYST BIOL, V60, P685, DOI 10.1093/SYSBIO/SYR041.;ARLAT M, 1994, EMBO J, V13, P543, DOI 10.1002/J.1460-2075.1994.TB06292.X.;BALTRUS DA, 2012, MOL PLANT MICROBE IN, V25, P877, DOI 10.1094/MPMI-08-11-0218.;BALTRUS DA, 2011, PLOS PATHOG, V7, DOI 10.1371/JOURNAL.PPAT.1002132.;BERNOUX M, 2008, PLANT CELL, V20, P2252, DOI 10.1105/TPC.108.058685.;BUTTNER D, 2002, J BACTERIOL, V184, P2389, DOI 10.1128/JB.184.9.2389-2398.2002.;CAO Y., 2013, GENOME ANNOUNC, V1.;CARNEY BF, 1990, J BACTERIOL, V172, P4836, DOI 10.1128/JB.172.9.4836-4843.1990.;CUNNAC S, 2004, MOL MICROBIOL, V53, P115, DOI 10.1111/J.1365-2958.2004.04118.X.;CUNNAC S, 2004, J BACTERIOL, V186, P2309, DOI 10.1128/JB.186.8.2309-2318.2004.;DE LANGE O, 2013, NEW PHYTOL, V199, P773, DOI 10.1111/NPH.12324.;DESLANDES L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/PNAS.1230660100.;DESLANDES L, 2002, P NATL ACAD SCI USA, V99, P2404, DOI 10.1073/PNAS.032485099.;DIDELOT X, 2010, TRENDS MICROBIOL, V18, P315, DOI 10.1016/J.TIM.2010.04.002.;DSOUZA M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4.;DUDLER R, 2013, ANNU REV PHYTOPATHOL, V51, P521, DOI 10.1146/ANNUREV-PHYTO-082712-102312.;DUFRAIGNE C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/NAR/GNI004.;EDGAR RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113.;ELPHINSTONE J. G., 2005, BACTERIAL WILT DISEASE AND THE RALSTONIA SOLANACEARUM SPECIES COMPLEX, P9.;FALL S, 2007, PLOS ONE, V2, DOI 10.1371/JOURNAL.PONE.0001055.;FEGAN M., 2005, BACTERIAL WILT DISEASE AND THE RALSTONIA SOLANACEARUM SPECIES COMPLEX, P449.;GENIN S, 2012, ANNU REV PHYTOPATHOL, V50, P67, DOI 10.1146/ANNUREV-PHYTO-081211-173000.;GENIN S, 2010, NEW PHYTOL, V187, P920, DOI 10.1111/J.1469-8137.2010.03397.X.;GIL M, 2013, MOL BIOL EVOL, V30, P1270, DOI 10.1093/MOLBEV/MST034.;GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725.;GOURE J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004.;GUENERON M, 2000, MOL MICROBIOL, V36, P261, DOI 10.1046/J.1365-2958.2000.01870.X.;GUIDOT A, 2007, J BACTERIOL, V189, P377, DOI 10.1128/JB.00999-06.;GUINDON S, 2010, SYST BIOL, V59, P307, DOI 10.1093/SYSBIO/SYQ010.;HAJRI A, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0006632.;KADO CI, 2009, MOL PLANT PATHOL, V10, P143, DOI 10.1111/J.1364-3703.2008.00518.X.;KAJAVA AV, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0001694.;KRISTENSEN DM, 2011, BRIEF BIOINFORM, V12, P379, DOI 10.1093/BIB/BBR030.;LAVIE M, 2004, MOL PLANT MICROBE IN, V17, P931, DOI 10.1094/MPMI.2004.17.8.931.;LAVIE M, 2002, MOL PLANT MICROBE IN, V15, P1058, DOI 10.1094/MPMI.2002.15.10.1058.;LE SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/MOLBEV/MSN067.;LEMOINE F, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-237.;LETUNIC I, 2011, NUCLEIC ACIDS RES, V39, PW475, DOI 10.1093/NAR/GKR201.;LI JG, 2010, MOL PLANT PATHOL, V11, P371, DOI [10.1111/J.1364-3703.2010.00610.X, 10.1111/J.1364-3703.2010.00610.X].;LI L, 2003, GENOME RES, V13, P2178, DOI 10.1101/GR.1224503.;LI ZF, 2011, J BACTERIOL, V193, P6088, DOI 10.1128/JB.06009-11.;LINDEBERG M, 2005, MOL PLANT MICROBE IN, V18, P275, DOI 10.1094/MPMI-18-0275.;MANSFIELD J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/J.1364-3703.2012.00804.X.;MCVEAN G, 2002, GENETICS, V160, P1231.;MEYER D, 2006, J BACTERIOL, V188, P4903, DOI 10.1128/JB.00180-06.;MUKAIHARA T, 2004, MOL MICROBIOL, V54, P863, DOI 10.1111/J.1365-2958.2004.04328.X.;MUKAIHARA T, 2010, MOL PLANT MICROBE IN, V23, P251, DOI 10.1094/MPMI-23-3-0251.;MUKAIHARA T, 2009, MICROBIOL-SGM, V155, P2235, DOI 10.1099/MIC.0.027763-0.;O'REILLY PF, 2008, GENOME RES, V18, P1304, DOI 10.1101/GR.067181.107.;PEETERS N, 2013, MOL PLANT PATHOL, V14, P651, DOI 10.1111/MPP.12038.;POUEYMIRO M, 2009, CURR OPIN MICROBIOL, V12, P44, DOI 10.1016/J.MIB.2008.11.008.;POUEYMIRO M, 2009, MOL PLANT MICROBE IN, V22, P538, DOI 10.1094/MPMI-22-5-0538.;REED FA, 2006, GENETICS, V172, P2011, DOI 10.1534/GENETICS.105.052183.;REMENANT B, 2012, J BACTERIOL, V194, P2742, DOI 10.1128/JB.00249-12.;REMENANT B, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0024356.;REMIGI P, 2011, NEW PHYTOL, V192, P976, DOI 10.1111/J.1469-8137.2011.03854.X.;ROHDE JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/J.CHOM.2007.02.002.;RYAN RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/NRMICRO2558.;SCHESSER K, 2000, MICROB PATHOGENESIS, V28, P59, DOI 10.1006/MPAT.1999.0324.;SCHIEX T, 2003, NUCLEIC ACIDS RES, V31, P3738, DOI 10.1093/NAR/GKG610.;SHARMA V, 2011, MOL BIOL EVOL, V28, P3195, DOI 10.1093/MOLBEV/MSR155.;SINGER AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/NSMB.1511.;SOLE M, 2012, MOL PLANT MICROBE IN, V25, P941, DOI 10.1094/MPMI-12-11-0321.;SZALKOWSKI AM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/NAR/GKT628.;SZALKOWSKI AM, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0020488.;TASSET C, 2010, PLOS PATHOG, V6, DOI 10.1371/JOURNAL.PPAT.1001202.;WICKER E, 2012, ISME J, V6, P961, DOI 10.1038/ISMEJ.2011.160.;WOLF YI, 2012, GENOME BIOL EVOL, V4, P1286, DOI 10.1093/GBE/EVS100.;YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897, DOI 10.1111/J.1348-0421.1995.TB03275.X.;YANG ZH, 2000, GENETICS, V155, P431.;YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154.","PEETERS, N (REPRINT AUTHOR), INRA, LAB INTERACT PLANTES MICROORGANISMES, UMR441, F-31326 CASTANET TOLOSAN, FRANCE.;PEETERS, NEMO, CARRERE, SEBASTIEN, PLENER, LAURE, CAZALE, ANNE-CLAIRE, GENIN, STEPHANE, INRA, LAB INTERACT PLANTES MICROORGANISMES, UMR441, F-31326 CASTANET TOLOSAN, FRANCE.;PEETERS, NEMO, CARRERE, SEBASTIEN, PLENER, LAURE, CAZALE, ANNE-CLAIRE, GENIN, STEPHANE, CNRS, LAB INTERACT PLANTES MICROORGANISMES, UMR2594, F-31326 CASTANET TOLOSAN, FRANCE.;ANISIMOVA, MARIA, ETH, DEPT COMP SCI, ZURICH, SWITZERLAND.;ANISIMOVA, MARIA, SWISS INST BIOINFORMAT, LAUSANNE, SWITZERLAND.;PLENER, LAURE, UNIV MUNICH, BIOZENTRUM, DEPT BIOL 1, D-82152 MARTINSRIED, GERMANY.","10.1186/1471-2164-14-859","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","859",NA,"``LABORATOIRE D'EXCELLENCE'' (LABEX) ENTITLED TULIP","WE THANK JEROME GOUZY FOR ADVICES AND DISCUSSIONS. THIS WORK WAS SUPPORTED BY FUNDS FROM THE ``LABORATOIRE D'EXCELLENCE'' (LABEX)",NA,"1471-2164",NA,NA,"BIOMED CENTRAL LTD","14",2013,"ISI000328648300001","74","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","26","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","PEETERSTOULOUSE.INRA.FR SGENINTOULOUSE.INRA.FR",NA,"275AU",NA,"PEETERS, N (REPRINT AUTHOR), INRA, LAB INTERACT PLANTES MICROORGANISMES, UMR441, F-31326 CASTANET TOLOSAN, FRANCE","ISI","LAB INTERACT PLANTES MICROORGANISMES;LAB INTERACT PLANTES MICROORGANISMES;DEPT COMP SCI;SWISS INST BIOINFORMAT;UNIV MUNICH","LAB INTERACT PLANTES MICROORGANISMES",NA,"PEETERS N, 2013, BMC GENOMICS","PEETERS N, 2013, BMC GENOMICS"
"BELAK S, 2013, REV SCI TECH OFF INT EPIZOOT","BELAK S;KARLSSON OE;LEIJON M;GRANBERG F","HIGH-THROUGHPUT SEQUENCING IN VETERINARY INFECTION BIOLOGY AND DIAGNOSTICS","REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES","REV. SCI. TECH. OFF. INT. EPIZOOT.","SEQUENCING METHODS HAVE IMPROVED RAPIDLY SINCE THE FIRST VERSIONS OF THE SANGER TECHNIQUES, FACILITATING THE DEVELOPMENT OF VERY POWERFUL TOOLS FOR DETECTING AND IDENTIFYING VARIOUS PATHOGENS, SUCH AS VIRUSES, BACTERIA AND OTHER MICROBES. THE ONGOING DEVELOPMENT OF HIGH-THROUGHPUT SEQUENCING (HTS, ALSO KNOWN AS NEXT-GENERATION SEQUENCING) TECHNOLOGIES HAS RESULTED IN A DRAMATIC REDUCTION IN DNA SEQUENCING COSTS, MAKING THE TECHNOLOGY MORE ACCESSIBLE TO THE AVERAGE LABORATORY. IN THIS WHITE PAPER OF THE WORLD ORGANISATION FOR ANIMAL HEALTH (0IE) COLLABORATING CENTRE FOR THE BIOTECHNOLOGY-BASED DIAGNOSIS OF INFECTIOUS DISEASES IN VETERINARY MEDICINE (UPPSALA, SWEDEN), SEVERAL APPROACHES AND EXAMPLES OF HTS ARE SUMMARISED, AND THEIR DIAGNOSTIC APPLICABILITY IS BRIEFLY DISCUSSED. SELECTED FUTURE ASPECTS OF HTS ARE OUTLINED, INCLUDING THE NEED FOR BIOINFORMATIC RESOURCES, WITH A FOCUS ON IMPROVING THE DIAGNOSIS AND CONTROL OF INFECTIOUS DISEASES IN VETERINARY MEDICINE.","AETIOLOGY; DETECTION OF VIRUSES AND BACTERIA; DIAGNOSIS; EMERGING VIRUSES AND BACTERIA; HIGH-THROUGHPUT SEQUENCING; METAGENOMICS; NEXT-GENERATION SEQUENCING","GALLID-HERPESVIRUS TYPE-2; POLYMERASE-CHAIN-REACTION; OIE COLLABORATING CENTER; AVIAN INFLUENZA; NEXT-GENERATION; METAGENOMIC DATASETS; ATTENUATED VACCINES; MOLECULAR DIAGNOSIS; VIRAL METAGENOMICS; IKOMA LYSSAVIRUS","ENGLISH","ARTICLE","ARTICLE",5,"ABOLNIK C, 2012, VIRUS GENES, V45, P537, DOI 10.1007/S11262-012-0805-Y.;AIRD D, 2011, GENOME BIOL, V12, DOI 10.1186/GB-2011-12-2-R18.;ALEXANDER DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7.;ALLANDER T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/PNAS.211424698.;[ANONYMOUS], 2009, NATURE, V462, P252, DOI 10.1038/462252A.;BARTLETT JOHN M S, 2003, METHODS MOL BIOL, V226, P3.;BEER M, 2013, EPIDEMIOL INFECT, V141, P1, DOI 10.1017/S0950268812002245.;BELAK S, 2007, DEV BIOLOGICALS, V128, P103.;BELAK S., 2013, ADV TECHNIQUES DIAGN, P661.;BELAK S, 2007, VACCINE, V25, P5444, DOI 10.1016/J.VACCINE.2006.11.068.;BELAK S, 2009, EXPERT REV MOL DIAGN, V9, P367, DOI [10.1586/ERM.09.19, 10.1586/ERM.09.19].;BENNER S, 2007, NAT NANOTECHNOL, V2, P718, DOI 10.1038/NNANO.2007.344.;BENNETT S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433.;BERTHET N, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-77.;BLOMSTROM AL, 2009, VIRUS RES, V146, P125, DOI 10.1016/J.VIRUSRES.2009.09.006.;BLOMSTROM AL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-192.;BLOMSTROM AL, 2010, VIRUS RES, V152, P59, DOI 10.1016/J.VIRUSRES.2010.06.004.;BOYLE DB, 2012, J VIROL, V86, P6724, DOI 10.1128/JVI.00182-12.;BRANTON D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/NBT.1495.;BRIESE T, 2009, PLOS PATHOG, V5, DOI 10.1371/JOURNAL.PPAT.1000455.;BROOKSBANK C, 2010, NUCLEIC ACIDS RES, V38, PD17, DOI 10.1093/NAR/GKP986.;BYBEE SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/GBE/EVR106.;CARDONA CJ, 2009, COMP IMMUNOL MICROB, V32, P255, DOI 10.1016/J.CIMID.2008.01.001.;CHANDRA YG, 2012, VIRUS GENES, V44, P470, DOI 10.1007/S11262-012-0728-7.;CHEN K, 2005, PLOS COMPUT BIOL, V1, P106, DOI 10.1371/JOURNAL.PCBI.0010024.;CHEVAL J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11.;COCK PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/NAR/GKP1137.;COX-FOSTER DL, 2007, SCIENCE, V318, P283, DOI 10.1126/SCIENCE.1146498.;CROVILLE G, 2012, J CLIN MICROBIOL, V50, P2881, DOI 10.1128/JCM.01142-12.;DALY GM, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0028879.;DAY JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-313.;DEKKER C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/NNANO.2007.27.;DJIKENG A, 2009, FUTURE VIROL, V4, P47, DOI 10.2217/17460794.4.1.47.;DUGAN VG, 2011, VIROLOGY, V417, P98, DOI 10.1016/J.VIROL.2011.05.004.;DUMAS MD, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0024785.;DUNNE WM, 2012, EUR J CLIN MICROBIOL, V31, P1719, DOI 10.1007/S10096-012-1641-7.;EDITORIAL, 2012, NAT CELL BIOL, V14, P1231.;EDWARDS RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/NRMICROL163.;EID J, 2009, SCIENCE, V323, P133, DOI 10.1126/SCIENCE.1162986.;EUROPEAN MOLECULAR BIOLOGY LABORATORY'S EUROPEAN BIOINFORMATICS INSTITUTE (EMBL-EBI), 2012, FAST IS LIF SCI DAT.;FEDURCO M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/NAR/GNJ023.;FIELD D, 2011, PLOS BIOL, V9, DOI 10.1371/JOURNAL.PBIO.1001088.;GILCHRIST P, 2005, WORLD POULTRY SCI J, V61, P198, DOI 10.1079/WPS200451.;GRANBERG F, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0057459.;HOPER D, 2012, J VIROL, V86, P1394, DOI 10.1128/JVI.00797-11.;HOPER D, 2009, J CLIN MICROBIOL, V47, P674, DOI 10.1128/JCM.01028-08.;HOFFMANN B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/EID1803.111905.;HONGOH Y, 2011, METHODS MOL BIOL, V733, P25, DOI 10.1007/978-1-61779-089-8\_2.;HONKAVUORI KS, 2011, EMERG INFECT DIS, V17, P480, DOI 10.3201/EID1703.101410.;HONKAVUORI KS, 2008, EMERG INFECT DIS, V14, P1883, DOI 10.3201/EID1412.080984.;HOWORKA S, 2001, NAT BIOTECHNOL, V19, P636, DOI 10.1038/90236.;HUBALEK Z, 2004, J WILDLIFE DIS, V40, P639, DOI 10.7589/0090-3558-40.4.639.;KAMPMANN ML, 2011, J VIROL METHODS, V178, P243, DOI 10.1016/J.JVIROMET.2011.09.001.;KASIANOWICZ JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/PNAS.93.24.13770.;KIM KH, 2011, APPL ENVIRON MICROB, V77, P7663, DOI 10.1128/AEM.00289-11.;KIM T, 2011, METHODS MOL BIOL, V733, P185, DOI 10.1007/978-1-61779-089-8\_13.;KODAMA Y, 2012, NUCLEIC ACIDS RES, V40, PD54, DOI 10.1093/NAR/GKR854.;LANDER ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062.;LAWRENCE J.E., 2010, MANUAL AQUATIC VIRAL, P166, DOI 10.4319/MAVE.2010.978-0-9845591-0-7.;TAN LV, 2011, J INFECT DEV COUNTR, V5, P142.;LEE SW, 2012, SCIENCE, V337, P188, DOI 10.1126/SCIENCE.1217134.;LEINONEN R, 2011, NUCLEIC ACIDS RES, V39, PD19, DOI 10.1093/NAR/GKQ1019.;LEVENE MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/SCIENCE.1079700.;LI H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/BIB/BBQ015.;LINNARSSON S, 2010, EXP CELL RES, V316, P1339, DOI 10.1016/J.YEXCR.2010.02.036.;MARGULIES M, 2005, NATURE, V437, P376, DOI 10.1038/NATURE03959.;MARSTON DA, 2012, J VIROL, V86, P10242, DOI 10.1128/JVI.01628-12.;MARSTON DA, 2012, EMERG INFECT DIS, V18, P664, DOI 10.3201/EID1804.111553.;MASEMBE C, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-218.;METZKER ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/NRG2626.;MOORE GE, 1998, P IEEE, V86, P82, DOI 10.1109/JPROC.1998.658762.;MOROZOVA O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/ANNUREV-GENOM-082908-145957.;MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032.;NIE QH, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0041645.;NORDENTOFT S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-187.;OIE, 2012, MANUAL DIAGNOSTIC TE.;OIE, 2009, MAN DIAGN TESTS AQ A.;PALACIOS G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMOA073785.;PEPKE S., 2009, NATURE METHODS S, V6, PS22.;POP M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/BIB/BBP026.;QUAIL MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341.;RAMAKRISHNAN MA, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0007105.;REUTER G, 2013, ARCH VIROL, V158, P281, DOI 10.1007/S00705-012-1456-Y.;REUTER G, 2012, ARCH VIROL, V157, P1143, DOI 10.1007/S00705-012-1272-4.;REYES GR, 1991, MOL CELL PROBE, V5, P473, DOI 10.1016/S0890-8508(05)80020-9.;ROSEGRANT M. W., 2001, 2020 GLOBAL FOOD OUT.;ROSSEEL T, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0041967.;ROSSEEL T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-463.;ROTHBERG JM, 2011, NATURE, V475, P348, DOI 10.1038/NATURE10242.;SACHSENRODER J, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0034631.;SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687A0.;SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/PNAS.74.12.5463.;SBONER A, 2011, GENOME BIOL, V12, DOI 10.1186/GB-2011-12-8-125.;SCHADT EE, 2010, HUM MOL GENET, V19, PR227, DOI 10.1093/HMG/DDQ416.;SCHMIEDER R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/BIOINFORMATICS/BTR026.;SCHMIEDER R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341.;SCHOLZ MB, 2012, CURR OPIN BIOTECH, V23, P9, DOI 10.1016/J.COPBIO.2011.11.013.;SERGEANT MJ, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0038094.;SHAN TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11.;SHENDURE J, 2005, SCIENCE, V309, P1728, DOI 10.1126/SCIENCE.1117389.;SHENDURE J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/NBT1486.;SIMON C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10.;SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674A0.;SPATZ SJ, 2012, VIRUS GENES, V44, P273, DOI 10.1007/S11262-011-0696-3.;SPATZ SJ, 2008, VIRUS GENES, V36, P479, DOI 10.1007/S11262-008-0213-5.;SPATZ SJ, 2010, VIRUS RES, V149, P135, DOI 10.1016/J.VIRUSRES.2010.01.007.;THURBER RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/NPROT.2009.10.;TROJNAR E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/VIR.0.047381-0.;VAN BORM S, 2012, ARCH VIROL, V157, P1509, DOI 10.1007/S00705-012-1323-X.;VENTER JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/SCIENCE.1058040.;WANG Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-278.;WRIGHT CF, 2011, J VIROL, V85, P2266, DOI 10.1128/JVI.01396-10.;XIAO SQ, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0011377.","BELAK, S (REPRINT AUTHOR), NATL VET INST SVA, DEPT VIROL LMMUNOBIOL \& PARASITOL VIP, ULLS VAG 2B, SE-75189 UPPSALA, SWEDEN.;BELAK, S., LEIJON, M., NATL VET INST SVA, DEPT VIROL LMMUNOBIOL \& PARASITOL VIP, SE-75189 UPPSALA, SWEDEN.;BELAK, S., KARLSSON, O. E., GRANBERG, F., SWEDISH UNIV AGR SCI SLU, DEPT BIOMED SCI \& VET PUBL HLTH BVF, SE-75189 UPPSALA, SWEDEN.;BELAK, S., KARLSSON, O. E., LEIJON, M., GRANBERG, F., WORLD ORG ANIM HLTH OIE, COLLABORATING CTR BIOTECHNOL BASED DIAG INFECT DI, SE-75189 UPPSALA, SWEDEN.;KARLSSON, O. E., SLU, GLOBAL BIOINFORMAT CTR, DEPT ANIM BREEDING \& GENET HGEN, SE-75651 UPPSALA, SWEDEN.",NA,"12 RUE DE PRONY, 75017 PARIS, FRANCE",NA,NA,"AWARD OF EXCELLENCE (EXCELLENSBIDRAG), SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES, EPISEQ PROJECT, RAPIDIA-FIELD PROJECT, ANIBIOTHREAT EU PROJECT, FORMAS BIOBRIDGES STRONG RESEARCH ENVIRONMENTS [2011-1692], NATIONAL VETERINARY INSTITUTE (SVA), DEPARTMENT OF BIOMEDICAL SCIENCES AND VETERINARY PUBLIC HEALTH, BVF, SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES","THE CONTINUING SUPPORT OF THE OIE IS GREATLY APPRECIATED, AND HAS DIRECTLY CONTRIBUTED TO THESE ACHIEVEMENTS. THIS WORK WAS SUPPORTED BY THE AWARD OF EXCELLENCE (EXCELLENSBIDRAG) PROVIDED TO S. BELAK BY THE SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES, BY THE EPISEQ, RAPIDIA-FIELD AND ANIBIOTHREAT EU PROJECTS, BY THE FORMAS BIOBRIDGES STRONG RESEARCH ENVIRONMENTS PROJECT NO. 2011-1692, BY THE NATIONAL VETERINARY INSTITUTE (SVA), AND BY THE DEPARTMENT OF BIOMEDICAL SCIENCES AND VETERINARY PUBLIC HEALTH, BVF, SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES.",NA,"0253-1933","3","893-915","OFFICE INT EPIZOOTIES","32",2013,"ISI000334816300026","113","VETERINARY SCIENCES","20","VETERINARY SCIENCES","SANDOR.BELAKSLU.SE",NA,"AF6HU",NA,"BELAK, S (REPRINT AUTHOR), NATL VET INST SVA, DEPT VIROL LMMUNOBIOL \& PARASITOL VIP, ULLS VAG 2B, SE-75189 UPPSALA, SWEDEN","ISI","NATL VET INST SVA;SWEDISH UNIV AGR SCI SLU;COLLABORATING CTR BIOTECHNOL BASED DIAG INFECT DI;GLOBAL BIOINFORMAT CTR","NATL VET INST SVA",NA,"BELAK S, 2013, REV SCI TECH OFF INT EPIZOOT","BELAK S, 2013, REV SCI TECH OFF INT EPIZOOT"
"DARLING T, 2013, J PEDIATR SURG","DARLING T;MAHFUZ I;WHITE SJ;CHENG W","NO TAP63 PROMOTER MUTATION IS DETECTED IN BLADDER EXSTROPHY-EPISPADIAS COMPLEX PATIENTS","JOURNAL OF PEDIATRIC SURGERY","J. PEDIATR. SURG.","BACKGROUND/PURPOSE: BLADDER EXSTROPHY-EPISPADIAS COMPLEX (BEEC) IS THOUGHT TO HAVE A GENETIC COMPONENT IN ITS PATHOGENESIS. PREVIOUSLY WE FOUND THAT P63(-/-) MICE SHOW INCREASED VENTRAL APOPTOSIS AND DEVELOP A BEEC PHENOTYPE. DOWN-REGULATION OF THE ANTI-APOPTOTIC TRIANGLE NP63 AND AN UP-REGULATION OF PRO-APOPTOTIC TAP63 ISOFORMS HAVE BEEN DEMONSTRATED IN BEEC PATIENT BLADDER TISSUES. WE HAVE PREVIOUSLY SHOWN THAT INSERTION/DELETION POLYMORPHISMS OF THE TRIANGLE NP63 PROMOTER ARE ASSOCIATED WITH AN INCREASED RISK OF BEEC. IN THIS STUDY, WE SPECIFICALLY EXAMINED THE TAP63 PROMOTER TO SEE IF ANY SEQUENCE CHANGES MIGHT LEAD TO UP-REGULATION OF TAP63 AND EXAGGERATED APOPTOSIS IN BEEC PATIENTS. METHODS: I) BIOINFORMATIC ANALYSIS OF THE TAP63 PROMOTER WAS PERFORMED TO IDENTIFY PUTATIVE REGULATORY REGIONS. II) HIGH-RESOLUTION MELT AND SANGER SEQUENCING WAS USED TO SCREEN TARGETED REGIONS IN 112 BEEC PATIENT DNA SAMPLES FOR POTENTIAL SEQUENCE VARIANTS. III) SEQUENCE VARIATION WAS ANALYSED FOR SIGNIFICANCE AGAINST NORMAL POPULATION FREQUENCY DATA. RESULTS: I) WE IDENTIFIED MULTIPLE EPIGENETIC MARKERS OF TRANSCRIPTIONAL REGULATION WITHIN HIGHLY CONSERVED AREAS OF THE TAP63 PROMOTER SEQUENCE. II) OF THE 112 BUCCAL SWAB DNA SAMPLES, ADEQUATE AND SUCCESSFUL SCREENING RANGED BETWEEN 48 AND 67 FOR EACH REGION. III) NO NOVEL SEQUENCE VARIATION OR MUTATION WAS UNCOVERED. IV) TWO KNOWN SNPS WERE IDENTIFIED. HOWEVER, ALLELE FREQUENCY ANALYSIS WAS NOT STATISTICALLY SIGNIFICANT. CONCLUSION: OUR DATA DO NOT ASSOCIATE GENETIC VARIATION WITHIN THE TAP63 PROMOTER REGION WITH AN INCREASED RISK OF BEEC. OUR DATA SO FAR SUGGESTS THAT ONLY TRIANGLE NP63 PROMOTER ABERRATION IS INVOLVED IN BEEC PATHOGENESIS. (C) 2013 ELSEVIER INC. ALL RIGHTS RESERVED.","BLADDER EXSTROPHY; BEEC; TAP63; P63","HUMAN GENOME; EPIDERMOLYSIS-BULLOSA; FAMILIES; P63; DYSREGULATION; SEQUENCE; BROWSER; TISSUE; CELLS; UCSC","ENGLISH","ARTICLE, PROCEEDINGS PAPER","ARTICLE",1,"[ANONYMOUS], 2010, NATURE, V467, P1061.;BOYADJIEV SA, 2004, BJU INT, V94, P1337, DOI 10.1111/J.1464-410X.2004.05170.X.;BOYADJIEV SA, 2005, GENOMICS, V85, P8.;CHENG W, 2006, DEVELOPMENT, V133, P4783, DOI 10.1242/DEV.02621.;CHING BJ, 2010, INT J MOL MED, V26, P861, DOI 10.3892/IJMM\_00000535.;COLLINS FS, 2004, NATURE, V431, P931, DOI 10.1038/NATURE03001.;DE BOER CARMELA M, 2012, BMC RES NOTES, V5, P569, DOI 10.1186/1756-0500-5-569.;DISETH TH, 1999, WORLD J UROL, V17, P239, DOI 10.1007/S003450050139.;DRAAKEN M, 2013, BIRTH DEFECTS RES A, V97, P133, DOI 10.1002/BDRA.23112.;GAMBHIR L, 2008, J UROLOGY, V179, P1539, DOI 10.1016/J.JURO.2007.11.092.;GOYAL A, 2012, J PEDIATR UROL, V8, P140, DOI 10.1016/J.JPUROL.2011.05.003.;IHRIE RA, 2005, CELL CYCLE, V4, P873, DOI 10.4161/CC.4.7.1836.;IHRIE RA, 2005, CELL, V120, P843, DOI 10.1016/J.CELL.2005.01.008.;JAYACHANDRAN DD, 2011, J UROLOGY, V186, P6.;JONKMAN MF, 2005, AM J HUM GENET, V77, P653, DOI 10.1086/496901.;KENT WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/GR.229102.;KENT WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/GR.229202, 10.1101/GR.229202. ARTICLE PUBLISHED ONLINE BEFORE MARCH 2002].;KOSAKI R, 2005, AM J MED GENET A, V135A, P224, DOI 10.1002/AJMG.A.30733.;LANDER ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062.;LEONARD NJ, 2002, AM J MED GENET, V112, P86, DOI 10.1002/AJMG.10662.;MARQUES MRM, 2005, J INVEST DERMATOL, V126, P69.;MATYS V, 2006, NUCLEIC ACIDS RES, V34, PD108, DOI 10.1093/NAR/GKJ143.;MORETTI G, 1995, PEDIATR DERMATOL, V12, P239, DOI 10.1111/J.1525-1470.1995.TB00167.X.;OOTTAMASATHIEN S, 2007, DEV BIOL, V304, P556, DOI 10.1016/J.YDBIO.2007.01.010.;QI LH, 2011, INT J MOL MED, V27, P755, DOI 10.3892/IJMM.2011.654.;REUTTER H, 2003, AM J MED GENET A, V120A, P215, DOI 10.1002/AJMG.A.20057.;REUTTER H, 2007, AM J MED GENET A, V143A, P2751, DOI 10.1002/AJMG.A.31975.;REUTTER H, 2011, J PEDIATR-US, V159, P825, DOI 10.1016/J.JPEDS.2011.04.042.;ROSENBLOOM KR, 2012, NUCLEIC ACIDS RES, V40, PD912, DOI 10.1093/NAR/GKR1012.;SHAPIRO E, 1984, J UROLOGY, V132, P308, DOI 10.1016/S0022-5347(17)49605-4.;SHERRY ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/NAR/29.1.308.;THAUVIN-ROBINET C, 2004, AM J MED GENET A, V126A, P303, DOI 10.1002/AJMG.A.20596.;WILKINS S, 2012, PLOS GENET, V8, DOI 10.1371/JOURNAL.PGEN.1003070.;YANG A, 2006, MOL CELL, V24, P593, DOI 10.1016/J.MOLCEL.2006.10.018.;ZWINK N, 2013, J UROLOGY, V189, P1524, DOI 10.1016/J.JURO.2012.11.108.","CHENG, W (REPRINT AUTHOR), SOUTHERN MED SCH, DEPT PAEDIAT, BLOCK E,LEVEL 5,245 CLAYTON RD, CLAYTON, VIC 3168, AUSTRALIA.;DARLING, TOM, MAHFUZ, ISTIAK, WHITE, STEFAN J., CHENG, WEI, MONASH UNIV, MONASH INST MED RES, MELBOURNE, VIC 3004, AUSTRALIA.;CHENG, WEI, MONASH UNIV, DEPT PAEDIAT, FAC MED NURSING \& HLTH SCI, MELBOURNE, VIC 3004, AUSTRALIA.;CHENG, WEI, MONASH UNIV, DEPT SURG, FAC MED NURSING \& HLTH SCI, MELBOURNE, VIC 3004, AUSTRALIA.","10.1016/J.JPEDSURG.2013.08.012","1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",NA,NA,NA,NA,NA,"0022-3468","12","2393-2400","W B SAUNDERS CO-ELSEVIER INC","48",2013,"ISI000327938200007","35","PEDIATRICS, SURGERY","2","PEDIATRICS, SURGERY","WEI.CHENGMONASH.EDU",NA,"265GM",NA,"CHENG, W (REPRINT AUTHOR), SOUTHERN MED SCH, DEPT PAEDIAT, BLOCK E,LEVEL 5,245 CLAYTON RD, CLAYTON, VIC 3168, AUSTRALIA","ISI","MONASH UNIV;MONASH UNIV;MONASH UNIV","SOUTHERN MED SCH",NA,"DARLING T, 2013, J PEDIATR SURG","DARLING T, 2013, J PEDIATR SURG"
"YE W, 2013, BMC GENOMICS","YE W;WANG Y;DONG S;TYLER BM;WANG Y","PHYLOGENETIC AND TRANSCRIPTIONAL ANALYSIS OF AN EXPANDED BZIP TRANSCRIPTION FACTOR FAMILY IN PHYTOPHTHORA SOJAE","BMC GENOMICS","BMC GENOMICS","BACKGROUND: BASIC LEUCINE ZIPPER (BZIP) TRANSCRIPTION FACTORS ARE PRESENT EXCLUSIVELY IN EUKARYOTES AND CONSTITUTE ONE OF THE LARGEST AND MOST DIVERSE TRANSCRIPTION FACTOR FAMILIES. THE PROTEINS ARE RESPONSIBLE FOR CENTRAL DEVELOPMENTAL AND PHYSIOLOGICAL PROCESSES IN PLANTS, ANIMALS, AND FUNGI, INCLUDING THE PATHOGENICITY OF FUNGAL PLANT PATHOGENS. HOWEVER, THERE IS LIMITED UNDERSTANDING OF BZIPS IN OOMYCETES, WHICH ARE FUNGUS-LIKE ORGANISMS IN THE KINGDOM STRAMENOPILA. OOMYCETES INCLUDE MANY DESTRUCTIVE PLANT PATHOGENS, INCLUDING THE WELL-STUDIED SPECIES PHYTOPHTHORA SOJAE, WHICH CAUSES SOYBEAN STEM AND ROOT ROT. RESULTS: CANDIDATE BZIPS ENCODED IN THE GENOMES OF P. SOJAE AND FOUR OTHER OOMYCETES, TWO DIATOMS, AND TWO FUNGAL SPECIES WERE PREDICTED USING BIOINFORMATIC METHODS. COMPARATIVE ANALYSIS REVEALED EXPANDED NUMBERS OF BZIP CANDIDATES IN OOMYCETES, ESPECIALLY THE PHYTOPHTHORA SPECIES, DUE TO THE EXPANSION OF SEVERAL NOVEL BZIP CLASSES WHOSE HIGHLY CONSERVED ASPARAGINES IN BASIC DNA-BINDING REGIONS WERE SUBSTITUTED BY OTHER RESIDUES SUCH AS CYSTEINE. THE MAJORITY OF THESE NOVEL BZIP CLASSES WERE MOSTLY RESTRICTED TO OOMYCETES. THE LARGE NUMBER OF NOVEL BZIPS APPEARS TO BE THE RESULT OF WIDESPREAD GENE DUPLICATIONS DURING OOMYCETE EVOLUTION. THE MAJORITY OF P. SOJAE BZIP CANDIDATES, INCLUDING BOTH CONVENTIONAL AND NOVEL BZIP CLASSES, WERE PREDICTED TO CONTAIN CANONICAL PROTEIN SECONDARY STRUCTURES. DETECTION OF GENE TRANSCRIPTS USING DIGITAL GENE EXPRESSION PROFILING AND QRT-PCR SUGGESTED THAT MOST OF THE CANDIDATES WERE NOT PSEUDOGENES. THE MAJOR TRANSCRIPTIONAL SHIFTS OF BZIPS OCCURRED DURING THE ZOOSPORANGIA/ZOOSPORE/CYST AND HOST INFECTION STAGES. SEVERAL INFECTION-ASSOCIATED BZIP GENES WERE IDENTIFIED THAT WERE POSITIVELY REGULATED BY H2O2 EXPOSURE. CONCLUSIONS: THE IDENTIFICATION OF LARGE CLASSES OF BZIP PROTEINS IN OOMYCETES WITH NOVEL BZIP MOTIF VARIANTS, THAT ARE CONSERVED AND DEVELOPMENTALLY REGULATED AND THUS PRESUMABLY FUNCTIONAL, EXTENDS OUR KNOWLEDGE OF THIS IMPORTANT FAMILY OF EUKARYOTIC TRANSCRIPTION FACTORS. IT ALSO LAYS THE FOUNDATION FOR DETAILED STUDIES OF THE ROLES OF THESE PROTEINS IN DEVELOPMENT AND INFECTION IN P. SOJAE AND OTHER OOMYCETES.","PHYTOPHTHORA; BZIP TRANSCRIPTION FACTOR; DNA-BINDING DOMAIN; DUPLICATION; GENE EXPRESSION","EXPRESSED SEQUENCE TAGS; LEUCINE-ZIPPER; DNA-BINDING; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; GENOME SEQUENCE; BASIC REGION; PATHOGEN; PROTEINS; MECHANISMS","ENGLISH","ARTICLE","ARTICLE",10,"AUKERMAN MJ, 1991, GENE DEV, V5, P310, DOI 10.1101/GAD.5.2.310.;BALDAUF SL, 2000, SCIENCE, V290, P972, DOI 10.1126/SCIENCE.290.5493.972.;BAXTER L, 2010, SCIENCE, V330, P1549, DOI 10.1126/SCIENCE.1195203.;BLANCO FA, 2005, MOL MICROBIOL, V56, P638, DOI 10.1111/J.1365-2958.2005.04575.X.;COMBET C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6.;DAS RK, 2012, J MOL BIOL, V416, P287, DOI 10.1016/J.JMB.2011.12.043.;EDGAR RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/NAR/GKH340.;ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4.;FINN RD, 2011, NUCLEIC ACIDS RES, V39, PW29, DOI 10.1093/NAR/GKR367.;FINN RD, 2010, NUCLEIC ACIDS RES, V38, PD211, DOI 10.1093/NAR/GKP985.;GOUY M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/MOLBEV/MSP259.;GUO M, 2011, PLOS PATHOG, V7, DOI 10.1371/JOURNAL.PPAT.1001302.;GUO M, 2010, MOL PLANT MICROBE IN, V23, P1053, DOI 10.1094/MPMI-23-8-1053.;HAAS BJ, 2009, NATURE, V461, P393, DOI 10.1038/NATURE08358.;HALL T. A., 1999, NUCL ACIDS S SER, P95, DOI DOI 10.1021/BK-1999-0734.CH008.;HARPER JT, 2005, INT J SYST EVOL MICR, V55, P487, DOI 10.1099/IJS.0.63216-0.;HURST HC, 1994, PROTEIN PROFILE, V1, P123.;JIANG RHY, 2012, ANNU REV PHYTOPATHOL, V50, P295, DOI 10.1146/ANNUREV-PHYTO-081211-172912.;KELLER W, 1995, J MOL BIOL, V254, P657, DOI 10.1006/JMBI.1995.0645.;LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/SCIENCE.3289117.;LETUNIC I, 2012, NUCLEIC ACIDS RES, V40, PD302, DOI 10.1093/NAR/GKR931.;LEV S, 2005, EUKARYOT CELL, V4, P443, DOI 10.1128/EC.4.2.443-454.2005.;LEVESQUE CA, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-7-R73.;LOPEZ-BERGES MS, 2012, PLANT CELL, V24, P3805, DOI 10.1105/TPC.112.098624.;LYON MF, 2003, HUM MOL GENET, V12, P585, DOI 10.1093/HMG/DDG063.;MARCHLER-BAUER A, 2011, NUCLEIC ACIDS RES, V39, PD225, DOI 10.1093/NAR/GKQ1189.;PARK J, 2008, BIOINFORMATICS, V24, P1024, DOI 10.1093/BIOINFORMATICS/BTN058.;ROY S, 2013, PLOS PATHOG, V9, DOI 10.1371/JOURNAL.PPAT.1003182.;ROY S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-106.;SAEED AI, 2003, BIOTECHNIQUES, V34, P374.;SEIDL MF, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0051295.;SHEN DY, 2011, CAN J MICROBIOL, V57, P84, DOI [10.1139/W10-103, 10.1139/W10-103].;SUCKOW M, 1994, NUCLEIC ACIDS RES, V22, P4395, DOI 10.1093/NAR/22.21.4395.;TAMURA K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/MOLBEV/MSR121.;TORTO-ALALIBO TA, 2007, MOL PLANT MICROBE IN, V20, P781, DOI 10.1094/MPMI-20-7-0781.;TRIPATHY S, 2006, NUCLEIC ACIDS RES, V34, PD379, DOI 10.1093/NAR/GKJ042.;TRIPATHY S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-303.;TYLER BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/J.1364-3703.2006.00373.X.;TYLER BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/SCIENCE.1128796.;VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/SCIENCE.2683088.;WALKER CLAIRE A., 2007, FUNGAL BIOLOGY REVIEWS, V21, P10, DOI 10.1016/J.FBR.2007.02.001.;YE WW, 2011, MOL PLANT MICROBE IN, V24, P1530, DOI 10.1094/MPMI-05-11-0106.","WANG, YC (REPRINT AUTHOR), NANJING AGR UNIV, DEPT PLANT PATHOL, NANJING 210095, JIANGSU, PEOPLES R CHINA.;YE, WENWU, WANG, YANG, DONG, SUOMENG, WANG, YUANCHAO, NANJING AGR UNIV, DEPT PLANT PATHOL, NANJING 210095, JIANGSU, PEOPLES R CHINA.;TYLER, BRETT M., OREGON STATE UNIV, CTR GENOME RES \& BIOCOMPUTING, CORVALLIS, OR 97331 USA.;TYLER, BRETT M., OREGON STATE UNIV, DEPT BOT \& PLANT PATHOL, CORVALLIS, OR 97331 USA.","10.1186/1471-2164-14-839","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","839",NA,"CHINA NATIONAL FUNDS FOR DISTINGUISHED YOUNG SCIENTISTS [31225022], SPECIAL FUND FOR AGRO-SCIENTIFIC RESEARCH IN THE PUBLIC INTEREST OF CHINA [201303018], AGRICULTURE AND FOOD RESEARCH INITIATIVE OF THE USDA NATIONAL INSTITUTE OF FOOD AND AGRICULTURE [2007-35600-18530, 2011-68004-30104], US NATIONAL SCIENCE FOUNDATION [MCB-0731969]","WE THANK XINYU YANG FOR PROVIDING ASSISTANCE IN PREPARING RNA. THIS WORK WAS SUPPORTED IN PART BY GRANTS TO YUANCHAO WANG FROM CHINA NATIONAL FUNDS FOR DISTINGUISHED YOUNG SCIENTISTS (31225022) AND SPECIAL FUND FOR AGRO-SCIENTIFIC RESEARCH IN THE PUBLIC INTEREST (201303018) OF CHINA, AND BY GRANTS TO BRETT M. TYLER FROM THE AGRICULTURE AND FOOD RESEARCH INITIATIVE OF THE USDA NATIONAL INSTITUTE OF FOOD AND AGRICULTURE, 2007-35600-18530 AND 2011-68004-30104 AND FROM THE US NATIONAL SCIENCE FOUNDATION MCB-0731969.",NA,"1471-2164",NA,NA,"BIOMED CENTRAL LTD","14",2013,"ISI000328646200002","42","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","31","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","WANGYCNJAU.EDU.CN",NA,"275AB",NA,"WANG, YC (REPRINT AUTHOR), NANJING AGR UNIV, DEPT PLANT PATHOL, NANJING 210095, JIANGSU, PEOPLES R CHINA","ISI","NANJING AGR UNIV;OREGON STATE UNIV;OREGON STATE UNIV","NANJING AGR UNIV",NA,"YE W, 2013, BMC GENOMICS","YE W, 2013, BMC GENOMICS"
"OTTESEN AR, 2013, PLOS ONE","OTTESEN AR;GONZALEZ A;BELL R;ARCE C;RIDEOUT S;ALLARD M;EVANS P;STRAIN E;MUSSER S;KNIGHT R;BROWN E;PETTENGILL JB","CO-ENRICHING MICROFLORA ASSOCIATED WITH CULTURE BASED METHODS TO DETECT SALMONELLA FROM TOMATO PHYLLOSPHERE","PLOS ONE","PLOS ONE","THE ABILITY TO DETECT A SPECIFIC ORGANISM FROM A COMPLEX ENVIRONMENT IS VITALLY IMPORTANT TO MANY FIELDS OF PUBLIC HEALTH, INCLUDING FOOD SAFETY. FOR EXAMPLE, TOMATOES HAVE BEEN IMPLICATED NUMEROUS TIMES AS VEHICLES OF FOODBORNE OUTBREAKS DUE TO STRAINS OF SALMONELLA BUT FEW STUDIES HAVE EVER RECOVERED SALMONELLA FROM A TOMATO PHYLLOSPHERE ENVIRONMENT. PRECISION OF CULTURING TECHNIQUES THAT TARGET AGENTS ASSOCIATED WITH OUTBREAKS DEPEND ON NUMEROUS FACTORS. ONE IMPORTANT FACTOR TO BETTER UNDERSTAND IS WHICH SPECIES CO-ENRICH DURING ENRICHMENT PROCEDURES AND HOW MICROBIAL DYNAMICS MAY IMPEDE OR ENHANCE DETECTION OF TARGET PATHOGENS. WE USED A SHOTGUN SEQUENCE APPROACH TO DESCRIBE TAXA ASSOCIATED WITH SAMPLES PRE-ENRICHMENT AND THROUGHOUT THE ENRICHMENT STEPS OF THE BACTERIOLOGICAL ANALYTICAL MANUAL'S (BAM) PROTOCOL FOR DETECTION OF SALMONELLA FROM ENVIRONMENTAL TOMATO SAMPLES. RECENT WORK HAS SHOWN THAT DURING EFFORTS TO ENRICH SALMONELLA (PROTEOBACTERIA) FROM TOMATO FIELD SAMPLES, FIRMICUTE GENERA ARE ALSO CO-ENRICHED AND AT LEAST ONE CO-ENRICHING FIRMICUTE GENUS (PAENIBACILLUS SP.) CAN INHIBIT AND EVEN KILLS STRAINS OF SALMONELLA. HERE WE PROVIDE A BASELINE DESCRIPTION OF MICROFLORA THAT CO-CULTURE DURING DETECTION EFFORTS AND THE UTILITY OF A BIOINFORMATIC APPROACH TO DETECT SPECIFIC TAXA FROM METAGENOMIC SEQUENCE DATA. WE OBSERVED THAT UNCULTURED SAMPLES CLUSTERED TOGETHER WITH DISTINCT TAXONOMIC PROFILES RELATIVE TO THE THREE CULTURED TREATMENTS (UNIVERSAL PRE-ENRICHMENT BROTH (UPB), TETRATHIONATE (TT), AND RAPPAPORT-VASSILIADIS (RV)). THERE WAS LITTLE CONSISTENCY AMONG SAMPLES EXPOSED TO THE SAME CULTURING MEDIAS, SUGGESTING SIGNIFICANT MICROBIAL DIFFERENCES IN STARTING MATRICES OR STOCHASTICITY ASSOCIATED WITH ENRICHMENT PROCESSES. INTERESTINGLY, PAENIBACILLUS SP. (SALMONELLA INHIBITOR) WAS SIGNIFICANTLY ENRICHED FROM UNCULTURED TO CULTURED (UPB) SAMPLES. ALSO OF INTEREST WAS THE SEQUENCE BASED IDENTIFICATION OF A NUMBER OF SEQUENCES AS SALMONELLA DESPITE INDICATION BY ALL MEDIA, THAT SAMPLES WERE CULTURE NEGATIVE FOR SALMONELLA. OUR RESULTS SUBSTANTIATE THE NASCENT UTILITY OF METAGENOMIC METHODS TO IMPROVE BOTH BIOLOGICAL AND BIOINFORMATIC PATHOGEN DETECTION METHODS.",NA,"ESCHERICHIA-COLI; ENRICHMENT BIAS; METAGENOMICS; MEDIA; DIVERSITY; OUTBREAK","ENGLISH","ARTICLE","ARTICLE",22,"ALLARD MW, 2013, PLOS ONE, V8, DOI 10.1371/JOURNAL.PONE.0055254.;BAILEY JS, 1992, J FOOD PROTECT, V55, P256, DOI 10.4315/0362-028X-55.4.256.;DUNBAR J, 1997, APPL ENVIRON MICROB, V63, P1326.;GORSKI L, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0034722.;HAMMACK TS, 2006, J AOAC INT, V89, P180.;JACKSON CR, 2011, MICROB ECOL, V61, P113, DOI 10.1007/S00248-010-9742-2.;KNIEF C, 2011, ISME J, DOI [DOI 10.1038/ISMEJ.2011.192, 10.1038/ISMEJ.2011.192].;KNOX R, 1942, J PATHOL BACTERIOL, V54, P469, DOI 10.1002/PATH.1700540409.;KUNIN V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08.;LIENAU EK, 2011, NEW ENGL J MED, V364, P981, DOI 10.1056/NEJMC1100443.;LOMAN NJ, 2013, JAMA-J AM MED ASSOC, V309, P1502, DOI 10.1001/JAMA.2013.3231.;LUO CW, 2012, PLOS ONE, V7, DOI [10.1371/JOURNAL.PONE.0030087, 10.1371/JOURNAL.PONE.0036568].;MAGOC T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/BIOINFORMATICS/BTR507.;MANDE SS, 2012, BRIEF BIOINFORM, V13, P669, DOI 10.1093/BIB/BBS054.;MEYER F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386.;MUNIESA M, 2005, APPL ENVIRON MICROB, V71, P4269, DOI 10.1128/AEM.71.8.4269-4275.2005.;NAMIKI T., 2012, NUCL ACIDS RES.;PETTENGILL JAMES B, 2012, BMC RES NOTES, V5, P378, DOI 10.1186/1756-0500-5-378.;R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7.;RAPPAPORT F, 1956, J CLIN PATHOL, V9, P261, DOI 10.1136/JCP.9.3.261.;REISBERG EE, 2012, ANTON LEEUW INT J G, V101, P551, DOI 10.1007/S10482-011-9669-8.;ROGOZIN IB, 2002, NUCLEIC ACIDS RES, V30, P4264, DOI 10.1093/NAR/GKF549.;SCHLOSS PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09.;SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/NAR/16.17.8207.;SINGER RS, 2009, J FOOD PROTECT, V72, P707, DOI 10.4315/0362-028X-72.4.707.;VASSILIADIS P, 1978, J APPL BACTERIOL, V44, P233, DOI 10.1111/J.1365-2672.1978.TB00795.X.;VORHOLT JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/NRMICRO2910.;ZERBINO DR, 2008, GENOME RES, V18, P821, DOI 10.1101/GR.074492.107.;ZHANG GD, 2011, APPL ENVIRON MICROB, V77, P6495, DOI 10.1128/AEM.00520-11.","OTTESEN, AR (REPRINT AUTHOR), US FDA, MOL METHODS \& SUBTYPING BRANCH, DIV MICROBIOL, OFF REGULATORY SCI,CTR FOOD SAFETY \& APPL NUTR, COLLEGE PK, MD 20740 USA.;OTTESEN, ANDREA R., BELL, REBECCA, ARCE, CAROLINE, ALLARD, MARC, EVANS, PETER, STRAIN, ERROL, MUSSER, STEVEN, BROWN, ERIC, PETTENGILL, JAMES B., US FDA, MOL METHODS \& SUBTYPING BRANCH, DIV MICROBIOL, OFF REGULATORY SCI,CTR FOOD SAFETY \& APPL NUTR, COLLEGE PK, MD 20740 USA.;GONZALEZ, ANTONIO, UNIV COLORADO, BIOFRONTIERS INST, BOULDER, CO 80309 USA.;RIDEOUT, STEVEN, VIRGINIA TECH, VIRGINIA AGR EXPT STN, PAINTER, VA USA.;KNIGHT, ROB, UNIV COLORADO, DEPT CHEM \& BIOCHEM, BOULDER, CO 80309 USA.;KNIGHT, ROB, UNIV COLORADO, HOWARD HUGHES MED INST, BOULDER, CO 80309 USA.","10.1371/JOURNAL.PONE.0073079","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E73079",NA,"FEDERAL TAX DOLLARS DESIGNATED FOR FOOD BORNE PATHOGEN PREVENTION","THIS RESEARCH WAS SUPPORTED BY FEDERAL TAX DOLLARS DESIGNATED FOR FOOD BORNE PATHOGEN PREVENTION. THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT.",NA,"1932-6203","9",NA,"PUBLIC LIBRARY SCIENCE","8",2013,"ISI000326405300047","29","SCIENCE \& TECHNOLOGY - OTHER TOPICS","32","MULTIDISCIPLINARY SCIENCES","ANDREA.OTTESENFDA.HHS.GOV",NA,"244QV",NA,"OTTESEN, AR (REPRINT AUTHOR), US FDA, MOL METHODS \& SUBTYPING BRANCH, DIV MICROBIOL, OFF REGULATORY SCI,CTR FOOD SAFETY \& APPL NUTR, COLLEGE PK, MD 20740 USA","ISI","COLLEGE PK;UNIV COLORADO;VIRGINIA TECH;UNIV COLORADO;UNIV COLORADO","COLLEGE PK",NA,"OTTESEN AR, 2013, PLOS ONE","OTTESEN AR, 2013, PLOS ONE"
"STOBBE AH, 2013, J MICROBIOL METHODS","STOBBE AH;DANIELS J;ESPINDOLA AS;VERMA R;MELCHER U;OCHOA CORONA F;GARZON C;FLETCHER J;SCHNEIDER W","E-PROBE DIAGNOSTIC NUCLEIC ACID ANALYSIS (EDNA): A THEORETICAL APPROACH FOR HANDLING OF NEXT GENERATION SEQUENCING DATA FOR DIAGNOSTICS","JOURNAL OF MICROBIOLOGICAL METHODS","J. MICROBIOL. METHODS","PLANT BIOSECURITY REQUIRES RAPID IDENTIFICATION OF PATHOGENIC ORGANISMS. WHILE THERE ARE MANY PATHOGEN-SPECIFIC DIAGNOSTIC ASSAYS, THE ABILITY TO TEST FOR LARGE NUMBERS OF PATHOGENS SIMULTANEOUSLY IS LACKING. NEXT GENERATION SEQUENCING (NGS) ALLOWS ONE TO DETECT ALL ORGANISMS WITHIN A GIVEN SAMPLE, BUT HAS COMPUTATIONAL LIMITATIONS DURING ASSEMBLY AND SIMILARITY SEARCHING OF SEQUENCE DATA WHICH EXTEND THE TIME NEEDED TO MAKE A DIAGNOSTIC DECISION. TO MINIMIZE THE AMOUNT OF BIOINFORMATIC PROCESSING TIME NEEDED, UNIQUE PATHOGEN-SPECIFIC SEQUENCES (TERMED E-PROBES) WERE DESIGNED TO BE USED IN SEARCHES OF UNASSEMBLED, NON-QUALITY CHECKED, SEQUENCE DATA. E-PROBES HAVE BEEN DESIGNED AND TESTED FOR SEVERAL SELECTED PHYTOPATHOGENS, INCLUDING AN RNA VIRUS, A DNA VIRUS, BACTERIA, FUNGI, AND AN OOMYCETE, ILLUSTRATING THE ABILITY TO DETECT SEVERAL DIVERSE PLANT PATHOGENS. E-PROBES OF 80 OR MORE NUCLEOTIDES IN LENGTH PROVIDED SATISFACTORY LEVELS OF PRECISION (75\%). THE NUMBER OF E-PROBES DESIGNED FOR EACH PATHOGEN VARIED WITH THE GENOME SIZE OF THE PATHOGEN. TO GIVE CONFIDENCE TO DIAGNOSTIC CALLS, A STATISTICAL METHOD OF DETERMINING THE PRESENCE OF A GIVEN PATHOGEN WAS DEVELOPED, IN WHICH TARGET E-PROBE SIGNALS (DETECTION SIGNAL) ARE COMPARED TO SIGNALS GENERATED BY A DECOY SET OF E-PROBES (BACKGROUND SIGNAL). THE E-PROBE DIAGNOSTIC NUCLEIC ACID ANALYSIS (EDNA) PROCESS PROVIDES THE FRAMEWORK FOR A NEW SEQUENCE-BASED DETECTION SYSTEM THAT ELIMINATES THE NEED FOR ASSEMBLY OF NGS DATA. PUBLISHED BY ELSEVIER B.V.","BIOINFORMATICS; NEXT-GENERATION SEQUENCING; PATHOGEN DETECTION","METAGENOMIC ANALYSIS; CROP BIOSECURITY; COMMUNITY","ENGLISH","ARTICLE","ARTICLE",14,"ADAMS IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/J.1364-3703.2009.00545.X].;BREITBART M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003.;BREITBART M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/PNAS.202488399.;COX-FOSTER DL, 2007, SCIENCE, V318, P283, DOI 10.1126/SCIENCE.1146498.;DANIEL R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/NRMICRO1160.;GAMLIEL A, 2008, NATO SCI PEACE SECUR, P37, DOI 10.1007/978-1-4020-8476-8\_5.;GILL SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/SCIENCE.1124234.;HODSON DP, 2005, 7 INT WHEAT C MAR PL, P142.;JONES WJ, 2010, ESTUAR COAST, V33, P944, DOI 10.1007/S12237-009-9182-8.;KREUZE JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/J.VIROL.2009.03.024.;MAGI A, 2010, GENES-BASEL, V1, P294, DOI 10.3390/GENES1020294.;METZKER ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/NRG2626.;MILES M.R., 2003, SOYBEAN RUST IS US S.;PALACIOS G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMOA073785.;PARAMESWARAN P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/NAR/GKM760.;PIVONIA S, 2006, PHYTOPATHOLOGY, V96, P400, DOI 10.1094/PHYTO-96-0400.;POP M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/J.TIG.2007.12.006.;POSTINIKOVA E, 2008, PHYTOPATHOLOGY, V98, P1156, DOI 10.1094/PHYTO-98-11-1156.;REIS-FILHO JS, 2009, BREAST CANCER RES, V11, P1.;RICHTER DC, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0003373.;RIZZO DM, 2003, FRONT ECOL ENVIRON, V1, P197, DOI 10.2307/3868064.;RONAGHI M, 2001, GENOME RES, V11, P3, DOI 10.1101/GR.11.1.3.;ROOSSINCK MJ, 2010, MOL ECOL, V19, P81, DOI 10.1111/J.1365-294X.2009.04470.X.;SCHAAD NW, 2003, ANNU REV PHYTOPATHOL, V41, P305, DOI 10.1146/ANNUREV.PHYTO.41.052002.095435.;TRINGE SG, 2005, NAT REV GENET, V6, P805, DOI 10.1038/NRG1709.;TUCKER T, 2009, AM J HUM GENET, V85, P142, DOI 10.1016/J.AJHG.2009.06.022.;TYLER BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/SCIENCE.1128796.;TYSON GW, 2004, NATURE, V428, P37, DOI 10.1038/NATURE02340.;VIJAYA SATYA R., 2008, BMC BIOINFORMATICS, V9, P185.","SCHNEIDER, W (REPRINT AUTHOR), 1301 DITTO AVE,BLDG 1301, FT DETRICK, MD 21702 USA.;STOBBE, ANTHONY H., VERMA, RUCHI, MELCHER, ULRICH, OKLAHOMA STATE UNIV, DEPT BIOCHEM \& MOL BIOL, STILLWATER, OK 74078 USA.;DANIELS, JON, ESPINDOLA, ANDRES S., OCHOA-CORONA, FRANCISCO, GARZON, CARLA, FLETCHER, JACQUELINE, OKLAHOMA STATE UNIV, DEPT ENTOMOL \& PLANT PATHOL, STILLWATER, OK 74078 USA.;SCHNEIDER, WILLIAM, USDA ARS, FOREIGN DIS WEED SCI RES UNIT, WASHINGTON, DC 20250 USA.","10.1016/J.MIMET.2013.07.002","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"USDA-CSREES PLANT BIOSECURITY PROGRAM [2010-85605-20542]","THIS WORK WAS FUNDED BY THE USDA-CSREES PLANT BIOSECURITY PROGRAM, GRANT NUMBER 2010-85605-20542. THE AUTHORS WOULD LIKE TO THANK DR. RAKESH KAUNDAL FOR A CRITICAL REVIEW OF THIS MANUSCRIPT.",NA,"0167-7012","3","356-366","ELSEVIER SCIENCE BV","94",2013,"ISI000324664500031","29","BIOCHEMISTRY \& MOLECULAR BIOLOGY, MICROBIOLOGY","28","BIOCHEMICAL RESEARCH METHODS, MICROBIOLOGY","WILLIAM.SCHNEIDERARS.USDA.GOV",NA,"221NB",NA,"SCHNEIDER, W (REPRINT AUTHOR), 1301 DITTO AVE,BLDG 1301, FT DETRICK, MD 21702 USA","ISI","OKLAHOMA STATE UNIV;OKLAHOMA STATE UNIV;SCHNEIDER","SCHNEIDER",NA,"STOBBE AH, 2013, J MICROBIOL METHODS","STOBBE AH, 2013, J MICROBIOL METHODS"
"CONTE N, 2013, LEUKEMIA","CONTE N;VARELA I;GROVE C;MANES N;YUSA K;MORENO T;SEGONDS PICHON A;BENCH A;GUDGIN E;HERMAN B;BOLLI N;ELLIS P;HADDAD D;COSTEAS P;RAD R;SCOTT M;HUNTLY B;BRADLEY A;VASSILIOU GS","DETAILED MOLECULAR CHARACTERISATION OF ACUTE MYELOID LEUKAEMIA WITH A NORMAL KARYOTYPE USING TARGETED DNA CAPTURE","LEUKEMIA","LEUKEMIA","ADVANCES IN SEQUENCING TECHNOLOGIES ARE GIVING UNPRECEDENTED INSIGHTS INTO THE SPECTRUM OF SOMATIC MUTATIONS UNDERLYING ACUTE MYELOID LEUKAEMIA WITH A NORMAL KARYOTYPE (AML-NK). IT IS CLEAR THAT THE PROGNOSIS OF INDIVIDUAL PATIENTS IS STRONGLY INFLUENCED BY THE COMBINATION OF MUTATIONS IN THEIR LEUKAEMIA AND THAT MANY LEUKAEMIAS ARE COMPOSED OF MULTIPLE SUBCLONES, WITH DIFFERENTIAL SUSCEPTIBILITIES TO TREATMENT. HERE, WE DESCRIBE A METHOD, EMPLOYING TARGETED CAPTURE COUPLED WITH NEXT-GENERATION SEQUENCING AND TAILORED BIOINFORMATIC ANALYSIS, FOR THE SIMULTANEOUS STUDY OF 24 GENES RECURRENTLY MUTATED IN AML-NK. MUTATIONAL ANALYSIS WAS PERFORMED USING OPEN SOURCE SOFTWARE AND AN IN-HOUSE SCRIPT (MUTATION IDENTIFICATION AND ANALYSIS SOFTWARE), WHICH IDENTIFIED DOMINANT CLONE MUTATIONS WITH 100\% SPECIFICITY. IN EACH OF SEVEN CASES OF AML-NK STUDIED, WE IDENTIFIED AND VERIFIED MUTATIONS IN 2-4 GENES IN THE MAIN LEUKAEMIC CLONE. ADDITIONALLY, HIGH SEQUENCING DEPTH ENABLED US TO IDENTIFY PUTATIVE SUBCLONAL MUTATIONS AND DETECT LEUKAEMIA-SPECIFIC MUTATIONS IN DNA FROM REMISSION MARROW. FINALLY, WE USED NORMALISED READ DEPTHS TO DETECT COPY NUMBER CHANGES AND IDENTIFIED AND SUBSEQUENTLY VERIFIED A TANDEM DUPLICATION OF EXONS 2-9 OF MLL AND AT LEAST ONE DELETION INVOLVING PTEN. THIS METHODOLOGY RELIABLY DETECTS SEQUENCE AND COPY NUMBER MUTATIONS, AND CAN THUS GREATLY FACILITATE THE CLASSIFICATION, CLINICAL RESEARCH, DIAGNOSIS AND MANAGEMENT OF AML-NK.","ACUTE MYELOID LEUKAEMIA; DIAGNOSIS; CLASSIFICATION; TARGETED CAPTURE; NEXT GENERATION SEQUENCING; MINIMAL RESIDUAL DISEASE; MIDAS","PROGNOSTIC RELEVANCE; MUTATIONS; GENOME; FLT3; EVOLUTION; NUMBER; CANCER; TET2","ENGLISH","ARTICLE","ARTICLE",17,"BULLINGER L, 2010, CANCER CELL, V17, P1, DOI 10.1016/J.CCR.2009.12.033.;DELHOMMEAU F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMOA0810069.;DING L, 2012, NATURE, V481, P506, DOI 10.1038/NATURE10738.;FALINI B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMOA041974.;GALE RE, 2008, BLOOD, V111, P2776, DOI 10.1182/BLOOD-2007-08-109090.;GNIRKE A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/NBT.1523.;GROSSMANN V, 2011, LEUKEMIA, V25, P877, DOI 10.1038/LEU.2011.10.;GROSSMANN V, 2011, BLOOD, V118, P6153, DOI 10.1182/BLOOD-2011-07-365320.;HUMMEL M, 2011, BIOINFORMATICS, V27, P1316, DOI 10.1093/BIOINFORMATICS/BTR122.;KIYOI H, 1999, BLOOD, V93, P3074.;KOBOLDT DC, 2012, GENOME RES, V22, P568, DOI 10.1101/GR.129684.111.;LARSON DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/BIOINFORMATICS/BTR665.;LEY TJ, 2008, NATURE, V456, P66, DOI 10.1038/NATURE07485.;LEY TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMOA1005143.;LI H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/BIOINFORMATICS/BTP352.;LOVE MI, 2011, STAT APPL GENET MOL, V10.;MARDIS ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMOA0903840.;PATEL JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMOA1112304.;PREUDHOMME C, 2002, BLOOD, V100, P2717, DOI 10.1182/BLOOD-2002-03-0990.;QUINLAN AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/BIOINFORMATICS/BTQ033.;SANZ M, 2009, CURR OPIN ONCOL, V21, P594, DOI 10.1097/CCO.0B013E32833118FD.;SMITH BD, 2004, BLOOD, V103, P3669, DOI 10.1182/BLOOD-2003-11-3775.;STRATTON MR, 2009, NATURE, V458, P719, DOI 10.1038/NATURE07943.;WELCH JS, 2012, CELL, V150, P264, DOI 10.1016/J.CELL.2012.06.023.","VASSILIOU, GS (REPRINT AUTHOR), WELLCOME TRUST SANGER INST, WELLCOME TRUST GENOME CAMPUS, CAMBRIDGE CB10 1SA, ENGLAND.;CONTE, N., GROVE, C., MANES, N., YUSA, K., BOLLI, N., ELLIS, P., HADDAD, D., RAD, R., BRADLEY, A., VASSILIOU, G. S., WELLCOME TRUST SANGER INST, CAMBRIDGE CB10 1SA, ENGLAND.;CONTE, N., EMBL EUROPEAN BIOINFORMAT INST, CAMBRIDGE, ENGLAND.;VARELA, I., MORENO, T., UNIV CANTABRIA, INST BIOMED \& BIOTECNOL CANTABRIA, E-39005 SANTANDER, SPAIN.;SEGONDS-PICHON, A., BABRAHAM INST, BIOINFORMAT DEPT, CAMBRIDGE, ENGLAND.;BENCH, A., GUDGIN, E., BOLLI, N., SCOTT, M., HUNTLY, B., CAMBRIDGE UNIV HOSP NHS FDN TRUST, DEPT HAEMATOL, CAMBRIDGE, ENGLAND.;HERMAN, B., AGILENT TECHNOL, IQ WINNERSH, READING, BERKS, ENGLAND.;COSTEAS, P., CTR STUDY HAEMATOL MALIGNACIES, NICOSIA, CYPRUS.","10.1038/LEU.2013.117","MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",NA,NA,"WELLCOME TRUST, LEUKAEMIA LYMPHOMA RESEARCH, KAY KENDAL LEUKAEMIA FUND","WE ACKNOWLEDGE THE USE OF THE NATIONAL INSTITUTE OF HEALTH RESEARCH (NIHR) BIOMEDICAL RESEARCH CENTRE, UNIVERSITY OF CAMBRIDGE. WE THANK DRS J CRAIG AND C CRAWLEY OF CAMBRIDGE UNIVERSITY NHS HOSPITALS TRUST FOR ALLOWING US TO APPROACH THEIR PATIENTS FOR SAMPLES. GV IS FUNDED BY A WELLCOME TRUST SENIOR FELLOWSHIP IN CLINICAL SCIENCE. WORK IN GV'S LABORATORY IS ALSO FUNDED BY LEUKAEMIA LYMPHOMA RESEARCH AND THE KAY KENDAL LEUKAEMIA FUND.",NA,"0887-6924","9","1820-1825","NATURE PUBLISHING GROUP","27",2013,"ISI000324162700004","24","ONCOLOGY, HEMATOLOGY","7","ONCOLOGY, HEMATOLOGY","GSV20SANGER.AC.UK",NA,"214UT",NA,"VASSILIOU, GS (REPRINT AUTHOR), WELLCOME TRUST SANGER INST, WELLCOME TRUST GENOME CAMPUS, CAMBRIDGE CB10 1SA, ENGLAND","ISI","WELLCOME TRUST SANGER INST;EMBL EUROPEAN BIOINFORMAT INST;UNIV CANTABRIA;BABRAHAM INST;CAMBRIDGE UNIV HOSP NHS FDN TRUST;AGILENT TECHNOL;CTR STUDY HAEMATOL MALIGNACIES","WELLCOME TRUST SANGER INST",NA,"CONTE N, 2013, LEUKEMIA","CONTE N, 2013, LEUKEMIA"
"ROSSET C, 2013, HAEMOPHILIA","ROSSET C;VIEIRA IA;SINIGAGLIA M;GORZIZA RP;SALZANO FM;BANDINELLI E","DETECTION OF NEW MUTATIONS AND MOLECULAR PATHOLOGY OF MILD AND MODERATE HAEMOPHILIA A PATIENTS FROM SOUTHERN BRAZIL","HAEMOPHILIA","HAEMOPHILIA","A TOTAL OF 76 UNRELATED MALE PATIENTS WITH MILD (N=55) OR MODERATE (N=21) HAEMOPHILIA A LIVING IN THE SOUTHERN BRAZILIAN STATE OF RIO GRANDE DO SUL WERE STUDIED BY DIRECT SEQUENCING OF ALL F8 26 EXONS, THE 5 UTR AND 3 UTR, INTRON-EXON JUNCTIONS AND THE PROMOTER REGION. WHEN NO MUTATION WAS FOUND, A MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION ANALYSIS WAS PERFORMED. WE IDENTIFIED THE DISEASE-CAUSING MUTATIONS IN 69 PATIENTS, WHO SHOWED 33 DIFFERENT MUTATIONS: 27 MISSENSE, ONE SMALL DELETION, TWO SMALL DUPLICATIONS AND THREE SPLICE SITE MUTATIONS. SEVEN MISSENSE AND TWO SPLICE SITE MUTATIONS WERE NOT PREVIOUSLY REPORTED IN HAMSTERS AND WERE NOT IDENTIFIED IN ANY CURRENT LITERATURE SEARCH. NINE RECURRENT MUTATIONS WERE FOUND, ONE OF THEM NEVER DESCRIBED BEFORE (P.TYR1786PHE). HAPLOTYPE ANALYSIS INDICATED THAT THIS MUTATION HAD ORIGINATED IN THE BRAZILIAN POPULATION AS A SINGLE EVENT IN A COMMON ANCESTOR. THE POSSIBLE INFLUENCE OF THESE MUTATIONS IN THE DETERMINATION OF THE DISEASE WAS CAREFULLY CONSIDERED, INCLUDING BIOINFORMATIC TOOLS. THESE DATA ADD TO THE GENERAL KNOWLEDGE OF THE DISEASE AND CAN ALSO BE USEFUL FOR HA DIAGNOSIS AND DETECTION OF CARRIERS IN THE SOUTHERN BRAZILIAN POPULATION.","AMINO ACID CHANGES; FACTOR VIII; GENOTYPE-PHENOTYPE CORRELATION; HAEMOPHILIA A; MUTATION EFFECTS; STRUCTURAL ANALYSIS","FACTOR-VIII GENE; COAGULATION FACTOR-VIII; VON-WILLEBRAND-FACTOR; PROTEIN-STRUCTURE; BINDING-SITE; C2 DOMAIN; FACTOR-IX; BLOOD; ETIOLOGY; INVERSIONS","ENGLISH","ARTICLE","ARTICLE",4,"ADZHUBEI IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/NMETH0410-248.;AGOSTINI D, 2012, HAEMOPHILIA, V18, P416.;ANTONARAKIS SE, 1995, HUM MUTAT, V5, P1, DOI 10.1002/HUMU.1380050102.;AUSTEN DEG, 1975, LAB MANUAL BLOOD COA, P109.;BAGNALL RD, 2002, BLOOD, V99, P168, DOI 10.1182/BLOOD.V99.1.168.;BOEKHORST J, 2005, BRIT J HAEMATOL, V131, P109, DOI 10.1111/J.1365-2141.2005.05737.X.;DORNER AJ, 1987, J CELL BIOL, V105, P2665, DOI 10.1083/JCB.105.6.2665.;FANG H, 2007, THROMB RES, V119, P1, DOI 10.1016/J.THROMRES.2005.12.015.;FAY PJ, 1994, J BIOL CHEM, V269, P20522.;FIGUEIREDO MS, 1995, J BIOL CHEM, V270, P1.;FOSTER PA, 1990, BLOOD, V75, P1999.;GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326A0.;GORZIZA RP, 2013, BLOOD COAGUL FIBRIN, V24, P164, DOI 10.1097/MBC.0B013E32835AEFA2.;HARRAWAY JR, 2006, J THROMB HAEMOST, V4, P587, DOI 10.1111/J.1538-7836.2006.01790.X.;HWANG SH, 2009, HAEMOPHILIA, V15, P1311, DOI 10.1111/J.1365-2516.2009.02086.X.;JAMES EA, 2010, THROMBOSIS HAEMOST, V9, P689.;KANE WH, 1988, BLOOD, V71, P539.;LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/NAR/19.19.5444.;LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/NG1193-236.;LANNOY N, 2012, HAEMOPHILIA, V18, P331.;LAPPAN KA, 1998, THROMB HAEMOSTASIS, V80, P418.;LAURIE AD, 2007, HAEMOPHILIA, V13, P420, DOI 10.1111/J.1365-2516.2007.01487.X.;LEIRIA LB, 2009, HAEMOPHILIA, V15, P309, DOI 10.1111/J.1365-2516.2008.01868.X.;LENTING PJ, 1996, J BIOL CHEM, V271, P1935, DOI 10.1074/JBC.271.4.1935.;LEYTE A, 1991, J BIOL CHEM, V266, P740.;MACHADO FB, 2009, HAEMOPHILIA, V15, P297, DOI 10.1111/J.1365-2516.2008.01866.X.;NAKAMURA M, 2007, BIOCHEMISTRY-US, V46, P12737, DOI 10.1021/BI701079Z.;NAKAYA S, 2001, BRIT J HAEMATOL, V115, P977, DOI 10.1046/J.1365-2141.2001.03173.X.;OLDENBURG J, 1998, THROMB HAEMOSTASIS, V79, P452.;SAENKO EL, 1997, J BIOL CHEM, V272, P18007, DOI 10.1074/JBC.272.29.18007.;SURIN VL, 1990, NUCLEIC ACIDS RES, V18, P3432, DOI 10.1093/NAR/18.11.3432.;TUDDENHAM EGD, 1995, METABOLIC MOL BASES, P3241.;TUDDENHAM EGD, 1989, MOL BIOL COAGULATION, P849.;VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337A0.;VENSELAAR H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548.;WHITE GC, 2001, THROMB HAEMOSTASIS, V85, P560.;WORTH C.L., 2011, NUCLEIC ACIDS RES, V39, P215.","SALZANO, FM (REPRINT AUTHOR), UNIV FED RIO GRANDE DO SUL, DEPT GENET, INST BIOCIENCIAS, CAIXA POSTAL 15053, BR-91501970 PORTO ALEGRE, RS, BRAZIL.;ROSSET, C., VIEIRA, I. A., SINIGAGLIA, M., GORZIZA, R. P., SALZANO, F. M., BANDINELLI, E., UNIV FED RIO GRANDE DO SUL, DEPT GENET, INST BIOCIENCIAS, BR-91501970 PORTO ALEGRE, RS, BRAZIL.","10.1111/HAE.12172","111 RIVER ST, HOBOKEN 07030-5774, NJ USA",NA,NA,"CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTIFICO E TECNOLOGICO, FUNDACAO DE AMPARO A PESQUISA DO ESTADO DO RIO GRANDE DO SUL (APOIO A NUCLEOS DE EXCELENCIA PROGRAM)","WE WOULD LIKE TO THANK ANA M. C. B. PEREIRA AND ANA P. ORNAGHI FOR LABORATORY HELP, GUSTAVO F. VIEIRA AND DINLER AMARAL ANTUNES FOR BIOINFORMATICS ADVICE, AS WELL AS THE PATIENTS AND STAFF OF HEMOCENTRO-RS FOR AGREEING TO PARTICIPATE IN THE STUDY AND FOR LOGISTICAL SUPPORT. FINANCING WAS PROVIDED BY CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTIFICO E TECNOLOGICO AND FUNDACAO DE AMPARO A PESQUISA DO ESTADO DO RIO GRANDE DO SUL (APOIO A NUCLEOS DE EXCELENCIA PROGRAM).",NA,"1351-8216","5","773-781","WILEY-BLACKWELL","19",2013,"ISI000323453200035","37","HEMATOLOGY","7","HEMATOLOGY","FRANCISCO.SALZANOUFRGS.BR",NA,"205OG",NA,"SALZANO, FM (REPRINT AUTHOR), UNIV FED RIO GRANDE DO SUL, DEPT GENET, INST BIOCIENCIAS, CAIXA POSTAL 15053, BR-91501970 PORTO ALEGRE, RS, BRAZIL","ISI","UNIV FED RIO GRANDE DO SUL","UNIV FED RIO GRANDE DO SUL",NA,"ROSSET C, 2013, HAEMOPHILIA","ROSSET C, 2013, HAEMOPHILIA"
"BALLOUZ S, 2013, BMC BIOINFORMATICS","BALLOUZ S;LIU JY;GEORGE RA;BAINS N;LIU A;OTI M;GAETA B;FATKIN D;WOUTERS MA","GENTREPID V2.0: A WEB SERVER FOR CANDIDATE DISEASE GENE PREDICTION","BMC BIOINFORMATICS","BMC BIOINFORMATICS","BACKGROUND: CANDIDATE DISEASE GENE PREDICTION IS A RAPIDLY DEVELOPING AREA OF BIOINFORMATICS RESEARCH WITH THE POTENTIAL TO DELIVER GREAT BENEFITS TO HUMAN HEALTH. AS EXPERIMENTAL STUDIES DETECTING ASSOCIATIONS BETWEEN GENETIC INTERVALS AND DISEASE PROLIFERATE, BETTER BIOINFORMATIC TECHNIQUES THAT CAN EXPAND AND EXPLOIT THE DATA ARE REQUIRED. DESCRIPTION: GENTREPID IS A WEB RESOURCE WHICH PREDICTS AND PRIORITIZES CANDIDATE DISEASE GENES FOR BOTH MENDELIAN AND COMPLEX DISEASES. THE SYSTEM CAN TAKE INPUT FROM LINKAGE ANALYSIS OF SINGLE GENETIC INTERVALS OR MULTIPLE MARKER LOCI FROM GENOME-WIDE ASSOCIATION STUDIES. THE UNDERLYING DATABASE OF THE GENTREPID TOOL SOURCES DATA FROM NUMEROUS GENE AND PROTEIN RESOURCES, TAKING ADVANTAGE OF THE WEALTH OF BIOLOGICAL INFORMATION AVAILABLE. USING KNOWN DISEASE GENE INFORMATION FROM OMIM, THE SYSTEM PREDICTS AND PRIORITIZES DISEASE GENE CANDIDATES THAT PARTICIPATE IN THE SAME PROTEIN PATHWAYS OR SHARE SIMILAR PROTEIN DOMAINS. ALTERNATIVELY, USING AN AB INITIO APPROACH, THE SYSTEM CAN DETECT ENRICHMENT OF THESE PROTEIN ANNOTATIONS WITHOUT PRIOR KNOWLEDGE OF THE PHENOTYPE. CONCLUSIONS: THE SYSTEM AIMS TO INTEGRATE THE WEALTH OF PROTEIN INFORMATION CURRENTLY AVAILABLE WITH KNOWN AND NOVEL PHENOTYPE/GENOTYPE INFORMATION TO ACQUIRE KNOWLEDGE OF BIOLOGICAL MECHANISMS UNDERPINNING DISEASE. WE HAVE UPDATED THE SYSTEM TO FACILITATE ANALYSIS OF GWAS DATA AND THE STUDY OF COMPLEX DISEASES. APPLICATION OF THE SYSTEM TO GWAS DATA ON HYPERTENSION USING THE ICBP DATA IS PROVIDED AS AN EXAMPLE. AN INTERESTING PREDICTION IS A ZIP TRANSPORTER ADDITIONAL TO THE ONE FOUND BY THE ICBP ANALYSIS. THE WEBSERVER URL IS HTTPS://WWW.GENTREPID.ORG/.","CANDIDATE DISEASE GENE PREDICTION; CANDIDATE DISEASE GENES; MENDELIAN DISEASES; COMPLEX DISEASES; GENOME-WIDE ASSOCIATION STUDIES; GENOTYPE; PHENOTYPE; CANDIDATE GENE IDENTIFICATION; GENETIC-ASSOCIATION STUDIES; HYPERTENSION","GENOME-WIDE ASSOCIATION; RENIN-ANGIOTENSIN SYSTEM; BLOOD-PRESSURE; SPONDYLOCOSTAL DYSOSTOSIS; INTERACTION DATABASE; SEQUENCE DATABASE; PROTEIN-SEQUENCE; EXPRESSION; TOOLS; HAIRY-AND-ENHANCER-OF-SPLIT-7","ENGLISH","ARTICLE","ARTICLE",11,"ADIE EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/BIOINFORMATICS/BTK031.;ALARCON-RIQUELME ME, 2004, ARTHRITIS RES THER, V6, P169, DOI 10.1186/AR1203.;BADANO JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/NRG910.;BADER GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/NAR/GKG056.;BAIROCH A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/NAR/28.1.45.;BALLOUZ S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-98.;BATEMAN A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/NAR/30.1.276.;BROWN KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/BIOINFORMATICS/BTI273.;CAMON E, 2004, NUCLEIC ACIDS RES, V32, PD262, DOI 10.1093/NAR/GKH021.;CANTOR RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/J.AJHG.2009.11.017.;CARDON LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543.;CAREY RM, 2003, ENDOCR REV, V24, P261, DOI 10.1210/ER.2003-0001.;CONSORTIUM TEP, 2011, PLOS BIOL, P9, DOI DOI 10.1371/JOURNAL.PBIO.1001046.;DELORENZI M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/BIOINFORMATICS/18.4.617.;DIETTERICH T, 1995, ACM COMPUT SURV, V27, P326, DOI 10.1145/212094.212114.;EDDY SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/BIOINFORMATICS/14.9.755.;EDGAR R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/NAR/30.1.207.;EHRET GB, 2011, NATURE, V478, P103, DOI 10.1038/NATURE10405.;EMANUELSSON O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/NPROT.2007.131.;FRANKE L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300.;FREUDENBERG J, 2002, BIOINFORMATICS, V18, PS110, DOI 10.1093/BIOINFORMATICS/18.SUPPL\_2.S110.;FYHRQUIST F, 2008, J INTERN MED, V264, P224, DOI 10.1111/J.1365-2796.2008.01981.X.;GEORGE RA, 2002, PROTEINS, V48, P672, DOI 10.1002/PROT.10175.;GEORGE RA, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/NAR/GKL707.;GROSSMAN E, 2008, DIABETES CARE, V31, PS185, DOI 10.2337/DC08-S246.;GUIJARRO C, 2001, KIDNEY INT, V59, P415, DOI 10.1046/J.1523-1755.2001.059002415.X.;HAMOSH A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/NAR/30.1.52.;HE L, 2009, TOXICOL APPL PHARM, V238, P250, DOI 10.1016/J.TAAP.2009.02.017.;JIMENEZ-SANCHEZ G, 2001, NATURE, V409, P853, DOI 10.1038/35057050.;KANEHISA M, 2004, NUCLEIC ACIDS RES, V32, PD277, DOI 10.1093/NAR/GKH063.;KENT WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/GR.229102.;KLEINJAN DIRK-JAN, 2009, BRIEFINGS IN FUNCTIONAL GENOMICS \& PROTEOMICS, V8, P317, DOI 10.1093/BFGP/ELP022.;KROGH A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/JMBI.2000.4315.;LEVY D, 2009, NAT GENET, V41, P677, DOI 10.1038/NG.384.;LIU X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271.;LIU Z, 2008, BIOCHEM BIOPH RES CO, V365, P814, DOI 10.1016/J.BBRC.2007.11.067.;MEOLA NICOLA, 2009, PATHOGENETICS, V2, P7, DOI 10.1186/1755-8417-2-7.;NEWTON-CHEH C, 2009, NAT GENET, V41, P666, DOI 10.1038/NG.361.;NISHIMURA D, 2001, BIOTECT SOFTWARE INT, V2, P117, DOI DOI 10.1089/152791601750294344.;OTI M, 2006, J MED GENET, V43, DOI 10.1136/JMG.2006.041376.;PARKINSON H, 2007, NUCLEIC ACIDS RES, V35, PD747, DOI 10.1093/NAR/GKL995.;PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/PNAS.85.8.2444.;PERI S, 2003, GENOME RES, V13, P2363, DOI 10.1101/GR.1680803.;PRUITT KD, 2007, NUCLEIC ACIDS RES, V35, PD61, DOI 10.1093/NAR/GKL842.;RAYCHAUDHURI S, 2009, PLOS GENET, V5, DOI 10.1371/JOURNAL.PGEN.1000534.;REBHAN M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/BIOINFORMATICS/14.8.656.;SHERRY ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/NAR/29.1.308.;SPARROW DB, 2008, HUM MOL GENET, V17, P3761, DOI 10.1093/HMG/DDN272.;SPARROW DB, 2010, EUR J HUM GENET, V18, P674, DOI 10.1038/EJHG.2009.241.;TATUSOV RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41.;TEBER ET, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S69.;TORIELLI L, 2008, AM J PHYSIOL-RENAL, V295, PF478, DOI 10.1152/AJPRENAL.90226.2008.;TRANCHEVENT LC, 2008, NUCLEIC ACIDS RES, V36, PW377, DOI 10.1093/NAR/GKN325.;TRANCHEVENT LC, 2011, BRIEF BIOINFORM, V12, P22, DOI 10.1093/BIB/BBQ007.;WOLF E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/PRO.5560060606.;ZANZONI A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8.","WOUTERS, MA (REPRINT AUTHOR), DEAKIN UNIV, SCH MED, GEELONG, VIC 3217, AUSTRALIA.;BALLOUZ, SARA, LIU, JASON Y., GEORGE, RICHARD A., BAINS, NARESH, LIU, ARTHUR, VICTOR CHANG CARDIAC RES INST, STRUCT \& COMPUTAT BIOL DEPT, DARLINGHURST, NSW 2010, AUSTRALIA.;BALLOUZ, SARA, GAETA, BRUNO, UNIV NEW S WALES, SCH ENGN \& COMP SCI, KENSINGTON, NSW 2052, AUSTRALIA.;OTI, MARTIN, RADBOUD UNIV NIJMEGEN, MED CTR, CTR MOL \& BIOMOL INFORMAT, NL-6525 ED NIJMEGEN, NETHERLANDS.;FATKIN, DIANE, UNIV NEW S WALES, SCH MED SCI, KENSINGTON, NSW 2052, AUSTRALIA.;FATKIN, DIANE, VICTOR CHANG CARDIAC RES INST, MOL CARDIOL \& BIOPHYS DIV, DARLINGHURST, NSW 2010, AUSTRALIA.;WOUTERS, MERRIDEE A., DEAKIN UNIV, SCH MED, GEELONG, VIC 3217, AUSTRALIA.;BALLOUZ, SARA, COLD SPRING HARBOR LAB, STANLEY INST COGNIT GENOM, WOODBURY, NY 11797 USA.","10.1186/1471-2105-14-249","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","249",NA,NA,NA,NA,"1471-2105",NA,NA,"BIOMED CENTRAL LTD","14",2013,"ISI000324126000001","56","BIOCHEMISTRY \& MOLECULAR BIOLOGY, BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, MATHEMATICAL \& COMPUTATIONAL BIOLOGY","3","BIOCHEMICAL RESEARCH METHODS, BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, MATHEMATICAL \& COMPUTATIONAL BIOLOGY","M.WOUTERSDEAKIN.EDU.AU",NA,"214IN",NA,"WOUTERS, MA (REPRINT AUTHOR), DEAKIN UNIV, SCH MED, GEELONG, VIC 3217, AUSTRALIA","ISI","VICTOR CHANG CARDIAC RES INST;UNIV NEW S WALES;RADBOUD UNIV NIJMEGEN;UNIV NEW S WALES;VICTOR CHANG CARDIAC RES INST;DEAKIN UNIV;STANLEY INST COGNIT GENOM","DEAKIN UNIV",NA,"BALLOUZ S, 2013, BMC BIOINFORMATICS","BALLOUZ S, 2013, BMC BIOINFORMATICS"
"SARKAR A, 2013, BMC INFECT DIS","SARKAR A;BANIK A;PATHAK BK;MUKHOPADHYAY SK;CHATTERJEE S","ENVELOPE PROTEIN GENE BASED MOLECULAR CHARACTERIZATION OF JAPANESE ENCEPHALITIS VIRUS CLINICAL ISOLATES FROM WEST BENGAL, INDIA: A COMPARATIVE APPROACH WITH RESPECT TO SA14-14-2 LIVE ATTENUATED VACCINE STRAIN","BMC INFECTIOUS DISEASES","BMC INFECT. DIS.","BACKGROUND: INCREASING VIRULENCE OF JAPANESE ENCEPHALITIS VIRUS (JEV), A MOSQUITO-BORNE ZOONOTIC PATHOGEN IS OF GRAVE CONCERN BECAUSE IT CAUSES A NEUROTROPHIC KILLER DISEASE JAPANESE ENCEPHALITIS (JE) WHICH, IN TURN, IS RESPONSIBLE GLOBALLY FOR VIRAL ACUTE ENCEPHALITIS SYNDROME (AES). DESPITE THE AVAILABILITY OF VACCINE, JE/AES CASES AND DEATHS HAVE BECOME REGULAR FEATURES IN THE DIFFERENT RURAL DISTRICTS OF WEST BENGAL (WB) STATE, INDIA, INDICATING EITHER THE PARTIAL COVERAGE OF VACCINE OR THE EMERGENCE OF NEW STRAIN OF JEV. THEREFORE, A STUDY WAS UNDERTAKEN TO CHARACTERIZE AND COMPARE THE COMPLETE ENVELOPE (E) PROTEIN GENE BASED MOLECULAR CHANGES/PATTERNS OF JEVS CIRCULATING IN WB. METHODS: TOTAL OF 98 AES CASE-PATIENTS' SAMPLES WERE TESTED TO DETECT THE PRESENCE OF JEV SPECIFIC IMMUNOGLOBULIN M (IGM) ANTIBODY BY MAC-ELISA METHOD. ONLY JEV IGM NEGATIVE SAMPLES WITH A HISTORY OF <= 3 DAYS' ILLNESS WERE SCREENED FOR VIRUS ISOLATION AND RT-PCR. E GENE SEQUENCES OF JEV ISOLATES WERE SUBJECTED TO MOLECULAR PHYLOGENY AND IMMUNOINFORMATICS ANALYSIS. RESULTS: PRESENT STUDY CONFIRMED JEV ETIOLOGY IN 39.7\% AND 29.1\% OF PATIENTS PRESENTING <= 15 DAYS' FEBRILE ILLNESS, AS DETERMINED BY MAC-ELISA AND RT-PCR RESPECTIVELY. PHYLOGENETIC ANALYSIS BASED ON COMPLETE E GENE SEQUENCES OF JEV ISOLATES SHOWED THE CO-CIRCULATION OF JEV GENOTYPE I (GI) WITH GENOTYPE III (GIII). THIS STUDY ALSO DEMONSTRATED THAT ISOLATE-SPECIFIC CRUCIAL AMINO ACID SUBSTITUTIONS WERE CLOSELY RELATED TO NEUROVIRULENCE/NEUROINVASIVENESS OF JE. ON THE BASIS OF IMMUNOINFORMATICS ANALYSIS, SOME SUBSTITUTIONS WERE PREDICTED TO DISRUPT T-CELL EPITOPE IMMUNOGENICITY/ANTIGENICITY THAT MIGHT LARGELY INFLUENCE THE OUTCOME OF VACCINE DERIVED FROM JEV GIII SA14-14-2 STRAIN AND THIS HAS BEEN OBSERVED IN A PREVIOUSLY VACCINATED BOY WITH MILD JE/AES DUE TO JEV GI INFECTION. CONCLUSIONS: BASED ON MOLECULAR EVOLUTIONARY AND BIOINFORMATIC APPROACHES, WE REPORT EVOLUTION OF JEV AT A LOCAL LEVEL. SUCH NATURALLY OCCURRING EVOLUTION IS LIKELY TO AFFECT THE DISEASE PROFILE AND THE VACCINE EFFICACY TO PROTECT AGAINST JEV GI MAY DEMAND CAREFUL EVALUATION.","JAPANESE ENCEPHALITIS VIRUS; ENVELOPE PROTEIN GENE; MOLECULAR PHYLOGENY; GENOTYPE III; GENOTYPE I; HOMOLOGY MODELING; HYDROPHILICITY; T-CELL EPITOPE; WEST BENGAL","SEROLOGICAL SURVEY; BANKURA DISTRICT; GENOTYPE I; DOMAIN-III; NILE; FLAVIVIRUSES; ANTIBODY; GLYCOPROTEIN; REPLICATION; DEFINITION","ENGLISH","ARTICLE","ARTICLE",9,"ARINDAM SARKAR, 2012, HEALTH, V4, P6, DOI 10.4236/HEALTH.2012.41002.;BANERJEE K, 1976, INDIAN J MED RES, V64, P121.;BEASLEY DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005.;CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/ANNUREV.MI.44.100190.003245.;CHERRIER MV, 2009, EMBO J, V28, P3269, DOI 10.1038/EMBOJ.2009.245.;COCQUEREL L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000.;DHILLON GP, 2008, INDIAN J MED ASS, V106, P660.;DIAGANA M, 2007, J NEUROL SCI, V262, P165, DOI 10.1016/J.JNS.2007.06.041.;FIELDS BN, 2007, FIELDS VIROLOGY.;FULMALI PV, 2011, EMERG INFECT DIS, V17, P319, DOI 10.3201/EID1702.100815.;GEEVARGHESE G, 2004, NIV PUNE YB.;GHOSH SN, 1975, INDIAN J MED RES, V63, P1472.;GRANT EN, 2006, J VIROL, V80, P11467.;HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/PNAS.78.6.3824.;KABILAN LALITHA, 2004, INDIAN JOURNAL OF PEDIATRICS, V71, P609, DOI 10.1007/BF02724120.;KOLASKAR AS, 1999, VIROLOGY, V261, P31, DOI 10.1006/VIRO.1999.9859.;LIN CW, 2003, J VIROL, V77, P2600, DOI 10.1128/JVI.77.4.2600-2606.2003.;LINDENBACH BD, 2007, FIELDS VIROLOGY, V1, P1101.;LUCA VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11.;MACKENZIE JS, 2004, NAT MED, V10, PS98, DOI 10.1038/NM1144.;MCMINN PC, 1997, J GEN VIROL, V78, P2711, DOI 10.1099/0022-1317-78-11-2711.;MONATH TP, 1990, VIROLOGY, P763.;MUKHOPADHYAY B B, 1990, INDIAN J PUBLIC HEALTH, V34, P107.;NAMACHIVAYAM V, 1982, P NAT C JAP ENC, P30.;NI HL, 1995, J GEN VIROL, V76, P401, DOI 10.1099/0022-1317-76-2-401.;NI HL, 1996, J GEN VIROL, V77, P1449, DOI 10.1099/0022-1317-77-7-1449.;PROGRAMME IMPLEMENTATION PLAN 2011-12/NATIONAL RURAL HEALTH MISSION/HEALTH AND FAMILY WELFARE DEPARTMENT WEST BENGAL, DIS CONTR PROGR SCHE.;PUJHARI SK, 2011, EPIDEMIOL INFECT, V139, P849, DOI 10.1017/S0950268810001937.;QI SC, 2011, VIROL J, V8, P472.;RAJAGOPALAN P K, 1978, INDIAN J MED RES, V68, P3938.;REUBEN RACHEL, 1997, INDIAN JOURNAL OF PEDIATRICS, V64, P243, DOI 10.1007/BF02752458.;REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291A0.;RICE C. M., 1986, TOGAVIRIDAE FLAVIVIR, P279.;RODRIGUES FM, 1975, INDIAN J MED RES, V63, P1478.;RYUTA K, 2006, J VIROL, V80, P11000.;SARKAR A, 2012, T ROY SOC TROP MED H, V106, P15, DOI 10.1016/J.TRSTMH.2011.08.011.;SARKAR A, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-271.;SCHUH AJ, 2010, J GEN VIROL, V91, P95, DOI 10.1099/VIR.0.013631-0.;SIDNEY J, 1996, HUM IMMUNOL, V45, P79, DOI 10.1016/0198-8859(95)00173-5.;SMITHBURN KC, 1954, J IMMUNOL, V72, P248.;SOLOMON T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003.;SULTANA H, 2009, J IMMUNOL, V183, P650, DOI 10.4049/JIMMUNOL.0900093.;SUMIYOSHI H, 1987, VIROLOGY, V161, P497, DOI 10.1016/0042-6822(87)90144-9.;TAJIMA S, 2010, VIROLOGY, V396, P298, DOI 10.1016/J.VIROL.2009.10.035.;TAKADA K, 2000, ARCH VIROL, V145, P523, DOI 10.1007/S007050050043.;TANAKA M, 1991, TROPICAL MEDICINE, V33, P15.;TANG WF, 2010, INFECT GENET EVOL, V10, P329, DOI 10.1016/J.MEEGID.2009.12.005.;THE CENTER FOR FOOD SECURITY AND PUBLIC HEALTH IOWA STATE UNIVERSITY, JAP ENC JAP B ENC AR.;THOMAS PM, 2002, J VIROL, V76, P1932.;WESTAWAY EG, 1987, ADV VIRUS RES, V33, P45, DOI 10.1016/S0065-3527(08)60316-4.;*WHO, 2006, WKLY EPIDEMIOL REC, V81, P331.","SARKAR, A (REPRINT AUTHOR), ID \& BG HOSP, ICMR VIRUS UNIT, GB-4,1ST FLOOR,57,DR SC BANERJEE RD, KOLKATA 700010, W BENGAL, INDIA.;SARKAR, ARINDAM, CHATTERJEE, SHYAMALENDU, ID \& BG HOSP, ICMR VIRUS UNIT, KOLKATA 700010, W BENGAL, INDIA.;BANIK, AVISHEK, MUKHOPADHYAY, SUBHRA K., UNIV BURDWAN, DEPT MICROBIOL, BURDWAN 713104, W BENGAL, INDIA.;PATHAK, BANI K., ST XAVIERS COLL, DEPT BIOTECHNOL, KOLKATA, W BENGAL, INDIA.","10.1186/1471-2334-13-368","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","368",NA,"DEPARTMENT OF SCIENCE AND TECHNOLOGY (DST), GOVERNMENT OF WEST BENGAL, INDIA [396(SANC.)/ST/P/ST/9G-27/2007]","THIS WORK WAS SUPPORTED BY THE GRANT FROM THE DEPARTMENT OF SCIENCE AND TECHNOLOGY (DST), GOVERNMENT OF WEST BENGAL, INDIA [NO. 396(SANC.)/ST/P/S\&T/9G-27/2007]. THE AUTHORS ARE INDEBTED TO DR. SEKHAR CHAKRABARTI, THE OFFICER-IN-CHARGE, ICMR VIRUS UNIT, FOR ALLOWING THEM TO CARRY OUT THE WORK. WE ALSO GRATEFULLY ACKNOWLEDGE THE HELP WE RECEIVED FROM NIV, PUNE FOR PROVIDING US WITH THE ELISA KIT FOR THE DETECTION OF IGM ANTIBODY TO JAPANESE ENCEPHALITIS VIRUS. THE ENTHUSIASTIC HELP OBTAINED FROM THE PHYSICIANS OF THE DISTRICT HOSPITALS, FOR PROVIDING US THE SAMPLES FROM CLINICALLY SUSPECTED JE/AES FOR THIS STUDY, IS GRATEFULLY ACKNOWLEDGED.",NA,"1471-2334",NA,NA,"BIOMED CENTRAL LTD","13",2013,"ISI000323175300001","54","INFECTIOUS DISEASES","6","INFECTIOUS DISEASES","ARIMICRO.SARKARGMAIL.COM",NA,"201XC",NA,"SARKAR, A (REPRINT AUTHOR), ID \& BG HOSP, ICMR VIRUS UNIT, GB-4,1ST FLOOR,57,DR SC BANERJEE RD, KOLKATA 700010, W BENGAL, INDIA","ISI","ID AND BG HOSP;UNIV BURDWAN;ST XAVIERS COLL","ID AND BG HOSP",NA,"SARKAR A, 2013, BMC INFECT DIS","SARKAR A, 2013, BMC INFECT DIS"
"CHIEN WH, 2013, MOL AUTISM","CHIEN WH;GAU SSF;LIAO HM;CHIU YN;WU YY;HUANG YS;TSAI WC;TSAI HM;CHEN CH","DEEP EXON RESEQUENCING OF DLGAP2 AS A CANDIDATE GENE OF AUTISM SPECTRUM DISORDERS","MOLECULAR AUTISM","MOL. AUTISM","BACKGROUND: WE RECENTLY REPORTED A TERMINAL DELETION OF APPROXIMATELY 2.4 MB AT CHROMOSOME 8P23.2-PTER IN A BOY WITH AUTISM. THE DELETED REGION CONTAINED THE DLGAP2 GENE THAT ENCODES THE NEURONAL POST-SYNAPTIC DENSITY PROTEIN, DISCS, LARGE (DROSOPHILA) HOMOLOG-ASSOCIATED PROTEIN 2. THE STUDY AIMED TO INVESTIGATE WHETHER DLGAP2 IS GENETICALLY ASSOCIATED WITH AUTISM SPECTRUM DISORDERS (ASD) IN GENERAL. METHODS: WE RE-SEQUENCED ALL THE EXONS OF DLGPA2 IN 515 PATIENTS WITH ASD AND 596 CONTROL SUBJECTS FROM TAIWAN. WE ALSO CONDUCTED BIOINFORMATIC ANALYSIS AND FAMILY STUDY OF VARIANTS IDENTIFIED IN THIS STUDY. RESULTS: WE DETECTED NINE COMMON SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS) AND SIXTEEN NOVEL MISSENSE RARE VARIANTS IN THIS SAMPLE. WE FOUND THAT AA HOMOZYGOTES OF RS2906569 (MINOR ALLELE G, ALTERNATE ALLELE A) AT INTRON 1 (P=0.003) AND CC HOMOZYGOTES OF RS2301963 (MINOR ALLELE A, ALTERNATE ALLELE C) AT EXON 3 (P=0.0003) WERE SIGNIFICANTLY OVER-REPRESENTED IN THE PATIENT GROUP COMPARED TO THE CONTROLS. WE ALSO FOUND NO DIFFERENCES IN THE COMBINED FREQUENCY OF RARE MISSENSE VARIANTS BETWEEN THE TWO GROUPS. SOME OF THESE RARE VARIANTS WERE PREDICTED TO HAVE AN IMPACT ON THE FUNCTION OF DLGAP2 USING INFORMATICS ANALYSIS, AND THE FAMILY STUDY REVEALED MOST OF THE RARE MISSENSE MUTATIONS IN PATIENTS WERE INHERITED FROM THEIR UNAFFECTED PARENTS. CONCLUSIONS: WE DETECTED SOME COMMON AND RARE GENETIC VARIANTS OF DLGAP2 THAT MIGHT HAVE IMPLICATION IN THE PATHOGENESIS OF ASD, BUT THEY ALONE MAY NOT BE SUFFICIENT TO LEAD TO CLINICAL PHENOTYPES. WE SUGGEST THAT FURTHER GENETIC OR ENVIRONMENTAL FACTORS IN AFFECTED PATIENTS MAY BE PRESENT AND DETERMINE THE CLINICAL MANIFESTATIONS.","AUTISM SPECTRUM DISORDERS; DLGAP2; COMMON VARIANTS; RARE VARIANTS","PERVASIVE DEVELOPMENTAL DISORDERS; PSYCHOMETRIC PROPERTIES; CHINESE VERSION; POSTSYNAPTIC DENSITY; NOVO MUTATIONS; ABNORMALITIES; IDENTIFICATION; REARRANGEMENTS; SCHIZOPHRENIA; MICRODELETION","ENGLISH","ARTICLE","ARTICLE",20,"ABRAHAMS BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/NRG2346.;ANNEY R, 2012, HUM MOL GENET, V21, P4781, DOI 10.1093/HMG/DDS301.;[ANONYMOUS], 2012, MMWR SURVEILL SUMM, V61, P1.;BENEYTO M, 2006, SYNAPSE, V60, P585, DOI 10.1002/SYN.20329.;BOECKERS TM, 2006, CELL TISSUE RES, V326, P409, DOI 10.1007/S00441-006-0274-5.;BREMER A, 2011, AM J MED GENET B, V156B, P115, DOI 10.1002/AJMG.B.31142.;BUGGE M, 2000, J MED GENET, V37, P858, DOI 10.1136/JMG.37.11.858.;CHAKRABARTI S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/APPI.AJP.162.6.1133.;CHIEN S-FG, 2010, CLIN GENET, V78, P8.;CHIEN WH, 2010, CLIN GENET, V78, P449, DOI 10.1111/J.1399-0004.2010.01395.X.;CHRISTIAN SL, 2008, BIOL PSYCHIAT, V63, P1111, DOI 10.1016/J.BIOPSYCH.2008.01.009.;DE BARTOLOMEIS A, 2004, INT REV NEUROBIOL, V59, P221.;DEN DUNNEN JT, 2001, HUM GENET, V109, P121, DOI 10.1007/S004390100505.;DEVLIN B, 2011, BRAIN RES, V1380, P78, DOI 10.1016/J.BRAINRES.2010.11.026.;FOMBONNE E, 2003, J AUTISM DEV DISORD, V33, P365, DOI 10.1023/A:1025054610557.;GAU SSF, 2013, RES AUTISM SPECT DIS, V7, P349, DOI 10.1016/J.RASD.2012.10.004.;GAU SSF, 2011, RES AUTISM SPECT DIS, V5, P809, DOI 10.1016/J.RASD.2010.09.010.;GIRIRAJAN S, 2010, NAT GENET, V42, P203, DOI 10.1038/NG.534.;GOLDSTEIN DB, 2003, COLD SPRING HARB SYM, V68, P395, DOI 10.1101/SQB.2003.68.395.;JACQUEMONT ML, 2006, J MED GENET, V43, P843, DOI 10.1136/JMG.2006.043166.;KRISTIANSEN LV, 2005, SCHIZOPHR RES, V78, P87, DOI 10.1016/J.SCHRES.2005.06.012.;KUMAR RA, 2010, CLIN GENET.;KUMAR RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/HMG/DDM376.;LAU WYP, 2013, RES DEV DISABIL, V34, P294, DOI 10.1016/J.RIDD.2012.08.005.;MARSHALL CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/J.AJHG.2007.12.009.;MARTIN CHRISTA LESE, 2007, CURR PSYCHIATRY REP, V9, P141.;NEALE BM, 2012, NATURE, V485, P242, DOI 10.1038/NATURE11011.;O'ROAK BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/NG.835.;OZGEN HM, 2009, CLIN GENET, V76, P348, DOI 10.1111/J.1399-0004.2009.01254.X.;RANTA S, 2000, EUR J HUM GENET, V8, P381, DOI 10.1038/SJ.EJHG.5200440.;REDDY KAVITA S, 2005, BMC MED GENET, V6, P3, DOI 10.1186/1471-2350-6-3.;SCHAAF CP, 2011, HUM MOL GENET, V20, P3366, DOI 10.1093/HMG/DDR243.;SEBAT J, 2007, SCIENCE, V316, P445, DOI 10.1126/SCIENCE.1138659.;SHI YY, 2005, CELL RES, V15, P97, DOI 10.1038/SJ.CR.7290272.;STOREY JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/PNAS.1530509100.;VAAGS AK, 2012, AM J HUM GENET, V90, P133, DOI 10.1016/J.AJHG.2011.11.025.;VEENSTRA-VANDERWEELE J, 2004, MOL PSYCHIATR, V9, P819, DOI 10.1038/SJ.MP.4001505.;VORSTMAN JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/SJ.MP.4001757.;WEISS LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMOA075974.;WU K, 2013, PSYCHIAT RES-NEUROIM, V211, P214, DOI 10.1016/J.PSCYCHRESNS.2012.07.003.","GAU, SSF (REPRINT AUTHOR), NATL TAIWAN UNIV HOSP, DEPT PSYCHIAT, 7 CHUNG SHAN SOUTH RD, TAIPEI 10002, TAIWAN.;CHIEN, WEI-HSIEN, FU JEN CATHOLIC UNIV, DEPT OCCUPAT THERAPY, COLL MED, NEW TAIPEI CITY, TAIWAN.;GAU, SUSAN SHUR-FEN, LIAO, HSIAO-MEI, CHIU, YEN-NAN, TSAI, WEN-CHE, CHEN, CHIA-HSIANG, NATL TAIWAN UNIV HOSP, DEPT PSYCHIAT, TAIPEI 10002, TAIWAN.;GAU, SUSAN SHUR-FEN, LIAO, HSIAO-MEI, CHIU, YEN-NAN, TSAI, WEN-CHE, CHEN, CHIA-HSIANG, COLL MED, TAIPEI 10002, TAIWAN.;GAU, SUSAN SHUR-FEN, NATL TAIWAN UNIV, DEPT PSYCHOL, SCH OCCUPAT THERAPY, GRAD INST BRAIN \& MIND SCI, TAIPEI 10764, TAIWAN.;GAU, SUSAN SHUR-FEN, NATL TAIWAN UNIV, GRAD INST EPIDEMIOL \& PREVENT MED, TAIPEI 10764, TAIWAN.;WU, YU-YU, HUANG, YU-SHU, CHEN, CHIA-HSIANG, CHANG GUNG UNIV, COLL MED, CHANG GUNG MEM HOSP, DEPT PSYCHIAT,LINKOU MED CTR, TAO YUAN, TAIWAN.;TSAI, HO-MIN, CHEN, CHIA-HSIANG, TZU CHI UNIV, INST MED SCI, HUALIEN, TAIWAN.","10.1186/2040-2392-4-26","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","26",NA,"NATIONAL SCIENCE COUNCIL [NSC96-3112-B-002-033, NSC97-3112-B-002-009, NSC98-3112-B-002-004, NSC99-3112-B-002-036], NATIONAL TAIWAN UNIVERSITY [10R81918-03101R892103, 102R892103], NATIONAL HEALTH RESEARCH INSTITUTES, TAIWAN","THIS WORK WAS SUPPORTED BY GRANTS FROM NATIONAL SCIENCE COUNCIL (NSC96-3112-B-002-033, NSC97-3112-B-002-009, NSC98-3112-B-002-004, AND NSC99-3112-B-002-036 TO SS GAU), NATIONAL TAIWAN UNIVERSITY (AIM FOR TOP UNIVERSITY EXCELLENT RESEARCH PROJECT: 10R81918-03101R892103, 102R892103 TO SS GAU), AND AN INTRAMURAL GRANT FROM NATIONAL HEALTH RESEARCH INSTITUTES (TO CH CHEN), TAIWAN.",NA,"2040-2392",NA,NA,"BIOMED CENTRAL LTD","4",2013,"ISI000327199800001","40","GENETICS \& HEREDITY, NEUROSCIENCES \& NEUROLOGY","4","GENETICS \& HEREDITY, NEUROSCIENCES","GAUSHUFENTU.EDU.TW CCHEN3801GMAIL.COM",NA,"254WM",NA,"GAU, SSF (REPRINT AUTHOR), NATL TAIWAN UNIV HOSP, DEPT PSYCHIAT, 7 CHUNG SHAN SOUTH RD, TAIPEI 10002, TAIWAN","ISI","FU JEN CATHOLIC UNIV;NATL TAIWAN UNIV HOSP;COLL MED;NATL TAIWAN UNIV;NATL TAIWAN UNIV;CHANG GUNG UNIV;TZU CHI UNIV","NATL TAIWAN UNIV HOSP",NA,"CHIEN WH, 2013, MOL AUTISM","CHIEN WH, 2013, MOL AUTISM"
"LAM TTY, 2013, INFECT GENET EVOL","LAM TTY;CHONG YL;SHI M;HON CC;LI J;MARTIN DP;TANG JWT;MOK CK;SHIH SR;YIP CW;JIANG J;HUI RKH;PYBUS OG;HOLMES EC;LEUNG FCC","SYSTEMATIC PHYLOGENETIC ANALYSIS OF INFLUENZA A VIRUS REVEALS MANY NOVEL MOSAIC GENOME SEGMENTS","INFECTION GENETICS AND EVOLUTION","INFECT. GENET. EVOL.","RECOMBINATION PLAYS AN IMPORTANT ROLE IN SHAPING THE GENETIC DIVERSITY OF A NUMBER OF DNA AND RNA VIRUSES. ALTHOUGH SOME RECENT STUDIES HAVE REPORTED BIOINFORMATIC EVIDENCE OF MOSAIC SEQUENCES IN A VARIETY OF INFLUENZA A VIRUSES, IT REMAINS CONTROVERSIAL AS TO WHETHER THESE REPRESENT BONA FIDE NATURAL RECOMBINATION EVENTS OR LABORATORY ARTIFACTS. IMPORTANTLY, MOSAIC GENOME STRUCTURES CAN CREATE SIGNIFICANT TOPOLOGICAL INCONGRUENCE DURING PHYLOGENETIC ANALYSES, WHICH CAN MISLEAD ADDITIONAL PHYLOGENY-BASED MOLECULAR EVOLUTIONARY ANALYSES SUCH AS MOLECULAR CLOCK DATING, THE DETECTION OF SELECTION PRESSURES AND PHYLOGEOGRAPHIC INFERENCE. AS A RESULT, THERE IS A STRONG NEED FOR SYSTEMATIC SCREENINGS FOR MOSAIC STRUCTURES WITHIN THE INFLUENZA VIRUS GENOME DATABASE. WE USED A COMBINATION OF SEQUENCE-BASED AND PHYLOGENY-BASED METHODS TO IDENTIFY 388 MOSAIC INFLUENZA GENOMIC SEGMENTS, OF WHICH 332 ARE PREVIOUSLY UNREPORTED AND ARE SIGNIFICANTLY SUPPORTED BY PHYLOGENETIC METHODS. IT IS IMPOSSIBLE, HOWEVER, TO ASCERTAIN WHETHER THESE REPRESENT NATURAL RECOMBINANTS. TO FACILITATE THE FUTURE IDENTIFICATION OF RECOMBINANTS, REFERENCE SETS OF NON-RECOMBINANT SEQUENCES WERE SELECTED FOR USE IN AN AUTOMATIC SCREENING PROTOCOL FOR DETECTING MOSAIC SEQUENCES. TESTS USING REAL AND SIMULATED MOSAIC SEQUENCES INDICATE THAT OUR SCREENING PROTOCOL IS BOTH SENSITIVE (AVERAGE >90\%) AND ACCURATE (AVERAGE >77\%) ENOUGH TO IDENTIFY A RANGE OF DIFFERENT MOSAIC PATTERNS. THE RELATIVELY HIGH PREVALENCE OF MOSAIC INFLUENZA VIRUS SEQUENCES IMPLIES THAT EFFICIENT SYSTEMATIC SCREENS, SUCH AS THAT PROPOSED HERE, SHOULD BE PERFORMED ROUTINELY TO DETECT NATURAL RECOMBINANT STRAINS, POTENTIAL LABORATORY ARTIFACTS, AND SEQUENCING CONTAMINANTS EITHER PRIOR TO SEQUENCES BEING DEPOSITED IN GENBANK OR BEFORE THEY ARE USED FOR PHYLOGENETIC ANALYSES. (C) 2013 ELSEVIER B.V. ALL RIGHTS RESERVED.","INFLUENZA A VIRUS; MOSAIC PATTERN; RECOMBINATION; MOSAIC SCREENING PROTOCOL","PCR-MEDIATED RECOMBINATION; SOUTHERN CHINA; DNA-SEQUENCES; RNA VIRUSES; HOMOLOGOUS RECOMBINATION; POSITIVE SELECTION; MOLECULAR CLOCK; H5N1; EVOLUTION; GENE","ENGLISH","ARTICLE","ARTICLE",19,"ANISIMOVA M, 2003, GENETICS, V164, P1229.;BAO YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07.;BONI MF, 2008, J VIROL, V82, P4807, DOI 10.1128/JVI.02683-07.;BONI MF, 2007, GENETICS, V176, P1035, DOI 10.1534/GENETICS.106.068874.;BONI MF, 2012, GENE, V494, P242, DOI 10.1016/J.GENE.2011.10.041.;BONI MF, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0010434.;BROWN I.H., 1998, J GEN VIROL, V79.;CAUTHEN AN, 2000, J VIROL, V74, P6592, DOI 10.1128/JVI.74.14.6592-6599.2000.;CHARE ELIZABETH R., 2003, JOURNAL OF GENERAL VIROLOGY, V84, P2691, DOI 10.1099/VIR.0.19277-0.;CHEN H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/PNAS.0403212101.;CHEN RB, 2006, MOL BIOL EVOL, V23, P2336, DOI 10.1093/MOLBEV/MSL102.;DE SILVA A, 2004, LANCET, V364, P500, DOI 10.1016/S0140-6736(04)16802-5.;DUGAN VG, 2008, PLOS PATHOG, V4, DOI 10.1371/JOURNAL.PPAT.1000076.;EDGAR RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113.;EMERSON BC, 2001, TRENDS ECOL EVOL, V16, P707, DOI 10.1016/S0169-5347(01)02305-9.;GALLI A, 2008, J GEN VIROL, V89, P3119, DOI 10.1099/VIR.0.2008/003418-0.;GHEDIN E, 2009, J VIROL, V83, P8832, DOI 10.1128/JVI.00773-09.;GUAN Y, 2002, VIROLOGY, V292, P16, DOI 10.1006/VIRO.2001.1207.;GUINDON S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520.;HE CQ, 2008, VIROLOGY, V380, P12, DOI 10.1016/J.VIROL.2008.07.014.;HE CQ, 2009, MOL BIOL EVOL, V26, P177, DOI 10.1093/MOLBEV/MSN238.;HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163.;HOFFMANN E, 2000, J VIROL, V74, P6309, DOI 10.1128/JVI.74.14.6309-6315.2000.;HOLMES EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A026121.;JENKINS GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/S00239-001-0064-3.;JUDO MSB, 1998, NUCLEIC ACIDS RES, V26, P1819, DOI 10.1093/NAR/26.7.1819.;KOU Z, 2005, J VIROL, V79, P15460, DOI 10.1128/JVI.79.24.15460-15466.2005.;KRASNITZ M, 2008, J VIROL, V82, P8947, DOI 10.1128/JVI.00101-08.;LAM TY, 2008, VIRUS RES, V131, P271, DOI 10.1016/J.VIRUSRES.2007.08.012.;LI CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/J.VIROL.2005.06.025.;LIU JH, 2003, VIRUS GENES, V27, P197, DOI 10.1023/A:1025736829103.;LOLE KS, 1999, J VIROL, V73, P152.;MARTIN D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/BIOINFORMATICS/16.6.562.;MARTIN DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/BIOINFORMATICS/BTH490.;MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/NAR/18.7.1687.;PADIDAM M, 1999, VIROLOGY, V265, P218, DOI 10.1006/VIRO.1999.0056.;PARRISH CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/ANNUREV.MICRO.59.030804.121059.;POON AFY, 2009, METHODS MOL BIOL, V537, P163, DOI 10.1007/978-1-59745-251-9\_8.;POSADA D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/PNAS.241370698.;POSADA D, 2002, ANNU REV GENET, V36, P75, DOI 10.1146/ANNUREV.GENET.36.040202.111115.;POSADA D, 2001, MOL BIOL EVOL, V18, P1976, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A003738.;SCHEFFLER K, 2006, BIOINFORMATICS, V22, P2493, DOI 10.1093/BIOINFORMATICS/BTL427.;SCHIERUP MH, 2000, GENETICS, V156, P879.;SCHIERUP MH, 2000, MOL BIOL EVOL, V17, P1578, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A026256.;SHAFIKHANI S, 2002, ENVIRON MICROBIOL, V4, P482, DOI 10.1046/J.1462-2920.2002.00326.X.;SHIMODAIRA H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A026201.;SHRINER D, 2003, GENET RES, V81, P115, DOI 10.1017/S0016672303006128.;SIMON-LORIERE E., 2009, PLOS PATHOG, V5.;SIMON-LORIERE E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/NRMICRO2614.;SMITH GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/PNAS.0608157103.;SMITH JM, 1992, J MOL EVOL, V34, P126.;SWOFFORD DL, 2003, PAUP PHYLOGENETIC AN.;WEBSTER RG, 1992, MICROBIOL REV, V56, P152.;WOROBEY M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535.;WOROBEY MICHAEL, 2002, SCIENCE, V296, P211.;XU KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07.","LAM, TTY (REPRINT AUTHOR), UNIV OXFORD, DEPT ZOOL, S PARKS RD, OXFORD OX1 3PS, ENGLAND.;LAM, TOMMY TSAN-YUK, PYBUS, OLIVER G., UNIV OXFORD, DEPT ZOOL, OXFORD OX1 3PS, ENGLAND.;CHONG, YEE LING, UNIV MALAYSIA SARAWAK, FAC RESOURCE SCI \& TECHNOL, DEPT ZOOL, SARAWAK, MALAYSIA.;SHI, MANG, HOLMES, EDWARD C., UNIV SYDNEY, SCH BIOL SCI, SYDNEY EMERGING INFECT \& BIOSECUR INST, SYDNEY, NSW 2006, AUSTRALIA.;SHI, MANG, HOLMES, EDWARD C., UNIV SYDNEY, SYDNEY MED SCH, SYDNEY, NSW 2006, AUSTRALIA.;HON, CHUNG-CHAU, INST PASTEUR, UNITE BIOL CELLULAIRE PARASITISME, DEPT BIOL CELLULAIRE \& INFECT, F-75015 PARIS, FRANCE.;LI, JUN, YIP, CHI-WAI, JIANG, JINGWEI, HUI, RAYMOND KIN-HEI, LEUNG, FREDERICK CHI-CHING, UNIV HONG KONG, SCH BIOL SCI, HONG KONG, HONG KONG, PEOPLES R CHINA.;MARTIN, DARREN P., UNIV CAPE TOWN, INST INFECT DIS \& MOL MED, COMPUTAT BIOL GRP, ZA-7925 CAPE TOWN, SOUTH AFRICA.;TANG, JULIAN WEI-TZE, UNIV ALBERTA, DEPT MED MICROBIOL \& IMMUNOL, EDMONTON, AB T6G 2M7, CANADA.;MOK, CHEE-KENG, SHIH, SHIN-RU, CHANG GUNG UNIV, RES CTR EMERGING VIRAL INFECT, TAO YUAN, TAIWAN.;HOLMES, EDWARD C., NIH, FOGARTY INT CTR, BETHESDA, MD 20892 USA.","10.1016/J.MEEGID.2013.03.015","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"NEWTON INTERNATIONAL FELLOWSHIP OF ROYAL SOCIETY, UK","WE GRATEFULLY THANK THE SCIENTISTS WHO CONTRIBUTED TO THE INFLUENZA GENOME SEQUENCING PROJECTS AND SHARED THEIR SEQUENCES. WE ACKNOWLEDGE THE SUPPORT OF HPCPOWER PROJECTS FOR PROVIDING COMPUTATIONAL SERVICE FROM COMPUTER CENTRE IN THE UNIVERSITY OF HONG KONG. WE ALSO THANK W.K.KWAN AND FRANKIE CHEUNG (CC, HKU) FOR THEIR TECHNICAL ASSISTANCE. THIS STUDY WAS GREATLY BENEFITED FROM DISCUSSIONS THAT TOOK PLACE AT THE `WORKSHOP ON PHYLOGENETICS FOR INFECTIOUS DISEASES - WITH A FOCUS ON DNA VIRUSES' (10-14 OCTOBER 2011) HOSTED BY THE INSTITUTE OF MATHEMATICAL SCIENCES, NATIONAL UNIVERSITY OF SINGAPORE. TILL IS SUPPORTED BY NEWTON INTERNATIONAL FELLOWSHIP OF ROYAL SOCIETY, UK.",NA,"1567-1348",NA,"367-378","ELSEVIER SCIENCE BV","18",2013,"ISI000324660900048","56","INFECTIOUS DISEASES","7","INFECTIOUS DISEASES","TYLAM.TOMMYGMAIL.COM",NA,"221LR",NA,"LAM, TTY (REPRINT AUTHOR), UNIV OXFORD, DEPT ZOOL, S PARKS RD, OXFORD OX1 3PS, ENGLAND","ISI","UNIV OXFORD;UNIV MALAYSIA SARAWAK;UNIV SYDNEY;UNIV SYDNEY;INST PASTEUR;UNIV HONG KONG;UNIV CAPE TOWN;UNIV ALBERTA;CHANG GUNG UNIV;FOGARTY INT CTR","UNIV OXFORD",NA,"LAM TTY, 2013, INFECT GENET EVOL","LAM TTY, 2013, INFECT GENET EVOL"
"CHEN Y, 2013, INVEST OPHTHALMOL VIS SCI","CHEN Y;ZHANG Q;SHEN T;XIAO X;LI S;GUAN L;ZHANG J;ZHU Z;YIN Y;WANG P;GUO X;WANG J;ZHANG Q","COMPREHENSIVE MUTATION ANALYSIS BY WHOLE-EXOME SEQUENCING IN 41 CHINESE FAMILIES WITH LEBER CONGENITAL AMAUROSIS","INVESTIGATIVE OPHTHALMOLOGY \& VISUAL SCIENCE","INVEST. OPHTHALMOL. VIS. SCI.","PURPOSE. LEBER CONGENITAL AMAUROSIS (LCA) IS A GENETICALLY HETEROGENEOUS DISEASE WITH, TO DATE, 19 IDENTIFIED CAUSATIVE GENES. OUR AIM WAS TO EVALUATE THE MUTATIONS IN ALL 19 GENES IN CHINESE FAMILIES WITH LCA. METHODS. LCA PATIENTS FROM 41 UNRELATED CHINESE FAMILIES WERE ENROLLED, INCLUDING 25 PREVIOUSLY UNANALYZED FAMILIES AND 16 FAMILIES SCREENED PREVIOUSLY BY SANGER SEQUENCING, BUT WITH NO IDENTIFIED MUTATIONS. GENETIC VARIATIONS WERE SCREENED BY WHOLE-EXOME SEQUENCING AND THEN VALIDATED USING SANGER SEQUENCING. RESULTS. A TOTAL OF 41 VARIANTS PREDICTED TO AFFECT PROTEIN CODING OR SPLICING WAS DETECTED BY WHOLE-EXOME SEQUENCING, AND 40 WERE CONFIRMED BY SANGER SEQUENCING. BIOINFORMATIC AND SEGREGATION ANALYSES REVEALED 22 POTENTIALLY PATHOGENIC VARIANTS (17 NOVEL) IN 15 PROBANDS, COMPRISED OF 3 OF 16 PREVIOUSLY ANALYZED FAMILIES AND 12 OF 25 (48\%) PREVIOUSLY UNANALYZED FAMILIES. IN THE LATTER 12 FAMILIES, MUTATIONS WERE FOUND IN CEP290 (THREE PROBANDS), GUCY2D (TWO PROBANDS), AND CRB1, CRX, RPE65, IQCB1, LCA5, TULP1, AND IMPDH1 (ONE PROBAND EACH). BASED ON THE RESULTS FROM 87 PREVIOUSLY ANALYZED PROBANDS AND 25 NEW CASES, GUCY2D, CRB1, RPGRIP1, CEP290, AND CRX WERE THE FIVE MOST FREQUENTLY MUTATED GENES, WHICH WAS SIMILAR TO THE RESULTS FROM STUDIES IN CAUCASIAN SUBJECTS. CONCLUSIONS. WHOLE-EXOME SEQUENCING DETECTED MUTATIONS IN THE 19 KNOWN LCA GENES IN APPROXIMATELY HALF OF CHINESE FAMILIES WITH LCA. THESE RESULTS, TOGETHER WITH OUR PREVIOUS RESULTS, DEMONSTRATE THE SPECTRUM AND FREQUENCY OF MUTATIONS OF THE 19 GENES RESPONSIBLE FOR LCA IN HAN CHINESE INDIVIDUALS. WHOLE-EXOME SEQUENCING IS AN EFFICIENT METHOD FOR DETECTING MUTATIONS IN HIGHLY HETEROGENEOUS HEREDITARY DISEASES.","LEBER CONGENITAL AMAUROSIS; EXOME SEQUENCING; MUTATION SCREENING; GENOTYPE-PHENOTYPE; CHINESE","RETINITIS-PIGMENTOSA; RETINAL DEGENERATION; MOLECULAR DIAGNOSIS; CRB1 GENE; PHENOTYPE; ALIGNMENT; MODIFIER; ALLELES; PROTEIN; MODEL","ENGLISH","ARTICLE","ARTICLE",35,"AHMED EDNAN, 2008, SEMIN OPHTHALMOL, V23, P39, DOI 10.1080/08820530701745215.;ALDAHMESH MA, 2010, MOL VIS, V16, P207.;BADANO JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/HMG/DDG188.;BOWNE SJ, 2006, INVEST OPHTH VIS SCI, V47, P34.;COPPIETERS F, 2012, GENET MED, V14, P576, DOI 10.1038/GIM.2011.51.;DEN HOLLANDER AI, 2001, AM J HUM GENET, V69, P198.;DEN HOLLANDER AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/J.PRETEYERES.2008.05.003.;DEN HOLLANDER AI, 2007, NAT GENET, V39, P889, DOI 10.1038/NG2066.;DEN HOLLANDER AI, 2007, ARCH OPHTHALMOL-CHIC, V125, P932, DOI 10.1001/ARCHOPHT.125.7.932.;DRYJA TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113.;ESTRADA-CUZCANO A, 2011, INVEST OPHTH VIS SCI, V52, P834, DOI 10.1167/IOVS.10-5221.;FALK MJ, 2012, NAT GENET, V44, P1040, DOI 10.1038/NG.2361.;FLANAGAN SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/GTMB.2010.0036.;FRANCESCHETTI A, 1954, CONFIN NEUROL, V14, P184.;FREUND CL, 1998, NAT GENET, V18, P311, DOI 10.1038/NG0498-311.;FRIEDMAN JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021.;HANEIN S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/HUMU.20010.;HENDERSON RH, 2009, MOL VIS, V15, P2442.;KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/SCIENCE.8202715.;KHANNA H, 2009, NAT GENET, V41, P739, DOI 10.1038/NG.366.;KOENEKOOP RK, 2004, SURV OPHTHALMOL, V49, P379, DOI 10.1016/J.SURVOPHTHAL.2004.04.003.;LI L, 2011, MOL VIS, V17, P3326.;LI L, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0019458.;LI RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/BIOINFORMATICS/BTN025.;LI RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/BIOINFORMATICS/BTP336.;LI RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/GR.088013.108.;LI YR, 2010, NAT GENET, V42, P969, DOI 10.1038/NG.680.;LI YM, 2009, INVEST OPHTH VIS SCI, V50, P1336, DOI 10.1167/IOVS.08-2589.;LIU LB, 2007, DNA CELL BIOL, V26, P477, DOI 10.1089/DNA.2007.0583.;LOTERY AJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P415, DOI 10.1001/ARCHOPHT.119.3.415.;MARLHENS F, 1997, NAT GENET, V17, P139, DOI 10.1038/NG1097-139.;PERRAULT I, 2004, AM J HUM GENET, V75, P639, DOI 10.1086/424889.;PERRAULT I, 1996, NAT GENET, V14, P461, DOI 10.1038/NG1296-461.;POMARES E, 2010, EUR J HUM GENET, V18, P118, DOI 10.1038/EJHG.2009.114.;SCHAPPERT-KIMMIJSER J, 1959, AMA ARCH OPHTHALMOL, V61, P211.;SENECHAL A, 2006, AM J OPHTHALMOL, V142, P702, DOI 10.1016/J.AJO.2006.04.057.;SERGOUNIOTIS PI, 2011, AM J HUM GENET, V89, P183, DOI 10.1016/J.AJHG.2011.06.002.;SIEPEL A, 2004, MOL BIOL EVOL, V21, P468, DOI 10.1093/MOLBEV/MSH039.;SINGLETON AB, 2011, LANCET NEUROL, V10, P942, DOI 10.1016/S1474-4422(11)70196-X.;SOHOCKI MM, 2000, NAT GENET, V24, P79.;SOHOCKI MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO,2-K.;STONE EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/J.AJO.2007.08.022.;WANG H, 2009, AM J HUM GENET, V84, P380, DOI 10.1016/J.AJHG.2009.02.005.;WANG Q, 2010, MOL VIS, V16, P303.;XU F, 2012, MOL VIS, V18, P744.;ZERNANT J, 2005, INVEST OPHTH VIS SCI, V46, P3052, DOI 10.1167/IOVS.05-0111.","ZHANG, QJ (REPRINT AUTHOR), SUN YAT SEN UNIV, ZHONGSHAN OPHTHALM CTR, STATE KEY LAB OPHTHALMOL, 54 XIANLIE RD, GUANGZHOU 510060, GUANGDONG, PEOPLES R CHINA.;CHEN, YABIN, SHEN, TAO, XIAO, XUESHAN, LI, SHIQIANG, WANG, PANFENG, GUO, XIANGMING, ZHANG, QINGJIONG, SUN YAT SEN UNIV, ZHONGSHAN OPHTHALM CTR, STATE KEY LAB OPHTHALMOL, GUANGZHOU 510060, GUANGDONG, PEOPLES R CHINA.;ZHANG, QINGYAN, GUAN, LIPING, ZHANG, JIANGUO, ZHU, ZHIHONG, YIN, YE, WANG, JUN, BGI SHENZHEN, SHENZHEN, PEOPLES R CHINA.","10.1167/IOVS.13-11606","12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA",NA,NA,"NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA [81170881, U1201221], GUANGDONG TRANSLATIONAL MEDICINE PUBLIC PLATFORM [4202037], ``985 PROJECT'' OF SUN YAT-SEN UNIVERSITY, FUNDAMENTAL RESEARCH FUNDS OF THE STATE KEY LABORATORY OF OPHTHALMOLOGY","SUPPORTED BY THE NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA (81170881, U1201221), GUANGDONG TRANSLATIONAL MEDICINE PUBLIC PLATFORM (4202037), THE ``985 PROJECT'' OF SUN YAT-SEN UNIVERSITY, AND THE FUNDAMENTAL RESEARCH FUNDS OF THE STATE KEY LABORATORY OF OPHTHALMOLOGY.",NA,"0146-0404","6","4351-4357","ASSOC RESEARCH VISION OPHTHALMOLOGY INC","54",2013,"ISI000321120700069","46","OPHTHALMOLOGY","6","OPHTHALMOLOGY","QINGJIONGZHANGYAHOO.COM",NA,"173YW",NA,"ZHANG, QJ (REPRINT AUTHOR), SUN YAT SEN UNIV, ZHONGSHAN OPHTHALM CTR, STATE KEY LAB OPHTHALMOL, 54 XIANLIE RD, GUANGZHOU 510060, GUANGDONG, PEOPLES R CHINA","ISI","SUN YAT SEN UNIV","SUN YAT SEN UNIV",NA,"CHEN Y, 2013, INVEST OPHTHALMOL VIS SCI","CHEN Y, 2013, INVEST OPHTHALMOL VIS SCI"
"MULINGE M, 2013, PLOS ONE","MULINGE M;LEMAIRE M;SERVAIS JY;RYBICKI A;STRUCK D;DA SILVA ES;VERHOFSTEDE C;LIE Y;SEGUIN DEVAUX C;SCHMIT JC;BERCOFF DP","HIV-1 TROPISM DETERMINATION USING A PHENOTYPIC ENV RECOMBINANT VIRAL ASSAY HIGHLIGHTS OVERESTIMATION OF CXCR4-USAGE BY GENOTYPIC PREDICTION ALGORITHMS FOR CRRF01\_AE AND CRF02\_AG","PLOS ONE","PLOS ONE","BACKGROUND: HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HIV) ENTRY INTO TARGET CELLS INVOLVES BINDING OF THE VIRAL ENVELOPE (ENV) TO CD4 AND A CORECEPTOR, MAINLY CCR5 OR CXCR4. THE ONLY CURRENTLY LICENSED HIV ENTRY INHIBITOR, MARAVIROC, TARGETS CCR5, AND THE PRESENCE OF CXCX4-USING STRAINS MUST BE EXCLUDED PRIOR TO TREATMENT. CO-RECEPTOR USAGE CAN BE ASSESSED BY PHENOTYPIC ASSAYS OR THROUGH GENOTYPIC PREDICTION. HERE WE COMPARED THE PERFORMANCE OF A PHENOTYPIC ENV-RECOMBINANT VIRAL ASSAY (RVA) TO THE TWO MOST WIDELY USED GENOTYPIC PREDICTION ALGORITHMS, GENO2PHENO([CORECEPTOR]) AND WEBPSSM. METHODS: CO-RECEPTOR TROPISM OF SAMPLES FROM 73 SUBTYPE B AND 219 NON-B INFECTIONS WAS MEASURED PHENOTYPICALLY USING A LUCIFERASE-TAGGED, NL4-3-BASED, RVA TARGETING ENV. IN PARALLEL, TROPISM WAS INFERRED GENOTYPICALLY FROM THE CORRESPONDING V3-LOOP SEQUENCES USING GENO2PHENO([CORECEPTOR]) (5-20\% FPR) AND WEBPSSM-R5X4. FOR DISCORDANT SAMPLES, PHENOTYPIC OUTCOME WAS RETESTED USING CO-RECEPTOR ANTAGONISTS OR THE VALIDATED TROFILE (R) ENHANCED-SENSITIVITY-TROPISM-ASSAY. RESULTS: THE LOWER DETECTION LIMIT OF THE RVA WAS 2.5\% AND 5\% FOR X4 AND R5 MINORITY VARIANTS RESPECTIVELY. A PHENOTYPE/GENOTYPE RESULT WAS OBTAINED FOR 210 SAMPLES. OVERALL, CONCORDANCE OF PHENOTYPIC RESULTS WITH GENO2PHENO([CORECEPTOR]) WAS 85.2\% AND CONCORDANCE WITH WEBPSSM WAS 79.5\%. FOR SUBTYPE B, CONCORDANCE WITH GENO2PHENO([CORECEPTOR]) WAS 94.4\% AND CONCORDANCE WITH WEBPSSM WAS 79.6\%. HIGH CONCORDANCE OF GENOTYPIC TOOLS WITH PHENOTYPIC OUTCOME WAS SEEN FOR SUBTYPE C (90\% FOR BOTH TOOLS). MAIN DISCORDANCES INVOLVED CRF01\_AE AND CRF02\_AG FOR BOTH ALGORITHMS (CRF01\_AE: 35.9\% DISCORDANCES WITH GENO2PHENO([CORECEPTOR]) AND 28.2\% WITH WEBPSSM, CRF02\_AG: 20.7\% FOR BOTH ALGORITHMS). GENOTYPIC PREDICTION OVERESTIMATED CXCR4-USAGE FOR BOTH CRFS. FOR WEBPSSM, 40\% DISCORDANCE WAS OBSERVED FOR SUBTYPE A. CONCLUSIONS: PHENOTYPIC ASSAYS REMAIN THE MOST ACCURATE FOR MOST NON-B SUBTYPES AND NEW SUBTYPE-SPECIFIC RULES SHOULD BE DEVELOPED FOR NON-B SUBTYPES, AS RESEARCH STUDIES MORE AND MORE DRAW CONCLUSIONS FROM GENOTYPICALLY-INFERRED TROPISM, AND TO AVOID UNNECESSARILY PRECLUDING PATIENTS WITH LIMITED TREATMENT OPTIONS FROM RECEIVING MARAVIROC OR OTHER ENTRY INHIBITORS.",NA,"IMMUNODEFICIENCY-VIRUS TYPE-1; N-LINKED GLYCOSYLATION; T-CELL-LINE; CORECEPTOR USAGE; V3 LOOP; BIOINFORMATIC TOOLS; CHEMOKINE RECEPTORS; CCR5 ANTAGONISTS; DRUG-RESISTANCE; INFECTION","ENGLISH","ARTICLE","ARTICLE",24,"ALKHATIB G, 1996, SCIENCE, V272, P1955, DOI 10.1126/SCIENCE.272.5270.1955.;ASBOE D, 2012, HIV MED, V13, P1, DOI 10.1111/J.1468-1293.2011.00971.X.;BAATZ F, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0021535.;BATRA M, 2000, AIDS RES HUM RETROV, V16, P973, DOI 10.1089/08892220050058399.;BEERENWINKEL N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/NAR/GKG575.;BERGER EA, 1998, NATURE, V391, P240, DOI 10.1038/34571.;BJORNDAL A, 1997, J VIROL, V71, P7478.;BLAAK H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/PNAS.97.3.1269.;BRATT G, 1998, AIDS, V12, P2193, DOI 10.1097/00002030-199816000-00015.;CARDOZO T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/AID.2006.0130.;CHAKRABARTI AYAN K, 2009, AIDS RES THER, V6, P20, DOI 10.1186/1742-6405-6-20.;CHALMET K, 2011, J INFECT DIS.;CHOE H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6.;CHUECA N, 2009, J MED VIROL, V81, P763, DOI 10.1002/JMV.21425.;CLEVESTIG P, 2005, AIDS RES HUM RETROV, V21, P371, DOI 10.1089/AID.2005.21.371.;CONNOR RI, 1997, J EXP MED, V185, P621, DOI 10.1084/JEM.185.4.621.;DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763A0.;DE MENDOZA C, 2008, JAIDS-J ACQ IMM DEF, V48, P241, DOI 10.1097/QAI.0B013E3181734F0E.;DE OLIVEIRA T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/BIOINFORMATICS/BTI607.;DELGADO E, 2012, J ANTIMICROB CHEMOTH, V67, P25, DOI 10.1093/JAC/DKR438.;DELOBEL P, 2007, J CLIN MICROBIOL, V45, P1572, DOI 10.1128/JCM.02090-06.;DENG HK, 1996, NATURE, V381, P661, DOI 10.1038/381661A0.;DRAGIC T, 1996, NATURE, V381, P667, DOI 10.1038/381667A0.;ESBJORNSSON J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23.;FATKENHEUER G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMOA0803154.;FENG Y, 1996, SCIENCE, V272, P872, DOI 10.1126/SCIENCE.272.5263.872.;FENYO EM, 2011, J INTERN MED, V270, P520, DOI 10.1111/J.1365-2796.2011.02455.X.;GARRIDO C, 2008, J CLIN MICROBIOL, V46, P887, DOI 10.1128/JCM.01611-07.;GONZALEZ N, 2010, J ANTIMICROB CHEMOTH, V65, P2493, DOI 10.1093/JAC/DKQ379.;GULICK RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMOA0803152.;HARRIGAN PR, 2011, AIDS, V25, P257, DOI 10.1097/QAD.0B013E32834113F9.;HARTLEY O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/AID.2005.21.171.;HOFFMAN NG, 2002, J VIROL, V76, P3852, DOI 10.1128/JVI.76.8.3852-3864.2002.;HUANG CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/SCIENCE.1118398.;RODRIGUEZ JJ, 2011, ENFERM INFEC MICR CL, V29, P4, DOI 10.1016/J.EIMC.2010.08.013.;JENSEN MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003.;KUHMANN SE, 2008, ANNU REV PHARMACOL, V48, P425, DOI 10.1146/ANNUREV.PHARMTOX.48.113006.094847.;LIN NH, 2010, J VIROL METHODS, V169, P39, DOI 10.1016/J.JVIROMET.2010.06.012.;MCCAFFREY RA, 2004, J VIROL, V78, P3279, DOI 10.1128/JVI.78.7.3279-3295.2004.;MCGOVERN RA, 2010, J VIS EXP, PE2531.;NABATOV AA, 2004, J VIROL, V78, P524, DOI 10.1128/JVI.78.1.524-530.2004.;O'DOHERTY U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000.;OBERLIN E, 1996, NATURE, V382, P833, DOI 10.1038/382833A0.;PASTORE C, 2006, J VIROL, V80, P750, DOI 10.1128/JVI.80.2.750-758.2006.;POLLAKIS G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/JBC.M009779200.;POVEDA E, 2007, AIDS, V21, P1487, DOI 10.1097/QAD.0B013E32826FB741.;POVEDA E, 2009, J ANTIMICROB CHEMOTH, V63, P1006, DOI 10.1093/JAC/DKP063.;PUGACH P, 2007, VIROLOGY, V361, P212, DOI 10.1016/J.VIROL.2006.11.004.;QU SL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-280.;RAYMOND S, 2012, J CLIN MICROBIOL, V5, P5.;RAYMOND S, 2008, AIDS, V22, PF11, DOI 10.1097/QAD.0B013E32830EBCD4.;RAYMOND S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-56.;RAYMOND S, 2010, J CLIN VIROL, V47, P126, DOI 10.1016/J.JCV.2009.11.018.;RAYMOND S, 2009, J CLIN MICROBIOL, V47, P2292, DOI 10.1128/JCM.02439-08.;RECORDON-PINSON P, 2010, ANTIMICROB AGENTS CH, V54, P3335, DOI 10.1128/AAC.00148-10.;REEVES JD, 2009, J VIRAL ENTRY, V3, P94.;ROSE JD, 2009, CURR OPIN HIV AIDS, V4, P136, DOI 10.1097/COH.0B013E328322F973.;ROSS TM, 1998, P NATL ACAD SCI USA, V95, P7682, DOI 10.1073/PNAS.95.13.7682.;SCHUITEMAKER H, 2011, J TRANSL MED, V9, P1.;SECLEN E, 2010, J ANTIMICROB CHEMOTH, V65, P1486, DOI 10.1093/JAC/DKQ137.;SHIODA T, 1992, P NATL ACAD SCI USA, V89, P9434, DOI 10.1073/PNAS.89.20.9434.;SWENSON LC, 2010, JAIDS-J ACQ IMM DEF, V54, P506, DOI 10.1097/QAI.0B013E3181D0558F.;TROUPLIN V, 2001, J VIROL, V75, P251, DOI 10.1128/JVI.75.1.251-259.2001.;VAN BAELEN K, 2007, J VIROL METHODS, V146, P61, DOI 10.1016/J.JVIROMET.2007.06.003.;VAN LAETHEM K, 2005, J VIROL METHODS, V123, P25, DOI 10.1016/J.JVIROMET.2004.09.003.;VANDEKERCKHOVE LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4.;VERHOFSTEDE C, 2011, HIV MED, V12, P544, DOI 10.1111/J.1468-1293.2011.00922.X.;VIDAL V., 2007, 5 EUR HIV DRUG RES W.;WEISSENHORN W, 1997, NATURE, V387, P426, DOI 10.1038/387426A0.;WESTBY M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06.;WHITCOMB JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06.;ZOLLA-PAZNER S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/NRI2801.","BERCOFF, DP (REPRINT AUTHOR), CTR RECH PUBL SANTE, LAB RETROVIROL, LUXEMBOURG, LUXEMBOURG.;MULINGE, MARTIN, LEMAIRE, MORGANE, SERVAIS, JEAN-YVES, RYBICKI, ARKADIUSZ, STRUCK, DANIEL, DA SILVA, EVELINE SANTOS, SEGUIN-DEVAUX, CAROLE, SCHMIT, JEAN-CLAUDE, BERCOFF, DANIELLE PEREZ, CTR RECH PUBL SANTE, LAB RETROVIROL, LUXEMBOURG, LUXEMBOURG.;SCHMIT, JEAN-CLAUDE, CTR HOSP LUXEMBOURG, SERV NATL MALAD INFECT, LUXEMBOURG, LUXEMBOURG.;VERHOFSTEDE, CHRIS, UNIV GHENT, AIDS REFERENCE LAB, B-9000 GHENT, BELGIUM.;LIE, YOLANDA, MONOGRAM BIOSCI INC, SAN FRANCISCO, CA USA.","10.1371/JOURNAL.PONE.0060566","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E60566",NA,"LUXEMBOURG MINISTRY OF RESEARCH AND EDUCATION [MCESR LRTV20081003], FONDS NATIONAL DE LA RECHERCHE [PHD08-074, PHD-09-115]","THIS WORK WAS SUPPORTED BY THE LUXEMBOURG MINISTRY OF RESEARCH AND EDUCATION GRANT \#MCESR LRTV20081003. MM AND ESS WERE SUPPORTED BY PHD SCHOLARSHIPS FROM THE FONDS NATIONAL DE LA RECHERCHE (\# AFR GRANT PHD08-074 AND AFR GRANT PHD-09-115, RESPECTIVELY). THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT.",NA,"1932-6203","5",NA,"PUBLIC LIBRARY SCIENCE","8",2013,"ISI000319055600006","72","SCIENCE \& TECHNOLOGY - OTHER TOPICS","10","MULTIDISCIPLINARY SCIENCES","DANIELLE.PEREZBERCOFFCRP-SANTE.LU",NA,"145YI",NA,"BERCOFF, DP (REPRINT AUTHOR), CTR RECH PUBL SANTE, LAB RETROVIROL, LUXEMBOURG, LUXEMBOURG","ISI","SCHMIT;SCHMIT;UNIV GHENT;MONOGRAM BIOSCI INC","CTR RECH PUBL SANTE",NA,"MULINGE M, 2013, PLOS ONE","MULINGE M, 2013, PLOS ONE"
"ROY B, 2013, CURR GENOMICS","ROY B;HAUPT LM;GRIFFITHS LR","REVIEW: ALTERNATIVE SPLICING (AS) OF GENES AS AN APPROACH FOR GENERATING PROTEIN COMPLEXITY","CURRENT GENOMICS","CURR. GENOMICS","PRIOR TO THE COMPLETION OF THE HUMAN GENOME PROJECT, THE HUMAN GENOME WAS THOUGHT TO HAVE A GREATER NUMBER OF GENES AS IT SEEMED STRUCTURALLY AND FUNCTIONALLY MORE COMPLEX THAN OTHER SIMPLER ORGANISMS. THIS ALONG WITH THE BELIEF OF ``ONE GENE, ONE PROTEIN'' WERE DEMONSTRATED TO BE","ALTERNATIVE SPLICING (AS); BIOINFORMATICS; DATABASE; EXPRESSED SEQUENCE TAGS (ESTS); MICROARRAY; MRNA; PROTEIN; SPLICE VARIANTS","RNA-SEQ DATA; GENOME-WIDE DETECTION; MESSENGER-RNA; TAU GENE; FRONTOTEMPORAL DEMENTIA; PROSTATE-CANCER; EXPRESSION DATA; HUMAN-BRAIN; BCL-X; DATABASE","ENGLISH","ARTICLE","ARTICLE",29,"ALIZADEH AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501.;ANDERS S, 2012, GENOME RES, V22, P2008, DOI 10.1101/GR.133744.111.;BARBAZUK WB, 2007, PLANT J, V51, P910, DOI 10.1111/J.1365-313X.2007.03193.X.;BIECHE I, 1999, CANCER RES, V59, P2546.;BLAIR CA, 2011, INDIAN J EXP BIOL, V49, P836.;BLENCOWE BJ, 2006, CELL, V126, P37, DOI 10.1016/J.CELL.2006.06.023.;BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N.;BRETT D, 2002, NAT GENET, V30, P29, DOI 10.1038/NG803.;BURATTI E, 2011, NUCLEIC ACIDS RES, V39, PD86, DOI 10.1093/NAR/GKQ887.;CAMPBELL MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327.;CASTRIGNANO T, 2008, BIOINFORMATICS, V24, P1300, DOI 10.1093/BIOINFORMATICS/BTN113.;CLARK LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/PNAS.95.22.13103.;CLOONAN N, 2008, NAT METHODS, V5, P613, DOI 10.1038/NMETH.1223.;COGAN JD, 1997, HUM MOL GENET, V6, P909, DOI 10.1093/HMG/6.6.909.;CUPERLOVIC-CULF M, 2006, DRUG DISCOV TODAY, V11, P983, DOI 10.1016/J.DRUDIS.2006.09.011.;D'SOUZA I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/PNAS.96.10.5598.;DIMON MT, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0013875.;EBLEN ST, 2012, BIOCHEM PHARMACOL, V83, P1063, DOI 10.1016/J.BCP.2011.12.041.;ELSHARAWY A, 2006, HUM MUTAT, V27, P1129, DOI 10.1002/HUMU.20377.;EMIG D, 2010, NUCLEIC ACIDS RES, V38, PW755, DOI 10.1093/NAR/GKQ405.;EWING B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115.;FAUSTINO NA, 2003, GENE DEV, V17, P419, DOI 10.1101/GAD.1048803.;FEDOR MJ, 2008, J BIOL CHEM, V283, P1209, DOI 10.1074/JBC.R700046200.;FOISSAC S, 2007, NUCLEIC ACIDS RES, V35, PW297, DOI 10.1093/NAR/GKM311.;GAO QS, 2000, J NEUROCHEM, V74, P490, DOI 10.1046/J.1471-4159.2000.740490.X.;GARCIA-BLANCO MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/NBT964.;GERHARD DS, 2004, GENOME RES, V14, P2121.;GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/J.1460-2075.1989.TB03390.X.;GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/PNAS.85.11.4051.;GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/J.1460-2075.1990.TB07870.X.;GRABOWSKI P, 2002, NAT BIOTECHNOL, V20, P346, DOI 10.1038/NBT0402-346.;HAAS BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/NAR/GKG770.;HAGIWARA M, 2005, BBA-PROTEINS PROTEOM, V1754, P324, DOI 10.1016/J.BBAPAP.2005.09.010.;HANAMURA A, 1998, RNA, V4, P430.;HARBERS M, 2005, NAT METHODS, V2, P495, DOI 10.1038/NMETH768.;HERRERA-GAYOL A, 1999, EXP MOL PATHOL, V66, P149, DOI 10.1006/EXMP.1999.2251.;HILLER M, 2007, PLOS GENET, V3, P2147, DOI 10.1371/JOURNAL.PGEN.0030204.;HILLIER LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179.;HOLSTE D, 2006, NUCLEIC ACIDS RES, V34, PD56, DOI 10.1093/NAR/GKJ048.;HOMMA K, 2004, J MOL BIOL, V343, P1207, DOI 10.1016/J.JMB.2004.09.028.;HONG M, 1998, SCIENCE, V282, P1914, DOI 10.1126/SCIENCE.282.5395.1914.;HU GK, 2001, GENOME RES, V11, P1237, DOI 10.1101/GR.165501.;HUANG HD, 2005, NUCLEIC ACIDS RES, V33, PD80.;HUANG HD, 2003, GENOME BIOL, V4, DOI 10.1186/GB-2003-4-4-R29.;HUANG YH, 2002, NUCLEIC ACIDS RES, V30, P186, DOI 10.1093/NAR/30.1.186.;HUTTON M, 1998, NATURE, V393, P702, DOI 10.1038/31508.;JI HK, 2001, NUCLEIC ACIDS RES, V29, P260, DOI 10.1093/NAR/29.1.260.;JIN W, 2000, CANCER RES, V60, P1221.;JOHNSON JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/SCIENCE.1090100.;KATZ Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528.;KAWAMOTO S, 2000, GENOME RES, V10, P1817, DOI 10.1101/GR.151500.;KIM N, 2005, NUCLEIC ACIDS RES, V33, PW681, DOI 10.1093/NAR/GKI407.;KIM N, 2004, NUCLEIC ACIDS RES, V32, PW181, DOI 10.1093/NAR/GKH404.;KIM YUN-JI, 2012, GENOMICS \& INFORMATICS, V10, P74, DOI 10.5808/GI.2012.10.2.74.;KODZIUS R, 2006, NAT METHODS, V3, P211, DOI 10.1038/NMETH0306-211.;KOSCIELNY G, 2009, GENOMICS, V93, P213, DOI 10.1016/J.YGENO.2008.11.003.;KRAUSE A, 2002, NUCLEIC ACIDS RES, V30, P299, DOI 10.1093/NAR/30.1.299.;KRAWCZAK M, 1992, HUM GENET, V90, P41.;KWABI-ADDO B, 2001, PROSTATE, V46, P163, DOI 10.1002/1097-0045(20010201)46:2<163::AID-PROS1020>3.0.CO,2-T.;LANDER ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062.;LEE C, 2003, NUCLEIC ACIDS RES, V31, P101, DOI 10.1093/NAR/GKG029.;LEE C., 2004, GENOME BIOL, V5, P231.;LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0.;LEE Y, 2007, NUCLEIC ACIDS RES, V35, PD99, DOI 10.1093/NAR/GKL992.;LEIPZIG J, 2004, NUCLEIC ACIDS RES, V32, P3977, DOI 10.1039/NAR/GKH731.;LEVANON E.Y., 2003, TARGETS, V2, P109.;LIU Q, 2012, GENOMICS, V99, P178, DOI 10.1016/J.YGENO.2011.12.003.;LYNCH T, 1994, NEUROLOGY, V44, P1878, DOI 10.1212/WNL.44.10.1878.;MABON SA, 2005, PLOS BIOL, V3, P1893, DOI 10.1371/JOURNAL.PBIO.0030374.;MARWICK C, 1998, JAMA-J AM MED ASSOC, V280, P871, DOI 10.1001/JAMA.280.10.871.;MISSLER M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3.;MODREK B, 2002, NAT GENET, V30, P13, DOI 10.1038/NG0102-13.;MODREK B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/NAR/29.13.2850.;MOORE MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/SCIENCE.1111443.;MORIN RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900.;MORTAZAVI A, 2008, NAT METHODS, V5, P621, DOI 10.1038/NMETH.1226.;NAGALAKSHMI U, 2008, SCIENCE, V320, P1344, DOI 10.1126/SCIENCE.1158441.;NAGASAKI H, 2006, BIOINFORMATICS, V22, P1211, DOI 10.1093/BIOINFORMATICS/BTL067.;ORBAN TI, 2001, BIOCHEM BIOPH RES CO, V280, P32, DOI 10.1006/BBRC.2000.4068.;PAN Q, 2005, TRENDS GENET, V21, P73, DOI 10.1016/J.TIG.2004.12.004.;PERTEA M, 2001, NUCLEIC ACIDS RES, V29, P1185, DOI 10.1093/NAR/29.5.1185.;REINARTZ JEANNETTE, 2002, BRIEFINGS IN FUNCTIONAL GENOMICS \& PROTEOMICS, V1, P95, DOI 10.1093/BFGP/1.1.95.;RELOGIO A, 2005, J BIOL CHEM, V280, P4779, DOI 10.1074/JBC.M411976200.;ROGERS MF, 2012, GENOME BIOL, V13, DOI 10.1186/GB-2012-13-1-R4.;SCHMUCKER D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8.;SEOK J, 2012, BIOINFORMATICS, V28, P1274, DOI 10.1093/BIOINFORMATICS/BTS134.;SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9.;SHEN SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/NAR/GKR1291.;SHKRETA L, 2008, MOL CANCER THER, V7, P1398, DOI 10.1158/1535-7163.MCT-08-0192.;SHOEMAKER DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141.;SNEATH R. J. S., 1998, MOLECULAR PATHOLOGY, V51, P191.;SPILLANTINI MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/PNAS.95.13.7737.;STAMM S, 2005, GENE, V344, P1, DOI 10.1016/J.GENE.2004.10.022.;STAMM S, 2002, HUM MOL GENET, V11, P2409, DOI 10.1093/HMG/11.20.2409.;STAMM S, 2000, DNA CELL BIOL, V19, P739, DOI 10.1089/104454900750058107.;STAMM S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/JBC.R700034200.;STAMM S, 2006, NUCLEIC ACIDS RES, V34, PD46, DOI 10.1093/NAR/GKJ031.;STICKELER E, 1999, ONCOGENE, V18, P3574, DOI 10.1038/SJ.ONC.1202671.;SUN L, 2008, ANAL CHEM, V80, P3342, DOI 10.1021/AC702542N.;TAKAISHI S, 2000, BIOCHEM BIOPH RES CO, V267, P658, DOI 10.1006/BBRC.1999.2010.;TAKEDA J, 2007, NUCLEIC ACIDS RES, V35, PD104, DOI 10.1093/NAR/GKL854.;TAKEDA J, 2013, NUCLEIC ACIDS RES, V41, PD915, DOI 10.1093/NAR/GKS1245.;THORSEN K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/MCP.M700590-MCP200.;TRAPNELL C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/BIOINFORMATICS/BTP120.;TWINE NA, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0016266.;VALDIVIA HH, 2007, CIRC RES, V100, P761, DOI 10.1161/01.RES.0000263400.64391.37.;VENTER JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/SCIENCE.1058040.;VERA JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/J.1365-294X.2008.03666.X.;WANG CY, 1998, GENE DEV, V12, P1409, DOI 10.1101/GAD.12.10.1409.;WANG H, 2003, BIOINFORMATICS, V19, PI315, DOI 10.1093/BIOINFORMATICS/BTG1044.;WANG JZ, 1995, HUM MOL GENET, V4, P599, DOI 10.1093/HMG/4.4.599.;WANG K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/NAR/GKQ622.;WANG M, 2006, GENE, V366, P219, DOI 10.1016/J.GENE.2005.07.015.;WANG P, 2005, P NATL ACAD SCI USA, V102, P18920, DOI 10.1073/PNAS.0506770102.;WANG Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/NRG2484.;WATSON FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/SCIENCE.1116887.;WU J, 2011, BIOINFORMATICS, V27, P3010, DOI 10.1093/BIOINFORMATICS/BTR508.;XING Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/NRG1896.;XU Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/NAR/GKF492.;YEAKLEY JM, 2002, NAT BIOTECHNOL, V20, P353, DOI 10.1038/NBT0402-353.;ZHANG YJ, 2012, BIOINFORMATICS, V28, P479, DOI 10.1093/BIOINFORMATICS/BTR712.;ZHENG CL, 2005, RNA, V11, P1767, DOI 10.1261/RNA.2650905.;ZHU J, 2003, SCIENCE, V301, P836, DOI 10.1126/SCIENCE.1085792.","GRIFFITHS, LR (REPRINT AUTHOR), GRIFFITH UNIV, GRIFFITH HLTH INST, GENOM RES CTR, GOLD COAST, QLD 4222, AUSTRALIA.;ROY, BISHAKHA, HAUPT, LARISA M., GRIFFITHS, LYN R., GRIFFITH UNIV, GRIFFITH HLTH INST, GENOM RES CTR, GOLD COAST, QLD 4222, AUSTRALIA.","10.2174/1389202911314030004","EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES",NA,NA,NA,NA,NA,"1389-2029","3","182-194","BENTHAM SCIENCE PUBL LTD","14",2013,"ISI000318347300004","123","BIOCHEMISTRY \& MOLECULAR BIOLOGY, GENETICS \& HEREDITY","25","BIOCHEMISTRY \& MOLECULAR BIOLOGY, GENETICS \& HEREDITY","L.GRIFFITHSGRIFFITH.EDU.AU",NA,"136FJ",NA,"GRIFFITHS, LR (REPRINT AUTHOR), GRIFFITH UNIV, GRIFFITH HLTH INST, GENOM RES CTR, GOLD COAST, QLD 4222, AUSTRALIA","ISI","GRIFFITH UNIV","GRIFFITH UNIV",NA,"ROY B, 2013, CURR GENOMICS","ROY B, 2013, CURR GENOMICS"
"VINCENT AL, 2013, MOL VIS","VINCENT AL;JORDAN C;SHECK L;NIEDERER R;PATEL DV;MCGHEE CNJ","SCREENING THE VISUAL SYSTEM HOMEOBOX 1 GENE IN KERATOCONUS AND POSTERIOR POLYMORPHOUS DYSTROPHY COHORTS IDENTIFIES A NOVEL VARIANT","MOLECULAR VISION","MOL. VIS.","PURPOSE: MUTATIONS IN THE VISUAL SYSTEM HOMEOBOX 1 (VSX1) GENE HAVE BEEN DESCRIBED AT A LOW FREQUENCY IN KERATOCONUS AND POSTERIOR POLYMORPHOUS CORNEAL DYSTROPHY (PPCD). THE PUTATIVE ROLE IS CONTROVERSIAL FOR SEVERAL REASONS, INCLUDING A LACK OF MUTATIONS DETECTED IN OTHER POPULATION COHORTS. THIS STUDY AIMS TO DETERMINE WHETHER VSX1 CONTRIBUTES TO THE GENETIC PATHOGENESIS OF KERATOCONUS AND PPCD IN A NEW ZEALAND POPULATION, AND INCLUDES ANALYSIS OF A POLYNESIAN POPULATION. METHODS: RECRUITMENT OF PATIENTS WITH KERATOCONUS AND PPCD, COMPREHENSIVE CLINICAL EXAMINATION INCLUDING CORNEAL TOPOGRAPHY AND PACHYMETRY, AND COLLECTION OF BIOLOGIC SAMPLES FOR DNA EXTRACTION WERE UNDERTAKEN. MUTATIONAL ANALYSIS OF VSX1 (EXONS 1-7) WITH PCR AND SEQUENCING WITH BIOINFORMATIC ASSESSMENT OF VARIANTS WAS PERFORMED. PROBABLE PATHOGENIC VARIANTS WERE SCREENED FOR IN A CONTROL POPULATION USING HIGH-RESOLUTION MELTING ANALYSIS. RESULTS: FORTY-SEVEN PATIENTS WITH KERATOCONUS, INCLUDING 15 FAMILIAL CASES, AND TEN UNRELATED PATIENTS WITH PPCD WERE RECRUITED. TWO PATHOGENIC CHANGES WERE DETECTED, A NOVEL CHANGE C. 173C>T (P.PRO58LEU) WAS FOUND IN A PATIENT WITH PPCD, PREDICTED TO BE PATHOGENIC, AND NOT SEEN IN 200 ETHNICALLY MATCHED CONTROL ALLELES. THE PREVIOUSLY REPORTED C.731A>G (P.HIS244ARG) WAS DETECTED IN A PATIENT WITH SPORADIC KERATOCONUS, AND NOT PRESENT IN THE CONTROLS. NO FAMILY MEMBERS WERE AVAILABLE FOR SEGREGATION ANALYSIS. CONCLUSIONS: THIS STUDY REPORTS THE PRESENCE OF PATHOGENIC MUTATIONS IN VSX1 IN PPCD AND KERATOCONUS, INCLUDING A NOVEL DISEASE-CAUSING VARIANT. THE AFFECTED NUMBERS ARE SMALL, BUT GIVEN THE GROWING BODY OF EVIDENCE OF PATHOGENIC SEGREGATING CHANGES IN VSX1 IN DISEASE COHORTS, THE EXPRESSION IN KERATOCYTES AS PART OF WOUND HEALING, AND THE DOCUMENTED ASSOCIATION OF PPCD AND KERATOCONUS, IT SEEMS LIKELY THAT THE ROLE OF VSX1 AS A GENETIC FACTOR CONTRIBUTING TO DISEASE IS REAL.",NA,"BIPOLAR CELL-DIFFERENTIATION; CORNEAL-DYSTROPHY; VSX1 GENE; MISSENSE MUTATIONS; CONE; EXPRESSION; SOD1; POPULATION; EXCLUSION; FEATURES","ENGLISH","ARTICLE","ARTICLE",9,"ADZHUBEI IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/NMETH0410-248.;ALDAVE AJ, 2006, INVEST OPHTH VIS SCI, V47, P2820, DOI 10.1167/IOVS.05-1530.;ALDAVE AJ, 2005, CORNEA, V24, P151, DOI 10.1097/01.ICO.0000141235.26096.1D.;ALDAVE AJ, 2009, CORNEA, V28, P801, DOI 10.1097/ICO.0B013E31819672FB.;ALTSHULER DM, 2010, NATURE, V467, P52, DOI 10.1038/NATURE09298.;BARBARO V, 2006, INVEST OPHTH VIS SCI, V47, P5243, DOI 10.1167/IOVS.06-0185.;BECHARA SJ, 1991, AM J OPHTHALMOL, V112, P729, DOI 10.1016/S0002-9394(14)77284-8.;BISCEGLIA L, 2005, INVEST OPHTH VIS SCI, V46, P39, DOI 10.1167/IOVS.04-0533.;BISWAS S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/HMG/10.21.2415.;BLAIR SD, 1992, CORNEA, V11, P255.;BURDON KP, 2011, INVEST OPHTH VIS SCI, V52, P8514, DOI 10.1167/IOVS.11-8261.;CHOW RL, 2004, P NATL ACAD SCI USA, V101, P1754, DOI 10.1073/PNAS.0306520101.;CHOW RL, 2001, MECH DEVELOP, V109, P315, DOI 10.1016/S0925-4773(01)00585-8.;CREMONA FA, 2009, CORNEA, V28, P127, DOI 10.1097/ICO.0B013E3181859935.;DASH DP, 2010, EYE, V24, P1085, DOI 10.1038/EYE.2009.217.;DE BONIS P, 2011, MOL VIS, V17, P2482.;EDWARDS M, 2001, CLIN EXP OPHTHALMOL, V29, P345, DOI 10.1046/J.1442-9071.2001.D01-16.X.;ERAN P, 2008, OPHTHALMIC GENET, V29, P53, DOI 10.1080/13816810802008242.;GWILLIAM R, 2005, INVEST OPHTH VIS SCI, V46, P4480, DOI 10.1167/IOVS.05-0269.;HEON E, 1995, HUM MOL GENET, V4, P485, DOI 10.1093/HMG/4.3.485.;HEON E, 2002, HUM MOL GENET, V11, P1029, DOI 10.1093/HMG/11.9.1029.;HOSSEINI SM, 2008, MOL VIS, V14, P71.;HUGHES AE, 2011, AM J HUM GENET, V89, P628, DOI 10.1016/J.AJHG.2011.09.014.;JORDAN CA, 2011, J CATARACT REFR SURG, V37, P1493, DOI 10.1016/J.JCRS.2011.03.040.;KRAFCHAK CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348.;LAI IN, 2010, MOL VIS, V16, P2829.;LAM HY, 2010, CORNEA, V29, P1180, DOI 10.1097/ICO.0B013E3181D007E1.;LISKOVA PETRA, 2007, HUM MUTAT, V28, P638, DOI 10.1002/HUMU.9495.;LISKOVA P, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0045495.;LISKOVA P, 2010, OPHTHALMIC GENET, V31, P230, DOI 10.3109/13816810.2010.518577.;MCGHEE CNJ, 2009, CLIN EXP OPHTHALMOL, V37, P160, DOI 10.1111/J.1442-9071.2009.02009.X.;MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/NAR/16.3.1215.;MINTZ-HITTNER HA, 2004, OPHTHALMOLOGY, V111, P828, DOI 10.1016/J.OPHTHA.2003.07.006.;MOK JW, 2008, J HUM GENET, V53, P842, DOI 10.1007/S10038-008-0319-6.;NIELSEN K, 2012, ACTA OPHTHALMOL COPE.;OHTOSHI A, 2004, CURR BIOL, V14, P530, DOI 10.1016/J.CUB.2004.02.027.;OWENS H, 2007, CORNEA, V26, P312, DOI 10.1097/ICO.0B013E31802F8D87.;PALIWAL P, 2011, MOL VIS, V17, P481.;PALIWAL P, 2009, MOL VIS, V15, P2475.;PATEL HY, 2011, CORNEA, V30, P760, DOI 10.1097/ICO.0B013E3182014668.;RABER IM, 2011, CORNEA, V30, P1120, DOI 10.1097/ICO.0B013E3182114452.;SAEE-RAD S, 2011, MOL VIS, V17, P3128.;SEMINA EV, 2000, GENOMICS, V63, P289, DOI 10.1006/GENO.1999.6093.;STABUC-SILIH M, 2010, CORNEA, V29, P172, DOI 10.1097/ICO.0B013E3181AEBF7A.;TANG YMG, 2008, CORNEA, V27, P189, DOI 10.1097/ICO.0B013E31815A50E7.;VALLEIX S, 2006, INVEST OPHTH VIS SCI, V47, P48, DOI 10.1167/IOVS.05-0479.;WATSON T, 2011, MOL VIS, V17, P737.;WEISSMAN BA, 1989, OPTOMETRY VISION SCI, V66, P243, DOI 10.1097/00006324-198904000-00012.","VINCENT, AL (REPRINT AUTHOR), UNIV AUCKLAND, DEPT OPHTHALMOL, PRIVATE BAG 92019, AUCKLAND 1, NEW ZEALAND.;VINCENT, ANDREA L., JORDAN, CHARLOTTE, SHECK, LEO, NIEDERER, RACHEL, PATEL, DIPIKA V., MCGHEE, CHARLES N. J., UNIV AUCKLAND, FAC MED \& HLTH SCI, NEW ZEALAND NATL EYE CTR, DEPT OPHTHALMOL, AUCKLAND 1, NEW ZEALAND.;VINCENT, ANDREA L., JORDAN, CHARLOTTE, SHECK, LEO, NIEDERER, RACHEL, PATEL, DIPIKA V., MCGHEE, CHARLES N. J., AUCKLAND DIST HLTH BOARD, GREENLANE CLIN CTR, DEPT OPHTHALMOL, AUCKLAND, NEW ZEALAND.",NA,"C/O JEFF BOATRIGHT, LAB B, 5500 EMORY EYE CENTER, 1327 CLIFTON RD, N E, ATLANTA, GA 30322 USA",NA,NA,"SAVE SIGHT SOCIETY OF NEW ZEALAND, AUCKLAND MEDICAL RESEARCH FOUNDATION","JIAN LI FOR TECHNICAL WORK DURING A SUMMER STUDENTSHIP, AMANDA RICHARDS, AND BRYAN HAY FOR EXCELLENT TECHNICAL ASSISTANCE. FUNDING. SAVE SIGHT SOCIETY OF NEW ZEALAND, AUCKLAND MEDICAL RESEARCH FOUNDATION.",NA,"1090-0535",NA,"852-860","MOLECULAR VISION","19",2013,"ISI000317607100003","48","BIOCHEMISTRY \& MOLECULAR BIOLOGY, OPHTHALMOLOGY","2","BIOCHEMISTRY \& MOLECULAR BIOLOGY, OPHTHALMOLOGY","A.VINCENTAUCKLAND.AC.NZ",NA,"126II",NA,"VINCENT, AL (REPRINT AUTHOR), UNIV AUCKLAND, DEPT OPHTHALMOL, PRIVATE BAG 92019, AUCKLAND 1, NEW ZEALAND","ISI","UNIV AUCKLAND;GREENLANE CLIN CTR","UNIV AUCKLAND",NA,"VINCENT AL, 2013, MOL VIS","VINCENT AL, 2013, MOL VIS"
"MOKILI JL, 2013, PLOS ONE","MOKILI JL;DUTILH BE;LIM YW;SCHNEIDER BS;TAYLOR T;HAYNES MR;METZGAR D;MYERS CA;BLAIR PJ;NOSRAT B;WOLFE ND;ROHWER F","IDENTIFICATION OF A NOVEL HUMAN PAPILLOMAVIRUS BY METAGENOMIC ANALYSIS OF SAMPLES FROM PATIENTS WITH FEBRILE RESPIRATORY ILLNESS","PLOS ONE","PLOS ONE","AS PART OF A VIRUS DISCOVERY INVESTIGATION USING A METAGENOMIC APPROACH, A HIGHLY DIVERGENT NOVEL HUMAN PAPILLOMAVIRUS TYPE WAS IDENTIFIED IN POOLED CONVENIENCE NASAL/OROPHARYNGEAL SWAB SAMPLES COLLECTED FROM PATIENTS WITH FEBRILE RESPIRATORY ILLNESS. PHYLOGENETIC ANALYSIS OF THE WHOLE GENOME AND THE L1 GENE REVEALS THAT THE NEW HPV IDENTIFIED IN THIS STUDY CLUSTERS WITH PREVIOUSLY DESCRIBED GAMMA PAPILLOMAVIRUSES, SHARING ONLY 61.1\% (WHOLE GENOME) AND 63.1\% (L1) SEQUENCE IDENTITY WITH ITS CLOSEST RELATIVE IN THE PAPILLOMAVIRUS EPISTEME (PAVE) DATABASE. THIS NEW VIRUS WAS NAMED HPV\_SD2 PENDING OFFICIAL CLASSIFICATION. THE COMPLETE GENOME OF HPV-SD2 IS 7,299 BP LONG (36.3\% G/C) AND CONTAINS 7 OPEN READING FRAMES (L2, L1, E6, E7, E1, E2 AND E4) AND A NON-CODING LONG CONTROL REGION (LCR) BETWEEN L1 AND E6. THE METAGENOMIC PROCEDURES, COUPLED WITH THE BIOINFORMATIC METHODS DESCRIBED HEREIN ARE WELL SUITED TO DETECT SMALL CIRCULAR GENOMES SUCH AS THOSE OF HUMAN PAPILLOMAVIRUSES.",NA,"VIRAL METAGENOMICS; GENE-PRODUCT; DNA; AMPLIFICATION; DATASETS; PLASMID; REGIONS","ENGLISH","ARTICLE","ARTICLE",31,"ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;ANDROPHY EJ, 1987, NATURE, V325, P70, DOI 10.1038/325070A0.;BARTHOLOMEW DA, 2011, J CLIN VIROL, V51, P38, DOI 10.1016/J.JCV.2011.01.016.;BERNARD HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/J.VIROL.2010.02.002.;CASTRESANA J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A026334.;CHATURVEDI AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596.;DE VILLIERS EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/J.VIROL.2004.03.033.;DEAN FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/GR.180501.;DELWART EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/RMV.532.;DEUTSCH MJ, 2010, J VIROL, V84, P2533, DOI 10.1128/JVI.01909-09.;DONG XL, 2004, NUCLEIC ACIDS RES, V32, PW660, DOI 10.1093/NAR/GKH410.;DRUMMOND A.J, 2011, GENEIOUS V5 4.;EDWARDS RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/NRMICROL163.;FIGGE J, 1988, J VIROL, V62, P1814.;FORSLUND O, 2003, J VIROL METHODS, V110, P129, DOI 10.1016/S0166-0934(03)00109-5.;GUINDON S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520.;JEMAL A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/CAAC.20107.;KRUBKE J, 1987, J GEN VIROL, V68, P3091, DOI 10.1099/0022-1317-68-12-3091.;LETUNIC I, 2011, NUCL ACIDS RES.;MARGULIES M, 2005, NATURE, V437, P376, DOI 10.1038/NATURE03959.;MOKILI JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/J.COVIRO.2011.12.004.;OTT E, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0018609.;RAMAMOORTHY SONIA, 2010, INFECT AGENT CANCER, V5, P17, DOI 10.1186/1750-9378-5-17.;RIESENFELD CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/ANNUREV.GENET.38.072902.091216.;SARKARI F, 2009, PLOS PATHOG, V5, DOI 10.1371/JOURNAL.PPAT.1000624.;SCHMIEDER R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/BIOINFORMATICS/BTR026.;SCHMIEDER R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341.;SPALHOLZ BA, 1985, CELL, V42, P183, DOI 10.1016/S0092-8674(85)80114-8.;TOMLINS SA, 2006, NEOPLASIA, V8, P153, DOI 10.1593/NEO.05754.;TRINDADE-SILVA AE, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0039905.;TSE H, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0043986.;WEGLEY L, 2006, ENVIRON MICROBIOL, V8, P1775, DOI 10.1111/J.1462-2920.2006.01062.X.","MOKILI, JL (REPRINT AUTHOR), SAN DIEGO STATE UNIV, DEPT BIOL, SAN DIEGO, CA 92182 USA.;MOKILI, JOHN L., LIM, YAN WEI, HAYNES, MATTHEW R., NOSRAT, BAHADOR, ROHWER, FOREST, SAN DIEGO STATE UNIV, DEPT BIOL, SAN DIEGO, CA 92182 USA.;MOKILI, JOHN L., LIM, YAN WEI, SCHNEIDER, BRADLEY S., TAYLOR, TRAVIS, WOLFE, NATHAN D., METABIOTA, SAN FRANCISCO, CA USA.;DUTILH, BAS E., RADBOUD UNIV NIJMEGEN, MED CTR, NIJMEGEN CTR MOL LIFE SCI, CTR MOL \& BIOMOL INFORMAT, NL-6525 ED NIJMEGEN, NETHERLANDS.;METZGAR, DAVID, MYERS, CHRISTOPHER A., BLAIR, PATRICK J., USN, NAVAL HLTH RES CTR, SAN DIEGO, CA 92152 USA.;ROHWER, FOREST, SAN DIEGO STATE UNIV, CTR MICROBIAL SCI, SAN DIEGO, CA 92182 USA.","10.1371/JOURNAL.PONE.0058404","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E58404",NA,"DUTCH SCIENCE FOUNDATION (NWO) [016.111.075], U.S. DEPARTMENT OF DEFENSE GLOBAL EMERGING INFECTIONS, SURVEILLANCE AND RESPONSE SYSTEMS (DOD GEIS), DEFENSE THREAT REDUCTION AGENCY (DTRA), COOPERATIVE BIOLOGICAL ENGAGEMENT PROGRAM (CBEP), GOOGLE.ORG, SKOLL FOUNDATION, U.S. AGENCY FOR INTERNATIONAL DEVELOPMENT (USAID) EMERGING PANDEMIC THREATS PROGRAM, PREDICT PROJECT [GHN-A-OO-09-00010-00]","BED IS SUPPORTED BY THE DUTCH SCIENCE FOUNDATION (NWO) VENI GRANT (016.111.075). GLOBAL VIRAL FORECASTING (JLM, BSS AND NDW) WAS GRACIOUSLY SUPPORTED BY THE U.S. DEPARTMENT OF DEFENSE GLOBAL EMERGING INFECTIONS, SURVEILLANCE AND RESPONSE SYSTEMS (DOD GEIS) AND THE DEFENSE THREAT REDUCTION AGENCY (DTRA), COOPERATIVE BIOLOGICAL ENGAGEMENT PROGRAM (CBEP), GOOGLE.ORG, THE SKOLL FOUNDATION, AND THE U.S. AGENCY FOR INTERNATIONAL DEVELOPMENT (USAID) EMERGING PANDEMIC THREATS PROGRAM, PREDICT PROJECT, UNDER THE TERMS OF COOPERATIVE AGREEMENT NUMBER GHN-A-OO-09-00010-00. THE SURVEILLANCE CONDUCTED BY NAVAL HEALTH RESEARCH CENTER (NHRC) WAS SUPPORTED BY THE GLOBAL EMERGING INFECTIONS SYSTEM DIVISION OF THE ARMED FORCES HEALTH SURVEILLANCE CENTER. THE VIEWS EXPRESSED IN THIS WORK ARE THOSE OF THE AUTHORS AND DO NOT REFLECT THE OFFICIAL POLICY OF THE DEPARTMENT OF THE NAVY, DEPARTMENT OF DEFENSE, OR THE US GOVERNMENT. APPROVED FOR PUBLIC RELEASES, DISTRIBUTION IS UNLIMITED. THIS RESEARCH HAS BEEN CONDUCTED IN COMPLIANCE WITH ALL APPLICABLE FEDERAL REGULATIONS GOVERNING THE PROTECTION OF HUMAN SUBJECTS IN RESEARCH. THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT.",NA,"1932-6203","3",NA,"PUBLIC LIBRARY SCIENCE","8",2013,"ISI000316409800015","32","SCIENCE \& TECHNOLOGY - OTHER TOPICS","15","MULTIDISCIPLINARY SCIENCES","JMOKILIGMAIL.COM",NA,"109ZC",NA,"MOKILI, JL (REPRINT AUTHOR), SAN DIEGO STATE UNIV, DEPT BIOL, SAN DIEGO, CA 92182 USA","ISI","SAN DIEGO STATE UNIV;SCHNEIDER;RADBOUD UNIV NIJMEGEN;NAVAL HLTH RES CTR;SAN DIEGO STATE UNIV","SAN DIEGO STATE UNIV",NA,"MOKILI JL, 2013, PLOS ONE","MOKILI JL, 2013, PLOS ONE"
"SHANKS ME, 2013, EUR J HUM GENET","SHANKS ME;DOWNES SM;COPLEY RR;LISE S;BROXHOLME J;HUDSPITH KAZ;KWASNIEWSKA A;DAVIES WIL;HANKINS MW;PACKHAM ER;CLOUSTON P;SELLER A;WILKIE AOM;TAYLOR JC;RAGOUSSIS J;NEMETH AH","NEXT-GENERATION SEQUENCING (NGS) AS A DIAGNOSTIC TOOL FOR RETINAL DEGENERATION REVEALS A MUCH HIGHER DETECTION RATE IN EARLY-ONSET DISEASE","EUROPEAN JOURNAL OF HUMAN GENETICS","EUR. J. HUM. GENET.","INHERITED RETINAL DEGENERATION (IRD) IS A COMMON CAUSE OF VISUAL IMPAIRMENT (PREVALENCE SIMILAR TO 1/3500). THERE IS CONSIDERABLE PHENOTYPE AND GENOTYPE HETEROGENEITY, MAKING A SPECIFIC DIAGNOSIS VERY DIFFICULT WITHOUT MOLECULAR TESTING. WE INVESTIGATED TARGETED CAPTURE COMBINED WITH NEXT-GENERATION SEQUENCING USING NIMBLEGEN 12PLEX ARRAYS AND THE ROCHE 454 SEQUENCING PLATFORM TO EXPLORE ITS POTENTIAL FOR CLINICAL DIAGNOSTICS IN TWO COMMON TYPES OF IRD, RETINITIS PIGMENTOSA AND CONE-ROD DYSTROPHY. 50 PATIENTS (36 UNKNOWNS AND 14 POSITIVE CONTROLS) WERE SCREENED, AND PATHOGENIC MUTATIONS WERE IDENTIFIED IN 25\% OF PATIENTS IN THE UNKNOWN, WITH 53\% IN THE EARLY-ONSET CASES. ALL PATIENTS WITH NEW MUTATIONS DETECTED HAD AN AGE OF ONSET <21 YEARS AND 44\% HAD A FAMILY HISTORY. THIRTY-ONE PERCENT OF MUTATIONS DETECTED WERE NOVEL. A DE NOVA MUTATION IN RHODOPSIN WAS IDENTIFIED IN ONE EARLY-ONSET CASE WITHOUT A FAMILY HISTORY. BIOINFORMATIC PIPELINES WERE DEVELOPED TO IDENTIFY LIKELY PATHOGENIC MUTATIONS AND STRINGENT CRITERIA WERE USED FOR ASSIGNMENT OF PATHOGENICITY. ANALYSIS OF SEQUENCING METRICS REVEALED SIGNIFICANT VARIABILITY IN CAPTURE EFFICIENCY AND DEPTH OF COVERAGE. WE CONCLUDE THAT TARGETED CAPTURE AND NEXT-GENERATION SEQUENCING ARE LIKELY TO BE VERY USEFUL IN A DIAGNOSTIC SETTING, BUT PATIENTS WITH EARLIER ONSET OF DISEASE ARE MORE LIKELY TO BENEFIT FROM USING THIS STRATEGY. THE MUTATION-DETECTION RATE SUGGESTS THAT MANY PATIENTS ARE LIKELY TO HAVE MUTATIONS IN NOVEL GENES. EUROPEAN JOURNAL OF HUMAN GENETICS (2013) 21, 274-280, DOI:10.1038/EJHG.2012.172, PUBLISHED ONLINE 12 SEPTEMBER 2012","RETINAL DEGENERATION; MOLECULAR DIAGNOSTICS; NEXT-GENERATION SEQUENCING","CONE-ROD DYSTROPHY; AMINO-ACID SUBSTITUTIONS; ABCA4 ABCR GENE; RETINITIS-PIGMENTOSA; MUTATION SPECTRUM; STARGARDT-DISEASE; SPLICING SIGNALS; BETA-SUBUNIT; PHOSPHODIESTERASE","ENGLISH","ARTICLE","ARTICLE",70,"ADZHUBEI IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/NMETH0410-248.;AUDO I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8.;BRANCATI F, AM J HUM GENET, V81, P104.;DAVIES WIL, 2012, GENET MED, V14, P891, DOI 10.1038/GIM.2012.73.;DEN HOLLANDER AI, 2004, HUM MUTAT, V24, P355, DOI 10.1002/HUMU.20093.;DEN HOLLANDER AI, 1999, NAT GENET, V23, P217.;DEN HOLLANDER AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318.;DESMET FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/NAR/GKP215.;DOWNES SM, ARCH OPHTHA IN PRESS.;HOPPMAN-CHANEY N, 2010, CLIN CHEM, V56, P1297, DOI 10.1373/CLINCHEM.2010.145441.;INGLEHEARN CF, 1992, HUM MOL GENET, V1, P41, DOI 10.1093/HMG/1.1.41.;JAAKSON K, 2003, HUM MUTAT, V22, P395, DOI 10.1002/HUMU.10263.;KLEVERING BJ, 2004, EUR J HUM GENET, V12, P1024, DOI 10.1038/SJ.EJHG.5201258.;LI B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/BIOINFORMATICS/BTP528.;MARGULIES M, 2005, NATURE, V437, P376, DOI 10.1038/NATURE03959.;MAUGERI A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079.;MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/PNAS.92.8.3249.;MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/NG0693-130.;NEVELING K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/HUMU.22045.;NG PC, 2001, GENOME RES, V11, P863, DOI 10.1101/GR.176601.;REESE MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/CMB.1997.4.311.;SEPTEMBER AV, 2004, INVEST OPHTH VIS SCI, V45, P1705, DOI 10.1167/IOVS.03-1167.;SHROYER NF, 2000, HUM GENET, V106, P244, DOI 10.1007/S004390051034.;WEIGELL-WEBER M, 2000, ARCH OPHTHALMOL-CHIC, V118, P300.;WORLD MEDICAL ASSOCIATION DECLARATION OF HELSINKI, 2002, J POSTGRAD MED, V48, P206.;YEO G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418.;ZERNANT J, 2011, INVEST OPHTH VIS SCI, V52, P8479, DOI 10.1167/IOVS.11-8182.","NEMETH, AH (REPRINT AUTHOR), UNIV OXFORD, NUFFIELD DEPT CLIN NEUROSCI, NUFFIELD LAB OPHTHALMOL, JOHN RADCLIFFE HOSP, 6TH FLOOR, OXFORD OX3 9DU, ENGLAND.;SHANKS, MORAG E., COPLEY, RICHARD R., LISE, STEFANO, HUDSPITH, KARL A. Z., TAYLOR, JENNY C., NEMETH, ANDREA H., UNIV OXFORD, OXFORD BIOMED RES CTR, WELLCOME TRUST CTR HUMAN GENET, OXFORD OX3 9DU, ENGLAND.;DOWNES, SUSAN M., OXFORD UNIV HOSP NHS TRUST, OXFORD EYE HOSP, JOHN RADCLIFFE HOSP, OXFORD, ENGLAND.;DOWNES, SUSAN M., DAVIES, WAYNE I. L., HANKINS, MARK W., NEMETH, ANDREA H., UNIV OXFORD, NUFFIELD DEPT CLIN NEUROSCI, NUFFIELD LAB OPHTHALMOL, OXFORD OX3 9DU, ENGLAND.;BROXHOLME, JOHN, KWASNIEWSKA, ALEXANDRA, RAGOUSSIS, JIANNIS, UNIV OXFORD, WELLCOME TRUST CTR HUMAN GENET, OXFORD OX3 9DU, ENGLAND.;KWASNIEWSKA, ALEXANDRA, UNIV OXFORD, NUFFIELD DEPT CLIN NEUROSCI, OXFORD OX3 9DU, ENGLAND.;DAVIES, WAYNE I. L., UNIV WESTERN AUSTRALIA, SCH ANIM BIOL, PERTH, WA 6009, AUSTRALIA.;DAVIES, WAYNE I. L., UNIV WESTERN AUSTRALIA, OCEANS INST, PERTH, WA 6009, AUSTRALIA.;PACKHAM, EMILY R., CLOUSTON, PENNY, SELLER, ANNEKE, OXFORD UNIV HOSP NHS TRUST, OXFORD NHS REG MOL GENET LAB, OXFORD, ENGLAND.;WILKIE, ANDREW O. M., UNIV OXFORD, WEATHERALL INST MOL MED, OXFORD OX3 9DU, ENGLAND.;NEMETH, ANDREA H., OXFORD UNIV HOSP NHS TRUST, DEPT CLIN GENET, CHURCHILL HOSP, OXFORD, ENGLAND.","10.1038/EJHG.2012.172","MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",NA,NA,"OXFORD PARTNERSHIP COMPREHENSIVE BIOMEDICAL RESEARCH CENTRE, DEPARTMENT OF HEALTH'S NIHR BIOMEDICAL RESEARCH CENTRE PROGRAMME, ROCHE DIAGNOSTICS, ATAXIA UK, WELLCOME TRUST [075491/Z/04], BIOTECHNOLOGY AND BIOLOGICAL SCIENCES RESEARCH COUNCIL (BBSRC)","THIS WORK WAS SUPPORTED BY THE OXFORD PARTNERSHIP COMPREHENSIVE BIOMEDICAL RESEARCH CENTRE WITH FUNDING FROM THE DEPARTMENT OF HEALTH'S NIHR BIOMEDICAL RESEARCH CENTRE PROGRAMME. THE VIEWS EXPRESSED IN THIS PUBLICATION ARE THOSE OF THE AUTHORS AND NOT NECESSARILY THOSE OF THE DEPARTMENT OF HEALTH. THIS WORK WAS ALSO SUPPORTED IN PART BY ROCHE DIAGNOSTICS, AK WAS FUNDED BY ATAXIA UK, AND JB AND JR WERE FUNDED BY THE WELLCOME TRUST (GRANT 075491/Z/04). WILD WAS SUPPORTED BY A BIOTECHNOLOGY AND BIOLOGICAL SCIENCES RESEARCH COUNCIL (BBSRC) GRANT TO MWH.",NA,"1018-4813","3","274-280","NATURE PUBLISHING GROUP","21",2013,"ISI000315754800007","27","BIOCHEMISTRY \& MOLECULAR BIOLOGY, GENETICS \& HEREDITY","21","BIOCHEMISTRY \& MOLECULAR BIOLOGY, GENETICS \& HEREDITY","ANDREA.NEMETHEYE.OX.AC.UK",NA,"101DG",NA,"NEMETH, AH (REPRINT AUTHOR), UNIV OXFORD, NUFFIELD DEPT CLIN NEUROSCI, NUFFIELD LAB OPHTHALMOL, JOHN RADCLIFFE HOSP, 6TH FLOOR, OXFORD OX3 9DU, ENGLAND","ISI","UNIV OXFORD;OXFORD UNIV HOSP NHS TRUST;UNIV OXFORD;UNIV OXFORD;UNIV OXFORD;UNIV WESTERN AUSTRALIA;UNIV WESTERN AUSTRALIA;OXFORD UNIV HOSP NHS TRUST;UNIV OXFORD;OXFORD UNIV HOSP NHS TRUST","UNIV OXFORD",NA,"SHANKS ME, 2013, EUR J HUM GENET","SHANKS ME, 2013, EUR J HUM GENET"
"ZANEVELD J, 2013, SCI CHINA-LIFE SCI","ZANEVELD J;WANG FENG WF;WANG XIA WX;CHEN RUI CR","DAWN OF OCULAR GENE THERAPY: IMPLICATIONS FOR MOLECULAR DIAGNOSIS IN RETINAL DISEASE","SCIENCE CHINA-LIFE SCIENCES","SCI. CHINA-LIFE SCI.","PERSONALIZED MEDICINE AIMS TO UTILIZE GENOMIC INFORMATION ABOUT PATIENTS TO TAILOR TREATMENT. GENE REPLACEMENT THERAPY FOR RARE GENETIC DISORDERS IS PERHAPS THE MOST EXTREME FORM OF PERSONALIZED MEDICINE, IN THAT THE PATIENTS' GENOME WHOLLY DETERMINES THEIR TREATMENT REGIMEN. GENE THERAPY FOR RETINAL DISORDERS IS POISED TO BECOME A CLINICAL REALITY. THE EYE IS AN OPTIMAL SITE FOR GENE THERAPY DUE TO THE RELATIVE EASE OF PRECISE VECTOR DELIVERY, IMMUNE SYSTEM ISOLATION, AND AVAILABILITY FOR MONITORING OF ANY POTENTIAL DAMAGE OR SIDE EFFECTS. DUE TO THESE ADVANTAGES, CLINICAL TRIALS FOR GENE THERAPY OF RETINAL DISEASES ARE CURRENTLY UNDERWAY. A NECESSARY PRECURSOR TO SUCH GENE THERAPIES IS ACCURATE MOLECULAR DIAGNOSIS OF THE MUTATION(S) UNDERLYING DISEASE. IN THIS REVIEW, WE DISCUSS THE APPLICATION OF NEXT GENERATION SEQUENCING (NGS) TO OBTAIN SUCH A DIAGNOSIS AND IDENTIFY DISEASE CAUSING GENES, USING RETINAL DISORDERS AS A CASE STUDY. AFTER REVIEWING OCULAR GENE THERAPY, WE DISCUSS THE APPLICATION OF NGS TO THE IDENTIFICATION OF NOVEL MENDELIAN DISEASE GENES. WE THEN COMPARE CURRENT, ARRAY BASED MUTATION DETECTION METHODS AGAINST NEXT NGS-BASED METHODS IN THREE RETINAL DISEASES: LEBER'S CONGENITAL AMAUROSIS, RETINITIS PIGMENTOSA, AND STARGARDT'S DISEASE. WE CONCLUDE THAT NEXT-GENERATION SEQUENCING BASED DIAGNOSIS OFFERS SEVERAL ADVANTAGES OVER ARRAY BASED METHODS, INCLUDING A HIGHER RATE OF SUCCESSFUL DIAGNOSIS AND THE ABILITY TO MORE DEEPLY AND EFFICIENTLY ASSAY A BROAD SPECTRUM OF MUTATIONS. HOWEVER, THE RELATIVE DIFFICULTY OF INTERPRETING SEQUENCE RESULTS AND THE DEVELOPMENT OF STANDARDIZED, RELIABLE BIOINFORMATIC TOOLS REMAIN OUTSTANDING CONCERNS. IN THIS REVIEW, RECENT ADVANCES NGS BASED MOLECULAR DIAGNOSES ARE DISCUSSED, AS WELL AS THEIR IMPLICATIONS FOR THE DEVELOPMENT OF PERSONALIZED MEDICINE.","NEXT-GENERATION SEQUENCING (NGS); RETINAL DISEASE; MOLECULAR DIAGNOSIS; LEBER'S CONGENITAL AMAROSIS (LCA); RETINITUS PIGMENTOSA (RP); STARGARDT DISEASE; APEX; PERSONAL MEDICINE","LEBER CONGENITAL AMAUROSIS; RECESSIVE RETINITIS-PIGMENTOSA; CELL INTRAOCULAR IMPLANTS; PHASE-I TRIAL; ADENOASSOCIATED VIRUS; GENOTYPING MICROARRAY; NEXT-GENERATION; ABCA4 GENE; STEM-CELL; MACULAR DEGENERATION","ENGLISH","REVIEW","ARTICLE",7,"ACLAND GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327.;ALLARD R E, 1983, J AM OPTOM ASSOC, V54, P793.;AURICCHIO A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/HMG/10.26.3075.;AVILA-FERNANDEZ A, 2010, MOL VIS, V16, P2550.;BAINBRIDGE JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMOA0802268.;BELTRAN WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/PNAS.1118847109.;BENNETT J, 1996, NAT MED, V2, P649, DOI 10.1038/NM0696-649.;BENNETT J, 2012, SCI TRANSL MED, V4, DOI 10.1126/SCITRANSLMED.3002865.;BLANCO-KELLY F, 2012, MOL VIS, V18, P1478.;BOGNI S, 2011, ACTA NEUROCHIR SUPPL, V112, P45, DOI 10.1007/978-3-7091-0661-7\_9.;BOWNE SJ, 2006, INVEST OPHTH VIS SCI, V47, P34, DOI 10.1167/IOVS.05-0868.;BURKE TR, 2011, OPHTHALMIC GENET, V32, P165, DOI 10.3109/13816810.2011.565397.;CAMERLENGO TERRY, 2012, AMIA JT SUMMITS TRANSL SCI PROC, V2012, P1.;CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489.;CIDECIYAN AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/PNAS.0807027105.;COPPIETERS F, 2012, GENET MED, V14, P576, DOI 10.1038/GIM.2011.51.;DAIGER SP, 1996, RETINAL INFORM NETWO.;DE BIE MK, 2011, CURR MED RES OPIN, V27, P1347, DOI 10.1185/03007995.2011.580732.;DEN HOLLANDER AI, 2001, AM J HUM GENET, V69, P198.;DEN HOLLANDER AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/J.PRETEYERES.2008.05.003.;DEN HOLLANDER AI, 2007, NAT GENET, V39, P889, DOI 10.1038/NG2066.;DEN HOLLANDER AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318.;DENG WT, 2012, INVEST OPHTH VIS SCI, V53, P1895, DOI 10.1167/IOVS.11-8831.;DHARMARAJ S R, 2000, OPHTHALMIC GENET, V21, P135.;DORNSTAUDER B, 2012, INVEST OPHTH VIS SCI, V53, P2256, DOI 10.1167/IOVS.11-8569.;DOWNS K, 2007, ARCH OPHTHALMOL-CHIC, V125, P252, DOI 10.1001/ARCHOPHT.125.2.252.;DRYJA TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113.;EDWARDS AO, 2001, INVEST OPHTH VIS SCI, V42, P2652.;ERNEST PJG, 2009, MOL VIS, V15, P2841.;ESTRADA-CUZCANO A, 2011, INVEST OPHTH VIS SCI, V52, P834, DOI 10.1167/IOVS.10-5221.;FRANCESCHETTI A, 1954, CONFIN NEUROL, V14, P184.;FREUND CL, 1998, NAT GENET, V18, P311, DOI 10.1038/NG0498-311.;FRIEDMAN JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021.;FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/SCIENCE.175.4025.949.;GONZALEZ-RODRIGUEZ ML, 2011, EXPERT OPIN DRUG DEL, V8, P857, DOI 10.1517/17425247.2011.574610.;GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234A0.;HAMEL C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40.;HAUSWIRTH WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/HUM.2008.107.;HENDERSON RH, 2007, INVEST OPHTH VIS SCI, V48, P5684, DOI 10.1167/IOVS.07-0207.;HENDERSON RH, 2009, MOL VIS, V15, P2442.;HERMONAT PL, 1984, P NATL ACAD SCI-BIOL, V81, P6466, DOI 10.1073/PNAS.81.20.6466.;HUGHES AE, 2012, INVEST OPHTH VIS SCI, V53, P4748, DOI 10.1167/IOVS.12-10061.;HUMAN GENOMICS STRATEGY GROUP, 2012, BUILD OUR INH GEN TE.;JAAKSON K, 2003, HUM MUTAT, V22, P395, DOI 10.1002/HUMU.10263.;JANECKE AR, 2004, NAT GENET, V36, P850, DOI 10.1038/NG1394.;KAPLAN J, 1993, NAT GENET, V5, P308, DOI 10.1038/NG1193-308.;KINNUNEN KATI, 2012, FRONT BIOSCI (ELITE ED), V4, P2546.;KLAMBAUER G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/NAR/GKS003.;KLIMCZAK RR, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0007467.;KNIAZEVA M, 1999, AM J HUM GENET, V64, P1394, DOI 10.1086/302377.;KOCH S, 2012, HUM MOL GENET.;KOENEKOOP RK, 2007, CLIN EXP OPHTHALMOL, V35, P473, DOI 10.1111/J.1442-9071.2007.01534.X.;KOENEKOOP RK, 2012, NAT GENET, V44, P1035, DOI 10.1038/NG.2356.;KOILKONDA RD, 2010, ARCH OPHTHALMOL-CHIC, V128, P876, DOI 10.1001/ARCHOPHTHALMOL.2010.135.;KOLSTAD KD, 2010, HUM GENE THER, V21, P571, DOI 10.1089/HUM.2009.194.;KURG A, 2000, GENET TEST, V4, P1, DOI 10.1089/109065700316408.;LEM J, 1992, P NATL ACAD SCI USA, V89, P4422, DOI 10.1073/PNAS.89.10.4422.;LIU L, 2012, BMC PUBLIC HEALTH, V12, DOI [10.1186/1471-2458-12-219, 10.1155/2012/251364].;LIU MM, 2011, BRIT J OPHTHALMOL, V95, P604, DOI 10.1136/BJO.2009.174912.;MAGUIRE AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMOA0802315.;MANCUSO K, 2009, NATURE, V461, P784, DOI 10.1038/NATURE08401.;MARLHENS F, 1997, NAT GENET, V17, P139, DOI 10.1038/NG1097-139.;MATAFTSI A, 2007, INVEST OPHTH VIS SCI, V48, P5160, DOI 10.1167/IOVS.06-1013.;MEYER UA, 2012, CLIN PHARMACOL THER, V91, P373, DOI 10.1038/CLPT.2011.238.;MIN SH, 2005, MOL THER, V12, P644, DOI 10.1016/J.YMTHE.2005.06.002.;MORI S, 2004, VIROLOGY, V330, P375, DOI 10.1016/J.VIROL.2004.10.012.;NELSON MR, 2012, SCIENCE, V337, P100, DOI 10.1126/SCIENCE.1217876.;NEVELING K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/HUMU.22045.;NG SB, 2010, NAT GENET, V42, P30, DOI 10.1038/NG.499.;NGUYEN QD, 2012, EYE.;NIEDERKORN JY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/FIMMU.2012.00148.;O'SULLIVAN J, 2012, J MED GENET, V49, P322, DOI 10.1136/JMEDGENET-2012-100847.;PAGON R. A., 1993, GENEREVIEWS.;PALFI A, 2010, HUM GENE THER, V21, P311, DOI 10.1089/HUM.2009.119.;PANG JJ, 2011, MOL THER, V19, P234, DOI 10.1038/MT.2010.273.;PERRAULT I, 2004, AM J HUM GENET, V75, P639, DOI 10.1086/424889.;PERRAULT I, 1996, NAT GENET, V14, P461, DOI 10.1038/NG1296-461.;PETRS-SILVA H, 2009, MOL THER, V17, P463, DOI 10.1038/MT.2008.269.;PHILLIPS MI, 2012, CLIN PHARMACOL THER, V92, P182, DOI 10.1038/CLPT.2012.82.;PIERSMA AH, 2011, CRIT REV TOXICOL, V41, P545, DOI 10.3109/10408444.2011.554794.;QUAZI F, 2012, NAT COMMUN, V3, DOI 10.1038/NCOMMS1927.;RABBANI B, 2012, J HUM GENET, V57, P621, DOI 10.1038/JHG.2012.91.;RICHARDS AJ, 2012, EUR J HUM GENET, V20, P552, DOI 10.1038/EJHG.2011.223.;RIORDAN JR, 1989, SCIENCE, V245, P1066.;ROZET JM, 1999, J MED GENET, V36, P447.;SAMULSKI RJ, 1982, P NATL ACAD SCI-BIOL, V79, P2077, DOI 10.1073/PNAS.79.6.2077.;SCHWARTZ SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2.;SEILER MJ, 2012, PROG RET EYE RES.;SEONG MW, 2008, MOL VIS, V14, P1429.;SERGOUNIOTIS PI, 2011, AM J HUM GENET, V89, P183, DOI 10.1016/J.AJHG.2011.06.002.;SIEVING PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/PNAS.0600236103.;SOHOCKI MM, 2000, NAT GENET, V24, P79.;SOHOCKI MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO,2-K.;STONE EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/J.AJO.2007.08.022.;STONE EM, 2011, ARCH OPHTHALMOL-CHIC, V129, P81, DOI 10.1001/ARCHOPHTHALMOL.2010.330.;TIBBETTS MD, 2012, CURR OPIN OPHTHALMOL, V23, P226, DOI 10.1097/ICU.0B013E328352407D.;VANDENBERGHE LH, 2012, GENE THER, V19, P162, DOI 10.1038/GT.2011.151.;VIJVERBERG SJH, 2011, CLIN EXP ALLERGY, V41, P615, DOI 10.1111/J.1365-2222.2011.03694.X.;VRABEC TR, 2003, AM J OPHTHALMOL, V136, P542, DOI 10.1016/S0002-9394(03)00227-7.;WANG H, 2009, AM J HUM GENET, V84, P380, DOI 10.1016/J.AJHG.2009.02.005.;WANG Y, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0033673.;WEBSTER AR, 2001, INVEST OPHTH VIS SCI, V42, P1179.;WENG J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9.;XI QS, 2009, MOL VIS, V15, P638.;XU F, 2012, MOL VIS, V18, P744.;YANG Y, 2009, MOL THER, V17, P787, DOI 10.1038/MT.2009.28.;YZER S, 2006, INVEST OPHTH VIS SCI, V47, P1167, DOI 10.1167/IOVS.05-0848.;ZAREMBA CM, 2005, INVEST OPHTH VIS SCI, V46, P1794.;ZERNANT J, 2005, INVEST OPHTH VIS SCI, V46, P3052, DOI 10.1167/IOVS.05-0111.;ZERNANT J, 2011, INVEST OPHTH VIS SCI, V52, P8479, DOI 10.1167/IOVS.11-8182.;ZHANG K, 2012, NAT REV DRUG DISCOV, V11, P541, DOI 10.1038/NRD3745.;ZHANG K, 2011, P NATL ACAD SCI USA, V108, P6241, DOI 10.1073/PNAS.1018987108.;ZHI D, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0031358.;ZHONG L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/PNAS.0802866105.","CHEN, R (REPRINT AUTHOR), BAYLOR COLL MED, DEPT MOL \& HUMAN GENET, HUMAN GENOME SEQUENCING CTR, HOUSTON, TX 77030 USA.;ZANEVELD, JACQUES, WANG FENG, WANG XIA, CHEN RUI, BAYLOR COLL MED, DEPT MOL \& HUMAN GENET, HUMAN GENOME SEQUENCING CTR, HOUSTON, TX 77030 USA.","10.1007/S11427-013-4443-Y","16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA",NA,NA,"NIH [T32 EY007102], RETINAL RESEARCH FOUNDATION, NATIONAL EYE INSTITUTE [R01EY018571, R01EY022356]","WE ACKNOWLEDGE JESSE ZANEVELD, VIOLET GELOWANI, HAN-FANG TUAN, JESSICA SOWA, YERIM LEE, AND RICHARD CHAPPLE FOR THEIR HELP EDITING THE MANUSCRIPT. JACQUES ZANEVELD IS SUPPORTED BY NIH TRAINING GRANT T32 EY007102. CHEN RUI IS SUPPORTED BY GRANTS FROM THE RETINAL RESEARCH FOUNDATION AND NATIONAL EYE INSTITUTE (R01EY018571, R01EY022356).",NA,"1674-7305","2","125-133","SCIENCE PRESS","56",2013,"ISI000314697200005","114","LIFE SCIENCES \& BIOMEDICINE - OTHER TOPICS","37","BIOLOGY","RUICHENBCM.EDU",NA,"086PF",NA,"CHEN, R (REPRINT AUTHOR), BAYLOR COLL MED, DEPT MOL \& HUMAN GENET, HUMAN GENOME SEQUENCING CTR, HOUSTON, TX 77030 USA","ISI","BAYLOR COLL MED","BAYLOR COLL MED",NA,"ZANEVELD J, 2013, SCI CHINA-LIFE SCI","ZANEVELD J, 2013, SCI CHINA-LIFE SCI"
"ZHOU JB, 2013, MOL MED REP","ZHOU JB;ZHANG T;WANG BF;GAO HZ;XU X","IDENTIFICATION OF A NOVEL GENE FUSION RNF213-SLC26A11 IN CHRONIC MYELOID LEUKEMIA BY RNA-SEQ","MOLECULAR MEDICINE REPORTS","MOL. MED. REP.","CHRONIC MYELOID LEUKEMIA (CML) WAS THE FIRST HEMATOLOGICAL MALIGNANCY TO BE ASSOCIATED WITH A SPECIFIC GENETIC LESION. THE PHILADELPHIA TRANSLOCATION, PRODUCING A BCR-ABL HYBRID ONCOGENE, IS THE MOST COMMON MECHANISM OF CML DEVELOPMENT. HOWEVER, IN THE PRESENT STUDY, B3A2, B2A2 AND ELA2 FUSION JUNCTIONS OF THE BREAKPOINT CLUSTER REGION (BCR)-V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1 (ABL) GENE WERE NOT DETECTED IN PATIENTS DIAGNOSED WITH CML THREE AND FOUR YEARS PREVIOUSLY. RNA-SEQ TECHNOLOGY, WITH AN AVERAGE COVERAGE OF SIMILAR TO 30-FOLD, WAS USED TO DETECT GENE FUSION EVENTS IN A PATIENT WITH A 6-YEAR HISTORY OF CML, IDENTIFIED TO BE IN THE CHRONIC PHASE OF THE DISEASE. USING DEFUSE AND TOP HAT-FUSION PROGRAMS WITH IMPROVED FILTERING METHODS, WE IDENTIFIED TWO RELIABLE GENE FUSIONS IN A BLOOD SAMPLE OBTAINED FROM THE CML PATIENT, INCLUDING EXTREMELY LOW EXPRESSION LEVELS OF THE CLASSIC BCR-ABL1 GENE FUSION. IN ADDITION, A NOVEL GENE FUSION INVOLVING THE RING FINGER PROTEIN 213 (RNF213)-SOLUTE CARRIER FAMILY 26, MEMBER 11 (SLC26A11) WAS IDENTIFIED AND VALIDATED BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION. FURTHER BIOINFORMATIC ANALYSIS REVEALED THAT SPECIFIC DOMAINS OF SLC26A11 WERE DAMAGED, WHICH MAY AFFECT THE FUNCTION OF SULFATE TRANSPORTATION OF THE NORMAL GENE. THE PRESENT STUDY DEMONSTRATED THAT, IN SPECIFIC CASES, ALTERNATIVE GENE FUSIONS, BESIDES BCR-ABL, MAY BE ASSOCIATED WITH THE DEVELOPMENT OF CML.","CHRONIC MYELOID LEUKEMIA; RNA SEQUENCING; GENE FUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BCR-ABL","CHRONIC MYELOGENOUS LEUKEMIA; MOLECULAR-BIOLOGY; MESSENGER-RNA; CELL-LINES; TRANSCRIPTS; ABL; CANCER; EXPRESSION","ENGLISH","ARTICLE","ARTICLE",7,"CAMPBELL PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/NG.128.;CHEN W, 2008, GENOME RES, V18, P1143, DOI 10.1101/GR.076166.108.;DEININGER MWN, 2000, BLOOD, V96, P3343.;FADERL S, 1999, ANN INTERN MED, V131, P207, DOI 10.7326/0003-4819-131-3-199908030-00008.;FRAZER RACHEL, 2007, ULSTER MED J, V76, P8.;HA KCH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-75.;HERMANS A, 1988, BLOOD, V72, P2066.;HUBBARD TJP, 2009, NUCLEIC ACIDS RES, V37, PD690, DOI 10.1093/NAR/GKN828.;JIANG H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/BIOINFORMATICS/BTP113.;KIM D, 2011, GENOME BIOL, V12, DOI 10.1186/GB-2011-12-8-R72.;LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/SCIENCE.2408149.;MAHER CA, 2009, NATURE, V458, P97, DOI 10.1038/NATURE07638.;MCPHERSON A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/JOURNAL.PCBI.1001138.;MELO JV, 1993, BLOOD, V81, P158.;MITELMAN F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/NRC2091.;MORTAZAVI A, 2008, NAT METHODS, V5, P621, DOI 10.1038/NMETH.1226.;NACU S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-11.;NOWELL P, 1960, SCIENCE, V142, P1497.;PRUITT KD, 2005, NUCLEIC ACIDS RES, V33, PD501, DOI 10.1093/NAR/GKI025.;QUINTAS-CARDAMA A, 2009, BLOOD, V113, P1619, DOI 10.1182/BLOOD-2008-03-144790.;ROBERTS A, 2011, GENOME BIOL, V12, DOI 10.1186/GB-2011-12-3-R22.;ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290A0.;SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550A0.;SKOTHEIM RI, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-5.;STEIDL C, 2011, NATURE, V471, P377, DOI 10.1038/NATURE09754.;TANG FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/NMETH.1315].;TEFFERI A, 1990, LEUKEMIA, V4, P839.;TRAPNELL C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/BIOINFORMATICS/BTP120.;VERMA D, 2009, BLOOD, V114, P2232, DOI 10.1182/BLOOD-2009-02-204693.;VINCOURT JB, 2003, FASEB J, V17, P890, DOI 10.1096/FJ.02-0787FJE.;WANG Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/NRG2484.","ZHOU, JB (REPRINT AUTHOR), JIANG YIN PEOPLES HOSP, DEPT CLIN LABS, JIANG YIN 214400, JIANGSU, PEOPLES R CHINA.;ZHOU, JIAN-BO, ZHANG, TING, WANG, BEN-FANG, GAO, HAI-ZHEN, XU, XIN, JIANG YIN PEOPLES HOSP, DEPT CLIN LABS, JIANG YIN 214400, JIANGSU, PEOPLES R CHINA.","10.3892/MMR.2012.1183","POB 18179, ATHENS, 116 10, GREECE",NA,NA,NA,NA,NA,"1791-2997","2","591-597","SPANDIDOS PUBL LTD","7",2013,"ISI000313764300042","31","ONCOLOGY, RESEARCH \& EXPERIMENTAL MEDICINE","9","ONCOLOGY, MEDICINE, RESEARCH \& EXPERIMENTAL","ZHOUJB9800163.COM",NA,"073TB",NA,"ZHOU, JB (REPRINT AUTHOR), JIANG YIN PEOPLES HOSP, DEPT CLIN LABS, JIANG YIN 214400, JIANGSU, PEOPLES R CHINA","ISI","JIANG YIN PEOPLES HOSP","JIANG YIN PEOPLES HOSP",NA,"ZHOU JB, 2013, MOL MED REP","ZHOU JB, 2013, MOL MED REP"
"LEGUIZAMON J, 2013, MOL CELL PROBES","LEGUIZAMON J;HERNANDEZ J;MURCIA MI;SOTO CY","IDENTIFICATION OF POTENTIAL BIOMARKERS TO DISTINGUISH MYCOBACTERIUM COLOMBIENSE FROM OTHER MYCOBACTERIAL SPECIES","MOLECULAR AND CELLULAR PROBES","MOL. CELL. PROBES","MYCOBACTERIUM AVIUM COMPLEX (MAC) CONSISTS OF 9 SPECIES OF SLOW-GROWING MYCOBACTERIA WITH DIFFERING DEGREES OF PATHOGENICITY, HOST PREFERENCE AND ENVIRONMENTAL DISTRIBUTION. MYCOBACTERIUM COLOMBIENSE IS A NOVEL MEMBER OF MAC THAT IS RESPONSIBLE FOR DISSEMINATED INFECTIONS IN HIV-INFECTED PATIENTS IN COLOMBIA AND LYMPHADENOPATHY CASES IN EUROPE. AT PRESENT, METHODS TO EASILY DIFFERENTIATE NOVEL MEMBERS OF MAC ARE LACKING. IN THIS STUDY, WE IDENTIFIED POSSIBLE BIOMARKERS THAT ARE POTENTIALLY USEFUL FOR THE DETECTION OF M. COLOMBIENSE BY PCR OR CHROMATOGRAPHY. THE RANDOMLY AMPLIFIED POLYMORPHIC DNA (RAPD) TECHNIQUE WAS USED TO AMPLIFY GENOMIC FRAGMENTS OF M. COLOMBIENSE CECT 3035 THAT WERE SUBSEQUENTLY USED IN THE DEVELOPMENT OF A DIRECT COLONY-SPECIFIC PCR ASSAY USING SPECIFIC PRIMERS. THE DESIGNED PRIMERS AMPLIFIED A 634-BP FRAGMENT OF DNA FROM M. COLOMBIENSE, WHICH INCLUDED A 450-BP GENOMIC REGION THAT ENCODES A HYPOTHETICAL PROTEIN OF 149 AMINO ACIDS THAT IS EXCLUSIVE TO M. COLOMBIENSE. BIOINFORMATIC ANALYSES REVEALED THAT THIS HYPOTHETICAL PROTEIN HAD NO SIGNAL PEPTIDE, ACTIVE SITES OR FUNCTIONAL DOMAINS TO AID ITS IDENTIFICATION OR CLASSIFICATION. IN ADDITION, USING THIN-LAYER CHROMATOGRAPHY, WE IDENTIFIED A DIFFERENT PROFILE OF MYCOLATES FOR M. COLOMBIENSE STRAINS. THE TEST DEVELOPED IN THIS STUDY HAS POTENTIAL APPLICATIONS IN THE ROUTINE IDENTIFICATION OF M. COLOMBIENSE AND IN MOLECULAR ASSAYS DESIGNED FOR THE SURVEILLANCE OF MAC STRAINS. (C) 2012 ELSEVIER LTD. ALL RIGHTS RESERVED.","MYCOBACTERIUM COLOMBIENSE; MYCOBACTERIUM AVIUM COMPLEX; PCR ASSAY; THIN-LAYER CHROMATOGRAPHY","AVIUM SUBSP PARATUBERCULOSIS; AMPLIFIED POLYMORPHIC DNA; ARBITRARY PRIMERS; SP-NOV.; SEQUENCE-ANALYSIS; GENETIC VARIANT; COMPLEX; DIAGNOSIS; DISEASES; PROPOSAL","ENGLISH","ARTICLE","ARTICLE",2,"ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/NAR/25.17.3389.;ARNOLD K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/BIOINFORMATICS/BTI770.;BACRIE CS, 2011, J MED CASE REP, V5, P473.;BANG D, 2008, INT J SYST EVOL MICR, V58, P2398, DOI 10.1099/IJS.0.65503-0.;BEGGS ML, 2000, J CLIN MICROBIOL, V38, P508.;BELISLE JT, 1994, RES MICROBIOL, V145, P237, DOI 10.1016/0923-2508(94)90024-8.;BEN SALAH I, 2009, INT J SYST EVOL MICR, V59, P2803, DOI 10.1099/IJS.0.010637-0.;BEN SALAH I, 2008, MICROBIOL-SGM, V154, P3715, DOI 10.1099/MIC.0.2008/020164-0.;BLACKWOOD KS, 2000, J CLIN MICROBIOL, V38, P2846.;C D C, 1996, C F STAND METH HPLC.;CAYROU C, 2010, MICROBIOL-SGM, V156, P687, DOI 10.1099/MIC.0.033522-0.;CLARRIDGE JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004.;ELLINGSON JLE, 1998, MOL CELL PROBE, V12, P133, DOI 10.1006/MCPR.1998.0167.;ESPARCIA O, 2008, J CLIN MICROBIOL, V46, P1885, DOI 10.1128/JCM.01441-07.;ESWAR NARAYANAN, 2006, CURR PROTOC BIOINFORMATICS, VCHAPTER 5, PUNIT, DOI 10.1002/0471250953.BI0506S15.;FALKINHAM J. O., 2004, ENV SOURCES MYCOBACT, P26.;FALKINHAM JO, 2010, J MED MICROBIOL, V59, P1198, DOI 10.1099/JMM.0.022376-0.;FIELD SK, 2006, CHEST, V129, P1653, DOI 10.1378/CHEST.129.6.1653.;GONZALEZ-PEREZ M, 2011, J BACTERIOL, V193, P5866, DOI 10.1128/JB.05928-11.;GRIFFITH DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/RCCM.200604-571ST.;HOSEK J, 2006, VET MED-CZECH, V51, P180.;HUGHES MS, 1997, FEMS MICROBIOL LETT, V156, P31, DOI 10.1016/S0378-1097(97)00398-4.;KASAI H, 2000, J CLIN MICROBIOL, V38, P301.;LEVY-FREBAULT W, 1992, INT J SYST BACTERIOL, V42, P315.;LINTON CJ, 1994, J CLIN MICROBIOL, V32, P2169.;LIU XF, 2001, FEMS MICROBIOL LETT, V202, P233, DOI 10.1016/S0378-1097(01)00325-1.;LUQUIN M, 1991, J CLIN MICROBIOL, V29, P120.;TABCHOURY CPM, 2008, J APPL ORAL SCI, V16, P403, DOI 10.1590/S1678-77572008000600009.;MIJS W, 2002, INT J SYST EVOL MICR, V52, P1505, DOI 10.1099/IJS.0.02037-0.;MORITA Y, 2004, J MED MICROBIOL, V53, P813, DOI 10.1099/JMM.0.45601-0.;MURCIA MI, 2006, INT J SYST EVOL MICR, V56, P2049, DOI 10.1099/IJS.0.64190-0.;OHKUSU K, 2004, J INFECT DIS, V190, P1347, DOI 10.1086/424488.;PAUSTIAN ML, 2004, J CLIN MICROBIOL, V42, P2675, DOI 10.1128/JCM.42.6.2675-2681.2004.;PETERSEN TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/NMETH.1701.;PFYFFER GE, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P543.;PILLAI SR, 2001, VET MICROBIOL, V79, P275, DOI 10.1016/S0378-1135(00)00358-8.;PINI G, 2005, MYCOSES, V48, P45, DOI 10.1111/J.1439-0507.2004.01062.X.;SECANELLA-FANDOS S, 2011, J CHROMATOGR B, V879, P282.;SIGRIST CJA, 2010, NUCLEIC ACIDS RES, V8, P161.;SMOLE SC, 2002, J CLIN MICROBIOL, V40, P3374, DOI 10.1128/JCM.40.9.3374-3380.2002.;SOMERVILLE W, 2005, J CLIN MICROBIOL, V43, P2996, DOI 10.1128/JCM.43.6.2996-2997.2005.;THOREL MF, 1990, INT J SYST BACTERIOL, V40, P254, DOI 10.1099/00207713-40-3-254.;TORTOLI E, 2004, INT J SYST EVOL MICR, V54, P1277, DOI 10.1099/IJS.0.02777-0.;TORTOLI E, 2006, FEMS IMMUNOL MED MIC, V48, P159, DOI 10.1111/J.1574-695X.2006.00123.X.;VAN INGEN J, 2009, INT J SYST EVOL MICR, V59, P2277, DOI 10.1099/IJS.0.008854-0.;VUORENMAA K., 2009, EMERG INFECT DIS, V15, P618.;WARDS BJ, 1995, VET MICROBIOL, V43, P227, DOI 10.1016/0378-1135(94)00096-F.;WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/NAR/18.24.7213.;WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/NAR/18.22.6531.;WOLINSKY E, 1979, AM REV RESPIR DIS, V119, P107.;WORLD HEALTH ORGANIZATION (WHO), 2004, PATH MYC WAT GUID PU.;YUAN GF, 1995, APPL ENVIRON MICROB, V61, P2384.;ZHANG YS, 1997, J CLIN MICROBIOL, V35, P3132.","SOTO, CY (REPRINT AUTHOR), UNIV NACL COLOMBIA, DEPT CHEM, FAC SCI, CARRERA 30 45-03,CIUDAD UNIV, BOGOTA, COLOMBIA.;LEGUIZAMON, JOHN, SOTO, CARLOS-YESID, UNIV NACL COLOMBIA, DEPT CHEM, FAC SCI, BOGOTA, COLOMBIA.;HERNANDEZ, JOHANA, MURCIA, MARTHA-ISABEL, UNIV NACL COLOMBIA, DEPT MICROBIOL, FAC MED, BOGOTA, COLOMBIA.","10.1016/J.MCP.2012.08.009","24-28 OVAL RD, LONDON NW1 7DX, ENGLAND",NA,NA,"``DIVISION DE INVESTIGACION BOGOTA (DIB)''-VICERRECTORIA DE","THIS WORK WAS SUPPORTED BY THE ``DIVISION DE INVESTIGACION BOGOTA (DIB)''-VICERRECTORIA DE INVESTIGACION, UNIVERSIDAD NACIONAL DE",NA,"0890-8508","1","46-52","ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD","27",2013,"ISI000312237800008","53","BIOCHEMISTRY \& MOLECULAR BIOLOGY, BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, CELL BIOLOGY","10","BIOCHEMICAL RESEARCH METHODS, BIOCHEMISTRY \& MOLECULAR BIOLOGY, BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, CELL BIOLOGY","CYSOTOOUNAL.EDU.CO",NA,"052YY",NA,"SOTO, CY (REPRINT AUTHOR), UNIV NACL COLOMBIA, DEPT CHEM, FAC SCI, CARRERA 30 45-03,CIUDAD UNIV, BOGOTA, COLOMBIA","ISI","UNIV NACL COLOMBIA;UNIV NACL COLOMBIA","UNIV NACL COLOMBIA",NA,"LEGUIZAMON J, 2013, MOL CELL PROBES","LEGUIZAMON J, 2013, MOL CELL PROBES"
"ZHANG C, 2013, PLOS ONE","ZHANG C;ZHANG C;CHEN S;YIN X;PAN X;LIN G;TAN Y;TAN K;XU Z;HU P;LI X;CHEN F;XU X;LI Y;ZHANG X;JIANG H;WANG W","A SINGLE CELL LEVEL BASED METHOD FOR COPY NUMBER VARIATION ANALYSIS BY LOW COVERAGE MASSIVELY PARALLEL SEQUENCING","PLOS ONE","PLOS ONE","COPY NUMBER VARIATIONS (CNVS), A COMMON GENOMIC MUTATION ASSOCIATED WITH VARIOUS DISEASES, ARE IMPORTANT IN RESEARCH AND CLINICAL APPLICATIONS. WHOLE GENOME AMPLIFICATION (WGA) AND MASSIVELY PARALLEL SEQUENCING HAVE BEEN APPLIED TO SINGLE CELL CNVS ANALYSIS, WHICH PROVIDES NEW INSIGHT FOR THE FIELDS OF BIOLOGY AND MEDICINE. HOWEVER, THE WGA-INDUCED BIAS SIGNIFICANTLY LIMITS SENSITIVITY AND SPECIFICITY FOR CNVS DETECTION. ADDRESSING THESE LIMITATIONS, WE DEVELOPED A PRACTICAL BIOINFORMATIC METHODOLOGY FOR CNVS DETECTION AT THE SINGLE CELL LEVEL USING LOW COVERAGE MASSIVELY PARALLEL SEQUENCING. THIS METHOD CONSISTS OF GC CORRECTION FOR WGA-INDUCED BIAS REMOVAL, BINARY SEGMENTATION ALGORITHM FOR LOCATING CNVS BREAKPOINTS, AND DYNAMIC THRESHOLD DETERMINATION FOR FINAL SIGNALS FILTERING. AFTERWARDS, WE EVALUATED OUR METHOD WITH SEVEN TEST SAMPLES USING LOW COVERAGE SEQUENCING (4 SIMILAR TO 9.5\%). FOUR SINGLE-CELL SAMPLES FROM PERIPHERAL BLOOD, WHOSE KARYOTYPES WERE CONFIRMED BY WHOLE GENOME SEQUENCING ANALYSIS, WERE ACQUIRED. THREE OTHER TEST SAMPLES DERIVED FROM BLASTOCYSTS WHOSE KARYOTYPES WERE CONFIRMED BY SNP-ARRAY ANALYSIS WERE ALSO RECRUITED. THE DETECTION RESULTS FOR CNVS OF LARGER THAN 1 MB WERE HIGHLY CONSISTENT WITH CONFIRMED RESULTS REACHING 99.63\% SENSITIVITY AND 97.71\% SPECIFICITY AT BASE-PAIR LEVEL. OUR STUDY DEMONSTRATES THE POTENTIAL TO OVERCOME WGA-BIAS AND TO DETECT CNVS (>1 MB) AT THE SINGLE CELL LEVEL THROUGH LOW COVERAGE MASSIVELY PARALLEL SEQUENCING. IT HIGHLIGHTS THE POTENTIAL FOR CNVS RESEARCH ON SINGLE CELLS OR LIMITED DNA SAMPLES AND MAY PROVE AS A PROMISING TOOL FOR RESEARCH AND CLINICAL APPLICATIONS, SUCH AS PRE-IMPLANTATION GENETIC DIAGNOSIS/SCREENING, FETAL NUCLEATED RED BLOOD CELLS RESEARCH AND CANCER HETEROGENEITY ANALYSIS.",NA,"WHOLE-GENOME AMPLIFICATION; CHROMOSOME; TUMOR; DNA; HYBRIDIZATION; EVOLUTION; DELETION; BLOOD; 22Q11; MAPS","ENGLISH","ARTICLE","ARTICLE",22,"ALKAN C, 2009, NAT GENET, V41, P1061, DOI 10.1038/NG.437.;ARRIOLA E, 2007, LAB INVEST, V87, P75, DOI 10.1038/LABINVEST.3700495.;BEN-SHACHAR S, 2008, AM J HUM GENET, V82, P214, DOI 10.1016/J.AJHG.2007.09.014.;BEROUKHIM R, 2010, NATURE, V463, P899, DOI 10.1038/NATURE08822.;BI WM, 2012, PRENATAL DIAG, V32, P10, DOI 10.1002/PD.2855.;BIANCHI DW, 1990, P NATL ACAD SCI USA, V87, P3279, DOI 10.1073/PNAS.87.9.3279.;BREDEL M, 2005, J MOL DIAGN, V7, P171, DOI 10.1016/S1525-1578(10)60543-0.;CARLSON C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508.;CHIANG DY, 2009, NAT METHODS, V6, P99, DOI 10.1038/NMETH.1276.;CORNEVEAUX JJ, 2007, BIOTECHNIQUES, V42, P77, DOI 10.2144/000112308.;DAN S, 2012, PLOS ONE, V7, DOI 10.1371/JOURNAL.PONE.0027835.;DOKRAS A, 1990, HUM REPROD, V5, P821, DOI 10.1093/OXFORDJOURNALS.HUMREP.A137191.;EDELMANN L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/HMG/8.7.1157.;GRIFFIN DK, 1991, HUM REPROD, V6, P101, DOI 10.1093/OXFORDJOURNALS.HUMREP.A137241.;GUTIERREZ-MATEO C, 2011, FERTIL STERIL, V95, P953, DOI 10.1016/J.FERTNSTERT.2010.09.010.;HOU Y, 2012, CELL, V148, P873, DOI 10.1016/J.CELL.2012.02.028.;HUANG R, 2008, PRENATAL DIAG, V28, P892, DOI 10.1002/PD.2079.;KRUMM N, 2012, GENOME RES.;LAGE JM, 2003, GENOME RES, V13, P294, DOI 10.1101/GR.377203.;LEJEUNE J, 1963, CR HEBD ACAD SCI, V257, P3098.;LI RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/BIOINFORMATICS/BTP336.;MARDIS ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/J.TIG.2007.12.007.;NAVIN N, 2011, NATURE, V472, P90, DOI 10.1038/NATURE09807.;OLIVER JL, 2002, GENE, V300, P117, DOI 10.1016/S0378-1119(02)01034-X.;PAEZ JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/NAR/GNH069.;STROM CM, 1990, LANCET, V336, P306, DOI 10.1016/0140-6736(90)91835-X.;VAN UUM CMJ, 2010, HUM REPROD, V25, PI61.;WANG J, 2008, NATURE, V456, P60, DOI 10.1038/NATURE07484.;XU X, 2012, CELL, V148, P886, DOI 10.1016/J.CELL.2012.02.025.;YU M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/JCB.201010021.","JIANG, H (REPRINT AUTHOR), BGI SHENZHEN, SCI \& TECHNOL, SHENZHEN, GUANGDONG, PEOPLES R CHINA.;ZHANG, CHUNLEI, ZHANG, CHUNSHENG, CHEN, SHENGPEI, YIN, XUYANG, PAN, XIAOYU, LI, XUCHAO, CHEN, FANG, XU, XUN, LI, YINGRUI, ZHANG, XIUQING, JIANG, HUI, WANG, WEI, BGI SHENZHEN, SCI \& TECHNOL, SHENZHEN, GUANGDONG, PEOPLES R CHINA.;LIN, GE, TAN, YUEQIU, CENT S UNIV, INST REPROD \& STEM CELL ENGN, CHANGSHA, HUNAN, PEOPLES R CHINA.;XU, ZHENGFENG, HU, PING, NANJING MED UNIV, NANJING MATERNAL \& CHILD HLTH HOSP, CTR PRENATAL DIAG, NANJING, PEOPLES R CHINA.;ZHANG, CHUNLEI, ZHANG, CHUNSHENG, CHEN, SHENGPEI, YIN, XUYANG, PAN, XIAOYU, LI, XUCHAO, CHEN, FANG, JIANG, HUI, WANG, WEI, BGI SHENZHEN, SHENZHEN MUNICIPAL KEY LAB BIRTH DEFECTS SCREENIN, SHENZHEN, GUANGDONG, PEOPLES R CHINA.;ZHANG, CHUNLEI, ZHANG, CHUNSHENG, CHEN, SHENGPEI, YIN, XUYANG, PAN, XIAOYU, LI, XUCHAO, CHEN, FANG, ZHANG, XIUQING, JIANG, HUI, BGI SHENZHEN, GUANGDONG PROV KEY LAB HUMAN DIS GENOME, SHENZHEN, GUANGDONG, PEOPLES R CHINA.;LIN, GE, TAN, KE, CENT S UNIV, INST REPROD \& STEM CELL ENGN, CHANGSHA, HUNAN, PEOPLES R CHINA.;LIN, GE, TAN, YUEQIU, MINIST HLTH, KEY LAB STEM CELL \& REPROD ENGN, CHANGSHA, HUNAN, PEOPLES R CHINA.;CHEN, SHENGPEI, SOUTHEAST UNIV, SCH BIOL SCI \& MED ENGN, STATE KEY LAB BIOELECT, NANJING, JIANGSU, PEOPLES R CHINA.;PAN, XIAOYU, S CHINA UNIV TECHNOL, SCH BIOSCI \& BIOENGN, GUANGZHOU, GUANGDONG, PEOPLES R CHINA.;CHEN, FANG, JIANG, HUI, UNIV COPENHAGEN, DEPT BIOL, COPENHAGEN, DENMARK.","10.1371/JOURNAL.PONE.0054236","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E54236",NA,"KEY LABORATORY PROJECT IN GUANGDONG PROVINCE [2011A060906007], KEY LABORATORY PROJECT IN SHENZHEN (SHENZHEN MUNICIPAL COMMISSION OF DEVELOPMENT AND REFORM [861]","THIS PROJECT IS SUPPORTED BY KEY LABORATORY PROJECT IN GUANGDONG PROVINCE, (2011A060906007) AND KEY LABORATORY PROJECT IN SHENZHEN (SHENZHEN MUNICIPAL COMMISSION OF DEVELOPMENT AND REFORM [2011] NO. 861). THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT.",NA,"1932-6203","1",NA,"PUBLIC LIBRARY SCIENCE","8",2013,"ISI000314021500042","30","SCIENCE \& TECHNOLOGY - OTHER TOPICS","33","MULTIDISCIPLINARY SCIENCES","JIANGHUIGENOMICS.CN WANGWGENOMICS.CN",NA,"077IQ",NA,"JIANG, H (REPRINT AUTHOR), BGI SHENZHEN, SCI \& TECHNOL, SHENZHEN, GUANGDONG, PEOPLES R CHINA","ISI","SCI AND TECHNOL;CENT S UNIV;NANJING MED UNIV;SHENZHEN MUNICIPAL KEY LAB BIRTH DEFECTS SCREENIN;GUANGDONG PROV KEY LAB HUMAN DIS GENOME;CENT S UNIV;KEY LAB STEM CELL AND REPROD ENGN;SOUTHEAST UNIV;S CHINA UNIV TECHNOL;UNIV COPENHAGEN","SCI AND TECHNOL",NA,"ZHANG C, 2013, PLOS ONE","ZHANG C, 2013, PLOS ONE"
"LIU H, 2013, CELL PHYSIOL BIOCHEM","LIU H;SONG G;ZHOU L;HU X;LIU M;NIE J;LU S;WU X;CAO Y;TAO L;CHEN L;QIAN L","COMPARED ANALYSIS OF LNCRNA EXPRESSION PROFILING IN PDK1 GENE KNOCKOUT MICE AT TWO TIME POINTS","CELLULAR PHYSIOLOGY AND BIOCHEMISTRY","CELL. PHYSIOL. BIOCHEM.","BACKGROUND/AIMS: PREVIOUS STUDIES HAVE INDICATED THAT LONG NON-CODING RNAS (LNCRNA) ARE RELATED TO THE OCCURRENCE AND DEVELOPMENT OF MANY HUMAN DISEASES, SUCH AS CANCER AND THE HELLP AND THE BRACHYDACTYLY SYNDROMES. HOWEVER, STUDIES OF LNCRNA IN HEART FAILURE HAVE NOT YET BEEN REPORTED. HERE, WE INVESTIGATED CARDIAC LNCRNA EXPRESSION PROFILES IN THE MYOCARDIAL-SPECIFIC KNOCKOUT PDK1 GENE (KO) MOUSE MODEL OF HEART FAILURE. METHODS: CARDIAC SAMPLES WERE OBTAINED FROM PDK1 KO AND WT MICE ON POSTNATAL (P) DAY 8 (P8) AND DAY 40 (P40), AND LNCRNA EXPRESSION PROFILES WERE ANALYZED BY SEQUENCING AND SCREENING USING THE ARRAYSTAR MOUSE LNCRNA MICROARRAY. QUANTITATIVE REAL-TIME PCR ANALYSIS OF THESE LNCRNAS CONFIRMED THE IDENTITY OF SOME GENES. RESULTS: COMPARISONS OF THE KO AND CONTROL GROUPS SHOWED FOLD CHANGES OF >1.5 IN THE EXPRESSION LEVELS OF 2,024 LNCRNAS AT P8, WHILE FOLD CHANGES OF >2 IN THE EXPRESSION LEVELS OF 4,095 LNCRNAS WERE DETECTED AT P40. NINETEEN LNCRNAS WERE VALIDATED BY RT-PCR. BIOINFORMATIC AND PATHWAY ANALYSES INDICATED THAT MKK7, A SENSE OVERLAP LNCRNA, MAY BE INVOLVED IN THE PATHOLOGICAL PROCESSES OF HEART FAILURE THROUGH THE MAPK SIGNALING PATHWAY. CONCLUSION: THESE DATA REVEAL DIFFERENTIALLY EXPRESSED LNCRNA IN MICE WITH A MYOCARDIAL-SPECIFIC DELETION OF THE PDK1 GENE, WHICH MAY PROVIDE NEW INSIGHTS INTO THE MECHANISM OF HEART FAILURE IN PDK1 KNOCKOUT MICE. COPYRIGHT (C) 2013 S. KARGER AG, BASEL","LNCRNA; PDK1 GENE KNOCKOUT; HEART FAILURE; MICROARRAY","LONG NONCODING RNA; ACTIVATED PROTEIN-KINASES; HEART-FAILURE; MOUSE HEART; DEFICIENCY; MECHANISMS; PATHWAYS; DIFFERENTIATION; HYPERTROPHY; MYOCARDIUM","ENGLISH","ARTICLE","ARTICLE",18,"BARSOTTI AM, 2010, CELL, V142, P358, DOI 10.1016/J.CELL.2010.07.029.;BAYASCAS JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07.;BELGARDT BF, 2008, CELL METAB, V7, P291, DOI 10.1016/J.CMET.2008.01.006.;CESANA M, 2011, CELL, V147, P358, DOI 10.1016/J.CELL.2011.09.028.;CHEN LL, 2010, CURR OPIN CELL BIOL, V22, P357, DOI 10.1016/J.CEB.2010.03.003.;COOK SA, 1999, J MOL CELL CARDIOL, V31, P1429, DOI 10.1006/JMCC.1999.0979.;COOPER C, 2011, BIOCHIMIE, V93, P1973, DOI 10.1016/J.BIOCHI.2011.07.002.;DI RM, 2010, CHINESE MED J-PEKING, V123, P2358, DOI 10.3760/CMA.J.ISSN.0366-6999.2010.17.014.;DINGER ME, 2010, ALZHEIMERS DEMENT, PE47.;DONG LQ, 1999, J BIOL CHEM, V274, P8117, DOI 10.1074/JBC.274.12.8117.;FLESCH M, 2001, CIRCULATION, V104, P2273, DOI 10.1161/HC4401.099449.;FOLTZ IN, 1998, J BIOL CHEM, V273, P9344, DOI 10.1074/JBC.273.15.9344.;FRIEDRICHS F, 2009, GENOME RES, V19, P395, DOI 10.1101/GR.076653.108.;GONG CG, 2011, NATURE, V470, P284, DOI 10.1038/NATURE09701.;GROTE P, 2013, DEV CELL, V24, P206, DOI 10.1016/J.DEVCEL.2012.12.012.;GUPTA RA, 2010, NATURE, V464, P1071, DOI 10.1038/NATURE08975.;GUTSCHNER T, 2012, RNA BIOL, V9, P703, DOI 10.4161/RNA.20481.;HAQ S, 2001, CIRCULATION, V103, P670.;HOBBS FDR, 2002, EUR HEART J, V23, P1867, DOI 10.1053/EUHJ.2002.3255.;HUNG T, 2010, RNA BIOL, V7, P582, DOI 10.4161/RNA.7.5.13216.;IETSWAART R, 2012, TRENDS GENET, V28, P445, DOI 10.1016/J.TIG.2012.06.002.;ITO K, 2009, P NATL ACAD SCI USA, V106, P8689, DOI 10.1073/PNAS.0900064106.;JANKOWSKA EA, 2013, EUR HEART J, V34, P816, DOI 10.1093/EURHEARTJ/EHS224.;JUENGER J, 2002, HEART, P87235.;KLATTENHOFF CA, 2013, CELL, V152, P570, DOI 10.1016/J.CELL.2013.01.003.;LAWLOR MA, 2002, EMBO J, V21, P3728, DOI 10.1093/EMBOJ/CDF387.;LI YUWEN, 2010, WORLD J BIOL CHEM, V1, P239, DOI 10.4331/WJBC.V1.I8.239.;MAASS PG, 2012, J CLIN INVEST, V122, P3990, DOI 10.1172/JCI65508.;MITCHELL S, 2006, PHYSIOL GENOMICS, V25, P50, DOI 10.1152/PHYSIOLGENOMICS.00224.2005.;MONDAL T, 2012, CIRC RES, V110, P1162, DOI 10.1161/RES.0B013E318257C489.;MORA A, 2003, EMBO J, V22, P4666, DOI 10.1093/EMBOJ/CDG469.;MORAN VA, 2012, NUCLEIC ACIDS RES, V40, P6391, DOI 10.1093/NAR/GKS296.;NEUBAUER S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMRA063052.;NG WA, 1991, CIRC RES, V68, P1742, DOI 10.1161/01.RES.68.6.1742.;O'BRIEN JE, 2012, CIRC-CARDIOVASC GENE, V5, P279, DOI 10.1161/CIRCGENETICS.111.961474.;PAULI A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/NRG2904.;PONTING CP, 2009, CELL, V136, P629, DOI 10.1016/J.CELL.2009.02.006.;RAVASI T, 2006, GENOME RES, V16, P11, DOI 10.1101/GR.4200206.;RAVINGEROVA T, 2003, MOL CELL BIOCHEM, V247, P127, DOI 10.1023/A:1024119224033.;RITTER O, 1999, J CELL BIOCHEM, V74, P551, DOI 10.1002/(SICI)1097-4644(19990915)74:4<551::AID-JCB5>3.3.CO,2-0.;ROGER VL, 2013, J AM COLL CARDIOL, V61, P1268, DOI 10.1016/J.JACC.2013.01.011.;SWIEZEWSKI S, 2009, NATURE, V462, P799, DOI 10.1038/NATURE08618.;VALADKHAN SABA, 2010, J BIOL, V9, P5, DOI 10.1186/JBIOL197.;VAN DIJK M, 2012, J CLIN INVEST, V122, P4003, DOI 10.1172/JCI65171.;WANG KC, 2011, MOL CELL, V43, P904, DOI 10.1016/J.MOLCEL.2011.08.018.;WANG XT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/CSHPERSPECT.A003756.;WANG YB, 1998, J BIOL CHEM, V273, P5423, DOI 10.1074/JBC.273.10.5423.;YIN YZ, 2006, MOL ENDOCRINOL, V20, P268, DOI 10.1210/ME.2005-0197.","QIAN, LM (REPRINT AUTHOR), NANJING MED UNIV, AFFILIATED HOSP 1, DEPT CARDIOL, 140 HANZHONG RD, NANJING 210029, JIANGSU, PEOPLES R CHINA.;LIU, HAILANG, SONG, GUIXIAN, ZHOU, LIJUAN, LIU, MING, WU, XIANGQI, CAO, YUNSHAN, TAO, LICHAN, QIAN, LINGMEI, NANJING MED UNIV, AFFILIATED HOSP 1, DEPT CARDIOL, NANJING 210029, JIANGSU, PEOPLES R CHINA.;HU, XIAOSHAN, CHEN, LING, NANJING MED UNIV, NANJING MATERNAL \& CHILD HLTH HOSP, DEPT PEDIAT, NANJING 210029, JIANGSU, PEOPLES R CHINA.;NIE, JUNWEI, LU, SHUANGSHUANG, NANJING UNIV, MODEL ANIM RES CTR, KEY LAB MODEL ANIM DIS STUDY, MINIST EDUC, NANJING 210008, JIANGSU, PEOPLES R CHINA.","10.1159/000356586","ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",NA,NA,"NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA [81070138], NATIONAL NATURAL SCIENCE FOUNDATION OF JIANGSU PROVINCE OF CHINA [BK.2010582], TALENT FOUNDATION OF JIANGSU PROVINCE OF CHINA [WSN-020], PRIORITY ACADEMIC PROGRAM DEVELOPMENT OF JIANGSU HIGHER EDUCATION INSTITUTIONS (PAPD)","THIS STUDY WAS SUPPORTED BY GRANTS FROM THE NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA (NO. 81070138), THE NATIONAL NATURAL SCIENCE FOUNDATION OF JIANGSU PROVINCE OF CHINA (BK.2010582), THE TALENT FOUNDATION OF JIANGSU PROVINCE OF CHINA (WSN-020) AND THE PRIORITY ACADEMIC PROGRAM DEVELOPMENT OF JIANGSU HIGHER EDUCATION INSTITUTIONS (PAPD). WE THANK ZHOUZHOU YANG OF THE MODEL ANIMAL RESEARCH CENTRE, NANJING UNIVERSITY FOR PROVIDING THE PDK1 KNOCKOUT MOUSE.",NA,"1015-8987","5","1497-1508","KARGER","32",2013,"ISI000328699600033","48","CELL BIOLOGY, PHYSIOLOGY","10","CELL BIOLOGY, PHYSIOLOGY","LMQIANNJMU.EDU.CN",NA,"275TD",NA,"QIAN, LM (REPRINT AUTHOR), NANJING MED UNIV, AFFILIATED HOSP 1, DEPT CARDIOL, 140 HANZHONG RD, NANJING 210029, JIANGSU, PEOPLES R CHINA","ISI","NANJING MED UNIV;NANJING MED UNIV;NANJING UNIV","NANJING MED UNIV",NA,"LIU H, 2013, CELL PHYSIOL BIOCHEM","LIU H, 2013, CELL PHYSIOL BIOCHEM"
"HOLMES KV, 2013, MBIO","HOLMES KV;DOMINGUEZ SR","THE NEW AGE OF VIRUS DISCOVERY: GENOMIC ANALYSIS OF A NOVEL HUMAN BETACORONAVIRUS ISOLATED FROM A FATAL CASE OF PNEUMONIA","MBIO","MBIO","A NEW HUMAN BETACORONAVIRUS IN LINEAGE C, TENTATIVELY CALLED HCOV-EMC, WAS ISOLATED FROM A PATIENT FROM THE KINGDOM OF SAUDI ARABIA WHO DIED FROM ACUTE SEVERE PNEUMONIA AND RENAL FAILURE. THE VIRAL RNA HAS BEEN DETECTED IN EIGHT ADDITIONAL CASES. SEQUENCING AND BIOINFORMATIC ANALYSIS OF THE VIRAL GENOMIC RNA SHOWED THAT IT IS A NOVEL VIRUS NOT PREVIOUSLY DETECTED IN ANY OTHER SPECIES AND THAT ITS CLOSEST RELATIVES ARE TWO ASIAN BAT CORONAVIRUSES. HCOV-EMC MAY REPRESENT A SPORADIC SPILLOVER TO HUMANS FROM AN UNKNOWN ANIMAL RESERVOIR. IN A RECENT ARTICLE, VAN BOHEEMEN ET AL. DEMONSTRATED HOW STATE-OF-THEART SEQUENCING TECHNOLOGY AND BIOINFORMATIC ANALYSIS CAN QUICKLY PROVIDE CRITICAL INSIGHT INTO THE VIRAL GENOME SEQUENCE, PHYLOGENY, REPLICATION STRATEGY, AND POTENTIAL DRUG AND VACCINE TARGETS AND GENERATE TOOLS TO EVALUATE THE POSSIBLE EPIDEMIC RISK ASSOCIATED WITH THIS NOVEL HUMAN VIRUS.",NA,"RESPIRATORY SYNDROME CORONAVIRUS; EMERGENCE; BATS","ENGLISH","EDITORIAL MATERIAL","ARTICLE",6,"[ANONYMOUS], 2012, BACKGR SUMM NOV COR.;LAU SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/PNAS.0506735102.;LI WD, 2005, SCIENCE, V310, P676, DOI 10.1126/SCIENCE.1118391.;LIPKIN WI, 2010, MICROBIOL MOL BIOL R, V74, P363, DOI 10.1128/MMBR.00007-10.;PARRISH CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08.;SONG HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/PNAS.0409608102.;VAN BOHEEMEN S, 2012, MBIO, V3, DOI 10.1128/MBIO.00473-12.;WOLFE ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/EID1112.040789.;WOO PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11.;ZAKI AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMOA1211721.","HOLMES, KV (REPRINT AUTHOR), UNIV COLORADO SCH MED, DEPT MICROBIOL, AURORA, CO USA.;HOLMES, KATHRYN V., DOMINGUEZ, SAMUEL R., UNIV COLORADO SCH MED, DEPT MICROBIOL, AURORA, CO USA.;DOMINGUEZ, SAMUEL R., UNIV COLORADO SCH MED, DEPT PEDIAT, AURORA, CO USA.;DOMINGUEZ, SAMUEL R., CHILDRENS HOSP COLORADO, AURORA, CO USA.","10.1128/MBIO.00548-12","1752 N ST NW, WASHINGTON, DC 20036-2904 USA","E00548-12",NA,NA,NA,NA,"2150-7511","1",NA,"AMER SOC MICROBIOLOGY","4",2013,"ISI000315814300030","10","MICROBIOLOGY","11","MICROBIOLOGY","KATHRYN.HOLMESUCDENVER.EDU",NA,"102AA",NA,"HOLMES, KV (REPRINT AUTHOR), UNIV COLORADO SCH MED, DEPT MICROBIOL, AURORA, CO USA","ISI","UNIV COLORADO SCH MED;UNIV COLORADO SCH MED;CHILDRENS HOSP COLORADO","UNIV COLORADO SCH MED",NA,"HOLMES KV, 2013, MBIO","HOLMES KV, 2013, MBIO"
"PRICE JR, 2013, J HOSP INFECT","PRICE JR;DIDELOT X;CROOK DW;LLEWELYN MJ;PAUL J","WHOLE GENOME SEQUENCING IN THE PREVENTION AND CONTROL OF STAPHYLOCOCCUS AUREUS INFECTION","JOURNAL OF HOSPITAL INFECTION","J. HOSP. INFECT.","BACKGROUND: STAPHYLOCOCCUS AUREUS REMAINS A LEADING CAUSE OF HOSPITAL-ACQUIRED INFECTION BUT WEAKNESSES INHERENT IN CURRENTLY AVAILABLE TYPING METHODS IMPEDE EFFECTIVE INFECTION PREVENTION AND CONTROL. THE HIGH RESOLUTION OFFERED BY WHOLE GENOME SEQUENCING HAS THE POTENTIAL TO REVOLUTIONISE OUR UNDERSTANDING AND MANAGEMENT OF S. AUREUS INFECTION. AIM: TO OUTLINE THE PRACTICALITIES OF WHOLE GENOME SEQUENCING AND DISCUSS HOW IT MIGHT SHAPE FUTURE INFECTION CONTROL PRACTICE. METHODS: WE REVIEW CONVENTIONAL TYPING METHODS AND COMPARE THESE WITH THE POTENTIAL OFFERED BY WHOLE GENOME SEQUENCING. FINDINGS: IN CONTRAST WITH CONVENTIONAL METHODS, WHOLE GENOME SEQUENCING DISCRIMINATES DOWN TO SINGLE NUCLEOTIDE DIFFERENCES AND ALLOWS ACCURATE CHARACTERISATION OF TRANSMISSION EVENTS AND OUTBREAKS AND ADDITIONALLY PROVIDES INFORMATION ABOUT THE GENETIC BASIS OF PHENOTYPIC CHARACTERISTICS, INCLUDING ANTIBIOTIC SUSCEPTIBILITY AND VIRULENCE. HOWEVER, TRANSLATING ITS POTENTIAL INTO ROUTINE PRACTICE WILL DEPEND ON AFFORDABILITY, ACCEPTABLE TURNAROUND TIMES AND ON CREATING A RELIABLE STANDARDISED BIOINFORMATIC INFRASTRUCTURE. CONCLUSION: WHOLE GENOME SEQUENCING HAS THE POTENTIAL TO PROVIDE A UNIVERSAL TEST THAT FACILITATES OUTBREAK INVESTIGATION, ENABLES THE DETECTION OF EMERGING STRAINS AND PREDICTS THEIR CLINICAL IMPORTANCE. (C) 2012 THE HEALTHCARE INFECTION SOCIETY. PUBLISHED BY ELSEVIER LTD. ALL RIGHTS RESERVED.","OUTBREAK INVESTIGATION; STAPHYLOCOCCUS AUREUS; TYPING; WHOLE GENOME SEQUENCING","FIELD GEL-ELECTROPHORESIS; CASSETTE CHROMOSOME MEC; TANDEM-REPEAT ANALYSIS; METHICILLIN-RESISTANT; HOMOLOGOUS RECOMBINATION; EVOLUTIONARY DYNAMICS; SCCMEC ELEMENTS; TYPING METHODS; STRAINS; GENERATION","ENGLISH","REVIEW","ARTICLE",27,"ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/NAR/25.17.3389.;BRANTON D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/NBT.1495.;CHEUNG MAN KIT, 2011, BMC RES NOTES, V4, P533, DOI 10.1186/1756-0500-4-533.;CHIN CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMOA1012928.;CHONGTRAKOOL P, 2006, ANTIMICROB AGENTS CH, V50, P1001, DOI 10.1128/AAC.50.3.1001-1012.2006.;DIDELOT X, 2007, GENETICS, V175, P1251, DOI 10.1534/GENETICS.106.063305.;DIDELOT X, 2010, GENETICS, V186, P1435, DOI 10.1534/GENETICS.110.120121.;DIDELOT X, 2010, TRENDS MICROBIOL, V18, P315, DOI 10.1016/J.TIM.2010.04.002.;DRUMMOND AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214.;EID J, 2009, SCIENCE, V323, P133, DOI 10.1126/SCIENCE.1162986.;ENRIGHT MC, 2000, J CLIN MICROBIOL, V38, P1008.;ENRIGHT MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/PNAS.122108599.;EYRE DW, 2012, BMJ OPEN, V2, DOI 10.1136/BMJOPEN-2012-001124.;FALUSH D, 2006, TRENDS MICROBIOL, V14, P353, DOI 10.1016/J.TIM.2006.06.003.;FARIA NA, 2008, J CLIN MICROBIOL, V46, P136, DOI 10.1128/JCM.01684-07.;FEIL EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307.3316.2003.;FEIL EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004.;GARDY JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMOA1003176.;HANAGE WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/J.JTBI.2005.08.035.;HARRIS SR, 2012, NAT GENET, V44, P413, DOI 10.1038/NG.2214.;HARRIS SR, 2010, SCIENCE, V327, P469, DOI 10.1126/SCIENCE.1182395.;HE M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/PNAS.0914322107.;HILLENKAMP F, 1991, ANAL CHEM, V63, PA1193.;HOLDEN MATTHEW T. G., 2008, P1.;ICHIYAMA S, 1991, J CLIN MICROBIOL, V29, P2690.;ITO T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09.;JOLLEY KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595.;KATAYAMA Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000.;KOSER CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMOA1109910.;KURODA M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2.;LINDSAY JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006.;MAIDEN MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/PNAS.95.6.3140.;MALACHOWA N, 2005, J CLIN MICROBIOL, V43, P3095, DOI 10.1128/JCM.43.7.3095-3100.2005.;MARRA MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/SCIENCE.1085953.;MCADAM PR, 2012, P NATL ACAD SCI USA, V109, P9107, DOI 10.1073/PNAS.1202869109.;MCADAM PR, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0024301.;MCDOUGAL LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003.;METZKER ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/NRG2626.;NIELSEN R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/NRG2986.;PEREZ-LOSADA M, 2006, INFECT GENET EVOL, V6, P97, DOI 10.1016/J.MEEGID.2005.02.003.;POURCEL C, 2009, J CLIN MICROBIOL, V47, P3121, DOI 10.1128/JCM.00267-09.;PRUITT KD, 2012, NUCLEIC ACIDS RES, V40, PD130, DOI 10.1093/NAR/GKR1079.;ROBICSEK A, 2008, J CLIN MICROBIOL, V46, P588, DOI 10.1128/JCM.01746-07.;ROBINSON DA, 2004, CLIN MICROBIOL INFEC, V10, P92, DOI 10.1111/J.1469-0691.2004.00768.X.;ROSSNEY AS, 1994, J MED MICROBIOL, V41, P430, DOI 10.1099/00222615-41-6-430.;SABAT A, 2003, J CLIN MICROBIOL, V41, P1801, DOI 10.1128/JCM.41.4.1801-1804.2003.;SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/PNAS.74.12.5463.;SCHADT EE, 2010, HUM MOL GENET, V19, PR227, DOI 10.1093/HMG/DDQ416.;SCHATZ MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/GR.101360.109.;SCHOULS LM, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0005082.;SHOPSIN B, 1999, J CLIN MICROBIOL, V37, P3556.;STROMMENGER B, 2008, J CLIN MICROBIOL, V46, P574, DOI 10.1128/JCM.01599-07.;TENOVER FC, 2007, J CLIN MICROBIOL, V45, P2215, DOI 10.1128/JCM.02451-06.;THWAITES GE, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0014170.;VOS M, 2009, ISME J, V3, P199, DOI 10.1038/ISMEJ.2008.93.;WALDRON DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06.;WALKER A. S., 2011, PLOS MED, V9.;WELLER TMA, 2000, J HOSP INFECT, V44, P160, DOI 10.1053/JHIN.1999.0701.;WERTHEIM HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4.;WERTHEIM HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9.;WILLIAMS RE, 1963, BACTERIOL REV, V27, P56.;WOLTERS M, 2011, INT J MED MICROBIOL, V301, P64, DOI 10.1016/J.IJMM.2010.06.002.;YOUNG BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/PNAS.1113219109.;ZERBINO DR, 2008, GENOME RES, V18, P821, DOI 10.1101/GR.074492.107.;ZHU WM, 2008, ANTIMICROB AGENTS CH, V52, P452, DOI 10.1128/AAC.00908-07.;ZHU WM, 2010, ANTIMICROB AGENTS CH, V54, P4314, DOI 10.1128/AAC.00185-10.","PRICE, JR (REPRINT AUTHOR), ROYAL SUSSEX CTY HOSP, DEPT INFECT DIS \& MICROBIOL, HLTH PROTECT AGCY, EASTERN RD, BRIGHTON BN2 5BE, E SUSSEX, ENGLAND.;PRICE, J. R., PAUL, J., ROYAL SUSSEX CTY HOSP, DEPT INFECT DIS \& MICROBIOL, HLTH PROTECT AGCY, BRIGHTON BN2 5BE, E SUSSEX, ENGLAND.;DIDELOT, X., UNIV LONDON IMPERIAL COLL SCI TECHNOL \& MED, DEPT INFECT DIS EPIDEMIOL, LONDON, ENGLAND.;CROOK, D. W., JOHN RADCLIFFE HOSP, DIV EXPT MED, NUFFIELD DEPT MED, OXFORD OX3 9DU, ENGLAND.","10.1016/J.JHIN.2012.10.003","32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND",NA,NA,"UKCRC MODERNISING MEDICAL MICROBIOLOGY CONSORTIUM, UKCRC TRANSLATIONAL INFECTION RESEARCH INITIATIVE, WELLCOME TRUST [087646/Z/08/Z], MEDICAL RESEARCH COUNCIL, BIOTECHNOLOGY AND BIOLOGICAL SCIENCES RESEARCH COUNCIL, NATIONAL INSTITUTE FOR HEALTH RESEARCH ON BEHALF OF THE DEPARTMENT OF HEALTH [G0800778], MEDICAL RESEARCH COUNCIL [MR/K010174/1, G0800778, MR/K010174/1B, G0600719B], NATIONAL INSTITUTE FOR HEALTH RESEARCH [NF-SI-0512-10047]","J.R.P. AND X.D. WERE SUPPORTED BY THE UKCRC MODERNISING MEDICAL MICROBIOLOGY CONSORTIUM, WHICH IS FUNDED UNDER THE UKCRC TRANSLATIONAL INFECTION RESEARCH INITIATIVE SUPPORTED BY THE WELLCOME TRUST (GRANT 087646/Z/08/Z) AND BY THE MEDICAL RESEARCH COUNCIL, BIOTECHNOLOGY AND BIOLOGICAL SCIENCES RESEARCH COUNCIL AND THE NATIONAL INSTITUTE FOR HEALTH RESEARCH ON BEHALF OF THE DEPARTMENT OF HEALTH (GRANT G0800778).",NA,"0195-6701","1","14-21","W B SAUNDERS CO LTD","83",2013,"ISI000312394600002","66","PUBLIC, ENVIRONMENTAL \& OCCUPATIONAL HEALTH, INFECTIOUS DISEASES","33","PUBLIC, ENVIRONMENTAL \& OCCUPATIONAL HEALTH, INFECTIOUS DISEASES","JRPRICEDOCTORS.ORG.UK",NA,"055DE",NA,"PRICE, JR (REPRINT AUTHOR), ROYAL SUSSEX CTY HOSP, DEPT INFECT DIS \& MICROBIOL, HLTH PROTECT AGCY, EASTERN RD, BRIGHTON BN2 5BE, E SUSSEX, ENGLAND","ISI","ROYAL SUSSEX CTY HOSP;UNIV LONDON IMPERIAL COLL SCI TECHNOL AND MED;JOHN RADCLIFFE HOSP","ROYAL SUSSEX CTY HOSP",NA,"PRICE JR, 2013, J HOSP INFECT","PRICE JR, 2013, J HOSP INFECT"
"ALAM SI, 2012, ANAL CHEM","ALAM SI;KUMAR B;KAMBOJ DV","MULTIPLEX DETECTION OF PROTEIN TOXINS USING MALDI-TOF-TOF TANDEM MASS SPECTROMETRY: APPLICATION IN UNAMBIGUOUS TOXIN DETECTION FROM BIOAEROSOL","ANALYTICAL CHEMISTRY","ANAL. CHEM.","PROTEIN TOXINS, SUCH AS BOTULINUM NEUROTOXINS (BONTS), CLOSTRIDIUM PERFRINGENS EPSILON TOXIN (ETX), STAPHYLOCOCCAL ENTEROTOXIN B (SEB), SHIGA TOXIN (STX), AND PLANT TOXIN RICIN, ARE INVOLVED IN A NUMBER OF DISEASES AND ARE CONSIDERED AS POTENTIAL AGENTS FOR BIOTERRORISM AND WARFARE. FROM A BIOTERRORISM AND WARFARE PERSPECTIVE, THESE AGENTS ARE LIKELY TO CAUSE MAXIMUM DAMAGE TO A CIVILIAN OR MILITARY POPULATION THROUGH AN INHALATIONAL ROUTE OF EXPOSURE AND AEROSOL IS CONSIDERED THE ENVISAGED MODE OF DELIVERY. UNAMBIGUOUS DETECTION OF TOXIN FROM AEROSOL IS OF PARAMOUNT IMPORTANCE, BOTH FOR BRINGING MITIGATION PROTOCOLS INTO OPERATION AND FOR IMPLEMENTATION OF EFFECTIVE MEDICAL COUNTERMEASURES, IN CASE A ``BIOLOGICAL CLOUD'' IS SEEN OVER A POPULATION. A MULTIPLEX,",NA,"ENTEROTOXIN-B; QUANTIFICATION; RICIN; FOOD; IMMUNOASSAY; SYSTEMS; SAMPLES; PLASMA; AGENTS","ENGLISH","ARTICLE","ARTICLE",26,"ARNON SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/JAMA.285.8.1059.;AWAD MM, 1995, MOL MICROBIOL, V15, P191, DOI 10.1111/J.1365-2958.1995.TB02234.X.;BARR JR, 2005, EMERG INFECT DIS, V11, P1578, DOI 10.3201/EID1110.041279.;BROWN M. B., 2011, FEBS J, V278, P4589.;CALLAHAN JH, 2006, ANAL CHEM, V78, P1789, DOI 10.1021/AC051292V.;DUPUIS A, 2008, PROTEOMICS, V8, P4633, DOI 10.1002/PMIC.200800326.;DURIEZ E, 2008, J PROTEOME RES, V7, P4154, DOI 10.1021/PR8003437.;DURIEZ E, 2009, ANAL CHEM, V81, P5935, DOI 10.1021/AC900827S.;ECKER DJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-19.;FRANZ D., 1997, MED ASPECTS CHEM BIO, P631.;GALLIEN S, 2011, J MASS SPECTROM, V46, P298, DOI 10.1002/JMS.1895.;GRIFFITHS GD, 1986, J FORENSIC SCI SOC, V26, P349, DOI 10.1016/S0015-7368(86)72516-4.;HINES HB, 2005, APPL ENVIRON MICROB, V71, P4478, DOI 10.1128/AEM.71.8.4478-4486.2005.;KALB SR, 2009, ANAL CHEM, V81, P2037, DOI 10.1021/AC802769S.;KULL S, 2010, ANAL CHEM, V82, P2916, DOI 10.1021/AC902909R.;MACLENNAN JD, 1943, LANCET, V2, P123.;MCGRATH SC, 2011, ANAL CHEM, V83, P2897, DOI 10.1021/AC102571F.;NORRGRAN J, 2009, ANAL BIOCHEM, V393, P48, DOI 10.1016/J.AB.2009.05.050.;PAULY D, 2009, ANALYST, V134, P2028, DOI 10.1039/B911525K.;POPOFF MR, 2011, FEBS J, V278, P4602, DOI 10.1111/J.1742-4658.2011.08145.X.;PROC JL, 2010, J PROTEOME RES, V9, P5422, DOI 10.1021/PR100656U.;RUSSELL WK, 2001, ANAL CHEM, V73, P2682, DOI 10.1021/AC001332P.;SASAKI T, 2005, MICROBIOL IMMUNOL, V49, P589, DOI 10.1111/J.1348-0421.2005.TB03650.X.;SEYER A, 2012, ANAL CHEM, V84, P5103, DOI 10.1021/AC300880X.;SHYU HF, 2002, HYBRIDOMA HYBRIDOM, V21, P69, DOI 10.1089/15368590252917665.;SOELBERG SD, 2009, ANAL CHEM, V81, P2357, DOI 10.1021/AC900007C.;SPEICHER K D, 2000, J BIOMOL TECH, V11, P74.;VAN BAAR BLM, 2002, ANAL BIOCHEM, V301, P278, DOI 10.1006/ABIO.2001.5496.;WILLIAMS JP, 2005, BIOCHEMISTRY-US, V44, P8282, DOI 10.1021/BI0503706.;XIA X, 2001, J HERED, V92, P371, DOI 10.1093/JHERED/92.4.371.","ALAM, SI (REPRINT AUTHOR), DEF RES \& DEV ESTAB, DIV BIOTECHNOL, GWALIOR 474002, INDIA.;ALAM, SYED IMTEYAZ, KUMAR, BHOJ, KAMBOJ, DEV VRAT, DEF RES \& DEV ESTAB, DIV BIOTECHNOL, GWALIOR 474002, INDIA.","10.1021/AC3028678","1155 16TH ST, NW, WASHINGTON, DC 20036 USA",NA,NA,"DEFENCE RESEARCH AND DEVELOPMENT ORGANIZATION, GOVERNMENT OF INDIA","WE THANK PROF. (DR.) M. P. KAUSHIK, DIRECTOR, DRDE, GWALIOR, FOR PROVIDING ALL FACILITIES AND SUPPORT REQUIRED FOR THIS STUDY. THE WORK HAS BEEN FUNDED BY DEFENCE RESEARCH AND DEVELOPMENT ORGANIZATION, GOVERNMENT OF INDIA.",NA,"0003-2700","23","10500-10507","AMER CHEMICAL SOC","84",2012,"ISI000311815300049","30","CHEMISTRY","64","CHEMISTRY, ANALYTICAL","SYIMTEYAZGMAIL.COM",NA,"047CM",NA,"ALAM, SI (REPRINT AUTHOR), DEF RES \& DEV ESTAB, DIV BIOTECHNOL, GWALIOR 474002, INDIA","ISI","DIV BIOTECHNOL","DIV BIOTECHNOL",NA,"ALAM SI, 2012, ANAL CHEM","ALAM SI, 2012, ANAL CHEM"
"TOMAR J, 2012, CURR BIOINFORM","TOMAR J;GERA VK;CHAKRABORTY C","CAN BIOINFORMATIC METHODS INFORM US ABOUT THE MOLECULAR EVOLUTION OF DIFFERENT HUMAN CASPASES?","CURRENT BIOINFORMATICS","CURR. BIOINFORM.","CASPASES ARE VERY IMPORTANT MOLECULES WHICH ARE PLAYING A KEY ROLE FOR APOPTOSIS. DEREGULATION OF APOPTOSIS CONTRIBUTES TO THE PATHOGENESIS OF MANY HUMAN DISEASES. THEREFORE, THE REGULATION OF THIS PROTEIN CAN BE CONTROLLED FOR THE THERAPEUTIC PURPOSE. TO DETERMINE MOLECULAR EVOLUTION, IN SILICO OF PROTEINS IS POPULAR A METHOD FOR CERTAIN LABORATORIES AND BIOTECHNOLOGY COMPANIES. IT MAY HELP TO DETECT THAT MUTATIONS OFTEN OCCUR FAR AWAY FROM THE ACTIVE SITE OF THE PROTEIN. IT CAN GIVE US AN INSIGHT THINKING ABOUT DRUG DEVELOPMENT. USING SEQUENCE ANALYSIS AND PHYLOGENETIC APPROACH, WE HAVE DESCRIBED ABOUT DIFFERENT HUMAN CASPASES AND ABOUT THEIR ORIGIN IN TERMS OF ANCESTRAL RELATIONSHIP. IT WAS ENVISAGED USING THE TOOLS OF BIOINFORMATICS. AMONG THE FOURTEEN MAMMALIAN CASPASES DEFINED, WE ARE ABLE TO MAKE USE OF TWELVE HUMAN CASPASES, WHOSE DATA IS PUBLICLY AVAILABLE. IT IS EVIDENT FROM THE DATA STUDIED THAT HUMAN CASPASES 4 AND 5 SHARE THE SAME ORIGIN IN COMPARISON TO HUMAN CASPASE 1 AND CASPASE 12, IRRESPECTIVE OF THE FACT THAT BOTH SHARE QUITE HIGH LEVEL OF SIMILARITY. ALTHOUGH, HUMAN CASPASE RELATED ANCESTRAL ASPECT HAD BEEN STUDIED EARLIER BUT THE VARIATION WHICH SEEMS TO BE QUITE PECULIAR IN THIS STUDY IS THAT THE EXECUTIONER, CASPASE 3 SHARES A REMARKABLE HIGH LEVEL OF SIMILARITY WITH CASPASE 7 BUT THIS IS NOT APPLICABLE TO HUMAN CASPASE 6, THE OTHER MEMBER OF EXECUTIONER GROUP. HUMAN CASPASES 3 AND 7 WERE SEEN TO HAVE SIMILAR SUBSTRATE SPECIFICITY BUT IT WAS NOT EVIDENT IN TERMS OF THE ORIGIN. OUR FINDINGS ARE ASSUMED TO PLAY A SIGNIFICANT ROLE IN THE STUDIES OF PROGRAMMED CELL DEATH, INFLAMMATORY RESPONSES AND FOR SCHOLARLY STUDIES IN THE NEAR FUTURE.","APOPTOSIS; BIOINFORMATICS; COMPUTATIONAL ANALYSIS; HUMAN CASPASES; MOLECULAR EVOLUTION; PROGRAMMED CELL DEATH","ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH; INTERLEUKIN-1-BETA-CONVERTING ENZYME; CYSTEINE PROTEASE; CRYSTAL-STRUCTURE; INFLAMMATORY CASPASES; PHYLOGENETIC ANALYSIS; ENDOGENOUS INHIBITOR; APOPTOSIS; ACTIVATION","ENGLISH","ARTICLE","ARTICLE",0,"CHAI JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X.;CHEN ACH, 2009, IEEE INT C BIOINF BI, P374, DOI 10.1109/BIBE.2009.66.;CHUN HJ, 2002, NATURE, V419, P395, DOI 10.1038/NATURE01063.;COHEN GM, 1997, BIOCHEM J, V326, P1.;DANIAL NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7.;DEGTEREV A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/SJ.ONC.1207107.;DEREEPER A, 2008, NUCLEIC ACIDS RES, V36, PW465, DOI 10.1093/NAR/GKN180.;DROIN N, 2000, CANCER RES, V60, P7039.;ECKHART L, 2000, BIOCHEM BIOPH RES CO, V277, P655, DOI 10.1006/BBRC.2000.3698.;ECKHART L, 2006, BIOCHEM BIOPH RES CO, V348, P682, DOI 10.1016/J.BBRC.2006.07.104.;FAN TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/J.1745-7270.2005.00108.X.;FAUCHEU C, 1995, EMBO J, V14, P1914, DOI 10.1002/J.1460-2075.1995.TB07183.X.;FERNANDESALNEMRI T, 1995, CANCER RES, V55, P6045.;FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761.;FISCHER H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9.;FRIEDLANDER RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMRA022366.;GHAVAMI S, 2009, J MED GENET, V46, P497, DOI 10.1136/JMG.2009.066944.;GRENET J, 1999, GENE, V226, P225, DOI 10.1016/S0378-1119(98)00565-4.;GUINDON S, 2005, NUCLEIC ACIDS RES, V33, PW557, DOI 10.1093/NAR/GKI352.;KACHAPATI KRITIKA, 2006, HUM MUTAT, V27, P975, DOI 10.1002/HUMU.9448.;KAMENS J, 1995, J BIOL CHEM, V270, P15250, DOI 10.1074/JBC.270.25.15250.;KERSSE K, 2007, BIOCHEM SOC T, V35, P1508, DOI 10.1042/BST0351508.;KIM SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/HMG/DDL105.;LAMKANFI M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/SJ/CDD/4400989.;LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/BIOINFORMATICS/BTM404.;LI P, 2004, CELL, V116, PS57.;LIAN IB, 2001, FUZZY SET SYST, V122, P443, DOI 10.1016/S0165-0114(00)00053-1.;MORISHIMA N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/JBC.M204973200.;MUNDAY NA, 1995, J BIOL CHEM, V270, P15870, DOI 10.1074/JBC.270.26.15870.;NADIRI A, 2006, J IMMUNOL, V177, P4239, DOI 10.4049/JIMMUNOL.177.7.4239.;NG PWP, 1999, J BIOL CHEM, V274, P10301, DOI 10.1074/JBC.274.15.10301.;NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037A0.;OBENG EA, 2005, J BIOL CHEM, V280, P29578, DOI 10.1074/JBC.M502685200.;PELLETIER M, 2004, BIOCHEM BIOPH RES CO, V316, P93, DOI 10.1016/J.BBRC.2004.02.021.;PISTRITTO G, 2002, CELL DEATH DIFFER, V9, P995, DOI 10.1038/SJ.CDD.4401061.;RAO RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/JBC.M102225200.;RENATUS M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/PNAS.231465798.;SAITOU N, 1987, MOL BIOL EVOL, V4, P406.;SCHWEIZER A, 2003, J BIOL CHEM, V278, P42441, DOI 10.1074/JBC.M304895200.;SEOL DW, 1999, J BIOL CHEM, V274, P2072, DOI 10.1074/JBC.274.4.2072.;SHI YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3.;SLEE EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/JBC.M008363200.;SRINIVASULA SM, 1996, J BIOL CHEM, V271, P27099, DOI 10.1074/JBC.271.43.27099.;SUZUKI A, 2004, ONCOGENE, V23, P7067, DOI 10.1038/SJ.ONC.1207963.;TALAVERA G, 2007, SYSTEMATIC BIOL, V56, P564, DOI 10.1080/10635150701472164.;THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768A0.;THORNBERRY NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/JBC.272.29.17907.;WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4.;WANG L, 2001, P NATL ACAD SCI USA, V98, P13884.;WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7.;WANG ZB, 2005, CELL BIOL INT, V29, P489, DOI 10.1016/J.CELLBI.2005.04.001.;WATT W, 1999, STRUCT FOLD DES, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4.;XUE YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116.;YUAN CQ, 2002, GUOWAI YIXUE FENZI S, V24, P146.;YUAN JUNYING, 2004, CELL, VS116, PS53, DOI 10.1016/S0092-8674(04)00028-5.","CHAKRABORTY, C (REPRINT AUTHOR), VIT UNIV, SCH BIOSCI \& TECHNOL, MED BIOTECHNOL DIV, VELLORE, TAMIL NADU, INDIA.;CHAKRABORTY, CHIRANJIB, VIT UNIV, SCH BIOSCI \& TECHNOL, MED BIOTECHNOL DIV, VELLORE, TAMIL NADU, INDIA.;TOMAR, JINNY, GERA, VISHNU KUMAR, CHAKRABORTY, CHIRANJIB, IILM ACAD HIGHER LEARNING, COLL ENGN \& TECHNOL, DEPT BIOTECHNOL, GREATER NOIDA, UP, INDIA.","10.2174/157489312803901027","EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES",NA,NA,NA,NA,NA,"1574-8936","4","402-410","BENTHAM SCIENCE PUBL LTD","7",2012,"ISI000311138400007","55","BIOCHEMISTRY \& MOLECULAR BIOLOGY, MATHEMATICAL \& COMPUTATIONAL BIOLOGY","2","BIOCHEMICAL RESEARCH METHODS, MATHEMATICAL \& COMPUTATIONAL BIOLOGY","DRCHIRANJIBYAHOO.CON",NA,"037WY",NA,"CHAKRABORTY, C (REPRINT AUTHOR), VIT UNIV, SCH BIOSCI \& TECHNOL, MED BIOTECHNOL DIV, VELLORE, TAMIL NADU, INDIA","ISI","VIT UNIV;COLL ENGN AND TECHNOL","VIT UNIV",NA,"TOMAR J, 2012, CURR BIOINFORM","TOMAR J, 2012, CURR BIOINFORM"
"SABATH N, 2012, MOL BIOL EVOL","SABATH N;WAGNER A;KARLIN D","EVOLUTION OF VIRAL PROTEINS ORIGINATED DE NOVO BY OVERPRINTING","MOLECULAR BIOLOGY AND EVOLUTION","MOL. BIOL. EVOL.","NEW PROTEIN-CODING GENES CAN ORIGINATE EITHER THROUGH MODIFICATION OF EXISTING GENES OR DE NOVO. RECENTLY, THE IMPORTANCE OF DE NOVO ORIGINATION HAS BEEN RECOGNIZED IN EUKARYOTES, ALTHOUGH EUKARYOTIC GENES ORIGINATED DE NOVO ARE RELATIVELY RARE AND DIFFICULT TO IDENTIFY. IN CONTRAST, VIRUSES CONTAIN MANY DE NOVO GENES, NAMELY THOSE IN WHICH AN EXISTING GENE HAS BEEN ``OVERPRINTED'' BY A NEW OPEN READING FRAME, A","OVERLAPPING GENES; DE NOVO ORIGIN; NEW GENES","INFLUENZA-A VIRUS; BIOINFORMATIC ANALYSIS SUGGESTS; OVERLAPPING READING FRAMES; HEPATITIS-B-VIRUS; INTRINSICALLY UNSTRUCTURED PROTEINS; MEDIATED DEMYELINATING DISEASE; CODON ADAPTATION INDEX; CODING SEQUENCE; NUCLEOTIDE SUBSTITUTION; THEILERS VIRUS","ENGLISH","ARTICLE","ARTICLE",49,"ABROI A, 2011, BIOESSAYS, V33, P626, DOI 10.1002/BIES.201000126.;ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/NAR/25.17.3389.;ANISIMOVA M, 2009, MOL BIOL EVOL, V26, P255, DOI 10.1093/MOLBEV/MSN232.;BABUSHOK DV, 2007, CELL MOL LIFE SCI, V64, P542, DOI 10.1007/S00018-006-6453-4.;BAO YM, 2004, J VIROL, V78, P7291, DOI 10.1128/JVI.78.14.7291-7298.2004.;BECK J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/WJG.V13.I1.48.;BEGUN DJ, 2007, GENETICS, V176, P1131, DOI 10.1534/GENETICS.106.069245.;BELSHAW R, 2007, GENOME RES, V17, P1496, DOI 10.1101/GR.6305707.;BORNBERG-BAUER E, 2010, CURR OPIN STRUC BIOL, V20, P390, DOI 10.1016/J.SBI.2010.02.005.;BOZARTH CS, 1992, VIROLOGY, V187, P124, DOI 10.1016/0042-6822(92)90301-5.;BRUENN JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/NAR/GKG277.;CAI J, 2008, GENETICS, V179, P487, DOI 10.1534/GENETICS.107.084491.;CAMPITELLI L, 2006, J GEN VIROL, V87, P955, DOI 10.1099/VIR.0.81397-0.;CHEN HH, 1995, NAT MED, V1, P927, DOI 10.1038/NM0995-927.;CHEN SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/SCIENCE.1196380.;CHEN WS, 2001, NAT MED, V7, P1306, DOI 10.1038/NM1201-1306.;CHIRICO N, 2010, P ROY SOC B-BIOL SCI, V277, P3809, DOI 10.1098/RSPB.2010.1052.;CHUNG BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/PNAS.0800468105.;DUFFY S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/NRG2323.;DYSON HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/NRM1589.;EKMAN D, 2010, J MOL BIOL, V396, P396, DOI 10.1016/J.JMB.2009.11.053.;ELHAIK E, 2006, MOL BIOL EVOL, V23, P1, DOI 10.1093/MOLBEV/MSJ006.;FARRIS JS, 1972, AM NAT, V106, P645, DOI 10.1086/282802.;FENNER BJ, 2006, J VIROL, V80, P85, DOI 10.1128/JVI.80.1.85-94.2006.;FINN RD, 2008, NUCLEIC ACIDS RES, V36, PD281, DOI 10.1093/NAR/GKM960.;FIRTH AE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-75.;FIRTH AE, 2005, BIOINFORMATICS, V21, P282, DOI 10.1093/BIOINFORMATICS/BTI007.;FIRTH AE, 2008, ARCH VIROL, V153, P1379, DOI 10.1007/S00705-008-0119-5.;FIRTH AE, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-17.;FIRTH AE, 2010, VIROLOGY, V399, P153, DOI 10.1016/J.VIROL.2009.12.033.;FIRTH AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-222.;FIRTH AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-136.;FIRTH AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-32.;FIRTH AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-48.;FIRTH AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-62.;FISCHER F, 1997, J VIROL, V71, P996.;FUJII Y, 2001, VIRUS GENES, V22, P47, DOI 10.1023/A:1008130318633.;GASCUEL O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A025808.;GHADGE GD, 1998, J VIROL, V72, P8605.;GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725.;GUERZONI D, 2011, PLOS GENET, V7, DOI 10.1371/JOURNAL.PGEN.1002381.;GUYADER S, 2002, J GEN VIROL, V83, P1799, DOI 10.1099/0022-1317-83-7-1799.;HANZLIK TN, 1995, J GEN VIROL, V76, P799, DOI 10.1099/0022-1317-76-4-799.;HARTL D. L., 1997, PRINCIPLES POPULATIO.;HERNANDEZ M, 2010, VIRUS GENES, V41, P59, DOI 10.1007/S11262-010-0485-4.;HOLMES EDWARD C, 2006, SCIENCE, V313, P1573.;HUGHES AL, 2005, VIRUS RES, V113, P81, DOI 10.1016/J.VIRUSRES.2005.03.030.;HUGHES AL, 2001, J VIROL, V75, P7966, DOI 10.1128/JVI.75.17.7966-7972.2001.;IWAMOTO T, 2005, J GEN VIROL, V86, P2807, DOI 10.1099/VIR.0.80902-0.;JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/SCIENCE.860134.;JORDAN IK, 2000, MOL BIOL EVOL, V17, P75, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A026240.;KAESSMANN H, 2010, GENOME RES, V20, P1313, DOI 10.1101/GR.101386.109.;KATOH K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/NAR/GKF436.;KEESE PK, 1992, P NATL ACAD SCI USA, V89, P9489, DOI 10.1073/PNAS.89.20.9489.;KNOWLES DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/GR.095026.109.;KRUMBHOLZ A, 2011, MED MICROBIOL IMMUN, V200, P69, DOI 10.1007/S00430-010-0176-8.;LE DUFF Y, 2009, J VIROL, V83, P12443, DOI 10.1128/JVI.01594-09.;LEE S, 2010, EVOL BIOINFORM, V6, P47.;LEVINE MT, 2006, P NATL ACAD SCI USA, V103, P9935, DOI 10.1073/PNAS.0509809103.;LI CY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/JOURNAL.PCBI.1000734.;LI D, 2010, CELL RES, V20, P408, DOI 10.1038/CR.2010.31.;LI F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/ANNUREV.MICRO.60.080805.142205.;LI KS, 2004, NATURE, V430, P209, DOI 10.1038/NATURE02746.;LONG M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/NRG1204.;MAZUR I, 2008, CELL MICROBIOL, V10, P1140, DOI 10.1111/J.1462-5822.2008.01116.X.;MCAULEY JL, 2010, J VIROL, V84, P558, DOI 10.1128/JVI.01785-09.;MCGEOCH DJ, 1985, J MOL BIOL, V181, P1, DOI 10.1016/0022-2836(85)90320-1.;MCGIRR KM, 2006, VIRUS GENES, V32, P229, DOI 10.1007/S11262-005-6907-Z.;MCVEIGH A, 2000, INFECT IMMUN, V68, P5710, DOI 10.1128/IAI.68.10.5710-5715.2000.;MIZOKAMI M, 1997, J MOL EVOL, V44, PS83, DOI 10.1007/PL00000061.;NARECHANIA A, 2005, J GEN VIROL, V86, P1307, DOI 10.1099/VIR.0.080747-0.;NEI M, 1986, MOL BIOL EVOL, V3, P418.;NEKRUTENKO A, 2005, PLOS GENET, V1, P197, DOI 10.1371/JOURNAL.PGEN.0010018.;NIELSEN R, 1998, GENETICS, V148, P929.;OBENAUER JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/SCIENCE.1121586.;OHNO S, 1984, P NATL ACAD SCI-BIOL, V81, P2421, DOI 10.1073/PNAS.81.8.2421.;OHNO S., 1970, EVOLUTION GENE DUPLI.;OOI HS, 2009, NUCLEIC ACIDS RES, V37, PW435, DOI 10.1093/NAR/GKP254.;PATTERSON JB, 2000, VIROLOGY, V267, P80, DOI 10.1006/VIRO.1999.0118.;PAVESI A, 2006, J GEN VIROL, V87, P1013, DOI 10.1099/VIR.0.81375-0.;PAVESI A, 1997, J MOL EVOL, V44, P625, DOI 10.1007/PL00006185.;PAVESI A, 2007, GENE, V402, P28, DOI 10.1016/J.GENE.2007.07.013.;PETERSON DL, 1981, J BIOL CHEM, V256, P6975.;PLOTKIN JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/NRG2899.;RANCUREL C, 2009, J VIROL, V83, P10719, DOI 10.1128/JVI.00595-09.;ROGOZIN IB, 2002, TRENDS GENET, V18, P228, DOI 10.1016/S0168-9525(02)02649-5.;ROZANOV MN, 1992, J GEN VIROL, V73, P2129, DOI 10.1099/0022-1317-73-8-2129.;RYABOV EV, 1998, VIROLOGY, V242, P303, DOI 10.1006/VIRO.1997.9025.;RYABOV EV, 1999, P NATL ACAD SCI USA, V96, P1212, DOI 10.1073/PNAS.96.4.1212.;SABATH N, 2010, J MOL EVOL, V71, P308, DOI 10.1007/S00239-010-9386-3.;SABATH N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-144.;SABATH N, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0003996.;SANZ AI, 1999, J MOL EVOL, V49, P672, DOI 10.1007/PL00006588.;SCHEETS K, 2000, VIROLOGY, V267, P90, DOI 10.1006/VIRO.1999.0107.;SENANAYAKE SD, 1992, J VIROL, V66, P5277.;SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/NAR/15.3.1281.;SICKMEIER M, 2007, NUCLEIC ACIDS RES, V35, PD786, DOI 10.1093/NAR/GKL893.;SOREK R, 2007, RNA, V13, P1603, DOI 10.1261/RNA.682507.;STAVROU S, 2010, J VIROL, V84, P1348, DOI 10.1128/JVI.01585-09.;SUZUKI Y, 2006, MOL BIOL EVOL, V23, P1902, DOI 10.1093/MOLBEV/MSL050.;TAUTZ D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/NRG3053.;TOLL-RIERA M, 2009, MOL BIOL EVOL, V26, P603, DOI 10.1093/MOLBEV/MSN281.;TOMPA P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/J.FEBSLET.2005.03.072.;TRIFONOV V, 2009, PLOS CURR, V1, DOI [10.1371/CURRENTS.RRN1006, DOI 10.1371/CURRENTS.RRN1006].;VAN EYLL O, 2002, J VIROL, V76, P10665, DOI 10.1128/JVI.76.21.10665-10673.2002.;VARGASON JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X.;WANG J, 2003, NAT REV GENET, V4, P741, DOI 10.1038/NRG1160.;WARDROP EA, 1991, J VIROL, V65, P3421.;WEILAND JJ, 1989, NUCLEIC ACIDS RES, V17, P4675, DOI 10.1093/NAR/17.12.4675.;WU DD, 2011, PLOS GENET, V7, DOI 10.1371/JOURNAL.PGEN.1002379.;XIN HW, 1998, J VIROL, V72, P6956.;YANG ZF, 2011, FEBS LETT, V585, P641, DOI 10.1016/J.FEBSLET.2011.01.017.;ZAAIJER HL, 2007, J GEN VIROL, V88, P2137, DOI 10.1099/VIR.0.82906-0.;ZAMARIN D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06.;ZHANG JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/MOLBEV/MSI237.;ZHANG N, 1999, MOL GEN GENET, V262, P659, DOI 10.1007/S004380051128.;ZHOU Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/GR.076588.108.;ZHOU Q, 2008, J GENET GENOMICS, V35, P639, DOI 10.1016/S1673-8527(08)60085-5.","SABATH, N (REPRINT AUTHOR), UNIV ZURICH, INST EVOLUTIONARY BIOL \& ENVIRONM STUDIES, ZURICH, SWITZERLAND.;SABATH, NIV, WAGNER, ANDREAS, UNIV ZURICH, INST EVOLUTIONARY BIOL \& ENVIRONM STUDIES, ZURICH, SWITZERLAND.;SABATH, NIV, WAGNER, ANDREAS, SWISS INST BIOINFORMAT, BASEL, SWITZERLAND.;WAGNER, ANDREAS, SANTA FE INST, SANTA FE, NM 87501 USA.;KARLIN, DAVID, UNIV OXFORD, OXFORD, ENGLAND.","10.1093/MOLBEV/MSS179","GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND",NA,NA,"WELLCOME TRUST [090005], SWISS NATIONAL SCIENCE FOUNDATION [315230-129708], YEASTX PROJECT OF SYSTEMSX.CH, UNIVERSITY PRIORITY RESEARCH PROGRAM IN SYSTEMS BIOLOGY AT THE UNIVERSITY OF ZURICH","THE AUTHORS THANK ROBERT BELSHAW, GKIKAS MAGIORKINIS, AND ANGELO PAVESI FOR COMMENTS ON THE MANUSCRIPT AND ANDREW FIRTH FOR BIBLIOGRAPHICAL REFERENCES. D. K. ACKNOWLEDGES SUPPORT BY THE WELLCOME TRUST GRANT NUMBER 090005. A. W. ACKNOWLEDGES SUPPORT THROUGH SWISS NATIONAL SCIENCE FOUNDATION GRANT 315230-129708, AS WELL AS THROUGH THE YEASTX PROJECT OF SYSTEMSX.CH, AND THE UNIVERSITY PRIORITY RESEARCH PROGRAM IN SYSTEMS BIOLOGY AT THE UNIVERSITY OF ZURICH.",NA,"0737-4038","12","3767-3780","OXFORD UNIV PRESS","29",2012,"ISI000310970000014","118","BIOCHEMISTRY \& MOLECULAR BIOLOGY, EVOLUTIONARY BIOLOGY, GENETICS \& HEREDITY","20","BIOCHEMISTRY \& MOLECULAR BIOLOGY, EVOLUTIONARY BIOLOGY, GENETICS \& HEREDITY","NSABATHGMAIL.COM",NA,"035SW",NA,"SABATH, N (REPRINT AUTHOR), UNIV ZURICH, INST EVOLUTIONARY BIOL \& ENVIRONM STUDIES, ZURICH, SWITZERLAND","ISI","UNIV ZURICH;SWISS INST BIOINFORMAT;SANTA FE INST;UNIV OXFORD","UNIV ZURICH",NA,"SABATH N, 2012, MOL BIOL EVOL","SABATH N, 2012, MOL BIOL EVOL"
"ZHANG L, 2012, VIROL J","ZHANG L;WANG X;ZHANG Y;GONG L;MAO H;FENG C;OJCIUS DM;YAN J","RAPID AND SENSITIVE IDENTIFICATION OF RNA FROM THE EMERGING PATHOGEN, COXSACKIEVIRUS A6","VIROLOGY JOURNAL","VIROL. J.","BACKGROUND: HAND, FOOT AND MOUTH DISEASE (HFMD) IS CAUSED BY MEMBERS OF THE FAMILY PICORNAVIRIDAE IN THE GENUS ENTEROVIRUS. IT HAS BEEN REPORTED THAT COXSACKIEVIRUS A6 (CVA6) INFECTIONS ARE EMERGING AS A NEW AND MAJOR CAUSE OF EPIDEMIC HFMD. SPORADIC HFMD CASES POSITIVE FOR CVA6 WERE DETECTED IN THE MAINLAND OF CHINA IN RECENT YEARS. TO STRENGTHEN THE SURVEILLANCE OF CVA6 INFECTIONS AND OUTBREAK CONTROL, THE CLINICAL DIAGNOSIS IS URGENTLY NEEDED TO DISTINGUISH THE CVA6 INFECTION DISEASE FROM OTHER INFECTIONS. METHODS: IN ORDER TO DEVELOP A SENSITIVE QUANTITATIVE REAL-TIME RT-PCR ASSAY FOR RAPID DETECTION OF CVA6 RNA, PRIMERS AND PROBE WERE DESIGNED TO TARGET THE VP1 GENE SEGMENT OF CVA6. THE CONSERVATION OF THE TARGET SEGMENT WAS FIRSTLY ANALYZED BY BIOINFORMATIC TECHNOLOGY. THE SPECIFICITY OF THE REAL-TIME RT-PCR WAS FURTHER CONFIRMED BY DETECTING OTHER RELATED VIRUSES AND STANDARD CURVES WERE ESTABLISHED FOR THE SENSITIVITY EVALUATION. THE PHARYNGEAL SWAB SAMPLES FROM THE EV71 AND CVA16 UNRELATED HFMD PATIENTS WERE APPLIED FOR CVA6 DETECTION THROUGH THE ESTABLISHED METHOD. RESULTS: BASED ON THE PRIMER-PROBE SET TO DETECT THE TARGET VP1 GENE SEGMENT OF CVA6, THE QUANTITATIVE REAL-TIME RT-PCR ASSAY COULD DISCRIMINATE CVA6 INFECTION FROM OTHER RESEMBLE VIRAL DISEASES WITH A POTENTIAL DETECTION LIMIT OF 10 VIRAL COPIES/ML. THE SPECIFICITY OF THE ASSAY WAS DETERMINED BY SEQUENCE ALIGNMENT AND EXPERIMENTALLY TESTED ON VARIOUS RELATED VIRUSES. THE STANDARD CURVE SHOWED THAT THE AMPLIFICATION EFFICIENCY OF TEMPLATES WITH DIFFERENT CONCENTRATIONS OF TEMPLATES WAS ALMOST THE SAME (R-2 > 0.99). EVALUATION OF THE ESTABLISHED METHOD WITH PHARYNGEAL SWABS SAMPLES SHOWED GOOD ACCORDANCE WITH THE RESULTS FROM SEROLOGY DIAGNOSIS. CONCLUSION: THIS STUDY IS THE FIRST REPORT DEVELOPING A VP1 GENE-BASED QUANTITATIVE REAL-TIME RT-PCR FOR RAPID, STABLE AND SPECIFIC DETECTION OF CVA6 VIRUS. THE REAL-TIME RT-PCR ESTABLISHED IN THIS STUDY CAN BE USED AS A RELIABLE METHOD FOR EARLY DIAGNOSIS OF CVA6 INFECTION.","HAND; FOOT AND MOUTH DISEASE; ENTEROVIRUS; COXSACKIEVIRUS A6; QUANTITATIVE REAL-TIME RT-PCR","MOUTH-DISEASE OUTBREAK; REAL-TIME PCR; ENTEROVIRUS 71; FOOT; HAND; CHINA; ASSAY","ENGLISH","ARTICLE","ARTICLE",11,"BLOMQVIST S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/J.JCV.2010.02.002.;CHEN L, 2012, MOL MED REP, V5, P1001, DOI 10.3892/MMR.2012.742.;FUJIMOTO T, 2012, EMERG INFECT DIS, V18, P337, DOI 10.3201/EID1802.111147.;HAN JF, 2012, EMERG INFECT DIS, V18, P351, DOI 10.3201/EID1802.111524.;KALTENBOECK B, 2005, ADV CLIN CHEM, V40, P219, DOI 10.1016/S0065-2423(05)40006-2.;LIN TL, 2008, J CLIN MICROBIOL, V46, P785, DOI 10.1128/JCM.01114-07.;MACKAY IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/NAR/30.6.1292.;OOI MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X.;OSTERBACK R, 2009, EMERG INFECT DIS, V15, P1485, DOI 10.3201/EID1509.090438.;PETITJEAN J, 2006, J CLIN VIROL, V35, P278, DOI 10.1016/J.JCV.2005.09.006.;PIQUEUR MAC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-95.;SHE RC, 2009, J VIROL METHODS, V162, P245, DOI 10.1016/J.JVIROMET.2009.08.018.;WEI SH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-346.;WU Y, 2010, INT J INFECT DIS, V14, PE1076, DOI 10.1016/J.IJID.2010.07.006.;YANG F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-508.;ZHANG Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09.","ZHANG, YJ (REPRINT AUTHOR), ZHEJIANG PROV CTR DIS CONTROL \& PREVENT, 630 XINCHENG RD, HANGZHOU 310051, ZHEJIANG, PEOPLES R CHINA.;ZHANG, LEI, WANG, XINYING, ZHANG, YANJUN, GONG, LIMING, MAO, HAIYAN, FENG, CEN, ZHEJIANG PROV CTR DIS CONTROL \& PREVENT, HANGZHOU 310051, ZHEJIANG, PEOPLES R CHINA.;YAN, JIE, ZHEJIANG UNIV, SCH MED, AFFILIATED HOSP 1, DIV BASIC MED MICROBIOL,STATE KEY LAB DIAG \& TREA, HANGZHOU 310003, ZHEJIANG, PEOPLES R CHINA.;YAN, JIE, ZHEJIANG UNIV, SCH MED, DEPT MED MICROBIOL \& PARASITOL, HANGZHOU 310058, ZHEJIANG, PEOPLES R CHINA.;OJCIUS, DAVID M., UNIV CALIF, HLTH SCI RES INST, MERCED, CA 95343 USA.;OJCIUS, DAVID M., UNIV CALIF, SCH NAT SCI, MERCED, CA 95343 USA.","10.1186/1743-422X-9-298","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","298",NA,"PROVINCIAL MEDICAL RESEARCH FUND OF ZHEJIANG, CHINA [U201129691], GENERAL ADMINISTRATION OF QUALITY SUPERVISION, INSPECTION AND QUARANTINE OF P.R.C. [20100043], MONITOR TECHNOLOGY PLATFORM OF INFECTIOUS DISEASES OF THE STATE MAJOR SCIENCE AND TECHNOLOGY SPECIAL PROJECTS DURING THE 12TH FIVE-YEAR PLAN OF CHINA [2012ZX10004-210]","THIS WORK WAS SUPPORTED BY GRANTS FROM PROVINCIAL MEDICAL RESEARCH FUND OF ZHEJIANG, CHINA (U201129691), GENERAL ADMINISTRATION OF QUALITY SUPERVISION, INSPECTION AND QUARANTINE OF P.R.C. (20100043) AND MONITOR TECHNOLOGY PLATFORM OF INFECTIOUS DISEASES OF THE STATE MAJOR SCIENCE AND TECHNOLOGY SPECIAL PROJECTS DURING THE 12TH FIVE-YEAR PLAN OF CHINA (2012ZX10004-210).",NA,"1743-422X",NA,NA,"BIOMED CENTRAL LTD","9",2012,"ISI000314780100001","16","VIROLOGY","9","VIROLOGY","YJZHANGCDC.ZJ.CN MED\_BPZJU.EDU.CN",NA,"087RO",NA,"ZHANG, YJ (REPRINT AUTHOR), ZHEJIANG PROV CTR DIS CONTROL \& PREVENT, 630 XINCHENG RD, HANGZHOU 310051, ZHEJIANG, PEOPLES R CHINA","ISI","ZHEJIANG PROV CTR DIS CONTROL AND PREVENT;ZHEJIANG UNIV;ZHEJIANG UNIV;UNIV CALIF;UNIV CALIF","ZHEJIANG PROV CTR DIS CONTROL AND PREVENT",NA,"ZHANG L, 2012, VIROL J","ZHANG L, 2012, VIROL J"
"GARAGUSO I, 2012, PLOS ONE","GARAGUSO I;BORLAK J","A RAPID SCREENING ASSAY TO SEARCH FOR PHOSPHORYLATED PROTEINS IN TISSUE EXTRACTS","PLOS ONE","PLOS ONE","REVERSIBLE PROTEIN PHOSPHORYLATION IS AN ESSENTIAL MECHANISM IN THE REGULATION OF DIVERSE BIOLOGICAL PROCESSES, NONETHELESS IS FREQUENTLY ALTERED IN DISEASE. AS MOST PHOSPHOPROTEOME STUDIES ARE BASED ON OPTIMIZED IN-VITRO CELL CULTURE STUDIES NEW METHODS ARE IN NEED TO IMPROVE DE NOVO IDENTIFICATION AND CHARACTERIZATION OF PHOSPHOPROTEINS IN EXTRACTS FROM TISSUES. HERE, WE DESCRIBE A RAPID AND RELIABLE METHOD FOR THE DETECTION OF PHOSPHOPROTEINS IN TISSUE EXTRACT BASED ON AN EXPERIMENTAL STRATEGY THAT EMPLOYS 1D AND 2D SDS PAGE, WESTERN IMMUNOBLOTTING OF PHOSPHOPROTEINS, IN-GEL PROTEASE DIGESTION AND ENRICHMENT OF PHOSPHORPEPTIDES USING METAL OXIDE AFFINITY CHROMATOGRAPHY (MOAC). SUBSEQUENTLY, PHOSPHOPROTEINS ARE IDENTIFIED BY MALDI-TOF-MS/MS WITH THE CHCA-TL OR DHB ML SAMPLE MATRIX PREPARATION METHOD AND FURTHER CHARACTERIZED BY VARIOUS BIOINFORMATIC SOFTWARE TOOLS TO SEARCH FOR CANDIDATE KINASES AND PHOSPHORYLATION-DEPENDENT BINDING MOTIFS. THE METHOD WAS APPLIED TO MOUSE LUNG TISSUE EXTRACTS AND RESULTED IN AN IDENTIFICATION OF 160 UNIQUE PHOSPHOPROTEINS. NOTABLY, TIO2 ENRICHMENT OF PULMONARY PROTEIN EXTRACTS RESULTED IN AN IDENTIFICATION OF ADDITIONAL 17 PHOSPHOPROTEINS AND 20 PHOSPHORYLATION SITES. BY USE OF MOAC, NEW PHOSPHORYLATION SITES WERE IDENTIFIED AS EVIDENCED FOR THE ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR. SO FAR THIS PROTEIN WAS UNKNOWN TO BE PHOSPHORYLATED IN LUNG TISSUE OF MICE. OVERALL THE DEVELOPED METHODOLOGY ALLOWED EFFICIENT AND RAPID SCREENING OF PHOSPHORYLATED PROTEINS AND CAN BE EMPLOYED AS A GENERAL EXPERIMENTAL STRATEGY FOR AN IDENTIFICATION OF PHOSPHOPROTEINS IN TISSUE EXTRACTS.",NA,"2-DIMENSIONAL GEL-ELECTROPHORESIS; SITE-SPECIFIC PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; CANCER-CELLS; EXPRESSION; SEQUENCE; IDENTIFICATION; ENRICHMENT; PREDICTION; ANTIBODIES","ENGLISH","ARTICLE","ARTICLE",1,"BLOM N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/JMBI.1999.3310.;BLUME-JENSEN P, 2001, NATURE, V411, P355, DOI 10.1038/35077225.;COHEN B, 1990, P NATL ACAD SCI USA, V87, P4458, DOI 10.1073/PNAS.87.12.4458.;DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/PNAS.80.10.2926.;DELOM F, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-15.;DIELLA F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79.;FERRARI G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/PMIC.200500164.;GARAGUSO I, 2008, PROTEOMICS, V8, P2583, DOI 10.1002/PMIC.200701147.;GAZDAR AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/J.MOLMED.2004.08.008.;GHAFOURI B, 2002, PROTEOMICS, V2, P112, DOI 10.1002/1615-9861(200201)2:1<112::AID-PROT112>3.3.CO,2-E.;GRONBORG M, 2002, MOL CELL PROTEOMICS, V1, P517, DOI 10.1074/MCP.M200010-MCP200.;GUY GR, 1994, ELECTROPHORESIS, V15, P417, DOI 10.1002/ELPS.1150150160.;HORNBECK PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/PMIC.200300772.;JAIN E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136.;JENSEN ON, 1999, METH MOL B, V112, P513.;KRISTENSEN DB, 2000, HEPATOLOGY, V32, P268.;LARSEN MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/MCP.T500007-MCP200.;LEUNG KY, 2001, PROTEOMICS, V1, P787.;LIM YP, 2005, CLIN CANCER RES, V11, P3163, DOI 10.1158/1078-0432.CCR-04-2243.;LINTHICUM DS, 2001, TISSUE CELL, V33, P514, DOI 10.1054/TICE.2001.0205.;MANNING G, 2002, SCIENCE, V298, P1912, DOI 10.1126/SCIENCE.1075762.;NOEL-GEORIS I, 2001, DIS MARKERS, V17, P271, DOI 10.1155/2001/607263.;OBENAUER JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/NAR/GKG584.;ODA Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/PNAS.96.12.6591.;OLSEN JV, 2006, CELL, V127, P635, DOI 10.1016/J.CELL.2006.09.026.;PERKINS DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO,2-2.;PINKSE MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/AC0498617.;PRATT WB, 1998, P SOC EXP BIOL MED, V217, P420.;PREDIC J, 2002, BIOCHEMISTRY-US, V41, P1070, DOI 10.1021/BI0117854.;RUSH J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/NBT1046.;SHIMAMURA T, 2008, J THORAC ONCOL, V3, PS152, DOI 10.1097/JTO.0B013E318174EA3A.;STRIPP BR, 2002, AM J RESP CELL MOL, V27, P170, DOI 10.1165/AJRCMB.27.2.200200270C.;WU CH, 2002, NUCLEIC ACIDS RES, V30, P35, DOI 10.1093/NAR/30.1.35.;YAMAGATA A, 2002, PROTEOMICS, V2, P1267, DOI 10.1002/1615-9861(200209)2:9<1267::AID-PROT1267>3.0.CO,2-R.;ZHANG XL, 2002, RAPID COMMUN MASS SP, V16, P2325, DOI 10.1002/RCM.864.;ZHENG XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2.","BORLAK, J (REPRINT AUTHOR), HANNOVER MED SCH, CTR PHARMACOL \& TOXICOL, D-3000 HANNOVER, GERMANY.;GARAGUSO, IGNAZIO, BORLAK, JUERGEN, HANNOVER MED SCH, CTR PHARMACOL \& TOXICOL, D-3000 HANNOVER, GERMANY.","10.1371/JOURNAL.PONE.0050025","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E50025",NA,"VIRTUAL LIVER NETWORK OF THE GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH (BMBF) [031 6154], LOWER SAXONY MINISTRY OF CULTURE AND SCIENCES, VOLKSWAGEN FOUNDATION, GERMANY [25A.5-7251-99-3/00], GERMAN RESEARCH FOUNDATION (DFG)","THE AUTHORS GRATEFULLY ACKNOWLEDGE SUPPORT FROM THE VIRTUAL LIVER NETWORK (GRANT 031 6154) OF THE GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH (BMBF). PART OF THIS WORK WAS ALSO FUNDED BY THE LOWER SAXONY MINISTRY OF CULTURE AND SCIENCES AND THE VOLKSWAGEN FOUNDATION, GERMANY TO JB. GRANT NUMBER: 25A.5-7251-99-3/00. THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT. THE CHARGE FOR THIS PUBLICATION WAS COVERED BY THE GERMAN RESEARCH FOUNDATION (DFG) SPONSORSHIP ``OPEN ACCESS PUBLICATION.''",NA,"1932-6203","11",NA,"PUBLIC LIBRARY SCIENCE","7",2012,"ISI000311272300084","36","SCIENCE \& TECHNOLOGY - OTHER TOPICS","13","MULTIDISCIPLINARY SCIENCES","BORLAK.JUERGENMH-HANNOVER.DE",NA,"039UP",NA,"BORLAK, J (REPRINT AUTHOR), HANNOVER MED SCH, CTR PHARMACOL \& TOXICOL, D-3000 HANNOVER, GERMANY","ISI","HANNOVER MED SCH","HANNOVER MED SCH",NA,"GARAGUSO I, 2012, PLOS ONE","GARAGUSO I, 2012, PLOS ONE"
"ARCHER J, 2012, PLOS ONE","ARCHER J;WEBER J;HENRY K;WINNER D;GIBSON R;LEE L;PAXINOS E;ARTS EJ;ROBERTSON DL;MIMMS L;QUINONES MATEU ME","USE OF FOUR NEXT-GENERATION SEQUENCING PLATFORMS TO DETERMINE HIV-1 CORECEPTOR TROPISM","PLOS ONE","PLOS ONE","HIV-1 CORECEPTOR TROPISM ASSAYS ARE REQUIRED TO RULE OUT THE PRESENCE OF CXCR4-TROPIC (NON-R5) VIRUSES PRIOR TREATMENT WITH CCR5 ANTAGONISTS. PHENOTYPIC (E.G., TROFILE (TM), MONOGRAM BIOSCIENCES) AND GENOTYPIC (E.G., POPULATION SEQUENCING LINKED TO BIOINFORMATIC ALGORITHMS) ASSAYS ARE THE MOST WIDELY USED. ALTHOUGH SEVERAL NEXT-GENERATION SEQUENCING (NGS) PLATFORMS ARE AVAILABLE, TO DATE ALL PUBLISHED DEEP SEQUENCING HIV-1 TROPISM STUDIES HAVE USED THE 454 (TM) LIFE SCIENCES/ROCHE PLATFORM. IN THIS STUDY, HIV-1 CO-RECEPTOR USAGE WAS PREDICTED FOR TWELVE PATIENTS SCHEDULED TO START A MARAVIROC-BASED ANTIRETROVIRAL REGIMEN. THE V3 REGION OF THE HIV-1 ENV GENE WAS SEQUENCED USING FOUR NGS PLATFORMS: 454 (TM), PACBIO (R) RS (PACIFIC BIOSCIENCES), ILLUMINA (R), AND ION TORRENT (TM) (LIFE TECHNOLOGIES). CROSS-PLATFORM VARIATION WAS EVALUATED, INCLUDING NUMBER OF READS, READ LENGTH AND ERROR RATES. HIV-1 TROPISM WAS INFERRED USING GENO2PHENO, WEB PSSM, AND THE 11/24/25 RULE AND COMPARED WITH TROFILE (TM) AND VIROLOGIC RESPONSE TO ANTIRETROVIRAL THERAPY. ERROR RATES RELATED TO INSERTIONS/DELETIONS (INDELS) AND NUCLEOTIDE SUBSTITUTIONS INTRODUCED BY THE FOUR NGS PLATFORMS WERE LOW COMPARED TO THE ACTUAL HIV-1 SEQUENCE VARIATION. EACH PLATFORM DETECTED ALL MAJOR VIRUS VARIANTS WITHIN THE HIV-1 POPULATION WITH SIMILAR FREQUENCIES. IDENTIFICATION OF NON-R5 VIRUSES WAS COMPARABLE AMONG THE FOUR PLATFORMS, WITH MINOR DIFFERENCES ATTRIBUTABLE TO THE ALGORITHMS USED TO INFER HIV-1 TROPISM. ALL NGS PLATFORMS SHOWED SIMILAR CONCORDANCE WITH VIROLOGIC RESPONSE TO THE MARAVIROC-BASED REGIMEN (75\% TO 80\% RANGE DEPENDING ON THE ALGORITHM USED), COMPARED TO TROFILE (80\%) AND POPULATION SEQUENCING (70\%). IN CONCLUSION, ALL FOUR NGS PLATFORMS WERE ABLE TO DETECT MINORITY NON-R5 VARIANTS AT COMPARABLE LEVELS SUGGESTING THAT ANY NGS-BASED METHOD CAN BE USED TO PREDICT HIV-1 CORECEPTOR USAGE.",NA,"IMMUNODEFICIENCY-VIRUS TYPE-1; TREATMENT-EXPERIENCED PATIENTS; TREATMENT-NAIVE PATIENTS; PHENOTYPIC ASSAY; REVERSE-TRANSCRIPTASE; VIROLOGICAL RESPONSE; GENOTYPIC PREDICTION; CCR5 ANTAGONISTS; GENOME SEQUENCE; V3 LOOP","ENGLISH","ARTICLE","ARTICLE",56,"ABBATE I, 2011, AIDS, V25, P611, DOI 10.1097/QAD.0B013E328343489E.;ADRIAENSSENS EM, 2012, J VIROL, V86, P6369, DOI 10.1128/JVI.00641-12.;ARCHER J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-47.;ARCHER J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/JOURNAL.PCBI.1001022.;ARCHER J, 2009, AIDS, V23, P1209, DOI 10.1097/QAD.0B013E32832B4399.;ARMENIA D, 2012, J INFECT DIS, V205, P557, DOI 10.1093/INFDIS/JIR821.;BENTLEY DR, 2008, NATURE, V456, P53, DOI 10.1038/NATURE07517.;BUNNIK EM, 2011, PLOS PATHOG, V7, DOI 10.1371/JOURNAL.PPAT.1002106.;BUZON MJ, 2011, PLOS PATHOG, V7, DOI 10.1371/JOURNAL.PPAT.1002314.;CARDOZO T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/AID.2006.0130.;CHIN CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMOA1012928.;DE MENDOZA C, 2008, JAIDS-J ACQ IMM DEF, V48, P241, DOI 10.1097/QAI.0B013E3181734F0E.;DEJONG JJ, 1992, J VIROL, V66, P6777.;DELOBEL P, 2007, J CLIN MICROBIOL, V45, P1572, DOI 10.1128/JCM.02090-06.;DENG HK, 1996, NATURE, V381, P661, DOI 10.1038/381661A0.;DORR P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005.;DRAGIC T, 1996, NATURE, V381, P667, DOI 10.1038/381667A0.;DROEGE M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/J.JBIOTEC.2008.03.021.;FOUCHIER RAM, 1995, J CLIN MICROBIOL, V33, P906.;GONZALEZ-SERNA A, 2012, ANTIMICROB AGENTS CH, V56, P1202, DOI 10.1128/AAC.05857-11.;HARRIGAN PR, 2009, MOTIVATE TROPISM STU.;HOWDEN BP, 2011, PLOS PATHOG, V7, DOI 10.1371/JOURNAL.PPAT.1002359.;JENSEN MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003.;LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/BIOINFORMATICS/BTM404.;LIN NH, 2009, CURR OPIN HIV AIDS, V4, P481, DOI 10.1097/COH.0B013E328331B929.;LIU J, 2011, ANTIMICROB AGENTS CH, V55, P1114, DOI 10.1128/AAC.01492-10.;LOMAN NJ, 2012, NATURE BIOTECHNOLOGY.;LOW AJ, 2007, AIDS, V21, PF19.;MARGULIES M, 2005, NATURE, V437, P376, DOI 10.1038/NATURE03959.;MATSUSHITA H, 2012, NATURE, V482, P400, DOI 10.1038/NATURE10755.;MESSIAEN P, 2012, VIROLOGY, V426, P7, DOI 10.1016/J.VIROL.2012.01.002.;METZKER ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/NRG2626.;MILLER W, 2011, P NATL ACAD SCI USA, V108, P12348, DOI 10.1073/PNAS.1102838108.;MORENO S, 2009, HIV CLIN TRIALS, V10, P394, DOI 10.1310/HCT1006-394.;MUKHERJEE R, 2011, AIDS, V25, P1951, DOI 10.1097/QAD.0B013E32834B34DE.;PALMER S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005.;POINAR HN, 2006, SCIENCE, V311, P392, DOI 10.1126/SCIENCE.1123360.;POVEDA E, 2010, AIDS REV, V12, P135.;POVEDA E, 2009, J ANTIMICROB CHEMOTH, V63, P1006, DOI 10.1093/JAC/DKP063.;RASKO DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMOA1106920.;RAYMOND S, 2008, AIDS, V22, PF11, DOI 10.1097/QAD.0B013E32830EBCD4.;RAYMOND S, 2011, J ANTIMICROB CHEMOTH, V66, P1972, DOI 10.1093/JAC/DKR224.;RAYMOND S, 2011, AIDS, V25, P1668, DOI 10.1097/QAD.0B013E3283498305.;RAYMOND S, 2010, J CLIN VIROL, V47, P126, DOI 10.1016/J.JCV.2009.11.018.;RECORDON-PINSON P, 2010, ANTIMICROB AGENTS CH, V54, P3335, DOI 10.1128/AAC.00148-10.;REEVES JD, 2009, J VIRAL ENTRY, V3, P94.;ROBINSON BF, 1998, BEHAV RES METH INS C, V30, P731, DOI 10.3758/BF03209495.;ROSE JD, 2009, CURR OPIN HIV AIDS, V4, P136, DOI 10.1097/COH.0B013E328322F973.;ROSEN O, 2006, P NATL ACAD SCI USA, V103, P13950, DOI 10.1073/PNAS.0606312103.;ROTHBERG JM, 2011, NATURE, V475, P348, DOI 10.1038/NATURE10242.;SAAG M, 2009, J INFECT DIS, V199, P1638, DOI 10.1086/598965.;SALIOU A, 2011, ANTIMICROB AGENTS CH, V55, P2831, DOI 10.1128/AAC.00091-11.;SCALLY A, 2012, NATURE, V483, P169, DOI 10.1038/NATURE10842.;SECLEN E, 2011, J CLIN MICROBIOL, V49, P3380, DOI 10.1128/JCM.00908-11.;SHENDURE J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/NBT1486.;SIMEN BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736.;SING T, 2007, ANTIVIR THER, V12, P1097.;SKRABAL K, 2007, J CLIN MICROBIOL, V45, P279, DOI 10.1128/JCM.01118-06.;SWENSON LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/CID/CIR493.;SWENSON LC, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0017402.;SWENSON LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/INFDIS/JIQ030.;SWENSON LC, 2010, JAIDS-J ACQ IMM DEF, V54, P506, DOI 10.1097/QAI.0B013E3181D0558F.;TAMURA K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/MOLBEV/MSR121.;TEAM RDC, 2010, R LANG ENV STAT COMP.;TILTON JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/J.ANTIVIRAL.2009.07.022.;TRABAUD MA, 2012, J MED VIROL, V84, P402, DOI 10.1002/JMV.23209.;TRAN B, 2012, J CLIN ONCOL, V30, P647, DOI 10.1200/JCO.2011.39.2316.;TROUPLIN V, 2001, J VIROL, V75, P251, DOI 10.1128/JVI.75.1.251-259.2001.;VANDENBROUCKE I, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-4.;VARGHESE V, 2009, JAIDS-J ACQ IMM DEF, V52, P309, DOI 10.1097/QAI.0B013E3181BCA669.;WEBER J, 2012, 28TH ANNUAL CLINICAL.;WEBER J, 2006, AIDS REV, V8, P60.;WESTBY M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006.;WHITCOMB JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06.;YANG Z, 2011, J VIROL, V85, P5897, DOI 10.1128/JVI.00428-11.;YE L, 2011, GENOME BIOL, V12, DOI 10.1186/GB-2011-12-3-R31.","ARCHER, J (REPRINT AUTHOR), UNIV MANCHESTER, FAC LIFE SCI, MANCHESTER, LANCS, ENGLAND.;ARCHER, JOHN, ROBERTSON, DAVID L., UNIV MANCHESTER, FAC LIFE SCI, MANCHESTER, LANCS, ENGLAND.","10.1371/JOURNAL.PONE.0049602","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E49602",NA,"MEDICAL RESEARCH COUNCIL [G1001806], BIOTECHNOLOGY AND BIOLOGICAL SCIENCES RESEARCH COUNCIL [BB/H012419/1]",NA,NA,"1932-6203","11",NA,"PUBLIC LIBRARY SCIENCE","7",2012,"ISI000311151900171","76","SCIENCE \& TECHNOLOGY - OTHER TOPICS","26","MULTIDISCIPLINARY SCIENCES","MEQCASE.EDU",NA,"038CD",NA,"ARCHER, J (REPRINT AUTHOR), UNIV MANCHESTER, FAC LIFE SCI, MANCHESTER, LANCS, ENGLAND","ISI","UNIV MANCHESTER","UNIV MANCHESTER",NA,"ARCHER J, 2012, PLOS ONE","ARCHER J, 2012, PLOS ONE"
"CLIFFORD RJ, 2012, PLOS ONE","CLIFFORD RJ;MILILLO M;PRESTWOOD J;QUINTERO R;ZURAWSKI DV;KWAK YI;WATERMAN PE;LESHO EP;MC GANN P","DETECTION OF BACTERIAL 16S RRNA AND IDENTIFICATION OF FOUR CLINICALLY IMPORTANT BACTERIA BY REAL-TIME PCR","PLOS ONE","PLOS ONE","WITHIN THE PARADIGM OF CLINICAL INFECTIOUS DISEASE RESEARCH, ACINETOBACTER BAUMANNII, ESCHERICHIA COLI, KLEBSIELLA PNEUMONIAE, AND PSEUDOMONAS AERUGINOSA REPRESENT THE FOUR MOST CLINICALLY RELEVANT, AND HENCE MOST EXTENSIVELY STUDIED BACTERIA. CURRENT CULTURE-BASED METHODS FOR IDENTIFYING THESE ORGANISMS ARE SLOW AND CUMBERSOME, AND THERE IS INCREASING NEED FOR MORE RAPID AND ACCURATE MOLECULAR DETECTION METHODS. USING BIOINFORMATIC TOOLS, 962,279 BACTERIAL 16S RRNA GENE SEQUENCES WERE ALIGNED, AND REGIONS OF HOMOLOGY WERE SELECTED TO GENERATE A SET OF REAL-TIME PCR PRIMERS THAT TARGET 93.6\% OF ALL BACTERIAL 16S RRNA SEQUENCES PUBLISHED TO DATE. A SET OF FOUR SPECIES-SPECIFIC REAL-TIME PCR PRIMER PAIRS WERE ALSO DESIGNED, CAPABLE OF DETECTING LESS THAN 100 GENOME COPIES OF A. BAUMANNII, E. COLI, K. PNEUMONIAE, AND P. AERUGINOSA. ALL PRIMERS WERE TESTED FOR SPECIFICITY IN VITRO AGAINST 50 SPECIES OF GRAM-POSITIVE AND -NEGATIVE BACTERIA. ADDITIONALLY, THE SPECIES-SPECIFIC PRIMERS WERE TESTED AGAINST A PANEL OF 200 CLINICAL ISOLATES OF EACH SPECIES, RANDOMLY SELECTED FROM A LARGE REPOSITORY OF CLINICAL ISOLATES FROM DIVERSE AREAS AND SOURCES. A COMPARISON OF CULTURE AND REAL-TIME PCR DEMONSTRATED 100\% CONCORDANCE. THE PRIMERS WERE INCORPORATED INTO A RAPID ASSAY CAPABLE OF POSITIVE IDENTIFICATION FROM PLATE OR BROTH CULTURES IN LESS THAN 90 MINUTES. FURTHERMORE, OUR DATA DEMONSTRATE THAT CURRENT TARGETS, SUCH AS THE UIDA GENE IN E. COLI, ARE NOT SUITABLE AS SPECIES-SPECIFIC GENES DUE TO SEQUENCE VARIATION. THE ASSAY DESCRIBED HEREIN IS RAPID, COST-EFFECTIVE AND ACCURATE, AND CAN BE EASILY INCORPORATED INTO ANY RESEARCH LABORATORY CAPABLE OF REAL-TIME PCR.",NA,"RESISTANT STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; KLEBSIELLA-PNEUMONIAE; ACINETOBACTER-BAUMANNII; MULTIPLEX PCR; VITEK 2; ENTEROBACTERIACEAE; GENES; DNA","ENGLISH","ARTICLE","ARTICLE",70,"ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/NAR/25.17.3389.;ANKLAM KS, 2012, J FOOD PROTECT, V75, P643, DOI 10.4315/0362-028X.JFP-11-392.;ANUJ SN, 2009, DIAGN MICR INFEC DIS, V63, P127, DOI 10.1016/J.DIAGMICROBIO.2008.09.018.;BUSTIN SA, 2010, METHODS, V50, P217, DOI 10.1016/J.YMETH.2009.12.006.;BUSTIN SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/CLINCHEM.2008.112797.;CANTON R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/J.1469-0691.2012.03821.X.;CATTOIR V, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-21.;CHEN L, 2012, ANTIMICROB AGENTS CH, V56, P3444, DOI 10.1128/AAC.00316-12.;CHERN EC, 2011, LETT APPL MICROBIOL, V52, P298, DOI 10.1111/J.1472-765X.2010.03001.X.;COLE JR, 2009, NUCLEIC ACIDS RES, V37, PD141, DOI 10.1093/NAR/GKN879.;DONHAUSER SC, 2009, ANAL SCI, V25, P669, DOI 10.2116/ANALSCI.25.669.;FRAHM E, 2003, J MICROBIOL METH, V52, P123, DOI 10.1016/S0167-7012(02)00150-1.;HARTMAN LJ, 2009, J MOL DIAGN, V11, P464, DOI 10.2353/JMOLDX.2009.080136.;HILLENBRAND ME, 2011, INT J OPHTHALMOL-CHI, V4, P262, DOI 10.3980/J.ISSN.2222-3959.2011.03.10.;JIN WY, 2011, DIAGN MICR INFEC DIS, V70, P442, DOI 10.1016/J.DIAGMICROBIO.2011.04.013.;LAVENIR R, 2007, J MICROBIOL METH, V70, P20, DOI 10.1016/J.MIMET.2007.03.008.;LIU CM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-56.;LUKJANCENKO O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/S00248-010-9717-3.;MAURER JJ, 2011, ANNU REV FOOD SCI T, V2, P259, DOI 10.1146/ANNUREV.FOOD.080708.100730.;MCCONNELL MJ, 2012, J CLIN MICROBIOL, V50, P1412, DOI 10.1128/JCM.06566-11.;MCGANN P, 2011, INFECT CONT HOSP EP, V32, P1116, DOI 10.1086/662380.;NADKARNI MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257.;NORDMANN P, 2012, CLIN MICROBIOL INFEC, V18, P411, DOI 10.1111/J.1469-0691.2012.03795.X.;O'LEARY J, 2009, J CLIN MICROBIOL, V47, P3449, DOI 10.1128/JCM.01026-09.;PAVLOVIC M, 2011, J APPL MICROBIOL, V110, P1245, DOI 10.1111/J.1365-2672.2011.04973.X.;PENEL S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S3.;STENGER DA, 2002, CURR OPIN BIOTECH, V13, P208, DOI 10.1016/S0958-1669(02)00321-X.;THONG KL, 2011, TROP BIOMED, V28, P21.;WALSH TR, 2010, INT J ANTIMICROB AG, V36, PS8, DOI 10.1016/S0924-8579(10)70004-2.;WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991.;WINSTANLEY T, 2011, CLIN MICROBIOL REV, V24, P515, DOI 10.1128/CMR.00061-10.;WOODFORD N, 2010, J CLIN MICROBIOL, V48, P2999, DOI 10.1128/JCM.00341-10.","MC GANN, P (REPRINT AUTHOR), WALTER REED ARMY INST RES, MULTIDRUG RESISTANT ORGANISM REPOSITORY \& SURVEIL, SILVER SPRING, MD 20910 USA.;CLIFFORD, ROBERT J., MILILLO, MICHAEL, PRESTWOOD, JACKSON, QUINTERO, REYES, KWAK, YOON I., WATERMAN, PAIGE E., LESHO, EMIL P., MC GANN, PATRICK, WALTER REED ARMY INST RES, MULTIDRUG RESISTANT ORGANISM REPOSITORY \& SURVEIL, SILVER SPRING, MD 20910 USA.;ZURAWSKI, DANIEL V., WALTER REED ARMY INST RES, DEPT WOUND INFECT, SILVER SPRING, MD USA.","10.1371/JOURNAL.PONE.0048558","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E48558",NA,NA,NA,NA,"1932-6203","11",NA,"PUBLIC LIBRARY SCIENCE","7",2012,"ISI000311315300038","32","SCIENCE \& TECHNOLOGY - OTHER TOPICS","54","MULTIDISCIPLINARY SCIENCES","PATRICK.MCGANNAMEDD.ARMY.MIL",NA,"040IE",NA,"MC GANN, P (REPRINT AUTHOR), WALTER REED ARMY INST RES, MULTIDRUG RESISTANT ORGANISM REPOSITORY \& SURVEIL, SILVER SPRING, MD 20910 USA","ISI","WALTER REED ARMY INST RES;WALTER REED ARMY INST RES","WALTER REED ARMY INST RES",NA,"CLIFFORD RJ, 2012, PLOS ONE","CLIFFORD RJ, 2012, PLOS ONE"
"MANICHANH C, 2012, NAT REV GASTROENTEROL HEPATOL","MANICHANH C;BORRUEL N;CASELLAS F;GUARNER F","THE GUT MICROBIOTA IN IBD","NATURE REVIEWS GASTROENTEROLOGY \& HEPATOLOGY","NAT. REV. GASTROENTEROL. HEPATOL.","IBD-ULCERATIVE COLITIS AND CROHN'S DISEASE-IS EMERGING AS A WORLDWIDE EPIDEMIC. AN ASSOCIATION BETWEEN THE INCREASED INCIDENCE OF IBD AND ENVIRONMENTAL FACTORS LINKED TO SOCIOECONOMIC DEVELOPMENT HAS BEEN PERSISTENTLY DETECTED IN DIFFERENT PARTS OF THE WORLD. THE LIFESTYLE IN DEVELOPED COUNTRIES MIGHT IMPAIR THE NATURAL PATTERNS OF MICROBIAL COLONIZATION OF THE HUMAN GUT. THE INTERACTION OF MICROBES WITH MUCOSAL IMMUNE COMPARTMENTS IN THE GUT SEEMS TO HAVE A MAJOR ROLE IN PRIMING AND REGULATING IMMUNITY. IN IBD, MUCOSAL LESIONS ARE GENERATED BY AN EXCESSIVE OR DYSREGULATED IMMUNE RESPONSE AGAINST COMMENSAL MICROBES IN THE GUT. IN INDIVIDUALS WITH A GENETIC SUSCEPTIBILITY TO IBD, ABNORMAL MICROBIAL COLONIZATION OF THE GASTROINTESTINAL TRACT MIGHT BE THE ORIGIN OF SUCH DYSREGULATION. DEVELOPMENTS IN GENE-SEQUENCING TECHNOLOGIES, AS WELL AS INCREASED AVAILABILITY OF POWERFUL BIOINFORMATIC TOOLS, HAVE ENABLED NOVEL INSIGHTS INTO THE MICROBIAL COMPOSITION OF THE HUMAN GUT MICROBIOTA AND THE EFFECT OF MICROBIAL COMMUNITIES ON HUMAN PHYSIOLOGY AND DISEASE. STUDIES THAT USED THESE TECHNOLOGIES INDICATE THAT DYSBIOSIS (THAT IS, ABNORMAL MICROBIOTA COMPOSITION) AND DECREASED COMPLEXITY OF THE GUT MICROBIAL ECOSYSTEM ARE COMMON FEATURES IN PATIENTS WITH CROHN'S DISEASE OR ULCERATIVE COLITIS. WHETHER SUCH CHANGES ARE A CAUSE OR A CONSEQUENCE OF THE DISEASE REMAINS TO BE ELUCIDATED.",NA,"INFLAMMATORY BOWEL DISEASES; CROHNS-DISEASE; ULCERATIVE-COLITIS; PROBIOTIC BACTERIA; ESCHERICHIA-COLI; FECAL MICROBIOTA; COLONIC-MUCOSA; FAECALIBACTERIUM-PRAUSNITZII; CLINICAL REMISSION; HYGIENE HYPOTHESIS","ENGLISH","REVIEW","ARTICLE",397,"ARUMUGAM M, 2011, NATURE, V473, P174, DOI 10.1038/NATURE09944.;ASQUITH M, 2010, J EXP MED, V207, P1573, DOI 10.1084/JEM.20101330.;ATARASHI K, 2011, SCIENCE, V331, P337, DOI 10.1126/SCIENCE.1198469.;BAGER P, 2012, INFLAMM BOWEL DIS, V18, P857, DOI 10.1002/IBD.21805.;BERNSTEIN CN, 2008, GUT, V57, P1185, DOI 10.1136/GUT.2007.122143.;BORRUEL N, 2002, GUT, V51, P659, DOI 10.1136/GUT.51.5.659.;BORRUEL N, 2003, AM J GASTROENTEROL, V98, P865, DOI 10.1016/S0002-9270(03)00048-0.;BRANDTZAEG P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/J.1365-3083.2009.02319.X.;CAPORASO JG, 2011, GENOME BIOL, V12, DOI 10.1186/GB-2011-12-5-R50.;CAROL M, 2006, J LEUKOCYTE BIOL, V79, P917, DOI 10.1189/JLB.0405188.;CASELLAS F, 1998, INFLAMM BOWEL DIS, V4, P1.;CHASSAING B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/J.GASTRO.2011.01.054.;CHASSAING B, 2011, J CLIN INVEST, V121, P966, DOI 10.1172/JCI44632.;COLE JR, 2009, NUCLEIC ACIDS RES, V37, PD141, DOI 10.1093/NAR/GKN879.;COSTELLO EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/SCIENCE.1177486.;CROHN BB, 1932, J AMER MED ASSOC, V99, P1323, DOI 10.1001/JAMA.1932.02740680019005.;D'HAENS GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7.;DARFEUILLE-MICHAUD A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/J.GASTRO.2004.04.061.;DE FILIPPO C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/PNAS.1005963107.;DESANTIS TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05.;DICKSVED J, 2008, ISME J, V2, P716, DOI 10.1038/ISMEJ.2008.37.;ECKBURG PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/SCIENCE.1110591.;FOX GE, 1977, P NATL ACAD SCI USA, V74, P4537, DOI 10.1073/PNAS.74.10.4537.;FRANK DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0B013E3282F2B0E8.;FRANK DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/PNAS.0706625104.;GILL SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/SCIENCE.1124234.;GUARNER F, 2008, INFLAMM BOWEL DIS, V14, PS83, DOI 10.1002/IBD.20548.;GUARNER F, 2006, NAT CLIN PRACT GASTR, V3, P275, DOI 10.1038/NCPGASTHEP0471.;HANDELSMAN J, 1998, CHEM BIOL, V5, PR245, DOI 10.1016/S1074-5521(98)90108-9.;HART AL, 2004, GUT, V53, P1602, DOI 10.1136/GUT.2003.037325.;HVIID A, 2011, GUT, V60, P49, DOI 10.1136/GUT.2010.219683.;GOSALBES MJ, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0017447.;KANG S, 2010, INFLAMM BOWEL DIS, V16, P2034, DOI 10.1002/IBD.21319.;KELLY D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/NI1018.;LEES CW, 2011, GUT, V60, P1739, DOI 10.1136/GUT.2009.199679.;LEPAGE P, 2005, INFLAMM BOWEL DIS, V11, P473, DOI 10.1097/01.MIB.0000159662.62651.06.;LEPAGE P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/J.GASTRO.2011.04.011.;LLOPIS M, 2009, INFLAMM BOWEL DIS, V15, P275, DOI 10.1002/IBD.20736.;MACPHERSON A, 1996, GUT, V38, P365, DOI 10.1136/GUT.38.3.365.;MAI V, 2006, J CLIN MICROBIOL, V44, P4550, DOI 10.1128/JCM.01542-06.;MANICHANH C, 2006, GUT, V55, P205, DOI 10.1136/GUT.2005.073817.;MARTINEZ C, 2008, AM J GASTROENTEROL, V103, P643, DOI 10.1111/J.1572-0241.2007.01592.X.;MARTINEZ-MEDINA M, 2009, INFLAMM BOWEL DIS, V15, P872, DOI 10.1002/IBD.20860.;MARWAHA AK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/FIMMU.2012.00129.;MAZMANIAN SK, 2008, NATURE, V453, P620, DOI 10.1038/NATURE07008.;MCLAUGHLIN SD, 2010, ANN SURG, V252, P90, DOI 10.1097/SLA.0B013E3181E3DC8B.;METAHIT, 2012, MET HUM GASTR TRACT.;MOLODECKY NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/J.GASTRO.2011.10.001.;NELSON KE, 2010, SCIENCE, V328, P994, DOI 10.1126/SCIENCE.1183605.;NOOR S. O., 2010, BMC GASTROENTEROL, V12, P134.;OHKUSA T, 2003, GUT, V52, P79, DOI 10.1136/GUT.52.1.79.;OHKUSA T, 2002, J GASTROEN HEPATOL, V17, P849, DOI 10.1046/J.1440-1746.2002.02834.X.;OTT SJ, 2004, GUT, V53, P685, DOI 10.1136/GUT.2003.025403.;PENDER SLF, 2008, INFLAMM BOWEL DIS, V14, PS136, DOI 10.1002/IBD.20630.;PIRZER U, 1991, LANCET, V338, P1238, DOI 10.1016/0140-6736(91)92104-A.;PITCHER MCL, 2000, GUT, V46, P64, DOI 10.1136/GUT.46.1.64.;PROCTOR LM, 2011, CELL HOST MICROBE, V10, P287, DOI 10.1016/J.CHOM.2011.10.001.;PRUESSE E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/NAR/GKM864.;QIN JJ, 2010, NATURE, V464, P59, DOI 10.1038/NATURE08821.;RODRIGUE S, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0006864.;ROEDIGER WEW, 1997, DIGEST DIS SCI, V42, P1571, DOI 10.1023/A:1018851723920.;ROOK GAW, 2009, IMMUNOLOGY, V126, P3, DOI 10.1111/J.1365-2567.2008.03007.X.;ROUND JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/NRI2515.;ROWAN F, 2010, DIS COLON RECTUM, V53, P1530, DOI 10.1007/DCR.0B013E3181F1E620.;SARTOR RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/J.GASTRO.2007.11.059.;SCANLAN PD, 2006, J CLIN MICROBIOL, V44, P3980, DOI 10.1128/JCM.00312-06.;SELBY W, 2007, GASTROENTEROLOGY, V132, P2313, DOI 10.1053/J.GASTRO.2007.03.031.;SHEN B, 2012, NAT REV GASTRO HEPAT, V9, P323, DOI 10.1038/NRGASTRO.2012.58.;SOKOL H, 2006, J CLIN MICROBIOL, V44, P3172, DOI 10.1128/JCM.02600-05.;SOKOL H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/IBD.20903.;SOKOL H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/PNAS.0804812105.;STRAUSS J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/IBD.21606.;STROBER W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587.;SWIDSINSKI A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/GAST.2002.30294.;THE NIH COMMON FUND OFFICE OF STRATEGIC COORDINATION, 2012, HUM MICR PROJ.;VARELA E, 2011, GASTROENTEROLOGY, V140, PS47.;WHITE W. H., 1888, GUYS HOSP REP, V45, P131.;WILLING BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/J.GASTRO.2010.08.049.;WU GD, 2011, SCIENCE, V334, P105, DOI 10.1126/SCIENCE.1208344.","GUARNER, F (REPRINT AUTHOR), UNIV HOSP VALL DHEBRON, DIGEST SYST RES UNIT, PASSEIG VALL DHEBRON 119-129, BARCELONA 08035, SPAIN.;MANICHANH, CHAYSAVANH, BORRUEL, NATALIA, CASELLAS, FRANCESC, GUARNER, FRANCISCO, UNIV HOSP VALL DHEBRON, DIGEST SYST RES UNIT, BARCELONA 08035, SPAIN.","10.1038/NRGASTRO.2012.152","75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA",NA,NA,"EUROPEAN COMMISSION SEVENTH FRAMEWORK PROGRAMME (METAHIT) [HEALTH-F4-2007-201052], FONDO DE INVESTIGACIONES SANITARIAS [FIS PI10/00902], INSTITUTO DE SALUD CARLOS III (MADRID, SPAIN)","THE AUTHORS RECEIVED FUNDING FROM THE EUROPEAN COMMISSION SEVENTH FRAMEWORK PROGRAMME (METAHIT, GRANT AGREEMENT HEALTH-F4-2007-201052), AND FONDO DE INVESTIGACIONES SANITARIAS (FIS PI10/00902, MINISTERIO DE CIENCIA E INNOVACION, SPAIN). CIBEREHD IS FUNDED BY THE INSTITUTO DE SALUD CARLOS III (MADRID, SPAIN).",NA,"1759-5045","10","599-608","NATURE PUBLISHING GROUP","9",2012,"ISI000309592200007","79","GASTROENTEROLOGY \& HEPATOLOGY","196","GASTROENTEROLOGY \& HEPATOLOGY","FGUARNERAMEDYNET.COM",NA,"017LU",NA,"GUARNER, F (REPRINT AUTHOR), UNIV HOSP VALL DHEBRON, DIGEST SYST RES UNIT, PASSEIG VALL DHEBRON 119-129, BARCELONA 08035, SPAIN","ISI","UNIV HOSP VALL DHEBRON","UNIV HOSP VALL DHEBRON",NA,"MANICHANH C, 2012, NAT REV GASTROENTEROL HEPATOL","MANICHANH C, 2012, NAT REV GASTROENTEROL HEPATOL"
"KAGAN RM, 2012, PLOS ONE","KAGAN RM;JOHNSON EP;SIAW M;BISWAS P;CHAPMAN DS;SU Z;PLATT JL;PESANO RL","A GENOTYPIC TEST FOR HIV-1 TROPISM COMBINING SANGER SEQUENCING WITH ULTRADEEP SEQUENCING PREDICTS VIROLOGIC RESPONSE IN TREATMENT-EXPERIENCED PATIENTS","PLOS ONE","PLOS ONE","A TROPISM TEST IS REQUIRED PRIOR TO INITIATION OF CCR5 ANTAGONIST THERAPY IN HIV-1 INFECTED INDIVIDUALS, AS THESE AGENTS ARE NOT EFFECTIVE IN PATIENTS HARBORING CXCR4 (X4) CORECEPTOR-USING VIRAL VARIANTS. WE DEVELOPED A CLINICAL LABORATORY-BASED GENOTYPIC TROPISM TEST FOR DETECTION OF CCR5-USING (R5) OR X4 VARIANTS THAT UTILIZES TRIPLICATE POPULATION SEQUENCING (TPS) FOLLOWED BY ULTRADEEP SEQUENCING (UDS) FOR SAMPLES CLASSIFIED AS R5. TROPISM WAS INFERRED USING THE BIOINFORMATIC ALGORITHMS GENO2PHENO([CORECEPTOR]) AND PSSMX4R5. VIROLOGIC RESPONSE AS A FUNCTION OF TROPISM READOUT WAS RETROSPECTIVELY ASSESSED USING BLINDED SAMPLES FROM TREATMENT-EXPERIENCED SUBJECTS WHO RECEIVED MARAVIROC (N=327) IN THE MOTIVATE AND A4001029 CLINICAL TRIALS. MOTIVATE PATIENTS WERE CLASSIFIED AS R5 AND A4001029 PATIENTS WERE CLASSIFIED AS NON-R5 BY THE ORIGINAL TROFILE TEST. VIROLOGIC RESPONSE WAS COMPARED BETWEEN THE R5 AND NON-R5 GROUPS DETERMINED BY TPS, UDS ALONE, THE REFLEX STRATEGY AND THE TROFILE ENHANCED SENSITIVITY (TF-ES) TEST. UDS HAD GREATER SENSITIVITY THAN TPS TO DETECT MINORITY NON-R5 VARIANTS. THE MEDIAN LOG(10) VIRAL LOAD CHANGE AT WEEK 8 WAS -2.4 FOR R5 SUBJECTS, REGARDLESS OF THE METHOD USED FOR CLASSIFICATION, FOR SUBJECTS WITH NON-R5 VIRUS, MEDIAN CHANGES WERE -1.2 FOR TF-ES OR THE REFLEX TEST AND -1.0 FOR UDS. THE DIFFERENCES BETWEEN R5 AND NON-R5 GROUPS WERE HIGHLY SIGNIFICANT IN ALL 3 CASES (P < 0.0001). AT WEEK 8, THE POSITIVE PREDICTIVE VALUE WAS 66\% FOR TF-ES AND 65\% FOR BOTH THE REFLEX TEST AND UDS. NEGATIVE PREDICTIVE VALUES WERE 59\% FOR TF-ES, 58\% FOR THE REFLEX TEST AND 61\% FOR UDS. IN CONCLUSION, GENOTYPIC TROPISM TESTING USING UDS ALONE OR A REFLEX STRATEGY SEPARATED MARAVIROC RESPONDERS AND NON-RESPONDERS AS WELL AS A SENSITIVE PHENOTYPIC TEST, AND BOTH ASSAYS SHOWED IMPROVED PERFORMANCE COMPARED TO TPS ALONE. GENOTYPIC TROPISM TESTS MAY PROVIDE AN ALTERNATIVE TO PHENOTYPIC TESTING WITH SIMILAR DISCRIMINATING ABILITY.",NA,"TYPE-1 CORECEPTOR TROPISM; DISEASE PROGRESSION; ANTIRETROVIRAL THERAPY; ENHANCED SENSITIVITY; PHENOTYPIC ASSAY; CCR5 ANTAGONISTS; CELL TROPISM; V3 LOOP; MARAVIROC; USAGE","ENGLISH","ARTICLE","ARTICLE",37,"ARCHER J, 2009, AIDS, V23, P1209, DOI 10.1097/QAD.0B013E32832B4399.;BERGER EA, 1998, NATURE, V391, P240, DOI 10.1038/34571.;BUONAGURO L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07.;CHO MW, 1998, J VIROL, V72, P2509.;CONNOR RI, 1997, J EXP MED, V185, P621, DOI 10.1084/JEM.185.4.621.;COOPER DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697.;DAAR ES, 2007, CLIN INFECT DIS, V45, P643, DOI 10.1086/520650.;DORR P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005.;FATKENHEUER G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMOA0803154.;FRANK DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362.;GILLES A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245.;GOODENOW MM, 2006, J LEUKOCYTE BIOL, V80, P965, DOI 10.1189/JLB.0306148.;GULICK RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMOA0803152.;HARRIGAN PR, 2011, AIDS, V25, P257, DOI 10.1097/QAD.0B013E32834113F9.;HUSE SM, 2007, GENOME BIOL, V8, DOI 10.1186/GB-2007-8-7-R143.;HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/SCIENCE.1905842.;IRLBECK DM, 2008, AIDS, V22, P1425, DOI 10.1097/QAD.0B013E32830184BA.;JABARA CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/PNAS.1110064108.;JENSEN MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003.;JENSEN MARK A., 2003, AIDS REVIEWS, V5, P104.;MARGULIES M, 2005, NATURE, V437, P376, DOI 10.1038/NATURE03959.;MCGOVERN RA, 2010, J VISUALIZED EXPT JO.;MCGOVERN RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0B013E32833E6CFB.;NABATOV AA, 2004, J VIROL, V78, P524, DOI 10.1128/JVI.78.1.524-530.2004.;POVEDA E, 2007, J MED VIROL, V79, P1040, DOI 10.1002/JMV.20900.;POVEDA E, 2009, J ANTIMICROB CHEMOTH, V63, P1006, DOI 10.1093/JAC/DKP063.;PROSPERI MCF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-56.;RAY N, 2006, CURR TOP MICROBIOL, V303, P97, DOI 10.1007/978-3-540-33397-5\_5.;RAYMOND S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-56.;RAYMOND S, 2010, JAIDS-J ACQ IMM DEF, V53, P167, DOI 10.1097/QAI.0B013E3181C8413B.;RAYMOND S, 2009, J CLIN MICROBIOL, V47, P2292, DOI 10.1128/JCM.02439-08.;RECORDON-PINSON P, 2010, ANTIMICROB AGENTS CH, V54, P3335, DOI 10.1128/AAC.00148-10.;REEVES JD, 2009, J VIRAL ENTRY, V3, P94.;SAAG M, 2008, 48 INT C ANT AG CHEM.;SAAG M, 2009, J INFECT DIS, V199, P1638, DOI 10.1086/598965.;SECLEN E, 2011, J CLIN MICROBIOL, V49, P3380, DOI 10.1128/JCM.00908-11.;SECLEN E, 2010, J ANTIMICROB CHEMOTH, V65, P1486, DOI 10.1093/JAC/DKQ137.;SHANKARAPPA R, 1999, J VIROL, V73, P10489.;SING T, 2007, ANTIVIR THER, V12, P1097.;SU ZH, 2009, J INFECT DIS, V200, P1724, DOI 10.1086/648090.;SWENSON LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/CID/CIR493.;SWENSON LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/INFDIS/JIQ030.;SWENSON LC, 2010, JAIDS-J ACQ IMM DEF, V54, P506, DOI 10.1097/QAI.0B013E3181D0558F.;THIELEN A, 2012, INTERVIROLOGY, V55, P113, DOI 10.1159/000332002.;TSIBRIS AMN, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0005683.;VANDEKERCKHOVE LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4.;VANDENBROUCKE INA, 2008, OPEN VIROL J, V2, P8, DOI 10.2174/1874357900802010008.;WANG CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/GR.6468307.;WEISER B, 2008, AIDS, V22, P469, DOI 10.1097/QAD.0B013E3282F4196C.;WESTBY M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006.;WHITCOMB JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06.;WILKIN TJ, 2011, CLIN INFECT DIS, V52, P925, DOI 10.1093/CID/CIR072.","KAGAN, RM (REPRINT AUTHOR), QUEST DIAGNOST NICHOLS INST, DEPT INFECT DIS, SAN JUAN CAPISTRANO, CA USA.;KAGAN, RON M., JOHNSON, ERIK P., SIAW, MARTIN, PLATT, JAMIE L., PESANO, RICK L., QUEST DIAGNOST NICHOLS INST, DEPT INFECT DIS, SAN JUAN CAPISTRANO, CA USA.;BISWAS, PINAKI, PFIZER, COLLEGEVILLE, PA USA.;CHAPMAN, DOUGLASS S., PFIZER, NEW YORK, NY USA.;SU, ZHAOHUI, OUTCOME SCI, CAMBRIDGE, MA USA.","10.1371/JOURNAL.PONE.0046334","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E46334",NA,NA,NA,NA,"1932-6203","9",NA,"PUBLIC LIBRARY SCIENCE","7",2012,"ISI000309517500090","52","SCIENCE \& TECHNOLOGY - OTHER TOPICS","2","MULTIDISCIPLINARY SCIENCES","RON.M.KAGANQUESTDIAGNOSTICS.COM",NA,"016KQ",NA,"KAGAN, RM (REPRINT AUTHOR), QUEST DIAGNOST NICHOLS INST, DEPT INFECT DIS, SAN JUAN CAPISTRANO, CA USA","ISI","QUEST DIAGNOST NICHOLS INST;COLLEGEVILLE;OUTCOME SCI","QUEST DIAGNOST NICHOLS INST",NA,"KAGAN RM, 2012, PLOS ONE","KAGAN RM, 2012, PLOS ONE"
"VASMATZIS G, 2012, BLOOD","VASMATZIS G;JOHNSON SH;KNUDSON RA;KETTERLING RP;BRAGGIO E;FONSECA R;VISWANATHA DS;LAW ME;KIP NS;OZSAN N;GREBE SK;FREDERICK LA;ECKLOFF BW;THOMPSON EA;KADIN ME;MILOSEVIC D;PORCHER JC;ASMANN YW;SMITH DI;KOVTUN IV;ANSELL SM;DOGAN A;FELDMAN AL","GENOME-WIDE ANALYSIS REVEALS RECURRENT STRUCTURAL ABNORMALITIES OF TP63 AND OTHER P53-RELATED GENES IN PERIPHERAL T-CELL LYMPHOMAS","BLOOD","BLOOD","PERIPHERAL T-CELL LYMPHOMAS (PTCLS) ARE AGGRESSIVE MALIGNANCIES OF MATURE T LYMPHOCYTES WITH 5-YEAR OVERALL SURVIVAL RATES OF ONLY SIMILAR TO 35\%. IMPROVEMENT IN OUTCOMES HAS BEEN STYMIED BY POOR UNDERSTANDING OF THE GENETICS AND MOLECULAR PATHOGENESIS OF PTCL, WITH A RESULTING PAUCITY OF MOLECULAR TARGETS FOR THERAPY. WE DEVELOPED BIOINFORMATIC TOOLS TO IDENTIFY CHROMOSOMAL REARRANGEMENTS USING GENOME-WIDE, NEXT-GENERATION SEQUENCING ANALYSIS OF MATE-PAIR DNA LIBRARIES AND APPLIED THESE TOOLS TO 16 PTCL PATIENT TISSUE SAMPLES AND 6 PTCL CELL LINES. THIRTEEN RECURRENT ABNORMALITIES WERE IDENTIFIED, OF WHICH 5 INVOLVED P53-RELATED GENES (TP53, TP63, CDKN2A, WWOX, AND ANKRD11). AMONG THESE ABNORMALITIES WERE NOVEL TP63 REARRANGEMENTS ENCODING FUSION PROTEINS HOMOLOGOUS TO DELTA NP63, A DOMINANT-NEGATIVE P63 ISOFORM THAT INHIBITS THE P53 PATHWAY. TP63 REARRANGEMENTS WERE SEEN IN 11 (5.8\%) OF 190 PTCLS AND WERE ASSOCIATED WITH INFERIOR OVERALL SURVIVAL, THEY ALSO WERE DETECTED IN 2 (1.2\%) OF 164 DIFFUSE LARGE B-CELL LYMPHOMAS. AS TP53 MUTATIONS ARE RARE IN PTCL COMPARED WITH OTHER MALIGNANCIES, OUR FINDINGS SUGGEST THAT A CONSTELLATION OF ALTERNATE GENETIC ABNORMALITIES MAY CONTRIBUTE TO DISRUPTION OF P53-ASSOCIATED TUMOR SUPPRESSOR FUNCTION IN PTCL. (BLOOD. 2012,120(11):2280-2289)",NA,"CANCER DEVELOPMENT; LUNG-CANCER; P53 PROTEIN; P63; MUTATIONS; EXPRESSION; CARCINOMA; TRANSLOCATIONS; OVEREXPRESSION; IDENTIFICATION","ENGLISH","ARTICLE","ARTICLE",90,"AMORESANA A, 2010, J PROTEOME RES, V9, P2042, DOI 10.1021/PR9011156.;CHANG NS, 2005, J BIOL CHEM, V280, P43100, DOI 10.1074/JBC.M505590200.;CHEUNG KJJ, 2009, BRIT J HAEMATOL, V146, P257, DOI 10.1111/J.1365-2141.2009.07739.X.;CHIANG CT, 2009, J CELL PHYSIOL, V219, P117, DOI 10.1002/JCP.21656.;COSTA LJ, 2008, BRIT J HAEMATOL, V142, P404, DOI 10.1111/J.1365-2141.2008.07207.X.;CROOK T, 2000, ONCOGENE, V19, P3439, DOI 10.1038/SJ.ONC.1203656.;DEYOUNG MP, 2006, CANCER RES, V66, P9362, DOI 10.1158/0008-5472.CAN-06-1619.;FELDMAN AL, 2008, LEUKEMIA, V22, P1139, DOI 10.1038/LEU.2008.77.;FELDMAN AL, 2009, LEUKEMIA, V23, P574, DOI 10.1038/LEU.2008.320.;FELDMAN AL, 2008, AM J CLIN PATHOL, V130, P178, DOI 10.1309/PNXUKA1CFJMVGCN1.;FELDMAN AL, 2011, BLOOD, V117, P915, DOI 10.1182/BLOOD-2010-08-303305.;FOMENKOV A, 2003, J BIOL CHEM, V278, P23906, DOI 10.1074/JBC.M300746200.;FOSS FM, 2011, BLOOD, V117, P6756, DOI 10.1182/BLOOD-2010-05-231548.;GERBER DE, 2010, CANCER CELL, V18, P548, DOI 10.1016/J.CCR.2010.11.033.;GRAZIANO V, 2011, BBA-REV CANCER, V1816, P57, DOI 10.1016/J.BBCAN.2011.04.002.;GREENBLATT MS, 1994, CANCER RES, V54, P4855.;GUO XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/NCB1988.;HASTAK K, 2010, CANCER RES, V70, P7970, DOI 10.1158/0008-5472.CAN-09-4521.;HEDVAT CV, 2005, APPL IMMUNOHISTO M M, V13, P237, DOI 10.1097/01.PAI.0000142160.52670.CE.;JENNER MW, 2007, BLOOD, V110, P3291, DOI 10.1182/BLOOD-2007-02-075069.;LAHARANNE E, 2010, MODERN PATHOL, V23, P547, DOI 10.1038/MODPATHOL.2009.196.;LEONG CO, 2007, J CLIN INVEST, V117, P1370, DOI 10.1172/JCI30866.;SANCHEZ-SCHMIDT JM, 2011, J INVEST DERMATOL, V131, P269, DOI 10.1038/JID.2010.271.;MASSION PP, 2003, CANCER RES, V63, P7113.;MATSUSHIMA AY, 1994, AM J PATHOL, V144, P573.;MILOSEVIC D, 2010, CLIN BIOCHEM, V43, P700, DOI 10.1016/J.CLINBIOCHEM.2010.01.016.;MUNDT HM, 2010, BIOCHEM BIOPH RES CO, V396, P335, DOI 10.1016/J.BBRC.2010.04.093.;NEILSEN PM, 2008, J CELL SCI, V121, P3541, DOI 10.1242/JCS.026351.;NEKULOVA M, 2011, CELL MOL BIOL LETT, V16, P296, DOI 10.2478/S11658-011-0009-9.;NOLL JE, 2012, ONCOGENE, V31, P2836, DOI 10.1038/ONC.2011.456.;OSADA M, 1998, NAT MED, V4, P839, DOI 10.1038/NM0798-839.;PACKARD A, 2011, J NEUROSCI, V31, P8748, DOI 10.1523/JNEUROSCI.0681-11.2011.;PETIT B, 2001, HUM PATHOL, V32, P196, DOI 10.1053/HUPA.2001.21569.;PINYOL M, 1998, BLOOD, V91, P2977.;POWELL JA, 2002, GENOMICS, V80, P303, DOI 10.1006/GENO.2002.6828.;RASSIDAKIS GZ, 2005, LEUKEMIA, V19, P1663, DOI 10.1038/SJ.LEU.2403840.;ROCCO JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/J.CCR.2005.12.013.;SAVAGE KJ, 2008, BLOOD, V111, P5496, DOI 10.1182/BLOOD-2008-01-134270.;SAVAGE KJ, 2004, ANN ONCOL, V15, P1467, DOI 10.1093/ANNONC/MDH392.;SCOTT DW, 2012, BLOOD, V119, P4949, DOI 10.1182/BLOOD-2012-02-414441.;SHARPLESS NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/J.MRFMMM.2004.08.021.;SU XH, 2010, NATURE, V467, P986, DOI 10.1038/NATURE09459.;SWERDLOW SH, 2008, WHO CLASSIFICATION T.;TRINK B, 2007, CELL CYCLE, V6, P240, DOI 10.4161/CC.6.3.3803.;VILGELM A, 2008, DRUG RESIST UPDATE, V11, P152, DOI 10.1016/J.DRUP.2008.08.001.;WADA DA, 2011, MODERN PATHOL, V24, P596, DOI 10.1038/MODPATHOL.2010.225.;YANG A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127.;YANG AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0.","FELDMAN, AL (REPRINT AUTHOR), MAYO CLIN, DEPT LAB MED \& PATHOL, 200 1ST ST SW, ROCHESTER, MN 55905 USA.;KNUDSON, RYAN A., KETTERLING, RHETT P., VISWANATHA, DAVID S., LAW, MARK E., KIP, N. SERTAC, GREBE, STEFAN K., FREDERICK, LORI A., MILOSEVIC, DRAGANA, SMITH, DAVID I., DOGAN, AHMET, FELDMAN, ANDREW L., MAYO CLIN, DEPT LAB MED \& PATHOL, ROCHESTER, MN 55905 USA.;VASMATZIS, GEORGE, JOHNSON, SARAH H., KOVTUN, IRINA V., MAYO CLIN, CTR INDIVIDUALIZED MED, ROCHESTER, MN 55905 USA.;BRAGGIO, ESTEBAN, MAYO CLIN, DEPT BIOCHEM \& MOL BIOL, SCOTTSDALE, AZ USA.;FONSECA, RAFAEL, MAYO CLIN, DEPT HEMATOL ONCOL, SCOTTSDALE, AZ USA.;OZSAN, NAZAN, EGE UNIV, DEPT PATHOL, IZMIR, TURKEY.;ECKLOFF, BRUCE W., MAYO CLIN, ADV GENOM TECHNOL CTR, ROCHESTER, MN 55905 USA.;THOMPSON, E. AUBREY, MAYO CLIN, CTR COMPREHENS CANC, DEPT CANC BIOL, JACKSONVILLE, FL USA.;KADIN, MARSHALL E., ROGER WILLIAMS MED CTR, DEPT DERMATOL, PROVIDENCE, RI USA.;PORCHER, JULIE C., ANSELL, STEPHEN M., MAYO CLIN, DIV HEMATOL, ROCHESTER, MN 55905 USA.;ASMANN, YAN W., MAYO CLIN, DIV BIOMED STAT \& INFORMAT, ROCHESTER, MN 55905 USA.;KOVTUN, IRINA V., MAYO CLIN, DEPT MOL PHARMACOL \& EXPT THERAPEUT, ROCHESTER, MN 55905 USA.","10.1182/BLOOD-2012-03-419937","2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA",NA,NA,"MAYO CLINIC CENTER FOR INDIVIDUALIZED MEDICINE, MAYO CLINIC DEPARTMENT OF LABORATORY MEDICINE AND PATHOLOGY, DAMON RUNYON CANCER RESEARCH FOUNDATION [CI-48-09]","THIS WORK WAS SUPPORTED BY A WATERMAN BIOMARKER DISCOVERY GRANT FROM THE MAYO CLINIC CENTER FOR INDIVIDUALIZED MEDICINE, AND AN EXPERIMENTAL PATHOLOGY DEVELOPMENT AWARD FROM THE MAYO CLINIC DEPARTMENT OF LABORATORY MEDICINE AND PATHOLOGY. A. L. F. IS A DAMON RUNYON CLINICAL INVESTIGATOR SUPPORTED BY THE DAMON RUNYON CANCER RESEARCH FOUNDATION (CI-48-09).",NA,"0006-4971","11","2280-2289","AMER SOC HEMATOLOGY","120",2012,"ISI000309044200020","48","HEMATOLOGY","7","HEMATOLOGY","FELDMAN.ANDREWMAYO.EDU",NA,"009RZ",NA,"FELDMAN, AL (REPRINT AUTHOR), MAYO CLIN, DEPT LAB MED \& PATHOL, 200 1ST ST SW, ROCHESTER, MN 55905 USA","ISI","DEPT LAB MED AND PATHOL;CTR INDIVIDUALIZED MED;MAYO CLIN;MAYO CLIN;EGE UNIV;ADV GENOM TECHNOL CTR;CTR COMPREHENS CANC;ROGER WILLIAMS MED CTR;MAYO CLIN;MAYO CLIN;MAYO CLIN","DEPT LAB MED AND PATHOL",NA,"VASMATZIS G, 2012, BLOOD","VASMATZIS G, 2012, BLOOD"
"MEGGYESI N, 2012, MED ONCOL","MEGGYESI N;KALMAR L;FEKETE S;MASSZI T;TORDAI A;ANDRIKOVICS H","CHARACTERIZATION OF ABL EXON 7 DELETION BY MOLECULAR GENETIC AND BIOINFORMATIC METHODS REVEALS NO ASSOCIATION WITH IMATINIB RESISTANCE IN CHRONIC MYELOID LEUKEMIA","MEDICAL ONCOLOGY","MED. ONCOL.","IN CHRONIC MYELOID LEUKEMIA (CML), THE BEST CHARACTERIZED IMATINIB RESISTANCE MECHANISMS ARE BCR-ABL TYROSINE KINASE DOMAIN MUTATIONS AND CLONAL EVOLUTION, BUT RECENTLY ALTERNATIVE SPLICING OF BCR-ABL WAS ALSO PROPOSED AS A MECHANISM FOR IMATINIB RESISTANCE. AMONG RECENTLY REPORTED BCR-ABL SPLICE VARIANTS, EXON 7 DELETION (DELTA EXON7) WAS CHARACTERIZED IN THIS STUDY. THE FREQUENCY OF DELTA EXON7 WAS INVESTIGATED IN 30 HEALTHY CONTROLS AND IN 76 CML PATIENTS AT DIFFERENT TIME POINTS OF THE DISEASE COURSE BY FOUR DIFFERENT MOLECULAR GENETIC METHODS (DIRECT SEQUENCING, FRAGMENT ANALYSIS, ALLELE-SPECIFIC AND QUANTITATIVE PCR). THE FUNCTIONALITY AND VIABILITY OF THE VARIANT PROTEIN WAS TESTED BY BIOINFORMATIC PREDICTION. THE DELTA EXON7 WAS ABUNDANTLY DETECTED WITH SIMILAR FREQUENCY IN HEALTHY CONTROLS, IN IMATINIB NAIVE AND RESISTANT CML PATIENTS ON BCR-ABL AND ALSO ON THE NONTRANSLOCATED ABL. THE DETECTION RATE OF DELTA EXON7 (VARYING BETWEEN 17 AND 100\%) WAS HIGHLY DEPENDENT ON THE EXPRESSION LEVELS OF BCR-ABL OR ABL AND THE SENSITIVITY OF DETECTION METHOD. ACCORDING TO SECONDARY STRUCTURE PREDICTION BY BIOINFORMATIC METHODS, THE EXON 7 DELETED MRNA IS A TARGET FOR NONSENSE-MEDIATED DECAY, AND THE TRANSLATED PROTEIN IS LIKELY TO BE NONFUNCTIONAL AND UNSTABLE. TAKEN TOGETHER ALL THE ABOVE OBSERVATIONS, WE CONCLUDED THAT DELTA EXON7 IS A COMMON SPLICE VARIANT NOT ASSOCIATING WITH IMATINIB RESISTANCE.","CML; BCR-ABL; IMATINIB RESISTANCE; SPLICE VARIANT; EXON 7 DELETION; BIOINFORMATIC PREDICTION","SECONDARY STRUCTURE PREDICTION; CHRONIC MYELOGENOUS LEUKEMIA; RECURRENT SPLICING VARIANT; KINASE INHIBITORS; TYROSINE KINASE; CML PATIENTS; MECHANISM; TRANSLATION; TRUNCATION; MUTATIONS","ENGLISH","ARTICLE","ARTICLE",2,"APCHER S, 2011, P NATL ACAD SCI USA, V108, P11572, DOI 10.1073/PNAS.1104104108.;BACCARANI M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779.;CHO EH, 2009, LEUKEMIA RES, V33, P505, DOI 10.1016/J.LEUKRES.2008.08.024.;COWAN-JACOB SW, 2007, ACTA CRYSTALLOGR D, V63, P80, DOI 10.1107/S0907444906047287.;CUFF JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO,2-Q.;CURVO RPM, 2008, LEUKEMIA RES, V32, P508, DOI 10.1016/J.LEUKRES.2007.04.018.;DRUKER BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMOA062867.;ERNST T, 2008, HAEMATOL-HEMATOL J, V93, P1389, DOI 10.3324/HAEMATOL.12964.;FLEMING PJ, 2005, PROTEIN SCI, V14, P111, DOI 10.1110/PS.041017005.;FLORIS M, 2011, BIOINFORMATICS, V27, P1625, DOI 10.1093/BIOINFORMATICS/BTR198.;GAILLARD JB, 2010, MOL CANCER THER, V9, P3083, DOI 10.1158/1535-7163.MCT-10-0595.;GRUBER FX, 2006, LEUKEMIA, V20, P2057, DOI 10.1038/SJ.LEU.2404400.;GRUBER FX, 2012, MED ONCOL, V29, P219, DOI 10.1007/S12032-010-9781-Z.;HEGYI H, 2011, NUCLEIC ACIDS RES, V39, P1208, DOI 10.1093/NAR/GKQ843.;KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/BIP.360221211.;KHORASHAD JS, 2010, MOL CANCER THER, V9, P2152, DOI 10.1158/1535-7163.MCT-10-0311.;KINCAID MM, 2007, ANTIOXID REDOX SIGN, V9, P2373, DOI 10.1089/ARS.2007.1817.;LAUDADIO J, 2008, J MOL DIAGN, V10, P177, DOI 10.2353/JMOLDX.2008.070128.;LEE TS, 2008, MOL CANCER THER, V7, P3834, DOI 10.1158/1535-7163.MCT-08-0482.;LEWIS BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/PNAS.0136770100.;MA W, 2011, INT J LAB HEMATOL, V33, P326, DOI 10.1111/J.1751-553X.2010.01291.X.;MA W, 2009, ACTA HAEMATOL-BASEL, V121, P27, DOI 10.1159/000210060.;MAQUAT LE, 2010, CELL, V142, P368, DOI 10.1016/J.CELL.2010.07.022.;MILOJKOVIC D, 2009, CLIN CANCER RES, V15, P7519, DOI 10.1158/1078-0432.CCR-09-1068.;OUALI M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/PS.9.6.1162.;PAN Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/NG.259.;PETTERSEN EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/JCC.20084.;SANTAMARIA I, 2010, MOL CANCER THER, V9, P772, DOI 10.1158/1535-7163.MCT-09-0078.;SCHINDLER T, 2000, SCIENCE, V289, P1938, DOI 10.1126/SCIENCE.289.5486.1938.;SHERBENOU DW, 2008, LEUKEMIA, V22, P1184, DOI 10.1038/LEU.2008.65.;VAN DONGEN JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/SJ.LEU.2401592.;VASHIST S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/JCB.200309132.;WANG ET, 2008, NATURE, V456, P470, DOI 10.1038/NATURE07509.","MEGGYESI, N (REPRINT AUTHOR), HUNGARIAN NATL BLOOD TRANSFUS SERV, LAB MOL DIAGNOST, KAROLINA STR 19-21, H-1113 BUDAPEST, HUNGARY.;MEGGYESI, NORA, TORDAI, ATTILA, ANDRIKOVICS, HAJNALKA, HUNGARIAN NATL BLOOD TRANSFUS SERV, LAB MOL DIAGNOST, H-1113 BUDAPEST, HUNGARY.;KALMAR, LAJOS, HUNGARIAN ACAD SCI, BIOL RES CTR, INST ENZYMOL, BUDAPEST, HUNGARY.;FEKETE, SANDOR, MASSZI, TAMAS, ST ISTVAN ST LASZLO HOSP, DEPT HAEMATOL \& STEM CELL TRANSPLANTAT, BUDAPEST, HUNGARY.","10.1007/S12032-011-0092-9","999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA",NA,NA,"ORSZAGOS TUDOMANYOS KUTATASI ALAPPROGRAMOK OTKA [K69102, PD83613], KOZEP-MAGYARORSZAGI OPERATIV PROGRAM KMOP [1.1.2-07/1-2008-0003], HUNGARIAN ACADEMY OF SCIENCES","WE THANK HORVATH CSONGORNE FOR HER TECHNICAL ASSISTANCE. THIS WORK WAS SUPPORTED BY GRANTS FROM ORSZAGOS TUDOMANYOS KUTATASI ALAPPROGRAMOK OTKA K69102, PD83613 AND KOZEP-MAGYARORSZAGI OPERATIV PROGRAM KMOP 1.1.2-07/1-2008-0003. LK AND HA ARE RECIPIENTS OF JANOS BOLYAI RESEARCH SCHOLARSHIP OF THE HUNGARIAN ACADEMY OF SCIENCES.",NA,"1357-0560","3","2136-2142","HUMANA PRESS INC","29",2012,"ISI000307964100106","33","ONCOLOGY","16","ONCOLOGY","NORA.MEGGYESIKKK.ORG.HU",NA,"994WE",NA,"MEGGYESI, N (REPRINT AUTHOR), HUNGARIAN NATL BLOOD TRANSFUS SERV, LAB MOL DIAGNOST, KAROLINA STR 19-21, H-1113 BUDAPEST, HUNGARY","ISI","LAB MOL DIAGNOST;INST ENZYMOL;ST ISTVAN ST LASZLO HOSP","LAB MOL DIAGNOST",NA,"MEGGYESI N, 2012, MED ONCOL","MEGGYESI N, 2012, MED ONCOL"
"CELIK N, 2012, PLOS ONE","CELIK N;WEBB CT;LEYTON DL;HOLT KE;HEINZ E;GORRELL R;KWOK T;NADERER T;STRUGNELL RA;SPEED TP;TEASDALE RD;LIKIC VA;LITHGOW T","A BIOINFORMATIC STRATEGY FOR THE DETECTION, CLASSIFICATION AND ANALYSIS OF BACTERIAL AUTOTRANSPORTERS","PLOS ONE","PLOS ONE","AUTOTRANSPORTERS ARE SECRETED PROTEINS THAT ARE ASSEMBLED INTO THE OUTER MEMBRANE OF BACTERIAL CELLS. THE PASSENGER DOMAINS OF AUTOTRANSPORTERS ARE CRUCIAL FOR BACTERIAL PATHOGENESIS, WITH SOME REMAINING ATTACHED TO THE BACTERIAL SURFACE WHILE OTHERS ARE RELEASED BY PROTEOLYSIS. AN ENIGMA REMAINS AS TO WHETHER AUTOTRANSPORTERS SHOULD BE CONSIDERED A CLASS OF SECRETION SYSTEM, OR SIMPLY A CLASS OF SUBSTRATE WITH PECULIAR REQUIREMENTS FOR THEIR SECRETION. WE SOUGHT TO ESTABLISH A SENSITIVE SEARCH PROTOCOL THAT COULD IDENTIFY AND CHARACTERIZE DIVERSE AUTOTRANSPORTERS FROM BACTERIAL GENOME SEQUENCE DATA. THE NEW SEQUENCE ANALYSIS PIPELINE IDENTIFIED MORE THAN 1500 AUTOTRANSPORTER SEQUENCES FROM DIVERSE BACTERIA, INCLUDING NUMEROUS SPECIES OF CHLAMYDIALES AND FUSOBACTERIA AS WELL AS ALL CLASSES OF PROTEOBACTERIA. INTERROGATION OF THE PROTEINS REVEALED THAT THERE ARE NUMEROUS CLASSES OF PASSENGER DOMAINS BEYOND THE KNOWN PROTEASES, ADHESINS AND ESTERASES. IN ADDITION THE BARREL-DOMAIN-A CHARACTERISTIC FEATURE OF AUTOTRANSPORTERS-WAS FOUND TO BE COMPOSED FROM SEVEN CONSERVED SEQUENCE SEGMENTS THAT CAN BE ARRANGED IN MULTIPLE WAYS IN THE TERTIARY STRUCTURE OF THE ASSEMBLED AUTOTRANSPORTER. ONE OF THESE CONSERVED MOTIFS OVERLAYS THE TARGETING INFORMATION REQUIRED FOR AUTOTRANSPORTERS TO REACH THE OUTER MEMBRANE. ANOTHER CONSERVED AND DIAGNOSTIC MOTIF MAPS TO THE LINKER REGION BETWEEN THE PASSENGER DOMAIN AND BARREL-DOMAIN, INDICATING IT AS AN IMPORTANT FEATURE IN THE ASSEMBLY OF AUTOTRANSPORTERS.",NA,"PROTEIN SECRETION SYSTEMS; GRAM-NEGATIVE PATHOGENS; ESCHERICHIA-COLI; OUTER-MEMBRANE; SERINE-PROTEASE; CRYSTAL-STRUCTURE; PASSENGER DOMAIN; CITROBACTER-RODENTIUM; INTERACTIVE TREE; COMMON THEMES","ENGLISH","ARTICLE","ARTICLE",38,"ALLSOPP LP, 2010, INFECT IMMUN, V78, P1659, DOI 10.1128/IAI.01010-09.;ASHGAR SSA, 2007, J BACTERIOL, V189, P1856, DOI 10.1128/JB.01427-06.;BAILEY TL, 2009, NUCLEIC ACIDS RES, V37, PW202, DOI 10.1093/NAR/GKP335.;BARNARD TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/NSMB1322.;BARNARD TJ, 2012, J MOL BIOL, V415, P128, DOI 10.1016/J.JMB.2011.10.049.;BENDTSEN JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/J.JMB.2004.05.028.;BERMAN HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/NAR/28.1.235.;BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/PNAS.86.10.3867.;BERNSTEIN HD, 2007, TRENDS MICROBIOL, V15, P441, DOI 10.1016/J.TIM.2007.09.007.;BITTO E, 2003, J BIOL CHEM, V278, P49316, DOI 10.1074/JBC.M308853200.;BLANKE SR, 2005, TRENDS MICROBIOL, V13, P64, DOI 10.1016/J.TIM.2004.12.007.;BORENSHTEIN D, 2008, CURR OPIN GASTROEN, V24, P32, DOI 10.1097/MOG.0B013E3282F2B0FB.;BRANDON LD, 2001, J BACTERIOL, V183, P951, DOI 10.1128/JB.183.3.951-958.2001.;COUTTE L, 2001, EMBO J, V20, P5040, DOI 10.1093/EMBOJ/20.18.5040.;CROOKS GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/GR.849004.;DAUTIN N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/ANNUREV.MICRO.61.080706.093233.;DAUTIN N, 2011, J BACTERIOL, V193, P3748, DOI 10.1128/JB.05070-11.;DECOCK H, 1997, J MOL BIOL, V269, P473, DOI 10.1006/JMBI.1997.1069.;DESVAUX M, 2005, BBA-BIOMEMBRANES, V1713, P92, DOI 10.1016/J.BBAMEM.2005.05.002.;DURAND E., 2009, INFECTIOUS DISORDERS - DRUG TARGETS, V9, P518.;EMSLEY P, 1996, NATURE, V381, P90, DOI 10.1038/381090A0.;FELSENSTEIN J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X.;FERNANDEZ RC, 1994, INFECT IMMUN, V62, P4727.;FINN RD, 2010, NUCLEIC ACIDS RES, V38, PD211, DOI 10.1093/NAR/GKP985.;GANGWER KA, 2007, P NATL ACAD SCI USA, V104, P16293, DOI 10.1073/PNAS.0707447104.;GEER LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/GR.278202.;GERLACH RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/J.IJMM.2007.03.017.;HENDERSON IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004.;HENDERSON IR, 2001, TRENDS MICROBIOL, V9, P573, DOI 10.1016/S0966-842X(01)02234-X.;HENDERSON IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3.;HODAK H, 2007, RES MICROBIOL, V158, P631, DOI 10.1016/J.RESMIC.2007.08.001.;HOLLAND IB, 2010, METHODS MOL BIOL, V619, P1, DOI 10.1007/978-1-60327-412-8\_1.;HOOPMAN TC, 2008, J BACTERIOL, V190, P1459, DOI 10.1128/JB.01688-07.;IEVA R, 2011, P NATL ACAD SCI USA, V108, PE383, DOI 10.1073/PNAS.1103827108.;IEVA R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/PNAS.0907912106.;JAIN S, 2007, J BACTERIOL, V189, P5393, DOI 10.1128/JB.00228-07.;JANSEN C, 2000, EUR J BIOCHEM, V267, P3792, DOI 10.1046/J.1432-1327.2000.01417.X.;JOHNSON TA, 2009, J MOL BIOL, V389, P559, DOI 10.1016/J.JMB.2009.04.041.;JUNKER M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/PNAS.0507923103.;KAJAVA AV, 2006, J STRUCT BIOL, V155, P306, DOI 10.1016/J.JSB.2006.01.015.;KHAN S, 2011, J MOL BIOL, V413, P985, DOI 10.1016/J.JMB.2011.09.028.;KILLIAN JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1.;KINGSLEY RA, 2002, MOL MICROBIOL, V43, P895, DOI 10.1046/J.1365-2958.2002.02805.X.;KISELEV AO, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0005191.;KLEMM P, 2006, INT J MED MICROBIOL, V296, P187, DOI 10.1016/J.IJMM.2005.10.002.;KOSTAKIOTI M, 2006, INFECT IMMUN, V74, P4961, DOI 10.1128/IAI.00103-06.;KUTIK S, 2008, CELL, V132, P1011, DOI 10.1016/J.CELL.2008.01.028.;LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/BIOINFORMATICS/BTM404.;LETUNIC I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/BIOINFORMATICS/BTL529.;LETUNIC I, 2011, NUCLEIC ACIDS RES, V39, PW475, DOI 10.1093/NAR/GKR201.;LEYTON DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/NRMICRO2733.;LEYTON DL, 2011, J BIOL CHEM, V286, P42283, DOI 10.1074/JBC.M111.306118.;LEYTON DL, 2003, INFECT IMMUN, V71, P6307, DOI 10.1128/IAI.71.11.6307-6319.2003.;LIKIC VA, 2010, METHODS MOL BIOL, V619, P271, DOI 10.1007/978-1-60327-412-8\_16.;MARSDEN RL, 2002, PROTEIN SCI, V11, P2814, DOI 10.1110/PS.0209902.;MAZAR J, 2007, TRENDS MICROBIOL, V15, P508, DOI 10.1016/J.TIM.2007.10.005.;MENG GY, 2011, EMBO J, V30, P3864, DOI 10.1038/EMBOJ.2011.279.;MUNDY R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/J.1462-5822.2005.00625.X.;NISHIMURA K, 2010, J MOL MED, V88, P451, DOI 10.1007/S00109-010-0600-Y.;OHNISHI Y, 1997, J BIOCHEM-TOKYO, V121, P902.;OOMEN CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/SJ.EMBOJ.7600148.;OTTO BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/JBC.M412885200.;PETTY NK, 2010, J BACTERIOL, V192, P525, DOI 10.1128/JB.01144-09.;REGO AT, 2010, BIOCHEM J, V425, P475, DOI 10.1042/BJ20091518.;RENN JP, 2011, CHEM BIOL.;ROBERT V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/JOURNAL.PBIO.0040377.;ROSSITER AE, 2011, J BACTERIOL, V193, P4250, DOI 10.1128/JB.00192-11.;RUIZ-PEREZ F, 2009, J BACTERIOL, V191, P6571, DOI 10.1128/JB.00754-09.;SALACHA R, 2010, ENVIRON MICROBIOL, V12, P1498, DOI 10.1111/J.1462-2920.2010.02174.X.;SAURI A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/MIC.0.034991-0.;SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/NAR/18.20.6097.;SELKRIG J, 2012, NAT STRUCT MOL BIOL, V19, P506, DOI 10.1038/NSMB.2261.;SKILLMAN KM, 2005, MOL MICROBIOL, V58, P945, DOI 10.1111/J.1365-2958.2005.04885.X.;STYMEST KH, 2008, FEBS J, V275, P3470, DOI 10.1111/J.1742-4658.2008.06493.X.;SWANSON KA, 2009, INFECT IMMUN, V77, P508, DOI 10.1128/IAI.01173-08.;TAJIMA N, 2010, J MOL BIOL, V402, P645, DOI 10.1016/J.JMB.2010.06.068.;THANASSI DG, 2000, CURR OPIN CELL BIOL, V12, P420, DOI 10.1016/S0955-0674(00)00111-3.;VAN DEN BERG B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/J.JMB.2009.12.061.;VAN ULSEN P, 2011, ADV EXP MED BIOL, V715, P125, DOI 10.1007/978-94-007-0940-9\_8.;VEIGA E, 2004, MOL MICROBIOL, V52, P1069, DOI 10.1111/J.1365-2958.2004.04014.X.;VOULHOUX R, 2003, SCIENCE, V299, P262, DOI 10.1126/SCIENCE.1078973.;WEHRL W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/J.1365-2958.2003.03838.X.;WELLS TJ, 2007, FEMS MICROBIOL LETT, V274, P163, DOI 10.1111/J.1574-6968.2007.00833.X.;WELLS TJ, 2010, MICROBIOL-SGM, V156, P2459, DOI 10.1099/MIC.0.039024-0.;YAU WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/BI980809C.;YEN YT, 2008, TRENDS MICROBIOL, V16, P370, DOI 10.1016/J.TIM.2008.05.003.;ZHAI YJ, 2011, BIOCHEM J, V435, P577, DOI 10.1042/BJ20101548.","CELIK, N (REPRINT AUTHOR), MONASH UNIV, DEPT BIOCHEM \& MOL BIOL, CLAYTON, VIC, AUSTRALIA.;CELIK, NERMIN, WEBB, CHAILLE T., LEYTON, DENISSE L., HEINZ, EVA, GORRELL, REBECCA, KWOK, TERRY, NADERER, THOMAS, LITHGOW, TREVOR, MONASH UNIV, DEPT BIOCHEM \& MOL BIOL, CLAYTON, VIC, AUSTRALIA.;LEYTON, DENISSE L., GORRELL, REBECCA, KWOK, TERRY, MONASH UNIV, DEPT MICROBIOL, CLAYTON, VIC 3168, AUSTRALIA.;HOLT, KATHRYN E., STRUGNELL, RICHARD A., UNIV MELBOURNE, DEPT MICROBIOL \& IMMUNOL, PARKVILLE, VIC 3052, AUSTRALIA.;SPEED, TERENCE P., ROYAL MELBOURNE HOSP, WALTER \& ELIZA HALL INST MED RES, BIOINFORMAT DIV, PARKVILLE, VIC 3050, AUSTRALIA.;TEASDALE, ROHAN D., UNIV QUEENSLAND, INST MOL BIOSCI, ST LUCIA, QLD, AUSTRALIA.;LIKIC, VLADIMIR A., UNIV MELBOURNE, MOL SCI \& BIOTECHNOL INST BIO21, PARKVILLE, VIC 3052, AUSTRALIA.","10.1371/JOURNAL.PONE.0043245","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E43245",NA,"NATIONAL HEALTH \& MEDICAL RESEARCH COUNCIL (NHMRC) [606788], AUSTRALIAN RESEARCH COUNCIL (ARC) [FS110200015]","THE PROJECT WAS SUPPORTED BY NATIONAL HEALTH \& MEDICAL RESEARCH COUNCIL (NHMRC) PROGRAM GRANT 606788 (TO RAS, RT AND TL) AND AUSTRALIAN RESEARCH COUNCIL (ARC) SUPER-SCIENCE FELLOWSHIPS GRANT FS110200015 (TO RAS AND TL). THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT.",NA,"1932-6203","8",NA,"PUBLIC LIBRARY SCIENCE","7",2012,"ISI000307500800064","87","SCIENCE \& TECHNOLOGY - OTHER TOPICS","19","MULTIDISCIPLINARY SCIENCES","R.TEASDALEUQ.EDU.AU VLIKICUNIMELB.EDU.AU TREVOR.LITHGOWMONASH.EDU",NA,"988OQ",NA,"CELIK, N (REPRINT AUTHOR), MONASH UNIV, DEPT BIOCHEM \& MOL BIOL, CLAYTON, VIC, AUSTRALIA","ISI","MONASH UNIV;MONASH UNIV;UNIV MELBOURNE;WALTER AND ELIZA HALL INST MED RES;UNIV QUEENSLAND;UNIV MELBOURNE","MONASH UNIV",NA,"CELIK N, 2012, PLOS ONE","CELIK N, 2012, PLOS ONE"
"SEGURITAN V, 2012, PLOS COMPUT BIOL","SEGURITAN V;ALVES N;ARNOULT M;RAYMOND A;LORIMER D;BURGIN AB;SALAMON P;SEGALL AM","ARTIFICIAL NEURAL NETWORKS TRAINED TO DETECT VIRAL AND PHAGE STRUCTURAL PROTEINS","PLOS COMPUTATIONAL BIOLOGY","PLOS COMPUT. BIOL.","PHAGES PLAY CRITICAL ROLES IN THE SURVIVAL AND PATHOGENICITY OF THEIR HOSTS, VIA LYSOGENIC CONVERSION FACTORS, AND IN NUTRIENT REDISTRIBUTION, VIA CELL LYSIS. ANALYSES OF PHAGE-AND VIRAL-ENCODED GENES IN ENVIRONMENTAL SAMPLES PROVIDE INSIGHTS INTO THE PHYSIOLOGICAL IMPACT OF VIRUSES ON MICROBIAL COMMUNITIES AND HUMAN HEALTH. HOWEVER, PHAGE ORFS ARE EXTREMELY DIVERSE OF WHICH OVER 70\% OF THEM ARE DISSIMILAR TO ANY GENES WITH ANNOTATED FUNCTIONS IN GENBANK. BETTER IDENTIFICATION OF VIRUSES WOULD ALSO AID IN BETTER DETECTION AND DIAGNOSIS OF DISEASE, IN VACCINE DEVELOPMENT, AND GENERALLY IN BETTER UNDERSTANDING THE PHYSIOLOGICAL POTENTIAL OF ANY ENVIRONMENT. IN CONTRAST TO ENZYMES, VIRAL STRUCTURAL PROTEIN FUNCTION CAN BE MUCH MORE CHALLENGING TO DETECT FROM SEQUENCE DATA BECAUSE OF LOW SEQUENCE CONSERVATION, FEW KNOWN CONSERVED CATALYTIC SITES OR SEQUENCE DOMAINS, AND RELATIVELY LIMITED EXPERIMENTAL DATA. WE HAVE DESIGNED A METHOD OF PREDICTING PHAGE STRUCTURAL PROTEIN SEQUENCES THAT USES ARTIFICIAL NEURAL NETWORKS (ANNS). FIRST, WE TRAINED ANNS TO CLASSIFY VIRAL STRUCTURAL PROTEINS USING AMINO ACID FREQUENCY, THESE CORRECTLY CLASSIFY A LARGE FRACTION OF TEST CASES WITH A HIGH DEGREE OF SPECIFICITY AND SENSITIVITY. SUBSEQUENTLY, WE ADDED ESTIMATES OF PROTEIN ISOELECTRIC POINTS AS A FEATURE TO ANNS THAT CLASSIFY SPECIALIZED FAMILIES OF PROTEINS, NAMELY MAJOR CAPSID AND TAIL PROTEINS. AS EXPECTED, THESE MORE SPECIALIZED ANNS ARE MORE ACCURATE THAN THE STRUCTURAL ANNS. TO EXPERIMENTALLY VALIDATE THE ANN PREDICTIONS, SEVERAL ORFS WITH NO SIGNIFICANT SIMILARITIES TO KNOWN SEQUENCES THAT ARE ANN-PREDICTED STRUCTURAL PROTEINS WERE EXAMINED BY TRANSMISSION ELECTRON MICROSCOPY. SOME OF THESE SELF-ASSEMBLED INTO STRUCTURES STRONGLY RESEMBLING VIRION STRUCTURES. THUS, OUR ANNS ARE NEW TOOLS FOR IDENTIFYING PHAGE AND POTENTIAL PROPHAGE STRUCTURAL PROTEINS THAT ARE DIFFICULT OR IMPOSSIBLE TO DETECT BY OTHER BIOINFORMATIC ANALYSIS. THE NETWORKS WILL BE VALUABLE WHEN SEQUENCE IS AVAILABLE BUT IN VITRO PROPAGATION OF THE PHAGE MAY NOT BE PRACTICAL OR POSSIBLE.",NA,"SUPPORT VECTOR MACHINES; STRUCTURE PREDICTION; GENE-COMPOSER; TAILED-BACTERIOPHAGES; SECONDARY STRUCTURE; IN-VITRO; BINDING; SPECIFICITY; SENSITIVITY; SEQUENCES","ENGLISH","ARTICLE","ARTICLE",27,"ABREMSKI KE, 1992, PROTEIN ENG, V5, P87, DOI 10.1093/PROTEIN/5.1.87.;ACKERMANN HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/S00705-006-0849-1.;ANGLY FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/JOURNAL.PBIO.0040368.;BAILEY TL, 2009, NUCLEIC ACIDS RES, V37, PW202, DOI 10.1093/NAR/GKP335.;BANCROFT JB, 1967, VIROLOGY, V31, P354, DOI 10.1016/0042-6822(67)90180-8.;BARTENSCHLAGER R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/J.TIM.2010.11.005.;BASHTOVYY D, 2001, PROTEIN SCI, V10, P979, DOI 10.1110/PS.43801.;BENDTSEN JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/PROTEIN/GZH037.;BIEGERT A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/PNAS.0810767106.;CALDENTEY J, 1986, J MOL BIOL, V188, P39, DOI 10.1016/0022-2836(86)90478-X.;CASJENS SR, 2008, RES MICROBIOL, V159, P340, DOI 10.1016/J.RESMIC.2008.04.005.;CATTAMANCHI A, 2010, J CLIN MICROBIOL, V48, P2433, DOI 10.1128/JCM.00208-10.;CHEN B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S15.;CHENG JL, 2006, DATA MIN KNOWL DISC, V13, P1, DOI 10.1007/S10618-005-0023-5.;DE GREVE H, 2007, CURR OPIN STRUC BIOL, V17, P506, DOI 10.1016/J.SBI.2007.06.011.;DINSDALE EA, 2008, NATURE, V452, P629, DOI 10.1038/NATURE06810.;DINSDALE EA, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0001584.;DRAWID A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-208.;DUDA RL, 2006, CURR BIOL, V16, PR11, DOI 10.1016/J.CUB.2005.12.023.;ELIASON JL, 1985, P NATL ACAD SCI USA, V82, P2339, DOI 10.1073/PNAS.82.8.2339.;FOGEL GB, 2008, BRIEF BIOINFORM, V9, P307, DOI 10.1093/BIB/BBN021.;FRASER JS, 2007, CURR OPIN MICROBIOL, V10, P382, DOI 10.1016/J.MIB.2007.05.018.;FRASER JS, 2006, J MOL BIOL, V359, P496, DOI 10.1016/J.JMB.2006.03.043.;FUCHS A, 2009, PROTEINS, V74, P857, DOI 10.1002/PROT.22194.;GNIADECKA M, 2004, J INVEST DERMATOL, V122, P443, DOI 10.1046/J.0022-202X.2004.22208.X.;GRANT JR, 2008, NUCLEIC ACIDS RES, V36, PW181, DOI 10.1093/NAR/GKN179.;HAGGARDLJUNGQUIST E, 1992, J BACTERIOL, V174, P1462, DOI 10.1128/JB.174.5.1462-1477.1992.;HANSEN LK, 1990, IEEE T PATTERN ANAL, V12, P993, DOI 10.1109/34.58871.;HASSAN SEH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-88.;HECKER J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S9.;HUET A, 2010, J VIROL, V84, P9350, DOI 10.1128/JVI.00942-10.;JOHNSON JE, 2007, CURR OPIN STRUC BIOL, V17, P237, DOI 10.1016/J.SBI.2007.03.011.;JUUTI JT, 1995, J MOL BIOL, V249, P545, DOI 10.1006/JMBI.1995.0317.;KELLEY LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/NPROT.2009.2.;KHAYAT R, 2005, P NATL ACAD SCI USA, V102, P18944, DOI 10.1073/PNAS.0506383102.;KLOCK HE, 2008, PROTEINS, V71, P982, DOI 10.1002/PROT.21786.;KRUPOVIC M, 2008, NAT REV MICROBIOL, V6, P941, DOI 10.1038/NRMICRO2033.;LAMINA C, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0001853.;LARSSON LI, 1981, J HISTOCHEM CYTOCHEM, V29, P408, DOI 10.1177/29.3.7016977.;LEIMAN PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355.;LEIMAN PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/PNAS.0813360106.;LEIMAN PG, 2006, J MOL BIOL, V358, P912, DOI 10.1016/J.JMB.2006.02.058.;LERA G, 2002, IEEE T NEURAL NETWOR, V13, P1200, DOI 10.1109/TNN.2002.1031951.;LIN CT, 2005, INT J NEURAL SYST, V15, P71, DOI 10.1142/S0129065705000116.;LOBLEY A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/BIOINFORMATICS/BTP302.;LORIMER D, 2011, ACTA CRYSTALLOGR F, V67, P985, DOI 10.1107/S1744309111027424.;LORIMER D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-36.;MAILLARD JY, 1995, J MED MICROBIOL, V42, P415, DOI 10.1099/00222615-42-6-415.;MILLER ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003.;MORAIS MC, 2003, NAT STRUCT BIOL, V10, P572, DOI 10.1038/NSB939.;MORE J. J., 1978, PROCEEDINGS OF THE BIENNIAL CONFERENCE ON NUMERICAL ANALYSIS, P105.;MOSSESSOVA E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3.;MURVAI J, 2001, GENOME RES, V11, P1410, DOI 10.1101/GR.168701.;NIELSEN H, 1997, INT J NEURAL SYST, V8, P581, DOI 10.1142/S0129065797000537.;PAREKATTIL SJ, 2003, J UROLOGY, V169, P917, DOI 10.1097/01.JU.0000051322.60266.06.;PASSERINI A, 2006, PROTEINS, V65, P305, DOI 10.1002/PROT.21135.;PELL LG, 2010, J MOL BIOL, V403, P468, DOI 10.1016/J.JMB.2010.08.044.;PELL LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/PNAS.0900044106.;PLEWCZYNSKI D, 2008, ACTA BIOCHIM POL, V55, P261.;POON TCW, 2001, ONCOLOGY-BASEL, V61, P275, DOI 10.1159/000055334.;QIAO XY, 2003, J BACTERIOL, V185, P6409, DOI 10.1128/JB.185.21.6409-6414.2003.;RAYMOND A, 2011, ACTA CRYSTALLOGR F, V67, P992, DOI 10.1107/S1744309111026698.;RAYMOND A, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-37.;REYNOLDS SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/JOURNAL.PCBI.1000213.;ROHWER F, 2009, ENVIRON MICROBIOL, V11, P2771, DOI 10.1111/J.1462-2920.2009.02101.X.;SEGURITAN V, 2003, J BACTERIOL, V185, P6434, DOI 10.1128/JB.185.21.6434-6447.2003.;SEGURITAN V, 2002, THESIS SAN DIEGO STA.;SMEESTERS PR, 2011, RES MICROBIOL, V162, P446, DOI 10.1016/J.RESMIC.2011.02.009.;STEPHAN C, 2002, CLIN CHEM, V48, P1279.;SULLIVAN MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/JOURNAL.PBIO.0030144.;SUMMER EJ, 2006, J BACTERIOL, V188, P255, DOI 10.1128/JB.188.1.255-268.2006.;SUTTLE CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/NRMICRO1750.;TEAM RDC, 2010, R LANG ENV STAT COMP.;TOYODA Y, 2008, BRIT J CANCER, V98, P1602, DOI 10.1038/SJ.BJC.6604351.;WEINBAUER MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/J.FEMSRE.2003.08.001.;WESTERLUND-WIKSTROM B, 2005, INT J MED MICROBIOL, V295, P479, DOI 10.1016/J.IJMM.2005.06.010.;WILKINS MR, 1997, J THEOR BIOL, V186, P7, DOI 10.1006/JTBI.1996.0346.;WU C, 1992, PROTEIN SCI, V1, P667, DOI 10.1002/PRO.5560010512.;XIONG WW, 2009, NUCLEIC ACIDS RES, V37, P5632, DOI 10.1093/NAR/GKP628.;YAO XQ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-49.;YU YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57.","SEGURITAN, V (REPRINT AUTHOR), SAN DIEGO STATE UNIV, PROGRAM COMPUTAT SCI, SAN DIEGO, CA 92182 USA.;SEGURITAN, VICTOR, SEGALL, ANCA M., SAN DIEGO STATE UNIV, PROGRAM COMPUTAT SCI, SAN DIEGO, CA 92182 USA.;ALVES, NELSON, JR., UNIV FED RIO DE JANEIRO, DEPT GENET, RIO DE JANEIRO, BRAZIL.;ARNOULT, MICHAEL, SEGALL, ANCA M., SAN DIEGO STATE UNIV, DEPT BIOL, SAN DIEGO, CA 92182 USA.;RAYMOND, AMY, LORIMER, DON, BURGIN, ALEX B., JR., EMERALD BIOSTRUCT, SEATTLE, WA USA.;SALAMON, PETER, SAN DIEGO STATE UNIV, DEPT MATH \& STAT, SAN DIEGO, CA 92182 USA.","10.1371/JOURNAL.PCBI.1002657","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E1002657",NA,"NSF [DMS-0827278, DEB-1046413]","THIS WORK WAS SUPPORTED BY NSF GRANTS DMS-0827278 UNDERGRADUATE BIOMATHEMATICS (AWARDED TO A. M. SEGALL AND P. SALAMON) AND DEB-1046413 VIRAL DARK MATTER (AWARDED TO F. ROHWER, A. M. SEGALL, R. EDWARDS, AND A. B. BURGIN). THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT.",NA,"1553-734X","8",NA,"PUBLIC LIBRARY SCIENCE","8",2012,"ISI000308553500040","81","BIOCHEMISTRY \& MOLECULAR BIOLOGY, MATHEMATICAL \& COMPUTATIONAL BIOLOGY","16","BIOCHEMICAL RESEARCH METHODS, MATHEMATICAL \& COMPUTATIONAL BIOLOGY","ASEGALLSUNSTROKE.SDSU.EDU",NA,"002SA",NA,"SEGURITAN, V (REPRINT AUTHOR), SAN DIEGO STATE UNIV, PROGRAM COMPUTAT SCI, SAN DIEGO, CA 92182 USA","ISI","SAN DIEGO STATE UNIV;UNIV FED RIO DE JANEIRO;SAN DIEGO STATE UNIV;SAN DIEGO STATE UNIV","SAN DIEGO STATE UNIV",NA,"SEGURITAN V, 2012, PLOS COMPUT BIOL","SEGURITAN V, 2012, PLOS COMPUT BIOL"
"VASLI N, 2012, ACTA NEUROPATHOL","VASLI N;BOEHM J;LE GRAS S;MULLER J;PIZOT C;JOST B;ECHANIZ LAGUNA A;LAUGEL V;TRANCHANT C;BERNARD R;PLEWNIAK F;VICAIRE S;LEVY N;CHELLY J;MANDEL JL;BIANCALANA V;LAPORTE J","NEXT GENERATION SEQUENCING FOR MOLECULAR DIAGNOSIS OF NEUROMUSCULAR DISEASES","ACTA NEUROPATHOLOGICA","ACTA NEUROPATHOL.","INHERITED NEUROMUSCULAR DISORDERS (NMD) ARE CHRONIC GENETIC DISEASES POSING A SIGNIFICANT BURDEN ON PATIENTS AND THE HEALTH CARE SYSTEM. DESPITE TREMENDOUS RESEARCH AND CLINICAL EFFORTS, THE MOLECULAR CAUSES REMAIN UNKNOWN FOR NEARLY HALF OF THE PATIENTS, DUE TO GENETIC HETEROGENEITY AND CONVENTIONAL MOLECULAR DIAGNOSIS BASED ON A GENE-BY-GENE APPROACH. WE AIMED TO TEST NEXT GENERATION SEQUENCING (NGS) AS AN EFFICIENT AND COST-EFFECTIVE STRATEGY TO ACCELERATE PATIENT DIAGNOSIS. WE DESIGNED A CAPTURE LIBRARY TO TARGET THE CODING AND SPLICE SITE SEQUENCES OF ALL KNOWN NMD GENES AND USED NGS AND DNA MULTIPLEXING TO RETRIEVE THE PATHOGENIC MUTATIONS IN PATIENTS WITH HETEROGENEOUS NMD WITH OR WITHOUT KNOWN MUTATIONS. WE RETRIEVED ALL KNOWN MUTATIONS, INCLUDING POINT MUTATIONS AND SMALL INDELS, INTRONIC AND EXONIC MUTATIONS, AND A LARGE DELETION IN A PATIENT WITH DUCHENNE MUSCULAR DYSTROPHY, VALIDATING THE SENSITIVITY AND REPRODUCIBILITY OF THIS STRATEGY ON A HETEROGENEOUS SUBSET OF NMD WITH DIFFERENT GENETIC INHERITANCE. MOST PATHOGENIC MUTATIONS WERE RANKED ON TOP IN OUR BLIND BIOINFORMATIC PIPELINE. FOLLOWING THE SAME STRATEGY, WE CHARACTERIZED PROBABLE TTN, RYR1 AND COL6A3 MUTATIONS IN SEVERAL PATIENTS WITHOUT PREVIOUS MOLECULAR DIAGNOSIS. THE COST WAS LESS THAN CONVENTIONAL TESTING FOR A SINGLE LARGE GENE. WITH APPROPRIATE ADAPTATIONS, THIS STRATEGY COULD BE IMPLEMENTED INTO A ROUTINE GENETIC DIAGNOSIS SET-UP AS A FIRST SCREENING APPROACH TO DETECT MOST KIND OF MUTATIONS, POTENTIALLY BEFORE THE NEED OF MORE INVASIVE AND SPECIFIC CLINICAL INVESTIGATIONS. AN EARLIER GENETIC DIAGNOSIS SHOULD PROVIDE IMPROVED DISEASE MANAGEMENT AND HIGHER QUALITY GENETIC COUNSELING, AND EASE ACCESS TO THERAPY OR INCLUSION INTO THERAPEUTIC TRIALS.","NEUROMUSCULAR DISORDER; SEQUENCING; MOLECULAR DIAGNOSIS; DNA BARCODING; MYOPATHY; NEUROPATHY","MUSCULAR-DYSTROPHY; SPLICING SIGNALS; CENTRAL CORE; MUTATIONS; DISORDERS; CAPTURE; GENOME; TITIN","ENGLISH","ARTICLE","ARTICLE",50,"BANG ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/HH2301.100981.;DESMET FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/NAR/GKP215.;EMERY A E, 1991, NEUROMUSCUL DISORD, V1, P19, DOI 10.1016/0960-8966(91)90039-U.;GE DL, 2011, BIOINFORMATICS, V27, P1998, DOI 10.1093/BIOINFORMATICS/BTR317.;HACKMAN P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380.;HOISCHEN A, 2010, HUM MUTAT, V31, P492, DOI 10.1002/HUMU.21221.;HUBISZ MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/BIB/BBQ072.;KAPLAN JC, 2010, NEUROMUSCULAR DISORD, V20, P852, DOI 10.1016/J.NMD.2010.10.001.;KINGSMORE SF, 2011, SCI TRANSL MED, V3, DOI 10.1126/SCITRANSLMED.3002695.;LEVY SAMUEL, 2007, PLOS BIOL, V5, PE254, DOI 10.1371/JOURNAL.PBIO.0050254.;LI H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/BIOINFORMATICS/BTP352.;LI H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/BIOINFORMATICS/BTP324.;LIM BC, 2011, J MED GENET, V48, P731, DOI 10.1136/JMEDGENET-2011-100133.;LUPSKI JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMOA0908094.;MESSINA S, 2004, NEUROPEDIATRICS, V35, P262, DOI 10.1055/S-2004-821173.;MONTENEGRO G, 2011, ANN NEUROL, V69, P464, DOI 10.1002/ANA.22235.;NG PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/NAR/GKG509.;NG SB, 2010, HUM MOL GENET, V19, PR119, DOI 10.1093/HMG/DDQ390.;NG SB, 2010, NAT GENET, V42, P30, DOI 10.1038/NG.499.;NG SB, 2009, NATURE, V461, P272, DOI 10.1038/NATURE08250.;NORTH K, 2008, NEUROMUSCULAR DISORD, V18, P433, DOI 10.1016/J.NMD.2008.04.002.;PAREYSON D, 2009, LANCET NEUROL, V8, P654, DOI 10.1016/S1474-4422(09)70110-3.;RAMENSKY V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/NAR/GKF493.;REESE MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/CMB.1997.4.311.;ROBINSON JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/NBT.1754.;ROMERO NB, 2003, BRAIN, V126, P2341, DOI 10.1093/BRAIN/AWG244.;SAILLOUR Y, 2008, HUM MUTAT, V29, P1083, DOI 10.1002/HUMU.20829.;SAUNA ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/NRG3051.;TREVES S, 2008, CURR OPIN PHARMACOL, V8, P319, DOI 10.1016/J.COPH.2008.01.005.;WALSH T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/PNAS.1007983107.;WHEELER DA, 2008, NATURE, V452, P872, DOI 10.1038/NATURE06884.;YEO G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418.","LAPORTE, J (REPRINT AUTHOR), IGBMC, 1 RUE LAURENT FRIES,BP10142, F-67404 ILLKIRCH GRAFFENSTADEN, FRANCE.;VASLI, NASIM, BOEHM, JOHANN, LE GRAS, STEPHANIE, MULLER, JEAN, PIZOT, CECILE, JOST, BERNARD, PLEWNIAK, FREDERIC, VICAIRE, SERGE, MANDEL, JEAN-LOUIS, BIANCALANA, VALERIE, LAPORTE, JOCELYN, IGBMC, F-67404 ILLKIRCH GRAFFENSTADEN, FRANCE.;VASLI, NASIM, BOEHM, JOHANN, LE GRAS, STEPHANIE, MULLER, JEAN, PIZOT, CECILE, JOST, BERNARD, PLEWNIAK, FREDERIC, VICAIRE, SERGE, MANDEL, JEAN-LOUIS, BIANCALANA, VALERIE, LAPORTE, JOCELYN, INSERM, U964, ILLKIRCH GRAFFENSTADEN, FRANCE.;VASLI, NASIM, BOEHM, JOHANN, LE GRAS, STEPHANIE, MULLER, JEAN, PIZOT, CECILE, JOST, BERNARD, PLEWNIAK, FREDERIC, VICAIRE, SERGE, MANDEL, JEAN-LOUIS, BIANCALANA, VALERIE, LAPORTE, JOCELYN, CNRS, UMR7104, ILLKIRCH GRAFFENSTADEN, FRANCE.;VASLI, NASIM, BOEHM, JOHANN, LE GRAS, STEPHANIE, MULLER, JEAN, PIZOT, CECILE, JOST, BERNARD, PLEWNIAK, FREDERIC, VICAIRE, SERGE, MANDEL, JEAN-LOUIS, BIANCALANA, VALERIE, LAPORTE, JOCELYN, UNIV STRASBOURG, ILLKIRCH GRAFFENSTADEN, FRANCE.;VASLI, NASIM, BOEHM, JOHANN, MULLER, JEAN, PIZOT, CECILE, MANDEL, JEAN-LOUIS, BIANCALANA, VALERIE, LAPORTE, JOCELYN, COLL FRANCE, CHAIRE GENET HUMAINE, ILLKIRCH GRAFFENSTADEN, FRANCE.;MULLER, JEAN, MANDEL, JEAN-LOUIS, BIANCALANA, VALERIE, CHRU, FAC MED, LAB DIAGNOST GENET, STRASBOURG, FRANCE.;ECHANIZ-LAGUNA, ANDONI, TRANCHANT, CHRISTINE, HOSPICES CIVILS STRASBOURG, DEPT NEUROL, STRASBOURG, FRANCE.;LAUGEL, VINCENT, CHU STRASBOURG, SERV PEDIAT, F-67000 STRASBOURG, FRANCE.;BERNARD, RAFAELLE, LEVY, NICOLAS, UNIV AIX MARSEILLE 2, FAC MED MARSEILLE, INSERM UMRS GENET MED \& GENOM FONCT 910, MARSEILLE, FRANCE.;CHELLY, JAMEL, UNIV PARIS 05, CNR UMR 1408, INSERM UNITE 1016, INST COCHIN, PARIS, FRANCE.","10.1007/S00401-012-0982-8","233 SPRING ST, NEW YORK, NY 10013 USA",NA,NA,"INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITY OF STRASBOURG (UDS), COLLEGE DE FRANCE, AGENCE NATIONALE DE LA RECHERCHE, MUSCULAR DYSTROPHY ASSOCIATION, MYOTUBULAR TRUST","WE THANK MICHEL KOENIG AND MATHIEU ANHEIM FOR DNA SAMPLES WITH KNOWN MUTATIONS, NGOC-HOAN NGUYEN AND CELINE KEIME FOR HELP IN THE BIOINFORMATICS SETUP AND ANALYSIS, CLAUDIA STRAFELLA, NICOLAS DONDAINE, GABRIELLE RUDOLF, JULIETTE NECTOUX, CELINE LEROUX, ISABELLE ATLAN AND FRANCE LETURCQ FOR TECHNICAL ASSISTANCE, AND GISELE BONNE FOR DISCUSSIONS. THIS STUDY WAS SUPPORTED BY THE INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), THE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITY OF STRASBOURG (UDS), COLLEGE DE FRANCE AND GRANTS FROM THE AGENCE NATIONALE DE LA RECHERCHE, MUSCULAR DYSTROPHY ASSOCIATION AND MYOTUBULAR TRUST.",NA,"0001-6322","2","273-283","SPRINGER","124",2012,"ISI000306586600010","32","NEUROSCIENCES \& NEUROLOGY, PATHOLOGY","17","CLINICAL NEUROLOGY, NEUROSCIENCES, PATHOLOGY","JOCELYNIGBMC.FR",NA,"976LQ",NA,"LAPORTE, J (REPRINT AUTHOR), IGBMC, 1 RUE LAURENT FRIES,BP10142, F-67404 ILLKIRCH GRAFFENSTADEN, FRANCE","ISI","CNRS;UNIV STRASBOURG;COLL FRANCE;LAB DIAGNOST GENET;HOSPICES CIVILS STRASBOURG;MARSEILLE;NA","NOTREPORTED",NA,"VASLI N, 2012, ACTA NEUROPATHOL","VASLI N, 2012, ACTA NEUROPATHOL"
"NISHIGUCHI KM, 2012, PLOS ONE","NISHIGUCHI KM;RIVOLTA C","GENES ASSOCIATED WITH RETINITIS PIGMENTOSA AND ALLIED DISEASES ARE FREQUENTLY MUTATED IN THE GENERAL POPULATION","PLOS ONE","PLOS ONE","BACKGROUND: RETINITIS PIGMENTOSA AND OTHER HEREDITARY RETINAL DEGENERATIONS (HRD) ARE RARE GENETIC DISEASES LEADING TO PROGRESSIVE BLINDNESS. RECESSIVE HRD ARE CAUSED BY MUTATIONS IN MORE THAN 100 DIFFERENT GENES. LAWS OF POPULATION GENETICS PREDICT THAT, ON A PURELY THEORETICAL GROUND, SUCH A HIGH NUMBER OF GENES SHOULD TRANSLATE INTO AN EXTREMELY ELEVATED FREQUENCY OF UNAFFECTED CARRIERS OF MUTATIONS. IN THIS STUDY WE ESTIMATE THE PROPORTION OF THESE INDIVIDUALS WITHIN THE GENERAL POPULATION, VIA THE ANALYSES OF DATA FROM WHOLE-GENOME SEQUENCING. METHODOLOGY/PRINCIPAL FINDINGS: WE SCREENED COMPLETE AND HIGH-QUALITY GENOME SEQUENCES FROM 46 CONTROL INDIVIDUALS FROM VARIOUS WORLD POPULATIONS FOR HRD MUTATIONS, USING BIOINFORMATIC TOOLS DEVELOPED IN-HOUSE. ALL MUTATIONS DETECTED IN SILICO WERE VALIDATED BY SANGER SEQUENCING. WE IDENTIFIED CLEAR-CUT, NULL RECESSIVE HRD MUTATIONS IN 10 OUT OF THE 46 UNAFFECTED INDIVIDUALS ANALYZED (SIMILAR TO 22\%). CONCLUSIONS/SIGNIFICANCE: BASED ON OUR DATA, APPROXIMATELY ONE IN 4-5 INDIVIDUALS FROM THE GENERAL POPULATION MAY BE A CARRIER OF NULL MUTATIONS THAT ARE RESPONSIBLE FOR HRD. THIS WOULD BE THE HIGHEST MUTATION CARRIER FREQUENCY SO FAR MEASURED FOR A CLASS OF MENDELIAN DISORDERS, ESPECIALLY CONSIDERING THAT MISSENSES AND OTHER FORMS OF PATHOGENIC CHANGES WERE NOT INCLUDED IN OUR ASSESSMENT. AMONG OTHER THINGS, OUR RESULTS INDICATE THAT THE RISK FOR A CONSANGUINEOUS COUPLE OF GENERATING A CHILD WITH A BLINDING DISEASE IS PARTICULARLY HIGH, COMPARED TO OTHER GENETIC CONDITIONS.",NA,"CHILDHOOD BLINDNESS; GENOME; PREVALENCE","ENGLISH","ARTICLE","ARTICLE",28,"ALTSHULER D, 2010, NATURE, V467, P1061, DOI 10.1038/NATURE09534.;BAGHDASSARIAN SA, 1975, AM J OPHTHALMOL, V79, P827, DOI 10.1016/0002-9394(75)90744-8.;BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659.;BITTLES AH, 2001, CLIN GENET, V60, P89, DOI 10.1034/J.1399-0004.2001.600201.X.;BRANCATI F, 2007, AM J HUM GENET, V81, P104, DOI 10.1086/519026.;DRMANAC R, 2010, SCIENCE, V327, P78, DOI 10.1126/SCIENCE.1181498.;ELDER MJ, 1993, EYE, V7, P580, DOI 10.1038/EYE.1993.126.;HAMEL CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7.;HARTONG DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7.;LUPSKI JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMOA0908094.;RAZAVI H, 2010, OPHTHAL EPIDEMIOL, V17, P95, DOI 10.3109/09286581003624954.;RIVOLTA C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/HMG/11.10.1219.;STENSON PD, 2009, GENOME MED, V1, DOI 10.1186/GM13.;TABBARA KF, 1985, BRIT J OPHTHALMOL, V69, P312, DOI 10.1136/BJO.69.4.312.;WHEELER DA, 2008, NATURE, V452, P872, DOI 10.1038/NATURE06884.","NISHIGUCHI, KM (REPRINT AUTHOR), UNIV LAUSANNE, DEPT MED GENET, LAUSANNE, SWITZERLAND.;NISHIGUCHI, KOJI M., RIVOLTA, CARLO, UNIV LAUSANNE, DEPT MED GENET, LAUSANNE, SWITZERLAND.","10.1371/JOURNAL.PONE.0041902","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E41902",NA,"SWISS NATIONAL SCIENCE FOUNDATION [310030\_138346], GEBERT RUF FOUNDATION","THIS WORK WAS SUPPORTED BY THE SWISS NATIONAL SCIENCE FOUNDATION (GRANT NUMBER 310030\_138346) AND THE GEBERT RUF FOUNDATION (RARE DISEASES - NEW TECHNOLOGIES GRANT). THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT.",NA,"1932-6203","7",NA,"PUBLIC LIBRARY SCIENCE","7",2012,"ISI000306950200125","15","SCIENCE \& TECHNOLOGY - OTHER TOPICS","7","MULTIDISCIPLINARY SCIENCES","CARLO.RIVOLTAUNIL.CH",NA,"981ER",NA,"NISHIGUCHI, KM (REPRINT AUTHOR), UNIV LAUSANNE, DEPT MED GENET, LAUSANNE, SWITZERLAND","ISI","UNIV LAUSANNE","UNIV LAUSANNE",NA,"NISHIGUCHI KM, 2012, PLOS ONE","NISHIGUCHI KM, 2012, PLOS ONE"
"JAHANGIRI A, 2012, J THEOR BIOL","JAHANGIRI A;RASOOLI I;RAHBAR MR;KHALILI S;AMANI J;ZANOOS KA","PRECISE DETECTION OF L-MONOCYTOGENES HITTING ITS HIGHLY CONSERVED REGION POSSESSING SEVERAL SPECIFIC ANTIBODY BINDING SITES","JOURNAL OF THEORETICAL BIOLOGY","J. THEOR. BIOL.","LISTERIA MONOCYTOGENES, A FACULTATIVE INTRACELLULAR FAST-GROWING GRAM-POSITIVE FOOD-BORNE PATHOGEN, CAN INFECT IMMUNOCOMPROMISED INDIVIDUALS LEADING TO MENINGITIS, MENINGOENCEPHALITIS AND SEPTICAEMIAS. FROM THE POOL OF VIRULENCE FACTORS OF THE ORGANISM, ACTA, A MEMBRANE PROTEIN, HAS A CRITICAL ROLE IN THE LIFE CYCLE OF L MONOCYTOGENES. HIGH MORTALITY RATE OF LISTERIOSIS NECESSITATES A SENSITIVE AND RAPID DIAGNOSTIC TEST FOR PRECISE IDENTIFICATION OF L MONOCYTOGENES. WE USED BIOINFORMATIC TOOLS TO LOCATE A SPECIFIC CONSERVED REGION OF ACTA FOR DESIGNING AND DEVELOPING AN ANTIBODY-ANTIGEN BASED DIAGNOSTIC TEST FOR THE DETECTION OF L. MONOCYTOGENES. A NUMBER OF DATABASES WERE LOOKED FOR ACTA RELATED SEQUENCES. SEQUENCES WERE ANALYZED WITH SEVERAL ONLINE SOFTWARE TO FIND AN APPROPRIATE REGION FOR OUR PURPOSE. ACTA PROTEIN WAS FOUND SPECIFIC TO LISTERIA SPECIES WITH NO HOMOLOGS IN OTHER ORGANISMS. WE FINALLY INTRODUCED A HIGHLY CONSERVED REGION WITHIN ACTA SEQUENCE THAT POSSESS SEVERAL ANTIBODY BINDING SITES SPECIFIC TO L. MONOCYTOGENES. THIS PROTEIN SEQUENCE CAN SERVE AS AN ANTIGEN FOR DESIGNING A RELATIVELY CHEAP, SENSITIVE, AND SPECIFIC DIAGNOSTIC TEST FOR DETECTION OF L MONOCYTOGENES. (C) 2012 ELSEVIER LTD. ALL RIGHTS RESERVED.","ACTA; DIAGNOSTIC TEST; BIOINFORMATICS; IN SILICO; B CELL EPITOPE","SURFACE PROTEIN ACTA; AMINO-ACID-SEQUENCE; IN-SILICO ANALYSIS; B-CELL EPITOPES; LISTERIA-MONOCYTOGENES; ESCHERICHIA-COLI; SECONDARY-STRUCTURE; MAMMALIAN-CELLS; PREDICTION; IDENTIFICATION","ENGLISH","ARTICLE","ARTICLE",18,"AAGAARD C, 2003, J CLIN MICROBIOL, V41, P3719, DOI [10.1128/JCM.41.8.3719-3728.2003, 10.1128/JCM.41.8.3719-3798.2003].;ALVAREZDOMINGUEZ C, 1997, INFECT IMMUN, V65, P78.;AMANI J, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-28.;BANNANTINE JP, 2002, J CLIN MICROBIOL, V40, P1303, DOI 10.1128/JCM.40.4.1303-1310.2002.;BERNSEL A, 2009, NUCLEIC ACIDS RES, V37, PW465, DOI 10.1093/NAR/GKP363.;BRUNDAGE RA, 1993, P NATL ACAD SCI USA, V90, P11890, DOI 10.1073/PNAS.90.24.11890.;CAI H., 2011, MOL BIOTECHNOL, P1.;CHONG R, 2009, CELL HOST MICROBE, V6, P268, DOI 10.1016/J.CHOM.2009.08.006.;CHOU P Y, 1978, ADV ENZYMOL RELAT AREAS MOL BIOL, V47, P45.;CLERMONT G, 2004, CRIT CARE MED, V32, P2061, DOI 10.1097/01.CCM.0000142394.28791.C3.;COSSART P, 1998, EMBO J, V17, P3797, DOI 10.1093/EMBOJ/17.14.3797.;COSSART P, 2000, GRAM-POSITIVE PATHOGENS, P507.;CZUPRYNSKI CHARLES J., 2005, ANIMAL HEALTH RESEARCH REVIEWS, V6, P211, DOI 10.1079/AHR2005111.;DARJI A, 1998, J IMMUNOL, V161, P2414.;DAVIES MN, 2007, DRUG DISCOV TODAY, V12, P389, DOI 10.1016/J.DRUDIS.2007.03.010.;DAVIS GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO,2-9.;DE GROOT AS, 2001, VACCINE, V19, P4385, DOI 10.1016/S0264-410X(01)00145-1.;DOYTCHINOVA IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4.;EMINI EA, 1985, J VIROL, V55, P836.;FATTAHIAN Y., 2011, MICROB PATHOG.;GARNIER J, 1996, METHOD ENZYMOL, V266, P540.;GASTEIGER E., 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571.;GRANSETH E, 2006, BIOINFORMATICS, V22, PE191, DOI 10.1093/BIOINFORMATICS/BTL206.;GRAVES LM, 2005, J CLIN MICROBIOL, V43, P2350, DOI 10.1128/JCM.43.5.2350-2355.2005.;HARRISON RG, 2000, INNOVATIONS, V11, P4.;HOFMANN K., 1996, BOXSHADE 3 21 PRETTY.;JAHANGIRI A., 2011, VACCINE, P6948.;JUNIER T, 2000, BIOINFORMATICS, V16, P178, DOI 10.1093/BIOINFORMATICS/16.2.178.;KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768.;KEMP DJ, 1987, ANNU REV MICROBIOL, V41, P181, DOI 10.1146/ANNUREV.MI.41.100187.001145.;KORBER B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/JOURNAL.PCBI.0020071.;LARSEN JENS ERIK PONTOPPIDAN, 2006, IMMUNOME RES, V2, P2, DOI 10.1186/1745-7580-2-2.;LE MONNIER A, 2007, INFECT IMMUN, V75, P950, DOI 10.1128/IAI.01570-06.;LEERKES MR, 2002, GENOMICS, V79, P257, DOI 10.1006/GENO.2002.6691.;LEONG ML, 2009, INFECT IMMUN, V77, P3958, DOI 10.1128/IAI.01274-08.;LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/BI00613A026.;NOTREDAME C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/JMBI.2000.4042.;OLFA F.G., BMC MICROBIOL, V8.;PAILLARD D, 2003, APPL ENVIRON MICROB, V69, P6386, DOI 10.1128/AEM.69.11.6386-6392.2003.;PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/BI00367A013.;PETERSEN TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/NMETH.1701.;PORTNOY DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/JCB.200205009.;POUSSIN M., 2009, CELL RES, V20, P109.;RAFELSKI SM, 2006, MOL MICROBIOL, V59, P1262, DOI 10.1111/J.1365-2958.2005.05025.X.;RAHBAR M.R., 2011, J THEOR BIOL.;RAHBAR MR, 2010, J THEOR BIOL, V266, P275, DOI 10.1016/J.JTBI.2010.06.014.;REEDER JC, 1996, IMMUNOL CELL BIOL, V74, P546, DOI 10.1038/ICB.1996.88.;REZA RAHBAR M., 2010, J THEOR BIOL.;ROMERO S, 2009, NAT CELL BIOL, V11, P1174, DOI 10.1038/NCB1009-1174.;ROUKOS DH, 2009, EXPERT REV MOL DIAGN, V9, P227, DOI [10.1586/ERM.09.6, 10.1586/ERM.09.6].;SAHA S, 2006, PROTEINS, V65, P40, DOI 10.1002/PROT.21078.;SHUKLA S., 2011, J MED SCI MJMS, V18, P13.;SKEIKY YAW, 1994, INFECT IMMUN, V62, P1643.;SMITH GA, 1996, J CELL BIOL, V135, P647, DOI 10.1083/JCB.135.3.647.;SUAREZ M, 2001, CELL MICROBIOL, V3, P853, DOI 10.1046/J.1462-5822.2001.00160.X.;SWEREDOSKI MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/PROTEIN/GZN075.;SZKLARCZYK D, 2011, NUCLEIC ACIDS RES, V39, PD561, DOI 10.1093/NAR/GKQ973.;TOMAS-ROCA L., 2011, INT J DEV NEUROSCI.;VAZQUEZ-BOLAND JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001.;VIKLUND H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/PS.04625404.;VIKLUND H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/BIOINFORMATICS/BTN221.;VOLOKHOV D, 2002, J CLIN MICROBIOL, V40, P4720, DOI 10.1128/JCM.40.12.4720-4728.2002.;WATSON R., 2009, BMJ, V338.;WILKINSON DL, 1991, BIO-TECHNOL, V9, P443, DOI 10.1038/NBT0591-443.;YOSHIKAWA Y., 2009, AUTOPHAGY, V5.;YOSHIKAWA Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/NCB1967.;YU KY, 2004, CLIN DIAGN LAB IMMUN, V11, P446, DOI 10.1128/CDLI.11.3.446-451.2004.;ZENEWICZ LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/J.MICINF.2007.05.008.;ZHANG T., 2002, J EXP CLIN VIROL, V16, P44.;ZHOU Y, 2007, NUCLEIC ACIDS RES, V35, PW678, DOI 10.1093/NAR/GKM278.","RASOOLI, I (REPRINT AUTHOR), SHAHED UNIV, DEPT BIOL, TEHRAN QOM EXPRESS WAY, TEHRAN 3319118651, IRAN.;JAHANGIRI, ABOLFAZL, RASOOLI, IRAJ, ZANOOS, KOBRA AHMADI, SHAHED UNIV, DEPT BIOL, TEHRAN 3319118651, IRAN.;RAHBAR, MOHAMMAD REZA, SAADATIS LAB, DEPT MOL BIOL, SHIRAZ, IRAN.;KHALILI, SAEED, TARBIAT MODARES UNIV, DEPT MED BIOTECHNOL, TEHRAN, IRAN.;AMANI, JAFAR, BAQIYATALLAH MED SCI UNIV, APPL BIOTECHNOL RES CTR, TEHRAN, IRAN.","10.1016/J.JTBI.2012.04.010","24-28 OVAL RD, LONDON NW1 7DX, ENGLAND",NA,NA,"SHAHED UNIVERSITY","THIS STUDY WAS SUPPORTED BY A GRANT FROM SHAHED UNIVERSITY. THE AUTHORS DECLARE NO CONFLICT OF INTERESTS.",NA,"0022-5193",NA,"15-23","ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD","305",2012,"ISI000305308000002","70","LIFE SCIENCES \& BIOMEDICINE - OTHER TOPICS, MATHEMATICAL \& COMPUTATIONAL BIOLOGY","12","BIOLOGY, MATHEMATICAL \& COMPUTATIONAL BIOLOGY","RASOOLISHAHED.AC.IR",NA,"959JF",NA,"RASOOLI, I (REPRINT AUTHOR), SHAHED UNIV, DEPT BIOL, TEHRAN QOM EXPRESS WAY, TEHRAN 3319118651, IRAN","ISI","SHAHED UNIV;SAADATIS LAB;TARBIAT MODARES UNIV;BAQIYATALLAH MED SCI UNIV","SHAHED UNIV",NA,"JAHANGIRI A, 2012, J THEOR BIOL","JAHANGIRI A, 2012, J THEOR BIOL"
"SHANMUGAKANI RK, 2012, AFR J MICROBIOL RES","SHANMUGAKANI RK;GHOSH AR","SINGLE PRIMER DESIGNED FOR DETECTION OF SHIGELLA SPECIES","AFRICAN JOURNAL OF MICROBIOLOGY RESEARCH","AFR. J. MICROBIOL. RES.","IN INFECTIOUS DISEASE DIAGNOSIS PRIOR TO TREATMENT, IDENTIFICATION OF THE CAUSATIVE AGENT PLAYS A CRUCIAL ROLE. POLYMERASE CHAIN REACTION (PCR) HAS PAVED A MOLECULAR WAY FOR SPECIFIC SPECIES IDENTIFICATION. IN THIS STUDY, WE HAVE ATTEMPTED TO DESIGN A SINGLE COMMON PRIMER TO IDENTIFY THE CAUSATIVE AGENT FOR SHIGELLOSIS - SHIGELLA SPP. BIOINFORMATIC TOOLS LIKE CLUSTALX FOR MULTIPLE SEQUENCE ALIGNMENT, PRIMER3 FOR PRIMER DESIGNING, NETPRIMER FOR PRIMER ANALYSIS, IN SILICO PCR AMPLIFICATION TOOL FOR AMPLIFICATION WERE USED. IN SILICO PCR AMPLIFICATION GAVE THE DESIRED AMPLICON WITH THE SAME SEQUENCE THAT HAD BEEN USED FOR PRIMER DESIGNING. A SINGLE PRIMER WAS THUS DESIGNED FOR THE GENUS SHIGELLA AND IS PREDICTED TO BE A PROTOTYPE SEQUENCE FOR EASY AND RAPID DETECTION OF SHIGELLA SPP.","VIRULENCE FACTOR DATA BASE (VFDB); CLUSTALX; PRIMER3; NETPRIMER; IN SILICO POLYMERASE CHAIN REACTION (PCR) AMPLIFICATION","NICOBAR ISLANDS; ANDAMAN; INFECTIONS; INDIA","ENGLISH","ARTICLE","ARTICLE",0,"CASTELLANI A., 1919, MANUAL TROPICAL MED, P959.;CHEN LH, 2005, NUCLEIC ACIDS RES, V33, PD325, DOI 10.1093/NAR/GKI008.;CROCKETT CS, 1996, INT J FOOD MICROBIOL, V30, P87, DOI 10.1016/0168-1605(96)00993-2.;GHOSH AR, 2003, ANTIMICROB AGENTS CH, V47, P1483, DOI 10.1128/AAC.47.4.1483.2003.;GHOSH AR, 1998, EPIDEMIOL INFECT, V121, P43, DOI 10.1017/S0950268898008978.;GRIMONT F, 2007, J MED MICROBIOL, V56, P749, DOI 10.1099/JMM.0.46818-0.;KOTLOFF KL, 1999, B WORLD HEALTH ORGAN, V77, P651.;LAMPEL KA, 1990, APPL ENVIRON MICROB, V56, P1536.;MAHEUX AF, 2009, WATER RES, V43, P3019, DOI 10.1016/J.WATRES.2009.04.017.;ROY S, 2005, TROP MED INT HEALTH, V10, P604, DOI 10.1111/J.1365-3156.2005.01423.X.","GHOSH, AR (REPRINT AUTHOR), VIT UNIV, SCH BIOSCI \& TECHNOL, VELLORE 632 014, TAMIL NADU, INDIA.;SHANMUGAKANI, RATHINA KUMAR, GHOSH, ASIT R., VIT UNIV, SCH BIOSCI \& TECHNOL, VELLORE 632 014, TAMIL NADU, INDIA.;GHOSH, ASIT R., VIT UNIV, CTR INFECT DIS \& CONTROL, VELLORE 632014, TAMIL NADU, INDIA.","10.5897/AJMR11.1330","P O BOX 5170-00200 NAIROBI, VICTORIA ISLAND, LAGOS 73023, NIGERIA",NA,NA,NA,NA,NA,"1996-0808","25","5288-5293","ACADEMIC JOURNALS","6",2012,"ISI000307506000001","10","MICROBIOLOGY","3","MICROBIOLOGY","ASITRANJANGHOSHVIT.AC.IN",NA,"988QQ",NA,"GHOSH, AR (REPRINT AUTHOR), VIT UNIV, SCH BIOSCI \& TECHNOL, VELLORE 632 014, TAMIL NADU, INDIA","ISI","VIT UNIV;VIT UNIV","VIT UNIV",NA,"SHANMUGAKANI RK, 2012, AFR J MICROBIOL RES","SHANMUGAKANI RK, 2012, AFR J MICROBIOL RES"
"BETHKE J, 2012, J FISH DIS","BETHKE J;ROJAS V;BERENDSEN J;CARDENAS C;GUZMAN F;GALLARDO JA;MERCADO L","DEVELOPMENT OF A NEW ANTIBODY FOR DETECTING NATURAL KILLER ENHANCING FACTOR (NKEF)-LIKE PROTEIN IN INFECTED SALMONIDS","JOURNAL OF FISH DISEASES","J. FISH DIS.","THE MAIN CELLULAR RESPONSES OF INNATE IMMUNITY ARE PHAGOCYTIC ACTIVITY AND THE RESPIRATORY BURST, WHICH PRODUCES A HIGH AMOUNT OF REACTIVE OXYGEN SPECIES. NATURAL KILLER ENHANCING FACTOR (NKEF) BELONGS TO THE PEROXIREDOXIN FAMILY THAT HAS AN ANTIOXIDANT FUNCTION AND ENHANCES CYTOTOXIC CELL ACTIVITY. THIS MOLECULE MAY PLAY A KEY ROLE IN MACROPHAGE AND CYTOTOXIC CELL COMMUNICATION DURING THE INNATE IMMUNE RESPONSE OF FISH AGAINST PATHOGENS. IN FISH, THE NKEF GENE HAS BEEN CHARACTERIZED IN SOME SPECIES AS SHOWING AN UP-REGULATION IN INFECTED FISH, SUGGESTING A TRIGGER EFFECT UPON NK-LIKE CELLS. TO DETECT AND LOCALIZE THIS MOLECULE IN SALMONIDS AT PROTEIN LEVEL, A MONOSPECIFIC POLYCLONAL ANTIBODY WAS GENERATED. A PROBABLE NKEF-LIKE PROTEIN EPITOPE REGION WAS IDENTIFIED AND CHARACTERIZED USING BIOINFORMATIC TOOLS, AND THE SEQUENCE WAS CHEMICALLY SYNTHESIZED USING FMOC STRATEGY, ANALYSED BY RP-HPLC AND ITS MOLECULAR WEIGHT CONFIRMED BY MASS SPECTROMETRY. THE SYNTHETIC PEPTIDE WAS IMMUNIZED AND ANTIBODIES FROM ASCITIC FLUID WERE OBTAINED. THE RESULTING ANTIBODY IS A VERSATILE TOOL FOR DETECTING NKEF BY DIFFERENT IMMUNE TECHNIQUES SUCH AS ELISA, WESTERN BLOTTING AND IMMUNOHISTOCHEMISTRY. ANALYSIS OF NKEF-LIKE PROTEIN IS A USEFUL METHOD FOR CHARACTERIZING IMMUNE PROPERTIES OF THIS MOLECULE IN FISH DURING RESPONSE TO PATHOGENS.","ELISA; FISH INNATE IMMUNITY; IMMUNOHISTOCHEMISTRY; NATURAL KILLER ENHANCING FACTOR; ONCORHYNCUS MYKISS; SALMO SALAR","TROUT ONCORHYNCHUS-MYKISS; ATLANTIC SALMON; RAINBOW-TROUT; CHANNEL CATFISH; CYTOTOXIC-CELLS; FACTOR GENES; NKEF GENE; SEA LICE; FISH; EXPRESSION","ENGLISH","ARTICLE","ARTICLE",20,"ALVAREZ-PELLITERO P, 2008, VET IMMUNOL IMMUNOP, V126, P171, DOI 10.1016/J.VETIMM.2008.07.013.;ARNOLD K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/BIOINFORMATICS/BTI770.;BOOY AT, 2005, J PROTEOME RES, V4, P325, DOI 10.1021/PR04984GT.;BUCHMANN K, 1999, FOLIA PARASIT, V46, P1.;CHEN J, 2009, FISH SHELLFISH IMMUN, V26, P567, DOI 10.1016/J.FSI.2009.02.004.;CHEN Y., 2006, AQUACULTURE, V26, P1186.;CORRALES J, 2009, FISH SHELLFISH IMMUN, V27, P154, DOI 10.1016/J.FSI.2009.02.023.;DONG WR, 2007, FISH SHELLFISH IMMUN, V22, P1, DOI 10.1016/J.FSI.2006.03.007.;FAST MD, 2002, DIS AQUAT ORGAN, V52, P57, DOI 10.3354/DAO052057.;GANASSIN RC, 1998, FISH SHELLFISH IMMUN, V8, P457, DOI 10.1006/FSIM.1998.0153.;GASTEIGER E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/NAR/GKG563.;GASTEIGER E., 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571.;HAUGARVOLL E, 2008, J ANAT, V213, P202, DOI 10.1111/J.1469-7580.2008.00943.X.;HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/PNAS.82.15.5131.;HUANG R, 2009, FISH SHELLFISH IMMUN, V26, P220, DOI 10.1016/J.FSI.2008.10.013.;KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q.;KULKARNI-KALE U, 2005, NUCLEIC ACIDS RES, V33, P168.;LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/BIOINFORMATICS/BTM404.;LI RW, 2006, FISH SHELLFISH IMMUN, V20, P72, DOI 10.1016/J.FSI.2005.04.002.;LIANG SD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-302.;MORRISON RN, 2006, VET IMMUNOL IMMUNOP, V109, P297, DOI 10.1016/J.VETIMM.2005.08.026.;NARVAEZ E, 2010, FISH SHELLFISH IMMUN, V28, P235, DOI 10.1016/J.FSI.2009.10.004.;PRIETO I, 1995, EUR J IMMUNOL, V25, P877, DOI 10.1002/EJI.1830250403.;RANDELLI E, 2008, FISH SHELLFISH IMMUN, V25, P326, DOI 10.1016/J.FSI.2008.03.019.;ROCCATANO D, 2002, P NATL ACAD SCI USA, V99, P12179, DOI 10.1073/PNAS.182199699.;SAURI H, 1996, J LEUKOCYTE BIOL, V59, P925.;SECOMBES C.J., 1990, TECHNIQUES FISH IMMU, P137.;SHAU HG, 1994, IMMUNOGENETICS, V40, P129.;SHEN L., 2004, DEV COMP IMMUNOL, V26, P139.;SHEN LL, 2002, DEV COMP IMMUNOL, V26, P141, DOI 10.1016/S0145-305X(01)00056-8.;SHIN DH, 2001, DEV COMP IMMUNOL, V25, P597, DOI 10.1016/S0145-305X(01)00021-0.;SUN J., 2009, NUCLEIC ACIDS RES, V37, P612.;TORREALBA DA, 2011, CRUSTACEANA, V84, P939, DOI 10.1163/001121611X579178.;TORT L., 2001, INMUNOLOGIA, V22, P277.;UTKE K, 2007, FISH SHELLFISH IMMUN, V22, P182, DOI 10.1016/J.FSI.2006.04.008.;WHYTE SK, 2007, FISH SHELLFISH IMMUN, V23, P1127, DOI 10.1016/J.FSI.2007.06.005.;YASUKO I., 2004, FISH SHELLFISH IMMUN, V166, P163.;YODER JA, 2004, COMP BIOCHEM PHYS C, V138, P271, DOI 10.1016/J.CCA.2004.03.008.;ZHANG H, 2001, DEV COMP IMMUNOL, V25, P25, DOI 10.1016/S0145-305X(00)00038-0.","MERCADO, L (REPRINT AUTHOR), PONTIFICIA UNIV CATOLICA VALPARAISO, GRP MARCADORES INMUNOL ORGANISMOS ACUAT, LAB GENET \& INMUNOL MOL, INST BIOL,FAC CIENCIAS, VALPARAISO, CHILE.;BETHKE, J., ROJAS, V., BERENDSEN, J., MERCADO, L., PONTIFICIA UNIV CATOLICA VALPARAISO, GRP MARCADORES INMUNOL ORGANISMOS ACUAT, LAB GENET \& INMUNOL MOL, INST BIOL,FAC CIENCIAS, VALPARAISO, CHILE.;CARDENAS, C., GUZMAN, F., MERCADO, L., PONTIFICIA UNIV CATOLICA VALPARAISO, NBC, VALPARAISO, CHILE.;GALLARDO, J. A., PONTIFICIA UNIV CATOLICA VALPARAISO, ESCUELA CIENCIAS MAR, VALPARAISO, CHILE.","10.1111/J.1365-2761.2012.01354.X","COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA",NA,NA,"INNOVACHILE-CORFO [07CN13PBT-61], AQUAIN-NOVO S.A., ANTARES S.A., DIRECCION DE INVESTIGACION, PONTIFICIA UNIVERSIDAD CATOLICA DE VALPARAISO [PIA 037.358/2011]","THIS WORK WAS SUPPORTED BY GRANT 07CN13PBT-61 OF INNOVACHILE-CORFO AND AQUAIN-NOVO S.A. AND ANTARES S.A. AND PIA 037.358/2011 FROM THE DIRECCION DE INVESTIGACION, PONTIFICIA UNIVERSIDAD CATOLICA DE VALPARAISO. F. G. AND C. C. ARE POSTDOCTORAL FELLOWS OF THE BICENTENNIAL PROGRAM (CONICYT-CHILE). WE THANK THE STAFF OF AQUACHILE FOR THEIR ASSISTANCE IN THE COLLECTION OF FISH AND THE MEMBERS OF THE LABORATORIO EXPERIMENTAL DE ACUICULTURA (PUCV) FOR THE CARE OF FISH DURING THIS RESEARCH. WE THANK MR EDGAR NARVAEZ FOR HIS REVIEW OF THE ENGLISH AND TECHNICAL ASSISTANCE.",NA,"0140-7775","5","379-388","WILEY-BLACKWELL","35",2012,"ISI000302615000006","39","FISHERIES, MARINE \& FRESHWATER BIOLOGY, VETERINARY SCIENCES","8","FISHERIES, MARINE \& FRESHWATER BIOLOGY, VETERINARY SCIENCES","LMERCADOUCV.CL",NA,"923JG",NA,"MERCADO, L (REPRINT AUTHOR), PONTIFICIA UNIV CATOLICA VALPARAISO, GRP MARCADORES INMUNOL ORGANISMOS ACUAT, LAB GENET \& INMUNOL MOL, INST BIOL,FAC CIENCIAS, VALPARAISO, CHILE","ISI","PONTIFICIA UNIV CATOLICA VALPARAISO;PONTIFICIA UNIV CATOLICA VALPARAISO;PONTIFICIA UNIV CATOLICA VALPARAISO","PONTIFICIA UNIV CATOLICA VALPARAISO",NA,"BETHKE J, 2012, J FISH DIS","BETHKE J, 2012, J FISH DIS"
"SACHSENROEDER J, 2012, PLOS ONE","SACHSENROEDER J;TWARDZIOK S;HAMMERL JA;JANCZYK P;WREDE P;HERTWIG S;JOHNE R","SIMULTANEOUS IDENTIFICATION OF DNA AND RNA VIRUSES PRESENT IN PIG FAECES USING PROCESS-CONTROLLED DEEP SEQUENCING","PLOS ONE","PLOS ONE","BACKGROUND: ANIMAL FAECES COMPRISE A COMMUNITY OF MANY DIFFERENT MICROORGANISMS INCLUDING BACTERIA AND VIRUSES. ONLY SCARCE INFORMATION IS AVAILABLE ABOUT THE DIVERSITY OF VIRUSES PRESENT IN THE FAECES OF PIGS. HERE WE DESCRIBE A PROTOCOL, WHICH WAS OPTIMIZED FOR THE PURIFICATION OF THE TOTAL FRACTION OF VIRAL PARTICLES FROM PIG FAECES. THE GENOMES OF THE PURIFIED DNA AND RNA VIRUSES WERE SIMULTANEOUSLY AMPLIFIED BY PCR AND SUBJECTED TO DEEP SEQUENCING FOLLOWED BY BIOINFORMATIC ANALYSES. THE EFFICIENCY OF THE METHOD WAS MONITORED USING A PROCESS CONTROL CONSISTING OF THREE BACTERIOPHAGES (T4, M13 AND MS2) WITH DIFFERENT MORPHOLOGY AND GENOME TYPES. DEFINED AMOUNTS OF THE BACTERIOPHAGES WERE ADDED TO THE SAMPLE AND THEIR ABUNDANCE WAS ASSESSED BY QUANTITATIVE PCR DURING THE PREPARATION PROCEDURE. RESULTS: THE PROCEDURE WAS APPLIED TO A POOLED FAECAL SAMPLE OF FIVE PIGS. FROM THIS SAMPLE, 69,613 SEQUENCE READS WERE GENERATED. ALL OF THE ADDED BACTERIOPHAGES WERE IDENTIFIED BY SEQUENCE ANALYSIS OF THE READS. IN TOTAL, 7.7\% OF THE READS SHOWED SIGNIFICANT SEQUENCE IDENTITIES WITH PUBLISHED VIRAL SEQUENCES. THEY MAINLY ORIGINATED FROM BACTERIOPHAGES (73.9\%) AND MAMMALIAN VIRUSES (23.9\%), 0.8\% OF THE SEQUENCES SHOWED IDENTITIES TO PLANT VIRUSES. THE MOST ABUNDANT DETECTED PORCINE VIRUSES WERE KOBUVIRUS, ROTAVIRUS C, ASTROVIRUS, ENTEROVIRUS B, SAPOVIRUS AND PICOBIRNAVIRUS. IN ADDITION, SEQUENCES WITH IDENTITIES TO THE CHIMPANZEE STOOL-ASSOCIATED CIRCULAR SSDNA VIRUS WERE IDENTIFIED. WHOLE GENOME ANALYSIS INDICATES THAT THIS VIRUS, TENTATIVELY DESIGNATED AS PIG STOOL-ASSOCIATED CIRCULAR SSDNA VIRUS (PIGSCV), REPRESENTS A NOVEL PIG VIRUS. CONCLUSION: THE ESTABLISHED PROTOCOL ENABLES THE SIMULTANEOUS DETECTION OF DNA AND RNA VIRUSES IN PIG FAECES INCLUDING THE IDENTIFICATION OF SO FAR UNKNOWN VIRUSES. IT MAY BE APPLIED IN STUDIES INVESTIGATING AETIOLOGY, EPIDEMIOLOGY AND ECOLOGY OF DISEASES. THE IMPLEMENTED PROCESS CONTROL SERVES AS QUALITY CONTROL, ENSURES COMPARABILITY OF THE METHOD AND MAY BE USED FOR FURTHER METHOD OPTIMIZATION.",NA,"HEPATITIS-E VIRUS; METAGENOMIC ANALYSES; GENOMIC ANALYSIS; INTERNAL CONTROL; VIRAL COMMUNITY; STOOL SAMPLES; PCR ASSAYS; GUT; AMPLIFICATION; CALICIVIRUS","ENGLISH","ARTICLE","ARTICLE",46,"ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/NAR/25.17.3389.;ARUMUGAM M, 2011, NATURE, V473, P174, DOI 10.1038/NATURE09944.;BLINKOVA O, 2010, J GEN VIROL, V91, P74, DOI 10.1099/VIR.0.015446-0.;BREITBART M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/RSPB.2003.2628.;BREITBART M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003.;BREITBART M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/PNAS.202488399.;CANN AJ, 2005, VIRUS GENES, V30, P151, DOI 10.1007/S11262-004-5624-3.;COSTAFREDA MI, 2006, APPL ENVIRON MICROB, V72, P3846, DOI 10.1128/AEM.02660-05.;DAY JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-313.;DJIKENG A, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0007264.;DREIER J, 2005, J CLIN MICROBIOL, V43, P4551, DOI 10.1128/JCM.43.9.4551-4557.2005.;FINKBEINER SR, 2008, PLOS PATHOG, V4, DOI 10.1371/JOURNAL.PPAT.1000011.;GE XY, 2011, J GEN VIROL, V92, P2646, DOI 10.1099/VIR.0.034108-0.;HALAIHEL N, 2010, EPIDEMIOL INFECT, V138, P542, DOI 10.1017/S0950268809990872.;JERE KC, 2011, J MED VIROL, V83, P2018, DOI 10.1002/JMV.22207.;JOHNE R, 2009, TRENDS MICROBIOL, V17, P205, DOI 10.1016/J.TIM.2009.02.004.;KIM HK, 2011, J GEN VIROL.;KIM YJ, 1999, J CLIN MICROBIOL, V37, P1484.;LAMENDELLA R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103.;LI LL, 2011, J GEN VIROL, V92, P2534, DOI 10.1099/VIR.0.034611-0.;LI LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11.;LI LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09.;LIN Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/BIOINFORMATICS/BTR319.;MAIDANA-GIRET MT, 2009, AIDS, V23, P2277, DOI 10.1097/QAD.0B013E32832D7A11.;MARGULIES M, 2005, NATURE, V437, P376, DOI 10.1038/NATURE03959.;MIDGLEY SE, 2011, VET MICROBIOL.;MILLER JR, 2010, GENOMICS, V95, P315, DOI 10.1016/J.YGENO.2010.03.001.;MINOT S, 2011, GENOME RES, V21, P1616, DOI 10.1101/GR.122705.111.;PALMENBERG AC, 2005, VIRUS TAXONOMY, P12.;PHAN TG, 2011, PLOS PATHOG, V7, DOI 10.1371/JOURNAL.PPAT.1002218.;PIGNATELLI M, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0019984.;R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7.;REYES A, 2010, NATURE, V466, P334, DOI 10.1038/NATURE09199.;RIESENFELD CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/ANNUREV.GENET.38.072902.091216.;ROOSSINCK MJ, 2010, MOL ECOL, V1, P81.;SAMBROOK J, 2001, MOL CLONING LAB MANU.;SENCER DJ, 2011, CLIN INFECT DIS S1, V52, P4.;SHAN TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11.;SHANNON CE, 1997, M D COMPUT, V14, P306.;SMITH HW, 1983, J GEN MICROBIOL, V129, P2659.;TANG P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/FMB.09.120, 10.2217/FMB.09.120].;THURBER RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/NPROT.2009.10.;VAN DER POEL WHM, 2001, EMERG INFECT DIS, V7, P970, DOI 10.3201/EID0706.010608.;VICTORIA JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08.;WARD P, 2009, J APPL MICROBIOL, V106, P1360, DOI 10.1111/J.1365-2672.2008.04104.X.;ZHANG TAO, 2006, JOURNAL OF FUNGAL RESEARCH, V4, P1.","SACHSENRODER, J (REPRINT AUTHOR), FED INST RISK ASSESSMENT, BERLIN, GERMANY.;SACHSENROEDER, JANA, HAMMERL, JENS A., JANCZYK, PAWEL, HERTWIG, STEFAN, JOHNE, REIMAR, FED INST RISK ASSESSMENT, BERLIN, GERMANY.;TWARDZIOK, SVEN, WREDE, PAUL, INST MOL BIOL \& BIOINFORMAT, CHARITE, BERLIN, GERMANY.","10.1371/JOURNAL.PONE.0034631","1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA","E34631",NA,"GERMAN RESEARCH FOUNDATION (DFG) [SFB 852/1]","THIS STUDY WAS SUPPORTED BY THE GERMAN RESEARCH FOUNDATION (DFG) THROUGH GRANT SFB 852/1. THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT.",NA,"1932-6203","4",NA,"PUBLIC LIBRARY SCIENCE","7",2012,"ISI000305341600054","46","SCIENCE \& TECHNOLOGY - OTHER TOPICS","23","MULTIDISCIPLINARY SCIENCES","REIMAR.JOHNEBFR.BUND.DE",NA,"959UT",NA,"SACHSENRODER, J (REPRINT AUTHOR), FED INST RISK ASSESSMENT, BERLIN, GERMANY","ISI","FED INST RISK ASSESSMENT;INST MOL BIOL AND BIOINFORMAT","FED INST RISK ASSESSMENT",NA,"SACHSENROEDER J, 2012, PLOS ONE","SACHSENROEDER J, 2012, PLOS ONE"
"LEE N, 2012, J CLIN MICROBIOL","LEE N;GATTON ML;PELECANOS A;BUBB M;GONZALEZ I;BELL D;CHENG Q;MCCARTHY JS","IDENTIFICATION OF OPTIMAL EPITOPES FOR PLASMODIUM FALCIPARUM RAPID DIAGNOSTIC TESTS THAT TARGET HISTIDINE-RICH PROTEINS 2 AND 3","JOURNAL OF CLINICAL MICROBIOLOGY","J. CLIN. MICROBIOL.","RAPID DIAGNOSTIC TESTS (RDTS) REPRESENT IMPORTANT TOOLS TO DIAGNOSE MALARIA INFECTION. TO IMPROVE UNDERSTANDING OF THE VARIABLE PERFORMANCE OF RDTS THAT DETECT THE MAJOR TARGET IN PLASMODIUM FALCIPARUM, NAMELY, HISTIDINE-RICH PROTEIN 2 (HRP2), AND TO INFORM THE DESIGN OF BETTER TESTS, WE UNDERTOOK DETAILED MAPPING OF THE EPITOPES RECOGNIZED BY EIGHT HRP-SPECIFIC MONOCLONAL ANTIBODIES (MABS). TO INVESTIGATE THE GEOGRAPHIC SKEWING OF THIS POLYMORPHIC PROTEIN, WE ANALYZED THE DISTRIBUTION OF THESE EPITOPES IN PARASITES FROM GEOGRAPHICALLY DIVERSE AREAS. TO IDENTIFY AN IDEAL AMINO ACID MOTIF FOR A MAB TO TARGET IN HRP2 AND IN THE RELATED PROTEIN HRP3, WE USED A PURPOSE-DESIGNED SCRIPT TO PERFORM BIOINFORMATIC ANALYSIS OF 448 DISTINCT GENE SEQUENCES FROM PFHRP2 AND FROM 99 SEQUENCES FROM THE CLOSELY RELATED GENE PFHRP3. THE FREQUENCY AND DISTRIBUTION OF THESE MOTIFS WERE ALSO COMPARED TO THE MAB EPITOPES. HEAT STABILITY TESTING OF MABS IMMOBILIZED ON NITROCELLULOSE MEMBRANES WAS ALSO PERFORMED. RESULTS OF THESE EXPERIMENTS ENABLED THE IDENTIFICATION OF MABS WITH THE MOST DESIRABLE CHARACTERISTICS FOR INCLUSION IN RDTS, INCLUDING COPY NUMBER AND COVERAGE OF TARGET EPITOPES, GEOGRAPHIC SKEWING, HEAT STABILITY, AND MATCH WITH THE MOST ABUNDANT AMINO ACID MOTIFS IDENTIFIED. THIS STUDY THEREFORE INFORMS THE SELECTION OF MABS TO INCLUDE IN MALARIA RDTS AS WELL AS IN THE GENERATION OF IMPROVED MABS THAT SHOULD IMPROVE THE PERFORMANCE OF HRP-DETECTING MALARIA RDTS.",NA,"SEQUENCE VARIATION; MALARIA PARASITES; PERFORMANCE; CULTURE; PFHRP2","ENGLISH","ARTICLE","ARTICLE",23,"BAKER J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010.;BAKER J, 2011, PLOS ONE, V6, DOI 10.1371/JOURNAL.PONE.0022593.;BAKER J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-129.;GAMBOA D, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0008091.;HAYWARD RE, 2000, EXP PARASITOL, V96, P139, DOI 10.1006/EXPR.2000.4557.;HOWARD RJ, 1986, J CELL BIOL, V103, P1269, DOI 10.1083/JCB.103.4.1269.;LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287.;LEE N, 2006, J CLIN MICROBIOL, V44, P2773, DOI 10.1128/JCM.02557-05.;PANTON LJ, 1989, MOL BIOCHEM PARASIT, V35, P149, DOI 10.1016/0166-6851(89)90117-5.;ROCK EP, 1987, PARASITOLOGY, V95, P209, DOI 10.1017/S0031182000057681.;TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/SCIENCE.781840.;WELLEMS TE, 1986, P NATL ACAD SCI USA, V83, P6065, DOI 10.1073/PNAS.83.16.6065.","MCCARTHY, JS (REPRINT AUTHOR), UNIV QUEENSLAND, QUEENSLAND INST MED RES, CLIN TROP MED LAB, HERSTON, QLD, AUSTRALIA.;LEE, NELSON, MCCARTHY, JAMES S., UNIV QUEENSLAND, QUEENSLAND INST MED RES, CLIN TROP MED LAB, HERSTON, QLD, AUSTRALIA.;GATTON, MICHELLE L., PELECANOS, ANITA, CHENG, QIN, QUEENSLAND INST MED RES, MALARIA DRUG RESISTANCE \& CHEMOTHERAPY LAB, HERSTON, QLD 4006, AUSTRALIA.;BUBB, MARTIN, NATL BIOPROD INST, PINETOWN, NATAL, SOUTH AFRICA.;GONZALEZ, IVETH, BELL, DAVID, FIND, GENEVA, SWITZERLAND.;CHENG, QIN, AUSTRALIAN ARMY MALARIA INST, DEPT DRUG RESISTANCE \& DIAGNOST, ENOGGERA, QLD, AUSTRALIA.;MCCARTHY, JAMES S., UNIV QUEENSLAND, SCH POPULAT HLTH, HERSTON, QLD, AUSTRALIA.","10.1128/JCM.06533-11","1752 N ST NW, WASHINGTON, DC 20036-2904 USA",NA,NA,"NHMRC, GOVERNMENT OF QUEENSLAND, FIND","N.L. WAS SUPPORTED BY AN NHMRC TRAINING SCHOLARSHIP. J.S.M. WAS SUPPORTED BY AN NHMRC PRACTITIONER FELLOWSHIP AND A GOVERNMENT OF QUEENSLAND CLINICAL RESEARCH FELLOWSHIP. M.L.G. WAS SUPPORTED BY AN NHMRC CAREER DEVELOPMENT AWARD. FUNDING FOR THIS PROJECT WAS PROVIDED IN PART BY FIND.",NA,"0095-1137","4","1397-1405","AMER SOC MICROBIOLOGY","50",2012,"ISI000302148700041","12","MICROBIOLOGY","5","MICROBIOLOGY","J.MCCARTHYUQ.EDU.AU",NA,"917CC",NA,"MCCARTHY, JS (REPRINT AUTHOR), UNIV QUEENSLAND, QUEENSLAND INST MED RES, CLIN TROP MED LAB, HERSTON, QLD, AUSTRALIA","ISI","UNIV QUEENSLAND;QUEENSLAND INST MED RES;NATL BIOPROD INST;AUSTRALIAN ARMY MALARIA INST;UNIV QUEENSLAND","UNIV QUEENSLAND",NA,"LEE N, 2012, J CLIN MICROBIOL","LEE N, 2012, J CLIN MICROBIOL"
"GUO JJ, 2012, PLOS NEGLECT TROP DIS","GUO JJ;ZHENG HJ;XU J;ZHU XQ;WANG SY;XIA CM","SENSITIVE AND SPECIFIC TARGET SEQUENCES SELECTED FROM RETROTRANSPOSONS OF SCHISTOSOMA JAPONICUM FOR THE DIAGNOSIS OF SCHISTOSOMIASIS","PLOS NEGLECTED TROPICAL DISEASES","PLOS NEGLECT. TROP. DIS.","BACKGROUND: SCHISTOSOMIASIS JAPONICA IS A SERIOUS DEBILITATING AND SOMETIMES FATAL DISEASE. ACCURATE DIAGNOSTIC TESTS PLAY A KEY ROLE IN PATIENT MANAGEMENT AND CONTROL OF THE DISEASE. HOWEVER, CURRENTLY AVAILABLE DIAGNOSTIC METHODS ARE NOT IDEAL, AND THE DETECTION OF THE PARASITE DNA IN BLOOD SAMPLES HAS TURNED OUT TO BE ONE OF THE MOST PROMISING TOOLS FOR THE DIAGNOSIS OF SCHISTOSOMIASIS. IN OUR PREVIOUS INVESTIGATIONS, A 230-BP SEQUENCE FROM THE HIGHLY REPETITIVE RETROTRANSPOSON SJR2 WAS IDENTIFIED AND IT SHOWED HIGH SENSITIVITY AND SPECIFICITY FOR DETECTING SCHISTOSOMA JAPONICUM DNA IN THE SERA OF RABBIT MODEL AND PATIENTS. RECENTLY, 29 RETROTRANSPOSONS WERE FOUND IN S. JAPONICUM GENOME BY OUR GROUP. THE PRESENT STUDY HIGHLIGHTED THE KEY FACTORS FOR SELECTING A NEW PERSPECTIVE SENSITIVE TARGET DNA SEQUENCE FOR THE DIAGNOSIS OF SCHISTOSOMIASIS, WHICH CAN SERVE AS EXAMPLE FOR OTHER PARASITIC PATHOGENS. METHODOLOGY/PRINCIPAL FINDINGS: IN THIS STUDY, WE DEMONSTRATED THAT THE KEY FACTORS BASED ON THE BIOINFORMATIC ANALYSIS FOR SELECTING TARGET SEQUENCE ARE THE HIGHER GENOME PROPORTION, REPETITIVE COMPLETE COPIES AND PARTIAL COPIES, AND ACTIVE ESTS THAN THE OTHERS IN THE CHROMOSOME GENOME. NEW PRIMERS BASED ON 25 NOVEL RETROTRANSPOSONS AND SJR2 WERE DESIGNED AND THEIR SENSITIVITY AND SPECIFICITY FOR DETECTING S. JAPONICUM DNA WERE COMPARED. THE RESULTS SHOWED THAT A NEW 303-BP SEQUENCE FROM NON-LONG TERMINAL REPEAT (LTR) RETROTRANSPOSON (SJCHGCS19) HAD HIGH SENSITIVITY AND SPECIFICITY. THE 303-BP TARGET SEQUENCE WAS AMPLIFIED FROM THE SERA OF RABBIT MODEL AT 3 D POST-INFECTION BY NESTED-PCR AND IT BECAME NEGATIVE AT 17 WEEKS POST-TREATMENT. FURTHERMORE, THE PERCENTAGE SENSITIVITY OF THE NESTED-PCR WAS 97.67\% IN 43 SERUM SAMPLES OF S. JAPONICUM-INFECTED PATIENTS. CONCLUSIONS/SIGNIFICANCE: OUR FINDINGS HIGHLIGHTED THE KEY FACTORS BASED ON THE BIOINFORMATIC ANALYSIS FOR SELECTING TARGET SEQUENCE FROM S. JAPONICUM GENOME, WHICH PROVIDE BASIS FOR ESTABLISHING POWERFUL MOLECULAR DIAGNOSTIC TECHNIQUES THAT CAN BE USED FOR MONITORING EARLY INFECTION AND THERAPY EFFICACY TO SUPPORT SCHISTOSOMIASIS CONTROL PROGRAMS.",NA,"POLYMERASE-CHAIN-REACTION; HUMAN BLOOD FLUKE; MANSONI INFECTION; PARASITE DNA; PCR; AMPLIFICATION; MODEL; SAMPLES; REGION","ENGLISH","ARTICLE","ARTICLE",15,"BARKER RH, 1992, AM J TROP MED HYG, V46, P416, DOI 10.4269/AJTMH.1992.46.416.;CHITSULO L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4.;CROFT S L, 2003, EAST MEDITERR HEALTH J, V9, P518.;DEBRUIJN MHL, 1992, ACTA TROP, V52, P45, DOI 10.1016/0001-706X(92)90006-J.;DREW AC, 1999, MOL BIOL EVOL, V16, P1256, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A026216.;EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/INFDIS/161.5.977.;GOBERT GN, 2005, MOL CELL PROBE, V19, P250, DOI 10.1016/J.MCP.2005.01.006.;GORDON CA, 2011, MOL CELL PROBE, V25, P143, DOI 10.1016/J.MCP.2011.05.002.;IMAGAWA DT, 1989, NEW ENGL J MED, V320, P1458, DOI 10.1056/NEJM198906013202205.;JANNOTTIPASSOS LK, 1997, J PARASITOL, V83, P395, DOI 10.2307/3284400.;KING CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4.;LAHA T, 2002, INT J PARASITOL, V32, P1163, DOI 10.1016/S0020-7519(02)00063-2.;LIER T, 2008, ACTA TROP, V105, P74, DOI 10.1016/J.ACTATROPICA.2007.10.004.;PATZ JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7.;PONTES LA, 2003, AM J TROP MED HYG, V68, P652, DOI 10.4269/AJTMH.2003.68.652.;PONTES LA, 2002, AM J TROP MED HYG, V66, P157, DOI 10.4269/AJTMH.2002.66.157.;RABELLO A, 2002, MEM I OSWALDO CRUZ, V97, P171, DOI 10.1590/S0074-02762002000900033.;ROSS AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMRA012396.;SANDOVAL N, 2006, PARASITOLOGY, V133, P581, DOI 10.1017/S0031182006000898.;STEINER JJ, 1995, NUCLEIC ACIDS RES, V23, P2569, DOI 10.1093/NAR/23.13.2569-A.;STURM NR, 1989, MOL BIOCHEM PARASIT, V33, P205, DOI 10.1016/0166-6851(89)90082-0.;SUZUKI T, 2006, PARASITOL INT, V55, P213, DOI 10.1016/J.PARINT.2006.05.004.;WICHMANN D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/JOURNAL.PNTD.0000422.;XIA CM, 2009, EXP PARASITOL, V121, P175, DOI 10.1016/J.EXPPARA.2008.10.017.;XIANYI CHEN, 2005, BULLETIN OF THE WORLD HEALTH ORGANIZATION, V83, P43.;XU J, 2010, INT J PARASITOL, V40, P327, DOI 10.1016/J.IJPARA.2009.08.010.;ZHOU Y, 2009, NATURE, V460, P345, DOI 10.1038/NATURE08140.","GUO, JJ (REPRINT AUTHOR), SOOCHOW UNIV, COLL MED, DEPT PARASITOL, SUZHOU, PEOPLES R CHINA.;GUO, JUN-JIE, XU, JING, XIA, CHAO-MING, SOOCHOW UNIV, COLL MED, DEPT PARASITOL, SUZHOU, PEOPLES R CHINA.;GUO, JUN-JIE, QIQIHAER MED COLL, DEPT PARASITOL, QIQIHAR, PEOPLES R CHINA.;ZHENG, HUA-JUN, WANG, SHENG-YUE, CHINESE NATL HUMAN GENOME CTR SHANGHAI, SHANGHAI MOST KEY LAB HLTH \& DIS GENOM, SHANGHAI, PEOPLES R CHINA.;ZHU, XING-QUAN, CHINESE ACAD AGR SCI, STATE KEY LAB VET ETIOL BIOL, KEY LAB VET PARASITOL GANSU PROV, LANZHOU VET RES INST, LANZHOU, PEOPLES R CHINA.","10.1371/JOURNAL.PNTD.0001579","185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA","E1579",NA,"NATIONAL BASIC RESEARCH PROGRAM OF CHINA (973 PROGRAM) [2007CB513102, 2007CB513104], PROGRAM OF ``DEVELOPMENT OF SCIENCE AND TECHNOLOGY'', SUZHOU, CHINA [SYS201007], KEY LABORATORY OF HEALTHY MINISTRY OF PREVENTION AND CONTROL [WK09-004]","THIS STUDY WAS SUPPORTED BY THE NATIONAL BASIC RESEARCH PROGRAM OF CHINA (973 PROGRAM, GRANT NO. 2007CB513102 AND 2007CB513104), THE PROGRAM OF ``DEVELOPMENT OF SCIENCE AND TECHNOLOGY'' (GRANT NO. SYS201007), SUZHOU, CHINA, AND THE PROGRAM OF ``KEY LABORATORY OF HEALTHY MINISTRY OF PREVENTION AND CONTROL'' (GRANT NO. WK09-004). THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT.",NA,"1935-2727","3",NA,"PUBLIC LIBRARY SCIENCE","6",2012,"ISI000302132100031","27","INFECTIOUS DISEASES, PARASITOLOGY, TROPICAL MEDICINE","6","INFECTIOUS DISEASES, PARASITOLOGY, TROPICAL MEDICINE","WANGSYCHGC.SH.CN XCM624HOTMAIL.COM",NA,"916VU",NA,"GUO, JJ (REPRINT AUTHOR), SOOCHOW UNIV, COLL MED, DEPT PARASITOL, SUZHOU, PEOPLES R CHINA","ISI","SOOCHOW UNIV;QIQIHAER MED COLL;CHINESE NATL HUMAN GENOME CTR SHANGHAI;LANZHOU VET RES INST","SOOCHOW UNIV",NA,"GUO JJ, 2012, PLOS NEGLECT TROP DIS","GUO JJ, 2012, PLOS NEGLECT TROP DIS"
"YOZWIAK NL, 2012, PLOS NEGLECT TROP DIS","YOZWIAK NL;SKEWES COX P;STENGLEIN MD;BALMASEDA A;HARRIS E;DERISI JL","VIRUS IDENTIFICATION IN UNKNOWN TROPICAL FEBRILE ILLNESS CASES USING DEEP SEQUENCING","PLOS NEGLECTED TROPICAL DISEASES","PLOS NEGLECT. TROP. DIS.","DENGUE VIRUS IS AN EMERGING INFECTIOUS AGENT THAT INFECTS AN ESTIMATED 50-100 MILLION PEOPLE ANNUALLY WORLDWIDE, YET CURRENT DIAGNOSTIC PRACTICES CANNOT DETECT AN ETIOLOGIC PATHOGEN IN SIMILAR TO 40\% OF DENGUE-LIKE ILLNESSES. METAGENOMIC APPROACHES TO PATHOGEN DETECTION, SUCH AS VIRAL MICROARRAYS AND DEEP SEQUENCING, ARE PROMISING TOOLS TO ADDRESS EMERGING AND NON-DIAGNOSABLE DISEASE CHALLENGES. IN THIS STUDY, WE USED THE VIROCHIP MICROARRAY AND DEEP SEQUENCING TO CHARACTERIZE THE SPECTRUM OF VIRUSES PRESENT IN HUMAN SERA FROM 123 NICARAGUAN PATIENTS PRESENTING WITH DENGUE-LIKE SYMPTOMS BUT TESTING NEGATIVE FOR DENGUE VIRUS. WE UTILIZED A BARCODING STRATEGY TO SIMULTANEOUSLY DEEP SEQUENCE MULTIPLE SERUM SPECIMENS, GENERATING ON AVERAGE OVER 1 MILLION READS PER SAMPLE. WE THEN IMPLEMENTED A STEPWISE BIOINFORMATIC FILTERING PIPELINE TO REMOVE THE MAJORITY OF HUMAN AND LOW-QUALITY SEQUENCES TO IMPROVE THE SPEED AND ACCURACY OF SUBSEQUENT UNBIASED DATABASE SEARCHES. BY DEEP SEQUENCING, WE WERE ABLE TO DETECT VIRUS SEQUENCE IN 37\% (45/123) OF PREVIOUSLY NEGATIVE CASES. THESE INCLUDED 13 CASES WITH HUMAN HERPESVIRUS 6 SEQUENCES. OTHER SAMPLES CONTAINED SEQUENCES WITH SIMILARITY TO SEQUENCES FROM VIRUSES IN THE HERPESVIRIDAE, FLAVIVIRIDAE, CIRCOVIRIDAE, ANELLOVIRIDAE, ASFARVIRIDAE, AND PARVOVIRIDAE FAMILIES. IN SOME CASES, THE PUTATIVE VIRAL SEQUENCES WERE VIRTUALLY IDENTICAL TO KNOWN VIRUSES, AND IN OTHERS THEY DIVERGED, SUGGESTING THAT THEY MAY DERIVE FROM NOVEL VIRUSES. THESE RESULTS DEMONSTRATE THE UTILITY OF UNBIASED METAGENOMIC APPROACHES IN THE DETECTION OF KNOWN AND DIVERGENT VIRUSES IN THE STUDY OF TROPICAL FEBRILE ILLNESS.",NA,"HUMAN HERPESVIRUS-6 INFECTION; CLINICAL-FEATURES; VIRAL PATHOGENS; DISEASES; METAGENOMICS; MICROARRAY; NICARAGUA; CHILDREN; DENGUE; DIAGNOSTICS","ENGLISH","ARTICLE","ARTICLE",78,"ACHOUR A, 2007, J CLIN VIROL, V38, P280, DOI 10.1016/J.JCV.2006.12.019.;ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;ANSORGE WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/J.NBT.2008.12.009.;ARRON ST, 2011, J INVEST DERMATOL.;ASANO Y, 1994, PEDIATRICS, V93, P104.;BEXFIELD N, 2010, VET J.;BHATTARAKOSOL PARVAPAN, 2001, SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, V32, P143.;BLINKOVA O, 2009, J CLIN MICROBIOL, V47, P3507, DOI 10.1128/JCM.01062-09.;BOZDECH Z, 2003, GENOME BIOL, V4, DOI 10.1186/GB-2003-4-2-R9.;BRIESE T, 2009, PLOS PATHOG, V5, DOI 10.1371/JOURNAL.PPAT.1000455.;CASERTA MT, 2010, J CLIN VIROL, V48, P55, DOI 10.1016/J.JCV.2010.02.007.;CHIU CY, 2008, P NATL ACAD SCI USA, V105, P14124, DOI 10.1073/PNAS.0805968105.;CHIU CY, 2006, CLIN INFECT DIS, V43, PE71, DOI 10.1086/507896.;DAIBATA M, 1999, BLOOD, V94, P1545.;DE BOLLE L, 2005, CLIN MICROBIOL REV, V18, P217, DOI 10.1128/CMR.18.1.217-245.2005.;DELWART EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/RMV.532.;DOMINGUEZ G, 1999, J VIROL, V73, P8040.;DONG J, 2008, J MOL DIAGN, V10, P185, DOI 10.2353/JMOLDX.2008.070063.;DRUMMOND AJ, 2010, GENEIOUS V5 1 P.;EISEN MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/PNAS.95.25.14863.;FENG HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/SCIENCE.1152586.;FINKBEINER SR, 2008, PLOS PATHOG, V4, DOI 10.1371/JOURNAL.PPAT.1000011.;GE X., 2011, J GEN VIROL.;GILLESPIE J, 2009, J VET INTERN MED, V23, P1151, DOI 10.1111/J.1939-1676.2009.0389.X.;GRENINGER AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82.;HAAGMANS BL, 2009, PLOS PATHOG, V5, DOI 10.1371/JOURNAL.PPAT.1000557.;HALL CB, 1994, NEW ENGL J MED, V331, P432, DOI 10.1056/NEJM199408183310703.;HALSTEAD SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0.;HARRIS E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/AJTMH.2000.63.5.;HEROLD J, 2000, J VIROL, V74, P6394, DOI 10.1128/JVI.74.14.6394-6400.2000.;HINO S, 2007, REV MED VIROL, V17, P45, DOI 10.1002/RMV.524.;JONES KE, 2008, NATURE, V451, P990, DOI 10.1038/NATURE06536.;KENT WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/GR.229202, 10.1101/GR.229202. ARTICLE PUBLISHED ONLINE BEFORE MARCH 2002].;KISTLER A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816.;KISTLER AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88.;KONDO K, 1991, J GEN VIROL, V72, P1401, DOI 10.1099/0022-1317-72-6-1401.;KYLE JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/ANNUREV.MICRO.62.081307.163005.;LEONG HN, 2007, J MED VIROL, V79, P45, DOI 10.1002/JMV.20760.;LI LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09.;LI WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/BIOINFORMATICS/BTL158.;LIPKIN WI, 2010, MICROBIOL MOL BIOL R, V74, P363, DOI 10.1128/MMBR.00007-10.;LOH J, 2009, J VIROL, V83, P13019, DOI 10.1128/JVI.00638-09.;LUPPI M, 1999, J VIROL, V73, P754.;MABEY D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/NRMICRO841.;MAEDA E, 2009, JPN J RADIOL, V27, P4, DOI 10.1007/S11604-008-0291-2.;NAKAMURA S, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0004219.;ODUMADE OA, 2011, CLIN MICROBIOL REV, V24, P193, DOI 10.1128/CMR.00044-10.;OKUNO T, 1989, J CLIN MICROBIOL, V27, P651.;PALACIOS G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMOA073785.;PEELING RW, 2010, NAT REV MICROBIOL S, V12, PS30.;ROCHA C, 2009, AM J TROP MED HYG, V81, P287, DOI 10.4269/AJTMH.2009.81.287.;ROHWER F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002.;ROSARIO K, 2009, J GEN VIROL, V90, P2418, DOI 10.1099/VIR.0.012955-0.;SERVEY JT, 2007, AM FAM PHYSICIAN, V75, P373.;SVRAKA S, 2010, J GEN VIROL, V91, P2846, DOI 10.1099/VIR.0.024612-0.;TANG P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/FMB.09.120, 10.2217/FMB.09.120].;TODD D, 2004, VET MICROBIOL, V98, P169, DOI 10.1016/J.VETMIC.2003.10.010.;URISMAN A, 2005, GENOME BIOL, V6, DOI 10.1186/GB-2005-6-9-R78.;URISMAN A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/JOURNAL.PPAT.0020025.;VASILYEV EV, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-134.;VICTORIA JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08.;WANG D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/PNAS.242579699.;WANG D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/JOURNAL.PBIO.0000002.;WHO, 1997, DENG HAEM FEV DIAGN.;YOZWIAK NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10.","YOZWIAK, NL (REPRINT AUTHOR), UNIV CALIF BERKELEY, SCH PUBL HLTH, DIV INFECT DIS \& VACCINOL, BERKELEY, CA 94720 USA.;YOZWIAK, NATHAN L., HARRIS, EVA, UNIV CALIF BERKELEY, SCH PUBL HLTH, DIV INFECT DIS \& VACCINOL, BERKELEY, CA 94720 USA.;SKEWES-COX, PETER, UNIV CALIF SAN FRANCISCO, BIOL \& MED INFORMAT PROGRAM, SAN FRANCISCO, CA 94143 USA.;SKEWES-COX, PETER, STENGLEIN, MARK D., DERISI, JOSEPH L., UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, SAN FRANCISCO, CA USA.;SKEWES-COX, PETER, STENGLEIN, MARK D., DERISI, JOSEPH L., UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM \& BIOPHYS, SAN FRANCISCO, CA 94143 USA.;BALMASEDA, ANGEL, MINIST SALUD, DEPT VIROL, CTR NACL DIAGNOST \& REFERENCIA, MANAGUA, NICARAGUA.;DERISI, JOSEPH L., UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA USA.","10.1371/JOURNAL.PNTD.0001485","185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA","E1485",NA,"PACIFIC SOUTHWEST REGIONAL CENTER OF EXCELLENCE (PSWRCE), NIH [U54-AI65359, 5T32HL007185-34], PEDIATRIC DENGUE VACCINE INITIATIVE [VE-1], HOWARD HUGHES MEDICAL INSTITUTE, DORIS DUKE FOUNDATION, PACKARD FOUNDATION, PHRMA FOUNDATION","THIS WORK WAS SUPPORTED IN PART BY GRANTS FROM THE PACIFIC SOUTHWEST REGIONAL CENTER OF EXCELLENCE (PSWRCE) (TO JD AND AB), AS PART OF NIH GRANT U54-AI65359 AND A GRANT FROM THE PEDIATRIC DENGUE VACCINE INITIATIVE (\#VE-1 TO EH). JD IS SUPPORTED BY THE HOWARD HUGHES MEDICAL INSTITUTE, THE DORIS DUKE FOUNDATION, AND THE PACKARD FOUNDATION. PS-C IS SUPPORTED BY A PHRMA FOUNDATION PRE DOCTORAL INFORMATICS FELLOWSHIP. MDS IS SUPPORTED BY NIH GRANT 5T32HL007185-34. THE FUNDERS HAD NO ROLE IN STUDY DESIGN, DATA COLLECTION AND ANALYSIS, DECISION TO PUBLISH, OR PREPARATION OF THE MANUSCRIPT.",NA,"1935-2727","2",NA,"PUBLIC LIBRARY SCIENCE","6",2012,"ISI000300949200012","65","INFECTIOUS DISEASES, PARASITOLOGY, TROPICAL MEDICINE","10","INFECTIOUS DISEASES, PARASITOLOGY, TROPICAL MEDICINE","JOEDERISILAB.UCSF.EDU",NA,"901FX",NA,"YOZWIAK, NL (REPRINT AUTHOR), UNIV CALIF BERKELEY, SCH PUBL HLTH, DIV INFECT DIS \& VACCINOL, BERKELEY, CA 94720 USA","ISI","UNIV CALIF BERKELEY;UNIV CALIF SAN FRANCISCO;UNIV CALIF SAN FRANCISCO;UNIV CALIF SAN FRANCISCO;CTR NACL DIAGNOST AND REFERENCIA;UNIV CALIF SAN FRANCISCO","UNIV CALIF BERKELEY",NA,"YOZWIAK NL, 2012, PLOS NEGLECT TROP DIS","YOZWIAK NL, 2012, PLOS NEGLECT TROP DIS"
"MISRA RV, 2012, J MICROBIOL METHODS","MISRA RV;AHMOD NZ;PARKER R;FANG M;SHAH H;GHARBIA S","DEVELOPING AN INTEGRATED PROTEO-GENOMIC APPROACH FOR THE CHARACTERISATION OF BIOMARKERS FOR THE IDENTIFICATION OF BACILLUS ANTHRACIS","JOURNAL OF MICROBIOLOGICAL METHODS","J. MICROBIOL. METHODS","BACILLUS ANTHRACIS IS THE CAUSATIVE AGENT OF ANTHRAX, AN ACUTE AND OFTEN FATAL DISEASE IN HUMANS. DUE TO THE HIGH GENOMIC RELATEDNESS WITHIN THE BACILLUS CEREUS GROUP OF SPECIES IT IS A CHALLENGE TO IDENTIFY B. ANTHRACIS CONSISTENTLY. ALTERNATIVE STRATEGIES SUCH AS PROTEOMICS COUPLED WITH MASS SPECTROMETRY (MS) PROVIDE A POWERFUL APPROACH FOR BIOMARKER DISCOVERY. HOWEVER, VALIDATING AND EVALUATING THESE MARKERS, PARTICULARLY FOR GENETICALLY HOMOGENEOUS SPECIES SUCH AS B. ANTHRACIS ARE CHALLENGING. THE OBJECTIVE OF THIS STUDY IS TO DEVELOP A ROBUST BIOMARKER DISCOVERY AND VALIDATION PIPELINE, USING PROTEOMIC METHODOLOGY COMBINED WITH IN SILICO AND MOLECULAR APPROACHES, TO DETERMINE A BIOMARKER LIST, USING B. ANTHRACIS AS A MODEL. IN THIS EXPLORATORY STUDY WE PROFILED THE PROTEOME OF B. ANTHRACIS AND GENETICALLY RELATED SPECIES USING GELC-LIQUID CHROMATOGRAPHY MS/MS (GELC-LC MS/MS), IDENTIFYING PEPTIDES THAT COULD BE USED TO DETECT B. ANTHRACIS. PEPTIDES WERE FILTERED TO REMOVE LOW QUALITY IDENTIFICATIONS. USING COMPARATIVE BIOINFORMATIC APPROACHES, MATCHING AND SEARCHING AGAINST GENOMIC SEQUENCE DATA A SHORTLIST OF PEPTIDE BIOMARKERS WAS DETERMINED AND VALIDATED USING DNA SEQUENCING, AGAINST A PANEL OF CLOSELY RELATED STRAINS, TO DETERMINE MARKER SPECIFICITY. FURTHER VALIDATION WAS PERFORMED USING MS QUANTITATION METHODS TO ASSESS SENSITIVITY AND SPECIFICITY. A BIOMARKER DISCOVERY PIPELINE WAS SUCCESSFULLY DEVELOPED IN THIS STUDY, COMPRISING FOUR DISTINCT STAGES: PROTEOME PROFILING, COMPARATIVE BIOINFORMATIC VALIDATION, DNA SEQUENCING AND MS VALIDATION. USING THE PIPELINE, 5379 PEPTIDES SPECIFIC FOR BACILLUS SPECIES AND 36 PEPTIDES SPECIFIC FOR B. ANTHRACIS WERE IDENTIFIED AND VALIDATED. THE 36 PEPTIDES, REPRESENTING 30 PROTEINS WERE DERIVED FROM OVER 15 DIFFERENT CLUSTERS OF ORTHOLOGOUS GROUP CATEGORIES, INCLUDING PROTEINS INVOLVED IN TRANSCRIPTION, ENERGY PRODUCTION/CONSERVATION AS WELL AS MULTIFUNCTIONAL PROTEINS. WE DEMONSTRATED THAT THE PEPTIDE BIOMARKERS IDENTIFIED IN THIS STUDY COULD BE DETECTED IN A COMPLEX BACKGROUND, IN WHICH 0.1 MU G OF PROTEIN EXTRACT FROM B. ANTHRACIS WAS SPIKED INTO 9.90 MU G OF B. CEREUS PROTEIN EXTRACTS. THE INTEGRATION OF BOTH STABLE NON-REDUNDANT PEPTIDES WITH MOLECULAR METHODOLOGY FOR MARKER DISCOVERY AND VALIDATION, IMPROVES THE ROBUSTNESS OF IDENTIFYING AND CHARACTERISING CANDIDATE BIOMARKERS FOR THE IDENTIFICATION OF BACTERIA SUCH AS B. ANTHRACIS. (C) 2011 ELSEVIER B.V. ALL RIGHTS RESERVED.","BIOMARKER; ANTHRAX; PROTEOMICS; MASS SPECTROMETRY; BACILLUS; DISCOVERY","MEDIATED CONJUGATION SYSTEM; CLOSELY-RELATED BACTERIA; MASS-SPECTROMETRY; CEREUS GROUP; THURINGIENSIS; SEQUENCE; PLASMIDS; TIME; DISCOVERY; VIRULENCE","ENGLISH","ARTICLE","ARTICLE",2,"ADDONA TA, 2011, NAT BIOTECHNOL, V29, P635, DOI 10.1038/NBT.1899.;ANDRUP L, 1996, PLASMID, V36, P75, DOI 10.1006/PLAS.1996.0035.;BANSAL R, 2011, APPL ENVIRON MICROB, V77, P810, DOI 10.1128/AEM.01323-10.;BATTISTI L, 1985, J BACTERIOL, V162, P543.;BEYER W, 2009, MOL ASPECTS MED, V30, P481, DOI 10.1016/J.MAM.2009.08.004.;CHALLACOMBE JF, 2007, J BACTERIOL, V189, P3680, DOI 10.1128/JB.00241-07.;DEMIREV PA, 2008, J MASS SPECTROM, V43, P1441, DOI 10.1002/JMS.1474.;DEMIREV PA, 2008, ANNU REV ANAL CHEM, V1, P71, DOI 10.1146/ANNUREV.ANCHEM.1.031207.112838.;DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324.;DWORZANSKI JP, 2010, ANAL CHEM, V82, P145, DOI 10.1021/AC9015648.;DWYER KG, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-15.;FENG XS, 2011, J PROTEOMICS, V74, P567, DOI 10.1016/J.JPROT.2011.01.017.;FERREIRA L, 2010, J CLIN MICROBIOL, V48, P2110, DOI 10.1128/JCM.02215-09.;GOTO K, 2000, J GEN APPL MICROBIOL, V46, P1, DOI 10.2323/JGAM.46.1.;HONDA A, 2010, J STEROID BIOCHEM, V121, P556, DOI 10.1016/J.JSBMB.2010.03.030.;JENSEN GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/J.1462-2920.2003.00461.X.;JENSEN GB, 1996, CURR MICROBIOL, V33, P228, DOI 10.1007/S002849900105.;KESHISHIAN H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/MCP.M700354-MCP200.;KIM W, 2008, J MED MICROBIOL, V57, P279, DOI 10.1099/JMM.0.47542-0.;KLEE SR, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0010986.;KOEHLER TM, 2009, MOL ASPECTS MED, V30, P386, DOI 10.1016/J.MAM.2009.07.004.;KOLSTO AB, 2009, ANNU REV MICROBIOL, V63, P451, DOI 10.1146/ANNUREV.MICRO.091208.073255.;KOTIRANTA A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0.;KUMAR S, 2009, J MICROBIOL BIOTECHN, V19, P1475, DOI 10.4014/JMB.0902.0101.;LECHNER S, 1998, INT J SYST BACTERIOL, V48, P1373, DOI 10.1099/00207713-48-4-1373.;LI WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/BIOINFORMATICS/BTL158.;LOGAN N.A., 2009, BERGEYS MANUAL SYSTE.;LUN SC, 2007, J BIOL CHEM, V282, P18348, DOI 10.1074/JBC.M700035200.;LUNA VA, 2006, J CLIN MICROBIOL, V44, P2367, DOI 10.1128/JCM.00154-06.;MOODY KL, 2010, MICROBIOL-SGM, V156, P174, DOI 10.1099/MIC.0.033407-0.;PANNUCCI J, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-34.;QI YA, 2001, APPL ENVIRON MICROB, V67, P3720, DOI 10.1128/AEM.67.8.3720-3727.2001.;RAMANATHAN R, 2011, J MASS SPECTROM, V46, P595, DOI 10.1002/JMS.1921.;RAMSAY CN, 2010, EURO SURVEILL, V15, P19465.;READ TD, 2003, NATURE, V423, P81, DOI 10.1038/NATURE01586.;REDDY GSN, 2008, INT J SYST EVOL MICR, V58, P2330, DOI 10.1099/IJS.0.65515-0.;TATUSOV RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41.;TOURNIER JN, 2009, MOL ASPECTS MED, V30, P456, DOI 10.1016/J.MAM.2009.06.002.;VILAS-BOAS GT, 2007, CAN J MICROBIOL, V53, P673, DOI 10.1139/W07-029.;WAHAB T, 2005, EMERG INFECT DIS, V11, P1527, DOI 10.3201/EID1110.041316.;WHITEAKER J.R., 2011, NAT BIOTECHNOL, V29, P600.;WILCKS A, 1998, MICROBIOL-UK, V144, P1263, DOI 10.1099/00221287-144-5-1263.;WOLF M, 2004, INT J SYST EVOL MICR, V54, P871, DOI 10.1099/IJS.0.02868-0.","MISRA, RV (REPRINT AUTHOR), HLTH PROTECT AGCY, DEPT BIOANAL \& HORIZON TECHNOL, 61 COLINDALE AVE, LONDON NW9 5EQ, ENGLAND.;MISRA, RAJU V., AHMOD, NADIA Z., PARKER, ROBERT, FANG, MIN, SHAH, HAROUN, GHARBIA, SAHEER, HLTH PROTECT AGCY, DEPT BIOANAL \& HORIZON TECHNOL, LONDON NW9 5EQ, ENGLAND.","10.1016/J.MIMET.2011.12.001","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"HOME OFFICE","THIS PROJECT WAS SUPPORTED BY A SCIENCE AND TECHNOLOGY RESEARCH GRANT FROM THE HOME OFFICE. THE AUTHORS ACKNOWLEDGE SALLY LANGHAM CONTRIBUTION FOR STRAIN CULTURE AND SAMPLE PREPARATIVE METHODS.",NA,"0167-7012","2","237-247","ELSEVIER SCIENCE BV","88",2012,"ISI000301165400008","43","BIOCHEMISTRY \& MOLECULAR BIOLOGY, MICROBIOLOGY","10","BIOCHEMICAL RESEARCH METHODS, MICROBIOLOGY","RAJU.MISRAHPA.ORG.UK NADIA.AHMODHPA.ORG.UK ROB.PARKERMQ.EDU.AU MIN.FANGHPA.ORG.UK HAROUN.SHAHHPA.ORG.UK SAHEER.GHARBIAHPA.ORG.UK",NA,"904AG",NA,"MISRA, RV (REPRINT AUTHOR), HLTH PROTECT AGCY, DEPT BIOANAL \& HORIZON TECHNOL, 61 COLINDALE AVE, LONDON NW9 5EQ, ENGLAND","ISI","DEPT BIOANAL AND HORIZON TECHNOL","DEPT BIOANAL AND HORIZON TECHNOL",NA,"MISRA RV, 2012, J MICROBIOL METHODS","MISRA RV, 2012, J MICROBIOL METHODS"
"MOSIG RA, 2012, J OVARIAN RES","MOSIG RA;LOBL M;SENTURK E;SHAH H;COHEN S;CHUDIN E;FRUSCIO R;MARCHINI S;D INCALCI M;SACHIDANANDAM R;DOTTINO P;MARTIGNETTI JA","IGFBP-4 TUMOR AND SERUM LEVELS ARE INCREASED ACROSS ALL STAGES OF EPITHELIAL OVARIAN CANCER","JOURNAL OF OVARIAN RESEARCH","J. OVARIAN RES.","BACKGROUND: WE SOUGHT TO IDENTIFY CANDIDATE SERUM BIOMARKERS FOR THE DETECTION AND SURVEILLANCE OF EOC. BASED ON RNA-SEQ TRANSCRIPTOME ANALYSIS OF PATIENT-DERIVED TUMORS, HIGHLY EXPRESSED SECRETED PROTEINS WERE IDENTIFIED USING A BIOINFORMATIC APPROACH. METHODS: RNA-SEQ WAS USED TO QUANTIFY PAPILLARY SEROUS OVARIAN CANCER TRANSCRIPTOMES. PAIRED END SEQUENCING OF 22 FLASH FROZEN TUMORS WAS PERFORMED. SEQUENCE ALIGNMENTS WERE PROCESSED WITH THE PROGRAM ELAND, EXPRESSION LEVELS WITH ERANGE AND THEN BIOINFORMATICALLY SCREENED FOR SECRETED PROTEIN SIGNATURES. SERUM SAMPLES FROM WOMEN WITH BENIGN AND MALIGNANT PELVIC MASSES AND SERIAL SAMPLES FROM WOMEN DURING CHEMOTHERAPY REGIMENS WERE MEASURED FOR IGFBP-4 BY ELISA. STUDENT'S T TEST, ANOVA, AND ROC CURVES WERE USED FOR STATISTICAL ANALYSIS. RESULTS: INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN (IGFBP-4) WAS CONSISTENTLY PRESENT IN THE TOP 7.5\% OF ALL EXPRESSED GENES IN ALL TUMOR SAMPLES. WE THEN SCREENED SERUM SAMPLES TO DETERMINE IF INCREASED TUMOR EXPRESSION CORRELATED WITH SERUM EXPRESSION. IN AN INITIAL DISCOVERY SET OF 21 SAMPLES, IGFBP-4 LEVELS WERE FOUND TO BE ELEVATED IN PATIENTS, INCLUDING THOSE WITH EARLY STAGE DISEASE AND NORMAL CA125 LEVELS. IN A LARGER AND INDEPENDENT VALIDATION SET (82 CONTROLS, 78 CASES), IGFBP-4 LEVELS WERE SIGNIFICANTLY INCREASED (P < 5 X 10(-5)). IGFBP-4 LEVELS WERE SIMILAR TO 3X GREATER IN WOMEN WITH MALIGNANT PELVIC MASSES COMPARED TO WOMEN WITH BENIGN MASSES. ROC SENSITIVITY WAS 73\% AT 93\% SPECIFICITY (AUC 0.816). IN WOMEN RECEIVING CHEMOTHERAPY, AVERAGE IGFBP-4 LEVELS WERE BELOW THE ROC-DETERMINED THRESHOLD AND LOWER IN NED PATIENTS COMPARED TO AWD PATIENTS. CONCLUSIONS: THIS STUDY, THE FIRST TO OUR KNOWLEDGE TO USE RNA-SEQ FOR BIOMARKER DISCOVERY, IDENTIFIED IGFBP-4 AS OVEREXPRESSED IN OVARIAN CANCER PATIENTS. BEYOND THIS, THESE STUDIES IDENTIFIED TWO ADDITIONAL INTRIGUING FINDINGS. FIRST, IGFBP-4 CAN BE ELEVATED IN EARLY STAGE DISEASE WITHOUT ELEVATED CA125. SECOND, IGFBP-4 LEVELS ARE SIGNIFICANTLY ELEVATED WITH MALIGNANT VERSUS BENIGN DISEASE. THESE FINDINGS PROVIDE THE RATIONALE FOR FUTURE VALIDATION STUDIES.","IGFBP-4; EPITHELIAL OVARIAN CANCER; SERUM BIOMARKER; RNA-SEQ; TRANSCRIPTOME","FACTOR-BINDING PROTEIN-4; SIGNATURES; MARKERS; GENOME","ENGLISH","ARTICLE","ARTICLE",10,"AMERICAN COLLEGE OF OBSTETRICIANS GYNECOLOGISTS COMMITTEE ON GYNECOLOGIC PRACTICE, 2011, OBSTET GYNECOL, V117, P742, DOI DOI 10.1097/AOG.0B013E31821477DB.;BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380.;BIGNELL GR, 2010, NATURE, V463, P893, DOI 10.1038/NATURE08768.;CHAVES J, 2011, ANTI-CANCER DRUG, V22, P206, DOI 10.1097/CAD.0B013E32834258A1.;CHEN YJ, 2005, NUCLEIC ACIDS RES, V33, PD169.;DURAI R, 2006, INT J ONCOL, V28, P1317.;FERLAY J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/IJC.25516.;HONDA Y, 1996, J CLIN ENDOCR METAB, V81, P1389, DOI 10.1210/JC.81.4.1389.;KARAM AK, 2010, NAT REV CLIN ONCOL, V7, P335, DOI 10.1038/NRCLINONC.2010.44.;KUK C, 2009, MOL CELL PROTEOMICS, V8, P661, DOI 10.1074/MCP.M800313-MCP200.;LEARY RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/SCITRANSLMED.3000702.;MENON U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9.;MOK SC, 2007, ADV CANCER RES, V96, P1, DOI 10.1016/S0065-230X(06)96001-1.;MORTAZAVI A, 2008, NAT METHODS, V5, P621, DOI 10.1038/NMETH.1226.;PARKIN DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/CANJCLIN.49.1.33.;PARTRIDGE E, 2009, OBSTET GYNECOL, V113, P775, DOI 10.1097/AOG.0B013E31819CDA77.;PLEASANCE ED, 2010, NATURE, V463, P184, DOI 10.1038/NATURE08629.;SKATES SJ, 2004, J CLIN ONCOL, V22, P4059, DOI 10.1200/JCO.2004.03.091.;SKATES SJ, 1995, CANCER, V76, P2004, DOI 10.1002/1097-0142(19951115)76:10+<2004::AID-CNCR2820761317>3.0.CO,2-G.;STURGEON CM, 2008, CLIN CHEM, V54, PE11, DOI 10.1373/CLINCHEM.2008.105601.;SU F, 2007, BIOMARK INSIGHTS, V2, P369.;TIMMERMANN B, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0015661.;TUMMALA MOHAN K, 2005, CLIN ADV HEMATOL ONCOL, V3, P723.;VAN GORP T, 2011, BR J CANC.;YU JZ, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-70.","MARTIGNETTI, JA (REPRINT AUTHOR), MT SINAI SCH MED, DEPT GENET \& GENOM SCI, NEW YORK, NY 10029 USA.;MOSIG, REBECCA A., LOBL, MOLLIE, SENTURK, EMIR, SHAH, HARDIK, SACHIDANANDAM, RAVI, MARTIGNETTI, JOHN A., MT SINAI SCH MED, DEPT GENET \& GENOM SCI, NEW YORK, NY 10029 USA.;COHEN, SAMANTHA, DOTTINO, PETER, MT SINAI SCH MED, DIV GYNECOL ONCOL, NEW YORK, NY USA.;CHUDIN, EUGENE, PROGNOSYS BIOSCI, LA JOLLA, CA USA.;FRUSCIO, ROBERT, UNIV MILANO BICOCCA, SAN GERARDO HOSP, MONZA, ITALY.;D'INCALCI, MAURIZIO, INST MARIO NEGRI, DEPT ONCOL, MILAN, ITALY.;FRUSCIO, ROBERT, MARCHINI, SERGIO, D'INCALCI, MAURIZIO, MARIO NEGRI GYNECOL ONCOL GRP MANGO, MILAN, ITALY.","10.1186/1757-2215-5-3","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","3",NA,NA,NA,NA,"1757-2215",NA,NA,"BIOMED CENTRAL LTD","5",2012,"ISI000300343900001","25","REPRODUCTIVE BIOLOGY","4","REPRODUCTIVE BIOLOGY","JOHN.MARTIGNETTIMSSM.EDU",NA,"893GJ",NA,"MARTIGNETTI, JA (REPRINT AUTHOR), MT SINAI SCH MED, DEPT GENET \& GENOM SCI, NEW YORK, NY 10029 USA","ISI","MT SINAI SCH MED;MT SINAI SCH MED;PROGNOSYS BIOSCI;UNIV MILANO BICOCCA;INST MARIO NEGRI;FRUSCIO","MT SINAI SCH MED",NA,"MOSIG RA, 2012, J OVARIAN RES","MOSIG RA, 2012, J OVARIAN RES"
"HECKER M, 2012, AUTOIMMUN REV","HECKER M;LORENZ P;STEINBECK F;HONG L;RIEMEKASTEN G;LI Y;ZETTL UK;THIESEN HJ","COMPUTATIONAL ANALYSIS OF HIGH-DENSITY PEPTIDE MICROARRAY DATA WITH APPLICATION FROM SYSTEMIC SCLEROSIS TO MULTIPLE SCLEROSIS","AUTOIMMUNITY REVIEWS","AUTOIMMUN. REV.","AUTO-ANTIBODIES ARE IMPLICATED IN THE PATHOPHYSIOLOGY OF VARIOUS AUTOIMMUNE DISEASES. HIGH-DENSITY PEPTIDE MICROARRAYS INCUBATED WITH HUMAN SERUM CAN DETECT ANTIBODY REACTIVITIES AGAINST THOUSANDS OF PEPTIDES. THIS ENABLES THE IDENTIFICATION OF NEW AUTO-ANTIGENS AND THE DETERMINATION OF THE PARTS OF PROTEIN ANTIGENS (EPITOPES) THAT ARE RECOGNIZED BY ANTIBODY PARATOPES. WE DISCUSS THE UTILITY OF PEPTIDE MICROARRAYS TO INVESTIGATE EPITOPE-ANTIBODY-RECOGNITIONS (EAR) FROM SYSTEMIC SCLEROSIS TO MULTIPLE SCLEROSIS. THE TECHNOLOGY CAN HELP TO ESTABLISH RELIABLE DIAGNOSTIC AND PROGNOSTIC BIOMARKERS EMPLOYING A COMBINATION OF ANTIGENIC PEPTIDES. WE DESCRIBE THE SPECIFICS OF PEPTIDE MICROARRAY DATA AND PRESENT BIOINFORMATIC METHODS FOR THEIR ANALYSIS. QUALITY CONTROL, DATA PRE-PROCESSING AND THE FILTERING OF SPECIFIC PEPTIDES ARE DEMONSTRATED ON AN EXAMPLE DATA SET. PEPTIDE MICROARRAYS REPRESENTING 24 SELECTED PROTEINS BY 3235 OVERLAPPING 15MER PEPTIDES WERE USED TO MEASURE ANTIBODIES IN SERUM OF 10 PATIENTS WITH LIMITED CUTANEOUS SYSTEMIC SCLEROSIS (SSC) AND 10 HEALTHY BLOOD DONORS. THE DATA SHOWED A SPARSE AND SKEWED DISTRIBUTION, AND WE OBSERVED STRONG INDIVIDUAL DIFFERENCES SINCE MANY PEPTIDE SEQUENCES WERE BOUND BY ANTIBODIES OF ONLY ONE SERUM SAMPLE. IN THE SERA OF THE SSC PATIENTS, BUT NOT OF THE HEALTHY CONTROLS, WE FOUND ANTIBODIES TO THREE PEPTIDES MGPRRRSRKPEAPRR, TPTPGPSRRGPSLGA AND GPSRRGPSLGASSHQ THAT SHARE A SIMILAR SEQUENCE MOTIF (GP-R/S-RR). THESE PEPTIDES MAP TO TWO KNOWN LINEAR EPITOPES AT THE N-TERMINUS OF CENTROMERE PROTEIN A (CENPA), DEMONSTRATING THE UTILITY OF PEPTIDE MICROARRAYS. PRESENTED EXPERIMENTAL AND BIOINFORMATIC APPROACH CAN BE APPLIED IN THE SAME MANNER FOR MULTIPLE SCLEROSIS RESEARCH. (C) 2011 ELSEVIER B.V. ALL RIGHTS RESERVED.","PEPTIDE MICROARRAYS; ANTIBODY EPITOPE MAPPING; BIOINFORMATICS; MULTIPLE SCLEROSIS; SYSTEMIC SCLEROSIS","CEREBROSPINAL-FLUID ANTIBODIES; RELAPSING-REMITTING MULTIPLE; MYELIN BASIC-PROTEIN; NEUROFILAMENT SUBUNIT; AUTOIMMUNE-DISEASES; CENP-A; AUTOANTIBODIES; SERUM; CELL; SPECIFICITY","ENGLISH","REVIEW","ARTICLE",20,"ANNUNZIATA P, 1999, J NEUROL SCI, V168, P32, DOI 10.1016/S0022-510X(99)00168-9.;BAIG S, 1991, SCAND J IMMUNOL, V33, P73, DOI 10.1111/J.1365-3083.1991.TB02493.X.;BANKI K, 1994, J EXP MED, V180, P1649, DOI 10.1084/JEM.180.5.1649.;BARTOS A, 2007, J NEUROL, V254, P20, DOI 10.1007/S00415-006-0185-0.;BELOGUROV AA, 2008, J IMMUNOL, V180, P1258, DOI 10.4049/JIMMUNOL.180.2.1258.;BRONSTEIN JM, 1999, NEUROLOGY, V53, P154, DOI 10.1212/WNL.53.1.154.;CHIBA S, 2006, J NEUROL SCI, V241, P39, DOI 10.1016/J.JNS.2005.10.009.;CID C, 2007, J NEUROIMMUNOL, V184, P223, DOI 10.1016/J.JNEUROIM.2006.11.001.;COMPSTON A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7.;CRETICH M, 2006, BIOMOL ENG, V23, P77, DOI 10.1016/J.BIOENG.2006.02.001.;DE SEZE J, 2003, NEUROLOGY, V61, P268, DOI 10.1212/01.WNL.0000071217.95981.0E.;DE VEGVAR HEN, 2003, J VIROL, V77, P11125, DOI 10.1128/JVI.77.20.11125-11138.2003.;DERFUSS T, 2009, P NATL ACAD SCI USA, V106, P8302, DOI 10.1073/PNAS.0901496106.;EGGERT M, 2010, CURR PHARM DESIGN, V16, P1634, DOI 10.2174/138161210791164144.;GASEITSIWE S, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0003840.;GIOVANNONI G, 2002, J NEUROL NEUROSUR PS, V73, P465, DOI 10.1136/JNNP.73.5.465.;HACHULLA E, 2011, CLIN REV ALLERG IMMU, V40, P78, DOI 10.1007/S12016-010-8198-Y.;HALL DA, 2007, MECH AGEING DEV, V128, P161, DOI 10.1016/J.MAD.2006.11.021.;HAMAGUCHI Y, 2010, J DERMATOL, V37, P42, DOI 10.1111/J.1346-8138.2009.00762.X.;HAUSER SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMOA0706383.;HECKER M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-262.;HOLMOY T, 2009, EUR NEUROL, V62, P311, DOI 10.1159/000235944.;HUEBER W, 2005, ARTHRITIS RHEUM, V52, P2645, DOI 10.1002/ART.21269.;ILYAS AA, 2003, J NEUROIMMUNOL, V139, P76, DOI 10.1016/S0165-5728(03)00131-0.;JAFARI N, 2010, J CLIN VIROL, V49, P26, DOI 10.1016/J.JCV.2010.06.007.;KAPPOS L, 2010, MULT SCLER, V16, PS7.;KIDD BA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/AR2523.;KIMURA A, 2010, J NEUROIMMUNOL, V219, P105, DOI 10.1016/J.JNEUROIM.2009.11.014.;KOLLN J, 2006, J IMMUNOL, V177, P5652, DOI 10.4049/JIMMUNOL.177.8.5652.;LALIVE PH, 2008, SWISS MED WKLY, V138, P692, DOI /AOP/SMW-AOP12283.;LENNON VA, 2005, J EXP MED, V202, P473, DOI 10.1084/JEM.20050304.;LEROY EC, 1988, J RHEUMATOL, V15, P202.;LINDSTROM JM, 1976, NEUROLOGY, V26, P1054, DOI 10.1212/WNL.26.11.1054.;LORENZ P, 2009, METHODS MOL BIOL, V524, P247, DOI 10.1007/978-1-59745-450-6\_18.;LOVATO L, 2008, MOL CELL PROTEOMICS, V7, P2337, DOI 10.1074/MCP.M700277-MCP200.;MAHLER M, 2000, J MOL MED-JMM, V78, P460, DOI 10.1007/S001090000128.;MAHLER M, 2010, ANN NY ACAD SCI, V1183, P267, DOI 10.1111/J.1749-6632.2009.05127.X.;MASCH A, 2010, METHODS MOL BIOL, V669, P161, DOI 10.1007/978-1-60761-845-4\_13.;MATHEY EK, 2007, J EXP MED, V204, P2363, DOI 10.1084/JEM.20071053.;MCLAUGHLIN KA, 2009, J IMMUNOL, V183, P4067, DOI 10.4049/JIMMUNOL.0801888.;MICHAUD GA, 2003, NAT BIOTECHNOL, V21, P1509, DOI 10.1038/NBT910.;MURO Y, 2000, CLIN EXP IMMUNOL, V120, P218, DOI 10.1046/J.1365-2249.2000.01189.X.;NAHTMAN T, 2007, J IMMUNOL METHODS, V328, P1, DOI 10.1016/J.JIM.2007.07.015.;ONOUE H, 2007, ACTA NEUROL SCAND, V115, P153, DOI 10.1111/J.1600-0404.2006.00735.X.;PEROSA F, 2010, CLIN IMMUNOL, V137, P60, DOI 10.1016/J.CLIM.2010.06.008.;POLMAN CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMOA044397.;QUINTANA FJ, 2004, P NATL ACAD SCI USA, V101, P14615, DOI 10.1073/PNAS.0404848101.;QUINTANA FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/PNAS.0806310105.;RAINE C. S, 2008, MULTIPLE SCLEROSIS C.;REILLY M, 2009, METHODS MOL BIOL, V570, P373, DOI 10.1007/978-1-60327-394-7\_21.;REINDL M, 2003, J NEUROIMMUNOL, V145, P139, DOI 10.1016/J.JNEUROIM.2003.09.010.;ROBINSON WH, 2002, BIOTECHNIQUES, P66.;ROBINSON WH, 2003, NAT BIOTECHNOL, V21, P1033, DOI 10.1038/NBT859.;ROBINSON WH, 2002, NAT MED, V8, P295, DOI 10.1038/NM0302-295.;RUBINSTEIN ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/J.MOLIMM.2007.10.016.;SCHWARZ M, 2006, J NEUROL SCI, V244, P59, DOI 10.1016/J.JNS.2005.12.006.;SEKULIC N, 2010, NATURE, V467, P347, DOI 10.1038/NATURE09323.;SHREFFLER WG, 2004, J ALLERGY CLIN IMMUN, V113, P776, DOI 10.1016/J.JACI.2003.12.588.;SILBER E, 2002, NEUROLOGY, V58, P1372, DOI 10.1212/WNL.58.9.1372.;SOMERS K, 2010, J NEUROIMMUNOL, V228, P162.;SOMERS K, 2009, AUTOIMMUN REV, V8, P573, DOI 10.1016/J.AUTREV.2009.02.001.;SOSPEDRA M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/ANNUREV.IMMUNOL.23.021704.115707.;SUN JP, 1991, EUR J IMMUNOL, V21, P1461, DOI 10.1002/EJI.1830210620.;SVARCOVA J, 2008, EUR J NEUROL, V15, P1173, DOI 10.1111/J.1468-1331.2008.02223.X.;THUY-TIEN H, 2008, SCAND J IMMUNOL, V67, P400, DOI 10.1111/J.1365-3083.2008.02073.X.;TUSHER VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/PNAS.091062498.;VOJDANI A, 2003, J INTERN MED, V254, P363, DOI 10.1046/J.1365-2796.2003.01203.X.;WALKER UA, 2007, ANN RHEUM DIS, V66, P754, DOI 10.1136/ARD.2006.062901.;WANG H, 2008, NEUROLOGY, V71, P1142, DOI 10.1212/01.WNL.0000316195.52001.E1.;YANG I, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-11-RESEARCH0062.;YUKITAKE M, 2008, J NEUROVIROL, V14, P130, DOI 10.1080/13550280701883840.","HECKER, M (REPRINT AUTHOR), UNIV ROSTOCK, DEPT IMMUNOL, SCHILLINGALLEE 68, D-18057 ROSTOCK, GERMANY.;HECKER, MICHAEL, LORENZ, PETER, STEINBECK, FELIX, HONG, LI, THIESEN, HANS-JUERGEN, UNIV ROSTOCK, DEPT IMMUNOL, D-18057 ROSTOCK, GERMANY.;HECKER, MICHAEL, ZETTL, UWE K., UNIV ROSTOCK, DEPT NEUROL, D-18057 ROSTOCK, GERMANY.;STEINBECK, FELIX, THIESEN, HANS-JUERGEN, GESELL INDIVIDUALISIERTE MED MBH INDYMED, ROSTOCK, GERMANY.;HONG, LI, LI, YIXUE, CHINESE ACAD SCI, SHANGHAI INST BIOL SCI, KEY LAB SYST BIOL, SHANGHAI, PEOPLES R CHINA.;RIEMEKASTEN, GABRIELA, CHARITE UNIV MED BERLIN, DEPT RHEUMATOL \& CLIN IMMUNOL, BERLIN, GERMANY.","10.1016/J.AUTREV.2011.05.010","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,"EU [LSHM-CT-2004-005264, E-RARE 01GM 0803, UR 08051, 0315450D/G, CHN07/38]","THIS WORK WAS PARTLY FINANCED BY REGIONAL, NATIONAL AND INTERNATIONAL GRANTS (EU AUTOROME LSHM-CT-2004-005264, E-RARE 01GM 0803, MV EXCELLENCE UR 08051, BMBF MEDSYS 0315450D/G, COMBIO CHN07/38). WE THANK PROF. DR. MIKE SCHUTKOWSKI AND JOHANNES ZERWECK FROM JPT PEPTIDE TECHNOLOGIES GMBH FOR CONTINUED ASSISTANCE WITH THE PEPTIDE MICROARRAY TECHNOLOGY. THANKS TO DR. RENATE CLAUS AND ALL COLLABORATORS IN THE CLINIC FOR PROVIDING SERA SAMPLES AS WELL AS TO OUR LAB ASSISTANT EVA LORBEER-REHFELDT FOR HER HELP IN PERFORMING THE EXPERIMENTS.",NA,"1568-9972","3","180-190","ELSEVIER SCIENCE BV","11",2012,"ISI000301872000005","71","IMMUNOLOGY","12","IMMUNOLOGY","MICHAEL.HECKERROCKETMAIL.COM",NA,"913IX",NA,"HECKER, M (REPRINT AUTHOR), UNIV ROSTOCK, DEPT IMMUNOL, SCHILLINGALLEE 68, D-18057 ROSTOCK, GERMANY","ISI","UNIV ROSTOCK;UNIV ROSTOCK;SHANGHAI INST BIOL SCI;CHARITE UNIV MED BERLIN","UNIV ROSTOCK",NA,"HECKER M, 2012, AUTOIMMUN REV","HECKER M, 2012, AUTOIMMUN REV"
"DELGADO E, 2012, J ANTIMICROB CHEMOTHER","DELGADO E;FERNANDEZ GARCIA A;VEGA Y;CUEVAS T;PINILLA M;GARCIA V;SANCHEZ M;GONZALEZ M;MARIA SANCHEZ A;THOMSON MM;PEREZ ALVAREZ L","EVALUATION OF GENOTYPIC TROPISM PREDICTION TESTS COMPARED WITH IN VITRO CO-RECEPTOR USAGE IN HIV-1 PRIMARY ISOLATES OF DIVERSE SUBTYPES","JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY","J. ANTIMICROB. CHEMOTHER.","OBJECTIVES: TO EVALUATE THE SENSITIVITY AND SPECIFICITY OF GENOTYPIC METHODS FOR PREDICTING THE CO-RECEPTOR USAGE OF SUBTYPES B AND NON-B HIV-1 PRIMARY ISOLATES, USING AS GOLD STANDARD THE INFECTIVITY OF EACH PRIMARY ISOLATE IN GHOST CELLS STABLY EXPRESSING HIV-1 CO-RECEPTORS. METHODS: PRIMARY ISOLATES WERE OBTAINED BY CO-CULTURING EITHER PATIENT'S PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) OR ULTRACENTRIFUGED PLASMA WITH DONOR-ACTIVATED PBMCS. IN VITRO CO-RECEPTOR USAGE WAS DETERMINED BY INFECTING GHOST CELLS. TROPISM PREDICTION, BASED ON V3 SEQUENCES, WAS DETERMINED WITH SIMPLE RULES AND BIOINFORMATIC TOOLS (GENO2PHENO[CORECEPTOR] AND WEBPSSM). RESULTS: THIS STUDY INCLUDES 102 HIV-1 PRIMARY ISOLATES, 23 (22.5\%) SUBTYPE B AND 79 (77.5\%) NON-B GENETIC FORMS. V3 SEQUENCES WERE CLASSIFIED INTO SIX SUBTYPES (A-G), ALTHOUGH 32 (31.4\%) WERE CIRCULATING RECOMBINANT FORMS AND 21 (20.6\%) WERE UNIQUE RECOMBINANT FORMS. SIXTY-NINE ISOLATES WERE R5, 27 R5X4 AND 6 X4. THE HIGHEST LEVELS OF SENSITIVITY AND SPECIFICITY FOR THE DETECTION OF X4 STRAINS AMONG V3 SEQUENCES, BETWEEN 91\% AND 100\%, WERE OBTAINED BY USING PSSMX4R5, PSSMSI/NSI AND THE 11/25 RULE FOR SEQUENCES OF SUBTYPES A, B AND G, BUT NOT FOR SUBTYPE F. ESTABLISHING THE RECOMMENDED CUT-OFF FOR CLINICAL SETTINGS OF A 10\% FALSE POSITIVE RATE FOR GENO2PHENO, WE OBTAINED 93\% SPECIFICITY AND 97\% SENSITIVITY. CONCLUSIONS: COMPARING GENOTYPIC ASSAYS FOR HIV-1 CO-RECEPTOR USE WITH A CELL-CULTURE PHENOTYPIC ASSAY COULD PROVIDE MORE RELIABLE RESULTS OF SENSITIVITY AND SPECIFICITY FOR THE DETECTION OF X4 STRAINS THAN COMPARING THEM WITH RECOMBINANT ASSAYS, CONSIDERED AS GOLD STANDARD. IN GENERAL, EXCEPT FOR SUBTYPE F ISOLATES, THERE IS A GOOD CORRELATION FOR TROPISM PREDICTION.","V3; MARAVIROC; CCR5; CXCR4; SENSITIVITY; SPECIFICITY","VIRUS TYPE-1 TROPISM; V3 LOOP SEQUENCES; CCR5 ANTAGONISTS; EVOLVING EPIDEMIC; PHENOTYPIC ASSAY; CXCR4 TROPISM; TOOLS; ENV; DETERMINANTS; RECOMBINANTS","ENGLISH","ARTICLE","ARTICLE",27,"ABEBE A, 1999, AIDS, V13, P1305, DOI 10.1097/00002030-199907300-00006.;BERGER EA, 1998, NATURE, V391, P240, DOI 10.1038/34571.;BJORNDAL A, 1997, J VIROL, V71, P7478.;BLEUL CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/PNAS.94.5.1925.;BOYD MT, 1993, J VIROL, V67, P3649.;BRAUN P, 2007, EUR J MED RES, V12, P463.;CARRILLO A, 1996, J VIROL, V70, P1301.;CHUECA N, 2009, J MED VIROL, V81, P763, DOI 10.1002/JMV.21425.;CILLIERS T, 2003, J VIROL, V77, P4449, DOI 10.1128/JVI.77.7.4449-4456.2003.;CONNELL BJ, 2008, AIDS, V22, P896, DOI 10.1097/QAD.0B013E3282F57F7A.;CUEVAS MT, 2010, AIDS RES HUM RETROV, V26, P1019, DOI 10.1089/AID.2010.0018.;DELGADO E, 2002, J ACQ IMMUN DEF SYND, V29, P536.;DELGADO E, 2010, 6 IAS C HIV PATH TRE.;DELOBEL P, 2007, J CLIN MICROBIOL, V45, P1572, DOI 10.1128/JCM.02090-06.;DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/SCIENCE.8235655.;DORR P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005.;ESBJORNSSON J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23.;FERNANDEZ-GARCIA A, 2009, AIDS RES HUM RETROV, V25, P93, DOI 10.1089/AID.2008.0174.;FOUCHIER RAM, 1992, J VIROL, V66, P3183.;GARRIDO C, 2008, J CLIN MICROBIOL, V46, P887, DOI 10.1128/JCM.01611-07.;GONZALEZ N, 2010, J ANTIMICROB CHEMOTH, V65, P2493, DOI 10.1093/JAC/DKQ379.;GROENINK M, 1993, SCIENCE, V260, P1513, DOI 10.1126/SCIENCE.8502996.;HOLLINGER FB, 1992, J CLIN MICROBIOL, V30, P1787.;HOLM-HANSEN C, 2000, AIDS RES HUM RETROV, V16, P867.;HUANG W, 2007, J VIROL, V81, P7885, DOI 10.1128/JVI.00218-07.;JENSEN MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003.;KALEEBU P, 2007, JAIDS-J ACQ IMM DEF, V45, P28, DOI 10.1097/QAI.0B013E3180385AA0.;LENGAUER T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/NBT1207-1405.;LOW AJ, 2007, AIDS, V21, P17.;LOW AJ, 2008, AIDS REV, V10, P143.;NEOGI U, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-24.;PEREZ-ALVAREZ L, 2002, AIDS, V16, P669, DOI 10.1097/00002030-200203080-00021.;PEREZ-ALVAREZ L, 2006, J MED VIROL, V78, P1520, DOI 10.1002/JMV.20734.;PILLAI S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658.;POVEDA E, 2010, AIDS REV, V12, P135.;POVEDA E, 2009, J ANTIMICROB CHEMOTH, V63, P1006, DOI 10.1093/JAC/DKP063.;RAGUPATHY VISWANATH, 2009, AIDS RES THER, V6, P27, DOI 10.1186/1742-6405-6-27.;RAYMOND S, 2010, J ACQ IMMUN DEF SYND, V3, P167.;RAYMOND S, 2008, AIDS, V22, P11.;RAYMOND S, 2010, J CLIN VIROL, V47, P126, DOI 10.1016/J.JCV.2009.11.018.;RAYMOND S, 2009, J CLIN MICROBIOL, V47, P2292, DOI 10.1128/JCM.02439-08.;RECORDON-PINSON P, 2010, ANTIMICROB AGENTS CH, V54, P3335, DOI 10.1128/AAC.00148-10.;REEVES D, 2009, J VIRAL ENTRY, V3, P94.;ROSE JD, 2009, CURR OPIN HIV AIDS, V4, P136, DOI 10.1097/COH.0B013E328322F973.;SANCHEZ V, 2011, JAIDS-J ACQ IMM DEF, V56, P51, DOI 10.1097/QAI.0B013E3181FC012B.;SECLEN E, 2010, J ANTIMICROB CHEMOTH, V65, P1486, DOI 10.1093/JAC/DKQ137.;SKRABAL K, 2007, J CLIN MICROBIOL, V45, P279, DOI 10.1128/JCM.01118-06.;TRINH L, 2008, ANTIVIR THER, V13, PA128.;WHITCOMB JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06.","PEREZ-ALVAREZ, L (REPRINT AUTHOR), INST SALUD CARLOS III, CTR NACL MICROBIOL, HIV BIOL \& VARIABIL DEPT, MADRID, SPAIN.;DELGADO, ELENA, FERNANDEZ-GARCIA, AURORA, VEGA, YOLANDA, CUEVAS, TERESA, PINILLA, MILAGROS, GARCIA, VALENTINA, SANCHEZ, MONICA, GONZALEZ, MARIA, MARIA SANCHEZ, ANA, THOMSON, MICHAEL M., PEREZ-ALVAREZ, LUCIA, INST SALUD CARLOS III, CTR NACL MICROBIOL, HIV BIOL \& VARIABIL DEPT, MADRID, SPAIN.","10.1093/JAC/DKR438","GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND",NA,NA,"FIS (FONDO DE INVESTIGACIONES SANITARIAS), MINISTRY OF SCIENCE AND INNOVATION, SPAIN [PI 080496], COMMISSION OF THE EUROPEAN COMMUNITIES, EUROPEAN NETWORK OF EXCELLENCE EURO-PRISE: RATIONAL DESIGN OF HIV VACCINES AND MICROBICIDES [LSHP-CT-2006-037611], CONSELLERIA DE SANIDADE, GOVERNMENT OF GALICIA, SPAIN [MVI 1291/08], CONSELLERIA DE SANIDADE DA XUNTA DE GALICIA, SPAIN, UNIDAD DE COORDINACION DEL PLAN DE PREVENCION Y CONTROL DEL SIDA, OSAKIDETZA-SERVICIO VASCO DE SALUD, SPAIN","THIS STUDY WAS FUNDED THROUGH FIS (FONDO DE INVESTIGACIONES SANITARIAS), MINISTRY OF SCIENCE AND INNOVATION, SPAIN (GRANT PI 080496), COMMISSION OF THE EUROPEAN COMMUNITIES, EUROPEAN NETWORK OF EXCELLENCE EURO-PRISE: RATIONAL DESIGN OF HIV VACCINES AND MICROBICIDES (GRANT LSHP-CT-2006-037611), AND CONSELLERIA DE SANIDADE, GOVERNMENT OF GALICIA, SPAIN (MVI 1291/08)., WE THANK DR JOSE ANTONIO TABOADA, CONSELLERIA DE SANIDADE DA XUNTA DE GALICIA, SPAIN AND DR DANIEL ZULAICA, UNIDAD DE COORDINACION DEL PLAN DE PREVENCION Y CONTROL DEL SIDA, OSAKIDETZA-SERVICIO VASCO DE SALUD, SPAIN, FOR THEIR SUPPORT IN THE DEVELOPMENT OF THE STUDY. WE ALSO THANK THE GENOMIC UNIT AT CNM, INSTITUTO DE SALUD CARLOS III, MAJADAHONDA, MADRID FOR THE EXCELLENT TECHNICAL ASSISTANCE IN SEQUENCING.",NA,"0305-7453","1","25-31","OXFORD UNIV PRESS","67",2012,"ISI000300833700005","49","INFECTIOUS DISEASES, MICROBIOLOGY, PHARMACOLOGY \& PHARMACY","12","INFECTIOUS DISEASES, MICROBIOLOGY, PHARMACOLOGY \& PHARMACY","LPEREZALISCIII.ES",NA,"899RL",NA,"PEREZ-ALVAREZ, L (REPRINT AUTHOR), INST SALUD CARLOS III, CTR NACL MICROBIOL, HIV BIOL \& VARIABIL DEPT, MADRID, SPAIN","ISI","INST SALUD CARLOS III","INST SALUD CARLOS III",NA,"DELGADO E, 2012, J ANTIMICROB CHEMOTHER","DELGADO E, 2012, J ANTIMICROB CHEMOTHER"
"MICHAEL GB, 2012, J ANTIMICROB CHEMOTHER","MICHAEL GB;KADLEC K;SWEENEY MT;BRZUSZKIEWICZ E;LIESEGANG H;DANIEL R;MURRAY RW;WATTS JL;SCHWARZ S","ICEPMU1, AN INTEGRATIVE CONJUGATIVE ELEMENT (ICE) OF PASTEURELLA MULTOCIDA: STRUCTURE AND TRANSFER","JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY","J. ANTIMICROB. CHEMOTHER.","BACKGROUND: INTEGRATIVE AND CONJUGATIVE ELEMENTS (ICES) HAVE NOT BEEN DETECTED IN PASTEURELLA MULTOCIDA. IN THIS STUDY THE MULTIRESISTANCE ICEPMU1 FROM BOVINE P. MULTOCIDA WAS ANALYSED FOR ITS CORE GENES AND ITS ABILITY TO CONJUGATIVELY TRANSFER INTO STRAINS OF THE SAME AND DIFFERENT GENERA. METHODS: ICEPMU1 WAS IDENTIFIED DURING WHOLE GENOME SEQUENCING. CODING SEQUENCES WERE PREDICTED BY BIOINFORMATIC TOOLS AND MANUALLY CURATED USING THE ANNOTATION SOFTWARE ERGO. CONJUGATION INTO P. MULTOCIDA, MANNHEIMIA HAEMOLYTICA AND ESCHERICHIA COLI RECIPIENTS WAS PERFORMED BY MATING ASSAYS. THE PRESENCE OF ICEPMU1 AND ITS CIRCULAR INTERMEDIATE IN THE RECIPIENT STRAINS WAS CONFIRMED BY PCR AND SEQUENCE ANALYSIS. INTEGRATION SITES WERE SEQUENCED. SUSCEPTIBILITY TESTING OF THE ICEPMU1-CARRYING RECIPIENTS WAS CONDUCTED BY BROTH MICRODILUTION. RESULTS: THE 82214 BP ICEPMU1 HARBOURS 88 GENES. THE CORE GENES OF ICEPMU1, WHICH ARE INVOLVED IN EXCISION/ INTEGRATION AND CONJUGATIVE TRANSFER, RESEMBLE THOSE FOUND IN A 66641 BP ICE FROM HISTOPHILUS SOMNI. ICEPMU1 INTEGRATES INTO A TRNA(LEU) AND IS FLANKED BY 13 BP DIRECT REPEATS. IT IS ABLE TO CONJUGATIVELY TRANSFER TO P. MULTOCIDA, M. HAEMOLYTICA AND E. COLI, WHERE IT ALSO USES A TRNA(LEU) FOR INTEGRATION AND PRODUCES CLOSELY RELATED 13 BP DIRECT REPEATS. PCR ASSAYS AND SUSCEPTIBILITY TESTING CONFIRMED THE PRESENCE AND THE FUNCTIONAL ACTIVITY OF THE ICEPMU1-ASSOCIATED RESISTANCE GENES IN THE RECIPIENT STRAINS. CONCLUSIONS: THE OBSERVATION THAT THE MULTIRESISTANCE ICEPMU1 IS PRESENT IN A BOVINE P. MULTOCIDA AND CAN EASILY SPREAD ACROSS STRAIN AND GENUS BOUNDARIES UNDERLINES THE RISK OF A RAPID DISSEMINATION OF MULTIPLE RESISTANCE GENES, WHICH WILL DISTINCTLY DECREASE THE THERAPEUTIC OPTIONS.","HORIZONTAL GENE TRANSFER; BOVINE RESPIRATORY DISEASE; INSERTION SITE; INTEGRASES; RECOMBINASES","BOVINE RESPIRATORY-DISEASE; SUBSP ENTERICA SEROVAR; BORDETELLA-BRONCHISEPTICA; MANNHEIMIA-HAEMOLYTICA; RESISTANCE; IDENTIFICATION; FAMILY; GENOME; SITE; CHLORAMPHENICOL","ENGLISH","ARTICLE","ARTICLE",41,"ABBOTT JAMES C., 2007, V395, P57.;BIRBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513.;BISHOP AL, 2005, J BACTERIOL, V187, P2469, DOI 10.1128/JB.187.7.2469-2482.2005.;BURRUS V, 2002, PLASMID, V48, P77, DOI 10.1016/S0147-619X(02)00102-6.;BURRUS V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/J.1365-2958.2002.03191.X.;CARVER T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/BIOINFORMATICS/BTN578.;CLINICAL AND LABORATORY STANDARDS INSTITUTE, 2008, M31A3 CLSI.;DABO S. M., 2007, ANIMAL HEALTH RESEARCH REVIEWS, V8, P129, DOI 10.1017/S1466252307001399.;ESPOSITO D, 1997, NUCLEIC ACIDS RES, V25, P3605, DOI 10.1093/NAR/25.18.3605.;FLANNERY EL, 2011, J BACTERIOL, V193, P4104, DOI 10.1128/JB.05119-11.;FRECH G, 2003, J ANTIMICROB CHEMOTH, V51, P180, DOI 10.1093/JAC/DKG058.;GIOIA J, 2006, J BACTERIOL, V188, P7257, DOI 10.1128/JB.00675-06.;HAFT DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/JOURNAL.PCBI.0010060.;HAUSER MA, 1992, J BIOL CHEM, V267, P6859.;JUHAS M, 2007, GENOME BIOL, V8, PR2371.;KADLEC K, 2007, J ANTIMICROB CHEMOTH, V59, P191, DOI 10.1093/JAC/DKL498.;KADLEC K, 2007, J ANTIMICROB CHEMOTH, V59, P396, DOI 10.1093/JAC/DKL515.;KADLEC K, 2011, ANTIMICROB AGENTS CH, V55, P2475, DOI 10.1128/AAC.00092-11.;KADO CI, 1981, J BACTERIOL, V145, P1365.;KEHRENBERG C, 2001, FEMS MICROBIOL LETT, V205, P283, DOI 10.1016/S0378-1097(01)00481-5.;KEHRENBERG C, 2001, J ANTIMICROB CHEMOTH, V48, P631, DOI 10.1093/JAC/48.5.631.;KEHRENBERG C, 2006, J ANTIMICROB CHEMOTH, V58, P13, DOI 10.1093/JAC/DKL174.;LIANG XY, 2001, J BACTERIOL, V183, P843, DOI 10.1128/JB.183.3.843-853.2001.;MAVRODI DV, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-8.;MAY BJ, 2001, P NATL ACAD SCI USA, V98, P3460, DOI 10.1073/PNAS.051634598.;MICHAEL GB, 2012, J ANTIMICROB CHEMOTH, V67, P84, DOI 10.1093/JAC/DKR406.;MOHD-ZAIN Z, 2004, J BACTERIOL, V186, P8114, DOI 10.1128/JB.186.23.8114-8122.2004.;NUESCHINDERBINEN MT, 1997, ANTIMICROB AGENTS CH, V41, P943.;NUNES-DUBY SE, 1998, NUCLEIC ACIDS RES, V26, P391, DOI 10.1093/NAR/26.2.391.;POURCEL C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/MIC.0.27437-0.;ROCHE D, 2010, J BACTERIOL, V192, P5026, DOI 10.1128/JB.00609-10.;SCHWARZ S, 1994, ZBL BAKT-INT J MED M, V281, P442.;SCHWARZ S., 2008, PASTEURELLACEAE BIOL, P199.;SETH-SMITH H, 2009, NAT REV MICROBIOL, V7, P328, DOI 10.1038/NRMICRO2137.;TOWNSEND KM, 1998, J CLIN MICROBIOL, V36, P1096.;TOWNSEND KM, 2001, J CLIN MICROBIOL, V39, P924, DOI 10.1128/JCM.39.3.924-929.2001.;WATTS JL, 2010, VET CLIN N AM-FOOD A, V26, P79, DOI 10.1016/J.CVFA.2009.10.009.;WOLLHERR A, 2010, THESIS G AUGUST U GO.;ZHAO SH, 2002, J BACTERIOL, V184, P859, DOI 10.1128/JB.184.3.859-860.2002.","SCHWARZ, S (REPRINT AUTHOR), FLI, INST FARM ANIM GENET, NEUSTADT, GERMANY.;MICHAEL, GEOVANA BRENNER, KADLEC, KRISTINA, SCHWARZ, STEFAN, FLI, INST FARM ANIM GENET, NEUSTADT, GERMANY.;MICHAEL, GEOVANA BRENNER, BRZUSZKIEWICZ, ELZBIETA, LIESEGANG, HEIKO, DANIEL, ROLF, UNIV GOTTINGEN, INST MICROBIOL \& GENET, GOTTINGEN GENOM LAB, GOTTINGEN, GERMANY.;SWEENEY, MICHAEL T., MURRAY, ROBERT W., WATTS, JEFFREY L., PFIZER ANIM HLTH, KALAMAZOO, MI USA.","10.1093/JAC/DKR411","GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND",NA,NA,"GERMAN RESEARCH FOUNDATION (DFG) [SCHW382/10-1], GESELLSCHAFT DER FREUNDE DER TIERARZLICHEN HOCHSCHULE HANNOVER E.V.","THIS STUDY WAS FINANCIALLY SUPPORTED BY GRANT SCHW382/10-1 FROM THE GERMAN RESEARCH FOUNDATION (DFG). G. B. M. RECEIVED A SCHOLARSHIP FROM THE GESELLSCHAFT DER FREUNDE DER TIERARZLICHEN HOCHSCHULE HANNOVER E.V.",NA,"0305-7453","1","91-100","OXFORD UNIV PRESS","67",2012,"ISI000300833700014","39","INFECTIOUS DISEASES, MICROBIOLOGY, PHARMACOLOGY \& PHARMACY","9","INFECTIOUS DISEASES, MICROBIOLOGY, PHARMACOLOGY \& PHARMACY","STEFAN.SCHWARZFLI.BUND.DE",NA,"899RL",NA,"SCHWARZ, S (REPRINT AUTHOR), FLI, INST FARM ANIM GENET, NEUSTADT, GERMANY","ISI","SCHWARZ;UNIV GOTTINGEN","SCHWARZ",NA,"MICHAEL GB, 2012, J ANTIMICROB CHEMOTHER","MICHAEL GB, 2012, J ANTIMICROB CHEMOTHER"
"LOGAN AC, 2011, PROC NATL ACAD SCI U S A","LOGAN AC;GAO H;WANG C;SAHAF B;JONES CD;MARSHALL EL;BUNO I;ARMSTRONG R;FIRE AZ;WEINBERG KI;MINDRINOS M;ZEHNDER JL;BOYD SD;XIAO W;DAVIS RW;MIKLOS DB","HIGH-THROUGHPUT VDJ SEQUENCING FOR QUANTIFICATION OF MINIMAL RESIDUAL DISEASE IN CHRONIC LYMPHOCYTIC LEUKEMIA AND IMMUNE RECONSTITUTION ASSESSMENT","PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA","PROC. NATL. ACAD. SCI. U. S. A.","THE PRIMARY CAUSE OF POOR OUTCOME FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IS DISEASE RECURRENCE. DETECTION OF INCREASING MINIMAL RESIDUAL DISEASE (MRD) FOLLOWING HCT MAY PERMIT EARLY INTERVENTION TO PREVENT CLINICAL RELAPSE, HOWEVER, MRD QUANTIFICATION REMAINS AN UNCOMMON DIAGNOSTIC TEST BECAUSE OF LOGISTICAL AND FINANCIAL BARRIERS TO WIDESPREAD USE. HERE WE DESCRIBE A METHOD FOR QUANTIFYING CLL MRD USING WIDELY AVAILABLE CONSENSUS PRIMERS FOR AMPLIFICATION OF ALL IG HEAVY CHAIN (IGH) GENES IN A MIXTURE OF PERIPHERAL BLOOD MONONUCLEAR CELLS, FOLLOWED BY HIGH-THROUGHPUT SEQUENCING (HTS) FOR DISEASE-SPECIFIC IGH SEQUENCE QUANTIFICATION. TO ACHIEVE ACCURATE MRD QUANTIFICATION, WE DEVELOPED A SYSTEMATIC BIOINFORMATIC METHODOLOGY TO AGGREGATE CANCER CLONE SEQUENCE VARIANTS ARISING FROM SYSTEMATIC AND RANDOM ARTIFACTS OCCURRING DURING IGH-HTS. WE THEN COMPARED THE SENSITIVITY OF IGH-HTS, FLOW CYTOMETRY, AND ALLELE-SPECIFIC OLIGONUCLEOTIDE PCR FOR MRD QUANTIFICATION IN 28 SAMPLES COLLECTED FROM 6 CLL PATIENTS FOLLOWING ALLOGENEIC HCT. USING AMPLIMER LIBRARIES GENERATED WITH CONSENSUS PRIMERS FROM PATIENT BLOOD SAMPLES, WE DEMONSTRATE THE SENSITIVITY OF IGH-HTS WITH 454 PYROSEQUENCING TO BE 10(-5), WITH A HIGH CORRELATION BETWEEN QUANTIFICATION BY ALLELE-SPECIFIC OLIGONUCLEOTIDE PCR AND IGH-HTS (R = 0.85). FROM THE SAME DATASET USED TO QUANTIFY MRD, IGH-HTS ALSO ALLOWED US TO PROFILE IGH REPERTOIRE RECONSTITUTION AFTER HCT-INFORMATION NOT PROVIDED BY THE OTHER MRD METHODS. IGH-HTS USING CONSENSUS PRIMERS WILL BROADEN THE AVAILABILITY OF MRD QUANTIFICATION IN CLL AND OTHER B CELL MALIGNANCIES, AND THIS APPROACH HAS POTENTIAL FOR QUANTITATIVE EVALUATION OF IMMUNE DIVERSIFICATION FOLLOWING TRANSPLANT AND NONTRANSPLANT THERAPIES.","NEXT-GENERATION SEQUENCING; CONSENSUS-PRIMED POLYMERASE CHAIN REACTION; IMMUNE RECONSTITUTION","STEM-CELL TRANSPLANTATION; POLYMERASE-CHAIN-REACTION; VERSUS-HOST-DISEASE; ALLOGENEIC TRANSPLANTATION; FLOW-CYTOMETRY; RQ-PCR; CLL; IMMUNOGLOBULIN; ERADICATION; RITUXIMAB","ENGLISH","ARTICLE","ARTICLE",90,"ARAI S, 2008, BLOOD, V112, P466.;BOTTCHER S, 2009, LEUKEMIA, V23, P2007, DOI 10.1038/LEU.2009.140.;BOTTCHER S, 2011, BLOOD REV, V25, P91, DOI 10.1016/J.BLRE.2011.01.001.;BOTTCHER S, 2004, LEUKEMIA, V18, P1637, DOI 10.1038/SJ.LEU.2403478.;BOYD SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/SCITRANSLMED.3000540.;BRISCO MJ, 1990, BRIT J HAEMATOL, V75, P163, DOI 10.1111/J.1365-2141.1990.TB02643.X.;CAMPBELL PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/PNAS.0801523105.;DREGER P, 2005, LEUKEMIA, V19, P1135, DOI 10.1038/SJ.LEU.2403800.;ESTEVE J, 2001, LEUKEMIA, V15, P445, DOI 10.1038/SJ.LEU.2402036.;FARINA L, 2009, HAEMATOL-HEMATOL J, V94, P654, DOI 10.3324/HAEMATOL.2008.000273.;GIUDICELLI W, 2005, NUCLEIC ACIDS RES, V33, PD256, DOI 10.1093/NAR/GKI010.;GRIBBEN JG, 2010, BLOOD, V115, P187, DOI 10.1182/BLOOD-2009-08-207126.;HALLEK M, 2008, BLOOD, V111, P5446, DOI 10.1182/BLOOD-2007-06-093906.;HALLEK MICHAEL, 2009, HEMATOLOGY AM SOC HEMATOL EDUC PROGRAM, P440, DOI 10.1182/ASHEDUCATION-2009.1.440.;ITALA M, 2008, EUR J HAEMATOL, V81, P100, DOI 10.1111/J.1600-0609.2008.01082.X.;KHOURI IF, 2004, EXP HEMATOL, V32, P28, DOI 10.1016/J.EXPHEM.2003.09.021.;KOHRT HE, 2009, BLOOD, V114, P1099, DOI 10.1182/BLOOD-2009-03-211441.;LADETTO M, 2000, BIOL BLOOD MARROW TR, V6, P241, DOI 10.1016/S1083-8791(00)70006-1.;LOWSKY R, 2005, NEW ENGL J MED, V353, P1321, DOI 10.1056/NEJMOA050642.;MAGNAC C, 1999, HEMATOL CELL THER, V41, P13, DOI 10.1007/S00282-999-0013-Y.;MARGULIES M, 2005, NATURE, V437, P376, DOI 10.1038/NATURE03959.;MORENO C, 2010, BEST PRACT RES CL HA, V23, P97, DOI 10.1016/J.BEHA.2010.01.005.;MORETON P, 2005, J CLIN ONCOL, V23, P2971, DOI 10.1200/JCO.2005.04.021.;NABHAN C, 2007, BRIT J HAEMATOL, V136, P379, DOI 10.1111/J.1365-2141.2006.06428.X.;NATIONAL CANCER INSTITUTE, 2011, SEER CANC STAT REV.;NGUYEN PHUONG, 2011, BMC GENOMICS, V12, P106, DOI 10.1186/1471-2164-12-106.;POLLARD P, 1993, BRIT J HAEMATOL, V84, P169, DOI 10.1111/J.1365-2141.1993.TB03043.X.;PROVAN D, 1996, BLOOD, V88, P2228.;RAWSTRON AC, 2006, LEUKEMIA, V20, P2102, DOI 10.1038/SJ.LEU.2404416.;RITGEN M, 2008, LEUKEMIA, V22, P1377, DOI 10.1038/LEU.2008.96.;RITGEN M, 2004, BLOOD, V104, P2600, DOI 10.1182/BLOOD-2003-12-4321.;SARANTOPOULOS S, 2011, BLOOD, V117, P2275, DOI 10.1182/BLOOD-2010-10-307819.;SIOUTOS N, 1995, DIAGN MOL PATHOL, V4, P8, DOI 10.1097/00019606-199503000-00004.;SORROR ML, 2005, J CLIN ONCOL, V23, P3819, DOI 10.1200/JCO.2005.04.569.;VAN DONGEN JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/SJ.LEU.2403202.;VARGHESE AM, 2010, CURR HEMATOL MALIG R, V5, P35, DOI 10.1007/S11899-009-0041-2.;WANG CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/GR.6468307.","DAVIS, RW (REPRINT AUTHOR), STANFORD GENOME TECHNOL CTR, STANFORD, CA 94304 USA.;GAO, HONG, WANG, CHUNLIN, MINDRINOS, MICHAEL, XIAO, WENZHONG, DAVIS, RONALD W., STANFORD GENOME TECHNOL CTR, STANFORD, CA 94304 USA.;LOGAN, AARON C., SAHAF, BITA, MIKLOS, DAVID B., STANFORD UNIV, DIV BLOOD \& MARROW TRANSPLANTAT, SCH MED, STANFORD, CA 94305 USA.;ZEHNDER, JAMES L., STANFORD UNIV, DEPT MED, DIV HEMATOL, SCH MED, STANFORD, CA 94305 USA.;JONES, CAROL D., MARSHALL, ELEANOR L., FIRE, ANDREW Z., BOYD, SCOTT D., STANFORD UNIV, DEPT PATHOL, SCH MED, STANFORD, CA 94305 USA.;STANFORD UNIV, DEPT PEDIAT, DIV PEDIAT STEM CELL TRANSPLANTAT, SCH MED, STANFORD, CA 94305 USA.;BUNO, ISMAEL, HOSP GEN UNIV GREGORIO MARANON, DEPT HEMATOL, MADRID 28007, SPAIN.;XIAO, WENZHONG, HARVARD UNIV, SCH MED, MASSACHUSETTS GEN HOSP, BOSTON, MA 02114 USA.;ARMSTRONG, RANDALL, STANFORD HOSP \& CLIN, STANFORD CELLULAR THERAPEUT \& TRANSPLANTAT LAB, STANFORD, CA 94305 USA.","10.1073/PNAS.1118357109","2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA",NA,NA,"LEUKEMIA AND LYMPHOMA TRANSLATIONAL RESEARCH AWARD [R618-09], NATIONAL CANCER INSTITUTE [P01 CA049605], STANFORD UNIVERSITY CANCER INSTITUTE, STANFORD GENOME TECHNOLOGY CENTER NATIONAL INSTITUTES OF HEALTH [P01 HG000205], INSTITUTO DE SALUD CARLOS III BOLSAS DE AMPLIACION DE ESTUDIOS (MINISTERIO DE CIENCIA E INNOVACION, SPAIN), AMERICAN SOCIETY OF HEMATOLOGY RESEARCH","WE THANK THE PATIENTS WHO PARTICIPATED IN THIS STUDY AND THE BONE MARROW TRANSPLANT NURSES, PATIENT COORDINATORS, AND STAFF AT STANFORD UNIVERSITY MEDICAL CENTER WHO MADE THIS WORK POSSIBLE. THIS WORK WAS SUPPORTED BY LEUKEMIA AND LYMPHOMA TRANSLATIONAL RESEARCH AWARD R618-09, NATIONAL CANCER INSTITUTE GRANT P01 CA049605, AND THE STANFORD UNIVERSITY CANCER INSTITUTE. H. G. WAS SUPPORTED BY STANFORD GENOME TECHNOLOGY CENTER NATIONAL INSTITUTES OF HEALTH GRANT P01 HG000205. I. B. WAS SUPPORTED BY AN INSTITUTO DE SALUD CARLOS III BOLSAS DE AMPLIACION DE ESTUDIOS GRANT (MINISTERIO DE CIENCIA E INNOVACION, SPAIN). A. C. L. IS AN AMERICAN SOCIETY OF HEMATOLOGY RESEARCH TRAINING AWARD FELLOW.",NA,"0027-8424","52","21194-21199","NATL ACAD SCIENCES","108",2011,"ISI000298479900065","37","SCIENCE \& TECHNOLOGY - OTHER TOPICS","16","MULTIDISCIPLINARY SCIENCES","DBOWESTANFORD.EDU DMIKLOSSTANFORD.EDU",NA,"867UI",NA,"DAVIS, RW (REPRINT AUTHOR), STANFORD GENOME TECHNOL CTR, STANFORD, CA 94304 USA","ISI","STANFORD GENOME TECHNOL CTR;STANFORD UNIV;STANFORD UNIV;STANFORD UNIV;STANFORD UNIV;HOSP GEN UNIV GREGORIO MARANON;HARVARD UNIV;STANFORD HOSP AND CLIN","STANFORD GENOME TECHNOL CTR",NA,"LOGAN AC, 2011, PROC NATL ACAD SCI U S A","LOGAN AC, 2011, PROC NATL ACAD SCI U S A"
"LEE JH, 2011, CIRC RES","LEE JH;GAO C;PENG G;GREER C;REN S;WANG Y;XIAO X","ANALYSIS OF TRANSCRIPTOME COMPLEXITY THROUGH RNA SEQUENCING IN NORMAL AND FAILING MURINE HEARTS","CIRCULATION RESEARCH","CIRC.RES.","RATIONALE: ACCURATE AND COMPREHENSIVE DE NOVO TRANSCRIPTOME PROFILING IN HEART IS A CENTRAL ISSUE TO BETTER UNDERSTAND CARDIAC PHYSIOLOGY AND DISEASES. ALTHOUGH SIGNIFICANT PROGRESS HAS BEEN MADE IN GENOME-WIDE PROFILING FOR QUANTITATIVE CHANGES IN CARDIAC GENE EXPRESSION, CURRENT KNOWLEDGE OFFERS LIMITED INSIGHTS TO THE TOTAL COMPLEXITY IN CARDIAC TRANSCRIPTOME AT INDIVIDUAL EXON LEVEL. OBJECTIVE: TO DEVELOP MORE ROBUST BIOINFORMATIC APPROACHES TO ANALYZE HIGH-THROUGHPUT RNA SEQUENCING (RNA-SEQ) DATA, WITH THE FOCUS ON THE INVESTIGATION OF TRANSCRIPTOME COMPLEXITY AT INDIVIDUAL EXON AND TRANSCRIPT LEVELS. METHODS AND RESULTS: IN ADDITION TO OVERALL GENE EXPRESSION ANALYSIS, THE METHODS DEVELOPED IN THIS STUDY WERE USED TO ANALYZE RNA-SEQ DATA WITH RESPECT TO INDIVIDUAL TRANSCRIPT ISOFORMS, NOVEL SPLICED EXONS, NOVEL ALTERNATIVE TERMINAL EXONS, NOVEL TRANSCRIPT CLUSTERS (IE, NOVEL GENES), AND LONG NONCODING RNA GENES. WE APPLIED THESE APPROACHES TO RNA-SEQ DATA OBTAINED FROM MOUSE HEARTS AFTER PRESSURE-OVERLOAD INDUCED BY TRANSAORTIC CONSTRICTION. BASED ON EXPERIMENTAL VALIDATIONS, ANALYSES OF THE FEATURES OF THE IDENTIFIED EXONS/TRANSCRIPTS, AND EXPRESSION ANALYSES INCLUDING PREVIOUSLY PUBLISHED RNA-SEQ DATA, WE DEMONSTRATE THAT THE METHODS ARE HIGHLY EFFECTIVE IN DETECTING AND QUANTIFYING INDIVIDUAL EXONS AND TRANSCRIPTS. NOVEL INSIGHTS INFERRED FROM THE EXAMINED ASPECTS OF THE CARDIAC TRANSCRIPTOME OPEN WAYS TO FURTHER EXPERIMENTAL INVESTIGATIONS. CONCLUSIONS: OUR WORK PROVIDED A COMPREHENSIVE SET OF METHODS TO ANALYZE MOUSE CARDIAC TRANSCRIPTOME COMPLEXITY AT INDIVIDUAL EXON AND TRANSCRIPT LEVELS. APPLICATIONS OF THE METHODS MAY INFER IMPORTANT NEW INSIGHTS TO GENE REGULATION IN NORMAL AND DISEASE HEARTS IN TERMS OF EXON UTILIZATION AND POTENTIAL INVOLVEMENT OF NOVEL COMPONENTS OF CARDIAC TRANSCRIPTOME. (CIRC RES. 2011,109:1332-1341.)","RNA-SEQ; TRANSCRIPTOME PROFILING; HYPERTROPHY; HEART FAILURE","SEQ; QUANTIFICATION; EXPRESSION; ALIGNMENT; REVEALS; NETWORK; TOOL","ENGLISH","ARTICLE","ARTICLE",99,"GABORY A, 2010, BIOESSAYS, V32, P473, DOI 10.1002/BIES.200900170.;GARBER M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/NMETH.1613].;GREGG C, 2010, SCIENCE, V329, P643, DOI 10.1126/SCIENCE.1190830.;GUTTMAN M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/NBT.1633.;HANSEN KD, 2010, BMC BIOINFORMATICS, V11, P94.;HILL JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMRA072139.;KENT WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/GR.229202, 10.1101/GR.229202. ARTICLE PUBLISHED ONLINE BEFORE MARCH 2002].;KONG L, 2007, NUCLEIC ACIDS RES, V35, PW345, DOI 10.1093/NAR/GKM391.;LANGFELDER P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559.;LANGMEAD B, 2009, GENOME BIOL, V10, DOI 10.1186/GB-2009-10-3-R25.;MARIONI JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/GR.079558.108.;MATKOVICH SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513.;MORTAZAVI A, 2008, NAT METHODS, V5, P621, DOI 10.1038/NMETH.1226.;OLSON EN, 2006, NOVART FDN SYMP, V274, P272.;OLSON EN, 2006, NOVART FDN SYMP, V274, P13.;OLSON EN, 2006, NOVART FDN SYMP, V274, P152.;OLSON ERIC N, 2006, NOVARTIS FOUND SYMP, V274, P3.;OLSON EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/SCIENCE.1132292.;PONJAVIC J, 2009, PLOS GENET, V5, DOI 10.1371/JOURNAL.PGEN.1000617.;STUART JM, 2003, SCIENCE, V302, P249, DOI 10.1126/SCIENCE.1087447.;TRAPNELL C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/NBT.1621.;WANG Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/NRG2484.;WILUSZ JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/GAD.1800909.;XIANG SY, 2011, J CLIN INVEST, V121, P3269, DOI 10.1172/JCI44371.;ZHANG Y, 2011, CIRC-HEART FAIL, V4, P659, DOI 10.1161/CIRCHEARTFAILURE.111.962563.;ZHANG Y, 2011, J BIOL CHEM, V286, P26943, DOI 10.1074/JBC.M111.234757.","XIAO, XS (REPRINT AUTHOR), UNIV CALIF LOS ANGELES, DAVID GEFFEN SCH MED, INST MOL BIOL, 611 CHARLES E YOUNG DR,BOYER HALL,ROOM 660, LOS ANGELES, CA 90095 USA.;GAO, CHEN, WANG, YIBIN, XIAO, XINSHU, UNIV CALIF LOS ANGELES, DAVID GEFFEN SCH MED, INST MOL BIOL, LOS ANGELES, CA 90095 USA.;LEE, JAE-HYUNG, GAO, CHEN, GREER, CHRISTOPHER, XIAO, XINSHU, UNIV CALIF LOS ANGELES, DAVID GEFFEN SCH MED, DEPT INTEGRAT BIOL \& PHYSIOL, LOS ANGELES, CA 90095 USA.;REN, SHUXUN, WANG, YIBIN, UNIV CALIF LOS ANGELES, DAVID GEFFEN SCH MED, DEPT ANESTHESIOL, LOS ANGELES, CA 90095 USA.;REN, SHUXUN, WANG, YIBIN, UNIV CALIF LOS ANGELES, DAVID GEFFEN SCH MED, DEPT PHYSIOL, LOS ANGELES, CA 90095 USA.;REN, SHUXUN, WANG, YIBIN, UNIV CALIF LOS ANGELES, DAVID GEFFEN SCH MED, DEPT MED, LOS ANGELES, CA 90095 USA.;GAO, CHEN, REN, SHUXUN, WANG, YIBIN, UNIV CALIF LOS ANGELES, DAVID GEFFEN SCH MED, CARDIOVASC RES LABS, LOS ANGELES, CA 90095 USA.","10.1161/CIRCRESAHA.111.249433","TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",NA,NA,"NIH [R21DA027039, HL088640, HL070079, HL103205, HL098954], ALFRED P. SLOAN FOUNDATION, MARCH OF DIMES FOUNDATION [5-FY10-486], AMERICAN HEART ASSOCIATION","THIS WORK WAS SUPPORTED IN PART BY NIH GRANT R21DA027039, AN ALFRED P. SLOAN FOUNDATION RESEARCH FELLOWSHIP, AND RESEARCH GRANT NO. 5-FY10-486 FROM THE MARCH OF DIMES FOUNDATION TO X.X., AN AMERICAN HEART ASSOCIATION POSTDOCTORAL FELLOWSHIP TO J.H.L., AND NIH GRANTS HL088640, HL070079. HL103205, AND HL098954 TO Y.W.",NA,"0009-7330","12","1332-1341","LIPPINCOTT WILLIAMS \& WILKINS","109",2011,"ISI000298167400030","26","CARDIOVASCULAR SYSTEM \& CARDIOLOGY, HEMATOLOGY","17","CARDIAC \& CARDIOVASCULAR SYSTEMS, HEMATOLOGY, PERIPHERAL VASCULAR DISEASE","GXXIAOUCLA.EDU",NA,"863MD",NA,"XIAO, XS (REPRINT AUTHOR), UNIV CALIF LOS ANGELES, DAVID GEFFEN SCH MED, INST MOL BIOL, 611 CHARLES E YOUNG DR,BOYER HALL,ROOM 660, LOS ANGELES, CA 90095 USA","ISI","UNIV CALIF LOS ANGELES;UNIV CALIF LOS ANGELES;UNIV CALIF LOS ANGELES;UNIV CALIF LOS ANGELES;UNIV CALIF LOS ANGELES;UNIV CALIF LOS ANGELES","UNIV CALIF LOS ANGELES",NA,"LEE JH, 2011, CIRC RES","LEE JH, 2011, CIRC RES"
"JANG BG, 2011, CANCER RES TREAT","JANG BG;JUNG EJ;KIM WH","EXPRESSION OF BAMHI-A RIGHTWARD TRANSCRIPTS IN EPSTEIN-BARR VIRUS-ASSOCIATED GASTRIC CANCERS","CANCER RESEARCH AND TREATMENT","CANCER RES. TREAT.","PURPOSE ABOUT 10\% OF ALL GASTRIC CANCERS (GCS) ARE EPSTEIN-BARR VIRUS (EBV)-ASSOCIATED. HOWEVER, THE ONCOGENE OF EBV IN GASTRIC CARCINOGENESIS HAS NOT YET BEEN ESTABLISHED. IN THE PRESENT STUDY, WE INVESTIGATED THE VIRUS-DERIVED TRANSCRIPTS IN THE EBV-INFECTED GC CELL LINE TO EXPLORE THE VIRAL ONCOGENE OF EBV-POSITIVE GCS. MATERIALS AND METHODS WE USED THE SNU719 CELL LINE, A NATURALLY DERIVED EBV-INFECTED GC CELL LINE. THE INDIVIDUAL EXPRESSED SEQUENCE TAGS FROM THE CDNA LIBRARIES OF SNU719 WERE SEARCHED AGAINST THE MRNA SUBSET EXTRACTED FROM THE GENBANK DATA BASE. SEQUENCE REACTION WAS CARRIED OUT FOR THE EBV-ASSOCIATED CLONES. REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION WAS PERFORMED AFTER CELLS WERE PARTITIONED INTO NUCLEAR AND CYTOPLASMIC FRACTIONS. RESULTS USING BIOINFORMATIC TOOLS, WE SELECTED 13 EBV-ASSOCIATED CLONES FROM CDNA LIBRARIES OF SNU719. BY SEQUENCING ANALYSIS, WE REVEALED THAT THEY WERE ALL ASSOCIATED WITH RPMS1, ONE OF THE BAMHI-A RIGHTWARD TRANSCRIPTS (BART) OF EBV. SOME BART CDNAS SUCH AS RPMS1 AND A73 ARE KNOWN TO BE TRANSLATED INTO PROTEIN IN VITRO, AND HAVE BEEN SHOWN TO HAVE SOME BIOCHEMICAL FUNCTIONS RELEVANT TO TUMORIGENESIS. BUT, PRESENTLY, THE BART TRANSCRIPTS WERE EXPRESSED ONLY IN THE NUCLEUS AND NOT IN THE CYTOPLASM, ARGUING AGAINST THEIR ROLE AS MESSENGER RNAS. SOME OTHER BART TRANSCRIPTS EXPRESSED IN GCS (BARF0, CST, VIL, BARF1, BLLF1, AND BCLF1) WERE ALSO EXTENSIVELY DETECTED IN THE NUCLEUS. CONCLUSION BART TRANSCRIPTS ARE THE PREDOMINANT VIRAL TRANSCRIPTS EXPRESSED IN EBV-ASSOCIATED GCS, AND THEY ARE LOCATED ONLY IN THE NUCLEUS. THEREFORE, IT SEEMS LESS LIKELY THAT BART TRANSCRIPTS PRODUCE FUNCTIONAL PROTEINS TO PLAY A ROLE IN CARCINOGENESIS OF EBV-ASSOCIATED GCS.","STOMACH NEOPLASMS; EPSTEIN-BARR VIRUS; ONCOGENES; RPMS PROTEIN","GENE-EXPRESSION; ENCODED MICRORNAS; CELL-LINES; EBV; CARCINOMA; LATENCY; TUMOR","ENGLISH","ARTICLE","ARTICLE",6,"AL-MOZAINI M, 2009, J GEN VIROL, V90, P307, DOI 10.1099/VIR.0.006551-0.;BARTH S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/NAR/GKM1080.;CHOY EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/JEM.20072581.;EDWARDS RH, 2008, J VIROL, V82, P9094, DOI 10.1128/JVI.00785-08.;HITT MM, 1989, EMBO J, V8, P2639, DOI 10.1002/J.1460-2075.1989.TB08404.X.;JUNG EJ, 2007, ANTI-CANCER DRUG, V18, P79.;KIM DN, 2007, J VIROL, V81, P1033, DOI 10.1128/JVI.02271-06.;KIM DN, 2011, EXP MOL MED, V43, P401, DOI 10.3858/EMM.2011.43.7.044.;LEE JE, 2011, CELL PROLIFERAT, V44, P59, DOI 10.1111/J.1365-2184.2010.00717.X.;LI A, 2005, CELL CYCLE, V4, P304.;LO AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/PNAS.0702896104.;OH ST, 2004, VIROLOGY, V320, P330, DOI 10.1016/J.VIROL.2003.12.005.;PFEFFER S, 2004, SCIENCE, V304, P734, DOI 10.1126/SCIENCE.1096781.;SMITH PR, 2000, J VIROL, V74, P3082, DOI 10.1128/JVI.74.7.3082-3092.2000.;SONG LI-BING, 2004, AI ZHENG, V23, P1361.;SUGIURA M, 1996, BRIT J CANCER, V74, P625, DOI 10.1038/BJC.1996.412.;TAKADA K, 2000, J CLIN PATHOL-MOL PA, V53, P255.;TAKANO Y, 1999, VIRCHOWS ARCH, V434, P17, DOI 10.1007/S004280050299.;THOMPSON MP, 2004, CLIN CANCER RES, V10, P803, DOI 10.1158/1078-0432.CCR-0670-3.;WIECH T, 2008, VIRCHOWS ARCH, V452, P621, DOI 10.1007/S00428-008-0594-9.;ZHANG JX, 2001, J VIROL, V75, P2946, DOI 10.1128/JVI.75.6.2946-2956.2001.;ZUR HAUSEN A, 2000, CANCER RES, V60, P2745.","KIM, WH (REPRINT AUTHOR), SEOUL NATL UNIV, DEPT PATHOL, COLL MED, SEOUL 110799, SOUTH KOREA.;JANG, BO-GUN, KIM, WOO HO, SEOUL NATL UNIV, DEPT PATHOL, COLL MED, SEOUL 110799, SOUTH KOREA.;JUNG, EUN JI, KIM, WOO HO, SEOUL NATL UNIV, CANC RES INST, COLL MED, SEOUL 110799, SOUTH KOREA.","10.4143/CRT.2011.43.4.250","RM 1824, GWANGHWAMUN OFFICIA, 92 SAEMUNAN-RO, JONGNO-GU, SEOUL, 110-999, SOUTH KOREA",NA,NA,"NATIONAL R\&D PROGRAM FOR CANCER CONTROL, MINISTRY OF HEALTH AND WELFARE, REPUBLIC OF KOREA [101146]","THIS STUDY WAS SUPPORTED BY A GRANT FROM THE NATIONAL R\&D PROGRAM FOR CANCER CONTROL, MINISTRY OF HEALTH AND WELFARE, REPUBLIC OF KOREA (101146).",NA,"1598-2998","4","250-254","KOREAN CANCER ASSOCIATION","43",2011,"ISI000309998200008","22","ONCOLOGY","3","ONCOLOGY","WOOHOKIMSNU.AC.KR",NA,"022XT",NA,"KIM, WH (REPRINT AUTHOR), SEOUL NATL UNIV, DEPT PATHOL, COLL MED, SEOUL 110799, SOUTH KOREA","ISI","SEOUL NATL UNIV;SEOUL NATL UNIV","SEOUL NATL UNIV",NA,"JANG BG, 2011, CANCER RES TREAT","JANG BG, 2011, CANCER RES TREAT"
"SABATH N, 2011, J MOL EVOL","SABATH N;MORRIS JS;GRAUR D","IS THERE A TWELFTH PROTEIN-CODING GENE IN THE GENOME OF INFLUENZA A? A SELECTION-BASED APPROACH TO THE DETECTION OF OVERLAPPING GENES IN CLOSELY RELATED SEQUENCES","JOURNAL OF MOLECULAR EVOLUTION","J. MOL. EVOL.","PROTEIN-CODING GENES OFTEN CONTAIN LONG OVERLAPPING OPEN-READING FRAMES (ORFS), WHICH MAY OR MAY NOT BE FUNCTIONAL. CURRENT METHODS THAT UTILIZE THE SIGNATURE OF PURIFYING SELECTION TO DETECT FUNCTIONAL OVERLAPPING GENES ARE LIMITED TO THE ANALYSIS OF SEQUENCES FROM DIVERGENT SPECIES, THUS RENDERING THEM INAPPLICABLE TO GENES FOUND ONLY IN CLOSELY RELATED SEQUENCES. HERE, WE PRESENT A METHOD FOR THE DETECTION OF SELECTION SIGNATURES ON OVERLAPPING READING FRAMES BY USING CLOSELY RELATED SEQUENCES, AND APPLY THE METHOD TO SEVERAL KNOWN OVERLAPPING GENES, AND TO AN OVERLAPPING ORF ON THE NEGATIVE STRAND OF SEGMENT 8 OF INFLUENZA A VIRUS (NEG8), FOR WHICH THE SUGGESTION HAS BEEN MADE THAT IT IS FUNCTIONAL. WE FIND NO EVIDENCE THAT NEG8 IS UNDER SELECTION, SUGGESTING THAT THE INTACT READING FRAME MIGHT BE NON-FUNCTIONAL, ALTHOUGH WE CANNOT FULLY EXCLUDE THE POSSIBILITY THAT THE METHOD IS NOT SENSITIVE ENOUGH TO DETECT THE SIGNATURE OF SELECTION ACTING ON THIS GENE. WE PRESENT THE LIMITATIONS OF THE METHOD USING KNOWN OVERLAPPING GENES AND SUGGEST SEVERAL APPROACHES TO IMPROVE IT IN FUTURE STUDIES. FINALLY, WE EXAMINE ALTERNATIVE EXPLANATIONS FOR THE SEQUENCE CONSERVATION OF NEG8 IN THE ABSENCE OF SELECTION. WE SHOW THAT OVERLAP TYPE AND GENOMIC CONTEXT AFFECT THE CONSERVATION OF INTACT OVERLAPPING ORFS AND SHOULD THEREFORE BE CONSIDERED IN ANY ATTEMPT OF ESTIMATING THE SIGNATURE OF SELECTION IN OVERLAPPING GENES.","OVERLAPPING GENES; INFLUENZA A; GENE DISCOVERY","BIOINFORMATIC ANALYSIS SUGGESTS; READING FRAMES; NUCLEOTIDE SUBSTITUTION; VIRAL GENOMES; VIRUS; EVOLUTION; LIKELIHOOD; RATES; ANTISENSE; ORF","ENGLISH","ARTICLE","ARTICLE",8,"ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;BAEZ M, 1980, NUCLEIC ACIDS RES, V8, P5845, DOI 10.1093/NAR/8.23.5845.;BAO YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07.;CAMPITELLI L, 2006, J GEN VIROL, V87, P955, DOI 10.1099/VIR.0.81397-0.;CHEN WS, 2001, NAT MED, V7, P1306, DOI 10.1038/NM1201-1306.;CHUNG BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/PNAS.0800468105.;CHUNG WY, 2007, PLOS COMPUT BIOL, V3, P855, DOI 10.1371/JOURNAL.PCBI.0030091.;CLIFFORD M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-198.;DE GROOT S, 2007, BIOINFORMATICS, V23, P1080, DOI 10.1093/BIOINFORMATICS/BTM078.;DE GROOT S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-304.;DELPORT W, 2008, PLOS PATHOG, V4, DOI 10.1371/JOURNAL.PPAT.1000242.;DRUMMOND AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214.;FIRTH AE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-75.;FIRTH AE, 2005, BIOINFORMATICS, V21, P282, DOI 10.1093/BIOINFORMATICS/BTI007.;FIRTH AE, 2008, ARCH VIROL, V153, P1379, DOI 10.1007/S00705-008-0119-5.;FIRTH AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-193.;FIRTH AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-32.;FIRTH AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-48.;FIRTH AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-62.;FISHER R. A., 1925, STAT METHODS RES WOR.;FITCH WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/PNAS.94.15.7712.;FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116.;GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725.;HEIN J, 1995, J MOL EVOL, V40, P181, DOI 10.1007/BF00167112.;HOLMES EDWARD C, 2006, SCIENCE, V313, P1573.;HUGHES AL, 2001, J VIROL, V75, P7966, DOI 10.1128/JVI.75.17.7966-7972.2001.;KEESE PK, 1992, P NATL ACAD SCI USA, V89, P9489, DOI 10.1073/PNAS.89.20.9489.;KRAKAUER DC, 2000, EVOLUTION, V54, P731.;LAVORGNA G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/J.TIBS.2003.12.002.;LI KS, 2004, NATURE, V430, P209, DOI 10.1038/NATURE02746.;LI WH, 1985, MOL BIOL EVOL, V2, P150.;LIANG H, 2006, GENOME RES, V16, P190, DOI 10.1101/GR.4246506.;MCCAULEY S, 2006, BIOINFORMATICS, V22, P1308, DOI 10.1093/BIOINFORMATICS/BT/092.;MCCAULEY S, 2007, BIOINFORMATICS, V23, P2978, DOI 10.1093/BIOINFORMATICS/BTM472.;MIYATA T, 1978, NATURE, V272, P532, DOI 10.1038/272532A0.;NEI M, 1986, MOL BIOL EVOL, V3, P418.;NEKRUTENKO A, 2005, PLOS GENET, V1, P197, DOI 10.1371/JOURNAL.PGEN.0010018.;NEKRUTENKO A, 2006, TRENDS GENET, V22, P645, DOI 10.1016/J.TIG.2006.09.012.;NEUHAUS K, 2010, P 8 EUR C EV COMP MA.;OBENAUER JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/SCIENCE.1121586.;PALLEJA A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-335.;PAMILO P, 1993, MOL BIOL EVOL, V10, P271.;PAVESI A, 2007, GENE, V402, P28, DOI 10.1016/J.GENE.2007.07.013.;PEDERSEN AMK, 2001, MOL BIOL EVOL, V18, P763, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A003859.;PYBUS OG, 2007, MOL BIOL EVOL, V24, P845, DOI 10.1093/MOLBEV/MSM001.;RIBRIOUX S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-122.;ROGOZIN IB, 2002, TRENDS GENET, V18, P228, DOI 10.1016/S0168-9525(02)02649-5.;SABATH N, 2010, J MOL EVOL, V71, P308, DOI 10.1007/S00239-010-9386-3.;SABATH N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-144.;SABATH N, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0003996.;SABATH N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-36.;SAITOU N, 1987, MOL BIOL EVOL, V4, P406.;SILKE J, 1997, GENE, V194, P143, DOI 10.1016/S0378-1119(97)00199-6.;SMITH TF, 1981, J THEOR BIOL, V91, P379, DOI 10.1016/0022-5193(81)90239-3.;SUZUKI Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A026042.;SUZUKI Y, 2006, MOL BIOL EVOL, V23, P1902, DOI 10.1093/MOLBEV/MSL050.;SWOFFORD DL, 2003, PAUP PHYLOGENETIC AN.;SZKLARCZYK R, 2007, P NATL ACAD SCI USA, V104, P12807, DOI 10.1073/PNAS.0703238104.;TODD D, 2001, VIROLOGY, V286, P354, DOI 10.1006/VIRO.2001.0985.;TRIFONOV V, 2009, PLOS CURR, V1, DOI [10.1371/CURRENTS.RRN1006, DOI 10.1371/CURRENTS.RRN1006].;WILLIAMS TA, 2009, MOL BIOL EVOL, V26, P445, DOI 10.1093/MOLBEV/MSN267.;XU H, 2010, CELL RES, V20, P445, DOI 10.1038/CR.2010.25.;YANG ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A026236.;ZHANG JZ, 1997, J MOL EVOL, V44, PS139, DOI 10.1007/PL00000067.;ZHIRNOV OP, 2007, DOKL BIOCHEM BIOPHYS, V414, P127, DOI 10.1134/S1607672907030106.;ZHONG WM, 2003, J BIOL CHEM, V278, P45135, DOI 10.1074/JBC.M307417200.","SABATH, N (REPRINT AUTHOR), UNIV ZURICH, INST EVOLUTIONARY BIOL \& ENVIRONM STUDIES, CH-8057 ZURICH, SWITZERLAND.;SABATH, NIV, UNIV ZURICH, INST EVOLUTIONARY BIOL \& ENVIRONM STUDIES, CH-8057 ZURICH, SWITZERLAND.;SABATH, NIV, SWISS INST BIOINFORMAT, BASEL, SWITZERLAND.;MORRIS, JEFFREY S., UNIV TEXAS MD ANDERSON CANC CTR, DEPT BIOSTAT, HOUSTON, TX 77230 USA.;GRAUR, DAN, UNIV HOUSTON, DEPT BIOL \& BIOCHEM, HOUSTON, TX 77204 USA.","10.1007/S00239-011-9477-9","233 SPRING ST, NEW YORK, NY 10013 USA",NA,NA,"UNIVERSITY OF HOUSTON, US NATIONAL LIBRARY OF MEDICINE [LM010009-01]","WE THANK DR. CHRIS UPTON FOR SUGGESTING THIS PROBLEM AND PROVIDING VALUABLE INFORMATION. DG AND NS WERE SUPPORTED BY A SMALL GRANT AWARD FROM THE UNIVERSITY OF HOUSTON AND BY THE US NATIONAL LIBRARY OF MEDICINE GRANT LM010009-01 TO DG AND GIDDY LANDAN.",NA,"0022-2844","56","305-315","SPRINGER","73",2011,"ISI000299938500006","66","BIOCHEMISTRY \& MOLECULAR BIOLOGY, EVOLUTIONARY BIOLOGY, GENETICS \& HEREDITY","9","BIOCHEMISTRY \& MOLECULAR BIOLOGY, EVOLUTIONARY BIOLOGY, GENETICS \& HEREDITY","NSABATHGMAIL.COM JEFMORRISMDANDERSON.ORG DGRAURUH.EDU",NA,"887OT",NA,"SABATH, N (REPRINT AUTHOR), UNIV ZURICH, INST EVOLUTIONARY BIOL \& ENVIRONM STUDIES, CH-8057 ZURICH, SWITZERLAND","ISI","UNIV ZURICH;SWISS INST BIOINFORMAT;UNIV TEXAS MD ANDERSON CANC CTR;UNIV HOUSTON","UNIV ZURICH",NA,"SABATH N, 2011, J MOL EVOL","SABATH N, 2011, J MOL EVOL"
"ZHANG L, 2011, DIAGN MOL PATHOL","ZHANG L;DING G;WEI L;PAN X;MEI L;ZHANG Y;LU Y","ESTABLISHMENT OF A NOVEL TARGET-BASED REAL-TIME QUANTITATIVE PCR METHOD FOR ACINETOBACTER BAUMANNII DETECTION","DIAGNOSTIC MOLECULAR PATHOLOGY","DIAGN. MOL. PATHOL.","BIOFILM FORMATION IS A WELL-KNOWN PATHOGENIC MECHANISM IN INFECTIONS CAUSED BY ACINETOBACTER BAUMANNII. RECENTLY, A BIOFILM SYNTHESIS-ASSOCIATED GENE HAS BEEN FOUND IN A. BAUMANNII ATCC19606. BIOINFORMATIC ANALYSIS SHOWED 2 TRANSMEMBRANE STRUCTURES AND AN HMSS SUPERFAMILY DOMAIN, WHICH WAS RELATED TO BIOFILM FORMATION. WHAT IS MORE, HIGH HOMOLOGY SEQUENCES OF THE BFS GENE WERE ONLY PRESENT IN A. BAUMANNII SPP., AND THE SIMILARITIES OF NUCLEOTIDE SEQUENCES OF THE BFS GENE FROM A. BAUMANNII STRAINS ATCC17978, ACICU, S1, AB307-0294, AND AB0057 COMPARED WITH THE REPORTED SEQUENCE OF BFS (GENBANK ACCESSION NO.: NZ\_GG704572) WERE ALL ABOVE 95\%. THE DISTRIBUTION AND CONSERVATION OF THE BFS GENE FROM CLINICALLY DERIVED A. BAUMANNII STRAINS WERE VERIFIED THROUGH CONVENTIONAL POLYMERASE CHAIN REACTION (PCR). AFTER THIS, WE ESTABLISHED A BFS GENE-BASED REAL-TIME QUANTITATIVE PCR ASSAY TO DETECT A. BAUMANNII. SPECIES SPECIFICITY AND SENSITIVITY ASSAYS WERE DESIGNED AND VALIDATED. BY USING THIS METHOD, ALL THE A. BAUMANNII STRAINS SEPARATED FROM CLINICAL SAMPLES WERE IDENTIFIED AND SHOWED GOOD ACCORDANCE WITH THE RESULTS FROM BIOCHEMICAL IDENTIFICATION. THIS STUDY IS THE FIRST REPORT OF DEVELOPING A BFS GENE-BASED QUANTITATIVE POLYMERASE CHAIN REACTION FOR RAPID, STABLE, AND SPECIFIC DETECTION OF A. BAUMANNII. THIS METHOD CAN BE APPLIED TO CLINICAL LABORATORY DIAGNOSIS, AND DETECTION OF A. BAUMANNII PRESENT ON MEDICAL INSTRUMENTS.","ACINETOBACTER BAUMANNII; BFS GENE; BIOINFORMATIC ANALYSIS; QPCR","BIOFILM FORMATION; MEMBRANE-VESICLES; EXTRACELLULAR DNA; EPIDEMIC STRAINS; ABIOTIC SURFACES; INFECTIONS; IDENTIFICATION; PATHOGEN; CELLS; RESISTANCE","ENGLISH","ARTICLE","ARTICLE",3,"BASSETTI M, 2008, FUTURE MICROBIOL, V3, P649, DOI 10.2217/17460913.3.6.649.;BEN OA, 2007, ARCH I PASTEUR TUNIS, V84, P11.;BERGOGNEBEREZIN E, 1996, CLIN MICROBIOL REV, V9, P148.;BRINKMAN NE, 2003, APPL ENVIRON MICROB, V69, P1775, DOI 10.1128/AEM.69.3.1775-1782.2003.;CHABAN B, 2009, APPL ENVIRON MICROB, V75, P3055, DOI 10.1128/AEM.00101-09.;DIJKSHOORN L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/NRMICRO1789.;ECKER JA, 2006, J CLIN MICROBIOL, V44, P2921, DOI 10.1128/JCM.00619-06.;GADDY JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09.;GARNACHO-MONTERO J, 2010, CURR OPIN INFECT DIS, V23, P332, DOI 10.1097/QCO.0B013E32833AE38B.;HORREVORTS A, 1997, J ANTIMICROB CHEMOTH, V40, P460, DOI 10.1093/JAC/40.3.460.;JANE FT, 2006, J CLIN MICROBIOL, V44, P2974.;JAWAD A, 1998, J CLIN MICROBIOL, V36, P1938.;KARAGEORGOPOULOS DE, 2008, J ANTIMICROB CHEMOTH, V62, P45, DOI 10.1093/JAC/DKN165.;KOELEMAN JGM, 1998, J CLIN MICROBIOL, V36, P2522.;KOELEMAN JGM, 2001, J CLIN MICROBIOL, V39, P8, DOI 10.1128/JCM.39.1.8-13.2001.;LEE HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/J.1469-0691.2007.01842.X.;LEE JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/J.RESMIC.2005.09.011.;MICHALOPOULOS A, 2010, EXPERT OPIN PHARMACO, V11, P779, DOI 10.1517/14656561003596350.;MONTEFOUR K, 2008, CRIT CARE NURSE, V28, P15.;PELEG AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07.;RICHET H, 2006, INFECT CONT HOSP EP, V27, P645, DOI 10.1086/505900.;RYDER C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/J.MIB.2007.09.010.;SCHOOLING SR, 2006, J BACTERIOL, V188, P5945, DOI 10.1128/JB.00257-06.;SCHOOLING SR, 2009, J BACTERIOL, V191, P4097, DOI 10.1128/JB.00717-08.;STEINBERGER RE, 2005, APPL ENVIRON MICROB, V71, P5404, DOI 10.1128/AEM.71.9.5404-5410.2005.;STEWART PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1.;TAKAHASHI A, 2000, J CLIN MICROBIOL, V38, P526.;TOMARAS AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/MIC.0.26541-0.;TURTON JF, 2005, J CLIN MICROBIOL, V43, P3074, DOI 10.1128/JCM.43.7.3074-3082.2005.;VAN DER MEIDE W, 2008, J CLIN MICROBIOL, V46, P73, DOI 10.1128/JCM.01416-07.;VAN LM, 2004, CLIN MICROBIOL INFEC, V10, P684.;VILA J, 2008, EXPERT OPIN PHARMACO, V9, P587, DOI 10.1517/14656566.9.4.587.;WHITCHURCH CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/SCIENCE.295.5559.1487.","ZHANG, YJ (REPRINT AUTHOR), CTR DIS CONTROL \& PREVENT ZHEJIANG PROV, 630 XIN CHENG RD, HANGZHOU 310051, ZHEJIANG, PEOPLES R CHINA.;ZHANG, LEI, DING, GANGQIANG, WEI, LANFEN, PAN, XIESHANG, MEI, LINGLING, ZHANG, YANJUN, LU, YIYU, CTR DIS CONTROL \& PREVENT ZHEJIANG PROV, HANGZHOU 310051, ZHEJIANG, PEOPLES R CHINA.","10.1097/PDM.0B013E31821BBB1E","530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA",NA,NA,"PROVINCIAL MEDICAL RESEARCH FUND OF ZHEJIANG, CHINA [2004B022], MONITOR TECHNOLOGY PLATFORM OF INFECTIOUS DISEASES OF THE STATE MAJOR SCIENCE AND TECHNOLOGY SPECIAL PROJECTS [2009ZX10004-210]","SUPPORTED BY GRANTS FROM THE PROVINCIAL MEDICAL RESEARCH FUND OF ZHEJIANG, CHINA (2004B022) AND FROM THE MONITOR TECHNOLOGY PLATFORM OF INFECTIOUS DISEASES OF THE STATE MAJOR SCIENCE AND TECHNOLOGY SPECIAL PROJECTS DURING THE 11TH 5-YEAR PLAN OF CHINA (2009ZX10004-210).",NA,"1052-9551","4","242-248","LIPPINCOTT WILLIAMS \& WILKINS","20",2011,"ISI000297253000008","33","BIOCHEMISTRY \& MOLECULAR BIOLOGY, BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, PATHOLOGY","4","BIOCHEMISTRY \& MOLECULAR BIOLOGY, BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, PATHOLOGY","LZHANGCDC.ZJ.CN",NA,"851FE",NA,"ZHANG, YJ (REPRINT AUTHOR), CTR DIS CONTROL \& PREVENT ZHEJIANG PROV, 630 XIN CHENG RD, HANGZHOU 310051, ZHEJIANG, PEOPLES R CHINA","ISI","CTR DIS CONTROL AND PREVENT ZHEJIANG PROV","CTR DIS CONTROL AND PREVENT ZHEJIANG PROV",NA,"ZHANG L, 2011, DIAGN MOL PATHOL","ZHANG L, 2011, DIAGN MOL PATHOL"
"PEDERSEN AE, 2011, J IMMUNOTHER","PEDERSEN AE;STRYHN A;JUSTESEN S;HARNDAHL M;RASMUSSEN S;DONSKOV F;CLAESSON MH;PEDERSEN JW;WANDALL HH;SVANE IM;BUUS S","WILDTYPE P53-SPECIFIC ANTIBODY AND T-CELL RESPONSES IN CANCER PATIENTS","JOURNAL OF IMMUNOTHERAPY","J. IMMUNOTHER.","MUTATION IN THE P53 GENE BASED ON SINGLE AMINO ACID SUBSTITUTIONS IS A FREQUENT EVENT IN HUMAN CANCER. ACCUMULATED MUTANT P53 PROTEIN IS RELEASED TO ANTIGEN PRESENTING CELLS OF THE IMMUNE SYSTEM AND ANTI-P53 IMMUNE RESPONSES EVEN AGAINST WT P53 IS INDUCED AND OBSERVED IN A NUMBER OF HUMAN CANCER PATIENTS. DETECTION OF ANTIBODIES AGAINST WT P53 PROTEIN HAS BEEN USED AS A DIAGNOSTIC AND PROGNOSTIC MARKER AND DISCOVERY OF NEW T-CELL EPITOPES HAS ENABLED DESIGN OF CANCER VACCINATION PROTOCOLS WITH PROMISING RESULTS. HERE, WE IDENTIFIED WT P53-SPECIFIC ANTIBODIES IN VARIOUS CANCER PATIENTS AND IDENTIFIED A BROAD RANGE OF RESPONSES AGAINST WT P53 PROTEIN AND 15-MER PEPTIDES USING A NOVEL PRINT ARRAY TECHNOLOGY. LIKEWISE, USING BIOINFORMATIC TOOLS IN SILICO, WE IDENTIFIED CD8(+) T-CELL SPECIFICITY OR REACTIVITY AGAINST HLA-A*02:01 BINDING","P53; CANCER; CD8(+) T CELLS; ANTIBODY","SEQUENCE P53(264-272) PEPTIDE; ADVANCED BREAST-CANCER; P53 PROTEIN; COLORECTAL-CANCER; DENDRITIC CELLS; IDENTIFICATION; EPITOPE; CARCINOMA; VACCINATION; GENERATION","ENGLISH","ARTICLE","ARTICLE",7,"ATZPODIEN J, 2002, CANCER, V95, P1045, DOI 10.1002/CNCR.10783.;BORDIN V, 2000, UROL INT, V64, P3, DOI 10.1159/000030473.;CACCAMO N, 2010, EUR J IMMUNOL, V40, P2139.;CHIKAMATSU K, 2003, CANCER RES, V63, P3675.;DONSKOV F, 2006, J CLIN ONCOL, V24, P1997, DOI 10.1200/JCO.2005.03.9594.;DOWELL SP, 1994, CANCER RES, V54, P2914.;FABIAN CJ, 1996, J CELL BIOCHEM, P112.;FERRIES E, 2001, HUM IMMUNOL, V62, P791, DOI 10.1016/S0198-8859(01)00266-X.;FISCHER RI, 2000, CANCER J SCI AM, P55.;GNJATIC S, 1995, EUR J IMMUNOL, V25, P1638, DOI 10.1002/EJI.1830250625.;HARNDAHL M, 2010, J IMMUNOL M IN PRESS.;HARNDAHL M, 2009, J BIOMOL SCREEN, V14, P173, DOI 10.1177/1087057108329453.;HOFFMANN TK, 2000, J IMMUNOL, V165, P5938, DOI 10.4049/JIMMUNOL.165.10.5938.;HOFFMANN TK, 2002, CANCER RES, V62, P3521.;KEOGH E, 2001, J IMMUNOL, V167, P787, DOI 10.4049/JIMMUNOL.167.2.787.;LARSEN MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/EJI.200425811.;LEISNER C, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0001678.;LEVESQUE MA, 1998, J CLIN ONCOL, V16, P2641, DOI 10.1200/JCO.1998.16.8.2641.;LJUNGBERG B, 2007, EUR UROL, V51, P1502, DOI 10.1016/J.EURURO.2007.03.035.;LUBIN R, 1995, NAT MED, V1, P701, DOI 10.1038/NM0795-701.;LUBIN R, 1995, CLIN CANCER RES, V1, P1463.;LUDWIG RL, 1996, MOL CELL BIOL, V16, P4952.;MENON AG, 2003, CANCER GENE THER, V10, P509, DOI 10.1038/SJ.CGT.7700600.;PETERSEN TR, 2001, SCAND J IMMUNOL, V53, P357, DOI 10.1046/J.1365-3083.2001.00887.X.;ROPKE M, 1995, SCAND J IMMUNOL, V42, P98, DOI 10.1111/J.1365-3083.1995.TB03631.X.;ROPKE M, 1996, P NATL ACAD SCI USA, V93, P14704, DOI 10.1073/PNAS.93.25.14704.;SAKAKURA K, 2007, CLIN IMMUNOL, V125, P43, DOI 10.1016/J.CLIM.2007.05.015.;SOUSSI T, 2000, HUM MUTAT, V15, P105, DOI 10.1002/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO,2-G.;SUPPIAH A, 2008, INT J COLORECTAL DIS, V23, P595, DOI 10.1007/S00384-008-0458-4.;SVANE IM, 2004, CANCER IMMUNOL IMMUN, V53, P633, DOI 10.1007/S00262-003-0493-5.;SVANE IM, 2007, CANCER IMMUNOL IMMUN, V56, P1485, DOI 10.1007/S00262-007-0293-4.;TILKIN AF, 1995, EUR J IMMUNOL, V25, P1765, DOI 10.1002/EJI.1830250642.;VAN DER BURG SH, 2002, CLIN CANCER RES, V8, P1019.;WOLFI M, 2010, CANC IMMUNOL IMMUNOT.;WURTZEN PA, 2002, INT J CANCER, V99, P568, DOI 10.1002/IJC.10375.;WURTZEN PA, 2001, INT J CANCER, V93, P855, DOI 10.1002/IJC.1417.","PEDERSEN, AE (REPRINT AUTHOR), UNIV COPENHAGEN, PANUM INST, DEPT INT HLTH IMMUNOL \& MICROBIOL, DK-2200 COPENHAGEN, DENMARK.;PEDERSEN, ANDERS ELM, STRYHN, ANETTE, JUSTESEN, SUNE, HARNDAHL, MIKKEL, RASMUSSEN, SUSANNE, CLAESSON, MOGENS H., BUUS, SOREN, UNIV COPENHAGEN, PANUM INST, DEPT INT HLTH IMMUNOL \& MICROBIOL, DK-2200 COPENHAGEN, DENMARK.;PEDERSEN, JOHANNES W., WANDALL, HANS H., UNIV COPENHAGEN, PANUM INST, DEPT CELLULAR \& MOL MED, DK-2200 COPENHAGEN, DENMARK.;SVANE, INGE MARIE, COPENHAGEN UNIV HOSP, DEPT HEMATOL, CCIT, HERLEV, DENMARK.;DONSKOV, FREDE, AARHUS UNIV HOSP, DEPT ONCOL, DK-8000 AARHUS, DENMARK.","10.1097/CJI.0B013E3182281381","530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA",NA,NA,"UNIVERSITY OF COPENHAGEN, DEPARTMENT OF INTERNATIONAL HEALTH, IMMUNOLOGY AND MICROBIOLOGY, FACULTY OF HEALTH SCIENCES, DANISH CANCER SOCIETY, LUNDBECK FOUNDATION, DANISH COUNCIL FOR INDEPENDENT RESEARCH (MEDICAL SCIENCES)","THIS WORK WAS SUPPORTED BY UNIVERSITY OF COPENHAGEN, DEPARTMENT OF INTERNATIONAL HEALTH, IMMUNOLOGY AND MICROBIOLOGY, FACULTY OF HEALTH SCIENCES AND BY GRANTS FROM THE DANISH CANCER SOCIETY, THE LUNDBECK FOUNDATION, AND THE DANISH COUNCIL FOR INDEPENDENT RESEARCH (MEDICAL SCIENCES).",NA,"1524-9557","9","629-640","LIPPINCOTT WILLIAMS \& WILKINS","34",2011,"ISI000296234800002","36","ONCOLOGY, IMMUNOLOGY, RESEARCH \& EXPERIMENTAL MEDICINE","2","ONCOLOGY, IMMUNOLOGY, MEDICINE, RESEARCH \& EXPERIMENTAL","ELMPEDERSENSUND.KU.DK",NA,"837VO",NA,"PEDERSEN, AE (REPRINT AUTHOR), UNIV COPENHAGEN, PANUM INST, DEPT INT HLTH IMMUNOL \& MICROBIOL, DK-2200 COPENHAGEN, DENMARK","ISI","UNIV COPENHAGEN;UNIV COPENHAGEN;COPENHAGEN UNIV HOSP;AARHUS UNIV HOSP","UNIV COPENHAGEN",NA,"PEDERSEN AE, 2011, J IMMUNOTHER","PEDERSEN AE, 2011, J IMMUNOTHER"
"JONES MA, 2011, GENET MED","JONES MA;BHIDE S;CHIN E;NG BG;RHODENIZER D;ZHANG VW;SUN JJ;TANNER A;FREEZE HH;HEGDE MR","TARGETED POLYMERASE CHAIN REACTION-BASED ENRICHMENT AND NEXT GENERATION SEQUENCING FOR DIAGNOSTIC TESTING OF CONGENITAL DISORDERS OF GLYCOSYLATION","GENETICS IN MEDICINE","GENET. MED.","PURPOSE: CONGENITAL DISORDERS OF GLYCOSYLATION ARE A HETEROGENEOUS GROUP OF DISORDERS CAUSED BY DEFICIENT GLYCOSYLATION, PRIMARILY AFFECTING THE N-LINKED PATHWAY. IT IS ESTIMATED THAT MORE THAN 40\% OF CONGENITAL DISORDERS OF GLYCOSYLATION PATIENTS LACK A CONFIRMATORY MOLECULAR DIAGNOSIS. THE PURPOSE OF THIS STUDY WAS TO IMPROVE MOLECULAR DIAGNOSIS FOR CONGENITAL DISORDERS OF GLYCOSYLATION BY DEVELOPING AND VALIDATING A NEXT GENERATION SEQUENCING PANEL FOR COMPREHENSIVE MUTATION DETECTION IN 24 GENES KNOWN TO CAUSE CONGENITAL DISORDERS OF GLYCOSYLATION. METHODS: NEXT GENERATION SEQUENCING VALIDATION WAS PERFORMED ON 12 POSITIVE CONTROL CONGENITAL DISORDERS OF GLYCOSYLATION PATIENTS. THESE SAMPLES WERE BLINDED AS TO THE DISEASE-CAUSING MUTATIONS. BOTH RAINDANCE AND FLUIDIGM PLATFORMS WERE USED FOR SEQUENCE ENRICHMENT AND TARGETED AMPLIFICATION. THE SOLID PLATFORM WAS USED FOR SEQUENCING THE AMPLIFIED PRODUCTS. BIOINFORMATIC ANALYSIS WAS PERFORMED USING NEXTGENE (R) SOFTWARE. RESULTS: THE DISEASE-CAUSING MUTATIONS WERE IDENTIFIED BY NEXT GENERATION SEQUENCING FOR ALL 12 POSITIVE CONTROLS. ADDITIONAL VARIANTS WERE ALSO DETECTED IN THREE CONTROLS THAT ARE KNOWN OR PREDICTED TO IMPAIR GENE FUNCTION AND MAY CONTRIBUTE TO THE CLINICAL PHENOTYPE. CONCLUSIONS: WE CONCLUDE THAT DEVELOPMENT OF NEXT GENERATION SEQUENCING PANELS IN THE DIAGNOSTIC LABORATORY WHERE MULTIPLE GENES ARE IMPLICATED IN A DISORDER IS MORE COST-EFFECTIVE AND WILL RESULT IN IMPROVED AND FASTER PATIENT DIAGNOSIS COMPARED WITH A GENE-BY-GENE APPROACH. RECOMMENDATIONS ARE ALSO PROVIDED FOR DATA ANALYSIS FROM THE NEXT GENERATION SEQUENCING-DERIVED DATA IN THE CLINICAL LABORATORY, WHICH WILL BE IMPORTANT FOR THE WIDESPREAD USE OF THIS TECHNOLOGY. GENET MED 2011:13(11):921-932.","CONGENITAL DISORDERS OF GLYCOSYLATION; NEXT GENERATION SEQUENCING; MOLECULAR DIAGNOSTIC TESTING; TARGET ENRICHMENT; BIOINFORMATICS","DEFICIENT GLYCOPROTEIN SYNDROME; IA CDG-IA; SERUM TRANSFERRIN; MUTATIONS; DEFECTS; CHROMATOGRAPHY; NOMENCLATURE; CAPTURE; PATIENT; GLYCAN","ENGLISH","ARTICLE","ARTICLE",52,"ADAMOWICZ M, 1996, EUR J PEDIATR, V155, P347.;AEBI M, 1999, GLYCOCONJ J, V16, P669.;APWEILER R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8.;CHARLWOOD J, 1998, GLYCOBIOLOGY, V8, P351, DOI 10.1093/GLYCOB/8.4.351.;CHOI M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/PNAS.0910672106.;EKLUND EA, 2006, BIOCHEM BIOPH RES CO, V339, P755, DOI 10.1016/J.BBRC.2005.11.073.;EKLUND EA, 2005, J PEDIATR-US, V147, P847, DOI 10.1016/J.JPEDS.2005.07.042.;EKLUND EA, 2005, MOL GENET METAB, V84, P25, DOI 10.1016/J.YMGME.2004.09.014.;FAID V, 2007, PROTEOMICS, V7, P1800, DOI 10.1002/PMIC.200600977.;FOOTITT E. J., 2009, J INHERIT METAB DIS, DOI [10.1007/S10545-009-1262-1, DOI 10.1007/S10545-009-1262-1].;FREEZE HH, 2001, GLYCOBIOLOGY, V11, P129R, DOI 10.1093/GLYCOB/11.12.129R.;FREEZE HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/J.SBI.2005.08.010.;FREEZE HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/NRG1894.;GILISSEN C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/J.AJHG.2010.08.004.;GNIRKE A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/NBT.1523.;HAEUPTLE MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/HUMU.21126.;IMBACH T, 2000, J CLIN INVEST, V105, P233, DOI 10.1172/JCI8691.;JAEKEN J, 2001, ANNU REV GENOM HUM G, V2, P129, DOI 10.1146/ANNUREV.GENOM.2.1.129.;JAEKEN J, 2008, J INHERIT METAB DIS, V31, P669, DOI 10.1007/S10545-008-0983-X.;JAEKEN J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/ANNUREV.GENOM.8.080706.092327.;JAEKEN J, 2010, ANN NY ACAD SCI, V1214, P190, DOI 10.1111/J.1749-6632.2010.05840.X.;JAEKEN J, 2009, BBA-MOL BASIS DIS, V1792, P825, DOI 10.1016/J.BBADIS.2009.08.005.;KIM S, 2000, J CLIN INVEST, V105, P191, DOI 10.1172/JCI7302.;KIRKNESS EF, 2009, NAT BIOTECHNOL, V27, P998, DOI 10.1038/NBT1109-998.;KJAERGAARD S, 2001, ARCH DIS CHILD, V85, P236, DOI 10.1136/ADC.85.3.236.;KORNER C, 1999, EMBO J, V18, P6816, DOI 10.1093/EMBOJ/18.23.6816.;KORNER C, 1998, P NATL ACAD SCI USA, V95, P13200, DOI 10.1073/PNAS.95.22.13200.;KRANZ C, 2007, AM J MED GENET A, V143A, P1414, DOI 10.1002/AJMG.A.31796.;LACEY JM, 2001, CLIN CHEM, V47, P513.;LEROY JG, 2006, PEDIATR RES, V60, P643, DOI 10.1203/01.PDR.0000246802.57692.EA.;MARKLOVA E, 2007, CLIN CHIM ACTA, V385, P6, DOI 10.1016/J.CCA.2007.07.002.;MATTHIJS G, 2000, TRENDS BIOCHEM SCI, V25, P428, DOI 10.1016/S0968-0004(00)01629-7.;MATTHIJS G, 2000, HUM MUTAT, V16, P386, DOI 10.1002/1098-1004(200011)16:5<386::AID-HUMU2>3.0.CO,2-Y.;METZKER ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/NRG2626.;NG SB, 2010, NAT GENET, V42, P790, DOI 10.1038/NG.646.;NG SB, 2010, NAT GENET, V42, P30, DOI 10.1038/NG.499.;NG SB, 2009, NATURE, V461, P272, DOI 10.1038/NATURE08250.;RICHARDS CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0B013E31816B5CAE.;RIOS J, 2010, HUM MOL GENET, V19, P4313, DOI 10.1093/HMG/DDQ352.;SCHACHTER H, 2009, BBA-MOL BASIS DIS, V1792, P925, DOI 10.1016/J.BBADIS.2008.11.002.;SCHENK B, 2001, J CLIN INVEST, V108, P1687, DOI 10.1172/JCI200113419.;STIBLER H, 1986, ALCOHOL CLIN EXP RES, V10, P535, DOI 10.1111/J.1530-0277.1986.TB05138.X.;STIBLER H, 1990, ARCH DIS CHILD, V65, P107, DOI 10.1136/ADC.65.1.107.;SUMMERER D, 2009, GENOME RES, V19, P1616, DOI 10.1101/GR.091942.109.;SUN LW, 2005, AM J MED GENET A, V137A, P22, DOI 10.1002/AJMG.A.30831.;TAYEH MK, 2009, GENET MED, V11, P232, DOI 10.1097/GIM.0B013E318195E191.;TEWHEY R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/NBT.1583.;VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/GLYCOB/3.2.97.;VLEUGELS W, 2009, BIOCHEM BIOPH RES CO, V390, P769, DOI 10.1016/J.BBRC.2009.10.047.;VLEUGELS W, 2009, HUM MUTAT, V30, P1428, DOI 10.1002/HUMU.21085.;VOCKLEY J, 2000, MOL GENET METAB, V71, P10, DOI 10.1006/MGME.2000.3066.;VODOPIUTZ J, 2008, J INHERIT METAB DIS, V31, P267, DOI 10.1007/S10545-008-0849-2.;VOELKERDING KV, 2010, J MOL DIAGN, V12, P539, DOI 10.2353/JMOLDX.2010.100043.;VOELKERDING KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/CLINCHEM.2008.112789.;WESTPHAL V, 2003, HUM MUTAT, V22, P1, DOI 10.1002/HUMU.9195.;WU XH, 2004, NAT MED, V10, P518, DOI 10.1038/NM1041.","HEGDE, MR (REPRINT AUTHOR), WHITEHEAD BIOMED RES BLDG,615 MICHAEL ST,STE 301, ATLANTA, GA 30322 USA.;JONES, MELANIE A., BHIDE, SHRUTI, CHIN, EPHREM, RHODENIZER, DEVIN, ZHANG, VICTOR W., SUN, JESSICA J., TANNER, ALICE, HEGDE, MADHURI R., EMORY UNIV, SCH MED, DEPT HUMAN GENET, ATLANTA, GA USA.;NG, BOBBY G., FREEZE, HUDSON H., SANFORD BURNHAM MED RES INST, GENET DIS PROGRAM, LA JOLLA, CA USA.","10.1097/GIM.0B013E318226FBF2","75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA",NA,NA,"NIH [RC1NS 069541-01], MDA [G6396330, 1T32MH087977], ROCKET WILLIAMS FUND, SANFORD PROFESSORSHIP, PHS FROM NATIONAL INSTITUTES OF HEALTH, NATIONAL CENTER FOR RESEARCH RESOURCES [UL1 RR025008, KL2 R0025009, TL1 RR025010]","THIS WORK WAS SUPPORTED BY GRANTS FROM NIH RC1NS 069541-01, MDA G6396330, 1T32MH087977 TRAINING PROGRAM IN HUMAN DISEASE GENETICS AND THE ROCKET WILLIAMS FUND AND A SANFORD PROFESSORSHIP TO DR. FREEZE. THIS RESEARCH WAS SUPPORTED IN PART BY PHS GRANT (UL1 RR025008, KL2 R0025009, OR TL1 RR025010) FROM THE CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAM, NATIONAL INSTITUTES OF HEALTH, NATIONAL CENTER FOR RESEARCH RESOURCES. THE AUTHORS THANK THE PATIENTS WHO PARTICIPATED AND MADE THIS STUDY POSSIBLE. THEY ALSO THANK MIAO HE, PHD, FOR HELPFUL SUGGESTIONS.",NA,"1098-3600","11","921-932","NATURE PUBLISHING GROUP","13",2011,"ISI000296666300003","56","GENETICS \& HEREDITY","13","GENETICS \& HEREDITY","MHEGDEEMORY.EDU",NA,"843IU",NA,"HEGDE, MR (REPRINT AUTHOR), WHITEHEAD BIOMED RES BLDG,615 MICHAEL ST,STE 301, ATLANTA, GA 30322 USA","ISI","EMORY UNIV;SANFORD BURNHAM MED RES INST","WHITEHEAD BIOMED RES BLDG",NA,"JONES MA, 2011, GENET MED","JONES MA, 2011, GENET MED"
"AS-SADI F, 2011, BMC GENOMICS","AS SADI F;CARRERE S;GASCUEL Q;HOURLIER T;RENGEL D;LE PASLIER MC;BORDAT A;BONIFACE MC;BRUNEL D;GOUZY J;GODIARD L;VINCOURT P","TRANSCRIPTOMIC ANALYSIS OF THE INTERACTION BETWEEN HELIANTHUS ANNUUS AND ITS OBLIGATE PARASITE PLASMOPARA HALSTEDII SHOWS SINGLE NUCLEOTIDE POLYMORPHISMS IN CRN SEQUENCES","BMC GENOMICS","BMC GENOMICS","BACKGROUND: DOWNY MILDEW IN SUNFLOWERS (HELIANTHUS ANNUUS L.) IS CAUSED BY THE OOMYCETE PLASMOPARA HALSTEDII (FARL.) BERLESE ET DE TONI. DESPITE EFFORTS BY THE INTERNATIONAL COMMUNITY TO BREED MILDEW-RESISTANT VARIETIES, DOWNY MILDEW REMAINS A MAJOR THREAT TO THE SUNFLOWER CROP. VERY FEW GENOMIC, GENETIC AND MOLECULAR RESOURCES ARE CURRENTLY AVAILABLE TO STUDY THIS PATHOGEN. USING A 454 SEQUENCING METHOD, EXPRESSED SEQUENCE TAGS (EST) DURING THE INTERACTION BETWEEN H. ANNUUS AND P. HALSTEDII HAVE BEEN GENERATED AND A SEARCH WAS PERFORMED FOR SITES IN PUTATIVE EFFECTORS TO SHOW POLYMORPHISMS BETWEEN THE DIFFERENT RACES OF P. HALSTEDII. RESULTS: A 454 PYROSEQUENCING RUN OF TWO INFECTED SUNFLOWER SAMPLES (INBRED LINES XRQ AND PSC8 INFECTED WITH RACE 710 OF P. HALSTEDII, WHICH EXHIBIT INCOMPATIBLE AND COMPATIBLE INTERACTIONS, RESPECTIVELY) GENERATED 113,720 AND 172,107 USEABLE READS. FROM THESE READS, 44,948 CONTIGS AND SINGLETONS HAVE BEEN PRODUCED. A BIOINFORMATIC PORTAL, HP, WAS SPECIFICALLY CREATED FOR IN-DEPTH ANALYSIS OF THESE CLUSTERS. USING IN SILICO FILTERING, 405 CLUSTERS WERE DEFINED AS BEING SPECIFIC TO OOMYCETES, AND 172 WERE DEFINED AS NON-SPECIFIC OOMYCETE CLUSTERS. A SUBSET OF THESE TWO CATEGORIES WAS CHECKED USING PCR AMPLIFICATION, AND 86\% OF THE TESTED CLUSTERS WERE VALIDATED. TWENTY PUTATIVE RXLR AND CRN EFFECTORS WERE DETECTED USING PSI-BLAST. USING CORRESPONDING SEQUENCES FROM FOUR RACES (100, 304, 703 AND 710), 22 SNPS WERE DETECTED, PROVIDING NEW INFORMATION ON PATHOGEN POLYMORPHISMS. CONCLUSIONS: THIS STUDY IDENTIFIED A LARGE NUMBER OF GENES THAT ARE EXPRESSED DURING H. ANNUUS/P. HALSTEDII COMPATIBLE OR INCOMPATIBLE INTERACTIONS. IT ALSO REVEALS, FOR THE FIRST TIME, THAT AN INFECTION MECHANISM EXISTS IN P. HALSTEDII SIMILAR TO THAT IN OTHER OOMYCETES ASSOCIATED WITH THE PRESENCE OF PUTATIVE RXLR AND CRN EFFECTORS. SNPS DISCOVERED IN CRN EFFECTOR SEQUENCES WERE USED TO DETERMINE THE GENETIC DISTANCES BETWEEN THE FOUR RACES OF P. HALSTEDII. THIS WORK THEREFORE PROVIDES VALUABLE TOOLS FOR FURTHER DISCOVERIES REGARDING THE H. ANNUUS/P. HALSTEDII PATHOSYSTEM.",NA,"PLANT-OOMYCETE INTERACTIONS; SUNFLOWER DOWNY MILDEW; HIGH-THROUGHPUT GENE; EFFECTOR PROTEINS; HYALOPERONOSPORA-ARABIDOPSIDIS; PHYTOPHTHORA-INFESTANS; PATHOGEN PHYTOPHTHORA; GENOME SEQUENCE; RESISTANCE; BIOLOGY","ENGLISH","ARTICLE","ARTICLE",17,"ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/NAR/25.17.3389.;BAXTER L, 2010, SCIENCE, V330, P1549, DOI 10.1126/SCIENCE.1195203.;BIRCH PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/J.TIM.2005.11.007.;BOUZIDI MF, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-110.;CHEUNG F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-542.;COATES ME, 2010, ANNU REV PHYTOPATHOL, V48, P329, DOI 10.1146/ANNUREV-PHYTO-080508-094422.;CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/NAR/16.22.10881.;DELMOTTE F, 2008, INFECT GENET EVOL, V8, P534, DOI 10.1016/J.MEEGID.2008.02.012.;GIRESSE X, 2007, MOL ECOL NOTES, V7, P1363, DOI 10.1111/J.1471-8286.2007.01887.X.;GOUZY J, 2009, BIOINFORMATICS, V25, P670, DOI 10.1093/BIOINFORMATICS/BTP024.;HAAS BJ, 2009, NATURE, V461, P393, DOI 10.1038/NATURE08358.;HARDHAM AR, 2007, CELL MICROBIOL, V9, P31, DOI 10.1111/J.1462-5822.2006.00833.X.;HOGENHOUT SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115.;HUANG XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/GR.9.9.868.;KAMOUN S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/J.PBI.2007.04.017.;KAMOUN S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/ANNUREV.PHYTO.44.070505.143436.;LAMOUR KH, 2007, FEMS MICROBIOL LETT, V274, P1, DOI 10.1111/J.1574-6968.2007.00786.X.;LEBEDA A, 2008, EUR J PLANT PATHOL, V122, P71, DOI 10.1007/S10658-008-9292-3.;LEVESQUE CA, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-7-R73.;MARDIS ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/J.TIG.2007.12.007.;MARGULIES M, 2005, NATURE, V437, P376, DOI 10.1038/NATURE03959.;MOUZEYAR S, 1993, J PHYTOPATHOL, V139, P289, DOI 10.1111/J.1439-0434.1993.TB01430.X.;NOVAES E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312.;OLIVA R, 2010, CELL MICROBIOL, V12, P705, DOI 10.1111/J.1462-5822.2010.01471.X.;PERTEA G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/BIOINFORMATICS/BTG034.;PILORGE E, 2000, MILDIOU TOURNESOL.;RADWAN O, 2005, J EXP BOT, V56, P567, DOI 10.1093/JXB/ERI030.;RADWAN O, 2003, THEOR APPL GENET, V106, P1438, DOI 10.1007/S00122-003-1196-1.;RADWAN O, 2008, MOL GENET GENOMICS, V280, P111, DOI 10.1007/S00438-008-0346-1.;REHMANY AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/TPC.105.031807.;ROECKEL-DREVET P, 1999, CAN J MICROBIOL, V45, P797, DOI 10.1139/CJM-45-9-797.;ROZEN S, 2000, BIOINFORMATICS METHO, P365, DOI DOI 10.1385/1-59259-192-2:365.;SCHAFLEITNER R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-604.;SCHORNACK S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/PNAS.1008491107.;SIERRA R, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0009847.;SPURGEON SL, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0001662.;THINES M, 2010, CURR OPIN PLANT BIOL, V13, P427, DOI 10.1016/J.PBI.2010.04.001.;TORTO TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/GR.910003.;TROWER MK, 1990, NUCLEIC ACIDS RES, V18, P4615, DOI 10.1093/NAR/18.15.4615.;TYLER BM, 2009, CELL MICROBIOL, V11, P13, DOI 10.1111/J.1462-5822.2008.01240.X.;VEAR F, 2008, EUPHYTICA, V164, P561, DOI 10.1007/S10681-008-9759-5.;VEAR F, 1997, THEOR APPL GENET, V95, P584, DOI 10.1007/S001220050599.;VIRANYI F, 2002, ADVANCES IN DOWNY MILDEW RESEARCH, P167, DOI 10.1007/0-306-47914-1\_6.;WHISSON SC, 2007, NATURE, V450, P115, DOI 10.1038/NATURE06203.;PLANTGDB RESOURCES P.","GODIARD, L (REPRINT AUTHOR), INRA, LIPM, UMR441, F-31326 CASTANET TOLOSAN, FRANCE.;AS-SADI, FALAH, CARRERE, SEBASTIEN, GASCUEL, QUENTIN, HOURLIER, THIBAUT, RENGEL, DAVID, BORDAT, AMANDINE, BONIFACE, MARIE-CLAUDE, GOUZY, JEROME, GODIARD, LAURENCE, VINCOURT, PATRICK, INRA, LIPM, UMR441, F-31326 CASTANET TOLOSAN, FRANCE.;AS-SADI, FALAH, CARRERE, SEBASTIEN, GASCUEL, QUENTIN, HOURLIER, THIBAUT, RENGEL, DAVID, BORDAT, AMANDINE, BONIFACE, MARIE-CLAUDE, GOUZY, JEROME, GODIARD, LAURENCE, VINCOURT, PATRICK, CNRS, LIPM, UMR2594, F-31326 CASTANET TOLOSAN, FRANCE.;LE PASLIER, MARIE-CHRISTINE, BRUNEL, DOMINIQUE, ETUD POLYMORPHISME GENOMES VEGETAUX INRA, CEA, INST GENOM, CTR NATL GENOTYPAGE, F-91057 EVRY, FRANCE.","10.1186/1471-2164-12-498","CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND","498",NA,"AIP BIORESSOURCES, PROMOSOL ASSOCIATION","FUNDING FOR 454 (R) SEQUENCING WAS PROVIDED BY AIP BIORESSOURCES 2008 INRA. THIS WORK BENEFITED ALSO FROM PARTIAL FUNDING FROM THE PROMOSOL ASSOCIATION. THE AUTHORS WOULD LIKE TO THANK F. DELMOTTE AND COLLABORATORS FOR KINDLY ALLOWING US TO USE THEIR SEQUENCING RESULTS, D. TOURVIEILLE AND HIS TEAM (INRA CLERMONT-FERRAND) FOR PROVIDING THE P. HALSTEDII SAMPLES, E. GAULIN FOR HIGHLIGHTING PUBLIC INFORMATION FROM THE HYALOPERONOSPORA ARABIDOPSIDIS SEQUENCING PROJECT, F. VEAR AND P. GAMAS FOR CAREFUL READING OF THE MANUSCRIPT, AND THE REVIEWERS FOR THEIR HELPFUL COMMENTS.",NA,"1471-2164",NA,NA,"BMC","12",2011,"ISI000296334700002","45","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","18","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","LAURENCE.GODIARDTOULOUSE.INRA.FR PATRICK.VINCOURTTOULOUSE.FR",NA,"838ZX",NA,"GODIARD, L (REPRINT AUTHOR), INRA, LIPM, UMR441, F-31326 CASTANET TOLOSAN, FRANCE","ISI","BONIFACE;CNRS;INST GENOM","NOTREPORTED",NA,"AS-SADI F, 2011, BMC GENOMICS","AS-SADI F, 2011, BMC GENOMICS"
"MA M, 2011, PLOS ONE","MA M;HUANG Y;GONG Z;ZHUANG L;LI C;YANG H;TONG Y;LIU W;CAO W","DISCOVERY OF DNA VIRUSES IN WILD-CAUGHT MOSQUITOES USING SMALL RNA HIGH THROUGHPUT SEQUENCING","PLOS ONE","PLOS ONE","BACKGROUND: MOSQUITO-BORNE INFECTIOUS DISEASES POSE A SEVERE THREAT TO PUBLIC HEALTH IN MANY AREAS OF THE WORLD. CURRENT METHODS FOR PATHOGEN DETECTION AND SURVEILLANCE ARE USUALLY DEPENDENT ON PRIOR KNOWLEDGE OF THE ETIOLOGIC AGENTS INVOLVED. HENCE, EFFICIENT APPROACHES ARE REQUIRED FOR SCREENING WILD MOSQUITO POPULATIONS TO DETECT KNOWN AND UNKNOWN PATHOGENS. METHODOLOGY/PRINCIPAL FINDINGS: IN THIS STUDY, WE EXPLORED THE USE OF NEXT GENERATION SEQUENCING TO IDENTIFY VIRAL AGENTS IN WILD-CAUGHT MOSQUITOES. WE EXTRACTED TOTAL RNA FROM DIFFERENT MOSQUITO SPECIES FROM SOUTH CHINA. SMALL 18-30 BP LENGTH RNA MOLECULES WERE PURIFIED, REVERSE-TRANSCRIBED INTO CDNA AND SEQUENCED USING ILLUMINA GAIIX INSTRUMENTATION. BIOINFORMATIC ANALYSES TO IDENTIFY PUTATIVE VIRAL AGENTS WERE CONDUCTED AND THE RESULTS CONFIRMED BY PCR. WE IDENTIFIED A NON-ENVELOPED SINGLE-STRANDED DNA DENSOVIRUS IN THE WILD-CAUGHT CULEX PIPIENS MOLESTUS MOSQUITOES. THE MAJORITY OF THE VIRAL TRANSCRIPTS (.>80\% OF THE REGION) WERE COVERED BY THE SMALL VIRAL RNAS, WITH A FEW PEAKS OF VERY HIGH COVERAGE OBTAINED. THE +/- STRAND SEQUENCE RATIO OF THE SMALL RNAS WAS APPROXIMATELY 7:1, INDICATING THAT THE MOLECULES WERE MAINLY DERIVED FROM THE VIRAL RNA TRANSCRIPTS. THE SMALL VIRAL RNAS OVERLAPPED, ENABLING CONTIG ASSEMBLY OF THE VIRAL GENOME SEQUENCE. WE IDENTIFIED SOME SMALL RNAS IN THE REVERSE REPEAT REGIONS OF THE VIRAL 5'- AND 3'-UNTRANSLATED REGIONS WHERE NO TRANSCRIPTS WERE EXPECTED. CONCLUSIONS/SIGNIFICANCE: OUR RESULTS DEMONSTRATE FOR THE FIRST TIME THAT HIGH THROUGHPUT SEQUENCING OF SMALL RNA IS FEASIBLE FOR IDENTIFYING VIRAL AGENTS IN WILD-CAUGHT MOSQUITOES. OUR RESULTS SHOW THAT IT IS POSSIBLE TO DETECT DNA VIRUSES BY SEQUENCING THE SMALL RNAS OBTAINED FROM INSECTS, ALTHOUGH THE UNDERLYING MECHANISM OF SMALL VIRAL RNA BIOGENESIS IS UNCLEAR. OUR DATA AND THOSE OF OTHER RESEARCHERS SHOW THAT HIGH THROUGHPUT SMALL RNA SEQUENCING CAN BE USED FOR PATHOGEN SURVEILLANCE IN WILD MOSQUITO VECTORS.",NA,"COMPLETE NUCLEOTIDE-SEQUENCE; SMALL SILENCING RNAS; DENSONUCLEOSIS VIRUS; GENOMIC ORGANIZATION; INFECTIOUS-DISEASES; VIRAL GENOME; CELL-LINE; DENSOVIRUS; DROSOPHILA; DIAGNOSIS","ENGLISH","ARTICLE","ARTICLE",44,"AFANASIEV BN, 1991, VIROLOGY, V185, P323, DOI 10.1016/0042-6822(91)90780-F.;BINDER S, 1999, SCIENCE, V284, P1311, DOI 10.1126/SCIENCE.284.5418.1311.;BISHOPLILLY KA, 2010, PLOS NEGLECT TROP D, V4, P1101.;BOUBLIK Y, 1994, VIROLOGY, V200, P752, DOI 10.1006/VIRO.1994.1239.;CAMACHO C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421.;CARLSON J, 2006, ADV VIRUS RES, V68, P361, DOI 10.1016/S0065-3527(06)38010-X.;CHEN SX, 2004, VIROLOGY, V318, P123, DOI 10.1016/J.VIROL.2003.09.013.;COSTA J. V., 1990, MOLECULAR BIOLOGY OF IRIDOVIRUSES., P247.;COX-FOSTER DL, 2007, SCIENCE, V318, P283, DOI 10.1126/SCIENCE.1146498.;CZECH B, 2008, NATURE, V453, P798, DOI 10.1038/NATURE07007.;DUMAS B, 1992, VIROLOGY, V191, P202, DOI 10.1016/0042-6822(92)90182-O.;GHILDIYAL M, 2008, SCIENCE, V320, P1077, DOI 10.1126/SCIENCE.1157396.;HIRUNKANOKPUN S, 2008, AM J TROP MED HYG, V78, P784, DOI 10.4269/AJTMH.2008.78.784.;*INC I, 2008, PREPARING SAMPLES AN.","MA, MJ (REPRINT AUTHOR), BEIJING INST MICROBIOL \& EPIDEMIOL, STATE KEY LAB PATHOGEN \& BIOSECUR, BEIJING, PEOPLES R CHINA.;MA, MAIJUAN, HUANG, YONG, ZHUANG, LU, LI, CUN, YANG, HONG, TONG, YIGANG, LIU, WEI, CAO, WUCHUN, BEIJING INST MICROBIOL \& EPIDEMIOL, STATE KEY LAB PATHOGEN \& BIOSECUR, BEIJING, PEOPLES R CHINA.;GONG, ZHENGDA, YUNNAN INST ENDEM DIS CONTROL \& PREVENT, DALI, YUNNAN, PEOPLES R CHINA.","10.1371/JOURNAL.PONE.0024758","185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA","E24758",NA,"NATIONAL SCIENCE FUND FOR DISTINGUISHED YOUNG SCHOLARS [30725032], NATIONAL SCIENCE FUND [30872223, 81072250, 81072350], HI-TECH RESEARCH AND DEVELOPMENT (863) PROGRAM OF CHINA [2009AA02Z111], NATIONAL ``973'' PROGRAM [2010 CB530201]","THIS STUDY WAS SUPPORTED BY GRANTS FROM THE NATIONAL SCIENCE FUND FOR DISTINGUISHED YOUNG SCHOLARS 30725032), THE NATIONAL SCIENCE FUND (30872223, 81072250, 81072350), THE HI-TECH RESEARCH AND DEVELOPMENT (863) PROGRAM OF CHINA (2009AA02Z111) AND NATIONAL ``973'' PROGRAM",NA,"1932-6203","9",NA,"PUBLIC LIBRARY SCIENCE","6",2011,"ISI000295260400012","33","SCIENCE \& TECHNOLOGY - OTHER TOPICS","15","MULTIDISCIPLINARY SCIENCES","TONG.YIGANGGMAIL.COM",NA,"825GY",NA,"MA, MJ (REPRINT AUTHOR), BEIJING INST MICROBIOL \& EPIDEMIOL, STATE KEY LAB PATHOGEN \& BIOSECUR, BEIJING, PEOPLES R CHINA","ISI","BEIJING INST MICROBIOL AND EPIDEMIOL;YUNNAN INST ENDEM DIS CONTROL AND PREVENT","BEIJING INST MICROBIOL AND EPIDEMIOL",NA,"MA M, 2011, PLOS ONE","MA M, 2011, PLOS ONE"
"EBBINGHAUS P, 2011, MALAR J","EBBINGHAUS P;KRUECKEN J","CHARACTERIZATION AND TISSUE-SPECIFIC EXPRESSION PATTERNS OF THE PLASMODIUM CHABAUDI CIR MULTIGENE FAMILY","MALARIA JOURNAL","MALAR. J.","BACKGROUND: VARIANT ANTIGENS EXPRESSED ON THE SURFACE OF PARASITIZED RED BLOOD CELLS (PRBCS) ARE IMPORTANT VIRULENCE FACTORS OF MALARIA PARASITES. WHEREAS PLASMODIUM FALCIPARUM ERYTHROCYTE MEMBRANE PROTEINS 1 (PFEMP1) ARE RESPONSIBLE FOR SEQUESTRATION OF MATURE PARASITES, LITTLE IS KNOWN ABOUT PUTATIVE LIGANDS MEDIATING CYTOADHERENCE TO HOST RECEPTORS IN OTHER PLASMODIUM SPECIES. CANDIDATES INCLUDE MEMBERS OF THE PIR SUPERFAMILY FOUND IN THE HUMAN PARASITE PLASMODIUM VIVAX (VIR), IN THE SIMIAN PATHOGEN PLASMODIUM KNOWLESI (KIR) AND IN THE RODENT MALARIAS PLASMODIUM YOELII (YIR), PLASMODIUM BERGHEI (BIR) AND PLASMODIUM CHABAUDI (CIR). THE AIM OF THIS STUDY WAS TO REVEAL A POTENTIAL INVOLVEMENT OF CIR GENES IN P. CHABAUDI SEQUESTRATION. METHODS: SUBFAMILIES OF CIR GENES WERE IDENTIFIED BY BIOINFORMATIC ANALYSES OF ANNOTATED SEQUENCE DATA IN THE PLASMODIUM GENOME DATABASE. IN ORDER TO EXAMINE TISSUE-SPECIFIC DIFFERENCES IN THE EXPRESSION OF CIR MRNAS, RTPCR WITH SUBFAMILY-SPECIFIC PRIMERS WAS USED. IN TOTAL, 432 CDNA CLONES DERIVED FROM SIX DIFFERENT TISSUES WERE SEQUENCED TO CHARACTERIZE THE TRANSCRIBED CIR GENE REPERTOIRE. TO CONFIRM DIFFERENCES IN TRANSCRIPTION PROFILES OF CIR GENES, RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP) ANALYSES WERE PERFORMED TO COMPARE DIFFERENT HOST TISSUES AND TO IDENTIFY CHANGES DURING THE COURSE OF P. CHABAUDI INFECTIONS IN IMMUNOCOMPETENT MICE. RESULTS: THE PHYLOGENETIC ANALYSIS OF ANNOTATED P. CHABAUDI PUTATIVE CIR PROTEINS IDENTIFIED TWO MAJOR SUBFAMILIES. COMPARISON OF TRANSCRIBED CIR GENES FROM SIX DIFFERENT TISSUES REVEALED SIGNIFICANT DIFFERENCES IN THE FREQUENCY CLONES BELONGING TO INDIVIDUAL CIR GENE SUBGROUPS WERE OBTAINED FROM DIFFERENT TISSUES. FURTHER HINTS OF DIFFERENCE IN THE TRANSCRIPTION OF CIR GENES IN INDIVIDUAL TISSUES WERE OBTAINED BY RFLP. WHEREAS ONLY MINIMAL CHANGES IN THE TRANSCRIPTION PATTERN OF CIR GENES COULD BE DETECTED DURING THE DEVELOPMENTAL CYCLE OF THE PARASITES, SWITCHING TO EXPRESSION OF OTHER CIR GENES DURING THE COURSE OF AN INFECTION WAS OBSERVED AROUND OR AFTER PEAK PARASITEMIA. CONCLUSIONS: THE TISSUE-SPECIFIC EXPRESSION OF CIR MRNAS FOUND IN THIS STUDY INDICATES CORRELATION BETWEEN EXPRESSION OF CIR ANTIGENS AND DISTRIBUTION OF PARASITES IN INNER ORGANS. TOGETHER WITH COMPARABLE RESULTS FOR OTHER MEMBERS OF THE PIR SUPERFAMILY THIS SUGGESTS A ROLE OF CIR AND OTHER PIR GENES IN ANTIGENIC VARIATION AND SEQUESTRATION OF MALARIA PARASITES.",NA,"KNOWLESI VARIANT ANTIGEN; RED-BLOOD-CELLS; MALARIA PARASITES; INFECTED ERYTHROCYTES; RODENT MALARIA; PROTEIN SEQUENCES; GENE FAMILY; FALCIPARUM; VIVAX; SUPERFAMILY","ENGLISH","ARTICLE","ARTICLE",14,"AL-KHEDERY B, 1999, MOL CELL, V3, P131, DOI 10.1016/S1097-2765(00)80304-4.;AURRECOECHEA C, 2009, NUCLEIC ACIDS RES, V37, PD539, DOI 10.1093/NAR/GKN814.;BARNWELL JW, 1982, J IMMUNOL, V128, P224.;BOZDECH Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/PNAS.0807404105.;BROWN KN, 1965, NATURE, V208, P1286, DOI 10.1038/2081286A0.;BULL PC, 2008, MOL MICROBIOL, V68, P1519, DOI 10.1111/J.1365-2958.2008.06248.X.;CARLTON JM, 2002, NATURE, V419, P512, DOI 10.1038/NATURE01099.;CARVALHO BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815.;CUNNINGHAM DA, 2005, MOL MICROBIOL, V58, P636, DOI 10.1111/J.1365-2958.2005.04840.X.;CUNNINGHAM D, 2010, MOL BIOCHEM PARASIT, V170, P65, DOI 10.1016/J.MOLBIOPARA.2009.12.010.;CUNNINGHAM D, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0004285.;DAILY JP, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-30.;DAILY JP, 2005, J INFECT DIS, V191, P1196, DOI 10.1086/428289.;DEITSCH KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146.;DEITSCH KW, 1997, MICROBIOL MOL BIOL R, V61, P281.;DEL PORTILLO HA, 2004, INT J PARASITOL, V34, P1547, DOI 10.1016/J.IJPARA.2004.10.012.;DEL PORTILLO HA, 2001, NATURE, V410, P839, DOI 10.1038/35071118.;DI GIROLAMO F, 2008, PROTEOMICS, V8, P2500, DOI 10.1002/PMIC.200700763.;DZIKOWSKI R, 2006, CELL MICROBIOL, V8, P1371, DOI 10.1111/J.1462-5822.2006.00760.X.;EMANUELSSON O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/NPROT.2007.131.;FERNANDEZ-BECERRA C, 2005, MOL MICROBIOL, V58, P648, DOI 10.1111/J.1365-2958.2005.04850.X.;FISCHER K, 2003, MOL MICROBIOL, V48, P1209, DOI 10.1046/J.1365-2958.2003.03491.X.;FONAGER J, 2007, MOL BIOCHEM PARASIT, V156, P1, DOI 10.1016/J.MOLBIOPARA.2007.06.006.;FRANKE-FAYARD B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/PNAS.0503386102.;FRANKE-FAYARD B, 2010, PLOS PATHOG, V6.;GUINDON S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520.;HALL N, 2005, SCIENCE, V307, P82, DOI 10.1126/SCIENCE.1103717.;HISS JA, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0001560.;JANSSEN CS, 2004, NUCLEIC ACIDS RES, V32, P5712, DOI 10.1093/NAR/GKH907.;JANSSEN CS, 2002, P ROY SOC B-BIOL SCI, V269, P431, DOI 10.1098/RSPB.2001.1903.;JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/BI00176A037.;JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275.;KORIR CC, 2006, INFECT GENET EVOL, V6, P75, DOI 10.1016/J.MEEGID.2005.01.003.;KROGH A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/JMBI.2000.4315.;KRUCKEN J, 2005, INFECT IMMUN, V73, P6390, DOI 10.1128/IAI.73.10.6390-6398.2005.;KRUCKEN J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-54.;KUMAR S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/BIB/BBN017.;KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0.;LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/BIOINFORMATICS/BTM404.;LOPEZRUBIO JJ, 2007, CURR OPIN MICROBIOL.;MACKINTOSH CL, 2004, TRENDS PARASITOL, V20, P597, DOI 10.1016/J.PT.2004.09.006.;MARCHLER-BAUER A, 2004, NUCLEIC ACIDS RES, V32, PW327, DOI 10.1093/NAR/GKH454.;MARCHLER-BAUER A, 2011, NUCLEIC ACIDS RES, V39, PD225, DOI 10.1093/NAR/GKQ1189.;MARCHLER-BAUER A, 2009, NUCLEIC ACIDS RES, V37, PD205, DOI 10.1093/NAR/GKN845.;MARINHO CRF, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0005630.;MARTI M, 2004, SCIENCE, V306, P1930, DOI 10.1126/SCIENCE.1102452.;MCLEAN SA, 1982, EXP PARASITOL, V54, P296, DOI 10.1016/0014-4894(82)90038-8.;MENDIS KN, 1988, AM J TROP MED HYG, V38, P42, DOI 10.4269/AJTMH.1988.38.42.;MERINO EF, 2006, MOL BIOCHEM PARASIT, V149, P10, DOI 10.1016/J.MOLBIOPARA.2006.04.002.;MILLER LH, 2002, NATURE, V415, P673, DOI 10.1038/415673A.;MOTA MM, 2000, INFECT IMMUN, V68, P4135, DOI 10.1128/IAI.68.7.4135-4144.2000.;NERES R, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0001608.;RASTI N, 2004, FEMS IMMUNOL MED MIC, V41, P9, DOI 10.1016/J.FEMSIM.2004.01.010.;RECKER M, 2011, PLOS PATHOG, V7, DOI 10.1371/JOURNAL.PPAT.1001306.;SCHERF A, 1998, EMBO J, V17, P5418, DOI 10.1093/EMBOJ/17.18.5418.;SHERMAN IW, 2003, MICROBES INFECT, V5, P897, DOI 10.1016/S1286-4579(03)00162-X.;SPACCAPELO R, 2010, AM J PATHOL, V176, P205, DOI 10.2353/AJPATH.2010.090504.;SPIELMANN T, 2010, TRENDS PARASITOL, V26, P6, DOI 10.1016/J.PT.2009.10.001.;SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1.;TAMURA K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/MOLBEV/MSM092.;VANHAMME L, 2001, TRENDS PARASITOL, V17, P338, DOI 10.1016/S1471-4922(01)01922-5.;VOSS TS, 2006, NATURE, V439, P1004, DOI 10.1038/NATURE04407.;WUNDERLICH F, 2005, MICROBES INFECT, V7, P399, DOI 10.1016/J.MICINF.2004.11.016.;WUNDERLICH F, 1982, J PROTOZOOL, V29, P60, DOI 10.1111/J.1550-7408.1982.TB02880.X.;ZARNBRANO-VILLA S, 2002, TRENDS PARASITOL, V18, P272, DOI 10.1016/S1471-4922(02)02289-4.","KRUCKEN, J (REPRINT AUTHOR), FREE UNIV BERLIN, INST PARASITOL \& TROP VET MED, KONIGSWEG 67, D-14163 BERLIN, GERMANY.;EBBINGHAUS, PETRA, KRUECKEN, JUERGEN, FREE UNIV BERLIN, INST PARASITOL \& TROP VET MED, D-14163 BERLIN, GERMANY.","10.1186/1475-2875-10-272","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","272",NA,"DEUTSCHE FORSCHUNGSGEMEINSCHAFT (DFG) [KR 2245/5-1]","THIS STUDY WAS SUPPORTED BY A RESEARCH GRANT FROM THE DEUTSCHE FORSCHUNGSGEMEINSCHAFT (DFG) (KR 2245/5-1). THE AUTHORS THANK GEORG VON SAMSON-HIMMELSTJERNA AND JANINA DEMELER FOR SUPPORT AND CRITICAL REVISION OF THE MANUSCRIPT.",NA,"1475-2875",NA,NA,"BIOMED CENTRAL LTD","10",2011,"ISI000295829000003","65","INFECTIOUS DISEASES, PARASITOLOGY, TROPICAL MEDICINE","8","INFECTIOUS DISEASES, PARASITOLOGY, TROPICAL MEDICINE","KRUECKEN.JUERGENVETMED.FU-BERLIN.DE",NA,"832SX",NA,"KRUCKEN, J (REPRINT AUTHOR), FREE UNIV BERLIN, INST PARASITOL \& TROP VET MED, KONIGSWEG 67, D-14163 BERLIN, GERMANY","ISI","FREE UNIV BERLIN","FREE UNIV BERLIN",NA,"EBBINGHAUS P, 2011, MALAR J","EBBINGHAUS P, 2011, MALAR J"
"HAGEN C, 2011, ARCH VIROL","HAGEN C;FRIZZI A;KAO J;JIA L;HUANG M;ZHANG Y;HUANG S","USING SMALL RNA SEQUENCES TO DIAGNOSE, SEQUENCE, AND INVESTIGATE THE INFECTIVITY CHARACTERISTICS OF VEGETABLE-INFECTING VIRUSES","ARCHIVES OF VIROLOGY","ARCH. VIROL.","IN A VIRUS-INFECTED PLANT, SMALL INTERFERING RNAS (SIRNAS) CORRESPONDING TO THE VIRAL GENOME FORM A LARGE PROPORTION OF THE SMALL RNA POPULATION. IT IS POSSIBLE TO REASSEMBLE SIGNIFICANT PORTIONS OF THE VIRUS SEQUENCE FROM OVERLAPPING SIRNA SEQUENCES AND USE THESE TO IDENTIFY THE VIRUS. WE TESTED THIS TECHNIQUE WITH A RESISTANCE-BREAKING AND A NON-RESISTANCE-BREAKING STRAIN OF TOMATO SPOTTED WILT VIRUS (TSWV). WE WERE ABLE TO ASSEMBLE CONTIGS COVERING 99\% OF THE GENOMES OF BOTH VIRUSES. THE ABUNDANCE OF TSWV SIRNAS ALLOWED US TO DETECT TSWV AT EARLY TIME POINTS BEFORE THE ONSET OF SYMPTOMS, AT LEVELS TOO LOW FOR CONVENTIONAL DETECTION. COMBINING TRADITIONAL AND BIOINFORMATIC DETECTION METHODS, WE ALSO MEASURED HOW REPLICATION OF THE RESISTANCE-BREAKING STRAIN DIFFERED FROM THE NON-RESISTANCE-BREAKING STRAIN IN SUSCEPTIBLE AND RESISTANT TOMATO VARIETIES. WE REPEATED THIS TECHNIQUE IN IDENTIFICATION OF A SQUASH-INFECTING GEMINIVIRUS AND ALSO USED IT TO IDENTIFY AN UNSPECIFIED TOSPOVIRUS.",NA,"SPOTTED-WILT-VIRUS; RESISTANCE-BREAKING STRAINS; ARABIDOPSIS-THALIANA; TOMATO; GENE; TOSPOVIRUS; PEPPER; GENOME; TSWV; INHERITANCE","ENGLISH","ARTICLE","ARTICLE",31,"ADAMS IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/J.1364-3703.2009.00545.X].;ADKINS S, 2000, MOL PLANT PATHOL, V1, P151, DOI 10.1046/J.1364-3703.2000.00022.X.;AL RWAHNIH M, 2009, VIROLOGY, V387, P395, DOI 10.1016/J.VIROL.2009.02.028.;ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;BENSON DA, 2009, NUCLEIC ACIDS RES, V37, PD26, DOI 10.1093/NAR/GKN723.;BOITEUX LS, 1994, EUPHYTICA, V75, P139, DOI 10.1007/BF00024541.;CHO J, 1996, ACTA HORTIC, V431, P367.;COETZEE B, 2010, VIROLOGY, V400, P157, DOI 10.1016/J.VIROL.2010.01.023.;DING SW, 2007, CELL, V130, P413, DOI 10.1016/J.CELL.2007.07.039.;GERMAN TL, 1995, PLANT MOL BIOL REP, V13, P110, DOI 10.1007/BF02668780.;GERMAN TL, 1992, ANNU REV PHYTOPATHOL, V30, P315, DOI 10.1146/ANNUREV.PY.30.090192.001531.;GROVES RL, 2001, PHYTOPATHOLOGY, V91, P891, DOI 10.1094/PHYTO.2001.91.9.891.;HAGEN C, 2008, PHYTOPATHOLOGY, V98, P1029, DOI 10.1094/PHYTO-98-9-1029.;HOFFMANN K, 2001, MOL PLANT MICROBE IN, V14, P242, DOI 10.1094/MPMI.2001.14.2.242.;JAHN M, 2000, MOL PLANT MICROBE IN, V13, P673, DOI 10.1094/MPMI.2000.13.6.673.;KREUZE JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/J.VIROL.2009.03.024.;LANGMEAD B, 2009, GENOME BIOL, V10, DOI 10.1186/GB-2009-10-3-R25.;LATHAM LJ, 1998, ANN APPL BIOL, V133, P385, DOI 10.1111/J.1744-7348.1998.TB05838.X.;MARGARIA P, 2007, MOL PLANT MICROBE IN, V20, P547, DOI 10.1094/MPMI-20-5-0547.;ROGGERO P, 2002, PLANT DIS, V86, P950, DOI 10.1094/PDIS.2002.86.9.950.;SPASSOVA MI, 2001, MOL BREEDING, V7, P151, DOI 10.1023/A:1011363119763.;STEVENS MR, 1991, EUPHYTICA, V59, P9.;TAKEDA A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3.;THOMAS-CARROLL ML, 2003, ANN APPL BIOL, V142, P235, DOI 10.1111/J.1744-7348.2003.TB00246.X.;TSOMPANA M, 2005, MOL ECOL, V14, P53, DOI 10.1111/J.1365-294X.2004.02392.X.;VAUCHERET H, 2006, GENE DEV, V20, P759, DOI 10.1101/GAD.1410506.;WANG XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/PNAS.0904086107.;WU QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/PNAS.0911353107.;ZERBINO DR, 2008, GENOME RES, V18, P821, DOI 10.1101/GR.074492.107.","HAGEN, C (REPRINT AUTHOR), MONSANTO CO, CALGENE CAMPUS, DAVIS, CA 95616 USA.;HAGEN, CHARLES, FRIZZI, ALESSANDRA, HUANG, SHIHSHIEH, MONSANTO CO, DAVIS, CA 95616 USA.;KAO, JOHN, JIA, LIJIE, MONSANTO VEGETABLE SEEDS, WOODLAND, CA USA.;HUANG, MINGYA, ZHANG, YUANJI, MONSANTO CO, ST LOUIS, MO USA.","10.1007/S00705-011-0979-Y","SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA",NA,NA,NA,NA,NA,"0304-8608","7","1209-1216","SPRINGER WIEN","156",2011,"ISI000292159800011","29","VIROLOGY","13","VIROLOGY","CHARLES.HAGENMONSANTO.COM",NA,"784LW",NA,"HAGEN, C (REPRINT AUTHOR), MONSANTO CO, CALGENE CAMPUS, DAVIS, CA 95616 USA","ISI","NOTREPORTED","NOTREPORTED",NA,"HAGEN C, 2011, ARCH VIROL","HAGEN C, 2011, ARCH VIROL"
"KUBOTA R, 2011, J GEN PLANT PATHOL","KUBOTA R;SCHELL MA;PECKHAM GD;RUE J;ALVAREZ AM;ALLEN C;JENKINS DM","IN SILICO GENOMIC SUBTRACTION GUIDES DEVELOPMENT OF HIGHLY ACCURATE, DNA-BASED DIAGNOSTICS FOR RALSTONIA SOLANACEARUM RACE 3 BIOVAR 2 AND BLOOD DISEASE BACTERIUM","JOURNAL OF GENERAL PLANT PATHOLOGY","J. GEN. PLANT PATHOL.","NEW RAPID DIAGNOSTIC METHODS ARE URGENTLY NEEDED TO DISCRIMINATE THE QUARANTINE PATHOGEN RALSTONIA SOLANACEARUM (RS) RACE 3 BIOVAR 2 (R3B2) FROM OTHER POPULATIONS OF RS THAT LACK THE ADAPTATION TO CAUSE BACTERIAL WILT DISEASE IN TEMPERATE REGIONS. WE USED AN IN SILICO BIOINFORMATIC APPROACH TO IDENTIFY SEVERAL GENOME SEQUENCES POTENTIALLY SPECIFIC TO R3B2 STRAINS. PRIMER SETS WERE DESIGNED TO PCR-AMPLIFY SEQUENCES IN THESE REGIONS, AND FOUR SETS WERE ULTIMATELY SHOWN TO BE > 99\% ACCURATE FOR DETECTION OF R3B2 STRAINS. ON THE BASIS OF THESE RESULTS, SEVERAL PRIMERS WERE DESIGNED TO ENABLE DEVELOPMENT OF A LOOP-MEDIATED ISOTHERMAL AMPLIFICATION ASSAY THAT WAS RAPID, TECHNOLOGICALLY SIMPLE, AND ESSENTIALLY 100\% ACCURATE FOR IDENTIFICATION OF R3B2 WHEN APPLIED TO A COMPREHENSIVE COLLECTION OF GEOGRAPHICALLY DIVERSE RS STRAINS. WE FORTUITOUSLY FOUND THAT A SEQUENCE IN ONE OF THE ``R3B2-SPECIFIC''","LOOP-MEDIATED ISOTHERMAL AMPLIFICATION; BACTERIAL WILT; POTATO BROWN ROT; PCR","MEDIATED ISOTHERMAL AMPLIFICATION; VISUAL DETECTION; SPECIES COMPLEX; IDENTIFICATION; PCR; DIVERSITY; STRAINS; PRIMERS; GENES; LAMP","ENGLISH","ARTICLE","ARTICLE",12,"CHAMPOISEAU PG, 2009, PLANT HLTH PROGR, DOI [10.1094/PHP-2009-0313-01-RV, DOI 10.1094/PHP-2009-0313-01-RV].;DENNY TP, 2006, PLANT-ASSOCIATED BACTERIA, P573.;ELPHINSTONE J. G., 2005, BACTERIAL WILT DISEASE AND THE RALSTONIA SOLANACEARUM SPECIES COMPLEX, P9.;ELPHINSTONE JG, 1998, BACTERIAL WILT DISEASE, P133.;FEGAN M, 2006, AUSTRALAS PLANT PATH, V35, P93, DOI 10.1071/AP05105.;FEGAN M., 2005, BACTERIAL WILT DISEASE AND THE RALSTONIA SOLANACEARUM SPECIES COMPLEX, P449.;FEGAN M, 1998, BACTERIAL WILT DISEASE, P34.;GABRIEL DW, 2006, MOL PLANT MICROBE IN, V19, P69, DOI 10.1094/MPMI-19-0069.;GUIDOT A, 2009, PHYTOPATHOLOGY, V99, P1105, DOI 10.1094/PHYTO-99-9-1105.;JANSE JD, 2004, J PLANT PATHOL, V86, P147.;JENKINS DM, 2009, SENSOR ACTUAT B-CHEM, V137, P222, DOI 10.1016/J.SNB.2008.09.046.;JI PS, 2007, PLANT DIS, V91, P195, DOI 10.1094/PDIS-91-2-0195.;KIM S. H., 2003, PLANT DISEASE, V87, P450, DOI 10.1094/PDIS.2003.87.4.450C.;KUBOTA R, 2008, PHYTOPATHOLOGY, V98, P1045, DOI 10.1094/PHYTO-98-9-1045.;KUBOTA R, 2009, 097412 ASABE.;LAMBERT CD, 2002, FED REGISTER, V67, P76908.;LEUNG PINGSUN, 2008, EC IMPACTS INCREASIN.;MAEDA H, 2005, FEMS IMMUNOL MED MIC, V43, P233, DOI 10.1016/J.FEMSIM.2004.08.005.;MAHJOOB S, 2008, INT J HEAT MASS TRAN, V51, P2109, DOI 10.1016/J.IJHEATMASSTRANSFER.2007.11.014.;MALTEZOS G, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3046789.;MORI Y, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-3.;MORI Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/BBRC.2001.5921.;NAGAMINE K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/MCPR.2002.0415.;NORMAN D, 1989, PLANT DIS, V73, P654, DOI 10.1094/PD-73-0654.;NOTOMI T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/NAR/28.12.E63.;OPINA N, 1997, ASIA-PAC J MOL BIOL, V5, P19.;PARET ML, 2010, HORTTECHNOLOGY, V20, P539.;POUSSIER S, 2000, SYST APPL MICROBIOL, V23, P479, DOI 10.1016/S0723-2020(00)80021-1.;POUSSIER S, 2000, MICROBIOL-SGM, V146, P1679, DOI 10.1099/00221287-146-7-1679.;PRIOR P., 2005, BACTERIAL WILT DISEASE AND THE RALSTONIA SOLANACEARUM SPECIES COMPLEX, P405.;SCHONFELD J, 2003, APPL ENVIRON MICROB, V69, P7248, DOI 10.1128/AEM.69.12.7248-7254.2003.;SUPRIADI, 2005, BACTERIAL WILT DISEASE AND THE RALSTONIA SOLANACEARUM SPECIES COMPLEX, P395.;SWANSON JK, 2007, PLANT DIS, V91, P828, DOI 10.1094/PDIS-91-7-0828.;TOMITA N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/NPROT.2008.57.;ULRICH RL, 2006, DIAGN MICR INFEC DIS, V55, P37, DOI 10.1016/J.DIAGMICROBIO.2005.11.007.;VILLA JOSELITO E., 2005, JOURNAL OF GENERAL PLANT PATHOLOGY, V71, P39, DOI 10.1007/S10327-004-0156-1.;WEIGL B, 2008, LAB CHIP, V8, P1999, DOI 10.1039/B811314A.;XIANG Q, 2007, BIOMED MICRODEVICES, V9, P443, DOI 10.1007/S10544-007-9048-4.","JENKINS, DM (REPRINT AUTHOR), UNIV HAWAII, DEPT MOL BIOSCI \& BIOENGN, HONOLULU, HI 96822 USA.;KUBOTA, RYO, JENKINS, DANIEL M., UNIV HAWAII, DEPT MOL BIOSCI \& BIOENGN, HONOLULU, HI 96822 USA.;SCHELL, MARK A., RUE, JOANNE, UNIV GEORGIA, DEPT MICROBIOL \& PLANT PATHOL, ATHENS, GA 30602 USA.;PECKHAM, GABRIEL D., ALVAREZ, ANNE M., UNIV HAWAII, DEPT PLANT \& ENVIRONM PROTECT SCI, HONOLULU, HI 96822 USA.;ALLEN, CAITILYN, UNIV WISCONSIN, DEPT PLANT PATHOL, MADISON, WI 53706 USA.","10.1007/S10327-011-0305-2","1-11-11 KUDAN-KITA, CHIYODA-KU, TOKYO, 102-0073, JAPAN",NA,NA,"USDA-NRI [07-55605-17843, 2005-55605-16683], USDA-TSTAR [HAW00559-04G]","WE GRATEFULLY ACKNOWLEDGE THE SUPPORT FROM USDA-NRI PLANT BIOSECURITY AWARD 07-55605-17843, USDA-NRI PROJECT 2005-55605-16683, AND USDA-TSTAR PROJECT HAW00559-04G AND THE GIFT OF RESEARCH MATERIALS FROM AGDIA, INC.",NA,"1345-2630","3","182-193","SPRINGER TOKYO","77",2011,"ISI000289901900006","38","PLANT SCIENCES","17","PLANT SCIENCES","DANIELJEHAWAII.EDU",NA,"755BP",NA,"JENKINS, DM (REPRINT AUTHOR), UNIV HAWAII, DEPT MOL BIOSCI \& BIOENGN, HONOLULU, HI 96822 USA","ISI","UNIV HAWAII;UNIV GEORGIA;UNIV HAWAII;UNIV WISCONSIN","UNIV HAWAII",NA,"KUBOTA R, 2011, J GEN PLANT PATHOL","KUBOTA R, 2011, J GEN PLANT PATHOL"
"CORRALES I, 2011, J THROMB HAEMOST","CORRALES I;RAMIREZ L;ALTISENT C;PARRA R;VIDAL F","THE STUDY OF THE EFFECT OF SPLICING MUTATIONS IN VON WILLEBRAND FACTOR USING RNA ISOLATED FROM PATIENTS' PLATELETS AND LEUKOCYTES","JOURNAL OF THROMBOSIS AND HAEMOSTASIS","J. THROMB. HAEMOST.","BACKGROUND: IN VON WILLEBRAND FACTOR (VWF) THE EFFECT OF MUTATIONS POTENTIALLY AFFECTING MRNA PROCESSING OR SPLICING IS LESS PREDICTABLE THAN THAT OF OTHER MUTATIONS (E.G. NONSENSE OR MISSENSE SUBSTITUTIONS). BIOINFORMATIC TOOLS CAN PROVIDE A VALUABLE MEANS TO DETERMINE THE CONSEQUENCES OF POTENTIAL SPLICE SITE MUTATIONS (PSSM), BUT FUNCTIONAL STUDIES ARE MANDATORY TO ELUCIDATE THE TRUE EFFECT OF THE VARIATION DETECTED. OBJECTIVES, PATIENTS AND METHODS: AFTER IDENTIFICATION OF PSSM IN VWD PATIENTS, WE BEGAN A SYSTEMATIC STUDY OF THEIR IN VIVO EFFECT IN RNA EXTRACTED FROM THE PATIENTS' PLATELETS AND LEUKOCYTES. RESULTS AND CONCLUSIONS: THIRTEEN PAIRS OF PRIMERS WERE DESIGNED FOR FULL AMPLIFICATION OF VWF MRNA BY RTPCR THAT, AFTER SEQUENCING OF ABERRANT PRODUCTS, ENABLED ELUCIDATION OF THE PSSM CONSEQUENCES FOR MRNA PROCESSING. THIS PROCEDURE WAS USED TO STUDY SEVEN DIFFERENT PSSM IDENTIFIED IN FOUR PATIENTS DEMONSTRATING DIVERSE MOLECULAR MECHANISMS SUCH AS EXON SKIPPING (C.533-2A > G AND C.8155 + 3G > C) AND THE ACTIVATION OF A CRYPTIC SPLICE SITE (C.7730-1G > C). NO VISIBLE EFFECT WAS EVIDENT FOR C.1533 + 15G > A AND C.5170 + 10C > T AND THE CONSEQUENCE OF C.[546G > A, 7082-2A > G] WAS HIDDEN BY NONSENSE-MEDIATED MRNA DECAY (NMD). RESULTS WERE COMPARED WITH IN SILICO PREDICTIONS OF FOUR SPLICE-SITE ANALYSIS TOOLS. WE DEMONSTRATE SELECTIVE DEGRADATION OF VWF MRNA BEARING PSSM BY NMD FOR SEVERAL MUTATIONS, WHICH SUGGESTS THAT NMD REPRESENTS A GENERAL MECHANISM FOR TRUNCATING MUTATIONS IN VWF. FURTHERMORE, BECAUSE NMD EFFICIENCY VARIES BETWEEN CELL TYPES, USE OF RNA FROM BOTH PLATELETS AND LEUKOCYTES FOR IN VIVO STUDY OF VWF PSSM OFFERS COMPLEMENTARY RESULTS, PARTICULARLY IN CASES IN WHICH NMD OCCURS IN THE ALLELE CARRYING THE MUTATION.","ALTERNATIVE SPLICING; EXON SKIPPING; NONSENSE MEDIATED MRNA DECAY; SPLICE-SITE MUTATION; SYNONYMOUS MUTATION","ECTOPIC TRANSCRIPT ANALYSIS; MESSENGER-RNA; SITE MUTATION; MOLECULAR DIAGNOSIS; FACTOR GENE; DISEASE; NONSENSE; FAMILIES; DECAY; PREDICTION","ENGLISH","ARTICLE","ARTICLE",11,"BARONCIANI L, 2003, BLOOD CELL MOL DIS, V30, P264, DOI 10.1016/S1079-9796(03)00033-0.;BERBER E, 2009, J THROMB HAEMOST, V7, P1672, DOI 10.1111/J.1538-7836.2009.03551.X.;BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/JBC.270.6.2411.;BIDICHANDANI SI, 1995, HUM GENET, V95, P531.;BYERS PH, 2002, J CLIN INVEST, V109, P3, DOI 10.1172/JCI14841.;CARTEGNI L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/NRG775.;COOPER DN, 1994, ANN MED, V26, P9, DOI 10.3109/07853899409147321.;CORRALES I, 2010, HAEMATOL-HEMATOL J, V95, P1982, DOI 10.3324/HAEMATOL.2010.028977.;CORRALES I, 2009, THROMB HAEMOSTASIS, V101, P570, DOI 10.1160/TH08-08-0500.;CUMMING A, 2006, THROMB HAEMOSTASIS, V96, P630, DOI 10.1160/TH06-07-0383.;EIKENBOOM JCJ, 1993, LANCET, V341, P982, DOI 10.1016/0140-6736(93)91070-3.;FINK L, 2003, THROMB HAEMOSTASIS, V90, P749, DOI 10.1160/TH03-02-0095.;GALLINARO L, 2006, THROMB HAEMOSTASIS, V96, P711, DOI 10.1160/TH06-07-0417.;GOODEVE A, 2007, BLOOD, V109, P112, DOI 10.1182/BLOOD-2006-05-020784.;GOODEVE AC, 2010, BLOOD REV, V24, P123, DOI 10.1016/J.BLRE.2010.03.003.;HOUDAYER C, 2008, HUM MUTAT, V29, P975, DOI 10.1002/HUMU.20765.;*INT SOC THROMB HA, VWFDB.","VIDAL, F (REPRINT AUTHOR), BANC SANG \& TEIXITS, UNITAT DIAGNOST \& TERAPIA MOL, PASSEIG VALL DHEBRON 119-129, BARCELONA 08035, SPAIN.;CORRALES, I., RAMIREZ, L., PARRA, R., VIDAL, F., BANC SANG \& TEIXITS, UNITAT DIAGNOST \& TERAPIA MOL, BARCELONA 08035, SPAIN.;ALTISENT, C., PARRA, R., HOSP GEN VALLE HEBRON, UNITAT HEMOFILIA, BARCELONA, SPAIN.","10.1111/J.1538-7836.2011.04204.X","COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA",NA,NA,"FONDO DE INVESTIGACIONES SANITARIAS, SPANISH MINISTRY OF SCIENCE AND INNOVATION (FIS) [PI080385], FUNDACIO PRIVADA CATALANA DE L'HEMOFILIA","THIS PROJECT WAS SUPPORTED IN PART WITH A GRANT (FIS, PI080385) FROM THE FONDO DE INVESTIGACIONES SANITARIAS, SPANISH MINISTRY OF SCIENCE AND INNOVATION. WE ARE GRATEFUL TO THE FUNDACIO PRIVADA CATALANA DE L'HEMOFILIA FOR THEIR FUNDING FOR THIS PROJECT. WE ARE GRATEFUL TO N. KELLEHER FOR HIS ASSISTANCE WITH THE ENGLISH REVISION OF THIS MANUSCRIPT.",NA,"1538-7933","4","679-688","WILEY-BLACKWELL","9",2011,"ISI000289156800008","35","HEMATOLOGY, CARDIOVASCULAR SYSTEM \& CARDIOLOGY","3","HEMATOLOGY, PERIPHERAL VASCULAR DISEASE","FVIDALBSTCAT.NET",NA,"745HP",NA,"VIDAL, F (REPRINT AUTHOR), BANC SANG \& TEIXITS, UNITAT DIAGNOST \& TERAPIA MOL, PASSEIG VALL DHEBRON 119-129, BARCELONA 08035, SPAIN","ISI","HOSP GEN VALLE HEBRON","NOTREPORTED",NA,"CORRALES I, 2011, J THROMB HAEMOST","CORRALES I, 2011, J THROMB HAEMOST"
"KULSETH MA, 2011, EUR J MED GENET","KULSETH MA;LYLE R;RODNINGEN OK;SORTE H;PRESCOTT T","EXON TRAPPING ANALYSIS OF C.301-19G > A IN INTRON 1 OF THE SHH GENE IN A PATIENT WITH A MICROFORM OF HOLOPROSENCEPHALY","EUROPEAN JOURNAL OF MEDICAL GENETICS","EUR. J. MED. GENET.","IT CAN BE DIFFICULT TO ASSESS THE CLINICAL SIGNIFICANCE OF NOVEL GENOMIC SEQUENCE VARIANTS WHICH MAY POTENTIALLY ALTER MRNA SPLICING. SEGREGATION ANALYSIS IS NOT HELPFUL IN ISOLATED CASES OR SMALL FAMILIES. BIOINFORMATIC TOOLS CAN PROVIDE ADDITIONAL INFORMATION, BUT DIRECT ANALYSIS OF MRNA FROM AN APPROPRIATE TISSUE REMAINS THE PREFERRED APPROACH FOR ANALYZING THE EFFECT OF A SEQUENCE VARIANT ON SPLICING. HOWEVER, HUNDREDS OF DISEASE-ASSOCIATED AND DEVELOPMENTAL GENES, INCLUDING THE SONIC HEDGEHOG HOMOLOG (SHH) GENE, ARE NOT EXPRESSED IN BLOOD OR FIBROBLASTS POSTNATALLY. WE IDENTIFIED A DE NOVO NUCLEOTIDE CHANGE, C.301-19G > A, IN INTRON 1 OF SHH IN A FOUR YEAR OLD BOY WITH A MICROFORM OF HOLOPROSENCEPHALY. IN SILICO ANALYSES PREDICTED UNALTERED SPLICING. WE USED A MINIGENE APPROACH TO STUDY THE VARIANT MORE CLOSELY. THE GENOMIC REGION OF INTEREST WAS INSERTED INTO AN EXON TRAPPING VECTOR TO CREATE AN ARTIFICIAL PRE-MRNA IN TRANSFECTED CELLS. WE FOUND VIRTUALLY COMPLETE INACTIVATION OF THE SPLICE ACCEPTOR SITE IN INTRON 1 IN TWO DIFFERENT TRANSFECTED CELL LINES. IN LIGHT OF THE CLINICAL CONTEXT, THE DE NOVO NATURE OF THE SUBSTITUTION AND THE RESULTS OF THE EXON TRAPPING ANALYSES, WE CONCLUDE THAT THE DETECTED VARIANT IS PATHOGENIC AND THAT THE RECURRENCE RISK FOR SIBS IS LOW. THIS CASE DEMONSTRATES THAT IN THE ABSENCE OF A READILY AVAILABLE MRNA SOURCE, EXON TRAPPING CAN BE A ROBUST AND PRACTICAL AID IN CLINICAL PRACTICE FOR ASSESSING THE EFFECT OF GENOMIC VARIANTS ON PRE-MRNA SPLICING. (C) 2010 ELSEVIER MASSON SAS. ALL RIGHTS RESERVED.","EXON TRAPPING; MINIGENE; SHH; HOLOPROSENCEPHALY; SPLICING; VARIANT OF UNCERTAIN SIGNIFICANCE; SPLICE MUTATION; BLOOD; FIBROBLASTS; GENE EXPRESSION","RNA; MUTATION; DISEASE; PREDICTION; DONOR","ENGLISH","ARTICLE","ARTICLE",1,"BARALLE D, 2009, EMBO REP, V10, P810, DOI 10.1038/EMBOR.2009.170.;BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O.;BURATTI E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/NAR/GKL498.;COGAN JD, 1997, HUM MOL GENET, V6, P909, DOI 10.1093/HMG/6.6.909.;COOPER TA, 2009, CELL, V136, P777, DOI 10.1016/J.CELL.2009.02.011.;ENGEL K, 2008, MOL GENET METAB, V94, P292, DOI 10.1016/J.YMGME.2008.03.009.;FAA V, 2009, J BIOL CHEM.;MARTINEZ-CONTRERAS R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/JOURNAL.PBIO.0040021.;MASUDA A, 2008, HUM MOL GENET, V17, P4022, DOI 10.1093/HMG/DDN305.;MAYDAN G, 2006, J INHERIT METAB DIS, V29, P620, DOI 10.1007/S10545-006-0407-8.;MING JE, 2002, AM J HUM GENET, V71, P1017, DOI 10.1086/344412.;ORIOLI IM, 2010, AM J MED GENET C, V154C, P13, DOI 10.1002/AJMG.C.30233.;POHLENZ J, 2002, J CLIN ENDOCR METAB, V87, P336, DOI 10.1210/JC.87.1.336.;REESE MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/CMB.1997.4.311.;ROESSLER E, 2009, HUM MUTAT, V30, PE921, DOI 10.1002/HUMU.21090.;ROESSLER E, 2010, AM J MED GENET C, V154C, P52, DOI 10.1002/AJMG.C.30236.;SCHAUB MC, 2007, J BIOL CHEM, V282, P13617, DOI 10.1074/JBC.M700774200.;SOLOMON BD, 2010, AM J MED GENET C, V154C, P133, DOI 10.1002/AJMG.C.30240.;SPURDLE AB, 2008, HUM MUTAT, V29, P1304, DOI 10.1002/HUMU.20901.;WANG GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/NRG2164.","KULSETH, MA (REPRINT AUTHOR), OSLO UNIV HOSP, DEPT MED GENET, OSLO, NORWAY.;KULSETH, MARI ANN, LYLE, ROBERT, RODNINGEN, OLAUG K., SORTE, HANNE, PRESCOTT, TRINE, OSLO UNIV HOSP, DEPT MED GENET, OSLO, NORWAY.","10.1016/J.EJMG.2010.10.011","PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",NA,NA,NA,NA,NA,"1769-7212","2","130-135","ELSEVIER SCIENCE BV","54",2011,"ISI000293744000006","20","GENETICS \& HEREDITY","2","GENETICS \& HEREDITY","MARI.ANN.KULSETHOSLO-UNIVERSITETSSYKEHUS.NO",NA,"805QL",NA,"KULSETH, MA (REPRINT AUTHOR), OSLO UNIV HOSP, DEPT MED GENET, OSLO, NORWAY","ISI","OSLO UNIV HOSP","OSLO UNIV HOSP",NA,"KULSETH MA, 2011, EUR J MED GENET","KULSETH MA, 2011, EUR J MED GENET"
"MITHANI A, 2011, MOL BIOL EVOL","MITHANI A;HEIN J;PRESTON GM","COMPARATIVE ANALYSIS OF METABOLIC NETWORKS PROVIDES INSIGHT INTO THE EVOLUTION OF PLANT PATHOGENIC AND NONPATHOGENIC LIFESTYLES IN PSEUDOMONAS","MOLECULAR BIOLOGY AND EVOLUTION","MOL. BIOL. EVOL.","PLANT PATHOGENIC PSEUDOMONADS SUCH AS PSEUDOMONAS SYRINGAE COLONIZE PLANT SURFACES AND TISSUES AND HAVE BEEN REPORTED TO BE NUTRITIONALLY SPECIALIZED RELATIVE TO NONPATHOGENIC PSEUDOMONADS. WE PERFORMED COMPARATIVE ANALYSES OF METABOLIC NETWORKS RECONSTRUCTED FROM GENOME SEQUENCE DATA IN ORDER TO INVESTIGATE THE HYPOTHESIS THAT P. SYRINGAE HAS EVOLVED TO BE METABOLICALLY SPECIALIZED FOR A PLANT PATHOGENIC LIFESTYLE. WE USED THE METABOLIC NETWORK COMPARISON TOOL RAHNUMA AND COMPLEMENTARY BIOINFORMATIC ANALYSES TO COMPARE THE DISTRIBUTION OF 1,299 METABOLIC REACTIONS ACROSS NINE GENOME-SEQUENCED STRAINS OF PSEUDOMONAS, INCLUDING THREE STRAINS OF P. SYRINGAE. THE TWO PATHOGENIC PSEUDOMONAS SPECIES ANALYZED, P. SYRINGAE AND THE OPPORTUNISTIC HUMAN PATHOGEN P. AERUGINOSA, EACH DISPLAYED A HIGH LEVEL OF INTRASPECIES METABOLIC SIMILARITY COMPARED WITH NONPATHOGENIC PSEUDOMONAS. THE THREE P. SYRINGAE STRAINS LACKED A SIGNIFICANT NUMBER OF REACTIONS PREDICTED TO BE PRESENT IN ALL OTHER PSEUDOMONAS STRAINS ANALYZED, WHICH IS CONSISTENT WITH THE HYPOTHESIS THAT P. SYRINGAE IS ADAPTED FOR GROWTH IN A NUTRITIONALLY CONSTRAINED ENVIRONMENT. PATHWAY PREDICTIONS DEMONSTRATED THAT SOME OF THE DIFFERENCES DETECTED IN METABOLIC NETWORK COMPARISONS COULD ACCOUNT FOR DIFFERENCES IN AMINO ACID ASSIMILATION ABILITY REPORTED IN EXPERIMENTAL ANALYSES. PARSIMONY ANALYSIS AND REACTION NEIGHBORHOOD APPROACHES WERE USED TO MODEL THE EVOLUTION OF METABOLIC NETWORKS AND AMINO ACID ASSIMILATION PATHWAYS IN PSEUDOMONADS. BOTH METHODS SUPPORTED A MODEL OF PSEUDOMONAS EVOLUTION IN WHICH THE COMMON ANCESTOR OF P. SYRINGAE HAD EXPERIENCED A SIGNIFICANT NUMBER OF DELETION EVENTS RELATIVE TO OTHER NONPATHOGENIC PSEUDOMONADS. WE DISCUSS HOW THE CHARACTERISTIC METABOLIC FEATURES OF P. SYRINGAE COULD REFLECT ADAPTATION TO A PATHOGENIC LIFESTYLE.","METABOLIC PATHWAY; AMINO ACID; PSEUDOMONAS; PSEUDOMONAD; ANCESTRAL NETWORK; PLANT PATHOGEN","COMPLETE GENOME SEQUENCE; PV. PHASEOLICOLA 1448A; ESCHERICHIA-COLI; TOMATO DC3000; SYRINGAE; AERUGINOSA; GENES; PATHWAYS; COLONIZATION; RECONSTRUCTION","ENGLISH","ARTICLE","ARTICLE",24,"ANFORA AT, 2007, INFECT IMMUN, V75, P5298, DOI 10.1128/IAI.00652-07.;ARAI H, 2003, MICROBIOL-SGM, V149, P29, DOI 10.1099/MIC.0.25936-0.;BEATTIE GA, 1999, PHYTOPATHOLOGY, V89, P353, DOI 10.1094/PHYTO.1999.89.5.353.;BENTLEY SD, 2008, J BACTERIOL, V190, P2150, DOI 10.1128/JB.01598-07.;BLACKMORE MA, 1971, J GEN MICROBIOL, V67, P243, DOI 10.1099/00221287-67-2-243.;CASPI R, 2008, NUCLEIC ACIDS RES, V36, PD623, DOI 10.1093/NAR/GKM900.;CHEN C, 2008, J BACTERIOL, V190, P2717, DOI 10.1128/JB.01585-07.;CIOFU O, 2010, MICROBIOL-SGM, V156, P1108, DOI 10.1099/MIC.0.033993-0.;COLLMER A, 2002, TRENDS MICROBIOL, V10, P462, DOI 10.1016/S0966-842X(02)02451-4.;CONWAY T, 1992, FEMS MICROBIOL LETT, V103, P1.;DEL CASTILLO T, 2008, J BACTERIOL, V190, P2331, DOI 10.1128/JB.01726-07.;EFRON B, 1994, INTRO BOOTSTRAP.;ERIKSON O, 2005, PLANT MOL BIOL, V57, P425, DOI 10.1007/S11103-004-7902-9.;FARROW JM, 2007, J BACTERIOL, V189, P3425, DOI 10.1128/JB.00209-07.;FEIL H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/PNAS.0504930102.;FELSENSTEIN J, 1996, METHOD ENZYMOL, V266, P418.;FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/SCIENCE.155.3760.279.;FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116.;FORSTER-FROMME K, 2008, FEMS MICROBIOL LETT, V286, P78, DOI 10.1111/J.1574-6968.2008.01266.X.;FORST CV, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-67.;FUHRER T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005.;GOTO M, 2005, J BIOL CHEM, V280, P40875, DOI 10.1074/JBC.M507399200.;HJERDE E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-616.;HOLDEN MTG, 2009, PLOS PATHOG, V5, DOI 10.1371/JOURNAL.PPAT.1000346.;JOARDAR V, 2005, MOL PLANT PATHOL, V6, P53, DOI 10.1111/J.1364-3703.2004.00263.X.;JOARDAR V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005.;KANEHISA M, 2008, NUCLEIC ACIDS RES, V36, PD480, DOI 10.1093/NAR/GKM882.;LESSIE TG, 1984, ANNU REV MICROBIOL, V38, P359, DOI 10.1146/ANNUREV.MI.38.100184.002043.;LIGHT S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-159.;LINDEBERG M, 2008, MOL PLANT MICROBE IN, V21, P685, DOI 10.1094/MPMI-21-6-0685.;LINDEBERG M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S4.;LINDOW SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003.;LIU Y, 2004, GENOME BIOL, V5, DOI 10.1186/GB-2004-5-9-R64.;LOPER JE, 2007, EUR J PLANT PATHOL, V119, P265, DOI 10.1007/S10658-007-9179-8.;LUGTENBERG BJJ, 2001, ANNU REV PHYTOPATHOL, V39, P461, DOI 10.1146/ANNUREV.PHYTO.39.1.461.;MA HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/BIOINFORMATICS/19.2.270.;MERLIN C, 2003, J BACTERIOL, V185, P6415, DOI 10.1128/JB.185.21.6415-6424.2003.;MITHANI A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/JOURNAL.PCBI.1000868.;MITHANI A, 2009, BIOINFORMATICS, V25, P1831, DOI 10.1093/BIOINFORMATICS/BTP269.;NELSON KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/J.1462-2920.2002.00366.X.;NOGALES J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-79.;OBERHARDT MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07.;PARKHILL J, 2003, NAT GENET, V35, P32, DOI 10.1038/NG1227.;PERUMAL D, 2008, INT J BIOL SCI, V4, P309.;PLATT MD, 2008, J BACTERIOL, V190, P2739, DOI 10.1128/JB.01683-07.;PRESTON GM, 2004, PHILOS T R SOC B, V359, P907, DOI 10.1098/RSTB.2003.1384.;RAKHIMOVA E, 2009, J INFECT DIS, V200, P1928, DOI 10.1086/648404.;REYNOLDS PE, 2005, ANTIMICROB AGENTS CH, V49, P21, DOI 10.1128/AAC.49.1.21-25.2005.;RICO A., 2008, PLANT PATHOGENIC BAC, P63.;RICO A, 2008, MOL PLANT MICROBE IN, V21, P269, DOI 10.1094/MPMI-21-2-0269.;SARKAR SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004.;SILBY MW, 2009, GENOME BIOL, V10, DOI 10.1186/GB-2009-10-5-R51.;SOHLENKAMP C, 2003, PROG LIPID RES, V42, P115, DOI 10.1016/S0163-7827(02)00050-4.;STUDHOLME DJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-17.;VENCATO M, 2006, MOL PLANT MICROBE IN, V19, P1193, DOI 10.1094/MPMI-19-1193.;VODOVAR N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/NBT1212.;WALKER TS, 2004, PLANT PHYSIOL, V134, P320, DOI 10.1104/PP.103.027888.;WANG Z, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-100.;WILLIAMS H. D., 2006, ADV MICROB PHYSL, V52, P1.;YAMAMOTO S, 2000, MICROBIOL-UK, V146, P2385, DOI 10.1099/00221287-146-10-2385.;YAMANISHI Y, 2007, FEBS J, V274, P2262, DOI 10.1111/J.1742-4658.2007.05763.X.;YEUNG M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-363.","PRESTON, GM (REPRINT AUTHOR), UNIV OXFORD, DEPT PLANT SCI, OXFORD, ENGLAND.;PRESTON, GAIL M., UNIV OXFORD, DEPT PLANT SCI, OXFORD, ENGLAND.;MITHANI, AZIZ, HEIN, JOTUN, UNIV OXFORD, DEPT STAT, OXFORD OX1 3TG, ENGLAND.","10.1093/MOLBEV/MSQ213","GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND",NA,NA,"HIGHER EDUCATION COMMISSION, GOVERNMENT OF PAKISTAN, BIOTECHNOLOGY AND BIOLOGICAL SCIENCES RESEARCH COUNCIL [BB/E007872/1]","WE WOULD LIKE TO THANK ROBERT JACKSON, RUNE LYNGSO, CRAIG MACLEAN, ISTVAN MIKLOS, AND ARANTZA RICO FOR COMMENTS ON A DRAFT OF THIS MANUSCRIPT. GAIL PRESTON IS A ROYAL SOCIETY UNIVERSITY RESEARCH FELLOW. THIS WORK WAS SUPPORTED BY GRANTS FROM THE HIGHER EDUCATION COMMISSION, GOVERNMENT OF PAKISTAN AND BY THE BIOTECHNOLOGY AND BIOLOGICAL SCIENCES RESEARCH COUNCIL (GRANT BB/E007872/1).",NA,"0737-4038","1","483-499","OXFORD UNIV PRESS","28",2011,"ISI000285418600049","62","BIOCHEMISTRY \& MOLECULAR BIOLOGY, EVOLUTIONARY BIOLOGY, GENETICS \& HEREDITY","13","BIOCHEMISTRY \& MOLECULAR BIOLOGY, EVOLUTIONARY BIOLOGY, GENETICS \& HEREDITY","GAIL.PRESTONPLANTS.OX.AC.UK",NA,"696CD",NA,"PRESTON, GM (REPRINT AUTHOR), UNIV OXFORD, DEPT PLANT SCI, OXFORD, ENGLAND","ISI","UNIV OXFORD;UNIV OXFORD","UNIV OXFORD",NA,"MITHANI A, 2011, MOL BIOL EVOL","MITHANI A, 2011, MOL BIOL EVOL"
"JOSEPH SJ, 2010, TRENDS BIOTECHNOL","JOSEPH SJ;READ TD","BACTERIAL POPULATION GENOMICS AND INFECTIOUS DISEASE DIAGNOSTICS","TRENDS IN BIOTECHNOLOGY","TRENDS BIOTECHNOL.","NEW SEQUENCING TECHNOLOGIES HAVE MADE THE PRODUCTION OF BACTERIAL GENOME SEQUENCES INCREASINGLY EASY, AND IT CAN BE CONFIDENTLY FORECASTED THAT VAST GENOMIC DATABASES WILL BE GENERATED IN THE NEXT FEW YEARS HERE, WE DETAIL HOW COLLECTIONS OF BACTERIAL GENOMES FROM A PARTICULAR SPECIES (POPULATION GENOMICS LIBRARIES) HAVE ALREADY BEEN USED TO IMPROVE THE DESIGN OF SEVERAL DIAGNOSTIC ASSAYS FOR BACTERIAL PATHOGENS GENOME SEQUENCING ITSELF IS ALSO BECOMING MORE COMMONLY USED FOR EPIDEMIOLOGICAL, FORENSIC AND CLINICAL INVESTIGATIONS THERE IS AN OPPORTUNITY FOR THE FURTHER DEVELOPMENT OF BIOINFORMATIC TOOLS TO BRING EVEN FURTHER VALUE TO BACTERIAL DIAGNOSTIC GENOMICS",NA,"TANDEM-REPEAT ANALYSIS; REAL-TIME PCR; BACILLUS-ANTHRACIS; DNA MICROARRAY; STREPTOCOCCUS-AGALACTIAE; GENETIC-RELATIONSHIPS; ESCHERICHIA-COLI; RAPID DETECTION; MULTIPLEX PCR; PAN-GENOME","ENGLISH","REVIEW","ARTICLE",19,"ACHTMAN M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/ANNUREV.MICRO.62.081307.162832.;AL AMRI A, 2007, J MED MICROBIOL, V56, P1350, DOI 10.1099/JMM.0.47220-0.;AMBUR OH, 2009, FEMS MICROBIOL REV, V33, P453, DOI 10.1111/J.1574-6976.2009.00173.X.;APTE ARUN, 2007, V402, P329.;AZIZ RK, 2010, SCI TRANSL MED, V2, DOI 10.1126/SCITRANSLMED.3000713.;BALDRY S, 2010, NAT REV MICROBIOL, V8, P390, DOI 10.1038/NRMICRO2369.;BEN SHABAT M, 2010, J CLIN MICROBIOL, V48, P2909, DOI 10.1128/JCM.00699-10.;BEN-DARIF E, 2010, J CLIN MICROBIOL, V48, P1055, DOI 10.1128/JCM.01566-09.;BENTLEY SD, 2004, ANNU REV GENET, V38, P771, DOI 10.1146/ANNUREV.GENET.38.072902.094318.;BENTLEY S, 2009, NAT REV MICROBIOL, V7, P258, DOI 10.1038/NRMICRO2123.;BERES SB, 2010, P NATL ACAD SCI USA, V107, P4371, DOI 10.1073/PNAS.0911295107.;BERGLUND EC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/JOURNAL.PCBI.1000481.;BEST EL, 2005, J MED MICROBIOL, V54, P919, DOI 10.1099/JMM.0.45971-0.;BOUAKAZE C, 2010, J CLIN MICROBIOL, V48, P1758, DOI 10.1128/JCM.02255-09.;BRIESE T, 2009, PLOS PATHOG, V5, DOI 10.1371/JOURNAL.PPAT.1000455.;BRUSSOW H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004.;BURRUS V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/J.RESMIC.2004.01.012.;CHAIN PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/SCIENCE.1180614.;CHEN PE, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0012397.;COMAS I, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0007815.;DEAN D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/EID1509.090272.;DIDELOT X, 2010, TRENDS MICROBIOL, V18, P315, DOI 10.1016/J.TIM.2010.04.002.;FRICKE WF, 2009, PLOS BIOL, V7, DOI 10.1371/JOURNAL.PBIO.1000217.;GILMOUR MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120.;GOECKS J, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-8-R86.;GRICE EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/SCIENCE.1171700.;GRYADUNOV D, 2005, CLIN MICROBIOL INFEC, V11, P531, DOI 10.1111/J.1469-0691.2005.01183.X.;HARRIS SR, 2010, SCIENCE, V327, P469, DOI 10.1126/SCIENCE.1182395.;HOLT KE, 2008, NAT GENET, V40, P987, DOI 10.1038/NG.195.;HOLT KE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-144.;INCE J, 2009, EXPERT REV MED DEVIC, V6, P641, DOI [10.1586/ERD.09.46, 10.1586/ERD.09.46].;IOERGER TR, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0007778.;JOHANSSON A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004.;KEIM P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000.;KIMURA B, 2001, APPL ENVIRON MICROB, V67, P206, DOI 10.1128/AEM.67.1.206-216.2001.;KOSTRZYNSKA M, 2006, CAN J MICROBIOL, V52, P1, DOI 10.1139/W05-105.;KURODA M, 2010, J CLIN MICROBIOL, V48, P2821, DOI 10.1128/JCM.00137-10.;LEFEBURE T, 2007, GENOME BIOL, V8, DOI 10.1186/GB-2007-8-5-R71.;LEINBERGER DM, 2010, J CLIN MICROBIOL, V48, P460, DOI 10.1128/JCM.00765-09.;LEWIS T, 2010, J HOSP INFECT, V75, P37, DOI 10.1016/J.JHIN.2010.01.012.;MAIDEN MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/ANNUREV.MICRO.59.030804.121325.;MCNAMARA SE, 2009, J CLIN MICROBIOL, V47, P596, DOI 10.1128/JCM.01693-08.;MIRA A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7.;MORSE SA, 2006, INFECT DIS CLIN N AM, V20, P455, DOI 10.1016/J.IDC.2006.03.004.;MOSER MJ, 2006, J MOL DIAGN, V8, P89, DOI 10.2353/JMOLDX.2006.050049.;NAKAMURA A, 2010, J CLIN MICROBIOL, V48, P2030, DOI 10.1128/JCM.01700-09.;NORDBERG EK, 2005, BIOINFORMATICS, V21, P1365, DOI 10.1093/BIOINFORMATICS/BTI182.;O'SULLIVAN MVN, 2010, J CLIN MICROBIOL, V48, P2741, DOI 10.1128/JCM.02201-09.;ORVIS J, 2010, BIOINFORMATICS, V26, P1488, DOI 10.1093/BIOINFORMATICS/BTQ167.;OYARZABAL A, 2007, J CLIN MICROBIOL, V45, P402.;PALACIOS G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMOA073785.;PARKHILL J, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-7-402.;PEARSON T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/PNAS.0403844101.;PETERSON J, 2009, GENOME RES, V19, P2317, DOI 10.1101/GR.096651.109.;PHILLIPPY AM, 2007, PLOS COMPUT BIOL, V3, P887, DOI 10.1371/JOURNAL.PCBI.0030098.;PHILLIPPY AM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-293.;POURCEL C, 2009, J CLIN MICROBIOL, V47, P3121, DOI 10.1128/JCM.00267-09.;PROBERT WS, 2008, J CLIN MICROBIOL, V46, P3228, DOI 10.1128/JCM.00386-08.;RADTKE A, 2010, J CLIN MICROBIOL, V48, P2502, DOI 10.1128/JCM.00234-10.;READ TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/SCIENCE.1071837.;READ TD, 2010, PLOS ONE, V5, DOI 10.1371/JOURNAL.PONE.0010595.;RIVERO-PEREZ B, 2010, J CLIN MICROBIOL, V48, P2991, DOI 10.1128/JCM.02220-09.;ROTH EP, 2001, J CLIN MICROBIOL, V39, P4037.;SCHOULS LM, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0005082.;SCHUCH R, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0006532.;SCHWARZ R, 2010, J CLIN MICROBIOL, V48, P3105, DOI 10.1128/JCM.00233-10.;SHENDURE J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/NBT1486.;SHI LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/NBT1239.;SLEZAK TOM, 2003, BRIEFINGS IN BIOINFORMATICS, V4, P133, DOI 10.1093/BIB/4.2.133.;SOYER Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-264.;STABLER RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06.;STEWART AC, 2009, BIOINFORMATICS, V25, P962, DOI 10.1093/BIOINFORMATICS/BTP097.;TETTELIN H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/PNAS.0506758102.;THOMAS CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/NRMICRO1234.;TOUZAIN F, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-4-R45.;VAN ERT MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06.;WANG Q, 2010, J CLIN MICROBIOL, V48, P2066, DOI 10.1128/JCM.02014-09.;WOOLEY JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/JOURNAL.PCBI.1000667.;XIAO L, 2010, J CLIN MICROBIOL, V48, P2715, DOI 10.1128/JCM.01877-09.;YAZDANKHAH SIAMAK P., 2007, V396, P395.;YOO SM, 2010, MOL CELL PROBE, V24, P44, DOI 10.1016/J.MCP.2009.09.003.;YOU YH, 2008, J MICROBIOL METH, V75, P566, DOI 10.1016/J.MIMET.2008.09.007.;ZWICK ME, 2008, PLOS ONE, V3, DOI 10.1371/JOURNAL.PONE.0002513.","READ, TD (REPRINT AUTHOR), EMORY UNIV, SCH MED, DEPT MED, DIV INFECT DIS, 615 MICHAEL ST, ATLANTA, GA 30322 USA.;JOSEPH, SANDEEP J., READ, TIMOTHY D., EMORY UNIV, SCH MED, DEPT MED, DIV INFECT DIS, ATLANTA, GA 30322 USA.;READ, TIMOTHY D., EMORY UNIV, SCH MED, DEPT HUMAN GENET, ATLANTA, GA 30322 USA.","10.1016/J.TIBTECH.2010.09.001","84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND",NA,NA,NA,NA,NA,"0167-7799","12","611-618","ELSEVIER SCIENCE LONDON","28",2010,"ISI000285128600005","83","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY","18","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY",NA,NA,"692CH",NA,"READ, TD (REPRINT AUTHOR), EMORY UNIV, SCH MED, DEPT MED, DIV INFECT DIS, 615 MICHAEL ST, ATLANTA, GA 30322 USA","ISI","EMORY UNIV;EMORY UNIV","EMORY UNIV",NA,"JOSEPH SJ, 2010, TRENDS BIOTECHNOL","JOSEPH SJ, 2010, TRENDS BIOTECHNOL"
"ITAN Y, 2010, ANN HUM GENET","ITAN Y;BRYSON K;THOMAS MG","DETECTING GENE DUPLICATIONS IN THE HUMAN LINEAGE","ANNALS OF HUMAN GENETICS","ANN. HUM. GENET.","P>GENE DUPLICATIONS REPRESENT AN IMPORTANT CLASS OF EVOLUTIONARY EVENTS THAT IS LIKELY TO HAVE CONTRIBUTED TO THE UNIQUE HUMAN PHENOTYPE IN THE SHORT EVOLUTIONARY TIME SINCE THE HUMAN-CHIMPANZEE DIVERGENCE. WITH THE AVAILABILITY OF BOTH HUMAN AND CHIMPANZEE GENOME DRAFTS IN HIGH COVERAGE RE-SEQUENCING ASSEMBLIES AND THE HIGH ANNOTATION QUALITY OF MOST HUMAN GENES, IT SHOULD NOW BE POSSIBLE TO IDENTIFY ALL HUMAN LINEAGE-SPECIFIC GENE DUPLICATION EVENTS (HUMAN INPARALOGUES) AND A FEW PIONEERING STUDIES HAVE ATTEMPTED TO DO THAT. HOWEVER, THE DIFFERENT LEVELS OF COVERAGE IN THE HUMAN AND CHIMPANZEE'S GENOMES ASSEMBLIES, AND THE DIFFERING LEVELS OF GENE ANNOTATION, HAVE LED TO PROBLEMATIC ASSUMPTIONS AND OVERSIMPLIFICATIONS IN THE ALGORITHMS AND THE DATASETS USED TO DETECT HUMAN LINEAGE-SPECIFIC GENE DUPLICATIONS. IN THIS STUDY, WE HAVE DEVELOPED A SET OF BIOINFORMATIC TOOLS TO OVERCOME A NUMBER OF THE CONCEPTUAL PROBLEMS THAT ARE PREVALENT IN PREVIOUS STUDIES AND HAVE COLLECTED A RELIABLE AND REPRESENTATIVE SET OF HUMAN INPARALOGUES.","HUMAN INPARALOGUES; GENE DUPLICATION; BIOINFORMATICS METHOD; HUMAN EVOLUTION","MULTIPLE SEQUENCE ALIGNMENT; GC-CONTENT EVOLUTION; SEGMENTAL DUPLICATIONS; DNA-SEQUENCES; CONVERSION; DISEASE; GENOME; DIVERGENCE; CHIMPANZEE; ORTHOLOGS","ENGLISH","ARTICLE","ARTICLE",4,"ALTENHOFF AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/JOURNAL.PCBI.1000262.;ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2.;ASHBURNER M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556.;BAILEY JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/NRG1895.;BENTON MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/MOLBEV/MSL150.;BERGLUND AC, 2008, NUCLEIC ACIDS RES, V36, PD263, DOI 10.1093/NAR/GKM1020.;BRITTEN RJ, 2002, P NATL ACAD SCI USA, V99, P13633, DOI 10.1073/PNAS.172510699.;CHEN JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/NRG2193.;COSTANTINI M, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0005972.;EDGAR RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/NAR/GKH340.;ENARD W, 2002, NATURE, V418, P869, DOI 10.1038/NATURE01025.;FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359.;FELSENSTEIN J, 1989, PHYLIP PHYLOGENY INF, P164, DOI DOI 10.1101/GR.1725103.;FORCE A, 1999, GENETICS, V151, P1531.;GALTIER N, 2003, TRENDS GENET, V19, P65, DOI 10.1016/S0168-9525(02)00002-1.;GALTIER N, 2001, GENETICS, V159, P907.;HUBBARD TJP, 2009, NUCLEIC ACIDS RES, V37, PD690, DOI 10.1093/NAR/GKN828.;HUNT KD, 1994, J HUM EVOL, V26, P183, DOI 10.1006/JHEV.1994.1011.;KATOH K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/NAR/GKF436.;KATOH K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/NAR/GKI198.;KELLEY DR, 2010, GENOME BIOL, V11, DOI 10.1186/GB-2010-11-3-R28.;KENT WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/GR.229202, 10.1101/GR.229202. ARTICLE PUBLISHED ONLINE BEFORE MARCH 2002].;KOONIN EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/ANNUREV.GENET.39.073003.114725.;KUMAR S, 2005, P NATL ACAD SCI USA, V102, P18842, DOI 10.1073/PNAS.0509585102.;MARAIS G, 2003, TRENDS GENET, V19, P330, DOI 10.1016/S0168-9525(03)00116-1.;MIKKELSEN TS, 2005, NATURE, V437, P69, DOI 10.1038/NATURE04072.;MONTGOMERY S, 2009, METHODS MOL BIOL, V569, P89, DOI 10.1007/978-1-59745-524-4\_5.;NIEUWENHUYS R., 2007, HUMAN CENTRAL NERVOU.;NOTREDAME C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/JMBI.2000.4042.;O'BRIEN KP, 2005, NUCLEIC ACIDS RES, V33, PD476, DOI 10.1093/NAR/GKI107.;OHNO S., 1970, EVOLUTION GENE DUPLI.;PATTERSON N, 2006, NATURE, V441, P1103, DOI 10.1038/NATURE04789.;PRINCE VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/NRG928.;REMM M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/JMBI.2001.5197.;SAWYER S, 1989, MOL BIOL EVOL, V6, P526.;SMEDLEY D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22.;SPENCER CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/JOURNAL.PGEN.0020148.;STAUFFER RL, 2001, J HERED, V92, P469, DOI 10.1093/JHERED/92.6.469.;STEIPER ME, 2006, MOL PHYLOGENET EVOL, V41, P384, DOI 10.1016/J.YMPEV.2006.05.021.;STEWART CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/GR.2188104.;TATUSOV RL, 1997, SCIENCE, V278, P631, DOI 10.1126/SCIENCE.278.5338.631.;THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/NAR/22.22.4673.;TRAHERNE JA, 2006, PLOS GENET, V2, P81, DOI 10.1371/JOURNAL.PGEN.0020009.;VAN NOORT V, 2003, TRENDS GENET, V19, P238, DOI 10.1016/S0168-9525(03)00056-8.;WANG XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/JOURNAL.PBIO.0040052.;WATERSTON RH, 2002, NATURE, V420, P520, DOI 10.1038/NATURE01262.;YANG Z, 2006, COMPUTATIONAL MOL EV.;ZHANG F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/J.TIG.2009.05.005.","ITAN, Y (REPRINT AUTHOR), UCL, RES DEPT GENET EVOLUT \& ENVIRONM, MORTIMER ST, LONDON WC1E 6BT, ENGLAND.;ITAN, YUVAL, THOMAS, MARK G., UCL, RES DEPT GENET EVOLUT \& ENVIRONM, LONDON WC1E 6BT, ENGLAND.;BRYSON, KEVIN, UCL, DEPT COMP SCI, LONDON WC1E 6BT, ENGLAND.;ITAN, YUVAL, BRYSON, KEVIN, THOMAS, MARK G., UCL, COMPLEX CTR MATH \& PHYS LIFE SCI \& EXPT BIOL, LONDON WC1E 6BT, ENGLAND.;THOMAS, MARK G., UCL, INST ARCHAEOL, AHRC CTR EVOLUT CULTURAL DIVERS, LONDON WC1H 0PY, ENGLAND.;THOMAS, MARK G., UPPSALA UNIV, EVOLUTIONARY BIOL CTR, DEPT EVOLUTIONARY BIOL, SE-75236 UPPSALA, SWEDEN.","10.1111/J.1469-1809.2010.00609.X","COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA",NA,NA,"UCL ORS, UCL GRADUATE SCHOOL, B'NAI B'RITH, ANGLO-JEWISH ASSOCIATION","WE THANK ZIHENG YANG, NEIL BRADMAN, RICHARD EMES, AND JESSICA VAMATHEVAN FOR THEIR VERY IMPORTANT CONTRIBUTION, AS WELL AS THE ENSEMBL (PARTICULARLY BERT OVERDUIN) AND BLAT TEAMS FOR THEIR ONGOING SUPPORT AND PATIENCE. YI WAS FUNDED BY THE UCL ORS, UCL GRADUATE SCHOOL, B'NAI B'RITH AND THE ANGLO-JEWISH ASSOCIATION SCHOLARSHIPS.",NA,"0003-4800","6","555-565","WILEY-BLACKWELL","74",2010,"ISI000283066700010","48","GENETICS \& HEREDITY","4","GENETICS \& HEREDITY","Y.ITANUCL.AC.UK",NA,"665WJ",NA,"ITAN, Y (REPRINT AUTHOR), UCL, RES DEPT GENET EVOLUT \& ENVIRONM, MORTIMER ST, LONDON WC1E 6BT, ENGLAND","ISI","RES DEPT GENET EVOLUT AND ENVIRONM;DEPT COMP SCI;COMPLEX CTR MATH AND PHYS LIFE SCI AND EXPT BIOL;INST ARCHAEOL;UPPSALA UNIV","RES DEPT GENET EVOLUT AND ENVIRONM",NA,"ITAN Y, 2010, ANN HUM GENET","ITAN Y, 2010, ANN HUM GENET"
"SANCHEZ V, 2010, J CLIN MICROBIOL","SANCHEZ V;MASIA M;ROBLEDANO C;PADILLA S;MANUEL RAMOS J;GUTIERREZ F","PERFORMANCE OF GENOTYPIC ALGORITHMS FOR PREDICTING HIV-1 TROPISM MEASURED AGAINST THE ENHANCED-SENSITIVITY TROFILE CORECEPTOR TROPISM ASSAY","JOURNAL OF CLINICAL MICROBIOLOGY","J. CLIN. MICROBIOL.","THE OBJECTIVES OF THIS STUDY WERE TO ASSESS THE PERFORMANCE OF GENOTYPIC ALGORITHMS FOR PREDICTING CXCR4-USING VIRUS, WITH ENHANCED SENSITIVITY TROFILE HIV CORECEPTOR TROPISM ASSAY (ES TROFILE) AS THE REFERENCE, AND TO COMPARE THE CONCORDANCE/ACCURACY OF GENOTYPIC TESTS WITH ES TROFILE AND WITH THE ORIGINAL TROFILE ASSAY. PAIRED PHENOTYPIC AND GENOTYPIC DETERMINATIONS OF HIV-1 CORECEPTOR USAGE WERE COMPARED IN PLASMA SAMPLES FROM HIV-1-INFECTED PATIENTS. SEQUENCING OF THE THIRD HYPERVARIABLE (V3) LOOP OF THE VIRAL GENE AND PHENOTYPIC ASSAYS WERE PERFORMED FOR EACH SAMPLE. GENOTYPIC RULES USED TO PREDICT TROPISM WERE GENO2PHENO (FALSE-POSITIVE RATE AT 1 TO 20\%), POSITION-SPECIFIC SCORING MATRIX X4R5 (PSSMX4R5) AND PSSMSINSI (WHERE ``SINSI'' STANDS FOR SYNCYTIUM",NA,"BIOINFORMATIC TOOLS; USAGE; TRANSMISSION; PREVALENCE; VALIDATION; SUBTYPES; CCR5","ENGLISH","ARTICLE","ARTICLE",23,"BRAUN P, 2007, EUR J MED RES, V12, P463.;CHUECA N, 2009, J MED VIROL, V81, P763, DOI 10.1002/JMV.21425.;DE MENDOZA C, 2007, J ANTIMICROB CHEMOTH, V59, P698, DOI 10.1093/JAC/DKM012.;DELOBEL P, 2007, J CLIN MICROBIOL, V45, P1572, DOI 10.1128/JCM.02090-06.;GARRIDO C, 2008, J CLIN MICROBIOL, V46, P887, DOI 10.1128/JCM.01611-07.;HOLGUIN A, 2008, J CLIN MICROBIOL, V46, P3896, DOI 10.1128/JCM.00515-08.;HUNT PW, 2006, J INFECT DIS, V194, P926, DOI 10.1086/507312.;LENGAUER T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/NBT1207-1405.;LOW AJ, 2008, AIDS REV, V10, P143.;LOW AJ, 2007, AIDS, V21, PF19.;MCGOVERN R, 2010, 17 C RETR OPP INF.;OBERMEIER M, 2010, 8 EUR HIV DRUG RES W.;PHILPOTT SM, 2003, CURR HIV RES, V1, P217, DOI 10.2174/1570162033485357.;POVEDA E, 2007, AIDS, V21, P1487, DOI 10.1097/QAD.0B013E32826FB741.;POVEDA E, 2009, J ANTIMICROB CHEMOTH, V63, P1006, DOI 10.1093/JAC/DKP063.;RAYMOND S, 2008, AIDS, V22, PF11, DOI 10.1097/QAD.0B013E32830EBCD4.;REEVES JD, 2007, 47 ANN INT C ANT AG.;ROSE JD, 2009, CURR OPIN HIV AIDS, V4, P136, DOI 10.1097/COH.0B013E328322F973.;SANCHEZ V, 2010, 17 C RETR OPP INF.;SANDER O, 2007, PLOS COMPUT BIOL, V3, P555, DOI 10.1371/JOURNAL.PCBI.0030058.;SIERRA S, 2010, 8 EUR HIV DRUG RES W.;SKRABAL K, 2007, J CLIN MICROBIOL, V45, P279, DOI 10.1128/JCM.01118-06.;TRINH L, 2008, ANTIVIR THER, V13, PA128.;VAN LELYVELD S, 2010, 8 EUR HIV DRUG RES W.;WHITCOMB JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06.","MASIA, M (REPRINT AUTHOR), HOSP GEN UNIV ELCHE, UNIDAD ENFERMEDADES INFECCIOSAS, CAMI ALMAZARA 11, ELCHE 03203, SPAIN.;SANCHEZ, VICTORIA, MASIA, MAR, ROBLEDANO, CATALINA, PADILLA, SERGIO, MANUEL RAMOS, JOSE, GUTIERREZ, FELIX, UNIV MIGUEL HERNANDEZ, HOSP UNIV ELCHE, DEPT CLIN MED, INFECT DIS UNIT, ELCHE, SPAIN.","10.1128/JCM.01204-10","1752 N ST NW, WASHINGTON, DC 20036-2904 USA",NA,NA,"ISCIII-RETIC [RD06/0006/0027], FIBELX [19/2007], CONSELLERIA DE SANITAT VALENCIANA [AP-089/07]","THIS WORK WAS FINANCIALLY SUPPORTED BY THE ISCIII-RETIC RD06/0006/0027, FIBELX 19/2007, AND CONSELLERIA DE SANITAT VALENCIANA AP-089/07 GRANTS.",NA,"0095-1137","11","4135-4139","AMER SOC MICROBIOLOGY","48",2010,"ISI000283588500044","25","MICROBIOLOGY","2","MICROBIOLOGY","MARMASIAYA.COM",NA,"672MK",NA,"MASIA, M (REPRINT AUTHOR), HOSP GEN UNIV ELCHE, UNIDAD ENFERMEDADES INFECCIOSAS, CAMI ALMAZARA 11, ELCHE 03203, SPAIN","ISI","UNIV MIGUEL HERNANDEZ","HOSP GEN UNIV ELCHE",NA,"SANCHEZ V, 2010, J CLIN MICROBIOL","SANCHEZ V, 2010, J CLIN MICROBIOL"
"MONDAL SI, 2010, J MICROBIOL BIOTECHNOL","MONDAL SI;ZUBAER A;THAPA S;SAHA C;ALUM MA;REZA MS;AKTER A;AZAD AK","ENVELOPE PROTEINS PERTAIN WITH EVOLUTION AND ADAPTIVE MECHANISM OF THE NOVEL INFLUENZA A/H1N1 IN HUMANS","JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY","J. MICROBIOL. BIOTECHNOL.","THE NOVEL SWINE-ORIGIN INFLUENZA A/H1N1 VIRUS (S-OIV) FIRST DETECTED IN APRIL 2009 HAS BEEN IDENTIFIED TO TRANSMIT FROM HUMANS TO HUMANS DIRECTLY AND IS THE CAUSE OF THE CURRENTLY EMERGED PANDEMIC. IN THIS STUDY, NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF THE HEMAGGLUTININ (HA) AND NEURAMINIDASE (NA) OF THE S-OIV AND OTHER INFLUENZA A VIRUSES WERE ANALYZED THROUGH BIOINFORMATIC TOOLS FOR PHYLOGENETIC ANALYSIS, GENETIC RECOMBINATION, AND POINT MUTATION TO INVESTIGATE THE EMERGENCE AND ADAPTATION OF THE S-OIV IN HUMANS. THE PHYLOGENETIC ANALYSIS SHOWED THAT THE HA COMES FROM TRIPLE REASSORTANT INFLUENZA A/H1N2 AND THE NA FROM EURASIAN SWINE INFLUENZA A/H1N1, INDICATING THAT HA AND NA DESCEND FROM DIFFERENT LINEAGES DURING THE GENESIS OF THE S-OIV. RECOMBINATION ANALYSIS NULLIFIED THE POSSIBILITY OF OCCURRENCE OF RECOMBINATION IN HA AND NA, DENOTING THE ROLE OF REASSORTMENT IN THE OUTBREAK. SEVERAL CONSERVATIVE MUTATIONS WERE OBSERVED IN THE AMINO ACID SEQUENCES OF THE HA AND NA, AND THESE MUTATED RESIDUES WERE IDENTICAL IN THE S-OIV. THE RESULTS REPORTED HEREIN SUGGEST THE NOTION THAT THE RECENT PANDEMIC IS THE RESULT OF REASSORTMENT OF DIFFERENT GENES FROM DIFFERENT LINEAGES OF TWO ENVELOPE PROTEINS, HA AND NA, WHICH ARE RESPONSIBLE FOR THE ANTIGENIC ACTIVITY OF THE VIRUS. THIS STUDY FURTHER SUGGESTS THAT THE ADAPTIVE CAPABILITY OF THE S-OIV IN HUMANS IS ACQUIRED BY THE UNIQUE MUTATIONS GENERATED DURING EMERGENCE.","HEMAGGLUTININ; INFLUENZA A/H1N1; MUTATION; NEURAMINIDASE; REASSORTMENT; S-OIV","A VIRUS; EMERGENCE; ORIGIN; RECOMBINATION; EPIDEMIC","ENGLISH","ARTICLE","ARTICLE",0,"BONI MF, 2008, J VIROL, V82, P4807, DOI 10.1128/JVI.02683-07.;CLAMP M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/BIOINFORMATICS/BTG430.;DING N, 2009, VIRUS GENES, V39, P293, DOI 10.1007/S11262-009-0393-7.;ETHERINGTON GJ, 2005, BIOINFORMATICS, V21, P278, DOI 10.1093/BIOINFORMATICS/BTH500.;GARTEN RJ, 2009, SCIENCE, V325, P192.;KINGSFORD C, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0006402.;LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/BIOINFORMATICS/BTM404.;NICOLE MB, 2008, VACCINE S, V26, PD49.;OLSEN CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8.;PARRISH CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08.;PEIRIS JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/J.JCV.2009.06.006.;SMITH GJD, 2009, NATURE, V459, P1122, DOI 10.1038/NATURE08182.;TAMURA K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/MOLBEV/MSM092.;TAUBENBERGER JK, 2001, PHILOS T ROY SOC B, V356, P1829, DOI 10.1098/RSTB.2001.1020.;WALEWSKI JL, 2002, RNA, V8, P557, DOI 10.1017/S1355838202029023.;WEBBY RJ, 2001, PHILOS T R SOC B, V356, P1817, DOI 10.1098/RSTB.2001.0997.;ZHANG YH, 2009, BIOCHEM BIOPH RES CO, V387, P405, DOI 10.1016/J.BBRC.2009.07.040.","AZAD, AK (REPRINT AUTHOR), SHAHJALAL UNIV SCI \& TECHNOL, DEPT GENET ENGN \& BIOTECHNOL, SYLHET 3114, BANGLADESH.;MONDAL, SHAKHINUR ISLAM, ZUBAER, ABDULLAH, THAPA, SIMRIKA, SAHA, CHINMOY, ALUM, MD. ASRAFUL, REZA, MD. SALMAN, AZAD, ABUL KALAM, SHAHJALAL UNIV SCI \& TECHNOL, DEPT GENET ENGN \& BIOTECHNOL, SYLHET 3114, BANGLADESH.;AKTER, ARZUBA, UNIV DHAKA, DEPT BIOCHEM \& MOL BIOL, DHAKA 1000, BANGLADESH.;AZAD, ABUL KALAM, SHIMANE UNIV, DEPT LIFE SCI \& BIOTECHNOL, MATSUE, SHIMANE 6908504, JAPAN.","10.4014/JMB.1006.06031","KOREA SCI TECHNOL CENTER \#507, 635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL 135-703, SOUTH KOREA",NA,NA,NA,NA,NA,"1017-7825","11","1500-1505","KOREAN SOC MICROBIOLOGY \& BIOTECHNOLOGY","20",2010,"ISI000284866800005","17","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, MICROBIOLOGY","2","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, MICROBIOLOGY","DAKAZAD-BTCSUST.EDU",NA,"688QP",NA,"AZAD, AK (REPRINT AUTHOR), SHAHJALAL UNIV SCI \& TECHNOL, DEPT GENET ENGN \& BIOTECHNOL, SYLHET 3114, BANGLADESH","ISI","SHAHJALAL UNIV SCI AND TECHNOL;UNIV DHAKA;SHIMANE UNIV","SHAHJALAL UNIV SCI AND TECHNOL",NA,"MONDAL SI, 2010, J MICROBIOL BIOTECHNOL","MONDAL SI, 2010, J MICROBIOL BIOTECHNOL"
"SECLEN E, 2010, J ANTIMICROB CHEMOTHER","SECLEN E;GARRIDO C;DEL MAR GONZALEZ M;GONZALEZ LAHOZ J;DE MENDOZA C;SORIANO V;POVEDA E","HIGH SENSITIVITY OF SPECIFIC GENOTYPIC TOOLS FOR DETECTION OF X4 VARIANTS IN ANTIRETROVIRAL-EXPERIENCED PATIENTS SUITABLE TO BE TREATED WITH CCR5 ANTAGONISTS","JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY","J. ANTIMICROB. CHEMOTHER.","OBJECTIVES: EVALUATION OF THE RELIABILITY OF SEVERAL V3-BASED GENOTYPIC PREDICTORS TO INFER VIRAL TROPISM IN PATIENTS INFECTED WITH B AND NON-B STRAINS OF HIV-1. METHODS: SEVERAL GENOTYPIC TROPISM PREDICTORS WERE EVALUATED IN PLASMA (RNA) SAMPLES FROM 198 HIV-1-INFECTED PATIENTS, TAKING AS GOLD STANDARD THE RESULTS OF THE PHENOTYPIC RECOMBINANT VIRUS ASSAY PHENOSCRIPT (R). IN ADDITION, FOR 37 B SUBTYPE HIV-1 PATIENTS THE PHENOTYPIC RESULTS FROM PLASMA SAMPLES WERE ALSO COMPARED WITH TROPISM PREDICTIONS BASED ON V3 AMPLIFICATION FROM PAIRED PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS). RESULTS: A TOTAL OF 150 PAIRED GENOTYPIC/PHENOTYPIC RESULTS WERE OBTAINED FROM PLASMA SPECIMENS. CONCORDANCE VALUES RANGED FROM 63\% TO 85\%, DEPENDING ON THE GENOTYPIC ALGORITHM USED. THE BEST PREDICTORS IN TERMS OF SENSITIVITY/SPECIFICITY TO DETECT X4 VARIANTS WERE WEBPSSM(X4/R5) (77\%/87\%), GENO2PHENO(FPR=5\%) (80\%/77\%) AND AN ALGORITHM COMBINING THE `11/25' AND `NET CHARGE' RULES, TERMED GARRIDO'S RULE (80\%/79\%). THE PERFORMANCE OF GENOTYPIC PREDICTORS WAS BETTER TESTING B THAN NON-B CLADES. THE OVERALL SENSITIVITY RANGED FROM 28\% TO 94\%, REACHING 100\% IN SUBTYPE B ANTIRETROVIRAL-EXPERIENCED PATIENTS USING WEBPSSM(SI/NSI), GENO2PHENOFPR >= 5\% AND GARRIDO'S RULE. CONVERSELY, THE SENSITIVITY WHEN TESTING NON-B SUBTYPES WAS POORER, RANGING FROM 17\% TO 67\%. INTERESTINGLY, THE CORRELATION BETWEEN GENOTYPIC AND PHENOTYPIC RESULTS WAS BETTER WHEN TESTING PBMCS THAN PLASMA USING ALL GENOTYPIC PREDICTORS. CONCLUSIONS: GENOTYPIC TOOLS BASED ON V3 SEQUENCES MAY PROVIDE RELIABLE INFORMATION ON HIV-1 TROPISM WHEN TESTING CLADE B VIRUSES, ESPECIALLY IN ANTIRETROVIRAL-EXPERIENCED PATIENTS. THE SENSITIVITY TO DETECT X4 VARIANTS USING GENOTYPIC TOOLS MAY IMPROVE BY TESTING PROVIRAL DNA INSTEAD OF PLASMA RNA.","TROPISM; CO-RECEPTOR; GENOTYPIC PREDICTORS; CCR5 ANTAGONISTS","IMMUNODEFICIENCY-VIRUS TYPE-1; CORECEPTOR USAGE; V3 LOOP; BIOINFORMATIC TOOLS; PHENOTYPIC ASSAY; HIV-1 TROPISM; PREDICTION; SEQUENCES; SAMPLES; ENV","ENGLISH","ARTICLE","ARTICLE",48,"CARDOZO T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/AID.2006.0130.;CHUECA N, 2009, J MED VIROL, V81, P763, DOI 10.1002/JMV.21425.;DELOBEL P, 2007, J CLIN MICROBIOL, V45, P1572, DOI 10.1128/JCM.02090-06.;DORR P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005.;GARRIDO C, 2008, J CLIN MICROBIOL, V46, P887, DOI 10.1128/JCM.01611-07.;GULICK RM, 2007, J INFECT DIS, V196, P304, DOI 10.1086/518797.;HARRIGAN PR, 2009, ANTIVIR THER, V14, PA17.;HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/SCIENCE.1905842.;JENSEN MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003.;JENSEN MARK A., 2003, AIDS REVIEWS, V5, P104.;LABERNARDIERE JL, 2004, ANTIVIR THER, V9, PU99.;LOW AJ, 2007, AIDS, V21, PF19.;OBERMEIER M, 2009, REV ANTIVIR THER S, V1, P84.;PILLAI S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658.;POVEDA E, 2007, AIDS, V21, P1487, DOI 10.1097/QAD.0B013E32826FB741.;POVEDA E, 2009, J ANTIMICROB CHEMOTH, V63, P1006, DOI 10.1093/JAC/DKP063.;RAYMOND S, 2008, AIDS, V22, PF11, DOI 10.1097/QAD.0B013E32830EBCD4.;ROULET V, 2007, 14 C RETR OPP INF LO.;SECLEN E, 2009, REV ANTIVIR THER, V1, P55.;SING T, 2007, ANTIVIR THER, V12, P1097.;SKRABAL K, 2007, J CLIN MICROBIOL, V45, P279, DOI 10.1128/JCM.01118-06.;TROUPLIN V, 2001, J VIROL, V75, P251, DOI 10.1128/JVI.75.1.251-259.2001.;VERHOFSTEDE C, 2009, JAIDS-J ACQ IMM DEF, V50, P126, DOI 10.1097/QAI.0B013E31819118FA.;WHITCOMB JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06.","POVEDA, E (REPRINT AUTHOR), HOSP CARLOS III, MOL BIOL LAB, DEPT INFECT DIS, SINESIO DELGADO 10, MADRID 28029, SPAIN.;POVEDA, EVA, HOSP CARLOS III, MOL BIOL LAB, DEPT INFECT DIS, MADRID 28029, SPAIN.","10.1093/JAC/DKQ137","GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND",NA,NA,"FUNDACION INVESTIGACION Y EDUCACION EN SIDA (IES), EUROPEAN AIDS TREATMENT NETWORK (NEAT)","THIS WORK WAS SUPPORTED BY GRANTS FROM: FUNDACION INVESTIGACION Y EDUCACION EN SIDA (IES), THE EUROPEAN AIDS TREATMENT NETWORK (NEAT) PROJECT, RED DE INVESTIGACION EN SIDA (RIS, ISCIII-RETIC-RD06), FONDO DE INVESTIGACION SANITARIA-FIS (CP08/00214, CP0610284, PI06/01826, FI09/00868), AND AGENCIA LAIN ENTRALGO.",NA,"0305-7453","7","1486-1492","OXFORD UNIV PRESS","65",2010,"ISI000279926500028","24","INFECTIOUS DISEASES, MICROBIOLOGY, PHARMACOLOGY \& PHARMACY","6","INFECTIOUS DISEASES, MICROBIOLOGY, PHARMACOLOGY \& PHARMACY","EVAPOVEDAHOTMAIL.COM",NA,"625WC",NA,"POVEDA, E (REPRINT AUTHOR), HOSP CARLOS III, MOL BIOL LAB, DEPT INFECT DIS, SINESIO DELGADO 10, MADRID 28029, SPAIN","ISI","HOSP CARLOS III","HOSP CARLOS III",NA,"SECLEN E, 2010, J ANTIMICROB CHEMOTHER","SECLEN E, 2010, J ANTIMICROB CHEMOTHER"
"JABBOUR RE, 2010, APPL ENVIRON MICROBIOL","JABBOUR RE;DESHPANDE SV;WADE MM;STANFORD MF;WICK CH;ZULICH AW;SKOWRONSKI EW;SNYDER AP","DOUBLE-BLIND CHARACTERIZATION OF NON-GENOME-SEQUENCED BACTERIA BY MASS SPECTROMETRY-BASED PROTEOMICS","APPLIED AND ENVIRONMENTAL MICROBIOLOGY","APPL. ENVIRON. MICROBIOL.","DUE TO THE POSSIBILITY OF A BIOTHREAT ATTACK ON CIVILIAN OR MILITARY INSTALLATIONS, A NEED EXISTS FOR TECHNOLOGIES THAT CAN DETECT AND ACCURATELY IDENTIFY PATHOGENS IN A NEAR-REAL-TIME APPROACH. ONE TECHNOLOGY POTENTIALLY CAPABLE OF MEETING THESE NEEDS IS A HIGH-THROUGHPUT MASS SPECTROMETRY (MS)-BASED PROTEOMIC APPROACH. THIS APPROACH UTILIZES THE KNOWLEDGE OF AMINO ACID SEQUENCES OF PEPTIDES DERIVED FROM THE PROTEOLYSIS OF PROTEINS AS A BASIS FOR RELIABLE BACTERIAL IDENTIFICATION. TO EVALUATE THIS APPROACH, THE TRYPTIC DIGEST PEPTIDES GENERATED FROM DOUBLE-BLIND BIOLOGICAL SAMPLES CONTAINING EITHER A SINGLE BACTERIUM OR A MIXTURE OF BACTERIA WERE ANALYZED USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY. BIOINFORMATIC TOOLS THAT PROVIDE BACTERIAL CLASSIFICATION WERE USED TO EVALUATE THE PROTEOMIC APPROACH. RESULTS SHOWED THAT BACTERIA IN ALL OF THE DOUBLE-BLIND SAMPLES WERE ACCURATELY IDENTIFIED WITH NO FALSE-POSITIVE ASSIGNMENT. THE MS PROTEOMIC APPROACH SHOWED STRAIN-LEVEL DISCRIMINATION FOR THE VARIOUS BACTERIA EMPLOYED. THE APPROACH ALSO CHARACTERIZED DOUBLE-BLIND BACTERIAL SAMPLES TO THE RESPECTIVE GENUS, SPECIES, AND STRAIN LEVELS WHEN THE EXPERIMENTAL ORGANISM WAS NOT IN THE DATABASE DUE TO ITS GENOME NOT HAVING BEEN SEQUENCED. ONE EXPERIMENTAL SAMPLE DID NOT HAVE ITS GENOME SEQUENCED, AND THE PEPTIDE EXPERIMENTAL RECORD WAS ADDED TO THE VIRTUAL BACTERIAL PROTEOME DATABASE. A REPLICATE ANALYSIS IDENTIFIED THE SAMPLE TO THE PEPTIDE EXPERIMENTAL RECORD STORED IN THE DATABASE. THE MS PROTEOMIC APPROACH PROVED CAPABLE OF IDENTIFYING AND CLASSIFYING ORGANISMS WITHIN A MICROBIAL MIXTURE.",NA,"ASSISTED-LASER-DESORPTION/IONIZATION; PROTEIN IDENTIFICATION TECHNOLOGY; RAPID IDENTIFICATION; SHOTGUN PROTEOMICS; TANDEM; DATABASE; DIFFERENTIATION; MICROORGANISMS; MIXTURES; SPECTRA","ENGLISH","ARTICLE","ARTICLE",26,"AKOTO L, 2005, J ANAL APPL PYROL, V73, P69, DOI 10.1016/J.JAAP.2004.11.006.;BROWN SD, 2006, MOL CELL PROTEOMICS, V5, P1054, DOI 10.1074/MCP.M500394-MCP200.;BURKE SA, 2004, APPL ENVIRON MICROB, V70, P2786, DOI 10.1128/AEM.70.5.2786-2790.2004.;CAIN TC, 1994, RAPID COMMUN MASS SP, V8, P1026, DOI 10.1002/RCM.1290081224.;CHEN WB, 2001, ANALYST, V126, P52, DOI 10.1039/B008012H.;CRAIG R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/BIOINFORMATICS/BTH092.;DEMIREV PA, 2001, ANAL CHEM, V73, P5725, DOI 10.1021/AC010672N.;DUCHE O, 2002, FEMS MICROBIOL LETT, V215, P183, DOI 10.1016/S0378-1097(02)00938-2.;DWORZANSKI JP, 2006, J PROTEOME RES, V5, P76, DOI 10.1021/PR050294T.;DWORZANSKI JP, 2004, ANAL CHEM, V76, P2355, DOI 10.1021/AC0349781.;ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2.;HESKETH AR, 2002, MOL MICROBIOL, V46, P917, DOI 10.1046/J.1365-2958.2002.03219.X.;HOLLAND RD, 1996, RAPID COMMUN MASS SP, V10, P1227, DOI 10.1002/(SICI)1097-0231(19960731)10:10<1227::AID-RCM659>3.0.CO,2-6.;KELLER A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/AC025747H.;LIPTON MS, 2002, P NATL ACAD SCI USA, V99, P11049, DOI 10.1073/PNAS.172170199.;MAYR BM, 2005, ANAL CHEM, V77, P4563, DOI 10.1021/AC050378L.;MOE MK, 2005, J AM SOC MASS SPECTR, V16, P46, DOI 10.1016/J.JASMS.2004.09.014.;NORBECK AD, 2006, J MICROBIOL METH, V67, P473, DOI 10.1016/J.MIMET.2006.04.024.;PERKINS DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO,2-2.;RYZHOV V, 2000, APPL ENVIRON MICROB, V66, P3828, DOI 10.1128/AEM.66.9.3828-3834.2000.;SAIKALY PE, 2007, APPL ENVIRON MICROB, V73, P6557, DOI 10.1128/AEM.00779-07.;TAN YP, 2002, FEMS INFECT IMMUN, V215, P6475.;VERBERKMOES NC, 2005, ANAL CHEM, V77, P923, DOI 10.1021/AC049127N.;WARSCHEID B, 2004, PROTEOMICS, V4, P2877, DOI 10.1002/PMIC.200400911.;WARSCHEID B, 2003, ANAL CHEM, V75, P5618, DOI 10.1021/AC034200F.;WASHBURN MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686.;WOESE CR, 1985, SYST APPL MICROBIOL, V6, P143, DOI 10.1016/S0723-2020(85)80047-3.;WOLTERS DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/AC010617E.;XIANG F, 2000, ANAL CHEM, V72, P2475, DOI 10.1021/AC991307N.;YATES J. R., 2000, U.S. PATENT, PATENT NO. [6017693, 6,017,693].","JABBOUR, RE (REPRINT AUTHOR), SAIC, EDGEWOOD AREA, GUNPOWDER BRANCH, BLDG E3160, ABERDEEN PROVING GROUND, MD 21010 USA.;JABBOUR, RABIH E., SAIC, EDGEWOOD AREA, GUNPOWDER BRANCH, ABERDEEN PROVING GROUND, MD 21010 USA.;DESHPANDE, SAMIR V., SCI \& TECHNOL CORP, EDGEWOOD, MD 21040 USA.;WADE, MARY MARGARET, STANFORD, MICHAEL F., WICK, CHARLES H., ZULICH, ALAN W., SKOWRONSKI, EVAN W., SNYDER, A. PETER, USA, EDGEWOOD CHEM BIOL CTR, ABERDEEN PROVING GROUND, MD 21010 USA.","10.1128/AEM.00055-10","1752 N ST NW, WASHINGTON, DC 20036-2904 USA",NA,NA,NA,NA,NA,"0099-2240","11","3637-3644","AMER SOC MICROBIOLOGY","76",2010,"ISI000277871400027","30","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, MICROBIOLOGY","13","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, MICROBIOLOGY","RABIH.E.JABBOURSAIC.COM",NA,"598WW",NA,"JABBOUR, RE (REPRINT AUTHOR), SAIC, EDGEWOOD AREA, GUNPOWDER BRANCH, BLDG E3160, ABERDEEN PROVING GROUND, MD 21010 USA","ISI","SCI AND TECHNOL CORP;EDGEWOOD CHEM BIOL CTR","NOTREPORTED",NA,"JABBOUR RE, 2010, APPL ENVIRON MICROBIOL","JABBOUR RE, 2010, APPL ENVIRON MICROBIOL"
"GALAN M, 2010, BMC GENOMICS","GALAN M;GUIVIER E;CARAUX G;CHARBONNEL N;COSSON JF","A 454 MULTIPLEX SEQUENCING METHOD FOR RAPID AND RELIABLE GENOTYPING OF HIGHLY POLYMORPHIC GENES IN LARGE-SCALE STUDIES","BMC GENOMICS","BMC GENOMICS","BACKGROUND: HIGH-THROUGHPUT SEQUENCING TECHNOLOGIES OFFER NEW PERSPECTIVES FOR BIOMEDICAL, AGRONOMICAL AND EVOLUTIONARY RESEARCH. PROMISING PROGRESSES NOW CONCERN THE APPLICATION OF THESE TECHNOLOGIES TO LARGE-SCALE STUDIES OF GENETIC VARIATION. SUCH STUDIES REQUIRE THE GENOTYPING OF HIGH NUMBERS OF SAMPLES. THIS IS THEORETICALLY POSSIBLE USING 454 PYROSEQUENCING, WHICH GENERATES BILLIONS OF BASE PAIRS OF SEQUENCE DATA. HOWEVER SEVERAL CHALLENGES ARISE: FIRST IN THE ATTRIBUTION OF EACH READ PRODUCED TO ITS ORIGINAL SAMPLE, AND SECOND, IN BIOINFORMATIC ANALYSES TO DISTINGUISH TRUE FROM ARTIFACTUAL SEQUENCE VARIATION. THIS PILOT STUDY PROPOSES A NEW APPLICATION FOR THE 454 GS FLX PLATFORM, ALLOWING THE INDIVIDUAL GENOTYPING OF THOUSANDS OF SAMPLES IN ONE RUN. A PROBABILISTIC MODEL HAS BEEN DEVELOPED TO DEMONSTRATE THE RELIABILITY OF THIS METHOD. RESULTS: DNA AMPLICONS FROM 1,710 RODENT SAMPLES WERE INDIVIDUALLY BARCODED USING A COMBINATION OF TAGS LOCATED IN FORWARD AND REVERSE PRIMERS. AMPLICONS CONSISTED IN 222 BP FRAGMENTS CORRESPONDING TO DRB EXON 2, A HIGHLY POLYMORPHIC GENE IN MAMMALS. A TOTAL OF 221,789 READS WERE OBTAINED, OF WHICH 153,349 WERE FINALLY ASSIGNED TO ORIGINAL SAMPLES. RULES BASED ON A PROBABILISTIC MODEL AND A FOUR-STEP PROCEDURE, WERE DEVELOPED TO VALIDATE SEQUENCES AND PROVIDE A CONFIDENCE LEVEL FOR EACH GENOTYPE. THE METHOD GAVE PROMISING RESULTS, WITH THE GENOTYPING OF DRB EXON 2 SEQUENCES FOR 1,407 SAMPLES FROM 24 DIFFERENT RODENT SPECIES AND THE SEQUENCING OF 392 VARIANTS IN ONE HALF OF A 454 RUN. USING REPLICATES, WE ESTIMATED THAT THE REPRODUCIBILITY OF GENOTYPING REACHED 95\%. CONCLUSIONS: THIS NEW APPROACH IS A PROMISING ALTERNATIVE TO CLASSICAL METHODS INVOLVING ELECTROPHORESIS-BASED TECHNIQUES FOR VARIANT SEPARATION AND CLONING-SEQUENCING FOR SEQUENCE DETERMINATION. THE 454 SYSTEM IS LESS COSTLY AND TIME CONSUMING AND MAY ENHANCE THE RELIABILITY OF GENOTYPES OBTAINED WHEN HIGH NUMBERS OF SAMPLES ARE STUDIED. IT OPENS UP NEW PERSPECTIVES FOR THE STUDY OF EVOLUTIONARY AND FUNCTIONAL GENETICS OF HIGHLY POLYMORPHIC GENES LIKE MAJOR HISTOCOMPATIBILITY COMPLEX GENES IN VERTEBRATES OR LOCI REGULATING SELF-COMPATIBILITY IN PLANTS. IMPORTANT APPLICATIONS IN BIOMEDICAL RESEARCH WILL INCLUDE THE DETECTION OF INDIVIDUAL VARIATION IN DISEASE SUSCEPTIBILITY. SIMILARLY, AGRONOMY WILL BENEFIT FROM THIS APPROACH, THROUGH THE STUDY OF GENES IMPLICATED IN PRODUCTIVITY OR DISEASE SUSCEPTIBILITY TRAITS.",NA,"HISTOCOMPATIBILITY COMPLEX LOCI; PLANT SELF-INCOMPATIBILITY; CLASS-II POLYMORPHISM; PRIMERS PCR-SSP; BALANCING SELECTION; DIVERSIFYING SELECTION; EVOLUTIONARY GENETICS; POPULATION-GENETICS; ALLELIC DIVERSITY; SEX-DETERMINATION","ENGLISH","ARTICLE","ARTICLE",125,"AXTNER J, 2007, IMMUNOGENETICS, V59, P417, DOI 10.1007/S00251-007-0205-Y.;BABIK W, 2009, MOL ECOL RESOUR, V9, P713, DOI 10.1111/J.1755-0998.2009.02622.X.;BIERNE N, 2007, MOL ECOL NOTES, V7, P562, DOI 10.1111/J.1471-8286.2007.01685.X.;BINLADEN J, 2007, PLOS ONE, V2, DOI 10.1371/JOURNAL.PONE.0000197.;BLAIS C, 2009, PLOS ONE, V4, DOI 10.1371/JOURNAL.PONE.0006448.;BORDONI R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-464.;BRYJA J, 2007, MOL ECOL, V16, P5084, DOI 10.1111/J.1365-294X.2007.03584.X.;BRYJA J, 2006, IMMUNOGENETICS, V58, P191, DOI 10.1007/S00251-006-0085-6.;BRYJA J, 2005, MOL ECOL NOTES, V5, P273.;BUNCE M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/J.1399-0039.1995.TB03127.X.;BUSS LW, 1990, TRENDS ECOL EVOL, V5, P352, DOI 10.1016/0169-5347(90)90093-S.;CHARLESWORTH B, 1993, GENETICS, V134, P1289.;CHARLESWORTH D, 1998, HEREDITY, V81, P1, DOI 10.1038/SJ.HDY.6884000.;CHARLESWORTH D, 2004, CURR BIOL, V14, PR568, DOI 10.1016/J.CUB.2004.07.014.;CHO SC, 2006, GENOME RES, V16, P1366, DOI 10.1101/GR.4695306.;DE BELLOCQ JG, 2008, J EVOLUTION BIOL, V21, P1144, DOI 10.1111/J.1420-9101.2008.01538.X.;DE BELLOCQ JG, 2005, GLOBAL ECOL BIOGEOGR, V14, P115, DOI 10.1111/J.1466-822X.2005.00143.X.;EDWARDS SV, 1997, GENETICS, V146, P655.;EIZAGUIRRE C, 2009, ECOL LETT, V12, P5, DOI 10.1111/J.1461-0248.2008.01247.X.;ELLEGREN H, 2008, MOL ECOL, V17, P1629, DOI 10.1111/J.1365-294X.2008.03699.X.;ELLIS SA, 1998, EUR J IMMUNOGENET, V25, P365, DOI 10.1046/J.1365-2370.1998.00112.X.;FU YX, 1993, GENETICS, V133, P693.;GARRIGAN D, 2001, IMMUNOGENETICS, V53, P483, DOI 10.1007/S002510100352.;HARF R, 2005, MOL ECOL, V14, P85, DOI 10.1111/J.1365-294X.2004.02402.X.;HOELZEL AR, 1999, MOL BIOL EVOL, V16, P611, DOI 10.1093/OXFORDJOURNALS.MOLBEV.A026143.;HUGHES AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/ANNUREV.GENET.32.1.415.;HUSE SM, 2007, GENOME BIOL, V8, DOI 10.1186/GB-2007-8-7-R143.;JONES JDG, 2001, CURR OPIN PLANT BIOL, V4, P281, DOI 10.1016/S1369-5266(00)00174-6.;KENNEDY LJ, 2002, IMMUNOGENETICS, V54, P348, DOI 10.1007/S00251-002-0465-5.;KLEIN J, 1987, HUM IMMUNOL, V19, P155, DOI 10.1016/0198-8859(87)90066-8.;KLEIN J, 2007, ANNU REV GENET, V41, P281, DOI 10.1146/ANNUREV.GENET.41.110306.130137.;LENZ TL, 2008, GENE, V427, P117, DOI 10.1016/J.GENE.2008.09.013.;LIU ZY, 2005, MOL BIOL EVOL, V22, P659, DOI 10.1093/MOLBEV/MSI049.;LOISEAU C, 2009, MOL ECOL, V18, P1331, DOI 10.1111/J.1365-294X.2009.04105.X.;MARGULIES M, 2005, NATURE, V437, P376, DOI 10.1038/NATURE03959.;MCCUBBIN AG, 1996, CURR OPIN BIOTECH, V7, P150, DOI 10.1016/S0958-1669(96)80005-X.;MEYER M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/NAR/GKM566.;MEYER M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/NPROT.2007.520.;MUSOLF K, 2004, IMMUNOGENETICS, V56, P420, DOI 10.1007/S00251-004-0715-9.;NASRALLAH JB, 2005, TRENDS IMMUNOL, V26, P412, DOI 10.1016/J.IT.2005.06.005.;OBBARD DJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-274.;OLIVER MK, 2006, IMMUNOGENETICS, V58, P390, DOI 10.1007/S00251-006-0121-6.;PARAMESWARAN P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/NAR/GKM760.;ROBINSON J, 2009, NUCLEIC ACIDS RES, V37, PD1013, DOI 10.1093/NAR/GKN662.;SCHAD J, 2004, CONSERV GENET, V5, P299, DOI 10.1023/B:COGE.0000031137.50239.D3.;SHENDURE J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/NBT1486.;SUSSKIND B, 2007, CURR OPIN ORGAN TRAN, V12, P393, DOI 10.1097/MOT.0B013E32825EABFD.;TAKAHATA N, 1992, GENETICS, V130, P925.;TAMURA K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/MOLBEV/MSM092.;WEGNER KM, 2009, MOL ECOL, V18, P1818, DOI 10.1111/J.1365-294X.2009.04173.X.;WEI HF, 2007, HUM IMMUNOL, V68, P135, DOI 10.1016/J.HUMIMM.2006.10.010.;WU J, 1998, P NATL ACAD SCI USA, V95, P12398, DOI 10.1073/PNAS.95.21.12398.;ZHOU L, 2004, TISSUE ANTIGENS, V64, P156, DOI 10.1111/J.1399-0039.2004.00248.X.","GALAN, M (REPRINT AUTHOR), INRA IRD CIRAD MONTPELLIER SUPAGRO, UMR CBGP, INRA EFPA, CAMPUS INT BAILLARGUET,CS 30016, F-34988 MONTFERRIER SUR LEZ, FRANCE.;GALAN, MAXIME, GUIVIER, EMMANUEL, CHARBONNEL, NATHALIE, COSSON, JEAN-FRANCOIS, INRA IRD CIRAD MONTPELLIER SUPAGRO, UMR CBGP, INRA EFPA, F-34988 MONTFERRIER SUR LEZ, FRANCE.;CARAUX, GILLES, UNIV MONTPELLIER 2, UMR5506, CNRS, LIRMM, F-34095 MONTPELLIER 5, FRANCE.;CARAUX, GILLES, MONTPELLIER SUPAGRO, F-34060 MONTPELLIER, FRANCE.","10.1186/1471-2164-11-296","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","296",NA,"INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE, FRENCH NATIONAL AGENCY FOR RESEARCH [00121 0505, 07 BDIV 012], EDEN [GOCE-CT-2003-010284], MNRT (MINISTERE DE L'EDUCATION NATIONALE, DE LA RECHERCHE ET DE LA TECHNOLOGIE)","WE THANK S MORAND AND JP HUGOT FOR MANAGING RESEARCH PROJECTS IN ASIA, H HENTONNEN FOR RESEARCH PROJECTS IN EUROPE, AND Y CHAVAL FOR HELP IN FIELD WORK. JF MARTIN AND N BIERNE PROVIDED HELPFUL COMMENTS ON LABORATORY PROTOCOLS, J SERRET HELPED IN SOME LABORATORY EXPERIMENTS AND E MEGLECZ HELPED FOR BIOINFORMATICS. R STREIFF GAVE CONSTRUCTIVE COMMENTS ON EARLY DRAFTS AND L MANSO-SILVAN IMPROVED THE STYLE OF WRITTEN ENGLISH. THIS WORK WAS SUPPORTED BY THE INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE [PROJET INNOVANT DU DEPARTEMENT EFPA 2008], THE FRENCH NATIONAL AGENCY FOR RESEARCH PROJECT CEROPATH [00121 0505, 07 BDIV 012] AND THE EUROPEAN PROJECT EDEN [GOCE-CT-2003-010284]. E GUIVIER WAS FUNDED BY A MNRT (MINISTERE DE L'EDUCATION NATIONALE, DE LA RECHERCHE ET DE LA TECHNOLOGIE) PHD GRANT. THE MANUSCRIPT IS CATALOGUED BY THE EDEN STEERING COMMITTEE AS EDEN0171 HTTP://WWW.EDEN-FP6PROJECT.NET.",NA,"1471-2164",NA,NA,"BIOMED CENTRAL LTD","11",2010,"ISI000278374300001","53","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","28","BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY","GALANSUPAGRO.INRA.FR",NA,"605VE",NA,"GALAN, M (REPRINT AUTHOR), INRA IRD CIRAD MONTPELLIER SUPAGRO, UMR CBGP, INRA EFPA, CAMPUS INT BAILLARGUET,CS 30016, F-34988 MONTFERRIER SUR LEZ, FRANCE","ISI","FRANCE.","NOTREPORTED",NA,"GALAN M, 2010, BMC GENOMICS","GALAN M, 2010, BMC GENOMICS"
"ONIONS D, 2010, BIOLOGICALS","ONIONS D;KOLMAN J","MASSIVELY PARALLEL SEQUENCING, A NEW METHOD FOR DETECTING ADVENTITIOUS AGENTS","BIOLOGICALS","BIOLOGICALS","THERE HAS BEEN AN UPSURGE OF INTEREST IN DEVELOPING NEW VETERINARY AND HUMAN VACCINES AND, IN TURN, THIS HAS INVOLVED THE DEVELOPMENT OF NEW MAMMALIAN AND INSECT CELL SUBSTRATES. EXCLUDING ADVENTITIOUS AGENTS FROM THESE CELLS CAN BE PROBLEMATIC, PARTICULARLY FOR CELLS DERIVED FROM SPECIES WITH LIMITED VIROLOGICAL INVESTIGATION. MASSIVELY PARALLEL SEQUENCING IS A POWERFUL NEW METHOD FOR THE IDENTIFICATION OF VIRUSES AND OTHER ADVENTITIOUS AGENTS, WITHOUT PRIOR KNOWLEDGE OF THE NATURE OF THE AGENT. WE HAVE DEVELOPED METHODS USING RANDOM PRIMING TO DETECT VIRUSES IN THE SUPERNATANTS FROM CELL SUBSTRATES OR IN VIRUS SEED STOCKS. USING THESE METHODS WE HAVE RECENTLY DISCOVERED A NEW PARVOVIRUS IN BOVINE SERUM. WHEN APPLIED TO SEQUENCING THE TRANSCRIPTOME, MASSIVELY PARALLEL SEQUENCING CAN REVEAL LATENT OR SILENT INFECTIONS. ENORMOUS AMOUNTS OF DATA ARE DEVELOPED IN THIS PROCESS USUALLY BETWEEN 100 AND 400 MBP. CONSEQUENTLY, SOPHISTICATED BIOINFORMATIC ALGORITHMS ARE REQUIRED TO ANALYSE AND VERIFY VIRUS TARGETS. (C) 2010 PUBLISHED BY ELSEVIER LTD ON BEHALF OF THE INTERNATIONAL ASSOCIATION FOR BIOLOGICALS.","MASSIVELY PARALLEL SEQUENCING; ROCHE 454; VACCINE; ADVENTITIOUS VIRUS; PARVOVIRUS; BOVINE SERUM","PESTIVIRUS; GENOME; VIRUS; CYTOPATHOGENICITY; IDENTIFICATION; INSERTION","ENGLISH","ARTICLE","ARTICLE",24,"ALLANDER T, 2005, P NATL ACAD SCI USA, V102, P15712, DOI 10.1073/PNAS.0508068102.;ALLANDER T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/PNAS.211424698.;ALLANDER T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07.;BECHER P, 1998, J VIROL, V72, P8697.;BECHER P, 2002, J VIROL, V76, P13069, DOI 10.1128/JVI.76.24.13069-13076.2002.;FENG H, 2008, SCIENCE, V319, P1049.;FENG HC, 2007, J VIROL, V81, P11332, DOI 10.1128/JVI.00875-07.;GALLEI A, 2004, J VIROL, V78, P6271, DOI 10.1128/JVI.78.12.6271-6281.2004.;GAYNOR AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/JOURNAL.PPAT.0030064.;JOHNSTON JB, 2003, J VIROL, V77, P6093, DOI 10.1128/JVI.77.11.6093-6100.2003.;KURTH R, 2010, INT J CANCER, V126, P306, DOI 10.1002/IJC.24902.;MEYERS G, 1998, J VIROL, V72, P4139.;MEYERS G, 1996, ADV VIRUS RES, V47, P53, DOI 10.1016/S0065-3527(08)60734-4.;PALACIOS G, 2008, NEW ENGL J MED, V358, P988.;QI FX, 1998, VIRUS RES, V57, P1, DOI 10.1016/S0168-1702(98)00073-2.","ONIONS, D (REPRINT AUTHOR), BIORELIANCE, TODD CAMPUS,W SCOTLAND SCI PK,MARYHILL RD, GLASGOW G20 0XA, LANARK, SCOTLAND.;ONIONS, DAVID, BIORELIANCE, GLASGOW G20 0XA, LANARK, SCOTLAND.;KOLMAN, JOHN, BIORELIANCE, ROCKVILLE, MD 20850 USA.","10.1016/J.BIOLOGICALS.2010.01.003","24-28 OVAL RD, LONDON NW1 7DX, ENGLAND",NA,NA,NA,NA,NA,"1045-1056","3","377-380","ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD","38",2010,"ISI000278793600014","15","BIOCHEMISTRY \& MOLECULAR BIOLOGY, BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, PHARMACOLOGY \& PHARMACY","1","BIOCHEMICAL RESEARCH METHODS, BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, PHARMACOLOGY \& PHARMACY","DAVID.ONIONSBIORELIANCE.COM JOHN.KOLMANBIORELIANCE.COM",NA,"611EH",NA,"ONIONS, D (REPRINT AUTHOR), BIORELIANCE, TODD CAMPUS,W SCOTLAND SCI PK,MARYHILL RD, GLASGOW G20 0XA, LANARK, SCOTLAND","ISI","NOTREPORTED","W SCOTLAND SCI PK",NA,"ONIONS D, 2010, BIOLOGICALS","ONIONS D, 2010, BIOLOGICALS"
"LU L, 2010, VIROL J","LU L;CHENG A;WANG M;JIANG J;ZHU D;JIA R;LUO Q;LIU F;CHEN Z;CHEN X;YANG J","POLYCLONAL ANTIBODY AGAINST THE DPV UL46M PROTEIN CAN BE A DIAGNOSTIC CANDIDATE","VIROLOGY JOURNAL","VIROL. J.","BACKGROUND: THE DUCK PLAGUE VIRUS (DPV) UL46 PROTEIN (VP11/12) IS A 739-AMINO ACID TEGUMENT PROTEIN ENCODED BY THE UL46 GENE. WE ANALYZED THE AMINO ACID SEQUENCE OF UL46 USING BIOINFORMATICS TOOLS AND DEFINED THE MAIN ANTIGENIC DOMAINS TO BE BETWEEN NUCLEOTIDES 700-2,220 IN THE UL46 SEQUENCE. THIS REGION WAS DESIGNATED UL46M. THE DPV UL46 AND UL46M GENES WERE BOTH EXPRESSED IN ESCHERICHIA COLI ROSETTA (DE3) INDUCED BY ISOPROPY 1-BETA-D-THIOGALACTOPYRANOSIDE (IPTG) FOLLOWING POLYMERASE CHAIN REACTION (PCR) AMPLIFICATION AND SUBCLONING INTO THE PROKARYOTIC EXPRESSION VECTOR PET32A(+). THE RECOMBINANT PROTEINS WERE PURIFIED USING A NI-NTA SPIN COLUMN AND USED TO GENERATE THE POLYCLONAL ANTIBODY AGAINST UL46 AND UL46M IN NEW ZEALAND WHITE RABBITS. THE TITER WAS THEN TESTED USING ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) AND AGAR DIFFUSION REACTION, AND THE SPECIFICITY WAS TESTED BY WESTERN BLOT ANALYSIS. SUBSEQUENTLY, WE ESTABLISHED DOT-ELISA USING THE POLYCLONAL ANTIBODY AND APPLIED IT TO DPV DETECTION. RESULTS: IN OUR STUDY, THE DPV UL46M FUSION PROTEIN, WITH A RELATIVE MOLECULAR MASS OF 79 KDA, WAS EXPRESSED IN E. COLI ROSETTA (DE3). EXPRESSION OF THE FULL UL46 GENE FAILED, WHICH WAS CONSISTENT WITH THE RESULTS FROM THE BIOINFORMATIC ANALYSIS. THE EXPRESSED PRODUCT WAS DIRECTLY PURIFIED USING NI-NTA SPIN COLUMN TO PREPARE THE POLYCLONAL ANTIBODY AGAINST UL46M. THE TITER OF THE ANTI-UL46M ANTISERA WAS OVER 1: 819,200 AS DETERMINED BY ELISA AND 1: 8 BY AGAR DIFFUSION REACTION. DOT-ELISA WAS USED TO DETECT DPV USING A 1: 60 DILUTION OF ANTI-UL46M IGG AND A 1: 5,000 DILUTION OF HORSERADISH PEROXIDASE (HRP)-LABELED GOAT ANTI-RABBIT IGG. CONCLUSIONS: THE ANTI-UL46M POLYCLONAL ANTIBODY REPORTED HERE SPECIFICALLY IDENTIFIES DPV, AND THEREFORE, IT IS A PROMISING DIAGNOSTIC TOOL FOR DPV DETECTION IN ANIMALS. UL46M AND THE ANTI-UL46M ANTIBODY CAN BE USED FOR FURTHER CLINICAL EXAMINATION AND RESEARCH OF DPV.",NA,"DUCK ENTERITIS VIRUS; DNA-SEQUENCE; EXPRESSION; PLAGUE; GENOME; TYPE-1","ENGLISH","ARTICLE","ARTICLE",9,"BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207A0.;BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/ABIO.1976.9999.;CAI MS, 2009, INTERVIROLOGY, V52, P141, DOI 10.1159/000221833.;CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125.;[ CHENG ANCHUN], 2006, [, HIGH TECHNOLOGY LETTERS], V16, P948.;CHENG QM, 2005, J EUR CERAM SOC, V25, P233, DOI 10.1016/J.JEURCERAMSOC.2004.08.005.;FAUQUET C., 2005, VIRUS TAXONOMY 8 REP.;FUCHS W, 2003, J VIROL, V77, P12891, DOI 10.1128/JVI.77.23.12891-12900.2003.;GARDNER R, 1993, INTERVIROLOGY, V36, P99, DOI 10.1159/000150328.;HANSEN WR, 2000, AVIAN DIS, V44, P266, DOI 10.2307/1592539.;HONESS RW, 1974, J VIROL, V14, P8.;HU YX, 2002, CELL RES, V12, P157, DOI 10.1038/SJ.CR.7290122.;JIA REN-YONG, 2007, CHINESE JOURNAL OF VIROLOGY, V23, P202.;KALETA EF, 1990, AVIAN PATHOL, V19, P193, DOI 10.1080/03079459008418673.;KATO K, 2000, ARCH VIROL, V145, P2149, DOI 10.1007/S007050070045.;MCGEOCH DJ, 1988, J GEN VIROL, V69, P1531, DOI 10.1099/0022-1317-69-7-1531.;QI XF, 2008, AVIAN DIS, V52, P338, DOI 10.1637/8120-100207-RESNOTE.1.;SAMBROOK J, 2003, MOL CLONING LAB MANU, P27.;SANDHU TS, 2003, DIS POULTRY, P354.;SHAWKY S, 2002, AVIAN DIS, V46, P308, DOI 10.1637/0005-2086(2002)046[0308:LSAROD]2.0.CO,2.;WALKER JM, 1996, PROTEIN PROTOCOLS HD, P11.;YUAN GP, 2005, AVIAN DIS, V49, P50, DOI 10.1637/7237-071004R.;[ YUAN GUIPING], 2005, [, ACTA VETERINARIA ET ZOOTECHNICA SINICA], V36, P486.;ZHANG YZ, 1993, J VIROL, V67, P1482.","CHENG, AC (REPRINT AUTHOR), SICHUAN AGR UNIV, COLL VET MED, AVIAN DIS RES CTR, YAAN, SICHUAN, PEOPLES R CHINA.;LU, LITING, CHENG, ANCHUN, WANG, MINGSHU, JIANG, JINFENG, ZHU, DEKANG, CHEN, XIAOYUE, SICHUAN AGR UNIV, COLL VET MED, AVIAN DIS RES CTR, YAAN, SICHUAN, PEOPLES R CHINA.;CHENG, ANCHUN, WANG, MINGSHU, ZHU, DEKANG, JIA, RENYONG, LUO, QIHUI, LIU, FEI, CHEN, ZHENGLI, CHEN, XIAOYUE, YANG, JINLONG, KEY LAB ANIM DIS \& HUMAN HLTH SICHUAN PROV, YAAN, SICHUAN, PEOPLES R CHINA.;CHENG, ANCHUN, CHEN, XIAOYUE, SICHUAN AGR UNIV, EPIZOOT DIS INST, YAAN 625014, SICHUAN, PEOPLES R CHINA.;YANG, JINLONG, CHONGQING ACAD ANIM SCI, CHONGQING 402460, PEOPLES R CHINA.","10.1186/1743-422X-7-83","236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND","83",NA,"CHANGJIANG SCHOLARS AND INNOVATIVE RESEARCH TEAM IN UNIVERSITY [PCSIRT0848], MODERN AGRO-INDUSTRY TECHNOLOGY RESEARCH SYSTEM [NYCYTX-45-12]","THE RESEARCH WAS SUPPORTED BY CHANGJIANG SCHOLARS AND INNOVATIVE RESEARCH TEAM IN UNIVERSITY (PCSIRT0848) AND THE EARMARKED FUND FOR MODERN AGRO-INDUSTRY TECHNOLOGY RESEARCH SYSTEM (NYCYTX-45-12).",NA,"1743-422X",NA,NA,"BIOMED CENTRAL LTD","7",2010,"ISI000278335700001","24","VIROLOGY","1","VIROLOGY","CHENGANCHUNVIP.163.COM MSHWANG163.COM",NA,"605GL",NA,"CHENG, AC (REPRINT AUTHOR), SICHUAN AGR UNIV, COLL VET MED, AVIAN DIS RES CTR, YAAN, SICHUAN, PEOPLES R CHINA","ISI","SICHUAN AGR UNIV;KEY LAB ANIM DIS AND HUMAN HLTH SICHUAN PROV;SICHUAN AGR UNIV;CHONGQING ACAD ANIM SCI","SICHUAN AGR UNIV",NA,"LU L, 2010, VIROL J","LU L, 2010, VIROL J"
"BEGLEY M, 2010, ANNU REV FOOD SCI TECHNOL","BEGLEY M;HILL C","FOOD SAFETY: WHAT CAN WE LEARN FROM GENOMICS?","ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 1","ANNU. REV. FOOD SCI. TECHNOL.","THE ENTIRE GENOME SEQUENCES OF NUMEROUS FOODBORNE PATHOGENS HAVE BEEN DETERMINED, AND GENOME SEQUENCING PROJECTS OF MANY OTHERS ARE CURRENTLY UNCLES-WAY. THE RESULTING SEQUENCE INFORMATION WILL PERMIT DETAILED BIOINFORMATIC ANALYSES AND PROVIDE DIRECTION FOR SUBSEQUENT FUNCTIONAL ANALYSES. GENOMICS-DRIVEN STUDIES WILL HAVE MANY APPLICATIONS IN FOOD SAFETY, SUCH AS ASSISTING WITH THE DEVELOPMENT OF TOOLS FOR THE RAPID DETECTION AND IDENTIFICATION OF PATHOGENS AND HELPING TO PROVIDE INSIGHTS INTO THEIR EVOLUTION, BIOLOGY, AND ECOLOGICAL FITNESS. THESE STUDIES WILL ALSO AID IN ELUCIDATING THE MECHANISMS EMPLOYED BY PATHOGENS AS THEY ADAPT TO THE VARIETY OF CONDITIONS ENCOUNTERED THROUGHOUT THEIR LIFE CYCLE, FROM THE FOOD-PROCESSING ENVIRONMENT TO IN VIVO DURING INFECTION. IT IS ANTICIPATED THAT GENOMICS WILL AID IN THE DEVELOPMENT OF NOVEL PREVENTATIVE AND CONTROL STRATEGIES, WHICH IN TURN WILL ULTIMATELY LEAD TO A SAFER FOOD SUPPLY.","FOOD PATHOGEN; COMPARATIVE GENOMICS; FUNCTIONAL GENOMICS; VIRULENCE; STRESS RESPONSES","LISTERIA-MONOCYTOGENES STRAINS; ESCHERICHIA-COLI O157-H7; GRAM-POSITIVE BACTERIA; TANDEM-REPEAT ANALYSIS; SIGMA-FACTOR SIGMA(B); BILE-SALT HYDROLASE; CEREUS ATCC 14579; BACILLUS-CEREUS; GENE-EXPRESSION; SALMONELLA-ENTERICA","ENGLISH","REVIEW, BOOK CHAPTER","INCOLLECTION",7,"ABEE T, 2004, TRENDS BIOTECHNOL, V22, P653, DOI 10.1016/J.TIBTECH.2004.10.007.;ABRAM F, 2008, APPL ENVIRON MICROB, V74, P6848, DOI 10.1128/AEM.00442-08.;ABRAM F, 2008, APPL ENVIRON MICROB, V74, P594, DOI 10.1128/AEM.01921-07.;ALLEN KJ, 2008, FOODBORNE PATHOG DIS, V5, P437, DOI 10.1089/FPD.2008.0100.;AMINI S, 2009, PLOS PATHOG, V5, DOI 10.1371/JOURNAL.PPAT.1000432.;ANDERSEN JB, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-55.;ATTILA C, 2009, APPL MICROBIOL BIOT, V82, P525, DOI 10.1007/S00253-009-1860-8.;BANSAL AK, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-19.;BECKER LA, 1998, J BACTERIOL, V180, P4547.;BEGLEY M, 2006, APPL ENVIRON MICROB, V72, P2231, DOI 10.1128/AEM.72.3.2231-2234.2006.;BEGLEY M, 2005, INFECT IMMUN, V73, P894, DOI 10.1128/IAI.73.2.894-904.2005.;BEGLEY M, 2004, FEBS LETT, V561, P99, DOI 10.1016/S0014-5793(04)00131-0.;BEGLEY M, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-11.;BEGLEY M, 2009, APPL ENVIRON MICROB, V75, P5451, DOI 10.1128/AEM.00730-09.;BEGLEY M, 2008, INFECT IMMUN, V76, P5392, DOI 10.1128/IAI.01376-07.;BEUCHAT LR, 2009, INT J FOOD MICROBIOL, V136, P204, DOI 10.1016/J.IJFOODMICRO.2009.02.029.;BHAGWAT AA, 2008, FOODBORNE PATHOG DIS, V5, P487, DOI [10.1089/FPD.2008.0117, 10.1089/FPD.08.0117].;BINNEWIES TIM T., 2006, FUNCTIONAL \& INTEGRATIVE GENOMICS, V6, P165, DOI 10.1007/S10142-006-0027-2.;BORUCKI MK, 2003, VET MICROBIOL, V92, P351, DOI 10.1016/S0378-1135(02)00423-6.;BOWMAN JP, 2008, MICROBIOL-SGM, V154, P462, DOI 10.1099/MIC.0.2007/010314-0.;BRUL S, 2006, INT J FOOD MICROBIOL, V112, P195, DOI 10.1016/J.IJFOODMICRO.2006.04.014.;BRUL S, 2002, TRENDS FOOD SCI TECH, V13, P325, DOI 10.1016/S0924-2244(02)00161-9.;BRUL S, 2002, INT J FOOD MICROBIOL, V79, P55, DOI 10.1016/S0168-1605(02)00179-4.;BRUL S, 2008, INT J FOOD MICROBIOL, V128, P16, DOI 10.1016/J.IJFOODMICRO.2008.04.029.;BUCHREISER C, 2003, FEMS IMMUNOL MED MIC, V35, P201.;BUDDE I, 2006, MICROBIOL-SGM, V152, P831, DOI 10.1099/MIC.0.28530-0.;BURRACK LS, 2007, CURR OPIN MICROBIOL, V10, P4, DOI 10.1016/J.MIB.2006.11.004.;CALL DR, 2005, CRIT REV MICROBIOL, V31, P91, DOI 10.1080/10408410590921736.;CALL DR, 2003, J CLIN MICROBIOL, V41, P632, DOI 10.1128/JCM.41.2.632-639.2003.;CAMEJO A, 2009, PLOS PATHOG, V5, DOI 10.1371/JOURNAL.PPAT.1000449.;CEBRIAN G, 2009, J APPL MICROBIOL, V107, P187, DOI 10.1111/J.1365-2672.2009.04194.X.;CHAN YC, 2007, APPL ENVIRON MICROB, V73, P6484, DOI 10.1128/AEM.00897-07.;CHATTERJEE SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006.;COTTER PD, 2008, PLOS PATHOG, V4, DOI 10.1371/JOURNAL.PPAT.1000144.;COTTER PD, 2005, APPL ENVIRON MICROB, V71, P2832, DOI 10.1128/AEM.71.6.2832-2839.2005.;COTTER PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/NRMICRO1240.;DE JONG A, 2006, NUCLEIC ACIDS RES, V34, PW273, DOI 10.1093/NAR/GKL237.;DEN BESTEN HMW, 2009, APPL ENVIRON MICROB, V75, P4111, DOI 10.1128/AEM.02891-08.;DEVOS WM, 2001, CURR OPIN BIOTECH, V12, P483.;DODD CER, 2002, INT J FOOD MICROBIOL, V74, P189, DOI 10.1016/S0168-1605(01)00679-1.;DONG T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349.;DOUMITH M, 2005, J FOOD PROTECT, V68, P2648, DOI 10.4315/0362-028X-68.12.2648.;DOUMITH M, 2004, INFECT IMMUN, V72, P1072, DOI 10.1128/IAI.72.2.1072-1083.2004.;DOUMITH M, 2004, J CLIN MICROBIOL, V42, P3819, DOI [10.1128/JCM.42.8.3819-3822.2004, 10.1128/JCM.42.3819-3822.2004].;DUSSURGET O, 2002, MOL MICROBIOL, V45, P1095, DOI 10.1046/J.1365-2958.2002.03080.X.;FRASER-LIGGETT CM, 2005, GENOME RES, V15, P1603, DOI 10.1101/GR.3724205.;FRATAMICO PM, 2008, FOODBORNE PATHOG DIS, V5, P5369.;GALVEZ A, 2008, CRIT REV BIOTECHNOL, V28, P125, DOI [10.1080/07388550802107202, 10.1080/07388550802107202 ].;GALVEZ A, 2007, INT J FOOD MICROBIOL, V120, P51, DOI 10.1016/J.IJFOODMICRO.2007.06.001.;GARNER MR, 2006, INFECT IMMUN, V74, P876, DOI 10.1128/IAI.74.2.876-886.2006.;GIANNINO ML, 2009, J MICROBIOL METH, V78, P181, DOI 10.1016/J.MIMET.2009.05.015.;GILBRETH SE, 2005, APPL ENVIRON MICROB, V71, P8115, DOI 10.1128/AEM.71.12.8115-8122.2005.;GILOT P, 1996, J CLIN MICROBIOL, V34, P1007.;GIOTIS ES, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-102.;GLASER P, 2001, SCIENCE, V294, P849, DOI 10.1126/SCIENCE.1063447.;HAIN T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-20.;HAIN T, 2007, INT J MED MICROBIOL, V297, P541, DOI 10.1016/J.IJMM.2007.03.016.;HALL-STOODLEY L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/NRMICRO821.;HALL-STOODLEY L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/J.TIM.2004.11.004.;HAMON M, 2006, NATURE REV MICROBIOL, V4, P424.;HAN CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006.;HAYASHI T, 2001, DNA RES, V8, P11, DOI 10.1093/DNARES/8.1.11.;HENGGE R, 2008, ADV EXP MED BIOL, V631, P40, DOI 10.1007/978-0-387-78885-2\_4.;HILL C, 2002, INT DAIRY J, V12, P273, DOI 10.1016/S0958-6946(01)00125-X.;HOFFMASTER AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/PNAS.0402414101.;HU Y, 2007, APPL ENVIRON MICROB, V73, P7967, DOI 10.1128/AEM.01085-07.;HU Y, 2007, APPL ENVIRON MICROB, V73, P7981, DOI 10.1128/AEM.01281-07.;IVANOVA N, 2003, NATURE, V423, P97.;JEFFERSON KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/J.FEMSLE.2004.06.005.;JOSEPH B, 2006, J BACTERIOL, V188, P556, DOI 10.1128/JB.188.2.556-568.2006.;KAZMIERCZAK MJ, 2003, J BACTERIOL, V185, P5722, DOI 10.1128/JB.185.19.5722-5734.2003.;KIM HJ, 2008, BIOSENS BIOELECTRON, V24, P238, DOI 10.1016/J.BIOS.2008.03.019.;KLAUCK EBERHARD, 2007, SCIENCE PROGRESS, V90, P103, DOI 10.3184/003685007X215922.;KUIPERS OP, 1999, CURR OPIN BIOTECH, V10, P511, DOI 10.1016/S0958-1669(99)00019-1.;KUMAR CG, 1998, INT J FOOD MICROBIOL, V42, P9, DOI 10.1016/S0168-1605(98)00060-9.;LAURI A, 2009, GENES NUTR, V4, P1, DOI 10.1007/S12263-008-0106-1.;LEISTNER L, 2000, INT J FOOD MICROBIOL, V55, P181, DOI 10.1016/S0168-1605(00)00161-6.;LI WJ, 2009, FEMS MICROBIOL REV, V33, P892, DOI 10.1111/J.1574-6976.2009.00182.X.;LIPPOLIS JD, 2009, J PROTEOME RES, V8, P149, DOI 10.1021/PR800458V.;LIU DY, 2006, J MED MICROBIOL, V55, P645, DOI 10.1099/JMM.0.46495-0.;LIU YH, 2008, APPL ENVIRON MICROB, V74, P6859, DOI 10.1128/AEM.00356-08.;MACFARLANE S, 2007, J APPL MICROBIOL, V102, P1187, DOI 10.1111/J.1365-2672.2007.03287.X.;MALONE AS, 2006, APPL ENVIRON MICROB, V72, P2661, DOI 10.1128/AEM.72.4.2661-2671.2006.;MANGALAPPALLI-ILLATHU AK, 2008, ANTIMICROB AGENTS CH, V52, P3669, DOI 10.1128/AAC.00073-08.;MCCLELLAND M, 2001, NATURE, V413, P852, DOI 10.1038/35101614.;MEAD PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/EID0505.990502.;MILOHANIC E, 2003, MOL MICROBIOL, V47, P1613, DOI 10.1046/J.1365-2958.2003.03413.X.;MOLS M, 2007, ENVIRON MICROBIOL, V9, P2933, DOI 10.1111/J.1462-2920.2007.01404.X.;MOZOLA MA, 2006, J AOAC INT, V89, P517.;MUJAHID S, 2008, INT J FOOD MICROBIOL, V128, P203, DOI 10.1016/J.IJFOODMICRO.2008.08.007.;MULLANE NR, 2008, APPL ENVIRON MICROB, V74, P1223, DOI 10.1128/AEM.01726-07.;NELSON KE, 2004, NUCLEIC ACIDS RES, V32, P2386, DOI 10.1093/NAR/GKH562.;OLLINGER J, 2009, INFECT IMMUN, V77, P2113, DOI 10.1128/IAI.01205-08.;PANE-FARRE J, 2006, INT J MED MICROBIOL, V296, P237, DOI 10.1016/J.IJMM.2005.11.011.;PARKHILL J, 2000, NATURE, V403, P665, DOI 10.1038/35001088.;PERNA NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089.;PFEILER EA, 2007, TRENDS MICROBIOL, V15, P546, DOI 10.1016/J.TIM.2007.09.010.;POOLE K, 2002, J APPL MICROBIOL, V92, P55S, DOI 10.1046/J.1365-2672.92.5S1.8.X.;POOLE K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262.;PUTTAMREDDY S, 2008, FOODBORNE PATHOG DIS, V5, P517, DOI 10.1089/FPD.2008.0112.;RAENGPRADUB S, 2008, APPL ENVIRON MICROB, V74, P158, DOI 10.1128/AEM.00951-07.;RASKIN DM, 2006, CELL, V124, P703, DOI 10.1016/J.CELL.2006.02.002.;RASKO DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/NAR/GKH258.;RYAN S, 2006, THESIS U COLL CORK.;RYAN S, 2009, ENVIRON MICROBIOL, V11, P432, DOI 10.1111/J.1462-2920.2008.01782.X.;SCARIA J, 2008, MOL CELL PROBE, V22, P238, DOI 10.1016/J.MCP.2008.04.002.;SEBAIHIA M, 2007, GENOME RES, V17, P1082, DOI 10.1101/GR.6282807.;SENN MM, 2005, J BACTERIOL, V187, P8006, DOI 10.1128/JB.187.23.8006-8019.2005.;SEVERINO P, 2007, APPL ENVIRON MICROB, V73, P6078, DOI 10.1128/AEM.02730-06.;SILAGYI K, 2009, FOOD MICROBIOL, V26, P514, DOI 10.1016/J.FM.2009.03.004.;STEIL L, 2003, J BACTERIOL, V185, P6358, DOI [10.1128/JB.185.21.6358-6370.2003, 10.1128/JBA.185.21.6358-6370.2003].;SUE D, 2003, MICROBIOL-SGM, V149, P3247, DOI 10.1099/MIC.0.26526-0.;TANG CM, 2001, ANNU REV GENOM HUM G, V2, P259, DOI 10.1146/ANNUREV.GENOM.2.1.259.;TOLEDO-ARANA A, 2009, NATURE, V459, P950, DOI 10.1038/NATURE08080.;UTTAMCHANDANI M, 2008, TRENDS BIOTECHNOL, V27, P53.;VAN BELKUM A, 2007, FEMS IMMUNOL MED MIC, V49, P22, DOI 10.1111/J.1574-695X.2006.00173.X.;VAN DER VEEN S, 2008, J APPL MICROBIOL, V105, P1246, DOI 10.1111/J.1365-2672.2008.03873.X.;VAN DER VOORT M, 2009, J APPL MICROBIOL, V107, P795, DOI 10.1111/J.1365-2672.2009.04252.X.;VAN SCHAIK W, 2005, CURR OPIN BIOTECH, V16, P218, DOI 10.1016/J.COPBIO.2005.01.008.;VAN SCHAIK W, 2007, J BACTERIOL, V189, P4384, DOI 10.1128/JB.00313-07.;VEENING JW, 2006, J APPL MICROBIOL, V101, P531, DOI 10.1111/J.1365-2672.2006.02911.X.;VOLOKHOV D, 2002, J CLIN MICROBIOL, V40, P4720, DOI 10.1128/JCM.40.12.4720-4728.2002.;WANG XW, 2007, APPL MICROBIOL BIOT, V76, P225, DOI 10.1007/S00253-007-0993-X.;WILLIAMS T, 2005, INFECT IMMUN, V73, P3152, DOI 10.1128/IAI.73.5.3152-3159.2005.;WOOD TK, 2009, ENVIRON MICROBIOL, V11, P1, DOI 10.1111/J.1462-2920.2008.01768.X.;WOODS DF, 2008, J CLIN MICROBIOL, V46, P4018, DOI 10.1128/JCM.01229-08.;YANG K, 2009, J FOOD PROTECT, V72, P990.;YOO SEUNG M, 2008, RECENT PAT BIOTECHNOL, V2, P124, DOI 10.2174/187220808784619711.;ZHOU JH, 2003, CURR OPIN MICROBIOL, V6, P288, DOI 10.1016/S1369-5274(03)00052-3.","BEGLEY, M (REPRINT AUTHOR), NATL UNIV IRELAND UNIV COLL CORK, DEPT MICROBIOL, CORK, IRELAND.;BEGLEY, MAIRE, HILL, COLIN, NATL UNIV IRELAND UNIV COLL CORK, DEPT MICROBIOL, CORK, IRELAND.;HILL, COLIN, NATL UNIV IRELAND UNIV COLL CORK, ALIMENTARY PHARMABIOT CTR, CORK, IRELAND.","10.1146/ANNUREV.FOOD.080708.100739","4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA",NA,"DOYLE, MP AND KLAENHAMMER, TR",NA,NA,"978-0-8243-4901-1","1941-1413",NA,"341-361","ANNUAL REVIEWS","1",2010,"ISI000278069300014","129","FOOD SCIENCE \& TECHNOLOGY","21","FOOD SCIENCE \& TECHNOLOGY","M.BEGLEYUCC.IE C.HILLUCC.IE","ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY","BOY68","ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 1","BEGLEY, M (REPRINT AUTHOR), NATL UNIV IRELAND UNIV COLL CORK, DEPT MICROBIOL, CORK, IRELAND","ISI","NATL UNIV IRELAND UNIV COLL CORK;NATL UNIV IRELAND UNIV COLL CORK","NATL UNIV IRELAND UNIV COLL CORK",NA,"BEGLEY M, 2010, ANNU REV FOOD SCI TECHNOL","BEGLEY M, 2010, ANNU REV FOOD SCI TECHNOL"
